Record_ID,Analysis_Date,Drug_Name,Brand_Name,Therapeutic_Class,NDC_Code,Insurance_Plan_Name,Plan_ID,Contract_Year,Current_Formulary_Tier,Previous_Formulary_Tier,Formulary_Change_Date,Days_Since_Formulary_Change,Tier_Change_Direction,Access_Barriers,Prior_Authorization_Required,Step_Therapy_Required,Quantity_Limit_Monthly,Current_Monthly_Prescriptions,Previous_Monthly_Prescriptions,Utilization_Change_Percent,Utilization_Trend,Current_Patient_Copay,Previous_Patient_Copay,Copay_Change_Amount,Plan_Cost_Per_Prescription,Total_Cost_Per_Prescription,Cost_Per_Member_Per_Month,Prior_Auth_Approval_Rate,Average_Prior_Auth_Days,Prescription_Abandonment_Rate,Switch_to_Alternative_Rate,Generic_Substitution_Rate,Adherence_Rate_Post_Change,Member_Appeals_This_Month,Appeals_Approved,Exception_Requests,Exceptions_Granted,Member_Satisfaction_Score,Market_Share_Percent,Competing_Drugs_Same_Class,Price_Relative_to_Competitors,Geographic_Region,State_Code,Urban_Rural_Classification,Primary_Age_Group,Month_Year,Quarter,Fiscal_Year,Formulary_Risk_Score,Access_Disruption_Probability,Cost_Trend_Projection
FIA001187,2022-01-07,Amoxicillin,Amoxil,Antibiotics,66392-837-29,Medicare Part D Plan B,PLAN_4404,2022,Tier 2,Specialty Tier,2021-10-06,93,Improved,None,No,No,,334,258,29.6,Increased,25.71,138.26,-112.55,63.57,89.28,29.82,0.0,0,0.016,0.237,0.857,0.875,11,5,2,0,3.7,15.5,3,Higher,Midwest,FL,Suburban,51-65,2022-01,Q1_2022,2021,1.1,0.402,Decreasing
FIA001267,2022-01-07,Amoxicillin,Amoxil,Antibiotics,95428-295-89,VA Plan,PLAN_4197,2022,Specialty Tier,Non-Formulary,2021-03-15,298,Improved,Step Therapy,No,Yes,,140,141,-0.4,Stable,110.52,643.23,-532.71,57.72,168.24,23.55,0.0,0,0.216,0.186,0.764,0.846,9,5,8,8,2.3,25.4,6,Higher,Southeast,NC,Suburban,66-75,2022-01,Q1_2022,2021,9.8,0.89,Increasing
FIA001896,2022-01-08,Amoxicillin,Amoxil,Antibiotics,96444-499-97,Tricare Standard,PLAN_4352,2022,Non-Formulary,Non-Formulary,2021-04-05,278,No Change,Non-Formulary Status,No,No,,437,441,-0.8,Stable,554.39,511.89,42.5,151.81,706.2,308.61,0.0,0,0.193,0.338,0.596,0.503,6,6,20,1,4.6,26.1,5,Higher,West,MI,Urban,75+,2022-01,Q1_2022,2021,5.4,0.68,Decreasing
FIA001011,2022-01-10,Amoxicillin,Amoxil,Antibiotics,18841-116-48,Commercial Plan Alpha,PLAN_8975,2022,Non-Formulary,Non-Formulary,2021-07-03,191,No Change,Non-Formulary Status,No,No,,837,877,-4.6,Stable,394.71,439.84,-45.13,163.59,558.3,467.3,0.0,0,0.077,0.323,0.615,0.543,6,5,8,4,2.3,33.7,2,Higher,Northeast,NC,Rural,75+,2022-01,Q1_2022,2021,4.7,0.894,Decreasing
FIA000521,2022-01-13,Amoxicillin,Amoxil,Antibiotics,20372-277-83,Medicaid Plan Y,PLAN_8275,2022,Non-Formulary,Tier 1,2021-10-20,85,Worsened,Non-Formulary Status,No,No,,282,505,-44.1,Decreased,484.75,12.74,472.01,63.3,548.05,154.55,0.0,0,0.19,0.376,0.828,0.912,8,7,4,13,4.4,30.6,7,Similar,Northeast,FL,Rural,18-35,2022-01,Q1_2022,2021,9.3,0.053,Decreasing
FIA001537,2022-01-16,Amoxicillin,Amoxil,Antibiotics,34875-861-23,Medicare Part D Plan B,PLAN_3453,2022,Tier 2,Non-Formulary,2021-07-24,176,Improved,None,No,No,,805,614,31.2,Increased,21.69,286.7,-265.01,125.14,146.83,118.2,0.0,0,0.071,0.278,0.237,0.786,11,8,18,13,3.0,23.4,6,Lower,West,PA,Suburban,18-35,2022-01,Q1_2022,2021,6.3,0.242,Stable
FIA000957,2022-01-17,Amoxicillin,Amoxil,Antibiotics,64141-594-93,Medicare Part D Plan A,PLAN_3046,2022,Tier 2,Tier 3,2021-02-16,335,Improved,None,No,No,,786,509,54.4,Increased,35.66,63.5,-27.84,163.64,199.3,156.65,0.0,0,0.054,0.189,0.465,0.862,15,10,9,1,2.5,31.9,8,Similar,Southeast,NY,Urban,36-50,2022-01,Q1_2022,2021,3.9,0.274,Increasing
FIA002848,2022-01-17,Amoxicillin,Amoxil,Antibiotics,36313-927-15,Medicare Part D Plan A,PLAN_2620,2022,Tier 2,Specialty Tier,2021-06-28,203,Improved,Quantity Limit,No,No,90.0,663,511,29.9,Increased,38.2,186.96,-148.76,171.16,209.36,138.81,0.0,0,0.076,0.119,0.581,0.439,15,2,4,0,4.4,7.6,7,Higher,Southeast,FL,Rural,36-50,2022-01,Q1_2022,2021,1.8,0.066,Increasing
FIA000279,2022-01-28,Amoxicillin,Amoxil,Antibiotics,31383-414-52,Tricare Standard,PLAN_3531,2022,Tier 1,Tier 1,2021-03-27,307,No Change,None,No,No,,755,824,-8.3,Decreased,16.04,10.08,5.96,105.54,121.58,91.79,0.0,0,0.049,0.135,0.58,0.547,3,0,1,3,3.6,8.1,8,Similar,Southeast,CA,Urban,18-35,2022-01,Q1_2022,2021,3.0,0.385,Stable
FIA000618,2022-02-02,Amoxicillin,Amoxil,Antibiotics,10147-252-60,Commercial Plan Alpha,PLAN_1551,2022,Tier 2,Non-Formulary,2021-11-18,76,Improved,None,No,No,,347,241,44.4,Increased,40.66,291.32,-250.66,160.4,201.06,69.77,0.0,0,0.052,0.236,0.551,0.439,8,5,4,14,2.7,32.4,7,Lower,Southwest,PA,Urban,36-50,2022-02,Q1_2022,2021,4.1,0.454,Increasing
FIA001157,2022-02-02,Amoxicillin,Amoxil,Antibiotics,60242-690-99,Commercial Plan Beta,PLAN_3910,2022,Tier 3,Specialty Tier,2021-07-18,199,Improved,None,No,No,,739,701,5.4,Increased,95.01,225.17,-130.16,110.72,205.73,152.03,0.0,0,0.041,0.234,0.369,0.755,1,2,10,9,3.2,30.6,7,Higher,Southwest,MI,Suburban,66-75,2022-02,Q1_2022,2021,7.7,0.445,Stable
FIA002711,2022-02-06,Amoxicillin,Amoxil,Antibiotics,31106-845-92,Medicaid Plan Y,PLAN_4545,2022,Tier 1,Tier 2,2021-04-01,311,Improved,Quantity Limit,No,No,30.0,274,300,-8.6,Decreased,5.31,24.3,-18.99,116.06,121.37,33.26,0.0,0,0.011,0.159,0.48,0.903,9,7,0,5,3.7,24.3,3,Higher,Southeast,OH,Suburban,75+,2022-02,Q1_2022,2021,7.5,0.425,Decreasing
FIA002567,2022-02-11,Amoxicillin,Amoxil,Antibiotics,71794-476-77,Tricare Standard,PLAN_9260,2022,Specialty Tier,Tier 3,2021-12-21,52,Worsened,None,No,No,,262,264,-0.7,Stable,290.38,63.19,227.19,62.81,353.19,92.54,0.0,0,0.099,0.067,0.517,0.645,11,8,7,3,2.6,25.5,2,Lower,West,GA,Rural,51-65,2022-02,Q1_2022,2021,9.6,0.152,Stable
FIA002870,2022-02-25,Amoxicillin,Amoxil,Antibiotics,73952-634-81,Medicaid Plan X,PLAN_4458,2022,Tier 3,Non-Formulary,2021-09-13,165,Improved,Step Therapy,No,Yes,,855,951,-10.0,Decreased,72.77,615.44,-542.67,151.38,224.15,191.65,0.0,0,0.019,0.069,0.899,0.837,10,0,14,6,3.0,14.8,3,Similar,Midwest,PA,Rural,36-50,2022-02,Q1_2022,2021,6.3,0.734,Stable
FIA000218,2022-03-07,Amoxicillin,Amoxil,Antibiotics,16117-888-81,Medicaid Plan X,PLAN_3476,2022,Tier 1,Tier 3,2021-06-30,250,Improved,None,No,No,,844,675,25.1,Increased,6.71,61.33,-54.62,90.39,97.1,81.95,0.0,0,0.034,0.349,0.812,0.732,3,0,14,14,4.9,27.7,2,Higher,West,TX,Rural,18-35,2022-03,Q1_2022,2021,5.6,0.167,Increasing
FIA002544,2022-03-07,Amoxicillin,Amoxil,Antibiotics,45694-353-47,Medicaid Plan X,PLAN_1515,2022,Tier 1,Tier 2,2021-05-19,292,Improved,None,No,No,,702,757,-7.2,Decreased,14.62,21.22,-6.6,142.19,156.81,110.08,0.0,0,0.045,0.139,0.693,0.695,0,2,2,14,4.5,18.4,2,Similar,Midwest,PA,Suburban,36-50,2022-03,Q1_2022,2021,8.7,0.738,Increasing
FIA002413,2022-03-10,Amoxicillin,Amoxil,Antibiotics,76368-684-47,Commercial Plan Beta,PLAN_8136,2022,Tier 2,Tier 3,2021-08-19,203,Improved,None,No,No,,1095,951,15.2,Increased,36.15,86.44,-50.29,62.55,98.7,108.08,0.0,0,0.075,0.352,0.494,0.563,1,5,9,15,2.3,33.6,6,Similar,Northeast,NY,Rural,18-35,2022-03,Q1_2022,2021,4.9,0.361,Decreasing
FIA001308,2022-03-19,Amoxicillin,Amoxil,Antibiotics,44380-809-58,Medicare Part D Plan A,PLAN_9931,2022,Tier 2,Tier 3,2021-09-25,175,Improved,None,No,No,,404,289,40.0,Increased,48.44,90.32,-41.88,109.44,157.88,63.78,0.0,0,0.04,0.21,0.735,0.639,6,1,8,6,4.1,20.5,3,Similar,Southeast,FL,Rural,36-50,2022-03,Q1_2022,2021,5.7,0.996,Stable
FIA002116,2022-04-09,Amoxicillin,Amoxil,Antibiotics,63760-350-25,Medicare Part D Plan A,PLAN_7650,2022,Non-Formulary,Specialty Tier,2021-08-14,238,Worsened,Non-Formulary Status,No,No,,261,264,-1.1,Stable,287.98,208.73,79.25,59.96,347.94,90.81,0.0,0,0.189,0.314,0.519,0.495,9,0,14,15,4.3,12.6,8,Higher,Northeast,OH,Rural,36-50,2022-04,Q2_2022,2021,9.4,0.279,Increasing
FIA001441,2022-04-13,Amoxicillin,Amoxil,Antibiotics,21186-821-95,VA Plan,PLAN_6541,2022,Tier 1,Specialty Tier,2021-05-02,346,Improved,Quantity Limit,No,No,,1226,994,23.4,Increased,17.98,137.52,-119.54,91.45,109.43,134.16,0.0,0,0.041,0.198,0.583,0.495,9,9,10,3,2.7,22.4,5,Higher,Northeast,IL,Suburban,51-65,2022-04,Q2_2022,2021,8.6,0.641,Stable
FIA001331,2022-04-17,Amoxicillin,Amoxil,Antibiotics,87577-565-37,Tricare Standard,PLAN_3548,2022,Tier 3,Tier 3,2021-11-01,167,No Change,Prior Authorization,Yes,No,,213,234,-8.8,Decreased,70.88,67.57,3.31,89.29,160.17,34.12,0.412,6,0.065,0.133,0.201,0.465,8,6,9,7,4.9,22.9,4,Similar,Southeast,NC,Urban,51-65,2022-04,Q2_2022,2021,3.3,0.017,Decreasing
FIA002128,2022-04-29,Amoxicillin,Amoxil,Antibiotics,44443-530-16,Medicaid Plan X,PLAN_2426,2022,Non-Formulary,Tier 3,2021-09-03,238,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,791,794,-0.3,Stable,241.81,71.29,170.52,118.22,360.03,284.78,0.0,0,0.12,0.255,0.836,0.636,6,2,4,0,4.7,24.8,6,Similar,West,NC,Urban,18-35,2022-04,Q2_2022,2021,2.9,0.297,Increasing
FIA001962,2022-04-30,Amoxicillin,Amoxil,Antibiotics,50997-707-86,Medicare Part D Plan B,PLAN_1925,2022,Non-Formulary,Tier 2,2021-11-13,168,Worsened,Non-Formulary Status,No,No,,206,312,-33.7,Decreased,758.66,28.2,730.46,86.93,845.59,174.19,0.0,0,0.179,0.229,0.517,0.669,13,6,7,10,3.5,5.0,3,Higher,West,TX,Rural,66-75,2022-04,Q2_2022,2021,7.8,0.202,Increasing
FIA002345,2022-05-04,Amoxicillin,Amoxil,Antibiotics,23934-874-27,Medicaid Plan Y,PLAN_9837,2022,Specialty Tier,Non-Formulary,2021-11-20,165,Improved,Prior Authorization; Quantity Limit,Yes,No,60.0,991,924,7.3,Increased,114.89,610.71,-495.82,54.62,169.51,167.98,0.472,8,0.066,0.319,0.365,0.653,9,8,9,7,4.3,17.3,6,Lower,Southeast,FL,Suburban,18-35,2022-05,Q2_2022,2021,6.1,0.217,Decreasing
FIA002438,2022-05-14,Amoxicillin,Amoxil,Antibiotics,34571-216-49,Commercial Plan Alpha,PLAN_2634,2022,Specialty Tier,Tier 3,2021-10-14,212,Worsened,Quantity Limit,No,No,90.0,397,435,-8.6,Decreased,264.54,80.57,183.97,87.65,352.19,139.82,0.0,0,0.274,0.097,0.632,0.687,4,3,14,4,2.5,9.0,3,Lower,Midwest,PA,Rural,36-50,2022-05,Q2_2022,2021,6.6,0.057,Stable
FIA002089,2022-06-01,Amoxicillin,Amoxil,Antibiotics,94153-417-69,VA Plan,PLAN_2999,2022,Non-Formulary,Tier 1,2021-10-17,227,Worsened,Non-Formulary Status,No,No,,588,995,-40.9,Decreased,496.21,12.3,483.91,107.31,603.52,354.87,0.0,0,0.219,0.09,0.44,0.804,15,3,16,9,2.0,20.6,2,Lower,Midwest,FL,Urban,36-50,2022-06,Q2_2022,2021,3.4,0.667,Stable
FIA001286,2022-06-04,Amoxicillin,Amoxil,Antibiotics,57679-965-34,Tricare Standard,PLAN_7372,2022,Tier 2,Tier 2,2021-06-04,365,No Change,Quantity Limit,No,No,60.0,831,774,7.4,Increased,43.48,26.69,16.79,146.95,190.43,158.25,0.0,0,0.033,0.332,0.433,0.487,10,6,4,5,2.5,21.2,7,Lower,Midwest,OH,Suburban,51-65,2022-06,Q2_2022,2021,8.2,0.132,Decreasing
FIA000493,2022-06-19,Amoxicillin,Amoxil,Antibiotics,27187-758-24,Medicaid Plan Y,PLAN_6199,2022,Specialty Tier,Tier 3,2022-05-07,43,Worsened,None,No,No,,127,140,-9.1,Decreased,127.23,92.55,34.68,192.94,320.17,40.66,0.0,0,0.108,0.074,0.204,0.587,1,8,6,13,3.7,10.5,2,Similar,Midwest,PA,Rural,75+,2022-06,Q2_2022,2021,6.6,0.386,Decreasing
FIA002672,2022-06-21,Amoxicillin,Amoxil,Antibiotics,37108-207-46,Commercial Plan Alpha,PLAN_5285,2022,Tier 3,Specialty Tier,2021-07-28,328,Improved,Step Therapy; Quantity Limit,No,Yes,30.0,107,109,-1.1,Stable,98.55,273.12,-174.57,98.32,196.87,21.07,0.0,0,0.061,0.364,0.3,0.482,8,2,18,10,2.3,34.2,3,Higher,Midwest,TX,Urban,36-50,2022-06,Q2_2022,2021,3.8,0.601,Stable
FIA000403,2022-06-23,Amoxicillin,Amoxil,Antibiotics,19884-109-11,Medicaid Plan Y,PLAN_2153,2022,Tier 3,Non-Formulary,2022-03-27,88,Improved,None,No,No,,810,880,-7.9,Decreased,51.15,277.12,-225.97,44.86,96.01,77.77,0.0,0,0.027,0.105,0.638,0.879,14,10,10,3,3.8,6.7,3,Lower,Northeast,FL,Urban,18-35,2022-06,Q2_2022,2021,1.0,0.792,Increasing
FIA002847,2022-06-28,Amoxicillin,Amoxil,Antibiotics,38058-689-88,Tricare Standard,PLAN_6704,2022,Tier 3,Tier 1,2021-07-26,337,Worsened,Quantity Limit,No,No,60.0,170,305,-44.0,Decreased,94.12,14.15,79.97,195.97,290.09,49.32,0.0,0,0.047,0.202,0.307,0.506,10,7,6,3,2.4,18.4,3,Similar,Northeast,IL,Urban,36-50,2022-06,Q2_2022,2021,6.1,0.579,Decreasing
FIA000545,2022-07-06,Amoxicillin,Amoxil,Antibiotics,78738-904-25,Tricare Standard,PLAN_1070,2022,Tier 3,Tier 2,2022-02-11,145,Worsened,Prior Authorization,Yes,No,,201,285,-29.5,Decreased,85.68,36.52,49.16,41.48,127.16,25.56,0.404,6,0.056,0.248,0.504,0.825,13,3,17,11,3.0,21.5,7,Higher,Midwest,MI,Rural,66-75,2022-07,Q3_2022,2021,7.2,0.47,Decreasing
FIA000263,2022-07-13,Amoxicillin,Amoxil,Antibiotics,80452-289-61,Medicare Part D Plan A,PLAN_7451,2022,Non-Formulary,Tier 2,2021-11-29,226,Worsened,Non-Formulary Status,No,No,,354,544,-34.9,Decreased,490.51,39.34,451.17,151.34,641.85,227.21,0.0,0,0.131,0.245,0.575,0.847,15,1,16,3,4.3,11.2,7,Lower,Southeast,MI,Rural,36-50,2022-07,Q3_2022,2021,1.0,0.447,Stable
FIA002626,2022-07-15,Amoxicillin,Amoxil,Antibiotics,74084-390-34,Commercial Plan Beta,PLAN_9884,2022,Tier 1,Specialty Tier,2022-01-23,173,Improved,None,No,No,,198,169,17.6,Increased,11.73,218.51,-206.78,33.6,45.33,8.98,0.0,0,0.04,0.254,0.596,0.694,1,9,0,14,3.0,14.0,3,Higher,Southeast,TX,Suburban,75+,2022-07,Q3_2022,2021,9.5,0.574,Decreasing
FIA001723,2022-07-26,Amoxicillin,Amoxil,Antibiotics,96416-627-63,Tricare Standard,PLAN_5324,2022,Tier 3,Non-Formulary,2022-03-04,144,Improved,Prior Authorization,Yes,No,,842,871,-3.2,Stable,96.29,773.41,-677.12,96.43,192.72,162.27,0.48,5,0.016,0.323,0.514,0.943,14,3,4,0,3.4,21.0,2,Similar,West,PA,Suburban,18-35,2022-07,Q3_2022,2021,7.0,0.985,Stable
FIA000700,2022-07-27,Amoxicillin,Amoxil,Antibiotics,94372-195-77,Tricare Standard,PLAN_4647,2022,Tier 2,Tier 2,2022-05-07,81,No Change,None,No,No,,148,143,3.6,Stable,29.69,30.21,-0.52,90.77,120.46,17.83,0.0,0,0.073,0.231,0.698,0.554,1,4,11,6,2.3,7.3,2,Similar,Southwest,CA,Rural,18-35,2022-07,Q3_2022,2021,7.8,0.936,Decreasing
FIA001429,2022-08-01,Amoxicillin,Amoxil,Antibiotics,58067-474-53,Commercial Plan Alpha,PLAN_6349,2022,Tier 3,Tier 1,2022-04-16,107,Worsened,Prior Authorization,Yes,No,,499,701,-28.8,Decreased,73.54,19.42,54.12,73.92,147.46,73.58,0.291,2,0.058,0.224,0.402,0.692,13,5,4,12,2.9,9.7,7,Similar,Southeast,GA,Suburban,36-50,2022-08,Q3_2022,2021,5.5,0.135,Increasing
FIA002443,2022-08-01,Amoxicillin,Amoxil,Antibiotics,24293-263-86,Medicare Part D Plan B,PLAN_7161,2022,Tier 1,Non-Formulary,2021-10-05,300,Improved,None,No,No,,514,377,36.4,Increased,15.86,387.46,-371.6,44.42,60.28,30.98,0.0,0,0.026,0.316,0.872,0.892,12,2,10,6,5.0,28.9,2,Lower,West,TX,Rural,51-65,2022-08,Q3_2022,2021,5.6,0.526,Stable
FIA001288,2022-08-05,Amoxicillin,Amoxil,Antibiotics,33095-423-90,Medicare Part D Plan A,PLAN_7280,2022,Tier 1,Tier 2,2021-12-03,245,Improved,None,No,No,,456,468,-2.5,Stable,14.76,39.02,-24.26,100.58,115.34,52.6,0.0,0,0.056,0.265,0.251,0.518,5,8,16,0,4.0,33.3,6,Higher,Southwest,CA,Rural,18-35,2022-08,Q3_2022,2021,1.8,0.896,Stable
FIA001029,2022-08-06,Amoxicillin,Amoxil,Antibiotics,86484-287-67,Medicare Part D Plan B,PLAN_6180,2022,Non-Formulary,Tier 3,2022-03-07,152,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,129,133,-2.8,Stable,597.0,86.01,510.99,160.43,757.43,97.71,0.0,0,0.2,0.061,0.487,0.684,13,7,0,4,4.9,27.2,7,Lower,Midwest,NY,Suburban,75+,2022-08,Q3_2022,2021,6.9,0.186,Decreasing
FIA000935,2022-08-11,Amoxicillin,Amoxil,Antibiotics,17965-640-90,VA Plan,PLAN_8121,2022,Tier 1,Tier 1,2022-04-07,126,No Change,None,No,No,,116,109,6.6,Increased,15.24,16.18,-0.94,112.86,128.1,14.86,0.0,0,0.067,0.313,0.857,0.524,1,7,1,7,2.8,13.1,3,Higher,Southwest,GA,Rural,51-65,2022-08,Q3_2022,2021,5.9,0.865,Decreasing
FIA001321,2022-08-12,Amoxicillin,Amoxil,Antibiotics,96039-809-92,Commercial Plan Beta,PLAN_3107,2022,Tier 1,Tier 3,2022-05-24,80,Improved,Quantity Limit,No,No,30.0,938,594,57.9,Increased,8.54,74.28,-65.74,166.77,175.31,164.44,0.0,0,0.052,0.145,0.621,0.664,14,1,18,13,3.4,14.9,5,Higher,Northeast,FL,Urban,75+,2022-08,Q3_2022,2021,3.8,0.264,Increasing
FIA001541,2022-08-12,Amoxicillin,Amoxil,Antibiotics,11712-312-49,VA Plan,PLAN_4553,2022,Tier 2,Tier 2,2022-07-10,33,No Change,None,No,No,,320,349,-8.0,Decreased,38.36,49.48,-11.12,113.43,151.79,48.57,0.0,0,0.021,0.33,0.716,0.499,14,4,20,4,4.4,17.5,5,Higher,Southwest,OH,Rural,18-35,2022-08,Q3_2022,2021,7.7,0.958,Decreasing
FIA000195,2022-08-20,Amoxicillin,Amoxil,Antibiotics,69892-714-49,Tricare Standard,PLAN_4700,2022,Tier 3,Tier 1,2021-11-25,268,Worsened,Step Therapy,No,Yes,,545,880,-38.1,Decreased,55.52,7.04,48.48,95.41,150.93,82.26,0.0,0,0.045,0.244,0.403,0.87,6,1,15,11,2.5,35.0,5,Higher,Northeast,OH,Suburban,75+,2022-08,Q3_2022,2021,6.9,0.085,Increasing
FIA002475,2022-08-23,Amoxicillin,Amoxil,Antibiotics,59779-181-27,Commercial Plan Beta,PLAN_5633,2022,Tier 2,Non-Formulary,2021-10-13,314,Improved,None,No,No,,481,360,33.8,Increased,43.75,474.66,-430.91,84.86,128.61,61.86,0.0,0,0.046,0.335,0.499,0.464,4,6,6,6,3.8,10.8,6,Lower,Southwest,IL,Rural,36-50,2022-08,Q3_2022,2021,2.4,0.229,Increasing
FIA002037,2022-08-25,Amoxicillin,Amoxil,Antibiotics,13589-855-84,Commercial Plan Beta,PLAN_7929,2022,Tier 2,Non-Formulary,2022-05-24,93,Improved,None,No,No,,1088,926,17.6,Increased,47.18,460.42,-413.24,146.98,194.16,211.25,0.0,0,0.011,0.24,0.514,0.436,4,1,11,2,3.6,12.9,8,Similar,Midwest,PA,Urban,18-35,2022-08,Q3_2022,2021,1.5,0.254,Increasing
FIA002822,2022-08-26,Amoxicillin,Amoxil,Antibiotics,61866-344-79,Tricare Standard,PLAN_4336,2022,Tier 1,Tier 1,2021-09-10,350,No Change,None,No,No,,908,982,-7.5,Decreased,16.5,18.59,-2.09,102.38,118.88,107.94,0.0,0,0.036,0.08,0.388,0.686,1,4,8,10,4.9,17.3,5,Similar,Midwest,GA,Urban,36-50,2022-08,Q3_2022,2021,9.0,0.792,Decreasing
FIA000813,2022-08-30,Amoxicillin,Amoxil,Antibiotics,94059-546-49,Medicare Part D Plan B,PLAN_7607,2022,Non-Formulary,Non-Formulary,2021-11-21,282,No Change,Non-Formulary Status,No,No,,382,374,2.3,Stable,454.64,400.79,53.85,90.89,545.53,208.39,0.0,0,0.068,0.204,0.619,0.531,0,0,18,6,3.1,20.1,3,Lower,Northeast,OH,Urban,18-35,2022-08,Q3_2022,2021,1.8,0.736,Decreasing
FIA001649,2022-09-03,Amoxicillin,Amoxil,Antibiotics,54998-443-74,Medicare Part D Plan B,PLAN_4342,2022,Specialty Tier,Specialty Tier,2022-05-09,117,No Change,Prior Authorization,Yes,No,,719,761,-5.4,Decreased,141.26,281.56,-140.3,176.06,317.32,228.15,0.415,3,0.162,0.328,0.504,0.504,8,2,14,0,2.2,34.6,8,Higher,Southeast,NY,Urban,36-50,2022-09,Q3_2022,2021,6.8,0.907,Increasing
FIA000390,2022-09-04,Amoxicillin,Amoxil,Antibiotics,96309-661-59,Tricare Standard,PLAN_2906,2022,Tier 3,Tier 3,2022-06-11,85,No Change,Quantity Limit,No,No,,588,630,-6.7,Decreased,67.45,59.02,8.43,189.43,256.88,151.05,0.0,0,0.074,0.168,0.456,0.532,15,3,12,1,3.1,32.5,5,Higher,West,TX,Rural,18-35,2022-09,Q3_2022,2021,7.0,0.321,Decreasing
FIA001652,2022-10-02,Amoxicillin,Amoxil,Antibiotics,49860-372-99,Medicaid Plan Y,PLAN_6991,2022,Tier 3,Tier 1,2022-06-03,121,Worsened,None,No,No,,568,809,-29.8,Decreased,55.19,13.19,42.0,130.79,185.98,105.64,0.0,0,0.06,0.359,0.827,0.805,12,2,11,6,3.2,30.0,2,Similar,Northeast,FL,Urban,36-50,2022-10,Q4_2022,2022,3.7,0.367,Stable
FIA002836,2022-10-20,Amoxicillin,Amoxil,Antibiotics,74412-687-56,Tricare Standard,PLAN_1269,2022,Non-Formulary,Tier 2,2022-02-21,241,Worsened,Non-Formulary Status,No,No,,609,819,-25.6,Decreased,472.49,32.53,439.96,173.32,645.81,393.3,0.0,0,0.052,0.268,0.335,0.458,3,8,2,9,2.7,27.8,5,Higher,West,CA,Urban,66-75,2022-10,Q4_2022,2022,7.4,0.817,Increasing
FIA001101,2022-10-21,Amoxicillin,Amoxil,Antibiotics,74918-347-44,VA Plan,PLAN_1702,2022,Tier 3,Tier 1,2022-07-18,95,Worsened,None,No,No,,63,158,-59.9,Decreased,95.38,15.47,79.91,170.87,266.25,16.77,0.0,0,0.06,0.286,0.274,0.454,9,0,15,4,4.4,27.4,5,Similar,Midwest,GA,Suburban,36-50,2022-10,Q4_2022,2022,5.4,0.289,Increasing
FIA000970,2022-11-17,Amoxicillin,Amoxil,Antibiotics,42779-945-68,Medicare Part D Plan A,PLAN_6109,2022,Tier 1,Tier 3,2021-12-23,329,Improved,Quantity Limit,No,No,,1453,984,47.7,Increased,14.06,54.35,-40.29,188.74,202.8,294.67,0.0,0,0.017,0.17,0.834,0.523,0,6,14,12,3.4,11.9,5,Lower,Northeast,MI,Rural,66-75,2022-11,Q4_2022,2022,2.1,0.801,Increasing
FIA000089,2022-11-19,Amoxicillin,Amoxil,Antibiotics,63004-975-67,Commercial Plan Beta,PLAN_2551,2022,Tier 3,Non-Formulary,2022-09-30,50,Improved,Prior Authorization,Yes,No,,230,251,-8.2,Decreased,60.75,713.94,-653.19,59.56,120.31,27.67,0.249,8,0.067,0.086,0.756,0.467,1,3,4,6,4.5,16.2,7,Higher,Northeast,MI,Rural,51-65,2022-11,Q4_2022,2022,9.3,0.075,Increasing
FIA000370,2022-11-21,Amoxicillin,Amoxil,Antibiotics,69151-856-29,Medicaid Plan Y,PLAN_2196,2022,Non-Formulary,Tier 1,2022-01-02,323,Worsened,Non-Formulary Status,No,No,,125,295,-57.6,Decreased,753.5,14.15,739.35,77.07,830.57,103.82,0.0,0,0.158,0.114,0.603,0.65,13,0,12,9,2.0,29.8,2,Lower,Southeast,IL,Suburban,36-50,2022-11,Q4_2022,2022,3.3,0.223,Decreasing
FIA001241,2022-11-23,Amoxicillin,Amoxil,Antibiotics,57497-262-67,Commercial Plan Alpha,PLAN_6956,2022,Tier 2,Non-Formulary,2022-06-27,149,Improved,Quantity Limit,No,No,90.0,453,365,24.2,Increased,28.98,718.48,-689.5,55.68,84.66,38.35,0.0,0,0.051,0.237,0.337,0.925,14,4,1,3,2.5,28.1,4,Higher,West,PA,Suburban,66-75,2022-11,Q4_2022,2022,6.7,0.773,Decreasing
FIA002255,2022-11-29,Amoxicillin,Amoxil,Antibiotics,23567-144-80,Medicare Part D Plan A,PLAN_9883,2022,Tier 3,Non-Formulary,2022-07-02,150,Improved,Step Therapy; Quantity Limit,No,Yes,60.0,480,463,3.7,Stable,64.01,577.98,-513.97,93.03,157.04,75.38,0.0,0,0.063,0.374,0.472,0.841,7,5,12,3,4.1,31.0,2,Higher,Northeast,PA,Rural,51-65,2022-11,Q4_2022,2022,2.2,0.643,Decreasing
FIA001332,2022-12-04,Amoxicillin,Amoxil,Antibiotics,86261-127-14,Commercial Plan Beta,PLAN_5449,2022,Tier 2,Tier 1,2022-01-14,324,Worsened,None,No,No,,590,583,1.2,Stable,30.65,18.87,11.78,146.37,177.02,104.44,0.0,0,0.07,0.272,0.734,0.515,5,9,5,12,2.4,31.8,7,Similar,Midwest,IL,Rural,66-75,2022-12,Q4_2022,2022,8.4,0.888,Stable
FIA000767,2022-12-08,Amoxicillin,Amoxil,Antibiotics,17760-534-83,Commercial Plan Beta,PLAN_2373,2022,Specialty Tier,Tier 3,2022-09-18,81,Worsened,Step Therapy,No,Yes,,595,626,-4.8,Stable,134.76,71.22,63.54,130.16,264.92,157.63,0.0,0,0.09,0.261,0.502,0.411,7,9,19,10,4.8,18.1,5,Lower,Midwest,IL,Urban,51-65,2022-12,Q4_2022,2022,7.5,0.822,Decreasing
FIA000876,2022-12-08,Amoxicillin,Amoxil,Antibiotics,25234-522-32,VA Plan,PLAN_7476,2022,Specialty Tier,Non-Formulary,2022-03-08,275,Improved,Step Therapy; Quantity Limit,No,Yes,,471,464,1.5,Stable,285.81,231.28,54.53,109.55,395.36,186.21,0.0,0,0.288,0.126,0.333,0.68,2,8,0,5,3.9,15.3,6,Higher,West,GA,Suburban,36-50,2022-12,Q4_2022,2022,7.5,0.97,Decreasing
FIA000078,2022-12-11,Amoxicillin,Amoxil,Antibiotics,65725-204-93,Commercial Plan Beta,PLAN_5877,2022,Specialty Tier,Non-Formulary,2022-03-03,283,Improved,Step Therapy,No,Yes,,205,216,-4.6,Stable,209.95,267.93,-57.98,67.15,277.1,56.81,0.0,0,0.16,0.356,0.223,0.545,2,7,3,7,2.6,27.1,7,Similar,West,OH,Urban,75+,2022-12,Q4_2022,2022,2.3,0.207,Increasing
FIA000908,2022-12-27,Amoxicillin,Amoxil,Antibiotics,20026-314-79,Medicare Part D Plan A,PLAN_9053,2022,Specialty Tier,Tier 1,2022-02-26,304,Worsened,Prior Authorization,Yes,No,,254,391,-34.9,Decreased,182.77,14.73,168.04,52.11,234.88,59.66,0.131,9,0.252,0.347,0.59,0.669,1,6,13,2,3.0,31.5,4,Higher,West,IL,Rural,66-75,2022-12,Q4_2022,2022,4.4,0.354,Stable
FIA002387,2023-01-16,Amoxicillin,Amoxil,Antibiotics,11738-233-25,Medicare Part D Plan A,PLAN_9954,2023,Non-Formulary,Tier 1,2022-04-22,269,Worsened,Non-Formulary Status,No,No,,75,101,-25.0,Decreased,507.91,7.82,500.09,89.6,597.51,44.81,0.0,0,0.217,0.376,0.609,0.431,13,0,16,8,2.6,24.0,8,Higher,Northeast,NY,Suburban,36-50,2023-01,Q1_2023,2022,8.0,0.781,Stable
FIA001379,2023-01-25,Amoxicillin,Amoxil,Antibiotics,20227-865-33,Commercial Plan Alpha,PLAN_6954,2023,Tier 1,Tier 1,2022-02-18,341,No Change,None,No,No,,524,521,0.7,Stable,5.97,15.14,-9.17,92.08,98.05,51.38,0.0,0,0.073,0.107,0.802,0.621,14,4,14,14,2.2,18.1,7,Higher,Southwest,PA,Suburban,36-50,2023-01,Q1_2023,2022,5.6,0.627,Increasing
FIA002967,2023-02-01,Amoxicillin,Amoxil,Antibiotics,99622-906-55,Commercial Plan Beta,PLAN_7492,2023,Non-Formulary,Tier 1,2022-07-16,200,Worsened,Non-Formulary Status,No,No,,554,821,-32.5,Decreased,227.43,16.66,210.77,89.25,316.68,175.44,0.0,0,0.128,0.226,0.888,0.467,1,3,20,11,4.4,30.5,3,Similar,Midwest,OH,Urban,75+,2023-02,Q1_2023,2022,6.0,0.949,Decreasing
FIA000825,2023-02-06,Amoxicillin,Amoxil,Antibiotics,94136-659-82,Commercial Plan Alpha,PLAN_6458,2023,Tier 2,Tier 1,2022-08-25,165,Worsened,None,No,No,,919,987,-6.8,Decreased,38.8,7.5,31.3,113.17,151.97,139.66,0.0,0,0.018,0.334,0.806,0.617,10,7,8,8,3.1,16.2,3,Lower,Midwest,IL,Suburban,51-65,2023-02,Q1_2023,2022,9.3,0.109,Increasing
FIA001590,2023-02-06,Amoxicillin,Amoxil,Antibiotics,50617-506-93,Medicaid Plan X,PLAN_5079,2023,Tier 3,Specialty Tier,2022-10-05,124,Improved,None,No,No,,642,593,8.3,Increased,60.78,232.64,-171.86,162.02,222.8,143.04,0.0,0,0.031,0.387,0.325,0.435,1,9,10,9,4.9,16.6,5,Lower,Southwest,GA,Rural,36-50,2023-02,Q1_2023,2022,1.5,0.903,Decreasing
FIA002990,2023-02-14,Amoxicillin,Amoxil,Antibiotics,91030-201-11,Medicaid Plan Y,PLAN_7811,2023,Tier 2,Tier 3,2022-09-08,159,Improved,None,No,No,,1087,853,27.5,Increased,47.25,57.07,-9.82,91.35,138.6,150.66,0.0,0,0.052,0.311,0.836,0.694,12,1,10,11,3.1,10.8,2,Higher,Southeast,IL,Rural,75+,2023-02,Q1_2023,2022,2.5,0.877,Stable
FIA001137,2023-02-15,Amoxicillin,Amoxil,Antibiotics,24353-822-96,Tricare Standard,PLAN_6140,2023,Tier 3,Tier 1,2022-07-25,205,Worsened,Prior Authorization; Quantity Limit,Yes,No,90.0,270,511,-47.1,Decreased,73.51,18.63,54.88,79.87,153.38,41.41,0.359,10,0.062,0.274,0.823,0.417,5,1,16,14,4.0,29.1,7,Higher,Southwest,MI,Rural,18-35,2023-02,Q1_2023,2022,4.5,0.506,Increasing
FIA001975,2023-02-23,Amoxicillin,Amoxil,Antibiotics,87887-300-19,Medicare Part D Plan B,PLAN_7379,2023,Tier 3,Non-Formulary,2022-10-07,139,Improved,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,60.0,526,480,9.8,Increased,60.14,604.05,-543.91,69.42,129.56,68.15,0.346,4,0.034,0.09,0.802,0.631,11,6,19,12,3.3,15.6,5,Lower,Midwest,GA,Urban,66-75,2023-02,Q1_2023,2022,1.8,0.622,Increasing
FIA002250,2023-03-07,Amoxicillin,Amoxil,Antibiotics,21126-469-71,Medicare Part D Plan B,PLAN_4250,2023,Non-Formulary,Tier 2,2022-12-11,86,Worsened,Non-Formulary Status,No,No,,168,232,-27.2,Decreased,581.06,29.3,551.76,115.17,696.23,116.97,0.0,0,0.293,0.185,0.672,0.766,10,3,14,4,5.0,6.8,3,Higher,Southwest,NC,Urban,51-65,2023-03,Q1_2023,2022,5.7,0.492,Decreasing
FIA002296,2023-03-14,Amoxicillin,Amoxil,Antibiotics,27119-369-83,Medicare Part D Plan A,PLAN_8314,2023,Tier 3,Tier 1,2022-05-15,303,Worsened,None,No,No,,50,110,-62.1,Decreased,58.75,15.41,43.34,46.17,104.92,5.25,0.0,0,0.025,0.148,0.557,0.692,8,1,17,6,3.9,11.5,5,Similar,Southeast,CA,Suburban,18-35,2023-03,Q1_2023,2022,8.2,0.588,Increasing
FIA002881,2023-04-04,Amoxicillin,Amoxil,Antibiotics,93014-272-43,Commercial Plan Alpha,PLAN_3996,2023,Specialty Tier,Tier 2,2022-12-26,99,Worsened,None,No,No,,162,291,-44.2,Decreased,139.16,37.59,101.57,127.27,266.43,43.16,0.0,0,0.097,0.203,0.332,0.562,13,2,19,1,3.4,29.0,3,Lower,Southwest,GA,Suburban,75+,2023-04,Q2_2023,2022,5.6,0.53,Increasing
FIA000139,2023-04-11,Amoxicillin,Amoxil,Antibiotics,47586-580-78,Medicare Part D Plan A,PLAN_9059,2023,Tier 1,Specialty Tier,2022-10-06,187,Improved,None,No,No,,473,410,15.5,Increased,10.49,151.96,-141.47,53.17,63.66,30.11,0.0,0,0.063,0.381,0.534,0.405,13,4,19,7,4.4,21.4,3,Similar,West,OH,Suburban,36-50,2023-04,Q2_2023,2022,2.5,0.737,Stable
FIA001882,2023-05-07,Amoxicillin,Amoxil,Antibiotics,76273-703-66,Medicaid Plan Y,PLAN_8554,2023,Tier 2,Non-Formulary,2022-08-18,262,Improved,None,No,No,,577,495,16.8,Increased,26.2,227.07,-200.87,188.26,214.46,123.74,0.0,0,0.021,0.13,0.72,0.654,13,10,9,3,2.1,22.7,4,Similar,Southeast,CA,Suburban,36-50,2023-05,Q2_2023,2022,9.7,0.338,Stable
FIA002588,2023-05-10,Amoxicillin,Amoxil,Antibiotics,45220-220-76,Medicaid Plan Y,PLAN_1296,2023,Tier 3,Tier 1,2023-02-27,72,Worsened,Step Therapy,No,Yes,,450,791,-43.1,Decreased,73.14,14.1,59.04,196.86,270.0,121.5,0.0,0,0.019,0.233,0.279,0.793,8,8,15,15,2.6,22.9,7,Higher,Southwest,IL,Urban,66-75,2023-05,Q2_2023,2022,6.2,0.939,Decreasing
FIA002257,2023-05-17,Amoxicillin,Amoxil,Antibiotics,60815-576-54,Medicare Part D Plan B,PLAN_7613,2023,Tier 3,Tier 3,2023-02-20,86,No Change,Step Therapy,No,Yes,,984,945,4.2,Stable,81.74,99.7,-17.96,81.74,163.48,160.86,0.0,0,0.012,0.135,0.295,0.565,6,3,10,0,4.9,32.9,4,Lower,Northeast,FL,Suburban,51-65,2023-05,Q2_2023,2022,9.2,0.924,Decreasing
FIA002808,2023-05-31,Amoxicillin,Amoxil,Antibiotics,76926-127-47,Medicare Part D Plan B,PLAN_9233,2023,Tier 2,Tier 1,2023-02-27,93,Worsened,None,No,No,,951,868,9.6,Increased,44.2,16.03,28.17,179.29,223.49,212.54,0.0,0,0.049,0.256,0.719,0.837,0,2,18,1,2.3,27.6,2,Higher,Northeast,PA,Urban,66-75,2023-05,Q2_2023,2022,6.8,0.964,Decreasing
FIA002068,2023-06-05,Amoxicillin,Amoxil,Antibiotics,87961-678-69,Medicare Part D Plan A,PLAN_6435,2023,Specialty Tier,Tier 1,2023-03-09,88,Worsened,None,No,No,,329,564,-41.5,Decreased,148.75,5.13,143.62,155.35,304.1,100.05,0.0,0,0.274,0.209,0.827,0.771,6,1,0,1,4.2,19.6,2,Lower,Southwest,FL,Urban,51-65,2023-06,Q2_2023,2022,4.3,0.52,Increasing
FIA002212,2023-07-01,Amoxicillin,Amoxil,Antibiotics,86089-800-45,Medicaid Plan X,PLAN_1493,2023,Tier 3,Tier 3,2022-12-16,197,No Change,Prior Authorization,Yes,No,,563,586,-3.8,Stable,87.75,93.79,-6.04,112.94,200.69,112.99,0.372,1,0.024,0.054,0.203,0.946,13,8,18,15,3.4,6.5,7,Similar,Midwest,MI,Suburban,51-65,2023-07,Q3_2023,2022,3.7,0.974,Increasing
FIA002551,2023-07-03,Amoxicillin,Amoxil,Antibiotics,92479-987-73,Tricare Standard,PLAN_2014,2023,Tier 2,Tier 2,2023-04-06,88,No Change,None,No,No,,957,910,5.2,Increased,23.57,44.45,-20.88,146.55,170.12,162.8,0.0,0,0.02,0.235,0.338,0.6,8,0,13,7,3.0,16.3,6,Higher,Midwest,TX,Rural,51-65,2023-07,Q3_2023,2022,9.9,0.69,Decreasing
FIA002432,2023-07-04,Amoxicillin,Amoxil,Antibiotics,80735-431-68,Medicaid Plan Y,PLAN_2184,2023,Tier 3,Tier 3,2023-05-28,37,No Change,Step Therapy,No,Yes,,572,541,5.9,Increased,95.69,81.32,14.37,156.57,252.26,144.29,0.0,0,0.034,0.096,0.822,0.804,11,3,15,13,3.9,31.4,4,Higher,Southeast,NC,Urban,51-65,2023-07,Q3_2023,2022,8.7,0.84,Decreasing
FIA002216,2023-07-09,Amoxicillin,Amoxil,Antibiotics,67920-181-44,VA Plan,PLAN_8713,2023,Tier 3,Specialty Tier,2022-10-05,277,Improved,Prior Authorization; Step Therapy,Yes,Yes,,555,591,-6.1,Decreased,57.18,202.2,-145.02,79.51,136.69,75.86,0.396,4,0.03,0.122,0.612,0.798,4,1,7,14,2.1,20.7,8,Lower,Southwest,PA,Urban,36-50,2023-07,Q3_2023,2022,9.8,0.437,Stable
FIA000708,2023-07-10,Amoxicillin,Amoxil,Antibiotics,57342-382-58,Medicare Part D Plan B,PLAN_7124,2023,Tier 3,Tier 3,2022-09-02,311,No Change,None,No,No,,699,646,8.2,Increased,69.97,57.03,12.94,41.24,111.21,77.74,0.0,0,0.077,0.29,0.405,0.856,4,5,2,3,2.8,28.5,5,Higher,West,GA,Rural,51-65,2023-07,Q3_2023,2022,2.9,0.134,Decreasing
FIA002619,2023-07-13,Amoxicillin,Amoxil,Antibiotics,90580-218-67,VA Plan,PLAN_4495,2023,Specialty Tier,Specialty Tier,2023-03-18,117,No Change,Prior Authorization,Yes,No,,808,812,-0.5,Stable,233.57,181.86,51.71,110.47,344.04,277.98,0.309,10,0.133,0.053,0.623,0.551,4,1,16,8,5.0,16.1,8,Higher,Northeast,OH,Suburban,51-65,2023-07,Q3_2023,2022,6.4,0.807,Decreasing
FIA001636,2023-07-15,Amoxicillin,Amoxil,Antibiotics,27131-701-84,Medicare Part D Plan A,PLAN_3744,2023,Tier 2,Tier 2,2022-07-25,355,No Change,None,No,No,,621,678,-8.4,Decreased,30.37,27.78,2.59,162.35,192.72,119.68,0.0,0,0.044,0.16,0.216,0.837,5,2,15,4,4.5,30.1,6,Higher,West,NC,Urban,51-65,2023-07,Q3_2023,2022,8.1,0.691,Decreasing
FIA000864,2023-07-17,Amoxicillin,Amoxil,Antibiotics,56358-881-59,Medicaid Plan X,PLAN_6156,2023,Tier 1,Specialty Tier,2022-10-28,262,Improved,None,No,No,,834,615,35.6,Increased,6.5,232.12,-225.62,47.78,54.28,45.27,0.0,0,0.012,0.216,0.862,0.484,10,10,15,8,4.4,18.6,4,Lower,Southeast,NY,Suburban,51-65,2023-07,Q3_2023,2022,3.3,0.627,Decreasing
FIA002768,2023-07-21,Amoxicillin,Amoxil,Antibiotics,99446-837-17,Medicaid Plan X,PLAN_1317,2023,Tier 2,Non-Formulary,2023-03-22,121,Improved,None,No,No,,243,189,28.9,Increased,27.77,520.93,-493.16,199.88,227.65,55.32,0.0,0,0.047,0.079,0.776,0.407,15,9,8,0,4.0,5.4,5,Similar,West,IL,Urban,51-65,2023-07,Q3_2023,2022,7.9,0.569,Stable
FIA000329,2023-08-16,Amoxicillin,Amoxil,Antibiotics,59725-428-66,Commercial Plan Alpha,PLAN_9334,2023,Specialty Tier,Tier 2,2023-04-15,123,Worsened,Step Therapy,No,Yes,,311,939,-66.8,Decreased,244.74,37.69,207.05,140.4,385.14,119.78,0.0,0,0.142,0.303,0.396,0.825,7,4,15,10,2.1,20.5,6,Higher,West,OH,Suburban,51-65,2023-08,Q3_2023,2022,4.5,0.757,Increasing
FIA000360,2023-08-23,Amoxicillin,Amoxil,Antibiotics,24651-839-31,Medicaid Plan Y,PLAN_7764,2023,Specialty Tier,Tier 1,2023-01-19,216,Worsened,None,No,No,,353,744,-52.5,Decreased,179.89,18.91,160.98,170.29,350.18,123.61,0.0,0,0.116,0.28,0.299,0.534,15,3,8,3,3.0,25.8,5,Higher,Southwest,NY,Suburban,51-65,2023-08,Q3_2023,2022,3.7,0.445,Stable
FIA000861,2023-08-25,Amoxicillin,Amoxil,Antibiotics,46942-410-48,Commercial Plan Alpha,PLAN_1242,2023,Tier 3,Specialty Tier,2022-09-04,355,Improved,None,No,No,,519,490,6.0,Increased,80.71,216.74,-136.03,123.78,204.49,106.13,0.0,0,0.033,0.101,0.759,0.543,4,4,17,12,2.6,7.1,8,Similar,Southeast,GA,Urban,51-65,2023-08,Q3_2023,2022,4.3,0.226,Increasing
FIA002039,2023-08-30,Amoxicillin,Amoxil,Antibiotics,47559-843-96,VA Plan,PLAN_3201,2023,Tier 2,Tier 2,2022-09-07,357,No Change,None,No,No,,468,489,-4.2,Stable,32.34,33.26,-0.92,78.73,111.07,51.98,0.0,0,0.034,0.186,0.426,0.526,11,5,11,10,5.0,22.7,7,Higher,West,MI,Urban,36-50,2023-08,Q3_2023,2022,9.4,0.472,Decreasing
FIA001835,2023-09-05,Amoxicillin,Amoxil,Antibiotics,83080-448-21,Medicare Part D Plan B,PLAN_9900,2023,Tier 1,Tier 1,2023-02-15,202,No Change,Quantity Limit,No,No,,748,816,-8.3,Decreased,19.22,9.33,9.89,163.48,182.7,136.66,0.0,0,0.038,0.078,0.675,0.823,15,8,15,6,2.8,34.6,6,Similar,Northeast,PA,Rural,66-75,2023-09,Q3_2023,2022,8.8,0.453,Stable
FIA002765,2023-09-05,Amoxicillin,Amoxil,Antibiotics,11623-619-96,Medicaid Plan Y,PLAN_9550,2023,Tier 1,Tier 2,2023-06-11,86,Improved,Quantity Limit,No,No,,502,482,4.3,Stable,15.12,47.55,-32.43,189.2,204.32,102.57,0.0,0,0.027,0.142,0.298,0.844,4,6,18,13,3.2,9.1,4,Higher,Midwest,GA,Suburban,66-75,2023-09,Q3_2023,2022,6.6,0.327,Stable
FIA002929,2023-09-08,Amoxicillin,Amoxil,Antibiotics,41597-904-46,Commercial Plan Alpha,PLAN_7850,2023,Non-Formulary,Non-Formulary,2022-12-01,281,No Change,Non-Formulary Status,No,No,,585,627,-6.7,Decreased,797.51,371.87,425.64,56.0,853.51,499.3,0.0,0,0.16,0.375,0.304,0.518,2,10,9,0,3.5,30.4,7,Similar,Southwest,NY,Rural,18-35,2023-09,Q3_2023,2022,9.7,0.85,Increasing
FIA000885,2023-09-18,Amoxicillin,Amoxil,Antibiotics,79547-684-69,Medicare Part D Plan A,PLAN_2786,2023,Tier 3,Specialty Tier,2023-01-21,240,Improved,None,No,No,,343,356,-3.5,Stable,98.58,188.43,-89.85,174.31,272.89,93.6,0.0,0,0.079,0.357,0.662,0.93,5,1,6,6,3.1,20.7,8,Similar,Northeast,CA,Rural,36-50,2023-09,Q3_2023,2022,3.5,0.433,Decreasing
FIA002694,2023-09-27,Amoxicillin,Amoxil,Antibiotics,77599-726-72,Commercial Plan Beta,PLAN_7509,2023,Non-Formulary,Non-Formulary,2022-12-02,299,No Change,Non-Formulary Status,No,No,,797,756,5.5,Increased,329.01,482.79,-153.78,101.02,430.03,342.73,0.0,0,0.132,0.169,0.853,0.643,13,0,2,2,3.9,21.8,3,Higher,West,CA,Urban,66-75,2023-09,Q3_2023,2022,7.9,0.626,Increasing
FIA001490,2023-10-01,Amoxicillin,Amoxil,Antibiotics,60804-681-38,Commercial Plan Alpha,PLAN_9590,2023,Specialty Tier,Tier 3,2023-07-08,85,Worsened,None,No,No,,837,827,1.3,Stable,224.36,74.12,150.24,192.0,416.36,348.49,0.0,0,0.132,0.362,0.386,0.439,2,7,2,6,4.7,27.5,7,Similar,Northeast,MI,Suburban,18-35,2023-10,Q4_2023,2023,5.8,0.412,Stable
FIA002722,2023-10-05,Amoxicillin,Amoxil,Antibiotics,59950-542-70,Commercial Plan Beta,PLAN_2657,2023,Specialty Tier,Non-Formulary,2023-07-02,95,Improved,None,No,No,,792,753,5.3,Increased,110.13,292.19,-182.06,161.94,272.07,215.48,0.0,0,0.217,0.179,0.764,0.8,3,7,3,8,4.4,23.4,5,Higher,Midwest,TX,Rural,75+,2023-10,Q4_2023,2023,1.1,0.398,Stable
FIA001177,2023-10-08,Amoxicillin,Amoxil,Antibiotics,91161-479-14,Tricare Standard,PLAN_1393,2023,Tier 2,Non-Formulary,2023-09-07,31,Improved,None,No,No,,637,446,42.8,Increased,30.94,644.99,-614.05,66.88,97.82,62.31,0.0,0,0.041,0.172,0.758,0.869,13,9,13,14,2.5,28.4,6,Lower,Midwest,OH,Rural,36-50,2023-10,Q4_2023,2023,6.0,0.781,Increasing
FIA000266,2023-10-10,Amoxicillin,Amoxil,Antibiotics,29179-989-38,Medicaid Plan X,PLAN_1161,2023,Specialty Tier,Specialty Tier,2023-08-28,43,No Change,Prior Authorization,Yes,No,,347,376,-7.5,Decreased,292.8,149.5,143.3,162.27,455.07,157.91,0.144,2,0.277,0.182,0.878,0.608,3,1,5,9,3.8,29.2,2,Higher,Midwest,MI,Suburban,75+,2023-10,Q4_2023,2023,3.4,0.099,Increasing
FIA000731,2023-10-24,Amoxicillin,Amoxil,Antibiotics,14182-380-20,Tricare Standard,PLAN_3064,2023,Tier 1,Non-Formulary,2023-05-03,174,Improved,None,No,No,,379,244,55.5,Increased,15.13,344.23,-329.1,30.81,45.94,17.41,0.0,0,0.031,0.158,0.704,0.588,12,9,3,10,3.6,14.5,4,Higher,Northeast,OH,Urban,66-75,2023-10,Q4_2023,2023,6.1,0.379,Increasing
FIA002468,2023-10-24,Amoxicillin,Amoxil,Antibiotics,88656-540-71,Medicare Part D Plan A,PLAN_9710,2023,Specialty Tier,Non-Formulary,2022-12-20,308,Improved,Step Therapy,No,Yes,,467,483,-3.2,Stable,191.91,756.44,-564.53,41.39,233.3,108.95,0.0,0,0.199,0.118,0.892,0.699,4,5,0,6,4.0,6.0,8,Lower,Northeast,GA,Urban,51-65,2023-10,Q4_2023,2023,5.0,0.287,Increasing
FIA002262,2023-11-02,Amoxicillin,Amoxil,Antibiotics,19092-586-65,Commercial Plan Alpha,PLAN_7623,2023,Non-Formulary,Non-Formulary,2023-03-15,232,No Change,Non-Formulary Status,No,No,,777,810,-4.1,Stable,732.77,614.68,118.09,91.81,824.58,640.7,0.0,0,0.081,0.249,0.524,0.497,4,5,15,13,4.4,15.4,8,Similar,Northeast,PA,Suburban,51-65,2023-11,Q4_2023,2023,6.5,0.506,Increasing
FIA002632,2023-12-03,Amoxicillin,Amoxil,Antibiotics,54218-580-77,Medicaid Plan Y,PLAN_7089,2023,Non-Formulary,Tier 3,2023-03-20,258,Worsened,Non-Formulary Status,No,No,,599,644,-6.9,Decreased,737.33,57.71,679.62,53.96,791.29,473.98,0.0,0,0.171,0.068,0.414,0.617,1,4,19,14,4.4,26.1,2,Higher,Midwest,FL,Rural,18-35,2023-12,Q4_2023,2023,4.5,0.579,Increasing
FIA001757,2023-12-04,Amoxicillin,Amoxil,Antibiotics,95322-201-59,VA Plan,PLAN_3526,2023,Tier 1,Tier 1,2022-12-22,347,No Change,None,No,No,,363,367,-0.9,Stable,9.41,14.25,-4.84,97.77,107.18,38.91,0.0,0,0.07,0.368,0.692,0.735,1,8,14,4,3.7,21.2,5,Lower,Southwest,GA,Suburban,66-75,2023-12,Q4_2023,2023,3.1,0.375,Increasing
FIA002931,2023-12-05,Amoxicillin,Amoxil,Antibiotics,49999-700-17,VA Plan,PLAN_5299,2023,Specialty Tier,Specialty Tier,2022-12-15,355,No Change,Prior Authorization; Step Therapy,Yes,Yes,,491,489,0.6,Stable,132.81,286.99,-154.18,106.76,239.57,117.63,0.227,7,0.225,0.12,0.864,0.86,2,1,9,0,2.3,6.5,8,Similar,West,IL,Urban,75+,2023-12,Q4_2023,2023,9.1,0.064,Decreasing
FIA000057,2023-12-08,Amoxicillin,Amoxil,Antibiotics,80592-377-81,Medicaid Plan X,PLAN_3249,2023,Tier 2,Tier 3,2023-10-18,51,Improved,None,No,No,,710,454,56.6,Increased,28.63,85.71,-57.08,66.38,95.01,67.46,0.0,0,0.062,0.088,0.719,0.532,1,10,16,7,3.9,6.6,5,Similar,Southwest,TX,Rural,36-50,2023-12,Q4_2023,2023,1.0,0.55,Increasing
FIA001506,2023-12-18,Amoxicillin,Amoxil,Antibiotics,10025-759-86,Commercial Plan Alpha,PLAN_7892,2023,Tier 3,Non-Formulary,2023-08-21,119,Improved,Prior Authorization,Yes,No,,560,595,-5.7,Decreased,66.54,295.43,-228.89,160.43,226.97,127.1,0.528,9,0.04,0.281,0.693,0.707,4,10,15,15,3.0,14.4,5,Higher,Southwest,FL,Urban,75+,2023-12,Q4_2023,2023,5.0,0.944,Stable
FIA000290,2024-01-11,Amoxicillin,Amoxil,Antibiotics,69168-992-63,Commercial Plan Beta,PLAN_5250,2024,Specialty Tier,Specialty Tier,2023-08-25,139,No Change,None,No,No,,908,876,3.7,Stable,110.82,273.6,-162.78,43.89,154.71,140.48,0.0,0,0.118,0.114,0.238,0.892,13,5,9,5,2.6,33.3,5,Similar,West,FL,Rural,66-75,2024-01,Q1_2024,2023,4.2,0.693,Stable
FIA001376,2024-01-18,Amoxicillin,Amoxil,Antibiotics,84761-453-17,Commercial Plan Alpha,PLAN_6658,2024,Non-Formulary,Tier 1,2023-02-10,342,Worsened,Non-Formulary Status,No,No,,67,133,-49.0,Decreased,212.98,8.63,204.35,111.98,324.96,21.77,0.0,0,0.135,0.333,0.534,0.524,6,0,0,15,2.0,17.6,2,Higher,Southwest,MI,Suburban,75+,2024-01,Q1_2024,2023,8.4,0.394,Stable
FIA001458,2024-01-18,Amoxicillin,Amoxil,Antibiotics,73023-331-38,Commercial Plan Beta,PLAN_9514,2024,Specialty Tier,Tier 2,2023-03-28,296,Worsened,Quantity Limit,No,No,30.0,459,729,-37.0,Decreased,279.0,38.47,240.53,34.17,313.17,143.75,0.0,0,0.258,0.206,0.879,0.576,6,4,17,1,4.6,25.8,6,Similar,Southwest,NC,Rural,75+,2024-01,Q1_2024,2023,7.3,0.235,Decreasing
FIA000628,2024-01-21,Amoxicillin,Amoxil,Antibiotics,25930-500-84,Medicare Part D Plan A,PLAN_7298,2024,Tier 3,Specialty Tier,2023-04-10,286,Improved,Step Therapy,No,Yes,,375,363,3.4,Stable,51.57,133.94,-82.37,61.66,113.23,42.46,0.0,0,0.038,0.261,0.734,0.703,14,4,12,15,2.1,29.0,7,Higher,Midwest,TX,Suburban,75+,2024-01,Q1_2024,2023,7.2,0.246,Stable
FIA001326,2024-01-21,Amoxicillin,Amoxil,Antibiotics,27295-211-93,Tricare Standard,PLAN_7230,2024,Tier 3,Non-Formulary,2023-04-17,279,Improved,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,30.0,323,330,-2.1,Stable,72.63,666.64,-594.01,78.83,151.46,48.92,0.583,1,0.055,0.367,0.657,0.866,5,8,19,7,4.7,32.5,3,Higher,Northeast,CA,Rural,75+,2024-01,Q1_2024,2023,2.5,0.019,Increasing
FIA002492,2024-01-22,Amoxicillin,Amoxil,Antibiotics,19830-900-34,Medicare Part D Plan A,PLAN_9720,2024,Specialty Tier,Tier 2,2023-04-28,269,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,267,804,-66.7,Decreased,120.11,39.92,80.19,100.91,221.02,59.01,0.201,6,0.136,0.099,0.548,0.717,7,5,6,1,4.9,33.9,8,Similar,Southwest,FL,Urban,75+,2024-01,Q1_2024,2023,5.2,0.378,Increasing
FIA000815,2024-02-07,Amoxicillin,Amoxil,Antibiotics,30216-502-15,VA Plan,PLAN_8938,2024,Non-Formulary,Specialty Tier,2023-06-18,234,Worsened,Non-Formulary Status,No,No,,438,454,-3.5,Stable,792.06,197.19,594.87,71.66,863.72,378.31,0.0,0,0.054,0.35,0.852,0.854,12,10,4,15,2.4,23.9,7,Lower,Southwest,PA,Rural,75+,2024-02,Q1_2024,2023,1.6,0.599,Increasing
FIA000247,2024-02-12,Amoxicillin,Amoxil,Antibiotics,38910-198-95,Commercial Plan Alpha,PLAN_3736,2024,Tier 2,Tier 2,2023-07-06,221,No Change,None,No,No,,114,116,-1.6,Stable,47.26,26.0,21.26,143.72,190.98,21.77,0.0,0,0.023,0.065,0.559,0.849,10,8,20,6,3.9,33.0,5,Similar,Northeast,NY,Urban,18-35,2024-02,Q1_2024,2023,4.2,0.174,Stable
FIA000578,2024-02-13,Amoxicillin,Amoxil,Antibiotics,62069-537-91,Commercial Plan Beta,PLAN_3620,2024,Non-Formulary,Tier 3,2023-12-09,66,Worsened,Non-Formulary Status,No,No,,310,294,5.8,Increased,567.25,93.75,473.5,183.64,750.89,232.78,0.0,0,0.206,0.382,0.618,0.574,7,4,5,14,4.8,19.2,8,Lower,Southeast,IL,Rural,36-50,2024-02,Q1_2024,2023,1.2,0.081,Stable
FIA002351,2024-02-19,Amoxicillin,Amoxil,Antibiotics,57180-313-91,Medicare Part D Plan A,PLAN_4757,2024,Non-Formulary,Tier 3,2023-08-19,184,Worsened,Non-Formulary Status,No,No,,159,177,-9.7,Decreased,282.6,53.31,229.29,37.61,320.21,50.91,0.0,0,0.203,0.11,0.742,0.835,2,5,3,14,2.3,12.7,7,Similar,Midwest,OH,Suburban,66-75,2024-02,Q1_2024,2023,3.1,0.577,Decreasing
FIA000258,2024-02-25,Amoxicillin,Amoxil,Antibiotics,39334-689-86,Medicare Part D Plan B,PLAN_6623,2024,Tier 3,Tier 2,2023-09-17,161,Worsened,None,No,No,,580,786,-26.2,Decreased,83.3,48.55,34.75,147.6,230.9,133.92,0.0,0,0.016,0.182,0.702,0.805,12,10,20,13,4.4,11.7,2,Similar,Northeast,TX,Urban,51-65,2024-02,Q1_2024,2023,7.7,0.937,Decreasing
FIA001881,2024-02-28,Amoxicillin,Amoxil,Antibiotics,70802-408-35,VA Plan,PLAN_2225,2024,Tier 1,Tier 3,2023-07-31,212,Improved,None,No,No,,242,173,40.3,Increased,5.26,53.84,-48.58,193.32,198.58,48.06,0.0,0,0.071,0.112,0.246,0.491,12,1,16,2,2.4,6.9,8,Higher,Southeast,TX,Urban,18-35,2024-02,Q1_2024,2023,8.1,0.79,Decreasing
FIA001519,2024-02-29,Amoxicillin,Amoxil,Antibiotics,63346-482-22,Commercial Plan Beta,PLAN_4538,2024,Tier 3,Tier 1,2023-03-08,358,Worsened,None,No,No,,145,424,-65.8,Decreased,61.42,5.75,55.67,105.31,166.73,24.18,0.0,0,0.013,0.168,0.787,0.555,11,7,13,1,2.7,34.7,8,Higher,Southwest,TX,Urban,75+,2024-02,Q1_2024,2023,3.4,0.975,Decreasing
FIA001122,2024-03-09,Amoxicillin,Amoxil,Antibiotics,38259-747-70,Medicare Part D Plan A,PLAN_4426,2024,Tier 2,Non-Formulary,2023-03-22,353,Improved,None,No,No,,1077,853,26.3,Increased,31.34,761.31,-729.97,191.95,223.29,240.48,0.0,0,0.066,0.29,0.441,0.946,15,8,14,5,3.2,7.9,8,Lower,Northeast,MI,Urban,36-50,2024-03,Q1_2024,2023,7.5,0.951,Increasing
FIA001039,2024-03-18,Amoxicillin,Amoxil,Antibiotics,79620-364-44,Commercial Plan Alpha,PLAN_8535,2024,Tier 1,Tier 2,2023-12-12,97,Improved,None,No,No,,352,336,5.0,Stable,10.58,39.47,-28.89,116.45,127.03,44.71,0.0,0,0.054,0.245,0.45,0.777,7,6,2,15,3.8,12.9,5,Higher,Midwest,IL,Suburban,75+,2024-03,Q1_2024,2023,7.3,0.896,Decreasing
FIA001657,2024-03-20,Amoxicillin,Amoxil,Antibiotics,43649-235-58,Medicare Part D Plan A,PLAN_8858,2024,Non-Formulary,Tier 3,2023-09-18,184,Worsened,Non-Formulary Status,No,No,,344,368,-6.5,Decreased,782.38,54.02,728.36,129.69,912.07,313.75,0.0,0,0.205,0.072,0.342,0.719,8,3,17,4,3.3,28.6,7,Similar,Northeast,FL,Urban,75+,2024-03,Q1_2024,2023,4.2,0.264,Decreasing
FIA000070,2024-03-23,Amoxicillin,Amoxil,Antibiotics,91083-402-41,Medicare Part D Plan B,PLAN_2344,2024,Tier 3,Tier 1,2023-04-04,354,Worsened,None,No,No,,412,602,-31.4,Decreased,63.67,19.89,43.78,94.61,158.28,65.21,0.0,0,0.051,0.144,0.466,0.831,4,6,10,11,2.3,5.2,4,Similar,Midwest,PA,Urban,36-50,2024-03,Q1_2024,2023,1.8,0.431,Decreasing
FIA001305,2024-04-10,Amoxicillin,Amoxil,Antibiotics,76455-554-59,Medicare Part D Plan B,PLAN_8068,2024,Tier 3,Tier 1,2023-10-28,165,Worsened,Quantity Limit,No,No,,232,295,-21.1,Decreased,53.14,8.5,44.64,128.14,181.28,42.06,0.0,0,0.021,0.376,0.767,0.745,3,7,0,5,4.0,10.6,3,Similar,Southeast,GA,Suburban,36-50,2024-04,Q2_2024,2023,5.2,0.534,Increasing
FIA001072,2024-05-04,Amoxicillin,Amoxil,Antibiotics,25899-504-84,Commercial Plan Beta,PLAN_5388,2024,Tier 1,Tier 2,2023-11-03,183,Improved,Quantity Limit,No,No,90.0,617,653,-5.4,Decreased,9.1,45.5,-36.4,122.56,131.66,81.23,0.0,0,0.048,0.197,0.248,0.474,6,7,15,7,3.9,23.3,8,Lower,Northeast,FL,Urban,18-35,2024-05,Q2_2024,2023,1.7,0.215,Decreasing
FIA002174,2024-05-05,Amoxicillin,Amoxil,Antibiotics,37077-356-83,Tricare Standard,PLAN_9429,2024,Non-Formulary,Tier 2,2024-01-24,102,Worsened,Non-Formulary Status,No,No,,289,929,-68.8,Decreased,208.01,26.44,181.57,124.47,332.48,96.09,0.0,0,0.247,0.161,0.773,0.911,4,3,4,12,3.1,34.3,3,Higher,Southeast,TX,Urban,75+,2024-05,Q2_2024,2023,4.7,0.007,Stable
FIA002898,2024-05-11,Amoxicillin,Amoxil,Antibiotics,31281-128-50,Medicare Part D Plan B,PLAN_3952,2024,Tier 1,Specialty Tier,2023-12-10,153,Improved,None,No,No,,276,185,49.3,Increased,12.0,294.08,-282.08,139.88,151.88,41.92,0.0,0,0.073,0.181,0.365,0.476,12,10,3,8,4.0,8.2,8,Lower,Southwest,TX,Suburban,51-65,2024-05,Q2_2024,2023,7.2,0.876,Stable
FIA001716,2024-05-17,Amoxicillin,Amoxil,Antibiotics,15012-515-66,Tricare Standard,PLAN_5868,2024,Specialty Tier,Specialty Tier,2024-02-13,94,No Change,Quantity Limit,No,No,30.0,310,296,5.0,Increased,167.15,189.74,-22.59,166.77,333.92,103.52,0.0,0,0.081,0.073,0.784,0.868,6,0,13,6,4.2,13.9,8,Higher,Southwest,TX,Urban,75+,2024-05,Q2_2024,2023,3.3,0.332,Decreasing
FIA001424,2024-06-08,Amoxicillin,Amoxil,Antibiotics,23888-730-46,Tricare Standard,PLAN_6147,2024,Tier 3,Non-Formulary,2023-06-26,348,Improved,None,No,No,,580,557,4.1,Stable,69.02,300.74,-231.72,49.24,118.26,68.59,0.0,0,0.013,0.067,0.864,0.596,5,2,1,3,2.2,31.5,8,Similar,Northeast,PA,Urban,36-50,2024-06,Q2_2024,2023,9.6,0.369,Decreasing
FIA000411,2024-06-28,Amoxicillin,Amoxil,Antibiotics,82427-588-57,Commercial Plan Alpha,PLAN_6165,2024,Tier 3,Tier 1,2024-01-10,170,Worsened,Quantity Limit,No,No,90.0,413,721,-42.7,Decreased,72.8,7.97,64.83,177.52,250.32,103.38,0.0,0,0.019,0.243,0.64,0.755,12,2,10,1,3.9,14.7,8,Higher,Northeast,NC,Urban,36-50,2024-06,Q2_2024,2023,5.5,0.927,Increasing
FIA000902,2024-06-28,Amoxicillin,Amoxil,Antibiotics,21587-927-68,Medicaid Plan X,PLAN_1760,2024,Specialty Tier,Specialty Tier,2023-08-10,323,No Change,Prior Authorization; Step Therapy,Yes,Yes,,544,558,-2.4,Stable,254.29,237.35,16.94,88.4,342.69,186.42,0.102,6,0.183,0.232,0.631,0.615,2,4,8,1,3.5,11.3,8,Similar,West,OH,Urban,51-65,2024-06,Q2_2024,2023,7.6,0.674,Stable
FIA001736,2024-06-29,Amoxicillin,Amoxil,Antibiotics,55638-147-51,VA Plan,PLAN_4331,2024,Non-Formulary,Tier 2,2024-01-29,152,Worsened,Non-Formulary Status; Quantity Limit,No,No,,59,128,-53.5,Decreased,781.63,47.01,734.62,81.14,862.77,50.9,0.0,0,0.296,0.07,0.464,0.487,9,4,2,14,4.4,19.0,5,Higher,West,MI,Suburban,18-35,2024-06,Q2_2024,2023,7.2,0.926,Decreasing
FIA000510,2024-07-02,Amoxicillin,Amoxil,Antibiotics,80851-964-31,Medicare Part D Plan B,PLAN_2458,2024,Tier 1,Tier 1,2024-01-19,165,No Change,None,No,No,,720,776,-7.2,Decreased,7.48,11.46,-3.98,169.37,176.85,127.33,0.0,0,0.046,0.194,0.789,0.763,0,10,20,8,2.3,32.9,6,Lower,Southeast,IL,Rural,75+,2024-07,Q3_2024,2023,6.1,0.595,Decreasing
FIA001568,2024-07-04,Amoxicillin,Amoxil,Antibiotics,38993-454-32,Medicare Part D Plan B,PLAN_9129,2024,Non-Formulary,Non-Formulary,2024-02-17,138,No Change,Non-Formulary Status,No,No,,501,516,-2.9,Stable,627.22,557.65,69.57,199.75,826.97,414.31,0.0,0,0.187,0.05,0.678,0.562,13,4,2,4,2.6,25.8,8,Higher,Northeast,IL,Suburban,18-35,2024-07,Q3_2024,2023,2.4,0.261,Stable
FIA002654,2024-07-05,Amoxicillin,Amoxil,Antibiotics,55625-157-47,Commercial Plan Beta,PLAN_5880,2024,Non-Formulary,Tier 2,2023-09-28,281,Worsened,Non-Formulary Status,No,No,,296,482,-38.4,Decreased,729.72,41.38,688.34,164.77,894.49,264.77,0.0,0,0.145,0.345,0.578,0.62,3,10,3,14,4.4,7.7,3,Lower,Northeast,FL,Suburban,75+,2024-07,Q3_2024,2023,9.8,0.905,Decreasing
FIA001240,2024-07-29,Amoxicillin,Amoxil,Antibiotics,24533-827-78,Medicare Part D Plan A,PLAN_1089,2024,Tier 1,Tier 3,2024-06-10,49,Improved,Quantity Limit,No,No,90.0,135,114,18.6,Increased,5.44,74.72,-69.28,158.82,164.26,22.18,0.0,0,0.042,0.369,0.588,0.498,9,5,11,14,3.3,20.9,5,Similar,Southwest,CA,Suburban,66-75,2024-07,Q3_2024,2023,5.4,0.688,Decreasing
FIA001232,2024-08-02,Amoxicillin,Amoxil,Antibiotics,73909-591-42,Tricare Standard,PLAN_9820,2024,Specialty Tier,Non-Formulary,2024-03-02,153,Improved,Prior Authorization,Yes,No,,647,639,1.4,Stable,246.76,727.81,-481.05,58.18,304.94,197.3,0.363,7,0.159,0.372,0.258,0.562,14,6,5,12,4.6,33.7,5,Similar,Southeast,PA,Urban,51-65,2024-08,Q3_2024,2023,5.4,0.074,Decreasing
FIA002207,2024-08-16,Amoxicillin,Amoxil,Antibiotics,94770-624-28,Medicare Part D Plan B,PLAN_2837,2024,Specialty Tier,Tier 2,2024-05-19,89,Worsened,Quantity Limit,No,No,30.0,69,120,-41.8,Decreased,122.11,47.27,74.84,48.33,170.44,11.76,0.0,0,0.197,0.05,0.303,0.928,9,1,16,10,4.3,7.1,5,Similar,Midwest,TX,Suburban,18-35,2024-08,Q3_2024,2023,6.4,0.368,Stable
FIA000066,2024-08-19,Amoxicillin,Amoxil,Antibiotics,29976-300-52,Commercial Plan Beta,PLAN_7223,2024,Tier 3,Tier 2,2024-01-13,219,Worsened,Quantity Limit,No,No,30.0,678,984,-31.1,Decreased,65.65,21.37,44.28,100.99,166.64,112.98,0.0,0,0.051,0.225,0.658,0.777,8,7,20,15,3.4,27.0,4,Lower,Southeast,NC,Suburban,36-50,2024-08,Q3_2024,2023,9.3,0.542,Decreasing
FIA002192,2024-08-19,Amoxicillin,Amoxil,Antibiotics,66776-341-81,Commercial Plan Beta,PLAN_9455,2024,Tier 3,Non-Formulary,2024-07-15,35,Improved,None,No,No,,345,336,2.7,Stable,58.44,631.0,-572.56,93.52,151.96,52.43,0.0,0,0.028,0.158,0.244,0.559,2,6,19,3,3.0,14.7,2,Lower,West,OH,Rural,18-35,2024-08,Q3_2024,2023,8.1,0.311,Decreasing
FIA002914,2024-08-19,Amoxicillin,Amoxil,Antibiotics,34114-627-82,Tricare Standard,PLAN_6573,2024,Tier 1,Tier 1,2024-06-30,50,No Change,None,No,No,,621,641,-3.0,Stable,10.88,12.55,-1.67,54.31,65.19,40.48,0.0,0,0.042,0.226,0.82,0.844,3,2,5,8,2.8,13.3,6,Higher,West,GA,Urban,75+,2024-08,Q3_2024,2023,2.9,0.404,Stable
FIA002971,2024-08-27,Amoxicillin,Amoxil,Antibiotics,91719-156-22,Medicare Part D Plan A,PLAN_4268,2024,Non-Formulary,Tier 2,2023-09-21,341,Worsened,Non-Formulary Status,No,No,,329,817,-59.7,Decreased,232.83,35.1,197.73,68.6,301.43,99.17,0.0,0,0.12,0.269,0.63,0.503,10,5,19,1,4.2,7.0,6,Higher,Southwest,FL,Urban,36-50,2024-08,Q3_2024,2023,6.8,0.355,Increasing
FIA002159,2024-09-12,Amoxicillin,Amoxil,Antibiotics,78895-716-27,Medicare Part D Plan B,PLAN_7256,2024,Tier 2,Tier 2,2023-11-03,314,No Change,None,No,No,,668,714,-6.4,Decreased,24.39,23.2,1.19,132.5,156.89,104.8,0.0,0,0.018,0.244,0.816,0.716,8,7,19,6,3.8,30.1,3,Higher,Southwest,PA,Suburban,75+,2024-09,Q3_2024,2023,1.1,0.998,Decreasing
FIA001671,2024-09-17,Amoxicillin,Amoxil,Antibiotics,13337-620-62,Commercial Plan Beta,PLAN_4409,2024,Tier 2,Non-Formulary,2023-12-27,265,Improved,None,No,No,,1120,892,25.6,Increased,24.47,670.22,-645.75,140.15,164.62,184.37,0.0,0,0.075,0.34,0.412,0.803,11,3,18,14,4.8,31.2,2,Higher,Southeast,MI,Rural,18-35,2024-09,Q3_2024,2023,7.2,0.954,Decreasing
FIA000101,2024-09-19,Amoxicillin,Amoxil,Antibiotics,13794-277-34,Commercial Plan Beta,PLAN_1944,2024,Non-Formulary,Tier 3,2024-07-23,58,Worsened,Non-Formulary Status,No,No,,435,418,4.2,Stable,509.16,57.95,451.21,179.49,688.65,299.56,0.0,0,0.263,0.137,0.52,0.905,6,4,11,14,3.5,24.1,2,Higher,Northeast,NY,Suburban,66-75,2024-09,Q3_2024,2023,6.3,0.178,Stable
FIA000710,2024-09-22,Amoxicillin,Amoxil,Antibiotics,69525-959-16,VA Plan,PLAN_9977,2024,Non-Formulary,Tier 1,2023-11-17,310,Worsened,Non-Formulary Status,No,No,,470,787,-40.3,Decreased,473.66,5.68,467.98,51.91,525.57,247.02,0.0,0,0.156,0.278,0.202,0.875,6,3,2,11,4.8,10.4,7,Lower,Northeast,OH,Urban,18-35,2024-09,Q3_2024,2023,2.7,0.054,Decreasing
FIA000852,2024-09-22,Amoxicillin,Amoxil,Antibiotics,39257-846-98,Medicaid Plan X,PLAN_5160,2024,Non-Formulary,Tier 1,2023-10-28,330,Worsened,Non-Formulary Status,No,No,,266,850,-68.7,Decreased,254.68,8.74,245.94,151.63,406.31,108.08,0.0,0,0.055,0.376,0.882,0.739,15,1,10,15,4.6,14.4,5,Lower,Southwest,OH,Urban,36-50,2024-09,Q3_2024,2023,9.6,0.632,Increasing
FIA000381,2024-09-24,Amoxicillin,Amoxil,Antibiotics,17425-753-23,Medicaid Plan X,PLAN_5519,2024,Tier 3,Tier 2,2023-12-02,297,Worsened,Prior Authorization; Quantity Limit,Yes,No,60.0,229,717,-68.0,Decreased,55.15,49.93,5.22,103.52,158.67,36.34,0.347,9,0.059,0.165,0.667,0.538,11,1,0,3,4.1,19.6,6,Similar,Southeast,MI,Suburban,51-65,2024-09,Q3_2024,2023,1.9,0.781,Decreasing
FIA001683,2024-09-24,Amoxicillin,Amoxil,Antibiotics,64781-573-66,Medicaid Plan Y,PLAN_8195,2024,Tier 2,Tier 2,2024-07-21,65,No Change,None,No,No,,312,326,-4.3,Stable,45.96,41.03,4.93,122.16,168.12,52.45,0.0,0,0.07,0.096,0.509,0.46,8,6,0,11,2.6,32.7,5,Higher,Midwest,GA,Suburban,18-35,2024-09,Q3_2024,2023,6.5,0.792,Increasing
FIA001113,2024-10-01,Amoxicillin,Amoxil,Antibiotics,54789-377-64,Tricare Standard,PLAN_4949,2024,Tier 3,Tier 2,2023-11-05,331,Worsened,Prior Authorization,Yes,No,,284,425,-33.0,Decreased,70.4,34.35,36.05,30.96,101.36,28.79,0.296,1,0.061,0.314,0.562,0.676,3,0,5,10,2.6,7.8,6,Lower,Southwest,OH,Urban,51-65,2024-10,Q4_2024,2024,3.4,0.495,Decreasing
FIA001710,2024-10-03,Amoxicillin,Amoxil,Antibiotics,36138-518-78,Tricare Standard,PLAN_7714,2024,Non-Formulary,Tier 3,2023-12-08,300,Worsened,Non-Formulary Status,No,No,,827,785,5.5,Increased,758.56,95.99,662.57,126.34,884.9,731.81,0.0,0,0.082,0.09,0.215,0.572,10,6,2,3,4.8,15.4,8,Similar,Midwest,TX,Urban,66-75,2024-10,Q4_2024,2024,9.4,0.807,Decreasing
FIA002922,2024-10-23,Amoxicillin,Amoxil,Antibiotics,41526-531-69,Medicaid Plan X,PLAN_4574,2024,Non-Formulary,Tier 3,2024-06-24,121,Worsened,Non-Formulary Status,No,No,,899,922,-2.4,Stable,508.47,76.45,432.02,168.51,676.98,608.61,0.0,0,0.196,0.116,0.425,0.712,12,4,4,4,2.7,14.0,6,Lower,West,TX,Suburban,36-50,2024-10,Q4_2024,2024,2.2,0.971,Decreasing
FIA002655,2024-10-25,Amoxicillin,Amoxil,Antibiotics,33204-420-50,Medicaid Plan X,PLAN_9702,2024,Tier 1,Tier 2,2024-06-24,123,Improved,None,No,No,,270,250,8.0,Increased,5.66,41.49,-35.83,99.41,105.07,28.37,0.0,0,0.022,0.128,0.422,0.831,5,2,18,6,2.1,34.3,2,Similar,West,OH,Rural,51-65,2024-10,Q4_2024,2024,1.9,0.299,Increasing
FIA000559,2024-11-01,Amoxicillin,Amoxil,Antibiotics,82564-327-81,Commercial Plan Alpha,PLAN_2468,2024,Tier 2,Tier 2,2024-03-21,225,No Change,None,No,No,,211,227,-6.9,Decreased,21.16,20.42,0.74,170.02,191.18,40.34,0.0,0,0.069,0.387,0.545,0.837,13,4,17,8,4.3,19.4,4,Similar,Midwest,FL,Urban,36-50,2024-11,Q4_2024,2024,9.8,0.964,Decreasing
FIA000985,2024-11-05,Amoxicillin,Amoxil,Antibiotics,85290-994-33,Medicaid Plan Y,PLAN_5650,2024,Tier 2,Tier 2,2024-02-21,258,No Change,None,No,No,,586,557,5.4,Increased,33.16,29.89,3.27,76.16,109.32,64.06,0.0,0,0.075,0.358,0.282,0.519,14,2,9,7,3.4,19.1,2,Lower,Southwest,CA,Rural,51-65,2024-11,Q4_2024,2024,8.9,0.893,Decreasing
FIA001623,2024-11-18,Amoxicillin,Amoxil,Antibiotics,75526-507-89,Commercial Plan Beta,PLAN_1903,2024,Specialty Tier,Non-Formulary,2023-12-26,328,Improved,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,30.0,686,637,7.7,Increased,133.49,577.17,-443.68,86.72,220.21,151.06,0.394,8,0.254,0.335,0.222,0.729,2,10,19,0,3.3,10.7,7,Higher,Northeast,IL,Rural,51-65,2024-11,Q4_2024,2024,3.0,0.307,Decreasing
FIA002783,2024-11-19,Amoxicillin,Amoxil,Antibiotics,25134-892-90,Commercial Plan Beta,PLAN_9077,2024,Non-Formulary,Specialty Tier,2024-09-13,67,Worsened,Non-Formulary Status,No,No,,477,441,8.2,Increased,751.05,214.34,536.71,33.13,784.18,374.05,0.0,0,0.112,0.374,0.762,0.861,6,2,14,12,3.3,32.2,7,Similar,West,IL,Urban,18-35,2024-11,Q4_2024,2024,5.0,0.758,Decreasing
FIA001808,2024-11-23,Amoxicillin,Amoxil,Antibiotics,75803-625-80,Medicaid Plan X,PLAN_3321,2024,Tier 2,Specialty Tier,2024-02-25,272,Improved,Quantity Limit,No,No,90.0,198,154,28.9,Increased,34.46,131.57,-97.11,175.55,210.01,41.58,0.0,0,0.08,0.346,0.716,0.798,13,5,13,9,4.8,15.8,3,Higher,Southeast,NC,Suburban,18-35,2024-11,Q4_2024,2024,8.9,0.944,Stable
FIA000690,2024-12-03,Amoxicillin,Amoxil,Antibiotics,19006-888-75,Tricare Standard,PLAN_5851,2024,Specialty Tier,Non-Formulary,2024-08-28,97,Improved,None,No,No,,170,173,-1.7,Stable,158.23,234.49,-76.26,81.43,239.66,40.74,0.0,0,0.114,0.052,0.761,0.858,6,8,13,13,2.1,28.3,8,Similar,Southwest,CA,Rural,18-35,2024-12,Q4_2024,2024,5.1,0.958,Stable
FIA002752,2024-12-03,Amoxicillin,Amoxil,Antibiotics,18853-324-30,Commercial Plan Beta,PLAN_8367,2024,Non-Formulary,Tier 3,2024-06-26,160,Worsened,Non-Formulary Status,No,No,,410,401,2.3,Stable,390.11,98.65,291.46,152.34,542.45,222.4,0.0,0,0.265,0.082,0.369,0.926,14,9,10,7,3.8,14.0,4,Higher,Midwest,MI,Urban,75+,2024-12,Q4_2024,2024,6.6,0.719,Decreasing
FIA000193,2024-12-07,Amoxicillin,Amoxil,Antibiotics,24643-179-12,Tricare Standard,PLAN_8065,2024,Tier 3,Tier 2,2024-06-05,185,Worsened,Prior Authorization,Yes,No,,240,327,-26.4,Decreased,51.44,44.44,7.0,102.22,153.66,36.88,0.205,1,0.079,0.119,0.223,0.763,1,7,3,8,2.1,14.0,2,Lower,Northeast,MI,Urban,75+,2024-12,Q4_2024,2024,9.1,0.185,Stable
FIA002470,2024-12-15,Amoxicillin,Amoxil,Antibiotics,32475-294-37,Medicare Part D Plan B,PLAN_9463,2024,Specialty Tier,Tier 2,2024-10-16,60,Worsened,None,No,No,,80,131,-38.9,Decreased,167.38,39.83,127.55,199.43,366.81,29.34,0.0,0,0.181,0.395,0.493,0.902,15,7,0,4,3.7,12.6,6,Higher,Southeast,NC,Rural,36-50,2024-12,Q4_2024,2024,3.2,0.104,Increasing
FIA001802,2025-01-02,Amoxicillin,Amoxil,Antibiotics,87086-573-28,Tricare Standard,PLAN_3942,2025,Tier 3,Tier 1,2024-06-18,198,Worsened,Prior Authorization,Yes,No,,88,192,-53.9,Decreased,90.06,8.72,81.34,43.54,133.6,11.76,0.127,9,0.068,0.208,0.523,0.516,1,4,4,7,3.5,25.1,6,Lower,West,CA,Urban,66-75,2025-01,Q1_2025,2024,8.3,0.738,Decreasing
FIA002962,2025-01-05,Amoxicillin,Amoxil,Antibiotics,17307-684-12,Medicaid Plan Y,PLAN_4480,2025,Tier 3,Specialty Tier,2024-06-01,218,Improved,Step Therapy,No,Yes,,379,391,-2.8,Stable,53.26,189.31,-136.05,139.62,192.88,73.1,0.0,0,0.051,0.251,0.216,0.423,8,4,8,3,4.6,8.4,5,Similar,West,NY,Suburban,18-35,2025-01,Q1_2025,2024,6.0,0.218,Stable
FIA000292,2025-01-23,Amoxicillin,Amoxil,Antibiotics,12122-409-49,Medicare Part D Plan B,PLAN_9177,2025,Tier 2,Non-Formulary,2024-06-14,223,Improved,None,No,No,,468,295,58.7,Increased,26.48,325.86,-299.38,168.34,194.82,91.18,0.0,0,0.011,0.277,0.519,0.626,11,8,13,10,2.3,10.3,5,Similar,Southeast,NC,Rural,36-50,2025-01,Q1_2025,2024,5.9,0.382,Decreasing
FIA002981,2025-02-10,Amoxicillin,Amoxil,Antibiotics,85420-274-14,Medicare Part D Plan A,PLAN_8584,2025,Specialty Tier,Tier 1,2024-09-06,157,Worsened,Prior Authorization,Yes,No,,279,625,-55.3,Decreased,235.83,12.95,222.88,188.43,424.26,118.37,0.443,3,0.162,0.364,0.521,0.894,0,9,0,11,4.6,15.3,8,Higher,Midwest,OH,Urban,18-35,2025-02,Q1_2025,2024,7.6,0.889,Stable
FIA001411,2025-02-18,Amoxicillin,Amoxil,Antibiotics,99411-813-44,VA Plan,PLAN_9532,2025,Tier 1,Specialty Tier,2024-05-02,292,Improved,Quantity Limit,No,No,,616,417,47.7,Increased,5.52,147.5,-141.98,195.31,200.83,123.71,0.0,0,0.01,0.078,0.691,0.51,8,3,7,13,2.0,15.7,4,Lower,Southeast,TX,Rural,18-35,2025-02,Q1_2025,2024,2.1,0.986,Stable
FIA000113,2025-02-21,Amoxicillin,Amoxil,Antibiotics,48270-660-76,Medicaid Plan Y,PLAN_2741,2025,Non-Formulary,Non-Formulary,2024-05-25,272,No Change,Non-Formulary Status,No,No,,519,563,-7.7,Decreased,629.99,417.98,212.01,137.72,767.71,398.44,0.0,0,0.139,0.066,0.315,0.477,13,1,8,6,2.6,32.9,5,Lower,Southwest,NY,Rural,51-65,2025-02,Q1_2025,2024,2.0,0.414,Decreasing
FIA000036,2025-02-22,Amoxicillin,Amoxil,Antibiotics,54541-459-10,Commercial Plan Alpha,PLAN_3347,2025,Non-Formulary,Non-Formulary,2024-02-29,359,No Change,Non-Formulary Status,No,No,,823,773,6.6,Increased,534.04,565.4,-31.36,159.61,693.65,570.87,0.0,0,0.118,0.248,0.481,0.478,0,1,16,6,3.1,18.6,3,Similar,Midwest,IL,Rural,75+,2025-02,Q1_2025,2024,1.8,0.053,Increasing
FIA000276,2025-02-25,Amoxicillin,Amoxil,Antibiotics,38879-403-44,Medicare Part D Plan B,PLAN_3803,2025,Specialty Tier,Specialty Tier,2024-03-22,340,No Change,Prior Authorization; Step Therapy,Yes,Yes,,266,263,1.4,Stable,154.3,136.81,17.49,81.58,235.88,62.74,0.454,4,0.181,0.066,0.367,0.421,4,4,4,8,4.6,6.5,3,Lower,West,TX,Urban,51-65,2025-02,Q1_2025,2024,6.7,0.972,Stable
FIA000338,2025-03-06,Amoxicillin,Amoxil,Antibiotics,10730-374-98,Commercial Plan Beta,PLAN_9007,2025,Tier 2,Tier 1,2024-05-28,282,Worsened,None,No,No,,474,445,6.7,Increased,27.56,9.67,17.89,99.11,126.67,60.04,0.0,0,0.05,0.241,0.419,0.759,10,7,15,2,4.8,17.8,2,Similar,Southeast,CA,Urban,75+,2025-03,Q1_2025,2024,7.7,0.166,Stable
FIA002066,2025-03-06,Amoxicillin,Amoxil,Antibiotics,40114-434-77,Medicare Part D Plan A,PLAN_6346,2025,Tier 2,Non-Formulary,2024-03-26,345,Improved,None,No,No,,374,301,24.5,Increased,36.32,345.84,-309.52,143.65,179.97,67.31,0.0,0,0.044,0.341,0.585,0.737,10,9,16,2,2.8,20.5,2,Similar,West,IL,Urban,51-65,2025-03,Q1_2025,2024,4.1,0.488,Stable
FIA000349,2025-03-09,Amoxicillin,Amoxil,Antibiotics,10110-774-28,Commercial Plan Beta,PLAN_3819,2025,Tier 2,Tier 2,2024-08-21,200,No Change,Quantity Limit,No,No,60.0,184,192,-3.8,Stable,43.66,21.61,22.05,58.11,101.77,18.73,0.0,0,0.042,0.158,0.329,0.872,13,1,7,4,4.1,30.4,4,Lower,Southwest,FL,Suburban,18-35,2025-03,Q1_2025,2024,5.2,0.687,Decreasing
FIA000567,2025-03-13,Amoxicillin,Amoxil,Antibiotics,43737-904-19,Medicaid Plan X,PLAN_2987,2025,Tier 3,Non-Formulary,2024-07-25,231,Improved,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,90.0,762,773,-1.3,Stable,67.43,369.02,-301.59,67.64,135.07,102.92,0.571,10,0.03,0.375,0.612,0.814,7,4,8,14,2.9,22.2,4,Similar,Midwest,CA,Rural,75+,2025-03,Q1_2025,2024,2.5,0.225,Decreasing
FIA001938,2025-03-15,Amoxicillin,Amoxil,Antibiotics,81031-526-18,Medicaid Plan X,PLAN_7930,2025,Tier 3,Tier 1,2024-07-06,252,Worsened,Step Therapy,No,Yes,,395,628,-37.0,Decreased,82.78,18.44,64.34,30.7,113.48,44.82,0.0,0,0.041,0.346,0.612,0.43,14,10,9,5,2.7,28.9,6,Lower,Southwest,OH,Urban,36-50,2025-03,Q1_2025,2024,2.0,0.868,Stable
FIA000159,2025-03-18,Amoxicillin,Amoxil,Antibiotics,18869-876-64,Medicare Part D Plan B,PLAN_5797,2025,Non-Formulary,Tier 2,2024-06-28,263,Worsened,Non-Formulary Status,No,No,,102,136,-24.7,Decreased,649.6,30.81,618.79,94.42,744.02,75.89,0.0,0,0.142,0.215,0.285,0.873,10,8,13,6,4.1,23.4,2,Higher,West,TX,Suburban,75+,2025-03,Q1_2025,2024,9.4,0.986,Stable
FIA000106,2025-03-26,Amoxicillin,Amoxil,Antibiotics,36137-848-57,Medicare Part D Plan A,PLAN_6279,2025,Tier 2,Specialty Tier,2025-01-10,75,Improved,Quantity Limit,No,No,30.0,717,539,33.2,Increased,23.88,186.74,-162.86,36.41,60.29,43.23,0.0,0,0.037,0.056,0.203,0.803,7,5,9,4,2.3,20.1,4,Lower,Northeast,CA,Suburban,51-65,2025-03,Q1_2025,2024,5.1,0.52,Decreasing
FIA002211,2025-04-30,Amoxicillin,Amoxil,Antibiotics,63291-958-48,Medicaid Plan X,PLAN_7685,2025,Tier 1,Specialty Tier,2024-08-25,248,Improved,None,No,No,,1108,867,27.9,Increased,13.56,209.88,-196.32,96.53,110.09,121.98,0.0,0,0.011,0.348,0.247,0.655,15,10,18,4,4.1,34.5,2,Lower,West,NC,Urban,51-65,2025-04,Q2_2025,2024,6.2,0.658,Decreasing
FIA000167,2025-05-06,Amoxicillin,Amoxil,Antibiotics,36956-797-50,Medicaid Plan X,PLAN_5989,2025,Specialty Tier,Tier 3,2024-07-27,283,Worsened,Prior Authorization,Yes,No,,342,322,6.3,Increased,229.0,53.07,175.93,106.02,335.02,114.58,0.246,7,0.204,0.301,0.841,0.945,0,9,16,12,4.5,30.6,2,Similar,West,CA,Urban,75+,2025-05,Q2_2025,2024,8.4,0.359,Stable
FIA001451,2025-05-07,Amoxicillin,Amoxil,Antibiotics,18013-721-83,Tricare Standard,PLAN_3465,2025,Tier 3,Tier 3,2024-12-29,129,No Change,None,No,No,,842,926,-9.0,Decreased,80.27,96.26,-15.99,70.03,150.3,126.55,0.0,0,0.048,0.232,0.428,0.745,3,7,18,6,4.1,28.1,4,Lower,Northeast,PA,Rural,18-35,2025-05,Q2_2025,2024,3.4,0.911,Stable
FIA001166,2025-06-01,Amoxicillin,Amoxil,Antibiotics,38428-894-99,Medicare Part D Plan B,PLAN_4475,2025,Non-Formulary,Tier 1,2024-11-17,196,Worsened,Non-Formulary Status,No,No,,310,941,-67.0,Decreased,375.46,13.24,362.22,127.56,503.02,155.94,0.0,0,0.214,0.393,0.474,0.715,15,4,13,0,2.5,12.5,8,Higher,West,PA,Urban,51-65,2025-06,Q2_2025,2024,5.5,0.084,Increasing
FIA002246,2025-06-02,Amoxicillin,Amoxil,Antibiotics,87011-963-64,Medicare Part D Plan A,PLAN_4723,2025,Non-Formulary,Tier 1,2024-06-22,345,Worsened,Non-Formulary Status,No,No,,574,792,-27.4,Decreased,304.56,13.84,290.72,199.51,504.07,289.34,0.0,0,0.166,0.39,0.809,0.544,13,2,13,8,3.3,7.5,5,Lower,Midwest,CA,Urban,75+,2025-06,Q2_2025,2024,4.7,0.338,Increasing
FIA001776,2025-06-03,Amoxicillin,Amoxil,Antibiotics,56487-295-20,Medicare Part D Plan A,PLAN_9603,2025,Non-Formulary,Tier 2,2024-10-21,225,Worsened,Non-Formulary Status,No,No,,198,254,-21.7,Decreased,345.25,42.91,302.34,99.1,444.35,87.98,0.0,0,0.236,0.215,0.892,0.418,9,6,3,15,4.6,6.7,7,Higher,Southeast,GA,Rural,36-50,2025-06,Q2_2025,2024,9.0,0.129,Stable
FIA002094,2025-06-21,Amoxicillin,Amoxil,Antibiotics,90350-471-59,Medicare Part D Plan A,PLAN_9483,2025,Non-Formulary,Tier 3,2024-10-23,241,Worsened,Non-Formulary Status,No,No,,666,682,-2.3,Stable,507.53,86.13,421.4,131.42,638.95,425.54,0.0,0,0.166,0.163,0.682,0.762,13,6,11,4,2.4,16.4,3,Higher,Midwest,NC,Suburban,75+,2025-06,Q2_2025,2024,9.9,0.379,Stable
FIA001839,2025-06-23,Amoxicillin,Amoxil,Antibiotics,45310-873-67,Commercial Plan Alpha,PLAN_1025,2025,Tier 1,Non-Formulary,2025-04-19,65,Improved,None,No,No,,429,317,35.3,Increased,11.44,768.42,-756.98,34.98,46.42,19.91,0.0,0,0.065,0.108,0.71,0.915,5,3,18,14,3.7,31.0,5,Lower,West,GA,Suburban,18-35,2025-06,Q2_2025,2024,8.8,0.316,Increasing
FIA002516,2025-07-08,Amoxicillin,Amoxil,Antibiotics,35184-906-21,Commercial Plan Alpha,PLAN_7556,2025,Tier 1,Tier 2,2025-03-17,113,Improved,None,No,No,,509,564,-9.6,Decreased,13.73,42.27,-28.54,132.88,146.61,74.62,0.0,0,0.079,0.293,0.632,0.731,5,8,18,5,4.6,18.6,8,Similar,West,PA,Suburban,75+,2025-07,Q3_2025,2024,6.8,0.967,Stable
FIA000598,2025-07-12,Amoxicillin,Amoxil,Antibiotics,79637-339-97,Medicaid Plan Y,PLAN_3682,2025,Specialty Tier,Tier 3,2024-12-20,204,Worsened,None,No,No,,739,699,5.8,Increased,110.53,79.38,31.15,128.16,238.69,176.39,0.0,0,0.17,0.083,0.259,0.727,9,4,5,9,3.2,27.1,6,Higher,Midwest,MI,Rural,75+,2025-07,Q3_2025,2024,7.5,0.583,Stable
FIA000626,2025-07-14,Amoxicillin,Amoxil,Antibiotics,78666-436-56,Medicare Part D Plan A,PLAN_2973,2025,Specialty Tier,Tier 2,2024-12-15,211,Worsened,Prior Authorization,Yes,No,,264,869,-69.5,Decreased,236.75,38.51,198.24,109.33,346.08,91.37,0.242,2,0.295,0.122,0.506,0.523,5,1,0,15,4.8,21.7,7,Similar,West,CA,Suburban,36-50,2025-07,Q3_2025,2024,8.0,0.599,Increasing
FIA002893,2025-07-22,Amoxicillin,Amoxil,Antibiotics,30683-177-58,Medicaid Plan X,PLAN_7845,2025,Tier 1,Tier 3,2024-08-29,327,Improved,Quantity Limit,No,No,90.0,492,344,43.2,Increased,18.76,70.03,-51.27,157.1,175.86,86.52,0.0,0,0.011,0.388,0.516,0.736,8,10,4,13,2.4,21.0,3,Higher,Southeast,FL,Rural,51-65,2025-07,Q3_2025,2024,3.0,0.162,Stable
FIA001525,2025-07-28,Amoxicillin,Amoxil,Antibiotics,80846-524-79,Medicaid Plan X,PLAN_9375,2025,Tier 1,Specialty Tier,2025-02-02,176,Improved,None,No,No,,1337,953,40.4,Increased,11.35,290.29,-278.94,159.68,171.03,228.67,0.0,0,0.016,0.22,0.39,0.791,5,0,6,4,2.5,21.6,5,Higher,Southwest,CA,Rural,36-50,2025-07,Q3_2025,2024,5.2,0.372,Decreasing
FIA002186,2025-07-31,Amoxicillin,Amoxil,Antibiotics,48095-266-75,Medicaid Plan X,PLAN_7393,2025,Specialty Tier,Tier 3,2024-10-08,296,Worsened,None,No,No,,669,674,-0.7,Stable,268.9,86.49,182.41,111.44,380.34,254.45,0.0,0,0.084,0.242,0.287,0.484,2,7,11,12,4.5,9.5,7,Higher,Midwest,FL,Rural,75+,2025-07,Q3_2025,2024,1.4,0.644,Increasing
FIA000668,2025-08-07,Amoxicillin,Amoxil,Antibiotics,63045-199-11,Medicare Part D Plan A,PLAN_9129,2025,Tier 3,Tier 1,2025-01-31,188,Worsened,Prior Authorization; Quantity Limit,Yes,No,90.0,404,602,-32.9,Decreased,62.4,19.09,43.31,135.17,197.57,79.82,0.428,8,0.044,0.119,0.319,0.673,11,0,7,13,2.3,22.3,7,Lower,Northeast,FL,Rural,51-65,2025-08,Q3_2025,2024,8.5,0.744,Decreasing
FIA000761,2025-08-07,Amoxicillin,Amoxil,Antibiotics,94664-411-42,Medicaid Plan Y,PLAN_4585,2025,Tier 3,Tier 3,2024-12-20,230,No Change,Step Therapy,No,Yes,,514,476,8.0,Increased,97.3,98.05,-0.75,65.41,162.71,83.63,0.0,0,0.045,0.139,0.707,0.554,13,8,17,13,3.1,31.2,3,Higher,Midwest,NC,Urban,51-65,2025-08,Q3_2025,2024,6.1,0.856,Decreasing
FIA000186,2025-08-16,Amoxicillin,Amoxil,Antibiotics,58745-395-16,Commercial Plan Alpha,PLAN_6785,2025,Tier 3,Specialty Tier,2024-09-17,333,Improved,Step Therapy,No,Yes,,653,661,-1.1,Stable,83.29,206.03,-122.74,68.55,151.84,99.15,0.0,0,0.065,0.15,0.869,0.74,5,8,9,5,4.9,30.2,7,Higher,Southeast,FL,Urban,18-35,2025-08,Q3_2025,2024,1.4,0.317,Increasing
FIA001752,2025-08-25,Amoxicillin,Amoxil,Antibiotics,47810-967-35,Medicaid Plan Y,PLAN_4778,2025,Non-Formulary,Tier 2,2025-01-17,220,Worsened,Non-Formulary Status,No,No,,90,294,-69.2,Decreased,210.68,32.88,177.8,69.19,279.87,25.19,0.0,0,0.222,0.223,0.327,0.561,7,0,15,1,3.9,6.7,4,Higher,Southeast,CA,Suburban,36-50,2025-08,Q3_2025,2024,7.9,0.885,Stable
FIA001911,2022-01-01,Atorvastatin,Lipitor,Statins,53190-835-61,Medicaid Plan X,PLAN_2503,2022,Tier 3,Tier 2,2021-08-21,133,Worsened,None,No,No,,107,141,-23.9,Decreased,65.99,45.59,20.4,92.08,158.07,16.91,0.0,0,0.073,0.143,0.473,0.8,14,3,10,4,4.1,10.9,7,Higher,Southwest,FL,Suburban,66-75,2022-01,Q1_2022,2021,8.8,0.262,Increasing
FIA002500,2022-01-04,Atorvastatin,Lipitor,Statins,54477-156-68,VA Plan,PLAN_6883,2022,Tier 1,Tier 1,2021-11-26,39,No Change,None,No,No,,590,628,-6.0,Decreased,9.2,10.9,-1.7,46.11,55.31,32.63,0.0,0,0.071,0.106,0.851,0.84,6,3,10,15,2.1,8.4,2,Similar,Midwest,CA,Rural,36-50,2022-01,Q1_2022,2021,6.4,0.879,Increasing
FIA002679,2022-01-15,Atorvastatin,Lipitor,Statins,28889-136-62,VA Plan,PLAN_7985,2022,Non-Formulary,Specialty Tier,2021-02-10,339,Worsened,Non-Formulary Status,No,No,,186,186,0.2,Stable,221.16,265.97,-44.81,99.18,320.34,59.58,0.0,0,0.11,0.08,0.792,0.816,2,1,14,8,3.1,25.2,7,Higher,West,MI,Urban,51-65,2022-01,Q1_2022,2021,5.0,0.221,Increasing
FIA001927,2022-01-19,Atorvastatin,Lipitor,Statins,49296-747-35,Commercial Plan Beta,PLAN_9419,2022,Tier 3,Tier 2,2021-04-19,275,Worsened,Prior Authorization,Yes,No,,221,716,-69.0,Decreased,51.99,35.44,16.55,129.41,181.4,40.09,0.528,1,0.071,0.37,0.457,0.911,13,3,8,14,4.4,23.9,7,Similar,Southwest,NC,Urban,51-65,2022-01,Q1_2022,2021,8.0,0.777,Stable
FIA002747,2022-02-26,Atorvastatin,Lipitor,Statins,62038-938-61,Medicare Part D Plan B,PLAN_1132,2022,Tier 3,Specialty Tier,2021-07-29,212,Improved,None,No,No,,516,476,8.6,Increased,58.57,167.04,-108.47,151.62,210.19,108.46,0.0,0,0.019,0.348,0.658,0.405,15,10,5,3,3.7,10.1,5,Higher,Midwest,NY,Rural,51-65,2022-02,Q1_2022,2021,8.7,0.228,Increasing
FIA001358,2022-03-18,Atorvastatin,Lipitor,Statins,16634-736-56,Tricare Standard,PLAN_8939,2022,Tier 2,Tier 3,2021-12-19,89,Improved,None,No,No,,1035,766,35.2,Increased,37.16,51.99,-14.83,162.79,199.95,206.95,0.0,0,0.059,0.364,0.786,0.693,15,4,14,12,2.7,31.9,2,Higher,West,NY,Suburban,66-75,2022-03,Q1_2022,2021,2.2,0.537,Increasing
FIA000040,2022-03-19,Atorvastatin,Lipitor,Statins,84928-767-34,Medicaid Plan Y,PLAN_8792,2022,Tier 3,Tier 3,2022-01-09,69,No Change,None,No,No,,196,192,2.3,Stable,82.23,98.87,-16.64,106.45,188.68,36.98,0.0,0,0.073,0.225,0.87,0.648,10,1,16,5,2.1,26.2,5,Higher,West,MI,Urban,51-65,2022-03,Q1_2022,2021,4.4,0.283,Stable
FIA001542,2022-03-25,Atorvastatin,Lipitor,Statins,16964-194-50,Medicaid Plan X,PLAN_4618,2022,Tier 1,Tier 3,2021-05-15,314,Improved,None,No,No,,1215,816,48.9,Increased,13.64,67.48,-53.84,171.47,185.11,224.91,0.0,0,0.033,0.29,0.891,0.81,10,7,17,3,3.7,6.5,5,Similar,West,PA,Rural,18-35,2022-03,Q1_2022,2021,8.2,0.88,Decreasing
FIA000413,2022-03-28,Atorvastatin,Lipitor,Statins,97771-831-99,VA Plan,PLAN_2113,2022,Tier 2,Tier 2,2021-12-10,108,No Change,None,No,No,,411,427,-3.5,Stable,48.63,24.13,24.5,113.68,162.31,66.71,0.0,0,0.064,0.064,0.613,0.515,15,0,11,2,3.7,16.0,8,Lower,Southwest,NY,Urban,75+,2022-03,Q1_2022,2021,1.1,0.628,Decreasing
FIA002304,2022-03-31,Atorvastatin,Lipitor,Statins,62568-699-87,Medicare Part D Plan A,PLAN_5395,2022,Specialty Tier,Tier 3,2021-05-02,333,Worsened,Prior Authorization; Quantity Limit,Yes,No,60.0,247,261,-5.0,Stable,236.88,75.19,161.69,59.73,296.61,73.26,0.396,1,0.266,0.285,0.591,0.409,5,6,19,4,3.4,10.0,7,Higher,Southwest,FL,Rural,51-65,2022-03,Q1_2022,2021,2.9,0.526,Decreasing
FIA001511,2022-04-13,Atorvastatin,Lipitor,Statins,87649-320-96,Commercial Plan Alpha,PLAN_8811,2022,Tier 1,Tier 1,2021-06-05,312,No Change,None,No,No,,623,625,-0.2,Stable,14.9,7.33,7.57,123.74,138.64,86.37,0.0,0,0.047,0.078,0.267,0.726,7,8,3,15,4.6,8.9,5,Similar,Northeast,TX,Rural,18-35,2022-04,Q2_2022,2021,5.2,0.362,Stable
FIA000939,2022-04-19,Atorvastatin,Lipitor,Statins,35775-799-25,Commercial Plan Beta,PLAN_9738,2022,Non-Formulary,Non-Formulary,2021-10-12,189,No Change,Non-Formulary Status,No,No,,126,134,-5.9,Decreased,285.54,324.57,-39.03,69.65,355.19,44.75,0.0,0,0.099,0.148,0.479,0.821,2,2,11,15,4.7,23.8,2,Similar,Southwest,NY,Suburban,18-35,2022-04,Q2_2022,2021,6.3,0.801,Decreasing
FIA001279,2022-04-22,Atorvastatin,Lipitor,Statins,20580-539-91,VA Plan,PLAN_7369,2022,Non-Formulary,Non-Formulary,2021-08-17,248,No Change,Non-Formulary Status; Quantity Limit,No,No,,566,532,6.5,Increased,774.33,229.99,544.34,82.41,856.74,484.91,0.0,0,0.258,0.086,0.731,0.777,8,2,0,13,4.7,19.1,6,Lower,Midwest,NC,Rural,51-65,2022-04,Q2_2022,2021,6.0,0.28,Decreasing
FIA000594,2022-04-26,Atorvastatin,Lipitor,Statins,93898-246-91,Tricare Standard,PLAN_9104,2022,Tier 2,Specialty Tier,2022-01-21,95,Improved,None,No,No,,1167,989,18.1,Increased,39.75,289.3,-249.55,186.93,226.68,264.54,0.0,0,0.043,0.105,0.741,0.695,7,9,11,10,4.1,14.6,4,Lower,Southeast,MI,Rural,51-65,2022-04,Q2_2022,2021,2.5,0.842,Increasing
FIA000093,2022-05-02,Atorvastatin,Lipitor,Statins,86810-203-53,Medicaid Plan X,PLAN_6285,2022,Tier 2,Non-Formulary,2022-01-20,102,Improved,None,No,No,,1289,981,31.4,Increased,43.23,707.89,-664.66,142.56,185.79,239.48,0.0,0,0.059,0.098,0.31,0.922,15,10,10,5,4.1,21.9,6,Similar,Southeast,MI,Urban,66-75,2022-05,Q2_2022,2021,3.8,0.688,Increasing
FIA001827,2022-05-04,Atorvastatin,Lipitor,Statins,62149-236-57,Medicaid Plan Y,PLAN_8714,2022,Tier 1,Tier 1,2022-01-08,116,No Change,None,No,No,,831,909,-8.6,Decreased,8.76,5.33,3.43,34.77,43.53,36.17,0.0,0,0.036,0.24,0.407,0.461,4,8,9,9,2.5,19.5,7,Lower,Southwest,PA,Rural,36-50,2022-05,Q2_2022,2021,1.7,0.71,Stable
FIA002152,2022-05-05,Atorvastatin,Lipitor,Statins,87620-410-89,Commercial Plan Alpha,PLAN_9903,2022,Non-Formulary,Specialty Tier,2021-05-31,339,Worsened,Non-Formulary Status,No,No,,131,136,-3.0,Stable,739.94,217.61,522.33,42.73,782.67,102.53,0.0,0,0.223,0.116,0.606,0.484,7,5,4,14,2.2,5.3,5,Higher,Northeast,PA,Rural,66-75,2022-05,Q2_2022,2021,4.6,0.143,Stable
FIA000479,2022-05-09,Atorvastatin,Lipitor,Statins,16280-167-58,Medicare Part D Plan A,PLAN_5575,2022,Tier 1,Specialty Tier,2021-07-26,287,Improved,None,No,No,,450,297,51.6,Increased,8.03,116.24,-108.21,175.26,183.29,82.48,0.0,0,0.078,0.078,0.641,0.44,10,0,14,13,4.3,30.9,6,Lower,West,GA,Rural,66-75,2022-05,Q2_2022,2021,6.6,0.05,Stable
FIA002285,2022-05-14,Atorvastatin,Lipitor,Statins,39395-953-76,Medicare Part D Plan B,PLAN_3431,2022,Non-Formulary,Tier 3,2021-07-10,308,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,742,721,2.9,Stable,422.15,72.82,349.33,179.24,601.39,446.23,0.0,0,0.221,0.057,0.758,0.67,12,9,12,8,3.6,17.9,8,Similar,West,TX,Urban,18-35,2022-05,Q2_2022,2021,3.7,0.168,Decreasing
FIA001771,2022-05-18,Atorvastatin,Lipitor,Statins,15646-925-74,Medicaid Plan Y,PLAN_6293,2022,Tier 3,Tier 2,2021-12-31,138,Worsened,None,No,No,,525,741,-29.0,Decreased,77.55,40.11,37.44,194.05,271.6,142.59,0.0,0,0.035,0.141,0.562,0.585,1,6,18,1,2.9,22.4,6,Similar,West,NC,Rural,75+,2022-05,Q2_2022,2021,6.2,0.289,Decreasing
FIA002548,2022-05-27,Atorvastatin,Lipitor,Statins,21735-733-38,Medicaid Plan Y,PLAN_4253,2022,Tier 2,Tier 1,2021-06-30,331,Worsened,None,No,No,,683,745,-8.2,Decreased,42.03,19.6,22.43,65.65,107.68,73.55,0.0,0,0.07,0.233,0.559,0.47,0,6,16,10,3.7,21.8,7,Lower,West,TX,Rural,36-50,2022-05,Q2_2022,2021,4.0,0.775,Stable
FIA001812,2022-06-01,Atorvastatin,Lipitor,Statins,65004-783-16,Medicaid Plan Y,PLAN_7176,2022,Tier 2,Specialty Tier,2022-03-20,73,Improved,None,No,No,,1046,756,38.4,Increased,38.31,170.32,-132.01,136.28,174.59,182.62,0.0,0,0.08,0.099,0.884,0.519,8,7,18,14,3.2,20.5,4,Higher,Midwest,NY,Suburban,66-75,2022-06,Q2_2022,2021,8.2,0.828,Stable
FIA001460,2022-06-02,Atorvastatin,Lipitor,Statins,29684-870-86,Tricare Standard,PLAN_3823,2022,Tier 2,Tier 2,2022-04-30,33,No Change,None,No,No,,144,153,-5.4,Decreased,40.73,23.17,17.56,39.31,80.04,11.53,0.0,0,0.063,0.258,0.772,0.646,11,1,4,13,2.6,6.7,2,Similar,West,OH,Rural,36-50,2022-06,Q2_2022,2021,2.9,0.023,Increasing
FIA001087,2022-06-06,Atorvastatin,Lipitor,Statins,32018-415-36,Medicare Part D Plan A,PLAN_2163,2022,Non-Formulary,Tier 1,2022-02-25,101,Worsened,Non-Formulary Status,No,No,,147,344,-57.1,Decreased,350.6,19.7,330.9,196.34,546.94,80.4,0.0,0,0.22,0.372,0.642,0.407,13,9,12,3,4.2,16.3,8,Higher,Southwest,NY,Rural,66-75,2022-06,Q2_2022,2021,9.2,0.607,Increasing
FIA001561,2022-06-10,Atorvastatin,Lipitor,Statins,85787-881-52,VA Plan,PLAN_8395,2022,Tier 3,Tier 3,2021-09-29,254,No Change,None,No,No,,320,309,3.6,Stable,74.76,83.15,-8.39,122.78,197.54,63.21,0.0,0,0.074,0.263,0.892,0.877,9,3,8,5,2.6,12.9,4,Similar,Southeast,TX,Urban,51-65,2022-06,Q2_2022,2021,7.4,0.965,Decreasing
FIA001234,2022-06-12,Atorvastatin,Lipitor,Statins,16071-841-99,Medicare Part D Plan B,PLAN_8555,2022,Tier 1,Tier 3,2021-08-25,291,Improved,Quantity Limit,No,No,60.0,1205,963,25.1,Increased,9.53,69.78,-60.25,111.12,120.65,145.38,0.0,0,0.067,0.249,0.265,0.923,11,6,0,15,5.0,5.2,2,Higher,Southwest,NY,Suburban,36-50,2022-06,Q2_2022,2021,3.1,0.596,Decreasing
FIA002283,2022-06-24,Atorvastatin,Lipitor,Statins,95152-452-41,Medicaid Plan Y,PLAN_2255,2022,Non-Formulary,Specialty Tier,2021-10-16,251,Worsened,Non-Formulary Status,No,No,,284,267,6.5,Increased,783.73,298.36,485.37,170.4,954.13,270.97,0.0,0,0.296,0.243,0.794,0.855,11,7,19,3,4.0,9.7,4,Higher,Southwest,NC,Rural,36-50,2022-06,Q2_2022,2021,6.7,0.557,Stable
FIA001558,2022-06-27,Atorvastatin,Lipitor,Statins,71511-547-91,Commercial Plan Alpha,PLAN_7241,2022,Tier 3,Specialty Tier,2022-04-16,72,Improved,None,No,No,,317,305,4.1,Stable,78.38,149.47,-71.09,189.68,268.06,84.98,0.0,0,0.078,0.052,0.328,0.518,13,4,0,7,2.0,23.4,6,Higher,Southwest,NC,Rural,18-35,2022-06,Q2_2022,2021,6.4,0.373,Stable
FIA002779,2022-06-29,Atorvastatin,Lipitor,Statins,50164-884-12,Medicaid Plan Y,PLAN_7524,2022,Non-Formulary,Tier 1,2021-08-04,329,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,221,722,-69.4,Decreased,686.94,8.17,678.77,143.96,830.9,183.63,0.0,0,0.285,0.193,0.665,0.725,3,9,15,10,2.6,32.7,6,Similar,Midwest,GA,Suburban,75+,2022-06,Q2_2022,2021,6.8,0.009,Stable
FIA000900,2022-07-07,Atorvastatin,Lipitor,Statins,58788-149-29,Medicaid Plan Y,PLAN_5735,2022,Non-Formulary,Tier 1,2022-05-12,56,Worsened,Non-Formulary Status,No,No,,114,208,-44.8,Decreased,605.77,5.76,600.01,60.02,665.79,75.9,0.0,0,0.057,0.248,0.314,0.819,7,10,19,5,2.1,5.4,7,Lower,West,GA,Suburban,75+,2022-07,Q3_2022,2021,8.1,0.473,Decreasing
FIA000407,2022-07-14,Atorvastatin,Lipitor,Statins,67030-972-30,Tricare Standard,PLAN_1979,2022,Specialty Tier,Specialty Tier,2022-03-30,106,No Change,Prior Authorization; Step Therapy,Yes,Yes,,595,609,-2.2,Stable,154.18,139.55,14.63,114.85,269.03,160.07,0.195,6,0.202,0.387,0.247,0.578,15,9,9,4,2.7,33.3,8,Lower,Southwest,GA,Urban,51-65,2022-07,Q3_2022,2021,6.7,0.339,Stable
FIA001843,2022-07-27,Atorvastatin,Lipitor,Statins,12432-260-16,VA Plan,PLAN_4193,2022,Non-Formulary,Specialty Tier,2021-08-19,342,Worsened,Non-Formulary Status,No,No,,542,518,4.7,Stable,589.59,244.08,345.51,60.7,650.29,352.46,0.0,0,0.118,0.074,0.418,0.843,4,4,8,6,2.5,15.7,4,Lower,Midwest,OH,Rural,66-75,2022-07,Q3_2022,2021,3.6,0.949,Stable
FIA002845,2022-08-06,Atorvastatin,Lipitor,Statins,88929-353-33,Commercial Plan Beta,PLAN_7385,2022,Specialty Tier,Non-Formulary,2021-11-03,276,Improved,Prior Authorization,Yes,No,,903,849,6.4,Increased,181.19,467.99,-286.8,186.57,367.76,332.09,0.152,5,0.098,0.273,0.264,0.922,13,5,19,2,3.4,31.9,5,Lower,West,CA,Suburban,75+,2022-08,Q3_2022,2021,3.6,0.832,Stable
FIA001642,2022-08-09,Atorvastatin,Lipitor,Statins,20524-782-75,Medicare Part D Plan B,PLAN_8980,2022,Specialty Tier,Tier 2,2021-09-29,314,Worsened,Step Therapy; Quantity Limit,No,Yes,60.0,257,377,-31.8,Decreased,132.93,28.21,104.72,154.79,287.72,73.94,0.0,0,0.192,0.351,0.246,0.648,3,5,9,7,3.2,21.7,8,Lower,Southeast,PA,Suburban,75+,2022-08,Q3_2022,2021,7.4,0.534,Decreasing
FIA001350,2022-08-12,Atorvastatin,Lipitor,Statins,95494-340-50,Medicaid Plan X,PLAN_5615,2022,Tier 1,Tier 3,2021-11-19,266,Improved,None,No,No,,1130,776,45.6,Increased,17.97,78.41,-60.44,128.09,146.06,165.05,0.0,0,0.022,0.246,0.827,0.405,3,2,14,15,2.2,31.6,5,Higher,Northeast,IL,Suburban,75+,2022-08,Q3_2022,2021,10.0,0.195,Decreasing
FIA001383,2022-08-18,Atorvastatin,Lipitor,Statins,14722-608-35,Tricare Standard,PLAN_2218,2022,Specialty Tier,Tier 1,2021-08-22,361,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,53,110,-51.6,Decreased,271.4,19.45,251.95,174.39,445.79,23.63,0.259,3,0.104,0.101,0.507,0.577,1,8,20,9,3.0,26.7,3,Similar,Northeast,NC,Rural,66-75,2022-08,Q3_2022,2021,7.5,0.034,Decreasing
FIA002160,2022-08-20,Atorvastatin,Lipitor,Statins,31733-287-40,Medicaid Plan Y,PLAN_4471,2022,Non-Formulary,Specialty Tier,2022-07-03,48,Worsened,Non-Formulary Status,No,No,,785,844,-6.9,Decreased,332.55,146.79,185.76,137.26,469.81,368.8,0.0,0,0.102,0.21,0.428,0.673,4,7,1,10,3.8,27.6,4,Lower,Northeast,NC,Rural,75+,2022-08,Q3_2022,2021,5.0,0.046,Decreasing
FIA000339,2022-08-21,Atorvastatin,Lipitor,Statins,98694-377-76,Medicaid Plan Y,PLAN_7088,2022,Specialty Tier,Specialty Tier,2022-04-26,117,No Change,None,No,No,,255,243,5.0,Stable,225.23,204.92,20.31,186.73,411.96,105.05,0.0,0,0.124,0.247,0.316,0.56,6,9,11,8,3.4,11.3,4,Higher,Southeast,FL,Rural,66-75,2022-08,Q3_2022,2021,1.1,0.416,Increasing
FIA002214,2022-09-02,Atorvastatin,Lipitor,Statins,80909-374-75,Medicare Part D Plan A,PLAN_1934,2022,Tier 1,Tier 1,2022-01-27,218,No Change,None,No,No,,154,165,-6.4,Decreased,9.6,11.89,-2.29,126.91,136.51,21.02,0.0,0,0.043,0.101,0.203,0.776,5,8,15,1,3.3,20.7,6,Similar,Northeast,GA,Rural,36-50,2022-09,Q3_2022,2021,8.2,0.663,Increasing
FIA000264,2022-09-09,Atorvastatin,Lipitor,Statins,57652-657-31,VA Plan,PLAN_1001,2022,Tier 2,Non-Formulary,2022-04-27,135,Improved,None,No,No,,555,362,53.3,Increased,39.58,252.69,-213.11,116.05,155.63,86.37,0.0,0,0.079,0.137,0.232,0.92,9,10,17,14,2.4,19.7,4,Higher,Midwest,MI,Rural,75+,2022-09,Q3_2022,2021,2.9,0.099,Increasing
FIA002828,2022-09-29,Atorvastatin,Lipitor,Statins,74489-298-21,Medicaid Plan X,PLAN_3355,2022,Specialty Tier,Tier 3,2022-01-15,257,Worsened,None,No,No,,165,174,-5.1,Decreased,194.3,69.69,124.61,95.48,289.78,47.81,0.0,0,0.198,0.323,0.386,0.696,6,0,12,4,4.9,23.5,7,Similar,Midwest,PA,Rural,36-50,2022-09,Q3_2022,2021,5.7,0.157,Decreasing
FIA001398,2022-09-30,Atorvastatin,Lipitor,Statins,53639-442-10,Medicare Part D Plan A,PLAN_6256,2022,Tier 2,Non-Formulary,2022-03-02,212,Improved,None,No,No,,1251,828,51.1,Increased,44.78,235.74,-190.96,105.9,150.68,188.5,0.0,0,0.04,0.117,0.725,0.666,12,0,20,7,3.2,18.6,3,Similar,Northeast,PA,Urban,51-65,2022-09,Q3_2022,2021,5.2,0.085,Stable
FIA000674,2022-10-28,Atorvastatin,Lipitor,Statins,17432-984-78,Commercial Plan Alpha,PLAN_4222,2022,Tier 3,Tier 2,2021-11-25,337,Worsened,Step Therapy,No,Yes,,329,587,-43.9,Decreased,95.25,40.34,54.91,192.96,288.21,94.82,0.0,0,0.061,0.078,0.726,0.559,2,9,18,10,4.2,22.3,5,Similar,Southwest,OH,Urban,66-75,2022-10,Q4_2022,2022,2.6,0.327,Decreasing
FIA000211,2022-11-11,Atorvastatin,Lipitor,Statins,69388-432-82,Commercial Plan Alpha,PLAN_4463,2022,Tier 1,Specialty Tier,2022-02-09,275,Improved,None,No,No,,1023,708,44.6,Increased,11.81,291.04,-279.23,135.8,147.61,151.01,0.0,0,0.013,0.352,0.761,0.556,1,1,17,12,2.3,12.7,3,Similar,Northeast,CA,Urban,36-50,2022-11,Q4_2022,2022,4.5,0.402,Decreasing
FIA000858,2022-11-11,Atorvastatin,Lipitor,Statins,54839-402-85,Medicare Part D Plan A,PLAN_9311,2022,Tier 1,Tier 2,2022-05-31,164,Improved,None,No,No,,526,483,9.1,Increased,14.97,24.15,-9.18,39.83,54.8,28.82,0.0,0,0.012,0.398,0.704,0.766,6,9,15,12,3.9,12.1,6,Similar,Southeast,PA,Suburban,18-35,2022-11,Q4_2022,2022,4.5,0.013,Stable
FIA002271,2022-11-15,Atorvastatin,Lipitor,Statins,30403-770-94,Commercial Plan Alpha,PLAN_2889,2022,Specialty Tier,Tier 3,2021-12-01,349,Worsened,Prior Authorization; Quantity Limit,Yes,No,60.0,444,431,3.0,Stable,265.7,79.33,186.37,125.17,390.87,173.55,0.466,5,0.195,0.35,0.605,0.943,13,3,0,7,3.8,25.9,5,Lower,Midwest,TX,Rural,75+,2022-11,Q4_2022,2022,3.1,0.561,Decreasing
FIA002061,2022-11-17,Atorvastatin,Lipitor,Statins,38927-420-41,Commercial Plan Alpha,PLAN_1521,2022,Tier 1,Tier 3,2022-06-21,149,Improved,None,No,No,,939,637,47.4,Increased,11.23,77.44,-66.21,103.46,114.69,107.69,0.0,0,0.049,0.086,0.528,0.627,2,2,18,8,4.8,34.4,7,Lower,Northeast,IL,Urban,18-35,2022-11,Q4_2022,2022,9.7,0.108,Decreasing
FIA001084,2022-11-20,Atorvastatin,Lipitor,Statins,35722-361-98,Medicaid Plan Y,PLAN_3900,2022,Tier 1,Specialty Tier,2022-03-18,247,Improved,None,No,No,,192,160,20.3,Increased,7.92,154.03,-146.11,93.65,101.57,19.5,0.0,0,0.019,0.39,0.491,0.621,13,2,6,6,3.1,6.0,4,Similar,Midwest,IL,Rural,18-35,2022-11,Q4_2022,2022,7.7,0.884,Stable
FIA002605,2022-12-05,Atorvastatin,Lipitor,Statins,74957-605-89,Medicaid Plan Y,PLAN_2063,2022,Specialty Tier,Tier 2,2022-10-02,64,Worsened,Step Therapy,No,Yes,,451,810,-44.2,Decreased,289.8,35.27,254.53,183.35,473.15,213.39,0.0,0,0.052,0.264,0.477,0.597,9,4,10,9,4.8,16.5,7,Higher,Southwest,GA,Suburban,75+,2022-12,Q4_2022,2022,6.5,0.98,Decreasing
FIA001608,2022-12-08,Atorvastatin,Lipitor,Statins,25274-955-11,Medicare Part D Plan B,PLAN_5685,2022,Non-Formulary,Non-Formulary,2022-07-11,150,No Change,Non-Formulary Status,No,No,,804,884,-9.0,Decreased,545.52,415.62,129.9,174.38,719.9,578.8,0.0,0,0.146,0.215,0.576,0.545,14,5,18,3,4.3,32.1,3,Higher,Northeast,OH,Suburban,51-65,2022-12,Q4_2022,2022,1.5,0.403,Decreasing
FIA002938,2023-01-09,Atorvastatin,Lipitor,Statins,43097-912-32,Medicare Part D Plan A,PLAN_3531,2023,Specialty Tier,Non-Formulary,2022-03-28,287,Improved,None,No,No,,640,602,6.5,Increased,270.31,726.46,-456.15,90.67,360.98,231.03,0.0,0,0.164,0.39,0.758,0.555,12,0,15,0,4.5,20.6,7,Similar,Northeast,MI,Suburban,18-35,2023-01,Q1_2023,2022,2.5,0.762,Increasing
FIA002750,2023-01-16,Atorvastatin,Lipitor,Statins,89518-505-24,VA Plan,PLAN_1309,2023,Tier 2,Tier 1,2022-06-19,211,Worsened,None,No,No,,959,966,-0.7,Stable,45.66,6.86,38.8,35.24,80.9,77.58,0.0,0,0.067,0.361,0.219,0.775,7,5,2,6,4.9,26.2,2,Similar,Northeast,CA,Rural,18-35,2023-01,Q1_2023,2022,6.1,0.556,Increasing
FIA002552,2023-01-23,Atorvastatin,Lipitor,Statins,79175-378-17,Tricare Standard,PLAN_7362,2023,Tier 2,Non-Formulary,2022-05-15,253,Improved,None,No,No,,1079,819,31.8,Increased,21.85,453.94,-432.09,41.77,63.62,68.65,0.0,0,0.018,0.192,0.375,0.905,1,4,18,0,3.3,31.8,3,Similar,Southeast,NY,Suburban,18-35,2023-01,Q1_2023,2022,9.2,0.002,Stable
FIA001033,2023-01-28,Atorvastatin,Lipitor,Statins,58704-199-75,Medicare Part D Plan B,PLAN_3720,2023,Tier 1,Non-Formulary,2022-05-25,248,Improved,Quantity Limit,No,No,90.0,301,239,26.1,Increased,16.52,373.05,-356.53,147.19,163.71,49.28,0.0,0,0.075,0.179,0.256,0.849,1,0,7,8,2.7,27.8,4,Lower,Southeast,IL,Suburban,66-75,2023-01,Q1_2023,2022,3.7,0.973,Decreasing
FIA000691,2023-02-02,Atorvastatin,Lipitor,Statins,80851-726-78,Commercial Plan Beta,PLAN_1498,2023,Non-Formulary,Tier 3,2022-08-19,167,Worsened,Non-Formulary Status,No,No,,744,758,-1.8,Stable,292.33,60.61,231.72,154.32,446.65,332.31,0.0,0,0.223,0.394,0.744,0.553,2,3,8,0,3.8,18.0,2,Higher,Southwest,MI,Suburban,75+,2023-02,Q1_2023,2022,8.9,0.135,Stable
FIA002553,2023-02-13,Atorvastatin,Lipitor,Statins,29593-788-46,Medicare Part D Plan A,PLAN_7323,2023,Tier 2,Tier 3,2022-04-07,312,Improved,Quantity Limit,No,No,30.0,1464,985,48.6,Increased,44.4,95.81,-51.41,188.38,232.78,340.79,0.0,0,0.065,0.309,0.641,0.855,13,6,2,3,3.5,32.7,8,Similar,Southeast,NC,Suburban,66-75,2023-02,Q1_2023,2022,5.1,0.523,Decreasing
FIA000448,2023-02-15,Atorvastatin,Lipitor,Statins,65895-308-30,Medicaid Plan Y,PLAN_2599,2023,Specialty Tier,Tier 1,2022-08-01,198,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,90,121,-25.0,Decreased,229.37,19.2,210.17,57.52,286.89,25.82,0.246,5,0.114,0.158,0.58,0.702,2,1,4,3,4.6,5.1,3,Lower,Midwest,FL,Urban,66-75,2023-02,Q1_2023,2022,4.0,0.5,Decreasing
FIA002984,2023-02-15,Atorvastatin,Lipitor,Statins,15766-136-24,Tricare Standard,PLAN_3672,2023,Tier 3,Tier 2,2022-12-03,74,Worsened,None,No,No,,50,133,-63.9,Decreased,54.07,40.71,13.36,91.9,145.97,7.3,0.0,0,0.072,0.098,0.778,0.871,13,6,20,8,2.2,19.4,8,Similar,Southeast,MI,Suburban,75+,2023-02,Q1_2023,2022,8.1,0.549,Increasing
FIA002203,2023-02-18,Atorvastatin,Lipitor,Statins,38900-938-25,VA Plan,PLAN_8966,2023,Tier 1,Tier 3,2022-05-28,266,Improved,Quantity Limit,No,No,,382,310,23.4,Increased,7.79,78.27,-70.48,58.98,66.77,25.51,0.0,0,0.018,0.197,0.296,0.883,13,8,2,14,4.3,14.2,2,Similar,Midwest,FL,Rural,36-50,2023-02,Q1_2023,2022,3.0,0.814,Increasing
FIA000808,2023-02-23,Atorvastatin,Lipitor,Statins,76905-553-58,Medicaid Plan Y,PLAN_7972,2023,Tier 1,Specialty Tier,2022-08-09,198,Improved,None,No,No,,1118,924,21.1,Increased,14.41,170.88,-156.47,116.47,130.88,146.32,0.0,0,0.044,0.294,0.838,0.737,7,1,6,12,4.0,6.6,7,Lower,Southeast,MI,Urban,18-35,2023-02,Q1_2023,2022,9.9,0.799,Increasing
FIA001643,2023-02-24,Atorvastatin,Lipitor,Statins,38304-292-34,Medicare Part D Plan B,PLAN_7513,2023,Tier 3,Non-Formulary,2022-09-08,169,Improved,None,No,No,,912,999,-8.6,Decreased,52.47,228.01,-175.54,121.08,173.55,158.28,0.0,0,0.017,0.215,0.872,0.493,12,4,0,7,4.1,18.4,2,Similar,West,MI,Rural,18-35,2023-02,Q1_2023,2022,6.9,0.431,Increasing
FIA000404,2023-03-07,Atorvastatin,Lipitor,Statins,47757-849-96,Medicare Part D Plan A,PLAN_8250,2023,Tier 1,Specialty Tier,2022-08-25,194,Improved,Quantity Limit,No,No,30.0,1160,937,23.9,Increased,14.38,138.53,-124.15,61.63,76.01,88.17,0.0,0,0.052,0.228,0.256,0.936,8,2,17,6,4.1,26.1,2,Lower,Southeast,IL,Urban,36-50,2023-03,Q1_2023,2022,4.6,0.836,Stable
FIA002796,2023-03-07,Atorvastatin,Lipitor,Statins,39305-728-27,Medicaid Plan X,PLAN_5490,2023,Tier 2,Specialty Tier,2022-08-31,188,Improved,None,No,No,,1353,854,58.5,Increased,46.48,250.47,-203.99,103.78,150.26,203.3,0.0,0,0.063,0.363,0.585,0.547,7,1,7,7,3.6,19.2,8,Similar,Midwest,FL,Rural,51-65,2023-03,Q1_2023,2022,2.5,0.528,Stable
FIA000655,2023-03-09,Atorvastatin,Lipitor,Statins,77095-562-75,VA Plan,PLAN_6391,2023,Specialty Tier,Specialty Tier,2022-12-08,91,No Change,Prior Authorization,Yes,No,,798,852,-6.3,Decreased,209.6,127.13,82.47,32.74,242.34,193.39,0.241,4,0.07,0.226,0.431,0.729,1,6,15,6,3.7,11.1,7,Lower,West,MI,Rural,66-75,2023-03,Q1_2023,2022,9.9,0.024,Stable
FIA001884,2023-03-14,Atorvastatin,Lipitor,Statins,65106-580-98,Medicare Part D Plan A,PLAN_9382,2023,Tier 3,Specialty Tier,2022-12-24,80,Improved,Prior Authorization,Yes,No,,305,332,-7.8,Decreased,90.36,225.73,-135.37,177.63,267.99,81.74,0.571,3,0.059,0.31,0.287,0.516,11,10,5,4,2.2,8.5,2,Higher,West,CA,Rural,75+,2023-03,Q1_2023,2022,2.9,0.731,Decreasing
FIA001586,2023-03-21,Atorvastatin,Lipitor,Statins,96025-680-94,Medicare Part D Plan A,PLAN_2737,2023,Non-Formulary,Tier 1,2022-09-29,173,Worsened,Non-Formulary Status,No,No,,337,932,-63.7,Decreased,204.41,8.71,195.7,155.01,359.42,121.12,0.0,0,0.127,0.362,0.23,0.587,10,0,4,11,3.4,19.7,7,Higher,West,CA,Rural,51-65,2023-03,Q1_2023,2022,6.5,0.143,Stable
FIA000981,2023-03-25,Atorvastatin,Lipitor,Statins,94235-707-25,Medicaid Plan Y,PLAN_5508,2023,Non-Formulary,Tier 2,2022-10-21,155,Worsened,Non-Formulary Status,No,No,,307,461,-33.2,Decreased,414.93,48.93,366.0,104.83,519.76,159.57,0.0,0,0.111,0.332,0.789,0.842,14,3,5,0,2.4,31.0,7,Higher,Midwest,NY,Urban,75+,2023-03,Q1_2023,2022,9.8,0.326,Increasing
FIA002885,2023-04-03,Atorvastatin,Lipitor,Statins,43811-563-45,Commercial Plan Beta,PLAN_9778,2023,Non-Formulary,Tier 3,2022-12-21,103,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,759,801,-5.2,Decreased,578.7,70.84,507.86,99.51,678.21,514.76,0.0,0,0.227,0.245,0.55,0.583,15,8,11,9,3.1,15.4,2,Similar,Northeast,IL,Rural,66-75,2023-04,Q2_2023,2022,6.8,0.789,Increasing
FIA002457,2023-04-05,Atorvastatin,Lipitor,Statins,88969-276-97,Medicaid Plan X,PLAN_7434,2023,Tier 3,Specialty Tier,2022-05-10,330,Improved,Step Therapy; Quantity Limit,No,Yes,30.0,846,936,-9.6,Decreased,70.86,237.11,-166.25,109.11,179.97,152.25,0.0,0,0.012,0.253,0.431,0.585,12,4,5,4,3.2,33.3,7,Higher,Northeast,GA,Suburban,75+,2023-04,Q2_2023,2022,5.2,0.004,Increasing
FIA002143,2023-04-29,Atorvastatin,Lipitor,Statins,67658-495-72,Medicaid Plan X,PLAN_9983,2023,Tier 1,Non-Formulary,2022-07-23,280,Improved,None,No,No,,1279,891,43.6,Increased,10.73,337.61,-326.88,71.51,82.24,105.18,0.0,0,0.042,0.081,0.864,0.452,4,0,7,15,3.1,16.8,4,Lower,Midwest,NY,Urban,51-65,2023-04,Q2_2023,2022,1.3,0.235,Decreasing
FIA000833,2023-04-30,Atorvastatin,Lipitor,Statins,44606-989-53,Medicare Part D Plan B,PLAN_1005,2023,Tier 2,Tier 2,2022-12-31,120,No Change,None,No,No,,922,866,6.6,Increased,27.93,43.74,-15.81,114.98,142.91,131.76,0.0,0,0.063,0.156,0.397,0.693,1,9,9,14,4.2,11.5,2,Higher,Northeast,IL,Suburban,18-35,2023-04,Q2_2023,2022,8.7,0.845,Increasing
FIA000265,2023-05-01,Atorvastatin,Lipitor,Statins,65314-176-80,Medicaid Plan X,PLAN_5270,2023,Tier 2,Tier 2,2022-10-30,183,No Change,None,No,No,,241,237,2.0,Stable,45.68,26.46,19.22,153.95,199.63,48.11,0.0,0,0.029,0.184,0.833,0.62,2,4,13,4,3.6,7.1,7,Similar,Southeast,IL,Rural,75+,2023-05,Q2_2023,2022,6.4,0.42,Increasing
FIA000554,2023-05-06,Atorvastatin,Lipitor,Statins,44704-766-79,Commercial Plan Beta,PLAN_5060,2023,Specialty Tier,Tier 3,2023-01-27,99,Worsened,Quantity Limit,No,No,30.0,770,702,9.7,Increased,147.92,88.85,59.07,143.51,291.43,224.4,0.0,0,0.063,0.379,0.772,0.566,10,4,6,1,3.4,17.4,7,Similar,Southeast,TX,Rural,18-35,2023-05,Q2_2023,2022,1.3,0.646,Decreasing
FIA000086,2023-05-16,Atorvastatin,Lipitor,Statins,84912-481-25,Medicare Part D Plan A,PLAN_3938,2023,Specialty Tier,Tier 3,2022-10-02,226,Worsened,Quantity Limit,No,No,30.0,887,978,-9.3,Decreased,284.05,58.95,225.1,170.42,454.47,403.11,0.0,0,0.13,0.332,0.887,0.925,2,7,9,9,3.0,21.6,2,Similar,Southeast,PA,Rural,51-65,2023-05,Q2_2023,2022,7.7,0.243,Stable
FIA002319,2023-05-24,Atorvastatin,Lipitor,Statins,91103-487-75,Commercial Plan Beta,PLAN_2092,2023,Tier 1,Tier 3,2022-10-27,209,Improved,None,No,No,,199,144,38.7,Increased,16.64,58.52,-41.88,177.01,193.65,38.54,0.0,0,0.032,0.081,0.615,0.509,13,7,13,8,4.7,13.0,2,Higher,Southeast,TX,Rural,18-35,2023-05,Q2_2023,2022,5.3,0.051,Increasing
FIA002506,2023-05-24,Atorvastatin,Lipitor,Statins,48669-868-85,Commercial Plan Beta,PLAN_4444,2023,Tier 3,Non-Formulary,2022-09-26,240,Improved,None,No,No,,1028,956,7.5,Increased,75.29,331.85,-256.56,103.45,178.74,183.74,0.0,0,0.071,0.161,0.758,0.617,2,7,20,10,4.5,30.3,5,Higher,Midwest,NC,Suburban,75+,2023-05,Q2_2023,2022,1.4,0.378,Decreasing
FIA000624,2023-05-26,Atorvastatin,Lipitor,Statins,65020-649-12,VA Plan,PLAN_7638,2023,Specialty Tier,Tier 2,2022-11-20,187,Worsened,Prior Authorization,Yes,No,,595,907,-34.4,Decreased,145.07,40.32,104.75,129.74,274.81,163.51,0.132,5,0.179,0.353,0.213,0.866,3,0,5,2,2.5,31.3,4,Lower,Midwest,TX,Rural,36-50,2023-05,Q2_2023,2022,3.2,0.029,Decreasing
FIA000325,2023-06-12,Atorvastatin,Lipitor,Statins,64521-173-92,VA Plan,PLAN_5638,2023,Tier 3,Non-Formulary,2023-04-21,52,Improved,None,No,No,,179,179,0.1,Stable,80.03,409.84,-329.81,169.86,249.89,44.73,0.0,0,0.036,0.1,0.429,0.833,10,6,20,11,3.4,34.2,6,Lower,Southeast,IL,Urban,51-65,2023-06,Q2_2023,2022,9.4,0.912,Increasing
FIA001944,2023-06-17,Atorvastatin,Lipitor,Statins,89770-229-43,VA Plan,PLAN_2134,2023,Tier 1,Tier 2,2022-09-08,282,Improved,None,No,No,,952,953,-0.0,Stable,9.04,37.24,-28.2,113.35,122.39,116.52,0.0,0,0.026,0.052,0.704,0.714,7,1,17,0,2.9,14.0,5,Higher,Midwest,CA,Suburban,18-35,2023-06,Q2_2023,2022,8.2,0.989,Stable
FIA002510,2023-07-30,Atorvastatin,Lipitor,Statins,12708-741-84,Medicare Part D Plan B,PLAN_8311,2023,Specialty Tier,Tier 1,2022-10-05,298,Worsened,Prior Authorization,Yes,No,,394,782,-49.5,Decreased,212.14,9.65,202.49,64.87,277.01,109.14,0.543,10,0.183,0.111,0.327,0.737,6,10,18,1,4.2,20.4,8,Similar,Southeast,FL,Suburban,66-75,2023-07,Q3_2023,2022,7.1,0.474,Stable
FIA002339,2023-08-04,Atorvastatin,Lipitor,Statins,66157-996-27,Tricare Standard,PLAN_8320,2023,Tier 2,Tier 2,2023-01-12,204,No Change,None,No,No,,634,697,-8.9,Decreased,38.38,32.74,5.64,32.85,71.23,45.16,0.0,0,0.032,0.395,0.587,0.722,13,8,6,1,2.3,19.8,3,Similar,Northeast,MI,Rural,51-65,2023-08,Q3_2023,2022,7.6,0.146,Decreasing
FIA002410,2023-09-02,Atorvastatin,Lipitor,Statins,59536-418-73,Medicare Part D Plan A,PLAN_9726,2023,Non-Formulary,Tier 2,2022-10-23,314,Worsened,Non-Formulary Status,No,No,,639,872,-26.6,Decreased,676.94,33.56,643.38,193.57,870.51,556.26,0.0,0,0.122,0.234,0.224,0.941,2,10,13,0,3.4,10.7,2,Lower,Southwest,IL,Rural,75+,2023-09,Q3_2023,2022,5.5,0.257,Increasing
FIA002781,2023-09-08,Atorvastatin,Lipitor,Statins,74081-513-68,VA Plan,PLAN_4926,2023,Tier 2,Tier 1,2023-07-31,39,Worsened,None,No,No,,759,810,-6.2,Decreased,42.04,14.84,27.2,94.22,136.26,103.42,0.0,0,0.036,0.251,0.754,0.655,2,0,9,7,2.8,30.7,2,Higher,Southwest,FL,Rural,66-75,2023-09,Q3_2023,2022,7.3,0.499,Decreasing
FIA002784,2023-09-24,Atorvastatin,Lipitor,Statins,92620-538-61,VA Plan,PLAN_5572,2023,Tier 1,Tier 3,2023-05-20,127,Improved,Quantity Limit,No,No,60.0,1175,929,26.5,Increased,11.02,83.28,-72.26,57.52,68.54,80.53,0.0,0,0.05,0.066,0.602,0.652,7,3,3,8,3.3,24.6,3,Lower,Midwest,FL,Rural,51-65,2023-09,Q3_2023,2022,5.7,0.717,Stable
FIA001725,2023-09-28,Atorvastatin,Lipitor,Statins,39331-189-81,Medicare Part D Plan B,PLAN_1606,2023,Tier 3,Tier 3,2023-07-19,71,No Change,Prior Authorization,Yes,No,,658,636,3.6,Stable,99.27,91.73,7.54,146.19,245.46,161.51,0.472,1,0.034,0.159,0.808,0.911,8,6,1,3,4.7,33.9,6,Higher,Midwest,PA,Rural,75+,2023-09,Q3_2023,2022,6.2,0.797,Decreasing
FIA001293,2023-10-01,Atorvastatin,Lipitor,Statins,74346-260-14,Medicaid Plan X,PLAN_6971,2023,Tier 1,Tier 3,2023-02-15,228,Improved,None,No,No,,1031,821,25.6,Increased,14.24,54.12,-39.88,114.21,128.45,132.43,0.0,0,0.075,0.067,0.699,0.926,0,6,6,11,2.7,33.8,4,Lower,Northeast,OH,Rural,36-50,2023-10,Q4_2023,2023,4.8,0.325,Increasing
FIA000248,2023-10-10,Atorvastatin,Lipitor,Statins,23344-829-78,Commercial Plan Alpha,PLAN_5127,2023,Specialty Tier,Tier 2,2023-01-19,264,Worsened,None,No,No,,182,385,-52.5,Decreased,144.02,39.74,104.28,131.81,275.83,50.2,0.0,0,0.125,0.386,0.62,0.94,12,10,4,10,2.5,27.9,7,Similar,Southwest,TX,Suburban,18-35,2023-10,Q4_2023,2023,6.5,0.585,Stable
FIA002724,2023-10-12,Atorvastatin,Lipitor,Statins,42224-392-16,Commercial Plan Alpha,PLAN_2300,2023,Specialty Tier,Specialty Tier,2023-06-12,122,No Change,Prior Authorization; Quantity Limit,Yes,No,90.0,374,369,1.5,Stable,158.34,180.75,-22.41,111.91,270.25,101.07,0.149,1,0.263,0.358,0.213,0.905,8,8,6,5,2.7,30.9,6,Similar,Southeast,PA,Urban,51-65,2023-10,Q4_2023,2023,8.0,0.896,Increasing
FIA001763,2023-10-25,Atorvastatin,Lipitor,Statins,96978-843-34,Medicare Part D Plan B,PLAN_5698,2023,Non-Formulary,Tier 2,2023-03-01,238,Worsened,Non-Formulary Status,No,No,,518,928,-44.1,Decreased,288.51,47.83,240.68,40.1,328.61,170.22,0.0,0,0.173,0.292,0.799,0.623,9,3,5,11,4.8,22.3,4,Similar,Northeast,MI,Rural,75+,2023-10,Q4_2023,2023,8.3,0.021,Decreasing
FIA000791,2023-10-30,Atorvastatin,Lipitor,Statins,36792-390-98,Commercial Plan Beta,PLAN_7028,2023,Tier 3,Tier 1,2022-12-27,307,Worsened,None,No,No,,54,120,-54.3,Decreased,86.4,11.34,75.06,146.13,232.53,12.56,0.0,0,0.072,0.264,0.648,0.639,10,0,8,10,4.3,5.5,4,Similar,Southwest,MI,Urban,66-75,2023-10,Q4_2023,2023,4.1,0.046,Decreasing
FIA002247,2023-11-01,Atorvastatin,Lipitor,Statins,99810-575-65,Tricare Standard,PLAN_1332,2023,Non-Formulary,Tier 1,2022-11-01,365,Worsened,Non-Formulary Status,No,No,,55,170,-67.6,Decreased,499.3,16.63,482.67,73.36,572.66,31.5,0.0,0,0.29,0.131,0.872,0.656,1,8,4,12,5.0,19.5,4,Higher,Southwest,PA,Suburban,36-50,2023-11,Q4_2023,2023,2.2,0.97,Increasing
FIA002341,2023-11-03,Atorvastatin,Lipitor,Statins,74703-298-19,Tricare Standard,PLAN_5056,2023,Tier 2,Non-Formulary,2023-05-14,173,Improved,None,No,No,,209,182,15.3,Increased,40.35,666.62,-626.27,191.1,231.45,48.37,0.0,0,0.056,0.201,0.784,0.87,4,3,2,1,4.8,8.6,2,Higher,Midwest,IL,Rural,66-75,2023-11,Q4_2023,2023,4.2,0.104,Increasing
FIA002368,2023-11-05,Atorvastatin,Lipitor,Statins,44715-195-77,Medicaid Plan X,PLAN_5841,2023,Tier 3,Tier 2,2023-01-19,290,Worsened,None,No,No,,143,195,-26.5,Decreased,69.56,45.88,23.68,40.37,109.93,15.72,0.0,0,0.021,0.147,0.502,0.816,1,4,5,9,3.0,27.0,7,Higher,Southwest,FL,Suburban,36-50,2023-11,Q4_2023,2023,7.9,0.798,Decreasing
FIA000012,2023-11-10,Atorvastatin,Lipitor,Statins,89457-623-24,VA Plan,PLAN_4114,2023,Tier 1,Tier 3,2023-07-12,121,Improved,None,No,No,,166,139,19.9,Increased,13.71,99.18,-85.47,83.33,97.04,16.11,0.0,0,0.061,0.139,0.696,0.401,6,5,13,2,4.8,32.6,6,Similar,Northeast,PA,Rural,51-65,2023-11,Q4_2023,2023,7.0,0.326,Decreasing
FIA000120,2023-11-11,Atorvastatin,Lipitor,Statins,63011-543-50,Medicare Part D Plan A,PLAN_7381,2023,Tier 1,Tier 1,2023-09-15,57,No Change,Quantity Limit,No,No,,174,172,1.5,Stable,7.67,8.78,-1.11,106.69,114.36,19.9,0.0,0,0.039,0.237,0.649,0.74,1,1,11,3,2.9,25.6,6,Lower,Midwest,GA,Suburban,66-75,2023-11,Q4_2023,2023,8.4,0.031,Increasing
FIA001849,2023-11-11,Atorvastatin,Lipitor,Statins,89641-405-32,Commercial Plan Alpha,PLAN_1714,2023,Tier 2,Tier 3,2023-05-26,169,Improved,Quantity Limit,No,No,60.0,489,314,56.0,Increased,47.09,68.62,-21.53,153.3,200.39,97.99,0.0,0,0.013,0.255,0.202,0.505,3,2,3,11,3.0,22.2,6,Higher,Midwest,MI,Urban,51-65,2023-11,Q4_2023,2023,1.6,0.695,Increasing
FIA001842,2023-11-17,Atorvastatin,Lipitor,Statins,49116-154-62,VA Plan,PLAN_2390,2023,Tier 3,Specialty Tier,2023-05-29,172,Improved,Quantity Limit,No,No,30.0,893,813,9.9,Increased,97.99,118.72,-20.73,182.64,280.63,250.6,0.0,0,0.048,0.144,0.218,0.439,1,1,5,8,4.1,34.7,8,Higher,Northeast,TX,Rural,66-75,2023-11,Q4_2023,2023,1.5,0.397,Decreasing
FIA001309,2023-11-27,Atorvastatin,Lipitor,Statins,34238-842-71,Commercial Plan Beta,PLAN_7670,2023,Tier 2,Tier 1,2022-12-04,358,Worsened,None,No,No,,388,383,1.4,Stable,35.74,16.08,19.66,73.36,109.1,42.33,0.0,0,0.044,0.244,0.267,0.883,15,10,4,5,3.9,29.3,8,Higher,Northeast,NC,Urban,51-65,2023-11,Q4_2023,2023,4.1,0.208,Decreasing
FIA002961,2023-11-27,Atorvastatin,Lipitor,Statins,80332-995-92,VA Plan,PLAN_6330,2023,Specialty Tier,Tier 3,2023-04-11,230,Worsened,None,No,No,,966,992,-2.6,Stable,104.75,90.6,14.15,126.56,231.31,223.45,0.0,0,0.185,0.23,0.36,0.941,7,6,13,9,4.6,27.1,8,Similar,Midwest,CA,Suburban,66-75,2023-11,Q4_2023,2023,4.3,0.481,Increasing
FIA000469,2023-11-28,Atorvastatin,Lipitor,Statins,39082-926-28,Medicare Part D Plan B,PLAN_2475,2023,Tier 3,Tier 1,2023-06-02,179,Worsened,Prior Authorization,Yes,No,,98,313,-68.5,Decreased,61.94,18.75,43.19,50.77,112.71,11.05,0.394,2,0.072,0.299,0.518,0.657,3,8,1,6,2.7,7.7,7,Lower,Southwest,NY,Urban,66-75,2023-11,Q4_2023,2023,6.8,0.999,Increasing
FIA000647,2023-12-19,Atorvastatin,Lipitor,Statins,82413-521-34,Medicaid Plan X,PLAN_3953,2023,Tier 1,Non-Formulary,2023-08-18,123,Improved,None,No,No,,999,750,33.3,Increased,10.29,677.49,-667.2,106.03,116.32,116.2,0.0,0,0.079,0.276,0.263,0.92,5,3,8,2,2.9,22.2,6,Lower,Northeast,MI,Rural,66-75,2023-12,Q4_2023,2023,4.5,0.831,Stable
FIA001454,2023-12-30,Atorvastatin,Lipitor,Statins,58515-429-26,Commercial Plan Beta,PLAN_8890,2023,Tier 1,Tier 1,2023-06-28,185,No Change,None,No,No,,1013,948,6.9,Increased,11.62,18.54,-6.92,89.06,100.68,101.99,0.0,0,0.014,0.226,0.686,0.415,15,5,15,9,2.9,32.8,4,Similar,Southeast,OH,Urban,36-50,2023-12,Q4_2023,2023,2.9,0.944,Decreasing
FIA002976,2024-01-06,Atorvastatin,Lipitor,Statins,48963-923-65,Tricare Standard,PLAN_4885,2024,Tier 2,Tier 2,2023-04-09,272,No Change,Quantity Limit,No,No,90.0,808,780,3.7,Stable,45.18,34.56,10.62,180.18,225.36,182.09,0.0,0,0.066,0.303,0.206,0.507,4,0,12,12,4.7,7.3,8,Higher,Southwest,GA,Urban,36-50,2024-01,Q1_2024,2023,8.1,0.965,Decreasing
FIA000220,2024-01-11,Atorvastatin,Lipitor,Statins,96530-756-29,Medicare Part D Plan A,PLAN_9516,2024,Specialty Tier,Tier 2,2023-12-07,35,Worsened,Step Therapy,No,Yes,,129,171,-24.2,Decreased,243.53,35.52,208.01,159.06,402.59,51.93,0.0,0,0.065,0.39,0.494,0.887,9,5,11,0,4.5,32.0,6,Lower,Southwest,GA,Rural,36-50,2024-01,Q1_2024,2023,9.0,0.624,Decreasing
FIA001184,2024-01-18,Atorvastatin,Lipitor,Statins,55767-324-63,Medicare Part D Plan B,PLAN_3084,2024,Tier 1,Specialty Tier,2023-08-12,159,Improved,None,No,No,,789,494,59.8,Increased,9.88,285.5,-275.62,56.31,66.19,52.22,0.0,0,0.026,0.204,0.615,0.649,5,2,18,11,4.8,28.8,7,Higher,Midwest,GA,Suburban,51-65,2024-01,Q1_2024,2023,1.3,0.06,Decreasing
FIA000485,2024-01-20,Atorvastatin,Lipitor,Statins,84431-507-68,Medicare Part D Plan A,PLAN_9753,2024,Tier 3,Non-Formulary,2023-05-06,259,Improved,Step Therapy,No,Yes,,521,514,1.4,Stable,96.85,612.05,-515.2,53.59,150.44,78.38,0.0,0,0.079,0.32,0.388,0.636,9,8,0,5,2.4,32.6,8,Similar,Northeast,MI,Rural,36-50,2024-01,Q1_2024,2023,7.0,0.542,Decreasing
FIA002770,2024-01-22,Atorvastatin,Lipitor,Statins,77555-534-97,VA Plan,PLAN_8061,2024,Tier 1,Tier 3,2023-05-14,253,Improved,None,No,No,,1232,988,24.8,Increased,12.88,72.83,-59.95,184.25,197.13,242.86,0.0,0,0.039,0.333,0.707,0.628,14,10,1,5,4.8,34.4,5,Similar,West,TX,Urban,18-35,2024-01,Q1_2024,2023,5.1,0.167,Stable
FIA000368,2024-02-08,Atorvastatin,Lipitor,Statins,64234-944-29,Commercial Plan Alpha,PLAN_5896,2024,Tier 1,Tier 1,2023-02-16,357,No Change,None,No,No,,594,548,8.5,Increased,10.14,13.07,-2.93,42.58,52.72,31.32,0.0,0,0.072,0.251,0.593,0.641,10,9,17,8,3.7,29.5,7,Lower,Southeast,TX,Rural,51-65,2024-02,Q1_2024,2023,9.6,0.361,Stable
FIA000372,2024-02-08,Atorvastatin,Lipitor,Statins,77698-224-30,Commercial Plan Beta,PLAN_2971,2024,Specialty Tier,Tier 2,2023-06-29,224,Worsened,Step Therapy,No,Yes,,211,303,-30.3,Decreased,109.84,33.16,76.68,185.26,295.1,62.27,0.0,0,0.094,0.379,0.718,0.597,10,6,6,6,5.0,29.0,4,Similar,Midwest,NC,Urban,66-75,2024-02,Q1_2024,2023,1.1,0.38,Stable
FIA001038,2024-02-17,Atorvastatin,Lipitor,Statins,56429-848-35,VA Plan,PLAN_1713,2024,Non-Formulary,Tier 1,2023-11-08,101,Worsened,Non-Formulary Status,No,No,,283,360,-21.2,Decreased,272.77,18.29,254.48,167.67,440.44,124.64,0.0,0,0.14,0.082,0.504,0.715,7,2,20,8,3.4,18.2,3,Similar,Southeast,IL,Rural,18-35,2024-02,Q1_2024,2023,7.4,0.297,Increasing
FIA002029,2024-03-02,Atorvastatin,Lipitor,Statins,34696-689-97,Medicaid Plan X,PLAN_9138,2024,Tier 1,Specialty Tier,2023-06-08,268,Improved,None,No,No,,255,195,31.3,Increased,17.66,165.58,-147.92,53.5,71.16,18.15,0.0,0,0.033,0.196,0.826,0.866,2,4,10,14,3.5,16.2,8,Higher,Northeast,MI,Suburban,18-35,2024-03,Q1_2024,2023,6.4,0.551,Increasing
FIA002155,2024-03-03,Atorvastatin,Lipitor,Statins,71616-178-19,Commercial Plan Beta,PLAN_7731,2024,Specialty Tier,Tier 2,2023-05-13,295,Worsened,Prior Authorization,Yes,No,,395,937,-57.8,Decreased,170.05,31.59,138.46,41.41,211.46,83.53,0.185,4,0.207,0.173,0.402,0.934,7,3,3,2,4.1,25.6,5,Higher,Northeast,OH,Rural,51-65,2024-03,Q1_2024,2023,3.9,0.48,Decreasing
FIA001615,2024-03-06,Atorvastatin,Lipitor,Statins,12280-592-50,VA Plan,PLAN_5984,2024,Non-Formulary,Tier 3,2023-07-24,226,Worsened,Non-Formulary Status,No,No,,197,186,6.4,Increased,441.76,92.04,349.72,44.78,486.54,95.85,0.0,0,0.082,0.127,0.593,0.531,15,5,7,6,4.1,10.9,4,Higher,Southeast,NC,Rural,75+,2024-03,Q1_2024,2023,4.7,0.579,Decreasing
FIA000425,2024-03-11,Atorvastatin,Lipitor,Statins,72965-920-37,Commercial Plan Beta,PLAN_8778,2024,Tier 3,Tier 1,2023-05-25,291,Worsened,Quantity Limit,No,No,90.0,520,781,-33.3,Decreased,89.4,6.69,82.71,71.42,160.82,83.63,0.0,0,0.032,0.218,0.269,0.613,2,2,4,4,4.6,7.0,6,Lower,West,FL,Urban,66-75,2024-03,Q1_2024,2023,8.6,0.362,Increasing
FIA002256,2024-03-14,Atorvastatin,Lipitor,Statins,89614-733-43,Tricare Standard,PLAN_7537,2024,Specialty Tier,Non-Formulary,2023-04-16,333,Improved,Prior Authorization; Step Therapy,Yes,Yes,,822,856,-3.9,Stable,131.23,252.6,-121.37,53.6,184.83,151.93,0.434,4,0.133,0.249,0.465,0.426,12,9,9,2,4.1,14.8,6,Similar,Northeast,TX,Suburban,36-50,2024-03,Q1_2024,2023,9.3,0.348,Stable
FIA001054,2024-03-18,Atorvastatin,Lipitor,Statins,34254-172-72,Medicaid Plan Y,PLAN_2016,2024,Non-Formulary,Tier 3,2023-12-15,94,Worsened,Non-Formulary Status,No,No,,481,450,7.0,Increased,205.05,83.56,121.49,179.68,384.73,185.06,0.0,0,0.128,0.151,0.636,0.686,4,9,17,15,5.0,19.0,4,Higher,Midwest,FL,Urban,18-35,2024-03,Q1_2024,2023,4.9,0.687,Decreasing
FIA002201,2024-03-19,Atorvastatin,Lipitor,Statins,73847-564-33,Commercial Plan Beta,PLAN_9370,2024,Tier 1,Specialty Tier,2023-05-14,310,Improved,None,No,No,,1320,885,49.2,Increased,13.59,151.6,-138.01,98.22,111.81,147.59,0.0,0,0.078,0.097,0.519,0.44,7,4,17,13,3.0,18.5,5,Higher,West,TX,Urban,36-50,2024-03,Q1_2024,2023,2.7,0.137,Stable
FIA000772,2024-03-23,Atorvastatin,Lipitor,Statins,91976-170-78,Commercial Plan Alpha,PLAN_4933,2024,Tier 2,Tier 1,2023-10-06,169,Worsened,None,No,No,,853,907,-5.9,Decreased,20.26,16.71,3.55,89.16,109.42,93.34,0.0,0,0.042,0.326,0.579,0.453,2,3,17,4,3.3,7.2,8,Similar,Northeast,NY,Urban,51-65,2024-03,Q1_2024,2023,4.4,0.101,Stable
FIA000625,2024-04-02,Atorvastatin,Lipitor,Statins,36429-207-86,Tricare Standard,PLAN_1810,2024,Tier 3,Non-Formulary,2023-06-07,300,Improved,Prior Authorization,Yes,No,,344,345,-0.1,Stable,71.19,694.28,-623.09,57.74,128.93,44.35,0.126,2,0.014,0.081,0.393,0.916,6,4,15,3,2.7,27.5,5,Higher,Northeast,MI,Suburban,75+,2024-04,Q2_2024,2023,4.7,0.781,Increasing
FIA000367,2024-04-07,Atorvastatin,Lipitor,Statins,60122-433-81,Commercial Plan Beta,PLAN_4522,2024,Specialty Tier,Tier 3,2023-04-13,360,Worsened,Step Therapy,No,Yes,,845,885,-4.5,Stable,261.07,98.75,162.32,84.71,345.78,292.18,0.0,0,0.143,0.266,0.508,0.551,2,3,5,10,4.2,33.2,6,Similar,Northeast,OH,Rural,66-75,2024-04,Q2_2024,2023,3.2,0.987,Decreasing
FIA002675,2024-04-10,Atorvastatin,Lipitor,Statins,37531-728-58,VA Plan,PLAN_1542,2024,Specialty Tier,Tier 2,2023-09-05,218,Worsened,Step Therapy,No,Yes,,434,603,-28.0,Decreased,219.35,43.42,175.93,166.03,385.38,167.25,0.0,0,0.079,0.234,0.487,0.831,8,0,20,2,3.7,7.6,4,Higher,Southwest,NC,Suburban,36-50,2024-04,Q2_2024,2023,9.6,0.543,Decreasing
FIA001907,2024-04-14,Atorvastatin,Lipitor,Statins,90291-894-69,Medicare Part D Plan B,PLAN_8925,2024,Tier 3,Tier 3,2023-04-20,360,No Change,None,No,No,,812,823,-1.2,Stable,87.42,77.17,10.25,103.87,191.29,155.33,0.0,0,0.056,0.101,0.287,0.62,3,5,7,7,2.8,35.0,3,Lower,West,PA,Urban,18-35,2024-04,Q2_2024,2023,6.5,0.138,Decreasing
FIA000484,2024-04-16,Atorvastatin,Lipitor,Statins,72694-816-17,VA Plan,PLAN_9134,2024,Tier 3,Tier 2,2023-05-29,323,Worsened,Prior Authorization,Yes,No,,68,123,-44.6,Decreased,87.51,48.79,38.72,50.23,137.74,9.37,0.301,4,0.075,0.365,0.563,0.844,0,5,0,12,3.6,7.5,8,Lower,Southeast,NY,Rural,51-65,2024-04,Q2_2024,2023,4.0,0.159,Stable
FIA000334,2024-04-17,Atorvastatin,Lipitor,Statins,38697-447-91,Medicare Part D Plan A,PLAN_6054,2024,Non-Formulary,Tier 3,2023-11-06,163,Worsened,Non-Formulary Status,No,No,,917,928,-1.2,Stable,604.99,70.56,534.43,112.54,717.53,657.98,0.0,0,0.064,0.207,0.355,0.882,6,10,3,10,2.4,21.2,7,Lower,Southwest,TX,Rural,51-65,2024-04,Q2_2024,2023,9.2,0.767,Decreasing
FIA002235,2024-04-18,Atorvastatin,Lipitor,Statins,41096-470-72,VA Plan,PLAN_9497,2024,Tier 3,Tier 3,2023-07-13,280,No Change,Prior Authorization; Step Therapy,Yes,Yes,,591,591,0.2,Stable,87.31,63.88,23.43,124.5,211.81,125.18,0.34,6,0.062,0.202,0.306,0.627,6,9,18,1,3.9,13.5,2,Similar,Southwest,PA,Rural,18-35,2024-04,Q2_2024,2023,4.8,0.422,Stable
FIA001067,2024-04-23,Atorvastatin,Lipitor,Statins,21570-108-82,Commercial Plan Alpha,PLAN_4014,2024,Tier 1,Tier 2,2023-12-03,142,Improved,None,No,No,,289,286,1.4,Stable,11.72,29.44,-17.72,138.36,150.08,43.37,0.0,0,0.046,0.39,0.29,0.451,8,5,11,15,4.8,24.0,8,Higher,Southeast,GA,Rural,36-50,2024-04,Q2_2024,2023,3.1,0.396,Increasing
FIA001983,2024-04-30,Atorvastatin,Lipitor,Statins,73557-304-69,Commercial Plan Alpha,PLAN_3490,2024,Tier 1,Specialty Tier,2024-02-19,71,Improved,None,No,No,,1296,863,50.3,Increased,11.54,202.49,-190.95,35.26,46.8,60.65,0.0,0,0.026,0.344,0.66,0.665,8,8,7,12,2.6,8.6,8,Lower,Northeast,NY,Rural,75+,2024-04,Q2_2024,2023,6.0,0.102,Increasing
FIA002987,2024-05-20,Atorvastatin,Lipitor,Statins,54293-236-57,Tricare Standard,PLAN_5857,2024,Tier 2,Non-Formulary,2023-06-21,334,Improved,Quantity Limit,No,No,,1089,781,39.5,Increased,48.19,688.36,-640.17,58.16,106.35,115.82,0.0,0,0.035,0.264,0.305,0.831,2,5,6,8,3.9,7.5,2,Higher,West,GA,Rural,66-75,2024-05,Q2_2024,2023,9.1,0.329,Increasing
FIA001867,2024-05-26,Atorvastatin,Lipitor,Statins,48524-842-45,Medicare Part D Plan A,PLAN_8443,2024,Tier 3,Tier 1,2023-09-25,244,Worsened,Step Therapy,No,Yes,,100,190,-47.0,Decreased,64.49,10.32,54.17,46.53,111.02,11.1,0.0,0,0.059,0.267,0.391,0.902,6,5,7,3,3.4,27.2,8,Similar,Southwest,TX,Suburban,51-65,2024-05,Q2_2024,2023,2.4,0.29,Decreasing
FIA002792,2024-05-26,Atorvastatin,Lipitor,Statins,89242-826-27,Medicare Part D Plan A,PLAN_6140,2024,Tier 2,Tier 1,2023-09-23,246,Worsened,Quantity Limit,No,No,,602,560,7.5,Increased,30.79,12.71,18.08,169.93,200.72,120.83,0.0,0,0.045,0.285,0.865,0.657,14,4,19,8,2.8,26.5,3,Lower,West,TX,Urban,51-65,2024-05,Q2_2024,2023,1.5,0.907,Stable
FIA002730,2024-05-29,Atorvastatin,Lipitor,Statins,89067-605-11,Tricare Standard,PLAN_9618,2024,Tier 1,Non-Formulary,2023-07-31,303,Improved,None,No,No,,975,636,53.4,Increased,16.41,697.98,-681.57,32.18,48.59,47.38,0.0,0,0.032,0.101,0.723,0.703,2,4,18,9,2.8,7.2,5,Higher,Midwest,MI,Suburban,51-65,2024-05,Q2_2024,2023,6.6,0.592,Stable
FIA001562,2024-06-06,Atorvastatin,Lipitor,Statins,91110-698-24,Medicaid Plan Y,PLAN_3033,2024,Specialty Tier,Tier 2,2023-06-13,359,Worsened,None,No,No,,260,739,-64.8,Decreased,293.79,20.15,273.64,178.38,472.17,122.76,0.0,0,0.213,0.329,0.411,0.457,0,5,1,11,2.0,7.4,3,Higher,Midwest,GA,Rural,51-65,2024-06,Q2_2024,2023,7.4,0.97,Decreasing
FIA000537,2024-06-10,Atorvastatin,Lipitor,Statins,92656-970-48,VA Plan,PLAN_3259,2024,Specialty Tier,Specialty Tier,2024-02-02,129,No Change,Prior Authorization,Yes,No,,916,834,9.9,Increased,217.66,143.81,73.85,68.73,286.39,262.33,0.584,9,0.129,0.067,0.434,0.645,14,4,1,12,3.1,23.6,4,Lower,Midwest,OH,Urban,36-50,2024-06,Q2_2024,2023,6.1,0.729,Increasing
FIA000396,2024-06-17,Atorvastatin,Lipitor,Statins,32271-841-51,Medicaid Plan Y,PLAN_1629,2024,Specialty Tier,Tier 1,2024-01-14,155,Worsened,Prior Authorization,Yes,No,,192,264,-27.2,Decreased,220.33,9.32,211.01,135.16,355.49,68.25,0.305,3,0.184,0.366,0.679,0.403,0,9,1,12,4.3,8.6,3,Higher,Northeast,MI,Rural,18-35,2024-06,Q2_2024,2023,1.2,0.824,Stable
FIA001869,2024-06-18,Atorvastatin,Lipitor,Statins,41997-708-42,Medicaid Plan X,PLAN_5177,2024,Non-Formulary,Tier 2,2024-04-08,71,Worsened,Non-Formulary Status,No,No,,394,781,-49.5,Decreased,571.71,34.75,536.96,194.17,765.88,301.76,0.0,0,0.076,0.266,0.203,0.759,9,5,14,8,2.8,24.5,2,Higher,Southeast,NY,Urban,66-75,2024-06,Q2_2024,2023,8.3,0.474,Stable
FIA000651,2024-06-22,Atorvastatin,Lipitor,Statins,68365-415-44,Medicaid Plan X,PLAN_2274,2024,Tier 1,Specialty Tier,2023-07-11,347,Improved,None,No,No,,594,406,46.4,Increased,14.23,137.76,-123.53,125.26,139.49,82.86,0.0,0,0.022,0.319,0.318,0.548,13,5,6,12,3.7,18.5,8,Lower,Southeast,IL,Suburban,75+,2024-06,Q2_2024,2023,4.3,0.225,Increasing
FIA000345,2024-06-27,Atorvastatin,Lipitor,Statins,21284-679-69,Medicare Part D Plan B,PLAN_2904,2024,Tier 3,Non-Formulary,2024-02-17,131,Improved,None,No,No,,787,750,4.9,Stable,84.44,445.55,-361.11,172.14,256.58,201.93,0.0,0,0.043,0.371,0.328,0.448,10,9,20,0,4.3,28.7,3,Higher,Midwest,GA,Urban,36-50,2024-06,Q2_2024,2023,3.8,0.681,Increasing
FIA002601,2024-07-02,Atorvastatin,Lipitor,Statins,83533-506-30,Medicare Part D Plan B,PLAN_9291,2024,Tier 1,Tier 1,2024-04-15,78,No Change,None,No,No,,990,978,1.3,Stable,16.86,16.82,0.04,88.76,105.62,104.56,0.0,0,0.064,0.352,0.659,0.691,13,3,12,1,2.5,22.2,5,Lower,West,OH,Rural,66-75,2024-07,Q3_2024,2023,1.5,0.256,Stable
FIA000658,2024-07-09,Atorvastatin,Lipitor,Statins,83585-624-45,Commercial Plan Beta,PLAN_1889,2024,Specialty Tier,Non-Formulary,2024-03-10,121,Improved,Step Therapy,No,Yes,,643,651,-1.2,Stable,112.7,403.99,-291.29,76.16,188.86,121.44,0.0,0,0.29,0.294,0.748,0.782,2,7,17,3,3.2,20.1,2,Similar,Southwest,PA,Rural,36-50,2024-07,Q3_2024,2023,7.1,0.344,Decreasing
FIA001831,2024-07-09,Atorvastatin,Lipitor,Statins,46463-581-16,Tricare Standard,PLAN_4080,2024,Tier 2,Tier 1,2023-10-13,270,Worsened,Quantity Limit,No,No,,167,157,6.4,Increased,32.06,14.89,17.17,171.21,203.27,33.95,0.0,0,0.056,0.229,0.405,0.553,7,7,11,14,4.8,26.3,7,Similar,Midwest,TX,Suburban,36-50,2024-07,Q3_2024,2023,7.8,0.194,Increasing
FIA001474,2024-07-14,Atorvastatin,Lipitor,Statins,59478-543-46,Medicaid Plan Y,PLAN_4491,2024,Tier 1,Specialty Tier,2024-03-22,114,Improved,None,No,No,,316,208,52.1,Increased,5.65,127.38,-121.73,161.76,167.41,52.9,0.0,0,0.042,0.186,0.78,0.47,7,5,1,3,2.3,13.1,6,Similar,West,MI,Suburban,18-35,2024-07,Q3_2024,2023,6.3,0.82,Increasing
FIA000328,2024-07-18,Atorvastatin,Lipitor,Statins,31880-174-26,VA Plan,PLAN_7919,2024,Tier 2,Tier 1,2023-11-17,244,Worsened,Quantity Limit,No,No,60.0,609,581,4.9,Stable,27.9,13.32,14.58,34.07,61.97,37.74,0.0,0,0.068,0.095,0.688,0.533,9,1,10,10,3.8,23.5,7,Lower,Northeast,IL,Suburban,66-75,2024-07,Q3_2024,2023,6.7,0.741,Stable
FIA001098,2024-08-09,Atorvastatin,Lipitor,Statins,92869-226-48,Medicaid Plan X,PLAN_9307,2024,Tier 2,Specialty Tier,2024-03-04,158,Improved,None,No,No,,1224,914,34.0,Increased,20.52,127.72,-107.2,48.04,68.56,83.92,0.0,0,0.03,0.217,0.31,0.913,13,4,17,7,4.2,12.6,3,Similar,West,GA,Urban,18-35,2024-08,Q3_2024,2023,2.6,0.282,Stable
FIA001939,2024-08-24,Atorvastatin,Lipitor,Statins,31282-339-59,Commercial Plan Alpha,PLAN_1855,2024,Tier 1,Tier 2,2024-01-06,231,Improved,Quantity Limit,No,No,,557,516,8.1,Increased,15.28,42.43,-27.15,95.91,111.19,61.93,0.0,0,0.019,0.397,0.362,0.478,3,4,16,15,3.3,5.9,7,Higher,West,OH,Urban,75+,2024-08,Q3_2024,2023,2.0,0.551,Increasing
FIA000671,2024-08-26,Atorvastatin,Lipitor,Statins,46214-118-41,Commercial Plan Alpha,PLAN_3919,2024,Tier 1,Tier 3,2024-07-22,35,Improved,None,No,No,,1063,920,15.6,Increased,13.82,94.61,-80.79,49.93,63.75,67.77,0.0,0,0.072,0.079,0.578,0.775,12,6,5,1,2.7,16.2,8,Higher,West,OH,Rural,51-65,2024-08,Q3_2024,2023,6.7,0.693,Increasing
FIA001560,2024-08-27,Atorvastatin,Lipitor,Statins,80692-953-44,Commercial Plan Beta,PLAN_2140,2024,Tier 2,Non-Formulary,2023-09-29,333,Improved,Quantity Limit,No,No,,748,544,37.6,Increased,38.14,445.04,-406.9,92.73,130.87,97.89,0.0,0,0.075,0.185,0.84,0.433,12,5,2,9,4.1,12.6,5,Lower,West,OH,Rural,51-65,2024-08,Q3_2024,2023,7.2,0.29,Increasing
FIA001206,2024-09-05,Atorvastatin,Lipitor,Statins,51912-149-42,Medicare Part D Plan A,PLAN_4510,2024,Tier 1,Specialty Tier,2023-11-23,287,Improved,None,No,No,,718,471,52.7,Increased,16.58,131.25,-114.67,149.41,165.99,119.18,0.0,0,0.067,0.216,0.258,0.811,10,9,12,14,2.8,5.5,6,Similar,Southeast,MI,Urban,51-65,2024-09,Q3_2024,2023,7.5,0.657,Stable
FIA000834,2024-09-17,Atorvastatin,Lipitor,Statins,71952-501-49,Tricare Standard,PLAN_6931,2024,Specialty Tier,Non-Formulary,2023-10-25,328,Improved,Prior Authorization,Yes,No,,723,693,4.4,Stable,278.2,415.93,-137.73,198.85,477.05,344.91,0.154,5,0.171,0.286,0.446,0.588,4,8,18,14,2.5,16.6,6,Lower,Midwest,NC,Suburban,51-65,2024-09,Q3_2024,2023,9.5,0.68,Increasing
FIA001225,2024-09-20,Atorvastatin,Lipitor,Statins,27664-473-12,Medicare Part D Plan B,PLAN_6897,2024,Tier 3,Tier 3,2024-01-06,258,No Change,Step Therapy; Quantity Limit,No,Yes,60.0,1037,944,9.9,Increased,73.87,74.07,-0.2,187.29,261.16,270.82,0.0,0,0.043,0.387,0.379,0.555,10,7,10,4,3.1,34.8,3,Similar,Midwest,PA,Rural,75+,2024-09,Q3_2024,2023,3.4,0.337,Stable
FIA001971,2024-09-21,Atorvastatin,Lipitor,Statins,32075-708-25,Commercial Plan Alpha,PLAN_4945,2024,Tier 1,Tier 3,2024-04-22,152,Improved,None,No,No,,859,606,41.9,Increased,7.9,93.92,-86.02,172.92,180.82,155.32,0.0,0,0.048,0.226,0.287,0.896,15,4,20,1,2.2,19.9,3,Lower,Southwest,FL,Rural,51-65,2024-09,Q3_2024,2023,2.9,0.959,Decreasing
FIA002560,2024-09-23,Atorvastatin,Lipitor,Statins,25158-175-54,VA Plan,PLAN_5662,2024,Tier 1,Tier 1,2023-11-14,314,No Change,None,No,No,,517,540,-4.1,Stable,9.1,9.21,-0.11,155.48,164.58,85.09,0.0,0,0.038,0.358,0.422,0.671,9,2,5,5,3.1,10.7,6,Similar,Northeast,NC,Urban,66-75,2024-09,Q3_2024,2023,7.9,0.122,Increasing
FIA000243,2024-09-27,Atorvastatin,Lipitor,Statins,52830-980-62,VA Plan,PLAN_3572,2024,Tier 2,Tier 2,2024-07-24,65,No Change,None,No,No,,293,310,-5.3,Decreased,47.34,31.58,15.76,31.88,79.22,23.21,0.0,0,0.036,0.396,0.29,0.63,2,6,6,4,4.6,14.3,8,Higher,Southwest,FL,Rural,75+,2024-09,Q3_2024,2023,9.5,0.587,Decreasing
FIA001785,2024-09-28,Atorvastatin,Lipitor,Statins,33847-637-21,Medicaid Plan X,PLAN_9288,2024,Tier 2,Tier 1,2024-07-06,84,Worsened,None,No,No,,560,512,9.4,Increased,32.35,16.23,16.12,143.42,175.77,98.43,0.0,0,0.048,0.262,0.838,0.889,3,7,17,3,4.9,33.0,4,Similar,West,NY,Suburban,18-35,2024-09,Q3_2024,2023,7.7,0.069,Increasing
FIA001917,2024-10-02,Atorvastatin,Lipitor,Statins,15279-645-52,Medicare Part D Plan B,PLAN_9774,2024,Tier 2,Tier 2,2024-07-05,89,No Change,Quantity Limit,No,No,30.0,535,594,-9.8,Decreased,30.52,42.93,-12.41,171.94,202.46,108.32,0.0,0,0.055,0.24,0.47,0.619,12,2,9,11,3.3,22.2,2,Lower,Southeast,CA,Rural,75+,2024-10,Q4_2024,2024,5.0,0.358,Stable
FIA002334,2024-10-02,Atorvastatin,Lipitor,Statins,88522-805-76,Tricare Standard,PLAN_7444,2024,Tier 2,Tier 3,2023-11-05,332,Improved,None,No,No,,1140,865,31.9,Increased,46.83,59.59,-12.76,40.06,86.89,99.05,0.0,0,0.043,0.216,0.626,0.888,3,9,11,5,2.1,30.4,4,Similar,Southeast,PA,Suburban,66-75,2024-10,Q4_2024,2024,5.2,0.105,Stable
FIA001440,2024-10-23,Atorvastatin,Lipitor,Statins,45217-896-48,Medicaid Plan Y,PLAN_3081,2024,Non-Formulary,Non-Formulary,2024-09-08,45,No Change,Non-Formulary Status,No,No,,155,163,-4.7,Stable,559.88,536.78,23.1,104.39,664.27,102.96,0.0,0,0.231,0.115,0.452,0.542,12,7,7,4,4.1,26.3,5,Lower,Southeast,FL,Urban,51-65,2024-10,Q4_2024,2024,10.0,0.238,Stable
FIA002895,2024-10-24,Atorvastatin,Lipitor,Statins,33374-518-74,Commercial Plan Beta,PLAN_5079,2024,Tier 3,Tier 1,2024-09-15,39,Worsened,None,No,No,,582,950,-38.7,Decreased,65.27,10.48,54.79,113.24,178.51,103.89,0.0,0,0.014,0.154,0.462,0.909,13,9,13,7,2.0,14.5,5,Similar,Midwest,IL,Urban,36-50,2024-10,Q4_2024,2024,5.0,0.936,Stable
FIA002393,2024-10-25,Atorvastatin,Lipitor,Statins,68020-695-91,Medicare Part D Plan A,PLAN_5433,2024,Specialty Tier,Non-Formulary,2024-05-21,157,Improved,Prior Authorization,Yes,No,,968,911,6.3,Increased,238.93,702.64,-463.71,159.7,398.63,385.87,0.178,5,0.07,0.35,0.201,0.672,2,9,8,5,2.6,23.6,7,Higher,Southeast,CA,Urban,66-75,2024-10,Q4_2024,2024,8.8,0.949,Increasing
FIA002194,2024-11-12,Atorvastatin,Lipitor,Statins,59400-362-16,Tricare Standard,PLAN_9877,2024,Non-Formulary,Tier 2,2024-02-02,284,Worsened,Non-Formulary Status; Quantity Limit,No,No,,114,175,-34.8,Decreased,785.9,42.35,743.55,146.22,932.12,106.26,0.0,0,0.287,0.384,0.365,0.46,10,7,10,4,2.8,15.9,2,Similar,Midwest,FL,Rural,18-35,2024-11,Q4_2024,2024,7.2,0.968,Increasing
FIA002578,2024-11-15,Atorvastatin,Lipitor,Statins,77001-883-95,Medicaid Plan Y,PLAN_4695,2024,Tier 2,Non-Formulary,2024-07-28,110,Improved,None,No,No,,944,680,39.0,Increased,40.89,642.71,-601.82,159.96,200.85,189.6,0.0,0,0.053,0.218,0.417,0.792,12,9,6,0,2.9,34.9,7,Similar,Northeast,CA,Rural,51-65,2024-11,Q4_2024,2024,5.8,0.714,Stable
FIA001061,2024-11-21,Atorvastatin,Lipitor,Statins,91229-112-69,Tricare Standard,PLAN_2576,2024,Non-Formulary,Non-Formulary,2023-12-16,341,No Change,Non-Formulary Status; Quantity Limit,No,No,30.0,353,371,-4.6,Stable,674.73,214.67,460.06,34.09,708.82,250.21,0.0,0,0.101,0.132,0.43,0.779,4,7,15,7,3.5,15.6,4,Similar,Southwest,TX,Suburban,36-50,2024-11,Q4_2024,2024,5.0,0.476,Increasing
FIA002195,2024-11-25,Atorvastatin,Lipitor,Statins,20712-766-27,Medicare Part D Plan B,PLAN_6974,2024,Non-Formulary,Tier 2,2023-11-26,365,Worsened,Non-Formulary Status,No,No,,222,675,-67.0,Decreased,562.56,27.56,535.0,190.07,752.63,167.08,0.0,0,0.071,0.252,0.418,0.632,6,3,17,3,4.3,27.3,6,Higher,West,PA,Urban,66-75,2024-11,Q4_2024,2024,9.8,0.908,Increasing
FIA002488,2024-11-26,Atorvastatin,Lipitor,Statins,50106-495-93,Medicare Part D Plan B,PLAN_8666,2024,Non-Formulary,Specialty Tier,2024-01-21,310,Worsened,Non-Formulary Status,No,No,,464,447,3.9,Stable,378.44,181.45,196.99,72.26,450.7,209.12,0.0,0,0.238,0.229,0.268,0.67,2,0,20,5,2.2,19.6,5,Similar,Northeast,TX,Rural,75+,2024-11,Q4_2024,2024,7.2,0.453,Stable
FIA002095,2024-12-03,Atorvastatin,Lipitor,Statins,26209-858-10,Commercial Plan Alpha,PLAN_3398,2024,Tier 1,Tier 1,2024-05-19,198,No Change,None,No,No,,590,617,-4.3,Stable,18.91,14.75,4.16,186.91,205.82,121.43,0.0,0,0.066,0.334,0.235,0.694,10,9,10,15,4.3,20.7,7,Higher,Southeast,IL,Urban,66-75,2024-12,Q4_2024,2024,8.7,0.726,Stable
FIA002429,2024-12-06,Atorvastatin,Lipitor,Statins,90717-726-77,Medicaid Plan Y,PLAN_7268,2024,Specialty Tier,Tier 1,2024-03-10,271,Worsened,Prior Authorization,Yes,No,,148,344,-56.8,Decreased,160.88,8.68,152.2,78.38,239.26,35.41,0.357,5,0.102,0.212,0.448,0.535,13,5,11,10,3.2,30.5,6,Lower,Southeast,NY,Rural,75+,2024-12,Q4_2024,2024,7.6,0.32,Stable
FIA002595,2025-01-03,Atorvastatin,Lipitor,Statins,66706-499-31,Medicare Part D Plan A,PLAN_4147,2025,Non-Formulary,Specialty Tier,2024-05-18,230,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,269,262,2.8,Stable,320.76,116.42,204.34,107.2,427.96,115.12,0.0,0,0.16,0.194,0.465,0.711,8,6,19,15,3.6,16.1,4,Lower,Northeast,PA,Suburban,75+,2025-01,Q1_2025,2024,4.7,0.151,Increasing
FIA001213,2025-01-11,Atorvastatin,Lipitor,Statins,68377-162-95,Medicaid Plan X,PLAN_5367,2025,Tier 2,Specialty Tier,2024-01-21,356,Improved,None,No,No,,1297,858,51.2,Increased,28.35,230.0,-201.65,164.81,193.16,250.53,0.0,0,0.017,0.188,0.414,0.601,9,0,14,15,4.6,5.5,4,Lower,Midwest,IL,Rural,75+,2025-01,Q1_2025,2024,5.7,0.854,Stable
FIA001227,2025-01-11,Atorvastatin,Lipitor,Statins,47417-301-98,Medicaid Plan Y,PLAN_1756,2025,Tier 2,Specialty Tier,2024-05-04,252,Improved,Quantity Limit,No,No,,801,653,22.8,Increased,40.44,161.25,-120.81,170.05,210.49,168.6,0.0,0,0.052,0.386,0.622,0.619,3,6,11,7,3.4,31.1,5,Higher,West,PA,Urban,51-65,2025-01,Q1_2025,2024,5.4,0.42,Stable
FIA001134,2025-01-17,Atorvastatin,Lipitor,Statins,86759-740-46,Medicare Part D Plan A,PLAN_6015,2025,Tier 2,Specialty Tier,2024-03-29,294,Improved,Quantity Limit,No,No,30.0,336,257,31.0,Increased,37.83,200.21,-162.38,145.32,183.15,61.54,0.0,0,0.065,0.253,0.742,0.464,0,2,12,10,3.4,18.2,3,Higher,Southwest,OH,Rural,51-65,2025-01,Q1_2025,2024,9.5,0.935,Increasing
FIA001300,2025-01-23,Atorvastatin,Lipitor,Statins,14741-459-80,Medicaid Plan X,PLAN_3698,2025,Non-Formulary,Tier 3,2024-07-24,183,Worsened,Non-Formulary Status,No,No,,385,372,3.6,Stable,755.66,74.59,681.07,106.35,862.01,331.87,0.0,0,0.294,0.244,0.512,0.737,6,9,12,3,2.1,32.5,8,Higher,Southeast,MI,Suburban,51-65,2025-01,Q1_2025,2024,4.9,0.109,Increasing
FIA002107,2025-01-25,Atorvastatin,Lipitor,Statins,76105-866-52,Medicare Part D Plan A,PLAN_8134,2025,Non-Formulary,Specialty Tier,2024-03-23,308,Worsened,Non-Formulary Status,No,No,,357,367,-2.5,Stable,303.94,163.19,140.75,179.79,483.73,172.69,0.0,0,0.289,0.075,0.247,0.465,4,1,14,2,3.3,10.5,5,Similar,West,NC,Suburban,51-65,2025-01,Q1_2025,2024,7.8,0.14,Increasing
FIA001549,2025-01-29,Atorvastatin,Lipitor,Statins,80894-418-77,Commercial Plan Alpha,PLAN_8674,2025,Specialty Tier,Tier 2,2024-03-01,334,Worsened,Quantity Limit,No,No,30.0,352,965,-63.4,Decreased,178.81,41.79,137.02,41.66,220.47,77.61,0.0,0,0.18,0.393,0.656,0.413,1,7,0,9,4.2,16.6,4,Similar,Northeast,NY,Urban,18-35,2025-01,Q1_2025,2024,4.4,0.003,Stable
FIA001687,2025-02-28,Atorvastatin,Lipitor,Statins,82794-214-56,VA Plan,PLAN_8835,2025,Non-Formulary,Tier 1,2024-10-31,120,Worsened,Non-Formulary Status; Quantity Limit,No,No,,60,184,-67.1,Decreased,500.18,6.15,494.03,165.66,665.84,39.95,0.0,0,0.104,0.062,0.872,0.614,5,5,3,6,2.6,17.6,8,Higher,Midwest,PA,Urban,66-75,2025-02,Q1_2025,2024,7.1,0.798,Increasing
FIA002069,2025-02-28,Atorvastatin,Lipitor,Statins,63060-543-13,Tricare Standard,PLAN_1237,2025,Tier 2,Tier 2,2024-11-25,95,No Change,None,No,No,,981,944,4.0,Stable,24.01,23.51,0.5,41.56,65.57,64.32,0.0,0,0.074,0.266,0.416,0.78,10,7,5,8,2.3,17.3,4,Higher,West,PA,Suburban,36-50,2025-02,Q1_2025,2024,7.5,0.567,Decreasing
FIA001750,2025-03-30,Atorvastatin,Lipitor,Statins,15005-516-29,Medicare Part D Plan B,PLAN_5669,2025,Non-Formulary,Non-Formulary,2024-10-19,162,No Change,Non-Formulary Status,No,No,,194,193,0.7,Stable,594.01,498.41,95.6,54.52,648.53,125.81,0.0,0,0.257,0.389,0.266,0.519,8,7,6,7,3.4,10.1,8,Similar,Midwest,IL,Rural,66-75,2025-03,Q1_2025,2024,2.7,0.63,Increasing
FIA000835,2025-04-02,Atorvastatin,Lipitor,Statins,88310-286-93,VA Plan,PLAN_2108,2025,Non-Formulary,Non-Formulary,2024-10-22,162,No Change,Non-Formulary Status,No,No,,948,978,-3.0,Stable,773.98,428.14,345.84,153.01,926.99,878.79,0.0,0,0.158,0.126,0.293,0.625,15,0,19,14,4.6,31.7,5,Higher,Midwest,GA,Urban,36-50,2025-04,Q2_2025,2024,6.1,0.893,Stable
FIA002164,2025-04-06,Atorvastatin,Lipitor,Statins,34432-386-49,Medicaid Plan Y,PLAN_9131,2025,Tier 3,Tier 1,2025-01-31,65,Worsened,Prior Authorization,Yes,No,,276,687,-59.8,Decreased,80.72,8.63,72.09,79.46,160.18,44.21,0.453,5,0.046,0.339,0.418,0.501,11,10,2,5,4.8,21.7,8,Higher,Midwest,FL,Rural,36-50,2025-04,Q2_2025,2024,8.9,0.726,Decreasing
FIA002930,2025-04-09,Atorvastatin,Lipitor,Statins,52965-809-17,Commercial Plan Beta,PLAN_1698,2025,Tier 1,Tier 3,2024-11-02,158,Improved,None,No,No,,253,171,48.1,Increased,9.44,89.93,-80.49,147.19,156.63,39.63,0.0,0,0.033,0.384,0.672,0.427,12,10,8,12,4.5,25.9,5,Lower,Northeast,NY,Suburban,75+,2025-04,Q2_2025,2024,1.3,0.611,Stable
FIA001491,2025-04-25,Atorvastatin,Lipitor,Statins,68645-453-88,Commercial Plan Alpha,PLAN_9033,2025,Non-Formulary,Specialty Tier,2024-07-26,273,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,351,321,9.4,Increased,679.81,146.83,532.98,165.09,844.9,296.56,0.0,0,0.25,0.195,0.233,0.424,12,10,19,14,3.4,6.5,6,Higher,Southwest,CA,Urban,75+,2025-04,Q2_2025,2024,2.9,0.37,Decreasing
FIA000854,2025-04-29,Atorvastatin,Lipitor,Statins,77298-637-74,Medicare Part D Plan B,PLAN_9813,2025,Tier 1,Tier 1,2025-02-18,70,No Change,None,No,No,,551,527,4.7,Stable,18.75,16.48,2.27,112.55,131.3,72.35,0.0,0,0.052,0.258,0.227,0.84,12,10,3,12,4.8,21.6,2,Similar,West,GA,Rural,75+,2025-04,Q2_2025,2024,7.6,0.089,Decreasing
FIA000538,2025-05-01,Atorvastatin,Lipitor,Statins,23071-185-22,Tricare Standard,PLAN_9315,2025,Non-Formulary,Tier 3,2024-10-17,196,Worsened,Non-Formulary Status,No,No,,784,816,-3.8,Stable,264.28,74.67,189.61,181.21,445.49,349.26,0.0,0,0.2,0.379,0.266,0.942,0,2,10,9,4.1,18.4,5,Lower,Southeast,FL,Rural,18-35,2025-05,Q2_2025,2024,4.7,0.621,Increasing
FIA000640,2025-05-03,Atorvastatin,Lipitor,Statins,14534-698-38,Commercial Plan Alpha,PLAN_3570,2025,Tier 2,Tier 2,2025-02-23,69,No Change,None,No,No,,437,406,7.6,Increased,47.12,43.3,3.82,122.18,169.3,73.98,0.0,0,0.03,0.172,0.335,0.513,0,2,7,11,2.2,9.6,4,Higher,Midwest,IL,Urban,18-35,2025-05,Q2_2025,2024,6.6,0.729,Stable
FIA000033,2025-05-05,Atorvastatin,Lipitor,Statins,32838-371-16,Commercial Plan Alpha,PLAN_7897,2025,Tier 3,Tier 2,2025-01-29,96,Worsened,None,No,No,,99,212,-53.1,Decreased,77.01,43.96,33.05,85.04,162.05,16.04,0.0,0,0.027,0.234,0.722,0.662,11,8,18,3,3.4,11.6,6,Lower,West,PA,Suburban,18-35,2025-05,Q2_2025,2024,1.5,0.479,Stable
FIA000894,2025-05-25,Atorvastatin,Lipitor,Statins,69912-546-86,Tricare Standard,PLAN_3680,2025,Specialty Tier,Specialty Tier,2025-04-13,42,No Change,Quantity Limit,No,No,,463,448,3.6,Stable,283.54,113.43,170.11,133.97,417.51,193.31,0.0,0,0.113,0.184,0.71,0.703,6,10,7,7,3.8,24.1,8,Lower,West,FL,Rural,66-75,2025-05,Q2_2025,2024,8.0,0.609,Increasing
FIA001468,2025-05-26,Atorvastatin,Lipitor,Statins,85924-488-94,Medicare Part D Plan A,PLAN_7585,2025,Non-Formulary,Tier 2,2024-09-04,264,Worsened,Non-Formulary Status; Quantity Limit,No,No,,178,577,-69.1,Decreased,421.8,33.43,388.37,170.83,592.63,105.49,0.0,0,0.264,0.368,0.497,0.552,6,5,3,5,4.5,12.9,8,Higher,Southeast,OH,Rural,51-65,2025-05,Q2_2025,2024,9.8,0.785,Decreasing
FIA002934,2025-05-26,Atorvastatin,Lipitor,Statins,44259-168-69,Commercial Plan Beta,PLAN_2309,2025,Specialty Tier,Tier 1,2024-07-04,326,Worsened,Prior Authorization,Yes,No,,622,872,-28.6,Decreased,125.99,15.83,110.16,159.8,285.79,177.76,0.238,5,0.165,0.084,0.242,0.744,15,8,7,9,3.2,7.9,6,Similar,Midwest,FL,Suburban,36-50,2025-05,Q2_2025,2024,3.6,0.677,Increasing
FIA002574,2025-05-29,Atorvastatin,Lipitor,Statins,67077-330-30,VA Plan,PLAN_3979,2025,Tier 2,Specialty Tier,2025-03-22,68,Improved,None,No,No,,469,375,25.1,Increased,41.5,286.78,-245.28,139.98,181.48,85.11,0.0,0,0.018,0.131,0.638,0.822,13,3,8,10,4.9,16.7,3,Similar,Southeast,IL,Rural,36-50,2025-05,Q2_2025,2024,4.0,0.125,Decreasing
FIA002853,2025-06-03,Atorvastatin,Lipitor,Statins,18216-511-57,Medicaid Plan Y,PLAN_6189,2025,Specialty Tier,Tier 2,2025-04-17,47,Worsened,None,No,No,,221,684,-67.6,Decreased,198.24,46.4,151.84,80.44,278.68,61.59,0.0,0,0.133,0.308,0.734,0.887,15,10,14,11,2.9,28.8,6,Lower,Southwest,CA,Rural,66-75,2025-06,Q2_2025,2024,1.8,0.491,Decreasing
FIA000037,2025-06-19,Atorvastatin,Lipitor,Statins,24534-390-96,Tricare Standard,PLAN_9633,2025,Tier 1,Tier 3,2024-10-06,256,Improved,None,No,No,,737,552,33.6,Increased,14.93,74.28,-59.35,88.68,103.61,76.36,0.0,0,0.046,0.283,0.232,0.617,1,0,6,9,4.8,28.0,8,Similar,Midwest,IL,Urban,18-35,2025-06,Q2_2025,2024,5.5,0.431,Increasing
FIA000670,2025-07-13,Atorvastatin,Lipitor,Statins,43527-137-87,Medicare Part D Plan B,PLAN_6800,2025,Non-Formulary,Tier 3,2025-04-29,75,Worsened,Non-Formulary Status,No,No,,721,773,-6.7,Decreased,489.99,61.94,428.05,62.74,552.73,398.52,0.0,0,0.138,0.228,0.441,0.7,2,1,10,14,2.8,26.5,6,Similar,Midwest,NY,Rural,18-35,2025-07,Q3_2025,2024,9.3,0.047,Stable
FIA001996,2025-07-13,Atorvastatin,Lipitor,Statins,48325-611-46,VA Plan,PLAN_8973,2025,Tier 2,Specialty Tier,2025-04-19,85,Improved,None,No,No,,468,381,23.1,Increased,43.6,263.08,-219.48,193.51,237.11,110.97,0.0,0,0.047,0.233,0.82,0.516,2,9,8,0,3.9,13.0,5,Lower,Midwest,NC,Urban,18-35,2025-07,Q3_2025,2024,7.7,0.649,Stable
FIA002505,2025-07-23,Atorvastatin,Lipitor,Statins,13752-952-65,VA Plan,PLAN_4852,2025,Tier 1,Specialty Tier,2024-10-12,284,Improved,None,No,No,,527,330,59.8,Increased,19.58,286.94,-267.36,51.71,71.29,37.57,0.0,0,0.017,0.11,0.506,0.898,11,8,19,9,3.5,32.8,6,Higher,Southwest,PA,Rural,66-75,2025-07,Q3_2025,2024,3.4,0.125,Stable
FIA002963,2025-07-23,Atorvastatin,Lipitor,Statins,39513-972-72,Commercial Plan Alpha,PLAN_1279,2025,Tier 1,Specialty Tier,2025-01-14,190,Improved,None,No,No,,1146,796,44.0,Increased,12.69,237.98,-225.29,154.77,167.46,191.91,0.0,0,0.025,0.192,0.576,0.662,12,9,13,15,2.5,5.9,2,Similar,Midwest,NY,Rural,75+,2025-07,Q3_2025,2024,8.4,0.891,Stable
FIA002764,2025-07-29,Atorvastatin,Lipitor,Statins,29434-615-78,Medicaid Plan X,PLAN_4354,2025,Specialty Tier,Tier 1,2025-01-27,183,Worsened,Prior Authorization,Yes,No,,474,614,-22.7,Decreased,114.11,10.6,103.51,166.79,280.9,133.15,0.139,6,0.188,0.268,0.634,0.885,1,3,11,12,3.0,7.1,8,Higher,West,NC,Suburban,18-35,2025-07,Q3_2025,2024,5.4,0.495,Decreasing
FIA001165,2025-08-20,Atorvastatin,Lipitor,Statins,64475-473-30,Tricare Standard,PLAN_3673,2025,Tier 3,Non-Formulary,2025-05-27,85,Improved,Prior Authorization,Yes,No,,497,472,5.3,Increased,54.52,644.54,-590.02,71.88,126.4,62.82,0.416,10,0.057,0.161,0.725,0.616,14,7,1,10,3.1,20.5,6,Higher,Northeast,GA,Urban,36-50,2025-08,Q3_2025,2024,7.2,0.92,Stable
FIA002944,2025-08-20,Atorvastatin,Lipitor,Statins,24174-386-86,Commercial Plan Alpha,PLAN_7319,2025,Specialty Tier,Non-Formulary,2025-05-04,108,Improved,None,No,No,,125,117,7.4,Increased,209.67,699.73,-490.06,60.48,270.15,33.77,0.0,0,0.243,0.373,0.802,0.556,11,1,19,9,4.0,17.4,5,Similar,Southwest,NC,Urban,66-75,2025-08,Q3_2025,2024,2.8,0.887,Increasing
FIA000948,2022-01-11,Clopidogrel,Plavix,Antiplatelet Agents,17680-317-71,VA Plan,PLAN_5252,2022,Non-Formulary,Tier 1,2021-08-27,137,Worsened,Non-Formulary Status,No,No,,481,736,-34.5,Decreased,398.07,9.66,388.41,129.86,527.93,253.93,0.0,0,0.276,0.204,0.522,0.804,3,10,2,13,2.2,10.3,8,Similar,Northeast,NY,Rural,75+,2022-01,Q1_2022,2021,8.3,0.405,Stable
FIA000291,2022-01-21,Clopidogrel,Plavix,Antiplatelet Agents,51486-114-29,Tricare Standard,PLAN_3416,2022,Non-Formulary,Tier 2,2021-11-13,69,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,158,248,-36.2,Decreased,633.63,37.35,596.28,156.28,789.91,124.81,0.0,0,0.285,0.353,0.28,0.933,13,4,16,0,5.0,33.3,8,Lower,Southwest,MI,Urban,18-35,2022-01,Q1_2022,2021,3.0,0.979,Stable
FIA000478,2022-01-31,Clopidogrel,Plavix,Antiplatelet Agents,45002-508-79,Commercial Plan Alpha,PLAN_4942,2022,Specialty Tier,Specialty Tier,2021-11-12,80,No Change,Step Therapy,No,Yes,,262,249,5.3,Increased,234.4,237.13,-2.73,62.65,297.05,77.83,0.0,0,0.113,0.256,0.741,0.867,8,10,1,0,4.5,9.9,8,Lower,Northeast,CA,Rural,75+,2022-01,Q1_2022,2021,4.9,0.391,Stable
FIA002431,2022-01-31,Clopidogrel,Plavix,Antiplatelet Agents,70380-720-79,Medicaid Plan X,PLAN_2004,2022,Specialty Tier,Non-Formulary,2021-11-28,64,Improved,Prior Authorization; Step Therapy,Yes,Yes,,754,699,8.0,Increased,138.83,304.84,-166.01,139.11,277.94,209.57,0.541,6,0.095,0.277,0.551,0.671,8,5,19,12,3.1,23.7,6,Higher,West,FL,Rural,18-35,2022-01,Q1_2022,2021,5.9,0.524,Increasing
FIA000799,2022-02-04,Clopidogrel,Plavix,Antiplatelet Agents,65418-392-12,Medicaid Plan Y,PLAN_5558,2022,Non-Formulary,Tier 1,2021-08-17,171,Worsened,Non-Formulary Status,No,No,,552,808,-31.6,Decreased,631.0,15.52,615.48,61.61,692.61,382.32,0.0,0,0.194,0.343,0.676,0.743,13,2,4,2,2.8,15.6,3,Lower,West,OH,Suburban,18-35,2022-02,Q1_2022,2021,3.8,0.308,Increasing
FIA000717,2022-02-09,Clopidogrel,Plavix,Antiplatelet Agents,67936-506-33,Medicaid Plan Y,PLAN_5554,2022,Tier 2,Specialty Tier,2021-08-23,170,Improved,None,No,No,,357,225,59.1,Increased,37.22,123.56,-86.34,160.6,197.82,70.62,0.0,0,0.024,0.343,0.724,0.945,5,6,9,11,4.3,11.2,8,Lower,West,TX,Suburban,36-50,2022-02,Q1_2022,2021,7.7,0.585,Decreasing
FIA001438,2022-02-18,Clopidogrel,Plavix,Antiplatelet Agents,11772-730-35,VA Plan,PLAN_1258,2022,Tier 1,Specialty Tier,2021-03-24,331,Improved,None,No,No,,176,152,16.1,Increased,10.54,167.18,-156.64,199.79,210.33,37.02,0.0,0,0.02,0.148,0.812,0.74,1,3,7,14,4.4,12.9,7,Lower,Southeast,GA,Suburban,66-75,2022-02,Q1_2022,2021,8.4,0.499,Decreasing
FIA001337,2022-02-21,Clopidogrel,Plavix,Antiplatelet Agents,16127-160-73,Medicaid Plan X,PLAN_2138,2022,Tier 2,Tier 1,2021-10-16,128,Worsened,None,No,No,,834,854,-2.3,Stable,20.34,5.08,15.26,198.16,218.5,182.23,0.0,0,0.033,0.333,0.468,0.608,8,3,1,12,2.1,13.9,6,Higher,Southeast,TX,Suburban,66-75,2022-02,Q1_2022,2021,2.3,0.131,Stable
FIA000989,2022-03-15,Clopidogrel,Plavix,Antiplatelet Agents,88278-180-21,Medicare Part D Plan B,PLAN_7052,2022,Non-Formulary,Non-Formulary,2021-05-30,289,No Change,Non-Formulary Status,No,No,,136,125,9.6,Increased,527.79,587.74,-59.95,123.82,651.61,88.62,0.0,0,0.248,0.344,0.321,0.489,9,0,1,6,4.1,27.0,7,Lower,West,OH,Urban,66-75,2022-03,Q1_2022,2021,6.3,0.185,Increasing
FIA001313,2022-03-18,Clopidogrel,Plavix,Antiplatelet Agents,82896-535-99,Medicare Part D Plan B,PLAN_8858,2022,Tier 2,Specialty Tier,2021-12-13,95,Improved,None,No,No,,798,615,29.8,Increased,28.55,189.29,-160.74,122.57,151.12,120.59,0.0,0,0.067,0.374,0.762,0.471,14,7,13,0,4.1,34.2,3,Higher,Midwest,TX,Rural,36-50,2022-03,Q1_2022,2021,4.7,0.569,Decreasing
FIA001347,2022-03-24,Clopidogrel,Plavix,Antiplatelet Agents,83452-576-60,VA Plan,PLAN_4652,2022,Tier 3,Tier 3,2021-10-10,165,No Change,Step Therapy,No,Yes,,239,243,-1.2,Stable,76.31,57.72,18.59,52.21,128.52,30.72,0.0,0,0.046,0.143,0.379,0.457,14,4,8,14,3.3,26.5,8,Lower,Midwest,OH,Rural,66-75,2022-03,Q1_2022,2021,5.6,0.331,Increasing
FIA002278,2022-03-26,Clopidogrel,Plavix,Antiplatelet Agents,95472-493-82,Commercial Plan Alpha,PLAN_6619,2022,Tier 2,Tier 3,2021-08-30,208,Improved,None,No,No,,851,562,51.5,Increased,21.71,92.78,-71.07,180.28,201.99,171.89,0.0,0,0.053,0.294,0.681,0.869,5,6,2,15,3.1,16.0,4,Lower,West,NC,Rural,36-50,2022-03,Q1_2022,2021,9.0,0.178,Decreasing
FIA002023,2022-03-28,Clopidogrel,Plavix,Antiplatelet Agents,25269-808-19,Commercial Plan Beta,PLAN_7249,2022,Non-Formulary,Specialty Tier,2021-08-26,214,Worsened,Non-Formulary Status,No,No,,655,671,-2.4,Stable,777.06,229.96,547.1,193.47,970.53,635.7,0.0,0,0.088,0.238,0.725,0.663,2,2,5,15,3.3,5.4,4,Similar,Midwest,GA,Urban,75+,2022-03,Q1_2022,2021,4.5,0.297,Increasing
FIA001675,2022-04-03,Clopidogrel,Plavix,Antiplatelet Agents,99250-975-32,Medicare Part D Plan B,PLAN_5259,2022,Tier 1,Non-Formulary,2021-08-12,234,Improved,None,No,No,,267,213,25.8,Increased,7.95,762.01,-754.06,147.79,155.74,41.58,0.0,0,0.076,0.171,0.45,0.566,14,2,4,15,2.1,6.5,4,Higher,West,MI,Suburban,51-65,2022-04,Q2_2022,2021,8.0,0.165,Increasing
FIA002864,2022-04-05,Clopidogrel,Plavix,Antiplatelet Agents,49647-240-84,Medicare Part D Plan B,PLAN_9337,2022,Tier 3,Tier 1,2021-12-26,100,Worsened,None,No,No,,564,828,-31.9,Decreased,57.09,5.55,51.54,120.88,177.97,100.38,0.0,0,0.025,0.158,0.466,0.452,4,3,18,3,4.8,9.1,7,Similar,Northeast,PA,Rural,18-35,2022-04,Q2_2022,2021,7.7,0.901,Stable
FIA000924,2022-04-10,Clopidogrel,Plavix,Antiplatelet Agents,78961-665-34,Commercial Plan Alpha,PLAN_4987,2022,Specialty Tier,Tier 2,2021-11-04,157,Worsened,Prior Authorization,Yes,No,,756,964,-21.5,Decreased,136.52,28.95,107.57,148.29,284.81,215.32,0.345,8,0.121,0.167,0.713,0.862,15,2,4,10,4.7,30.2,3,Higher,Midwest,NC,Suburban,51-65,2022-04,Q2_2022,2021,4.2,0.999,Increasing
FIA000112,2022-04-14,Clopidogrel,Plavix,Antiplatelet Agents,68598-423-25,Tricare Standard,PLAN_1291,2022,Tier 2,Non-Formulary,2021-04-20,359,Improved,Quantity Limit,No,No,,244,180,35.7,Increased,31.36,690.26,-658.9,175.62,206.98,50.5,0.0,0,0.041,0.191,0.225,0.702,2,9,19,9,4.7,21.9,7,Higher,Southwest,IL,Suburban,18-35,2022-04,Q2_2022,2021,8.3,0.844,Stable
FIA001019,2022-04-17,Clopidogrel,Plavix,Antiplatelet Agents,19573-119-98,Tricare Standard,PLAN_3369,2022,Specialty Tier,Specialty Tier,2022-01-09,98,No Change,Prior Authorization,Yes,No,,417,446,-6.4,Decreased,115.01,189.76,-74.75,164.53,279.54,116.57,0.209,5,0.059,0.329,0.763,0.476,8,2,13,11,2.9,6.9,7,Higher,West,MI,Rural,36-50,2022-04,Q2_2022,2021,6.3,0.485,Stable
FIA000134,2022-04-21,Clopidogrel,Plavix,Antiplatelet Agents,98356-315-58,Medicare Part D Plan B,PLAN_6331,2022,Specialty Tier,Specialty Tier,2021-06-19,306,No Change,None,No,No,,1017,981,3.7,Stable,106.51,169.46,-62.95,31.43,137.94,140.28,0.0,0,0.129,0.177,0.803,0.503,8,3,8,15,4.9,15.3,3,Similar,Southwest,NY,Suburban,51-65,2022-04,Q2_2022,2021,4.3,0.401,Stable
FIA000234,2022-04-25,Clopidogrel,Plavix,Antiplatelet Agents,60321-575-64,Medicare Part D Plan B,PLAN_6564,2022,Tier 1,Tier 3,2021-09-12,225,Improved,None,No,No,,652,520,25.5,Increased,11.03,80.87,-69.84,31.8,42.83,27.93,0.0,0,0.056,0.278,0.673,0.414,10,9,6,3,2.3,22.9,2,Higher,Southeast,MI,Urban,75+,2022-04,Q2_2022,2021,3.3,0.421,Decreasing
FIA000067,2022-05-01,Clopidogrel,Plavix,Antiplatelet Agents,58916-161-89,Tricare Standard,PLAN_8993,2022,Tier 1,Tier 1,2022-03-08,54,No Change,None,No,No,,987,962,2.6,Stable,16.47,11.19,5.28,115.97,132.44,130.72,0.0,0,0.011,0.056,0.573,0.626,0,8,8,9,2.1,29.4,7,Similar,Southeast,TX,Urban,75+,2022-05,Q2_2022,2021,2.3,0.192,Decreasing
FIA001889,2022-05-01,Clopidogrel,Plavix,Antiplatelet Agents,38058-946-91,Medicaid Plan Y,PLAN_7845,2022,Non-Formulary,Tier 3,2021-08-04,270,Worsened,Non-Formulary Status; Quantity Limit,No,No,,455,493,-7.7,Decreased,273.73,74.17,199.56,58.35,332.08,151.1,0.0,0,0.285,0.182,0.446,0.584,11,2,5,11,2.1,25.2,4,Lower,Southwest,CA,Rural,51-65,2022-05,Q2_2022,2021,5.8,0.812,Stable
FIA001088,2022-05-11,Clopidogrel,Plavix,Antiplatelet Agents,10291-242-34,Medicare Part D Plan B,PLAN_7804,2022,Specialty Tier,Non-Formulary,2021-05-25,351,Improved,None,No,No,,488,534,-8.4,Decreased,107.39,402.9,-295.51,58.0,165.39,80.71,0.0,0,0.077,0.065,0.837,0.819,5,7,5,13,4.4,33.9,6,Lower,Southeast,TX,Urban,18-35,2022-05,Q2_2022,2021,6.0,0.889,Stable
FIA001929,2022-05-15,Clopidogrel,Plavix,Antiplatelet Agents,97907-833-25,Medicare Part D Plan A,PLAN_6355,2022,Tier 3,Tier 1,2021-10-01,226,Worsened,None,No,No,,273,366,-25.2,Decreased,66.12,12.47,53.65,189.91,256.03,69.9,0.0,0,0.032,0.19,0.336,0.471,5,4,13,6,4.8,6.0,8,Similar,Southwest,NC,Rural,66-75,2022-05,Q2_2022,2021,4.0,0.233,Stable
FIA001864,2022-05-17,Clopidogrel,Plavix,Antiplatelet Agents,45737-527-17,Medicare Part D Plan A,PLAN_5028,2022,Non-Formulary,Specialty Tier,2021-10-30,199,Worsened,Non-Formulary Status,No,No,,620,619,0.3,Stable,527.72,136.5,391.22,56.67,584.39,362.32,0.0,0,0.081,0.357,0.263,0.819,5,8,14,0,4.5,16.2,5,Lower,West,MI,Suburban,75+,2022-05,Q2_2022,2021,5.0,0.339,Increasing
FIA001596,2022-05-18,Clopidogrel,Plavix,Antiplatelet Agents,60071-548-95,Medicaid Plan X,PLAN_3862,2022,Non-Formulary,Specialty Tier,2022-01-17,121,Worsened,Non-Formulary Status,No,No,,577,528,9.4,Increased,498.38,274.73,223.65,118.73,617.11,356.07,0.0,0,0.176,0.383,0.431,0.787,10,7,17,9,3.2,9.3,2,Similar,Southeast,PA,Suburban,51-65,2022-05,Q2_2022,2021,1.8,0.721,Stable
FIA002358,2022-05-23,Clopidogrel,Plavix,Antiplatelet Agents,91405-396-39,Commercial Plan Alpha,PLAN_1402,2022,Tier 2,Tier 1,2021-08-25,271,Worsened,Quantity Limit,No,No,,120,120,0.1,Stable,35.23,14.19,21.04,146.26,181.49,21.78,0.0,0,0.036,0.379,0.886,0.483,4,3,18,7,3.9,13.1,3,Similar,Southwest,TX,Urban,36-50,2022-05,Q2_2022,2021,7.9,0.26,Stable
FIA002537,2022-05-23,Clopidogrel,Plavix,Antiplatelet Agents,62381-912-35,Medicare Part D Plan B,PLAN_8422,2022,Tier 2,Specialty Tier,2022-02-08,104,Improved,None,No,No,,1169,885,32.1,Increased,45.34,279.62,-234.28,152.56,197.9,231.35,0.0,0,0.07,0.23,0.202,0.536,15,3,20,13,4.4,18.1,6,Similar,West,TX,Rural,66-75,2022-05,Q2_2022,2021,6.0,0.742,Increasing
FIA000318,2022-06-03,Clopidogrel,Plavix,Antiplatelet Agents,44478-768-13,Medicare Part D Plan A,PLAN_6538,2022,Non-Formulary,Tier 2,2021-08-12,295,Worsened,Non-Formulary Status,No,No,,249,508,-50.9,Decreased,759.09,35.0,724.09,129.07,888.16,221.15,0.0,0,0.273,0.197,0.34,0.888,1,2,6,10,4.8,24.9,2,Lower,Southwest,TX,Rural,75+,2022-06,Q2_2022,2021,7.3,0.766,Increasing
FIA002149,2022-06-08,Clopidogrel,Plavix,Antiplatelet Agents,99766-669-60,Commercial Plan Beta,PLAN_8371,2022,Specialty Tier,Specialty Tier,2021-09-24,257,No Change,None,No,No,,989,917,7.9,Increased,203.43,128.71,74.72,129.41,332.84,329.18,0.0,0,0.227,0.245,0.777,0.763,11,5,18,14,4.8,31.8,2,Higher,West,GA,Rural,36-50,2022-06,Q2_2022,2021,3.5,0.519,Increasing
FIA001727,2022-06-11,Clopidogrel,Plavix,Antiplatelet Agents,75503-143-60,Commercial Plan Alpha,PLAN_8599,2022,Specialty Tier,Tier 3,2021-08-20,295,Worsened,None,No,No,,255,279,-8.4,Decreased,238.79,64.12,174.67,64.72,303.51,77.4,0.0,0,0.274,0.1,0.434,0.615,6,6,2,3,2.7,33.6,6,Higher,Southwest,CA,Rural,51-65,2022-06,Q2_2022,2021,5.2,0.895,Stable
FIA000585,2022-06-20,Clopidogrel,Plavix,Antiplatelet Agents,24242-100-19,Commercial Plan Beta,PLAN_3540,2022,Tier 3,Tier 1,2021-07-02,353,Worsened,None,No,No,,335,868,-61.4,Decreased,98.17,18.7,79.47,81.8,179.97,60.29,0.0,0,0.04,0.282,0.754,0.511,7,9,4,3,4.0,30.5,7,Lower,Midwest,FL,Suburban,75+,2022-06,Q2_2022,2021,7.6,0.063,Stable
FIA002841,2022-06-28,Clopidogrel,Plavix,Antiplatelet Agents,48166-348-65,Medicaid Plan X,PLAN_3921,2022,Tier 3,Tier 1,2022-03-26,94,Worsened,Quantity Limit,No,No,,190,495,-61.4,Decreased,52.73,19.46,33.27,86.51,139.24,26.46,0.0,0,0.024,0.399,0.459,0.555,10,5,5,7,2.9,25.8,8,Lower,Southeast,PA,Urban,51-65,2022-06,Q2_2022,2021,7.1,0.504,Increasing
FIA001456,2022-08-16,Clopidogrel,Plavix,Antiplatelet Agents,38801-168-77,VA Plan,PLAN_8558,2022,Tier 2,Tier 1,2021-08-31,350,Worsened,Quantity Limit,No,No,,898,920,-2.3,Stable,45.52,7.39,38.13,126.73,172.25,154.68,0.0,0,0.057,0.286,0.663,0.853,1,2,7,7,4.7,34.9,7,Similar,Northeast,FL,Rural,51-65,2022-08,Q3_2022,2021,5.0,0.883,Increasing
FIA000605,2022-08-26,Clopidogrel,Plavix,Antiplatelet Agents,44095-811-94,Medicare Part D Plan A,PLAN_3845,2022,Non-Formulary,Tier 2,2021-09-27,333,Worsened,Non-Formulary Status,No,No,,62,122,-48.8,Decreased,390.19,26.34,363.85,114.2,504.39,31.27,0.0,0,0.061,0.111,0.576,0.872,14,4,10,11,2.3,26.2,8,Similar,West,GA,Urban,66-75,2022-08,Q3_2022,2021,2.1,0.266,Increasing
FIA000203,2022-09-05,Clopidogrel,Plavix,Antiplatelet Agents,40924-533-37,Commercial Plan Alpha,PLAN_2750,2022,Non-Formulary,Non-Formulary,2022-03-31,158,No Change,Non-Formulary Status,No,No,,660,714,-7.6,Decreased,497.87,254.15,243.72,96.29,594.16,392.15,0.0,0,0.196,0.111,0.879,0.642,8,9,1,15,3.6,26.0,2,Similar,West,OH,Suburban,36-50,2022-09,Q3_2022,2021,9.7,0.879,Increasing
FIA000364,2022-09-29,Clopidogrel,Plavix,Antiplatelet Agents,72691-219-66,Medicare Part D Plan B,PLAN_8799,2022,Tier 3,Tier 1,2022-05-16,136,Worsened,Step Therapy,No,Yes,,390,695,-43.9,Decreased,61.38,13.79,47.59,42.42,103.8,40.48,0.0,0,0.065,0.119,0.58,0.518,15,4,18,0,3.7,30.8,2,Higher,Southwest,NY,Rural,75+,2022-09,Q3_2022,2021,7.8,0.992,Stable
FIA002950,2022-10-17,Clopidogrel,Plavix,Antiplatelet Agents,92120-341-70,Medicare Part D Plan B,PLAN_3749,2022,Tier 1,Tier 3,2021-12-24,297,Improved,Quantity Limit,No,No,30.0,512,440,16.4,Increased,12.9,78.35,-65.45,162.95,175.85,90.04,0.0,0,0.01,0.223,0.227,0.411,15,3,13,7,4.4,24.1,3,Similar,West,MI,Suburban,51-65,2022-10,Q4_2022,2022,7.1,0.26,Stable
FIA002751,2022-10-18,Clopidogrel,Plavix,Antiplatelet Agents,79419-170-86,Tricare Standard,PLAN_3623,2022,Tier 2,Tier 2,2021-12-08,314,No Change,None,No,No,,108,111,-1.9,Stable,39.0,40.01,-1.01,84.15,123.15,13.3,0.0,0,0.022,0.354,0.595,0.456,4,4,5,4,3.9,10.2,2,Similar,Southwest,NY,Urban,66-75,2022-10,Q4_2022,2022,7.9,0.044,Increasing
FIA000915,2022-10-22,Clopidogrel,Plavix,Antiplatelet Agents,57969-938-37,Commercial Plan Beta,PLAN_8488,2022,Tier 2,Tier 2,2022-03-24,212,No Change,None,No,No,,461,428,7.8,Increased,32.73,38.74,-6.01,190.93,223.66,103.11,0.0,0,0.057,0.148,0.766,0.579,14,0,4,14,3.5,20.3,5,Lower,Midwest,OH,Suburban,75+,2022-10,Q4_2022,2022,4.9,0.621,Stable
FIA002453,2022-11-06,Clopidogrel,Plavix,Antiplatelet Agents,11035-266-81,Medicaid Plan X,PLAN_7710,2022,Non-Formulary,Tier 2,2022-02-27,252,Worsened,Non-Formulary Status; Quantity Limit,No,No,,139,346,-59.6,Decreased,289.84,33.61,256.23,125.25,415.09,57.7,0.0,0,0.25,0.293,0.768,0.574,11,1,3,15,4.3,14.5,6,Similar,West,NY,Rural,75+,2022-11,Q4_2022,2022,2.4,0.97,Stable
FIA000514,2022-11-10,Clopidogrel,Plavix,Antiplatelet Agents,85218-908-38,Medicaid Plan X,PLAN_9759,2022,Tier 3,Tier 1,2022-03-28,227,Worsened,None,No,No,,236,464,-49.0,Decreased,57.12,19.72,37.4,30.06,87.18,20.57,0.0,0,0.048,0.19,0.688,0.525,1,6,4,8,3.2,9.5,8,Higher,Southwest,MI,Rural,18-35,2022-11,Q4_2022,2022,4.8,0.623,Increasing
FIA002964,2022-11-14,Clopidogrel,Plavix,Antiplatelet Agents,76115-754-75,Tricare Standard,PLAN_1312,2022,Tier 2,Tier 2,2021-12-16,333,No Change,Quantity Limit,No,No,60.0,222,227,-1.9,Stable,44.04,26.96,17.08,116.48,160.52,35.64,0.0,0,0.048,0.096,0.479,0.51,7,5,8,12,3.2,30.5,2,Similar,Southeast,IL,Suburban,51-65,2022-11,Q4_2022,2022,2.3,0.656,Stable
FIA002074,2022-11-17,Clopidogrel,Plavix,Antiplatelet Agents,79191-424-98,Tricare Standard,PLAN_6292,2022,Tier 3,Non-Formulary,2022-05-10,191,Improved,None,No,No,,511,513,-0.3,Stable,52.43,245.19,-192.76,173.83,226.26,115.62,0.0,0,0.061,0.101,0.816,0.524,12,9,9,8,4.0,14.2,2,Lower,Southeast,MI,Urban,36-50,2022-11,Q4_2022,2022,1.2,0.489,Decreasing
FIA001284,2022-11-23,Clopidogrel,Plavix,Antiplatelet Agents,30608-745-91,Medicaid Plan Y,PLAN_9300,2022,Specialty Tier,Tier 2,2022-04-20,217,Worsened,Step Therapy,No,Yes,,614,866,-29.0,Decreased,246.93,35.65,211.28,179.03,425.96,261.54,0.0,0,0.242,0.383,0.707,0.609,1,5,11,4,4.5,9.1,3,Lower,Northeast,OH,Suburban,51-65,2022-11,Q4_2022,2022,8.6,0.064,Stable
FIA000600,2022-11-24,Clopidogrel,Plavix,Antiplatelet Agents,74446-954-78,Medicare Part D Plan B,PLAN_5507,2022,Specialty Tier,Non-Formulary,2022-09-02,83,Improved,Prior Authorization; Step Therapy,Yes,Yes,,682,753,-9.4,Decreased,116.6,635.67,-519.07,197.63,314.23,214.3,0.141,6,0.111,0.252,0.821,0.412,5,1,14,14,3.7,16.1,3,Higher,Southwest,OH,Rural,36-50,2022-11,Q4_2022,2022,3.0,0.789,Increasing
FIA001322,2022-12-01,Clopidogrel,Plavix,Antiplatelet Agents,98485-497-59,Tricare Standard,PLAN_5416,2022,Non-Formulary,Tier 3,2022-06-02,182,Worsened,Non-Formulary Status,No,No,,594,641,-7.2,Decreased,322.03,96.29,225.74,50.58,372.61,221.33,0.0,0,0.12,0.318,0.565,0.863,12,9,0,15,3.6,12.0,2,Similar,Northeast,NC,Rural,36-50,2022-12,Q4_2022,2022,3.9,0.038,Decreasing
FIA000436,2022-12-08,Clopidogrel,Plavix,Antiplatelet Agents,73861-303-12,Commercial Plan Beta,PLAN_8135,2022,Specialty Tier,Tier 2,2022-10-21,48,Worsened,Step Therapy,No,Yes,,180,476,-62.1,Decreased,141.38,37.99,103.39,34.06,175.44,31.58,0.0,0,0.125,0.321,0.725,0.647,4,10,9,12,2.7,5.5,3,Similar,Midwest,GA,Suburban,66-75,2022-12,Q4_2022,2022,7.4,0.372,Increasing
FIA000599,2022-12-16,Clopidogrel,Plavix,Antiplatelet Agents,89849-776-94,Medicare Part D Plan B,PLAN_3255,2022,Tier 3,Specialty Tier,2022-06-01,198,Improved,Prior Authorization,Yes,No,,875,872,0.4,Stable,81.76,214.2,-132.44,154.29,236.05,206.54,0.321,5,0.051,0.235,0.331,0.735,14,1,14,0,4.8,27.5,6,Similar,Midwest,IL,Urban,51-65,2022-12,Q4_2022,2022,8.2,0.206,Stable
FIA002866,2022-12-19,Clopidogrel,Plavix,Antiplatelet Agents,98254-902-34,Commercial Plan Alpha,PLAN_9418,2022,Tier 3,Tier 3,2022-07-23,149,No Change,Quantity Limit,No,No,,890,885,0.6,Stable,82.96,55.83,27.13,149.19,232.15,206.61,0.0,0,0.028,0.27,0.712,0.683,1,4,8,3,3.0,33.7,3,Higher,Midwest,CA,Rural,75+,2022-12,Q4_2022,2022,1.6,0.068,Decreasing
FIA000284,2022-12-22,Clopidogrel,Plavix,Antiplatelet Agents,65531-260-44,Medicare Part D Plan B,PLAN_9544,2022,Tier 2,Tier 1,2022-05-04,232,Worsened,Quantity Limit,No,No,90.0,986,996,-0.9,Stable,44.98,15.2,29.78,150.59,195.57,192.83,0.0,0,0.045,0.392,0.288,0.517,1,3,12,5,4.5,34.3,6,Lower,Southwest,GA,Suburban,66-75,2022-12,Q4_2022,2022,8.4,0.165,Stable
FIA002419,2023-01-05,Clopidogrel,Plavix,Antiplatelet Agents,78947-412-25,Tricare Standard,PLAN_2785,2023,Tier 2,Tier 1,2022-01-15,355,Worsened,Quantity Limit,No,No,30.0,235,220,7.2,Increased,48.71,5.1,43.61,146.61,195.32,45.9,0.0,0,0.024,0.094,0.804,0.582,2,7,14,2,3.5,6.3,4,Lower,West,GA,Rural,66-75,2023-01,Q1_2023,2022,3.0,0.024,Stable
FIA001659,2023-01-25,Clopidogrel,Plavix,Antiplatelet Agents,91580-612-48,Medicaid Plan Y,PLAN_6566,2023,Tier 2,Non-Formulary,2022-03-13,318,Improved,Quantity Limit,No,No,,1043,838,24.5,Increased,44.69,506.05,-461.36,105.21,149.9,156.35,0.0,0,0.032,0.177,0.474,0.465,3,10,2,8,3.2,18.8,6,Similar,Southwest,OH,Urban,18-35,2023-01,Q1_2023,2022,5.2,0.938,Stable
FIA000726,2023-01-29,Clopidogrel,Plavix,Antiplatelet Agents,80261-384-70,Medicaid Plan Y,PLAN_3548,2023,Tier 1,Tier 1,2022-07-04,209,No Change,None,No,No,,229,243,-5.4,Decreased,18.05,14.89,3.16,78.26,96.31,22.05,0.0,0,0.049,0.234,0.451,0.733,9,0,0,8,2.3,26.8,6,Similar,Southwest,MI,Urban,36-50,2023-01,Q1_2023,2022,4.4,0.782,Decreasing
FIA001159,2023-02-07,Clopidogrel,Plavix,Antiplatelet Agents,92793-257-27,Medicare Part D Plan A,PLAN_1720,2023,Non-Formulary,Specialty Tier,2022-07-12,210,Worsened,Non-Formulary Status,No,No,,792,737,7.6,Increased,375.24,291.99,83.25,124.17,499.41,395.53,0.0,0,0.227,0.243,0.651,0.413,0,1,8,5,3.5,17.2,5,Higher,Northeast,OH,Urban,51-65,2023-02,Q1_2023,2022,1.8,0.488,Decreasing
FIA001179,2023-02-12,Clopidogrel,Plavix,Antiplatelet Agents,52879-397-22,Medicare Part D Plan A,PLAN_6217,2023,Specialty Tier,Specialty Tier,2022-07-25,202,No Change,Prior Authorization,Yes,No,,505,508,-0.5,Stable,233.34,109.19,124.15,158.08,391.42,197.67,0.492,8,0.234,0.218,0.661,0.595,0,4,1,5,3.0,29.8,7,Higher,West,NC,Rural,18-35,2023-02,Q1_2023,2022,1.2,0.541,Stable
FIA001978,2023-03-02,Clopidogrel,Plavix,Antiplatelet Agents,75619-862-60,Commercial Plan Beta,PLAN_3056,2023,Tier 2,Tier 3,2023-01-24,37,Improved,None,No,No,,727,553,31.6,Increased,44.47,62.24,-17.77,133.12,177.59,129.11,0.0,0,0.06,0.069,0.848,0.864,0,6,10,6,2.6,12.1,7,Similar,West,TX,Urban,75+,2023-03,Q1_2023,2022,4.4,0.309,Decreasing
FIA002725,2023-03-06,Clopidogrel,Plavix,Antiplatelet Agents,83488-356-52,VA Plan,PLAN_9538,2023,Specialty Tier,Specialty Tier,2022-03-15,356,No Change,Step Therapy,No,Yes,,902,978,-7.7,Decreased,162.42,228.47,-66.05,71.52,233.94,211.01,0.0,0,0.166,0.148,0.588,0.449,5,4,16,8,4.3,11.6,8,Higher,West,MI,Urban,36-50,2023-03,Q1_2023,2022,7.2,0.652,Stable
FIA000800,2023-03-13,Clopidogrel,Plavix,Antiplatelet Agents,10349-292-51,Medicaid Plan X,PLAN_5620,2023,Non-Formulary,Tier 1,2022-10-05,159,Worsened,Non-Formulary Status,No,No,,320,447,-28.4,Decreased,472.27,16.11,456.16,170.69,642.96,205.75,0.0,0,0.266,0.086,0.851,0.81,5,3,16,15,3.9,30.1,2,Higher,Southwest,OH,Suburban,66-75,2023-03,Q1_2023,2022,5.3,0.096,Increasing
FIA001918,2023-03-13,Clopidogrel,Plavix,Antiplatelet Agents,98510-200-35,Medicare Part D Plan A,PLAN_7510,2023,Tier 1,Tier 3,2023-01-14,58,Improved,None,No,No,,313,200,56.9,Increased,17.1,88.49,-71.39,139.19,156.29,48.92,0.0,0,0.038,0.12,0.399,0.592,13,1,20,0,2.9,20.4,2,Higher,West,CA,Suburban,66-75,2023-03,Q1_2023,2022,9.1,0.995,Decreasing
FIA002181,2023-03-17,Clopidogrel,Plavix,Antiplatelet Agents,62696-736-76,Commercial Plan Beta,PLAN_3565,2023,Specialty Tier,Non-Formulary,2022-09-28,170,Improved,None,No,No,,350,389,-9.8,Decreased,131.53,326.71,-195.18,158.8,290.33,101.62,0.0,0,0.133,0.116,0.775,0.44,2,2,16,0,3.8,7.0,6,Lower,Southwest,GA,Rural,18-35,2023-03,Q1_2023,2022,1.7,0.843,Decreasing
FIA001837,2023-03-29,Clopidogrel,Plavix,Antiplatelet Agents,34113-855-64,Commercial Plan Alpha,PLAN_3629,2023,Specialty Tier,Non-Formulary,2022-04-19,344,Improved,Prior Authorization; Quantity Limit,Yes,No,30.0,309,307,0.7,Stable,235.38,313.46,-78.08,178.65,414.03,127.94,0.237,6,0.193,0.323,0.597,0.948,11,3,14,13,2.5,30.7,7,Higher,West,IL,Urban,36-50,2023-03,Q1_2023,2022,7.4,0.129,Increasing
FIA002515,2023-04-07,Clopidogrel,Plavix,Antiplatelet Agents,39763-329-73,Medicaid Plan Y,PLAN_4080,2023,Specialty Tier,Tier 2,2022-10-25,164,Worsened,Quantity Limit,No,No,90.0,199,427,-53.4,Decreased,210.14,32.19,177.95,182.77,392.91,78.19,0.0,0,0.152,0.368,0.386,0.494,12,9,19,11,2.7,30.7,6,Higher,Southeast,PA,Urban,75+,2023-04,Q2_2023,2022,7.7,0.089,Stable
FIA001449,2023-04-25,Clopidogrel,Plavix,Antiplatelet Agents,48570-191-43,Commercial Plan Alpha,PLAN_6829,2023,Tier 3,Tier 1,2022-11-30,146,Worsened,None,No,No,,589,965,-38.9,Decreased,80.15,11.99,68.16,39.76,119.91,70.63,0.0,0,0.051,0.377,0.727,0.739,12,3,13,1,2.7,14.9,4,Lower,West,NC,Urban,36-50,2023-04,Q2_2023,2022,2.0,0.21,Decreasing
FIA000990,2023-04-29,Clopidogrel,Plavix,Antiplatelet Agents,78122-201-62,Tricare Standard,PLAN_8082,2023,Non-Formulary,Specialty Tier,2022-07-08,295,Worsened,Non-Formulary Status,No,No,,165,164,1.2,Stable,301.74,230.98,70.76,189.65,491.39,81.08,0.0,0,0.121,0.191,0.723,0.55,4,0,17,7,2.9,26.0,3,Similar,Southeast,OH,Suburban,51-65,2023-04,Q2_2023,2022,5.3,0.149,Stable
FIA002910,2023-05-05,Clopidogrel,Plavix,Antiplatelet Agents,96265-460-90,Commercial Plan Alpha,PLAN_2221,2023,Specialty Tier,Specialty Tier,2022-12-01,155,No Change,Step Therapy,No,Yes,,681,676,0.9,Stable,124.64,206.17,-81.53,123.97,248.61,169.3,0.0,0,0.16,0.061,0.497,0.624,4,6,4,9,2.1,25.1,8,Lower,Southwest,CA,Urban,66-75,2023-05,Q2_2023,2022,7.0,0.162,Decreasing
FIA000342,2023-05-09,Clopidogrel,Plavix,Antiplatelet Agents,67310-673-66,Tricare Standard,PLAN_5104,2023,Specialty Tier,Specialty Tier,2022-09-24,227,No Change,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,,962,958,0.4,Stable,241.25,171.0,70.25,150.93,392.18,377.28,0.573,9,0.258,0.365,0.656,0.498,11,7,11,13,2.6,21.8,3,Similar,Midwest,FL,Rural,18-35,2023-05,Q2_2023,2022,2.8,0.361,Increasing
FIA000764,2023-05-10,Clopidogrel,Plavix,Antiplatelet Agents,49308-451-12,Commercial Plan Alpha,PLAN_2543,2023,Tier 1,Tier 1,2022-09-07,245,No Change,None,No,No,,423,459,-7.8,Decreased,7.07,13.39,-6.32,138.12,145.19,61.42,0.0,0,0.058,0.159,0.44,0.887,4,7,19,8,4.3,25.6,7,Lower,Southeast,GA,Rural,51-65,2023-05,Q2_2023,2022,2.7,0.797,Decreasing
FIA002718,2023-05-18,Clopidogrel,Plavix,Antiplatelet Agents,94808-738-41,Medicare Part D Plan B,PLAN_6826,2023,Tier 2,Tier 2,2022-10-03,227,No Change,None,No,No,,1000,916,9.2,Increased,30.0,47.37,-17.37,52.66,82.66,82.66,0.0,0,0.017,0.112,0.847,0.879,0,5,2,13,4.4,24.0,3,Lower,Midwest,NY,Urban,75+,2023-05,Q2_2023,2022,3.5,0.34,Stable
FIA000385,2023-05-19,Clopidogrel,Plavix,Antiplatelet Agents,11627-403-41,Medicare Part D Plan A,PLAN_8917,2023,Tier 2,Tier 3,2023-04-06,43,Improved,None,No,No,,408,324,26.0,Increased,34.83,91.66,-56.83,66.71,101.54,41.43,0.0,0,0.055,0.343,0.49,0.703,6,6,5,12,3.9,31.7,5,Higher,Midwest,IL,Suburban,66-75,2023-05,Q2_2023,2022,4.3,0.9,Increasing
FIA000631,2023-05-21,Clopidogrel,Plavix,Antiplatelet Agents,57484-365-29,VA Plan,PLAN_1747,2023,Tier 3,Tier 3,2023-02-24,86,No Change,Prior Authorization,Yes,No,,604,559,8.2,Increased,56.84,88.52,-31.68,46.74,103.58,62.56,0.483,10,0.045,0.212,0.359,0.611,4,4,9,13,4.3,30.3,4,Similar,Southwest,GA,Suburban,36-50,2023-05,Q2_2023,2022,1.3,0.065,Increasing
FIA000859,2023-05-25,Clopidogrel,Plavix,Antiplatelet Agents,46435-208-66,VA Plan,PLAN_6146,2023,Tier 2,Tier 1,2023-04-11,44,Worsened,None,No,No,,315,328,-3.7,Stable,20.9,6.19,14.71,33.02,53.92,16.98,0.0,0,0.026,0.397,0.489,0.613,15,3,11,3,3.6,29.0,3,Lower,Midwest,FL,Suburban,51-65,2023-05,Q2_2023,2022,6.7,0.056,Increasing
FIA001706,2023-05-25,Clopidogrel,Plavix,Antiplatelet Agents,23778-965-15,Medicare Part D Plan B,PLAN_1321,2023,Tier 1,Non-Formulary,2022-11-09,197,Improved,None,No,No,,260,187,39.4,Increased,16.09,739.51,-723.42,129.42,145.51,37.83,0.0,0,0.014,0.147,0.389,0.52,11,0,18,1,4.5,22.6,8,Lower,Midwest,CA,Rural,75+,2023-05,Q2_2023,2022,8.5,0.697,Increasing
FIA002568,2023-06-26,Clopidogrel,Plavix,Antiplatelet Agents,36829-703-55,Medicaid Plan Y,PLAN_5452,2023,Non-Formulary,Tier 2,2022-07-30,331,Worsened,Non-Formulary Status,No,No,,395,813,-51.3,Decreased,529.74,43.87,485.87,150.16,679.9,268.56,0.0,0,0.081,0.131,0.24,0.547,2,6,5,10,4.8,34.9,7,Higher,Northeast,NC,Urban,66-75,2023-06,Q2_2023,2022,8.6,0.505,Decreasing
FIA000824,2023-07-03,Clopidogrel,Plavix,Antiplatelet Agents,30102-499-13,Commercial Plan Alpha,PLAN_6614,2023,Tier 1,Tier 2,2023-05-29,35,Improved,None,No,No,,823,789,4.4,Stable,14.96,47.43,-32.47,92.01,106.97,88.04,0.0,0,0.041,0.114,0.894,0.628,15,9,8,2,2.4,20.2,8,Higher,Southwest,OH,Rural,18-35,2023-07,Q3_2023,2022,1.8,0.126,Increasing
FIA002809,2023-07-04,Clopidogrel,Plavix,Antiplatelet Agents,74136-353-73,Tricare Standard,PLAN_5087,2023,Non-Formulary,Tier 2,2023-05-02,63,Worsened,Non-Formulary Status,No,No,,536,966,-44.4,Decreased,514.56,20.13,494.43,91.23,605.79,324.7,0.0,0,0.249,0.338,0.601,0.76,14,1,8,1,3.8,16.8,6,Higher,Midwest,NY,Rural,36-50,2023-07,Q3_2023,2022,2.6,0.029,Increasing
FIA002236,2023-07-23,Clopidogrel,Plavix,Antiplatelet Agents,36693-472-78,Commercial Plan Beta,PLAN_6625,2023,Non-Formulary,Non-Formulary,2022-12-04,231,No Change,Non-Formulary Status,No,No,,474,444,6.9,Increased,271.4,757.81,-486.41,73.3,344.7,163.39,0.0,0,0.189,0.302,0.733,0.401,13,10,15,1,4.4,26.7,7,Similar,Northeast,NY,Rural,51-65,2023-07,Q3_2023,2022,7.8,0.366,Increasing
FIA002886,2023-07-28,Clopidogrel,Plavix,Antiplatelet Agents,44214-718-98,Commercial Plan Beta,PLAN_3104,2023,Tier 1,Specialty Tier,2023-06-08,50,Improved,Quantity Limit,No,No,30.0,1217,772,57.7,Increased,16.64,193.64,-177.0,77.62,94.26,114.71,0.0,0,0.023,0.08,0.294,0.581,1,4,12,9,4.5,28.5,6,Higher,West,PA,Urban,75+,2023-07,Q3_2023,2022,3.3,0.911,Stable
FIA000986,2023-08-06,Clopidogrel,Plavix,Antiplatelet Agents,74039-220-29,Medicaid Plan Y,PLAN_6964,2023,Tier 3,Non-Formulary,2022-12-06,243,Improved,None,No,No,,893,836,6.9,Increased,73.09,359.09,-286.0,101.7,174.79,156.09,0.0,0,0.034,0.255,0.44,0.416,5,7,13,14,2.8,27.0,2,Similar,Midwest,TX,Urban,36-50,2023-08,Q3_2023,2022,5.4,0.68,Stable
FIA001635,2023-08-08,Clopidogrel,Plavix,Antiplatelet Agents,10761-430-64,Commercial Plan Alpha,PLAN_1841,2023,Specialty Tier,Tier 2,2023-02-15,174,Worsened,Step Therapy; Quantity Limit,No,Yes,,135,232,-41.5,Decreased,203.6,37.53,166.07,145.33,348.93,47.11,0.0,0,0.221,0.228,0.215,0.661,0,9,16,5,2.5,6.1,8,Lower,Midwest,FL,Rural,18-35,2023-08,Q3_2023,2022,1.0,0.703,Decreasing
FIA001617,2023-08-18,Clopidogrel,Plavix,Antiplatelet Agents,67997-618-36,Medicaid Plan X,PLAN_1771,2023,Non-Formulary,Tier 2,2023-06-06,73,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,168,290,-42.0,Decreased,736.19,45.01,691.18,173.76,909.95,152.87,0.0,0,0.284,0.254,0.68,0.845,4,8,2,2,3.2,19.2,5,Similar,Northeast,TX,Urban,36-50,2023-08,Q3_2023,2022,3.6,0.175,Stable
FIA000013,2023-08-29,Clopidogrel,Plavix,Antiplatelet Agents,37549-540-84,Medicaid Plan Y,PLAN_8618,2023,Tier 2,Tier 2,2022-12-27,245,No Change,None,No,No,,935,866,8.1,Increased,39.95,31.37,8.58,81.66,121.61,113.71,0.0,0,0.068,0.205,0.673,0.681,5,10,2,9,3.5,24.0,4,Lower,Southeast,PA,Urban,36-50,2023-08,Q3_2023,2022,2.3,0.046,Stable
FIA001713,2023-09-05,Clopidogrel,Plavix,Antiplatelet Agents,20304-854-17,Medicaid Plan X,PLAN_7473,2023,Non-Formulary,Non-Formulary,2022-09-15,355,No Change,Non-Formulary Status; Quantity Limit,No,No,30.0,389,357,9.1,Increased,236.86,445.83,-208.97,105.29,342.15,133.1,0.0,0,0.269,0.32,0.247,0.439,12,7,0,2,3.7,19.8,8,Lower,Midwest,CA,Rural,51-65,2023-09,Q3_2023,2022,3.7,0.295,Decreasing
FIA002244,2023-09-05,Clopidogrel,Plavix,Antiplatelet Agents,23948-979-70,Tricare Standard,PLAN_2410,2023,Non-Formulary,Tier 2,2023-02-16,201,Worsened,Non-Formulary Status; Quantity Limit,No,No,,450,600,-24.9,Decreased,435.16,48.45,386.71,119.6,554.76,249.64,0.0,0,0.188,0.387,0.716,0.944,12,5,8,1,3.2,32.8,2,Lower,Southeast,IL,Suburban,51-65,2023-09,Q3_2023,2022,8.0,0.299,Increasing
FIA000366,2023-09-22,Clopidogrel,Plavix,Antiplatelet Agents,96847-260-51,Tricare Standard,PLAN_7830,2023,Tier 3,Tier 3,2022-11-25,301,No Change,None,No,No,,682,724,-5.8,Decreased,73.59,84.24,-10.65,56.85,130.44,88.96,0.0,0,0.022,0.323,0.389,0.913,15,4,11,4,2.9,26.8,8,Higher,Midwest,GA,Suburban,66-75,2023-09,Q3_2023,2022,6.1,0.763,Increasing
FIA001969,2023-09-27,Clopidogrel,Plavix,Antiplatelet Agents,45337-510-67,Medicare Part D Plan A,PLAN_1294,2023,Tier 2,Tier 3,2023-01-27,243,Improved,Quantity Limit,No,No,90.0,1068,889,20.2,Increased,44.78,84.13,-39.35,172.98,217.76,232.57,0.0,0,0.047,0.087,0.496,0.518,8,7,7,2,2.1,25.7,3,Similar,Northeast,GA,Urban,18-35,2023-09,Q3_2023,2022,6.1,0.037,Increasing
FIA002188,2023-10-09,Clopidogrel,Plavix,Antiplatelet Agents,99928-512-59,Medicare Part D Plan A,PLAN_7637,2023,Tier 1,Tier 1,2023-01-21,261,No Change,None,No,No,,836,772,8.3,Increased,12.18,13.73,-1.55,73.55,85.73,71.67,0.0,0,0.062,0.143,0.437,0.702,9,10,9,8,4.0,13.6,2,Similar,West,NC,Rural,66-75,2023-10,Q4_2023,2023,3.6,0.354,Decreasing
FIA000386,2023-10-18,Clopidogrel,Plavix,Antiplatelet Agents,72355-648-50,Medicare Part D Plan B,PLAN_4732,2023,Tier 3,Tier 1,2023-07-12,98,Worsened,Quantity Limit,No,No,60.0,554,819,-32.3,Decreased,66.08,17.41,48.67,116.27,182.35,101.02,0.0,0,0.065,0.301,0.651,0.705,7,7,8,1,3.4,18.1,6,Similar,Northeast,FL,Urban,75+,2023-10,Q4_2023,2023,5.0,0.65,Stable
FIA001180,2023-10-29,Clopidogrel,Plavix,Antiplatelet Agents,12151-912-46,Medicare Part D Plan B,PLAN_7059,2023,Specialty Tier,Tier 2,2023-06-13,138,Worsened,None,No,No,,541,874,-38.0,Decreased,168.52,35.12,133.4,190.0,358.52,193.96,0.0,0,0.088,0.071,0.527,0.922,9,9,7,3,3.2,5.4,7,Lower,Southwest,TX,Urban,51-65,2023-10,Q4_2023,2023,6.7,0.63,Stable
FIA000371,2023-10-31,Clopidogrel,Plavix,Antiplatelet Agents,88895-964-15,Commercial Plan Alpha,PLAN_9848,2023,Specialty Tier,Tier 2,2022-12-11,324,Worsened,Step Therapy,No,Yes,,304,832,-63.4,Decreased,285.07,46.8,238.27,34.46,319.53,97.14,0.0,0,0.095,0.172,0.248,0.879,7,10,6,6,2.9,17.7,4,Lower,Southeast,IL,Urban,36-50,2023-10,Q4_2023,2023,8.9,0.944,Increasing
FIA000568,2023-11-04,Clopidogrel,Plavix,Antiplatelet Agents,42660-261-23,Medicare Part D Plan A,PLAN_8299,2023,Specialty Tier,Tier 2,2022-11-30,339,Worsened,Prior Authorization,Yes,No,,98,323,-69.4,Decreased,244.59,41.71,202.88,75.83,320.42,31.4,0.361,3,0.265,0.071,0.321,0.873,1,7,10,9,4.7,20.6,3,Similar,Southwest,IL,Suburban,66-75,2023-11,Q4_2023,2023,8.2,0.132,Increasing
FIA002975,2023-11-10,Clopidogrel,Plavix,Antiplatelet Agents,82787-453-29,Tricare Standard,PLAN_9118,2023,Specialty Tier,Tier 2,2023-08-25,77,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,325,802,-59.4,Decreased,204.8,29.92,174.88,79.91,284.71,92.53,0.455,2,0.262,0.335,0.209,0.593,15,6,3,1,2.3,24.9,2,Lower,Southeast,PA,Urban,36-50,2023-11,Q4_2023,2023,2.8,0.722,Increasing
FIA002542,2023-12-03,Clopidogrel,Plavix,Antiplatelet Agents,46590-625-87,Medicare Part D Plan B,PLAN_3252,2023,Specialty Tier,Non-Formulary,2023-03-08,270,Improved,Quantity Limit,No,No,60.0,463,451,2.8,Stable,187.78,426.0,-238.22,57.62,245.4,113.62,0.0,0,0.175,0.163,0.865,0.599,14,2,8,4,2.1,6.7,3,Higher,West,MI,Suburban,75+,2023-12,Q4_2023,2023,4.1,0.538,Stable
FIA001606,2023-12-08,Clopidogrel,Plavix,Antiplatelet Agents,34151-213-10,Commercial Plan Alpha,PLAN_4855,2023,Specialty Tier,Tier 2,2023-04-29,223,Worsened,None,No,No,,519,922,-43.7,Decreased,138.08,25.62,112.46,96.11,234.19,121.54,0.0,0,0.201,0.242,0.507,0.489,0,7,7,13,4.9,33.0,8,Higher,Midwest,MI,Suburban,18-35,2023-12,Q4_2023,2023,4.4,0.625,Stable
FIA000579,2023-12-17,Clopidogrel,Plavix,Antiplatelet Agents,63806-323-15,Commercial Plan Alpha,PLAN_6205,2023,Tier 1,Tier 2,2023-01-12,339,Improved,None,No,No,,716,686,4.5,Stable,7.01,39.62,-32.61,42.13,49.14,35.18,0.0,0,0.03,0.161,0.665,0.72,7,6,7,14,4.0,29.4,7,Similar,Southeast,MI,Rural,51-65,2023-12,Q4_2023,2023,7.0,0.954,Increasing
FIA002343,2023-12-19,Clopidogrel,Plavix,Antiplatelet Agents,60447-274-40,Medicare Part D Plan B,PLAN_7715,2023,Tier 3,Non-Formulary,2023-09-05,105,Improved,Prior Authorization,Yes,No,,922,991,-6.9,Decreased,64.5,378.86,-314.36,177.7,242.2,223.31,0.578,2,0.022,0.324,0.9,0.586,0,2,9,10,4.8,31.7,8,Lower,Midwest,OH,Rural,66-75,2023-12,Q4_2023,2023,9.5,0.799,Increasing
FIA000949,2023-12-21,Clopidogrel,Plavix,Antiplatelet Agents,81278-525-94,VA Plan,PLAN_1020,2023,Specialty Tier,Non-Formulary,2023-10-17,65,Improved,None,No,No,,131,145,-9.2,Decreased,227.69,741.76,-514.07,52.27,279.96,36.67,0.0,0,0.104,0.085,0.356,0.573,0,0,5,10,4.4,19.5,8,Higher,Northeast,TX,Urban,18-35,2023-12,Q4_2023,2023,2.7,0.294,Stable
FIA002185,2023-12-21,Clopidogrel,Plavix,Antiplatelet Agents,76489-321-21,Commercial Plan Beta,PLAN_3806,2023,Tier 3,Tier 2,2023-05-28,207,Worsened,None,No,No,,277,654,-57.6,Decreased,84.9,22.61,62.29,125.26,210.16,58.21,0.0,0,0.027,0.268,0.445,0.414,9,0,19,14,4.6,26.9,8,Higher,Northeast,PA,Rural,51-65,2023-12,Q4_2023,2023,3.8,0.949,Increasing
FIA002695,2023-12-28,Clopidogrel,Plavix,Antiplatelet Agents,77563-758-46,Medicare Part D Plan A,PLAN_4951,2023,Specialty Tier,Tier 3,2023-10-06,83,Worsened,None,No,No,,170,155,10.0,Increased,151.21,51.0,100.21,150.29,301.5,51.26,0.0,0,0.14,0.276,0.387,0.94,2,9,11,8,2.0,32.3,5,Similar,West,IL,Urban,36-50,2023-12,Q4_2023,2023,9.5,0.273,Decreasing
FIA002310,2024-01-07,Clopidogrel,Plavix,Antiplatelet Agents,38105-285-43,Commercial Plan Alpha,PLAN_5772,2024,Tier 2,Tier 2,2023-03-17,296,No Change,None,No,No,,525,483,8.7,Increased,26.8,21.88,4.92,133.71,160.51,84.27,0.0,0,0.028,0.373,0.474,0.432,15,2,19,8,3.5,9.6,2,Higher,Northeast,CA,Urban,51-65,2024-01,Q1_2024,2023,3.0,0.986,Increasing
FIA002901,2024-01-09,Clopidogrel,Plavix,Antiplatelet Agents,41372-303-15,Medicare Part D Plan A,PLAN_3684,2024,Tier 3,Non-Formulary,2023-10-24,77,Improved,None,No,No,,773,759,1.8,Stable,62.21,608.79,-546.58,97.37,159.58,123.36,0.0,0,0.077,0.376,0.379,0.658,3,6,14,13,3.8,18.9,2,Higher,Midwest,OH,Suburban,66-75,2024-01,Q1_2024,2023,1.2,0.851,Increasing
FIA001459,2024-01-12,Clopidogrel,Plavix,Antiplatelet Agents,68534-377-17,Medicaid Plan Y,PLAN_2717,2024,Tier 3,Tier 3,2023-09-11,123,No Change,Prior Authorization,Yes,No,,234,214,9.6,Increased,51.36,50.08,1.28,54.0,105.36,24.65,0.525,9,0.044,0.349,0.526,0.935,4,2,3,14,3.4,23.5,2,Lower,Midwest,PA,Rural,75+,2024-01,Q1_2024,2023,9.4,0.53,Decreasing
FIA001469,2024-01-17,Clopidogrel,Plavix,Antiplatelet Agents,96020-213-57,VA Plan,PLAN_5125,2024,Tier 2,Specialty Tier,2023-04-25,267,Improved,None,No,No,,995,697,42.9,Increased,42.11,238.63,-196.52,131.84,173.95,173.08,0.0,0,0.02,0.259,0.504,0.411,5,7,13,3,2.1,10.1,3,Similar,Northeast,FL,Urban,75+,2024-01,Q1_2024,2023,7.9,0.259,Decreasing
FIA001956,2024-01-27,Clopidogrel,Plavix,Antiplatelet Agents,98236-740-73,Tricare Standard,PLAN_2105,2024,Non-Formulary,Non-Formulary,2023-01-31,361,No Change,Non-Formulary Status,No,No,,453,501,-9.5,Decreased,446.96,750.4,-303.44,169.74,616.7,279.37,0.0,0,0.079,0.33,0.579,0.762,14,10,16,5,3.7,12.2,6,Lower,Southwest,GA,Urban,51-65,2024-01,Q1_2024,2023,6.0,0.049,Increasing
FIA000581,2024-02-02,Clopidogrel,Plavix,Antiplatelet Agents,52823-368-81,Medicare Part D Plan A,PLAN_7380,2024,Tier 2,Specialty Tier,2023-03-31,308,Improved,None,No,No,,656,511,28.4,Increased,32.51,199.9,-167.39,48.65,81.16,53.24,0.0,0,0.063,0.158,0.414,0.473,0,0,12,5,3.7,20.1,5,Similar,West,GA,Urban,51-65,2024-02,Q1_2024,2023,5.7,0.776,Stable
FIA002527,2024-02-17,Clopidogrel,Plavix,Antiplatelet Agents,71371-208-99,Medicaid Plan X,PLAN_1662,2024,Tier 3,Tier 3,2023-07-24,208,No Change,None,No,No,,402,432,-6.9,Decreased,90.07,69.62,20.45,155.11,245.18,98.56,0.0,0,0.064,0.111,0.222,0.67,5,7,15,15,5.0,23.7,2,Lower,Southwest,PA,Rural,66-75,2024-02,Q1_2024,2023,1.4,0.142,Decreasing
FIA000038,2024-02-18,Clopidogrel,Plavix,Antiplatelet Agents,20205-982-50,VA Plan,PLAN_7626,2024,Tier 2,Non-Formulary,2023-04-08,316,Improved,None,No,No,,229,173,32.9,Increased,45.0,683.72,-638.72,108.16,153.16,35.07,0.0,0,0.041,0.298,0.492,0.463,0,5,5,14,4.5,32.6,2,Similar,Northeast,NY,Suburban,75+,2024-02,Q1_2024,2023,4.6,0.079,Stable
FIA002904,2024-02-18,Clopidogrel,Plavix,Antiplatelet Agents,66482-246-92,Commercial Plan Beta,PLAN_7332,2024,Tier 3,Tier 1,2023-06-30,233,Worsened,Prior Authorization,Yes,No,,272,594,-54.1,Decreased,83.87,17.86,66.01,145.67,229.54,62.43,0.507,1,0.052,0.062,0.766,0.462,13,8,0,7,2.3,33.4,8,Lower,Southwest,IL,Rural,75+,2024-02,Q1_2024,2023,2.3,0.123,Decreasing
FIA002834,2024-02-19,Clopidogrel,Plavix,Antiplatelet Agents,61952-328-10,Medicare Part D Plan B,PLAN_3106,2024,Non-Formulary,Specialty Tier,2023-07-29,205,Worsened,Non-Formulary Status,No,No,,570,529,7.9,Increased,462.68,236.93,225.75,115.66,578.34,329.65,0.0,0,0.173,0.311,0.674,0.724,14,10,7,15,2.4,29.0,8,Higher,Southwest,NY,Suburban,66-75,2024-02,Q1_2024,2023,2.7,0.202,Decreasing
FIA002884,2024-02-19,Clopidogrel,Plavix,Antiplatelet Agents,25975-298-48,Medicaid Plan Y,PLAN_8885,2024,Tier 2,Tier 1,2023-09-25,147,Worsened,None,No,No,,483,490,-1.3,Stable,26.86,10.32,16.54,69.06,95.92,46.33,0.0,0,0.05,0.344,0.235,0.938,15,7,10,6,2.9,11.6,4,Similar,West,MI,Rural,51-65,2024-02,Q1_2024,2023,7.8,0.86,Stable
FIA001968,2024-02-24,Clopidogrel,Plavix,Antiplatelet Agents,61347-810-71,Medicaid Plan Y,PLAN_4244,2024,Tier 1,Non-Formulary,2024-01-03,52,Improved,None,No,No,,456,376,21.3,Increased,10.71,536.4,-525.69,138.56,149.27,68.07,0.0,0,0.052,0.095,0.637,0.712,7,9,3,15,4.1,15.2,6,Lower,Midwest,NC,Rural,51-65,2024-02,Q1_2024,2023,9.5,0.584,Decreasing
FIA001420,2024-03-06,Clopidogrel,Plavix,Antiplatelet Agents,36176-624-96,Medicare Part D Plan A,PLAN_6615,2024,Tier 3,Tier 1,2023-09-08,180,Worsened,Step Therapy,No,Yes,,194,273,-28.8,Decreased,62.04,9.22,52.82,39.48,101.52,19.69,0.0,0,0.052,0.306,0.457,0.738,8,2,16,2,3.3,11.9,3,Similar,Southwest,GA,Urban,18-35,2024-03,Q1_2024,2023,1.2,0.502,Increasing
FIA000898,2024-03-25,Clopidogrel,Plavix,Antiplatelet Agents,58192-751-18,Commercial Plan Alpha,PLAN_8638,2024,Non-Formulary,Tier 1,2023-11-13,133,Worsened,Non-Formulary Status,No,No,,453,756,-40.1,Decreased,244.56,17.59,226.97,177.89,422.45,191.37,0.0,0,0.168,0.254,0.334,0.468,5,4,4,11,2.7,16.2,7,Similar,Northeast,OH,Urban,18-35,2024-03,Q1_2024,2023,6.2,0.086,Decreasing
FIA000084,2024-03-26,Clopidogrel,Plavix,Antiplatelet Agents,80305-434-60,Medicare Part D Plan B,PLAN_6081,2024,Tier 3,Non-Formulary,2023-07-28,242,Improved,None,No,No,,760,755,0.7,Stable,71.18,441.37,-370.19,167.37,238.55,181.3,0.0,0,0.024,0.295,0.711,0.866,1,3,2,13,2.3,23.4,2,Similar,Southeast,TX,Urban,36-50,2024-03,Q1_2024,2023,7.3,0.164,Stable
FIA001564,2024-03-30,Clopidogrel,Plavix,Antiplatelet Agents,50194-902-59,VA Plan,PLAN_3014,2024,Tier 3,Tier 2,2023-07-13,261,Worsened,None,No,No,,297,542,-45.2,Decreased,89.67,48.41,41.26,58.13,147.8,43.9,0.0,0,0.048,0.378,0.819,0.829,1,9,15,0,2.5,23.2,8,Similar,West,CA,Rural,66-75,2024-03,Q1_2024,2023,7.1,0.358,Increasing
FIA001276,2024-04-05,Clopidogrel,Plavix,Antiplatelet Agents,52526-363-72,Medicaid Plan Y,PLAN_6815,2024,Specialty Tier,Non-Formulary,2023-07-30,250,Improved,Prior Authorization; Quantity Limit,Yes,No,,389,359,8.4,Increased,299.25,468.19,-168.94,104.85,404.1,157.19,0.573,2,0.192,0.334,0.336,0.819,6,6,14,4,4.2,7.6,8,Similar,Southwest,GA,Rural,75+,2024-04,Q2_2024,2023,9.7,0.277,Decreasing
FIA000863,2024-04-18,Clopidogrel,Plavix,Antiplatelet Agents,24531-978-81,Medicare Part D Plan B,PLAN_6112,2024,Non-Formulary,Tier 2,2023-10-23,178,Worsened,Non-Formulary Status,No,No,,279,368,-23.9,Decreased,238.03,21.36,216.67,117.66,355.69,99.24,0.0,0,0.239,0.053,0.888,0.907,7,2,10,3,3.3,22.6,2,Similar,Midwest,GA,Urban,75+,2024-04,Q2_2024,2023,4.3,0.001,Decreasing
FIA000660,2024-04-29,Clopidogrel,Plavix,Antiplatelet Agents,85950-447-82,Commercial Plan Alpha,PLAN_8650,2024,Tier 2,Tier 3,2023-10-29,183,Improved,None,No,No,,188,130,44.7,Increased,45.27,66.31,-21.04,116.3,161.57,30.38,0.0,0,0.02,0.271,0.262,0.63,0,6,18,3,4.2,31.5,5,Lower,Southeast,GA,Suburban,66-75,2024-04,Q2_2024,2023,2.2,0.557,Decreasing
FIA000988,2024-04-29,Clopidogrel,Plavix,Antiplatelet Agents,16660-400-35,Medicare Part D Plan B,PLAN_8760,2024,Tier 1,Non-Formulary,2023-05-22,343,Improved,None,No,No,,1368,922,48.5,Increased,10.34,204.67,-194.33,159.05,169.39,231.73,0.0,0,0.045,0.081,0.838,0.774,10,2,2,14,3.7,11.7,6,Similar,Northeast,MI,Rural,36-50,2024-04,Q2_2024,2023,8.8,0.668,Stable
FIA001794,2024-05-05,Clopidogrel,Plavix,Antiplatelet Agents,54953-619-38,VA Plan,PLAN_6976,2024,Specialty Tier,Tier 1,2023-06-25,315,Worsened,None,No,No,,362,497,-27.1,Decreased,124.17,12.33,111.84,75.09,199.26,72.13,0.0,0,0.109,0.261,0.578,0.811,3,6,13,11,3.6,25.5,8,Lower,Southwest,OH,Rural,36-50,2024-05,Q2_2024,2023,2.5,0.96,Increasing
FIA000652,2024-05-06,Clopidogrel,Plavix,Antiplatelet Agents,10421-709-53,Commercial Plan Beta,PLAN_9206,2024,Non-Formulary,Tier 1,2023-11-15,173,Worsened,Non-Formulary Status,No,No,,366,628,-41.7,Decreased,612.93,7.59,605.34,32.05,644.98,236.06,0.0,0,0.066,0.356,0.638,0.572,8,2,2,12,4.2,12.0,8,Higher,West,CA,Urban,75+,2024-05,Q2_2024,2023,8.0,0.477,Increasing
FIA001570,2024-05-06,Clopidogrel,Plavix,Antiplatelet Agents,40469-311-38,Commercial Plan Alpha,PLAN_8998,2024,Specialty Tier,Non-Formulary,2023-08-29,251,Improved,None,No,No,,605,590,2.6,Stable,195.75,383.47,-187.72,163.95,359.7,217.62,0.0,0,0.051,0.265,0.593,0.841,4,1,14,0,2.5,33.5,7,Similar,Northeast,MI,Rural,66-75,2024-05,Q2_2024,2023,1.6,0.857,Stable
FIA002189,2024-05-16,Clopidogrel,Plavix,Antiplatelet Agents,58346-276-50,Medicaid Plan X,PLAN_2504,2024,Tier 3,Tier 3,2024-02-22,84,No Change,Step Therapy; Quantity Limit,No,Yes,90.0,280,281,-0.1,Stable,58.61,66.49,-7.88,48.46,107.07,29.98,0.0,0,0.027,0.34,0.895,0.9,2,1,4,12,4.9,33.6,6,Similar,West,IL,Urban,66-75,2024-05,Q2_2024,2023,2.9,0.326,Decreasing
FIA000613,2024-05-30,Clopidogrel,Plavix,Antiplatelet Agents,17705-109-74,Medicaid Plan X,PLAN_6111,2024,Specialty Tier,Tier 3,2023-06-25,340,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,359,361,-0.4,Stable,260.47,94.24,166.23,94.49,354.96,127.43,0.311,8,0.103,0.141,0.558,0.527,2,9,3,1,3.5,23.6,6,Lower,Northeast,OH,Suburban,18-35,2024-05,Q2_2024,2023,1.5,0.571,Decreasing
FIA002609,2024-06-05,Clopidogrel,Plavix,Antiplatelet Agents,49569-253-45,VA Plan,PLAN_5345,2024,Tier 3,Specialty Tier,2023-11-27,191,Improved,Prior Authorization,Yes,No,,910,855,6.4,Increased,98.43,172.99,-74.56,71.48,169.91,154.62,0.105,6,0.073,0.106,0.228,0.737,1,5,7,7,2.3,31.8,6,Similar,Midwest,NY,Suburban,75+,2024-06,Q2_2024,2023,8.5,0.835,Stable
FIA001967,2024-06-10,Clopidogrel,Plavix,Antiplatelet Agents,47570-378-49,Commercial Plan Alpha,PLAN_4082,2024,Tier 3,Specialty Tier,2024-02-21,110,Improved,Prior Authorization,Yes,No,,136,143,-4.8,Stable,99.56,237.39,-137.83,129.61,229.17,31.17,0.343,10,0.037,0.182,0.858,0.495,15,0,0,9,2.5,25.4,4,Similar,Midwest,GA,Urban,36-50,2024-06,Q2_2024,2023,1.4,0.441,Increasing
FIA001409,2024-06-13,Clopidogrel,Plavix,Antiplatelet Agents,35426-869-26,VA Plan,PLAN_8347,2024,Specialty Tier,Tier 2,2023-10-13,244,Worsened,Quantity Limit,No,No,30.0,505,785,-35.6,Decreased,226.54,44.97,181.57,98.65,325.19,164.22,0.0,0,0.058,0.248,0.644,0.607,0,4,4,9,2.4,23.3,3,Lower,Northeast,MI,Urban,51-65,2024-06,Q2_2024,2023,5.0,0.957,Decreasing
FIA001574,2024-06-15,Clopidogrel,Plavix,Antiplatelet Agents,53127-206-48,Medicaid Plan X,PLAN_5263,2024,Tier 2,Tier 2,2023-10-29,230,No Change,Quantity Limit,No,No,90.0,374,400,-6.4,Decreased,20.23,36.54,-16.31,172.14,192.37,71.95,0.0,0,0.063,0.169,0.39,0.413,12,2,0,12,3.6,14.3,7,Higher,Midwest,MI,Rural,18-35,2024-06,Q2_2024,2023,6.3,0.703,Increasing
FIA001589,2024-06-24,Clopidogrel,Plavix,Antiplatelet Agents,20576-405-31,Medicare Part D Plan A,PLAN_2658,2024,Non-Formulary,Tier 3,2024-05-13,42,Worsened,Non-Formulary Status,No,No,,233,215,8.4,Increased,260.85,94.36,166.49,186.56,447.41,104.25,0.0,0,0.066,0.134,0.785,0.849,9,3,17,5,3.6,27.9,2,Similar,Northeast,PA,Suburban,36-50,2024-06,Q2_2024,2023,3.8,0.533,Decreasing
FIA002916,2024-06-26,Clopidogrel,Plavix,Antiplatelet Agents,32864-390-24,Commercial Plan Alpha,PLAN_6246,2024,Tier 3,Tier 3,2023-10-24,246,No Change,Prior Authorization; Step Therapy,Yes,Yes,,123,137,-9.6,Decreased,69.18,72.78,-3.6,68.96,138.14,16.99,0.123,5,0.075,0.248,0.203,0.453,6,3,9,11,4.3,10.7,6,Lower,West,CA,Rural,75+,2024-06,Q2_2024,2023,5.4,0.458,Stable
FIA001111,2024-06-27,Clopidogrel,Plavix,Antiplatelet Agents,60282-926-11,Medicare Part D Plan B,PLAN_5665,2024,Tier 2,Tier 2,2024-02-12,136,No Change,Quantity Limit,No,No,,907,859,5.7,Increased,36.93,39.54,-2.61,158.62,195.55,177.36,0.0,0,0.063,0.104,0.522,0.628,3,8,10,7,3.2,26.2,5,Higher,Northeast,GA,Urban,18-35,2024-06,Q2_2024,2023,7.0,0.029,Increasing
FIA000672,2024-06-29,Clopidogrel,Plavix,Antiplatelet Agents,88684-311-36,Commercial Plan Beta,PLAN_6612,2024,Non-Formulary,Tier 1,2024-03-14,107,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,513,814,-36.9,Decreased,435.05,7.36,427.69,147.65,582.7,298.93,0.0,0,0.146,0.096,0.239,0.504,14,4,8,0,3.5,20.2,2,Similar,Southwest,CA,Rural,75+,2024-06,Q2_2024,2023,6.0,0.992,Increasing
FIA000817,2024-07-02,Clopidogrel,Plavix,Antiplatelet Agents,18476-567-71,Medicaid Plan Y,PLAN_7067,2024,Non-Formulary,Tier 1,2023-09-30,276,Worsened,Non-Formulary Status,No,No,,317,900,-64.7,Decreased,698.08,6.23,691.85,133.22,831.3,263.52,0.0,0,0.285,0.074,0.601,0.778,9,1,9,5,3.0,25.2,5,Similar,West,NC,Urban,75+,2024-07,Q3_2024,2023,7.8,0.76,Decreasing
FIA001908,2024-07-18,Clopidogrel,Plavix,Antiplatelet Agents,15673-758-56,VA Plan,PLAN_5239,2024,Non-Formulary,Tier 2,2024-03-03,137,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,96,280,-65.5,Decreased,270.73,49.44,221.29,146.89,417.62,40.09,0.0,0,0.176,0.265,0.207,0.504,8,0,10,11,3.3,27.0,8,Similar,Northeast,MI,Suburban,51-65,2024-07,Q3_2024,2023,7.3,0.776,Stable
FIA001406,2024-07-23,Clopidogrel,Plavix,Antiplatelet Agents,41349-357-53,Medicaid Plan X,PLAN_3106,2024,Tier 3,Tier 2,2024-03-17,128,Worsened,Prior Authorization,Yes,No,,390,711,-45.1,Decreased,97.83,49.9,47.93,162.14,259.97,101.39,0.246,5,0.015,0.217,0.81,0.816,2,5,10,5,4.6,33.5,6,Lower,West,IL,Urban,66-75,2024-07,Q3_2024,2023,1.8,0.604,Increasing
FIA001263,2024-07-24,Clopidogrel,Plavix,Antiplatelet Agents,73022-253-75,Commercial Plan Beta,PLAN_5846,2024,Specialty Tier,Specialty Tier,2023-07-31,359,No Change,Prior Authorization,Yes,No,,148,155,-4.1,Stable,246.29,275.63,-29.34,185.3,431.59,63.88,0.482,2,0.23,0.247,0.207,0.648,2,0,1,14,3.7,13.7,3,Higher,West,FL,Rural,75+,2024-07,Q3_2024,2023,3.2,0.379,Stable
FIA001942,2024-07-29,Clopidogrel,Plavix,Antiplatelet Agents,49821-450-73,Medicaid Plan X,PLAN_3288,2024,Non-Formulary,Specialty Tier,2023-10-20,283,Worsened,Non-Formulary Status,No,No,,785,804,-2.3,Stable,650.51,247.93,402.58,191.81,842.32,661.22,0.0,0,0.258,0.224,0.459,0.656,14,3,5,12,4.5,25.6,8,Similar,Southeast,GA,Urban,51-65,2024-07,Q3_2024,2023,3.8,0.569,Stable
FIA001777,2024-08-03,Clopidogrel,Plavix,Antiplatelet Agents,28528-892-43,Commercial Plan Beta,PLAN_7732,2024,Tier 2,Tier 1,2024-01-30,186,Worsened,None,No,No,,359,386,-6.8,Decreased,49.07,16.74,32.33,59.88,108.95,39.11,0.0,0,0.046,0.342,0.502,0.745,9,10,14,15,2.6,9.5,5,Lower,Midwest,MI,Rural,36-50,2024-08,Q3_2024,2023,6.4,0.649,Increasing
FIA000449,2024-08-10,Clopidogrel,Plavix,Antiplatelet Agents,42804-842-12,Medicare Part D Plan B,PLAN_2039,2024,Tier 1,Specialty Tier,2023-09-01,344,Improved,None,No,No,,1080,907,19.1,Increased,9.17,116.65,-107.48,122.7,131.87,142.42,0.0,0,0.066,0.107,0.439,0.687,6,7,20,11,2.1,30.6,8,Similar,Northeast,NC,Suburban,36-50,2024-08,Q3_2024,2023,2.5,0.621,Stable
FIA000348,2024-08-14,Clopidogrel,Plavix,Antiplatelet Agents,88766-445-71,VA Plan,PLAN_5918,2024,Tier 2,Tier 1,2023-12-04,254,Worsened,None,No,No,,715,689,3.9,Stable,44.28,11.85,32.43,152.97,197.25,141.03,0.0,0,0.027,0.064,0.85,0.529,3,6,13,8,4.9,17.0,2,Lower,West,FL,Suburban,75+,2024-08,Q3_2024,2023,9.7,0.943,Increasing
FIA000050,2024-09-07,Clopidogrel,Plavix,Antiplatelet Agents,26912-543-74,Medicare Part D Plan A,PLAN_3034,2024,Specialty Tier,Specialty Tier,2023-10-19,324,No Change,Prior Authorization; Quantity Limit,Yes,No,30.0,692,757,-8.5,Decreased,114.75,294.48,-179.73,60.93,175.68,121.57,0.49,5,0.21,0.108,0.426,0.79,11,8,9,2,2.8,24.1,6,Similar,Southeast,PA,Rural,75+,2024-09,Q3_2024,2023,1.8,0.641,Decreasing
FIA001529,2024-09-09,Clopidogrel,Plavix,Antiplatelet Agents,35817-313-47,Commercial Plan Alpha,PLAN_6748,2024,Specialty Tier,Tier 2,2023-09-22,353,Worsened,Quantity Limit,No,No,,386,718,-46.1,Decreased,171.98,23.42,148.56,35.18,207.16,79.96,0.0,0,0.199,0.239,0.525,0.949,4,6,20,13,2.6,7.6,2,Similar,Southwest,GA,Suburban,66-75,2024-09,Q3_2024,2023,8.3,0.538,Stable
FIA002309,2024-09-12,Clopidogrel,Plavix,Antiplatelet Agents,20291-993-60,Commercial Plan Alpha,PLAN_5609,2024,Tier 1,Tier 3,2024-06-16,88,Improved,None,No,No,,867,615,41.1,Increased,18.36,55.26,-36.9,195.95,214.31,185.81,0.0,0,0.036,0.353,0.616,0.907,11,5,7,15,2.1,19.3,6,Lower,Midwest,PA,Urban,36-50,2024-09,Q3_2024,2023,9.3,0.744,Increasing
FIA000382,2024-09-26,Clopidogrel,Plavix,Antiplatelet Agents,85448-197-25,Commercial Plan Beta,PLAN_6909,2024,Non-Formulary,Non-Formulary,2024-02-17,222,No Change,Non-Formulary Status,No,No,,764,783,-2.3,Stable,563.98,722.24,-158.26,192.19,756.17,577.71,0.0,0,0.248,0.253,0.697,0.732,12,0,11,14,4.6,22.2,6,Lower,Southwest,OH,Rural,18-35,2024-09,Q3_2024,2023,2.9,0.181,Decreasing
FIA001526,2024-10-02,Clopidogrel,Plavix,Antiplatelet Agents,76226-214-38,Commercial Plan Alpha,PLAN_3459,2024,Tier 3,Tier 3,2024-03-19,197,No Change,None,No,No,,533,495,7.7,Increased,74.21,84.68,-10.47,64.87,139.08,74.13,0.0,0,0.039,0.111,0.885,0.604,8,1,4,5,3.3,14.2,3,Higher,Midwest,CA,Rural,51-65,2024-10,Q4_2024,2024,8.5,0.315,Decreasing
FIA002452,2024-10-02,Clopidogrel,Plavix,Antiplatelet Agents,72517-366-95,Tricare Standard,PLAN_8439,2024,Tier 3,Tier 2,2024-02-28,217,Worsened,Prior Authorization,Yes,No,,110,190,-41.6,Decreased,55.88,40.99,14.89,179.17,235.05,25.86,0.138,6,0.05,0.343,0.818,0.611,14,9,15,1,3.3,16.4,6,Higher,West,IL,Suburban,18-35,2024-10,Q4_2024,2024,4.0,0.286,Increasing
FIA001031,2024-10-04,Clopidogrel,Plavix,Antiplatelet Agents,64845-363-44,Commercial Plan Alpha,PLAN_8100,2024,Tier 1,Tier 3,2024-07-18,78,Improved,None,No,No,,1290,810,59.4,Increased,19.14,51.15,-32.01,43.91,63.05,81.33,0.0,0,0.039,0.094,0.405,0.853,15,0,8,13,3.4,8.4,2,Lower,West,GA,Suburban,18-35,2024-10,Q4_2024,2024,3.1,0.157,Stable
FIA002663,2024-10-09,Clopidogrel,Plavix,Antiplatelet Agents,84262-108-23,Medicare Part D Plan B,PLAN_9040,2024,Tier 1,Tier 3,2024-04-03,189,Improved,None,No,No,,385,272,41.6,Increased,5.07,55.64,-50.57,187.98,193.05,74.32,0.0,0,0.052,0.299,0.301,0.895,15,3,2,8,3.0,6.2,3,Higher,Southeast,TX,Suburban,36-50,2024-10,Q4_2024,2024,2.9,0.364,Decreasing
FIA002958,2024-10-22,Clopidogrel,Plavix,Antiplatelet Agents,70837-624-78,VA Plan,PLAN_9920,2024,Tier 2,Tier 2,2024-04-11,194,No Change,None,No,No,,608,611,-0.4,Stable,22.8,31.91,-9.11,62.54,85.34,51.89,0.0,0,0.074,0.297,0.47,0.458,14,1,6,5,2.0,24.6,3,Lower,Southwest,GA,Suburban,36-50,2024-10,Q4_2024,2024,2.5,0.678,Stable
FIA000788,2024-11-25,Clopidogrel,Plavix,Antiplatelet Agents,43344-849-14,VA Plan,PLAN_6930,2024,Non-Formulary,Tier 2,2024-06-27,151,Worsened,Non-Formulary Status,No,No,,67,204,-67.0,Decreased,354.41,34.18,320.23,183.43,537.84,36.04,0.0,0,0.145,0.334,0.323,0.537,5,6,19,4,3.7,15.3,5,Similar,Southeast,IL,Urban,75+,2024-11,Q4_2024,2024,8.8,0.163,Decreasing
FIA002677,2024-11-30,Clopidogrel,Plavix,Antiplatelet Agents,96788-961-32,Medicaid Plan Y,PLAN_4960,2024,Tier 1,Tier 1,2024-01-06,329,No Change,None,No,No,,259,276,-5.9,Decreased,19.04,18.67,0.37,46.9,65.94,17.08,0.0,0,0.077,0.399,0.818,0.551,8,4,20,9,2.0,18.7,3,Lower,Northeast,TX,Urban,51-65,2024-11,Q4_2024,2024,6.3,0.892,Stable
FIA001392,2024-12-01,Clopidogrel,Plavix,Antiplatelet Agents,47870-862-95,VA Plan,PLAN_2227,2024,Tier 3,Tier 1,2024-04-10,235,Worsened,None,No,No,,219,610,-64.0,Decreased,69.93,13.44,56.49,163.29,233.22,51.08,0.0,0,0.03,0.202,0.653,0.469,5,7,14,4,3.3,5.6,4,Higher,Northeast,FL,Rural,66-75,2024-12,Q4_2024,2024,1.2,0.849,Decreasing
FIA000085,2024-12-07,Clopidogrel,Plavix,Antiplatelet Agents,44465-829-83,Medicare Part D Plan B,PLAN_9128,2024,Tier 3,Tier 2,2024-05-01,220,Worsened,Step Therapy,No,Yes,,162,375,-56.6,Decreased,56.35,43.43,12.92,119.06,175.41,28.42,0.0,0,0.04,0.209,0.452,0.675,5,5,5,8,4.3,31.8,7,Higher,Northeast,NY,Rural,75+,2024-12,Q4_2024,2024,1.0,0.859,Increasing
FIA002344,2024-12-11,Clopidogrel,Plavix,Antiplatelet Agents,82013-250-15,Medicaid Plan Y,PLAN_5999,2024,Tier 1,Specialty Tier,2024-07-29,135,Improved,None,No,No,,888,591,50.3,Increased,10.25,267.76,-257.51,136.67,146.92,130.46,0.0,0,0.045,0.083,0.528,0.873,5,8,5,3,2.5,7.5,4,Lower,Northeast,OH,Rural,51-65,2024-12,Q4_2024,2024,9.3,0.643,Increasing
FIA001952,2025-01-06,Clopidogrel,Plavix,Antiplatelet Agents,41381-447-86,Medicare Part D Plan B,PLAN_3608,2025,Tier 1,Specialty Tier,2024-06-28,192,Improved,None,No,No,,887,679,30.7,Increased,16.28,112.84,-96.56,121.71,137.99,122.4,0.0,0,0.078,0.214,0.813,0.928,5,4,15,1,3.1,28.0,7,Lower,Midwest,GA,Suburban,18-35,2025-01,Q1_2025,2024,8.2,0.759,Decreasing
FIA001819,2025-01-12,Clopidogrel,Plavix,Antiplatelet Agents,98780-490-84,Commercial Plan Beta,PLAN_5066,2025,Tier 3,Non-Formulary,2024-05-20,237,Improved,None,No,No,,380,369,3.0,Stable,86.53,455.71,-369.18,38.47,125.0,47.5,0.0,0,0.072,0.323,0.432,0.667,1,1,10,11,4.9,20.9,2,Similar,Southeast,MI,Suburban,75+,2025-01,Q1_2025,2024,3.6,0.272,Increasing
FIA001247,2025-02-06,Clopidogrel,Plavix,Antiplatelet Agents,23346-230-12,Medicare Part D Plan A,PLAN_9070,2025,Specialty Tier,Tier 3,2025-01-01,36,Worsened,Prior Authorization,Yes,No,,1010,986,2.4,Stable,243.91,56.1,187.81,169.69,413.6,417.74,0.112,5,0.237,0.271,0.229,0.551,11,1,10,13,3.7,32.4,3,Lower,Southeast,GA,Suburban,75+,2025-02,Q1_2025,2024,2.3,0.774,Decreasing
FIA002690,2025-02-09,Clopidogrel,Plavix,Antiplatelet Agents,20373-713-46,Medicare Part D Plan A,PLAN_7810,2025,Non-Formulary,Tier 3,2024-06-05,249,Worsened,Non-Formulary Status,No,No,,482,517,-6.6,Decreased,252.78,51.02,201.76,84.49,337.27,162.56,0.0,0,0.214,0.363,0.637,0.542,10,0,11,10,3.1,9.6,5,Similar,Midwest,MI,Urban,36-50,2025-02,Q1_2025,2024,6.0,0.116,Decreasing
FIA000071,2025-02-10,Clopidogrel,Plavix,Antiplatelet Agents,83339-348-83,Commercial Plan Alpha,PLAN_7237,2025,Specialty Tier,Tier 1,2024-12-29,43,Worsened,None,No,No,,356,711,-49.9,Decreased,117.92,13.31,104.61,44.4,162.32,57.79,0.0,0,0.147,0.109,0.388,0.548,4,1,5,13,2.8,14.0,8,Lower,Midwest,PA,Urban,66-75,2025-02,Q1_2025,2024,6.3,0.196,Increasing
FIA001455,2025-02-16,Clopidogrel,Plavix,Antiplatelet Agents,63161-777-42,Medicaid Plan X,PLAN_1672,2025,Tier 3,Specialty Tier,2024-07-26,205,Improved,Prior Authorization,Yes,No,,325,312,4.3,Stable,53.31,283.78,-230.47,165.09,218.4,70.98,0.204,4,0.018,0.178,0.721,0.534,9,1,15,15,4.2,23.8,3,Lower,Midwest,NY,Rural,18-35,2025-02,Q1_2025,2024,9.6,0.704,Stable
FIA001299,2025-03-04,Clopidogrel,Plavix,Antiplatelet Agents,35966-528-10,Tricare Standard,PLAN_5843,2025,Tier 2,Tier 3,2024-08-21,195,Improved,None,No,No,,543,370,46.9,Increased,21.7,76.08,-54.38,55.65,77.35,42.0,0.0,0,0.041,0.089,0.241,0.635,5,2,11,5,3.0,32.2,3,Higher,Northeast,NY,Suburban,18-35,2025-03,Q1_2025,2024,5.1,0.186,Increasing
FIA001576,2025-03-14,Clopidogrel,Plavix,Antiplatelet Agents,87581-318-97,VA Plan,PLAN_3930,2025,Tier 1,Tier 2,2024-05-22,296,Improved,None,No,No,,389,370,5.2,Increased,9.21,48.55,-39.34,144.61,153.82,59.84,0.0,0,0.039,0.146,0.241,0.808,10,1,20,13,2.7,12.2,2,Lower,Southwest,CA,Rural,51-65,2025-03,Q1_2025,2024,5.3,0.665,Increasing
FIA002525,2025-03-20,Clopidogrel,Plavix,Antiplatelet Agents,25685-337-10,Commercial Plan Beta,PLAN_8945,2025,Specialty Tier,Specialty Tier,2024-04-08,346,No Change,Prior Authorization; Step Therapy,Yes,Yes,,107,111,-2.8,Stable,230.04,131.99,98.05,180.37,410.41,43.91,0.335,4,0.25,0.103,0.773,0.66,5,9,2,9,2.2,10.5,3,Similar,West,CA,Rural,18-35,2025-03,Q1_2025,2024,3.6,0.398,Decreasing
FIA001695,2025-03-22,Clopidogrel,Plavix,Antiplatelet Agents,52328-400-50,Tricare Standard,PLAN_5672,2025,Non-Formulary,Non-Formulary,2024-07-07,258,No Change,Non-Formulary Status,No,No,,550,586,-6.1,Decreased,371.5,381.65,-10.15,199.0,570.5,313.77,0.0,0,0.21,0.363,0.847,0.654,12,0,16,10,4.2,21.6,6,Higher,Southeast,PA,Rural,51-65,2025-03,Q1_2025,2024,8.8,0.284,Decreasing
FIA000564,2025-03-27,Clopidogrel,Plavix,Antiplatelet Agents,50470-307-24,Medicare Part D Plan B,PLAN_7262,2025,Non-Formulary,Non-Formulary,2024-06-27,273,No Change,Non-Formulary Status; Quantity Limit,No,No,60.0,365,342,6.8,Increased,589.25,452.21,137.04,183.02,772.27,281.88,0.0,0,0.221,0.158,0.222,0.682,10,2,7,3,2.4,9.8,6,Lower,Midwest,CA,Suburban,66-75,2025-03,Q1_2025,2024,8.3,0.272,Stable
FIA001479,2025-03-30,Clopidogrel,Plavix,Antiplatelet Agents,83437-340-46,Commercial Plan Alpha,PLAN_1033,2025,Tier 1,Non-Formulary,2024-12-28,92,Improved,None,No,No,,1023,716,42.9,Increased,18.68,679.4,-660.72,169.04,187.72,192.04,0.0,0,0.018,0.194,0.333,0.762,10,5,6,9,2.6,13.5,7,Similar,Northeast,MI,Suburban,36-50,2025-03,Q1_2025,2024,6.6,0.27,Decreasing
FIA001335,2025-04-02,Clopidogrel,Plavix,Antiplatelet Agents,16159-573-46,Commercial Plan Beta,PLAN_1341,2025,Tier 1,Tier 2,2025-02-14,47,Improved,None,No,No,,841,778,8.1,Increased,12.28,46.58,-34.3,129.52,141.8,119.25,0.0,0,0.066,0.271,0.778,0.906,8,7,15,6,3.8,6.2,4,Higher,Midwest,PA,Urban,66-75,2025-04,Q2_2025,2024,3.1,0.101,Stable
FIA001108,2025-04-05,Clopidogrel,Plavix,Antiplatelet Agents,55224-748-98,Commercial Plan Beta,PLAN_2763,2025,Tier 3,Tier 3,2025-03-01,35,No Change,Prior Authorization; Quantity Limit,Yes,No,30.0,616,603,2.2,Stable,59.62,98.86,-39.24,91.41,151.03,93.03,0.115,3,0.026,0.299,0.718,0.469,14,5,13,14,4.5,22.5,4,Lower,Southeast,CA,Suburban,66-75,2025-04,Q2_2025,2024,5.5,0.555,Stable
FIA001919,2025-04-08,Clopidogrel,Plavix,Antiplatelet Agents,88638-712-28,Tricare Standard,PLAN_4767,2025,Specialty Tier,Tier 3,2024-06-11,301,Worsened,None,No,No,,896,838,7.0,Increased,241.68,62.65,179.03,66.64,308.32,276.25,0.0,0,0.067,0.168,0.397,0.875,8,10,8,10,4.4,21.2,7,Higher,Northeast,IL,Rural,66-75,2025-04,Q2_2025,2024,9.2,0.202,Increasing
FIA000102,2025-04-16,Clopidogrel,Plavix,Antiplatelet Agents,39012-762-38,Commercial Plan Beta,PLAN_5408,2025,Tier 3,Tier 3,2024-12-24,113,No Change,Quantity Limit,No,No,90.0,985,950,3.8,Stable,91.88,62.93,28.95,66.43,158.31,155.94,0.0,0,0.065,0.23,0.805,0.932,0,7,4,5,3.8,5.3,4,Higher,Midwest,PA,Suburban,66-75,2025-04,Q2_2025,2024,8.7,0.459,Increasing
FIA001602,2025-04-21,Clopidogrel,Plavix,Antiplatelet Agents,20258-315-59,Medicaid Plan X,PLAN_1525,2025,Tier 1,Tier 1,2025-01-08,103,No Change,Quantity Limit,No,No,60.0,794,869,-8.5,Decreased,7.08,7.73,-0.65,116.33,123.41,97.99,0.0,0,0.055,0.152,0.276,0.613,10,2,7,15,2.0,28.0,8,Similar,Southwest,GA,Suburban,18-35,2025-04,Q2_2025,2024,6.5,0.751,Increasing
FIA000699,2025-04-22,Clopidogrel,Plavix,Antiplatelet Agents,49818-722-68,Medicare Part D Plan A,PLAN_4974,2025,Tier 2,Specialty Tier,2024-06-13,313,Improved,None,No,No,,593,381,55.7,Increased,38.2,146.19,-107.99,104.23,142.43,84.46,0.0,0,0.075,0.3,0.231,0.67,14,8,19,13,4.6,28.5,8,Lower,Southeast,IL,Suburban,66-75,2025-04,Q2_2025,2024,1.1,0.487,Increasing
FIA002002,2025-04-24,Clopidogrel,Plavix,Antiplatelet Agents,48674-792-45,Commercial Plan Alpha,PLAN_3568,2025,Tier 1,Tier 3,2024-12-27,118,Improved,None,No,No,,673,478,40.9,Increased,14.78,55.78,-41.0,188.92,203.7,137.09,0.0,0,0.027,0.367,0.387,0.839,14,6,20,3,3.2,17.3,2,Lower,West,IL,Suburban,18-35,2025-04,Q2_2025,2024,7.7,0.094,Increasing
FIA002265,2025-05-04,Clopidogrel,Plavix,Antiplatelet Agents,14060-743-42,VA Plan,PLAN_5064,2025,Tier 3,Tier 2,2024-09-24,222,Worsened,Prior Authorization,Yes,No,,386,509,-24.1,Decreased,61.63,28.3,33.33,62.81,124.44,48.03,0.337,9,0.079,0.299,0.25,0.939,15,0,14,15,2.1,30.9,3,Lower,Northeast,PA,Urban,18-35,2025-05,Q2_2025,2024,5.6,0.911,Decreasing
FIA000045,2025-05-07,Clopidogrel,Plavix,Antiplatelet Agents,97584-187-77,Medicaid Plan Y,PLAN_2108,2025,Tier 1,Non-Formulary,2024-06-17,324,Improved,None,No,No,,620,539,15.1,Increased,8.63,286.15,-277.52,61.84,70.47,43.69,0.0,0,0.05,0.384,0.581,0.833,0,6,15,1,3.9,34.4,4,Higher,Northeast,IL,Urban,51-65,2025-05,Q2_2025,2024,3.2,0.657,Increasing
FIA001599,2025-05-15,Clopidogrel,Plavix,Antiplatelet Agents,94566-321-29,Commercial Plan Alpha,PLAN_4750,2025,Tier 1,Tier 1,2024-07-16,303,No Change,None,No,No,,448,422,6.3,Increased,8.81,19.61,-10.8,71.92,80.73,36.17,0.0,0,0.058,0.359,0.248,0.47,2,8,20,7,3.2,22.4,7,Similar,West,NC,Urban,51-65,2025-05,Q2_2025,2024,6.3,0.641,Decreasing
FIA002041,2025-05-16,Clopidogrel,Plavix,Antiplatelet Agents,90047-659-80,Tricare Standard,PLAN_2237,2025,Tier 2,Tier 2,2025-02-27,78,No Change,None,No,No,,859,926,-7.2,Decreased,24.3,29.78,-5.48,105.58,129.88,111.57,0.0,0,0.014,0.365,0.449,0.688,1,4,7,1,2.2,33.0,5,Similar,Midwest,NC,Rural,18-35,2025-05,Q2_2025,2024,3.8,0.209,Increasing
FIA000617,2025-05-22,Clopidogrel,Plavix,Antiplatelet Agents,52459-880-40,Medicaid Plan X,PLAN_7764,2025,Tier 3,Tier 3,2024-11-05,198,No Change,Quantity Limit,No,No,90.0,888,924,-3.8,Stable,75.06,87.96,-12.9,91.71,166.77,148.09,0.0,0,0.011,0.06,0.425,0.919,8,4,18,8,4.6,18.0,3,Higher,Northeast,TX,Urban,75+,2025-05,Q2_2025,2024,2.2,0.881,Decreasing
FIA002073,2025-05-23,Clopidogrel,Plavix,Antiplatelet Agents,63194-478-40,Medicare Part D Plan A,PLAN_3940,2025,Tier 3,Tier 2,2025-03-12,72,Worsened,Prior Authorization,Yes,No,,264,596,-55.5,Decreased,94.08,25.14,68.94,189.37,283.45,74.83,0.253,1,0.035,0.059,0.576,0.623,11,10,5,6,2.5,14.1,8,Lower,Midwest,FL,Urban,51-65,2025-05,Q2_2025,2024,5.2,0.825,Stable
FIA002645,2025-05-24,Clopidogrel,Plavix,Antiplatelet Agents,84503-546-58,Medicaid Plan Y,PLAN_4150,2025,Specialty Tier,Non-Formulary,2024-08-21,276,Improved,Step Therapy,No,Yes,,220,223,-1.3,Stable,235.15,527.08,-291.93,156.24,391.39,86.11,0.0,0,0.185,0.276,0.831,0.66,12,3,1,14,2.5,21.3,3,Similar,Midwest,GA,Rural,36-50,2025-05,Q2_2025,2024,2.0,0.96,Increasing
FIA000741,2025-06-05,Clopidogrel,Plavix,Antiplatelet Agents,17353-681-99,Medicaid Plan X,PLAN_6188,2025,Tier 2,Tier 1,2024-12-08,179,Worsened,None,No,No,,260,247,5.5,Increased,33.58,15.21,18.37,56.53,90.11,23.43,0.0,0,0.061,0.072,0.846,0.669,14,0,12,6,3.2,11.6,3,Higher,Southwest,NY,Urban,18-35,2025-06,Q2_2025,2024,1.6,0.138,Increasing
FIA000887,2025-06-13,Clopidogrel,Plavix,Antiplatelet Agents,10533-581-40,Tricare Standard,PLAN_5662,2025,Specialty Tier,Non-Formulary,2024-06-15,363,Improved,None,No,No,,384,364,5.5,Increased,120.98,663.78,-542.8,31.45,152.43,58.53,0.0,0,0.274,0.265,0.886,0.867,9,4,10,14,4.1,24.3,4,Similar,Midwest,TX,Urban,66-75,2025-06,Q2_2025,2024,4.6,0.906,Increasing
FIA001148,2025-06-14,Clopidogrel,Plavix,Antiplatelet Agents,82588-782-92,Medicare Part D Plan B,PLAN_3224,2025,Non-Formulary,Tier 3,2025-04-23,52,Worsened,Non-Formulary Status,No,No,,1093,1000,9.3,Increased,664.64,77.78,586.86,191.23,855.87,935.47,0.0,0,0.242,0.363,0.561,0.668,7,0,0,0,3.0,21.3,6,Higher,Northeast,IL,Rural,75+,2025-06,Q2_2025,2024,1.4,0.121,Increasing
FIA001089,2025-06-17,Clopidogrel,Plavix,Antiplatelet Agents,18081-762-18,Medicaid Plan X,PLAN_2388,2025,Tier 3,Tier 2,2024-11-09,220,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,210,504,-58.1,Decreased,51.83,33.86,17.97,57.87,109.7,23.04,0.326,5,0.071,0.343,0.295,0.616,15,3,15,5,2.7,30.3,5,Lower,Midwest,MI,Suburban,36-50,2025-06,Q2_2025,2024,5.7,0.927,Stable
FIA002807,2025-06-19,Clopidogrel,Plavix,Antiplatelet Agents,28068-216-98,Medicaid Plan X,PLAN_8453,2025,Specialty Tier,Tier 2,2024-12-18,183,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,403,825,-51.1,Decreased,275.49,31.95,243.54,88.07,363.56,146.51,0.149,10,0.244,0.325,0.625,0.509,13,9,6,6,4.5,6.1,3,Higher,Midwest,PA,Suburban,36-50,2025-06,Q2_2025,2024,5.7,0.834,Decreasing
FIA002200,2025-06-29,Clopidogrel,Plavix,Antiplatelet Agents,37370-283-49,VA Plan,PLAN_1849,2025,Tier 3,Non-Formulary,2025-04-07,83,Improved,Step Therapy,No,Yes,,940,891,5.6,Increased,89.35,475.12,-385.77,176.37,265.72,249.78,0.0,0,0.046,0.273,0.799,0.733,3,10,16,0,3.6,15.5,3,Lower,Southwest,CA,Rural,75+,2025-06,Q2_2025,2024,7.4,0.61,Decreasing
FIA002641,2025-06-30,Clopidogrel,Plavix,Antiplatelet Agents,83263-701-39,Medicare Part D Plan A,PLAN_9762,2025,Non-Formulary,Tier 1,2025-04-30,61,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,105,205,-48.6,Decreased,246.19,6.1,240.09,122.02,368.21,38.66,0.0,0,0.141,0.085,0.506,0.439,1,8,15,15,3.8,21.6,2,Higher,Southwest,PA,Suburban,66-75,2025-06,Q2_2025,2024,3.2,0.469,Decreasing
FIA000956,2025-07-08,Clopidogrel,Plavix,Antiplatelet Agents,78738-745-61,Medicare Part D Plan B,PLAN_8690,2025,Tier 3,Specialty Tier,2024-11-13,237,Improved,Quantity Limit,No,No,60.0,1019,999,2.0,Stable,87.64,220.96,-133.32,114.21,201.85,205.69,0.0,0,0.078,0.285,0.463,0.685,0,2,12,4,3.8,18.4,5,Lower,Northeast,OH,Suburban,36-50,2025-07,Q3_2025,2024,7.9,0.54,Stable
FIA000228,2025-07-26,Clopidogrel,Plavix,Antiplatelet Agents,70902-949-89,Medicaid Plan X,PLAN_3742,2025,Tier 2,Tier 2,2024-12-17,221,No Change,Quantity Limit,No,No,,353,351,0.8,Stable,36.21,25.05,11.16,37.1,73.31,25.88,0.0,0,0.049,0.071,0.845,0.55,8,10,12,11,4.5,11.4,8,Higher,Midwest,CA,Urban,75+,2025-07,Q3_2025,2024,6.1,0.301,Stable
FIA001922,2025-08-03,Clopidogrel,Plavix,Antiplatelet Agents,52905-881-39,Medicare Part D Plan B,PLAN_1820,2025,Specialty Tier,Tier 1,2024-12-22,224,Worsened,Prior Authorization,Yes,No,,233,561,-58.3,Decreased,200.84,12.96,187.88,98.23,299.07,69.68,0.171,8,0.113,0.189,0.609,0.431,0,0,18,12,2.1,22.2,5,Similar,Midwest,NY,Rural,51-65,2025-08,Q3_2025,2024,9.9,0.586,Increasing
FIA002911,2025-08-10,Clopidogrel,Plavix,Antiplatelet Agents,49646-220-39,Commercial Plan Beta,PLAN_9401,2025,Specialty Tier,Tier 2,2025-02-05,186,Worsened,Prior Authorization,Yes,No,,91,156,-41.5,Decreased,217.82,44.71,173.11,145.0,362.82,33.02,0.42,6,0.102,0.061,0.35,0.712,0,3,10,9,4.5,32.5,8,Similar,Southwest,IL,Urban,51-65,2025-08,Q3_2025,2024,7.4,0.013,Stable
FIA000746,2025-08-11,Clopidogrel,Plavix,Antiplatelet Agents,85825-771-85,Commercial Plan Alpha,PLAN_5625,2025,Tier 1,Non-Formulary,2025-01-15,208,Improved,None,No,No,,353,253,39.5,Increased,11.33,463.84,-452.51,197.86,209.19,73.84,0.0,0,0.077,0.106,0.48,0.478,14,7,10,1,2.2,14.9,8,Similar,Southwest,OH,Rural,66-75,2025-08,Q3_2025,2024,6.4,0.208,Increasing
FIA000532,2025-08-13,Clopidogrel,Plavix,Antiplatelet Agents,53813-624-85,Medicare Part D Plan B,PLAN_8360,2025,Tier 2,Tier 3,2025-05-28,77,Improved,None,No,No,,324,241,34.6,Increased,38.26,79.61,-41.35,190.31,228.57,74.06,0.0,0,0.02,0.069,0.695,0.948,8,5,8,4,2.3,21.6,7,Similar,Midwest,GA,Urban,51-65,2025-08,Q3_2025,2024,4.9,0.506,Increasing
FIA000917,2025-08-14,Clopidogrel,Plavix,Antiplatelet Agents,48718-827-47,Medicaid Plan Y,PLAN_3440,2025,Tier 2,Tier 1,2024-12-26,231,Worsened,None,No,No,,171,168,2.2,Stable,39.5,6.44,33.06,93.62,133.12,22.76,0.0,0,0.068,0.071,0.343,0.834,4,7,20,12,4.3,31.5,5,Lower,Northeast,NC,Rural,75+,2025-08,Q3_2025,2024,2.3,0.951,Increasing
FIA001185,2025-08-19,Clopidogrel,Plavix,Antiplatelet Agents,46404-276-58,Medicare Part D Plan B,PLAN_5342,2025,Non-Formulary,Specialty Tier,2025-05-20,91,Worsened,Non-Formulary Status,No,No,,298,325,-8.2,Decreased,479.75,146.31,333.44,102.13,581.88,173.4,0.0,0,0.074,0.342,0.739,0.646,13,5,1,8,2.8,8.1,3,Similar,Midwest,PA,Suburban,75+,2025-08,Q3_2025,2024,7.7,0.143,Stable
FIA002627,2025-08-26,Clopidogrel,Plavix,Antiplatelet Agents,38704-146-24,Medicare Part D Plan B,PLAN_7723,2025,Specialty Tier,Tier 1,2025-03-13,166,Worsened,Quantity Limit,No,No,,106,168,-36.5,Decreased,181.23,18.42,162.81,156.81,338.04,35.83,0.0,0,0.176,0.379,0.396,0.611,12,8,2,7,3.0,26.7,5,Higher,Southwest,NY,Urban,18-35,2025-08,Q3_2025,2024,6.1,0.44,Decreasing
FIA001976,2025-08-28,Clopidogrel,Plavix,Antiplatelet Agents,82226-412-24,Medicare Part D Plan A,PLAN_4977,2025,Tier 2,Tier 2,2025-04-05,145,No Change,None,No,No,,913,890,2.6,Stable,26.97,31.86,-4.89,86.99,113.96,104.05,0.0,0,0.019,0.305,0.258,0.892,14,3,4,0,4.8,24.1,3,Lower,Northeast,TX,Suburban,36-50,2025-08,Q3_2025,2024,9.7,0.54,Increasing
FIA002731,2025-08-31,Clopidogrel,Plavix,Antiplatelet Agents,95292-784-74,Medicare Part D Plan A,PLAN_9015,2025,Non-Formulary,Specialty Tier,2025-07-11,51,Worsened,Non-Formulary Status,No,No,,672,689,-2.4,Stable,559.76,243.69,316.07,173.53,733.29,492.77,0.0,0,0.063,0.135,0.232,0.451,6,4,16,9,2.4,28.5,7,Higher,Northeast,PA,Rural,75+,2025-08,Q3_2025,2024,5.5,0.226,Decreasing
FIA001705,2022-01-15,Gabapentin,Neurontin,Anticonvulsants,61728-880-30,Commercial Plan Alpha,PLAN_6526,2022,Specialty Tier,Specialty Tier,2021-10-11,96,No Change,None,No,No,,266,274,-2.8,Stable,192.43,149.73,42.7,69.82,262.25,69.76,0.0,0,0.104,0.07,0.81,0.515,6,7,7,4,4.7,12.0,2,Lower,Midwest,OH,Suburban,66-75,2022-01,Q1_2022,2021,5.3,0.927,Increasing
FIA002947,2022-02-06,Gabapentin,Neurontin,Anticonvulsants,87445-722-76,Commercial Plan Beta,PLAN_3175,2022,Non-Formulary,Tier 1,2021-08-27,163,Worsened,Non-Formulary Status,No,No,,277,383,-27.6,Decreased,413.45,14.37,399.08,85.31,498.76,138.16,0.0,0,0.103,0.1,0.806,0.703,14,3,17,12,3.3,6.9,8,Lower,Northeast,CA,Suburban,75+,2022-02,Q1_2022,2021,3.8,0.725,Increasing
FIA001147,2022-02-10,Gabapentin,Neurontin,Anticonvulsants,59375-178-50,Commercial Plan Alpha,PLAN_8070,2022,Tier 1,Non-Formulary,2021-05-04,282,Improved,None,No,No,,474,302,57.2,Increased,11.35,295.7,-284.35,77.13,88.48,41.94,0.0,0,0.016,0.32,0.374,0.847,4,10,8,14,2.1,25.3,2,Lower,Northeast,PA,Rural,18-35,2022-02,Q1_2022,2021,2.5,0.721,Increasing
FIA000606,2022-02-13,Gabapentin,Neurontin,Anticonvulsants,78513-166-74,Tricare Standard,PLAN_4367,2022,Specialty Tier,Non-Formulary,2021-04-03,316,Improved,Prior Authorization; Step Therapy,Yes,Yes,,854,875,-2.3,Stable,297.02,673.3,-376.28,115.66,412.68,352.43,0.253,9,0.102,0.214,0.656,0.598,7,3,6,12,2.9,19.2,2,Similar,Northeast,NY,Rural,18-35,2022-02,Q1_2022,2021,6.4,0.623,Increasing
FIA000725,2022-02-16,Gabapentin,Neurontin,Anticonvulsants,65178-981-33,Medicaid Plan X,PLAN_1663,2022,Tier 1,Tier 1,2021-08-20,180,No Change,None,No,No,,351,381,-7.8,Decreased,17.89,14.81,3.08,116.57,134.46,47.2,0.0,0,0.067,0.326,0.558,0.828,3,0,0,13,3.2,23.0,7,Similar,Northeast,GA,Urban,75+,2022-02,Q1_2022,2021,2.3,0.472,Increasing
FIA000296,2022-02-17,Gabapentin,Neurontin,Anticonvulsants,57369-958-36,VA Plan,PLAN_2649,2022,Non-Formulary,Tier 1,2021-11-23,86,Worsened,Non-Formulary Status,No,No,,152,209,-27.1,Decreased,475.48,13.94,461.54,43.15,518.63,78.83,0.0,0,0.095,0.222,0.215,0.44,2,3,13,12,4.7,24.0,5,Lower,Southeast,PA,Urban,36-50,2022-02,Q1_2022,2021,6.9,0.631,Increasing
FIA000488,2022-03-04,Gabapentin,Neurontin,Anticonvulsants,70383-707-60,Commercial Plan Beta,PLAN_3299,2022,Tier 1,Tier 2,2021-09-12,173,Improved,None,No,No,,836,864,-3.1,Stable,18.5,25.28,-6.78,119.01,137.51,114.96,0.0,0,0.023,0.174,0.771,0.562,7,10,4,8,4.4,29.9,3,Lower,West,MI,Urban,51-65,2022-03,Q1_2022,2021,4.6,0.261,Decreasing
FIA002237,2022-03-06,Gabapentin,Neurontin,Anticonvulsants,17753-723-47,Commercial Plan Beta,PLAN_9612,2022,Specialty Tier,Tier 2,2021-09-14,173,Worsened,None,No,No,,161,382,-57.8,Decreased,117.53,24.65,92.88,64.14,181.67,29.25,0.0,0,0.08,0.069,0.728,0.876,15,5,6,14,4.9,8.2,3,Higher,Southwest,CA,Urban,36-50,2022-03,Q1_2022,2021,9.7,0.424,Decreasing
FIA001370,2022-03-21,Gabapentin,Neurontin,Anticonvulsants,62336-344-98,Medicare Part D Plan B,PLAN_2720,2022,Specialty Tier,Tier 3,2021-05-22,303,Worsened,None,No,No,,652,608,7.3,Increased,286.66,93.38,193.28,33.08,319.74,208.47,0.0,0,0.113,0.354,0.779,0.869,15,1,7,12,4.3,15.2,2,Higher,Northeast,PA,Rural,36-50,2022-03,Q1_2022,2021,8.5,0.976,Increasing
FIA002175,2022-03-30,Gabapentin,Neurontin,Anticonvulsants,48947-284-95,VA Plan,PLAN_5763,2022,Tier 2,Tier 3,2021-09-18,193,Improved,None,No,No,,1008,677,49.0,Increased,21.97,52.35,-30.38,59.32,81.29,81.94,0.0,0,0.037,0.275,0.549,0.67,15,0,6,9,3.0,10.2,4,Similar,Midwest,FL,Suburban,51-65,2022-03,Q1_2022,2021,2.4,0.853,Stable
FIA001741,2022-04-01,Gabapentin,Neurontin,Anticonvulsants,80173-779-14,Medicaid Plan X,PLAN_2032,2022,Tier 3,Non-Formulary,2022-01-20,71,Improved,Step Therapy,No,Yes,,685,625,9.7,Increased,75.04,416.19,-341.15,91.31,166.35,113.95,0.0,0,0.052,0.388,0.658,0.821,7,7,6,7,2.6,10.3,8,Higher,Southeast,NC,Suburban,51-65,2022-04,Q2_2022,2021,4.0,0.776,Stable
FIA001114,2022-04-10,Gabapentin,Neurontin,Anticonvulsants,71190-887-11,Medicare Part D Plan A,PLAN_1419,2022,Tier 1,Non-Formulary,2021-09-25,197,Improved,None,No,No,,1153,969,19.1,Increased,12.74,383.51,-370.77,83.63,96.37,111.11,0.0,0,0.019,0.075,0.606,0.431,1,7,6,10,2.8,18.2,8,Higher,Southeast,PA,Rural,66-75,2022-04,Q2_2022,2021,3.5,0.845,Decreasing
FIA000576,2022-04-13,Gabapentin,Neurontin,Anticonvulsants,23574-701-89,Medicaid Plan X,PLAN_6815,2022,Tier 1,Specialty Tier,2022-02-17,55,Improved,None,No,No,,944,810,16.6,Increased,17.94,196.95,-179.01,55.68,73.62,69.5,0.0,0,0.026,0.112,0.423,0.887,3,7,3,5,2.5,32.2,5,Higher,Midwest,NY,Urban,75+,2022-04,Q2_2022,2021,5.1,0.164,Stable
FIA001828,2022-04-23,Gabapentin,Neurontin,Anticonvulsants,87093-784-74,Medicare Part D Plan B,PLAN_3502,2022,Tier 3,Specialty Tier,2021-06-12,315,Improved,None,No,No,,721,787,-8.3,Decreased,86.18,269.85,-183.67,80.08,166.26,119.87,0.0,0,0.047,0.184,0.365,0.692,4,7,19,9,2.3,15.5,8,Similar,Northeast,MI,Suburban,36-50,2022-04,Q2_2022,2021,8.9,0.211,Increasing
FIA002576,2022-04-26,Gabapentin,Neurontin,Anticonvulsants,21757-860-88,Tricare Standard,PLAN_3556,2022,Tier 3,Non-Formulary,2021-11-19,158,Improved,None,No,No,,634,584,8.6,Increased,91.84,699.98,-608.14,193.0,284.84,180.59,0.0,0,0.056,0.368,0.557,0.682,1,2,0,5,2.1,28.1,7,Higher,Southwest,PA,Suburban,18-35,2022-04,Q2_2022,2021,9.4,0.964,Decreasing
FIA000335,2022-05-10,Gabapentin,Neurontin,Anticonvulsants,31155-482-52,VA Plan,PLAN_4532,2022,Tier 1,Non-Formulary,2021-12-24,137,Improved,None,No,No,,397,260,52.7,Increased,10.43,319.06,-308.63,79.33,89.76,35.63,0.0,0,0.06,0.244,0.374,0.408,0,8,3,12,4.4,6.3,4,Similar,Northeast,NY,Rural,36-50,2022-05,Q2_2022,2021,1.3,0.75,Stable
FIA002070,2022-06-01,Gabapentin,Neurontin,Anticonvulsants,93923-945-37,Medicare Part D Plan A,PLAN_9842,2022,Tier 1,Tier 3,2022-01-20,132,Improved,None,No,No,,589,472,25.0,Increased,15.95,65.46,-49.51,61.06,77.01,45.36,0.0,0,0.03,0.073,0.235,0.799,7,4,11,12,3.1,31.1,6,Higher,Northeast,GA,Rural,36-50,2022-06,Q2_2022,2021,4.5,0.83,Decreasing
FIA001162,2022-06-03,Gabapentin,Neurontin,Anticonvulsants,61685-502-62,Tricare Standard,PLAN_5472,2022,Tier 2,Non-Formulary,2022-04-19,45,Improved,None,No,No,,1238,776,59.6,Increased,48.67,447.76,-399.09,74.91,123.58,152.99,0.0,0,0.044,0.216,0.756,0.894,2,7,3,5,2.9,11.9,5,Similar,West,NY,Rural,18-35,2022-06,Q2_2022,2021,3.0,0.348,Increasing
FIA002741,2022-06-06,Gabapentin,Neurontin,Anticonvulsants,59514-465-54,Medicare Part D Plan B,PLAN_6177,2022,Tier 3,Tier 3,2021-07-01,340,No Change,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,,600,637,-5.8,Decreased,75.84,87.21,-11.37,176.29,252.13,151.28,0.175,10,0.023,0.1,0.65,0.829,8,1,0,13,3.5,20.4,6,Higher,Southeast,PA,Suburban,36-50,2022-06,Q2_2022,2021,9.5,0.693,Increasing
FIA001453,2022-06-07,Gabapentin,Neurontin,Anticonvulsants,73919-273-39,Medicaid Plan X,PLAN_7686,2022,Tier 1,Non-Formulary,2022-04-24,44,Improved,Quantity Limit,No,No,,1341,884,51.8,Increased,10.93,593.35,-582.42,78.1,89.03,119.39,0.0,0,0.054,0.177,0.229,0.465,2,7,1,4,3.7,9.2,6,Lower,Midwest,TX,Rural,36-50,2022-06,Q2_2022,2021,6.6,0.004,Decreasing
FIA002471,2022-06-12,Gabapentin,Neurontin,Anticonvulsants,35892-461-23,Tricare Standard,PLAN_5905,2022,Non-Formulary,Specialty Tier,2021-07-27,320,Worsened,Non-Formulary Status,No,No,,227,240,-5.2,Decreased,566.67,258.73,307.94,176.45,743.12,168.69,0.0,0,0.229,0.254,0.687,0.857,9,10,13,15,2.3,23.1,5,Lower,Midwest,NY,Rural,75+,2022-06,Q2_2022,2021,4.4,0.66,Stable
FIA001858,2022-06-15,Gabapentin,Neurontin,Anticonvulsants,22643-222-79,Medicaid Plan X,PLAN_6087,2022,Tier 1,Non-Formulary,2021-07-20,330,Improved,None,No,No,,441,332,33.0,Increased,8.95,697.13,-688.18,57.33,66.28,29.23,0.0,0,0.041,0.065,0.741,0.839,14,0,17,5,4.9,7.6,6,Similar,Northeast,GA,Rural,36-50,2022-06,Q2_2022,2021,4.2,0.856,Increasing
FIA002388,2022-07-04,Gabapentin,Neurontin,Anticonvulsants,19186-294-65,Commercial Plan Beta,PLAN_2894,2022,Tier 1,Non-Formulary,2021-09-30,277,Improved,None,No,No,,890,720,23.7,Increased,7.14,362.95,-355.81,103.51,110.65,98.48,0.0,0,0.043,0.09,0.614,0.609,11,10,11,9,4.7,25.5,7,Similar,West,CA,Rural,75+,2022-07,Q3_2022,2021,4.1,0.342,Stable
FIA001074,2022-07-20,Gabapentin,Neurontin,Anticonvulsants,70675-485-53,Commercial Plan Beta,PLAN_3853,2022,Specialty Tier,Specialty Tier,2021-07-30,355,No Change,Prior Authorization,Yes,No,,844,814,3.8,Stable,164.04,280.81,-116.77,43.46,207.5,175.13,0.419,5,0.238,0.347,0.571,0.541,6,8,15,3,3.1,7.2,4,Higher,Southwest,PA,Suburban,75+,2022-07,Q3_2022,2021,2.0,0.465,Decreasing
FIA002586,2022-07-21,Gabapentin,Neurontin,Anticonvulsants,21355-511-44,Medicaid Plan X,PLAN_8325,2022,Tier 3,Non-Formulary,2021-12-21,212,Improved,Step Therapy,No,Yes,,185,173,7.2,Increased,88.03,711.86,-623.83,84.36,172.39,31.89,0.0,0,0.061,0.236,0.81,0.701,9,4,6,14,4.3,16.4,8,Lower,Northeast,NC,Rural,66-75,2022-07,Q3_2022,2021,9.0,0.553,Stable
FIA002497,2022-08-09,Gabapentin,Neurontin,Anticonvulsants,41026-525-53,Medicaid Plan X,PLAN_7108,2022,Tier 2,Tier 3,2021-12-10,242,Improved,None,No,No,,145,103,41.4,Increased,43.29,85.16,-41.87,115.41,158.7,23.01,0.0,0,0.065,0.27,0.668,0.891,0,1,14,5,3.4,29.9,3,Higher,West,GA,Suburban,51-65,2022-08,Q3_2022,2021,7.2,0.498,Stable
FIA000031,2022-08-10,Gabapentin,Neurontin,Anticonvulsants,49608-764-62,Medicare Part D Plan B,PLAN_3290,2022,Tier 2,Specialty Tier,2022-06-29,42,Improved,None,No,No,,679,435,56.2,Increased,38.59,288.63,-250.04,170.06,208.65,141.67,0.0,0,0.014,0.066,0.226,0.948,3,1,7,4,3.2,16.1,7,Higher,West,OH,Rural,36-50,2022-08,Q3_2022,2021,9.0,0.655,Stable
FIA001796,2022-08-20,Gabapentin,Neurontin,Anticonvulsants,91337-482-11,Medicare Part D Plan B,PLAN_8918,2022,Specialty Tier,Tier 3,2022-01-10,222,Worsened,Quantity Limit,No,No,90.0,1038,951,9.2,Increased,185.85,69.28,116.57,189.12,374.97,389.22,0.0,0,0.109,0.079,0.735,0.474,3,6,10,0,4.9,18.8,5,Higher,Southwest,CA,Rural,51-65,2022-08,Q3_2022,2021,6.9,0.729,Decreasing
FIA002659,2022-08-23,Gabapentin,Neurontin,Anticonvulsants,39373-835-41,VA Plan,PLAN_7950,2022,Tier 2,Tier 3,2022-02-21,183,Improved,None,No,No,,705,452,56.1,Increased,31.94,70.17,-38.23,189.05,220.99,155.8,0.0,0,0.05,0.072,0.233,0.49,10,6,20,5,3.9,27.2,7,Similar,West,MI,Suburban,18-35,2022-08,Q3_2022,2021,3.5,0.517,Decreasing
FIA001495,2022-08-25,Gabapentin,Neurontin,Anticonvulsants,93568-233-11,Commercial Plan Beta,PLAN_2734,2022,Specialty Tier,Tier 3,2022-03-01,177,Worsened,None,No,No,,242,227,6.9,Increased,200.64,74.89,125.75,134.65,335.29,81.14,0.0,0,0.223,0.322,0.491,0.634,14,4,9,5,2.5,27.4,6,Lower,Southwest,NY,Rural,18-35,2022-08,Q3_2022,2021,1.4,0.834,Stable
FIA002472,2022-08-26,Gabapentin,Neurontin,Anticonvulsants,36429-484-22,Medicaid Plan X,PLAN_4541,2022,Specialty Tier,Tier 2,2022-03-13,166,Worsened,Quantity Limit,No,No,60.0,465,690,-32.6,Decreased,254.26,29.48,224.78,191.04,445.3,207.06,0.0,0,0.107,0.275,0.501,0.566,12,7,2,2,3.0,22.7,7,Similar,Southeast,CA,Urban,36-50,2022-08,Q3_2022,2021,3.3,0.966,Stable
FIA001550,2022-09-12,Gabapentin,Neurontin,Anticonvulsants,41347-831-27,Tricare Standard,PLAN_4003,2022,Non-Formulary,Non-Formulary,2022-07-20,54,No Change,Non-Formulary Status,No,No,,558,590,-5.4,Decreased,506.98,703.18,-196.2,170.1,677.08,377.81,0.0,0,0.173,0.108,0.748,0.522,13,9,10,1,2.8,11.2,7,Similar,Northeast,IL,Rural,18-35,2022-09,Q3_2022,2021,3.3,0.234,Increasing
FIA001977,2022-09-16,Gabapentin,Neurontin,Anticonvulsants,64152-926-46,VA Plan,PLAN_4741,2022,Specialty Tier,Tier 1,2022-01-26,233,Worsened,Prior Authorization,Yes,No,,302,992,-69.5,Decreased,207.79,14.44,193.35,136.19,343.98,103.88,0.1,10,0.17,0.312,0.557,0.649,13,8,3,5,3.9,27.8,6,Lower,Northeast,CA,Urban,75+,2022-09,Q3_2022,2021,9.4,0.305,Decreasing
FIA002009,2022-09-25,Gabapentin,Neurontin,Anticonvulsants,22792-680-32,Commercial Plan Beta,PLAN_3301,2022,Non-Formulary,Tier 1,2022-07-26,61,Worsened,Non-Formulary Status,No,No,,129,224,-42.1,Decreased,726.13,9.54,716.59,136.06,862.19,111.22,0.0,0,0.232,0.154,0.459,0.453,0,9,13,14,2.1,29.1,4,Higher,Northeast,TX,Suburban,75+,2022-09,Q3_2022,2021,8.8,0.223,Stable
FIA000706,2022-10-01,Gabapentin,Neurontin,Anticonvulsants,73992-466-89,Medicare Part D Plan A,PLAN_2536,2022,Tier 2,Tier 3,2021-10-22,344,Improved,Quantity Limit,No,No,90.0,462,313,47.6,Increased,37.65,51.98,-14.33,181.49,219.14,101.24,0.0,0,0.049,0.352,0.63,0.58,9,4,12,3,2.8,5.8,3,Lower,Southeast,IL,Urban,66-75,2022-10,Q4_2022,2022,3.7,0.395,Stable
FIA000755,2022-10-08,Gabapentin,Neurontin,Anticonvulsants,38873-175-21,Medicare Part D Plan A,PLAN_6715,2022,Specialty Tier,Non-Formulary,2022-08-05,64,Improved,Prior Authorization; Step Therapy,Yes,Yes,,891,879,1.4,Stable,169.76,790.49,-620.73,184.93,354.69,316.03,0.523,9,0.268,0.381,0.672,0.808,0,9,13,15,4.8,23.1,6,Higher,Midwest,FL,Urban,75+,2022-10,Q4_2022,2022,6.3,0.125,Stable
FIA000477,2022-10-11,Gabapentin,Neurontin,Anticonvulsants,89954-544-53,Medicare Part D Plan A,PLAN_9998,2022,Non-Formulary,Tier 1,2022-04-19,175,Worsened,Non-Formulary Status,No,No,,184,517,-64.4,Decreased,696.81,18.46,678.35,148.17,844.98,155.48,0.0,0,0.086,0.332,0.749,0.623,11,8,4,13,4.0,7.8,6,Similar,West,OH,Suburban,66-75,2022-10,Q4_2022,2022,6.7,0.923,Increasing
FIA000756,2022-10-14,Gabapentin,Neurontin,Anticonvulsants,74912-590-60,Commercial Plan Alpha,PLAN_9696,2022,Specialty Tier,Non-Formulary,2022-05-18,149,Improved,Prior Authorization; Quantity Limit,Yes,No,30.0,955,984,-2.9,Stable,194.87,444.92,-250.05,46.71,241.58,230.71,0.314,7,0.223,0.374,0.503,0.689,11,0,2,12,4.6,28.5,3,Similar,Southwest,FL,Rural,36-50,2022-10,Q4_2022,2022,2.7,0.432,Stable
FIA002652,2022-10-20,Gabapentin,Neurontin,Anticonvulsants,15845-122-81,VA Plan,PLAN_6304,2022,Non-Formulary,Tier 3,2022-06-07,135,Worsened,Non-Formulary Status,No,No,,380,377,0.8,Stable,223.51,51.86,171.65,155.41,378.92,143.99,0.0,0,0.098,0.287,0.538,0.655,15,0,8,3,4.3,19.2,3,Higher,West,PA,Urban,36-50,2022-10,Q4_2022,2022,1.7,0.973,Decreasing
FIA002320,2022-10-23,Gabapentin,Neurontin,Anticonvulsants,37744-778-83,Medicare Part D Plan A,PLAN_3613,2022,Tier 1,Specialty Tier,2021-12-20,307,Improved,None,No,No,,1179,883,33.6,Increased,19.61,161.59,-141.98,31.2,50.81,59.9,0.0,0,0.021,0.268,0.279,0.57,11,9,9,4,3.5,28.3,7,Higher,Northeast,TX,Urban,18-35,2022-10,Q4_2022,2022,1.3,0.59,Increasing
FIA001499,2022-11-01,Gabapentin,Neurontin,Anticonvulsants,57897-788-68,Tricare Standard,PLAN_1131,2022,Tier 1,Tier 2,2021-11-22,344,Improved,None,No,No,,358,338,6.2,Increased,13.21,23.39,-10.18,133.95,147.16,52.68,0.0,0,0.015,0.085,0.417,0.449,2,5,16,3,3.9,30.1,3,Lower,Midwest,NY,Rural,51-65,2022-11,Q4_2022,2022,2.4,0.073,Stable
FIA001283,2022-11-03,Gabapentin,Neurontin,Anticonvulsants,66682-433-65,Commercial Plan Alpha,PLAN_1106,2022,Tier 2,Tier 2,2022-05-15,172,No Change,None,No,No,,207,198,4.8,Stable,27.04,40.96,-13.92,127.94,154.98,32.08,0.0,0,0.044,0.222,0.821,0.606,0,6,8,10,4.3,26.6,2,Similar,West,FL,Rural,51-65,2022-11,Q4_2022,2022,1.4,0.858,Decreasing
FIA002868,2022-11-04,Gabapentin,Neurontin,Anticonvulsants,55899-671-59,Commercial Plan Alpha,PLAN_2931,2022,Tier 2,Tier 1,2022-05-04,184,Worsened,None,No,No,,536,558,-3.8,Stable,35.56,7.55,28.01,62.29,97.85,52.45,0.0,0,0.075,0.134,0.285,0.693,8,1,17,1,4.2,8.5,5,Higher,Northeast,MI,Rural,75+,2022-11,Q4_2022,2022,4.5,0.374,Decreasing
FIA001783,2022-11-06,Gabapentin,Neurontin,Anticonvulsants,80785-707-52,VA Plan,PLAN_3254,2022,Tier 2,Tier 2,2022-03-27,224,No Change,None,No,No,,495,509,-2.6,Stable,23.77,49.77,-26.0,168.11,191.88,94.98,0.0,0,0.015,0.378,0.429,0.874,11,10,2,5,3.8,5.6,4,Higher,West,OH,Urban,75+,2022-11,Q4_2022,2022,4.2,0.603,Stable
FIA000004,2022-11-10,Gabapentin,Neurontin,Anticonvulsants,25014-798-78,Medicaid Plan X,PLAN_6573,2022,Tier 2,Specialty Tier,2021-12-10,335,Improved,Quantity Limit,No,No,,803,579,38.8,Increased,21.91,176.32,-154.41,31.95,53.86,43.25,0.0,0,0.07,0.153,0.311,0.402,8,8,5,3,4.6,14.0,7,Higher,West,NY,Urban,51-65,2022-11,Q4_2022,2022,7.9,0.539,Decreasing
FIA001354,2022-11-13,Gabapentin,Neurontin,Anticonvulsants,93465-939-79,Tricare Standard,PLAN_5412,2022,Non-Formulary,Specialty Tier,2022-06-26,140,Worsened,Non-Formulary Status,No,No,,329,343,-3.9,Stable,399.28,253.78,145.5,125.11,524.39,172.52,0.0,0,0.148,0.266,0.446,0.449,4,3,7,11,3.1,20.7,4,Similar,Southeast,NC,Rural,36-50,2022-11,Q4_2022,2022,3.4,0.655,Decreasing
FIA001660,2022-11-28,Gabapentin,Neurontin,Anticonvulsants,45199-706-87,Tricare Standard,PLAN_6618,2022,Specialty Tier,Tier 2,2022-05-24,188,Worsened,Step Therapy,No,Yes,,72,226,-67.9,Decreased,146.01,35.16,110.85,89.65,235.66,16.97,0.0,0,0.256,0.121,0.224,0.563,12,3,7,8,3.0,13.5,8,Lower,Northeast,FL,Rural,36-50,2022-11,Q4_2022,2022,2.3,0.908,Decreasing
FIA001092,2022-12-05,Gabapentin,Neurontin,Anticonvulsants,86339-400-17,Medicaid Plan Y,PLAN_4836,2022,Tier 2,Specialty Tier,2022-05-30,189,Improved,Quantity Limit,No,No,60.0,285,206,38.7,Increased,45.15,157.14,-111.99,77.16,122.31,34.86,0.0,0,0.019,0.192,0.368,0.487,8,10,7,15,4.3,27.9,6,Similar,Northeast,GA,Rural,66-75,2022-12,Q4_2022,2022,9.3,0.927,Stable
FIA000184,2022-12-25,Gabapentin,Neurontin,Anticonvulsants,86037-992-99,Commercial Plan Beta,PLAN_4693,2022,Non-Formulary,Tier 1,2022-02-11,317,Worsened,Non-Formulary Status,No,No,,300,442,-31.9,Decreased,625.6,8.07,617.53,189.66,815.26,244.58,0.0,0,0.17,0.162,0.829,0.677,13,4,1,2,3.1,18.6,6,Higher,Northeast,GA,Rural,75+,2022-12,Q4_2022,2022,7.1,0.533,Stable
FIA000073,2023-01-04,Gabapentin,Neurontin,Anticonvulsants,63627-789-73,Commercial Plan Alpha,PLAN_5961,2023,Non-Formulary,Tier 1,2022-04-13,266,Worsened,Non-Formulary Status,No,No,,599,916,-34.6,Decreased,765.78,8.14,757.64,165.26,931.04,557.69,0.0,0,0.255,0.135,0.661,0.793,12,1,14,15,3.7,21.0,8,Higher,Southwest,NC,Urban,51-65,2023-01,Q1_2023,2022,7.3,0.812,Decreasing
FIA000122,2023-01-07,Gabapentin,Neurontin,Anticonvulsants,53365-465-26,Commercial Plan Beta,PLAN_2639,2023,Non-Formulary,Tier 1,2022-03-02,311,Worsened,Non-Formulary Status,No,No,,184,397,-53.6,Decreased,476.76,13.24,463.52,128.7,605.46,111.4,0.0,0,0.099,0.15,0.249,0.506,15,7,10,9,4.1,9.6,6,Similar,Midwest,OH,Urban,18-35,2023-01,Q1_2023,2022,3.8,0.786,Decreasing
FIA002798,2023-01-07,Gabapentin,Neurontin,Anticonvulsants,61561-525-40,Medicaid Plan Y,PLAN_1025,2023,Specialty Tier,Specialty Tier,2022-08-01,159,No Change,Quantity Limit,No,No,60.0,401,439,-8.6,Decreased,134.96,237.92,-102.96,156.36,291.32,116.82,0.0,0,0.281,0.325,0.788,0.401,3,7,16,15,3.2,23.8,4,Lower,West,NY,Urban,36-50,2023-01,Q1_2023,2022,2.9,0.74,Decreasing
FIA000637,2023-01-13,Gabapentin,Neurontin,Anticonvulsants,20536-509-34,Tricare Standard,PLAN_1644,2023,Specialty Tier,Tier 3,2022-04-05,283,Worsened,Step Therapy,No,Yes,,596,659,-9.5,Decreased,265.77,53.03,212.74,167.06,432.83,257.97,0.0,0,0.28,0.361,0.68,0.918,9,9,6,6,2.6,30.1,3,Similar,Midwest,OH,Rural,36-50,2023-01,Q1_2023,2022,8.7,0.863,Stable
FIA000317,2023-01-15,Gabapentin,Neurontin,Anticonvulsants,18802-549-64,VA Plan,PLAN_2161,2023,Non-Formulary,Specialty Tier,2022-09-10,127,Worsened,Non-Formulary Status,No,No,,585,585,0.0,Stable,699.44,214.07,485.37,53.44,752.88,440.43,0.0,0,0.19,0.249,0.289,0.684,3,1,15,7,2.2,21.2,2,Lower,Midwest,PA,Suburban,51-65,2023-01,Q1_2023,2022,1.6,0.871,Stable
FIA001026,2023-01-20,Gabapentin,Neurontin,Anticonvulsants,10254-167-11,Medicaid Plan X,PLAN_2810,2023,Tier 3,Specialty Tier,2022-08-13,160,Improved,None,No,No,,381,412,-7.4,Decreased,60.65,140.99,-80.34,173.39,234.04,89.17,0.0,0,0.011,0.12,0.364,0.602,14,9,9,4,2.1,19.2,3,Higher,Southeast,NY,Rural,51-65,2023-01,Q1_2023,2022,4.8,0.861,Decreasing
FIA001521,2023-01-27,Gabapentin,Neurontin,Anticonvulsants,15576-419-16,Medicare Part D Plan A,PLAN_3873,2023,Tier 3,Non-Formulary,2022-02-03,358,Improved,Step Therapy,No,Yes,,958,986,-2.7,Stable,78.82,551.63,-472.81,86.4,165.22,158.28,0.0,0,0.046,0.148,0.884,0.648,6,6,8,5,4.7,28.9,7,Lower,Southeast,TX,Urban,51-65,2023-01,Q1_2023,2022,8.4,0.149,Increasing
FIA002169,2023-02-16,Gabapentin,Neurontin,Anticonvulsants,14106-739-39,Commercial Plan Beta,PLAN_9183,2023,Tier 3,Tier 1,2022-11-29,79,Worsened,Step Therapy,No,Yes,,293,957,-69.3,Decreased,70.88,19.59,51.29,100.78,171.66,50.3,0.0,0,0.067,0.074,0.575,0.594,10,1,0,4,4.1,25.9,7,Lower,Midwest,OH,Suburban,51-65,2023-02,Q1_2023,2022,5.8,0.105,Decreasing
FIA000932,2023-02-18,Gabapentin,Neurontin,Anticonvulsants,26343-775-36,Medicare Part D Plan A,PLAN_3269,2023,Tier 2,Specialty Tier,2022-10-25,116,Improved,None,No,No,,1088,830,31.2,Increased,40.24,261.94,-221.7,198.9,239.14,260.18,0.0,0,0.044,0.195,0.428,0.551,14,7,3,2,3.0,21.8,7,Higher,Northeast,NC,Suburban,18-35,2023-02,Q1_2023,2022,7.1,0.522,Decreasing
FIA001164,2023-02-24,Gabapentin,Neurontin,Anticonvulsants,15013-697-50,Medicare Part D Plan B,PLAN_6519,2023,Specialty Tier,Tier 2,2022-12-02,84,Worsened,None,No,No,,312,981,-68.1,Decreased,254.19,31.85,222.34,177.47,431.66,134.68,0.0,0,0.106,0.188,0.894,0.52,0,0,20,12,2.6,9.4,2,Lower,Midwest,TX,Suburban,51-65,2023-02,Q1_2023,2022,1.5,0.51,Decreasing
FIA002599,2023-02-25,Gabapentin,Neurontin,Anticonvulsants,21668-448-21,VA Plan,PLAN_7742,2023,Non-Formulary,Tier 3,2022-09-14,164,Worsened,Non-Formulary Status; Quantity Limit,No,No,,715,768,-6.9,Decreased,626.68,61.09,565.59,118.96,745.64,533.13,0.0,0,0.259,0.314,0.542,0.942,13,3,2,6,3.2,13.2,7,Higher,West,OH,Rural,36-50,2023-02,Q1_2023,2022,9.7,0.638,Stable
FIA002479,2023-03-08,Gabapentin,Neurontin,Anticonvulsants,93511-107-25,Medicare Part D Plan A,PLAN_8616,2023,Tier 1,Specialty Tier,2022-09-19,170,Improved,None,No,No,,603,394,53.2,Increased,18.26,200.39,-182.13,164.77,183.03,110.37,0.0,0,0.023,0.277,0.599,0.859,4,10,11,15,2.6,24.8,6,Similar,Southeast,NC,Urban,51-65,2023-03,Q1_2023,2022,9.0,0.409,Stable
FIA001756,2023-03-19,Gabapentin,Neurontin,Anticonvulsants,24214-615-68,Medicare Part D Plan B,PLAN_7292,2023,Non-Formulary,Non-Formulary,2023-01-09,69,No Change,Non-Formulary Status; Quantity Limit,No,No,30.0,319,309,3.3,Stable,484.33,494.39,-10.06,61.47,545.8,174.11,0.0,0,0.105,0.184,0.877,0.715,15,7,7,10,4.2,8.5,2,Similar,West,GA,Urban,51-65,2023-03,Q1_2023,2022,3.7,0.9,Decreasing
FIA001152,2023-03-22,Gabapentin,Neurontin,Anticonvulsants,42165-419-14,Commercial Plan Beta,PLAN_7045,2023,Non-Formulary,Tier 3,2022-08-19,215,Worsened,Non-Formulary Status,No,No,,467,506,-7.6,Decreased,494.0,66.03,427.97,64.01,558.01,260.59,0.0,0,0.264,0.145,0.771,0.554,4,10,20,15,3.5,15.6,6,Higher,Northeast,MI,Urban,18-35,2023-03,Q1_2023,2022,4.9,0.383,Stable
FIA000480,2023-03-28,Gabapentin,Neurontin,Anticonvulsants,63955-787-26,Commercial Plan Alpha,PLAN_6645,2023,Tier 3,Tier 3,2023-02-18,38,No Change,Step Therapy; Quantity Limit,No,Yes,,681,713,-4.4,Stable,94.79,72.03,22.76,159.7,254.49,173.31,0.0,0,0.061,0.244,0.264,0.88,15,6,1,5,3.7,33.0,2,Similar,Northeast,OH,Rural,75+,2023-03,Q1_2023,2022,3.4,0.97,Increasing
FIA000944,2023-03-30,Gabapentin,Neurontin,Anticonvulsants,76190-562-44,Commercial Plan Beta,PLAN_2070,2023,Tier 2,Tier 3,2022-08-13,229,Improved,None,No,No,,1227,837,46.7,Increased,39.7,73.06,-33.36,64.77,104.47,128.18,0.0,0,0.076,0.199,0.474,0.838,3,0,19,0,2.9,20.6,5,Higher,Northeast,GA,Urban,36-50,2023-03,Q1_2023,2022,4.7,0.304,Stable
FIA002099,2023-04-01,Gabapentin,Neurontin,Anticonvulsants,47463-167-68,Commercial Plan Beta,PLAN_5078,2023,Specialty Tier,Tier 1,2022-04-13,353,Worsened,Step Therapy; Quantity Limit,No,Yes,90.0,310,847,-63.3,Decreased,254.99,16.29,238.7,63.23,318.22,98.65,0.0,0,0.245,0.089,0.364,0.52,2,8,18,8,3.0,23.9,7,Higher,West,GA,Suburban,18-35,2023-04,Q2_2023,2022,7.2,0.682,Stable
FIA001363,2023-04-03,Gabapentin,Neurontin,Anticonvulsants,20681-500-90,Medicare Part D Plan B,PLAN_9625,2023,Specialty Tier,Non-Formulary,2022-10-17,168,Improved,Prior Authorization; Quantity Limit,Yes,No,90.0,339,310,9.4,Increased,194.07,799.29,-605.22,115.96,310.03,105.1,0.367,8,0.103,0.184,0.877,0.574,1,8,9,6,2.2,23.5,7,Similar,Southeast,TX,Rural,66-75,2023-04,Q2_2023,2022,8.5,0.736,Decreasing
FIA001903,2023-04-04,Gabapentin,Neurontin,Anticonvulsants,21639-917-47,Commercial Plan Beta,PLAN_6303,2023,Tier 2,Tier 1,2023-03-05,30,Worsened,Quantity Limit,No,No,,725,756,-4.1,Stable,29.86,12.19,17.67,142.54,172.4,124.99,0.0,0,0.07,0.299,0.633,0.568,3,9,18,14,4.8,28.6,8,Lower,Southwest,OH,Urban,18-35,2023-04,Q2_2023,2022,7.0,0.595,Decreasing
FIA002970,2023-04-05,Gabapentin,Neurontin,Anticonvulsants,69215-826-55,Medicare Part D Plan B,PLAN_6901,2023,Tier 1,Tier 1,2022-04-26,344,No Change,Quantity Limit,No,No,30.0,419,405,3.5,Stable,18.74,13.08,5.66,150.5,169.24,70.91,0.0,0,0.031,0.3,0.892,0.611,10,2,11,7,4.3,10.3,2,Similar,Southwest,NY,Rural,18-35,2023-04,Q2_2023,2022,3.7,0.45,Stable
FIA000376,2023-04-07,Gabapentin,Neurontin,Anticonvulsants,70574-784-85,Medicaid Plan X,PLAN_3157,2023,Tier 1,Tier 1,2022-08-14,236,No Change,None,No,No,,335,355,-5.5,Decreased,9.23,14.23,-5.0,150.78,160.01,53.6,0.0,0,0.031,0.165,0.462,0.48,1,6,20,1,4.4,34.4,2,Lower,Northeast,NY,Urban,66-75,2023-04,Q2_2023,2022,3.9,0.572,Stable
FIA002638,2023-04-23,Gabapentin,Neurontin,Anticonvulsants,59813-473-66,Medicaid Plan X,PLAN_7329,2023,Tier 2,Tier 3,2023-02-15,67,Improved,Quantity Limit,No,No,90.0,976,800,22.0,Increased,43.9,87.28,-43.38,36.79,80.69,78.75,0.0,0,0.011,0.337,0.848,0.479,14,1,6,2,2.4,13.4,2,Lower,Southeast,OH,Suburban,36-50,2023-04,Q2_2023,2022,5.0,0.991,Increasing
FIA001428,2023-05-12,Gabapentin,Neurontin,Anticonvulsants,92296-885-91,Medicaid Plan Y,PLAN_6628,2023,Tier 1,Non-Formulary,2022-07-20,296,Improved,None,No,No,,666,434,53.5,Increased,6.57,449.24,-442.67,86.97,93.54,62.3,0.0,0,0.025,0.282,0.618,0.75,0,7,19,1,3.4,18.3,2,Similar,Midwest,IL,Urban,18-35,2023-05,Q2_2023,2022,9.9,0.071,Increasing
FIA001141,2023-05-14,Gabapentin,Neurontin,Anticonvulsants,74954-570-25,Medicaid Plan Y,PLAN_4195,2023,Specialty Tier,Tier 1,2023-03-15,60,Worsened,None,No,No,,299,701,-57.2,Decreased,267.9,9.84,258.06,147.84,415.74,124.31,0.0,0,0.249,0.3,0.201,0.749,15,4,7,0,2.8,33.9,3,Similar,Southwest,CA,Urban,51-65,2023-05,Q2_2023,2022,2.1,0.9,Stable
FIA001329,2023-05-19,Gabapentin,Neurontin,Anticonvulsants,66293-865-18,Commercial Plan Alpha,PLAN_2008,2023,Tier 2,Specialty Tier,2022-10-13,218,Improved,None,No,No,,1198,749,60.0,Increased,44.79,142.39,-97.6,91.54,136.33,163.32,0.0,0,0.073,0.127,0.732,0.554,13,7,5,13,2.8,25.2,2,Higher,West,MI,Urban,75+,2023-05,Q2_2023,2022,9.1,0.115,Stable
FIA000091,2023-05-26,Gabapentin,Neurontin,Anticonvulsants,45446-284-13,Medicaid Plan Y,PLAN_4588,2023,Non-Formulary,Tier 1,2022-10-13,225,Worsened,Non-Formulary Status,No,No,,268,657,-59.1,Decreased,669.15,10.39,658.76,84.67,753.82,202.02,0.0,0,0.191,0.06,0.767,0.555,15,8,11,7,4.9,8.0,7,Lower,Midwest,NC,Rural,18-35,2023-05,Q2_2023,2022,7.9,0.948,Decreasing
FIA002113,2023-05-27,Gabapentin,Neurontin,Anticonvulsants,45609-604-24,Medicaid Plan Y,PLAN_8510,2023,Tier 2,Tier 2,2022-10-06,233,No Change,Quantity Limit,No,No,90.0,740,731,1.3,Stable,42.57,46.04,-3.47,83.02,125.59,92.94,0.0,0,0.079,0.28,0.253,0.542,8,5,19,11,5.0,23.5,2,Similar,Northeast,MI,Suburban,66-75,2023-05,Q2_2023,2022,8.4,0.084,Decreasing
FIA002831,2023-05-31,Gabapentin,Neurontin,Anticonvulsants,12393-566-74,Medicare Part D Plan B,PLAN_9582,2023,Non-Formulary,Specialty Tier,2023-04-17,44,Worsened,Non-Formulary Status,No,No,,785,791,-0.7,Stable,370.62,257.51,113.11,71.82,442.44,347.32,0.0,0,0.145,0.059,0.441,0.93,14,3,6,2,2.9,29.2,4,Higher,West,GA,Urban,36-50,2023-05,Q2_2023,2022,4.1,0.734,Increasing
FIA000653,2023-06-21,Gabapentin,Neurontin,Anticonvulsants,69904-152-60,VA Plan,PLAN_2349,2023,Specialty Tier,Tier 1,2022-12-17,186,Worsened,Quantity Limit,No,No,90.0,224,520,-56.9,Decreased,197.75,14.71,183.04,76.89,274.64,61.52,0.0,0,0.181,0.345,0.874,0.593,13,4,13,14,2.4,31.3,8,Lower,Southwest,NC,Urban,51-65,2023-06,Q2_2023,2022,6.9,0.882,Increasing
FIA001901,2023-07-02,Gabapentin,Neurontin,Anticonvulsants,46621-224-84,Commercial Plan Beta,PLAN_7677,2023,Non-Formulary,Tier 1,2023-02-10,142,Worsened,Non-Formulary Status,No,No,,162,203,-20.0,Decreased,223.71,10.75,212.96,112.6,336.31,54.48,0.0,0,0.214,0.139,0.767,0.885,8,1,11,3,4.9,8.7,3,Lower,Southeast,PA,Urban,36-50,2023-07,Q3_2023,2022,7.0,0.869,Decreasing
FIA001523,2023-07-15,Gabapentin,Neurontin,Anticonvulsants,61402-275-71,Medicare Part D Plan B,PLAN_5527,2023,Tier 1,Tier 3,2022-08-19,330,Improved,Quantity Limit,No,No,60.0,774,529,46.5,Increased,10.84,54.01,-43.17,133.76,144.6,111.92,0.0,0,0.032,0.219,0.892,0.574,13,8,13,5,4.5,32.7,3,Similar,West,IL,Rural,66-75,2023-07,Q3_2023,2022,5.2,0.676,Stable
FIA002270,2023-08-01,Gabapentin,Neurontin,Anticonvulsants,20184-334-25,Commercial Plan Beta,PLAN_6556,2023,Tier 1,Tier 1,2022-10-27,278,No Change,None,No,No,,549,568,-3.3,Stable,19.68,14.61,5.07,136.38,156.06,85.68,0.0,0,0.022,0.165,0.225,0.631,3,6,2,11,4.5,13.9,3,Similar,Southeast,IL,Urban,51-65,2023-08,Q3_2023,2022,3.1,0.014,Stable
FIA002324,2023-08-01,Gabapentin,Neurontin,Anticonvulsants,87958-614-93,Commercial Plan Alpha,PLAN_1774,2023,Non-Formulary,Tier 2,2023-05-08,85,Worsened,Non-Formulary Status,No,No,,248,417,-40.5,Decreased,208.99,45.69,163.3,106.61,315.6,78.27,0.0,0,0.064,0.262,0.865,0.826,12,8,2,4,3.4,20.0,7,Higher,Northeast,TX,Rural,36-50,2023-08,Q3_2023,2022,2.3,0.881,Decreasing
FIA002919,2023-08-14,Gabapentin,Neurontin,Anticonvulsants,52075-476-97,Medicaid Plan Y,PLAN_7512,2023,Specialty Tier,Non-Formulary,2022-11-28,259,Improved,Step Therapy,No,Yes,,481,525,-8.2,Decreased,121.5,410.13,-288.63,42.63,164.13,78.95,0.0,0,0.297,0.169,0.382,0.766,12,7,12,11,4.5,6.1,8,Similar,Northeast,IL,Rural,66-75,2023-08,Q3_2023,2022,2.2,0.378,Stable
FIA002126,2023-08-19,Gabapentin,Neurontin,Anticonvulsants,14692-996-13,Tricare Standard,PLAN_6167,2023,Tier 2,Specialty Tier,2023-05-29,82,Improved,None,No,No,,610,424,43.9,Increased,21.8,157.32,-135.52,98.36,120.16,73.3,0.0,0,0.014,0.069,0.684,0.718,10,2,5,2,3.4,5.3,5,Similar,Southwest,PA,Rural,18-35,2023-08,Q3_2023,2022,5.6,0.98,Increasing
FIA002299,2023-08-20,Gabapentin,Neurontin,Anticonvulsants,14940-739-60,Medicare Part D Plan A,PLAN_5037,2023,Specialty Tier,Tier 3,2022-08-22,363,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,113,119,-4.7,Stable,101.56,62.02,39.54,99.0,200.56,22.66,0.167,1,0.249,0.209,0.784,0.882,10,6,19,6,4.5,27.5,6,Higher,Southwest,NY,Urban,36-50,2023-08,Q3_2023,2022,6.3,0.963,Decreasing
FIA002915,2023-08-27,Gabapentin,Neurontin,Anticonvulsants,44952-270-67,Tricare Standard,PLAN_8274,2023,Tier 3,Non-Formulary,2023-03-06,174,Improved,Prior Authorization,Yes,No,,108,106,1.9,Stable,84.85,461.48,-376.63,147.61,232.46,25.11,0.131,2,0.042,0.303,0.331,0.654,2,6,3,6,4.8,16.6,6,Higher,West,TX,Urban,75+,2023-08,Q3_2023,2022,8.9,0.047,Increasing
FIA001402,2023-09-04,Gabapentin,Neurontin,Anticonvulsants,36330-724-94,Medicare Part D Plan A,PLAN_2115,2023,Tier 2,Tier 2,2023-07-11,55,No Change,None,No,No,,129,134,-3.4,Stable,45.68,27.86,17.82,115.74,161.42,20.82,0.0,0,0.038,0.381,0.71,0.658,5,7,1,8,4.6,20.3,4,Higher,Southeast,NC,Suburban,18-35,2023-09,Q3_2023,2022,8.7,0.353,Decreasing
FIA001840,2023-09-07,Gabapentin,Neurontin,Anticonvulsants,38154-513-70,Medicaid Plan X,PLAN_1577,2023,Tier 2,Tier 3,2023-03-16,175,Improved,None,No,No,,327,229,42.9,Increased,27.46,52.22,-24.76,33.68,61.14,19.99,0.0,0,0.02,0.062,0.329,0.802,8,2,15,0,4.4,20.4,2,Higher,West,TX,Rural,18-35,2023-09,Q3_2023,2022,3.1,0.279,Increasing
FIA001010,2023-09-11,Gabapentin,Neurontin,Anticonvulsants,30699-151-89,Medicaid Plan X,PLAN_9447,2023,Tier 3,Tier 2,2023-02-14,209,Worsened,Quantity Limit,No,No,,136,178,-23.4,Decreased,62.38,47.75,14.63,194.68,257.06,34.96,0.0,0,0.02,0.307,0.332,0.725,11,7,20,11,5.0,10.6,6,Similar,Southeast,NY,Rural,18-35,2023-09,Q3_2023,2022,4.7,0.378,Stable
FIA000868,2023-09-13,Gabapentin,Neurontin,Anticonvulsants,40688-468-41,Medicare Part D Plan A,PLAN_1907,2023,Non-Formulary,Specialty Tier,2023-02-20,205,Worsened,Non-Formulary Status,No,No,,747,681,9.7,Increased,424.42,132.35,292.07,65.89,490.31,366.26,0.0,0,0.057,0.159,0.686,0.722,5,6,20,12,4.9,11.4,5,Higher,Northeast,MI,Suburban,66-75,2023-09,Q3_2023,2022,3.1,0.994,Increasing
FIA000703,2023-09-16,Gabapentin,Neurontin,Anticonvulsants,80456-353-84,VA Plan,PLAN_7374,2023,Tier 2,Tier 2,2023-04-23,146,No Change,None,No,No,,1071,975,9.9,Increased,25.25,22.71,2.54,155.61,180.86,193.7,0.0,0,0.034,0.058,0.527,0.514,9,6,15,8,3.2,26.8,4,Higher,West,IL,Rural,51-65,2023-09,Q3_2023,2022,6.9,0.922,Stable
FIA000268,2023-09-18,Gabapentin,Neurontin,Anticonvulsants,17525-186-46,Tricare Standard,PLAN_1175,2023,Tier 1,Tier 3,2023-01-23,238,Improved,None,No,No,,888,749,18.6,Increased,16.56,92.26,-75.7,58.07,74.63,66.27,0.0,0,0.076,0.387,0.497,0.68,4,7,15,3,3.2,23.5,8,Higher,Northeast,OH,Rural,75+,2023-09,Q3_2023,2022,7.7,0.244,Decreasing
FIA000889,2023-09-20,Gabapentin,Neurontin,Anticonvulsants,22310-802-91,Commercial Plan Beta,PLAN_6182,2023,Tier 1,Specialty Tier,2023-05-06,137,Improved,None,No,No,,938,786,19.4,Increased,5.85,188.57,-182.72,192.74,198.59,186.28,0.0,0,0.043,0.28,0.649,0.401,6,6,18,5,2.4,10.9,7,Higher,Midwest,PA,Urban,36-50,2023-09,Q3_2023,2022,9.1,0.409,Decreasing
FIA002736,2023-09-22,Gabapentin,Neurontin,Anticonvulsants,73568-732-96,Medicaid Plan Y,PLAN_9525,2023,Specialty Tier,Non-Formulary,2023-04-13,162,Improved,Prior Authorization,Yes,No,,916,842,8.8,Increased,264.18,625.52,-361.34,148.58,412.76,378.09,0.149,6,0.257,0.119,0.505,0.883,4,5,5,15,4.2,17.9,7,Similar,Midwest,PA,Urban,51-65,2023-09,Q3_2023,2022,6.4,0.483,Stable
FIA002708,2023-09-24,Gabapentin,Neurontin,Anticonvulsants,83559-977-91,Tricare Standard,PLAN_1393,2023,Tier 3,Non-Formulary,2023-03-04,204,Improved,Prior Authorization,Yes,No,,393,374,5.3,Increased,60.06,715.02,-654.96,101.04,161.1,63.31,0.154,5,0.071,0.201,0.743,0.801,1,1,8,2,2.6,19.6,6,Higher,Midwest,GA,Urban,66-75,2023-09,Q3_2023,2022,2.3,0.867,Increasing
FIA002496,2023-09-30,Gabapentin,Neurontin,Anticonvulsants,76798-830-97,Medicaid Plan Y,PLAN_9361,2023,Tier 3,Non-Formulary,2023-08-01,60,Improved,Quantity Limit,No,No,30.0,226,210,7.8,Increased,79.37,481.69,-402.32,55.12,134.49,30.39,0.0,0,0.059,0.362,0.835,0.762,1,2,6,3,2.8,28.6,8,Similar,West,CA,Rural,75+,2023-09,Q3_2023,2022,5.2,0.086,Increasing
FIA001766,2023-10-02,Gabapentin,Neurontin,Anticonvulsants,81616-484-32,Commercial Plan Beta,PLAN_4656,2023,Tier 3,Tier 1,2023-08-29,34,Worsened,Prior Authorization; Quantity Limit,Yes,No,60.0,121,310,-60.7,Decreased,91.12,16.48,74.64,95.75,186.87,22.61,0.535,9,0.049,0.22,0.247,0.526,5,1,2,9,3.3,13.5,5,Similar,Southwest,NY,Urban,51-65,2023-10,Q4_2023,2023,1.8,0.628,Increasing
FIA000497,2023-10-28,Gabapentin,Neurontin,Anticonvulsants,74631-324-30,VA Plan,PLAN_5748,2023,Tier 3,Tier 2,2022-12-07,325,Worsened,None,No,No,,222,427,-47.8,Decreased,92.78,36.2,56.58,155.31,248.09,55.08,0.0,0,0.055,0.136,0.214,0.583,8,9,15,3,2.5,18.4,8,Higher,Southwest,CA,Urban,75+,2023-10,Q4_2023,2023,2.6,0.07,Increasing
FIA000784,2023-11-05,Gabapentin,Neurontin,Anticonvulsants,13772-589-98,Commercial Plan Alpha,PLAN_2982,2023,Tier 1,Specialty Tier,2023-03-15,235,Improved,None,No,No,,387,311,24.7,Increased,12.62,113.31,-100.69,102.89,115.51,44.7,0.0,0,0.023,0.218,0.358,0.562,0,2,9,4,4.0,24.4,7,Similar,Northeast,MI,Rural,36-50,2023-11,Q4_2023,2023,8.3,0.061,Decreasing
FIA000807,2023-11-10,Gabapentin,Neurontin,Anticonvulsants,33845-368-11,VA Plan,PLAN_6875,2023,Non-Formulary,Tier 1,2023-07-28,105,Worsened,Non-Formulary Status,No,No,,403,509,-20.8,Decreased,748.12,19.22,728.9,34.88,783.0,315.55,0.0,0,0.122,0.347,0.82,0.545,12,9,10,1,4.2,5.7,8,Lower,West,MI,Rural,51-65,2023-11,Q4_2023,2023,4.9,0.963,Stable
FIA000646,2023-11-15,Gabapentin,Neurontin,Anticonvulsants,63022-907-32,Medicare Part D Plan A,PLAN_9321,2023,Non-Formulary,Tier 3,2023-01-20,299,Worsened,Non-Formulary Status,No,No,,611,654,-6.6,Decreased,518.24,91.48,426.76,111.23,629.47,384.61,0.0,0,0.228,0.143,0.538,0.762,5,5,9,6,4.6,24.1,4,Higher,Midwest,TX,Rural,66-75,2023-11,Q4_2023,2023,2.5,0.159,Increasing
FIA000041,2023-11-24,Gabapentin,Neurontin,Anticonvulsants,88997-994-29,Medicaid Plan Y,PLAN_2335,2023,Non-Formulary,Tier 1,2022-12-06,353,Worsened,Non-Formulary Status,No,No,,102,196,-47.9,Decreased,588.38,5.99,582.39,174.77,763.15,77.84,0.0,0,0.113,0.254,0.299,0.592,12,2,19,2,2.9,16.3,8,Similar,Southeast,NC,Urban,66-75,2023-11,Q4_2023,2023,5.6,0.018,Stable
FIA002146,2023-12-03,Gabapentin,Neurontin,Anticonvulsants,69068-231-39,Medicaid Plan Y,PLAN_6641,2023,Specialty Tier,Tier 2,2023-04-21,226,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,525,801,-34.4,Decreased,272.11,24.28,247.83,113.48,385.59,202.43,0.306,2,0.141,0.392,0.292,0.554,9,7,19,5,3.4,31.7,6,Higher,Midwest,PA,Suburban,18-35,2023-12,Q4_2023,2023,5.0,0.315,Stable
FIA002965,2023-12-09,Gabapentin,Neurontin,Anticonvulsants,83142-608-61,Medicaid Plan Y,PLAN_8849,2023,Non-Formulary,Non-Formulary,2023-08-23,108,No Change,Non-Formulary Status; Quantity Limit,No,No,60.0,689,633,8.9,Increased,675.18,698.1,-22.92,174.74,849.92,585.59,0.0,0,0.109,0.244,0.38,0.705,8,1,11,10,3.7,22.6,5,Similar,Northeast,IL,Suburban,36-50,2023-12,Q4_2023,2023,5.0,0.512,Decreasing
FIA001873,2023-12-12,Gabapentin,Neurontin,Anticonvulsants,39794-701-68,Medicare Part D Plan B,PLAN_2705,2023,Tier 1,Tier 3,2023-01-22,324,Improved,Quantity Limit,No,No,30.0,769,606,26.9,Increased,9.11,83.22,-74.11,110.41,119.52,91.91,0.0,0,0.071,0.084,0.852,0.813,14,6,1,10,4.0,28.0,4,Similar,West,GA,Urban,51-65,2023-12,Q4_2023,2023,2.3,0.223,Stable
FIA001139,2023-12-14,Gabapentin,Neurontin,Anticonvulsants,79417-428-57,VA Plan,PLAN_9094,2023,Non-Formulary,Tier 3,2023-05-10,218,Worsened,Non-Formulary Status,No,No,,169,163,4.1,Stable,315.98,85.66,230.32,64.54,380.52,64.31,0.0,0,0.275,0.058,0.775,0.639,8,4,17,3,2.8,14.2,2,Lower,Midwest,CA,Suburban,51-65,2023-12,Q4_2023,2023,4.7,0.149,Increasing
FIA000762,2023-12-25,Gabapentin,Neurontin,Anticonvulsants,13840-981-94,Tricare Standard,PLAN_8745,2023,Non-Formulary,Specialty Tier,2023-01-07,352,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,571,606,-5.7,Decreased,296.01,183.3,112.71,70.86,366.87,209.48,0.0,0,0.179,0.234,0.203,0.679,9,3,5,13,4.3,23.3,3,Higher,Midwest,PA,Urban,66-75,2023-12,Q4_2023,2023,10.0,0.691,Decreasing
FIA000928,2023-12-27,Gabapentin,Neurontin,Anticonvulsants,86945-582-44,Commercial Plan Alpha,PLAN_2621,2023,Specialty Tier,Specialty Tier,2023-11-13,44,No Change,Prior Authorization,Yes,No,,890,971,-8.3,Decreased,101.77,298.5,-196.73,118.85,220.62,196.35,0.175,8,0.105,0.31,0.762,0.615,7,8,11,1,4.8,14.7,7,Higher,Southwest,CA,Rural,36-50,2023-12,Q4_2023,2023,3.3,0.781,Decreasing
FIA002252,2024-01-05,Gabapentin,Neurontin,Anticonvulsants,13223-438-13,Medicaid Plan X,PLAN_1862,2024,Tier 3,Tier 2,2023-09-25,102,Worsened,Prior Authorization; Quantity Limit,Yes,No,,571,825,-30.8,Decreased,95.59,28.28,67.31,48.67,144.26,82.37,0.357,7,0.056,0.27,0.523,0.534,6,6,18,7,3.1,27.1,2,Similar,Southeast,NC,Suburban,18-35,2024-01,Q1_2024,2023,3.9,0.989,Stable
FIA000918,2024-01-13,Gabapentin,Neurontin,Anticonvulsants,67213-339-47,Medicare Part D Plan A,PLAN_5104,2024,Tier 2,Tier 2,2023-10-29,76,No Change,None,No,No,,420,391,7.6,Increased,43.57,42.13,1.44,129.07,172.64,72.51,0.0,0,0.059,0.082,0.758,0.449,1,5,5,11,3.4,14.5,6,Lower,Northeast,PA,Suburban,75+,2024-01,Q1_2024,2023,9.2,0.089,Decreasing
FIA002011,2024-01-20,Gabapentin,Neurontin,Anticonvulsants,51091-675-58,Tricare Standard,PLAN_5491,2024,Specialty Tier,Specialty Tier,2023-09-15,127,No Change,None,No,No,,1016,972,4.6,Stable,235.18,173.06,62.12,134.05,369.23,375.14,0.0,0,0.122,0.162,0.755,0.904,9,3,3,6,2.5,21.1,8,Higher,Midwest,OH,Urban,36-50,2024-01,Q1_2024,2023,4.8,0.186,Increasing
FIA000461,2024-01-21,Gabapentin,Neurontin,Anticonvulsants,21118-882-30,Commercial Plan Beta,PLAN_2199,2024,Tier 3,Specialty Tier,2023-10-05,108,Improved,None,No,No,,260,262,-0.5,Stable,84.4,266.72,-182.32,101.46,185.86,48.32,0.0,0,0.069,0.104,0.276,0.526,5,4,16,10,4.7,9.7,6,Higher,West,NY,Suburban,66-75,2024-01,Q1_2024,2023,2.5,0.837,Stable
FIA002511,2024-02-02,Gabapentin,Neurontin,Anticonvulsants,63482-798-50,Medicare Part D Plan A,PLAN_6545,2024,Tier 1,Tier 2,2023-05-10,268,Improved,None,No,No,,924,893,3.5,Stable,6.37,36.06,-29.69,110.39,116.76,107.89,0.0,0,0.073,0.355,0.796,0.547,15,5,14,8,2.9,7.3,2,Higher,Midwest,MI,Rural,51-65,2024-02,Q1_2024,2023,4.1,0.349,Stable
FIA001905,2024-02-04,Gabapentin,Neurontin,Anticonvulsants,19402-245-69,Medicaid Plan X,PLAN_5440,2024,Tier 2,Tier 1,2023-02-13,356,Worsened,Quantity Limit,No,No,,841,804,4.6,Stable,29.46,10.26,19.2,190.84,220.3,185.27,0.0,0,0.04,0.084,0.215,0.937,14,2,10,6,2.7,27.4,4,Higher,West,GA,Urban,66-75,2024-02,Q1_2024,2023,7.0,0.016,Decreasing
FIA002215,2024-02-04,Gabapentin,Neurontin,Anticonvulsants,27684-511-14,Medicare Part D Plan B,PLAN_8429,2024,Tier 1,Non-Formulary,2023-11-13,83,Improved,None,No,No,,634,469,35.4,Increased,16.8,632.11,-615.31,61.32,78.12,49.53,0.0,0,0.076,0.366,0.4,0.616,6,2,1,2,2.4,9.5,4,Higher,Southeast,MI,Rural,18-35,2024-02,Q1_2024,2023,7.5,0.079,Decreasing
FIA002529,2024-02-11,Gabapentin,Neurontin,Anticonvulsants,38932-291-51,Commercial Plan Alpha,PLAN_6115,2024,Tier 2,Tier 1,2023-06-04,252,Worsened,None,No,No,,253,280,-9.6,Decreased,28.71,9.15,19.56,116.75,145.46,36.8,0.0,0,0.047,0.157,0.821,0.832,6,1,15,5,3.3,9.0,8,Lower,Midwest,IL,Suburban,66-75,2024-02,Q1_2024,2023,9.9,0.088,Increasing
FIA000633,2024-03-18,Gabapentin,Neurontin,Anticonvulsants,68368-768-58,Commercial Plan Beta,PLAN_3356,2024,Non-Formulary,Specialty Tier,2023-12-04,105,Worsened,Non-Formulary Status,No,No,,669,628,6.7,Increased,736.1,137.19,598.91,53.14,789.24,528.0,0.0,0,0.157,0.217,0.247,0.859,6,5,6,12,3.4,25.7,4,Higher,Southeast,NY,Rural,66-75,2024-03,Q1_2024,2023,7.5,0.836,Decreasing
FIA001894,2024-04-03,Gabapentin,Neurontin,Anticonvulsants,68609-289-67,Medicaid Plan X,PLAN_8459,2024,Non-Formulary,Tier 2,2023-09-24,192,Worsened,Non-Formulary Status,No,No,,128,336,-61.9,Decreased,794.48,34.18,760.3,82.91,877.39,112.31,0.0,0,0.165,0.258,0.341,0.882,0,7,2,4,2.7,17.7,6,Lower,Southeast,TX,Suburban,51-65,2024-04,Q2_2024,2023,3.4,0.798,Increasing
FIA000866,2024-04-11,Gabapentin,Neurontin,Anticonvulsants,49362-997-81,VA Plan,PLAN_9500,2024,Tier 3,Tier 3,2023-08-17,238,No Change,Prior Authorization,Yes,No,,324,331,-2.1,Stable,89.34,58.29,31.05,108.86,198.2,64.22,0.245,10,0.046,0.145,0.377,0.438,0,10,7,12,4.4,5.8,2,Similar,Southwest,CA,Urban,66-75,2024-04,Q2_2024,2023,5.4,0.956,Increasing
FIA001005,2024-04-11,Gabapentin,Neurontin,Anticonvulsants,74980-903-16,Medicare Part D Plan B,PLAN_5547,2024,Tier 2,Non-Formulary,2024-02-29,42,Improved,None,No,No,,1136,784,45.0,Increased,30.34,706.41,-676.07,113.46,143.8,163.36,0.0,0,0.043,0.285,0.525,0.784,4,1,3,10,3.3,24.7,7,Higher,Southwest,PA,Suburban,18-35,2024-04,Q2_2024,2023,9.7,0.45,Decreasing
FIA002490,2024-04-11,Gabapentin,Neurontin,Anticonvulsants,54612-187-96,Commercial Plan Alpha,PLAN_9943,2024,Tier 1,Tier 2,2023-05-14,333,Improved,None,No,No,,449,433,3.9,Stable,17.44,23.15,-5.71,149.29,166.73,74.86,0.0,0,0.079,0.168,0.562,0.948,6,0,16,2,4.2,23.6,8,Lower,Northeast,IL,Rural,75+,2024-04,Q2_2024,2023,5.0,0.808,Decreasing
FIA000058,2024-04-13,Gabapentin,Neurontin,Anticonvulsants,32946-527-32,Medicare Part D Plan A,PLAN_7504,2024,Specialty Tier,Specialty Tier,2023-04-16,363,No Change,Prior Authorization,Yes,No,,409,428,-4.3,Stable,139.89,292.78,-152.89,189.23,329.12,134.61,0.368,8,0.231,0.115,0.724,0.88,9,0,0,9,3.7,8.2,4,Similar,Southwest,NC,Rural,66-75,2024-04,Q2_2024,2023,9.0,0.134,Decreasing
FIA001103,2024-04-14,Gabapentin,Neurontin,Anticonvulsants,53807-525-34,Commercial Plan Alpha,PLAN_3157,2024,Tier 1,Tier 3,2023-05-29,321,Improved,Quantity Limit,No,No,60.0,1084,812,33.6,Increased,18.24,65.68,-47.44,65.2,83.44,90.45,0.0,0,0.015,0.367,0.852,0.681,11,6,19,12,2.2,8.9,3,Higher,Southwest,MI,Suburban,51-65,2024-04,Q2_2024,2023,6.0,0.76,Stable
FIA001501,2024-04-25,Gabapentin,Neurontin,Anticonvulsants,64680-854-38,Medicare Part D Plan B,PLAN_2437,2024,Tier 2,Non-Formulary,2024-03-22,34,Improved,Quantity Limit,No,No,60.0,755,491,53.9,Increased,45.03,515.69,-470.66,167.67,212.7,160.59,0.0,0,0.071,0.136,0.723,0.652,7,9,16,15,5.0,13.3,4,Lower,Southwest,PA,Urban,75+,2024-04,Q2_2024,2023,3.0,0.794,Decreasing
FIA002336,2024-05-08,Gabapentin,Neurontin,Anticonvulsants,37028-633-77,Medicare Part D Plan A,PLAN_8025,2024,Non-Formulary,Tier 1,2023-08-15,267,Worsened,Non-Formulary Status,No,No,,79,155,-48.5,Decreased,423.23,5.53,417.7,70.12,493.35,38.97,0.0,0,0.051,0.247,0.522,0.53,6,8,4,15,3.5,23.5,7,Higher,Northeast,GA,Urban,36-50,2024-05,Q2_2024,2023,9.5,0.97,Increasing
FIA000034,2024-05-23,Gabapentin,Neurontin,Anticonvulsants,52622-490-86,Medicaid Plan X,PLAN_8433,2024,Tier 1,Specialty Tier,2023-09-09,257,Improved,None,No,No,,878,722,21.7,Increased,6.1,116.16,-110.06,129.51,135.61,119.07,0.0,0,0.054,0.227,0.501,0.836,3,10,20,6,3.3,31.6,5,Similar,Southwest,OH,Suburban,18-35,2024-05,Q2_2024,2023,3.8,0.313,Stable
FIA001384,2024-05-27,Gabapentin,Neurontin,Anticonvulsants,95837-727-83,Commercial Plan Beta,PLAN_2218,2024,Non-Formulary,Tier 2,2023-11-17,192,Worsened,Non-Formulary Status,No,No,,202,340,-40.4,Decreased,659.45,26.91,632.54,188.22,847.67,171.23,0.0,0,0.054,0.342,0.614,0.454,8,0,0,3,2.5,26.6,6,Similar,Northeast,MI,Urban,36-50,2024-05,Q2_2024,2023,5.6,0.447,Stable
FIA002749,2024-06-09,Gabapentin,Neurontin,Anticonvulsants,45181-817-30,Tricare Standard,PLAN_7951,2024,Non-Formulary,Non-Formulary,2023-09-07,276,No Change,Non-Formulary Status,No,No,,665,673,-1.1,Stable,543.96,685.22,-141.26,64.74,608.7,404.79,0.0,0,0.205,0.363,0.621,0.446,15,0,15,14,4.9,28.7,3,Higher,Northeast,MI,Rural,66-75,2024-06,Q2_2024,2023,4.9,0.294,Stable
FIA000293,2024-06-14,Gabapentin,Neurontin,Anticonvulsants,68209-615-84,Medicare Part D Plan A,PLAN_5749,2024,Tier 3,Non-Formulary,2024-03-26,80,Improved,Prior Authorization,Yes,No,,189,206,-8.2,Decreased,99.77,683.56,-583.79,46.95,146.72,27.73,0.476,7,0.075,0.124,0.744,0.703,3,3,15,3,3.1,28.8,5,Similar,Southwest,CA,Suburban,36-50,2024-06,Q2_2024,2023,5.6,0.268,Decreasing
FIA001530,2024-06-26,Gabapentin,Neurontin,Anticonvulsants,75716-906-83,Commercial Plan Beta,PLAN_4558,2024,Tier 2,Non-Formulary,2023-09-24,276,Improved,None,No,No,,846,723,17.0,Increased,22.26,797.52,-775.26,184.25,206.51,174.71,0.0,0,0.041,0.062,0.351,0.667,1,10,13,5,4.9,9.2,2,Lower,Southeast,NY,Urban,51-65,2024-06,Q2_2024,2023,9.9,0.693,Stable
FIA002286,2024-06-26,Gabapentin,Neurontin,Anticonvulsants,68361-998-51,Medicare Part D Plan A,PLAN_4129,2024,Tier 1,Specialty Tier,2024-02-14,133,Improved,Quantity Limit,No,No,,1234,789,56.5,Increased,16.09,154.72,-138.63,62.28,78.37,96.71,0.0,0,0.071,0.273,0.714,0.793,3,7,7,10,4.1,24.9,6,Higher,Southwest,TX,Suburban,66-75,2024-06,Q2_2024,2023,5.0,0.863,Stable
FIA001222,2024-06-28,Gabapentin,Neurontin,Anticonvulsants,52547-688-21,Medicaid Plan X,PLAN_5904,2024,Tier 2,Tier 3,2024-01-08,172,Improved,None,No,No,,1076,709,51.8,Increased,43.02,96.68,-53.66,157.19,200.21,215.43,0.0,0,0.05,0.39,0.837,0.716,9,0,0,9,3.2,30.5,8,Higher,Midwest,OH,Urban,75+,2024-06,Q2_2024,2023,2.4,0.749,Decreasing
FIA002026,2024-07-02,Gabapentin,Neurontin,Anticonvulsants,66595-619-75,Medicare Part D Plan A,PLAN_1414,2024,Tier 1,Tier 3,2024-04-30,63,Improved,None,No,No,,564,466,21.1,Increased,18.4,65.58,-47.18,79.34,97.74,55.13,0.0,0,0.043,0.298,0.377,0.743,10,2,12,0,3.0,31.3,7,Higher,West,IL,Suburban,66-75,2024-07,Q3_2024,2023,3.5,0.094,Increasing
FIA002554,2024-07-12,Gabapentin,Neurontin,Anticonvulsants,61894-273-33,Medicaid Plan X,PLAN_3012,2024,Specialty Tier,Tier 3,2024-01-19,175,Worsened,Prior Authorization,Yes,No,,259,270,-3.7,Stable,141.41,54.41,87.0,145.66,287.07,74.35,0.11,5,0.204,0.369,0.251,0.696,3,0,4,10,2.1,28.5,8,Similar,Southeast,GA,Urban,36-50,2024-07,Q3_2024,2023,3.9,0.956,Increasing
FIA001044,2024-07-18,Gabapentin,Neurontin,Anticonvulsants,72598-187-30,Medicare Part D Plan B,PLAN_9559,2024,Tier 3,Non-Formulary,2023-07-27,357,Improved,None,No,No,,593,638,-7.0,Decreased,91.47,618.03,-526.56,141.39,232.86,138.09,0.0,0,0.012,0.255,0.727,0.554,5,3,19,10,3.7,28.2,3,Lower,Southeast,TX,Suburban,75+,2024-07,Q3_2024,2023,9.2,0.894,Decreasing
FIA002010,2024-07-25,Gabapentin,Neurontin,Anticonvulsants,70530-250-25,Tricare Standard,PLAN_3877,2024,Non-Formulary,Specialty Tier,2023-11-01,267,Worsened,Non-Formulary Status,No,No,,556,583,-4.5,Stable,448.53,221.61,226.92,30.34,478.87,266.25,0.0,0,0.102,0.076,0.61,0.774,4,7,19,0,4.1,6.7,7,Higher,Midwest,OH,Suburban,36-50,2024-07,Q3_2024,2023,5.8,0.95,Stable
FIA000901,2024-08-01,Gabapentin,Neurontin,Anticonvulsants,90678-881-43,Commercial Plan Alpha,PLAN_1920,2024,Tier 3,Tier 2,2023-08-31,336,Worsened,Prior Authorization,Yes,No,,265,866,-69.4,Decreased,71.11,37.85,33.26,145.29,216.4,57.35,0.273,5,0.037,0.079,0.399,0.592,6,7,9,1,4.8,28.6,8,Similar,Northeast,NY,Urban,66-75,2024-08,Q3_2024,2023,9.4,0.983,Increasing
FIA002362,2024-08-13,Gabapentin,Neurontin,Anticonvulsants,49139-953-75,Tricare Standard,PLAN_2266,2024,Non-Formulary,Tier 1,2024-04-07,128,Worsened,Non-Formulary Status,No,No,,120,193,-37.7,Decreased,681.19,12.52,668.67,36.43,717.62,86.11,0.0,0,0.121,0.235,0.76,0.727,2,10,14,0,4.7,19.9,5,Similar,Northeast,IL,Suburban,51-65,2024-08,Q3_2024,2023,7.3,0.737,Decreasing
FIA002082,2024-08-23,Gabapentin,Neurontin,Anticonvulsants,66599-829-51,Tricare Standard,PLAN_2235,2024,Tier 1,Tier 2,2023-10-16,312,Improved,None,No,No,,177,172,3.4,Stable,13.92,40.33,-26.41,166.91,180.83,32.01,0.0,0,0.051,0.198,0.564,0.669,7,1,19,0,2.2,32.4,6,Similar,Midwest,PA,Urban,51-65,2024-08,Q3_2024,2023,7.8,0.754,Stable
FIA000814,2024-08-31,Gabapentin,Neurontin,Anticonvulsants,60013-520-80,Medicare Part D Plan A,PLAN_9518,2024,Tier 2,Tier 2,2024-03-11,173,No Change,None,No,No,,884,877,0.8,Stable,24.34,35.73,-11.39,58.46,82.8,73.2,0.0,0,0.056,0.318,0.505,0.782,2,10,16,1,2.8,28.8,3,Similar,West,CA,Urban,51-65,2024-08,Q3_2024,2023,8.8,0.439,Increasing
FIA001663,2024-08-31,Gabapentin,Neurontin,Anticonvulsants,74721-284-12,Medicaid Plan Y,PLAN_7143,2024,Tier 3,Specialty Tier,2024-03-02,182,Improved,None,No,No,,179,188,-4.6,Stable,64.52,142.11,-77.59,86.18,150.7,26.98,0.0,0,0.074,0.162,0.359,0.455,10,5,10,0,2.5,29.7,6,Similar,Midwest,CA,Suburban,75+,2024-08,Q3_2024,2023,8.3,0.727,Increasing
FIA001926,2024-09-08,Gabapentin,Neurontin,Anticonvulsants,44601-862-75,Commercial Plan Beta,PLAN_1108,2024,Tier 3,Tier 2,2024-06-21,79,Worsened,None,No,No,,515,977,-47.2,Decreased,52.35,28.0,24.35,130.38,182.73,94.11,0.0,0,0.069,0.357,0.565,0.856,1,8,0,14,3.1,26.4,3,Higher,Southeast,MI,Rural,51-65,2024-09,Q3_2024,2023,7.9,0.451,Stable
FIA002340,2024-09-09,Gabapentin,Neurontin,Anticonvulsants,28930-674-12,Medicaid Plan X,PLAN_2943,2024,Tier 3,Tier 3,2024-04-07,155,No Change,Quantity Limit,No,No,90.0,745,761,-2.0,Stable,73.49,68.57,4.92,98.46,171.95,128.1,0.0,0,0.014,0.266,0.461,0.695,6,0,7,7,3.0,5.8,3,Similar,Southwest,OH,Urban,18-35,2024-09,Q3_2024,2023,2.6,0.519,Stable
FIA000324,2024-09-10,Gabapentin,Neurontin,Anticonvulsants,43817-884-45,Medicaid Plan X,PLAN_9108,2024,Non-Formulary,Tier 2,2024-01-15,239,Worsened,Non-Formulary Status,No,No,,134,383,-64.9,Decreased,235.15,48.17,186.98,104.87,340.02,45.56,0.0,0,0.288,0.095,0.641,0.481,1,3,3,1,2.6,20.2,5,Higher,Midwest,CA,Rural,36-50,2024-09,Q3_2024,2023,1.5,0.715,Stable
FIA000829,2024-09-23,Gabapentin,Neurontin,Anticonvulsants,58989-672-83,Medicare Part D Plan B,PLAN_4077,2024,Tier 1,Tier 2,2024-03-25,182,Improved,None,No,No,,225,217,4.1,Stable,6.96,44.43,-37.47,41.76,48.72,10.96,0.0,0,0.019,0.189,0.581,0.719,14,0,14,8,2.5,33.8,3,Lower,West,NY,Rural,66-75,2024-09,Q3_2024,2023,7.6,0.781,Stable
FIA000996,2024-09-30,Gabapentin,Neurontin,Anticonvulsants,90688-179-72,Medicare Part D Plan A,PLAN_1625,2024,Non-Formulary,Tier 1,2024-04-11,172,Worsened,Non-Formulary Status,No,No,,158,198,-20.1,Decreased,277.31,8.07,269.24,166.07,443.38,70.05,0.0,0,0.295,0.177,0.289,0.445,8,5,14,9,3.7,28.0,4,Higher,West,CA,Suburban,36-50,2024-09,Q3_2024,2023,5.3,0.703,Stable
FIA000197,2024-10-17,Gabapentin,Neurontin,Anticonvulsants,74512-911-69,Commercial Plan Beta,PLAN_5809,2024,Tier 1,Tier 2,2024-03-06,225,Improved,None,No,No,,420,410,2.4,Stable,14.07,29.81,-15.74,118.39,132.46,55.63,0.0,0,0.056,0.282,0.543,0.544,10,8,17,0,4.9,5.9,5,Lower,Southwest,GA,Suburban,66-75,2024-10,Q4_2024,2024,5.0,0.036,Increasing
FIA001973,2024-10-18,Gabapentin,Neurontin,Anticonvulsants,77573-869-20,Commercial Plan Alpha,PLAN_5734,2024,Tier 3,Non-Formulary,2024-06-01,139,Improved,Step Therapy,No,Yes,,184,173,6.4,Increased,65.26,363.26,-298.0,44.23,109.49,20.15,0.0,0,0.071,0.306,0.804,0.478,3,2,19,13,4.9,15.7,6,Similar,Midwest,FL,Urban,75+,2024-10,Q4_2024,2024,7.3,0.228,Increasing
FIA000483,2024-10-20,Gabapentin,Neurontin,Anticonvulsants,33906-204-90,Commercial Plan Beta,PLAN_5277,2024,Non-Formulary,Tier 2,2024-06-17,125,Worsened,Non-Formulary Status,No,No,,568,754,-24.6,Decreased,245.11,45.02,200.09,121.16,366.27,208.04,0.0,0,0.255,0.232,0.882,0.494,10,7,19,14,2.7,17.8,8,Lower,West,NY,Urban,75+,2024-10,Q4_2024,2024,2.6,0.682,Stable
FIA001857,2024-10-25,Gabapentin,Neurontin,Anticonvulsants,60533-469-84,Commercial Plan Alpha,PLAN_8779,2024,Specialty Tier,Tier 3,2024-03-28,211,Worsened,Prior Authorization,Yes,No,,551,529,4.3,Stable,258.06,90.23,167.83,115.75,373.81,205.97,0.519,10,0.186,0.339,0.814,0.909,3,10,5,13,2.9,34.1,4,Higher,Southeast,GA,Suburban,18-35,2024-10,Q4_2024,2024,6.1,0.727,Decreasing
FIA001188,2024-10-27,Gabapentin,Neurontin,Anticonvulsants,34660-310-49,Medicare Part D Plan A,PLAN_4020,2024,Tier 1,Non-Formulary,2024-05-10,170,Improved,None,No,No,,403,276,46.4,Increased,14.71,515.35,-500.64,55.72,70.43,28.38,0.0,0,0.043,0.28,0.348,0.691,3,3,4,13,3.4,18.5,3,Lower,Southwest,FL,Suburban,66-75,2024-10,Q4_2024,2024,9.2,0.43,Stable
FIA002487,2024-10-28,Gabapentin,Neurontin,Anticonvulsants,25736-246-66,Medicare Part D Plan B,PLAN_1043,2024,Tier 1,Tier 1,2024-09-17,41,No Change,Quantity Limit,No,No,60.0,445,459,-3.0,Stable,15.58,8.02,7.56,92.44,108.02,48.07,0.0,0,0.046,0.362,0.692,0.769,6,4,19,14,4.9,18.9,7,Higher,Midwest,TX,Suburban,66-75,2024-10,Q4_2024,2024,5.3,0.444,Decreasing
FIA001130,2024-11-05,Gabapentin,Neurontin,Anticonvulsants,67735-993-60,Medicare Part D Plan A,PLAN_2969,2024,Non-Formulary,Tier 1,2024-04-07,212,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,314,621,-49.3,Decreased,671.68,7.71,663.97,48.81,720.49,226.23,0.0,0,0.139,0.196,0.501,0.584,1,5,1,15,4.2,34.6,3,Similar,West,TX,Urban,75+,2024-11,Q4_2024,2024,3.7,0.054,Decreasing
FIA000457,2024-11-09,Gabapentin,Neurontin,Anticonvulsants,24040-347-46,Medicaid Plan X,PLAN_5002,2024,Tier 2,Tier 1,2024-05-26,167,Worsened,None,No,No,,741,806,-8.0,Decreased,41.64,12.83,28.81,126.42,168.06,124.53,0.0,0,0.011,0.315,0.668,0.706,5,10,15,0,2.4,5.6,8,Higher,West,OH,Rural,51-65,2024-11,Q4_2024,2024,1.0,0.193,Increasing
FIA000249,2024-11-12,Gabapentin,Neurontin,Anticonvulsants,41922-734-20,Medicare Part D Plan A,PLAN_3253,2024,Tier 2,Non-Formulary,2023-12-18,330,Improved,Quantity Limit,No,No,60.0,172,121,42.7,Increased,41.14,207.98,-166.84,155.45,196.59,33.81,0.0,0,0.032,0.225,0.341,0.607,1,3,19,14,4.2,14.9,4,Similar,Northeast,NC,Suburban,51-65,2024-11,Q4_2024,2024,7.8,0.229,Decreasing
FIA002055,2024-11-13,Gabapentin,Neurontin,Anticonvulsants,82254-681-57,Commercial Plan Beta,PLAN_5884,2024,Specialty Tier,Non-Formulary,2024-01-23,295,Improved,Prior Authorization; Step Therapy,Yes,Yes,,294,287,2.5,Stable,264.4,682.37,-417.97,34.17,298.57,87.78,0.587,3,0.16,0.174,0.742,0.673,3,3,10,2,4.0,8.6,4,Similar,Southeast,PA,Rural,75+,2024-11,Q4_2024,2024,6.6,0.861,Decreasing
FIA002316,2024-11-19,Gabapentin,Neurontin,Anticonvulsants,97405-444-30,Medicaid Plan Y,PLAN_5985,2024,Specialty Tier,Specialty Tier,2024-10-19,31,No Change,Prior Authorization,Yes,No,,806,847,-4.7,Stable,263.9,214.01,49.89,112.38,376.28,303.28,0.369,9,0.254,0.378,0.483,0.755,10,0,16,11,3.0,7.8,8,Higher,West,CA,Urban,18-35,2024-11,Q4_2024,2024,4.6,0.116,Stable
FIA002577,2024-11-28,Gabapentin,Neurontin,Anticonvulsants,42018-735-37,Medicare Part D Plan B,PLAN_9370,2024,Tier 2,Specialty Tier,2024-02-08,294,Improved,None,No,No,,203,138,47.6,Increased,30.82,206.83,-176.01,31.37,62.19,12.62,0.0,0,0.063,0.201,0.605,0.658,0,4,9,13,5.0,24.0,3,Higher,Northeast,GA,Suburban,36-50,2024-11,Q4_2024,2024,9.5,0.944,Decreasing
FIA000125,2024-12-03,Gabapentin,Neurontin,Anticonvulsants,55224-598-71,Medicare Part D Plan A,PLAN_9222,2024,Tier 3,Tier 3,2024-01-12,326,No Change,Quantity Limit,No,No,30.0,750,769,-2.4,Stable,77.22,58.69,18.53,89.99,167.21,125.41,0.0,0,0.046,0.204,0.361,0.683,8,3,4,5,2.5,23.1,8,Lower,Southeast,OH,Suburban,18-35,2024-12,Q4_2024,2024,5.3,0.479,Increasing
FIA001661,2024-12-03,Gabapentin,Neurontin,Anticonvulsants,40697-124-82,Commercial Plan Alpha,PLAN_4036,2024,Non-Formulary,Tier 3,2024-01-22,316,Worsened,Non-Formulary Status,No,No,,168,154,9.2,Increased,260.08,53.95,206.13,135.0,395.08,66.37,0.0,0,0.193,0.103,0.228,0.795,9,1,15,13,3.2,28.5,5,Lower,Southwest,NC,Urban,75+,2024-12,Q4_2024,2024,2.4,0.165,Decreasing
FIA001158,2024-12-11,Gabapentin,Neurontin,Anticonvulsants,52672-733-47,Medicaid Plan Y,PLAN_3212,2024,Tier 1,Non-Formulary,2024-01-25,321,Improved,Quantity Limit,No,No,,1114,834,33.6,Increased,12.75,460.71,-447.96,177.85,190.6,212.33,0.0,0,0.071,0.09,0.592,0.812,5,3,20,10,4.9,6.5,6,Similar,Southwest,NY,Suburban,66-75,2024-12,Q4_2024,2024,6.1,0.138,Decreasing
FIA000269,2024-12-17,Gabapentin,Neurontin,Anticonvulsants,77329-461-16,VA Plan,PLAN_9118,2024,Non-Formulary,Tier 1,2024-01-12,340,Worsened,Non-Formulary Status,No,No,,474,882,-46.2,Decreased,469.19,7.53,461.66,172.7,641.89,304.26,0.0,0,0.069,0.183,0.461,0.462,7,8,3,9,2.9,13.8,3,Lower,West,OH,Urban,51-65,2024-12,Q4_2024,2024,9.4,0.959,Decreasing
FIA000507,2024-12-17,Gabapentin,Neurontin,Anticonvulsants,89555-512-30,Tricare Standard,PLAN_5165,2024,Tier 3,Specialty Tier,2024-04-13,248,Improved,Quantity Limit,No,No,90.0,550,608,-9.4,Decreased,85.17,219.23,-134.06,162.09,247.26,135.99,0.0,0,0.066,0.361,0.506,0.482,11,9,2,7,4.5,26.0,5,Lower,Northeast,CA,Suburban,66-75,2024-12,Q4_2024,2024,4.7,0.1,Stable
FIA002584,2024-12-19,Gabapentin,Neurontin,Anticonvulsants,36167-184-20,Tricare Standard,PLAN_6656,2024,Tier 3,Specialty Tier,2024-05-06,227,Improved,Step Therapy,No,Yes,,986,930,6.0,Increased,73.96,115.6,-41.64,106.01,179.97,177.45,0.0,0,0.049,0.389,0.815,0.603,1,10,9,10,2.6,29.9,8,Similar,Midwest,GA,Urban,36-50,2024-12,Q4_2024,2024,1.7,0.983,Increasing
FIA001401,2024-12-24,Gabapentin,Neurontin,Anticonvulsants,72741-470-59,Commercial Plan Alpha,PLAN_8442,2024,Tier 2,Specialty Tier,2024-05-26,212,Improved,None,No,No,,856,541,58.4,Increased,43.93,228.97,-185.04,143.5,187.43,160.44,0.0,0,0.026,0.179,0.376,0.771,8,0,7,9,3.8,34.1,8,Higher,Southeast,MI,Suburban,51-65,2024-12,Q4_2024,2024,6.6,0.329,Stable
FIA000826,2024-12-26,Gabapentin,Neurontin,Anticonvulsants,87740-321-66,VA Plan,PLAN_9404,2024,Tier 3,Tier 1,2024-08-09,139,Worsened,Prior Authorization,Yes,No,,197,623,-68.3,Decreased,69.1,11.75,57.35,47.05,116.15,22.88,0.513,5,0.055,0.323,0.576,0.894,15,1,8,12,4.0,10.0,2,Similar,West,NY,Urban,36-50,2024-12,Q4_2024,2024,3.9,0.975,Increasing
FIA001890,2024-12-29,Gabapentin,Neurontin,Anticonvulsants,88434-814-96,Medicare Part D Plan A,PLAN_1594,2024,Specialty Tier,Tier 1,2024-03-02,302,Worsened,None,No,No,,234,550,-57.4,Decreased,121.87,9.26,112.61,165.3,287.17,67.2,0.0,0,0.213,0.369,0.607,0.662,7,10,1,7,3.3,34.0,7,Lower,Southwest,GA,Suburban,66-75,2024-12,Q4_2024,2024,4.9,0.95,Increasing
FIA001632,2025-01-03,Gabapentin,Neurontin,Anticonvulsants,78574-541-92,Medicaid Plan X,PLAN_8195,2025,Tier 2,Tier 3,2024-07-11,176,Improved,None,No,No,,264,199,33.0,Increased,31.58,58.05,-26.47,30.66,62.24,16.43,0.0,0,0.052,0.357,0.299,0.794,6,2,4,8,2.5,18.0,5,Higher,Southeast,OH,Rural,18-35,2025-01,Q1_2025,2024,2.4,0.251,Stable
FIA002134,2025-01-18,Gabapentin,Neurontin,Anticonvulsants,34615-546-12,Medicare Part D Plan A,PLAN_9807,2025,Tier 1,Tier 1,2024-05-21,242,No Change,None,No,No,,570,533,7.0,Increased,11.0,5.45,5.55,138.72,149.72,85.34,0.0,0,0.066,0.328,0.713,0.871,1,0,13,7,4.2,23.1,3,Similar,West,FL,Urban,66-75,2025-01,Q1_2025,2024,6.3,0.951,Increasing
FIA001372,2025-01-20,Gabapentin,Neurontin,Anticonvulsants,31207-718-51,VA Plan,PLAN_2909,2025,Tier 2,Tier 3,2024-08-23,150,Improved,None,No,No,,1309,956,37.0,Increased,29.99,82.03,-52.04,87.06,117.05,153.22,0.0,0,0.075,0.273,0.539,0.626,8,8,8,13,4.2,29.0,4,Lower,West,MI,Suburban,66-75,2025-01,Q1_2025,2024,6.2,0.363,Stable
FIA002604,2025-01-28,Gabapentin,Neurontin,Anticonvulsants,31992-647-20,VA Plan,PLAN_8458,2025,Tier 2,Tier 3,2024-04-13,290,Improved,None,No,No,,1409,996,41.6,Increased,21.49,96.98,-75.49,101.26,122.75,172.95,0.0,0,0.016,0.306,0.787,0.808,14,9,12,12,4.3,13.3,8,Lower,Northeast,TX,Urban,75+,2025-01,Q1_2025,2024,3.1,0.265,Decreasing
FIA000608,2025-02-02,Gabapentin,Neurontin,Anticonvulsants,13691-701-81,Tricare Standard,PLAN_3474,2025,Tier 1,Tier 1,2024-02-20,348,No Change,None,No,No,,219,201,9.1,Increased,12.24,14.24,-2.0,191.86,204.1,44.7,0.0,0,0.029,0.311,0.888,0.876,13,3,5,5,3.1,34.8,8,Similar,Southeast,FL,Suburban,18-35,2025-02,Q1_2025,2024,3.4,0.89,Decreasing
FIA000899,2025-02-13,Gabapentin,Neurontin,Anticonvulsants,15165-591-69,Medicare Part D Plan B,PLAN_1898,2025,Tier 3,Non-Formulary,2025-01-04,40,Improved,Prior Authorization; Step Therapy,Yes,Yes,,756,819,-7.6,Decreased,76.11,201.66,-125.55,92.39,168.5,127.39,0.343,8,0.073,0.339,0.241,0.524,13,8,18,11,4.2,22.9,5,Higher,Southeast,PA,Suburban,18-35,2025-02,Q1_2025,2024,7.0,0.328,Increasing
FIA000198,2025-02-14,Gabapentin,Neurontin,Anticonvulsants,72378-675-30,Medicare Part D Plan A,PLAN_7412,2025,Tier 3,Tier 2,2024-05-09,281,Worsened,None,No,No,,277,498,-44.4,Decreased,71.53,29.37,42.16,127.28,198.81,55.07,0.0,0,0.058,0.142,0.614,0.608,11,4,10,1,2.1,6.4,8,Similar,Midwest,MI,Urban,51-65,2025-02,Q1_2025,2024,4.4,0.428,Stable
FIA001478,2025-02-14,Gabapentin,Neurontin,Anticonvulsants,93906-571-56,Medicaid Plan Y,PLAN_9946,2025,Non-Formulary,Specialty Tier,2024-05-27,263,Worsened,Non-Formulary Status,No,No,,241,263,-8.1,Decreased,325.84,291.21,34.63,62.16,388.0,93.51,0.0,0,0.279,0.362,0.75,0.933,7,2,2,8,4.4,28.1,4,Lower,Northeast,NC,Rural,51-65,2025-02,Q1_2025,2024,7.9,0.564,Decreasing
FIA001625,2025-02-20,Gabapentin,Neurontin,Anticonvulsants,70960-221-69,Medicare Part D Plan B,PLAN_1118,2025,Specialty Tier,Tier 1,2024-12-10,72,Worsened,Prior Authorization,Yes,No,,724,967,-25.1,Decreased,278.08,8.7,269.38,43.03,321.11,232.48,0.132,5,0.266,0.325,0.701,0.715,5,0,15,2,4.7,31.0,6,Higher,Northeast,FL,Urban,18-35,2025-02,Q1_2025,2024,3.2,0.992,Decreasing
FIA002953,2025-02-24,Gabapentin,Neurontin,Anticonvulsants,36012-981-49,Commercial Plan Beta,PLAN_5568,2025,Non-Formulary,Tier 2,2024-06-25,244,Worsened,Non-Formulary Status,No,No,,105,335,-68.4,Decreased,706.85,21.57,685.28,94.58,801.43,84.15,0.0,0,0.066,0.376,0.27,0.765,6,5,20,3,2.6,15.6,7,Higher,Southeast,GA,Rural,51-65,2025-02,Q1_2025,2024,4.4,0.097,Increasing
FIA000565,2025-02-27,Gabapentin,Neurontin,Anticonvulsants,85025-558-85,Tricare Standard,PLAN_6071,2025,Specialty Tier,Tier 3,2024-05-28,275,Worsened,None,No,No,,239,243,-1.6,Stable,101.38,52.5,48.88,98.16,199.54,47.69,0.0,0,0.159,0.36,0.262,0.849,12,5,13,1,2.8,14.9,2,Similar,Southeast,IL,Suburban,36-50,2025-02,Q1_2025,2024,5.2,0.038,Decreasing
FIA002558,2025-02-28,Gabapentin,Neurontin,Anticonvulsants,40919-246-63,VA Plan,PLAN_7791,2025,Non-Formulary,Tier 3,2024-12-27,63,Worsened,Non-Formulary Status,No,No,,232,230,1.1,Stable,295.25,68.87,226.38,155.6,450.85,104.6,0.0,0,0.063,0.213,0.242,0.628,12,1,17,3,4.1,19.0,5,Lower,Southeast,FL,Urban,51-65,2025-02,Q1_2025,2024,7.9,0.903,Decreasing
FIA000397,2025-03-16,Gabapentin,Neurontin,Anticonvulsants,80314-468-38,Commercial Plan Alpha,PLAN_5699,2025,Specialty Tier,Tier 3,2024-04-05,345,Worsened,Step Therapy,No,Yes,,355,343,3.7,Stable,177.35,95.51,81.84,56.03,233.38,82.85,0.0,0,0.28,0.273,0.322,0.932,8,2,11,0,3.3,14.0,2,Similar,Southwest,NC,Urban,66-75,2025-03,Q1_2025,2024,2.1,0.626,Increasing
FIA001275,2025-03-21,Gabapentin,Neurontin,Anticonvulsants,70448-377-88,VA Plan,PLAN_2134,2025,Specialty Tier,Specialty Tier,2024-04-14,341,No Change,Quantity Limit,No,No,30.0,718,708,1.5,Stable,186.15,140.55,45.6,38.28,224.43,161.14,0.0,0,0.147,0.102,0.804,0.681,0,8,15,9,4.1,18.6,6,Higher,West,NC,Urban,51-65,2025-03,Q1_2025,2024,8.0,0.455,Decreasing
FIA002233,2025-03-22,Gabapentin,Neurontin,Anticonvulsants,42733-740-68,Commercial Plan Alpha,PLAN_8835,2025,Tier 1,Non-Formulary,2024-06-22,273,Improved,None,No,No,,1148,774,48.4,Increased,14.56,320.56,-306.0,133.08,147.64,169.49,0.0,0,0.043,0.174,0.269,0.443,10,8,12,4,4.6,19.2,3,Higher,West,PA,Suburban,66-75,2025-03,Q1_2025,2024,9.8,0.554,Stable
FIA002440,2025-03-22,Gabapentin,Neurontin,Anticonvulsants,97270-271-76,Commercial Plan Alpha,PLAN_4536,2025,Tier 3,Tier 3,2024-04-11,345,No Change,Prior Authorization; Quantity Limit,Yes,No,30.0,829,818,1.4,Stable,61.49,97.53,-36.04,89.41,150.9,125.1,0.465,3,0.072,0.324,0.259,0.628,3,6,5,12,3.9,15.5,5,Lower,West,NC,Urban,66-75,2025-03,Q1_2025,2024,5.7,0.127,Increasing
FIA001510,2025-03-24,Gabapentin,Neurontin,Anticonvulsants,37418-239-59,Medicaid Plan X,PLAN_9133,2025,Tier 3,Tier 1,2024-06-04,293,Worsened,None,No,No,,406,536,-24.1,Decreased,96.82,15.68,81.14,174.06,270.88,109.98,0.0,0,0.034,0.145,0.275,0.79,2,2,8,0,4.0,30.1,3,Higher,Southwest,NC,Suburban,75+,2025-03,Q1_2025,2024,8.6,0.318,Stable
FIA000720,2025-03-30,Gabapentin,Neurontin,Anticonvulsants,64687-973-63,Medicare Part D Plan B,PLAN_7622,2025,Non-Formulary,Tier 1,2025-02-16,42,Worsened,Non-Formulary Status,No,No,,93,265,-64.7,Decreased,228.54,9.67,218.87,171.23,399.77,37.18,0.0,0,0.182,0.371,0.899,0.811,2,9,19,1,2.7,9.3,8,Lower,Midwest,NC,Rural,51-65,2025-03,Q1_2025,2024,3.7,0.261,Increasing
FIA001345,2025-04-02,Gabapentin,Neurontin,Anticonvulsants,35298-127-83,Medicare Part D Plan A,PLAN_6756,2025,Tier 1,Specialty Tier,2024-11-29,124,Improved,None,No,No,,244,189,29.4,Increased,13.21,252.79,-239.58,39.11,52.32,12.77,0.0,0,0.039,0.38,0.647,0.519,6,4,18,6,3.2,14.7,6,Lower,West,GA,Suburban,75+,2025-04,Q2_2025,2024,6.7,0.757,Increasing
FIA002383,2025-04-02,Gabapentin,Neurontin,Anticonvulsants,34146-545-65,Commercial Plan Beta,PLAN_2319,2025,Tier 1,Tier 1,2024-08-08,237,No Change,None,No,No,,177,181,-1.8,Stable,14.78,15.36,-0.58,136.67,151.45,26.81,0.0,0,0.038,0.23,0.295,0.931,14,6,17,4,2.9,20.6,4,Higher,Midwest,TX,Suburban,66-75,2025-04,Q2_2025,2024,9.0,0.936,Stable
FIA000916,2025-04-05,Gabapentin,Neurontin,Anticonvulsants,27564-676-90,Medicare Part D Plan B,PLAN_8259,2025,Tier 3,Tier 3,2024-06-26,283,No Change,Quantity Limit,No,No,,665,683,-2.6,Stable,67.03,67.16,-0.13,136.96,203.99,135.65,0.0,0,0.027,0.155,0.455,0.89,9,1,17,7,3.9,33.3,7,Similar,Southeast,IL,Urban,18-35,2025-04,Q2_2025,2024,9.5,0.894,Decreasing
FIA002824,2025-05-09,Gabapentin,Neurontin,Anticonvulsants,52115-708-49,Commercial Plan Beta,PLAN_5452,2025,Specialty Tier,Specialty Tier,2024-06-06,337,No Change,Prior Authorization,Yes,No,,338,351,-3.5,Stable,293.83,222.31,71.52,109.18,403.01,136.22,0.498,10,0.196,0.185,0.516,0.831,15,10,7,14,2.2,15.9,7,Similar,Southeast,NY,Urban,18-35,2025-05,Q2_2025,2024,8.2,0.428,Stable
FIA001897,2025-05-12,Gabapentin,Neurontin,Anticonvulsants,34803-513-26,Medicaid Plan X,PLAN_1089,2025,Tier 2,Tier 1,2024-07-31,285,Worsened,None,No,No,,683,623,9.8,Increased,39.77,15.93,23.84,48.38,88.15,60.21,0.0,0,0.072,0.227,0.334,0.735,4,6,8,12,3.4,31.2,4,Similar,Southeast,FL,Urban,51-65,2025-05,Q2_2025,2024,1.2,0.305,Stable
FIA002135,2025-05-20,Gabapentin,Neurontin,Anticonvulsants,90422-212-65,Medicaid Plan Y,PLAN_2496,2025,Non-Formulary,Specialty Tier,2024-07-25,299,Worsened,Non-Formulary Status,No,No,,168,166,1.5,Stable,471.74,265.7,206.04,142.24,613.98,103.15,0.0,0,0.052,0.197,0.229,0.548,15,2,3,10,2.6,19.2,7,Lower,Northeast,MI,Urban,51-65,2025-05,Q2_2025,2024,5.6,0.876,Stable
FIA001957,2025-05-26,Gabapentin,Neurontin,Anticonvulsants,10244-526-76,Medicare Part D Plan A,PLAN_3991,2025,Tier 1,Specialty Tier,2025-01-21,125,Improved,None,No,No,,1129,888,27.2,Increased,14.5,105.19,-90.69,30.64,45.14,50.96,0.0,0,0.057,0.335,0.719,0.804,14,3,14,8,2.1,24.8,4,Lower,West,CA,Urban,51-65,2025-05,Q2_2025,2024,8.4,0.41,Decreasing
FIA002948,2025-06-14,Gabapentin,Neurontin,Anticonvulsants,52389-581-33,Medicare Part D Plan B,PLAN_8902,2025,Non-Formulary,Tier 3,2025-01-03,162,Worsened,Non-Formulary Status,No,No,,505,468,8.1,Increased,750.93,79.32,671.61,198.33,949.26,479.38,0.0,0,0.269,0.346,0.892,0.733,0,2,12,12,4.0,31.3,7,Similar,Midwest,PA,Urban,75+,2025-06,Q2_2025,2024,5.6,0.19,Decreasing
FIA001680,2025-06-17,Gabapentin,Neurontin,Anticonvulsants,67805-853-38,Medicare Part D Plan B,PLAN_3474,2025,Tier 2,Tier 1,2025-01-21,147,Worsened,None,No,No,,103,110,-6.2,Decreased,35.29,17.84,17.45,186.67,221.96,22.86,0.0,0,0.017,0.376,0.6,0.838,0,4,17,3,4.3,21.2,7,Similar,West,MI,Suburban,36-50,2025-06,Q2_2025,2024,2.2,0.177,Decreasing
FIA002405,2025-06-23,Gabapentin,Neurontin,Anticonvulsants,31168-905-21,Medicare Part D Plan B,PLAN_5344,2025,Tier 1,Specialty Tier,2025-05-17,37,Improved,None,No,No,,545,425,28.4,Increased,10.98,212.52,-201.54,141.33,152.31,83.01,0.0,0,0.017,0.306,0.815,0.447,10,8,3,12,3.5,10.8,3,Lower,West,MI,Suburban,18-35,2025-06,Q2_2025,2024,8.6,0.292,Decreasing
FIA001646,2025-06-27,Gabapentin,Neurontin,Anticonvulsants,26621-369-59,Tricare Standard,PLAN_8122,2025,Tier 1,Tier 2,2024-10-15,255,Improved,None,No,No,,504,471,7.0,Increased,11.95,22.96,-11.01,75.23,87.18,43.94,0.0,0,0.045,0.324,0.758,0.411,8,10,4,11,3.8,31.5,4,Similar,Northeast,FL,Suburban,51-65,2025-06,Q2_2025,2024,3.7,0.35,Stable
FIA000872,2025-06-30,Gabapentin,Neurontin,Anticonvulsants,35325-643-48,VA Plan,PLAN_1839,2025,Non-Formulary,Tier 1,2025-03-21,101,Worsened,Non-Formulary Status,No,No,,78,101,-22.3,Decreased,768.54,17.83,750.71,141.38,909.92,70.97,0.0,0,0.178,0.317,0.681,0.889,12,7,4,6,4.0,11.5,2,Similar,Midwest,NC,Urban,66-75,2025-06,Q2_2025,2024,7.1,0.944,Stable
FIA001217,2025-07-02,Gabapentin,Neurontin,Anticonvulsants,12974-967-39,Medicaid Plan Y,PLAN_6256,2025,Tier 1,Tier 2,2025-05-21,42,Improved,None,No,No,,904,865,4.6,Stable,17.22,49.6,-32.38,194.85,212.07,191.71,0.0,0,0.067,0.054,0.885,0.454,13,8,8,8,3.0,14.8,7,Similar,West,TX,Rural,66-75,2025-07,Q3_2025,2024,3.4,0.996,Increasing
FIA001810,2025-07-08,Gabapentin,Neurontin,Anticonvulsants,66516-793-44,Medicare Part D Plan A,PLAN_7768,2025,Tier 3,Specialty Tier,2025-03-16,114,Improved,Step Therapy,No,Yes,,723,783,-7.5,Decreased,83.28,207.38,-124.1,174.9,258.18,186.66,0.0,0,0.018,0.257,0.862,0.418,11,1,16,9,2.1,24.3,5,Lower,Midwest,CA,Urban,18-35,2025-07,Q3_2025,2024,5.6,0.529,Decreasing
FIA000487,2025-07-09,Gabapentin,Neurontin,Anticonvulsants,85602-300-73,Medicare Part D Plan A,PLAN_9718,2025,Specialty Tier,Specialty Tier,2024-08-01,342,No Change,Step Therapy,No,Yes,,271,253,7.1,Increased,206.44,176.89,29.55,84.42,290.86,78.82,0.0,0,0.259,0.161,0.567,0.619,5,10,20,7,3.1,25.9,2,Higher,Midwest,OH,Suburban,75+,2025-07,Q3_2025,2024,4.0,0.457,Increasing
FIA000440,2025-07-17,Gabapentin,Neurontin,Anticonvulsants,76694-407-73,VA Plan,PLAN_1840,2025,Tier 3,Non-Formulary,2025-03-30,109,Improved,Prior Authorization; Step Therapy,Yes,Yes,,705,703,0.4,Stable,83.39,701.22,-617.83,76.27,159.66,112.56,0.507,10,0.04,0.155,0.804,0.459,4,8,7,7,4.6,12.5,3,Lower,West,NC,Suburban,66-75,2025-07,Q3_2025,2024,7.7,0.419,Stable
FIA001985,2025-07-18,Gabapentin,Neurontin,Anticonvulsants,77103-676-35,Medicare Part D Plan A,PLAN_5078,2025,Tier 2,Tier 3,2025-04-16,93,Improved,None,No,No,,332,276,20.6,Increased,34.58,61.9,-27.32,134.92,169.5,56.27,0.0,0,0.026,0.297,0.505,0.627,12,6,16,0,4.3,9.5,8,Similar,West,GA,Suburban,75+,2025-07,Q3_2025,2024,4.1,0.63,Increasing
FIA002234,2025-07-27,Gabapentin,Neurontin,Anticonvulsants,63475-406-62,Commercial Plan Alpha,PLAN_9899,2025,Tier 1,Specialty Tier,2024-09-01,329,Improved,None,No,No,,907,729,24.5,Increased,8.9,169.13,-160.23,67.11,76.01,68.94,0.0,0,0.023,0.163,0.463,0.619,4,0,12,8,3.4,5.2,4,Similar,Northeast,NY,Suburban,51-65,2025-07,Q3_2025,2024,1.1,0.898,Decreasing
FIA000232,2025-08-05,Gabapentin,Neurontin,Anticonvulsants,39431-148-45,VA Plan,PLAN_9723,2025,Tier 1,Tier 3,2024-11-27,251,Improved,None,No,No,,326,224,45.6,Increased,17.67,70.34,-52.67,159.03,176.7,57.6,0.0,0,0.035,0.207,0.204,0.507,2,9,0,7,4.9,17.7,2,Lower,Southeast,FL,Suburban,51-65,2025-08,Q3_2025,2024,1.6,0.625,Increasing
FIA001028,2025-08-10,Gabapentin,Neurontin,Anticonvulsants,76821-927-20,Tricare Standard,PLAN_4659,2025,Tier 2,Tier 1,2025-02-19,172,Worsened,None,No,No,,370,381,-2.8,Stable,35.2,8.37,26.83,99.68,134.88,49.91,0.0,0,0.062,0.148,0.577,0.894,0,7,18,12,4.3,26.8,2,Lower,Northeast,IL,Suburban,51-65,2025-08,Q3_2025,2024,5.6,0.62,Decreasing
FIA001069,2025-08-16,Gabapentin,Neurontin,Anticonvulsants,62805-568-97,Medicare Part D Plan A,PLAN_1824,2025,Non-Formulary,Tier 3,2025-04-07,131,Worsened,Non-Formulary Status,No,No,,583,579,0.8,Stable,562.07,96.06,466.01,157.76,719.83,419.66,0.0,0,0.214,0.383,0.507,0.486,9,6,13,12,3.1,14.3,6,Lower,Southwest,CA,Rural,75+,2025-08,Q3_2025,2024,6.7,0.21,Stable
FIA001527,2025-08-17,Gabapentin,Neurontin,Anticonvulsants,36402-668-29,Medicare Part D Plan A,PLAN_8885,2025,Specialty Tier,Tier 2,2025-05-29,80,Worsened,None,No,No,,249,775,-67.9,Decreased,157.29,37.1,120.19,102.84,260.13,64.77,0.0,0,0.173,0.387,0.243,0.479,10,8,16,13,2.8,23.9,7,Higher,Southeast,MI,Rural,66-75,2025-08,Q3_2025,2024,6.5,0.603,Decreasing
FIA001928,2025-08-28,Gabapentin,Neurontin,Anticonvulsants,34429-368-84,Medicare Part D Plan B,PLAN_5702,2025,Non-Formulary,Tier 1,2025-02-03,206,Worsened,Non-Formulary Status,No,No,,281,417,-32.5,Decreased,578.12,17.04,561.08,93.01,671.13,188.59,0.0,0,0.196,0.241,0.591,0.542,5,1,20,6,2.3,26.4,4,Higher,Southwest,OH,Rural,66-75,2025-08,Q3_2025,2024,8.3,0.729,Stable
FIA000895,2022-01-06,Hydrochlorothiazide,Microzide,Diuretics,68257-866-45,Commercial Plan Alpha,PLAN_8438,2022,Tier 3,Tier 2,2021-11-25,42,Worsened,Quantity Limit,No,No,,410,527,-22.1,Decreased,74.02,24.79,49.23,140.9,214.92,88.12,0.0,0,0.046,0.16,0.634,0.578,14,2,17,4,2.2,10.8,3,Higher,West,CA,Urban,36-50,2022-01,Q1_2022,2021,4.8,0.577,Increasing
FIA001351,2022-01-10,Hydrochlorothiazide,Microzide,Diuretics,80498-709-30,Commercial Plan Alpha,PLAN_1732,2022,Non-Formulary,Tier 1,2021-04-25,260,Worsened,Non-Formulary Status,No,No,,283,358,-20.7,Decreased,369.07,12.31,356.76,34.9,403.97,114.32,0.0,0,0.214,0.352,0.383,0.453,12,5,17,9,2.1,25.8,3,Similar,Southwest,PA,Suburban,36-50,2022-01,Q1_2022,2021,8.4,0.64,Decreasing
FIA002291,2022-01-27,Hydrochlorothiazide,Microzide,Diuretics,14053-789-83,Commercial Plan Alpha,PLAN_8680,2022,Non-Formulary,Specialty Tier,2021-06-07,234,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,681,620,10.0,Increased,787.57,153.61,633.96,187.59,975.16,664.08,0.0,0,0.104,0.131,0.425,0.707,5,5,15,0,4.5,26.4,5,Higher,Southwest,FL,Urban,75+,2022-01,Q1_2022,2021,2.5,0.489,Increasing
FIA000892,2022-01-30,Hydrochlorothiazide,Microzide,Diuretics,47130-529-81,Medicaid Plan Y,PLAN_5068,2022,Specialty Tier,Tier 3,2021-12-16,45,Worsened,Prior Authorization,Yes,No,,239,257,-6.6,Decreased,187.52,70.26,117.26,95.65,283.17,67.68,0.455,1,0.057,0.378,0.46,0.578,10,9,10,1,2.4,17.2,7,Similar,Southwest,CA,Suburban,66-75,2022-01,Q1_2022,2021,5.4,0.539,Decreasing
FIA001494,2022-02-10,Hydrochlorothiazide,Microzide,Diuretics,30536-833-20,Commercial Plan Alpha,PLAN_6334,2022,Tier 2,Tier 3,2021-09-04,159,Improved,None,No,No,,939,709,32.6,Increased,45.61,89.33,-43.72,150.04,195.65,183.72,0.0,0,0.078,0.342,0.384,0.689,10,7,11,10,2.0,31.4,4,Lower,Midwest,FL,Suburban,36-50,2022-02,Q1_2022,2021,3.2,0.375,Increasing
FIA000083,2022-02-24,Hydrochlorothiazide,Microzide,Diuretics,75481-753-86,Medicare Part D Plan B,PLAN_9655,2022,Tier 3,Tier 2,2021-05-05,295,Worsened,Step Therapy; Quantity Limit,No,Yes,,326,501,-34.8,Decreased,80.35,25.66,54.69,49.17,129.52,42.22,0.0,0,0.045,0.395,0.854,0.473,13,5,17,5,4.3,33.6,8,Lower,Northeast,MI,Urban,18-35,2022-02,Q1_2022,2021,3.4,0.04,Increasing
FIA000742,2022-02-25,Hydrochlorothiazide,Microzide,Diuretics,37854-533-67,VA Plan,PLAN_1375,2022,Tier 1,Non-Formulary,2021-08-30,179,Improved,None,No,No,,754,497,51.8,Increased,12.55,361.05,-348.5,64.6,77.15,58.17,0.0,0,0.071,0.381,0.557,0.916,12,7,20,2,4.1,16.4,8,Similar,Midwest,MI,Suburban,66-75,2022-02,Q1_2022,2021,8.9,0.599,Increasing
FIA001364,2022-02-26,Hydrochlorothiazide,Microzide,Diuretics,49582-444-89,Medicaid Plan Y,PLAN_9810,2022,Tier 3,Tier 2,2021-12-25,63,Worsened,Prior Authorization,Yes,No,,306,479,-35.9,Decreased,56.71,32.6,24.11,157.92,214.63,65.68,0.414,8,0.066,0.198,0.425,0.711,3,10,5,13,3.5,11.8,5,Higher,Southeast,GA,Urban,18-35,2022-02,Q1_2022,2021,8.0,0.695,Increasing
FIA001467,2022-02-27,Hydrochlorothiazide,Microzide,Diuretics,12188-792-75,Medicaid Plan X,PLAN_2471,2022,Tier 3,Non-Formulary,2021-05-22,281,Improved,Step Therapy,No,Yes,,398,368,8.2,Increased,68.35,511.89,-443.54,80.95,149.3,59.42,0.0,0,0.011,0.357,0.331,0.745,13,5,8,1,4.5,21.4,3,Similar,Midwest,CA,Rural,51-65,2022-02,Q1_2022,2021,3.8,0.335,Increasing
FIA000955,2022-03-03,Hydrochlorothiazide,Microzide,Diuretics,66649-708-81,Commercial Plan Beta,PLAN_9951,2022,Specialty Tier,Tier 1,2021-04-05,332,Worsened,Prior Authorization; Quantity Limit,Yes,No,60.0,169,440,-61.4,Decreased,236.02,17.74,218.28,87.88,323.9,54.74,0.446,10,0.164,0.279,0.541,0.478,8,1,9,4,4.0,24.7,4,Higher,Midwest,GA,Rural,66-75,2022-03,Q1_2022,2021,9.2,0.179,Increasing
FIA001507,2022-03-15,Hydrochlorothiazide,Microzide,Diuretics,47438-941-83,Commercial Plan Beta,PLAN_4366,2022,Specialty Tier,Specialty Tier,2021-04-04,345,No Change,Prior Authorization; Step Therapy,Yes,Yes,,700,757,-7.4,Decreased,218.56,236.81,-18.25,43.38,261.94,183.36,0.383,2,0.119,0.318,0.259,0.576,10,4,0,5,3.2,30.3,2,Higher,Northeast,OH,Rural,18-35,2022-03,Q1_2022,2021,7.4,0.75,Stable
FIA000447,2022-03-21,Hydrochlorothiazide,Microzide,Diuretics,66362-148-19,Medicaid Plan X,PLAN_9769,2022,Tier 2,Non-Formulary,2021-10-12,160,Improved,Quantity Limit,No,No,90.0,390,334,16.8,Increased,31.84,202.57,-170.73,97.49,129.33,50.44,0.0,0,0.041,0.056,0.808,0.803,9,9,1,15,5.0,11.4,7,Higher,Midwest,TX,Urban,66-75,2022-03,Q1_2022,2021,6.0,0.329,Decreasing
FIA000330,2022-03-27,Hydrochlorothiazide,Microzide,Diuretics,67529-329-31,Medicaid Plan X,PLAN_5250,2022,Tier 2,Specialty Tier,2021-06-05,295,Improved,None,No,No,,502,421,19.5,Increased,28.35,275.92,-247.57,76.55,104.9,52.66,0.0,0,0.018,0.396,0.727,0.908,8,2,3,6,3.7,20.3,3,Lower,West,CA,Rural,75+,2022-03,Q1_2022,2021,8.2,0.007,Increasing
FIA002927,2022-04-16,Hydrochlorothiazide,Microzide,Diuretics,88384-753-38,Commercial Plan Beta,PLAN_8583,2022,Specialty Tier,Non-Formulary,2021-09-01,227,Improved,None,No,No,,402,397,1.3,Stable,174.16,538.08,-363.92,76.63,250.79,100.82,0.0,0,0.075,0.254,0.552,0.66,0,8,8,15,2.2,18.1,5,Similar,Northeast,CA,Suburban,36-50,2022-04,Q2_2022,2021,8.2,0.672,Stable
FIA002681,2022-04-20,Hydrochlorothiazide,Microzide,Diuretics,92622-315-55,Medicare Part D Plan B,PLAN_3872,2022,Tier 3,Specialty Tier,2021-06-03,321,Improved,Step Therapy,No,Yes,,879,841,4.6,Stable,96.15,159.03,-62.88,50.16,146.31,128.61,0.0,0,0.029,0.055,0.395,0.793,3,5,16,5,4.2,14.3,8,Similar,Midwest,OH,Rural,51-65,2022-04,Q2_2022,2021,7.5,0.762,Stable
FIA000841,2022-04-24,Hydrochlorothiazide,Microzide,Diuretics,16658-335-60,Medicare Part D Plan A,PLAN_8885,2022,Tier 3,Specialty Tier,2021-08-25,242,Improved,None,No,No,,801,765,4.8,Stable,56.58,193.29,-136.71,76.88,133.46,106.9,0.0,0,0.041,0.237,0.737,0.561,6,3,0,11,3.5,19.8,3,Higher,West,NY,Suburban,75+,2022-04,Q2_2022,2021,7.4,0.01,Increasing
FIA002177,2022-04-28,Hydrochlorothiazide,Microzide,Diuretics,14232-294-24,Medicaid Plan Y,PLAN_7056,2022,Tier 1,Specialty Tier,2021-11-12,167,Improved,None,No,No,,1091,721,51.4,Increased,14.19,252.32,-238.13,36.71,50.9,55.53,0.0,0,0.016,0.201,0.525,0.873,10,2,3,13,2.6,23.6,3,Higher,Midwest,PA,Suburban,51-65,2022-04,Q2_2022,2021,9.1,0.029,Stable
FIA002923,2022-05-01,Hydrochlorothiazide,Microzide,Diuretics,48665-684-53,VA Plan,PLAN_2479,2022,Tier 2,Non-Formulary,2021-07-24,281,Improved,Quantity Limit,No,No,90.0,965,724,33.3,Increased,23.97,501.06,-477.09,99.45,123.42,119.1,0.0,0,0.025,0.161,0.791,0.542,1,1,6,12,4.8,9.0,2,Similar,Southeast,NY,Suburban,18-35,2022-05,Q2_2022,2021,4.6,0.405,Increasing
FIA001742,2022-05-02,Hydrochlorothiazide,Microzide,Diuretics,85569-996-99,Commercial Plan Alpha,PLAN_8371,2022,Tier 2,Tier 2,2022-03-29,34,No Change,None,No,No,,296,294,0.9,Stable,39.15,20.54,18.61,144.61,183.76,54.39,0.0,0,0.077,0.258,0.246,0.872,8,6,10,2,3.6,25.5,6,Lower,Midwest,OH,Urban,36-50,2022-05,Q2_2022,2021,1.4,0.73,Increasing
FIA001951,2022-05-03,Hydrochlorothiazide,Microzide,Diuretics,15445-299-82,Medicare Part D Plan A,PLAN_8946,2022,Tier 1,Tier 1,2022-01-08,115,No Change,Quantity Limit,No,No,30.0,959,883,8.7,Increased,18.58,11.83,6.75,109.48,128.06,122.81,0.0,0,0.023,0.245,0.507,0.724,9,9,7,15,4.7,34.2,6,Lower,Northeast,PA,Suburban,18-35,2022-05,Q2_2022,2021,3.7,0.256,Decreasing
FIA001236,2022-05-12,Hydrochlorothiazide,Microzide,Diuretics,84996-435-88,VA Plan,PLAN_1952,2022,Non-Formulary,Tier 1,2022-03-27,46,Worsened,Non-Formulary Status,No,No,,64,184,-64.7,Decreased,774.11,10.08,764.03,150.31,924.42,59.16,0.0,0,0.281,0.341,0.306,0.623,6,4,15,15,3.8,17.5,8,Similar,Midwest,NC,Suburban,66-75,2022-05,Q2_2022,2021,2.3,0.472,Increasing
FIA000842,2022-06-30,Hydrochlorothiazide,Microzide,Diuretics,70332-107-22,Medicaid Plan Y,PLAN_1725,2022,Tier 3,Tier 3,2021-10-15,258,No Change,None,No,No,,232,237,-2.0,Stable,98.89,57.68,41.21,135.56,234.45,54.39,0.0,0,0.059,0.303,0.596,0.673,15,10,4,0,3.9,15.5,6,Lower,Northeast,TX,Rural,36-50,2022-06,Q2_2022,2021,5.9,0.721,Increasing
FIA000752,2022-07-06,Hydrochlorothiazide,Microzide,Diuretics,74861-809-27,VA Plan,PLAN_7935,2022,Tier 3,Specialty Tier,2022-02-02,154,Improved,Prior Authorization,Yes,No,,573,523,9.7,Increased,98.51,242.18,-143.67,45.58,144.09,82.56,0.178,6,0.071,0.101,0.563,0.571,10,4,18,5,5.0,19.9,3,Similar,Northeast,CA,Urban,36-50,2022-07,Q3_2022,2021,1.2,0.391,Increasing
FIA001399,2022-07-10,Hydrochlorothiazide,Microzide,Diuretics,44658-768-40,VA Plan,PLAN_5943,2022,Specialty Tier,Tier 2,2022-03-26,106,Worsened,Step Therapy,No,Yes,,633,825,-23.2,Decreased,223.16,33.1,190.06,193.33,416.49,263.64,0.0,0,0.223,0.241,0.253,0.69,14,10,11,15,3.4,6.8,5,Lower,Midwest,OH,Urban,18-35,2022-07,Q3_2022,2021,5.4,0.255,Increasing
FIA000978,2022-07-14,Hydrochlorothiazide,Microzide,Diuretics,98102-204-99,Commercial Plan Beta,PLAN_5070,2022,Tier 2,Non-Formulary,2022-04-19,86,Improved,None,No,No,,471,359,31.4,Increased,23.82,495.19,-471.37,80.59,104.41,49.18,0.0,0,0.046,0.224,0.855,0.645,10,8,0,15,3.7,27.8,7,Similar,Midwest,TX,Urban,66-75,2022-07,Q3_2022,2021,3.4,0.496,Stable
FIA001051,2022-07-23,Hydrochlorothiazide,Microzide,Diuretics,35817-496-81,Tricare Standard,PLAN_2350,2022,Tier 3,Tier 2,2022-02-17,156,Worsened,Prior Authorization; Quantity Limit,Yes,No,90.0,62,152,-59.2,Decreased,93.59,20.94,72.65,191.51,285.1,17.68,0.344,4,0.032,0.226,0.692,0.64,2,5,15,15,4.4,30.0,7,Similar,Midwest,IL,Rural,66-75,2022-07,Q3_2022,2021,4.9,0.524,Stable
FIA002354,2022-07-24,Hydrochlorothiazide,Microzide,Diuretics,43386-216-17,Commercial Plan Alpha,PLAN_1444,2022,Tier 2,Tier 1,2021-11-01,265,Worsened,Quantity Limit,No,No,90.0,374,391,-4.3,Stable,20.69,13.78,6.91,41.11,61.8,23.11,0.0,0,0.015,0.091,0.472,0.454,10,3,13,2,2.2,20.0,5,Similar,West,OH,Suburban,18-35,2022-07,Q3_2022,2021,2.7,0.707,Decreasing
FIA002213,2022-08-24,Hydrochlorothiazide,Microzide,Diuretics,48457-612-50,VA Plan,PLAN_4075,2022,Specialty Tier,Non-Formulary,2021-12-29,238,Improved,None,No,No,,853,914,-6.6,Decreased,266.07,514.06,-247.99,69.77,335.84,286.47,0.0,0,0.253,0.349,0.532,0.471,6,1,10,4,4.3,25.2,2,Similar,Southwest,MI,Suburban,75+,2022-08,Q3_2022,2021,1.6,0.457,Decreasing
FIA000229,2022-09-09,Hydrochlorothiazide,Microzide,Diuretics,44257-870-67,Medicaid Plan X,PLAN_5029,2022,Tier 2,Non-Formulary,2022-03-20,173,Improved,None,No,No,,973,616,58.1,Increased,46.35,326.51,-280.16,88.25,134.6,130.97,0.0,0,0.058,0.282,0.425,0.516,10,0,4,0,3.8,5.1,2,Higher,Southeast,OH,Rural,66-75,2022-09,Q3_2022,2021,7.9,0.538,Decreasing
FIA002052,2022-09-09,Hydrochlorothiazide,Microzide,Diuretics,98987-872-96,Medicaid Plan Y,PLAN_7597,2022,Tier 2,Tier 2,2022-05-05,127,No Change,None,No,No,,581,531,9.6,Increased,43.45,23.52,19.93,132.1,175.55,101.99,0.0,0,0.06,0.134,0.673,0.942,9,0,5,3,3.0,34.8,6,Lower,Midwest,CA,Urban,66-75,2022-09,Q3_2022,2021,8.6,0.072,Stable
FIA002355,2022-09-09,Hydrochlorothiazide,Microzide,Diuretics,94326-606-78,Medicare Part D Plan B,PLAN_1989,2022,Tier 2,Specialty Tier,2022-06-18,83,Improved,None,No,No,,1100,901,22.1,Increased,34.1,148.53,-114.43,191.87,225.97,248.57,0.0,0,0.033,0.325,0.715,0.676,9,1,13,13,4.4,7.2,6,Similar,Midwest,FL,Rural,51-65,2022-09,Q3_2022,2021,4.7,0.379,Stable
FIA001059,2022-09-18,Hydrochlorothiazide,Microzide,Diuretics,84990-142-91,Medicaid Plan X,PLAN_6764,2022,Tier 1,Tier 2,2021-11-16,306,Improved,None,No,No,,219,203,8.3,Increased,19.33,33.63,-14.3,138.28,157.61,34.52,0.0,0,0.066,0.306,0.468,0.854,8,6,5,4,2.1,16.7,5,Similar,Southeast,NY,Rural,36-50,2022-09,Q3_2022,2021,9.9,0.353,Decreasing
FIA001830,2022-09-18,Hydrochlorothiazide,Microzide,Diuretics,83517-639-62,VA Plan,PLAN_1542,2022,Tier 2,Tier 1,2021-10-03,350,Worsened,None,No,No,,887,873,1.7,Stable,35.93,10.27,25.66,195.68,231.61,205.44,0.0,0,0.04,0.228,0.587,0.495,4,3,11,3,2.2,24.7,4,Higher,Southeast,FL,Suburban,51-65,2022-09,Q3_2022,2021,6.2,0.796,Stable
FIA000206,2022-09-24,Hydrochlorothiazide,Microzide,Diuretics,33840-502-58,Commercial Plan Beta,PLAN_1339,2022,Non-Formulary,Specialty Tier,2022-03-15,193,Worsened,Non-Formulary Status,No,No,,224,236,-4.8,Stable,470.89,274.7,196.19,100.46,571.35,127.98,0.0,0,0.1,0.382,0.846,0.756,7,1,14,6,2.8,30.6,2,Similar,West,OH,Rural,51-65,2022-09,Q3_2022,2021,2.3,0.958,Increasing
FIA000953,2022-09-27,Hydrochlorothiazide,Microzide,Diuretics,86127-837-27,Medicare Part D Plan A,PLAN_8031,2022,Tier 2,Non-Formulary,2021-10-21,341,Improved,None,No,No,,370,286,29.6,Increased,47.78,317.4,-269.62,160.73,208.51,77.15,0.0,0,0.062,0.326,0.355,0.835,10,9,13,3,4.5,31.4,7,Similar,Northeast,MI,Suburban,75+,2022-09,Q3_2022,2021,1.4,0.288,Increasing
FIA001681,2022-09-30,Hydrochlorothiazide,Microzide,Diuretics,66212-950-68,VA Plan,PLAN_4219,2022,Specialty Tier,Non-Formulary,2022-08-12,49,Improved,None,No,No,,600,634,-5.3,Decreased,224.39,285.95,-61.56,35.31,259.7,155.82,0.0,0,0.155,0.368,0.738,0.699,12,9,2,8,3.6,19.4,5,Higher,Southwest,MI,Rural,66-75,2022-09,Q3_2022,2021,8.6,0.819,Stable
FIA000661,2022-10-01,Hydrochlorothiazide,Microzide,Diuretics,45300-323-51,VA Plan,PLAN_4012,2022,Tier 1,Tier 2,2021-10-17,349,Improved,None,No,No,,928,875,6.1,Increased,6.8,21.7,-14.9,74.98,81.78,75.89,0.0,0,0.073,0.275,0.434,0.687,15,0,2,5,2.0,27.4,8,Higher,Southeast,PA,Urban,51-65,2022-10,Q4_2022,2022,2.9,0.597,Decreasing
FIA002101,2022-10-01,Hydrochlorothiazide,Microzide,Diuretics,53713-715-17,Commercial Plan Beta,PLAN_1855,2022,Specialty Tier,Tier 3,2022-08-12,50,Worsened,None,No,No,,305,278,10.0,Increased,264.72,50.65,214.07,95.87,360.59,109.98,0.0,0,0.105,0.318,0.471,0.911,2,10,6,9,3.2,27.1,5,Higher,Northeast,OH,Suburban,66-75,2022-10,Q4_2022,2022,1.6,0.112,Stable
FIA000017,2022-10-05,Hydrochlorothiazide,Microzide,Diuretics,12540-867-79,Medicare Part D Plan A,PLAN_6733,2022,Specialty Tier,Tier 2,2022-08-11,55,Worsened,Prior Authorization,Yes,No,,359,565,-36.3,Decreased,152.03,29.82,122.21,43.92,195.95,70.35,0.516,4,0.113,0.278,0.747,0.758,0,3,6,0,3.9,12.2,5,Higher,Northeast,MI,Urban,66-75,2022-10,Q4_2022,2022,7.3,0.767,Increasing
FIA002333,2022-10-07,Hydrochlorothiazide,Microzide,Diuretics,92505-156-25,Commercial Plan Alpha,PLAN_7308,2022,Tier 1,Specialty Tier,2022-06-20,109,Improved,None,No,No,,975,682,43.0,Increased,12.26,277.3,-265.04,134.3,146.56,142.9,0.0,0,0.05,0.198,0.824,0.822,7,10,12,14,2.8,20.2,5,Similar,Southwest,CA,Urban,36-50,2022-10,Q4_2022,2022,8.8,0.179,Stable
FIA000048,2022-10-20,Hydrochlorothiazide,Microzide,Diuretics,68972-479-57,Tricare Standard,PLAN_2259,2022,Non-Formulary,Specialty Tier,2022-09-03,47,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,739,760,-2.7,Stable,275.74,147.2,128.54,56.08,331.82,245.21,0.0,0,0.058,0.235,0.479,0.757,7,1,0,5,3.5,16.6,6,Lower,Midwest,PA,Rural,66-75,2022-10,Q4_2022,2022,2.9,0.612,Decreasing
FIA000151,2022-10-30,Hydrochlorothiazide,Microzide,Diuretics,81932-594-89,Commercial Plan Alpha,PLAN_1301,2022,Tier 3,Tier 1,2022-04-08,205,Worsened,Step Therapy,No,Yes,,316,560,-43.6,Decreased,84.69,6.67,78.02,157.56,242.25,76.55,0.0,0,0.048,0.182,0.834,0.69,8,2,1,9,2.6,25.9,4,Lower,Southwest,CA,Urban,66-75,2022-10,Q4_2022,2022,6.9,0.663,Decreasing
FIA000583,2022-11-11,Hydrochlorothiazide,Microzide,Diuretics,66621-532-62,Medicare Part D Plan A,PLAN_3754,2022,Specialty Tier,Non-Formulary,2021-12-04,342,Improved,Prior Authorization,Yes,No,,715,689,3.8,Stable,218.81,567.78,-348.97,67.29,286.1,204.56,0.468,1,0.055,0.072,0.443,0.508,5,8,10,6,3.6,10.7,2,Lower,Midwest,CA,Suburban,36-50,2022-11,Q4_2022,2022,3.4,0.886,Increasing
FIA002907,2022-11-18,Hydrochlorothiazide,Microzide,Diuretics,68436-734-36,Commercial Plan Alpha,PLAN_2392,2022,Tier 2,Tier 2,2021-12-02,351,No Change,None,No,No,,1086,997,9.0,Increased,28.38,48.19,-19.81,50.43,78.81,85.59,0.0,0,0.068,0.277,0.4,0.565,15,4,3,4,3.2,23.2,6,Higher,Northeast,IL,Urban,66-75,2022-11,Q4_2022,2022,6.2,0.892,Decreasing
FIA001583,2022-11-19,Hydrochlorothiazide,Microzide,Diuretics,67393-237-22,Medicaid Plan Y,PLAN_4530,2022,Tier 2,Tier 1,2021-12-05,349,Worsened,Quantity Limit,No,No,60.0,864,815,6.0,Increased,20.86,11.58,9.28,93.9,114.76,99.15,0.0,0,0.047,0.23,0.375,0.796,1,4,15,1,4.3,32.8,7,Similar,Northeast,FL,Suburban,51-65,2022-11,Q4_2022,2022,4.5,0.346,Decreasing
FIA001728,2022-11-28,Hydrochlorothiazide,Microzide,Diuretics,63983-220-44,VA Plan,PLAN_5580,2022,Non-Formulary,Non-Formulary,2022-06-08,173,No Change,Non-Formulary Status,No,No,,409,409,0.1,Stable,498.5,424.24,74.26,103.21,601.71,246.1,0.0,0,0.063,0.23,0.889,0.835,11,6,1,3,3.3,17.7,4,Higher,Southwest,GA,Suburban,75+,2022-11,Q4_2022,2022,6.4,0.231,Increasing
FIA002774,2022-12-25,Hydrochlorothiazide,Microzide,Diuretics,64335-122-65,Medicare Part D Plan B,PLAN_6380,2022,Tier 3,Specialty Tier,2022-11-06,49,Improved,Quantity Limit,No,No,,636,675,-5.7,Decreased,59.58,119.43,-59.85,144.37,203.95,129.71,0.0,0,0.056,0.146,0.453,0.682,9,3,18,1,4.9,5.9,3,Higher,Northeast,NC,Rural,75+,2022-12,Q4_2022,2022,2.0,0.057,Decreasing
FIA000344,2022-12-29,Hydrochlorothiazide,Microzide,Diuretics,35451-770-88,Medicare Part D Plan A,PLAN_6450,2022,Tier 2,Tier 1,2022-04-29,244,Worsened,None,No,No,,569,554,2.7,Stable,45.02,6.79,38.23,77.17,122.19,69.53,0.0,0,0.07,0.343,0.794,0.574,5,9,11,0,4.8,17.1,8,Higher,Northeast,TX,Urban,75+,2022-12,Q4_2022,2022,2.3,0.267,Increasing
FIA000145,2023-01-01,Hydrochlorothiazide,Microzide,Diuretics,43546-150-56,Commercial Plan Beta,PLAN_2161,2023,Tier 1,Tier 2,2022-10-09,84,Improved,None,No,No,,703,684,2.8,Stable,12.28,22.96,-10.68,149.22,161.5,113.53,0.0,0,0.047,0.055,0.845,0.761,2,7,20,1,3.1,27.3,5,Similar,Northeast,MI,Suburban,75+,2023-01,Q1_2023,2022,1.4,0.07,Stable
FIA000811,2023-01-16,Hydrochlorothiazide,Microzide,Diuretics,15470-547-75,Medicaid Plan Y,PLAN_7997,2023,Tier 2,Non-Formulary,2022-09-24,114,Improved,None,No,No,,1311,878,49.4,Increased,41.51,740.64,-699.13,93.5,135.01,177.0,0.0,0,0.021,0.237,0.409,0.918,13,7,13,15,3.5,23.3,5,Similar,Midwest,NC,Urban,66-75,2023-01,Q1_2023,2022,9.8,0.734,Decreasing
FIA002182,2023-01-18,Hydrochlorothiazide,Microzide,Diuretics,30261-182-67,Tricare Standard,PLAN_5634,2023,Specialty Tier,Specialty Tier,2022-01-23,360,No Change,Step Therapy,No,Yes,,680,704,-3.3,Stable,292.27,123.13,169.14,104.26,396.53,269.64,0.0,0,0.254,0.398,0.381,0.46,12,5,14,9,2.6,31.7,8,Similar,Midwest,MI,Rural,36-50,2023-01,Q1_2023,2022,3.6,0.533,Increasing
FIA000215,2023-01-21,Hydrochlorothiazide,Microzide,Diuretics,65296-122-24,Commercial Plan Alpha,PLAN_3497,2023,Tier 1,Tier 2,2022-04-20,276,Improved,None,No,No,,583,546,6.8,Increased,14.73,39.49,-24.76,55.19,69.92,40.76,0.0,0,0.064,0.309,0.512,0.667,0,7,18,7,2.6,22.1,8,Similar,Northeast,IL,Urban,18-35,2023-01,Q1_2023,2022,6.7,0.713,Stable
FIA000332,2023-01-25,Hydrochlorothiazide,Microzide,Diuretics,29848-596-33,Tricare Standard,PLAN_5630,2023,Non-Formulary,Tier 1,2022-02-05,354,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,428,700,-38.8,Decreased,576.37,8.69,567.68,75.1,651.47,278.83,0.0,0,0.218,0.12,0.813,0.923,6,0,13,2,3.5,23.3,7,Lower,Northeast,OH,Rural,51-65,2023-01,Q1_2023,2022,6.5,0.631,Increasing
FIA002804,2023-01-25,Hydrochlorothiazide,Microzide,Diuretics,75989-612-74,VA Plan,PLAN_7624,2023,Non-Formulary,Specialty Tier,2022-03-31,300,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,298,331,-10.0,Decreased,704.88,291.82,413.06,47.78,752.66,224.29,0.0,0,0.166,0.085,0.705,0.512,15,4,13,6,2.7,28.9,2,Lower,Midwest,MI,Suburban,66-75,2023-01,Q1_2023,2022,5.2,0.799,Increasing
FIA000428,2023-01-28,Hydrochlorothiazide,Microzide,Diuretics,36799-917-69,Commercial Plan Alpha,PLAN_2920,2023,Tier 3,Non-Formulary,2022-06-02,240,Improved,Prior Authorization,Yes,No,,809,785,3.2,Stable,63.93,558.66,-494.73,123.99,187.92,152.03,0.443,5,0.06,0.274,0.344,0.834,10,2,20,15,3.1,16.7,7,Similar,West,GA,Rural,51-65,2023-01,Q1_2023,2022,2.3,0.606,Stable
FIA000473,2023-01-31,Hydrochlorothiazide,Microzide,Diuretics,69720-174-51,Commercial Plan Beta,PLAN_2637,2023,Tier 1,Non-Formulary,2022-09-19,134,Improved,Quantity Limit,No,No,30.0,859,722,19.0,Increased,10.42,438.7,-428.28,56.18,66.6,57.21,0.0,0,0.012,0.319,0.378,0.587,1,6,16,5,3.3,8.3,7,Similar,Southwest,NC,Rural,36-50,2023-01,Q1_2023,2022,6.6,0.984,Stable
FIA000976,2023-02-07,Hydrochlorothiazide,Microzide,Diuretics,12771-283-90,Tricare Standard,PLAN_8146,2023,Non-Formulary,Non-Formulary,2022-05-11,272,No Change,Non-Formulary Status; Quantity Limit,No,No,,264,250,5.7,Increased,358.67,401.4,-42.73,179.11,537.78,141.97,0.0,0,0.067,0.219,0.573,0.775,10,1,12,9,4.9,12.9,5,Similar,West,GA,Urban,75+,2023-02,Q1_2023,2022,2.8,0.236,Increasing
FIA001855,2023-02-08,Hydrochlorothiazide,Microzide,Diuretics,25781-886-54,VA Plan,PLAN_7028,2023,Tier 3,Non-Formulary,2022-10-04,127,Improved,Prior Authorization,Yes,No,,340,365,-6.8,Decreased,94.78,336.4,-241.62,180.77,275.55,93.69,0.175,10,0.066,0.316,0.467,0.562,5,8,14,9,2.9,18.9,2,Similar,Midwest,NC,Urban,36-50,2023-02,Q1_2023,2022,3.2,0.5,Increasing
FIA001285,2023-02-10,Hydrochlorothiazide,Microzide,Diuretics,68173-588-53,VA Plan,PLAN_9926,2023,Tier 2,Specialty Tier,2022-12-30,42,Improved,Quantity Limit,No,No,90.0,608,407,49.5,Increased,49.65,143.01,-93.36,189.33,238.98,145.3,0.0,0,0.071,0.124,0.541,0.53,14,9,18,15,2.0,5.9,8,Higher,Midwest,NY,Rural,36-50,2023-02,Q1_2023,2022,5.9,0.583,Decreasing
FIA002634,2023-02-21,Hydrochlorothiazide,Microzide,Diuretics,86516-722-37,Medicaid Plan Y,PLAN_3376,2023,Tier 1,Tier 1,2022-09-26,148,No Change,None,No,No,,662,666,-0.5,Stable,18.62,8.66,9.96,113.82,132.44,87.68,0.0,0,0.019,0.155,0.282,0.525,8,0,3,0,2.9,25.3,6,Lower,Southwest,PA,Suburban,75+,2023-02,Q1_2023,2022,5.5,0.112,Increasing
FIA001330,2023-03-07,Hydrochlorothiazide,Microzide,Diuretics,94740-102-73,Medicare Part D Plan B,PLAN_5064,2023,Tier 3,Tier 2,2022-08-16,203,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,670,945,-29.0,Decreased,93.82,39.22,54.6,176.79,270.61,181.31,0.515,9,0.047,0.149,0.698,0.837,2,3,8,1,3.4,13.2,2,Higher,Midwest,CA,Suburban,75+,2023-03,Q1_2023,2022,9.0,0.139,Stable
FIA001043,2023-03-20,Hydrochlorothiazide,Microzide,Diuretics,39095-131-95,Medicaid Plan Y,PLAN_1847,2023,Specialty Tier,Tier 1,2022-08-18,214,Worsened,None,No,No,,67,214,-68.5,Decreased,280.52,12.15,268.37,124.54,405.06,27.14,0.0,0,0.099,0.217,0.347,0.528,14,3,3,4,3.8,34.7,4,Lower,Midwest,NC,Suburban,18-35,2023-03,Q1_2023,2022,9.0,0.767,Decreasing
FIA000910,2023-03-28,Hydrochlorothiazide,Microzide,Diuretics,12198-312-65,VA Plan,PLAN_9568,2023,Tier 2,Non-Formulary,2022-05-26,306,Improved,None,No,No,,290,193,50.7,Increased,36.66,742.79,-706.13,156.78,193.44,56.1,0.0,0,0.022,0.203,0.405,0.833,15,8,12,4,3.3,21.2,7,Similar,Southeast,GA,Urban,75+,2023-03,Q1_2023,2022,5.2,0.379,Increasing
FIA001797,2023-04-05,Hydrochlorothiazide,Microzide,Diuretics,88771-980-20,Commercial Plan Beta,PLAN_1160,2023,Non-Formulary,Non-Formulary,2022-11-17,139,No Change,Non-Formulary Status,No,No,,112,118,-4.6,Stable,757.96,237.09,520.87,172.4,930.36,104.2,0.0,0,0.274,0.145,0.746,0.418,11,9,1,11,2.5,11.8,2,Higher,Southwest,OH,Suburban,66-75,2023-04,Q2_2023,2022,5.4,0.186,Stable
FIA000517,2023-04-09,Hydrochlorothiazide,Microzide,Diuretics,84346-419-98,Medicare Part D Plan B,PLAN_6362,2023,Tier 3,Non-Formulary,2022-12-06,124,Improved,Prior Authorization,Yes,No,,374,371,0.9,Stable,95.96,575.95,-479.99,116.14,212.1,79.33,0.375,6,0.032,0.256,0.885,0.842,1,1,3,4,4.2,25.4,2,Higher,Southwest,IL,Urban,66-75,2023-04,Q2_2023,2022,9.0,0.044,Increasing
FIA001210,2023-04-09,Hydrochlorothiazide,Microzide,Diuretics,39325-504-47,Commercial Plan Alpha,PLAN_9004,2023,Tier 1,Non-Formulary,2022-09-05,216,Improved,None,No,No,,1117,800,39.6,Increased,10.38,709.03,-698.65,150.04,160.42,179.19,0.0,0,0.066,0.124,0.609,0.65,7,8,20,3,3.3,25.4,2,Lower,West,FL,Urban,36-50,2023-04,Q2_2023,2022,3.9,0.102,Decreasing
FIA000666,2023-04-10,Hydrochlorothiazide,Microzide,Diuretics,93305-963-79,Tricare Standard,PLAN_3169,2023,Tier 1,Tier 3,2022-05-27,318,Improved,Quantity Limit,No,No,,145,117,24.2,Increased,6.06,65.03,-58.97,55.89,61.95,8.98,0.0,0,0.045,0.257,0.578,0.754,12,4,5,4,2.9,5.3,6,Higher,Southeast,CA,Rural,36-50,2023-04,Q2_2023,2022,3.1,0.832,Increasing
FIA001115,2023-04-21,Hydrochlorothiazide,Microzide,Diuretics,78639-324-28,Medicare Part D Plan B,PLAN_4295,2023,Non-Formulary,Tier 1,2022-06-12,313,Worsened,Non-Formulary Status,No,No,,107,209,-48.7,Decreased,562.63,6.57,556.06,114.63,677.26,72.47,0.0,0,0.194,0.386,0.445,0.469,8,10,5,11,3.9,8.1,6,Higher,Northeast,NY,Suburban,75+,2023-04,Q2_2023,2022,3.7,0.748,Decreasing
FIA001472,2023-05-05,Hydrochlorothiazide,Microzide,Diuretics,48130-244-95,Medicaid Plan Y,PLAN_1279,2023,Tier 3,Tier 1,2022-05-31,339,Worsened,None,No,No,,465,896,-48.1,Decreased,74.54,16.64,57.9,159.01,233.55,108.6,0.0,0,0.018,0.055,0.747,0.748,9,2,4,8,4.3,20.0,7,Lower,West,NY,Rural,18-35,2023-05,Q2_2023,2022,3.1,0.492,Stable
FIA002295,2023-05-07,Hydrochlorothiazide,Microzide,Diuretics,37417-676-82,VA Plan,PLAN_8119,2023,Tier 1,Tier 2,2022-09-11,238,Improved,None,No,No,,580,638,-9.1,Decreased,18.49,32.63,-14.14,152.39,170.88,99.11,0.0,0,0.057,0.185,0.603,0.718,6,7,9,2,4.5,21.4,3,Higher,West,TX,Rural,66-75,2023-05,Q2_2023,2022,4.1,0.803,Stable
FIA000435,2023-05-11,Hydrochlorothiazide,Microzide,Diuretics,15540-168-58,Commercial Plan Alpha,PLAN_1009,2023,Non-Formulary,Tier 3,2022-06-22,323,Worsened,Non-Formulary Status,No,No,,528,565,-6.5,Decreased,669.89,73.12,596.77,133.02,802.91,423.94,0.0,0,0.091,0.151,0.57,0.669,12,8,17,12,4.7,19.0,7,Higher,Midwest,MI,Rural,66-75,2023-05,Q2_2023,2022,7.8,0.523,Stable
FIA001056,2023-05-11,Hydrochlorothiazide,Microzide,Diuretics,54975-635-73,Medicaid Plan Y,PLAN_7087,2023,Tier 1,Tier 1,2023-02-15,85,No Change,None,No,No,,590,620,-4.7,Stable,18.83,17.01,1.82,120.4,139.23,82.15,0.0,0,0.028,0.097,0.403,0.484,12,1,10,2,2.8,17.4,5,Similar,Midwest,GA,Rural,75+,2023-05,Q2_2023,2022,2.9,0.073,Stable
FIA000226,2023-05-18,Hydrochlorothiazide,Microzide,Diuretics,64386-124-77,Medicaid Plan Y,PLAN_7258,2023,Non-Formulary,Specialty Tier,2023-03-06,73,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,520,511,1.8,Stable,684.15,221.37,462.78,104.29,788.44,409.99,0.0,0,0.056,0.082,0.886,0.698,9,2,5,8,4.3,9.6,5,Higher,Southeast,CA,Rural,51-65,2023-05,Q2_2023,2022,2.6,0.713,Stable
FIA001132,2023-05-19,Hydrochlorothiazide,Microzide,Diuretics,76998-975-73,Medicare Part D Plan B,PLAN_6481,2023,Tier 2,Non-Formulary,2022-05-22,362,Improved,None,No,No,,155,120,30.0,Increased,21.4,391.59,-370.19,189.35,210.75,32.67,0.0,0,0.068,0.255,0.785,0.465,4,3,14,15,2.5,6.8,2,Similar,Midwest,PA,Suburban,66-75,2023-05,Q2_2023,2022,6.2,0.232,Increasing
FIA001888,2023-05-20,Hydrochlorothiazide,Microzide,Diuretics,34911-323-43,Medicaid Plan Y,PLAN_8289,2023,Tier 3,Non-Formulary,2022-12-12,159,Improved,Step Therapy,No,Yes,,409,432,-5.2,Decreased,94.38,777.91,-683.53,184.21,278.59,113.94,0.0,0,0.063,0.07,0.669,0.439,15,5,18,12,3.2,7.6,7,Similar,Midwest,OH,Suburban,51-65,2023-05,Q2_2023,2022,5.7,0.268,Decreasing
FIA002622,2023-05-24,Hydrochlorothiazide,Microzide,Diuretics,62739-891-97,Medicaid Plan Y,PLAN_7615,2023,Specialty Tier,Tier 2,2023-01-25,119,Worsened,None,No,No,,668,841,-20.5,Decreased,176.62,36.67,139.95,124.59,301.21,201.21,0.0,0,0.1,0.197,0.408,0.692,4,0,4,12,2.7,28.3,5,Higher,Midwest,NC,Urban,18-35,2023-05,Q2_2023,2022,1.1,0.867,Decreasing
FIA002469,2023-05-26,Hydrochlorothiazide,Microzide,Diuretics,68928-415-82,Medicaid Plan Y,PLAN_7876,2023,Non-Formulary,Tier 1,2022-10-16,222,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,145,244,-40.5,Decreased,229.15,5.39,223.76,63.08,292.23,42.37,0.0,0,0.113,0.377,0.316,0.874,8,7,1,14,2.4,34.5,5,Lower,Midwest,MI,Rural,75+,2023-05,Q2_2023,2022,5.4,0.517,Stable
FIA002364,2023-05-30,Hydrochlorothiazide,Microzide,Diuretics,40473-509-34,Commercial Plan Alpha,PLAN_6341,2023,Tier 1,Tier 3,2022-12-26,155,Improved,None,No,No,,1296,920,40.9,Increased,5.55,81.92,-76.37,108.41,113.96,147.69,0.0,0,0.072,0.364,0.762,0.595,2,0,8,7,2.1,5.8,4,Lower,Northeast,CA,Urban,36-50,2023-05,Q2_2023,2022,3.9,0.045,Stable
FIA000068,2023-06-01,Hydrochlorothiazide,Microzide,Diuretics,14152-195-61,VA Plan,PLAN_7179,2023,Tier 3,Tier 3,2022-10-11,233,No Change,Step Therapy,No,Yes,,577,570,1.3,Stable,53.95,97.96,-44.01,140.48,194.43,112.19,0.0,0,0.079,0.243,0.239,0.405,5,1,15,13,3.9,14.9,8,Lower,West,CA,Urban,36-50,2023-06,Q2_2023,2022,9.1,0.692,Decreasing
FIA002455,2023-07-08,Hydrochlorothiazide,Microzide,Diuretics,83542-704-48,Medicare Part D Plan A,PLAN_7521,2023,Non-Formulary,Tier 1,2022-11-01,249,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,275,474,-41.9,Decreased,548.54,6.81,541.73,171.98,720.52,198.14,0.0,0,0.236,0.301,0.436,0.944,2,8,13,4,4.1,28.5,5,Similar,West,NC,Urban,75+,2023-07,Q3_2023,2022,9.3,0.711,Stable
FIA002433,2023-07-14,Hydrochlorothiazide,Microzide,Diuretics,15404-746-70,Medicaid Plan Y,PLAN_9152,2023,Tier 2,Tier 1,2022-10-29,258,Worsened,None,No,No,,207,189,9.6,Increased,22.76,14.69,8.07,46.77,69.53,14.39,0.0,0,0.026,0.387,0.651,0.558,6,10,5,4,4.6,29.1,3,Lower,Southwest,PA,Urban,36-50,2023-07,Q3_2023,2022,2.3,0.605,Increasing
FIA000054,2023-07-27,Hydrochlorothiazide,Microzide,Diuretics,88966-621-61,Medicare Part D Plan A,PLAN_1742,2023,Non-Formulary,Non-Formulary,2023-04-28,90,No Change,Non-Formulary Status,No,No,,510,482,5.9,Increased,277.2,258.01,19.19,54.53,331.73,169.18,0.0,0,0.141,0.064,0.7,0.842,14,2,19,4,3.0,23.4,3,Similar,West,PA,Rural,51-65,2023-07,Q3_2023,2022,5.6,0.51,Stable
FIA001781,2023-07-27,Hydrochlorothiazide,Microzide,Diuretics,82276-224-32,Tricare Standard,PLAN_6685,2023,Non-Formulary,Non-Formulary,2022-09-17,313,No Change,Non-Formulary Status,No,No,,763,714,6.9,Increased,476.94,565.56,-88.62,36.32,513.26,391.62,0.0,0,0.223,0.191,0.263,0.406,1,8,13,15,4.5,10.6,4,Higher,Southwest,NC,Suburban,75+,2023-07,Q3_2023,2022,1.6,0.378,Increasing
FIA000471,2023-08-04,Hydrochlorothiazide,Microzide,Diuretics,17594-178-49,Medicare Part D Plan B,PLAN_3018,2023,Non-Formulary,Tier 1,2022-12-05,242,Worsened,Non-Formulary Status,No,No,,551,796,-30.7,Decreased,750.0,18.23,731.77,52.77,802.77,442.33,0.0,0,0.248,0.355,0.648,0.716,3,8,9,7,2.7,20.9,4,Lower,West,FL,Suburban,36-50,2023-08,Q3_2023,2022,2.5,0.723,Increasing
FIA000776,2023-08-10,Hydrochlorothiazide,Microzide,Diuretics,61246-490-32,Tricare Standard,PLAN_7951,2023,Tier 1,Tier 2,2023-05-01,101,Improved,None,No,No,,877,834,5.2,Increased,8.26,39.66,-31.4,81.33,89.59,78.57,0.0,0,0.077,0.122,0.353,0.563,3,1,14,13,4.3,25.5,3,Higher,Northeast,IL,Urban,51-65,2023-08,Q3_2023,2022,5.6,0.113,Stable
FIA002485,2023-08-11,Hydrochlorothiazide,Microzide,Diuretics,96670-784-32,Medicare Part D Plan B,PLAN_2661,2023,Non-Formulary,Tier 2,2023-06-20,52,Worsened,Non-Formulary Status,No,No,,106,205,-48.0,Decreased,723.29,21.16,702.13,94.16,817.45,86.65,0.0,0,0.267,0.291,0.704,0.664,14,1,0,12,3.2,22.3,8,Similar,Southwest,MI,Urban,75+,2023-08,Q3_2023,2022,7.4,0.055,Decreasing
FIA000490,2023-08-12,Hydrochlorothiazide,Microzide,Diuretics,31602-148-35,Medicaid Plan Y,PLAN_4866,2023,Tier 3,Tier 2,2023-07-10,33,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,80,222,-63.9,Decreased,59.71,38.84,20.87,131.83,191.54,15.32,0.516,5,0.074,0.328,0.26,0.6,12,4,2,10,2.9,8.2,8,Similar,Southeast,TX,Urban,36-50,2023-08,Q3_2023,2022,4.3,0.886,Stable
FIA001447,2023-08-19,Hydrochlorothiazide,Microzide,Diuretics,41054-491-70,Medicare Part D Plan B,PLAN_3081,2023,Specialty Tier,Tier 1,2022-12-12,250,Worsened,None,No,No,,282,426,-33.6,Decreased,120.09,17.39,102.7,148.04,268.13,75.61,0.0,0,0.217,0.224,0.382,0.402,11,3,2,5,2.3,28.7,8,Higher,Midwest,CA,Rural,66-75,2023-08,Q3_2023,2022,6.6,0.451,Decreasing
FIA002435,2023-08-21,Hydrochlorothiazide,Microzide,Diuretics,53617-665-90,Medicare Part D Plan B,PLAN_2764,2023,Tier 1,Tier 2,2023-04-03,140,Improved,None,No,No,,723,792,-8.7,Decreased,5.48,23.25,-17.77,187.3,192.78,139.38,0.0,0,0.016,0.349,0.378,0.541,7,4,20,4,2.8,24.9,2,Similar,Southwest,TX,Urban,51-65,2023-08,Q3_2023,2022,8.8,0.825,Stable
FIA002827,2023-08-24,Hydrochlorothiazide,Microzide,Diuretics,53511-945-50,Medicaid Plan Y,PLAN_6073,2023,Tier 1,Tier 2,2023-07-13,42,Improved,Quantity Limit,No,No,,390,428,-8.8,Decreased,15.87,31.51,-15.64,148.77,164.64,64.21,0.0,0,0.074,0.152,0.469,0.749,7,9,1,11,4.1,15.5,6,Similar,Southeast,OH,Urban,51-65,2023-08,Q3_2023,2022,6.4,0.278,Stable
FIA000702,2023-09-03,Hydrochlorothiazide,Microzide,Diuretics,86322-610-56,Tricare Standard,PLAN_3624,2023,Tier 1,Tier 1,2022-12-26,251,No Change,None,No,No,,424,426,-0.4,Stable,8.27,7.02,1.25,50.23,58.5,24.8,0.0,0,0.025,0.26,0.692,0.481,14,3,3,12,4.9,28.2,3,Higher,Northeast,FL,Rural,18-35,2023-09,Q3_2023,2022,4.0,0.368,Decreasing
FIA002428,2023-09-07,Hydrochlorothiazide,Microzide,Diuretics,43546-658-86,Commercial Plan Beta,PLAN_3172,2023,Tier 1,Specialty Tier,2022-09-13,359,Improved,Quantity Limit,No,No,30.0,1031,761,35.5,Increased,9.27,154.22,-144.95,121.39,130.66,134.71,0.0,0,0.071,0.272,0.513,0.746,9,10,16,15,4.2,8.4,3,Lower,Southeast,TX,Suburban,66-75,2023-09,Q3_2023,2022,4.4,0.309,Decreasing
FIA001423,2023-09-12,Hydrochlorothiazide,Microzide,Diuretics,27450-589-70,Medicare Part D Plan A,PLAN_3078,2023,Tier 3,Tier 2,2023-07-02,72,Worsened,Prior Authorization; Quantity Limit,Yes,No,90.0,323,589,-45.1,Decreased,64.1,33.95,30.15,53.48,117.58,37.98,0.268,1,0.074,0.309,0.594,0.62,15,9,18,14,4.1,15.5,7,Higher,Southwest,PA,Urban,18-35,2023-09,Q3_2023,2022,2.9,0.015,Stable
FIA001934,2023-09-21,Hydrochlorothiazide,Microzide,Diuretics,49219-417-46,Medicare Part D Plan A,PLAN_3389,2023,Tier 1,Tier 2,2023-05-11,133,Improved,Quantity Limit,No,No,,302,277,9.3,Increased,12.33,25.64,-13.31,132.12,144.45,43.62,0.0,0,0.046,0.232,0.298,0.657,11,9,18,3,3.7,8.8,4,Similar,West,OH,Suburban,51-65,2023-09,Q3_2023,2022,7.4,0.827,Increasing
FIA001229,2023-09-23,Hydrochlorothiazide,Microzide,Diuretics,33014-876-45,Medicaid Plan X,PLAN_2600,2023,Non-Formulary,Tier 1,2023-06-13,102,Worsened,Non-Formulary Status; Quantity Limit,No,No,,277,406,-31.6,Decreased,325.1,16.56,308.54,176.28,501.38,138.88,0.0,0,0.158,0.082,0.466,0.717,11,9,19,3,2.4,25.8,6,Similar,Southwest,PA,Urban,36-50,2023-09,Q3_2023,2022,1.6,0.107,Increasing
FIA002394,2023-09-25,Hydrochlorothiazide,Microzide,Diuretics,22894-206-18,VA Plan,PLAN_8972,2023,Non-Formulary,Non-Formulary,2022-12-19,280,No Change,Non-Formulary Status,No,No,,453,430,5.4,Increased,517.77,220.42,297.35,67.27,585.04,265.02,0.0,0,0.276,0.06,0.442,0.458,2,0,15,10,2.7,14.6,4,Higher,Midwest,FL,Rural,36-50,2023-09,Q3_2023,2022,4.8,0.669,Stable
FIA002746,2023-10-06,Hydrochlorothiazide,Microzide,Diuretics,43142-351-38,Medicare Part D Plan B,PLAN_6981,2023,Tier 2,Tier 2,2023-01-15,264,No Change,None,No,No,,418,443,-5.6,Decreased,46.65,46.66,-0.01,155.07,201.72,84.32,0.0,0,0.068,0.312,0.299,0.623,8,10,8,9,4.5,27.1,7,Similar,Midwest,FL,Urban,66-75,2023-10,Q4_2023,2023,5.7,0.519,Increasing
FIA000256,2023-10-08,Hydrochlorothiazide,Microzide,Diuretics,62665-842-27,Medicare Part D Plan A,PLAN_3013,2023,Tier 2,Tier 3,2023-02-16,234,Improved,Quantity Limit,No,No,60.0,715,464,54.3,Increased,31.35,52.86,-21.51,177.99,209.34,149.68,0.0,0,0.01,0.383,0.726,0.537,14,9,15,13,4.0,5.1,7,Similar,Northeast,IL,Urban,51-65,2023-10,Q4_2023,2023,7.1,0.234,Stable
FIA000539,2023-10-08,Hydrochlorothiazide,Microzide,Diuretics,17801-110-30,VA Plan,PLAN_1831,2023,Tier 3,Tier 1,2023-06-10,120,Worsened,None,No,No,,572,782,-26.8,Decreased,99.91,18.39,81.52,178.23,278.14,159.1,0.0,0,0.05,0.078,0.278,0.518,5,5,20,8,3.3,31.7,4,Lower,Southwest,PA,Urban,66-75,2023-10,Q4_2023,2023,1.9,0.443,Increasing
FIA000701,2023-10-23,Hydrochlorothiazide,Microzide,Diuretics,14911-696-91,Tricare Standard,PLAN_8378,2023,Tier 1,Tier 2,2023-03-02,235,Improved,Quantity Limit,No,No,90.0,443,432,2.6,Stable,13.04,33.32,-20.28,132.3,145.34,64.39,0.0,0,0.064,0.238,0.812,0.478,9,10,8,11,3.3,13.8,5,Similar,West,PA,Urban,36-50,2023-10,Q4_2023,2023,8.4,0.423,Stable
FIA002071,2023-10-23,Hydrochlorothiazide,Microzide,Diuretics,33891-592-22,Medicaid Plan Y,PLAN_4047,2023,Tier 2,Tier 2,2022-11-13,344,No Change,None,No,No,,699,687,1.9,Stable,31.26,29.51,1.75,34.98,66.24,46.3,0.0,0,0.049,0.355,0.517,0.665,5,2,13,6,4.7,33.3,5,Lower,Southwest,TX,Suburban,75+,2023-10,Q4_2023,2023,1.6,0.757,Decreasing
FIA002086,2023-10-25,Hydrochlorothiazide,Microzide,Diuretics,11665-556-60,Medicaid Plan Y,PLAN_8985,2023,Tier 1,Tier 2,2023-02-19,248,Improved,None,No,No,,280,306,-8.5,Decreased,9.55,24.02,-14.47,37.84,47.39,13.27,0.0,0,0.065,0.251,0.87,0.816,11,8,2,6,2.9,28.0,7,Similar,Southwest,GA,Rural,66-75,2023-10,Q4_2023,2023,7.7,0.232,Decreasing
FIA000812,2023-10-29,Hydrochlorothiazide,Microzide,Diuretics,53221-714-90,Commercial Plan Alpha,PLAN_9240,2023,Non-Formulary,Specialty Tier,2023-04-11,201,Worsened,Non-Formulary Status,No,No,,706,751,-6.0,Decreased,287.94,146.21,141.73,163.84,451.78,318.96,0.0,0,0.136,0.295,0.542,0.696,14,4,2,2,4.1,13.7,6,Similar,Southeast,OH,Suburban,51-65,2023-10,Q4_2023,2023,7.8,0.839,Decreasing
FIA001551,2023-11-02,Hydrochlorothiazide,Microzide,Diuretics,37422-676-69,Commercial Plan Beta,PLAN_6000,2023,Tier 2,Tier 2,2023-03-03,244,No Change,None,No,No,,451,474,-4.8,Stable,42.73,39.71,3.02,159.45,202.18,91.18,0.0,0,0.066,0.345,0.268,0.772,11,9,18,13,2.9,17.6,7,Similar,Northeast,CA,Rural,75+,2023-11,Q4_2023,2023,6.6,0.458,Stable
FIA000984,2023-11-04,Hydrochlorothiazide,Microzide,Diuretics,13991-622-83,Commercial Plan Alpha,PLAN_5182,2023,Tier 3,Tier 3,2023-01-22,286,No Change,None,No,No,,888,918,-3.2,Stable,72.67,55.17,17.5,173.7,246.37,218.78,0.0,0,0.072,0.151,0.698,0.423,10,0,14,13,3.8,15.8,8,Similar,West,NY,Suburban,51-65,2023-11,Q4_2023,2023,5.6,0.078,Increasing
FIA002105,2023-11-14,Hydrochlorothiazide,Microzide,Diuretics,80887-702-22,Medicaid Plan Y,PLAN_9056,2023,Tier 3,Tier 1,2023-04-09,219,Worsened,None,No,No,,173,340,-49.0,Decreased,92.13,15.97,76.16,140.51,232.64,40.25,0.0,0,0.03,0.314,0.5,0.579,9,6,11,12,2.6,27.3,8,Similar,Northeast,NY,Urban,75+,2023-11,Q4_2023,2023,7.0,0.511,Stable
FIA002375,2023-11-14,Hydrochlorothiazide,Microzide,Diuretics,15266-476-70,Medicaid Plan Y,PLAN_5452,2023,Specialty Tier,Non-Formulary,2023-05-10,188,Improved,None,No,No,,896,886,1.1,Stable,298.11,379.08,-80.97,67.89,366.0,327.94,0.0,0,0.209,0.267,0.258,0.682,9,4,19,3,3.0,5.4,3,Lower,West,IL,Urban,75+,2023-11,Q4_2023,2023,7.6,0.662,Decreasing
FIA000844,2023-11-16,Hydrochlorothiazide,Microzide,Diuretics,81488-343-98,Medicare Part D Plan B,PLAN_3913,2023,Specialty Tier,Tier 3,2023-08-22,86,Worsened,Prior Authorization,Yes,No,,275,287,-4.0,Stable,298.98,98.16,200.82,117.91,416.89,114.64,0.165,5,0.2,0.279,0.867,0.932,15,7,7,13,4.1,18.8,3,Similar,Midwest,NY,Rural,51-65,2023-11,Q4_2023,2023,2.8,0.883,Stable
FIA000938,2024-01-04,Hydrochlorothiazide,Microzide,Diuretics,79833-463-99,VA Plan,PLAN_3610,2024,Tier 2,Specialty Tier,2023-05-11,238,Improved,None,No,No,,327,239,37.2,Increased,38.01,141.77,-103.76,52.02,90.03,29.44,0.0,0,0.08,0.321,0.74,0.527,4,3,15,5,2.6,27.5,3,Lower,Northeast,NY,Urban,66-75,2024-01,Q1_2024,2023,8.4,0.733,Decreasing
FIA000152,2024-01-08,Hydrochlorothiazide,Microzide,Diuretics,21537-290-35,Tricare Standard,PLAN_1352,2024,Tier 1,Tier 1,2023-07-13,179,No Change,Quantity Limit,No,No,,368,336,9.6,Increased,18.01,14.74,3.27,131.51,149.52,55.02,0.0,0,0.044,0.137,0.571,0.583,12,2,0,11,4.1,15.7,4,Lower,West,PA,Urban,51-65,2024-01,Q1_2024,2023,8.9,0.89,Increasing
FIA000857,2024-01-19,Hydrochlorothiazide,Microzide,Diuretics,79370-954-54,VA Plan,PLAN_6427,2024,Specialty Tier,Tier 2,2023-07-18,185,Worsened,Prior Authorization,Yes,No,,476,615,-22.4,Decreased,149.79,42.51,107.28,52.9,202.69,96.48,0.173,4,0.23,0.134,0.529,0.662,7,0,6,3,3.1,25.6,5,Lower,West,FL,Suburban,18-35,2024-01,Q1_2024,2023,4.3,0.548,Decreasing
FIA001035,2024-01-19,Hydrochlorothiazide,Microzide,Diuretics,97565-882-89,Medicaid Plan X,PLAN_5425,2024,Tier 2,Non-Formulary,2023-08-07,165,Improved,Quantity Limit,No,No,30.0,642,534,20.4,Increased,40.09,389.58,-349.49,146.52,186.61,119.8,0.0,0,0.018,0.195,0.691,0.694,10,5,6,14,4.3,34.9,4,Higher,Southeast,OH,Rural,36-50,2024-01,Q1_2024,2023,7.5,0.625,Increasing
FIA001338,2024-02-22,Hydrochlorothiazide,Microzide,Diuretics,91075-268-19,Medicaid Plan X,PLAN_3002,2024,Tier 3,Tier 3,2023-05-26,272,No Change,None,No,No,,889,909,-2.1,Stable,55.78,69.04,-13.26,120.38,176.16,156.61,0.0,0,0.042,0.24,0.228,0.653,0,8,8,15,3.9,33.3,6,Higher,Northeast,TX,Rural,18-35,2024-02,Q1_2024,2023,5.1,0.735,Stable
FIA001870,2024-03-01,Hydrochlorothiazide,Microzide,Diuretics,14138-622-19,Medicare Part D Plan B,PLAN_4588,2024,Tier 3,Tier 1,2023-03-03,364,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,394,669,-41.1,Decreased,99.94,18.96,80.98,199.95,299.89,118.16,0.322,8,0.068,0.235,0.279,0.424,14,0,16,8,2.8,28.6,4,Similar,Southeast,FL,Suburban,66-75,2024-03,Q1_2024,2023,5.2,0.089,Decreasing
FIA000622,2024-03-13,Hydrochlorothiazide,Microzide,Diuretics,67933-622-44,Medicaid Plan X,PLAN_8754,2024,Specialty Tier,Specialty Tier,2023-08-17,209,No Change,Prior Authorization; Step Therapy,Yes,Yes,,274,256,7.1,Increased,286.38,256.63,29.75,174.89,461.27,126.39,0.321,8,0.299,0.34,0.664,0.718,6,5,0,1,3.2,33.0,8,Higher,Midwest,NC,Rural,66-75,2024-03,Q1_2024,2023,9.9,0.974,Increasing
FIA001863,2024-03-15,Hydrochlorothiazide,Microzide,Diuretics,74406-152-40,Medicare Part D Plan A,PLAN_4483,2024,Specialty Tier,Tier 2,2024-01-09,66,Worsened,Step Therapy,No,Yes,,282,750,-62.4,Decreased,275.12,40.72,234.4,78.05,353.17,99.59,0.0,0,0.101,0.195,0.37,0.872,13,10,1,4,3.2,20.3,8,Lower,Southwest,IL,Rural,51-65,2024-03,Q1_2024,2023,9.2,0.02,Increasing
FIA001325,2024-03-18,Hydrochlorothiazide,Microzide,Diuretics,63891-171-61,Commercial Plan Beta,PLAN_4710,2024,Tier 2,Tier 1,2023-06-17,275,Worsened,None,No,No,,479,512,-6.4,Decreased,43.33,6.01,37.32,174.64,217.97,104.41,0.0,0,0.061,0.318,0.475,0.835,3,3,0,6,2.4,29.0,3,Similar,West,NC,Suburban,51-65,2024-03,Q1_2024,2023,1.2,0.253,Stable
FIA001142,2024-03-23,Hydrochlorothiazide,Microzide,Diuretics,52702-109-62,Medicaid Plan X,PLAN_3923,2024,Specialty Tier,Specialty Tier,2023-08-26,210,No Change,Prior Authorization,Yes,No,,98,100,-1.2,Stable,129.53,255.28,-125.75,103.1,232.63,22.8,0.444,8,0.076,0.105,0.704,0.904,9,3,16,3,3.5,26.6,5,Similar,Southeast,FL,Suburban,18-35,2024-03,Q1_2024,2023,2.3,0.348,Increasing
FIA000373,2024-03-30,Hydrochlorothiazide,Microzide,Diuretics,95253-759-59,Tricare Standard,PLAN_1259,2024,Tier 1,Tier 3,2023-08-29,214,Improved,None,No,No,,857,544,57.6,Increased,19.19,91.83,-72.64,149.21,168.4,144.32,0.0,0,0.026,0.383,0.392,0.756,10,0,4,7,2.5,5.3,6,Lower,Southeast,GA,Urban,18-35,2024-03,Q1_2024,2023,6.4,0.21,Decreasing
FIA000025,2024-04-07,Hydrochlorothiazide,Microzide,Diuretics,36680-373-80,Commercial Plan Alpha,PLAN_5719,2024,Non-Formulary,Tier 1,2023-06-05,307,Worsened,Non-Formulary Status,No,No,,390,630,-38.1,Decreased,477.19,5.81,471.38,159.2,636.39,248.19,0.0,0,0.206,0.203,0.689,0.467,7,2,9,0,3.7,7.8,8,Lower,Southwest,TX,Rural,36-50,2024-04,Q2_2024,2023,5.5,0.717,Decreasing
FIA002501,2024-04-07,Hydrochlorothiazide,Microzide,Diuretics,65664-755-69,VA Plan,PLAN_5358,2024,Tier 3,Tier 1,2023-09-11,209,Worsened,None,No,No,,100,133,-24.7,Decreased,56.68,19.94,36.74,188.89,245.57,24.56,0.0,0,0.018,0.097,0.619,0.806,9,7,13,15,2.3,9.5,8,Lower,Midwest,GA,Rural,36-50,2024-04,Q2_2024,2023,2.5,0.731,Increasing
FIA000241,2024-04-10,Hydrochlorothiazide,Microzide,Diuretics,40634-628-85,Tricare Standard,PLAN_8559,2024,Non-Formulary,Tier 1,2023-07-14,271,Worsened,Non-Formulary Status,No,No,,92,252,-63.3,Decreased,592.45,19.84,572.61,65.68,658.13,60.55,0.0,0,0.231,0.169,0.26,0.865,13,6,6,14,3.3,21.8,4,Lower,West,FL,Suburban,18-35,2024-04,Q2_2024,2023,5.5,0.659,Stable
FIA000470,2024-04-12,Hydrochlorothiazide,Microzide,Diuretics,63372-897-80,Medicare Part D Plan A,PLAN_1174,2024,Tier 1,Tier 1,2024-01-31,72,No Change,Quantity Limit,No,No,30.0,616,617,-0.1,Stable,18.77,14.18,4.59,193.33,212.1,130.65,0.0,0,0.017,0.123,0.219,0.846,3,5,13,3,3.6,30.1,6,Lower,Southeast,OH,Suburban,66-75,2024-04,Q2_2024,2023,6.7,0.497,Decreasing
FIA002890,2024-04-30,Hydrochlorothiazide,Microzide,Diuretics,48340-414-16,Medicaid Plan X,PLAN_2565,2024,Specialty Tier,Tier 3,2024-01-20,101,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,420,414,1.6,Stable,276.18,50.27,225.91,57.24,333.42,140.04,0.257,1,0.202,0.392,0.578,0.85,4,4,0,6,2.1,25.7,7,Similar,Southwest,IL,Rural,66-75,2024-04,Q2_2024,2023,8.9,0.442,Stable
FIA002050,2024-05-02,Hydrochlorothiazide,Microzide,Diuretics,69283-243-97,Medicaid Plan X,PLAN_9049,2024,Tier 2,Tier 2,2023-12-03,151,No Change,None,No,No,,748,790,-5.3,Decreased,47.08,35.96,11.12,35.92,83.0,62.08,0.0,0,0.051,0.354,0.717,0.722,8,1,19,11,4.9,10.9,5,Similar,Midwest,IL,Urban,75+,2024-05,Q2_2024,2023,1.3,0.008,Stable
FIA002480,2024-05-02,Hydrochlorothiazide,Microzide,Diuretics,90798-576-30,Commercial Plan Beta,PLAN_9195,2024,Tier 3,Non-Formulary,2023-11-27,157,Improved,Quantity Limit,No,No,60.0,442,418,6.0,Increased,56.72,265.32,-208.6,149.01,205.73,90.93,0.0,0,0.072,0.231,0.594,0.684,12,6,13,11,3.0,13.0,6,Similar,Southeast,CA,Urban,51-65,2024-05,Q2_2024,2023,4.8,0.853,Decreasing
FIA001906,2024-05-21,Hydrochlorothiazide,Microzide,Diuretics,27887-938-98,Commercial Plan Alpha,PLAN_9898,2024,Non-Formulary,Non-Formulary,2023-08-24,271,No Change,Non-Formulary Status; Quantity Limit,No,No,60.0,874,947,-7.7,Decreased,778.47,703.92,74.55,150.98,929.45,812.34,0.0,0,0.256,0.151,0.388,0.478,2,6,12,8,3.0,6.8,4,Similar,Southeast,FL,Suburban,75+,2024-05,Q2_2024,2023,3.4,0.115,Increasing
FIA002157,2024-05-21,Hydrochlorothiazide,Microzide,Diuretics,55566-600-45,Medicare Part D Plan A,PLAN_9250,2024,Tier 1,Tier 3,2024-04-15,36,Improved,None,No,No,,581,501,16.0,Increased,10.75,87.05,-76.3,100.41,111.16,64.58,0.0,0,0.021,0.351,0.436,0.644,8,4,9,2,2.7,27.9,6,Lower,Midwest,NC,Rural,36-50,2024-05,Q2_2024,2023,7.5,0.776,Stable
FIA000504,2024-05-22,Hydrochlorothiazide,Microzide,Diuretics,30787-947-97,Medicare Part D Plan A,PLAN_4634,2024,Non-Formulary,Tier 1,2023-09-24,241,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,207,388,-46.6,Decreased,336.92,6.9,330.02,84.3,421.22,87.19,0.0,0,0.077,0.061,0.241,0.409,11,6,15,14,3.1,31.8,4,Higher,Northeast,IL,Suburban,75+,2024-05,Q2_2024,2023,7.1,0.998,Stable
FIA000015,2024-05-23,Hydrochlorothiazide,Microzide,Diuretics,45992-550-19,Medicaid Plan X,PLAN_4841,2024,Non-Formulary,Specialty Tier,2024-02-02,111,Worsened,Non-Formulary Status,No,No,,383,365,5.0,Increased,646.19,194.93,451.26,136.55,782.74,299.79,0.0,0,0.18,0.145,0.424,0.697,4,2,7,12,4.1,26.2,2,Similar,Southwest,IL,Rural,66-75,2024-05,Q2_2024,2023,4.7,0.207,Stable
FIA002335,2024-05-29,Hydrochlorothiazide,Microzide,Diuretics,18692-410-35,Medicaid Plan X,PLAN_3384,2024,Tier 2,Tier 2,2023-11-27,184,No Change,None,No,No,,230,225,2.2,Stable,40.4,48.0,-7.6,60.3,100.7,23.16,0.0,0,0.012,0.319,0.827,0.542,1,1,10,11,3.8,10.0,4,Similar,Midwest,FL,Urban,66-75,2024-05,Q2_2024,2023,8.9,0.605,Decreasing
FIA001536,2024-06-02,Hydrochlorothiazide,Microzide,Diuretics,94951-215-18,Tricare Standard,PLAN_4125,2024,Tier 2,Specialty Tier,2024-03-07,87,Improved,None,No,No,,336,243,38.4,Increased,39.52,112.74,-73.22,167.18,206.7,69.45,0.0,0,0.013,0.394,0.681,0.718,7,8,4,2,2.8,9.0,5,Higher,West,MI,Rural,75+,2024-06,Q2_2024,2023,4.6,0.505,Increasing
FIA000711,2024-06-03,Hydrochlorothiazide,Microzide,Diuretics,51292-177-42,Medicaid Plan Y,PLAN_3321,2024,Tier 3,Tier 3,2024-04-25,39,No Change,Step Therapy,No,Yes,,225,241,-6.6,Decreased,83.76,95.78,-12.02,36.23,119.99,27.0,0.0,0,0.039,0.057,0.888,0.621,7,3,16,4,2.4,30.6,4,Lower,Northeast,IL,Urban,75+,2024-06,Q2_2024,2023,2.2,0.665,Increasing
FIA001986,2024-07-01,Hydrochlorothiazide,Microzide,Diuretics,66076-677-30,VA Plan,PLAN_7022,2024,Specialty Tier,Specialty Tier,2024-04-04,88,No Change,Prior Authorization; Step Therapy,Yes,Yes,,974,920,6.0,Increased,129.47,198.32,-68.85,102.38,231.85,225.82,0.445,10,0.164,0.287,0.647,0.422,5,7,14,9,3.2,34.3,4,Higher,West,FL,Suburban,51-65,2024-07,Q3_2024,2023,8.2,0.468,Increasing
FIA002607,2024-07-07,Hydrochlorothiazide,Microzide,Diuretics,61232-237-25,Tricare Standard,PLAN_9261,2024,Specialty Tier,Tier 1,2023-12-28,192,Worsened,None,No,No,,464,873,-46.8,Decreased,290.34,11.84,278.5,111.13,401.47,186.28,0.0,0,0.262,0.232,0.317,0.917,2,4,9,14,4.6,25.9,7,Higher,Midwest,GA,Suburban,75+,2024-07,Q3_2024,2023,6.9,0.24,Increasing
FIA001407,2024-07-12,Hydrochlorothiazide,Microzide,Diuretics,61274-984-48,Medicaid Plan Y,PLAN_4994,2024,Tier 1,Specialty Tier,2023-10-23,263,Improved,Quantity Limit,No,No,30.0,1113,783,42.3,Increased,12.08,185.49,-173.41,46.52,58.6,65.22,0.0,0,0.018,0.118,0.823,0.489,10,0,7,11,2.7,25.8,7,Higher,Southeast,TX,Urban,18-35,2024-07,Q3_2024,2023,2.4,0.948,Decreasing
FIA002076,2024-07-13,Hydrochlorothiazide,Microzide,Diuretics,97745-723-63,Medicare Part D Plan A,PLAN_2896,2024,Tier 3,Tier 1,2024-02-22,142,Worsened,Prior Authorization,Yes,No,,296,747,-60.3,Decreased,82.23,19.94,62.29,153.5,235.73,69.78,0.196,3,0.04,0.059,0.347,0.411,3,9,14,1,4.0,18.3,4,Higher,Midwest,PA,Suburban,18-35,2024-07,Q3_2024,2023,6.0,0.556,Stable
FIA001485,2024-07-14,Hydrochlorothiazide,Microzide,Diuretics,53952-270-28,Medicaid Plan X,PLAN_3796,2024,Specialty Tier,Tier 2,2024-03-21,115,Worsened,None,No,No,,380,499,-23.7,Decreased,181.87,40.94,140.93,199.16,381.03,144.79,0.0,0,0.251,0.292,0.452,0.83,8,2,11,9,3.8,21.0,5,Similar,Southeast,GA,Urban,75+,2024-07,Q3_2024,2023,8.6,0.96,Stable
FIA002678,2024-07-15,Hydrochlorothiazide,Microzide,Diuretics,38414-319-84,Medicaid Plan Y,PLAN_8981,2024,Non-Formulary,Tier 3,2023-11-18,240,Worsened,Non-Formulary Status,No,No,,307,295,4.3,Stable,258.8,60.58,198.22,163.87,422.67,129.76,0.0,0,0.196,0.379,0.455,0.661,15,10,15,12,2.3,18.1,8,Similar,Midwest,TX,Suburban,75+,2024-07,Q3_2024,2023,2.4,0.729,Increasing
FIA001811,2024-07-31,Hydrochlorothiazide,Microzide,Diuretics,96978-105-33,Commercial Plan Beta,PLAN_6498,2024,Tier 3,Tier 1,2023-12-16,228,Worsened,Step Therapy,No,Yes,,411,639,-35.6,Decreased,61.19,7.48,53.71,101.8,162.99,66.99,0.0,0,0.077,0.101,0.83,0.833,15,10,18,4,5.0,8.2,8,Higher,Southeast,NC,Rural,18-35,2024-07,Q3_2024,2023,3.2,0.813,Stable
FIA000356,2024-08-04,Hydrochlorothiazide,Microzide,Diuretics,79414-478-48,Medicaid Plan X,PLAN_6166,2024,Specialty Tier,Tier 2,2023-10-07,302,Worsened,Prior Authorization,Yes,No,,216,361,-40.1,Decreased,239.55,40.19,199.36,44.13,283.68,61.27,0.343,8,0.296,0.286,0.221,0.744,5,9,11,13,3.2,27.9,8,Similar,West,GA,Urban,66-75,2024-08,Q3_2024,2023,9.3,0.132,Decreasing
FIA002821,2024-08-09,Hydrochlorothiazide,Microzide,Diuretics,45465-747-62,Medicare Part D Plan B,PLAN_6938,2024,Tier 2,Tier 1,2023-09-22,322,Worsened,None,No,No,,252,268,-5.7,Decreased,21.41,14.41,7.0,73.32,94.73,23.87,0.0,0,0.065,0.113,0.695,0.606,10,1,18,12,3.5,19.7,5,Lower,Southwest,PA,Rural,75+,2024-08,Q3_2024,2023,1.5,0.275,Decreasing
FIA002162,2024-08-11,Hydrochlorothiazide,Microzide,Diuretics,49162-763-17,Medicaid Plan X,PLAN_4358,2024,Tier 1,Specialty Tier,2024-06-09,63,Improved,None,No,No,,947,606,56.3,Increased,13.51,269.81,-256.3,43.07,56.58,53.58,0.0,0,0.025,0.356,0.579,0.449,6,1,11,0,2.0,15.8,6,Lower,Midwest,NY,Suburban,75+,2024-08,Q3_2024,2023,3.9,0.892,Stable
FIA001677,2024-08-16,Hydrochlorothiazide,Microzide,Diuretics,87610-398-96,Medicare Part D Plan A,PLAN_6349,2024,Tier 2,Tier 2,2024-03-20,149,No Change,None,No,No,,315,316,-0.0,Stable,29.97,26.67,3.3,188.14,218.11,68.7,0.0,0,0.047,0.203,0.712,0.773,14,6,3,5,3.4,27.2,6,Lower,Southeast,CA,Suburban,75+,2024-08,Q3_2024,2023,6.7,0.155,Decreasing
FIA000553,2024-08-25,Hydrochlorothiazide,Microzide,Diuretics,12900-648-99,Medicare Part D Plan A,PLAN_6440,2024,Tier 3,Specialty Tier,2024-01-11,227,Improved,Step Therapy,No,Yes,,599,614,-2.4,Stable,96.56,218.93,-122.37,78.54,175.1,104.88,0.0,0,0.022,0.374,0.856,0.904,9,8,2,10,2.6,17.0,3,Similar,Midwest,MI,Suburban,66-75,2024-08,Q3_2024,2023,3.7,0.447,Increasing
FIA001937,2024-08-25,Hydrochlorothiazide,Microzide,Diuretics,79269-745-64,Commercial Plan Alpha,PLAN_4864,2024,Non-Formulary,Tier 1,2023-11-13,286,Worsened,Non-Formulary Status,No,No,,501,915,-45.2,Decreased,536.15,17.03,519.12,164.03,700.18,350.79,0.0,0,0.187,0.261,0.527,0.547,14,1,18,11,3.4,15.3,5,Lower,Northeast,CA,Urban,18-35,2024-08,Q3_2024,2023,3.3,0.487,Increasing
FIA002047,2024-09-01,Hydrochlorothiazide,Microzide,Diuretics,75654-891-36,VA Plan,PLAN_4411,2024,Specialty Tier,Tier 1,2024-05-05,119,Worsened,Prior Authorization; Quantity Limit,Yes,No,,50,157,-67.7,Decreased,194.08,12.78,181.3,178.73,372.81,18.64,0.157,4,0.211,0.297,0.637,0.681,11,8,13,14,4.9,11.7,7,Similar,Northeast,PA,Rural,75+,2024-09,Q3_2024,2023,5.8,0.235,Stable
FIA000387,2024-09-03,Hydrochlorothiazide,Microzide,Diuretics,27479-505-37,Tricare Standard,PLAN_6076,2024,Tier 2,Tier 1,2024-02-05,211,Worsened,None,No,No,,649,683,-5.0,Stable,21.96,15.78,6.18,149.72,171.68,111.42,0.0,0,0.044,0.238,0.672,0.582,13,2,17,10,4.6,34.1,2,Higher,Midwest,MI,Urban,18-35,2024-09,Q3_2024,2023,6.5,0.53,Decreasing
FIA002791,2024-09-06,Hydrochlorothiazide,Microzide,Diuretics,61257-926-45,Medicaid Plan X,PLAN_4633,2024,Tier 3,Tier 2,2023-12-04,277,Worsened,Quantity Limit,No,No,30.0,616,937,-34.2,Decreased,93.16,48.78,44.38,104.28,197.44,121.62,0.0,0,0.061,0.335,0.291,0.848,10,5,15,8,4.0,22.6,8,Similar,Southeast,GA,Suburban,66-75,2024-09,Q3_2024,2023,2.9,0.677,Increasing
FIA002091,2024-09-09,Hydrochlorothiazide,Microzide,Diuretics,10122-732-77,Tricare Standard,PLAN_6870,2024,Non-Formulary,Non-Formulary,2023-11-02,312,No Change,Non-Formulary Status,No,No,,221,243,-8.9,Decreased,208.31,474.54,-266.23,42.21,250.52,55.36,0.0,0,0.276,0.169,0.853,0.62,1,0,9,15,3.1,21.4,2,Lower,Southeast,NC,Urban,75+,2024-09,Q3_2024,2023,5.1,0.192,Increasing
FIA001193,2024-09-10,Hydrochlorothiazide,Microzide,Diuretics,56375-288-64,VA Plan,PLAN_7855,2024,Non-Formulary,Non-Formulary,2023-12-01,284,No Change,Non-Formulary Status,No,No,,248,239,4.2,Stable,753.94,210.6,543.34,111.19,865.13,214.55,0.0,0,0.3,0.376,0.235,0.693,13,8,2,12,3.7,29.3,3,Lower,Midwest,CA,Suburban,36-50,2024-09,Q3_2024,2023,5.2,0.196,Decreasing
FIA001178,2024-09-17,Hydrochlorothiazide,Microzide,Diuretics,50655-186-38,Tricare Standard,PLAN_2694,2024,Non-Formulary,Tier 3,2024-04-26,144,Worsened,Non-Formulary Status,No,No,,706,670,5.4,Increased,469.88,93.87,376.01,127.5,597.38,421.75,0.0,0,0.29,0.218,0.202,0.888,6,9,1,11,3.6,6.0,6,Similar,West,NY,Suburban,75+,2024-09,Q3_2024,2023,9.4,0.423,Increasing
FIA001221,2024-09-18,Hydrochlorothiazide,Microzide,Diuretics,57477-414-58,Medicare Part D Plan B,PLAN_7771,2024,Specialty Tier,Tier 2,2024-06-29,81,Worsened,None,No,No,,137,334,-58.8,Decreased,225.17,40.72,184.45,39.84,265.01,36.31,0.0,0,0.151,0.228,0.844,0.553,13,4,11,5,2.8,14.2,7,Higher,Southeast,FL,Rural,18-35,2024-09,Q3_2024,2023,8.8,0.856,Increasing
FIA002887,2024-10-08,Hydrochlorothiazide,Microzide,Diuretics,19464-800-47,Medicare Part D Plan A,PLAN_2916,2024,Tier 3,Specialty Tier,2023-10-26,348,Improved,None,No,No,,597,596,0.3,Stable,88.5,197.01,-108.51,118.24,206.74,123.42,0.0,0,0.074,0.29,0.51,0.548,5,7,1,7,4.3,23.6,6,Similar,Midwest,MI,Rural,75+,2024-10,Q4_2024,2024,6.9,0.243,Increasing
FIA002444,2024-10-19,Hydrochlorothiazide,Microzide,Diuretics,33638-472-71,Commercial Plan Beta,PLAN_2416,2024,Specialty Tier,Specialty Tier,2024-08-13,67,No Change,Prior Authorization,Yes,No,,890,980,-9.1,Decreased,114.88,274.2,-159.32,136.63,251.51,223.84,0.105,7,0.281,0.261,0.501,0.883,10,9,2,12,5.0,7.1,6,Higher,Southeast,CA,Rural,18-35,2024-10,Q4_2024,2024,1.2,0.011,Stable
FIA002172,2024-10-28,Hydrochlorothiazide,Microzide,Diuretics,43386-375-54,Medicare Part D Plan B,PLAN_7484,2024,Tier 2,Tier 2,2024-08-16,73,No Change,None,No,No,,591,559,5.8,Increased,35.46,37.93,-2.47,79.49,114.95,67.94,0.0,0,0.021,0.263,0.488,0.518,0,3,8,0,4.5,25.1,6,Similar,West,IL,Urban,18-35,2024-10,Q4_2024,2024,3.9,0.044,Increasing
FIA002044,2024-10-31,Hydrochlorothiazide,Microzide,Diuretics,73016-744-34,Tricare Standard,PLAN_7633,2024,Specialty Tier,Tier 2,2024-05-15,169,Worsened,None,No,No,,393,653,-39.8,Decreased,110.62,30.54,80.08,144.89,255.51,100.42,0.0,0,0.277,0.378,0.776,0.706,1,3,13,14,4.6,26.3,6,Higher,West,PA,Rural,66-75,2024-10,Q4_2024,2024,7.7,0.826,Increasing
FIA002314,2024-11-07,Hydrochlorothiazide,Microzide,Diuretics,94238-665-87,Medicaid Plan Y,PLAN_3544,2024,Non-Formulary,Non-Formulary,2023-12-25,318,No Change,Non-Formulary Status,No,No,,622,633,-1.7,Stable,431.22,718.73,-287.51,151.42,582.64,362.4,0.0,0,0.1,0.162,0.758,0.681,9,9,20,12,4.1,15.7,4,Higher,Midwest,NC,Urban,36-50,2024-11,Q4_2024,2024,7.3,0.785,Increasing
FIA002328,2024-11-17,Hydrochlorothiazide,Microzide,Diuretics,61000-336-84,Medicare Part D Plan B,PLAN_9965,2024,Tier 2,Non-Formulary,2024-01-24,298,Improved,None,No,No,,1248,987,26.5,Increased,40.56,545.26,-504.7,96.74,137.3,171.35,0.0,0,0.027,0.251,0.23,0.465,0,7,7,5,4.3,20.6,8,Higher,Midwest,TX,Suburban,18-35,2024-11,Q4_2024,2024,6.5,0.692,Stable
FIA000757,2024-11-20,Hydrochlorothiazide,Microzide,Diuretics,34544-663-92,Medicare Part D Plan A,PLAN_8598,2024,Non-Formulary,Tier 1,2024-01-04,321,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,456,759,-39.9,Decreased,619.54,7.92,611.62,85.23,704.77,321.38,0.0,0,0.297,0.253,0.369,0.575,3,2,10,10,3.9,19.4,3,Similar,Midwest,MI,Suburban,66-75,2024-11,Q4_2024,2024,3.7,0.549,Increasing
FIA001355,2024-11-22,Hydrochlorothiazide,Microzide,Diuretics,93393-253-85,VA Plan,PLAN_2413,2024,Non-Formulary,Tier 1,2024-03-15,252,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,292,458,-36.1,Decreased,248.99,14.0,234.99,65.35,314.34,91.79,0.0,0,0.172,0.302,0.621,0.817,9,1,13,14,3.7,23.8,3,Higher,Northeast,FL,Suburban,75+,2024-11,Q4_2024,2024,8.0,0.508,Decreasing
FIA002874,2024-11-25,Hydrochlorothiazide,Microzide,Diuretics,35715-863-44,Medicaid Plan Y,PLAN_9211,2024,Non-Formulary,Non-Formulary,2024-09-25,61,No Change,Non-Formulary Status,No,No,,659,613,7.6,Increased,231.02,547.75,-316.73,165.4,396.42,261.24,0.0,0,0.17,0.288,0.23,0.785,3,7,10,5,2.9,26.6,5,Higher,Southeast,NC,Rural,51-65,2024-11,Q4_2024,2024,1.1,0.007,Stable
FIA002226,2024-12-02,Hydrochlorothiazide,Microzide,Diuretics,27410-622-73,Medicaid Plan X,PLAN_6050,2024,Tier 3,Tier 1,2023-12-06,362,Worsened,Prior Authorization; Quantity Limit,Yes,No,,436,643,-32.1,Decreased,74.9,13.61,61.29,139.91,214.81,93.66,0.524,3,0.02,0.249,0.864,0.516,4,7,13,0,4.6,22.6,3,Lower,West,TX,Suburban,51-65,2024-12,Q4_2024,2024,5.5,0.038,Stable
FIA001125,2024-12-08,Hydrochlorothiazide,Microzide,Diuretics,47942-504-69,Commercial Plan Beta,PLAN_7437,2024,Non-Formulary,Tier 2,2024-07-24,137,Worsened,Non-Formulary Status,No,No,,248,470,-47.2,Decreased,212.17,25.1,187.07,140.68,352.85,87.51,0.0,0,0.199,0.123,0.478,0.534,9,6,1,3,3.4,27.3,3,Higher,Northeast,NY,Urban,66-75,2024-12,Q4_2024,2024,3.8,0.049,Stable
FIA000816,2024-12-22,Hydrochlorothiazide,Microzide,Diuretics,95066-958-94,Commercial Plan Beta,PLAN_5028,2024,Tier 3,Specialty Tier,2024-04-09,257,Improved,Prior Authorization,Yes,No,,272,257,6.1,Increased,86.94,285.1,-198.16,84.57,171.51,46.65,0.541,1,0.035,0.286,0.518,0.881,4,1,5,12,2.5,12.8,6,Similar,Southwest,GA,Rural,75+,2024-12,Q4_2024,2024,3.4,0.748,Increasing
FIA002382,2024-12-27,Hydrochlorothiazide,Microzide,Diuretics,11130-863-37,Medicaid Plan Y,PLAN_2837,2024,Tier 2,Tier 1,2024-09-29,89,Worsened,None,No,No,,414,378,9.6,Increased,20.33,12.73,7.6,36.61,56.94,23.57,0.0,0,0.074,0.32,0.711,0.68,6,4,10,15,3.2,30.1,6,Similar,Southwest,NC,Rural,75+,2024-12,Q4_2024,2024,9.3,0.621,Stable
FIA001242,2024-12-28,Hydrochlorothiazide,Microzide,Diuretics,22587-860-11,Medicare Part D Plan A,PLAN_3436,2024,Non-Formulary,Tier 1,2024-10-13,76,Worsened,Non-Formulary Status,No,No,,190,450,-57.8,Decreased,305.82,16.61,289.21,66.75,372.57,70.79,0.0,0,0.065,0.175,0.777,0.421,2,6,20,5,4.2,27.1,5,Higher,Southeast,GA,Urban,36-50,2024-12,Q4_2024,2024,9.1,0.927,Decreasing
FIA001674,2025-01-03,Hydrochlorothiazide,Microzide,Diuretics,17589-628-37,Medicare Part D Plan B,PLAN_5166,2025,Tier 2,Tier 2,2024-09-19,106,No Change,None,No,No,,317,330,-3.9,Stable,26.83,34.85,-8.02,179.76,206.59,65.49,0.0,0,0.073,0.315,0.609,0.727,5,10,5,6,4.1,10.7,3,Higher,Midwest,OH,Suburban,18-35,2025-01,Q1_2025,2024,6.4,0.567,Increasing
FIA000419,2025-01-09,Hydrochlorothiazide,Microzide,Diuretics,85195-242-36,VA Plan,PLAN_2339,2025,Tier 2,Tier 1,2024-06-18,205,Worsened,None,No,No,,687,740,-7.1,Decreased,35.19,17.9,17.29,57.1,92.29,63.4,0.0,0,0.068,0.338,0.817,0.945,1,8,3,0,2.8,21.5,3,Higher,Southeast,IL,Suburban,18-35,2025-01,Q1_2025,2024,3.9,0.836,Stable
FIA001120,2025-01-17,Hydrochlorothiazide,Microzide,Diuretics,79737-109-87,Commercial Plan Beta,PLAN_9257,2025,Tier 3,Tier 1,2024-07-08,193,Worsened,None,No,No,,292,530,-44.7,Decreased,73.0,9.3,63.7,173.89,246.89,72.09,0.0,0,0.063,0.307,0.895,0.873,7,4,13,10,4.1,10.3,5,Similar,West,OH,Urban,36-50,2025-01,Q1_2025,2024,9.3,0.299,Decreasing
FIA001772,2025-01-20,Hydrochlorothiazide,Microzide,Diuretics,23800-679-77,Medicare Part D Plan A,PLAN_4069,2025,Tier 3,Tier 3,2024-12-21,30,No Change,None,No,No,,504,497,1.6,Stable,69.78,57.3,12.48,139.44,209.22,105.45,0.0,0,0.034,0.37,0.757,0.673,15,3,1,2,3.0,5.6,6,Lower,Southeast,NY,Suburban,66-75,2025-01,Q1_2025,2024,5.0,0.346,Decreasing
FIA002858,2025-01-26,Hydrochlorothiazide,Microzide,Diuretics,65816-775-31,VA Plan,PLAN_6767,2025,Non-Formulary,Specialty Tier,2024-05-04,267,Worsened,Non-Formulary Status; Quantity Limit,No,No,,929,914,1.7,Stable,700.09,277.29,422.8,105.09,805.18,748.01,0.0,0,0.17,0.35,0.535,0.742,6,9,2,2,3.5,10.2,3,Higher,West,NC,Rural,36-50,2025-01,Q1_2025,2024,3.5,0.67,Decreasing
FIA000496,2025-01-30,Hydrochlorothiazide,Microzide,Diuretics,83988-771-84,Commercial Plan Alpha,PLAN_1479,2025,Tier 2,Specialty Tier,2024-10-31,91,Improved,None,No,No,,828,568,45.9,Increased,39.36,135.11,-95.75,153.81,193.17,159.94,0.0,0,0.065,0.164,0.321,0.717,6,6,5,3,4.2,29.0,7,Higher,Northeast,PA,Urban,75+,2025-01,Q1_2025,2024,6.0,0.236,Increasing
FIA000966,2025-01-30,Hydrochlorothiazide,Microzide,Diuretics,80409-268-71,Medicaid Plan X,PLAN_8214,2025,Tier 2,Tier 1,2024-09-30,122,Worsened,Quantity Limit,No,No,30.0,212,230,-7.6,Decreased,43.62,14.68,28.94,177.09,220.71,46.79,0.0,0,0.045,0.199,0.696,0.519,6,3,0,9,4.2,15.8,6,Similar,West,FL,Rural,18-35,2025-01,Q1_2025,2024,9.1,0.401,Stable
FIA002665,2025-01-30,Hydrochlorothiazide,Microzide,Diuretics,29911-343-79,Commercial Plan Alpha,PLAN_2306,2025,Non-Formulary,Tier 1,2024-04-03,302,Worsened,Non-Formulary Status,No,No,,198,513,-61.4,Decreased,741.69,7.35,734.34,84.01,825.7,163.49,0.0,0,0.252,0.257,0.626,0.68,1,4,18,2,3.8,24.5,2,Similar,Northeast,CA,Urban,51-65,2025-01,Q1_2025,2024,6.4,0.931,Decreasing
FIA001183,2025-01-31,Hydrochlorothiazide,Microzide,Diuretics,75793-558-36,Medicare Part D Plan B,PLAN_9156,2025,Non-Formulary,Specialty Tier,2024-04-23,283,Worsened,Non-Formulary Status,No,No,,197,206,-4.0,Stable,579.18,268.43,310.75,125.99,705.17,138.92,0.0,0,0.159,0.339,0.867,0.676,3,6,13,3,2.7,5.5,8,Higher,West,PA,Suburban,75+,2025-01,Q1_2025,2024,2.0,0.181,Increasing
FIA002579,2025-02-01,Hydrochlorothiazide,Microzide,Diuretics,99471-458-54,Medicare Part D Plan A,PLAN_9055,2025,Tier 3,Non-Formulary,2024-04-15,292,Improved,None,No,No,,519,483,7.5,Increased,71.46,236.49,-165.03,133.98,205.44,106.62,0.0,0,0.055,0.215,0.578,0.525,11,10,0,3,3.6,13.7,7,Higher,West,NY,Suburban,18-35,2025-02,Q1_2025,2024,8.5,0.169,Stable
FIA000492,2025-02-16,Hydrochlorothiazide,Microzide,Diuretics,68953-651-66,Medicaid Plan X,PLAN_5893,2025,Tier 3,Specialty Tier,2024-10-26,113,Improved,Step Therapy; Quantity Limit,No,Yes,30.0,711,670,6.2,Increased,94.51,287.03,-192.52,100.64,195.15,138.75,0.0,0,0.051,0.098,0.694,0.681,8,8,20,10,4.2,17.7,4,Similar,West,PA,Urban,75+,2025-02,Q1_2025,2024,2.2,0.958,Increasing
FIA001136,2025-02-18,Hydrochlorothiazide,Microzide,Diuretics,36437-788-93,Tricare Standard,PLAN_8589,2025,Specialty Tier,Tier 2,2024-08-24,178,Worsened,Prior Authorization,Yes,No,,125,186,-32.7,Decreased,240.96,20.91,220.05,153.68,394.64,49.33,0.328,1,0.132,0.146,0.612,0.739,13,7,17,2,3.8,15.9,8,Similar,Midwest,MI,Suburban,66-75,2025-02,Q1_2025,2024,3.1,0.385,Increasing
FIA000793,2025-02-19,Hydrochlorothiazide,Microzide,Diuretics,28520-549-80,VA Plan,PLAN_6463,2025,Tier 1,Specialty Tier,2024-10-12,130,Improved,None,No,No,,175,119,47.4,Increased,9.85,170.16,-160.31,174.53,184.38,32.27,0.0,0,0.064,0.079,0.765,0.757,0,4,20,11,2.4,31.0,7,Similar,Southwest,IL,Rural,66-75,2025-02,Q1_2025,2024,7.8,0.049,Increasing
FIA002639,2025-03-03,Hydrochlorothiazide,Microzide,Diuretics,34184-142-75,VA Plan,PLAN_8597,2025,Specialty Tier,Non-Formulary,2024-07-28,218,Improved,Step Therapy; Quantity Limit,No,Yes,60.0,439,470,-6.4,Decreased,110.16,766.43,-656.27,133.7,243.86,107.05,0.0,0,0.115,0.062,0.625,0.508,9,4,6,13,3.1,21.9,2,Similar,Southeast,FL,Suburban,66-75,2025-03,Q1_2025,2024,9.1,0.792,Decreasing
FIA000869,2025-03-09,Hydrochlorothiazide,Microzide,Diuretics,96671-349-89,Commercial Plan Alpha,PLAN_8850,2025,Tier 3,Specialty Tier,2024-11-20,109,Improved,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,90.0,781,840,-7.0,Decreased,63.65,199.06,-135.41,86.03,149.68,116.9,0.523,9,0.036,0.209,0.265,0.786,7,4,18,6,4.4,31.8,5,Higher,Southwest,GA,Urban,66-75,2025-03,Q1_2025,2024,1.1,0.364,Decreasing
FIA002593,2025-03-24,Hydrochlorothiazide,Microzide,Diuretics,58310-805-87,VA Plan,PLAN_2687,2025,Non-Formulary,Non-Formulary,2024-04-26,332,No Change,Non-Formulary Status,No,No,,590,615,-3.9,Stable,211.96,201.55,10.41,93.47,305.43,180.2,0.0,0,0.12,0.124,0.292,0.767,5,4,18,11,2.8,32.9,3,Higher,West,CA,Urban,36-50,2025-03,Q1_2025,2024,4.0,0.421,Stable
FIA002122,2025-03-27,Hydrochlorothiazide,Microzide,Diuretics,10823-285-93,Commercial Plan Beta,PLAN_2509,2025,Tier 3,Non-Formulary,2024-12-11,106,Improved,Quantity Limit,No,No,60.0,760,789,-3.6,Stable,82.23,752.57,-670.34,172.88,255.11,193.88,0.0,0,0.045,0.271,0.652,0.456,0,9,13,2,2.5,32.7,3,Lower,Northeast,NC,Rural,51-65,2025-03,Q1_2025,2024,7.7,0.325,Decreasing
FIA002168,2025-04-02,Hydrochlorothiazide,Microzide,Diuretics,54837-924-51,Tricare Standard,PLAN_9364,2025,Tier 1,Tier 3,2024-12-17,106,Improved,None,No,No,,499,390,28.0,Increased,13.62,77.13,-63.51,193.69,207.31,103.45,0.0,0,0.014,0.103,0.807,0.509,3,3,0,5,2.5,29.3,3,Similar,Southeast,IL,Suburban,18-35,2025-04,Q2_2025,2024,8.7,0.365,Increasing
FIA002046,2025-04-03,Hydrochlorothiazide,Microzide,Diuretics,18524-587-55,Medicaid Plan Y,PLAN_3123,2025,Non-Formulary,Non-Formulary,2025-02-01,61,No Change,Non-Formulary Status,No,No,,118,120,-1.2,Stable,551.68,315.82,235.86,160.14,711.82,83.99,0.0,0,0.231,0.335,0.784,0.527,2,10,5,11,3.0,32.5,2,Lower,Southeast,CA,Rural,75+,2025-04,Q2_2025,2024,7.2,0.466,Increasing
FIA002657,2025-04-15,Hydrochlorothiazide,Microzide,Diuretics,38179-919-92,Medicaid Plan Y,PLAN_7879,2025,Tier 2,Tier 1,2024-07-24,265,Worsened,Quantity Limit,No,No,60.0,597,600,-0.4,Stable,34.36,10.27,24.09,62.55,96.91,57.86,0.0,0,0.043,0.208,0.787,0.723,12,0,3,4,4.2,20.4,6,Higher,Midwest,IL,Urban,75+,2025-04,Q2_2025,2024,4.5,0.582,Decreasing
FIA001281,2025-04-22,Hydrochlorothiazide,Microzide,Diuretics,91626-955-27,Commercial Plan Alpha,PLAN_8259,2025,Tier 3,Non-Formulary,2024-12-05,138,Improved,Step Therapy; Quantity Limit,No,Yes,90.0,723,713,1.5,Stable,59.06,417.74,-358.68,74.6,133.66,96.64,0.0,0,0.026,0.294,0.531,0.692,9,10,5,13,3.5,12.0,7,Higher,Midwest,IL,Suburban,36-50,2025-04,Q2_2025,2024,7.2,0.256,Increasing
FIA000951,2025-05-08,Hydrochlorothiazide,Microzide,Diuretics,88664-532-20,Commercial Plan Alpha,PLAN_4604,2025,Tier 2,Tier 2,2024-06-27,315,No Change,None,No,No,,1051,967,8.7,Increased,47.22,48.63,-1.41,149.34,196.56,206.58,0.0,0,0.074,0.123,0.298,0.819,8,9,11,5,4.9,6.3,8,Similar,Northeast,CA,Urban,66-75,2025-05,Q2_2025,2024,8.9,0.073,Stable
FIA002623,2025-05-11,Hydrochlorothiazide,Microzide,Diuretics,25178-184-65,Commercial Plan Beta,PLAN_4301,2025,Tier 1,Specialty Tier,2024-06-30,315,Improved,Quantity Limit,No,No,,1053,817,28.9,Increased,17.73,210.31,-192.58,181.06,198.79,209.33,0.0,0,0.034,0.247,0.372,0.809,1,10,16,12,3.5,12.2,5,Similar,Southwest,CA,Suburban,36-50,2025-05,Q2_2025,2024,4.1,0.882,Decreasing
FIA000452,2025-05-12,Hydrochlorothiazide,Microzide,Diuretics,20333-337-16,Medicaid Plan X,PLAN_6103,2025,Tier 1,Tier 3,2025-02-13,88,Improved,None,No,No,,570,441,29.3,Increased,6.43,63.21,-56.78,128.98,135.41,77.18,0.0,0,0.05,0.345,0.585,0.698,2,8,18,9,4.7,24.7,2,Similar,Northeast,PA,Suburban,18-35,2025-05,Q2_2025,2024,6.9,0.269,Increasing
FIA002167,2025-05-18,Hydrochlorothiazide,Microzide,Diuretics,88636-900-36,Tricare Standard,PLAN_4174,2025,Tier 1,Specialty Tier,2025-01-26,112,Improved,None,No,No,,475,353,34.6,Increased,19.22,194.25,-175.03,163.38,182.6,86.73,0.0,0,0.049,0.186,0.829,0.426,11,10,5,15,4.8,34.3,5,Similar,West,TX,Urban,75+,2025-05,Q2_2025,2024,3.7,0.546,Decreasing
FIA002407,2025-05-21,Hydrochlorothiazide,Microzide,Diuretics,38556-897-49,Medicaid Plan X,PLAN_6129,2025,Tier 1,Specialty Tier,2024-07-26,299,Improved,None,No,No,,1058,814,30.0,Increased,9.0,221.06,-212.06,156.93,165.93,175.55,0.0,0,0.022,0.336,0.865,0.423,6,7,11,8,3.7,6.6,6,Higher,Midwest,TX,Urban,51-65,2025-05,Q2_2025,2024,2.0,0.01,Increasing
FIA000947,2025-05-26,Hydrochlorothiazide,Microzide,Diuretics,98220-499-45,VA Plan,PLAN_3709,2025,Specialty Tier,Non-Formulary,2024-11-14,193,Improved,None,No,No,,469,504,-6.8,Decreased,223.79,502.02,-278.23,130.59,354.38,166.2,0.0,0,0.193,0.143,0.356,0.826,7,5,8,12,3.8,10.3,2,Lower,Northeast,IL,Suburban,18-35,2025-05,Q2_2025,2024,8.4,0.504,Increasing
FIA000014,2025-06-05,Hydrochlorothiazide,Microzide,Diuretics,10726-868-23,VA Plan,PLAN_4585,2025,Tier 1,Specialty Tier,2024-10-06,242,Improved,None,No,No,,1221,835,46.3,Increased,18.29,215.13,-196.84,141.53,159.82,195.14,0.0,0,0.027,0.112,0.871,0.685,1,8,7,3,3.4,29.0,7,Higher,West,MI,Suburban,66-75,2025-06,Q2_2025,2024,6.5,0.719,Decreasing
FIA002051,2025-06-11,Hydrochlorothiazide,Microzide,Diuretics,64472-347-10,Commercial Plan Beta,PLAN_1885,2025,Tier 2,Tier 1,2024-11-06,217,Worsened,None,No,No,,900,993,-9.3,Decreased,47.26,14.7,32.56,141.97,189.23,170.31,0.0,0,0.019,0.224,0.799,0.529,15,1,20,13,4.4,9.4,6,Similar,Southwest,TX,Urban,51-65,2025-06,Q2_2025,2024,6.8,0.488,Decreasing
FIA001910,2025-06-13,Hydrochlorothiazide,Microzide,Diuretics,18322-113-53,Commercial Plan Alpha,PLAN_6697,2025,Tier 3,Tier 3,2025-05-03,41,No Change,Prior Authorization,Yes,No,,449,411,9.4,Increased,78.38,89.55,-11.17,116.06,194.44,87.3,0.373,2,0.068,0.107,0.284,0.9,9,6,5,7,5.0,33.8,5,Similar,Midwest,IL,Suburban,36-50,2025-06,Q2_2025,2024,9.0,0.426,Increasing
FIA001856,2025-06-19,Hydrochlorothiazide,Microzide,Diuretics,50930-320-85,Commercial Plan Beta,PLAN_4652,2025,Non-Formulary,Tier 2,2025-01-03,167,Worsened,Non-Formulary Status,No,No,,159,233,-31.6,Decreased,719.03,28.52,690.51,122.87,841.9,133.86,0.0,0,0.061,0.283,0.771,0.839,12,0,12,4,4.6,10.9,7,Lower,Southeast,MI,Urban,75+,2025-06,Q2_2025,2024,2.2,0.296,Decreasing
FIA002187,2025-06-23,Hydrochlorothiazide,Microzide,Diuretics,47972-828-73,Tricare Standard,PLAN_4771,2025,Tier 1,Specialty Tier,2025-03-23,92,Improved,Quantity Limit,No,No,90.0,326,210,55.5,Increased,5.62,202.38,-196.76,81.0,86.62,28.24,0.0,0,0.044,0.155,0.235,0.475,14,0,4,1,3.5,12.3,8,Similar,Northeast,TX,Suburban,36-50,2025-06,Q2_2025,2024,9.7,0.423,Decreasing
FIA000287,2025-06-30,Hydrochlorothiazide,Microzide,Diuretics,50572-660-21,Tricare Standard,PLAN_2541,2025,Specialty Tier,Tier 1,2024-11-14,228,Worsened,None,No,No,,549,721,-23.7,Decreased,147.82,19.96,127.86,54.25,202.07,110.94,0.0,0,0.251,0.209,0.319,0.563,2,4,18,11,3.1,7.1,7,Similar,Midwest,GA,Suburban,66-75,2025-06,Q2_2025,2024,6.9,0.14,Increasing
FIA002840,2025-07-02,Hydrochlorothiazide,Microzide,Diuretics,86209-483-10,Medicaid Plan Y,PLAN_1667,2025,Specialty Tier,Tier 2,2024-11-10,234,Worsened,Prior Authorization,Yes,No,,578,909,-36.3,Decreased,271.9,46.88,225.02,56.86,328.76,190.02,0.157,9,0.252,0.197,0.753,0.443,3,6,11,1,2.9,24.1,6,Lower,West,NC,Urban,51-65,2025-07,Q3_2025,2024,1.1,0.793,Increasing
FIA000601,2025-07-10,Hydrochlorothiazide,Microzide,Diuretics,25972-689-40,Medicare Part D Plan B,PLAN_1170,2025,Tier 3,Non-Formulary,2024-09-08,305,Improved,Prior Authorization,Yes,No,,628,575,9.2,Increased,87.54,652.73,-565.19,156.55,244.09,153.29,0.437,4,0.011,0.385,0.573,0.869,15,4,4,10,3.0,12.3,5,Lower,West,CA,Rural,75+,2025-07,Q3_2025,2024,4.0,0.535,Increasing
FIA002995,2025-07-26,Hydrochlorothiazide,Microzide,Diuretics,66171-437-99,Commercial Plan Alpha,PLAN_9867,2025,Non-Formulary,Specialty Tier,2025-01-03,204,Worsened,Non-Formulary Status,No,No,,1016,950,7.0,Increased,264.25,106.95,157.3,134.15,398.4,404.77,0.0,0,0.078,0.113,0.269,0.522,3,10,12,3,2.6,29.9,4,Similar,Northeast,IL,Rural,51-65,2025-07,Q3_2025,2024,7.3,0.171,Decreasing
FIA002524,2025-07-29,Hydrochlorothiazide,Microzide,Diuretics,24366-984-65,Medicare Part D Plan A,PLAN_3105,2025,Tier 1,Tier 3,2024-08-18,345,Improved,None,No,No,,658,523,25.9,Increased,5.34,70.13,-64.79,92.39,97.73,64.31,0.0,0,0.02,0.381,0.345,0.662,15,9,20,8,3.1,6.7,4,Similar,West,IL,Urban,36-50,2025-07,Q3_2025,2024,2.2,0.63,Decreasing
FIA002217,2025-08-01,Hydrochlorothiazide,Microzide,Diuretics,20882-482-17,Commercial Plan Alpha,PLAN_2585,2025,Specialty Tier,Tier 3,2025-03-01,153,Worsened,Prior Authorization,Yes,No,,231,212,9.2,Increased,152.06,76.91,75.15,174.21,326.27,75.37,0.438,9,0.275,0.19,0.383,0.587,4,1,18,9,2.4,7.5,5,Lower,West,OH,Urban,75+,2025-08,Q3_2025,2024,6.9,0.027,Stable
FIA002891,2025-08-10,Hydrochlorothiazide,Microzide,Diuretics,20210-993-24,Commercial Plan Alpha,PLAN_3612,2025,Specialty Tier,Specialty Tier,2024-10-28,286,No Change,Step Therapy,No,Yes,,368,346,6.4,Increased,162.52,117.12,45.4,67.17,229.69,84.53,0.0,0,0.097,0.275,0.73,0.686,0,4,3,13,3.8,11.1,5,Higher,West,GA,Urban,75+,2025-08,Q3_2025,2024,4.9,0.164,Stable
FIA001826,2025-08-12,Hydrochlorothiazide,Microzide,Diuretics,74442-446-37,Medicare Part D Plan B,PLAN_8260,2025,Specialty Tier,Tier 3,2024-08-31,346,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,785,772,1.8,Stable,120.62,96.35,24.27,93.22,213.84,167.86,0.572,8,0.116,0.314,0.854,0.404,7,7,5,11,3.2,16.5,3,Similar,Southeast,PA,Urban,51-65,2025-08,Q3_2025,2024,5.9,0.608,Decreasing
FIA000994,2025-08-27,Hydrochlorothiazide,Microzide,Diuretics,65620-367-91,Medicaid Plan X,PLAN_5324,2025,Tier 3,Specialty Tier,2024-11-13,287,Improved,Step Therapy; Quantity Limit,No,Yes,30.0,166,155,7.7,Increased,69.27,235.4,-166.13,111.43,180.7,30.0,0.0,0,0.055,0.389,0.841,0.491,1,5,13,3,2.8,18.0,3,Similar,Midwest,FL,Urban,18-35,2025-08,Q3_2025,2024,3.6,0.088,Decreasing
FIA000593,2022-01-17,Insulin Glargine,Lantus,Insulin,47823-801-51,Medicaid Plan Y,PLAN_4650,2022,Tier 2,Tier 2,2021-01-27,355,No Change,None,No,No,,826,912,-9.4,Decreased,39.43,28.85,10.58,81.61,121.04,99.98,0.0,0,0.073,0.26,0.428,0.453,7,8,7,10,2.0,29.9,3,Similar,Midwest,IL,Urban,18-35,2022-01,Q1_2022,2021,2.5,0.829,Decreasing
FIA000610,2022-01-21,Insulin Glargine,Lantus,Insulin,34839-870-14,Tricare Standard,PLAN_3812,2022,Specialty Tier,Specialty Tier,2021-02-16,339,No Change,Prior Authorization,Yes,No,,574,606,-5.1,Decreased,162.6,111.99,50.61,108.45,271.05,155.58,0.499,3,0.104,0.083,0.343,0.847,1,8,15,2,4.0,19.9,3,Lower,Northeast,PA,Suburban,51-65,2022-01,Q1_2022,2021,7.7,0.792,Stable
FIA001274,2022-01-26,Insulin Glargine,Lantus,Insulin,85862-307-17,VA Plan,PLAN_2825,2022,Tier 2,Tier 3,2021-10-04,114,Improved,None,No,No,,884,602,46.9,Increased,36.3,50.0,-13.7,101.04,137.34,121.41,0.0,0,0.072,0.173,0.239,0.461,1,6,12,3,3.2,6.6,5,Similar,Northeast,IL,Rural,18-35,2022-01,Q1_2022,2021,3.4,0.12,Decreasing
FIA000630,2022-02-01,Insulin Glargine,Lantus,Insulin,48115-513-41,Commercial Plan Beta,PLAN_6406,2022,Tier 2,Tier 1,2021-10-19,105,Worsened,None,No,No,,483,486,-0.5,Stable,23.03,18.67,4.36,198.16,221.19,106.83,0.0,0,0.06,0.131,0.585,0.451,10,0,3,8,4.7,17.6,8,Lower,Southwest,NC,Rural,66-75,2022-02,Q1_2022,2021,8.7,0.122,Stable
FIA002631,2022-02-09,Insulin Glargine,Lantus,Insulin,24133-388-60,Commercial Plan Alpha,PLAN_1842,2022,Tier 1,Specialty Tier,2021-03-02,344,Improved,None,No,No,,243,171,42.5,Increased,9.99,212.68,-202.69,90.89,100.88,24.51,0.0,0,0.036,0.263,0.786,0.932,3,7,15,13,4.5,17.6,7,Lower,Northeast,GA,Urban,18-35,2022-02,Q1_2022,2021,2.9,0.167,Increasing
FIA000763,2022-03-06,Insulin Glargine,Lantus,Insulin,11073-152-68,Commercial Plan Beta,PLAN_5593,2022,Tier 1,Tier 3,2021-08-25,193,Improved,None,No,No,,975,838,16.4,Increased,17.0,68.06,-51.06,108.79,125.79,122.65,0.0,0,0.029,0.11,0.89,0.732,6,9,1,14,3.3,32.4,5,Lower,West,IL,Suburban,51-65,2022-03,Q1_2022,2021,7.0,0.969,Increasing
FIA002949,2022-03-20,Insulin Glargine,Lantus,Insulin,56013-113-90,Medicaid Plan Y,PLAN_1824,2022,Tier 2,Tier 2,2021-10-07,164,No Change,None,No,No,,816,763,7.0,Increased,26.4,31.28,-4.88,51.04,77.44,63.19,0.0,0,0.045,0.349,0.317,0.73,1,7,14,13,3.1,21.2,6,Lower,Southwest,FL,Suburban,36-50,2022-03,Q1_2022,2021,4.4,0.432,Stable
FIA001256,2022-03-21,Insulin Glargine,Lantus,Insulin,11776-882-24,Medicaid Plan Y,PLAN_8245,2022,Non-Formulary,Specialty Tier,2021-07-25,239,Worsened,Non-Formulary Status,No,No,,443,416,6.5,Increased,460.82,106.41,354.41,98.17,558.99,247.63,0.0,0,0.229,0.207,0.484,0.612,3,9,19,15,3.5,14.5,5,Similar,Southeast,IL,Suburban,51-65,2022-03,Q1_2022,2021,2.3,0.334,Stable
FIA000427,2022-03-23,Insulin Glargine,Lantus,Insulin,87274-811-81,Commercial Plan Alpha,PLAN_8689,2022,Tier 3,Specialty Tier,2021-10-01,173,Improved,Prior Authorization; Step Therapy,Yes,Yes,,431,449,-3.9,Stable,73.23,261.36,-188.13,172.72,245.95,106.0,0.344,6,0.063,0.082,0.543,0.588,2,4,20,8,4.8,31.2,6,Higher,Southeast,IL,Suburban,36-50,2022-03,Q1_2022,2021,6.1,0.349,Stable
FIA002649,2022-04-04,Insulin Glargine,Lantus,Insulin,61122-566-97,Commercial Plan Beta,PLAN_2994,2022,Tier 2,Specialty Tier,2021-07-19,259,Improved,None,No,No,,774,571,35.6,Increased,22.39,183.29,-160.9,131.34,153.73,118.99,0.0,0,0.075,0.157,0.265,0.546,15,9,11,13,2.1,25.1,2,Higher,Southeast,CA,Suburban,51-65,2022-04,Q2_2022,2021,1.6,0.452,Increasing
FIA002421,2022-04-12,Insulin Glargine,Lantus,Insulin,78970-780-17,Medicare Part D Plan B,PLAN_1579,2022,Tier 1,Specialty Tier,2021-08-01,254,Improved,None,No,No,,1030,774,33.2,Increased,6.73,266.24,-259.51,103.16,109.89,113.19,0.0,0,0.059,0.253,0.797,0.734,15,3,8,5,3.9,34.3,4,Lower,Midwest,GA,Urban,36-50,2022-04,Q2_2022,2021,7.6,0.634,Increasing
FIA002460,2022-04-21,Insulin Glargine,Lantus,Insulin,69908-832-60,Medicaid Plan X,PLAN_4082,2022,Tier 2,Non-Formulary,2022-02-05,75,Improved,None,No,No,,880,756,16.5,Increased,41.98,478.22,-436.24,54.48,96.46,84.88,0.0,0,0.068,0.093,0.316,0.748,12,10,0,8,2.7,17.5,6,Higher,Midwest,GA,Urban,51-65,2022-04,Q2_2022,2021,2.0,0.516,Increasing
FIA001118,2022-04-26,Insulin Glargine,Lantus,Insulin,51889-923-66,Medicaid Plan X,PLAN_1548,2022,Specialty Tier,Specialty Tier,2021-09-01,237,No Change,Prior Authorization; Step Therapy,Yes,Yes,,655,707,-7.3,Decreased,268.44,198.66,69.78,198.47,466.91,305.83,0.178,6,0.293,0.226,0.727,0.502,0,3,13,0,3.1,19.7,5,Lower,West,FL,Suburban,75+,2022-04,Q2_2022,2021,5.2,0.929,Stable
FIA000688,2022-04-29,Insulin Glargine,Lantus,Insulin,62535-413-69,Medicaid Plan X,PLAN_7412,2022,Non-Formulary,Tier 3,2022-02-24,64,Worsened,Non-Formulary Status,No,No,,745,814,-8.5,Decreased,432.76,52.47,380.29,139.21,571.97,426.12,0.0,0,0.114,0.059,0.676,0.683,14,9,8,12,2.6,25.3,3,Lower,West,GA,Urban,36-50,2022-04,Q2_2022,2021,4.6,0.119,Decreasing
FIA002422,2022-05-01,Insulin Glargine,Lantus,Insulin,97034-765-78,Medicaid Plan X,PLAN_6512,2022,Specialty Tier,Tier 2,2021-10-01,212,Worsened,None,No,No,,86,232,-62.8,Decreased,249.93,33.28,216.65,82.84,332.77,28.62,0.0,0,0.288,0.339,0.827,0.451,13,0,9,12,4.3,24.8,8,Lower,West,TX,Urban,36-50,2022-05,Q2_2022,2021,1.1,0.886,Stable
FIA000644,2022-05-09,Insulin Glargine,Lantus,Insulin,41164-782-16,Tricare Standard,PLAN_8948,2022,Tier 2,Tier 3,2021-10-10,211,Improved,None,No,No,,462,314,47.4,Increased,20.3,54.7,-34.4,47.86,68.16,31.49,0.0,0,0.051,0.371,0.523,0.477,14,9,4,11,4.1,12.5,3,Lower,Northeast,NC,Rural,36-50,2022-05,Q2_2022,2021,7.4,0.254,Decreasing
FIA000744,2022-05-11,Insulin Glargine,Lantus,Insulin,16545-301-15,Medicare Part D Plan A,PLAN_2689,2022,Specialty Tier,Specialty Tier,2021-07-25,290,No Change,None,No,No,,920,953,-3.4,Stable,167.99,237.42,-69.43,89.88,257.87,237.24,0.0,0,0.165,0.373,0.561,0.575,9,7,3,15,4.5,18.5,4,Lower,Northeast,MI,Urban,36-50,2022-05,Q2_2022,2021,9.0,0.79,Decreasing
FIA002709,2022-05-19,Insulin Glargine,Lantus,Insulin,92246-116-22,VA Plan,PLAN_5625,2022,Specialty Tier,Specialty Tier,2021-09-16,245,No Change,None,No,No,,1045,986,6.0,Increased,117.46,192.42,-74.96,131.8,249.26,260.48,0.0,0,0.114,0.312,0.82,0.711,13,7,20,5,2.9,12.1,7,Similar,Northeast,TX,Suburban,75+,2022-05,Q2_2022,2021,2.5,0.573,Increasing
FIA001385,2022-06-07,Insulin Glargine,Lantus,Insulin,94511-277-71,Commercial Plan Beta,PLAN_9725,2022,Non-Formulary,Tier 3,2021-06-24,348,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,704,751,-6.2,Decreased,290.01,67.8,222.21,102.48,392.49,276.31,0.0,0,0.087,0.269,0.798,0.862,8,8,2,2,2.1,7.1,8,Lower,West,FL,Rural,66-75,2022-06,Q2_2022,2021,2.3,0.271,Increasing
FIA001395,2022-06-10,Insulin Glargine,Lantus,Insulin,65993-994-50,Tricare Standard,PLAN_9225,2022,Tier 1,Tier 2,2022-03-15,87,Improved,None,No,No,,536,512,4.7,Stable,16.33,32.79,-16.46,190.72,207.05,110.98,0.0,0,0.011,0.287,0.694,0.471,11,6,11,4,4.3,11.6,8,Similar,Midwest,CA,Rural,51-65,2022-06,Q2_2022,2021,7.5,0.626,Increasing
FIA002854,2022-06-13,Insulin Glargine,Lantus,Insulin,47487-672-67,Medicare Part D Plan B,PLAN_1181,2022,Specialty Tier,Specialty Tier,2022-02-05,128,No Change,None,No,No,,576,566,1.9,Stable,217.69,185.58,32.11,143.9,361.59,208.28,0.0,0,0.123,0.1,0.718,0.548,6,10,18,12,4.5,25.2,4,Lower,Northeast,GA,Suburban,51-65,2022-06,Q2_2022,2021,3.6,0.28,Increasing
FIA000848,2022-06-18,Insulin Glargine,Lantus,Insulin,62780-432-11,Medicare Part D Plan A,PLAN_4322,2022,Tier 2,Non-Formulary,2022-05-09,40,Improved,None,No,No,,1384,887,56.1,Increased,43.69,299.7,-256.01,162.49,206.18,285.35,0.0,0,0.043,0.1,0.594,0.716,1,6,9,14,3.2,30.9,7,Similar,Midwest,FL,Suburban,75+,2022-06,Q2_2022,2021,5.4,0.842,Decreasing
FIA000463,2022-06-21,Insulin Glargine,Lantus,Insulin,38902-815-91,Medicare Part D Plan B,PLAN_9486,2022,Non-Formulary,Non-Formulary,2022-04-05,77,No Change,Non-Formulary Status,No,No,,254,239,6.6,Increased,355.79,399.25,-43.46,64.9,420.69,106.86,0.0,0,0.263,0.102,0.51,0.632,2,5,14,5,4.0,34.8,4,Lower,Northeast,CA,Urban,18-35,2022-06,Q2_2022,2021,8.8,0.723,Increasing
FIA000975,2022-06-28,Insulin Glargine,Lantus,Insulin,28501-517-56,Commercial Plan Beta,PLAN_9732,2022,Tier 1,Specialty Tier,2022-02-07,141,Improved,None,No,No,,554,363,52.7,Increased,7.65,297.89,-290.24,155.48,163.13,90.37,0.0,0,0.013,0.208,0.607,0.513,9,6,14,8,3.9,13.0,8,Similar,Southwest,CA,Urban,36-50,2022-06,Q2_2022,2021,8.7,0.952,Stable
FIA000603,2022-07-05,Insulin Glargine,Lantus,Insulin,59785-397-41,VA Plan,PLAN_1697,2022,Tier 3,Specialty Tier,2022-01-30,156,Improved,None,No,No,,526,495,6.4,Increased,54.3,166.86,-112.56,49.67,103.97,54.69,0.0,0,0.065,0.281,0.787,0.901,15,7,5,14,2.1,9.8,6,Similar,Southwest,OH,Urban,51-65,2022-07,Q3_2022,2021,9.2,0.295,Decreasing
FIA002780,2022-07-09,Insulin Glargine,Lantus,Insulin,33661-778-30,Medicaid Plan X,PLAN_9964,2022,Non-Formulary,Specialty Tier,2022-02-15,144,Worsened,Non-Formulary Status,No,No,,623,685,-9.0,Decreased,262.81,173.66,89.15,40.08,302.89,188.7,0.0,0,0.222,0.316,0.367,0.717,4,9,8,5,4.3,27.2,5,Lower,Southwest,OH,Suburban,18-35,2022-07,Q3_2022,2021,9.9,0.945,Decreasing
FIA001367,2022-07-13,Insulin Glargine,Lantus,Insulin,59981-619-56,Medicare Part D Plan A,PLAN_5312,2022,Tier 1,Tier 3,2021-07-21,357,Improved,None,No,No,,704,459,53.5,Increased,19.35,61.39,-42.04,63.66,83.01,58.44,0.0,0,0.019,0.306,0.756,0.572,11,2,12,1,3.9,27.5,8,Higher,Southeast,IL,Suburban,66-75,2022-07,Q3_2022,2021,2.4,0.168,Increasing
FIA001077,2022-07-16,Insulin Glargine,Lantus,Insulin,85153-406-20,Tricare Standard,PLAN_6537,2022,Tier 2,Non-Formulary,2021-11-25,233,Improved,None,No,No,,731,542,34.9,Increased,46.24,652.41,-606.17,36.94,83.18,60.8,0.0,0,0.022,0.123,0.8,0.556,0,5,6,2,3.8,13.4,2,Lower,Midwest,CA,Suburban,51-65,2022-07,Q3_2022,2021,8.2,0.003,Stable
FIA002204,2022-07-21,Insulin Glargine,Lantus,Insulin,79065-591-82,Commercial Plan Alpha,PLAN_9090,2022,Specialty Tier,Tier 1,2022-04-10,102,Worsened,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,,176,272,-35.0,Decreased,143.43,14.51,128.92,191.45,334.88,58.94,0.348,9,0.28,0.173,0.716,0.526,1,3,11,14,4.7,23.0,8,Higher,Northeast,NC,Suburban,75+,2022-07,Q3_2022,2021,6.7,0.29,Stable
FIA001578,2022-07-26,Insulin Glargine,Lantus,Insulin,15982-234-34,Medicaid Plan Y,PLAN_5095,2022,Non-Formulary,Tier 3,2022-04-26,91,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,584,638,-8.4,Decreased,703.43,77.55,625.88,78.49,781.92,456.64,0.0,0,0.063,0.272,0.614,0.618,5,8,18,0,2.3,13.1,2,Higher,Northeast,FL,Rural,36-50,2022-07,Q3_2022,2021,4.0,0.228,Increasing
FIA002353,2022-07-30,Insulin Glargine,Lantus,Insulin,47383-885-74,Medicare Part D Plan B,PLAN_8300,2022,Tier 2,Non-Formulary,2021-07-30,365,Improved,None,No,No,,677,433,56.4,Increased,20.74,746.66,-725.92,112.21,132.95,90.01,0.0,0,0.078,0.265,0.728,0.79,1,3,20,7,4.8,31.4,6,Lower,Southwest,IL,Rural,75+,2022-07,Q3_2022,2021,1.9,0.215,Increasing
FIA000082,2022-07-31,Insulin Glargine,Lantus,Insulin,37925-743-29,VA Plan,PLAN_8248,2022,Tier 3,Tier 3,2022-04-22,100,No Change,None,No,No,,921,995,-7.3,Decreased,69.14,90.67,-21.53,89.7,158.84,146.29,0.0,0,0.021,0.351,0.261,0.455,3,9,12,11,4.9,14.4,3,Lower,Midwest,TX,Urban,75+,2022-07,Q3_2022,2021,6.4,0.721,Stable
FIA001091,2022-07-31,Insulin Glargine,Lantus,Insulin,56604-885-80,VA Plan,PLAN_7276,2022,Tier 1,Tier 3,2022-03-06,147,Improved,None,No,No,,712,449,58.8,Increased,13.55,98.76,-85.21,52.67,66.22,47.15,0.0,0,0.012,0.199,0.211,0.74,6,5,9,14,4.7,16.8,5,Similar,Northeast,FL,Urban,18-35,2022-07,Q3_2022,2021,1.8,0.291,Stable
FIA001945,2022-07-31,Insulin Glargine,Lantus,Insulin,11397-494-19,Medicare Part D Plan A,PLAN_6930,2022,Non-Formulary,Tier 3,2021-08-26,339,Worsened,Non-Formulary Status,No,No,,378,348,8.7,Increased,207.66,88.07,119.59,108.42,316.08,119.48,0.0,0,0.299,0.064,0.892,0.73,15,1,19,11,2.7,9.5,2,Similar,Southwest,PA,Urban,75+,2022-07,Q3_2022,2021,6.5,0.524,Stable
FIA002401,2022-08-03,Insulin Glargine,Lantus,Insulin,75898-532-26,Commercial Plan Alpha,PLAN_5075,2022,Specialty Tier,Non-Formulary,2021-11-27,249,Improved,None,No,No,,258,255,1.2,Stable,124.01,356.59,-232.58,104.41,228.42,58.93,0.0,0,0.065,0.286,0.796,0.87,5,2,3,7,4.7,9.7,6,Similar,West,GA,Rural,75+,2022-08,Q3_2022,2021,6.9,0.498,Increasing
FIA000166,2022-08-08,Insulin Glargine,Lantus,Insulin,18658-448-36,VA Plan,PLAN_8132,2022,Non-Formulary,Tier 1,2022-02-05,184,Worsened,Non-Formulary Status,No,No,,356,523,-31.9,Decreased,519.65,11.01,508.64,112.0,631.65,224.87,0.0,0,0.09,0.249,0.44,0.782,5,10,2,15,2.3,22.9,4,Higher,Northeast,GA,Urban,51-65,2022-08,Q3_2022,2021,9.6,0.07,Increasing
FIA001597,2022-08-21,Insulin Glargine,Lantus,Insulin,91726-148-78,VA Plan,PLAN_9339,2022,Tier 2,Tier 1,2022-05-16,97,Worsened,None,No,No,,848,792,7.2,Increased,21.91,18.38,3.53,173.1,195.01,165.37,0.0,0,0.045,0.2,0.751,0.906,8,6,13,1,4.4,8.1,2,Higher,Midwest,MI,Urban,75+,2022-08,Q3_2022,2021,4.7,0.037,Decreasing
FIA001543,2022-08-23,Insulin Glargine,Lantus,Insulin,10488-988-62,Medicaid Plan Y,PLAN_7799,2022,Tier 1,Tier 3,2022-03-08,168,Improved,None,No,No,,1026,710,44.6,Increased,11.42,54.63,-43.21,45.84,57.26,58.75,0.0,0,0.018,0.345,0.837,0.615,11,4,10,10,2.7,31.2,7,Similar,Southeast,GA,Suburban,66-75,2022-08,Q3_2022,2021,4.9,0.604,Stable
FIA000297,2022-08-29,Insulin Glargine,Lantus,Insulin,57826-217-37,Medicare Part D Plan A,PLAN_6366,2022,Tier 3,Specialty Tier,2021-09-19,344,Improved,None,No,No,,664,634,4.8,Stable,80.0,101.0,-21.0,55.9,135.9,90.24,0.0,0,0.046,0.098,0.258,0.78,4,4,8,15,2.6,7.8,7,Higher,Midwest,GA,Rural,66-75,2022-08,Q3_2022,2021,4.9,0.946,Increasing
FIA002289,2022-09-01,Insulin Glargine,Lantus,Insulin,84769-596-80,Medicaid Plan X,PLAN_8332,2022,Tier 2,Specialty Tier,2022-07-28,35,Improved,None,No,No,,999,679,47.2,Increased,34.71,206.69,-171.98,118.74,153.45,153.3,0.0,0,0.046,0.26,0.893,0.791,12,6,10,2,2.8,12.8,2,Lower,Southeast,NY,Urban,36-50,2022-09,Q3_2022,2021,3.4,0.51,Decreasing
FIA002723,2022-09-03,Insulin Glargine,Lantus,Insulin,45636-417-85,VA Plan,PLAN_5285,2022,Tier 2,Tier 1,2022-04-18,138,Worsened,None,No,No,,341,325,5.1,Increased,29.86,19.93,9.93,179.09,208.95,71.25,0.0,0,0.043,0.08,0.768,0.602,5,10,15,0,2.1,16.4,6,Lower,Northeast,MI,Urban,75+,2022-09,Q3_2022,2021,1.5,0.955,Stable
FIA001477,2022-09-07,Insulin Glargine,Lantus,Insulin,34384-394-70,Commercial Plan Alpha,PLAN_3956,2022,Tier 3,Tier 2,2022-05-17,113,Worsened,Prior Authorization,Yes,No,,133,424,-68.5,Decreased,62.87,24.93,37.94,158.74,221.61,29.47,0.364,4,0.025,0.391,0.799,0.903,1,7,9,2,3.8,15.4,8,Similar,Northeast,CA,Suburban,36-50,2022-09,Q3_2022,2021,2.5,0.596,Decreasing
FIA002939,2022-09-08,Insulin Glargine,Lantus,Insulin,67711-894-98,Tricare Standard,PLAN_7711,2022,Tier 3,Tier 2,2021-10-30,313,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,313,462,-32.0,Decreased,59.48,31.32,28.16,57.35,116.83,36.57,0.124,5,0.021,0.143,0.833,0.743,2,2,0,4,2.7,18.5,8,Lower,Southwest,CA,Urban,51-65,2022-09,Q3_2022,2021,3.5,0.007,Increasing
FIA002696,2022-09-14,Insulin Glargine,Lantus,Insulin,96137-524-94,Medicaid Plan X,PLAN_1115,2022,Tier 2,Tier 1,2022-03-06,192,Worsened,None,No,No,,1075,981,9.6,Increased,43.59,16.04,27.55,185.37,228.96,246.13,0.0,0,0.036,0.059,0.618,0.511,14,5,10,12,4.8,30.3,5,Higher,Southwest,OH,Suburban,36-50,2022-09,Q3_2022,2021,1.3,0.45,Decreasing
FIA002728,2022-09-26,Insulin Glargine,Lantus,Insulin,58020-253-17,Medicare Part D Plan B,PLAN_5835,2022,Non-Formulary,Non-Formulary,2021-12-31,269,No Change,Non-Formulary Status,No,No,,605,573,5.8,Increased,230.63,394.07,-163.44,75.33,305.96,185.11,0.0,0,0.282,0.231,0.587,0.888,9,8,1,11,4.1,6.4,7,Higher,West,IL,Urban,66-75,2022-09,Q3_2022,2021,5.5,0.015,Increasing
FIA001082,2022-10-06,Insulin Glargine,Lantus,Insulin,40896-469-74,Tricare Standard,PLAN_3861,2022,Tier 2,Tier 2,2022-08-07,60,No Change,None,No,No,,722,702,2.9,Stable,38.52,30.6,7.92,124.46,162.98,117.67,0.0,0,0.047,0.392,0.87,0.741,6,3,20,10,4.1,31.8,7,Lower,Southeast,PA,Urban,75+,2022-10,Q4_2022,2022,3.2,0.503,Decreasing
FIA002532,2022-10-08,Insulin Glargine,Lantus,Insulin,14248-529-59,Medicaid Plan Y,PLAN_3049,2022,Specialty Tier,Tier 2,2021-12-28,284,Worsened,Step Therapy,No,Yes,,92,146,-36.5,Decreased,227.05,25.1,201.95,117.3,344.35,31.68,0.0,0,0.103,0.175,0.718,0.41,11,3,9,6,2.9,15.9,4,Lower,Southeast,OH,Suburban,18-35,2022-10,Q4_2022,2022,3.9,0.748,Decreasing
FIA002502,2022-10-13,Insulin Glargine,Lantus,Insulin,39478-761-59,VA Plan,PLAN_2725,2022,Non-Formulary,Non-Formulary,2022-09-01,42,No Change,Non-Formulary Status; Quantity Limit,No,No,30.0,737,797,-7.5,Decreased,708.64,442.78,265.86,143.02,851.66,627.67,0.0,0,0.05,0.317,0.259,0.835,6,7,19,4,3.5,30.2,4,Higher,West,CA,Urban,36-50,2022-10,Q4_2022,2022,7.9,0.624,Increasing
FIA002534,2022-10-14,Insulin Glargine,Lantus,Insulin,88297-919-59,Commercial Plan Beta,PLAN_7813,2022,Tier 2,Non-Formulary,2022-08-28,47,Improved,Quantity Limit,No,No,,450,291,54.7,Increased,30.26,776.12,-745.86,151.12,181.38,81.62,0.0,0,0.072,0.328,0.2,0.792,9,5,2,15,4.7,22.8,4,Higher,Midwest,IL,Urban,75+,2022-10,Q4_2022,2022,8.9,0.749,Increasing
FIA000281,2022-10-28,Insulin Glargine,Lantus,Insulin,28961-192-51,Commercial Plan Alpha,PLAN_3979,2022,Tier 2,Specialty Tier,2022-02-12,258,Improved,None,No,No,,893,589,51.7,Increased,41.64,257.11,-215.47,153.54,195.18,174.3,0.0,0,0.04,0.319,0.447,0.672,15,6,19,10,2.4,33.3,3,Similar,Southwest,NC,Suburban,75+,2022-10,Q4_2022,2022,5.8,0.532,Increasing
FIA002843,2022-10-29,Insulin Glargine,Lantus,Insulin,93896-476-63,Medicare Part D Plan A,PLAN_6632,2022,Non-Formulary,Tier 3,2022-02-03,268,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,274,271,1.3,Stable,624.03,92.18,531.85,49.86,673.89,184.65,0.0,0,0.227,0.229,0.453,0.754,12,2,10,10,3.9,7.3,8,Lower,Southwest,OH,Suburban,18-35,2022-10,Q4_2022,2022,8.0,0.936,Increasing
FIA000149,2022-11-03,Insulin Glargine,Lantus,Insulin,66614-396-60,Commercial Plan Alpha,PLAN_3165,2022,Non-Formulary,Tier 2,2022-07-18,108,Worsened,Non-Formulary Status,No,No,,157,502,-68.6,Decreased,230.31,41.95,188.36,45.31,275.62,43.27,0.0,0,0.194,0.168,0.533,0.81,12,4,2,12,3.5,28.2,3,Lower,Southwest,NC,Urban,66-75,2022-11,Q4_2022,2022,4.6,0.571,Decreasing
FIA002198,2022-11-08,Insulin Glargine,Lantus,Insulin,90272-553-64,Medicaid Plan X,PLAN_7391,2022,Tier 3,Non-Formulary,2022-06-13,148,Improved,None,No,No,,600,615,-2.4,Stable,62.34,519.45,-457.11,32.51,94.85,56.91,0.0,0,0.022,0.177,0.248,0.8,11,9,10,13,2.4,25.1,5,Similar,Southeast,NY,Urban,51-65,2022-11,Q4_2022,2022,9.5,0.122,Increasing
FIA002951,2022-11-12,Insulin Glargine,Lantus,Insulin,81508-784-52,Medicare Part D Plan A,PLAN_3865,2022,Non-Formulary,Non-Formulary,2022-06-07,158,No Change,Non-Formulary Status,No,No,,230,211,9.0,Increased,548.94,665.25,-116.31,54.21,603.15,138.72,0.0,0,0.177,0.383,0.846,0.803,8,0,13,1,3.2,30.2,6,Lower,Southwest,CA,Urban,75+,2022-11,Q4_2022,2022,2.8,0.608,Decreasing
FIA000468,2022-11-17,Insulin Glargine,Lantus,Insulin,97643-186-70,VA Plan,PLAN_6041,2022,Tier 3,Tier 3,2022-09-27,51,No Change,None,No,No,,867,838,3.5,Stable,59.33,89.43,-30.1,153.97,213.3,184.93,0.0,0,0.071,0.194,0.396,0.56,0,3,3,11,2.7,25.9,6,Lower,Midwest,IL,Rural,36-50,2022-11,Q4_2022,2022,5.2,0.832,Increasing
FIA001461,2022-11-21,Insulin Glargine,Lantus,Insulin,31021-201-36,Commercial Plan Beta,PLAN_5962,2022,Tier 1,Specialty Tier,2022-04-07,228,Improved,None,No,No,,1050,737,42.5,Increased,11.44,267.14,-255.7,78.56,90.0,94.5,0.0,0,0.021,0.178,0.823,0.591,5,10,19,11,4.9,33.1,5,Lower,Northeast,MI,Urban,75+,2022-11,Q4_2022,2022,9.4,0.326,Decreasing
FIA001699,2022-11-28,Insulin Glargine,Lantus,Insulin,30482-592-19,Tricare Standard,PLAN_7473,2022,Tier 1,Tier 1,2022-08-12,108,No Change,None,No,No,,212,219,-2.8,Stable,7.0,18.15,-11.15,197.75,204.75,43.41,0.0,0,0.042,0.311,0.836,0.607,9,2,19,6,2.6,5.7,8,Higher,Northeast,GA,Rural,18-35,2022-11,Q4_2022,2022,2.0,0.461,Stable
FIA002689,2022-12-03,Insulin Glargine,Lantus,Insulin,69905-435-31,Commercial Plan Alpha,PLAN_9468,2022,Tier 3,Specialty Tier,2022-05-05,212,Improved,Step Therapy,No,Yes,,265,277,-4.0,Stable,78.55,194.38,-115.83,118.66,197.21,52.26,0.0,0,0.056,0.093,0.228,0.9,4,4,10,11,2.4,34.6,8,Higher,Southeast,TX,Suburban,66-75,2022-12,Q4_2022,2022,2.2,0.549,Decreasing
FIA001650,2022-12-07,Insulin Glargine,Lantus,Insulin,58784-325-39,Medicare Part D Plan B,PLAN_2270,2022,Tier 2,Tier 1,2022-06-19,171,Worsened,None,No,No,,505,508,-0.6,Stable,44.9,18.04,26.86,122.57,167.47,84.57,0.0,0,0.042,0.169,0.407,0.679,10,6,5,14,3.0,25.6,8,Higher,Midwest,NC,Urban,36-50,2022-12,Q4_2022,2022,4.4,0.563,Increasing
FIA001131,2022-12-12,Insulin Glargine,Lantus,Insulin,16196-876-96,Commercial Plan Beta,PLAN_8894,2022,Tier 1,Tier 2,2022-03-08,279,Improved,None,No,No,,269,255,5.8,Increased,8.76,31.92,-23.16,77.89,86.65,23.31,0.0,0,0.045,0.275,0.448,0.516,8,2,17,11,4.2,5.6,3,Lower,West,OH,Rural,51-65,2022-12,Q4_2022,2022,8.4,0.287,Stable
FIA002643,2022-12-13,Insulin Glargine,Lantus,Insulin,66621-247-32,VA Plan,PLAN_5117,2022,Tier 3,Tier 1,2022-08-28,107,Worsened,None,No,No,,455,658,-30.8,Decreased,54.07,15.78,38.29,188.43,242.5,110.34,0.0,0,0.024,0.1,0.207,0.419,3,7,8,5,3.1,8.0,7,Similar,Southwest,NY,Rural,36-50,2022-12,Q4_2022,2022,7.9,0.885,Increasing
FIA000267,2022-12-16,Insulin Glargine,Lantus,Insulin,77314-830-29,Commercial Plan Alpha,PLAN_3337,2022,Specialty Tier,Tier 2,2022-05-24,206,Worsened,Step Therapy,No,Yes,,484,907,-46.6,Decreased,261.22,40.33,220.89,31.61,292.83,141.73,0.0,0,0.082,0.183,0.715,0.429,11,3,19,13,4.1,10.5,4,Similar,West,PA,Suburban,66-75,2022-12,Q4_2022,2022,5.7,0.718,Increasing
FIA001759,2022-12-23,Insulin Glargine,Lantus,Insulin,33532-795-48,Medicaid Plan X,PLAN_7355,2022,Specialty Tier,Tier 1,2022-04-25,242,Worsened,Step Therapy,No,Yes,,144,275,-47.6,Decreased,185.28,5.6,179.68,183.99,369.27,53.17,0.0,0,0.086,0.202,0.881,0.627,2,7,11,13,3.2,34.8,8,Similar,Midwest,GA,Urban,51-65,2022-12,Q4_2022,2022,9.2,0.544,Decreasing
FIA002163,2023-01-12,Insulin Glargine,Lantus,Insulin,78381-862-35,Commercial Plan Alpha,PLAN_6881,2023,Tier 3,Specialty Tier,2022-11-08,65,Improved,Prior Authorization; Quantity Limit,Yes,No,90.0,180,164,10.0,Increased,63.77,283.28,-219.51,34.79,98.56,17.74,0.532,10,0.042,0.229,0.282,0.785,11,10,7,11,2.4,25.2,5,Higher,Southeast,OH,Urban,51-65,2023-01,Q1_2023,2022,7.8,0.184,Decreasing
FIA002621,2023-01-12,Insulin Glargine,Lantus,Insulin,84529-163-26,Medicare Part D Plan B,PLAN_1996,2023,Tier 1,Tier 3,2022-04-13,274,Improved,Quantity Limit,No,No,60.0,839,698,20.2,Increased,10.11,75.59,-65.48,117.47,127.58,107.04,0.0,0,0.048,0.085,0.737,0.931,1,9,14,5,3.8,25.4,3,Similar,West,PA,Urban,51-65,2023-01,Q1_2023,2022,1.2,0.772,Increasing
FIA000154,2023-01-13,Insulin Glargine,Lantus,Insulin,13433-880-88,Medicaid Plan X,PLAN_4783,2023,Tier 2,Tier 1,2022-07-04,193,Worsened,None,No,No,,500,521,-3.9,Stable,46.4,11.21,35.19,52.36,98.76,49.38,0.0,0,0.023,0.259,0.362,0.414,2,7,4,15,4.1,16.2,8,Similar,Southwest,GA,Urban,36-50,2023-01,Q1_2023,2022,2.7,0.032,Increasing
FIA001310,2023-01-15,Insulin Glargine,Lantus,Insulin,50751-174-70,Tricare Standard,PLAN_7613,2023,Non-Formulary,Non-Formulary,2022-08-11,157,No Change,Non-Formulary Status,No,No,,297,304,-2.0,Stable,220.51,304.94,-84.43,71.54,292.05,86.74,0.0,0,0.213,0.055,0.558,0.57,0,7,5,13,4.7,25.6,6,Higher,Northeast,CA,Suburban,18-35,2023-01,Q1_2023,2022,3.2,0.088,Stable
FIA001585,2023-01-20,Insulin Glargine,Lantus,Insulin,35058-869-11,Medicaid Plan X,PLAN_4344,2023,Non-Formulary,Non-Formulary,2022-01-25,360,No Change,Non-Formulary Status,No,No,,617,628,-1.6,Stable,354.89,228.3,126.59,138.07,492.96,304.16,0.0,0,0.217,0.148,0.302,0.726,15,8,11,6,2.4,31.0,7,Higher,Northeast,TX,Rural,36-50,2023-01,Q1_2023,2022,3.0,0.583,Decreasing
FIA002072,2023-01-24,Insulin Glargine,Lantus,Insulin,69460-758-78,Commercial Plan Beta,PLAN_7003,2023,Non-Formulary,Tier 1,2022-04-17,282,Worsened,Non-Formulary Status,No,No,,337,467,-27.7,Decreased,504.14,5.44,498.7,61.96,566.1,190.78,0.0,0,0.13,0.159,0.25,0.464,6,10,20,10,3.4,28.8,2,Similar,Midwest,PA,Urban,18-35,2023-01,Q1_2023,2022,4.0,0.584,Stable
FIA001540,2023-01-26,Insulin Glargine,Lantus,Insulin,45650-609-19,Medicaid Plan X,PLAN_4068,2023,Tier 2,Tier 1,2022-03-12,320,Worsened,None,No,No,,991,927,6.9,Increased,41.96,18.98,22.98,184.11,226.07,224.04,0.0,0,0.042,0.138,0.657,0.493,3,1,20,1,2.4,24.4,8,Higher,Southeast,NY,Suburban,66-75,2023-01,Q1_2023,2022,2.7,0.632,Decreasing
FIA000043,2023-02-02,Insulin Glargine,Lantus,Insulin,42768-153-92,Tricare Standard,PLAN_7081,2023,Non-Formulary,Specialty Tier,2022-05-12,266,Worsened,Non-Formulary Status; Quantity Limit,No,No,,617,614,0.5,Stable,661.66,255.62,406.04,53.53,715.19,441.27,0.0,0,0.25,0.299,0.561,0.469,2,2,8,14,4.7,9.4,5,Lower,Southeast,GA,Suburban,18-35,2023-02,Q1_2023,2022,4.7,0.396,Stable
FIA002406,2023-02-04,Insulin Glargine,Lantus,Insulin,27957-424-69,VA Plan,PLAN_9918,2023,Specialty Tier,Tier 2,2022-10-03,124,Worsened,Prior Authorization,Yes,No,,394,515,-23.5,Decreased,195.05,21.42,173.63,113.8,308.85,121.69,0.503,8,0.211,0.172,0.662,0.623,7,7,19,15,4.8,28.5,6,Similar,Midwest,FL,Suburban,51-65,2023-02,Q1_2023,2022,2.2,0.942,Increasing
FIA001545,2023-02-08,Insulin Glargine,Lantus,Insulin,35091-556-31,Commercial Plan Alpha,PLAN_4713,2023,Specialty Tier,Tier 1,2022-11-15,85,Worsened,None,No,No,,148,267,-44.3,Decreased,289.25,18.45,270.8,128.2,417.45,61.78,0.0,0,0.295,0.319,0.822,0.811,15,6,2,13,3.7,31.4,4,Higher,West,IL,Rural,75+,2023-02,Q1_2023,2022,9.9,0.933,Stable
FIA000052,2023-02-22,Insulin Glargine,Lantus,Insulin,23917-426-40,Tricare Standard,PLAN_3007,2023,Non-Formulary,Tier 2,2022-08-16,190,Worsened,Non-Formulary Status,No,No,,615,981,-37.3,Decreased,716.89,29.58,687.31,117.55,834.44,513.18,0.0,0,0.24,0.144,0.374,0.453,9,6,19,13,2.7,31.0,3,Similar,West,IL,Urban,36-50,2023-02,Q1_2023,2022,5.5,0.515,Stable
FIA000347,2023-03-01,Insulin Glargine,Lantus,Insulin,34435-586-27,Tricare Standard,PLAN_6291,2023,Non-Formulary,Non-Formulary,2022-09-15,167,No Change,Non-Formulary Status,No,No,,343,364,-5.6,Decreased,254.45,664.05,-409.6,141.92,396.37,135.95,0.0,0,0.079,0.18,0.465,0.724,1,5,3,11,4.6,5.2,5,Similar,Midwest,IL,Rural,18-35,2023-03,Q1_2023,2022,2.7,0.358,Increasing
FIA001042,2023-03-07,Insulin Glargine,Lantus,Insulin,34524-181-54,Medicare Part D Plan B,PLAN_1672,2023,Tier 3,Tier 2,2022-10-11,147,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,398,567,-29.7,Decreased,91.0,49.84,41.16,156.85,247.85,98.64,0.208,1,0.039,0.098,0.201,0.643,5,1,8,6,4.7,23.8,7,Higher,Southwest,MI,Rural,66-75,2023-03,Q1_2023,2022,9.7,0.926,Stable
FIA002583,2023-03-20,Insulin Glargine,Lantus,Insulin,48688-797-92,VA Plan,PLAN_2471,2023,Specialty Tier,Tier 2,2023-01-17,62,Worsened,Prior Authorization,Yes,No,,174,256,-31.8,Decreased,297.64,20.75,276.89,61.74,359.38,62.53,0.267,2,0.18,0.154,0.487,0.597,11,7,16,8,4.8,13.5,8,Higher,Southwest,PA,Suburban,36-50,2023-03,Q1_2023,2022,4.1,0.561,Stable
FIA002384,2023-04-02,Insulin Glargine,Lantus,Insulin,25752-997-43,Commercial Plan Alpha,PLAN_2872,2023,Specialty Tier,Tier 3,2022-10-03,181,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,408,437,-6.5,Decreased,238.46,87.94,150.52,161.34,399.8,163.12,0.307,5,0.184,0.214,0.659,0.84,1,3,5,14,2.1,14.8,4,Similar,Northeast,FL,Suburban,51-65,2023-04,Q2_2023,2022,9.2,0.093,Increasing
FIA001024,2023-04-17,Insulin Glargine,Lantus,Insulin,38502-172-21,Medicaid Plan X,PLAN_4372,2023,Tier 3,Specialty Tier,2022-10-06,193,Improved,None,No,No,,202,222,-8.6,Decreased,93.87,290.84,-196.97,175.63,269.5,54.44,0.0,0,0.027,0.134,0.892,0.894,12,2,7,1,4.4,27.0,4,Higher,Midwest,CA,Urban,36-50,2023-04,Q2_2023,2022,8.3,0.533,Decreasing
FIA000623,2023-04-27,Insulin Glargine,Lantus,Insulin,66731-963-42,Medicaid Plan Y,PLAN_3680,2023,Tier 3,Tier 2,2022-10-22,187,Worsened,None,No,No,,430,999,-56.9,Decreased,52.68,41.78,10.9,164.41,217.09,93.35,0.0,0,0.016,0.175,0.602,0.495,12,10,8,9,3.9,7.6,2,Lower,West,GA,Urban,75+,2023-04,Q2_2023,2022,6.0,0.531,Stable
FIA002737,2023-04-30,Insulin Glargine,Lantus,Insulin,27453-718-95,Medicare Part D Plan A,PLAN_4845,2023,Specialty Tier,Non-Formulary,2022-11-05,176,Improved,Prior Authorization; Step Therapy,Yes,Yes,,304,303,0.6,Stable,176.74,260.94,-84.2,193.72,370.46,112.62,0.504,1,0.247,0.122,0.725,0.796,15,2,0,11,3.2,9.7,8,Lower,Midwest,GA,Suburban,36-50,2023-04,Q2_2023,2022,2.0,0.568,Stable
FIA002787,2023-05-05,Insulin Glargine,Lantus,Insulin,16555-691-46,Commercial Plan Beta,PLAN_3356,2023,Non-Formulary,Tier 3,2022-05-30,340,Worsened,Non-Formulary Status,No,No,,889,851,4.5,Stable,495.85,84.98,410.87,83.11,578.96,514.7,0.0,0,0.073,0.185,0.476,0.608,10,6,17,15,4.3,23.6,4,Similar,West,IL,Suburban,66-75,2023-05,Q2_2023,2022,5.2,0.7,Decreasing
FIA001446,2023-06-06,Insulin Glargine,Lantus,Insulin,23104-874-82,Medicare Part D Plan B,PLAN_7999,2023,Non-Formulary,Tier 1,2023-02-08,118,Worsened,Non-Formulary Status,No,No,,258,454,-43.0,Decreased,757.55,18.97,738.58,192.21,949.76,245.04,0.0,0,0.154,0.31,0.458,0.561,6,1,9,10,2.7,17.5,2,Lower,Southeast,NC,Suburban,18-35,2023-06,Q2_2023,2022,8.1,0.414,Decreasing
FIA002700,2023-06-17,Insulin Glargine,Lantus,Insulin,90126-644-39,Medicare Part D Plan B,PLAN_1713,2023,Tier 2,Tier 3,2023-02-14,123,Improved,Quantity Limit,No,No,30.0,666,478,39.4,Increased,39.22,50.95,-11.73,48.45,87.67,58.39,0.0,0,0.052,0.069,0.68,0.482,14,0,6,8,2.8,7.1,7,Similar,Midwest,CA,Rural,51-65,2023-06,Q2_2023,2022,2.9,0.704,Stable
FIA002873,2023-07-11,Insulin Glargine,Lantus,Insulin,55971-709-27,Medicare Part D Plan B,PLAN_3286,2023,Tier 2,Specialty Tier,2022-09-30,284,Improved,None,No,No,,436,341,27.9,Increased,38.89,196.04,-157.15,114.42,153.31,66.84,0.0,0,0.011,0.293,0.373,0.849,11,8,17,15,4.9,5.8,4,Lower,Southeast,CA,Rural,18-35,2023-07,Q3_2023,2022,7.4,0.972,Stable
FIA001923,2023-07-23,Insulin Glargine,Lantus,Insulin,12265-868-99,Medicare Part D Plan B,PLAN_4974,2023,Specialty Tier,Tier 1,2022-11-27,238,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,606,981,-38.1,Decreased,240.2,6.69,233.51,192.83,433.03,262.42,0.295,3,0.152,0.125,0.326,0.412,12,7,5,13,3.5,18.2,2,Higher,Northeast,OH,Rural,18-35,2023-07,Q3_2023,2022,2.8,0.029,Decreasing
FIA000462,2023-07-26,Insulin Glargine,Lantus,Insulin,26617-155-39,Medicare Part D Plan B,PLAN_8853,2023,Tier 3,Non-Formulary,2023-03-09,139,Improved,Step Therapy,No,Yes,,863,955,-9.6,Decreased,96.31,678.98,-582.67,128.84,225.15,194.3,0.0,0,0.016,0.188,0.655,0.792,4,0,16,5,3.6,12.0,3,Lower,Northeast,NC,Rural,75+,2023-07,Q3_2023,2022,9.0,0.241,Decreasing
FIA002668,2023-08-03,Insulin Glargine,Lantus,Insulin,55678-600-31,Medicaid Plan X,PLAN_3546,2023,Non-Formulary,Tier 2,2023-06-22,42,Worsened,Non-Formulary Status,No,No,,393,777,-49.4,Decreased,396.26,33.1,363.16,83.78,480.04,188.66,0.0,0,0.182,0.32,0.596,0.677,13,4,0,1,4.3,16.8,5,Similar,Southwest,MI,Urban,18-35,2023-08,Q3_2023,2022,8.4,0.409,Stable
FIA000641,2023-08-04,Insulin Glargine,Lantus,Insulin,31260-401-41,VA Plan,PLAN_3674,2023,Tier 1,Tier 2,2022-12-10,237,Improved,None,No,No,,938,927,1.2,Stable,13.71,44.39,-30.68,71.75,85.46,80.16,0.0,0,0.063,0.257,0.293,0.847,0,5,18,7,2.4,29.9,8,Similar,Midwest,TX,Urban,75+,2023-08,Q3_2023,2022,1.5,0.78,Decreasing
FIA000963,2023-08-10,Insulin Glargine,Lantus,Insulin,90259-970-71,Medicare Part D Plan B,PLAN_3006,2023,Tier 2,Non-Formulary,2022-09-09,335,Improved,None,No,No,,1118,824,35.8,Increased,31.46,383.53,-352.07,41.75,73.21,81.85,0.0,0,0.024,0.289,0.454,0.525,7,4,18,14,2.5,18.0,6,Similar,Northeast,TX,Urban,18-35,2023-08,Q3_2023,2022,7.7,0.792,Stable
FIA002331,2023-08-18,Insulin Glargine,Lantus,Insulin,63706-457-24,Medicaid Plan X,PLAN_1400,2023,Tier 2,Tier 1,2023-02-11,188,Worsened,Quantity Limit,No,No,30.0,907,837,8.4,Increased,24.02,6.63,17.39,101.14,125.16,113.52,0.0,0,0.058,0.189,0.819,0.93,8,0,4,2,3.3,19.6,8,Higher,Southeast,NY,Urban,66-75,2023-08,Q3_2023,2022,2.4,0.018,Increasing
FIA002493,2023-08-22,Insulin Glargine,Lantus,Insulin,99261-366-62,Commercial Plan Alpha,PLAN_9035,2023,Specialty Tier,Non-Formulary,2023-03-10,165,Improved,None,No,No,,957,920,4.1,Stable,202.68,540.85,-338.17,52.13,254.81,243.85,0.0,0,0.253,0.356,0.784,0.524,1,1,4,8,4.9,35.0,2,Lower,Northeast,NY,Rural,36-50,2023-08,Q3_2023,2022,6.8,0.215,Increasing
FIA000374,2023-08-24,Insulin Glargine,Lantus,Insulin,13929-609-36,Medicaid Plan X,PLAN_7613,2023,Non-Formulary,Specialty Tier,2023-05-06,110,Worsened,Non-Formulary Status,No,No,,689,631,9.3,Increased,451.54,134.93,316.61,163.71,615.25,423.91,0.0,0,0.281,0.269,0.836,0.546,10,0,0,10,2.1,19.1,7,Lower,Southwest,CA,Rural,66-75,2023-08,Q3_2023,2022,7.9,0.723,Increasing
FIA000962,2023-09-05,Insulin Glargine,Lantus,Insulin,61121-668-56,Commercial Plan Beta,PLAN_2683,2023,Non-Formulary,Specialty Tier,2023-06-27,70,Worsened,Non-Formulary Status,No,No,,735,740,-0.5,Stable,633.78,125.88,507.9,66.58,700.36,514.76,0.0,0,0.261,0.18,0.725,0.475,4,1,20,1,3.4,13.9,2,Similar,Midwest,NY,Urban,18-35,2023-09,Q3_2023,2022,1.1,0.388,Stable
FIA000415,2023-09-14,Insulin Glargine,Lantus,Insulin,75482-837-59,Medicaid Plan Y,PLAN_8501,2023,Specialty Tier,Tier 1,2022-09-18,361,Worsened,None,No,No,,648,963,-32.6,Decreased,225.22,13.5,211.72,86.77,311.99,202.17,0.0,0,0.095,0.394,0.621,0.491,15,7,17,9,4.4,25.0,3,Lower,West,TX,Urban,18-35,2023-09,Q3_2023,2022,6.6,0.857,Stable
FIA002230,2023-09-19,Insulin Glargine,Lantus,Insulin,14417-186-91,Medicare Part D Plan A,PLAN_2787,2023,Tier 1,Non-Formulary,2023-03-17,186,Improved,Quantity Limit,No,No,,819,668,22.7,Increased,6.87,582.78,-575.91,40.93,47.8,39.15,0.0,0,0.064,0.252,0.441,0.765,9,2,17,3,3.3,33.6,6,Higher,Northeast,NC,Urban,18-35,2023-09,Q3_2023,2022,6.7,0.397,Increasing
FIA002036,2023-10-01,Insulin Glargine,Lantus,Insulin,75453-175-89,Commercial Plan Alpha,PLAN_1154,2023,Tier 3,Tier 1,2023-04-29,155,Worsened,None,No,No,,128,205,-37.1,Decreased,56.9,15.72,41.18,178.17,235.07,30.09,0.0,0,0.05,0.215,0.392,0.769,9,10,16,12,2.5,29.7,7,Similar,West,NY,Urban,75+,2023-10,Q4_2023,2023,9.0,0.323,Decreasing
FIA002533,2023-10-06,Insulin Glargine,Lantus,Insulin,69374-688-97,Medicare Part D Plan A,PLAN_5306,2023,Specialty Tier,Tier 3,2023-09-03,33,Worsened,None,No,No,,683,733,-6.8,Decreased,158.96,62.74,96.22,40.59,199.55,136.29,0.0,0,0.17,0.395,0.664,0.686,11,6,14,6,3.6,15.9,5,Higher,Midwest,NC,Rural,18-35,2023-10,Q4_2023,2023,7.5,0.991,Decreasing
FIA001119,2023-10-25,Insulin Glargine,Lantus,Insulin,33291-463-66,Medicaid Plan X,PLAN_5868,2023,Specialty Tier,Tier 1,2023-06-21,126,Worsened,Prior Authorization,Yes,No,,569,961,-40.7,Decreased,284.69,9.23,275.46,106.94,391.63,222.84,0.473,9,0.129,0.236,0.888,0.578,13,10,19,1,4.1,29.5,4,Lower,Northeast,TX,Suburban,66-75,2023-10,Q4_2023,2023,5.3,0.25,Increasing
FIA000849,2023-10-28,Insulin Glargine,Lantus,Insulin,57668-930-44,Commercial Plan Beta,PLAN_4218,2023,Tier 3,Tier 1,2023-05-06,175,Worsened,Step Therapy,No,Yes,,250,510,-51.0,Decreased,58.8,8.73,50.07,105.29,164.09,41.02,0.0,0,0.061,0.157,0.362,0.716,0,4,10,6,4.2,25.2,8,Lower,Midwest,FL,Rural,66-75,2023-10,Q4_2023,2023,6.0,0.222,Stable
FIA002648,2023-10-31,Insulin Glargine,Lantus,Insulin,46929-794-92,Medicare Part D Plan A,PLAN_9726,2023,Tier 1,Specialty Tier,2023-05-04,180,Improved,None,No,No,,1144,776,47.5,Increased,5.88,140.25,-134.37,57.81,63.69,72.86,0.0,0,0.037,0.173,0.83,0.587,10,1,9,11,3.4,34.6,7,Lower,West,TX,Suburban,18-35,2023-10,Q4_2023,2023,7.6,0.325,Stable
FIA002598,2023-11-05,Insulin Glargine,Lantus,Insulin,91412-171-89,Medicare Part D Plan A,PLAN_8511,2023,Tier 3,Tier 2,2023-03-26,224,Worsened,Step Therapy,No,Yes,,162,360,-54.8,Decreased,84.77,33.09,51.68,158.07,242.84,39.34,0.0,0,0.011,0.339,0.593,0.554,2,7,8,6,4.8,21.6,2,Higher,Northeast,PA,Rural,18-35,2023-11,Q4_2023,2023,8.1,0.593,Stable
FIA001238,2023-11-08,Insulin Glargine,Lantus,Insulin,46568-864-27,Medicaid Plan X,PLAN_3374,2023,Specialty Tier,Tier 1,2022-12-28,315,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,402,661,-39.1,Decreased,134.08,12.38,121.7,80.83,214.91,86.39,0.467,7,0.073,0.223,0.64,0.692,1,5,1,2,3.0,8.7,5,Higher,West,OH,Urban,66-75,2023-11,Q4_2023,2023,5.6,0.878,Stable
FIA000105,2023-11-10,Insulin Glargine,Lantus,Insulin,64146-155-29,Commercial Plan Alpha,PLAN_4281,2023,Tier 3,Non-Formulary,2023-05-14,180,Improved,None,No,No,,165,154,7.3,Increased,73.19,270.67,-197.48,120.07,193.26,31.89,0.0,0,0.058,0.17,0.891,0.891,14,2,10,5,4.3,19.6,7,Lower,Midwest,CA,Urban,66-75,2023-11,Q4_2023,2023,3.5,0.761,Increasing
FIA000250,2023-11-10,Insulin Glargine,Lantus,Insulin,67981-744-10,Medicare Part D Plan B,PLAN_9055,2023,Tier 2,Tier 2,2023-01-08,306,No Change,None,No,No,,375,354,6.0,Increased,21.62,47.53,-25.91,84.68,106.3,39.86,0.0,0,0.037,0.074,0.335,0.749,4,3,4,2,2.5,21.5,8,Lower,Southeast,NC,Urban,66-75,2023-11,Q4_2023,2023,7.5,0.311,Decreasing
FIA002231,2023-11-10,Insulin Glargine,Lantus,Insulin,30790-397-73,VA Plan,PLAN_3229,2023,Tier 1,Non-Formulary,2023-02-02,281,Improved,None,No,No,,584,398,46.9,Increased,16.73,439.3,-422.57,172.68,189.41,110.62,0.0,0,0.039,0.292,0.79,0.914,8,5,18,15,2.4,6.4,2,Lower,Northeast,OH,Urban,18-35,2023-11,Q4_2023,2023,10.0,0.428,Stable
FIA001598,2023-11-17,Insulin Glargine,Lantus,Insulin,88786-469-72,Tricare Standard,PLAN_4205,2023,Tier 2,Tier 2,2023-04-03,228,No Change,None,No,No,,405,369,9.9,Increased,29.25,42.14,-12.89,188.98,218.23,88.38,0.0,0,0.058,0.372,0.28,0.699,4,0,5,5,4.4,18.9,2,Lower,Southeast,TX,Rural,18-35,2023-11,Q4_2023,2023,1.5,0.082,Stable
FIA001062,2023-11-23,Insulin Glargine,Lantus,Insulin,85641-862-26,Medicaid Plan X,PLAN_3936,2023,Tier 3,Non-Formulary,2023-08-31,84,Improved,None,No,No,,307,284,8.2,Increased,64.41,762.57,-698.16,165.77,230.18,70.67,0.0,0,0.051,0.212,0.236,0.476,2,5,1,3,2.6,12.6,8,Lower,Southeast,MI,Urban,66-75,2023-11,Q4_2023,2023,2.4,0.619,Decreasing
FIA002832,2023-12-02,Insulin Glargine,Lantus,Insulin,13319-687-28,Commercial Plan Alpha,PLAN_8144,2023,Tier 2,Tier 3,2023-09-18,75,Improved,None,No,No,,871,711,22.6,Increased,30.45,74.11,-43.66,83.8,114.25,99.51,0.0,0,0.054,0.379,0.466,0.923,4,10,20,7,4.7,32.3,6,Lower,Midwest,PA,Rural,36-50,2023-12,Q4_2023,2023,2.7,0.604,Stable
FIA001762,2023-12-05,Insulin Glargine,Lantus,Insulin,13039-273-56,Medicaid Plan X,PLAN_1431,2023,Tier 2,Tier 2,2023-10-21,45,No Change,None,No,No,,400,366,9.4,Increased,38.07,23.04,15.03,55.14,93.21,37.28,0.0,0,0.054,0.252,0.274,0.886,12,5,8,11,2.5,25.8,2,Similar,Southwest,IL,Suburban,75+,2023-12,Q4_2023,2023,6.0,0.422,Decreasing
FIA000189,2023-12-08,Insulin Glargine,Lantus,Insulin,28293-955-85,Medicare Part D Plan B,PLAN_3353,2023,Tier 3,Specialty Tier,2023-01-25,317,Improved,Prior Authorization; Quantity Limit,Yes,No,30.0,580,554,4.8,Stable,54.38,245.57,-191.19,182.39,236.77,137.33,0.585,5,0.04,0.216,0.807,0.943,2,9,12,2,2.0,24.2,4,Similar,Southeast,NC,Suburban,75+,2023-12,Q4_2023,2023,7.8,0.137,Increasing
FIA001030,2023-12-11,Insulin Glargine,Lantus,Insulin,75973-995-77,Commercial Plan Alpha,PLAN_3218,2023,Tier 3,Tier 3,2023-07-22,142,No Change,Prior Authorization; Step Therapy,Yes,Yes,,938,877,7.0,Increased,83.69,63.35,20.34,148.75,232.44,218.03,0.439,2,0.042,0.317,0.222,0.421,4,10,0,8,2.1,27.7,4,Similar,Northeast,TX,Urban,51-65,2023-12,Q4_2023,2023,4.6,0.688,Stable
FIA002395,2023-12-14,Insulin Glargine,Lantus,Insulin,77644-442-89,VA Plan,PLAN_2875,2023,Non-Formulary,Tier 3,2023-01-08,340,Worsened,Non-Formulary Status,No,No,,276,283,-2.3,Stable,257.54,81.77,175.77,75.71,333.25,91.98,0.0,0,0.192,0.228,0.406,0.623,10,4,14,7,4.5,34.1,6,Lower,Northeast,TX,Suburban,18-35,2023-12,Q4_2023,2023,9.7,0.954,Decreasing
FIA002701,2023-12-28,Insulin Glargine,Lantus,Insulin,57856-124-70,Commercial Plan Alpha,PLAN_4388,2023,Tier 3,Tier 1,2023-06-11,200,Worsened,Prior Authorization; Quantity Limit,Yes,No,,467,755,-38.1,Decreased,88.14,16.69,71.45,78.51,166.65,77.83,0.233,4,0.02,0.356,0.275,0.454,13,2,17,9,2.8,11.6,8,Similar,Midwest,NY,Rural,18-35,2023-12,Q4_2023,2023,10.0,0.553,Increasing
FIA001360,2024-01-02,Insulin Glargine,Lantus,Insulin,60399-373-74,Tricare Standard,PLAN_9603,2024,Tier 2,Tier 3,2023-03-18,290,Improved,None,No,No,,761,493,54.5,Increased,32.41,66.19,-33.78,102.45,134.86,102.63,0.0,0,0.061,0.109,0.481,0.881,15,1,7,1,2.2,10.3,4,Similar,Southwest,PA,Suburban,36-50,2024-01,Q1_2024,2023,3.1,0.445,Decreasing
FIA002550,2024-01-28,Insulin Glargine,Lantus,Insulin,87458-421-27,Commercial Plan Beta,PLAN_7750,2024,Non-Formulary,Tier 2,2023-06-30,212,Worsened,Non-Formulary Status,No,No,,69,109,-36.7,Decreased,314.74,28.95,285.79,46.82,361.56,24.95,0.0,0,0.277,0.088,0.544,0.641,7,4,5,8,3.1,23.4,2,Lower,Midwest,NY,Rural,66-75,2024-01,Q1_2024,2023,5.8,0.547,Stable
FIA001192,2024-02-18,Insulin Glargine,Lantus,Insulin,93767-719-26,Commercial Plan Alpha,PLAN_6519,2024,Tier 1,Tier 3,2023-06-30,233,Improved,None,No,No,,943,768,22.9,Increased,5.57,57.06,-51.49,114.06,119.63,112.81,0.0,0,0.07,0.087,0.747,0.946,4,6,20,3,4.8,28.3,4,Lower,Southwest,FL,Urban,18-35,2024-02,Q1_2024,2023,5.8,0.033,Stable
FIA000128,2024-02-20,Insulin Glargine,Lantus,Insulin,34775-105-10,Medicare Part D Plan B,PLAN_9515,2024,Non-Formulary,Non-Formulary,2023-12-02,80,No Change,Non-Formulary Status,No,No,,836,884,-5.3,Decreased,455.29,352.71,102.58,99.47,554.76,463.78,0.0,0,0.269,0.053,0.658,0.778,10,6,11,3,2.5,24.5,4,Similar,West,OH,Rural,51-65,2024-02,Q1_2024,2023,6.5,0.992,Stable
FIA002801,2024-02-21,Insulin Glargine,Lantus,Insulin,49663-464-39,Tricare Standard,PLAN_7540,2024,Non-Formulary,Non-Formulary,2023-09-03,171,No Change,Non-Formulary Status,No,No,,969,979,-1.0,Stable,751.01,658.96,92.05,176.58,927.59,898.83,0.0,0,0.07,0.202,0.379,0.707,1,1,7,15,2.9,10.5,6,Similar,Northeast,TX,Suburban,66-75,2024-02,Q1_2024,2023,1.9,0.711,Increasing
FIA000169,2024-02-27,Insulin Glargine,Lantus,Insulin,14963-681-71,Medicaid Plan Y,PLAN_2854,2024,Tier 2,Tier 2,2023-06-25,247,No Change,None,No,No,,1011,967,4.6,Stable,38.14,37.34,0.8,92.38,130.52,131.96,0.0,0,0.048,0.253,0.873,0.444,8,7,16,2,3.6,23.3,3,Similar,Northeast,NC,Rural,51-65,2024-02,Q1_2024,2023,6.5,0.904,Decreasing
FIA001327,2024-02-29,Insulin Glargine,Lantus,Insulin,38636-292-21,Medicaid Plan Y,PLAN_3179,2024,Tier 1,Tier 3,2023-03-12,354,Improved,None,No,No,,981,733,33.8,Increased,10.32,76.23,-65.91,132.19,142.51,139.8,0.0,0,0.075,0.332,0.21,0.55,3,5,20,14,3.0,25.7,7,Lower,Southwest,OH,Rural,66-75,2024-02,Q1_2024,2023,9.8,0.093,Increasing
FIA000794,2024-03-04,Insulin Glargine,Lantus,Insulin,42060-338-23,Medicare Part D Plan B,PLAN_3466,2024,Specialty Tier,Tier 2,2024-01-08,56,Worsened,Prior Authorization,Yes,No,,215,320,-32.7,Decreased,289.07,42.42,246.65,94.18,383.25,82.4,0.301,4,0.245,0.128,0.508,0.632,15,0,14,7,4.5,31.6,4,Similar,Midwest,GA,Suburban,66-75,2024-03,Q1_2024,2023,2.6,0.413,Increasing
FIA000092,2024-03-06,Insulin Glargine,Lantus,Insulin,28625-676-34,Tricare Standard,PLAN_9882,2024,Tier 2,Tier 2,2023-10-07,151,No Change,None,No,No,,791,814,-2.8,Stable,37.78,44.19,-6.41,126.5,164.28,129.95,0.0,0,0.035,0.158,0.543,0.45,7,9,7,0,3.6,5.0,6,Lower,Southeast,IL,Rural,36-50,2024-03,Q1_2024,2023,9.3,0.844,Stable
FIA000642,2024-03-15,Insulin Glargine,Lantus,Insulin,87070-480-45,Commercial Plan Alpha,PLAN_2074,2024,Non-Formulary,Non-Formulary,2023-04-06,344,No Change,Non-Formulary Status,No,No,,233,246,-5.1,Decreased,280.34,233.87,46.47,108.16,388.5,90.52,0.0,0,0.069,0.367,0.469,0.727,8,10,2,6,4.7,15.3,8,Lower,West,FL,Urban,66-75,2024-03,Q1_2024,2023,5.0,0.703,Increasing
FIA002161,2024-04-02,Insulin Glargine,Lantus,Insulin,37643-717-73,Commercial Plan Alpha,PLAN_1024,2024,Specialty Tier,Specialty Tier,2023-08-09,237,No Change,Step Therapy,No,Yes,,581,576,0.9,Stable,197.38,245.53,-48.15,191.92,389.3,226.18,0.0,0,0.114,0.371,0.474,0.634,4,9,10,13,3.5,21.2,5,Similar,Southwest,PA,Rural,75+,2024-04,Q2_2024,2023,7.9,0.974,Stable
FIA002459,2024-04-05,Insulin Glargine,Lantus,Insulin,71364-219-92,Medicare Part D Plan A,PLAN_3846,2024,Specialty Tier,Tier 2,2024-01-11,85,Worsened,None,No,No,,120,190,-36.4,Decreased,145.91,36.14,109.77,99.9,245.81,29.5,0.0,0,0.18,0.118,0.332,0.886,12,8,4,14,3.6,28.5,6,Higher,West,GA,Urban,66-75,2024-04,Q2_2024,2023,6.7,0.309,Increasing
FIA001832,2024-04-12,Insulin Glargine,Lantus,Insulin,93360-788-21,Tricare Standard,PLAN_3376,2024,Tier 3,Non-Formulary,2023-07-24,263,Improved,Prior Authorization,Yes,No,,209,192,9.2,Increased,69.61,469.23,-399.62,90.04,159.65,33.37,0.586,9,0.072,0.185,0.308,0.823,13,0,3,15,4.6,14.1,5,Lower,Southeast,FL,Rural,51-65,2024-04,Q2_2024,2023,4.0,0.946,Decreasing
FIA000804,2024-04-14,Insulin Glargine,Lantus,Insulin,49790-222-81,Commercial Plan Alpha,PLAN_2610,2024,Non-Formulary,Non-Formulary,2023-10-12,185,No Change,Non-Formulary Status,No,No,,556,567,-1.9,Stable,598.19,387.72,210.47,85.34,683.53,380.04,0.0,0,0.25,0.099,0.857,0.872,8,5,4,1,3.3,25.5,6,Higher,Northeast,CA,Suburban,18-35,2024-04,Q2_2024,2023,9.3,0.748,Decreasing
FIA000199,2024-04-23,Insulin Glargine,Lantus,Insulin,80571-433-14,Tricare Standard,PLAN_7921,2024,Tier 1,Tier 2,2023-11-19,156,Improved,Quantity Limit,No,No,90.0,201,186,8.2,Increased,8.52,29.36,-20.84,58.86,67.38,13.54,0.0,0,0.018,0.143,0.687,0.723,10,6,18,12,3.0,7.9,5,Lower,Southeast,IL,Suburban,75+,2024-04,Q2_2024,2023,8.3,0.667,Increasing
FIA000797,2024-05-15,Insulin Glargine,Lantus,Insulin,97963-880-11,Medicare Part D Plan A,PLAN_5263,2024,Tier 2,Tier 3,2024-01-14,122,Improved,None,No,No,,366,233,57.4,Increased,47.41,93.25,-45.84,146.2,193.61,70.86,0.0,0,0.012,0.213,0.799,0.714,2,1,1,7,4.4,22.5,8,Higher,Midwest,OH,Urban,18-35,2024-05,Q2_2024,2023,6.4,0.765,Decreasing
FIA001554,2024-05-17,Insulin Glargine,Lantus,Insulin,56718-904-36,Medicaid Plan X,PLAN_3925,2024,Specialty Tier,Tier 1,2024-01-01,137,Worsened,None,No,No,,199,271,-26.4,Decreased,116.06,5.05,111.01,117.69,233.75,46.52,0.0,0,0.225,0.076,0.401,0.681,10,4,10,14,2.9,20.2,7,Higher,Southeast,MI,Suburban,75+,2024-05,Q2_2024,2023,9.7,0.562,Increasing
FIA000353,2024-05-21,Insulin Glargine,Lantus,Insulin,61932-354-32,Medicare Part D Plan B,PLAN_9765,2024,Tier 3,Tier 1,2023-07-19,307,Worsened,None,No,No,,416,527,-20.9,Decreased,63.36,9.4,53.96,36.22,99.58,41.43,0.0,0,0.035,0.083,0.709,0.748,13,4,11,14,4.1,12.3,8,Higher,West,MI,Suburban,18-35,2024-05,Q2_2024,2023,1.7,0.373,Increasing
FIA000499,2024-06-16,Insulin Glargine,Lantus,Insulin,15300-306-12,Medicaid Plan X,PLAN_5949,2024,Tier 2,Tier 3,2023-08-28,293,Improved,None,No,No,,858,647,32.7,Increased,30.72,61.84,-31.12,157.6,188.32,161.58,0.0,0,0.069,0.133,0.471,0.445,10,1,14,2,3.0,31.2,3,Higher,West,TX,Urban,36-50,2024-06,Q2_2024,2023,6.8,0.167,Decreasing
FIA001437,2024-06-26,Insulin Glargine,Lantus,Insulin,40874-546-65,Medicare Part D Plan A,PLAN_9186,2024,Specialty Tier,Specialty Tier,2024-04-13,74,No Change,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,30.0,555,596,-6.8,Decreased,197.99,174.87,23.12,176.64,374.63,207.92,0.549,4,0.18,0.399,0.398,0.683,6,7,16,6,3.2,24.1,4,Higher,West,FL,Suburban,66-75,2024-06,Q2_2024,2023,5.7,0.383,Decreasing
FIA002802,2024-07-06,Insulin Glargine,Lantus,Insulin,24202-285-44,Medicaid Plan X,PLAN_5379,2024,Tier 3,Tier 1,2024-05-12,55,Worsened,Step Therapy,No,Yes,,361,562,-35.7,Decreased,79.28,17.26,62.02,93.93,173.21,62.53,0.0,0,0.012,0.132,0.556,0.577,8,2,0,13,4.7,29.4,5,Higher,Midwest,NC,Urban,75+,2024-07,Q3_2024,2023,6.1,0.574,Decreasing
FIA000406,2024-07-12,Insulin Glargine,Lantus,Insulin,52515-915-61,Tricare Standard,PLAN_8608,2024,Specialty Tier,Tier 3,2023-10-01,285,Worsened,None,No,No,,724,659,10.0,Increased,160.05,74.45,85.6,179.6,339.65,245.91,0.0,0,0.152,0.208,0.299,0.813,13,0,4,10,3.1,31.1,3,Similar,Midwest,CA,Suburban,36-50,2024-07,Q3_2024,2023,2.4,0.946,Increasing
FIA001273,2024-08-03,Insulin Glargine,Lantus,Insulin,52523-729-12,Commercial Plan Alpha,PLAN_4953,2024,Specialty Tier,Specialty Tier,2024-01-01,215,No Change,None,No,No,,781,842,-7.2,Decreased,249.21,276.48,-27.27,103.65,352.86,275.58,0.0,0,0.134,0.135,0.628,0.563,13,2,3,9,4.1,24.1,8,Similar,Northeast,OH,Suburban,36-50,2024-08,Q3_2024,2023,8.6,0.897,Increasing
FIA001045,2024-08-09,Insulin Glargine,Lantus,Insulin,17430-913-65,Medicare Part D Plan A,PLAN_5636,2024,Tier 1,Specialty Tier,2024-01-08,214,Improved,None,No,No,,370,302,22.5,Increased,11.68,224.21,-212.53,119.38,131.06,48.49,0.0,0,0.076,0.379,0.525,0.406,8,1,7,0,2.1,20.4,6,Similar,Southwest,IL,Rural,66-75,2024-08,Q3_2024,2023,3.9,0.683,Stable
FIA001432,2024-08-12,Insulin Glargine,Lantus,Insulin,45469-795-37,Medicaid Plan X,PLAN_3918,2024,Tier 1,Non-Formulary,2024-01-03,222,Improved,None,No,No,,920,690,33.3,Increased,12.09,675.61,-663.52,69.84,81.93,75.38,0.0,0,0.04,0.113,0.547,0.426,9,3,2,1,4.8,18.7,3,Lower,West,GA,Suburban,75+,2024-08,Q3_2024,2023,9.4,0.597,Stable
FIA000796,2024-08-14,Insulin Glargine,Lantus,Insulin,37257-160-89,Medicare Part D Plan A,PLAN_1529,2024,Tier 1,Tier 3,2023-09-14,335,Improved,None,No,No,,225,190,18.4,Increased,11.68,59.99,-48.31,140.8,152.48,34.31,0.0,0,0.064,0.275,0.233,0.868,1,6,11,12,3.1,20.2,3,Higher,Midwest,PA,Suburban,36-50,2024-08,Q3_2024,2023,5.7,0.959,Stable
FIA002924,2024-08-28,Insulin Glargine,Lantus,Insulin,42296-137-90,Medicare Part D Plan B,PLAN_8132,2024,Non-Formulary,Tier 3,2024-02-04,206,Worsened,Non-Formulary Status,No,No,,352,337,4.6,Stable,358.9,57.03,301.87,158.21,517.11,182.02,0.0,0,0.19,0.26,0.534,0.919,14,2,6,0,3.4,13.6,4,Higher,West,NC,Urban,18-35,2024-08,Q3_2024,2023,7.2,0.959,Increasing
FIA002883,2024-08-29,Insulin Glargine,Lantus,Insulin,39365-130-10,Medicaid Plan X,PLAN_8077,2024,Specialty Tier,Non-Formulary,2024-06-28,62,Improved,None,No,No,,526,534,-1.5,Stable,226.44,524.22,-297.78,167.89,394.33,207.42,0.0,0,0.155,0.175,0.31,0.949,14,8,5,0,3.4,14.4,4,Higher,West,PA,Rural,36-50,2024-08,Q3_2024,2023,9.9,0.074,Decreasing
FIA000867,2024-09-11,Insulin Glargine,Lantus,Insulin,85200-820-64,Medicare Part D Plan A,PLAN_1598,2024,Non-Formulary,Tier 3,2023-10-13,334,Worsened,Non-Formulary Status,No,No,,135,137,-1.1,Stable,318.36,60.1,258.26,105.2,423.56,57.18,0.0,0,0.271,0.147,0.217,0.907,8,4,9,2,4.8,29.3,4,Higher,Southwest,GA,Suburban,36-50,2024-09,Q3_2024,2023,3.1,0.666,Decreasing
FIA000643,2024-09-13,Insulin Glargine,Lantus,Insulin,62250-357-59,Medicare Part D Plan B,PLAN_3324,2024,Tier 2,Specialty Tier,2024-06-10,95,Improved,None,No,No,,517,380,36.3,Increased,48.32,270.99,-222.67,137.02,185.34,95.82,0.0,0,0.07,0.295,0.823,0.634,14,3,0,0,3.7,9.8,7,Higher,Midwest,IL,Urban,51-65,2024-09,Q3_2024,2023,1.5,0.166,Increasing
FIA000683,2024-09-16,Insulin Glargine,Lantus,Insulin,19101-306-80,Commercial Plan Beta,PLAN_3036,2024,Tier 3,Tier 1,2024-03-02,198,Worsened,Step Therapy,No,Yes,,80,229,-64.8,Decreased,92.14,15.35,76.79,133.59,225.73,18.06,0.0,0,0.05,0.06,0.702,0.616,9,3,6,4,2.6,27.8,7,Higher,Southeast,FL,Suburban,66-75,2024-09,Q3_2024,2023,5.2,0.218,Increasing
FIA000410,2024-09-19,Insulin Glargine,Lantus,Insulin,76077-389-41,VA Plan,PLAN_7930,2024,Non-Formulary,Non-Formulary,2024-05-10,132,No Change,Non-Formulary Status,No,No,,725,711,2.1,Stable,694.48,587.5,106.98,63.14,757.62,549.27,0.0,0,0.234,0.295,0.797,0.564,6,2,9,0,2.1,24.3,5,Lower,Midwest,GA,Urban,66-75,2024-09,Q3_2024,2023,6.6,0.555,Decreasing
FIA002999,2024-09-19,Insulin Glargine,Lantus,Insulin,16385-763-72,Medicaid Plan X,PLAN_5009,2024,Non-Formulary,Tier 1,2024-07-29,52,Worsened,Non-Formulary Status,No,No,,150,270,-44.4,Decreased,715.96,11.18,704.78,31.79,747.75,112.16,0.0,0,0.089,0.296,0.747,0.449,10,6,19,1,4.6,8.6,5,Lower,Southwest,PA,Suburban,51-65,2024-09,Q3_2024,2023,3.6,0.094,Increasing
FIA002697,2024-09-21,Insulin Glargine,Lantus,Insulin,76830-172-67,Tricare Standard,PLAN_5212,2024,Tier 1,Tier 2,2023-12-22,274,Improved,None,No,No,,806,756,6.7,Increased,17.64,36.39,-18.75,123.46,141.1,113.73,0.0,0,0.069,0.166,0.782,0.56,3,1,13,12,2.3,12.2,4,Higher,Southwest,PA,Urban,36-50,2024-09,Q3_2024,2023,8.3,0.58,Increasing
FIA000080,2024-09-26,Insulin Glargine,Lantus,Insulin,66314-944-37,Tricare Standard,PLAN_5399,2024,Non-Formulary,Tier 1,2024-07-11,77,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,352,780,-54.9,Decreased,638.56,11.88,626.68,97.61,736.17,259.13,0.0,0,0.249,0.34,0.436,0.718,15,5,1,1,2.3,28.5,5,Lower,Northeast,FL,Suburban,66-75,2024-09,Q3_2024,2023,1.0,0.958,Increasing
FIA001960,2024-10-05,Insulin Glargine,Lantus,Insulin,77463-559-92,Medicaid Plan X,PLAN_3424,2024,Specialty Tier,Tier 1,2023-12-22,288,Worsened,Quantity Limit,No,No,30.0,407,559,-27.0,Decreased,186.65,14.0,172.65,102.05,288.7,117.5,0.0,0,0.167,0.092,0.443,0.461,2,7,16,6,2.2,11.8,8,Similar,Northeast,MI,Urban,75+,2024-10,Q4_2024,2024,7.2,0.692,Stable
FIA002013,2024-10-07,Insulin Glargine,Lantus,Insulin,49816-158-60,Commercial Plan Beta,PLAN_3667,2024,Tier 1,Specialty Tier,2023-10-19,354,Improved,Quantity Limit,No,No,30.0,1173,875,34.2,Increased,15.99,140.89,-124.9,61.85,77.84,91.31,0.0,0,0.068,0.118,0.32,0.679,3,10,18,14,3.7,33.1,2,Lower,Northeast,NY,Urban,66-75,2024-10,Q4_2024,2024,3.1,0.42,Increasing
FIA000952,2024-10-12,Insulin Glargine,Lantus,Insulin,33765-524-26,Medicare Part D Plan A,PLAN_4760,2024,Non-Formulary,Non-Formulary,2024-03-18,208,No Change,Non-Formulary Status,No,No,,363,361,0.8,Stable,431.21,629.81,-198.6,186.08,617.29,224.08,0.0,0,0.067,0.371,0.896,0.726,11,1,13,10,3.5,7.8,2,Lower,West,OH,Urban,18-35,2024-10,Q4_2024,2024,5.9,0.899,Decreasing
FIA002111,2024-10-19,Insulin Glargine,Lantus,Insulin,62075-705-42,VA Plan,PLAN_8194,2024,Non-Formulary,Non-Formulary,2024-06-10,131,No Change,Non-Formulary Status,No,No,,623,665,-6.3,Decreased,334.15,420.28,-86.13,113.08,447.23,278.62,0.0,0,0.072,0.318,0.503,0.888,4,9,20,5,2.9,29.0,5,Higher,Northeast,GA,Urban,51-65,2024-10,Q4_2024,2024,5.2,0.571,Stable
FIA001078,2024-10-24,Insulin Glargine,Lantus,Insulin,74505-150-10,Commercial Plan Beta,PLAN_1388,2024,Tier 2,Non-Formulary,2024-04-28,179,Improved,None,No,No,,204,163,25.5,Increased,32.39,493.63,-461.24,106.85,139.24,28.4,0.0,0,0.028,0.278,0.475,0.763,1,5,16,7,3.0,26.5,2,Lower,Southwest,FL,Suburban,36-50,2024-10,Q4_2024,2024,5.1,0.595,Stable
FIA001464,2024-10-30,Insulin Glargine,Lantus,Insulin,90549-261-33,Medicaid Plan Y,PLAN_3863,2024,Tier 1,Tier 3,2024-08-09,82,Improved,None,No,No,,503,438,15.0,Increased,11.26,88.15,-76.89,34.69,45.95,23.11,0.0,0,0.055,0.088,0.736,0.847,0,2,18,9,2.8,29.6,8,Lower,Southwest,OH,Urban,51-65,2024-10,Q4_2024,2024,9.6,0.096,Stable
FIA001129,2024-11-22,Insulin Glargine,Lantus,Insulin,80895-447-39,Commercial Plan Beta,PLAN_4263,2024,Tier 1,Tier 2,2024-06-21,154,Improved,Quantity Limit,No,No,,466,454,2.8,Stable,14.92,20.77,-5.85,46.03,60.95,28.4,0.0,0,0.04,0.225,0.256,0.65,10,5,8,2,2.5,32.6,8,Higher,Southeast,PA,Rural,36-50,2024-11,Q4_2024,2024,2.4,0.821,Increasing
FIA000654,2024-11-29,Insulin Glargine,Lantus,Insulin,50378-442-15,Tricare Standard,PLAN_7308,2024,Non-Formulary,Non-Formulary,2024-01-12,322,No Change,Non-Formulary Status,No,No,,560,563,-0.5,Stable,220.13,235.89,-15.76,162.1,382.23,214.05,0.0,0,0.077,0.057,0.883,0.6,13,0,10,1,2.7,12.4,4,Similar,West,NC,Urban,36-50,2024-11,Q4_2024,2024,1.2,0.483,Stable
FIA002261,2024-12-05,Insulin Glargine,Lantus,Insulin,54418-589-65,Commercial Plan Alpha,PLAN_8148,2024,Tier 2,Tier 2,2024-02-11,298,No Change,None,No,No,,592,640,-7.5,Decreased,32.51,49.11,-16.6,31.1,63.61,37.66,0.0,0,0.068,0.215,0.566,0.851,9,1,19,14,3.5,29.5,6,Lower,Midwest,FL,Rural,75+,2024-12,Q4_2024,2024,5.4,0.682,Increasing
FIA000912,2024-12-22,Insulin Glargine,Lantus,Insulin,68741-123-49,Commercial Plan Alpha,PLAN_5170,2024,Non-Formulary,Specialty Tier,2024-08-03,141,Worsened,Non-Formulary Status,No,No,,540,573,-5.6,Decreased,236.54,125.17,111.37,187.16,423.7,228.8,0.0,0,0.136,0.065,0.709,0.484,10,5,9,13,3.6,26.8,7,Higher,Southeast,MI,Suburban,66-75,2024-12,Q4_2024,2024,6.8,0.293,Increasing
FIA002332,2025-01-10,Insulin Glargine,Lantus,Insulin,35580-517-99,Commercial Plan Alpha,PLAN_4503,2025,Non-Formulary,Non-Formulary,2024-07-28,166,No Change,Non-Formulary Status,No,No,,924,957,-3.4,Stable,485.43,539.39,-53.96,130.04,615.47,568.69,0.0,0,0.093,0.37,0.219,0.444,14,2,12,0,4.8,19.4,2,Lower,Midwest,FL,Urban,51-65,2025-01,Q1_2025,2024,3.3,0.333,Decreasing
FIA002541,2025-01-19,Insulin Glargine,Lantus,Insulin,46586-576-38,Tricare Standard,PLAN_3150,2025,Tier 2,Non-Formulary,2024-05-31,233,Improved,None,No,No,,870,662,31.5,Increased,46.47,318.71,-272.24,138.2,184.67,160.66,0.0,0,0.03,0.162,0.861,0.644,0,6,7,11,3.1,26.4,2,Higher,West,CA,Rural,18-35,2025-01,Q1_2025,2024,4.5,0.632,Increasing
FIA002656,2025-01-25,Insulin Glargine,Lantus,Insulin,41002-218-44,Commercial Plan Beta,PLAN_8565,2025,Tier 3,Non-Formulary,2024-01-28,363,Improved,Step Therapy,No,Yes,,415,396,4.8,Stable,53.89,757.28,-703.39,184.19,238.08,98.8,0.0,0,0.018,0.212,0.669,0.569,5,0,9,9,3.2,14.6,4,Lower,Northeast,TX,Urban,18-35,2025-01,Q1_2025,2024,5.4,0.886,Decreasing
FIA000118,2025-01-31,Insulin Glargine,Lantus,Insulin,55796-326-37,Medicaid Plan Y,PLAN_6424,2025,Tier 1,Tier 3,2024-04-07,299,Improved,None,No,No,,254,169,50.4,Increased,8.3,59.19,-50.89,98.58,106.88,27.15,0.0,0,0.048,0.176,0.353,0.814,15,8,20,0,2.3,15.4,3,Higher,West,MI,Urban,18-35,2025-01,Q1_2025,2024,7.1,0.321,Increasing
FIA000758,2025-02-14,Insulin Glargine,Lantus,Insulin,60794-437-71,Commercial Plan Beta,PLAN_2146,2025,Non-Formulary,Tier 1,2024-08-06,192,Worsened,Non-Formulary Status,No,No,,272,827,-67.1,Decreased,217.6,6.09,211.51,48.59,266.19,72.4,0.0,0,0.243,0.384,0.297,0.926,11,6,11,2,3.6,18.2,7,Lower,Midwest,NC,Suburban,18-35,2025-02,Q1_2025,2024,1.5,0.651,Increasing
FIA002717,2025-02-20,Insulin Glargine,Lantus,Insulin,29084-615-97,Medicaid Plan X,PLAN_7473,2025,Tier 1,Non-Formulary,2024-12-27,55,Improved,None,No,No,,179,139,29.1,Increased,12.63,457.41,-444.78,148.43,161.06,28.83,0.0,0,0.039,0.298,0.428,0.618,9,3,18,3,4.2,15.6,2,Similar,Midwest,OH,Rural,75+,2025-02,Q1_2025,2024,5.9,0.922,Stable
FIA002819,2025-02-21,Insulin Glargine,Lantus,Insulin,59343-997-87,Medicaid Plan Y,PLAN_6344,2025,Tier 3,Specialty Tier,2024-07-28,208,Improved,None,No,No,,124,123,1.1,Stable,73.88,120.22,-46.34,132.82,206.7,25.63,0.0,0,0.05,0.138,0.894,0.612,6,3,10,4,3.0,10.5,2,Similar,West,NC,Rural,36-50,2025-02,Q1_2025,2024,4.4,0.922,Decreasing
FIA000743,2025-02-25,Insulin Glargine,Lantus,Insulin,95601-995-10,Medicare Part D Plan B,PLAN_2774,2025,Specialty Tier,Tier 3,2024-04-11,320,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,925,987,-6.2,Decreased,243.04,52.6,190.44,38.49,281.53,260.42,0.382,6,0.104,0.152,0.277,0.59,1,8,1,6,4.9,27.0,6,Higher,Northeast,PA,Suburban,18-35,2025-02,Q1_2025,2024,1.6,0.061,Increasing
FIA002273,2025-03-05,Insulin Glargine,Lantus,Insulin,15766-576-83,Medicare Part D Plan B,PLAN_1743,2025,Specialty Tier,Tier 3,2024-10-18,138,Worsened,None,No,No,,612,609,0.6,Stable,297.55,57.21,240.34,119.15,416.7,255.02,0.0,0,0.163,0.343,0.285,0.527,9,6,18,5,3.7,23.7,3,Higher,West,OH,Rural,36-50,2025-03,Q1_2025,2024,3.4,0.504,Increasing
FIA001099,2025-03-06,Insulin Glargine,Lantus,Insulin,81591-285-78,Medicaid Plan X,PLAN_9695,2025,Specialty Tier,Tier 2,2024-08-12,206,Worsened,Prior Authorization,Yes,No,,143,334,-57.0,Decreased,133.55,21.01,112.54,57.34,190.89,27.3,0.327,9,0.242,0.261,0.259,0.768,9,9,11,2,3.2,26.8,6,Higher,Northeast,MI,Suburban,51-65,2025-03,Q1_2025,2024,8.5,0.394,Stable
FIA002519,2025-03-08,Insulin Glargine,Lantus,Insulin,44287-565-42,Medicaid Plan X,PLAN_3246,2025,Tier 2,Specialty Tier,2024-10-18,141,Improved,None,No,No,,244,198,23.6,Increased,42.22,196.1,-153.88,30.15,72.37,17.66,0.0,0,0.064,0.339,0.778,0.504,7,7,7,0,4.4,26.5,5,Lower,Southeast,OH,Rural,51-65,2025-03,Q1_2025,2024,8.0,0.679,Increasing
FIA001984,2025-03-11,Insulin Glargine,Lantus,Insulin,45856-984-28,Commercial Plan Alpha,PLAN_4730,2025,Specialty Tier,Non-Formulary,2024-05-19,296,Improved,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,60.0,340,313,8.6,Increased,125.3,793.56,-668.26,53.17,178.47,60.68,0.595,3,0.182,0.1,0.411,0.409,8,10,8,4,2.6,5.2,5,Similar,Midwest,GA,Suburban,66-75,2025-03,Q1_2025,2024,1.1,0.765,Increasing
FIA001412,2025-03-22,Insulin Glargine,Lantus,Insulin,91468-918-94,Medicare Part D Plan A,PLAN_2088,2025,Non-Formulary,Non-Formulary,2024-12-16,96,No Change,Non-Formulary Status,No,No,,596,585,1.9,Stable,546.76,655.15,-108.39,198.79,745.55,444.35,0.0,0,0.261,0.132,0.405,0.67,13,5,18,4,2.1,30.2,4,Higher,Midwest,NC,Rural,36-50,2025-03,Q1_2025,2024,8.1,0.025,Decreasing
FIA001902,2025-03-27,Insulin Glargine,Lantus,Insulin,80811-422-74,Medicare Part D Plan B,PLAN_5638,2025,Tier 1,Tier 1,2025-02-12,43,No Change,None,No,No,,1046,999,4.8,Stable,6.91,7.68,-0.77,145.91,152.82,159.85,0.0,0,0.05,0.393,0.546,0.574,5,2,3,8,4.3,29.2,2,Similar,Northeast,CA,Rural,18-35,2025-03,Q1_2025,2024,6.4,0.847,Stable
FIA001022,2025-03-31,Insulin Glargine,Lantus,Insulin,23214-300-34,Medicare Part D Plan A,PLAN_6364,2025,Tier 1,Non-Formulary,2024-10-21,161,Improved,None,No,No,,570,384,48.7,Increased,13.29,643.91,-630.62,86.58,99.87,56.93,0.0,0,0.036,0.264,0.446,0.453,13,3,11,3,4.8,26.1,2,Lower,West,OH,Suburban,51-65,2025-03,Q1_2025,2024,4.1,0.673,Stable
FIA001107,2025-04-08,Insulin Glargine,Lantus,Insulin,75865-880-20,Tricare Standard,PLAN_8936,2025,Non-Formulary,Specialty Tier,2024-12-28,101,Worsened,Non-Formulary Status,No,No,,329,304,8.4,Increased,596.79,212.44,384.35,188.12,784.91,258.24,0.0,0,0.073,0.328,0.221,0.917,12,6,12,12,2.7,24.5,6,Similar,Southwest,FL,Rural,18-35,2025-04,Q2_2025,2024,6.9,0.158,Stable
FIA002030,2025-04-16,Insulin Glargine,Lantus,Insulin,27565-845-98,Medicaid Plan Y,PLAN_2592,2025,Non-Formulary,Non-Formulary,2025-02-14,61,No Change,Non-Formulary Status; Quantity Limit,No,No,,340,320,6.4,Increased,414.96,210.62,204.34,159.91,574.87,195.46,0.0,0,0.26,0.131,0.455,0.536,14,0,7,7,2.0,33.5,4,Similar,Southwest,GA,Suburban,75+,2025-04,Q2_2025,2024,7.7,0.554,Decreasing
FIA002272,2025-04-23,Insulin Glargine,Lantus,Insulin,87619-324-57,Medicaid Plan X,PLAN_5227,2025,Tier 2,Tier 3,2024-05-28,330,Improved,None,No,No,,425,282,51.1,Increased,49.53,99.49,-49.96,100.98,150.51,63.97,0.0,0,0.048,0.258,0.653,0.407,10,5,9,11,2.6,21.4,3,Lower,Southeast,PA,Urban,75+,2025-04,Q2_2025,2024,2.1,0.033,Decreasing
FIA002993,2025-05-01,Insulin Glargine,Lantus,Insulin,63689-706-73,Commercial Plan Beta,PLAN_8897,2025,Specialty Tier,Non-Formulary,2025-02-02,88,Improved,Quantity Limit,No,No,,111,121,-8.0,Decreased,255.51,680.33,-424.82,73.86,329.37,36.56,0.0,0,0.116,0.349,0.483,0.667,0,9,15,9,2.4,26.3,3,Similar,Northeast,FL,Rural,18-35,2025-05,Q2_2025,2024,2.7,0.624,Decreasing
FIA002903,2025-05-03,Insulin Glargine,Lantus,Insulin,76088-638-61,Medicare Part D Plan A,PLAN_9977,2025,Tier 3,Tier 2,2024-09-16,229,Worsened,None,No,No,,413,686,-39.7,Decreased,88.35,32.29,56.06,153.72,242.07,99.97,0.0,0,0.04,0.09,0.794,0.493,3,10,2,6,2.7,20.6,5,Similar,Southeast,GA,Urban,75+,2025-05,Q2_2025,2024,9.0,0.832,Increasing
FIA002323,2025-05-20,Insulin Glargine,Lantus,Insulin,63926-757-21,VA Plan,PLAN_3839,2025,Tier 3,Tier 1,2024-11-23,178,Worsened,Prior Authorization,Yes,No,,161,535,-69.8,Decreased,78.46,6.66,71.8,173.54,252.0,40.57,0.228,4,0.032,0.318,0.645,0.809,13,2,11,2,4.5,19.0,3,Similar,Southwest,MI,Urban,51-65,2025-05,Q2_2025,2024,4.3,0.601,Decreasing
FIA000890,2025-05-22,Insulin Glargine,Lantus,Insulin,99571-920-60,Medicaid Plan Y,PLAN_4204,2025,Tier 2,Non-Formulary,2024-11-03,200,Improved,None,No,No,,364,291,25.1,Increased,40.46,225.93,-185.47,188.05,228.51,83.18,0.0,0,0.077,0.106,0.367,0.782,10,1,9,14,2.5,22.8,2,Lower,Southeast,FL,Urban,51-65,2025-05,Q2_2025,2024,5.3,0.075,Stable
FIA002862,2025-05-24,Insulin Glargine,Lantus,Insulin,14571-132-86,Medicare Part D Plan B,PLAN_8998,2025,Tier 3,Tier 1,2024-12-31,144,Worsened,Step Therapy,No,Yes,,89,228,-60.8,Decreased,68.6,7.11,61.49,37.24,105.84,9.42,0.0,0,0.048,0.187,0.528,0.563,1,5,1,6,2.3,19.8,2,Lower,Northeast,GA,Rural,18-35,2025-05,Q2_2025,2024,5.8,0.488,Decreasing
FIA000891,2025-06-08,Insulin Glargine,Lantus,Insulin,14816-141-62,Medicare Part D Plan B,PLAN_8704,2025,Tier 1,Non-Formulary,2025-01-05,154,Improved,Quantity Limit,No,No,60.0,661,452,46.3,Increased,15.66,388.38,-372.72,196.93,212.59,140.52,0.0,0,0.013,0.076,0.493,0.57,11,9,8,15,4.4,8.3,3,Lower,West,MI,Urban,75+,2025-06,Q2_2025,2024,1.8,0.635,Stable
FIA001344,2025-06-13,Insulin Glargine,Lantus,Insulin,39163-244-38,Medicare Part D Plan A,PLAN_6029,2025,Tier 1,Specialty Tier,2024-06-18,360,Improved,None,No,No,,1057,886,19.4,Increased,17.16,170.23,-153.07,143.46,160.62,169.78,0.0,0,0.037,0.221,0.544,0.585,13,1,2,11,3.9,24.3,7,Similar,Southeast,NY,Rural,51-65,2025-06,Q2_2025,2024,1.8,0.126,Decreasing
FIA002640,2025-06-14,Insulin Glargine,Lantus,Insulin,39058-999-77,Medicaid Plan X,PLAN_4624,2025,Specialty Tier,Non-Formulary,2024-11-17,209,Improved,Prior Authorization,Yes,No,,257,237,8.5,Increased,283.96,363.48,-79.52,171.13,455.09,116.96,0.285,7,0.098,0.183,0.805,0.442,11,8,20,8,3.1,32.5,7,Higher,Midwest,CA,Urban,75+,2025-06,Q2_2025,2024,5.1,0.351,Decreasing
FIA001040,2025-06-30,Insulin Glargine,Lantus,Insulin,29014-799-45,Medicare Part D Plan A,PLAN_3644,2025,Specialty Tier,Non-Formulary,2025-04-02,89,Improved,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,30.0,777,843,-7.8,Decreased,134.66,635.08,-500.42,68.86,203.52,158.14,0.32,10,0.077,0.388,0.476,0.766,4,7,12,3,3.4,32.5,4,Higher,Northeast,PA,Urban,51-65,2025-06,Q2_2025,2024,7.6,0.389,Decreasing
FIA002409,2025-07-05,Insulin Glargine,Lantus,Insulin,42775-848-22,VA Plan,PLAN_1488,2025,Tier 3,Non-Formulary,2024-09-25,283,Improved,None,No,No,,406,401,1.3,Stable,52.28,410.42,-358.14,98.93,151.21,61.39,0.0,0,0.021,0.374,0.367,0.45,11,0,8,15,3.6,9.2,4,Similar,Southwest,OH,Urban,36-50,2025-07,Q3_2025,2024,8.9,0.629,Increasing
FIA000940,2025-07-06,Insulin Glargine,Lantus,Insulin,56732-414-48,Commercial Plan Alpha,PLAN_2570,2025,Tier 1,Specialty Tier,2024-11-03,245,Improved,None,No,No,,180,116,55.2,Increased,13.57,177.13,-163.56,92.82,106.39,19.15,0.0,0,0.037,0.179,0.666,0.697,7,7,19,5,3.3,5.9,3,Higher,Southeast,GA,Urban,75+,2025-07,Q3_2025,2024,4.9,0.529,Decreasing
FIA002859,2025-07-06,Insulin Glargine,Lantus,Insulin,98770-870-77,Tricare Standard,PLAN_4902,2025,Non-Formulary,Specialty Tier,2025-03-15,113,Worsened,Non-Formulary Status,No,No,,666,628,6.2,Increased,445.33,206.27,239.06,49.37,494.7,329.47,0.0,0,0.274,0.216,0.751,0.495,9,4,7,10,4.6,17.8,4,Higher,Northeast,GA,Rural,75+,2025-07,Q3_2025,2024,3.3,0.394,Stable
FIA002032,2025-07-07,Insulin Glargine,Lantus,Insulin,59135-160-64,Commercial Plan Beta,PLAN_7590,2025,Specialty Tier,Tier 1,2024-12-18,201,Worsened,Prior Authorization,Yes,No,,103,324,-68.2,Decreased,276.5,8.4,268.1,78.34,354.84,36.55,0.24,9,0.206,0.385,0.346,0.743,5,8,12,6,3.1,22.5,7,Lower,Midwest,TX,Urban,51-65,2025-07,Q3_2025,2024,2.2,0.419,Increasing
FIA002685,2025-07-08,Insulin Glargine,Lantus,Insulin,30013-969-98,Medicare Part D Plan A,PLAN_9511,2025,Specialty Tier,Tier 2,2024-08-16,326,Worsened,None,No,No,,408,955,-57.2,Decreased,169.11,23.84,145.27,86.19,255.3,104.16,0.0,0,0.115,0.097,0.674,0.414,11,9,16,3,3.3,24.6,2,Lower,Southwest,CA,Urban,36-50,2025-07,Q3_2025,2024,3.6,0.965,Increasing
FIA001820,2025-07-09,Insulin Glargine,Lantus,Insulin,18065-722-80,Medicaid Plan Y,PLAN_7494,2025,Tier 2,Non-Formulary,2024-11-22,229,Improved,None,No,No,,1487,966,54.0,Increased,30.32,489.59,-459.27,115.4,145.72,216.69,0.0,0,0.039,0.242,0.837,0.43,3,8,7,8,2.9,5.9,5,Similar,Midwest,PA,Rural,66-75,2025-07,Q3_2025,2024,7.1,0.124,Stable
FIA000589,2025-07-14,Insulin Glargine,Lantus,Insulin,11294-911-87,Commercial Plan Alpha,PLAN_9433,2025,Tier 2,Specialty Tier,2024-08-21,327,Improved,None,No,No,,626,489,28.2,Increased,36.09,206.64,-170.55,79.3,115.39,72.23,0.0,0,0.012,0.332,0.813,0.58,5,1,1,5,3.2,33.8,2,Similar,Southwest,PA,Rural,75+,2025-07,Q3_2025,2024,9.1,0.018,Decreasing
FIA001410,2025-07-15,Insulin Glargine,Lantus,Insulin,25553-196-27,Medicare Part D Plan A,PLAN_4531,2025,Tier 1,Specialty Tier,2024-08-11,338,Improved,None,No,No,,321,273,17.7,Increased,14.96,208.3,-193.34,111.62,126.58,40.63,0.0,0,0.024,0.229,0.706,0.738,6,9,19,1,2.3,31.7,8,Higher,Midwest,MI,Suburban,51-65,2025-07,Q3_2025,2024,5.4,0.426,Stable
FIA000656,2025-07-29,Insulin Glargine,Lantus,Insulin,20190-658-61,Tricare Standard,PLAN_1487,2025,Tier 1,Tier 3,2024-09-10,322,Improved,None,No,No,,1098,811,35.5,Increased,7.07,91.42,-84.35,101.84,108.91,119.58,0.0,0,0.07,0.192,0.344,0.861,2,6,5,0,3.4,33.3,6,Higher,Southeast,NC,Rural,18-35,2025-07,Q3_2025,2024,7.1,0.567,Decreasing
FIA000333,2025-07-30,Insulin Glargine,Lantus,Insulin,38695-215-46,VA Plan,PLAN_8326,2025,Specialty Tier,Non-Formulary,2025-03-30,122,Improved,None,No,No,,954,996,-4.2,Stable,275.58,704.42,-428.84,80.22,355.8,339.43,0.0,0,0.186,0.164,0.664,0.464,14,5,3,11,4.1,26.1,8,Similar,Southwest,MI,Suburban,36-50,2025-07,Q3_2025,2024,1.3,0.268,Increasing
FIA002118,2025-07-31,Insulin Glargine,Lantus,Insulin,54351-295-99,Medicaid Plan X,PLAN_1588,2025,Tier 2,Tier 1,2024-11-25,248,Worsened,None,No,No,,492,482,2.2,Stable,46.54,11.62,34.92,184.32,230.86,113.58,0.0,0,0.049,0.219,0.642,0.916,5,8,20,9,3.0,29.7,6,Higher,West,NY,Urban,36-50,2025-07,Q3_2025,2024,8.6,0.525,Decreasing
FIA001709,2025-08-02,Insulin Glargine,Lantus,Insulin,66941-427-78,Medicaid Plan Y,PLAN_9344,2025,Tier 2,Tier 2,2024-11-06,269,No Change,None,No,No,,651,594,9.7,Increased,26.0,28.93,-2.93,151.9,177.9,115.81,0.0,0,0.071,0.1,0.818,0.637,11,4,20,12,4.6,32.3,6,Lower,Midwest,NC,Rural,66-75,2025-08,Q3_2025,2024,3.0,0.029,Increasing
FIA000392,2025-08-05,Insulin Glargine,Lantus,Insulin,66859-856-75,Commercial Plan Alpha,PLAN_9335,2025,Tier 1,Non-Formulary,2025-06-22,44,Improved,None,No,No,,382,292,30.8,Increased,5.71,381.77,-376.06,146.31,152.02,58.07,0.0,0,0.068,0.18,0.689,0.901,3,7,5,7,4.1,7.2,3,Similar,Southeast,MI,Rural,75+,2025-08,Q3_2025,2024,1.1,0.922,Increasing
FIA001704,2025-08-10,Insulin Glargine,Lantus,Insulin,14319-576-11,VA Plan,PLAN_5115,2025,Tier 3,Tier 3,2025-05-24,78,No Change,Prior Authorization,Yes,No,,958,982,-2.3,Stable,73.0,50.88,22.12,158.19,231.19,221.48,0.534,9,0.055,0.276,0.299,0.532,6,8,20,10,2.2,31.3,7,Lower,Northeast,PA,Suburban,66-75,2025-08,Q3_2025,2024,1.2,0.306,Increasing
FIA000818,2025-08-12,Insulin Glargine,Lantus,Insulin,90315-369-93,Commercial Plan Beta,PLAN_6012,2025,Non-Formulary,Specialty Tier,2025-02-24,169,Worsened,Non-Formulary Status,No,No,,515,488,5.6,Increased,463.98,186.87,277.11,81.51,545.49,280.93,0.0,0,0.14,0.128,0.736,0.695,15,1,10,13,4.4,10.2,3,Higher,Northeast,MI,Suburban,75+,2025-08,Q3_2025,2024,8.7,0.054,Stable
FIA002276,2025-08-14,Insulin Glargine,Lantus,Insulin,71550-131-20,Medicare Part D Plan B,PLAN_4434,2025,Non-Formulary,Tier 2,2024-10-30,288,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,557,744,-25.0,Decreased,242.43,42.57,199.86,172.71,415.14,231.23,0.0,0,0.234,0.323,0.288,0.666,4,10,17,7,3.2,18.0,5,Similar,West,NC,Suburban,51-65,2025-08,Q3_2025,2024,5.9,0.586,Decreasing
FIA000736,2025-08-20,Insulin Glargine,Lantus,Insulin,67907-124-59,Tricare Standard,PLAN_8005,2025,Specialty Tier,Non-Formulary,2025-06-23,58,Improved,None,No,No,,858,838,2.5,Stable,181.36,244.51,-63.15,123.01,304.37,261.15,0.0,0,0.17,0.122,0.372,0.483,15,1,17,11,3.8,7.1,3,Similar,West,PA,Rural,75+,2025-08,Q3_2025,2024,4.3,0.221,Stable
FIA000262,2025-08-24,Insulin Glargine,Lantus,Insulin,95563-863-58,Medicare Part D Plan B,PLAN_8596,2025,Non-Formulary,Specialty Tier,2025-05-10,106,Worsened,Non-Formulary Status,No,No,,123,134,-7.6,Decreased,576.18,180.8,395.38,192.27,768.45,94.52,0.0,0,0.222,0.353,0.655,0.551,14,5,0,3,2.3,8.7,7,Higher,West,NY,Urban,75+,2025-08,Q3_2025,2024,6.2,0.573,Stable
FIA000060,2025-08-31,Insulin Glargine,Lantus,Insulin,58174-729-38,Commercial Plan Beta,PLAN_3188,2025,Tier 2,Tier 1,2025-06-02,90,Worsened,None,No,No,,802,802,0.1,Stable,33.96,7.4,26.56,189.91,223.87,179.54,0.0,0,0.055,0.217,0.518,0.944,11,6,17,15,4.3,29.1,8,Lower,Southeast,MI,Urban,75+,2025-08,Q3_2025,2024,5.0,0.704,Increasing
FIA001431,2022-01-03,Levothyroxine,Synthroid,Thyroid Hormones,38497-506-42,Medicaid Plan X,PLAN_2182,2022,Tier 3,Tier 1,2021-05-15,233,Worsened,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,,552,743,-25.7,Decreased,94.68,10.82,83.86,89.71,184.39,101.78,0.36,1,0.029,0.33,0.756,0.773,1,8,18,12,3.5,27.4,4,Lower,Southwest,FL,Urban,36-50,2022-01,Q1_2022,2021,1.9,0.363,Decreasing
FIA002555,2022-01-26,Levothyroxine,Synthroid,Thyroid Hormones,84415-639-41,VA Plan,PLAN_6034,2022,Specialty Tier,Tier 2,2021-09-15,133,Worsened,None,No,No,,302,564,-46.4,Decreased,234.02,43.44,190.58,43.59,277.61,83.84,0.0,0,0.144,0.392,0.583,0.837,15,3,16,2,4.5,22.0,5,Similar,Southwest,OH,Rural,18-35,2022-01,Q1_2022,2021,6.8,0.136,Decreasing
FIA001999,2022-02-05,Levothyroxine,Synthroid,Thyroid Hormones,94457-178-26,Commercial Plan Beta,PLAN_9777,2022,Tier 1,Tier 3,2021-09-11,147,Improved,None,No,No,,525,417,26.0,Increased,13.74,93.6,-79.86,77.07,90.81,47.68,0.0,0,0.073,0.21,0.565,0.681,6,1,0,14,2.9,31.9,4,Higher,Southwest,OH,Suburban,36-50,2022-02,Q1_2022,2021,5.0,0.005,Increasing
FIA002139,2022-02-19,Levothyroxine,Synthroid,Thyroid Hormones,96543-890-71,Medicaid Plan X,PLAN_6797,2022,Tier 1,Tier 3,2021-12-21,60,Improved,Quantity Limit,No,No,90.0,576,483,19.4,Increased,8.31,97.86,-89.55,97.17,105.48,60.76,0.0,0,0.066,0.269,0.364,0.847,5,5,7,0,2.7,24.9,3,Similar,Northeast,FL,Suburban,36-50,2022-02,Q1_2022,2021,2.7,0.128,Decreasing
FIA001154,2022-02-24,Levothyroxine,Synthroid,Thyroid Hormones,39256-895-56,Commercial Plan Beta,PLAN_5547,2022,Tier 2,Non-Formulary,2021-08-27,181,Improved,None,No,No,,350,236,48.7,Increased,30.89,748.5,-717.61,75.47,106.36,37.23,0.0,0,0.05,0.083,0.816,0.753,7,9,2,0,4.2,10.6,3,Higher,Northeast,NC,Suburban,66-75,2022-02,Q1_2022,2021,9.7,0.857,Decreasing
FIA002322,2022-02-26,Levothyroxine,Synthroid,Thyroid Hormones,68891-493-20,Commercial Plan Beta,PLAN_5356,2022,Specialty Tier,Tier 3,2021-07-08,233,Worsened,None,No,No,,764,844,-9.5,Decreased,237.41,59.95,177.46,166.92,404.33,308.91,0.0,0,0.133,0.114,0.291,0.506,8,4,7,0,4.1,19.2,4,Lower,Southwest,FL,Rural,18-35,2022-02,Q1_2022,2021,4.1,0.736,Increasing
FIA002004,2022-02-28,Levothyroxine,Synthroid,Thyroid Hormones,89394-712-87,Medicare Part D Plan B,PLAN_3861,2022,Tier 2,Tier 3,2021-03-22,343,Improved,None,No,No,,1070,890,20.3,Increased,40.82,56.05,-15.23,37.91,78.73,84.24,0.0,0,0.056,0.269,0.613,0.5,8,8,13,3,2.7,7.5,2,Lower,Midwest,NC,Urban,66-75,2022-02,Q1_2022,2021,5.2,0.688,Increasing
FIA000096,2022-03-05,Levothyroxine,Synthroid,Thyroid Hormones,80795-371-94,Medicaid Plan X,PLAN_5872,2022,Tier 2,Non-Formulary,2021-06-26,252,Improved,None,No,No,,492,310,58.8,Increased,24.71,260.75,-236.04,187.35,212.06,104.33,0.0,0,0.049,0.133,0.235,0.714,15,2,1,11,2.0,7.6,8,Higher,West,GA,Urban,18-35,2022-03,Q1_2022,2021,1.2,0.171,Stable
FIA001769,2022-03-13,Levothyroxine,Synthroid,Thyroid Hormones,99669-249-78,Medicaid Plan Y,PLAN_6458,2022,Tier 2,Non-Formulary,2021-06-22,264,Improved,None,No,No,,273,226,21.2,Increased,25.63,364.64,-339.01,105.08,130.71,35.68,0.0,0,0.018,0.24,0.549,0.796,3,6,1,4,3.4,17.8,7,Higher,Midwest,NC,Suburban,66-75,2022-03,Q1_2022,2021,8.0,0.362,Stable
FIA002880,2022-03-13,Levothyroxine,Synthroid,Thyroid Hormones,32040-297-46,Commercial Plan Alpha,PLAN_4761,2022,Tier 2,Specialty Tier,2021-11-16,117,Improved,None,No,No,,212,174,22.2,Increased,48.23,194.8,-146.57,180.97,229.2,48.59,0.0,0,0.047,0.108,0.686,0.419,14,10,1,2,4.1,16.6,8,Lower,Northeast,NY,Urban,51-65,2022-03,Q1_2022,2021,2.2,0.193,Stable
FIA001877,2022-03-22,Levothyroxine,Synthroid,Thyroid Hormones,83290-782-84,Medicare Part D Plan B,PLAN_9157,2022,Specialty Tier,Tier 1,2021-08-13,221,Worsened,None,No,No,,57,126,-54.7,Decreased,274.43,16.36,258.07,52.4,326.83,18.63,0.0,0,0.052,0.068,0.816,0.676,14,2,8,4,4.9,19.3,3,Lower,West,GA,Suburban,36-50,2022-03,Q1_2022,2021,2.4,0.835,Stable
FIA001838,2022-03-24,Levothyroxine,Synthroid,Thyroid Hormones,43478-483-98,Medicare Part D Plan A,PLAN_9300,2022,Specialty Tier,Specialty Tier,2021-08-18,218,No Change,None,No,No,,688,763,-9.7,Decreased,294.03,276.11,17.92,110.35,404.38,278.21,0.0,0,0.217,0.319,0.562,0.402,12,8,4,8,3.5,30.7,2,Similar,West,OH,Suburban,36-50,2022-03,Q1_2022,2021,6.3,0.136,Decreasing
FIA002219,2022-03-29,Levothyroxine,Synthroid,Thyroid Hormones,49949-329-35,Tricare Standard,PLAN_5250,2022,Tier 1,Tier 1,2022-01-15,73,No Change,None,No,No,,98,104,-5.5,Decreased,15.55,14.47,1.08,72.46,88.01,8.62,0.0,0,0.057,0.162,0.773,0.786,10,6,1,4,3.2,26.1,2,Lower,Northeast,OH,Urban,75+,2022-03,Q1_2022,2021,2.5,0.314,Stable
FIA000529,2022-04-05,Levothyroxine,Synthroid,Thyroid Hormones,39464-388-10,Tricare Standard,PLAN_9874,2022,Specialty Tier,Specialty Tier,2021-08-02,246,No Change,None,No,No,,745,762,-2.1,Stable,153.73,114.77,38.96,198.83,352.56,262.66,0.0,0,0.26,0.163,0.479,0.85,8,9,15,1,3.6,5.5,8,Higher,Southeast,OH,Suburban,75+,2022-04,Q2_2022,2021,2.8,0.554,Stable
FIA000512,2022-04-06,Levothyroxine,Synthroid,Thyroid Hormones,30687-623-73,Medicaid Plan X,PLAN_3709,2022,Specialty Tier,Tier 3,2021-07-08,272,Worsened,None,No,No,,303,284,6.8,Increased,233.32,91.44,141.88,143.56,376.88,114.19,0.0,0,0.241,0.26,0.496,0.897,4,7,12,15,4.0,6.5,2,Higher,Midwest,NY,Rural,18-35,2022-04,Q2_2022,2021,3.3,0.79,Decreasing
FIA000730,2022-04-10,Levothyroxine,Synthroid,Thyroid Hormones,97016-673-18,Medicaid Plan X,PLAN_1959,2022,Tier 3,Specialty Tier,2021-07-19,265,Improved,None,No,No,,369,379,-2.6,Stable,62.03,190.47,-128.44,67.85,129.88,47.93,0.0,0,0.017,0.099,0.354,0.411,8,3,15,12,3.8,9.8,6,Similar,Midwest,PA,Suburban,66-75,2022-04,Q2_2022,2021,8.0,0.499,Increasing
FIA001314,2022-04-11,Levothyroxine,Synthroid,Thyroid Hormones,58697-526-20,Medicaid Plan X,PLAN_6792,2022,Tier 3,Specialty Tier,2021-10-14,179,Improved,Prior Authorization; Quantity Limit,Yes,No,30.0,628,661,-5.0,Stable,53.72,182.58,-128.86,156.03,209.75,131.72,0.222,6,0.027,0.219,0.537,0.673,11,9,4,8,4.9,20.2,5,Lower,West,NC,Rural,36-50,2022-04,Q2_2022,2021,5.0,0.312,Decreasing
FIA000634,2022-04-17,Levothyroxine,Synthroid,Thyroid Hormones,58564-896-40,Medicaid Plan X,PLAN_1098,2022,Tier 1,Tier 3,2021-06-27,294,Improved,None,No,No,,710,502,41.6,Increased,18.78,76.17,-57.39,86.88,105.66,75.02,0.0,0,0.014,0.171,0.218,0.689,4,7,6,13,4.2,33.7,4,Higher,Southwest,OH,Suburban,18-35,2022-04,Q2_2022,2021,3.8,0.682,Decreasing
FIA001463,2022-04-18,Levothyroxine,Synthroid,Thyroid Hormones,64110-615-68,Medicare Part D Plan A,PLAN_6085,2022,Specialty Tier,Non-Formulary,2021-05-26,327,Improved,None,No,No,,406,445,-8.7,Decreased,182.71,368.03,-185.32,173.36,356.07,144.56,0.0,0,0.268,0.355,0.497,0.608,15,9,11,1,4.5,21.4,8,Similar,Southwest,OH,Urban,66-75,2022-04,Q2_2022,2021,3.0,0.704,Increasing
FIA002573,2022-04-19,Levothyroxine,Synthroid,Thyroid Hormones,60160-176-88,Medicare Part D Plan B,PLAN_6134,2022,Tier 2,Tier 2,2022-01-22,87,No Change,None,No,No,,571,608,-5.9,Decreased,28.42,44.38,-15.96,79.43,107.85,61.58,0.0,0,0.017,0.247,0.449,0.89,13,7,8,12,2.7,29.1,7,Higher,Midwest,IL,Urban,36-50,2022-04,Q2_2022,2021,7.5,0.128,Increasing
FIA002147,2022-04-25,Levothyroxine,Synthroid,Thyroid Hormones,30562-494-13,Commercial Plan Alpha,PLAN_9310,2022,Non-Formulary,Tier 3,2021-10-29,178,Worsened,Non-Formulary Status,No,No,,555,532,4.5,Stable,499.07,84.05,415.02,40.78,539.85,299.62,0.0,0,0.202,0.209,0.646,0.413,14,1,3,0,3.3,13.9,2,Lower,Southeast,FL,Suburban,75+,2022-04,Q2_2022,2021,4.6,0.621,Decreasing
FIA002266,2022-04-26,Levothyroxine,Synthroid,Thyroid Hormones,94385-508-73,Medicare Part D Plan A,PLAN_6618,2022,Tier 1,Specialty Tier,2021-06-30,300,Improved,None,No,No,,248,182,36.3,Increased,7.51,242.34,-234.83,171.76,179.27,44.46,0.0,0,0.039,0.357,0.758,0.895,0,5,1,1,3.6,31.5,2,Lower,West,FL,Suburban,18-35,2022-04,Q2_2022,2021,7.2,0.185,Increasing
FIA000007,2022-05-05,Levothyroxine,Synthroid,Thyroid Hormones,82132-200-16,Medicare Part D Plan A,PLAN_2528,2022,Tier 3,Tier 1,2021-11-29,157,Worsened,Quantity Limit,No,No,30.0,143,243,-41.1,Decreased,59.58,13.04,46.54,176.43,236.01,33.75,0.0,0,0.041,0.108,0.54,0.518,12,0,5,12,2.0,16.7,8,Similar,Midwest,OH,Rural,75+,2022-05,Q2_2022,2021,7.0,0.487,Increasing
FIA000174,2022-05-08,Levothyroxine,Synthroid,Thyroid Hormones,66525-323-88,Medicare Part D Plan B,PLAN_8234,2022,Specialty Tier,Tier 3,2022-03-09,60,Worsened,Prior Authorization,Yes,No,,278,282,-1.2,Stable,151.65,90.64,61.01,121.91,273.56,76.05,0.423,5,0.077,0.086,0.251,0.714,8,7,0,15,2.4,24.2,2,Higher,Southwest,PA,Urban,51-65,2022-05,Q2_2022,2021,9.1,0.575,Decreasing
FIA002311,2022-05-19,Levothyroxine,Synthroid,Thyroid Hormones,24325-730-37,Medicaid Plan Y,PLAN_1512,2022,Tier 1,Non-Formulary,2021-09-05,256,Improved,None,No,No,,822,570,44.2,Increased,15.91,642.46,-626.55,57.29,73.2,60.17,0.0,0,0.027,0.226,0.768,0.604,5,3,7,11,3.5,7.2,2,Higher,Northeast,NY,Suburban,36-50,2022-05,Q2_2022,2021,7.2,0.639,Increasing
FIA001143,2022-05-28,Levothyroxine,Synthroid,Thyroid Hormones,47061-493-69,Commercial Plan Alpha,PLAN_1734,2022,Tier 2,Non-Formulary,2022-03-25,64,Improved,None,No,No,,675,531,27.3,Increased,29.56,385.39,-355.83,39.21,68.77,46.42,0.0,0,0.033,0.289,0.505,0.412,3,5,11,1,4.0,10.5,2,Lower,Midwest,CA,Rural,75+,2022-05,Q2_2022,2021,8.8,0.471,Increasing
FIA000604,2022-06-18,Levothyroxine,Synthroid,Thyroid Hormones,93206-406-62,Medicaid Plan X,PLAN_1702,2022,Tier 3,Tier 3,2022-04-14,65,No Change,Prior Authorization; Quantity Limit,Yes,No,60.0,161,178,-9.3,Decreased,90.85,84.15,6.7,86.91,177.76,28.62,0.262,2,0.072,0.063,0.668,0.701,4,7,6,0,2.8,19.6,3,Similar,Southeast,NC,Urban,51-65,2022-06,Q2_2022,2021,6.7,0.676,Stable
FIA000980,2022-06-19,Levothyroxine,Synthroid,Thyroid Hormones,13139-304-33,Medicare Part D Plan A,PLAN_8555,2022,Specialty Tier,Non-Formulary,2021-12-05,196,Improved,Prior Authorization,Yes,No,,406,373,9.0,Increased,249.22,501.55,-252.33,129.9,379.12,153.92,0.551,6,0.299,0.202,0.791,0.854,4,6,19,1,2.4,15.8,3,Higher,Northeast,FL,Rural,75+,2022-06,Q2_2022,2021,6.9,0.402,Increasing
FIA000099,2022-06-28,Levothyroxine,Synthroid,Thyroid Hormones,64997-215-63,Commercial Plan Alpha,PLAN_3428,2022,Non-Formulary,Specialty Tier,2021-08-20,312,Worsened,Non-Formulary Status,No,No,,616,569,8.3,Increased,395.68,155.24,240.44,118.84,514.52,316.94,0.0,0,0.206,0.248,0.608,0.931,3,1,18,3,4.4,31.0,4,Similar,Midwest,OH,Rural,66-75,2022-06,Q2_2022,2021,6.1,0.473,Increasing
FIA001708,2022-07-04,Levothyroxine,Synthroid,Thyroid Hormones,12851-848-99,Commercial Plan Beta,PLAN_6212,2022,Specialty Tier,Tier 1,2021-07-26,343,Worsened,None,No,No,,160,295,-45.5,Decreased,292.18,10.33,281.85,78.92,371.1,59.38,0.0,0,0.069,0.21,0.549,0.743,3,2,8,1,2.9,12.4,5,Higher,Southeast,OH,Urban,36-50,2022-07,Q3_2022,2021,10.0,0.92,Stable
FIA000546,2022-07-12,Levothyroxine,Synthroid,Thyroid Hormones,38304-168-80,VA Plan,PLAN_3532,2022,Non-Formulary,Non-Formulary,2022-05-21,52,No Change,Non-Formulary Status,No,No,,862,891,-3.2,Stable,625.3,650.25,-24.95,148.89,774.19,667.35,0.0,0,0.241,0.228,0.607,0.895,8,5,9,1,4.0,34.9,3,Lower,Southwest,FL,Urban,18-35,2022-07,Q3_2022,2021,2.6,0.214,Stable
FIA001665,2022-07-15,Levothyroxine,Synthroid,Thyroid Hormones,93530-974-54,Medicare Part D Plan A,PLAN_4001,2022,Tier 2,Specialty Tier,2022-06-06,39,Improved,Quantity Limit,No,No,60.0,537,366,46.7,Increased,33.82,132.37,-98.55,196.46,230.28,123.66,0.0,0,0.013,0.331,0.203,0.919,7,9,14,15,4.2,20.4,2,Lower,Midwest,NC,Suburban,75+,2022-07,Q3_2022,2021,1.9,0.348,Decreasing
FIA001712,2022-07-17,Levothyroxine,Synthroid,Thyroid Hormones,18807-719-48,Tricare Standard,PLAN_2369,2022,Non-Formulary,Specialty Tier,2021-11-16,243,Worsened,Non-Formulary Status; Quantity Limit,No,No,,340,352,-3.3,Stable,566.06,168.66,397.4,163.83,729.89,248.16,0.0,0,0.269,0.292,0.666,0.495,3,0,15,7,2.4,33.5,4,Higher,Southeast,TX,Urban,36-50,2022-07,Q3_2022,2021,8.3,0.807,Increasing
FIA000516,2022-07-19,Levothyroxine,Synthroid,Thyroid Hormones,18563-890-76,Commercial Plan Alpha,PLAN_5238,2022,Tier 3,Tier 1,2022-03-13,128,Worsened,None,No,No,,467,906,-48.4,Decreased,84.85,9.1,75.75,184.96,269.81,126.0,0.0,0,0.044,0.258,0.601,0.701,1,8,17,0,4.6,18.9,6,Lower,Northeast,PA,Urban,66-75,2022-07,Q3_2022,2021,3.4,0.517,Increasing
FIA001135,2022-07-22,Levothyroxine,Synthroid,Thyroid Hormones,73895-494-44,Commercial Plan Alpha,PLAN_9440,2022,Tier 2,Specialty Tier,2021-10-25,270,Improved,None,No,No,,320,253,26.8,Increased,35.7,191.99,-156.29,87.51,123.21,39.43,0.0,0,0.015,0.131,0.629,0.406,11,3,19,11,2.4,25.9,8,Similar,Northeast,NC,Rural,75+,2022-07,Q3_2022,2021,9.8,0.188,Decreasing
FIA002258,2022-07-24,Levothyroxine,Synthroid,Thyroid Hormones,83917-684-34,Commercial Plan Alpha,PLAN_2054,2022,Tier 2,Specialty Tier,2021-08-09,349,Improved,None,No,No,,162,125,30.3,Increased,35.9,134.7,-98.8,147.98,183.88,29.79,0.0,0,0.01,0.252,0.737,0.621,12,3,20,4,3.1,23.0,3,Higher,Southwest,OH,Urban,75+,2022-07,Q3_2022,2021,5.0,0.715,Decreasing
FIA001668,2022-07-27,Levothyroxine,Synthroid,Thyroid Hormones,50725-172-73,Medicare Part D Plan B,PLAN_8049,2022,Tier 3,Tier 2,2021-12-06,233,Worsened,None,No,No,,162,216,-24.7,Decreased,53.4,49.5,3.9,179.41,232.81,37.72,0.0,0,0.036,0.233,0.411,0.701,10,6,20,7,2.8,27.2,3,Similar,Northeast,CA,Urban,18-35,2022-07,Q3_2022,2021,1.2,0.658,Decreasing
FIA000745,2022-07-30,Levothyroxine,Synthroid,Thyroid Hormones,77811-532-24,Medicare Part D Plan B,PLAN_8700,2022,Non-Formulary,Non-Formulary,2021-09-17,316,No Change,Non-Formulary Status,No,No,,753,818,-7.9,Decreased,587.5,322.52,264.98,96.17,683.67,514.8,0.0,0,0.179,0.339,0.47,0.596,6,10,6,5,3.2,19.3,2,Higher,Midwest,CA,Suburban,75+,2022-07,Q3_2022,2021,2.9,0.19,Stable
FIA002997,2022-07-30,Levothyroxine,Synthroid,Thyroid Hormones,87617-887-96,Commercial Plan Alpha,PLAN_4120,2022,Tier 3,Specialty Tier,2022-02-06,174,Improved,Prior Authorization; Quantity Limit,Yes,No,90.0,564,624,-9.6,Decreased,89.87,174.98,-85.11,35.45,125.32,70.68,0.169,1,0.061,0.103,0.494,0.615,3,9,3,11,3.5,16.7,3,Higher,Northeast,NY,Suburban,51-65,2022-07,Q3_2022,2021,7.1,0.988,Increasing
FIA002815,2022-08-07,Levothyroxine,Synthroid,Thyroid Hormones,38112-516-79,Medicaid Plan X,PLAN_1000,2022,Tier 1,Specialty Tier,2021-12-25,225,Improved,None,No,No,,691,536,29.1,Increased,7.2,167.89,-160.69,154.4,161.6,111.67,0.0,0,0.075,0.305,0.758,0.647,5,5,14,5,2.7,7.0,2,Lower,Southwest,FL,Suburban,51-65,2022-08,Q3_2022,2021,2.4,0.963,Increasing
FIA001548,2022-08-12,Levothyroxine,Synthroid,Thyroid Hormones,76431-170-11,Medicare Part D Plan A,PLAN_8978,2022,Tier 3,Tier 1,2022-01-15,209,Worsened,Prior Authorization,Yes,No,,344,586,-41.3,Decreased,94.05,8.42,85.63,136.98,231.03,79.47,0.144,2,0.029,0.251,0.537,0.456,9,5,3,9,3.7,8.0,6,Higher,Midwest,IL,Rural,36-50,2022-08,Q3_2022,2021,5.9,0.857,Stable
FIA002478,2022-08-20,Levothyroxine,Synthroid,Thyroid Hormones,54338-112-37,Medicare Part D Plan A,PLAN_9501,2022,Non-Formulary,Specialty Tier,2022-07-12,39,Worsened,Non-Formulary Status,No,No,,520,551,-5.6,Decreased,407.91,170.95,236.96,191.32,599.23,311.6,0.0,0,0.235,0.122,0.636,0.543,1,0,19,2,4.8,31.0,4,Lower,Southeast,TX,Rural,51-65,2022-08,Q3_2022,2021,2.8,0.987,Increasing
FIA001292,2022-08-27,Levothyroxine,Synthroid,Thyroid Hormones,19102-570-87,Commercial Plan Alpha,PLAN_6306,2022,Tier 3,Tier 2,2021-12-08,262,Worsened,None,No,No,,237,666,-64.4,Decreased,58.37,31.89,26.48,33.16,91.53,21.69,0.0,0,0.075,0.073,0.478,0.75,4,3,17,0,2.2,24.9,2,Lower,Northeast,MI,Rural,75+,2022-08,Q3_2022,2021,9.0,0.091,Decreasing
FIA001621,2022-08-31,Levothyroxine,Synthroid,Thyroid Hormones,59391-463-68,Medicaid Plan X,PLAN_9831,2022,Non-Formulary,Non-Formulary,2022-05-13,110,No Change,Non-Formulary Status,No,No,,980,990,-0.9,Stable,637.22,786.85,-149.63,137.79,775.01,759.51,0.0,0,0.176,0.307,0.46,0.728,14,10,10,14,3.5,19.5,7,Higher,West,CA,Urban,66-75,2022-08,Q3_2022,2021,3.9,0.732,Stable
FIA000557,2022-09-03,Levothyroxine,Synthroid,Thyroid Hormones,92253-810-21,Tricare Standard,PLAN_3694,2022,Tier 1,Non-Formulary,2022-03-03,184,Improved,Quantity Limit,No,No,,1097,910,20.6,Increased,8.4,544.2,-535.8,119.94,128.34,140.79,0.0,0,0.063,0.119,0.339,0.742,11,2,16,12,2.5,26.6,6,Higher,Southeast,MI,Rural,66-75,2022-09,Q3_2022,2021,8.1,0.344,Decreasing
FIA002092,2022-09-04,Levothyroxine,Synthroid,Thyroid Hormones,98395-749-27,Tricare Standard,PLAN_1358,2022,Tier 2,Non-Formulary,2022-01-03,244,Improved,None,No,No,,796,642,24.0,Increased,22.22,254.63,-232.41,157.92,180.14,143.39,0.0,0,0.024,0.066,0.709,0.625,1,8,17,13,2.6,21.7,7,Similar,Northeast,MI,Suburban,36-50,2022-09,Q3_2022,2021,8.8,0.312,Increasing
FIA000429,2022-09-12,Levothyroxine,Synthroid,Thyroid Hormones,76993-681-63,Commercial Plan Beta,PLAN_5353,2022,Non-Formulary,Specialty Tier,2022-08-12,31,Worsened,Non-Formulary Status; Quantity Limit,No,No,,390,360,8.6,Increased,239.93,262.4,-22.47,169.6,409.53,159.72,0.0,0,0.188,0.394,0.64,0.669,3,7,13,12,2.9,9.2,2,Similar,Northeast,CA,Urban,51-65,2022-09,Q3_2022,2021,2.0,0.535,Increasing
FIA001739,2022-09-17,Levothyroxine,Synthroid,Thyroid Hormones,17143-982-32,Medicare Part D Plan B,PLAN_1976,2022,Tier 2,Tier 2,2022-05-26,114,No Change,None,No,No,,345,360,-4.1,Stable,46.15,35.67,10.48,123.84,169.99,58.65,0.0,0,0.023,0.126,0.724,0.408,4,3,6,10,3.6,10.9,8,Lower,Southwest,FL,Suburban,51-65,2022-09,Q3_2022,2021,7.0,0.742,Stable
FIA001761,2022-10-01,Levothyroxine,Synthroid,Thyroid Hormones,15704-601-39,Medicare Part D Plan B,PLAN_1753,2022,Tier 3,Specialty Tier,2022-03-18,197,Improved,Prior Authorization,Yes,No,,517,522,-0.8,Stable,90.32,217.44,-127.12,99.66,189.98,98.22,0.568,1,0.059,0.374,0.842,0.713,15,6,12,1,2.2,9.8,2,Higher,Southeast,OH,Suburban,36-50,2022-10,Q4_2022,2022,3.0,0.167,Increasing
FIA001970,2022-10-08,Levothyroxine,Synthroid,Thyroid Hormones,12658-873-24,Tricare Standard,PLAN_6688,2022,Tier 1,Specialty Tier,2022-05-04,157,Improved,None,No,No,,637,499,27.9,Increased,9.6,168.74,-159.14,197.93,207.53,132.2,0.0,0,0.033,0.391,0.774,0.434,0,1,14,11,3.1,13.8,7,Lower,Midwest,GA,Rural,18-35,2022-10,Q4_2022,2022,3.6,0.151,Stable
FIA000836,2022-10-23,Levothyroxine,Synthroid,Thyroid Hormones,67383-877-40,Medicaid Plan Y,PLAN_3018,2022,Tier 2,Specialty Tier,2022-01-27,269,Improved,None,No,No,,1382,927,49.1,Increased,37.68,275.87,-238.19,44.52,82.2,113.6,0.0,0,0.057,0.096,0.618,0.495,1,6,17,5,2.9,9.9,3,Higher,Southeast,CA,Urban,36-50,2022-10,Q4_2022,2022,6.6,0.929,Stable
FIA002806,2022-10-23,Levothyroxine,Synthroid,Thyroid Hormones,59427-750-62,Commercial Plan Alpha,PLAN_3436,2022,Tier 2,Tier 1,2022-09-16,37,Worsened,None,No,No,,389,355,9.7,Increased,22.53,18.38,4.15,132.42,154.95,60.28,0.0,0,0.039,0.118,0.6,0.751,5,6,13,14,3.1,15.3,6,Lower,Southwest,NY,Rural,51-65,2022-10,Q4_2022,2022,5.3,0.758,Decreasing
FIA000273,2022-10-27,Levothyroxine,Synthroid,Thyroid Hormones,65846-590-17,VA Plan,PLAN_1846,2022,Tier 1,Non-Formulary,2022-06-17,132,Improved,None,No,No,,716,517,38.6,Increased,6.36,230.57,-224.21,67.7,74.06,53.03,0.0,0,0.079,0.157,0.388,0.554,11,6,7,10,4.7,10.5,2,Lower,Midwest,NY,Suburban,66-75,2022-10,Q4_2022,2022,3.5,0.607,Stable
FIA001176,2022-10-30,Levothyroxine,Synthroid,Thyroid Hormones,18871-569-66,Medicaid Plan Y,PLAN_4330,2022,Tier 3,Tier 2,2022-02-13,259,Worsened,None,No,No,,337,495,-31.9,Decreased,75.84,30.37,45.47,114.98,190.82,64.31,0.0,0,0.035,0.254,0.788,0.926,14,2,8,10,3.7,26.5,6,Higher,Southwest,CA,Rural,75+,2022-10,Q4_2022,2022,3.7,0.495,Decreasing
FIA001124,2022-11-05,Levothyroxine,Synthroid,Thyroid Hormones,65919-948-74,VA Plan,PLAN_3281,2022,Specialty Tier,Tier 2,2022-04-22,197,Worsened,Step Therapy,No,Yes,,70,109,-35.4,Decreased,233.55,46.13,187.42,105.31,338.86,23.72,0.0,0,0.145,0.082,0.303,0.807,11,0,16,13,2.5,21.2,6,Similar,Southwest,PA,Rural,36-50,2022-11,Q4_2022,2022,3.7,0.387,Decreasing
FIA000019,2022-11-10,Levothyroxine,Synthroid,Thyroid Hormones,52245-972-41,Medicare Part D Plan B,PLAN_5569,2022,Tier 2,Non-Formulary,2021-11-12,363,Improved,None,No,No,,975,651,49.9,Increased,28.1,684.92,-656.82,130.72,158.82,154.85,0.0,0,0.068,0.359,0.371,0.656,12,5,0,15,4.6,10.5,3,Similar,Midwest,IL,Suburban,75+,2022-11,Q4_2022,2022,7.3,0.276,Increasing
FIA002905,2022-11-14,Levothyroxine,Synthroid,Thyroid Hormones,93514-979-71,Commercial Plan Alpha,PLAN_7846,2022,Tier 3,Tier 1,2022-06-02,165,Worsened,Prior Authorization,Yes,No,,127,271,-52.9,Decreased,52.07,13.73,38.34,40.11,92.18,11.71,0.223,5,0.033,0.363,0.208,0.646,5,1,3,6,4.9,23.8,6,Similar,Northeast,FL,Suburban,18-35,2022-11,Q4_2022,2022,5.7,0.582,Decreasing
FIA002197,2022-12-07,Levothyroxine,Synthroid,Thyroid Hormones,42433-930-13,Tricare Standard,PLAN_5045,2022,Specialty Tier,Tier 1,2022-08-04,125,Worsened,Step Therapy,No,Yes,,338,957,-64.6,Decreased,292.84,13.06,279.78,195.27,488.11,164.98,0.0,0,0.065,0.165,0.395,0.426,15,9,14,8,2.2,30.8,5,Similar,West,IL,Suburban,51-65,2022-12,Q4_2022,2022,3.3,0.756,Decreasing
FIA000685,2022-12-09,Levothyroxine,Synthroid,Thyroid Hormones,56770-749-61,Medicaid Plan X,PLAN_7744,2022,Specialty Tier,Specialty Tier,2022-08-31,100,No Change,None,No,No,,1043,962,8.5,Increased,174.25,285.2,-110.95,116.42,290.67,303.17,0.0,0,0.098,0.305,0.398,0.646,10,9,15,6,2.3,32.8,6,Higher,West,GA,Rural,75+,2022-12,Q4_2022,2022,8.5,0.708,Decreasing
FIA000830,2022-12-18,Levothyroxine,Synthroid,Thyroid Hormones,89099-337-35,Medicaid Plan Y,PLAN_9933,2022,Tier 1,Tier 2,2022-08-21,119,Improved,None,No,No,,790,874,-9.5,Decreased,6.7,37.14,-30.44,31.78,38.48,30.4,0.0,0,0.029,0.131,0.552,0.564,2,0,13,11,3.3,31.6,4,Lower,Southwest,PA,Suburban,51-65,2022-12,Q4_2022,2022,4.4,0.218,Decreasing
FIA001629,2022-12-21,Levothyroxine,Synthroid,Thyroid Hormones,89387-197-59,Commercial Plan Beta,PLAN_4917,2022,Tier 3,Tier 2,2022-03-02,294,Worsened,None,No,No,,54,126,-56.6,Decreased,63.26,34.16,29.1,38.28,101.54,5.48,0.0,0,0.011,0.248,0.714,0.483,7,6,4,10,3.7,11.6,8,Higher,Southwest,IL,Suburban,18-35,2022-12,Q4_2022,2022,2.0,0.694,Decreasing
FIA001851,2022-12-31,Levothyroxine,Synthroid,Thyroid Hormones,92190-698-86,VA Plan,PLAN_8559,2022,Tier 1,Tier 1,2022-03-24,282,No Change,None,No,No,,219,225,-2.5,Stable,8.52,5.22,3.3,91.63,100.15,21.93,0.0,0,0.071,0.128,0.339,0.459,3,3,2,5,2.9,12.7,7,Similar,Southwest,OH,Urban,75+,2022-12,Q4_2022,2022,2.0,0.201,Decreasing
FIA000612,2023-01-05,Levothyroxine,Synthroid,Thyroid Hormones,20341-767-69,Medicaid Plan X,PLAN_1394,2023,Non-Formulary,Tier 1,2022-08-22,136,Worsened,Non-Formulary Status,No,No,,461,740,-37.7,Decreased,604.64,11.31,593.33,109.96,714.6,329.43,0.0,0,0.281,0.39,0.674,0.549,11,5,18,11,2.3,6.1,2,Lower,West,TX,Suburban,75+,2023-01,Q1_2023,2022,6.2,0.842,Increasing
FIA001266,2023-01-09,Levothyroxine,Synthroid,Thyroid Hormones,16795-599-17,Medicaid Plan Y,PLAN_1463,2023,Tier 3,Tier 2,2022-10-23,78,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,286,427,-32.8,Decreased,98.61,35.33,63.28,195.17,293.78,84.02,0.209,8,0.043,0.059,0.46,0.755,0,10,12,4,3.2,11.5,5,Similar,Southeast,PA,Rural,36-50,2023-01,Q1_2023,2022,2.2,0.335,Increasing
FIA001531,2023-01-20,Levothyroxine,Synthroid,Thyroid Hormones,57753-583-33,Medicaid Plan X,PLAN_8653,2023,Tier 3,Tier 1,2022-03-26,300,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,104,213,-50.7,Decreased,76.83,16.7,60.13,98.04,174.87,18.19,0.171,7,0.031,0.347,0.62,0.592,4,6,16,10,2.1,19.0,6,Higher,Midwest,NY,Rural,51-65,2023-01,Q1_2023,2022,5.7,0.873,Increasing
FIA002686,2023-01-24,Levothyroxine,Synthroid,Thyroid Hormones,83607-586-55,Medicaid Plan Y,PLAN_3614,2023,Tier 1,Tier 2,2022-05-25,244,Improved,None,No,No,,580,629,-7.8,Decreased,5.12,24.23,-19.11,77.09,82.21,47.68,0.0,0,0.059,0.233,0.249,0.425,6,1,19,7,3.5,17.1,4,Similar,Southeast,NY,Urban,36-50,2023-01,Q1_2023,2022,3.2,0.968,Decreasing
FIA002034,2023-01-29,Levothyroxine,Synthroid,Thyroid Hormones,92066-262-65,Commercial Plan Beta,PLAN_7878,2023,Specialty Tier,Tier 2,2022-11-03,87,Worsened,None,No,No,,105,260,-59.3,Decreased,241.54,43.81,197.73,128.64,370.18,38.87,0.0,0,0.248,0.053,0.611,0.422,6,9,19,11,3.1,12.0,2,Lower,West,NC,Suburban,75+,2023-01,Q1_2023,2022,5.7,0.77,Increasing
FIA000439,2023-02-01,Levothyroxine,Synthroid,Thyroid Hormones,73263-905-18,Commercial Plan Beta,PLAN_8672,2023,Tier 2,Specialty Tier,2022-03-28,310,Improved,None,No,No,,362,315,15.0,Increased,37.05,298.09,-261.04,75.14,112.19,40.61,0.0,0,0.07,0.37,0.316,0.77,3,1,14,10,3.9,34.4,8,Similar,Midwest,MI,Rural,75+,2023-02,Q1_2023,2022,9.0,0.814,Stable
FIA002978,2023-02-03,Levothyroxine,Synthroid,Thyroid Hormones,36935-670-70,VA Plan,PLAN_2373,2023,Tier 2,Tier 3,2022-04-19,290,Improved,Quantity Limit,No,No,60.0,1051,913,15.2,Increased,49.15,99.08,-49.93,34.9,84.05,88.34,0.0,0,0.077,0.213,0.863,0.5,4,0,12,6,3.9,32.7,6,Similar,Southeast,PA,Urban,18-35,2023-02,Q1_2023,2022,3.1,0.836,Decreasing
FIA002450,2023-02-04,Levothyroxine,Synthroid,Thyroid Hormones,36658-301-29,VA Plan,PLAN_1897,2023,Tier 3,Tier 3,2022-07-27,192,No Change,None,No,No,,566,589,-3.9,Stable,62.26,81.86,-19.6,56.31,118.57,67.11,0.0,0,0.055,0.147,0.368,0.433,13,1,2,4,2.4,28.5,7,Lower,Midwest,NY,Suburban,75+,2023-02,Q1_2023,2022,4.8,0.35,Decreasing
FIA000129,2023-02-22,Levothyroxine,Synthroid,Thyroid Hormones,28096-975-94,Medicare Part D Plan B,PLAN_4764,2023,Non-Formulary,Non-Formulary,2022-05-21,277,No Change,Non-Formulary Status,No,No,,565,595,-4.9,Stable,307.23,535.46,-228.23,97.68,404.91,228.77,0.0,0,0.244,0.206,0.69,0.489,6,8,12,10,4.4,23.4,7,Higher,Northeast,FL,Suburban,18-35,2023-02,Q1_2023,2022,8.2,0.823,Stable
FIA001182,2023-03-22,Levothyroxine,Synthroid,Thyroid Hormones,48900-992-92,Commercial Plan Alpha,PLAN_5270,2023,Tier 3,Specialty Tier,2022-12-11,101,Improved,None,No,No,,456,433,5.4,Increased,93.54,160.88,-67.34,163.0,256.54,116.98,0.0,0,0.034,0.145,0.645,0.831,13,6,7,1,4.3,26.9,4,Similar,Southeast,MI,Rural,75+,2023-03,Q1_2023,2022,1.2,0.701,Decreasing
FIA001618,2023-03-25,Levothyroxine,Synthroid,Thyroid Hormones,79266-105-12,Medicare Part D Plan A,PLAN_1463,2023,Tier 1,Specialty Tier,2022-09-17,189,Improved,None,No,No,,439,367,19.7,Increased,9.79,251.37,-241.58,76.24,86.03,37.77,0.0,0,0.015,0.313,0.814,0.45,7,0,20,5,4.2,13.3,6,Higher,Northeast,PA,Urban,18-35,2023-03,Q1_2023,2022,1.8,0.821,Increasing
FIA000289,2023-04-02,Levothyroxine,Synthroid,Thyroid Hormones,36145-511-52,Medicare Part D Plan B,PLAN_6198,2023,Specialty Tier,Tier 1,2022-09-06,208,Worsened,Step Therapy; Quantity Limit,No,Yes,60.0,531,937,-43.2,Decreased,193.18,14.64,178.54,160.6,353.78,187.86,0.0,0,0.281,0.399,0.54,0.786,15,1,8,14,2.1,9.7,5,Lower,Southeast,IL,Rural,18-35,2023-04,Q2_2023,2022,9.9,0.774,Increasing
FIA002274,2023-04-05,Levothyroxine,Synthroid,Thyroid Hormones,93853-364-57,Tricare Standard,PLAN_6915,2023,Tier 2,Specialty Tier,2022-12-20,106,Improved,None,No,No,,785,614,27.9,Increased,35.75,249.84,-214.09,42.57,78.32,61.48,0.0,0,0.051,0.235,0.521,0.892,13,8,16,0,3.1,25.8,4,Similar,Northeast,TX,Suburban,36-50,2023-04,Q2_2023,2022,3.6,0.816,Decreasing
FIA001023,2023-04-15,Levothyroxine,Synthroid,Thyroid Hormones,65025-986-99,Tricare Standard,PLAN_9230,2023,Tier 3,Non-Formulary,2023-03-11,35,Improved,Step Therapy; Quantity Limit,No,Yes,90.0,124,131,-5.0,Stable,97.14,401.1,-303.96,74.34,171.48,21.26,0.0,0,0.02,0.354,0.87,0.946,6,10,5,6,3.9,21.3,3,Higher,Northeast,GA,Urban,75+,2023-04,Q2_2023,2022,8.3,0.654,Decreasing
FIA002888,2023-04-16,Levothyroxine,Synthroid,Thyroid Hormones,32794-826-92,Medicaid Plan Y,PLAN_7035,2023,Tier 2,Tier 2,2022-05-03,348,No Change,None,No,No,,153,155,-1.3,Stable,32.9,33.99,-1.09,157.88,190.78,29.19,0.0,0,0.053,0.142,0.864,0.541,3,8,9,11,3.5,34.5,5,Lower,Southeast,MI,Urban,36-50,2023-04,Q2_2023,2022,6.6,0.494,Stable
FIA001138,2023-04-20,Levothyroxine,Synthroid,Thyroid Hormones,24467-248-59,Medicaid Plan Y,PLAN_8816,2023,Tier 2,Tier 3,2023-02-14,65,Improved,Quantity Limit,No,No,30.0,1272,979,29.9,Increased,23.56,63.18,-39.62,101.33,124.89,158.86,0.0,0,0.074,0.242,0.247,0.933,3,2,15,11,4.7,9.9,6,Higher,West,TX,Rural,66-75,2023-04,Q2_2023,2022,1.2,0.53,Increasing
FIA000044,2023-04-28,Levothyroxine,Synthroid,Thyroid Hormones,71925-812-27,Tricare Standard,PLAN_8349,2023,Tier 1,Tier 3,2022-12-05,144,Improved,None,No,No,,1411,959,47.2,Increased,5.42,96.54,-91.12,36.51,41.93,59.16,0.0,0,0.02,0.265,0.834,0.41,6,2,17,13,2.3,13.6,4,Lower,Northeast,NY,Suburban,75+,2023-04,Q2_2023,2022,5.1,0.111,Stable
FIA002855,2023-05-08,Levothyroxine,Synthroid,Thyroid Hormones,13061-167-28,Commercial Plan Beta,PLAN_8205,2023,Tier 1,Specialty Tier,2023-03-19,50,Improved,Quantity Limit,No,No,,261,219,19.5,Increased,11.91,212.78,-200.87,151.65,163.56,42.69,0.0,0,0.068,0.103,0.709,0.924,1,2,17,7,4.4,17.1,7,Lower,Midwest,NY,Rural,75+,2023-05,Q2_2023,2022,6.2,0.346,Increasing
FIA001993,2023-05-24,Levothyroxine,Synthroid,Thyroid Hormones,43784-384-44,Medicaid Plan Y,PLAN_9367,2023,Tier 2,Tier 3,2022-11-10,195,Improved,None,No,No,,166,131,27.1,Increased,43.81,58.63,-14.82,159.15,202.96,33.69,0.0,0,0.022,0.083,0.411,0.935,13,1,10,5,3.9,17.3,2,Similar,West,TX,Suburban,66-75,2023-05,Q2_2023,2022,5.2,0.652,Increasing
FIA001921,2023-05-27,Levothyroxine,Synthroid,Thyroid Hormones,36772-222-64,Commercial Plan Alpha,PLAN_3903,2023,Non-Formulary,Tier 3,2022-09-10,259,Worsened,Non-Formulary Status,No,No,,170,161,5.9,Increased,223.79,86.44,137.35,71.21,295.0,50.15,0.0,0,0.26,0.12,0.425,0.501,7,4,6,7,3.1,18.4,8,Lower,Northeast,IL,Suburban,51-65,2023-05,Q2_2023,2022,6.6,0.82,Increasing
FIA000426,2023-06-22,Levothyroxine,Synthroid,Thyroid Hormones,39454-866-26,Tricare Standard,PLAN_9348,2023,Tier 1,Specialty Tier,2023-05-02,51,Improved,None,No,No,,158,128,23.7,Increased,18.06,256.13,-238.07,106.47,124.53,19.68,0.0,0,0.036,0.361,0.652,0.815,5,3,19,9,3.5,7.3,6,Lower,Southwest,TX,Rural,18-35,2023-06,Q2_2023,2022,7.3,0.777,Decreasing
FIA001815,2023-06-23,Levothyroxine,Synthroid,Thyroid Hormones,85649-101-83,Medicare Part D Plan B,PLAN_3525,2023,Tier 2,Tier 2,2023-03-07,108,No Change,None,No,No,,403,407,-0.8,Stable,40.43,46.54,-6.11,112.78,153.21,61.74,0.0,0,0.014,0.183,0.625,0.605,3,5,3,9,2.3,28.6,4,Higher,Midwest,CA,Urban,51-65,2023-06,Q2_2023,2022,9.6,0.997,Stable
FIA001925,2023-06-26,Levothyroxine,Synthroid,Thyroid Hormones,74764-397-65,Medicaid Plan X,PLAN_4804,2023,Specialty Tier,Specialty Tier,2022-10-20,249,No Change,Prior Authorization; Step Therapy,Yes,Yes,,236,231,2.3,Stable,286.43,179.85,106.58,192.75,479.18,113.09,0.107,9,0.275,0.282,0.212,0.685,5,5,14,0,2.8,32.0,8,Similar,Midwest,PA,Urban,75+,2023-06,Q2_2023,2022,3.2,0.634,Decreasing
FIA000155,2023-07-07,Levothyroxine,Synthroid,Thyroid Hormones,66040-514-15,VA Plan,PLAN_6126,2023,Tier 2,Tier 2,2023-02-23,134,No Change,None,No,No,,589,549,7.3,Increased,21.98,47.81,-25.83,180.89,202.87,119.49,0.0,0,0.071,0.188,0.857,0.715,1,8,3,14,3.4,31.3,3,Higher,West,OH,Rural,18-35,2023-07,Q3_2023,2022,6.0,0.516,Decreasing
FIA001600,2023-07-11,Levothyroxine,Synthroid,Thyroid Hormones,72152-209-92,Commercial Plan Beta,PLAN_8638,2023,Non-Formulary,Non-Formulary,2022-09-30,284,No Change,Non-Formulary Status,No,No,,891,900,-0.9,Stable,323.79,546.58,-222.79,102.59,426.38,379.9,0.0,0,0.239,0.069,0.301,0.903,12,9,16,8,3.0,21.3,6,Higher,Northeast,MI,Urban,66-75,2023-07,Q3_2023,2022,4.6,0.813,Decreasing
FIA000026,2023-07-14,Levothyroxine,Synthroid,Thyroid Hormones,10336-389-48,Tricare Standard,PLAN_3434,2023,Specialty Tier,Specialty Tier,2023-02-10,154,No Change,Prior Authorization,Yes,No,,319,295,8.4,Increased,191.36,128.93,62.43,116.32,307.68,98.15,0.307,8,0.284,0.239,0.442,0.704,12,7,10,6,4.9,12.2,5,Lower,Southwest,CA,Suburban,66-75,2023-07,Q3_2023,2022,7.3,0.811,Stable
FIA000100,2023-07-19,Levothyroxine,Synthroid,Thyroid Hormones,45203-481-12,Medicaid Plan Y,PLAN_5965,2023,Tier 2,Non-Formulary,2022-08-12,341,Improved,None,No,No,,782,505,55.0,Increased,40.42,441.03,-400.61,156.78,197.2,154.21,0.0,0,0.027,0.159,0.79,0.872,3,3,4,9,4.9,18.3,8,Similar,Midwest,OH,Rural,18-35,2023-07,Q3_2023,2022,2.7,0.211,Stable
FIA000853,2023-07-23,Levothyroxine,Synthroid,Thyroid Hormones,27225-109-10,Tricare Standard,PLAN_8140,2023,Tier 2,Tier 1,2022-11-15,250,Worsened,Quantity Limit,No,No,,1032,965,7.0,Increased,23.61,11.16,12.45,70.37,93.98,96.99,0.0,0,0.06,0.159,0.402,0.43,12,8,11,13,3.8,18.8,2,Similar,Southeast,NY,Rural,66-75,2023-07,Q3_2023,2022,1.2,0.933,Increasing
FIA000837,2023-07-28,Levothyroxine,Synthroid,Thyroid Hormones,10302-508-88,Medicaid Plan Y,PLAN_3138,2023,Tier 1,Specialty Tier,2023-06-14,44,Improved,Quantity Limit,No,No,30.0,682,486,40.5,Increased,17.52,290.39,-272.87,145.61,163.13,111.25,0.0,0,0.06,0.169,0.576,0.615,4,9,9,2,2.4,15.3,5,Higher,Northeast,CA,Suburban,51-65,2023-07,Q3_2023,2022,3.3,0.886,Decreasing
FIA002504,2023-08-03,Levothyroxine,Synthroid,Thyroid Hormones,29397-772-40,VA Plan,PLAN_4648,2023,Tier 2,Tier 2,2023-04-08,117,No Change,None,No,No,,835,879,-4.9,Stable,22.73,22.25,0.48,114.13,136.86,114.28,0.0,0,0.069,0.335,0.893,0.792,0,10,3,1,3.4,18.0,3,Similar,West,IL,Suburban,66-75,2023-08,Q3_2023,2022,5.2,0.171,Decreasing
FIA000252,2023-08-04,Levothyroxine,Synthroid,Thyroid Hormones,59054-603-61,VA Plan,PLAN_7465,2023,Non-Formulary,Non-Formulary,2022-11-01,276,No Change,Non-Formulary Status,No,No,,544,580,-6.1,Decreased,243.16,281.99,-38.83,154.16,397.32,216.14,0.0,0,0.265,0.39,0.461,0.669,2,6,1,3,3.2,22.0,3,Similar,Midwest,IL,Rural,66-75,2023-08,Q3_2023,2022,6.7,0.368,Increasing
FIA000505,2023-08-07,Levothyroxine,Synthroid,Thyroid Hormones,25533-916-75,Medicare Part D Plan B,PLAN_1634,2023,Tier 2,Tier 2,2023-03-02,158,No Change,None,No,No,,1015,956,6.2,Increased,34.39,23.19,11.2,124.34,158.73,161.11,0.0,0,0.018,0.123,0.764,0.805,13,8,7,3,3.3,13.3,2,Similar,Southeast,OH,Rural,18-35,2023-08,Q3_2023,2022,5.9,0.517,Decreasing
FIA001296,2023-08-18,Levothyroxine,Synthroid,Thyroid Hormones,88649-634-80,Medicare Part D Plan A,PLAN_7651,2023,Tier 3,Tier 2,2023-06-19,60,Worsened,None,No,No,,260,761,-65.7,Decreased,54.88,23.17,31.71,89.17,144.05,37.45,0.0,0,0.036,0.31,0.79,0.462,15,5,1,14,4.9,8.6,7,Higher,Southeast,OH,Suburban,66-75,2023-08,Q3_2023,2022,6.7,0.802,Stable
FIA001100,2023-09-04,Levothyroxine,Synthroid,Thyroid Hormones,59241-607-78,Medicaid Plan Y,PLAN_6410,2023,Tier 3,Tier 3,2023-05-24,103,No Change,Step Therapy; Quantity Limit,No,Yes,60.0,123,130,-4.8,Stable,61.91,79.21,-17.3,155.36,217.27,26.72,0.0,0,0.072,0.223,0.207,0.438,15,7,19,11,4.3,8.7,7,Similar,Southwest,GA,Urban,75+,2023-09,Q3_2023,2022,7.1,0.229,Stable
FIA000351,2023-09-11,Levothyroxine,Synthroid,Thyroid Hormones,65277-283-30,VA Plan,PLAN_9476,2023,Tier 1,Tier 3,2023-01-28,226,Improved,None,No,No,,504,391,29.0,Increased,14.81,71.29,-56.48,74.37,89.18,44.95,0.0,0,0.044,0.342,0.525,0.445,3,10,12,0,2.5,8.9,6,Similar,Southwest,CA,Suburban,66-75,2023-09,Q3_2023,2022,4.8,0.055,Stable
FIA002982,2023-09-17,Levothyroxine,Synthroid,Thyroid Hormones,29051-443-55,Medicaid Plan X,PLAN_6812,2023,Non-Formulary,Specialty Tier,2023-05-16,124,Worsened,Non-Formulary Status,No,No,,843,883,-4.5,Stable,711.51,269.58,441.93,133.0,844.51,711.92,0.0,0,0.291,0.397,0.459,0.497,4,1,13,15,2.4,31.4,7,Lower,Midwest,CA,Urban,75+,2023-09,Q3_2023,2022,5.1,0.659,Stable
FIA000927,2023-09-21,Levothyroxine,Synthroid,Thyroid Hormones,45338-488-54,Medicaid Plan X,PLAN_3874,2023,Tier 1,Tier 2,2023-02-11,222,Improved,None,No,No,,264,270,-2.0,Stable,6.14,35.49,-29.35,150.58,156.72,41.37,0.0,0,0.034,0.31,0.551,0.536,8,3,15,14,2.3,13.0,2,Lower,Midwest,PA,Rural,51-65,2023-09,Q3_2023,2022,3.5,0.338,Decreasing
FIA001700,2023-09-24,Levothyroxine,Synthroid,Thyroid Hormones,81775-877-35,Medicare Part D Plan B,PLAN_3163,2023,Tier 1,Non-Formulary,2023-05-04,143,Improved,None,No,No,,614,484,26.9,Increased,9.44,535.47,-526.03,31.62,41.06,25.21,0.0,0,0.062,0.386,0.356,0.871,7,4,19,15,3.1,8.1,5,Similar,Northeast,CA,Rural,36-50,2023-09,Q3_2023,2022,5.1,0.105,Increasing
FIA000635,2023-10-21,Levothyroxine,Synthroid,Thyroid Hormones,41619-951-77,Medicaid Plan X,PLAN_3411,2023,Specialty Tier,Tier 1,2023-01-22,272,Worsened,Quantity Limit,No,No,30.0,271,611,-55.5,Decreased,200.04,18.23,181.81,176.65,376.69,102.08,0.0,0,0.197,0.217,0.802,0.812,4,7,6,5,2.2,10.3,7,Lower,Southwest,TX,Urban,18-35,2023-10,Q4_2023,2023,8.5,0.83,Decreasing
FIA001672,2023-10-22,Levothyroxine,Synthroid,Thyroid Hormones,96379-487-80,Medicaid Plan X,PLAN_5850,2023,Non-Formulary,Non-Formulary,2023-08-30,53,No Change,Non-Formulary Status,No,No,,346,385,-10.0,Decreased,773.82,534.27,239.55,147.68,921.5,318.84,0.0,0,0.1,0.088,0.813,0.885,14,9,1,8,2.9,14.8,4,Lower,Southwest,MI,Urban,66-75,2023-10,Q4_2023,2023,9.0,0.018,Stable
FIA001488,2023-10-31,Levothyroxine,Synthroid,Thyroid Hormones,73072-285-50,Commercial Plan Beta,PLAN_1929,2023,Non-Formulary,Tier 3,2022-12-06,329,Worsened,Non-Formulary Status,No,No,,617,640,-3.4,Stable,787.73,94.31,693.42,103.29,891.02,549.76,0.0,0,0.21,0.316,0.275,0.691,12,7,16,8,3.1,8.2,6,Lower,Southeast,PA,Suburban,66-75,2023-10,Q4_2023,2023,1.6,0.714,Decreasing
FIA002461,2023-10-31,Levothyroxine,Synthroid,Thyroid Hormones,62168-798-20,Medicare Part D Plan A,PLAN_9928,2023,Tier 3,Tier 2,2023-06-07,146,Worsened,Step Therapy,No,Yes,,302,994,-69.6,Decreased,53.61,45.05,8.56,160.74,214.35,64.73,0.0,0,0.041,0.343,0.424,0.711,12,0,14,13,4.8,35.0,8,Lower,Southeast,PA,Urban,51-65,2023-10,Q4_2023,2023,5.3,0.766,Decreasing
FIA002208,2023-11-08,Levothyroxine,Synthroid,Thyroid Hormones,43972-698-39,Commercial Plan Alpha,PLAN_9475,2023,Non-Formulary,Tier 1,2023-09-02,67,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,112,178,-36.9,Decreased,588.47,8.79,579.68,173.39,761.86,85.33,0.0,0,0.2,0.323,0.345,0.787,12,3,8,15,4.5,10.0,8,Similar,Southeast,PA,Suburban,18-35,2023-11,Q4_2023,2023,9.1,0.763,Increasing
FIA001816,2023-11-18,Levothyroxine,Synthroid,Thyroid Hormones,84195-944-69,Tricare Standard,PLAN_6907,2023,Tier 1,Non-Formulary,2023-06-13,158,Improved,Quantity Limit,No,No,60.0,1000,786,27.2,Increased,10.8,421.37,-410.57,156.53,167.33,167.33,0.0,0,0.073,0.2,0.815,0.437,7,4,0,1,5.0,27.6,4,Lower,Southeast,MI,Urban,51-65,2023-11,Q4_2023,2023,1.2,0.09,Increasing
FIA002318,2023-11-21,Levothyroxine,Synthroid,Thyroid Hormones,33282-871-44,Commercial Plan Alpha,PLAN_8766,2023,Tier 1,Specialty Tier,2023-01-03,322,Improved,None,No,No,,621,431,44.2,Increased,14.52,167.84,-153.32,48.28,62.8,39.0,0.0,0,0.05,0.292,0.666,0.734,3,6,20,3,3.0,31.7,7,Similar,Midwest,PA,Urban,18-35,2023-11,Q4_2023,2023,4.4,0.221,Increasing
FIA000107,2023-11-23,Levothyroxine,Synthroid,Thyroid Hormones,12872-703-74,Commercial Plan Alpha,PLAN_3017,2023,Tier 2,Tier 3,2023-02-16,280,Improved,None,No,No,,1239,931,33.2,Increased,30.78,59.42,-28.64,52.3,83.08,102.94,0.0,0,0.061,0.178,0.655,0.421,8,8,19,1,3.8,6.4,2,Higher,Northeast,CA,Rural,18-35,2023-11,Q4_2023,2023,4.8,0.38,Decreasing
FIA002477,2023-11-24,Levothyroxine,Synthroid,Thyroid Hormones,94406-410-46,VA Plan,PLAN_6261,2023,Specialty Tier,Tier 3,2023-04-02,236,Worsened,Step Therapy,No,Yes,,339,363,-6.4,Decreased,217.51,67.65,149.86,84.01,301.52,102.22,0.0,0,0.213,0.329,0.823,0.647,3,6,4,11,4.7,14.1,7,Lower,Southwest,IL,Rural,51-65,2023-11,Q4_2023,2023,6.3,0.887,Stable
FIA002190,2023-11-30,Levothyroxine,Synthroid,Thyroid Hormones,49833-287-36,Medicaid Plan Y,PLAN_4027,2023,Non-Formulary,Specialty Tier,2023-02-25,278,Worsened,Non-Formulary Status,No,No,,840,768,9.4,Increased,238.03,157.79,80.24,81.46,319.49,268.37,0.0,0,0.225,0.236,0.564,0.661,0,5,4,11,2.2,11.3,3,Similar,Southeast,IL,Rural,66-75,2023-11,Q4_2023,2023,2.1,0.184,Increasing
FIA000272,2023-12-02,Levothyroxine,Synthroid,Thyroid Hormones,42698-387-24,Medicaid Plan X,PLAN_5052,2023,Non-Formulary,Tier 1,2023-03-25,252,Worsened,Non-Formulary Status,No,No,,77,184,-58.0,Decreased,488.12,9.23,478.89,116.91,605.03,46.59,0.0,0,0.088,0.283,0.5,0.661,3,8,19,5,2.6,30.6,7,Higher,Southeast,NY,Urban,36-50,2023-12,Q4_2023,2023,4.6,0.274,Increasing
FIA001121,2023-12-06,Levothyroxine,Synthroid,Thyroid Hormones,54433-178-50,Medicaid Plan Y,PLAN_8708,2023,Tier 2,Tier 2,2023-07-24,135,No Change,None,No,No,,336,350,-4.0,Stable,43.32,37.34,5.98,106.85,150.17,50.46,0.0,0,0.064,0.349,0.857,0.751,12,3,17,0,4.5,11.1,3,Similar,Southeast,GA,Urban,66-75,2023-12,Q4_2023,2023,2.0,0.525,Decreasing
FIA000482,2023-12-08,Levothyroxine,Synthroid,Thyroid Hormones,85865-430-16,Commercial Plan Alpha,PLAN_7481,2023,Tier 1,Tier 2,2023-07-20,141,Improved,None,No,No,,631,658,-4.1,Stable,11.71,46.74,-35.03,58.68,70.39,44.42,0.0,0,0.061,0.153,0.23,0.85,13,4,9,1,2.7,11.1,4,Lower,Southwest,GA,Rural,18-35,2023-12,Q4_2023,2023,9.3,0.905,Decreasing
FIA000299,2023-12-23,Levothyroxine,Synthroid,Thyroid Hormones,51215-225-11,Medicaid Plan Y,PLAN_1178,2023,Tier 1,Tier 1,2023-08-23,122,No Change,None,No,No,,281,290,-2.8,Stable,17.14,11.44,5.7,54.66,71.8,20.18,0.0,0,0.036,0.301,0.35,0.712,10,3,17,2,3.2,23.1,6,Lower,Northeast,NC,Suburban,75+,2023-12,Q4_2023,2023,9.5,0.807,Decreasing
FIA001457,2024-01-03,Levothyroxine,Synthroid,Thyroid Hormones,61399-266-49,Medicare Part D Plan A,PLAN_3569,2024,Tier 3,Tier 3,2023-11-02,62,No Change,Prior Authorization,Yes,No,,747,797,-6.2,Decreased,95.18,80.29,14.89,126.15,221.33,165.33,0.295,4,0.051,0.226,0.384,0.743,1,3,2,15,3.9,23.7,4,Similar,Northeast,MI,Urban,75+,2024-01,Q1_2024,2023,6.8,0.655,Decreasing
FIA000724,2024-01-06,Levothyroxine,Synthroid,Thyroid Hormones,69168-456-94,VA Plan,PLAN_4411,2024,Specialty Tier,Non-Formulary,2023-07-16,174,Improved,Quantity Limit,No,No,60.0,672,712,-5.6,Decreased,201.34,789.18,-587.84,87.92,289.26,194.38,0.0,0,0.225,0.177,0.553,0.888,5,7,20,2,3.4,16.7,3,Higher,Midwest,OH,Suburban,18-35,2024-01,Q1_2024,2023,3.3,0.874,Stable
FIA000922,2024-01-24,Levothyroxine,Synthroid,Thyroid Hormones,30119-466-93,Tricare Standard,PLAN_3490,2024,Tier 1,Specialty Tier,2023-11-16,69,Improved,None,No,No,,1177,888,32.6,Increased,8.84,203.85,-195.01,107.14,115.98,136.51,0.0,0,0.06,0.129,0.778,0.816,6,1,12,0,4.5,24.9,7,Higher,Northeast,TX,Rural,18-35,2024-01,Q1_2024,2023,3.8,0.889,Stable
FIA000147,2024-02-01,Levothyroxine,Synthroid,Thyroid Hormones,47287-710-12,Commercial Plan Alpha,PLAN_5945,2024,Specialty Tier,Tier 3,2023-02-25,341,Worsened,Quantity Limit,No,No,,509,484,5.3,Increased,148.14,77.28,70.86,35.89,184.03,93.67,0.0,0,0.05,0.155,0.355,0.871,0,4,17,4,2.3,18.8,3,Lower,Midwest,IL,Rural,36-50,2024-02,Q1_2024,2023,3.1,0.811,Increasing
FIA000712,2024-02-02,Levothyroxine,Synthroid,Thyroid Hormones,37403-328-83,Medicare Part D Plan B,PLAN_4152,2024,Tier 2,Tier 1,2023-11-16,78,Worsened,None,No,No,,795,875,-9.1,Decreased,48.83,16.09,32.74,120.81,169.64,134.86,0.0,0,0.025,0.13,0.322,0.5,12,1,6,5,2.7,22.9,4,Similar,Midwest,IL,Urban,36-50,2024-02,Q1_2024,2023,3.7,0.501,Stable
FIA002507,2024-02-13,Levothyroxine,Synthroid,Thyroid Hormones,64945-314-78,VA Plan,PLAN_3857,2024,Tier 1,Non-Formulary,2023-06-29,229,Improved,None,No,No,,715,462,54.8,Increased,14.77,532.7,-517.93,190.16,204.93,146.52,0.0,0,0.036,0.129,0.574,0.548,1,10,2,14,3.7,15.4,8,Lower,Midwest,MI,Suburban,66-75,2024-02,Q1_2024,2023,7.0,0.053,Stable
FIA001215,2024-02-20,Levothyroxine,Synthroid,Thyroid Hormones,23677-704-52,Medicaid Plan Y,PLAN_4608,2024,Specialty Tier,Specialty Tier,2023-12-21,61,No Change,Quantity Limit,No,No,,481,511,-5.7,Decreased,228.93,232.5,-3.57,148.48,377.41,181.53,0.0,0,0.23,0.258,0.543,0.8,6,4,1,7,3.5,23.7,5,Lower,Southeast,GA,Rural,36-50,2024-02,Q1_2024,2023,1.2,0.098,Decreasing
FIA001388,2024-03-12,Levothyroxine,Synthroid,Thyroid Hormones,64537-740-89,Commercial Plan Alpha,PLAN_6909,2024,Specialty Tier,Specialty Tier,2023-07-07,249,No Change,Prior Authorization; Quantity Limit,Yes,No,,417,462,-9.6,Decreased,101.72,243.2,-141.48,67.08,168.8,70.39,0.439,10,0.063,0.317,0.781,0.593,11,6,9,9,4.4,22.6,7,Similar,Northeast,FL,Suburban,36-50,2024-03,Q1_2024,2023,4.8,0.392,Stable
FIA000196,2024-03-19,Levothyroxine,Synthroid,Thyroid Hormones,65666-842-73,Medicaid Plan X,PLAN_5472,2024,Non-Formulary,Tier 1,2023-11-24,116,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,312,446,-30.0,Decreased,238.83,19.63,219.2,69.59,308.42,96.23,0.0,0,0.151,0.175,0.667,0.923,15,8,8,4,4.3,8.2,4,Similar,Southwest,NY,Rural,36-50,2024-03,Q1_2024,2023,1.3,0.738,Increasing
FIA002991,2024-03-22,Levothyroxine,Synthroid,Thyroid Hormones,98546-746-59,VA Plan,PLAN_3089,2024,Specialty Tier,Non-Formulary,2023-05-31,296,Improved,Step Therapy,No,Yes,,758,705,7.6,Increased,238.69,574.59,-335.9,163.94,402.63,305.19,0.0,0,0.28,0.119,0.386,0.617,5,2,14,15,3.2,7.5,6,Higher,Southwest,CA,Suburban,66-75,2024-03,Q1_2024,2023,1.3,0.893,Increasing
FIA001492,2024-03-26,Levothyroxine,Synthroid,Thyroid Hormones,12710-202-10,Commercial Plan Alpha,PLAN_3301,2024,Tier 1,Non-Formulary,2024-02-21,34,Improved,Quantity Limit,No,No,30.0,670,446,50.4,Increased,10.67,201.94,-191.27,114.94,125.61,84.16,0.0,0,0.013,0.304,0.318,0.618,6,9,1,10,2.3,27.4,2,Lower,West,TX,Rural,66-75,2024-03,Q1_2024,2023,6.1,0.79,Decreasing
FIA000398,2024-04-11,Levothyroxine,Synthroid,Thyroid Hormones,96419-902-89,Medicaid Plan Y,PLAN_8591,2024,Specialty Tier,Specialty Tier,2023-07-25,261,No Change,None,No,No,,456,472,-3.2,Stable,188.78,177.69,11.09,126.63,315.41,143.83,0.0,0,0.228,0.242,0.735,0.625,9,3,12,4,3.4,21.3,5,Similar,West,OH,Urban,36-50,2024-04,Q2_2024,2023,3.0,0.552,Increasing
FIA001627,2024-04-21,Levothyroxine,Synthroid,Thyroid Hormones,44329-313-51,Commercial Plan Alpha,PLAN_6194,2024,Tier 2,Tier 1,2023-12-13,130,Worsened,None,No,No,,543,521,4.3,Stable,31.46,8.49,22.97,189.33,220.79,119.89,0.0,0,0.014,0.347,0.201,0.94,2,6,11,7,3.2,18.8,8,Similar,Southwest,MI,Suburban,66-75,2024-04,Q2_2024,2023,5.4,0.625,Increasing
FIA001610,2024-05-01,Levothyroxine,Synthroid,Thyroid Hormones,11771-956-99,Medicare Part D Plan B,PLAN_4468,2024,Specialty Tier,Specialty Tier,2023-05-12,355,No Change,Step Therapy,No,Yes,,353,360,-1.8,Stable,286.47,246.41,40.06,188.87,475.34,167.8,0.0,0,0.054,0.316,0.874,0.545,14,8,8,15,4.2,5.5,5,Lower,West,FL,Urban,36-50,2024-05,Q2_2024,2023,2.3,0.847,Decreasing
FIA001071,2024-05-02,Levothyroxine,Synthroid,Thyroid Hormones,77266-505-31,VA Plan,PLAN_9518,2024,Tier 1,Tier 1,2023-10-05,210,No Change,None,No,No,,745,713,4.6,Stable,6.5,19.35,-12.85,94.33,100.83,75.12,0.0,0,0.013,0.293,0.869,0.918,5,4,8,8,4.7,27.6,7,Higher,West,IL,Urban,75+,2024-05,Q2_2024,2023,9.6,0.622,Stable
FIA001151,2024-05-09,Levothyroxine,Synthroid,Thyroid Hormones,23163-507-44,Medicaid Plan Y,PLAN_1646,2024,Tier 3,Specialty Tier,2023-07-22,292,Improved,Prior Authorization; Quantity Limit,Yes,No,90.0,429,392,9.6,Increased,81.59,142.22,-60.63,79.42,161.01,69.07,0.385,3,0.063,0.356,0.695,0.71,10,3,4,4,4.5,5.7,3,Similar,West,GA,Suburban,51-65,2024-05,Q2_2024,2023,1.8,0.186,Increasing
FIA002653,2024-05-12,Levothyroxine,Synthroid,Thyroid Hormones,41402-559-14,Tricare Standard,PLAN_4446,2024,Non-Formulary,Tier 2,2023-06-27,320,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,73,152,-51.5,Decreased,309.62,34.51,275.11,173.01,482.63,35.23,0.0,0,0.112,0.246,0.75,0.916,15,5,17,9,5.0,24.5,6,Lower,Northeast,MI,Suburban,51-65,2024-05,Q2_2024,2023,6.3,0.22,Stable
FIA001482,2024-05-22,Levothyroxine,Synthroid,Thyroid Hormones,39133-199-59,Commercial Plan Alpha,PLAN_6562,2024,Tier 3,Tier 1,2024-02-28,84,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,318,481,-33.8,Decreased,93.96,5.72,88.24,177.1,271.06,86.2,0.295,8,0.018,0.179,0.217,0.418,6,6,13,11,3.4,14.4,6,Similar,Southeast,NC,Suburban,66-75,2024-05,Q2_2024,2023,9.7,0.817,Increasing
FIA000580,2024-06-02,Levothyroxine,Synthroid,Thyroid Hormones,95813-651-15,Medicare Part D Plan A,PLAN_5466,2024,Tier 1,Tier 3,2023-12-23,162,Improved,None,No,No,,1096,784,39.8,Increased,14.35,51.35,-37.0,48.18,62.53,68.53,0.0,0,0.024,0.251,0.796,0.523,5,1,20,2,2.5,9.6,8,Lower,Northeast,IL,Rural,51-65,2024-06,Q2_2024,2023,5.6,0.912,Increasing
FIA001850,2024-06-06,Levothyroxine,Synthroid,Thyroid Hormones,80424-304-60,Medicare Part D Plan B,PLAN_5701,2024,Tier 3,Tier 3,2024-01-18,140,No Change,Prior Authorization,Yes,No,,603,658,-8.3,Decreased,68.95,52.3,16.65,90.37,159.32,96.07,0.435,5,0.021,0.391,0.687,0.742,15,9,4,2,4.0,15.1,4,Higher,Northeast,TX,Urban,51-65,2024-06,Q2_2024,2023,9.1,0.408,Stable
FIA002132,2024-06-18,Levothyroxine,Synthroid,Thyroid Hormones,43934-422-53,Medicaid Plan X,PLAN_3658,2024,Tier 1,Tier 2,2023-12-04,197,Improved,None,No,No,,202,205,-1.4,Stable,7.45,24.58,-17.13,150.63,158.08,31.93,0.0,0,0.066,0.272,0.768,0.655,8,4,20,14,3.0,11.1,6,Higher,West,GA,Rural,75+,2024-06,Q2_2024,2023,7.2,0.133,Increasing
FIA001318,2024-06-21,Levothyroxine,Synthroid,Thyroid Hormones,60733-987-89,Tricare Standard,PLAN_6376,2024,Specialty Tier,Tier 1,2024-02-28,114,Worsened,Prior Authorization,Yes,No,,242,485,-50.0,Decreased,158.66,15.4,143.26,182.33,340.99,82.52,0.206,8,0.24,0.166,0.754,0.545,0,6,17,6,2.8,35.0,5,Lower,Midwest,NY,Urban,75+,2024-06,Q2_2024,2023,5.9,0.813,Stable
FIA002936,2024-07-02,Levothyroxine,Synthroid,Thyroid Hormones,21389-330-31,VA Plan,PLAN_8414,2024,Tier 1,Tier 1,2024-05-06,57,No Change,None,No,No,,424,463,-8.3,Decreased,7.27,19.81,-12.54,176.07,183.34,77.74,0.0,0,0.048,0.275,0.539,0.762,7,2,17,11,3.5,13.2,3,Similar,Northeast,IL,Suburban,18-35,2024-07,Q3_2024,2023,2.0,0.652,Decreasing
FIA000402,2024-07-08,Levothyroxine,Synthroid,Thyroid Hormones,85189-119-48,VA Plan,PLAN_4270,2024,Tier 3,Tier 1,2024-01-21,169,Worsened,Quantity Limit,No,No,90.0,267,569,-53.0,Decreased,87.5,16.4,71.1,31.82,119.32,31.86,0.0,0,0.075,0.183,0.225,0.77,12,5,11,13,3.2,15.3,4,Higher,Midwest,NC,Urban,66-75,2024-07,Q3_2024,2023,3.5,0.083,Stable
FIA002767,2024-07-08,Levothyroxine,Synthroid,Thyroid Hormones,37772-221-21,Commercial Plan Beta,PLAN_8448,2024,Tier 2,Tier 1,2023-12-19,202,Worsened,Quantity Limit,No,No,,767,711,7.9,Increased,35.12,19.62,15.5,57.27,92.39,70.86,0.0,0,0.016,0.245,0.37,0.703,7,0,16,12,4.2,19.3,2,Lower,Southwest,GA,Rural,66-75,2024-07,Q3_2024,2023,1.2,0.602,Increasing
FIA002456,2024-07-21,Levothyroxine,Synthroid,Thyroid Hormones,16526-122-21,Medicaid Plan X,PLAN_6182,2024,Specialty Tier,Tier 1,2023-10-31,264,Worsened,Step Therapy,No,Yes,,592,752,-21.2,Decreased,191.37,5.91,185.46,37.7,229.07,135.61,0.0,0,0.109,0.061,0.777,0.638,9,4,9,0,5.0,5.8,2,Lower,Southwest,FL,Urban,51-65,2024-07,Q3_2024,2023,5.1,0.303,Stable
FIA001097,2024-07-23,Levothyroxine,Synthroid,Thyroid Hormones,24139-151-27,VA Plan,PLAN_4347,2024,Tier 3,Tier 3,2023-12-28,208,No Change,Prior Authorization; Step Therapy,Yes,Yes,,149,159,-5.8,Decreased,64.94,80.87,-15.93,152.73,217.67,32.43,0.201,10,0.064,0.16,0.344,0.852,4,3,7,6,4.0,31.4,3,Similar,Northeast,PA,Rural,75+,2024-07,Q3_2024,2023,3.8,0.747,Increasing
FIA001349,2024-07-23,Levothyroxine,Synthroid,Thyroid Hormones,43570-471-26,Medicaid Plan X,PLAN_9865,2024,Tier 1,Specialty Tier,2023-09-23,304,Improved,None,No,No,,921,721,27.9,Increased,16.6,139.3,-122.7,162.83,179.43,165.26,0.0,0,0.074,0.238,0.471,0.409,6,5,7,9,2.3,17.7,8,Similar,Midwest,OH,Urban,51-65,2024-07,Q3_2024,2023,1.9,0.645,Decreasing
FIA002635,2024-07-31,Levothyroxine,Synthroid,Thyroid Hormones,90067-742-88,Medicaid Plan X,PLAN_3244,2024,Tier 2,Specialty Tier,2023-08-14,352,Improved,Quantity Limit,No,No,60.0,992,666,49.1,Increased,35.08,134.57,-99.49,34.95,70.03,69.47,0.0,0,0.063,0.305,0.883,0.568,5,9,18,2,2.8,34.0,2,Lower,Midwest,CA,Suburban,36-50,2024-07,Q3_2024,2023,8.7,0.719,Stable
FIA001874,2024-08-17,Levothyroxine,Synthroid,Thyroid Hormones,10993-280-80,Tricare Standard,PLAN_4517,2024,Non-Formulary,Specialty Tier,2023-11-17,274,Worsened,Non-Formulary Status,No,No,,519,482,7.8,Increased,629.16,126.2,502.96,187.31,816.47,423.75,0.0,0,0.275,0.384,0.757,0.862,6,8,0,11,3.4,34.3,2,Similar,Southwest,FL,Rural,66-75,2024-08,Q3_2024,2023,7.0,0.386,Decreasing
FIA001226,2024-08-27,Levothyroxine,Synthroid,Thyroid Hormones,99892-560-30,Tricare Standard,PLAN_8702,2024,Specialty Tier,Tier 2,2024-03-27,153,Worsened,Prior Authorization; Quantity Limit,Yes,No,30.0,229,288,-20.2,Decreased,265.62,40.7,224.92,162.66,428.28,98.08,0.549,9,0.288,0.269,0.687,0.479,12,9,10,15,2.2,26.5,6,Similar,Southeast,OH,Suburban,18-35,2024-08,Q3_2024,2023,3.1,0.925,Decreasing
FIA002545,2024-08-28,Levothyroxine,Synthroid,Thyroid Hormones,27653-946-91,Tricare Standard,PLAN_1129,2024,Tier 3,Tier 2,2023-10-10,323,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,140,270,-48.0,Decreased,53.28,34.17,19.11,149.78,203.06,28.43,0.39,5,0.047,0.235,0.618,0.734,15,8,15,4,4.8,28.5,5,Lower,West,OH,Rural,66-75,2024-08,Q3_2024,2023,7.7,0.073,Stable
FIA000233,2024-09-09,Levothyroxine,Synthroid,Thyroid Hormones,53724-632-40,Medicare Part D Plan B,PLAN_8184,2024,Tier 1,Non-Formulary,2023-09-25,350,Improved,None,No,No,,423,353,19.9,Increased,19.03,704.3,-685.27,39.25,58.28,24.65,0.0,0,0.034,0.317,0.638,0.718,2,0,1,12,2.9,30.4,2,Lower,Northeast,GA,Urban,51-65,2024-09,Q3_2024,2023,6.5,0.432,Increasing
FIA001817,2024-09-15,Levothyroxine,Synthroid,Thyroid Hormones,39160-361-32,Commercial Plan Alpha,PLAN_1400,2024,Tier 2,Non-Formulary,2024-03-31,168,Improved,None,No,No,,1034,863,19.9,Increased,25.12,258.95,-233.83,130.66,155.78,161.08,0.0,0,0.023,0.231,0.296,0.931,2,10,19,11,3.4,26.8,5,Lower,Midwest,TX,Rural,36-50,2024-09,Q3_2024,2023,9.6,0.149,Increasing
FIA002769,2024-09-16,Levothyroxine,Synthroid,Thyroid Hormones,32336-389-68,Commercial Plan Alpha,PLAN_8448,2024,Tier 3,Tier 1,2024-04-29,140,Worsened,None,No,No,,240,320,-24.7,Decreased,80.47,5.77,74.7,68.27,148.74,35.7,0.0,0,0.062,0.292,0.755,0.752,9,6,7,9,3.6,7.6,4,Higher,West,OH,Rural,36-50,2024-09,Q3_2024,2023,3.8,0.146,Decreasing
FIA001972,2024-09-23,Levothyroxine,Synthroid,Thyroid Hormones,30609-533-46,Tricare Standard,PLAN_3445,2024,Tier 1,Tier 2,2024-03-14,193,Improved,None,No,No,,675,707,-4.4,Stable,10.66,48.98,-38.32,175.83,186.49,125.88,0.0,0,0.044,0.226,0.373,0.535,9,3,5,12,2.1,31.6,7,Higher,Southeast,FL,Urban,36-50,2024-09,Q3_2024,2023,6.9,0.33,Increasing
FIA002805,2024-09-27,Levothyroxine,Synthroid,Thyroid Hormones,11781-544-89,Medicare Part D Plan A,PLAN_5057,2024,Non-Formulary,Tier 1,2023-10-06,357,Worsened,Non-Formulary Status,No,No,,521,672,-22.4,Decreased,449.22,5.52,443.7,151.78,601.0,313.12,0.0,0,0.123,0.161,0.862,0.608,2,6,14,5,2.2,5.2,6,Lower,Southeast,FL,Urban,75+,2024-09,Q3_2024,2023,6.5,0.019,Decreasing
FIA000636,2024-09-30,Levothyroxine,Synthroid,Thyroid Hormones,45154-957-80,VA Plan,PLAN_4812,2024,Non-Formulary,Tier 1,2023-12-24,281,Worsened,Non-Formulary Status,No,No,,586,898,-34.7,Decreased,263.96,7.47,256.49,49.38,313.34,183.62,0.0,0,0.186,0.061,0.323,0.457,13,9,0,6,3.8,29.2,3,Lower,Southeast,OH,Rural,75+,2024-09,Q3_2024,2023,1.1,0.997,Stable
FIA002613,2024-10-12,Levothyroxine,Synthroid,Thyroid Hormones,94144-373-97,Tricare Standard,PLAN_6433,2024,Tier 2,Tier 2,2024-08-21,52,No Change,None,No,No,,971,897,8.3,Increased,25.25,29.96,-4.71,69.83,95.08,92.32,0.0,0,0.053,0.239,0.778,0.656,0,2,20,15,4.0,21.3,8,Lower,Southwest,FL,Rural,18-35,2024-10,Q4_2024,2024,6.4,0.141,Stable
FIA000883,2024-10-14,Levothyroxine,Synthroid,Thyroid Hormones,51856-618-97,VA Plan,PLAN_3974,2024,Tier 2,Tier 3,2024-06-05,131,Improved,Quantity Limit,No,No,90.0,248,209,18.9,Increased,37.87,52.34,-14.47,168.9,206.77,51.28,0.0,0,0.064,0.206,0.58,0.696,12,0,7,2,4.9,13.3,6,Lower,Southeast,CA,Suburban,51-65,2024-10,Q4_2024,2024,8.2,0.534,Decreasing
FIA002926,2024-10-22,Levothyroxine,Synthroid,Thyroid Hormones,17660-352-78,Tricare Standard,PLAN_5946,2024,Specialty Tier,Tier 2,2024-08-11,72,Worsened,Prior Authorization,Yes,No,,313,740,-57.7,Decreased,186.28,28.59,157.69,166.91,353.19,110.55,0.216,9,0.08,0.208,0.473,0.564,12,10,19,0,4.5,30.8,2,Lower,Midwest,NY,Urban,18-35,2024-10,Q4_2024,2024,9.6,0.283,Decreasing
FIA000995,2024-11-10,Levothyroxine,Synthroid,Thyroid Hormones,96166-122-53,VA Plan,PLAN_7128,2024,Specialty Tier,Tier 3,2024-02-21,263,Worsened,None,No,No,,218,240,-9.0,Decreased,243.07,93.27,149.8,144.01,387.08,84.38,0.0,0,0.182,0.27,0.365,0.574,10,0,17,2,3.9,34.7,3,Lower,West,NC,Suburban,66-75,2024-11,Q4_2024,2024,4.7,0.995,Increasing
FIA002205,2024-11-14,Levothyroxine,Synthroid,Thyroid Hormones,74452-289-13,Commercial Plan Alpha,PLAN_1841,2024,Specialty Tier,Non-Formulary,2023-11-18,362,Improved,Step Therapy; Quantity Limit,No,Yes,30.0,315,320,-1.3,Stable,256.52,569.52,-313.0,85.98,342.5,107.89,0.0,0,0.197,0.363,0.314,0.434,3,1,8,13,3.6,7.7,6,Higher,Southeast,NY,Urban,36-50,2024-11,Q4_2024,2024,5.7,0.199,Decreasing
FIA001426,2024-11-22,Levothyroxine,Synthroid,Thyroid Hormones,47435-828-58,Commercial Plan Beta,PLAN_8306,2024,Tier 1,Tier 2,2024-04-01,235,Improved,None,No,No,,926,990,-6.4,Decreased,9.52,26.31,-16.79,152.62,162.14,150.14,0.0,0,0.046,0.074,0.397,0.756,15,5,0,0,3.1,25.8,7,Lower,Northeast,GA,Rural,51-65,2024-11,Q4_2024,2024,6.7,0.279,Increasing
FIA000828,2024-11-23,Levothyroxine,Synthroid,Thyroid Hormones,48977-770-52,VA Plan,PLAN_5205,2024,Non-Formulary,Tier 1,2024-05-24,183,Worsened,Non-Formulary Status,No,No,,473,688,-31.1,Decreased,261.79,10.85,250.94,57.51,319.3,151.03,0.0,0,0.257,0.265,0.527,0.46,2,6,1,10,4.2,25.5,3,Higher,Northeast,OH,Suburban,75+,2024-11,Q4_2024,2024,1.3,0.565,Decreasing
FIA000926,2024-11-25,Levothyroxine,Synthroid,Thyroid Hormones,62381-138-25,Medicaid Plan X,PLAN_6871,2024,Specialty Tier,Tier 3,2024-09-06,80,Worsened,None,No,No,,175,190,-7.4,Decreased,178.58,74.55,104.03,105.19,283.77,49.66,0.0,0,0.092,0.23,0.203,0.457,8,4,2,11,3.3,21.3,7,Similar,Southeast,OH,Urban,18-35,2024-11,Q4_2024,2024,4.7,0.381,Increasing
FIA001886,2024-11-29,Levothyroxine,Synthroid,Thyroid Hormones,69232-597-94,VA Plan,PLAN_9196,2024,Tier 2,Non-Formulary,2024-06-25,157,Improved,None,No,No,,1171,835,40.2,Increased,46.49,421.55,-375.06,198.47,244.96,286.85,0.0,0,0.048,0.063,0.485,0.672,1,2,8,9,3.3,13.2,3,Higher,Midwest,MI,Rural,66-75,2024-11,Q4_2024,2024,3.4,0.273,Decreasing
FIA001487,2024-12-10,Levothyroxine,Synthroid,Thyroid Hormones,39413-537-43,Medicaid Plan Y,PLAN_5307,2024,Non-Formulary,Tier 1,2024-02-13,301,Worsened,Non-Formulary Status,No,No,,281,639,-55.9,Decreased,682.76,8.61,674.15,115.45,798.21,224.3,0.0,0,0.138,0.272,0.514,0.821,14,9,18,15,2.8,15.5,4,Lower,West,CA,Rural,51-65,2024-12,Q4_2024,2024,2.9,0.53,Stable
FIA002329,2024-12-12,Levothyroxine,Synthroid,Thyroid Hormones,57604-827-60,VA Plan,PLAN_9988,2024,Tier 1,Specialty Tier,2024-09-28,75,Improved,None,No,No,,537,420,28.1,Increased,11.82,246.87,-235.05,138.33,150.15,80.63,0.0,0,0.011,0.059,0.745,0.673,1,0,2,6,3.7,25.8,4,Higher,Southwest,NC,Suburban,18-35,2024-12,Q4_2024,2024,6.2,0.856,Increasing
FIA000705,2025-01-02,Levothyroxine,Synthroid,Thyroid Hormones,34532-219-81,Commercial Plan Beta,PLAN_7809,2025,Tier 3,Tier 2,2024-08-22,133,Worsened,Prior Authorization; Quantity Limit,Yes,No,90.0,149,255,-41.2,Decreased,88.53,20.86,67.67,129.47,218.0,32.48,0.115,8,0.061,0.211,0.62,0.608,13,6,13,2,2.0,34.9,7,Similar,Southeast,PA,Urban,18-35,2025-01,Q1_2025,2024,2.2,0.849,Increasing
FIA001795,2025-01-17,Levothyroxine,Synthroid,Thyroid Hormones,88942-687-43,Tricare Standard,PLAN_4181,2025,Tier 1,Tier 1,2024-10-08,101,No Change,Quantity Limit,No,No,60.0,858,826,4.0,Stable,6.51,17.87,-11.36,171.16,177.67,152.44,0.0,0,0.075,0.235,0.25,0.546,0,10,17,4,2.8,18.3,2,Higher,Southwest,MI,Rural,51-65,2025-01,Q1_2025,2024,9.3,0.311,Stable
FIA001744,2025-01-23,Levothyroxine,Synthroid,Thyroid Hormones,53793-977-79,Medicare Part D Plan B,PLAN_9733,2025,Tier 1,Tier 2,2024-10-04,111,Improved,None,No,No,,781,756,3.4,Stable,8.83,20.69,-11.86,113.98,122.81,95.91,0.0,0,0.05,0.13,0.227,0.425,4,8,15,8,2.0,25.1,6,Similar,Midwest,GA,Rural,75+,2025-01,Q1_2025,2024,7.5,0.87,Increasing
FIA001371,2025-01-26,Levothyroxine,Synthroid,Thyroid Hormones,47691-437-48,Commercial Plan Alpha,PLAN_3386,2025,Tier 1,Tier 2,2024-10-15,103,Improved,None,No,No,,851,795,7.1,Increased,8.24,36.61,-28.37,52.37,60.61,51.58,0.0,0,0.06,0.141,0.616,0.494,7,0,4,7,4.1,28.2,2,Lower,Northeast,TX,Urban,36-50,2025-01,Q1_2025,2024,5.0,0.938,Increasing
FIA000261,2025-01-27,Levothyroxine,Synthroid,Thyroid Hormones,73234-398-28,Commercial Plan Beta,PLAN_4573,2025,Tier 1,Tier 2,2024-07-16,195,Improved,None,No,No,,841,924,-8.9,Decreased,16.28,37.41,-21.13,53.39,69.67,58.59,0.0,0,0.021,0.332,0.337,0.758,11,9,3,4,3.1,34.5,7,Lower,Northeast,TX,Suburban,66-75,2025-01,Q1_2025,2024,2.6,0.052,Decreasing
FIA001930,2025-02-03,Levothyroxine,Synthroid,Thyroid Hormones,56916-381-71,Medicaid Plan X,PLAN_5349,2025,Specialty Tier,Specialty Tier,2024-05-14,265,No Change,Prior Authorization,Yes,No,,812,897,-9.4,Decreased,280.3,185.3,95.0,103.01,383.31,311.25,0.183,2,0.13,0.241,0.444,0.729,13,8,6,5,3.4,17.6,3,Higher,West,CA,Rural,36-50,2025-02,Q1_2025,2024,9.2,0.485,Increasing
FIA000809,2025-02-12,Levothyroxine,Synthroid,Thyroid Hormones,38091-621-12,Commercial Plan Beta,PLAN_6394,2025,Tier 1,Tier 3,2024-05-12,276,Improved,Quantity Limit,No,No,,1176,871,35.1,Increased,17.46,63.85,-46.39,134.62,152.08,178.85,0.0,0,0.063,0.316,0.711,0.871,10,3,17,5,4.9,22.1,4,Lower,West,TX,Suburban,66-75,2025-02,Q1_2025,2024,8.3,0.731,Stable
FIA001559,2025-02-22,Levothyroxine,Synthroid,Thyroid Hormones,99389-571-44,VA Plan,PLAN_2928,2025,Specialty Tier,Non-Formulary,2024-07-07,230,Improved,Prior Authorization; Step Therapy,Yes,Yes,,332,322,3.4,Stable,213.9,564.02,-350.12,125.53,339.43,112.69,0.547,3,0.192,0.132,0.662,0.729,0,0,4,9,2.3,15.1,5,Similar,West,OH,Urban,66-75,2025-02,Q1_2025,2024,2.9,0.204,Increasing
FIA001935,2025-02-28,Levothyroxine,Synthroid,Thyroid Hormones,30687-392-64,Medicaid Plan Y,PLAN_3493,2025,Tier 1,Tier 2,2025-01-23,36,Improved,None,No,No,,851,791,7.7,Increased,16.84,29.39,-12.55,38.1,54.94,46.75,0.0,0,0.018,0.367,0.246,0.765,4,2,11,12,2.5,13.7,5,Similar,Southeast,MI,Urban,18-35,2025-02,Q1_2025,2024,4.8,0.923,Stable
FIA002087,2025-03-11,Levothyroxine,Synthroid,Thyroid Hormones,73166-968-92,Medicaid Plan X,PLAN_1934,2025,Specialty Tier,Tier 2,2024-06-26,258,Worsened,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,60.0,157,222,-29.1,Decreased,209.92,49.05,160.87,161.53,371.45,58.32,0.592,10,0.173,0.172,0.765,0.618,5,5,2,3,2.3,24.8,5,Similar,Southeast,MI,Urban,66-75,2025-03,Q1_2025,2024,7.0,0.124,Increasing
FIA002022,2025-03-13,Levothyroxine,Synthroid,Thyroid Hormones,65869-151-16,Commercial Plan Alpha,PLAN_3260,2025,Tier 3,Tier 2,2024-09-23,171,Worsened,None,No,No,,162,389,-58.3,Decreased,85.79,21.85,63.94,42.68,128.47,20.81,0.0,0,0.051,0.103,0.677,0.935,13,7,19,5,3.3,9.0,3,Similar,Northeast,GA,Rural,18-35,2025-03,Q1_2025,2024,8.6,0.523,Decreasing
FIA000148,2025-03-14,Levothyroxine,Synthroid,Thyroid Hormones,22499-709-92,Medicaid Plan X,PLAN_1612,2025,Non-Formulary,Tier 2,2025-01-04,69,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,153,277,-44.4,Decreased,634.15,43.79,590.36,169.32,803.47,122.93,0.0,0,0.226,0.077,0.239,0.824,11,6,13,3,4.6,11.8,7,Higher,Northeast,OH,Urban,51-65,2025-03,Q1_2025,2024,5.7,0.319,Decreasing
FIA001418,2025-03-17,Levothyroxine,Synthroid,Thyroid Hormones,83922-655-67,Medicare Part D Plan A,PLAN_2026,2025,Tier 2,Tier 3,2024-08-15,214,Improved,None,No,No,,319,203,57.2,Increased,32.94,63.58,-30.64,147.7,180.64,57.62,0.0,0,0.06,0.369,0.241,0.505,4,1,10,4,3.8,8.2,8,Similar,Northeast,TX,Urban,51-65,2025-03,Q1_2025,2024,5.6,0.234,Stable
FIA000077,2025-03-23,Levothyroxine,Synthroid,Thyroid Hormones,91187-154-55,Medicare Part D Plan A,PLAN_8939,2025,Specialty Tier,Tier 2,2024-06-17,279,Worsened,None,No,No,,254,760,-66.5,Decreased,227.1,40.8,186.3,173.14,400.24,101.66,0.0,0,0.097,0.098,0.771,0.93,15,6,15,13,4.1,18.3,3,Lower,West,CA,Urban,51-65,2025-03,Q1_2025,2024,1.3,0.225,Stable
FIA000840,2025-03-28,Levothyroxine,Synthroid,Thyroid Hormones,50923-446-97,Medicare Part D Plan B,PLAN_3458,2025,Tier 3,Tier 3,2024-12-30,88,No Change,None,No,No,,822,878,-6.3,Decreased,71.36,61.72,9.64,119.6,190.96,156.97,0.0,0,0.013,0.379,0.303,0.488,0,1,15,11,2.9,33.4,2,Similar,Midwest,NC,Suburban,75+,2025-03,Q1_2025,2024,2.2,0.865,Increasing
FIA002585,2025-03-31,Levothyroxine,Synthroid,Thyroid Hormones,93108-717-39,Medicare Part D Plan A,PLAN_8240,2025,Non-Formulary,Tier 2,2024-08-03,240,Worsened,Non-Formulary Status,No,No,,217,638,-65.9,Decreased,250.81,39.83,210.98,186.08,436.89,94.81,0.0,0,0.22,0.284,0.232,0.643,14,0,18,14,2.9,29.1,2,Similar,Northeast,GA,Suburban,51-65,2025-03,Q1_2025,2024,1.3,0.673,Decreasing
FIA002232,2025-04-12,Levothyroxine,Synthroid,Thyroid Hormones,68041-737-48,Commercial Plan Beta,PLAN_2698,2025,Specialty Tier,Specialty Tier,2024-07-03,283,No Change,None,No,No,,255,281,-9.0,Decreased,186.6,124.27,62.33,142.79,329.39,83.99,0.0,0,0.258,0.288,0.618,0.868,12,7,2,2,3.2,29.3,3,Similar,Southeast,FL,Rural,36-50,2025-04,Q2_2025,2024,9.8,0.559,Increasing
FIA001879,2025-04-13,Levothyroxine,Synthroid,Thyroid Hormones,44028-573-20,Commercial Plan Beta,PLAN_4584,2025,Non-Formulary,Tier 2,2024-07-15,272,Worsened,Non-Formulary Status,No,No,,69,169,-58.6,Decreased,284.19,20.81,263.38,83.54,367.73,25.37,0.0,0,0.213,0.097,0.428,0.45,13,3,8,2,2.7,30.3,4,Higher,Southeast,OH,Urban,51-65,2025-04,Q2_2025,2024,6.8,0.391,Increasing
FIA000973,2025-05-02,Levothyroxine,Synthroid,Thyroid Hormones,68111-358-50,Medicare Part D Plan A,PLAN_3125,2025,Tier 3,Tier 3,2024-07-11,295,No Change,Prior Authorization; Step Therapy,Yes,Yes,,505,494,2.4,Stable,72.22,87.07,-14.85,70.56,142.78,72.1,0.521,5,0.067,0.058,0.455,0.643,5,9,20,0,3.7,13.2,8,Higher,West,MI,Suburban,51-65,2025-05,Q2_2025,2024,8.9,0.642,Stable
FIA001400,2025-05-04,Levothyroxine,Synthroid,Thyroid Hormones,65918-948-26,Tricare Standard,PLAN_9524,2025,Tier 3,Tier 1,2025-03-05,60,Worsened,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,30.0,164,258,-36.4,Decreased,53.07,15.93,37.14,141.31,194.38,31.88,0.438,9,0.075,0.216,0.535,0.581,0,2,7,9,4.8,19.1,2,Similar,Midwest,TX,Urban,66-75,2025-05,Q2_2025,2024,3.5,0.878,Increasing
FIA002839,2025-05-10,Levothyroxine,Synthroid,Thyroid Hormones,65333-974-55,VA Plan,PLAN_2305,2025,Tier 2,Non-Formulary,2025-01-21,109,Improved,None,No,No,,973,672,44.8,Increased,46.16,204.77,-158.61,70.96,117.12,113.96,0.0,0,0.061,0.079,0.651,0.649,8,0,15,8,3.8,25.5,8,Lower,Midwest,IL,Urban,75+,2025-05,Q2_2025,2024,1.3,0.124,Decreasing
FIA000130,2025-05-14,Levothyroxine,Synthroid,Thyroid Hormones,88311-158-32,Tricare Standard,PLAN_8192,2025,Tier 1,Tier 1,2024-12-01,164,No Change,None,No,No,,144,138,4.5,Stable,8.33,6.2,2.13,150.97,159.3,22.94,0.0,0,0.046,0.054,0.795,0.912,9,3,1,7,3.8,25.2,4,Lower,Northeast,FL,Urban,51-65,2025-05,Q2_2025,2024,8.0,0.353,Stable
FIA000405,2025-05-16,Levothyroxine,Synthroid,Thyroid Hormones,31137-166-17,Medicare Part D Plan B,PLAN_9092,2025,Non-Formulary,Tier 3,2024-12-26,141,Worsened,Non-Formulary Status,No,No,,808,853,-5.2,Decreased,455.91,91.22,364.69,72.78,528.69,427.18,0.0,0,0.292,0.17,0.713,0.741,13,1,14,0,4.9,25.2,4,Higher,Midwest,MI,Rural,18-35,2025-05,Q2_2025,2024,6.1,0.727,Stable
FIA002757,2025-06-04,Levothyroxine,Synthroid,Thyroid Hormones,66267-203-96,Medicaid Plan X,PLAN_1576,2025,Tier 1,Tier 1,2025-04-08,57,No Change,None,No,No,,912,889,2.6,Stable,12.2,10.93,1.27,136.87,149.07,135.95,0.0,0,0.03,0.19,0.393,0.828,10,4,13,1,4.5,20.4,2,Higher,Midwest,OH,Suburban,18-35,2025-06,Q2_2025,2024,2.8,0.13,Increasing
FIA001496,2025-06-07,Levothyroxine,Synthroid,Thyroid Hormones,89781-969-65,Medicaid Plan X,PLAN_2148,2025,Tier 2,Tier 1,2024-07-16,326,Worsened,None,No,No,,976,987,-1.0,Stable,47.44,11.26,36.18,137.57,185.01,180.57,0.0,0,0.036,0.367,0.646,0.541,15,1,13,9,4.5,22.9,8,Similar,Midwest,NC,Suburban,51-65,2025-06,Q2_2025,2024,9.2,0.344,Stable
FIA000032,2025-06-14,Levothyroxine,Synthroid,Thyroid Hormones,62184-382-34,Medicare Part D Plan B,PLAN_8450,2025,Tier 3,Tier 1,2024-11-07,219,Worsened,None,No,No,,126,341,-62.8,Decreased,60.86,11.67,49.19,90.97,151.83,19.13,0.0,0,0.078,0.082,0.348,0.752,0,0,10,7,5.0,28.6,3,Lower,West,NY,Rural,36-50,2025-06,Q2_2025,2024,8.3,0.233,Increasing
FIA000408,2025-06-20,Levothyroxine,Synthroid,Thyroid Hormones,72065-164-12,Tricare Standard,PLAN_7062,2025,Non-Formulary,Tier 1,2024-07-19,336,Worsened,Non-Formulary Status,No,No,,516,842,-38.7,Decreased,277.66,9.23,268.43,126.11,403.77,208.35,0.0,0,0.082,0.196,0.347,0.579,7,5,20,15,4.4,21.6,6,Similar,Southeast,FL,Suburban,75+,2025-06,Q2_2025,2024,9.7,0.229,Decreasing
FIA002778,2025-06-20,Levothyroxine,Synthroid,Thyroid Hormones,88607-545-62,Medicare Part D Plan A,PLAN_1039,2025,Tier 2,Tier 1,2024-10-07,256,Worsened,None,No,No,,464,489,-4.9,Stable,40.24,18.18,22.06,72.91,113.15,52.5,0.0,0,0.069,0.385,0.788,0.615,0,10,0,0,4.9,28.5,3,Lower,Northeast,NY,Suburban,75+,2025-06,Q2_2025,2024,1.1,0.358,Stable
FIA001450,2025-06-23,Levothyroxine,Synthroid,Thyroid Hormones,57444-624-60,Commercial Plan Alpha,PLAN_3322,2025,Specialty Tier,Non-Formulary,2025-02-03,140,Improved,Prior Authorization,Yes,No,,333,307,8.7,Increased,278.81,715.78,-436.97,72.03,350.84,116.83,0.541,6,0.167,0.299,0.688,0.548,15,6,6,13,3.2,20.1,2,Lower,Southwest,TX,Suburban,51-65,2025-06,Q2_2025,2024,8.8,0.965,Stable
FIA001604,2025-06-25,Levothyroxine,Synthroid,Thyroid Hormones,57931-613-74,Commercial Plan Beta,PLAN_3759,2025,Tier 3,Tier 3,2024-07-22,338,No Change,None,No,No,,233,252,-7.2,Decreased,97.99,70.98,27.01,90.47,188.46,43.91,0.0,0,0.016,0.291,0.215,0.699,8,1,4,10,3.4,24.9,5,Lower,Southwest,GA,Rural,36-50,2025-06,Q2_2025,2024,8.6,0.3,Decreasing
FIA002363,2025-07-14,Levothyroxine,Synthroid,Thyroid Hormones,36504-469-67,VA Plan,PLAN_2722,2025,Tier 1,Non-Formulary,2024-11-01,255,Improved,None,No,No,,427,320,33.6,Increased,5.79,789.5,-783.71,40.78,46.57,19.89,0.0,0,0.023,0.134,0.417,0.645,10,9,17,11,3.1,13.1,8,Lower,Southeast,FL,Rural,75+,2025-07,Q3_2025,2024,5.8,0.208,Stable
FIA000582,2025-07-30,Levothyroxine,Synthroid,Thyroid Hormones,28983-283-19,Commercial Plan Beta,PLAN_3998,2025,Tier 3,Specialty Tier,2025-01-22,189,Improved,None,No,No,,569,545,4.5,Stable,88.75,123.75,-35.0,104.14,192.89,109.75,0.0,0,0.06,0.056,0.683,0.425,5,9,8,6,4.4,8.4,7,Similar,West,MI,Rural,18-35,2025-07,Q3_2025,2024,1.8,0.863,Stable
FIA002260,2025-08-04,Levothyroxine,Synthroid,Thyroid Hormones,22160-191-98,VA Plan,PLAN_1870,2025,Tier 3,Tier 2,2025-06-08,57,Worsened,None,No,No,,198,635,-68.7,Decreased,72.7,28.79,43.91,170.97,243.67,48.25,0.0,0,0.026,0.29,0.506,0.87,7,2,20,11,3.1,28.2,8,Similar,West,GA,Suburban,75+,2025-08,Q3_2025,2024,9.4,0.746,Increasing
FIA000123,2025-08-05,Levothyroxine,Synthroid,Thyroid Hormones,28350-651-35,Medicaid Plan X,PLAN_2252,2025,Tier 3,Tier 3,2025-04-29,98,No Change,Prior Authorization,Yes,No,,586,591,-0.7,Stable,83.98,66.58,17.4,77.7,161.68,94.74,0.423,2,0.016,0.362,0.795,0.747,12,9,6,1,3.7,21.3,6,Similar,Southeast,IL,Suburban,36-50,2025-08,Q3_2025,2024,9.0,0.59,Stable
FIA002229,2025-08-08,Levothyroxine,Synthroid,Thyroid Hormones,36709-531-17,VA Plan,PLAN_4708,2025,Specialty Tier,Non-Formulary,2024-12-29,222,Improved,Prior Authorization,Yes,No,,943,866,8.9,Increased,203.03,302.39,-99.36,47.54,250.57,236.29,0.541,8,0.235,0.054,0.689,0.909,10,5,9,11,3.2,15.1,4,Similar,Northeast,PA,Urban,36-50,2025-08,Q3_2025,2024,7.3,0.538,Increasing
FIA000285,2025-08-17,Levothyroxine,Synthroid,Thyroid Hormones,18561-316-86,Medicare Part D Plan A,PLAN_6064,2025,Tier 2,Tier 3,2025-05-24,85,Improved,None,No,No,,1373,897,53.1,Increased,23.13,68.14,-45.01,122.07,145.2,199.36,0.0,0,0.03,0.116,0.341,0.911,7,4,2,1,3.7,28.7,2,Lower,Midwest,TX,Suburban,18-35,2025-08,Q3_2025,2024,9.8,0.752,Stable
FIA002125,2025-08-18,Levothyroxine,Synthroid,Thyroid Hormones,82091-357-95,Tricare Standard,PLAN_7268,2025,Specialty Tier,Non-Formulary,2024-09-16,336,Improved,None,No,No,,458,452,1.4,Stable,264.49,419.4,-154.91,173.75,438.24,200.71,0.0,0,0.284,0.176,0.308,0.416,11,6,5,5,4.1,27.8,2,Higher,Northeast,NY,Rural,75+,2025-08,Q3_2025,2024,5.8,0.07,Decreasing
FIA001626,2025-08-19,Levothyroxine,Synthroid,Thyroid Hormones,73238-823-42,Medicare Part D Plan B,PLAN_5568,2025,Tier 1,Tier 3,2025-07-03,47,Improved,None,No,No,,325,211,54.1,Increased,7.86,65.62,-57.76,80.21,88.07,28.62,0.0,0,0.043,0.193,0.861,0.6,10,1,5,7,4.6,33.0,4,Similar,West,TX,Suburban,51-65,2025-08,Q3_2025,2024,7.7,0.087,Decreasing
FIA002033,2025-08-23,Levothyroxine,Synthroid,Thyroid Hormones,46167-623-28,VA Plan,PLAN_3890,2025,Tier 3,Tier 1,2024-12-16,250,Worsened,Prior Authorization,Yes,No,,564,822,-31.4,Decreased,97.47,9.45,88.02,92.86,190.33,107.35,0.462,8,0.05,0.099,0.484,0.94,7,9,7,1,2.2,29.2,3,Higher,Southeast,PA,Urban,18-35,2025-08,Q3_2025,2024,5.3,0.118,Stable
FIA000253,2025-08-26,Levothyroxine,Synthroid,Thyroid Hormones,43330-353-87,Commercial Plan Alpha,PLAN_1202,2025,Specialty Tier,Tier 2,2025-03-25,154,Worsened,Prior Authorization,Yes,No,,227,470,-51.5,Decreased,195.55,47.64,147.91,145.78,341.33,77.48,0.231,2,0.164,0.32,0.651,0.904,12,9,2,6,4.6,10.0,5,Similar,Midwest,NC,Rural,66-75,2025-08,Q3_2025,2024,6.3,0.734,Decreasing
FIA002079,2022-01-06,Lisinopril,Prinivil,ACE Inhibitors,28087-637-74,Tricare Standard,PLAN_1969,2022,Tier 2,Tier 2,2021-10-05,93,No Change,None,No,No,,853,862,-0.9,Stable,43.17,27.05,16.12,168.51,211.68,180.56,0.0,0,0.021,0.287,0.897,0.805,0,0,20,11,2.4,17.7,8,Lower,Northeast,NC,Suburban,18-35,2022-01,Q1_2022,2021,8.9,0.809,Stable
FIA002954,2022-01-10,Lisinopril,Prinivil,ACE Inhibitors,32196-879-48,Tricare Standard,PLAN_2969,2022,Specialty Tier,Non-Formulary,2021-03-29,287,Improved,Step Therapy; Quantity Limit,No,Yes,,776,823,-5.7,Decreased,276.15,753.17,-477.02,98.77,374.92,290.94,0.0,0,0.117,0.1,0.437,0.655,10,9,10,15,4.4,14.3,8,Similar,West,NY,Suburban,66-75,2022-01,Q1_2022,2021,6.8,0.19,Increasing
FIA000747,2022-01-14,Lisinopril,Prinivil,ACE Inhibitors,43429-424-18,Medicaid Plan Y,PLAN_2003,2022,Non-Formulary,Tier 3,2021-09-02,134,Worsened,Non-Formulary Status,No,No,,281,283,-0.4,Stable,294.55,91.29,203.26,140.05,434.6,122.12,0.0,0,0.19,0.108,0.288,0.685,9,6,3,7,2.0,21.3,8,Lower,Northeast,NC,Rural,66-75,2022-01,Q1_2022,2021,2.1,0.722,Increasing
FIA001995,2022-02-08,Lisinopril,Prinivil,ACE Inhibitors,50669-806-81,VA Plan,PLAN_1470,2022,Tier 1,Non-Formulary,2021-05-24,260,Improved,None,No,No,,1275,872,46.2,Increased,14.31,750.95,-736.64,31.19,45.5,58.01,0.0,0,0.055,0.079,0.439,0.438,9,6,13,4,3.0,34.9,4,Lower,Southeast,IL,Urban,66-75,2022-02,Q1_2022,2021,8.1,0.865,Decreasing
FIA002484,2022-02-09,Lisinopril,Prinivil,ACE Inhibitors,28236-999-57,Commercial Plan Alpha,PLAN_5035,2022,Specialty Tier,Tier 2,2021-11-23,78,Worsened,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,60.0,223,529,-57.7,Decreased,147.82,24.14,123.68,135.16,282.98,63.1,0.256,1,0.135,0.113,0.683,0.466,1,6,9,6,4.7,17.8,8,Similar,Southwest,MI,Suburban,51-65,2022-02,Q1_2022,2021,8.6,0.66,Stable
FIA001556,2022-02-11,Lisinopril,Prinivil,ACE Inhibitors,27877-295-29,Medicaid Plan Y,PLAN_5249,2022,Tier 2,Tier 1,2021-11-02,101,Worsened,Quantity Limit,No,No,,434,472,-7.9,Decreased,26.29,10.07,16.22,117.04,143.33,62.21,0.0,0,0.039,0.142,0.289,0.49,7,10,4,13,4.2,27.4,2,Similar,Midwest,IL,Urban,66-75,2022-02,Q1_2022,2021,2.0,0.646,Stable
FIA002397,2022-02-15,Lisinopril,Prinivil,ACE Inhibitors,79762-330-26,Medicaid Plan X,PLAN_3770,2022,Specialty Tier,Specialty Tier,2021-05-30,261,No Change,Step Therapy,No,Yes,,632,684,-7.5,Decreased,230.79,231.52,-0.73,54.03,284.82,180.01,0.0,0,0.291,0.395,0.229,0.582,2,0,16,9,2.4,34.6,5,Higher,Southwest,GA,Suburban,51-65,2022-02,Q1_2022,2021,2.3,0.249,Increasing
FIA002899,2022-02-16,Lisinopril,Prinivil,ACE Inhibitors,77244-530-34,Medicaid Plan Y,PLAN_6204,2022,Tier 1,Non-Formulary,2021-10-23,116,Improved,None,No,No,,334,232,44.1,Increased,5.96,235.12,-229.16,74.17,80.13,26.76,0.0,0,0.027,0.363,0.78,0.942,15,5,8,6,5.0,18.6,8,Lower,West,IL,Suburban,18-35,2022-02,Q1_2022,2021,7.4,0.165,Stable
FIA001430,2022-02-18,Lisinopril,Prinivil,ACE Inhibitors,99989-209-45,Tricare Standard,PLAN_7871,2022,Tier 2,Tier 1,2021-09-01,170,Worsened,None,No,No,,671,684,-1.9,Stable,22.19,11.28,10.91,151.39,173.58,116.47,0.0,0,0.034,0.066,0.488,0.923,14,2,11,1,2.2,12.2,3,Lower,West,IL,Suburban,75+,2022-02,Q1_2022,2021,2.8,0.179,Stable
FIA002650,2022-02-21,Lisinopril,Prinivil,ACE Inhibitors,15703-471-92,Commercial Plan Beta,PLAN_7187,2022,Tier 3,Tier 1,2021-03-10,348,Worsened,Step Therapy,No,Yes,,352,486,-27.5,Decreased,88.57,10.26,78.31,103.14,191.71,67.48,0.0,0,0.033,0.104,0.489,0.618,9,8,3,1,2.3,24.3,5,Lower,Southwest,NC,Urban,18-35,2022-02,Q1_2022,2021,9.4,0.97,Stable
FIA002878,2022-03-05,Lisinopril,Prinivil,ACE Inhibitors,87998-334-54,Medicaid Plan Y,PLAN_1271,2022,Specialty Tier,Non-Formulary,2021-09-28,158,Improved,None,No,No,,185,182,2.1,Stable,221.81,632.35,-410.54,90.42,312.23,57.76,0.0,0,0.162,0.297,0.656,0.636,9,2,1,8,3.9,19.7,3,Lower,Northeast,TX,Urban,36-50,2022-03,Q1_2022,2021,9.7,0.317,Stable
FIA001592,2022-03-10,Lisinopril,Prinivil,ACE Inhibitors,43660-404-45,Medicare Part D Plan B,PLAN_6642,2022,Non-Formulary,Tier 1,2021-08-15,207,Worsened,Non-Formulary Status,No,No,,220,704,-68.7,Decreased,472.18,18.73,453.45,166.71,638.89,140.56,0.0,0,0.056,0.199,0.79,0.823,7,0,11,14,4.7,19.9,5,Lower,Southeast,CA,Urban,18-35,2022-03,Q1_2022,2021,5.1,0.541,Increasing
FIA000648,2022-03-23,Lisinopril,Prinivil,ACE Inhibitors,12459-834-39,Medicare Part D Plan B,PLAN_1817,2022,Specialty Tier,Specialty Tier,2022-02-21,30,No Change,Prior Authorization,Yes,No,,479,450,6.6,Increased,152.46,266.21,-113.75,139.99,292.45,140.08,0.133,2,0.259,0.251,0.372,0.82,5,2,5,9,4.5,7.8,6,Lower,Southwest,CA,Rural,18-35,2022-03,Q1_2022,2021,4.8,0.021,Decreasing
FIA000188,2022-03-24,Lisinopril,Prinivil,ACE Inhibitors,86471-639-38,Medicaid Plan X,PLAN_4206,2022,Non-Formulary,Tier 1,2021-09-18,187,Worsened,Non-Formulary Status,No,No,,187,325,-42.3,Decreased,214.88,14.26,200.62,139.02,353.9,66.18,0.0,0,0.064,0.058,0.577,0.645,2,8,12,6,3.5,23.1,6,Lower,Midwest,OH,Urban,66-75,2022-03,Q1_2022,2021,4.3,0.373,Stable
FIA000677,2022-03-30,Lisinopril,Prinivil,ACE Inhibitors,53172-330-75,Medicare Part D Plan B,PLAN_3037,2022,Specialty Tier,Tier 3,2021-06-21,282,Worsened,None,No,No,,385,363,6.2,Increased,286.89,83.08,203.81,147.89,434.78,167.39,0.0,0,0.201,0.245,0.641,0.466,12,5,20,11,3.6,13.5,8,Similar,Midwest,OH,Suburban,36-50,2022-03,Q1_2022,2021,8.8,0.597,Decreasing
FIA000572,2022-04-07,Lisinopril,Prinivil,ACE Inhibitors,30903-303-35,Commercial Plan Alpha,PLAN_9524,2022,Tier 2,Non-Formulary,2021-04-30,342,Improved,None,No,No,,549,446,23.2,Increased,48.33,453.27,-404.94,158.16,206.49,113.36,0.0,0,0.061,0.398,0.637,0.529,4,0,4,10,3.2,34.7,3,Lower,Northeast,NY,Urban,36-50,2022-04,Q2_2022,2021,2.8,0.408,Stable
FIA002777,2022-04-12,Lisinopril,Prinivil,ACE Inhibitors,39722-172-95,Commercial Plan Alpha,PLAN_4383,2022,Non-Formulary,Non-Formulary,2021-05-18,329,No Change,Non-Formulary Status,No,No,,440,415,6.2,Increased,581.65,414.87,166.78,111.04,692.69,304.78,0.0,0,0.094,0.149,0.377,0.491,2,7,8,11,3.9,24.7,5,Lower,Southeast,OH,Suburban,18-35,2022-04,Q2_2022,2021,3.8,0.401,Increasing
FIA001233,2022-04-13,Lisinopril,Prinivil,ACE Inhibitors,46677-355-98,Commercial Plan Beta,PLAN_8477,2022,Tier 1,Tier 3,2022-03-04,40,Improved,None,No,No,,146,108,35.7,Increased,8.96,85.22,-76.26,131.17,140.13,20.46,0.0,0,0.015,0.07,0.848,0.632,14,8,3,9,3.9,11.7,4,Similar,Northeast,TX,Rural,36-50,2022-04,Q2_2022,2021,4.3,0.903,Decreasing
FIA001269,2022-04-14,Lisinopril,Prinivil,ACE Inhibitors,70825-157-10,Medicaid Plan Y,PLAN_2976,2022,Tier 1,Tier 1,2022-03-05,40,No Change,Quantity Limit,No,No,30.0,631,641,-1.5,Stable,16.79,7.57,9.22,143.96,160.75,101.43,0.0,0,0.068,0.38,0.359,0.894,1,10,13,6,2.3,26.0,4,Lower,Southwest,OH,Rural,36-50,2022-04,Q2_2022,2021,2.5,0.556,Decreasing
FIA001575,2022-04-14,Lisinopril,Prinivil,ACE Inhibitors,47955-186-84,Medicare Part D Plan B,PLAN_2236,2022,Non-Formulary,Non-Formulary,2022-02-03,70,No Change,Non-Formulary Status; Quantity Limit,No,No,90.0,104,104,0.4,Stable,237.77,206.06,31.71,50.34,288.11,29.96,0.0,0,0.105,0.257,0.374,0.507,10,0,14,8,3.7,15.2,8,Similar,Midwest,NY,Urban,66-75,2022-04,Q2_2022,2021,1.9,0.84,Increasing
FIA000022,2022-04-20,Lisinopril,Prinivil,ACE Inhibitors,78494-489-67,Tricare Standard,PLAN_5871,2022,Tier 2,Non-Formulary,2021-10-17,185,Improved,None,No,No,,1002,671,49.4,Increased,22.56,348.91,-326.35,68.37,90.93,91.11,0.0,0,0.065,0.351,0.893,0.568,1,9,3,6,3.9,12.9,2,Lower,Southeast,FL,Rural,18-35,2022-04,Q2_2022,2021,2.4,0.409,Decreasing
FIA000639,2022-05-02,Lisinopril,Prinivil,ACE Inhibitors,92129-700-57,Medicare Part D Plan A,PLAN_8416,2022,Specialty Tier,Specialty Tier,2021-08-14,261,No Change,Quantity Limit,No,No,,272,275,-0.9,Stable,179.03,166.23,12.8,75.01,254.04,69.1,0.0,0,0.197,0.227,0.582,0.566,0,6,15,11,4.3,30.4,2,Lower,Northeast,NC,Urban,18-35,2022-05,Q2_2022,2021,6.1,0.842,Increasing
FIA001254,2022-05-03,Lisinopril,Prinivil,ACE Inhibitors,93881-720-83,Tricare Standard,PLAN_5975,2022,Tier 1,Tier 2,2022-02-27,65,Improved,None,No,No,,127,130,-1.6,Stable,15.05,35.13,-20.08,39.54,54.59,6.93,0.0,0,0.039,0.128,0.217,0.674,0,3,14,5,4.8,24.3,4,Higher,Southeast,GA,Urban,36-50,2022-05,Q2_2022,2021,4.8,0.877,Decreasing
FIA002994,2022-05-08,Lisinopril,Prinivil,ACE Inhibitors,15428-512-12,Medicare Part D Plan A,PLAN_7497,2022,Tier 2,Non-Formulary,2022-01-16,112,Improved,None,No,No,,567,404,40.5,Increased,41.27,541.59,-500.32,192.13,233.4,132.34,0.0,0,0.074,0.105,0.453,0.947,8,8,1,10,3.6,28.8,7,Higher,West,TX,Rural,75+,2022-05,Q2_2022,2021,3.9,0.241,Increasing
FIA001161,2022-05-11,Lisinopril,Prinivil,ACE Inhibitors,75235-554-37,Medicaid Plan X,PLAN_3131,2022,Tier 2,Tier 3,2021-12-27,135,Improved,None,No,No,,530,337,57.5,Increased,42.77,61.75,-18.98,145.57,188.34,99.82,0.0,0,0.057,0.186,0.783,0.584,15,5,1,6,4.0,5.3,7,Higher,West,GA,Rural,18-35,2022-05,Q2_2022,2021,3.3,0.47,Stable
FIA000162,2022-05-16,Lisinopril,Prinivil,ACE Inhibitors,14145-378-62,Medicare Part D Plan B,PLAN_9143,2022,Tier 3,Tier 1,2021-10-25,203,Worsened,Prior Authorization,Yes,No,,689,962,-28.3,Decreased,99.18,14.4,84.78,175.83,275.01,189.48,0.491,4,0.032,0.18,0.781,0.566,9,2,3,11,4.4,28.3,2,Similar,West,CA,Suburban,75+,2022-05,Q2_2022,2021,2.4,0.34,Stable
FIA001109,2022-05-18,Lisinopril,Prinivil,ACE Inhibitors,75901-273-10,Medicare Part D Plan B,PLAN_6374,2022,Specialty Tier,Tier 3,2022-01-31,107,Worsened,None,No,No,,422,399,5.9,Increased,156.81,92.72,64.09,70.45,227.26,95.9,0.0,0,0.289,0.092,0.611,0.643,13,4,18,2,2.7,26.8,5,Similar,Southwest,OH,Suburban,36-50,2022-05,Q2_2022,2021,5.6,0.995,Increasing
FIA000886,2022-05-25,Lisinopril,Prinivil,ACE Inhibitors,42298-848-83,Tricare Standard,PLAN_3074,2022,Non-Formulary,Non-Formulary,2021-08-04,294,No Change,Non-Formulary Status,No,No,,110,107,3.7,Stable,552.03,632.91,-80.88,155.88,707.91,77.87,0.0,0,0.276,0.213,0.643,0.911,12,0,7,6,3.6,19.6,6,Higher,Midwest,FL,Rural,51-65,2022-05,Q2_2022,2021,7.6,0.963,Decreasing
FIA000832,2022-05-31,Lisinopril,Prinivil,ACE Inhibitors,25113-874-81,Tricare Standard,PLAN_7614,2022,Tier 3,Specialty Tier,2022-04-29,32,Improved,Prior Authorization,Yes,No,,361,359,0.8,Stable,66.5,292.64,-226.14,124.96,191.46,69.12,0.204,8,0.041,0.213,0.667,0.872,0,6,8,7,2.9,33.3,7,Higher,West,GA,Rural,36-50,2022-05,Q2_2022,2021,8.6,0.639,Stable
FIA002065,2022-06-09,Lisinopril,Prinivil,ACE Inhibitors,42985-989-88,Medicare Part D Plan B,PLAN_4252,2022,Non-Formulary,Tier 3,2022-04-12,58,Worsened,Non-Formulary Status,No,No,,387,369,5.1,Increased,685.39,87.9,597.49,163.12,848.51,328.37,0.0,0,0.182,0.334,0.583,0.654,4,3,6,10,2.3,32.5,2,Higher,Southwest,FL,Urban,36-50,2022-06,Q2_2022,2021,3.7,0.026,Stable
FIA000137,2022-06-12,Lisinopril,Prinivil,ACE Inhibitors,78280-561-62,Commercial Plan Alpha,PLAN_4012,2022,Tier 3,Tier 2,2021-12-04,190,Worsened,Step Therapy,No,Yes,,185,373,-50.3,Decreased,65.84,28.74,37.1,157.14,222.98,41.25,0.0,0,0.076,0.349,0.288,0.529,8,1,6,5,3.2,7.9,5,Higher,Northeast,CA,Suburban,75+,2022-06,Q2_2022,2021,7.9,0.083,Stable
FIA002494,2022-06-15,Lisinopril,Prinivil,ACE Inhibitors,89094-522-58,Commercial Plan Alpha,PLAN_5976,2022,Non-Formulary,Specialty Tier,2021-07-10,340,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,349,361,-3.2,Stable,480.74,150.75,329.99,102.78,583.52,203.65,0.0,0,0.209,0.228,0.342,0.64,7,7,16,7,2.3,6.1,5,Similar,Southwest,TX,Urban,36-50,2022-06,Q2_2022,2021,7.2,0.532,Decreasing
FIA002852,2022-06-15,Lisinopril,Prinivil,ACE Inhibitors,11687-919-90,Medicare Part D Plan B,PLAN_5603,2022,Tier 1,Tier 2,2021-12-10,187,Improved,None,No,No,,306,317,-3.3,Stable,19.86,35.61,-15.75,141.9,161.76,49.5,0.0,0,0.015,0.067,0.362,0.673,3,2,7,11,4.0,18.4,2,Lower,Northeast,NY,Urban,18-35,2022-06,Q2_2022,2021,4.6,0.453,Stable
FIA002321,2022-06-25,Lisinopril,Prinivil,ACE Inhibitors,69185-205-31,Commercial Plan Beta,PLAN_4058,2022,Tier 3,Tier 3,2022-03-10,107,No Change,Quantity Limit,No,No,,111,107,4.0,Stable,85.14,59.87,25.27,131.43,216.57,24.04,0.0,0,0.059,0.358,0.619,0.796,10,5,9,0,3.9,13.4,5,Higher,West,NC,Suburban,75+,2022-06,Q2_2022,2021,1.9,0.55,Increasing
FIA002556,2022-07-14,Lisinopril,Prinivil,ACE Inhibitors,17531-707-99,Medicare Part D Plan A,PLAN_2888,2022,Tier 3,Specialty Tier,2021-08-29,319,Improved,None,No,No,,738,715,3.2,Stable,98.22,132.72,-34.5,123.11,221.33,163.34,0.0,0,0.044,0.299,0.217,0.501,15,8,7,6,2.5,6.8,5,Higher,Southwest,TX,Suburban,66-75,2022-07,Q3_2022,2021,8.8,0.69,Decreasing
FIA001770,2022-07-15,Lisinopril,Prinivil,ACE Inhibitors,88209-877-52,Commercial Plan Beta,PLAN_2295,2022,Non-Formulary,Tier 1,2021-11-18,239,Worsened,Non-Formulary Status,No,No,,173,425,-59.2,Decreased,563.69,18.4,545.29,36.05,599.74,103.76,0.0,0,0.081,0.189,0.277,0.61,12,7,17,10,3.8,27.6,3,Similar,Northeast,TX,Urban,75+,2022-07,Q3_2022,2021,2.3,0.536,Decreasing
FIA000803,2022-07-28,Lisinopril,Prinivil,ACE Inhibitors,42697-185-52,Medicaid Plan Y,PLAN_6938,2022,Tier 1,Non-Formulary,2022-01-19,190,Improved,None,No,No,,478,402,19.1,Increased,7.32,742.76,-735.44,44.98,52.3,25.0,0.0,0,0.061,0.119,0.238,0.435,7,0,6,1,4.4,13.9,5,Similar,West,TX,Rural,18-35,2022-07,Q3_2022,2021,9.0,0.617,Decreasing
FIA001798,2022-08-09,Lisinopril,Prinivil,ACE Inhibitors,86150-718-90,Commercial Plan Alpha,PLAN_3615,2022,Non-Formulary,Specialty Tier,2022-01-20,201,Worsened,Non-Formulary Status,No,No,,969,966,0.3,Stable,636.54,239.89,396.65,126.39,762.93,739.28,0.0,0,0.285,0.113,0.61,0.78,8,4,8,0,4.2,17.0,2,Similar,West,FL,Rural,36-50,2022-08,Q3_2022,2021,2.2,0.876,Stable
FIA002342,2022-08-12,Lisinopril,Prinivil,ACE Inhibitors,54442-120-27,Tricare Standard,PLAN_3739,2022,Tier 1,Specialty Tier,2022-03-21,144,Improved,None,No,No,,600,484,24.0,Increased,5.34,208.79,-203.45,33.57,38.91,23.35,0.0,0,0.018,0.383,0.762,0.582,14,7,5,13,2.3,23.1,6,Higher,Midwest,NY,Suburban,18-35,2022-08,Q3_2022,2021,7.3,0.967,Increasing
FIA000827,2022-08-16,Lisinopril,Prinivil,ACE Inhibitors,85105-110-63,Tricare Standard,PLAN_8135,2022,Specialty Tier,Tier 2,2021-10-13,307,Worsened,Step Therapy; Quantity Limit,No,Yes,,239,300,-20.1,Decreased,141.41,31.68,109.73,112.09,253.5,60.59,0.0,0,0.167,0.39,0.366,0.656,4,9,11,0,3.4,24.6,7,Lower,Southwest,FL,Urban,66-75,2022-08,Q3_2022,2021,2.3,0.282,Decreasing
FIA000523,2022-08-17,Lisinopril,Prinivil,ACE Inhibitors,21123-561-66,VA Plan,PLAN_4379,2022,Tier 2,Tier 2,2021-12-01,259,No Change,None,No,No,,924,883,4.7,Stable,28.56,36.12,-7.56,168.65,197.21,182.22,0.0,0,0.053,0.135,0.405,0.753,5,7,5,0,2.6,30.0,6,Similar,Southeast,TX,Suburban,51-65,2022-08,Q3_2022,2021,7.4,0.655,Increasing
FIA001943,2022-09-04,Lisinopril,Prinivil,ACE Inhibitors,16096-161-84,Medicare Part D Plan B,PLAN_3355,2022,Tier 2,Specialty Tier,2021-10-07,332,Improved,Quantity Limit,No,No,60.0,1183,764,54.9,Increased,29.43,114.62,-85.19,57.57,87.0,102.92,0.0,0,0.039,0.301,0.558,0.53,9,0,4,15,4.7,20.2,6,Similar,Southeast,NC,Rural,75+,2022-09,Q3_2022,2021,5.2,0.939,Decreasing
FIA002439,2022-09-05,Lisinopril,Prinivil,ACE Inhibitors,29306-391-79,Medicaid Plan X,PLAN_5409,2022,Tier 2,Tier 2,2022-07-22,45,No Change,Quantity Limit,No,No,60.0,708,785,-9.8,Decreased,24.71,30.15,-5.44,55.91,80.62,57.08,0.0,0,0.043,0.147,0.837,0.456,14,4,20,14,2.2,15.1,8,Higher,Northeast,CA,Suburban,66-75,2022-09,Q3_2022,2021,7.7,0.866,Increasing
FIA001208,2022-09-09,Lisinopril,Prinivil,ACE Inhibitors,20657-289-52,VA Plan,PLAN_8963,2022,Tier 1,Specialty Tier,2021-10-16,328,Improved,Quantity Limit,No,No,90.0,811,667,21.7,Increased,9.98,127.91,-117.93,71.04,81.02,65.71,0.0,0,0.021,0.098,0.202,0.78,6,8,11,13,2.4,10.2,5,Higher,Northeast,PA,Urban,36-50,2022-09,Q3_2022,2021,3.5,0.174,Decreasing
FIA001524,2022-09-09,Lisinopril,Prinivil,ACE Inhibitors,72688-101-95,Tricare Standard,PLAN_1185,2022,Tier 1,Non-Formulary,2021-10-12,332,Improved,None,No,No,,1170,810,44.5,Increased,13.56,316.98,-303.42,94.55,108.11,126.49,0.0,0,0.016,0.051,0.32,0.641,13,2,8,9,3.0,18.3,8,Similar,Southeast,CA,Rural,18-35,2022-09,Q3_2022,2021,3.0,0.545,Decreasing
FIA001018,2022-09-14,Lisinopril,Prinivil,ACE Inhibitors,43179-262-40,VA Plan,PLAN_8225,2022,Tier 3,Specialty Tier,2022-05-18,119,Improved,None,No,No,,187,183,2.6,Stable,97.13,195.32,-98.19,158.79,255.92,47.86,0.0,0,0.068,0.33,0.769,0.661,0,4,4,6,4.0,24.0,7,Higher,West,NC,Suburban,66-75,2022-09,Q3_2022,2021,7.4,0.91,Stable
FIA000880,2022-09-21,Lisinopril,Prinivil,ACE Inhibitors,40266-102-34,Medicaid Plan X,PLAN_3332,2022,Specialty Tier,Tier 2,2022-05-08,136,Worsened,None,No,No,,419,528,-20.5,Decreased,238.02,20.39,217.63,141.21,379.23,158.9,0.0,0,0.088,0.357,0.648,0.509,14,5,6,3,4.9,28.0,3,Higher,Northeast,MI,Urban,66-75,2022-09,Q3_2022,2021,7.4,0.221,Stable
FIA001144,2022-10-04,Lisinopril,Prinivil,ACE Inhibitors,46400-260-90,Medicare Part D Plan B,PLAN_7748,2022,Tier 1,Specialty Tier,2022-02-20,226,Improved,None,No,No,,549,430,27.9,Increased,11.59,181.19,-169.6,137.94,149.53,82.09,0.0,0,0.026,0.392,0.394,0.584,5,8,13,2,3.4,25.0,4,Higher,Northeast,NY,Rural,18-35,2022-10,Q4_2022,2022,9.6,0.453,Increasing
FIA002925,2022-10-06,Lisinopril,Prinivil,ACE Inhibitors,78898-221-58,Tricare Standard,PLAN_8901,2022,Tier 1,Specialty Tier,2022-06-02,126,Improved,None,No,No,,814,563,44.7,Increased,18.78,187.59,-168.81,61.77,80.55,65.57,0.0,0,0.071,0.167,0.813,0.76,11,10,14,9,3.2,32.5,8,Similar,Northeast,IL,Suburban,51-65,2022-10,Q4_2022,2022,9.5,0.54,Increasing
FIA002863,2022-10-17,Lisinopril,Prinivil,ACE Inhibitors,51046-986-14,VA Plan,PLAN_4254,2022,Tier 2,Non-Formulary,2022-03-31,200,Improved,None,No,No,,810,607,33.5,Increased,30.01,701.5,-671.49,94.56,124.57,100.9,0.0,0,0.042,0.148,0.527,0.721,9,4,5,15,2.8,19.4,5,Similar,Midwest,PA,Urban,18-35,2022-10,Q4_2022,2022,9.1,0.122,Increasing
FIA000164,2022-11-02,Lisinopril,Prinivil,ACE Inhibitors,42089-275-19,Medicaid Plan X,PLAN_6549,2022,Tier 3,Tier 1,2022-09-26,37,Worsened,None,No,No,,142,204,-30.3,Decreased,97.91,13.39,84.52,78.16,176.07,25.0,0.0,0,0.059,0.239,0.236,0.416,1,1,12,1,2.3,16.8,7,Higher,West,GA,Rural,51-65,2022-11,Q4_2022,2022,3.8,0.817,Decreasing
FIA000465,2022-11-05,Lisinopril,Prinivil,ACE Inhibitors,59531-453-91,Medicaid Plan Y,PLAN_2453,2022,Tier 3,Non-Formulary,2021-11-22,348,Improved,None,No,No,,526,580,-9.2,Decreased,89.42,388.47,-299.05,180.58,270.0,142.02,0.0,0,0.056,0.177,0.561,0.692,12,6,18,3,2.7,9.5,4,Higher,Southeast,IL,Suburban,18-35,2022-11,Q4_2022,2022,4.3,0.822,Decreasing
FIA002352,2022-11-07,Lisinopril,Prinivil,ACE Inhibitors,54384-749-73,Commercial Plan Beta,PLAN_6342,2022,Non-Formulary,Tier 3,2022-09-19,49,Worsened,Non-Formulary Status,No,No,,803,845,-4.9,Stable,798.08,97.5,700.58,185.59,983.67,789.89,0.0,0,0.224,0.227,0.433,0.931,8,1,13,7,2.3,23.1,3,Similar,Midwest,CA,Urban,66-75,2022-11,Q4_2022,2022,6.9,0.566,Increasing
FIA001127,2022-11-08,Lisinopril,Prinivil,ACE Inhibitors,64338-865-15,Medicare Part D Plan A,PLAN_3992,2022,Non-Formulary,Tier 3,2022-09-01,68,Worsened,Non-Formulary Status,No,No,,101,101,0.2,Stable,658.28,55.2,603.08,197.01,855.29,86.38,0.0,0,0.146,0.353,0.824,0.563,0,10,3,14,2.8,24.8,3,Higher,West,TX,Rural,66-75,2022-11,Q4_2022,2022,9.0,0.134,Stable
FIA000560,2022-11-09,Lisinopril,Prinivil,ACE Inhibitors,84196-257-95,Commercial Plan Alpha,PLAN_3926,2022,Tier 2,Non-Formulary,2022-10-02,38,Improved,None,No,No,,504,399,26.4,Increased,39.04,652.63,-613.59,143.96,183.0,92.23,0.0,0,0.049,0.307,0.448,0.431,5,9,10,6,3.1,6.5,5,Lower,Southwest,NY,Urban,18-35,2022-11,Q4_2022,2022,5.8,0.272,Decreasing
FIA000773,2022-11-24,Lisinopril,Prinivil,ACE Inhibitors,20065-870-96,VA Plan,PLAN_9568,2022,Tier 1,Tier 1,2022-06-27,150,No Change,None,No,No,,497,470,5.9,Increased,13.03,13.2,-0.17,63.49,76.52,38.03,0.0,0,0.049,0.093,0.746,0.626,13,0,7,2,3.9,26.0,3,Higher,Southwest,MI,Urban,66-75,2022-11,Q4_2022,2022,7.7,0.593,Stable
FIA000271,2022-11-28,Lisinopril,Prinivil,ACE Inhibitors,36082-590-95,Medicaid Plan X,PLAN_2946,2022,Tier 3,Specialty Tier,2022-10-27,32,Improved,None,No,No,,279,303,-7.8,Decreased,67.96,274.1,-206.14,57.25,125.21,34.93,0.0,0,0.073,0.197,0.585,0.84,4,5,12,12,2.4,33.7,8,Lower,Southeast,FL,Suburban,75+,2022-11,Q4_2022,2022,1.1,0.684,Increasing
FIA001603,2022-12-27,Lisinopril,Prinivil,ACE Inhibitors,65340-378-91,Commercial Plan Beta,PLAN_2271,2022,Specialty Tier,Tier 1,2022-03-29,273,Worsened,None,No,No,,313,575,-45.5,Decreased,148.38,16.4,131.98,120.43,268.81,84.14,0.0,0,0.114,0.322,0.772,0.944,4,3,7,11,4.4,12.3,7,Similar,Southwest,NY,Urban,51-65,2022-12,Q4_2022,2022,5.9,0.538,Increasing
FIA001966,2022-12-28,Lisinopril,Prinivil,ACE Inhibitors,63319-522-76,Medicaid Plan X,PLAN_5718,2022,Tier 1,Specialty Tier,2022-10-16,73,Improved,None,No,No,,504,320,57.6,Increased,16.55,228.62,-212.07,68.68,85.23,42.96,0.0,0,0.055,0.262,0.546,0.513,15,7,8,9,3.5,10.1,4,Similar,Southwest,TX,Rural,51-65,2022-12,Q4_2022,2022,9.6,0.366,Decreasing
FIA000575,2023-01-04,Lisinopril,Prinivil,ACE Inhibitors,73631-355-90,Commercial Plan Beta,PLAN_8395,2023,Tier 3,Non-Formulary,2022-11-15,50,Improved,Prior Authorization,Yes,No,,778,804,-3.1,Stable,90.13,550.96,-460.83,191.02,281.15,218.73,0.354,10,0.062,0.319,0.253,0.502,4,1,2,1,2.4,18.7,6,Lower,Southeast,IL,Rural,75+,2023-01,Q1_2023,2022,4.7,0.918,Decreasing
FIA000534,2023-01-10,Lisinopril,Prinivil,ACE Inhibitors,17733-193-24,Medicaid Plan Y,PLAN_1016,2023,Tier 3,Specialty Tier,2022-08-10,153,Improved,None,No,No,,170,174,-2.2,Stable,54.5,298.74,-244.24,139.05,193.55,32.9,0.0,0,0.076,0.264,0.791,0.887,3,10,2,10,2.6,7.4,2,Higher,Midwest,NY,Suburban,18-35,2023-01,Q1_2023,2022,8.4,0.136,Increasing
FIA001734,2023-01-13,Lisinopril,Prinivil,ACE Inhibitors,94443-765-28,Medicare Part D Plan A,PLAN_2052,2023,Tier 2,Tier 1,2022-01-31,347,Worsened,None,No,No,,897,829,8.2,Increased,34.71,12.57,22.14,128.76,163.47,146.63,0.0,0,0.047,0.367,0.227,0.774,2,0,15,5,2.7,26.8,3,Higher,Southwest,PA,Rural,66-75,2023-01,Q1_2023,2022,5.7,0.801,Increasing
FIA002294,2023-01-14,Lisinopril,Prinivil,ACE Inhibitors,48599-633-24,VA Plan,PLAN_2562,2023,Non-Formulary,Specialty Tier,2022-02-17,331,Worsened,Non-Formulary Status,No,No,,206,189,9.4,Increased,373.4,146.6,226.8,39.96,413.36,85.15,0.0,0,0.256,0.072,0.375,0.944,11,7,20,1,2.3,21.3,6,Similar,Southwest,TX,Rural,66-75,2023-01,Q1_2023,2022,4.1,0.644,Decreasing
FIA002220,2023-01-18,Lisinopril,Prinivil,ACE Inhibitors,16478-711-85,VA Plan,PLAN_1888,2023,Tier 2,Non-Formulary,2022-01-28,355,Improved,None,No,No,,986,650,51.8,Increased,34.63,367.02,-332.39,155.2,189.83,187.17,0.0,0,0.04,0.328,0.608,0.719,2,0,11,3,3.1,5.9,5,Lower,Northeast,NC,Urban,66-75,2023-01,Q1_2023,2022,7.8,0.824,Increasing
FIA000176,2023-01-24,Lisinopril,Prinivil,ACE Inhibitors,12151-137-53,Medicare Part D Plan A,PLAN_6533,2023,Tier 1,Tier 2,2022-12-13,42,Improved,None,No,No,,586,600,-2.2,Stable,15.8,37.79,-21.99,168.0,183.8,107.71,0.0,0,0.078,0.326,0.23,0.465,14,10,17,4,4.2,12.0,2,Lower,Southeast,GA,Rural,18-35,2023-01,Q1_2023,2022,5.2,0.918,Increasing
FIA002415,2023-02-23,Lisinopril,Prinivil,ACE Inhibitors,72096-358-89,Medicaid Plan Y,PLAN_1500,2023,Non-Formulary,Tier 1,2023-01-14,40,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,219,442,-50.4,Decreased,227.43,6.57,220.86,118.73,346.16,75.81,0.0,0,0.281,0.121,0.489,0.416,14,7,6,12,4.0,8.4,4,Lower,Southeast,FL,Suburban,75+,2023-02,Q1_2023,2022,4.1,0.806,Increasing
FIA002170,2023-02-26,Lisinopril,Prinivil,ACE Inhibitors,88897-622-66,Medicaid Plan Y,PLAN_1342,2023,Tier 2,Tier 1,2022-07-11,230,Worsened,None,No,No,,284,274,3.7,Stable,48.03,6.01,42.02,104.4,152.43,43.29,0.0,0,0.067,0.346,0.409,0.752,1,0,12,5,2.4,29.4,2,Lower,Southwest,GA,Suburban,75+,2023-02,Q1_2023,2022,1.7,0.686,Decreasing
FIA000527,2023-03-11,Lisinopril,Prinivil,ACE Inhibitors,66881-488-24,Medicare Part D Plan A,PLAN_1488,2023,Tier 2,Tier 1,2023-01-18,52,Worsened,None,No,No,,313,335,-6.5,Decreased,44.49,5.22,39.27,95.61,140.1,43.85,0.0,0,0.058,0.228,0.642,0.769,15,6,3,0,3.6,29.5,3,Similar,Southwest,TX,Suburban,18-35,2023-03,Q1_2023,2022,9.3,0.235,Decreasing
FIA000609,2023-03-15,Lisinopril,Prinivil,ACE Inhibitors,29570-659-61,Tricare Standard,PLAN_3782,2023,Specialty Tier,Tier 1,2022-12-20,85,Worsened,None,No,No,,95,136,-29.6,Decreased,206.71,14.33,192.38,110.73,317.44,30.16,0.0,0,0.104,0.07,0.851,0.828,1,9,10,7,3.2,29.1,7,Lower,Northeast,MI,Suburban,36-50,2023-03,Q1_2023,2022,4.7,0.544,Increasing
FIA000369,2023-03-16,Lisinopril,Prinivil,ACE Inhibitors,61944-925-72,Medicare Part D Plan A,PLAN_9657,2023,Tier 3,Specialty Tier,2022-10-21,146,Improved,Step Therapy,No,Yes,,867,793,9.4,Increased,73.04,166.6,-93.56,99.83,172.87,149.88,0.0,0,0.018,0.071,0.893,0.605,13,0,16,10,4.4,19.8,6,Similar,Northeast,TX,Rural,18-35,2023-03,Q1_2023,2022,9.8,0.781,Decreasing
FIA001480,2023-03-18,Lisinopril,Prinivil,ACE Inhibitors,70233-330-24,VA Plan,PLAN_4157,2023,Tier 3,Tier 2,2022-09-28,171,Worsened,None,No,No,,339,890,-61.8,Decreased,88.76,44.84,43.92,194.18,282.94,95.92,0.0,0,0.058,0.128,0.405,0.525,15,2,9,8,3.4,12.2,6,Higher,Northeast,GA,Urban,36-50,2023-03,Q1_2023,2022,1.8,0.905,Stable
FIA001753,2023-03-21,Lisinopril,Prinivil,ACE Inhibitors,36225-505-60,Tricare Standard,PLAN_4733,2023,Tier 2,Tier 1,2023-01-25,55,Worsened,None,No,No,,464,427,8.9,Increased,25.31,10.38,14.93,79.51,104.82,48.64,0.0,0,0.028,0.164,0.301,0.62,7,4,1,5,4.7,20.2,5,Similar,Northeast,MI,Urban,75+,2023-03,Q1_2023,2022,2.8,0.91,Decreasing
FIA001778,2023-04-18,Lisinopril,Prinivil,ACE Inhibitors,43068-479-13,Medicaid Plan Y,PLAN_7662,2023,Tier 3,Tier 1,2022-08-30,231,Worsened,None,No,No,,347,729,-52.3,Decreased,53.6,11.04,42.56,184.95,238.55,82.78,0.0,0,0.074,0.266,0.666,0.492,2,6,18,3,2.6,34.0,7,Higher,Northeast,FL,Suburban,75+,2023-04,Q2_2023,2022,9.4,0.185,Stable
FIA000911,2023-05-14,Lisinopril,Prinivil,ACE Inhibitors,97272-649-39,Commercial Plan Beta,PLAN_5357,2023,Tier 1,Non-Formulary,2022-08-10,277,Improved,None,No,No,,505,375,34.7,Increased,11.73,335.9,-324.17,99.14,110.87,55.99,0.0,0,0.062,0.273,0.443,0.879,11,7,7,10,4.7,10.2,7,Lower,Southwest,GA,Rural,18-35,2023-05,Q2_2023,2022,1.5,0.331,Stable
FIA002350,2023-05-16,Lisinopril,Prinivil,ACE Inhibitors,77126-227-55,Commercial Plan Beta,PLAN_2413,2023,Specialty Tier,Tier 2,2022-12-11,156,Worsened,None,No,No,,408,627,-34.9,Decreased,219.54,36.57,182.97,198.75,418.29,170.66,0.0,0,0.1,0.114,0.827,0.445,0,4,6,12,2.1,14.5,6,Lower,Midwest,NY,Suburban,51-65,2023-05,Q2_2023,2022,7.3,0.255,Decreasing
FIA000785,2023-05-19,Lisinopril,Prinivil,ACE Inhibitors,82449-993-44,Commercial Plan Alpha,PLAN_1504,2023,Tier 2,Specialty Tier,2022-11-10,190,Improved,None,No,No,,785,657,19.5,Increased,29.26,102.88,-73.62,58.59,87.85,68.96,0.0,0,0.03,0.105,0.396,0.845,11,0,19,9,3.3,15.5,2,Lower,West,OH,Rural,18-35,2023-05,Q2_2023,2022,9.8,0.417,Stable
FIA000455,2023-05-25,Lisinopril,Prinivil,ACE Inhibitors,37551-834-24,Medicare Part D Plan A,PLAN_7772,2023,Tier 1,Tier 2,2022-12-19,157,Improved,None,No,No,,783,800,-2.1,Stable,16.17,41.94,-25.77,30.48,46.65,36.53,0.0,0,0.018,0.087,0.344,0.479,3,5,10,13,3.1,20.6,4,Similar,Southeast,FL,Urban,66-75,2023-05,Q2_2023,2022,4.2,0.87,Decreasing
FIA001508,2023-05-27,Lisinopril,Prinivil,ACE Inhibitors,36118-811-17,Tricare Standard,PLAN_4939,2023,Tier 2,Tier 3,2023-02-24,92,Improved,None,No,No,,351,248,41.8,Increased,36.5,93.35,-56.85,97.83,134.33,47.15,0.0,0,0.067,0.33,0.561,0.641,9,8,9,10,4.9,14.2,8,Lower,Northeast,CA,Suburban,51-65,2023-05,Q2_2023,2022,8.0,0.815,Stable
FIA000298,2023-05-28,Lisinopril,Prinivil,ACE Inhibitors,68478-533-86,Medicaid Plan X,PLAN_6222,2023,Tier 2,Tier 3,2022-10-09,231,Improved,None,No,No,,904,701,29.0,Increased,23.09,89.66,-66.57,112.93,136.02,122.96,0.0,0,0.077,0.268,0.625,0.636,11,5,20,2,3.3,31.7,6,Similar,West,OH,Suburban,75+,2023-05,Q2_2023,2022,8.4,0.645,Decreasing
FIA000693,2023-07-08,Lisinopril,Prinivil,ACE Inhibitors,50917-257-15,Commercial Plan Beta,PLAN_2578,2023,Tier 1,Tier 2,2023-04-23,76,Improved,None,No,No,,817,881,-7.2,Decreased,10.31,35.91,-25.6,109.67,119.98,98.02,0.0,0,0.071,0.247,0.508,0.653,9,8,13,14,3.1,16.0,2,Higher,Midwest,TX,Rural,66-75,2023-07,Q3_2023,2022,7.6,0.993,Decreasing
FIA001924,2023-07-11,Lisinopril,Prinivil,ACE Inhibitors,82676-438-22,Medicare Part D Plan B,PLAN_8058,2023,Tier 1,Specialty Tier,2023-03-29,104,Improved,None,No,No,,1175,847,38.7,Increased,12.61,222.04,-209.43,181.76,194.37,228.38,0.0,0,0.02,0.234,0.591,0.523,5,1,2,9,4.4,24.0,5,Higher,Midwest,NC,Suburban,36-50,2023-07,Q3_2023,2022,2.7,0.803,Decreasing
FIA002706,2023-07-13,Lisinopril,Prinivil,ACE Inhibitors,72354-322-11,Medicare Part D Plan B,PLAN_5993,2023,Non-Formulary,Tier 2,2022-07-27,351,Worsened,Non-Formulary Status,No,No,,110,196,-43.7,Decreased,450.84,26.39,424.45,44.96,495.8,54.54,0.0,0,0.231,0.274,0.266,0.9,9,10,19,0,4.0,17.4,6,Higher,West,IL,Rural,66-75,2023-07,Q3_2023,2022,3.3,0.687,Increasing
FIA001237,2023-07-14,Lisinopril,Prinivil,ACE Inhibitors,24369-899-72,Medicaid Plan Y,PLAN_5224,2023,Tier 2,Tier 3,2022-11-21,235,Improved,None,No,No,,702,496,41.6,Increased,45.95,87.86,-41.91,115.04,160.99,113.01,0.0,0,0.062,0.358,0.717,0.488,15,1,3,9,3.7,29.8,2,Similar,Northeast,IL,Rural,18-35,2023-07,Q3_2023,2022,9.5,0.568,Decreasing
FIA000732,2023-07-23,Lisinopril,Prinivil,ACE Inhibitors,28258-637-59,Commercial Plan Beta,PLAN_1755,2023,Tier 3,Specialty Tier,2023-05-23,61,Improved,Prior Authorization,Yes,No,,336,326,3.1,Stable,61.96,252.58,-190.62,138.81,200.77,67.46,0.211,5,0.016,0.057,0.78,0.733,12,2,19,2,3.3,8.0,4,Lower,West,FL,Urban,18-35,2023-07,Q3_2023,2022,3.7,0.407,Decreasing
FIA000181,2023-07-29,Lisinopril,Prinivil,ACE Inhibitors,90154-274-83,Commercial Plan Beta,PLAN_2416,2023,Tier 1,Specialty Tier,2022-11-07,264,Improved,None,No,No,,503,325,54.9,Increased,11.27,252.07,-240.8,138.46,149.73,75.31,0.0,0,0.065,0.194,0.565,0.874,6,9,15,14,2.8,26.9,7,Lower,Southeast,IL,Suburban,75+,2023-07,Q3_2023,2022,3.0,0.927,Increasing
FIA002425,2023-07-30,Lisinopril,Prinivil,ACE Inhibitors,37834-484-50,Medicare Part D Plan B,PLAN_6721,2023,Tier 2,Tier 2,2023-02-09,171,No Change,None,No,No,,260,265,-1.7,Stable,23.13,24.38,-1.25,132.49,155.62,40.46,0.0,0,0.061,0.194,0.702,0.597,13,0,7,11,3.2,8.7,5,Lower,West,MI,Suburban,51-65,2023-07,Q3_2023,2022,1.6,0.937,Stable
FIA002064,2023-08-09,Lisinopril,Prinivil,ACE Inhibitors,71798-164-14,VA Plan,PLAN_4298,2023,Tier 2,Non-Formulary,2023-02-07,183,Improved,None,No,No,,292,232,26.1,Increased,27.52,741.12,-713.6,46.49,74.01,21.61,0.0,0,0.051,0.22,0.858,0.779,3,8,13,7,3.6,22.5,7,Higher,Midwest,PA,Urban,51-65,2023-08,Q3_2023,2022,6.6,0.941,Stable
FIA000577,2023-08-16,Lisinopril,Prinivil,ACE Inhibitors,10197-808-79,Commercial Plan Beta,PLAN_4315,2023,Tier 2,Tier 1,2023-01-06,222,Worsened,Quantity Limit,No,No,60.0,850,801,6.2,Increased,25.28,15.19,10.09,63.2,88.48,75.21,0.0,0,0.023,0.153,0.51,0.898,0,4,16,15,3.5,22.4,4,Lower,Midwest,GA,Urban,36-50,2023-08,Q3_2023,2022,1.1,0.374,Decreasing
FIA000982,2023-08-22,Lisinopril,Prinivil,ACE Inhibitors,26311-900-98,Medicare Part D Plan A,PLAN_4891,2023,Tier 2,Tier 1,2022-10-24,302,Worsened,Quantity Limit,No,No,,866,809,7.1,Increased,24.2,5.58,18.62,119.82,144.02,124.72,0.0,0,0.014,0.368,0.443,0.692,14,3,16,11,3.3,29.7,6,Similar,Southeast,MI,Rural,36-50,2023-08,Q3_2023,2022,3.4,0.717,Decreasing
FIA001116,2023-08-25,Lisinopril,Prinivil,ACE Inhibitors,42362-671-79,Tricare Standard,PLAN_7860,2023,Non-Formulary,Tier 3,2023-06-24,62,Worsened,Non-Formulary Status,No,No,,572,559,2.4,Stable,695.41,65.68,629.73,161.17,856.58,489.96,0.0,0,0.107,0.396,0.472,0.637,12,2,16,10,4.7,30.1,3,Similar,Northeast,NY,Rural,75+,2023-08,Q3_2023,2022,8.4,0.47,Increasing
FIA000905,2023-08-27,Lisinopril,Prinivil,ACE Inhibitors,20564-368-65,Medicare Part D Plan B,PLAN_8504,2023,Non-Formulary,Tier 2,2022-12-07,263,Worsened,Non-Formulary Status,No,No,,224,660,-65.9,Decreased,775.05,34.45,740.6,179.53,954.58,213.83,0.0,0,0.297,0.114,0.435,0.426,8,5,4,5,3.3,30.9,8,Similar,West,NC,Rural,75+,2023-08,Q3_2023,2022,5.1,0.993,Decreasing
FIA000551,2023-08-29,Lisinopril,Prinivil,ACE Inhibitors,93392-140-78,Tricare Standard,PLAN_2607,2023,Tier 3,Tier 2,2023-01-01,240,Worsened,Prior Authorization,Yes,No,,537,856,-37.2,Decreased,83.27,47.59,35.68,174.53,257.8,138.44,0.176,10,0.058,0.376,0.303,0.532,9,1,19,12,2.8,11.0,4,Lower,Southeast,PA,Suburban,36-50,2023-08,Q3_2023,2022,9.0,0.667,Stable
FIA000650,2023-09-06,Lisinopril,Prinivil,ACE Inhibitors,60903-635-56,Tricare Standard,PLAN_7884,2023,Tier 2,Tier 1,2023-01-20,229,Worsened,None,No,No,,363,394,-7.7,Decreased,30.47,18.5,11.97,141.94,172.41,62.58,0.0,0,0.042,0.363,0.726,0.632,6,4,19,9,2.5,34.2,8,Similar,Southwest,TX,Suburban,51-65,2023-09,Q3_2023,2022,8.7,0.1,Decreasing
FIA002067,2023-09-09,Lisinopril,Prinivil,ACE Inhibitors,48499-954-27,Medicare Part D Plan A,PLAN_5441,2023,Tier 2,Specialty Tier,2023-05-01,131,Improved,None,No,No,,640,500,28.2,Increased,21.57,183.02,-161.45,111.41,132.98,85.11,0.0,0,0.066,0.374,0.579,0.934,3,9,4,9,4.7,13.1,5,Lower,Southeast,GA,Suburban,75+,2023-09,Q3_2023,2022,6.2,0.24,Increasing
FIA001444,2023-09-10,Lisinopril,Prinivil,ACE Inhibitors,43734-554-36,Medicare Part D Plan B,PLAN_8433,2023,Tier 1,Non-Formulary,2022-12-09,275,Improved,Quantity Limit,No,No,60.0,1160,784,48.0,Increased,7.88,507.93,-500.05,185.85,193.73,224.73,0.0,0,0.05,0.085,0.663,0.725,11,8,7,10,2.0,27.1,3,Lower,Southwest,TX,Urban,51-65,2023-09,Q3_2023,2022,3.8,0.736,Stable
FIA002803,2023-09-15,Lisinopril,Prinivil,ACE Inhibitors,29908-618-77,Tricare Standard,PLAN_8323,2023,Non-Formulary,Tier 1,2023-07-03,74,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,379,526,-27.9,Decreased,281.38,7.81,273.57,169.45,450.83,170.86,0.0,0,0.104,0.239,0.777,0.673,3,3,10,0,2.7,34.1,4,Lower,Southeast,MI,Rural,51-65,2023-09,Q3_2023,2022,8.9,0.027,Decreasing
FIA002377,2023-09-28,Lisinopril,Prinivil,ACE Inhibitors,93534-405-88,Commercial Plan Beta,PLAN_9019,2023,Specialty Tier,Tier 3,2022-10-25,338,Worsened,None,No,No,,547,568,-3.6,Stable,189.93,75.2,114.73,61.57,251.5,137.57,0.0,0,0.129,0.099,0.621,0.842,4,0,8,6,2.1,17.1,4,Lower,Southwest,NY,Rural,66-75,2023-09,Q3_2023,2022,4.3,0.6,Decreasing
FIA000310,2023-09-29,Lisinopril,Prinivil,ACE Inhibitors,48972-680-90,Tricare Standard,PLAN_9942,2023,Non-Formulary,Specialty Tier,2023-03-18,195,Worsened,Non-Formulary Status,No,No,,832,886,-6.0,Decreased,682.63,127.84,554.79,81.85,764.48,636.05,0.0,0,0.1,0.114,0.748,0.859,3,2,16,14,4.1,20.1,7,Higher,Midwest,GA,Suburban,66-75,2023-09,Q3_2023,2022,5.2,0.961,Stable
FIA000875,2023-10-04,Lisinopril,Prinivil,ACE Inhibitors,81057-545-74,Medicare Part D Plan B,PLAN_2902,2023,Non-Formulary,Specialty Tier,2023-04-26,161,Worsened,Non-Formulary Status; Quantity Limit,No,No,,405,385,5.2,Increased,354.88,236.76,118.12,102.96,457.84,185.43,0.0,0,0.237,0.158,0.88,0.521,13,4,0,0,3.0,20.0,2,Similar,Midwest,IL,Rural,18-35,2023-10,Q4_2023,2023,7.9,0.91,Decreasing
FIA002603,2023-10-20,Lisinopril,Prinivil,ACE Inhibitors,16221-749-42,Tricare Standard,PLAN_4469,2023,Tier 3,Specialty Tier,2023-03-21,213,Improved,Step Therapy,No,Yes,,644,711,-9.3,Decreased,82.87,244.1,-161.23,120.14,203.01,130.74,0.0,0,0.069,0.145,0.421,0.88,14,1,14,10,3.4,27.0,8,Higher,Midwest,OH,Urban,51-65,2023-10,Q4_2023,2023,2.8,0.369,Increasing
FIA000464,2023-10-23,Lisinopril,Prinivil,ACE Inhibitors,92686-866-87,Medicare Part D Plan A,PLAN_3453,2023,Non-Formulary,Tier 1,2023-08-12,72,Worsened,Non-Formulary Status,No,No,,693,924,-24.9,Decreased,612.77,12.21,600.56,93.16,705.93,489.21,0.0,0,0.185,0.396,0.419,0.77,9,4,8,5,2.3,29.4,6,Higher,West,NC,Suburban,51-65,2023-10,Q4_2023,2023,5.4,0.91,Increasing
FIA000489,2023-11-03,Lisinopril,Prinivil,ACE Inhibitors,39133-451-77,Medicaid Plan Y,PLAN_2674,2023,Non-Formulary,Tier 3,2023-01-30,277,Worsened,Non-Formulary Status,No,No,,464,498,-6.6,Decreased,306.74,97.25,209.49,177.62,484.36,224.74,0.0,0,0.197,0.128,0.894,0.677,12,5,11,0,4.9,19.7,4,Similar,West,IL,Urban,75+,2023-11,Q4_2023,2023,3.9,0.488,Decreasing
FIA000692,2023-11-21,Lisinopril,Prinivil,ACE Inhibitors,59498-869-98,Tricare Standard,PLAN_5901,2023,Non-Formulary,Tier 3,2023-08-27,86,Worsened,Non-Formulary Status,No,No,,378,376,0.5,Stable,325.85,69.46,256.39,64.79,390.64,147.66,0.0,0,0.061,0.396,0.882,0.408,10,7,20,7,3.7,25.3,4,Higher,West,CA,Urban,66-75,2023-11,Q4_2023,2023,1.0,0.717,Stable
FIA000958,2023-11-28,Lisinopril,Prinivil,ACE Inhibitors,29686-108-90,Medicaid Plan Y,PLAN_4730,2023,Tier 3,Specialty Tier,2023-10-12,47,Improved,Prior Authorization; Step Therapy,Yes,Yes,,961,957,0.4,Stable,50.03,164.21,-114.18,39.62,89.65,86.15,0.154,6,0.077,0.12,0.261,0.795,8,5,13,0,3.0,33.8,6,Lower,Midwest,FL,Urban,36-50,2023-11,Q4_2023,2023,2.1,0.718,Increasing
FIA002667,2023-11-28,Lisinopril,Prinivil,ACE Inhibitors,55601-644-47,Commercial Plan Beta,PLAN_3885,2023,Non-Formulary,Tier 2,2023-06-05,176,Worsened,Non-Formulary Status,No,No,,433,904,-52.0,Decreased,784.94,40.84,744.1,142.76,927.7,401.69,0.0,0,0.122,0.273,0.599,0.503,15,8,1,15,3.5,9.7,4,Lower,Midwest,OH,Urban,36-50,2023-11,Q4_2023,2023,2.6,0.464,Decreasing
FIA001633,2023-12-03,Lisinopril,Prinivil,ACE Inhibitors,38158-379-44,Medicare Part D Plan B,PLAN_1057,2023,Non-Formulary,Specialty Tier,2023-01-30,307,Worsened,Non-Formulary Status,No,No,,102,107,-4.4,Stable,368.07,169.43,198.64,102.12,470.19,47.96,0.0,0,0.073,0.17,0.61,0.767,1,6,10,5,4.3,11.5,6,Lower,Southeast,PA,Suburban,51-65,2023-12,Q4_2023,2023,7.0,0.755,Stable
FIA002158,2023-12-05,Lisinopril,Prinivil,ACE Inhibitors,47019-971-36,Medicare Part D Plan B,PLAN_1867,2023,Specialty Tier,Tier 2,2023-03-15,265,Worsened,None,No,No,,50,160,-69.5,Decreased,141.12,36.06,105.06,125.86,266.98,13.35,0.0,0,0.2,0.054,0.351,0.401,11,0,14,12,2.4,5.1,4,Higher,Southwest,NC,Suburban,18-35,2023-12,Q4_2023,2023,8.8,0.434,Increasing
FIA000954,2023-12-06,Lisinopril,Prinivil,ACE Inhibitors,82980-887-11,Medicaid Plan X,PLAN_5179,2023,Tier 1,Tier 1,2023-08-26,102,No Change,None,No,No,,896,911,-1.6,Stable,16.32,17.64,-1.32,47.55,63.87,57.23,0.0,0,0.029,0.312,0.765,0.862,2,9,15,3,2.8,29.1,6,Lower,Midwest,OH,Rural,51-65,2023-12,Q4_2023,2023,3.4,0.566,Stable
FIA001651,2023-12-07,Lisinopril,Prinivil,ACE Inhibitors,37196-235-30,Medicare Part D Plan B,PLAN_8111,2023,Non-Formulary,Specialty Tier,2023-07-01,159,Worsened,Non-Formulary Status,No,No,,793,869,-8.7,Decreased,418.31,204.18,214.13,152.17,570.48,452.39,0.0,0,0.203,0.315,0.586,0.83,1,7,0,3,3.5,31.1,2,Higher,Midwest,IL,Suburban,51-65,2023-12,Q4_2023,2023,9.7,0.823,Increasing
FIA001361,2023-12-17,Lisinopril,Prinivil,ACE Inhibitors,14617-436-95,VA Plan,PLAN_4473,2023,Non-Formulary,Tier 3,2022-12-27,355,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,390,394,-0.9,Stable,576.01,75.44,500.57,82.93,658.94,256.99,0.0,0,0.222,0.219,0.499,0.9,3,1,16,3,3.8,24.4,3,Higher,Southwest,IL,Rural,75+,2023-12,Q4_2023,2023,4.1,0.564,Increasing
FIA001076,2023-12-19,Lisinopril,Prinivil,ACE Inhibitors,79354-862-37,Commercial Plan Alpha,PLAN_7328,2023,Specialty Tier,Specialty Tier,2023-08-29,112,No Change,None,No,No,,153,143,7.7,Increased,172.19,231.11,-58.92,79.32,251.51,38.48,0.0,0,0.137,0.223,0.219,0.812,2,6,14,3,2.3,18.0,5,Higher,West,OH,Rural,36-50,2023-12,Q4_2023,2023,9.6,0.007,Stable
FIA001484,2023-12-19,Lisinopril,Prinivil,ACE Inhibitors,74790-485-38,Medicare Part D Plan B,PLAN_8086,2023,Tier 2,Non-Formulary,2023-08-30,111,Improved,Quantity Limit,No,No,,1220,920,32.7,Increased,29.78,709.32,-679.54,144.31,174.09,212.39,0.0,0,0.063,0.154,0.448,0.727,1,3,12,10,2.7,35.0,8,Similar,Southeast,NY,Suburban,36-50,2023-12,Q4_2023,2023,9.9,0.256,Stable
FIA002078,2023-12-19,Lisinopril,Prinivil,ACE Inhibitors,56700-433-67,Medicaid Plan Y,PLAN_6126,2023,Tier 2,Non-Formulary,2023-10-02,78,Improved,None,No,No,,646,414,56.2,Increased,30.29,369.0,-338.71,133.14,163.43,105.58,0.0,0,0.065,0.133,0.79,0.526,0,6,11,8,2.2,28.8,8,Lower,Southwest,PA,Suburban,36-50,2023-12,Q4_2023,2023,2.1,0.485,Increasing
FIA002499,2023-12-29,Lisinopril,Prinivil,ACE Inhibitors,95353-355-41,Commercial Plan Alpha,PLAN_9887,2023,Non-Formulary,Tier 3,2023-05-30,213,Worsened,Non-Formulary Status,No,No,,817,883,-7.4,Decreased,308.51,94.27,214.24,52.59,361.1,295.02,0.0,0,0.134,0.307,0.423,0.787,15,8,13,15,3.9,26.3,7,Lower,Southeast,NY,Suburban,75+,2023-12,Q4_2023,2023,5.7,0.523,Stable
FIA002483,2023-12-31,Lisinopril,Prinivil,ACE Inhibitors,61590-981-64,Tricare Standard,PLAN_3041,2023,Non-Formulary,Non-Formulary,2023-03-16,290,No Change,Non-Formulary Status,No,No,,195,181,7.8,Increased,227.76,231.07,-3.31,190.89,418.65,81.64,0.0,0,0.253,0.162,0.67,0.51,0,10,14,11,3.7,15.2,5,Higher,Southwest,GA,Rural,66-75,2023-12,Q4_2023,2023,4.4,0.561,Increasing
FIA001168,2024-01-01,Lisinopril,Prinivil,ACE Inhibitors,73494-260-62,Medicaid Plan X,PLAN_9172,2024,Non-Formulary,Specialty Tier,2023-03-08,299,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,909,843,7.9,Increased,567.48,120.77,446.71,99.69,667.17,606.46,0.0,0,0.2,0.194,0.673,0.577,14,10,4,7,2.3,5.3,2,Higher,Midwest,CA,Rural,75+,2024-01,Q1_2024,2023,1.4,0.54,Stable
FIA001037,2024-01-04,Lisinopril,Prinivil,ACE Inhibitors,16397-545-11,VA Plan,PLAN_9717,2024,Tier 3,Specialty Tier,2023-03-28,282,Improved,None,No,No,,970,897,8.2,Increased,74.43,150.62,-76.19,167.14,241.57,234.32,0.0,0,0.04,0.356,0.847,0.615,13,2,14,11,4.4,29.1,5,Similar,West,NY,Rural,51-65,2024-01,Q1_2024,2023,9.1,0.865,Decreasing
FIA001555,2024-01-12,Lisinopril,Prinivil,ACE Inhibitors,59778-530-12,VA Plan,PLAN_9725,2024,Tier 3,Tier 3,2023-08-25,140,No Change,None,No,No,,465,449,3.8,Stable,51.8,92.86,-41.06,197.45,249.25,115.9,0.0,0,0.024,0.303,0.648,0.845,4,4,15,3,4.9,19.3,4,Similar,Northeast,CA,Rural,18-35,2024-01,Q1_2024,2023,7.0,0.077,Increasing
FIA001073,2024-01-22,Lisinopril,Prinivil,ACE Inhibitors,93513-878-97,Commercial Plan Beta,PLAN_2090,2024,Tier 1,Tier 1,2023-02-05,351,No Change,Quantity Limit,No,No,60.0,439,472,-7.0,Decreased,7.3,13.7,-6.4,170.41,177.71,78.01,0.0,0,0.027,0.319,0.616,0.498,5,7,1,5,2.7,21.5,5,Similar,Southeast,CA,Urban,36-50,2024-01,Q1_2024,2023,6.6,0.604,Increasing
FIA002705,2024-01-26,Lisinopril,Prinivil,ACE Inhibitors,10807-217-30,Medicare Part D Plan A,PLAN_9598,2024,Tier 3,Tier 1,2023-06-22,218,Worsened,None,No,No,,371,831,-55.2,Decreased,64.17,11.8,52.37,148.17,212.34,78.78,0.0,0,0.032,0.122,0.604,0.494,2,6,6,8,3.5,31.4,8,Similar,Midwest,PA,Urban,75+,2024-01,Q1_2024,2023,3.1,0.635,Decreasing
FIA000678,2024-01-30,Lisinopril,Prinivil,ACE Inhibitors,65050-960-27,Medicaid Plan X,PLAN_9876,2024,Tier 1,Specialty Tier,2023-02-19,345,Improved,None,No,No,,682,517,32.1,Increased,12.43,162.98,-150.55,47.43,59.86,40.82,0.0,0,0.067,0.198,0.513,0.563,4,6,12,0,2.4,15.6,2,Similar,West,IL,Urban,18-35,2024-01,Q1_2024,2023,4.4,0.199,Increasing
FIA001758,2024-02-02,Lisinopril,Prinivil,ACE Inhibitors,76894-336-74,Medicare Part D Plan A,PLAN_2601,2024,Specialty Tier,Tier 2,2023-06-11,236,Worsened,None,No,No,,348,563,-38.1,Decreased,102.29,43.71,58.58,63.28,165.57,57.62,0.0,0,0.079,0.073,0.422,0.482,4,0,20,15,3.8,34.6,5,Higher,West,NC,Rural,75+,2024-02,Q1_2024,2023,7.1,0.124,Decreasing
FIA002298,2024-02-02,Lisinopril,Prinivil,ACE Inhibitors,92946-142-18,VA Plan,PLAN_7561,2024,Tier 2,Tier 3,2023-03-08,331,Improved,None,No,No,,1205,760,58.7,Increased,35.62,97.79,-62.17,174.43,210.05,253.11,0.0,0,0.019,0.179,0.274,0.438,8,7,14,5,2.7,13.4,7,Similar,Southwest,OH,Suburban,66-75,2024-02,Q1_2024,2023,6.6,0.657,Decreasing
FIA000035,2024-02-06,Lisinopril,Prinivil,ACE Inhibitors,97819-225-62,Medicaid Plan Y,PLAN_7929,2024,Specialty Tier,Tier 1,2023-11-22,76,Worsened,None,No,No,,84,198,-57.2,Decreased,266.35,6.4,259.95,125.49,391.84,32.91,0.0,0,0.289,0.354,0.705,0.933,9,5,3,6,2.5,19.5,8,Lower,Midwest,NC,Suburban,18-35,2024-02,Q1_2024,2023,7.9,0.574,Stable
FIA001852,2024-02-12,Lisinopril,Prinivil,ACE Inhibitors,64931-845-24,Commercial Plan Alpha,PLAN_1153,2024,Tier 1,Tier 3,2023-09-19,146,Improved,None,No,No,,420,364,15.7,Increased,13.89,97.72,-83.83,191.0,204.89,86.05,0.0,0,0.015,0.17,0.89,0.551,9,4,14,11,2.7,11.0,2,Lower,Southwest,PA,Rural,18-35,2024-02,Q1_2024,2023,9.3,0.85,Increasing
FIA002042,2024-02-14,Lisinopril,Prinivil,ACE Inhibitors,66484-468-99,Commercial Plan Alpha,PLAN_1247,2024,Tier 2,Tier 2,2023-09-14,153,No Change,None,No,No,,471,494,-4.5,Stable,48.06,49.27,-1.21,145.59,193.65,91.21,0.0,0,0.029,0.177,0.566,0.688,1,7,6,4,3.1,23.0,5,Lower,West,CA,Suburban,66-75,2024-02,Q1_2024,2023,2.5,0.606,Stable
FIA000664,2024-03-03,Lisinopril,Prinivil,ACE Inhibitors,63501-281-34,Medicaid Plan Y,PLAN_7176,2024,Tier 2,Specialty Tier,2023-04-20,318,Improved,Quantity Limit,No,No,30.0,699,526,32.9,Increased,38.6,102.22,-63.62,126.76,165.36,115.59,0.0,0,0.076,0.256,0.716,0.835,7,3,10,15,4.6,17.0,6,Similar,Southwest,GA,Rural,36-50,2024-03,Q1_2024,2023,4.3,0.781,Increasing
FIA000395,2024-03-05,Lisinopril,Prinivil,ACE Inhibitors,37581-842-50,Medicare Part D Plan A,PLAN_1232,2024,Tier 1,Tier 1,2023-10-04,153,No Change,None,No,No,,794,856,-7.1,Decreased,11.54,10.56,0.98,195.67,207.21,164.52,0.0,0,0.045,0.382,0.439,0.923,5,5,14,6,4.7,6.7,5,Lower,Midwest,NC,Urban,36-50,2024-03,Q1_2024,2023,2.7,0.194,Decreasing
FIA000009,2024-03-21,Lisinopril,Prinivil,ACE Inhibitors,42018-478-46,Commercial Plan Alpha,PLAN_8179,2024,Tier 3,Specialty Tier,2023-09-12,191,Improved,None,No,No,,108,109,-0.8,Stable,96.45,287.15,-190.7,179.75,276.2,29.83,0.0,0,0.075,0.342,0.692,0.736,0,10,17,9,4.8,8.1,3,Similar,Northeast,TX,Rural,75+,2024-03,Q1_2024,2023,2.4,0.282,Increasing
FIA000336,2024-03-31,Lisinopril,Prinivil,ACE Inhibitors,87095-911-60,Commercial Plan Beta,PLAN_6114,2024,Tier 3,Tier 1,2024-01-22,69,Worsened,Step Therapy,No,Yes,,381,880,-56.6,Decreased,53.69,15.83,37.86,46.24,99.93,38.07,0.0,0,0.074,0.325,0.498,0.809,9,4,14,6,2.3,34.1,6,Similar,Southwest,PA,Suburban,18-35,2024-03,Q1_2024,2023,3.0,0.406,Stable
FIA002549,2024-03-31,Lisinopril,Prinivil,ACE Inhibitors,99076-537-84,Tricare Standard,PLAN_8393,2024,Tier 3,Specialty Tier,2024-02-10,50,Improved,Step Therapy,No,Yes,,992,939,5.7,Increased,59.28,235.23,-175.95,149.0,208.28,206.61,0.0,0,0.08,0.257,0.793,0.409,5,10,4,0,3.7,16.8,4,Higher,Southeast,IL,Urban,66-75,2024-03,Q1_2024,2023,7.3,0.622,Stable
FIA002088,2024-04-09,Lisinopril,Prinivil,ACE Inhibitors,70790-673-59,Commercial Plan Alpha,PLAN_7312,2024,Tier 3,Non-Formulary,2024-03-05,35,Improved,Prior Authorization,Yes,No,,588,592,-0.6,Stable,88.6,359.74,-271.14,136.3,224.9,132.24,0.494,4,0.014,0.346,0.808,0.545,2,3,10,1,2.6,30.2,5,Higher,Midwest,TX,Suburban,18-35,2024-04,Q2_2024,2023,2.6,0.843,Increasing
FIA002509,2024-04-09,Lisinopril,Prinivil,ACE Inhibitors,83984-494-15,Medicaid Plan X,PLAN_9305,2024,Tier 3,Tier 1,2023-08-05,248,Worsened,Step Therapy,No,Yes,,193,378,-48.8,Decreased,93.59,14.76,78.83,123.39,216.98,41.88,0.0,0,0.065,0.121,0.73,0.942,4,1,3,3,2.9,32.1,2,Similar,Northeast,NC,Suburban,75+,2024-04,Q2_2024,2023,6.3,0.249,Decreasing
FIA001174,2024-04-17,Lisinopril,Prinivil,ACE Inhibitors,90285-583-50,Medicare Part D Plan A,PLAN_7487,2024,Specialty Tier,Tier 1,2024-01-10,98,Worsened,Prior Authorization,Yes,No,,64,156,-58.7,Decreased,137.69,8.51,129.18,151.33,289.02,18.5,0.539,3,0.099,0.226,0.711,0.466,12,0,16,15,3.7,27.9,4,Higher,Southwest,NC,Rural,75+,2024-04,Q2_2024,2023,2.3,0.702,Stable
FIA002512,2024-04-29,Lisinopril,Prinivil,ACE Inhibitors,34884-834-54,Tricare Standard,PLAN_2223,2024,Tier 2,Tier 2,2024-02-24,65,No Change,None,No,No,,884,808,9.5,Increased,33.66,22.94,10.72,95.43,129.09,114.12,0.0,0,0.046,0.192,0.549,0.916,15,2,15,4,2.2,34.7,3,Higher,Midwest,IL,Suburban,51-65,2024-04,Q2_2024,2023,4.9,0.749,Increasing
FIA002687,2024-05-08,Lisinopril,Prinivil,ACE Inhibitors,16250-180-61,Commercial Plan Beta,PLAN_3421,2024,Specialty Tier,Non-Formulary,2023-10-14,207,Improved,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,,446,435,2.6,Stable,103.78,703.41,-599.63,38.31,142.09,63.37,0.528,1,0.145,0.067,0.676,0.491,6,9,12,1,3.5,10.7,3,Similar,Southwest,OH,Urban,51-65,2024-05,Q2_2024,2023,9.0,0.043,Increasing
FIA002872,2024-05-21,Lisinopril,Prinivil,ACE Inhibitors,79917-841-34,Commercial Plan Beta,PLAN_8095,2024,Tier 3,Tier 3,2024-01-25,117,No Change,Quantity Limit,No,No,90.0,669,686,-2.3,Stable,53.34,86.78,-33.44,39.68,93.02,62.23,0.0,0,0.054,0.288,0.47,0.82,12,0,16,10,4.1,21.5,6,Higher,Southeast,GA,Urban,18-35,2024-05,Q2_2024,2023,2.9,0.629,Decreasing
FIA000888,2024-05-22,Lisinopril,Prinivil,ACE Inhibitors,77553-314-88,Medicaid Plan Y,PLAN_1887,2024,Specialty Tier,Tier 3,2023-11-29,175,Worsened,Prior Authorization; Quantity Limit,Yes,No,90.0,599,562,6.6,Increased,230.84,64.89,165.95,140.88,371.72,222.66,0.23,10,0.135,0.296,0.601,0.636,10,7,16,7,4.8,19.9,5,Higher,West,TX,Suburban,66-75,2024-05,Q2_2024,2023,5.7,0.996,Increasing
FIA001964,2024-05-26,Lisinopril,Prinivil,ACE Inhibitors,25327-808-11,VA Plan,PLAN_9685,2024,Tier 3,Tier 3,2024-01-16,131,No Change,None,No,No,,442,421,5.1,Increased,53.97,56.16,-2.19,177.27,231.24,102.21,0.0,0,0.019,0.141,0.496,0.876,13,5,13,11,3.6,6.0,3,Higher,West,TX,Rural,18-35,2024-05,Q2_2024,2023,2.9,0.443,Decreasing
FIA001058,2024-06-04,Lisinopril,Prinivil,ACE Inhibitors,57433-956-24,Tricare Standard,PLAN_8496,2024,Tier 3,Specialty Tier,2023-07-02,338,Improved,Step Therapy; Quantity Limit,No,Yes,30.0,893,820,9.0,Increased,65.33,194.11,-128.78,103.37,168.7,150.65,0.0,0,0.03,0.202,0.595,0.861,1,1,0,4,4.0,32.9,8,Similar,Northeast,MI,Urban,75+,2024-06,Q2_2024,2023,3.8,0.72,Decreasing
FIA002691,2024-06-10,Lisinopril,Prinivil,ACE Inhibitors,34794-668-75,Medicaid Plan X,PLAN_8073,2024,Tier 1,Non-Formulary,2023-08-24,291,Improved,None,No,No,,1290,901,43.2,Increased,10.19,611.87,-601.68,154.26,164.45,212.14,0.0,0,0.054,0.25,0.516,0.855,7,8,9,14,5.0,16.6,4,Higher,Southeast,GA,Rural,66-75,2024-06,Q2_2024,2023,4.9,0.064,Decreasing
FIA001694,2024-06-15,Lisinopril,Prinivil,ACE Inhibitors,33533-531-52,Medicare Part D Plan A,PLAN_9643,2024,Specialty Tier,Tier 1,2024-04-29,47,Worsened,Prior Authorization; Quantity Limit,Yes,No,90.0,261,434,-39.9,Decreased,208.22,17.36,190.86,97.5,305.72,79.79,0.323,6,0.198,0.399,0.554,0.576,15,9,19,15,5.0,33.0,8,Lower,Southwest,OH,Rural,18-35,2024-06,Q2_2024,2023,6.6,0.33,Increasing
FIA001801,2024-06-15,Lisinopril,Prinivil,ACE Inhibitors,75214-154-29,Commercial Plan Alpha,PLAN_5791,2024,Tier 1,Tier 2,2023-09-14,275,Improved,None,No,No,,768,841,-8.6,Decreased,5.77,41.07,-35.3,110.76,116.53,89.5,0.0,0,0.074,0.078,0.75,0.63,3,0,17,6,2.0,11.2,3,Lower,West,TX,Suburban,36-50,2024-06,Q2_2024,2023,6.7,0.837,Increasing
FIA001381,2024-06-18,Lisinopril,Prinivil,ACE Inhibitors,44720-187-26,Medicare Part D Plan B,PLAN_1966,2024,Tier 2,Tier 1,2023-12-21,180,Worsened,None,No,No,,125,131,-4.3,Stable,47.53,7.59,39.94,79.16,126.69,15.84,0.0,0,0.077,0.21,0.67,0.551,6,1,0,11,3.1,5.3,2,Similar,West,NC,Suburban,75+,2024-06,Q2_2024,2023,3.8,0.387,Increasing
FIA002825,2024-06-20,Lisinopril,Prinivil,ACE Inhibitors,39335-531-52,Medicare Part D Plan A,PLAN_8705,2024,Specialty Tier,Tier 1,2024-04-19,62,Worsened,Step Therapy,No,Yes,,256,509,-49.6,Decreased,226.12,9.88,216.24,103.65,329.77,84.42,0.0,0,0.067,0.31,0.817,0.465,8,0,15,8,3.8,28.0,2,Lower,Southwest,NC,Urban,36-50,2024-06,Q2_2024,2023,4.9,0.044,Increasing
FIA002442,2024-06-23,Lisinopril,Prinivil,ACE Inhibitors,60183-548-91,Medicare Part D Plan A,PLAN_3238,2024,Specialty Tier,Tier 1,2024-02-10,134,Worsened,None,No,No,,401,980,-59.0,Decreased,142.96,17.21,125.75,34.67,177.63,71.23,0.0,0,0.198,0.127,0.271,0.652,10,0,16,3,2.0,12.3,3,Lower,Southwest,FL,Urban,75+,2024-06,Q2_2024,2023,4.7,0.132,Increasing
FIA002713,2024-07-04,Lisinopril,Prinivil,ACE Inhibitors,80713-776-58,Commercial Plan Beta,PLAN_9234,2024,Non-Formulary,Non-Formulary,2023-07-25,345,No Change,Non-Formulary Status; Quantity Limit,No,No,60.0,529,521,1.7,Stable,502.04,290.38,211.66,81.47,583.51,308.68,0.0,0,0.226,0.272,0.454,0.515,5,8,11,6,3.7,25.0,3,Similar,Northeast,NY,Rural,66-75,2024-07,Q3_2024,2023,1.4,0.666,Decreasing
FIA000225,2024-07-08,Lisinopril,Prinivil,ACE Inhibitors,21603-986-31,Medicare Part D Plan A,PLAN_6060,2024,Tier 3,Tier 1,2023-07-25,349,Worsened,None,No,No,,118,338,-65.0,Decreased,83.23,11.14,72.09,77.15,160.38,18.92,0.0,0,0.041,0.246,0.287,0.708,6,9,17,1,4.9,20.7,8,Similar,West,CA,Urban,75+,2024-07,Q3_2024,2023,2.6,0.019,Increasing
FIA000394,2024-07-08,Lisinopril,Prinivil,ACE Inhibitors,99247-832-98,VA Plan,PLAN_5666,2024,Tier 2,Tier 1,2023-07-18,356,Worsened,None,No,No,,907,910,-0.2,Stable,23.43,7.38,16.05,155.82,179.25,162.58,0.0,0,0.022,0.238,0.399,0.714,3,1,12,6,4.9,21.6,5,Lower,Southeast,NC,Urban,66-75,2024-07,Q3_2024,2023,5.3,0.111,Increasing
FIA001352,2024-07-16,Lisinopril,Prinivil,ACE Inhibitors,11068-473-84,Medicare Part D Plan A,PLAN_2968,2024,Non-Formulary,Tier 1,2024-03-22,116,Worsened,Non-Formulary Status; Quantity Limit,No,No,,251,427,-41.0,Decreased,342.8,18.18,324.62,32.27,375.07,94.14,0.0,0,0.061,0.052,0.373,0.4,6,7,17,4,3.6,16.9,6,Higher,Southwest,FL,Rural,36-50,2024-07,Q3_2024,2023,1.5,0.756,Increasing
FIA002842,2024-07-17,Lisinopril,Prinivil,ACE Inhibitors,10770-787-52,Medicare Part D Plan B,PLAN_1150,2024,Non-Formulary,Tier 3,2023-11-09,251,Worsened,Non-Formulary Status,No,No,,662,658,0.6,Stable,204.49,74.4,130.09,180.56,385.05,254.9,0.0,0,0.212,0.316,0.459,0.782,2,9,6,2,4.3,13.5,2,Similar,Northeast,TX,Rural,51-65,2024-07,Q3_2024,2023,5.5,0.128,Decreasing
FIA000971,2024-07-27,Lisinopril,Prinivil,ACE Inhibitors,94620-472-56,Tricare Standard,PLAN_4202,2024,Specialty Tier,Tier 3,2024-03-05,144,Worsened,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,30.0,658,621,6.0,Increased,234.93,52.86,182.07,142.98,377.91,248.66,0.41,8,0.167,0.213,0.283,0.775,9,10,19,3,4.5,19.0,5,Lower,Southeast,OH,Urban,75+,2024-07,Q3_2024,2023,4.8,0.34,Decreasing
FIA001664,2024-08-05,Lisinopril,Prinivil,ACE Inhibitors,93134-672-62,VA Plan,PLAN_9281,2024,Tier 2,Non-Formulary,2023-10-23,287,Improved,None,No,No,,481,304,58.2,Increased,28.46,546.94,-518.48,170.48,198.94,95.69,0.0,0,0.066,0.252,0.21,0.417,10,2,16,11,2.9,14.3,3,Lower,Midwest,FL,Rural,36-50,2024-08,Q3_2024,2023,7.7,0.425,Stable
FIA000437,2024-08-06,Lisinopril,Prinivil,ACE Inhibitors,88412-401-55,Tricare Standard,PLAN_1663,2024,Specialty Tier,Tier 1,2024-03-04,155,Worsened,None,No,No,,132,203,-34.8,Decreased,289.55,18.46,271.09,103.67,393.22,51.91,0.0,0,0.213,0.377,0.808,0.664,11,5,6,9,4.8,10.0,2,Lower,West,PA,Urban,18-35,2024-08,Q3_2024,2023,5.6,0.631,Stable
FIA001027,2024-08-08,Lisinopril,Prinivil,ACE Inhibitors,82655-608-80,Tricare Standard,PLAN_9046,2024,Tier 1,Specialty Tier,2023-12-29,223,Improved,None,No,No,,959,635,51.0,Increased,16.92,115.35,-98.43,189.96,206.88,198.4,0.0,0,0.063,0.198,0.715,0.905,2,3,16,15,3.4,7.3,8,Lower,West,NC,Urban,75+,2024-08,Q3_2024,2023,9.7,0.223,Stable
FIA002424,2024-08-08,Lisinopril,Prinivil,ACE Inhibitors,46742-454-35,Medicaid Plan X,PLAN_6673,2024,Non-Formulary,Non-Formulary,2024-01-26,195,No Change,Non-Formulary Status,No,No,,704,646,9.0,Increased,611.06,742.74,-131.68,169.9,780.96,549.8,0.0,0,0.108,0.109,0.778,0.689,11,2,3,9,3.2,8.7,7,Lower,Northeast,IL,Suburban,75+,2024-08,Q3_2024,2023,7.5,0.736,Decreasing
FIA000209,2024-08-16,Lisinopril,Prinivil,ACE Inhibitors,57263-540-46,Medicaid Plan X,PLAN_5321,2024,Tier 1,Tier 3,2023-10-20,301,Improved,None,No,No,,491,420,17.0,Increased,11.49,63.02,-51.53,171.92,183.41,90.05,0.0,0,0.071,0.231,0.505,0.491,15,2,17,14,2.2,9.5,3,Lower,Northeast,GA,Suburban,36-50,2024-08,Q3_2024,2023,7.4,0.436,Stable
FIA000313,2024-09-17,Lisinopril,Prinivil,ACE Inhibitors,28571-938-94,Commercial Plan Beta,PLAN_3797,2024,Tier 2,Non-Formulary,2024-04-07,163,Improved,None,No,No,,1415,979,44.6,Increased,44.65,608.79,-564.14,33.68,78.33,110.84,0.0,0,0.02,0.229,0.69,0.51,15,4,9,3,4.9,19.8,7,Similar,Southwest,OH,Rural,18-35,2024-09,Q3_2024,2023,5.2,0.813,Increasing
FIA002027,2024-09-22,Lisinopril,Prinivil,ACE Inhibitors,76086-133-32,Medicaid Plan Y,PLAN_7022,2024,Non-Formulary,Tier 1,2024-06-30,84,Worsened,Non-Formulary Status,No,No,,274,410,-33.1,Decreased,276.57,8.13,268.44,100.6,377.17,103.34,0.0,0,0.286,0.144,0.581,0.815,14,5,5,13,3.0,29.2,5,Lower,Northeast,IL,Suburban,36-50,2024-09,Q3_2024,2023,5.7,0.29,Increasing
FIA002359,2024-09-22,Lisinopril,Prinivil,ACE Inhibitors,96103-394-82,VA Plan,PLAN_1788,2024,Specialty Tier,Non-Formulary,2024-07-17,67,Improved,Prior Authorization; Step Therapy,Yes,Yes,,539,499,8.2,Increased,126.16,266.76,-140.6,44.49,170.65,91.98,0.216,7,0.142,0.202,0.513,0.945,13,4,15,2,2.4,11.3,7,Higher,Southwest,NC,Urban,51-65,2024-09,Q3_2024,2023,5.7,0.296,Stable
FIA000494,2024-10-01,Lisinopril,Prinivil,ACE Inhibitors,31981-477-46,Commercial Plan Beta,PLAN_2140,2024,Specialty Tier,Tier 2,2024-01-29,246,Worsened,None,No,No,,242,551,-56.0,Decreased,189.8,39.12,150.68,173.81,363.61,87.99,0.0,0,0.082,0.234,0.764,0.495,3,2,6,2,2.4,23.2,8,Higher,Northeast,PA,Rural,18-35,2024-10,Q4_2024,2024,1.5,0.738,Increasing
FIA000423,2024-10-02,Lisinopril,Prinivil,ACE Inhibitors,95704-280-58,Medicare Part D Plan A,PLAN_5952,2024,Specialty Tier,Tier 3,2024-06-11,113,Worsened,Prior Authorization,Yes,No,,494,536,-7.8,Decreased,107.96,80.06,27.9,156.57,264.53,130.68,0.225,3,0.147,0.128,0.806,0.721,15,3,14,3,2.3,9.2,7,Higher,West,CA,Suburban,66-75,2024-10,Q4_2024,2024,4.3,0.699,Increasing
FIA000278,2024-10-12,Lisinopril,Prinivil,ACE Inhibitors,34621-171-28,Medicare Part D Plan B,PLAN_7986,2024,Specialty Tier,Tier 2,2024-06-14,120,Worsened,Quantity Limit,No,No,30.0,600,846,-29.0,Decreased,137.77,34.72,103.05,146.85,284.62,170.77,0.0,0,0.254,0.209,0.652,0.621,4,0,19,3,3.1,5.6,8,Lower,Northeast,FL,Urban,18-35,2024-10,Q4_2024,2024,3.4,0.939,Decreasing
FIA000587,2024-10-15,Lisinopril,Prinivil,ACE Inhibitors,22347-241-51,Tricare Standard,PLAN_4344,2024,Tier 1,Tier 2,2024-02-28,230,Improved,None,No,No,,922,941,-2.0,Stable,10.65,40.88,-30.23,90.16,100.81,92.95,0.0,0,0.053,0.158,0.555,0.711,5,5,10,7,3.8,25.1,7,Higher,Northeast,GA,Rural,51-65,2024-10,Q4_2024,2024,9.0,0.579,Decreasing
FIA002165,2024-10-23,Lisinopril,Prinivil,ACE Inhibitors,54064-710-14,Medicare Part D Plan B,PLAN_4314,2024,Tier 1,Tier 1,2024-02-14,252,No Change,None,No,No,,882,911,-3.1,Stable,7.31,10.73,-3.42,107.71,115.02,101.45,0.0,0,0.013,0.114,0.772,0.594,14,0,20,9,2.9,30.7,8,Similar,West,FL,Urban,51-65,2024-10,Q4_2024,2024,7.8,0.795,Increasing
FIA002103,2024-10-31,Lisinopril,Prinivil,ACE Inhibitors,13827-437-62,VA Plan,PLAN_9233,2024,Tier 2,Specialty Tier,2023-12-11,325,Improved,None,No,No,,604,480,26.0,Increased,48.39,218.48,-170.09,137.95,186.34,112.55,0.0,0,0.019,0.058,0.519,0.902,5,6,14,10,4.9,15.6,3,Higher,West,CA,Suburban,36-50,2024-10,Q4_2024,2024,6.9,0.928,Increasing
FIA001070,2024-11-01,Lisinopril,Prinivil,ACE Inhibitors,29181-315-28,Medicaid Plan Y,PLAN_8338,2024,Tier 3,Tier 1,2024-01-05,301,Worsened,None,No,No,,179,442,-59.4,Decreased,66.35,13.69,52.66,126.15,192.5,34.46,0.0,0,0.036,0.307,0.311,0.535,9,6,17,5,3.4,6.6,7,Similar,Southwest,FL,Urban,36-50,2024-11,Q4_2024,2024,3.3,0.251,Stable
FIA001813,2024-11-02,Lisinopril,Prinivil,ACE Inhibitors,10903-378-68,Medicare Part D Plan B,PLAN_7244,2024,Non-Formulary,Tier 3,2024-05-24,162,Worsened,Non-Formulary Status,No,No,,1054,986,7.0,Increased,441.74,60.29,381.45,37.11,478.85,504.71,0.0,0,0.284,0.284,0.769,0.483,9,10,5,11,2.7,24.4,2,Lower,Southeast,NC,Rural,18-35,2024-11,Q4_2024,2024,6.3,0.012,Increasing
FIA001341,2024-11-04,Lisinopril,Prinivil,ACE Inhibitors,43847-666-91,Medicare Part D Plan A,PLAN_9769,2024,Tier 1,Specialty Tier,2024-07-08,119,Improved,None,No,No,,1010,801,26.2,Increased,19.73,291.33,-271.6,39.0,58.73,59.32,0.0,0,0.064,0.361,0.561,0.636,2,1,5,11,3.5,14.1,7,Lower,Northeast,OH,Suburban,66-75,2024-11,Q4_2024,2024,9.3,0.127,Increasing
FIA001580,2024-11-25,Lisinopril,Prinivil,ACE Inhibitors,49438-855-39,Medicare Part D Plan A,PLAN_5489,2024,Tier 1,Tier 2,2024-08-29,88,Improved,None,No,No,,960,958,0.2,Stable,15.56,40.92,-25.36,171.27,186.83,179.36,0.0,0,0.07,0.316,0.416,0.712,9,2,10,13,2.7,22.4,8,Lower,Northeast,TX,Rural,66-75,2024-11,Q4_2024,2024,4.8,0.72,Decreasing
FIA002465,2024-12-05,Lisinopril,Prinivil,ACE Inhibitors,40347-695-93,Tricare Standard,PLAN_1157,2024,Tier 1,Tier 3,2024-04-29,220,Improved,None,No,No,,1410,995,41.7,Increased,16.08,64.04,-47.96,149.37,165.45,233.28,0.0,0,0.01,0.309,0.866,0.663,1,4,19,4,2.5,5.4,8,Similar,Southwest,TX,Rural,36-50,2024-12,Q4_2024,2024,1.9,0.671,Decreasing
FIA001622,2024-12-10,Lisinopril,Prinivil,ACE Inhibitors,33030-544-73,VA Plan,PLAN_6535,2024,Tier 2,Tier 2,2024-03-12,273,No Change,None,No,No,,643,679,-5.2,Decreased,27.05,47.03,-19.98,187.52,214.57,137.97,0.0,0,0.058,0.207,0.513,0.755,11,4,12,0,4.2,27.7,3,Lower,Southwest,NY,Urban,18-35,2024-12,Q4_2024,2024,3.2,0.003,Stable
FIA001268,2024-12-15,Lisinopril,Prinivil,ACE Inhibitors,74766-201-56,Medicaid Plan Y,PLAN_4668,2024,Specialty Tier,Tier 2,2024-01-11,339,Worsened,Prior Authorization,Yes,No,,343,460,-25.2,Decreased,103.57,32.58,70.99,166.16,269.73,92.52,0.564,4,0.162,0.386,0.249,0.756,7,1,6,9,4.5,14.9,5,Lower,West,OH,Rural,18-35,2024-12,Q4_2024,2024,8.7,0.379,Decreasing
FIA000547,2025-01-04,Lisinopril,Prinivil,ACE Inhibitors,78799-865-24,Medicare Part D Plan B,PLAN_7905,2025,Tier 2,Tier 2,2024-09-17,109,No Change,None,No,No,,384,385,-0.3,Stable,21.77,22.66,-0.89,187.17,208.94,80.23,0.0,0,0.061,0.391,0.87,0.718,6,0,4,0,2.4,24.0,2,Similar,Southeast,NY,Urban,36-50,2025-01,Q1_2025,2024,7.5,0.498,Increasing
FIA002528,2025-01-06,Lisinopril,Prinivil,ACE Inhibitors,32668-724-41,Commercial Plan Alpha,PLAN_9016,2025,Tier 1,Non-Formulary,2024-09-12,116,Improved,None,No,No,,667,461,44.7,Increased,11.67,742.67,-731.0,173.12,184.79,123.25,0.0,0,0.065,0.201,0.367,0.949,1,2,5,6,4.5,21.5,6,Similar,Northeast,TX,Urban,66-75,2025-01,Q1_2025,2024,1.3,0.516,Decreasing
FIA001670,2025-01-08,Lisinopril,Prinivil,ACE Inhibitors,47762-267-52,Medicaid Plan X,PLAN_3923,2025,Tier 3,Specialty Tier,2024-12-05,34,Improved,None,No,No,,554,610,-9.1,Decreased,75.45,105.02,-29.57,62.82,138.27,76.6,0.0,0,0.029,0.287,0.675,0.433,5,6,19,3,3.9,29.7,7,Similar,Southwest,OH,Suburban,75+,2025-01,Q1_2025,2024,6.6,0.922,Increasing
FIA001324,2025-01-23,Lisinopril,Prinivil,ACE Inhibitors,94768-481-78,Tricare Standard,PLAN_8869,2025,Non-Formulary,Tier 1,2024-08-30,146,Worsened,Non-Formulary Status,No,No,,352,712,-50.5,Decreased,388.49,12.85,375.64,125.17,513.66,180.81,0.0,0,0.276,0.211,0.823,0.658,0,1,6,6,4.5,23.0,3,Similar,Southwest,GA,Rural,66-75,2025-01,Q1_2025,2024,7.2,0.304,Decreasing
FIA000201,2025-01-26,Lisinopril,Prinivil,ACE Inhibitors,90533-973-65,Medicare Part D Plan A,PLAN_9556,2025,Tier 1,Non-Formulary,2024-09-23,125,Improved,None,No,No,,1399,943,48.4,Increased,13.65,327.77,-314.12,120.56,134.21,187.76,0.0,0,0.076,0.12,0.524,0.532,9,6,13,10,4.6,32.3,7,Lower,Southwest,PA,Suburban,36-50,2025-01,Q1_2025,2024,3.3,0.601,Stable
FIA001520,2025-03-07,Lisinopril,Prinivil,ACE Inhibitors,68804-521-72,VA Plan,PLAN_3495,2025,Non-Formulary,Specialty Tier,2025-01-09,57,Worsened,Non-Formulary Status,No,No,,691,634,9.1,Increased,380.61,163.47,217.14,157.68,538.29,371.96,0.0,0,0.086,0.09,0.646,0.872,10,4,20,10,3.2,7.0,4,Higher,Southeast,TX,Suburban,36-50,2025-03,Q1_2025,2024,9.4,0.916,Decreasing
FIA002745,2025-03-14,Lisinopril,Prinivil,ACE Inhibitors,99173-139-19,Commercial Plan Alpha,PLAN_3583,2025,Tier 2,Tier 3,2024-06-30,257,Improved,None,No,No,,1286,851,51.1,Increased,27.14,82.84,-55.7,93.08,120.22,154.6,0.0,0,0.073,0.216,0.865,0.909,13,7,20,0,2.7,5.4,8,Lower,Southwest,TX,Rural,18-35,2025-03,Q1_2025,2024,9.7,0.529,Increasing
FIA002003,2025-03-20,Lisinopril,Prinivil,ACE Inhibitors,25111-723-53,Medicaid Plan Y,PLAN_8905,2025,Tier 1,Specialty Tier,2024-10-23,148,Improved,None,No,No,,727,547,33.1,Increased,11.65,282.83,-271.18,110.47,122.12,88.78,0.0,0,0.073,0.108,0.23,0.546,7,8,13,10,2.2,16.5,5,Higher,Southeast,GA,Urban,66-75,2025-03,Q1_2025,2024,2.5,0.837,Decreasing
FIA000475,2025-03-21,Lisinopril,Prinivil,ACE Inhibitors,91852-686-58,Medicaid Plan X,PLAN_8474,2025,Tier 1,Specialty Tier,2024-10-12,160,Improved,None,No,No,,1240,874,41.9,Increased,13.74,133.12,-119.38,101.53,115.27,142.93,0.0,0,0.076,0.081,0.566,0.48,11,9,12,7,2.4,22.0,4,Lower,West,PA,Rural,75+,2025-03,Q1_2025,2024,8.1,0.857,Increasing
FIA000533,2025-03-29,Lisinopril,Prinivil,ACE Inhibitors,54849-519-45,Medicare Part D Plan A,PLAN_8526,2025,Tier 2,Tier 3,2024-06-18,284,Improved,None,No,No,,185,118,57.2,Increased,44.92,85.52,-40.6,67.32,112.24,20.76,0.0,0,0.054,0.11,0.779,0.553,15,2,16,5,4.8,23.3,7,Similar,Northeast,CA,Urban,66-75,2025-03,Q1_2025,2024,5.7,0.945,Decreasing
FIA000051,2025-04-04,Lisinopril,Prinivil,ACE Inhibitors,85598-371-93,Commercial Plan Beta,PLAN_7825,2025,Tier 2,Non-Formulary,2024-04-30,339,Improved,None,No,No,,216,142,52.1,Increased,30.13,754.36,-724.23,139.05,169.18,36.54,0.0,0,0.013,0.266,0.221,0.889,9,10,9,15,2.7,29.2,5,Similar,Southwest,TX,Rural,18-35,2025-04,Q2_2025,2024,2.4,0.416,Stable
FIA001216,2025-04-04,Lisinopril,Prinivil,ACE Inhibitors,68820-809-48,Commercial Plan Alpha,PLAN_5891,2025,Tier 1,Tier 1,2024-10-10,176,No Change,Quantity Limit,No,No,90.0,210,232,-9.1,Decreased,19.77,10.57,9.2,170.78,190.55,40.02,0.0,0,0.037,0.246,0.852,0.534,11,5,1,13,4.8,30.0,6,Higher,West,CA,Suburban,36-50,2025-04,Q2_2025,2024,4.5,0.915,Stable
FIA001887,2025-04-10,Lisinopril,Prinivil,ACE Inhibitors,86394-665-14,Medicare Part D Plan B,PLAN_5934,2025,Specialty Tier,Tier 1,2024-12-27,104,Worsened,Step Therapy,No,Yes,,323,481,-32.8,Decreased,215.36,17.11,198.25,74.81,290.17,93.72,0.0,0,0.274,0.212,0.579,0.703,6,6,6,3,3.0,23.7,4,Higher,Southwest,OH,Rural,75+,2025-04,Q2_2025,2024,7.5,0.107,Increasing
FIA002000,2025-04-12,Lisinopril,Prinivil,ACE Inhibitors,17327-181-24,VA Plan,PLAN_3831,2025,Tier 1,Tier 1,2024-06-14,302,No Change,None,No,No,,881,896,-1.6,Stable,13.42,12.29,1.13,168.34,181.76,160.13,0.0,0,0.05,0.345,0.852,0.448,13,8,1,14,2.7,10.2,6,Lower,West,GA,Suburban,18-35,2025-04,Q2_2025,2024,5.1,0.15,Decreasing
FIA002462,2025-04-14,Lisinopril,Prinivil,ACE Inhibitors,94342-740-46,Medicare Part D Plan A,PLAN_4477,2025,Specialty Tier,Non-Formulary,2025-01-03,101,Improved,None,No,No,,790,829,-4.6,Stable,238.1,653.26,-415.16,41.18,279.28,220.63,0.0,0,0.149,0.351,0.429,0.723,11,7,7,1,2.0,19.2,5,Similar,Southeast,PA,Rural,36-50,2025-04,Q2_2025,2024,3.7,0.192,Decreasing
FIA000882,2025-04-15,Lisinopril,Prinivil,ACE Inhibitors,35577-225-52,Commercial Plan Alpha,PLAN_6429,2025,Tier 3,Tier 1,2025-01-15,90,Worsened,Prior Authorization,Yes,No,,55,118,-52.7,Decreased,67.93,9.77,58.16,152.2,220.13,12.11,0.453,6,0.017,0.106,0.371,0.489,1,5,16,6,5.0,24.4,7,Similar,Southeast,IL,Suburban,18-35,2025-04,Q2_2025,2024,9.6,0.851,Stable
FIA001049,2025-04-22,Lisinopril,Prinivil,ACE Inhibitors,34194-174-29,Commercial Plan Beta,PLAN_1079,2025,Tier 1,Tier 2,2025-01-01,111,Improved,None,No,No,,474,450,5.5,Increased,12.04,26.25,-14.21,112.24,124.28,58.91,0.0,0,0.037,0.059,0.746,0.652,11,9,3,11,2.7,26.2,3,Similar,Southwest,OH,Urban,18-35,2025-04,Q2_2025,2024,6.2,0.784,Increasing
FIA000839,2025-04-23,Lisinopril,Prinivil,ACE Inhibitors,62597-524-36,Commercial Plan Alpha,PLAN_9846,2025,Tier 2,Tier 1,2024-11-17,157,Worsened,None,No,No,,145,135,8.0,Increased,46.63,18.76,27.87,85.42,132.05,19.15,0.0,0,0.06,0.334,0.596,0.827,5,8,15,6,4.5,26.0,4,Lower,Midwest,MI,Suburban,66-75,2025-04,Q2_2025,2024,2.6,0.817,Stable
FIA000126,2025-04-24,Lisinopril,Prinivil,ACE Inhibitors,77717-515-86,Medicare Part D Plan A,PLAN_5644,2025,Specialty Tier,Tier 1,2024-11-21,154,Worsened,Step Therapy,No,Yes,,193,264,-26.7,Decreased,108.63,13.6,95.03,186.82,295.45,57.02,0.0,0,0.092,0.382,0.352,0.734,15,7,5,7,4.5,23.0,8,Higher,Southeast,MI,Rural,75+,2025-04,Q2_2025,2024,3.4,0.724,Stable
FIA002521,2025-04-25,Lisinopril,Prinivil,ACE Inhibitors,32807-670-11,Commercial Plan Beta,PLAN_2626,2025,Tier 1,Tier 3,2024-08-05,263,Improved,None,No,No,,1065,736,44.8,Increased,10.71,57.91,-47.2,146.93,157.64,167.89,0.0,0,0.051,0.276,0.231,0.879,9,6,3,14,3.0,32.7,5,Similar,West,MI,Urban,75+,2025-04,Q2_2025,2024,6.7,0.775,Stable
FIA000673,2025-05-06,Lisinopril,Prinivil,ACE Inhibitors,29039-930-59,VA Plan,PLAN_2642,2025,Tier 1,Tier 1,2024-06-04,336,No Change,Quantity Limit,No,No,,1001,959,4.5,Stable,15.49,6.39,9.1,63.95,79.44,79.52,0.0,0,0.016,0.167,0.393,0.586,1,5,5,12,2.7,24.7,2,Higher,Southwest,CA,Suburban,66-75,2025-05,Q2_2025,2024,8.2,0.672,Increasing
FIA001899,2025-05-29,Lisinopril,Prinivil,ACE Inhibitors,54122-339-90,Tricare Standard,PLAN_6158,2025,Non-Formulary,Non-Formulary,2024-11-29,181,No Change,Non-Formulary Status,No,No,,926,913,1.4,Stable,696.11,669.47,26.64,146.81,842.92,780.54,0.0,0,0.106,0.345,0.276,0.914,0,7,4,2,4.5,14.5,6,Higher,West,CA,Suburban,66-75,2025-05,Q2_2025,2024,1.0,0.915,Increasing
FIA001825,2025-05-30,Lisinopril,Prinivil,ACE Inhibitors,71141-968-96,VA Plan,PLAN_2502,2025,Specialty Tier,Non-Formulary,2024-10-08,234,Improved,Prior Authorization,Yes,No,,334,334,0.1,Stable,112.11,266.3,-154.19,170.33,282.44,94.33,0.148,5,0.186,0.106,0.754,0.476,9,3,13,15,3.4,26.2,8,Similar,Northeast,TX,Urban,75+,2025-05,Q2_2025,2024,1.4,0.632,Increasing
FIA002140,2025-05-31,Lisinopril,Prinivil,ACE Inhibitors,34434-682-40,Medicaid Plan X,PLAN_1185,2025,Specialty Tier,Tier 2,2024-06-10,355,Worsened,Prior Authorization,Yes,No,,143,288,-50.2,Decreased,203.51,20.78,182.73,41.86,245.37,35.09,0.265,10,0.262,0.322,0.603,0.594,14,8,18,11,3.9,13.2,7,Similar,West,NC,Rural,18-35,2025-05,Q2_2025,2024,7.8,0.442,Increasing
FIA002369,2025-06-09,Lisinopril,Prinivil,ACE Inhibitors,14729-568-45,Commercial Plan Beta,PLAN_9663,2025,Tier 1,Tier 1,2024-06-15,359,No Change,None,No,No,,1040,986,5.5,Increased,12.65,12.65,0.0,176.43,189.08,196.64,0.0,0,0.026,0.37,0.736,0.755,5,9,1,7,4.8,34.8,7,Similar,Midwest,TX,Suburban,51-65,2025-06,Q2_2025,2024,4.8,0.852,Stable
FIA000138,2025-06-19,Lisinopril,Prinivil,ACE Inhibitors,96972-465-51,Tricare Standard,PLAN_8654,2025,Tier 1,Specialty Tier,2024-12-13,188,Improved,None,No,No,,791,553,43.2,Increased,8.44,247.52,-239.08,34.86,43.3,34.25,0.0,0,0.069,0.391,0.578,0.55,14,2,17,5,3.8,18.7,7,Higher,West,OH,Rural,75+,2025-06,Q2_2025,2024,3.8,0.347,Decreasing
FIA001775,2025-07-24,Lisinopril,Prinivil,ACE Inhibitors,36900-771-49,Commercial Plan Beta,PLAN_7552,2025,Tier 3,Tier 1,2025-01-30,175,Worsened,Step Therapy; Quantity Limit,No,Yes,,199,262,-23.8,Decreased,65.17,5.31,59.86,180.33,245.5,48.85,0.0,0,0.08,0.146,0.455,0.418,5,9,0,8,2.7,32.4,6,Similar,West,OH,Suburban,66-75,2025-07,Q3_2025,2024,4.9,0.383,Stable
FIA000384,2025-08-02,Lisinopril,Prinivil,ACE Inhibitors,76338-817-92,Medicaid Plan X,PLAN_9818,2025,Specialty Tier,Tier 2,2025-02-18,165,Worsened,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,30.0,176,445,-60.3,Decreased,271.2,34.56,236.64,128.91,400.11,70.42,0.261,7,0.078,0.266,0.253,0.451,12,4,4,10,3.6,16.9,5,Lower,Midwest,MI,Rural,18-35,2025-08,Q3_2025,2024,3.9,0.225,Increasing
FIA002610,2025-08-02,Lisinopril,Prinivil,ACE Inhibitors,72514-975-60,Tricare Standard,PLAN_7538,2025,Tier 3,Non-Formulary,2025-01-31,183,Improved,Prior Authorization,Yes,No,,972,941,3.3,Stable,89.26,519.38,-430.12,135.94,225.2,218.89,0.328,1,0.057,0.382,0.739,0.827,9,0,2,3,4.7,13.7,3,Lower,Midwest,PA,Rural,75+,2025-08,Q3_2025,2024,1.0,0.224,Stable
FIA002142,2025-08-08,Lisinopril,Prinivil,ACE Inhibitors,77035-542-10,VA Plan,PLAN_3655,2025,Tier 1,Tier 2,2025-06-27,42,Improved,None,No,No,,136,151,-9.6,Decreased,16.55,30.67,-14.12,66.02,82.57,11.23,0.0,0,0.037,0.128,0.646,0.464,7,8,15,9,2.9,19.8,3,Lower,Midwest,NY,Suburban,75+,2025-08,Q3_2025,2024,4.8,0.944,Stable
FIA000027,2025-08-28,Lisinopril,Prinivil,ACE Inhibitors,30232-176-70,Medicaid Plan X,PLAN_6546,2025,Specialty Tier,Tier 1,2025-05-26,94,Worsened,Prior Authorization; Quantity Limit,Yes,No,90.0,742,990,-25.0,Decreased,200.46,13.85,186.61,178.06,378.52,280.86,0.108,2,0.086,0.348,0.797,0.873,12,5,20,15,4.6,6.1,2,Lower,Midwest,NY,Rural,18-35,2025-08,Q3_2025,2024,4.9,0.098,Decreasing
FIA001251,2025-08-28,Lisinopril,Prinivil,ACE Inhibitors,79457-159-81,Commercial Plan Alpha,PLAN_4297,2025,Specialty Tier,Tier 1,2025-05-08,112,Worsened,Prior Authorization,Yes,No,,307,618,-50.3,Decreased,192.82,12.15,180.67,112.54,305.36,93.75,0.278,4,0.293,0.359,0.23,0.653,2,9,18,5,2.9,20.0,7,Higher,Southwest,IL,Urban,75+,2025-08,Q3_2025,2024,7.2,0.396,Increasing
FIA000005,2022-01-02,Losartan,Cozaar,ARBs,19071-878-78,Commercial Plan Alpha,PLAN_3103,2022,Tier 3,Specialty Tier,2021-11-24,39,Improved,Step Therapy; Quantity Limit,No,Yes,90.0,1009,951,6.1,Increased,55.59,172.6,-117.01,112.62,168.21,169.72,0.0,0,0.016,0.381,0.316,0.69,13,3,17,6,4.1,17.0,7,Higher,Midwest,GA,Rural,66-75,2022-01,Q1_2022,2021,2.1,0.225,Stable
FIA001252,2022-01-07,Losartan,Cozaar,ARBs,11477-114-58,VA Plan,PLAN_9260,2022,Non-Formulary,Specialty Tier,2021-09-03,126,Worsened,Non-Formulary Status; Quantity Limit,No,No,,749,802,-6.5,Decreased,442.26,205.48,236.78,127.58,569.84,426.81,0.0,0,0.186,0.356,0.312,0.723,9,2,11,5,3.6,13.0,4,Higher,Northeast,OH,Rural,18-35,2022-01,Q1_2022,2021,7.1,0.597,Increasing
FIA001591,2022-01-07,Losartan,Cozaar,ARBs,46559-506-67,VA Plan,PLAN_2116,2022,Non-Formulary,Tier 1,2021-02-19,322,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,354,748,-52.6,Decreased,566.5,18.91,547.59,165.77,732.27,259.22,0.0,0,0.175,0.057,0.602,0.465,1,3,11,12,4.2,9.9,5,Higher,Southwest,FL,Urban,18-35,2022-01,Q1_2022,2021,9.8,0.726,Decreasing
FIA000158,2022-01-08,Losartan,Cozaar,ARBs,88656-106-41,Medicaid Plan X,PLAN_4401,2022,Tier 3,Tier 1,2021-04-19,264,Worsened,Prior Authorization,Yes,No,,738,926,-20.3,Decreased,74.88,12.48,62.4,43.5,118.38,87.36,0.338,1,0.039,0.115,0.239,0.592,4,0,18,9,3.0,7.6,2,Similar,Southeast,FL,Rural,51-65,2022-01,Q1_2022,2021,6.5,0.692,Decreasing
FIA002416,2022-01-10,Losartan,Cozaar,ARBs,48289-297-70,Tricare Standard,PLAN_3055,2022,Tier 3,Non-Formulary,2021-07-19,175,Improved,None,No,No,,927,887,4.6,Stable,85.24,435.42,-350.18,121.65,206.89,191.79,0.0,0,0.049,0.386,0.252,0.512,2,8,10,2,4.1,14.4,3,Lower,West,GA,Urban,18-35,2022-01,Q1_2022,2021,3.3,0.707,Stable
FIA001046,2022-01-11,Losartan,Cozaar,ARBs,68368-282-74,VA Plan,PLAN_6556,2022,Tier 3,Non-Formulary,2021-10-24,79,Improved,None,No,No,,781,733,6.6,Increased,65.18,225.86,-160.68,96.87,162.05,126.56,0.0,0,0.03,0.087,0.838,0.558,4,0,9,7,4.0,13.1,7,Similar,Northeast,PA,Suburban,36-50,2022-01,Q1_2022,2021,2.0,0.877,Stable
FIA000343,2022-01-12,Losartan,Cozaar,ARBs,43166-380-90,Medicare Part D Plan A,PLAN_1498,2022,Tier 3,Tier 3,2021-10-26,78,No Change,None,No,No,,665,614,8.4,Increased,95.55,95.79,-0.24,148.23,243.78,162.11,0.0,0,0.013,0.352,0.849,0.948,14,7,5,15,4.2,24.4,6,Lower,Northeast,IL,Urban,75+,2022-01,Q1_2022,2021,9.0,0.153,Decreasing
FIA000959,2022-01-14,Losartan,Cozaar,ARBs,19844-387-13,Tricare Standard,PLAN_9388,2022,Tier 1,Tier 2,2021-02-22,326,Improved,None,No,No,,814,862,-5.5,Decreased,9.06,27.74,-18.68,148.72,157.78,128.43,0.0,0,0.029,0.128,0.686,0.84,6,10,20,14,4.6,19.5,8,Higher,Southeast,PA,Urban,36-50,2022-01,Q1_2022,2021,1.9,0.115,Decreasing
FIA002476,2022-01-14,Losartan,Cozaar,ARBs,98896-960-80,Medicare Part D Plan B,PLAN_5360,2022,Tier 3,Specialty Tier,2021-08-24,143,Improved,None,No,No,,654,666,-1.7,Stable,65.14,206.17,-141.03,181.78,246.92,161.49,0.0,0,0.071,0.305,0.599,0.781,4,1,5,0,2.6,23.8,6,Higher,Southeast,GA,Urban,66-75,2022-01,Q1_2022,2021,8.4,0.2,Stable
FIA000786,2022-01-17,Losartan,Cozaar,ARBs,93399-237-48,Medicaid Plan Y,PLAN_2529,2022,Non-Formulary,Tier 3,2021-10-27,82,Worsened,Non-Formulary Status; Quantity Limit,No,No,,740,735,0.8,Stable,385.36,67.58,317.78,84.39,469.75,347.62,0.0,0,0.167,0.228,0.777,0.612,2,10,2,0,3.9,14.5,4,Higher,Midwest,FL,Rural,75+,2022-01,Q1_2022,2021,6.3,0.175,Decreasing
FIA002098,2022-02-02,Losartan,Cozaar,ARBs,87723-993-64,VA Plan,PLAN_4653,2022,Tier 3,Non-Formulary,2021-06-15,232,Improved,Step Therapy,No,Yes,,654,699,-6.3,Decreased,62.22,374.38,-312.16,128.85,191.07,124.96,0.0,0,0.028,0.257,0.808,0.647,4,10,12,13,2.6,20.1,7,Higher,Northeast,FL,Urban,75+,2022-02,Q1_2022,2021,8.9,0.027,Increasing
FIA002454,2022-02-02,Losartan,Cozaar,ARBs,48613-325-62,Medicaid Plan X,PLAN_5597,2022,Tier 3,Specialty Tier,2021-07-31,186,Improved,None,No,No,,700,721,-2.9,Stable,69.1,127.63,-58.53,76.88,145.98,102.19,0.0,0,0.033,0.254,0.534,0.942,15,9,0,15,4.2,32.9,7,Similar,West,NC,Urban,75+,2022-02,Q1_2022,2021,7.8,0.671,Decreasing
FIA000006,2022-02-13,Losartan,Cozaar,ARBs,77391-343-45,Tricare Standard,PLAN_4510,2022,Non-Formulary,Tier 2,2021-03-19,331,Worsened,Non-Formulary Status,No,No,,574,746,-22.9,Decreased,332.13,22.13,310.0,86.17,418.3,240.1,0.0,0,0.058,0.239,0.706,0.885,15,3,15,13,2.6,7.9,5,Similar,Southwest,OH,Suburban,18-35,2022-02,Q1_2022,2021,7.1,0.984,Increasing
FIA002732,2022-02-22,Losartan,Cozaar,ARBs,98957-217-38,Commercial Plan Beta,PLAN_3185,2022,Tier 1,Non-Formulary,2022-01-09,44,Improved,None,No,No,,325,229,42.0,Increased,11.94,470.54,-458.6,36.44,48.38,15.72,0.0,0,0.061,0.217,0.21,0.463,3,4,16,6,3.4,30.0,3,Similar,Southwest,GA,Urban,75+,2022-02,Q1_2022,2021,8.9,0.605,Decreasing
FIA001171,2022-02-24,Losartan,Cozaar,ARBs,51560-694-24,Medicare Part D Plan B,PLAN_8193,2022,Specialty Tier,Non-Formulary,2021-06-21,248,Improved,Step Therapy,No,Yes,,504,463,9.0,Increased,132.77,245.62,-112.85,120.55,253.32,127.67,0.0,0,0.054,0.313,0.539,0.796,12,6,11,6,3.8,24.4,6,Similar,West,GA,Suburban,75+,2022-02,Q1_2022,2021,7.7,0.683,Stable
FIA001532,2022-02-25,Losartan,Cozaar,ARBs,12151-434-18,Medicaid Plan X,PLAN_1470,2022,Non-Formulary,Non-Formulary,2021-05-10,291,No Change,Non-Formulary Status,No,No,,827,816,1.4,Stable,457.24,739.63,-282.39,83.21,540.45,446.95,0.0,0,0.269,0.159,0.729,0.811,11,9,15,11,2.8,30.1,8,Similar,Southeast,OH,Suburban,75+,2022-02,Q1_2022,2021,6.1,0.1,Increasing
FIA001207,2022-03-08,Losartan,Cozaar,ARBs,89377-750-32,Medicaid Plan X,PLAN_2260,2022,Tier 3,Specialty Tier,2021-04-20,322,Improved,None,No,No,,369,373,-1.1,Stable,57.66,113.48,-55.82,179.39,237.05,87.47,0.0,0,0.024,0.199,0.645,0.45,11,4,1,12,2.5,19.6,7,Higher,Northeast,NC,Rural,18-35,2022-03,Q1_2022,2021,4.5,0.799,Increasing
FIA001462,2022-03-09,Losartan,Cozaar,ARBs,82828-827-32,Medicaid Plan Y,PLAN_7839,2022,Non-Formulary,Tier 3,2021-09-08,182,Worsened,Non-Formulary Status,No,No,,512,473,8.4,Increased,245.05,64.93,180.12,106.81,351.86,180.15,0.0,0,0.099,0.377,0.739,0.595,13,4,15,13,3.3,15.7,7,Similar,Southwest,GA,Rural,18-35,2022-03,Q1_2022,2021,3.9,0.561,Stable
FIA001517,2022-03-14,Losartan,Cozaar,ARBs,16944-316-20,Medicare Part D Plan A,PLAN_8162,2022,Tier 2,Tier 3,2021-05-27,291,Improved,None,No,No,,337,216,56.4,Increased,25.5,86.8,-61.3,186.56,212.06,71.46,0.0,0,0.058,0.189,0.397,0.64,11,1,16,8,3.4,28.7,5,Higher,West,GA,Rural,75+,2022-03,Q1_2022,2021,5.6,0.305,Decreasing
FIA001259,2022-03-16,Losartan,Cozaar,ARBs,52346-416-53,Medicaid Plan X,PLAN_5073,2022,Specialty Tier,Tier 1,2021-09-22,175,Worsened,None,No,No,,740,977,-24.2,Decreased,220.97,5.54,215.43,130.79,351.76,260.3,0.0,0,0.259,0.064,0.267,0.887,8,6,4,15,4.2,30.9,7,Higher,Southeast,CA,Rural,51-65,2022-03,Q1_2022,2021,2.6,0.714,Stable
FIA001419,2022-03-19,Losartan,Cozaar,ARBs,93507-161-10,Medicare Part D Plan B,PLAN_2053,2022,Specialty Tier,Tier 3,2021-12-10,99,Worsened,Prior Authorization,Yes,No,,164,178,-7.4,Decreased,286.28,70.57,215.71,149.46,435.74,71.46,0.249,3,0.072,0.298,0.353,0.783,3,6,14,12,3.0,16.1,5,Higher,Southwest,NY,Urban,36-50,2022-03,Q1_2022,2021,5.9,0.647,Increasing
FIA002129,2022-03-28,Losartan,Cozaar,ARBs,91793-988-32,Tricare Standard,PLAN_5942,2022,Specialty Tier,Specialty Tier,2021-10-24,155,No Change,Prior Authorization,Yes,No,,494,496,-0.3,Stable,207.64,284.73,-77.09,34.28,241.92,119.51,0.294,10,0.164,0.384,0.26,0.527,7,9,14,10,4.5,15.3,3,Lower,West,NY,Urban,66-75,2022-03,Q1_2022,2021,7.9,0.874,Increasing
FIA002561,2022-04-16,Losartan,Cozaar,ARBs,23051-785-41,Tricare Standard,PLAN_4519,2022,Tier 1,Tier 2,2022-02-20,55,Improved,None,No,No,,628,666,-5.7,Decreased,19.62,35.31,-15.69,144.73,164.35,103.21,0.0,0,0.046,0.247,0.722,0.78,8,10,1,1,4.4,14.0,3,Lower,Midwest,CA,Suburban,18-35,2022-04,Q2_2022,2021,7.2,0.266,Increasing
FIA002844,2022-04-16,Losartan,Cozaar,ARBs,58447-514-97,Commercial Plan Beta,PLAN_2747,2022,Specialty Tier,Tier 2,2021-10-28,170,Worsened,Prior Authorization; Quantity Limit,Yes,No,60.0,476,957,-50.2,Decreased,284.09,45.7,238.39,176.02,460.11,219.01,0.524,5,0.084,0.283,0.388,0.775,8,7,14,10,4.5,9.8,6,Lower,Midwest,FL,Rural,36-50,2022-04,Q2_2022,2021,6.8,0.582,Stable
FIA000444,2022-05-01,Losartan,Cozaar,ARBs,67060-519-25,Medicaid Plan X,PLAN_4436,2022,Tier 1,Tier 2,2022-02-05,85,Improved,None,No,No,,768,840,-8.5,Decreased,19.97,23.78,-3.81,152.17,172.14,132.2,0.0,0,0.051,0.363,0.659,0.6,12,3,11,2,2.1,30.2,8,Similar,Southwest,FL,Suburban,66-75,2022-05,Q2_2022,2021,6.9,0.397,Decreasing
FIA000079,2022-05-02,Losartan,Cozaar,ARBs,63948-160-45,Commercial Plan Alpha,PLAN_3174,2022,Tier 3,Non-Formulary,2021-11-10,173,Improved,Prior Authorization; Quantity Limit,Yes,No,30.0,785,820,-4.1,Stable,79.84,301.03,-221.19,157.52,237.36,186.33,0.508,3,0.019,0.299,0.78,0.819,12,7,4,8,3.9,16.3,2,Higher,Northeast,OH,Rural,51-65,2022-05,Q2_2022,2021,7.3,0.877,Stable
FIA000689,2022-05-02,Losartan,Cozaar,ARBs,76396-516-45,Medicaid Plan Y,PLAN_9179,2022,Tier 2,Specialty Tier,2022-02-19,72,Improved,None,No,No,,269,201,33.8,Increased,31.53,126.48,-94.95,106.44,137.97,37.11,0.0,0,0.032,0.283,0.566,0.619,10,5,15,11,2.3,34.0,4,Similar,Southwest,PA,Urban,18-35,2022-05,Q2_2022,2021,1.5,0.524,Stable
FIA001871,2022-05-12,Losartan,Cozaar,ARBs,54752-465-21,Medicaid Plan X,PLAN_8104,2022,Tier 3,Tier 1,2022-02-27,74,Worsened,Prior Authorization; Quantity Limit,Yes,No,30.0,385,843,-54.3,Decreased,50.38,9.09,41.29,42.05,92.43,35.59,0.363,1,0.076,0.348,0.205,0.95,15,10,13,9,4.2,8.2,3,Similar,Southwest,FL,Urban,36-50,2022-05,Q2_2022,2021,5.6,0.326,Stable
FIA002704,2022-05-13,Losartan,Cozaar,ARBs,63370-424-27,Medicaid Plan X,PLAN_9657,2022,Non-Formulary,Tier 1,2022-03-14,60,Worsened,Non-Formulary Status,No,No,,263,627,-58.0,Decreased,757.91,16.58,741.33,74.98,832.89,219.05,0.0,0,0.116,0.246,0.499,0.474,8,3,1,9,2.1,31.2,3,Similar,Southeast,MI,Suburban,66-75,2022-05,Q2_2022,2021,6.3,0.086,Increasing
FIA000524,2022-05-18,Losartan,Cozaar,ARBs,91805-334-52,Commercial Plan Beta,PLAN_6006,2022,Specialty Tier,Tier 2,2022-03-28,51,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,234,299,-21.7,Decreased,150.99,41.44,109.55,54.62,205.61,48.11,0.46,1,0.176,0.063,0.845,0.785,3,8,2,12,3.3,20.2,6,Lower,Southwest,IL,Urban,51-65,2022-05,Q2_2022,2021,3.3,0.917,Stable
FIA000300,2022-06-03,Losartan,Cozaar,ARBs,87485-492-40,Medicare Part D Plan A,PLAN_5670,2022,Specialty Tier,Specialty Tier,2021-11-23,192,No Change,None,No,No,,159,150,6.1,Increased,262.68,139.63,123.05,132.24,394.92,62.79,0.0,0,0.163,0.056,0.748,0.717,0,7,9,4,4.5,17.1,6,Higher,Northeast,IL,Rural,18-35,2022-06,Q2_2022,2021,1.6,0.095,Stable
FIA002615,2022-06-08,Losartan,Cozaar,ARBs,40569-633-10,Medicare Part D Plan A,PLAN_3004,2022,Specialty Tier,Tier 3,2022-02-24,104,Worsened,Quantity Limit,No,No,30.0,181,172,5.5,Increased,185.65,63.52,122.13,96.47,282.12,51.06,0.0,0,0.214,0.347,0.546,0.687,15,1,16,1,2.7,29.3,8,Lower,Southeast,PA,Suburban,75+,2022-06,Q2_2022,2021,2.4,0.77,Decreasing
FIA001624,2022-06-11,Losartan,Cozaar,ARBs,79262-746-50,VA Plan,PLAN_4925,2022,Specialty Tier,Tier 3,2021-09-22,262,Worsened,None,No,No,,395,392,0.8,Stable,100.61,77.3,23.31,79.83,180.44,71.27,0.0,0,0.243,0.14,0.496,0.857,1,9,8,3,3.3,9.2,7,Higher,Southwest,GA,Urban,51-65,2022-06,Q2_2022,2021,1.1,0.607,Increasing
FIA000766,2022-06-15,Losartan,Cozaar,ARBs,69474-815-14,VA Plan,PLAN_3223,2022,Tier 2,Tier 3,2022-03-29,78,Improved,None,No,No,,536,411,30.5,Increased,22.35,83.28,-60.93,67.39,89.74,48.1,0.0,0,0.063,0.216,0.581,0.459,14,3,7,14,2.8,7.9,8,Lower,Northeast,IL,Suburban,51-65,2022-06,Q2_2022,2021,9.7,0.719,Decreasing
FIA002945,2022-06-24,Losartan,Cozaar,ARBs,35208-597-41,Commercial Plan Alpha,PLAN_3669,2022,Tier 2,Tier 2,2022-01-23,152,No Change,None,No,No,,854,783,9.1,Increased,43.84,25.24,18.6,192.54,236.38,201.87,0.0,0,0.072,0.39,0.242,0.896,3,5,11,1,3.3,15.6,3,Lower,Northeast,NC,Suburban,18-35,2022-06,Q2_2022,2021,3.1,0.144,Stable
FIA002458,2022-07-08,Losartan,Cozaar,ARBs,56530-189-57,Medicaid Plan X,PLAN_9471,2022,Tier 1,Non-Formulary,2022-05-18,51,Improved,Quantity Limit,No,No,30.0,806,568,42.0,Increased,17.58,745.31,-727.73,139.13,156.71,126.31,0.0,0,0.051,0.362,0.555,0.881,2,2,1,5,4.9,9.9,8,Higher,Northeast,TX,Suburban,18-35,2022-07,Q3_2022,2021,4.9,0.566,Increasing
FIA000179,2022-07-15,Losartan,Cozaar,ARBs,33111-263-95,Medicare Part D Plan A,PLAN_1885,2022,Tier 3,Non-Formulary,2021-09-29,289,Improved,Step Therapy,No,Yes,,729,775,-5.8,Decreased,60.96,662.2,-601.24,110.65,171.61,125.1,0.0,0,0.078,0.276,0.4,0.639,10,9,14,1,2.3,6.6,6,Lower,Southeast,CA,Suburban,75+,2022-07,Q3_2022,2021,2.0,0.895,Decreasing
FIA002120,2022-07-22,Losartan,Cozaar,ARBs,31807-622-31,Commercial Plan Alpha,PLAN_8316,2022,Specialty Tier,Specialty Tier,2021-12-01,233,No Change,Prior Authorization,Yes,No,,785,782,0.4,Stable,234.3,190.4,43.9,179.36,413.66,324.72,0.359,1,0.218,0.398,0.852,0.886,15,7,14,15,2.7,21.0,4,Lower,West,NC,Suburban,18-35,2022-07,Q3_2022,2021,5.1,0.438,Decreasing
FIA000326,2022-08-06,Losartan,Cozaar,ARBs,14272-772-29,VA Plan,PLAN_2285,2022,Tier 2,Tier 3,2021-10-19,291,Improved,None,No,No,,1273,902,41.2,Increased,41.47,87.1,-45.63,171.22,212.69,270.75,0.0,0,0.025,0.384,0.871,0.946,13,8,3,1,3.8,24.8,6,Similar,Midwest,PA,Urban,75+,2022-08,Q3_2022,2021,3.6,0.244,Increasing
FIA002582,2022-08-07,Losartan,Cozaar,ARBs,23434-724-54,Medicare Part D Plan B,PLAN_3586,2022,Specialty Tier,Tier 2,2022-01-19,200,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,247,656,-62.3,Decreased,286.46,23.23,263.23,160.14,446.6,110.31,0.217,2,0.085,0.392,0.431,0.844,14,8,19,15,2.1,18.3,8,Similar,Southwest,PA,Urban,75+,2022-08,Q3_2022,2021,1.1,0.38,Stable
FIA000611,2022-08-16,Losartan,Cozaar,ARBs,39567-877-48,Medicaid Plan X,PLAN_3158,2022,Tier 2,Non-Formulary,2022-06-12,65,Improved,None,No,No,,466,362,28.8,Increased,34.22,203.77,-169.55,54.6,88.82,41.39,0.0,0,0.079,0.114,0.301,0.756,0,2,10,5,2.6,22.6,8,Lower,Southeast,CA,Rural,51-65,2022-08,Q3_2022,2021,3.7,0.823,Stable
FIA000171,2022-08-17,Losartan,Cozaar,ARBs,14337-451-20,Commercial Plan Alpha,PLAN_3525,2022,Tier 2,Non-Formulary,2022-05-02,107,Improved,None,No,No,,353,279,26.8,Increased,39.77,421.86,-382.09,165.89,205.66,72.6,0.0,0,0.044,0.343,0.727,0.627,12,3,14,5,2.6,27.0,4,Lower,Midwest,TX,Urban,36-50,2022-08,Q3_2022,2021,5.2,0.476,Stable
FIA000775,2022-08-24,Losartan,Cozaar,ARBs,75598-525-28,VA Plan,PLAN_4940,2022,Tier 2,Specialty Tier,2021-12-18,249,Improved,Quantity Limit,No,No,60.0,823,556,48.0,Increased,34.96,147.27,-112.31,144.87,179.83,148.0,0.0,0,0.058,0.19,0.294,0.621,12,7,17,7,4.8,16.2,5,Lower,Southwest,TX,Urban,75+,2022-08,Q3_2022,2021,8.6,0.525,Decreasing
FIA000259,2022-08-26,Losartan,Cozaar,ARBs,99037-915-26,Commercial Plan Beta,PLAN_2746,2022,Tier 3,Tier 2,2022-02-17,190,Worsened,None,No,No,,65,101,-35.5,Decreased,97.7,37.31,60.39,161.12,258.82,16.82,0.0,0,0.04,0.188,0.577,0.653,4,4,7,15,4.0,9.4,4,Lower,Northeast,MI,Suburban,51-65,2022-08,Q3_2022,2021,5.5,0.689,Stable
FIA000451,2022-09-03,Losartan,Cozaar,ARBs,27946-812-43,VA Plan,PLAN_3507,2022,Tier 1,Tier 3,2022-04-01,155,Improved,None,No,No,,467,400,16.8,Increased,9.68,91.11,-81.43,143.02,152.7,71.31,0.0,0,0.076,0.148,0.795,0.94,11,1,15,9,4.2,17.2,2,Similar,Midwest,FL,Rural,18-35,2022-09,Q3_2022,2021,8.8,0.931,Decreasing
FIA001940,2022-09-03,Losartan,Cozaar,ARBs,78809-635-99,Commercial Plan Alpha,PLAN_5866,2022,Specialty Tier,Non-Formulary,2021-10-30,308,Improved,Prior Authorization,Yes,No,,159,170,-6.2,Decreased,165.96,418.83,-252.87,77.92,243.88,38.78,0.349,6,0.272,0.29,0.826,0.734,15,8,3,6,2.6,8.6,5,Lower,Southeast,FL,Rural,75+,2022-09,Q3_2022,2021,2.4,0.762,Decreasing
FIA002267,2022-09-07,Losartan,Cozaar,ARBs,31395-351-29,VA Plan,PLAN_7777,2022,Non-Formulary,Tier 1,2022-01-24,226,Worsened,Non-Formulary Status,No,No,,50,104,-57.5,Decreased,699.68,13.37,686.31,165.48,865.16,43.26,0.0,0,0.196,0.128,0.396,0.621,10,0,20,8,4.3,26.1,6,Higher,Midwest,FL,Rural,51-65,2022-09,Q3_2022,2021,8.6,0.141,Increasing
FIA002624,2022-09-07,Losartan,Cozaar,ARBs,74669-412-92,Medicare Part D Plan B,PLAN_6119,2022,Non-Formulary,Tier 3,2022-05-11,119,Worsened,Non-Formulary Status,No,No,,565,527,7.2,Increased,550.47,61.89,488.58,92.68,643.15,363.38,0.0,0,0.124,0.163,0.274,0.67,12,5,3,11,4.6,20.4,8,Similar,Southeast,PA,Suburban,75+,2022-09,Q3_2022,2021,2.6,0.154,Decreasing
FIA001920,2022-09-13,Losartan,Cozaar,ARBs,93901-511-64,Commercial Plan Beta,PLAN_8119,2022,Non-Formulary,Tier 3,2022-06-08,97,Worsened,Non-Formulary Status,No,No,,791,816,-2.9,Stable,437.49,88.32,349.17,80.16,517.65,409.46,0.0,0,0.093,0.125,0.451,0.476,2,6,6,14,3.9,18.1,2,Similar,Southeast,NY,Urban,75+,2022-09,Q3_2022,2021,8.5,0.396,Decreasing
FIA002786,2022-09-19,Losartan,Cozaar,ARBs,68009-978-53,Commercial Plan Alpha,PLAN_6315,2022,Non-Formulary,Non-Formulary,2022-01-06,256,No Change,Non-Formulary Status; Quantity Limit,No,No,,116,117,-0.2,Stable,301.22,660.05,-358.83,131.34,432.56,50.18,0.0,0,0.055,0.292,0.338,0.471,0,9,14,3,2.7,27.5,3,Higher,West,PA,Rural,51-65,2022-09,Q3_2022,2021,9.3,0.19,Stable
FIA001516,2022-10-05,Losartan,Cozaar,ARBs,40973-721-39,Commercial Plan Beta,PLAN_7158,2022,Non-Formulary,Specialty Tier,2022-02-02,245,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,821,882,-6.9,Decreased,703.32,173.34,529.98,137.4,840.72,690.23,0.0,0,0.254,0.349,0.541,0.541,3,0,17,8,2.6,19.1,2,Higher,Northeast,NC,Urban,18-35,2022-10,Q4_2022,2022,9.1,0.218,Stable
FIA001997,2022-10-08,Losartan,Cozaar,ARBs,75817-846-74,Medicaid Plan X,PLAN_2105,2022,Tier 1,Specialty Tier,2022-07-18,82,Improved,None,No,No,,334,211,58.7,Increased,9.0,121.12,-112.12,88.93,97.93,32.71,0.0,0,0.078,0.254,0.337,0.615,5,6,20,6,2.3,11.6,7,Similar,West,PA,Suburban,18-35,2022-10,Q4_2022,2022,5.2,0.069,Decreasing
FIA002943,2022-10-22,Losartan,Cozaar,ARBs,43291-994-96,Commercial Plan Alpha,PLAN_7052,2022,Tier 2,Tier 1,2022-07-09,105,Worsened,None,No,No,,497,492,1.2,Stable,47.5,12.52,34.98,30.93,78.43,38.98,0.0,0,0.02,0.198,0.411,0.505,2,2,3,13,4.7,22.5,6,Lower,Southwest,MI,Urban,75+,2022-10,Q4_2022,2022,7.0,0.39,Decreasing
FIA002012,2022-10-25,Losartan,Cozaar,ARBs,71628-236-46,Medicare Part D Plan A,PLAN_2781,2022,Tier 1,Tier 3,2022-02-17,250,Improved,Quantity Limit,No,No,90.0,528,399,32.4,Increased,5.06,75.87,-70.81,80.56,85.62,45.21,0.0,0,0.041,0.268,0.623,0.456,15,9,0,8,3.7,14.6,7,Lower,Southwest,GA,Rural,18-35,2022-10,Q4_2022,2022,1.7,0.735,Increasing
FIA002028,2022-10-27,Losartan,Cozaar,ARBs,84106-841-51,VA Plan,PLAN_2498,2022,Tier 1,Non-Formulary,2022-08-13,75,Improved,Quantity Limit,No,No,30.0,1266,830,52.6,Increased,15.59,455.65,-440.06,146.55,162.14,205.27,0.0,0,0.022,0.184,0.427,0.456,0,3,15,8,3.9,30.5,7,Lower,Northeast,FL,Urban,75+,2022-10,Q4_2022,2022,4.8,0.615,Decreasing
FIA001387,2022-11-06,Losartan,Cozaar,ARBs,12608-667-44,Medicare Part D Plan A,PLAN_4921,2022,Tier 3,Tier 1,2022-07-28,101,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,393,510,-22.9,Decreased,69.07,17.64,51.43,196.18,265.25,104.24,0.393,10,0.064,0.059,0.598,0.762,15,6,15,6,4.3,5.6,6,Similar,Southeast,NY,Urban,75+,2022-11,Q4_2022,2022,6.4,0.97,Increasing
FIA002019,2022-11-11,Losartan,Cozaar,ARBs,11857-511-80,Medicare Part D Plan B,PLAN_1959,2022,Specialty Tier,Tier 2,2021-12-01,345,Worsened,None,No,No,,525,844,-37.7,Decreased,160.74,23.53,137.21,165.28,326.02,171.16,0.0,0,0.214,0.359,0.639,0.876,11,10,0,6,3.9,30.1,7,Lower,Southwest,FL,Urban,66-75,2022-11,Q4_2022,2022,3.9,0.335,Decreasing
FIA000638,2022-11-24,Losartan,Cozaar,ARBs,90314-937-80,Medicaid Plan Y,PLAN_2781,2022,Tier 3,Specialty Tier,2022-03-18,251,Improved,Prior Authorization; Step Therapy,Yes,Yes,,105,105,0.8,Stable,98.94,283.18,-184.24,134.68,233.62,24.53,0.13,10,0.072,0.127,0.623,0.47,5,7,5,2,2.5,22.2,8,Similar,Southeast,IL,Rural,18-35,2022-11,Q4_2022,2022,3.7,0.772,Stable
FIA001998,2022-11-24,Losartan,Cozaar,ARBs,34275-968-38,Medicare Part D Plan B,PLAN_2299,2022,Tier 3,Tier 2,2022-08-31,85,Worsened,None,No,No,,211,657,-67.8,Decreased,97.87,39.87,58.0,41.14,139.01,29.33,0.0,0,0.019,0.177,0.888,0.666,14,10,0,8,4.6,27.0,7,Higher,West,NC,Rural,36-50,2022-11,Q4_2022,2022,1.7,0.862,Increasing
FIA002996,2022-12-07,Losartan,Cozaar,ARBs,94923-541-22,Medicaid Plan Y,PLAN_1753,2022,Non-Formulary,Tier 3,2022-03-20,262,Worsened,Non-Formulary Status,No,No,,203,207,-1.8,Stable,530.26,67.11,463.15,64.39,594.65,120.71,0.0,0,0.264,0.383,0.522,0.641,13,10,20,15,2.2,9.1,8,Similar,Southwest,FL,Suburban,66-75,2022-12,Q4_2022,2022,7.7,0.48,Decreasing
FIA000780,2022-12-11,Losartan,Cozaar,ARBs,19310-190-83,Commercial Plan Beta,PLAN_9610,2022,Specialty Tier,Tier 3,2022-05-15,210,Worsened,None,No,No,,1037,987,5.1,Increased,189.73,58.9,130.83,125.29,315.02,326.68,0.0,0,0.172,0.349,0.697,0.757,1,6,16,5,4.1,8.4,3,Higher,Northeast,GA,Urban,66-75,2022-12,Q4_2022,2022,9.9,0.348,Decreasing
FIA001572,2022-12-14,Losartan,Cozaar,ARBs,35064-156-38,Medicaid Plan X,PLAN_8907,2022,Tier 2,Tier 2,2022-05-26,202,No Change,None,No,No,,648,713,-9.1,Decreased,48.6,33.55,15.05,126.64,175.24,113.56,0.0,0,0.013,0.308,0.773,0.928,2,1,5,1,2.4,11.4,8,Higher,Southeast,NY,Rural,51-65,2022-12,Q4_2022,2022,6.7,0.832,Decreasing
FIA001949,2022-12-24,Losartan,Cozaar,ARBs,29464-962-51,Commercial Plan Alpha,PLAN_7973,2022,Tier 2,Tier 3,2022-03-30,269,Improved,None,No,No,,729,525,38.9,Increased,35.94,71.21,-35.27,147.4,183.34,133.65,0.0,0,0.011,0.067,0.248,0.449,3,2,7,0,3.4,20.7,8,Higher,Northeast,TX,Rural,36-50,2022-12,Q4_2022,2022,2.5,0.136,Decreasing
FIA000936,2022-12-27,Losartan,Cozaar,ARBs,21771-891-86,Commercial Plan Alpha,PLAN_9227,2022,Specialty Tier,Tier 3,2022-10-28,60,Worsened,None,No,No,,846,789,7.3,Increased,270.48,89.92,180.56,145.09,415.57,351.57,0.0,0,0.149,0.086,0.899,0.549,15,9,11,0,4.6,29.2,3,Similar,Midwest,FL,Urban,18-35,2022-12,Q4_2022,2022,2.7,0.975,Stable
FIA001362,2022-12-31,Losartan,Cozaar,ARBs,70557-836-21,Medicare Part D Plan B,PLAN_9516,2022,Non-Formulary,Tier 1,2022-08-26,127,Worsened,Non-Formulary Status,No,No,,167,255,-34.4,Decreased,347.69,18.97,328.72,174.01,521.7,87.12,0.0,0,0.204,0.052,0.276,0.781,14,7,9,6,3.1,29.9,6,Higher,Northeast,MI,Rural,51-65,2022-12,Q4_2022,2022,6.4,0.438,Stable
FIA000135,2023-01-04,Losartan,Cozaar,ARBs,29601-584-11,Commercial Plan Alpha,PLAN_7906,2023,Tier 2,Non-Formulary,2022-08-10,147,Improved,None,No,No,,1159,923,25.6,Increased,44.43,632.49,-588.06,54.79,99.22,115.0,0.0,0,0.037,0.225,0.897,0.867,10,7,9,8,3.7,22.0,5,Lower,Southeast,CA,Urban,51-65,2023-01,Q1_2023,2022,5.3,0.63,Stable
FIA002875,2023-01-14,Losartan,Cozaar,ARBs,48529-106-10,Medicare Part D Plan B,PLAN_4066,2023,Tier 3,Specialty Tier,2022-07-27,171,Improved,None,No,No,,253,264,-4.1,Stable,57.84,230.17,-172.33,166.37,224.21,56.73,0.0,0,0.037,0.225,0.559,0.451,7,4,3,5,2.8,10.6,6,Higher,Northeast,OH,Suburban,66-75,2023-01,Q1_2023,2022,8.8,0.158,Increasing
FIA001375,2023-01-15,Losartan,Cozaar,ARBs,94425-456-14,Medicaid Plan X,PLAN_7799,2023,Tier 2,Tier 3,2022-06-10,219,Improved,None,No,No,,918,634,44.9,Increased,31.64,83.77,-52.13,150.06,181.7,166.8,0.0,0,0.025,0.368,0.686,0.737,6,3,20,14,2.8,15.6,3,Similar,West,NY,Urban,75+,2023-01,Q1_2023,2022,5.0,0.644,Decreasing
FIA002251,2023-01-17,Losartan,Cozaar,ARBs,22264-982-25,Commercial Plan Alpha,PLAN_2552,2023,Specialty Tier,Tier 1,2022-08-29,141,Worsened,None,No,No,,467,861,-45.8,Decreased,113.55,15.21,98.34,143.1,256.65,119.86,0.0,0,0.103,0.292,0.803,0.802,5,9,3,8,3.0,31.4,5,Lower,Midwest,PA,Urban,36-50,2023-01,Q1_2023,2022,2.6,0.154,Decreasing
FIA002849,2023-01-20,Losartan,Cozaar,ARBs,48836-601-99,Medicare Part D Plan B,PLAN_5042,2023,Specialty Tier,Tier 3,2022-04-23,272,Worsened,Step Therapy; Quantity Limit,No,Yes,,876,828,5.9,Increased,130.69,90.86,39.83,192.81,323.5,283.39,0.0,0,0.214,0.332,0.758,0.479,0,6,3,0,2.5,28.8,4,Higher,Southwest,CA,Suburban,18-35,2023-01,Q1_2023,2022,4.5,0.277,Decreasing
FIA000877,2023-02-05,Losartan,Cozaar,ARBs,38386-500-68,Medicare Part D Plan A,PLAN_4578,2023,Tier 3,Specialty Tier,2022-03-16,326,Improved,None,No,No,,739,677,9.2,Increased,65.79,169.25,-103.46,111.51,177.3,131.02,0.0,0,0.015,0.299,0.498,0.929,12,10,14,13,2.3,9.8,6,Similar,Southeast,NY,Urban,18-35,2023-02,Q1_2023,2022,8.2,0.543,Stable
FIA002436,2023-02-08,Losartan,Cozaar,ARBs,19478-960-21,Commercial Plan Alpha,PLAN_5826,2023,Tier 1,Specialty Tier,2022-10-02,129,Improved,None,No,No,,703,545,29.1,Increased,17.21,192.01,-174.8,177.21,194.42,136.68,0.0,0,0.068,0.277,0.699,0.403,1,1,4,15,2.4,31.0,7,Lower,West,GA,Suburban,18-35,2023-02,Q1_2023,2022,2.4,0.556,Decreasing
FIA002486,2023-02-08,Losartan,Cozaar,ARBs,85433-100-91,Commercial Plan Beta,PLAN_1499,2023,Tier 2,Specialty Tier,2022-04-06,308,Improved,None,No,No,,1049,695,50.9,Increased,23.08,194.09,-171.01,117.4,140.48,147.36,0.0,0,0.043,0.272,0.418,0.453,14,9,19,3,4.8,27.1,7,Similar,Northeast,OH,Urban,36-50,2023-02,Q1_2023,2022,5.3,0.967,Increasing
FIA000925,2023-03-10,Losartan,Cozaar,ARBs,81127-674-36,Tricare Standard,PLAN_4202,2023,Tier 1,Non-Formulary,2022-07-08,245,Improved,None,No,No,,578,418,38.4,Increased,16.73,778.31,-761.58,102.82,119.55,69.1,0.0,0,0.063,0.189,0.594,0.749,4,3,17,0,2.1,25.8,5,Similar,Southwest,IL,Rural,51-65,2023-03,Q1_2023,2022,4.7,0.899,Stable
FIA000782,2023-03-23,Losartan,Cozaar,ARBs,52293-671-18,Medicaid Plan X,PLAN_9086,2023,Tier 2,Tier 2,2022-09-10,194,No Change,None,No,No,,205,208,-1.2,Stable,43.32,46.76,-3.44,155.76,199.08,40.81,0.0,0,0.052,0.354,0.829,0.898,3,2,6,12,4.4,8.6,6,Similar,Southeast,MI,Rural,51-65,2023-03,Q1_2023,2022,4.2,0.098,Increasing
FIA001747,2023-03-31,Losartan,Cozaar,ARBs,64567-320-42,Medicaid Plan X,PLAN_5717,2023,Tier 1,Tier 1,2023-01-01,89,No Change,None,No,No,,440,452,-2.5,Stable,14.64,5.19,9.45,42.22,56.86,25.02,0.0,0,0.041,0.132,0.242,0.517,8,10,15,10,4.7,5.6,6,Lower,Southeast,NC,Urban,75+,2023-03,Q1_2023,2022,6.7,0.558,Stable
FIA001439,2023-04-12,Losartan,Cozaar,ARBs,26510-725-41,Commercial Plan Beta,PLAN_7475,2023,Tier 2,Tier 2,2022-08-17,238,No Change,None,No,No,,704,737,-4.4,Stable,49.68,41.1,8.58,100.82,150.5,105.95,0.0,0,0.045,0.306,0.811,0.681,4,4,0,15,2.5,32.5,2,Higher,Midwest,MI,Rural,18-35,2023-04,Q2_2023,2022,6.7,0.667,Increasing
FIA002876,2023-04-23,Losartan,Cozaar,ARBs,51143-165-26,Commercial Plan Beta,PLAN_4605,2023,Tier 1,Specialty Tier,2022-06-08,319,Improved,None,No,No,,912,747,22.1,Increased,9.74,273.22,-263.48,44.61,54.35,49.57,0.0,0,0.011,0.216,0.212,0.642,1,0,6,1,2.5,13.3,3,Similar,West,NY,Urban,66-75,2023-04,Q2_2023,2022,4.5,0.726,Increasing
FIA001020,2023-04-25,Losartan,Cozaar,ARBs,92124-270-68,VA Plan,PLAN_9453,2023,Non-Formulary,Tier 3,2022-12-22,124,Worsened,Non-Formulary Status; Quantity Limit,No,No,,933,924,1.0,Stable,331.72,82.88,248.84,194.94,526.66,491.37,0.0,0,0.212,0.217,0.889,0.905,8,2,20,7,3.1,32.4,8,Higher,Southeast,TX,Rural,75+,2023-04,Q2_2023,2022,6.4,0.579,Increasing
FIA002837,2023-05-16,Losartan,Cozaar,ARBs,97655-933-82,Commercial Plan Alpha,PLAN_4432,2023,Specialty Tier,Tier 2,2023-01-11,125,Worsened,Prior Authorization,Yes,No,,580,770,-24.6,Decreased,149.28,25.19,124.09,164.55,313.83,182.02,0.109,7,0.164,0.172,0.83,0.825,3,4,13,10,3.3,12.7,3,Lower,Southwest,CA,Suburban,36-50,2023-05,Q2_2023,2022,2.0,0.153,Decreasing
FIA002180,2023-05-22,Losartan,Cozaar,ARBs,19317-469-96,VA Plan,PLAN_9021,2023,Tier 2,Specialty Tier,2023-04-04,48,Improved,None,No,No,,710,584,21.7,Increased,47.22,171.15,-123.93,64.25,111.47,79.14,0.0,0,0.058,0.352,0.489,0.496,7,8,13,11,3.6,17.2,2,Lower,Southwest,TX,Rural,18-35,2023-05,Q2_2023,2022,2.7,0.978,Decreasing
FIA002330,2023-05-27,Losartan,Cozaar,ARBs,43885-787-70,Tricare Standard,PLAN_4256,2023,Tier 2,Tier 1,2023-02-26,90,Worsened,None,No,No,,440,433,1.6,Stable,49.17,5.83,43.34,48.12,97.29,42.81,0.0,0,0.051,0.357,0.607,0.615,8,8,2,7,4.0,26.9,3,Higher,Midwest,PA,Rural,18-35,2023-05,Q2_2023,2022,6.7,0.029,Decreasing
FIA000562,2023-05-30,Losartan,Cozaar,ARBs,54855-437-64,Medicaid Plan X,PLAN_1277,2023,Tier 1,Tier 2,2022-06-14,350,Improved,None,No,No,,589,538,9.5,Increased,14.9,31.05,-16.15,186.11,201.01,118.39,0.0,0,0.05,0.249,0.669,0.717,12,9,6,10,3.4,19.9,8,Lower,Northeast,GA,Urban,36-50,2023-05,Q2_2023,2022,1.2,0.169,Increasing
FIA000361,2023-06-13,Losartan,Cozaar,ARBs,49943-586-66,Medicaid Plan X,PLAN_3530,2023,Tier 3,Non-Formulary,2023-04-26,48,Improved,Step Therapy,No,Yes,,357,395,-9.5,Decreased,88.07,288.81,-200.74,126.5,214.57,76.6,0.0,0,0.06,0.31,0.687,0.481,9,6,8,7,2.1,11.3,4,Lower,West,CA,Suburban,51-65,2023-06,Q2_2023,2022,7.5,0.745,Decreasing
FIA001980,2023-07-02,Losartan,Cozaar,ARBs,11068-418-44,Commercial Plan Alpha,PLAN_9239,2023,Specialty Tier,Tier 2,2023-04-03,90,Worsened,None,No,No,,328,473,-30.6,Decreased,276.2,44.8,231.4,57.37,333.57,109.41,0.0,0,0.075,0.357,0.773,0.531,13,1,13,1,4.3,5.6,6,Similar,Southeast,NC,Rural,36-50,2023-07,Q3_2023,2022,7.4,0.171,Increasing
FIA001682,2023-07-16,Losartan,Cozaar,ARBs,70211-334-11,Medicare Part D Plan B,PLAN_9259,2023,Tier 1,Tier 1,2022-09-10,309,No Change,None,No,No,,429,451,-4.7,Stable,10.27,5.63,4.64,84.9,95.17,40.83,0.0,0,0.078,0.311,0.568,0.475,9,2,7,0,2.4,24.2,5,Lower,Southwest,IL,Urban,18-35,2023-07,Q3_2023,2022,7.2,0.843,Increasing
FIA002057,2023-08-06,Losartan,Cozaar,ARBs,85524-130-79,Medicaid Plan Y,PLAN_8206,2023,Tier 2,Tier 1,2022-11-26,253,Worsened,None,No,No,,332,320,3.9,Stable,43.97,15.83,28.14,105.09,149.06,49.49,0.0,0,0.036,0.155,0.822,0.446,14,1,10,10,3.2,20.6,7,Similar,Midwest,NY,Urban,36-50,2023-08,Q3_2023,2022,7.4,0.779,Decreasing
FIA002726,2023-08-08,Losartan,Cozaar,ARBs,76929-794-90,VA Plan,PLAN_8453,2023,Non-Formulary,Tier 1,2022-10-15,297,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,517,955,-45.8,Decreased,618.4,17.08,601.32,157.19,775.59,400.98,0.0,0,0.085,0.38,0.523,0.612,0,8,13,0,4.0,20.7,4,Higher,West,CA,Urban,36-50,2023-08,Q3_2023,2022,2.5,0.733,Stable
FIA002347,2023-08-09,Losartan,Cozaar,ARBs,96691-479-68,Medicaid Plan Y,PLAN_5216,2023,Tier 3,Tier 2,2023-02-09,181,Worsened,Prior Authorization,Yes,No,,131,336,-60.7,Decreased,50.65,21.87,28.78,145.19,195.84,25.66,0.516,6,0.031,0.109,0.421,0.814,14,2,18,10,3.1,15.5,4,Lower,Midwest,TX,Urban,18-35,2023-08,Q3_2023,2022,5.7,0.643,Increasing
FIA002206,2023-08-15,Losartan,Cozaar,ARBs,46541-201-69,VA Plan,PLAN_4054,2023,Tier 2,Tier 2,2023-02-01,195,No Change,None,No,No,,248,237,4.9,Stable,40.86,40.76,0.1,37.55,78.41,19.45,0.0,0,0.066,0.332,0.589,0.583,3,0,7,0,4.8,31.4,2,Similar,Midwest,CA,Rural,51-65,2023-08,Q3_2023,2022,1.2,0.985,Decreasing
FIA000222,2023-09-03,Losartan,Cozaar,ARBs,88059-339-54,Medicaid Plan X,PLAN_5661,2023,Tier 1,Specialty Tier,2023-02-12,203,Improved,Quantity Limit,No,No,30.0,976,695,40.5,Increased,19.74,261.08,-241.34,120.66,140.4,137.03,0.0,0,0.054,0.3,0.564,0.536,10,8,18,6,4.5,15.8,2,Lower,Southwest,OH,Urban,18-35,2023-09,Q3_2023,2022,1.6,0.889,Stable
FIA000713,2023-09-03,Losartan,Cozaar,ARBs,69482-751-95,Tricare Standard,PLAN_4973,2023,Specialty Tier,Specialty Tier,2023-08-02,32,No Change,Quantity Limit,No,No,60.0,532,540,-1.4,Stable,134.65,216.73,-82.08,72.08,206.73,109.98,0.0,0,0.288,0.282,0.585,0.744,5,9,15,7,3.1,30.0,2,Similar,Southeast,OH,Suburban,51-65,2023-09,Q3_2023,2022,8.3,0.563,Increasing
FIA001729,2023-09-21,Losartan,Cozaar,ARBs,62045-214-90,Medicaid Plan Y,PLAN_8182,2023,Specialty Tier,Tier 3,2023-05-04,140,Worsened,Prior Authorization,Yes,No,,739,756,-2.2,Stable,222.63,52.06,170.57,163.39,386.02,285.27,0.289,5,0.055,0.394,0.807,0.862,6,6,17,6,3.3,20.7,7,Lower,Southwest,TX,Suburban,18-35,2023-09,Q3_2023,2022,5.9,0.322,Decreasing
FIA001822,2023-09-27,Losartan,Cozaar,ARBs,44202-467-53,Medicaid Plan X,PLAN_4146,2023,Tier 1,Specialty Tier,2023-02-17,222,Improved,Quantity Limit,No,No,90.0,589,430,37.2,Increased,17.99,174.76,-156.77,127.75,145.74,85.84,0.0,0,0.069,0.4,0.764,0.506,6,1,4,2,4.2,21.7,2,Higher,Northeast,NY,Rural,66-75,2023-09,Q3_2023,2022,5.2,0.929,Decreasing
FIA001006,2023-10-14,Losartan,Cozaar,ARBs,41478-976-82,Tricare Standard,PLAN_5625,2023,Tier 3,Specialty Tier,2022-11-30,318,Improved,Step Therapy; Quantity Limit,No,Yes,30.0,874,937,-6.7,Decreased,84.29,298.1,-213.81,92.63,176.92,154.63,0.0,0,0.078,0.173,0.234,0.596,13,7,8,13,3.9,10.7,6,Lower,West,FL,Rural,18-35,2023-10,Q4_2023,2023,5.4,0.497,Decreasing
FIA001565,2023-10-14,Losartan,Cozaar,ARBs,75386-712-70,Medicare Part D Plan A,PLAN_9706,2023,Tier 1,Tier 1,2023-01-17,270,No Change,None,No,No,,217,220,-1.2,Stable,10.12,8.2,1.92,64.65,74.77,16.23,0.0,0,0.035,0.186,0.416,0.756,14,7,11,14,2.5,16.0,5,Lower,Southwest,FL,Urban,18-35,2023-10,Q4_2023,2023,3.9,0.24,Increasing
FIA001064,2023-10-29,Losartan,Cozaar,ARBs,31019-866-82,VA Plan,PLAN_2522,2023,Tier 1,Tier 1,2023-09-28,31,No Change,None,No,No,,287,294,-2.1,Stable,15.76,17.51,-1.75,65.75,81.51,23.39,0.0,0,0.03,0.139,0.309,0.818,0,10,1,14,3.9,10.0,5,Similar,West,NY,Suburban,36-50,2023-10,Q4_2023,2023,5.2,0.047,Decreasing
FIA001631,2023-10-31,Losartan,Cozaar,ARBs,27994-835-49,Medicaid Plan Y,PLAN_1360,2023,Tier 1,Tier 2,2023-06-16,137,Improved,None,No,No,,457,482,-5.1,Decreased,10.42,22.47,-12.05,175.9,186.32,85.15,0.0,0,0.063,0.32,0.703,0.949,0,9,8,3,2.8,18.4,5,Lower,Southwest,NC,Urban,75+,2023-10,Q4_2023,2023,7.0,0.538,Increasing
FIA001017,2023-11-01,Losartan,Cozaar,ARBs,24900-673-93,Medicare Part D Plan A,PLAN_2558,2023,Tier 1,Specialty Tier,2023-04-26,189,Improved,Quantity Limit,No,No,,831,690,20.6,Increased,19.35,238.77,-219.42,165.3,184.65,153.44,0.0,0,0.032,0.117,0.562,0.885,6,1,11,12,4.5,21.0,3,Lower,Midwest,FL,Rural,51-65,2023-11,Q4_2023,2023,9.4,0.973,Decreasing
FIA002402,2023-11-03,Losartan,Cozaar,ARBs,89473-350-48,Medicaid Plan X,PLAN_4910,2023,Non-Formulary,Non-Formulary,2023-03-20,228,No Change,Non-Formulary Status,No,No,,907,825,10.0,Increased,231.02,546.08,-315.06,135.36,366.38,332.31,0.0,0,0.187,0.103,0.561,0.823,3,9,8,0,3.9,16.0,5,Similar,West,CA,Rural,18-35,2023-11,Q4_2023,2023,5.4,0.347,Stable
FIA002794,2023-11-09,Losartan,Cozaar,ARBs,43774-554-96,Commercial Plan Alpha,PLAN_4989,2023,Tier 2,Non-Formulary,2022-12-31,313,Improved,None,No,No,,733,536,36.8,Increased,34.95,415.59,-380.64,33.21,68.16,49.96,0.0,0,0.021,0.135,0.295,0.641,1,8,2,0,3.7,20.2,8,Similar,Northeast,NY,Suburban,51-65,2023-11,Q4_2023,2023,3.8,0.632,Increasing
FIA002035,2023-11-13,Losartan,Cozaar,ARBs,14725-722-60,Medicaid Plan X,PLAN_3549,2023,Tier 3,Tier 1,2023-08-03,102,Worsened,None,No,No,,213,583,-63.4,Decreased,61.26,15.07,46.19,152.69,213.95,45.57,0.0,0,0.043,0.098,0.49,0.68,11,1,13,0,4.9,8.3,2,Higher,Northeast,PA,Suburban,36-50,2023-11,Q4_2023,2023,7.6,0.541,Increasing
FIA002448,2023-11-30,Losartan,Cozaar,ARBs,79113-313-87,Medicare Part D Plan A,PLAN_7721,2023,Non-Formulary,Tier 2,2023-02-23,280,Worsened,Non-Formulary Status,No,No,,209,305,-31.4,Decreased,649.39,21.4,627.99,69.63,719.02,150.28,0.0,0,0.244,0.295,0.756,0.692,1,0,10,2,3.0,11.1,3,Similar,Northeast,NY,Urban,36-50,2023-11,Q4_2023,2023,6.5,0.306,Decreasing
FIA002221,2023-12-01,Losartan,Cozaar,ARBs,95735-481-40,Medicaid Plan X,PLAN_3470,2023,Non-Formulary,Tier 3,2023-09-30,62,Worsened,Non-Formulary Status,No,No,,312,305,2.5,Stable,664.23,82.17,582.06,124.93,789.16,246.22,0.0,0,0.204,0.278,0.648,0.582,2,5,5,0,2.2,29.4,4,Higher,Southwest,TX,Rural,51-65,2023-12,Q4_2023,2023,5.0,0.457,Decreasing
FIA000738,2023-12-03,Losartan,Cozaar,ARBs,56281-267-99,VA Plan,PLAN_7437,2023,Tier 1,Tier 3,2023-07-19,137,Improved,None,No,No,,234,196,19.4,Increased,18.79,56.97,-38.18,168.47,187.26,43.82,0.0,0,0.071,0.152,0.502,0.876,7,5,2,4,3.5,34.8,4,Similar,Southeast,NY,Suburban,51-65,2023-12,Q4_2023,2023,7.1,0.314,Stable
FIA001676,2023-12-04,Losartan,Cozaar,ARBs,16605-869-16,VA Plan,PLAN_1072,2023,Specialty Tier,Tier 2,2023-10-19,46,Worsened,Prior Authorization,Yes,No,,389,980,-60.3,Decreased,143.68,27.59,116.09,67.79,211.47,82.26,0.319,9,0.117,0.136,0.647,0.65,7,6,12,15,4.3,33.6,4,Higher,West,GA,Suburban,18-35,2023-12,Q4_2023,2023,7.5,0.912,Stable
FIA000002,2023-12-06,Losartan,Cozaar,ARBs,19116-146-94,Commercial Plan Beta,PLAN_5741,2023,Tier 3,Tier 1,2023-03-16,265,Worsened,Quantity Limit,No,No,,370,487,-23.9,Decreased,76.81,19.6,57.21,62.69,139.5,51.62,0.0,0,0.035,0.349,0.807,0.609,14,10,11,5,3.1,11.3,4,Higher,Northeast,MI,Rural,36-50,2023-12,Q4_2023,2023,5.8,0.245,Stable
FIA001365,2023-12-15,Losartan,Cozaar,ARBs,47876-455-50,Tricare Standard,PLAN_2270,2023,Tier 3,Tier 1,2023-08-20,117,Worsened,Prior Authorization; Quantity Limit,Yes,No,,233,367,-36.4,Decreased,86.83,16.47,70.36,157.35,244.18,56.89,0.447,7,0.014,0.398,0.768,0.656,6,5,3,9,3.8,20.4,5,Lower,Southeast,GA,Rural,18-35,2023-12,Q4_2023,2023,2.4,0.1,Stable
FIA000224,2024-01-27,Losartan,Cozaar,ARBs,49998-390-37,Commercial Plan Alpha,PLAN_9008,2024,Tier 3,Tier 1,2023-04-05,297,Worsened,Step Therapy,No,Yes,,313,483,-35.2,Decreased,57.67,10.57,47.1,38.27,95.94,30.03,0.0,0,0.051,0.051,0.583,0.437,1,6,15,9,3.7,32.0,8,Similar,Southwest,MI,Urban,36-50,2024-01,Q1_2024,2023,5.5,0.461,Stable
FIA000558,2024-02-04,Losartan,Cozaar,ARBs,10186-394-56,Tricare Standard,PLAN_4638,2024,Tier 3,Tier 2,2023-09-07,150,Worsened,None,No,No,,335,809,-58.5,Decreased,57.42,24.52,32.9,133.35,190.77,63.91,0.0,0,0.047,0.324,0.358,0.525,13,1,16,11,4.9,19.1,2,Lower,West,GA,Urban,75+,2024-02,Q1_2024,2023,2.7,0.607,Increasing
FIA001931,2024-02-05,Losartan,Cozaar,ARBs,26894-379-34,Tricare Standard,PLAN_6171,2024,Specialty Tier,Tier 1,2023-10-14,114,Worsened,Step Therapy,No,Yes,,490,621,-21.0,Decreased,139.47,15.35,124.12,193.25,332.72,163.03,0.0,0,0.173,0.386,0.72,0.795,3,6,4,11,3.7,32.6,6,Higher,Southwest,TX,Rural,51-65,2024-02,Q1_2024,2023,1.6,0.268,Stable
FIA002928,2024-02-23,Losartan,Cozaar,ARBs,12730-664-24,Medicaid Plan X,PLAN_1511,2024,Tier 3,Non-Formulary,2023-08-12,195,Improved,None,No,No,,799,768,4.1,Stable,61.6,690.22,-628.62,138.68,200.28,160.02,0.0,0,0.024,0.356,0.259,0.554,12,4,5,4,2.6,16.1,5,Lower,Midwest,NY,Rural,75+,2024-02,Q1_2024,2023,4.8,0.69,Increasing
FIA000358,2024-02-25,Losartan,Cozaar,ARBs,84620-740-70,Medicare Part D Plan B,PLAN_7066,2024,Specialty Tier,Specialty Tier,2023-06-30,240,No Change,Step Therapy; Quantity Limit,No,Yes,,305,329,-7.2,Decreased,137.77,105.81,31.96,72.49,210.26,64.13,0.0,0,0.131,0.31,0.818,0.76,6,2,14,11,4.2,12.2,5,Higher,Southeast,IL,Urban,51-65,2024-02,Q1_2024,2023,1.6,0.031,Decreasing
FIA001470,2024-02-25,Losartan,Cozaar,ARBs,36271-309-71,Medicaid Plan Y,PLAN_9387,2024,Tier 1,Tier 3,2023-05-31,270,Improved,None,No,No,,567,367,54.6,Increased,8.08,63.05,-54.97,142.28,150.36,85.25,0.0,0,0.075,0.293,0.388,0.781,7,8,15,15,4.6,8.4,6,Lower,Northeast,TX,Rural,36-50,2024-02,Q1_2024,2023,3.1,0.473,Stable
FIA001244,2024-03-04,Losartan,Cozaar,ARBs,36226-751-46,Medicare Part D Plan B,PLAN_1916,2024,Tier 3,Tier 1,2023-03-27,343,Worsened,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,,224,574,-61.0,Decreased,71.96,17.01,54.95,172.82,244.78,54.83,0.349,1,0.017,0.203,0.426,0.561,9,3,18,7,4.9,27.7,4,Similar,Northeast,NY,Rural,51-65,2024-03,Q1_2024,2023,8.5,0.715,Increasing
FIA001405,2024-03-24,Losartan,Cozaar,ARBs,92466-745-33,Commercial Plan Alpha,PLAN_5221,2024,Non-Formulary,Non-Formulary,2023-05-04,325,No Change,Non-Formulary Status,No,No,,469,502,-6.6,Decreased,585.83,458.95,126.88,108.96,694.79,325.86,0.0,0,0.095,0.223,0.657,0.889,13,7,1,14,2.3,30.3,2,Higher,Midwest,NC,Rural,75+,2024-03,Q1_2024,2023,4.2,0.61,Stable
FIA000131,2024-04-10,Losartan,Cozaar,ARBs,55544-935-45,Commercial Plan Beta,PLAN_4187,2024,Tier 2,Non-Formulary,2024-03-04,37,Improved,None,No,No,,268,192,39.7,Increased,42.11,241.17,-199.06,129.1,171.21,45.88,0.0,0,0.049,0.209,0.483,0.403,5,6,16,3,3.7,20.1,4,Lower,West,PA,Rural,75+,2024-04,Q2_2024,2023,3.3,0.443,Stable
FIA000011,2024-04-12,Losartan,Cozaar,ARBs,42527-373-30,Medicare Part D Plan B,PLAN_7267,2024,Tier 2,Tier 2,2023-12-21,113,No Change,None,No,No,,472,522,-9.5,Decreased,49.29,44.32,4.97,143.88,193.17,91.18,0.0,0,0.039,0.355,0.801,0.522,14,5,9,7,2.7,24.8,5,Similar,Midwest,TX,Suburban,51-65,2024-04,Q2_2024,2023,6.8,0.4,Decreasing
FIA000365,2024-04-13,Losartan,Cozaar,ARBs,92040-550-24,Commercial Plan Alpha,PLAN_8988,2024,Tier 3,Specialty Tier,2023-04-26,353,Improved,None,No,No,,598,626,-4.3,Stable,58.83,201.46,-142.63,115.52,174.35,104.26,0.0,0,0.057,0.052,0.825,0.68,15,2,5,2,4.3,25.2,2,Similar,Midwest,NC,Urban,36-50,2024-04,Q2_2024,2023,8.0,0.763,Increasing
FIA001348,2024-04-24,Losartan,Cozaar,ARBs,69543-129-90,Medicaid Plan Y,PLAN_1116,2024,Tier 2,Tier 1,2023-07-25,274,Worsened,None,No,No,,343,353,-2.6,Stable,31.12,11.92,19.2,74.29,105.41,36.16,0.0,0,0.031,0.269,0.448,0.887,8,10,10,1,3.5,17.6,6,Similar,West,PA,Urban,36-50,2024-04,Q2_2024,2023,5.9,0.25,Increasing
FIA001443,2024-04-24,Losartan,Cozaar,ARBs,40735-561-95,Medicare Part D Plan A,PLAN_5406,2024,Specialty Tier,Specialty Tier,2024-02-23,61,No Change,None,No,No,,465,487,-4.5,Stable,248.13,127.58,120.55,174.08,422.21,196.33,0.0,0,0.222,0.119,0.676,0.936,9,9,3,13,2.5,10.9,5,Similar,Southwest,PA,Rural,51-65,2024-04,Q2_2024,2023,2.3,0.145,Increasing
FIA002766,2024-05-02,Losartan,Cozaar,ARBs,32361-158-46,Medicare Part D Plan A,PLAN_8744,2024,Tier 2,Tier 3,2023-09-04,241,Improved,None,No,No,,447,380,17.6,Increased,39.49,76.45,-36.96,53.86,93.35,41.73,0.0,0,0.02,0.243,0.387,0.659,1,0,7,2,4.4,14.6,6,Lower,Southeast,CA,Suburban,18-35,2024-05,Q2_2024,2023,7.6,0.043,Increasing
FIA002637,2024-05-05,Losartan,Cozaar,ARBs,21107-290-90,Tricare Standard,PLAN_1854,2024,Non-Formulary,Tier 2,2023-09-30,218,Worsened,Non-Formulary Status,No,No,,575,990,-41.9,Decreased,479.07,27.34,451.73,136.84,615.91,354.15,0.0,0,0.293,0.232,0.37,0.595,6,0,14,3,2.3,33.7,4,Higher,Southeast,MI,Suburban,51-65,2024-05,Q2_2024,2023,5.0,0.219,Stable
FIA002308,2024-05-07,Losartan,Cozaar,ARBs,40468-631-33,Medicare Part D Plan A,PLAN_1889,2024,Tier 3,Tier 1,2024-01-18,110,Worsened,Step Therapy,No,Yes,,50,101,-62.2,Decreased,73.86,19.34,54.52,161.02,234.88,11.74,0.0,0,0.054,0.053,0.226,0.723,2,1,1,1,2.2,33.5,8,Higher,Southeast,TX,Urban,36-50,2024-05,Q2_2024,2023,8.7,0.544,Decreasing
FIA000881,2024-05-23,Losartan,Cozaar,ARBs,67133-500-43,Tricare Standard,PLAN_1070,2024,Specialty Tier,Non-Formulary,2023-08-26,271,Improved,None,No,No,,333,354,-5.9,Decreased,245.38,383.33,-137.95,96.22,341.6,113.75,0.0,0,0.286,0.061,0.583,0.56,10,8,0,3,3.0,24.7,5,Similar,Midwest,FL,Rural,66-75,2024-05,Q2_2024,2023,8.5,0.17,Increasing
FIA000160,2024-05-24,Losartan,Cozaar,ARBs,48074-298-10,Medicare Part D Plan B,PLAN_1392,2024,Tier 3,Tier 3,2023-07-30,299,No Change,None,No,No,,237,232,2.3,Stable,78.76,81.16,-2.4,133.6,212.36,50.33,0.0,0,0.023,0.213,0.758,0.806,6,9,13,13,2.1,15.5,8,Higher,Southeast,CA,Rural,36-50,2024-05,Q2_2024,2023,7.2,0.254,Increasing
FIA002357,2024-05-24,Losartan,Cozaar,ARBs,24991-881-41,Tricare Standard,PLAN_7947,2024,Non-Formulary,Tier 1,2024-03-29,56,Worsened,Non-Formulary Status,No,No,,244,615,-60.3,Decreased,791.83,13.36,778.47,32.01,823.84,201.02,0.0,0,0.255,0.145,0.229,0.903,15,0,6,7,2.9,5.1,2,Lower,Northeast,IL,Suburban,66-75,2024-05,Q2_2024,2023,7.8,0.863,Increasing
FIA001504,2024-06-01,Losartan,Cozaar,ARBs,55404-855-54,Commercial Plan Beta,PLAN_6483,2024,Tier 2,Tier 2,2024-01-02,151,No Change,None,No,No,,904,848,6.7,Increased,37.0,44.04,-7.04,51.73,88.73,80.21,0.0,0,0.054,0.351,0.328,0.752,12,3,14,15,4.0,11.5,3,Similar,Southeast,PA,Suburban,75+,2024-06,Q2_2024,2023,7.5,0.489,Increasing
FIA002942,2024-06-01,Losartan,Cozaar,ARBs,84603-861-31,Commercial Plan Beta,PLAN_8502,2024,Non-Formulary,Non-Formulary,2023-10-11,234,No Change,Non-Formulary Status,No,No,,718,751,-4.4,Stable,370.62,649.68,-279.06,96.41,467.03,335.33,0.0,0,0.12,0.321,0.478,0.824,0,1,15,9,2.7,33.6,3,Lower,Southwest,NC,Rural,18-35,2024-06,Q2_2024,2023,3.4,0.582,Stable
FIA001316,2024-06-14,Losartan,Cozaar,ARBs,87802-573-10,Tricare Standard,PLAN_9231,2024,Non-Formulary,Tier 1,2023-08-27,292,Worsened,Non-Formulary Status,No,No,,724,979,-26.0,Decreased,638.69,9.78,628.91,47.28,685.97,496.64,0.0,0,0.244,0.122,0.753,0.773,7,2,19,9,2.1,25.3,8,Similar,West,PA,Urban,51-65,2024-06,Q2_2024,2023,9.1,0.066,Stable
FIA000740,2024-06-21,Losartan,Cozaar,ARBs,10572-290-28,Commercial Plan Beta,PLAN_5795,2024,Tier 2,Tier 3,2024-01-06,167,Improved,None,No,No,,826,689,20.0,Increased,45.99,53.65,-7.66,93.11,139.1,114.9,0.0,0,0.065,0.363,0.523,0.941,0,4,11,15,4.2,18.9,3,Similar,Northeast,NC,Suburban,18-35,2024-06,Q2_2024,2023,5.1,0.204,Decreasing
FIA001647,2024-06-21,Losartan,Cozaar,ARBs,87000-121-52,Medicaid Plan X,PLAN_5926,2024,Tier 3,Tier 1,2023-07-23,334,Worsened,Step Therapy; Quantity Limit,No,Yes,60.0,339,974,-65.1,Decreased,69.55,8.81,60.74,74.99,144.54,49.0,0.0,0,0.056,0.35,0.496,0.757,11,2,3,13,3.0,21.5,8,Higher,Southwest,NY,Rural,18-35,2024-06,Q2_2024,2023,5.1,0.404,Decreasing
FIA000180,2024-06-29,Losartan,Cozaar,ARBs,36208-484-38,Medicare Part D Plan B,PLAN_8716,2024,Non-Formulary,Tier 3,2023-10-29,244,Worsened,Non-Formulary Status,No,No,,409,433,-5.4,Decreased,319.25,83.84,235.41,155.42,474.67,194.14,0.0,0,0.075,0.255,0.238,0.64,6,9,14,5,3.2,9.1,7,Lower,Midwest,PA,Urban,51-65,2024-06,Q2_2024,2023,2.1,0.692,Increasing
FIA002734,2024-07-06,Losartan,Cozaar,ARBs,76996-120-15,Commercial Plan Alpha,PLAN_5184,2024,Tier 2,Specialty Tier,2023-11-22,227,Improved,None,No,No,,1115,917,21.6,Increased,44.56,259.88,-215.32,53.94,98.5,109.83,0.0,0,0.036,0.332,0.245,0.442,4,5,17,0,2.8,25.0,4,Higher,Midwest,TX,Urban,18-35,2024-07,Q3_2024,2023,4.3,0.583,Stable
FIA000185,2024-07-14,Losartan,Cozaar,ARBs,29392-608-29,Commercial Plan Beta,PLAN_9530,2024,Tier 3,Tier 1,2024-03-10,126,Worsened,Step Therapy,No,Yes,,110,182,-39.5,Decreased,94.6,11.87,82.73,49.04,143.64,15.8,0.0,0,0.022,0.383,0.216,0.629,4,7,11,13,3.3,24.3,4,Lower,Northeast,CA,Urban,75+,2024-07,Q3_2024,2023,6.8,0.412,Stable
FIA000127,2024-07-17,Losartan,Cozaar,ARBs,29603-720-22,Commercial Plan Alpha,PLAN_8796,2024,Non-Formulary,Tier 1,2024-02-21,147,Worsened,Non-Formulary Status; Quantity Limit,No,No,,81,116,-30.1,Decreased,426.93,6.98,419.95,101.37,528.3,42.79,0.0,0,0.176,0.357,0.572,0.814,2,7,4,0,4.7,28.2,7,Similar,West,OH,Suburban,18-35,2024-07,Q3_2024,2023,7.3,0.429,Stable
FIA001743,2024-07-17,Losartan,Cozaar,ARBs,23106-853-13,Commercial Plan Beta,PLAN_2798,2024,Non-Formulary,Tier 2,2024-01-29,170,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,225,555,-59.4,Decreased,210.94,33.49,177.45,137.31,348.25,78.36,0.0,0,0.213,0.332,0.416,0.734,13,3,5,3,3.1,11.6,8,Lower,West,GA,Suburban,36-50,2024-07,Q3_2024,2023,1.9,0.982,Increasing
FIA002743,2024-07-22,Losartan,Cozaar,ARBs,64947-836-83,Commercial Plan Alpha,PLAN_4578,2024,Tier 3,Tier 2,2024-01-22,182,Worsened,None,No,No,,292,485,-39.7,Decreased,61.72,27.09,34.63,188.84,250.56,73.16,0.0,0,0.021,0.368,0.313,0.49,11,0,5,11,4.5,21.1,3,Higher,West,PA,Suburban,75+,2024-07,Q3_2024,2023,9.7,0.898,Stable
FIA000431,2024-07-30,Losartan,Cozaar,ARBs,63547-829-66,Tricare Standard,PLAN_3463,2024,Tier 2,Tier 2,2024-03-10,142,No Change,None,No,No,,756,787,-3.8,Stable,28.38,20.1,8.28,174.04,202.42,153.03,0.0,0,0.026,0.309,0.469,0.738,12,0,17,8,2.6,25.2,5,Higher,Midwest,IL,Urban,66-75,2024-07,Q3_2024,2023,5.6,0.388,Stable
FIA000770,2024-08-15,Losartan,Cozaar,ARBs,90528-185-16,Tricare Standard,PLAN_4745,2024,Tier 2,Specialty Tier,2024-01-25,203,Improved,None,No,No,,488,318,53.6,Increased,44.27,281.94,-237.67,54.01,98.28,47.96,0.0,0,0.069,0.337,0.309,0.454,7,6,18,2,4.4,18.3,7,Similar,Southwest,GA,Urban,18-35,2024-08,Q3_2024,2023,4.2,0.565,Decreasing
FIA002427,2024-08-22,Losartan,Cozaar,ARBs,66598-699-15,Medicare Part D Plan B,PLAN_9899,2024,Specialty Tier,Tier 1,2024-04-05,139,Worsened,Prior Authorization,Yes,No,,659,916,-28.0,Decreased,274.46,5.36,269.1,67.04,341.5,225.05,0.208,8,0.288,0.373,0.333,0.631,15,6,5,15,4.3,9.8,6,Higher,Southwest,CA,Urban,36-50,2024-08,Q3_2024,2023,1.9,0.111,Increasing
FIA000098,2024-08-30,Losartan,Cozaar,ARBs,91300-250-25,Tricare Standard,PLAN_3832,2024,Tier 2,Specialty Tier,2024-02-29,183,Improved,None,No,No,,968,831,16.6,Increased,22.37,280.56,-258.19,127.15,149.52,144.74,0.0,0,0.046,0.382,0.317,0.517,6,2,1,13,2.2,25.5,3,Higher,Southeast,MI,Suburban,51-65,2024-08,Q3_2024,2023,9.2,0.914,Increasing
FIA000907,2024-09-07,Losartan,Cozaar,ARBs,27342-818-40,Medicare Part D Plan A,PLAN_8624,2024,Tier 2,Specialty Tier,2024-02-12,208,Improved,None,No,No,,272,171,59.2,Increased,32.21,284.22,-252.01,53.14,85.35,23.22,0.0,0,0.066,0.06,0.493,0.737,0,5,7,3,3.1,8.9,3,Similar,Midwest,NY,Urban,18-35,2024-09,Q3_2024,2023,2.9,0.44,Decreasing
FIA001885,2024-09-14,Losartan,Cozaar,ARBs,94519-721-81,VA Plan,PLAN_1344,2024,Non-Formulary,Tier 2,2024-04-25,142,Worsened,Non-Formulary Status,No,No,,723,942,-23.2,Decreased,323.97,38.03,285.94,44.02,367.99,266.06,0.0,0,0.212,0.107,0.801,0.852,4,8,18,13,4.0,24.9,6,Higher,Northeast,NC,Urban,51-65,2024-09,Q3_2024,2023,3.1,0.764,Decreasing
FIA001773,2024-10-07,Losartan,Cozaar,ARBs,39406-246-57,Commercial Plan Beta,PLAN_5072,2024,Tier 2,Tier 3,2024-05-11,149,Improved,Quantity Limit,No,No,30.0,1088,896,21.5,Increased,36.22,55.06,-18.84,137.46,173.68,188.96,0.0,0,0.041,0.296,0.564,0.708,8,10,0,9,4.3,17.7,5,Similar,Southeast,FL,Urban,36-50,2024-10,Q4_2024,2024,7.0,0.112,Decreasing
FIA001481,2024-10-12,Losartan,Cozaar,ARBs,33482-582-30,Medicaid Plan X,PLAN_5765,2024,Non-Formulary,Non-Formulary,2024-02-04,251,No Change,Non-Formulary Status,No,No,,140,151,-7.1,Decreased,760.72,790.8,-30.08,168.6,929.32,130.1,0.0,0,0.176,0.278,0.452,0.95,14,6,18,2,3.1,29.5,6,Lower,Northeast,TX,Rural,66-75,2024-10,Q4_2024,2024,5.4,0.576,Increasing
FIA002447,2024-10-13,Losartan,Cozaar,ARBs,12544-162-19,Medicare Part D Plan A,PLAN_4692,2024,Specialty Tier,Tier 2,2024-06-03,132,Worsened,Step Therapy,No,Yes,,674,888,-24.1,Decreased,212.37,24.57,187.8,79.13,291.5,196.47,0.0,0,0.141,0.368,0.83,0.455,3,9,4,8,3.9,13.7,7,Lower,Southeast,CA,Urban,75+,2024-10,Q4_2024,2024,5.0,0.83,Decreasing
FIA002707,2024-10-17,Losartan,Cozaar,ARBs,26064-541-61,Commercial Plan Beta,PLAN_4540,2024,Specialty Tier,Tier 1,2023-12-17,305,Worsened,None,No,No,,266,377,-29.3,Decreased,161.76,15.91,145.85,142.52,304.28,80.94,0.0,0,0.104,0.36,0.361,0.515,15,3,12,2,3.5,22.3,4,Similar,West,MI,Rural,75+,2024-10,Q4_2024,2024,8.3,0.372,Stable
FIA002617,2024-10-24,Losartan,Cozaar,ARBs,75659-942-30,Medicare Part D Plan A,PLAN_4389,2024,Tier 1,Specialty Tier,2023-11-27,332,Improved,None,No,No,,608,484,25.8,Increased,9.49,150.37,-140.88,33.94,43.43,26.41,0.0,0,0.066,0.084,0.281,0.632,1,9,20,3,3.2,32.6,5,Similar,Northeast,NC,Suburban,66-75,2024-10,Q4_2024,2024,8.9,0.252,Stable
FIA002403,2024-10-26,Losartan,Cozaar,ARBs,39877-555-46,Medicare Part D Plan A,PLAN_7254,2024,Tier 3,Non-Formulary,2024-04-16,193,Improved,Quantity Limit,No,No,60.0,936,959,-2.3,Stable,52.7,349.87,-297.17,177.43,230.13,215.4,0.0,0,0.049,0.25,0.375,0.601,4,1,10,15,4.6,13.7,6,Similar,Southwest,OH,Suburban,51-65,2024-10,Q4_2024,2024,4.8,0.215,Decreasing
FIA001433,2024-11-03,Losartan,Cozaar,ARBs,94036-582-95,Tricare Standard,PLAN_4496,2024,Tier 2,Specialty Tier,2024-01-29,279,Improved,None,No,No,,1122,845,32.9,Increased,47.97,132.88,-84.91,197.36,245.33,275.26,0.0,0,0.064,0.367,0.734,0.684,3,1,2,6,2.1,15.5,7,Higher,Southeast,NY,Rural,36-50,2024-11,Q4_2024,2024,4.3,0.965,Increasing
FIA002367,2024-11-11,Losartan,Cozaar,ARBs,37297-240-87,Medicare Part D Plan A,PLAN_1808,2024,Specialty Tier,Non-Formulary,2024-06-09,155,Improved,Prior Authorization; Quantity Limit,Yes,No,60.0,249,241,3.6,Stable,172.5,220.22,-47.72,82.23,254.73,63.43,0.112,1,0.135,0.331,0.248,0.675,5,7,10,0,4.3,17.9,3,Higher,Southwest,FL,Urban,75+,2024-11,Q4_2024,2024,5.8,0.176,Increasing
FIA000659,2024-12-16,Losartan,Cozaar,ARBs,10193-304-67,Medicare Part D Plan A,PLAN_2874,2024,Tier 1,Tier 1,2024-05-06,224,No Change,Quantity Limit,No,No,90.0,904,890,1.6,Stable,14.76,8.79,5.97,45.84,60.6,54.78,0.0,0,0.056,0.069,0.619,0.486,9,0,14,1,2.6,20.4,6,Lower,West,TX,Suburban,36-50,2024-12,Q4_2024,2024,4.6,0.529,Decreasing
FIA002974,2024-12-22,Losartan,Cozaar,ARBs,99657-795-22,Medicare Part D Plan A,PLAN_6469,2024,Tier 1,Specialty Tier,2024-06-14,191,Improved,None,No,No,,922,737,25.2,Increased,13.7,190.83,-177.13,183.54,197.24,181.86,0.0,0,0.025,0.301,0.522,0.637,9,3,18,2,4.1,28.5,4,Similar,West,OH,Suburban,51-65,2024-12,Q4_2024,2024,6.9,0.654,Stable
FIA001416,2024-12-23,Losartan,Cozaar,ARBs,35130-589-13,Commercial Plan Beta,PLAN_8408,2024,Tier 2,Tier 3,2024-02-21,306,Improved,None,No,No,,942,626,50.6,Increased,44.85,66.22,-21.37,122.54,167.39,157.68,0.0,0,0.067,0.215,0.726,0.484,11,8,17,13,3.7,25.6,6,Similar,Southeast,CA,Suburban,51-65,2024-12,Q4_2024,2024,5.7,0.947,Increasing
FIA001245,2024-12-28,Losartan,Cozaar,ARBs,16676-750-50,Commercial Plan Beta,PLAN_1945,2024,Specialty Tier,Tier 1,2024-05-16,226,Worsened,Step Therapy,No,Yes,,541,799,-32.2,Decreased,155.18,17.93,137.25,133.8,288.98,156.34,0.0,0,0.167,0.142,0.21,0.669,0,2,14,13,2.8,8.4,3,Lower,Northeast,IL,Rural,18-35,2024-12,Q4_2024,2024,9.1,0.118,Decreasing
FIA002106,2024-12-31,Losartan,Cozaar,ARBs,99854-642-30,Commercial Plan Beta,PLAN_2595,2024,Specialty Tier,Non-Formulary,2024-01-23,343,Improved,Prior Authorization,Yes,No,,559,605,-7.5,Decreased,160.59,616.39,-455.8,31.77,192.36,107.53,0.169,5,0.277,0.117,0.664,0.793,4,5,4,1,2.0,8.8,6,Higher,West,MI,Urban,51-65,2024-12,Q4_2024,2024,2.5,0.414,Decreasing
FIA002660,2024-12-31,Losartan,Cozaar,ARBs,44335-662-45,Medicare Part D Plan A,PLAN_4406,2024,Specialty Tier,Tier 2,2024-09-26,96,Worsened,Prior Authorization; Quantity Limit,Yes,No,90.0,124,377,-66.9,Decreased,296.64,33.88,262.76,62.95,359.59,44.59,0.596,3,0.186,0.244,0.633,0.578,9,4,15,4,3.6,23.0,2,Higher,Southeast,OH,Rural,75+,2024-12,Q4_2024,2024,9.4,0.944,Increasing
FIA001063,2025-01-10,Losartan,Cozaar,ARBs,88710-212-28,Tricare Standard,PLAN_6679,2025,Tier 3,Non-Formulary,2024-09-10,122,Improved,Prior Authorization,Yes,No,,547,584,-6.2,Decreased,94.58,687.41,-592.83,49.03,143.61,78.55,0.122,10,0.041,0.135,0.688,0.599,14,10,2,9,4.4,7.5,7,Lower,Southwest,FL,Urban,18-35,2025-01,Q1_2025,2024,8.5,0.706,Decreasing
FIA000697,2025-01-12,Losartan,Cozaar,ARBs,58443-622-87,VA Plan,PLAN_3746,2025,Tier 1,Specialty Tier,2024-08-28,137,Improved,None,No,No,,821,697,17.9,Increased,11.94,113.26,-101.32,128.78,140.72,115.53,0.0,0,0.014,0.192,0.585,0.678,14,6,6,0,4.6,33.8,7,Similar,Southwest,TX,Urban,36-50,2025-01,Q1_2025,2024,6.3,0.681,Increasing
FIA001205,2025-01-17,Losartan,Cozaar,ARBs,79060-332-11,Medicaid Plan X,PLAN_2744,2025,Tier 1,Specialty Tier,2024-03-19,304,Improved,None,No,No,,1122,867,29.5,Increased,11.42,267.12,-255.7,124.76,136.18,152.79,0.0,0,0.014,0.293,0.426,0.872,8,10,9,15,2.9,19.9,3,Similar,Southeast,IL,Rural,75+,2025-01,Q1_2025,2024,5.2,0.432,Decreasing
FIA001146,2025-01-23,Losartan,Cozaar,ARBs,18245-474-21,Tricare Standard,PLAN_8319,2025,Specialty Tier,Tier 2,2024-07-15,192,Worsened,None,No,No,,597,995,-40.0,Decreased,212.26,37.9,174.36,143.14,355.4,212.17,0.0,0,0.097,0.293,0.454,0.876,6,7,16,8,3.8,11.5,8,Lower,Southwest,NY,Suburban,51-65,2025-01,Q1_2025,2024,8.3,0.334,Decreasing
FIA001260,2025-01-31,Losartan,Cozaar,ARBs,62410-683-23,Medicare Part D Plan A,PLAN_8330,2025,Non-Formulary,Specialty Tier,2024-09-22,131,Worsened,Non-Formulary Status; Quantity Limit,No,No,,282,303,-6.8,Decreased,233.9,254.75,-20.85,161.6,395.5,111.53,0.0,0,0.143,0.27,0.675,0.622,2,1,15,2,2.6,32.4,2,Higher,Southeast,IL,Urban,18-35,2025-01,Q1_2025,2024,4.7,0.176,Stable
FIA002408,2025-02-05,Losartan,Cozaar,ARBs,26611-990-58,VA Plan,PLAN_7973,2025,Non-Formulary,Specialty Tier,2024-02-12,359,Worsened,Non-Formulary Status,No,No,,113,117,-3.0,Stable,300.61,214.21,86.4,62.71,363.32,41.06,0.0,0,0.1,0.389,0.462,0.927,2,10,16,6,4.3,26.5,3,Higher,Midwest,GA,Rural,36-50,2025-02,Q1_2025,2024,7.4,0.775,Increasing
FIA001503,2025-02-12,Losartan,Cozaar,ARBs,26006-121-11,Medicare Part D Plan B,PLAN_5918,2025,Non-Formulary,Tier 2,2024-10-10,125,Worsened,Non-Formulary Status,No,No,,205,453,-54.6,Decreased,755.46,28.63,726.83,77.53,832.99,170.76,0.0,0,0.213,0.273,0.628,0.465,15,7,16,10,4.4,16.2,6,Higher,Northeast,IL,Suburban,75+,2025-02,Q1_2025,2024,5.9,0.384,Increasing
FIA002001,2025-02-13,Losartan,Cozaar,ARBs,13013-151-29,VA Plan,PLAN_9078,2025,Tier 1,Specialty Tier,2024-06-14,244,Improved,None,No,No,,227,157,44.9,Increased,18.6,170.04,-151.44,69.67,88.27,20.04,0.0,0,0.072,0.079,0.248,0.474,14,7,10,7,4.0,30.7,4,Similar,Southeast,TX,Rural,66-75,2025-02,Q1_2025,2024,1.8,0.074,Stable
FIA000519,2025-02-14,Losartan,Cozaar,ARBs,80453-129-83,Tricare Standard,PLAN_6054,2025,Specialty Tier,Specialty Tier,2024-05-06,284,No Change,Prior Authorization; Step Therapy,Yes,Yes,,520,546,-4.8,Stable,182.09,165.37,16.72,105.33,287.42,149.46,0.533,6,0.173,0.388,0.335,0.679,0,6,4,7,4.6,16.1,8,Similar,Southwest,FL,Rural,36-50,2025-02,Q1_2025,2024,7.9,0.337,Stable
FIA002392,2025-02-16,Losartan,Cozaar,ARBs,81715-955-90,Medicare Part D Plan B,PLAN_2661,2025,Tier 1,Non-Formulary,2024-05-04,288,Improved,None,No,No,,1000,714,40.1,Increased,11.66,733.06,-721.4,67.52,79.18,79.18,0.0,0,0.074,0.31,0.355,0.891,7,6,0,12,2.1,11.8,4,Higher,Southwest,TX,Urban,66-75,2025-02,Q1_2025,2024,6.2,0.002,Increasing
FIA002932,2025-02-20,Losartan,Cozaar,ARBs,35537-568-86,Medicare Part D Plan B,PLAN_9695,2025,Tier 3,Tier 3,2024-06-10,255,No Change,None,No,No,,738,711,3.9,Stable,54.0,73.34,-19.34,190.9,244.9,180.74,0.0,0,0.02,0.054,0.327,0.855,4,10,4,13,3.2,9.2,7,Lower,Southwest,PA,Rural,18-35,2025-02,Q1_2025,2024,3.2,0.118,Increasing
FIA001334,2025-02-22,Losartan,Cozaar,ARBs,12323-952-67,Medicaid Plan X,PLAN_6594,2025,Non-Formulary,Specialty Tier,2024-07-22,215,Worsened,Non-Formulary Status,No,No,,916,885,3.6,Stable,578.7,217.7,361.0,147.61,726.31,665.3,0.0,0,0.248,0.354,0.31,0.576,12,10,14,0,4.7,32.4,5,Lower,West,NC,Suburban,51-65,2025-02,Q1_2025,2024,5.7,0.823,Increasing
FIA000391,2025-02-27,Losartan,Cozaar,ARBs,62984-545-58,Medicare Part D Plan B,PLAN_9035,2025,Non-Formulary,Non-Formulary,2024-07-11,231,No Change,Non-Formulary Status,No,No,,375,389,-3.6,Stable,654.15,585.92,68.23,136.48,790.63,296.49,0.0,0,0.123,0.058,0.273,0.709,12,4,15,9,4.3,26.0,6,Lower,Southeast,TX,Suburban,75+,2025-02,Q1_2025,2024,7.7,0.571,Increasing
FIA002404,2025-03-02,Losartan,Cozaar,ARBs,57414-797-30,Commercial Plan Alpha,PLAN_7726,2025,Specialty Tier,Non-Formulary,2024-10-12,141,Improved,None,No,No,,111,104,7.4,Increased,100.82,464.79,-363.97,160.9,261.72,29.05,0.0,0,0.261,0.307,0.782,0.833,9,7,3,6,4.6,5.7,3,Lower,Southwest,PA,Rural,18-35,2025-03,Q1_2025,2024,9.6,0.979,Increasing
FIA000719,2025-03-08,Losartan,Cozaar,ARBs,99869-380-78,Medicare Part D Plan B,PLAN_5611,2025,Tier 3,Non-Formulary,2025-01-20,47,Improved,Step Therapy,No,Yes,,313,331,-5.4,Decreased,88.07,248.78,-160.71,166.02,254.09,79.53,0.0,0,0.044,0.066,0.594,0.838,8,1,1,2,4.6,19.8,3,Lower,Northeast,PA,Rural,18-35,2025-03,Q1_2025,2024,1.9,0.01,Stable
FIA000798,2025-03-08,Losartan,Cozaar,ARBs,22190-622-92,VA Plan,PLAN_9374,2025,Specialty Tier,Tier 3,2024-12-27,71,Worsened,Prior Authorization,Yes,No,,425,425,0.0,Stable,117.35,55.09,62.26,106.28,223.63,95.04,0.256,8,0.127,0.284,0.396,0.654,13,6,20,12,3.6,9.4,6,Lower,Midwest,FL,Suburban,66-75,2025-03,Q1_2025,2024,4.1,0.6,Stable
FIA002115,2025-03-18,Losartan,Cozaar,ARBs,56432-421-43,Tricare Standard,PLAN_1832,2025,Tier 2,Non-Formulary,2024-09-27,172,Improved,None,No,No,,818,557,46.9,Increased,30.36,297.74,-267.38,166.19,196.55,160.78,0.0,0,0.017,0.069,0.802,0.91,15,3,0,4,4.4,17.5,3,Lower,Midwest,OH,Rural,36-50,2025-03,Q1_2025,2024,3.1,0.391,Stable
FIA002566,2025-03-23,Losartan,Cozaar,ARBs,14612-119-54,Medicaid Plan X,PLAN_4616,2025,Tier 2,Non-Formulary,2024-08-10,225,Improved,Quantity Limit,No,No,,356,275,29.5,Increased,27.26,230.68,-203.42,139.94,167.2,59.52,0.0,0,0.077,0.182,0.776,0.645,0,4,1,8,4.6,9.3,8,Lower,Midwest,CA,Rural,66-75,2025-03,Q1_2025,2024,8.6,0.435,Stable
FIA002940,2025-04-03,Losartan,Cozaar,ARBs,50123-876-93,Commercial Plan Beta,PLAN_9584,2025,Non-Formulary,Tier 2,2025-01-01,92,Worsened,Non-Formulary Status,No,No,,89,160,-44.0,Decreased,572.3,43.92,528.38,36.8,609.1,54.21,0.0,0,0.13,0.177,0.327,0.631,2,4,3,6,4.7,25.7,8,Similar,Northeast,PA,Urban,75+,2025-04,Q2_2025,2024,1.9,0.584,Increasing
FIA002241,2025-04-13,Losartan,Cozaar,ARBs,11706-783-23,Medicare Part D Plan A,PLAN_8343,2025,Non-Formulary,Tier 1,2024-05-05,343,Worsened,Non-Formulary Status,No,No,,112,157,-28.5,Decreased,255.67,18.96,236.71,145.68,401.35,44.95,0.0,0,0.29,0.302,0.597,0.55,7,4,0,6,3.8,17.7,2,Similar,Southwest,TX,Rural,66-75,2025-04,Q2_2025,2024,2.6,0.879,Stable
FIA001587,2025-05-17,Losartan,Cozaar,ARBs,35284-886-76,VA Plan,PLAN_5369,2025,Tier 1,Tier 3,2024-09-29,230,Improved,None,No,No,,253,169,50.0,Increased,7.89,80.23,-72.34,117.78,125.67,31.79,0.0,0,0.074,0.236,0.579,0.609,13,9,13,2,3.2,10.8,5,Higher,Southwest,TX,Suburban,66-75,2025-05,Q2_2025,2024,3.9,0.598,Decreasing
FIA000018,2025-05-25,Losartan,Cozaar,ARBs,92213-348-23,Medicaid Plan X,PLAN_2983,2025,Tier 1,Tier 2,2024-11-17,189,Improved,None,No,No,,425,419,1.5,Stable,6.62,20.77,-14.15,42.92,49.54,21.05,0.0,0,0.06,0.329,0.596,0.423,13,10,11,2,3.5,15.2,8,Similar,Southwest,TX,Suburban,51-65,2025-05,Q2_2025,2024,6.7,0.829,Decreasing
FIA000472,2025-05-27,Losartan,Cozaar,ARBs,48528-233-76,VA Plan,PLAN_1702,2025,Non-Formulary,Tier 2,2025-03-21,67,Worsened,Non-Formulary Status,No,No,,262,445,-40.9,Decreased,344.09,28.25,315.84,148.22,492.31,128.99,0.0,0,0.283,0.34,0.641,0.828,10,3,15,12,3.3,34.0,7,Lower,West,TX,Urban,36-50,2025-05,Q2_2025,2024,4.8,0.847,Increasing
FIA000874,2025-06-02,Losartan,Cozaar,ARBs,39899-774-32,Medicaid Plan Y,PLAN_3292,2025,Tier 1,Specialty Tier,2024-09-09,266,Improved,None,No,No,,424,349,21.6,Increased,11.52,102.99,-91.47,151.21,162.73,69.0,0.0,0,0.057,0.326,0.574,0.887,12,7,3,5,3.1,23.1,5,Higher,Midwest,MI,Rural,75+,2025-06,Q2_2025,2024,3.9,0.86,Increasing
FIA002699,2025-06-02,Losartan,Cozaar,ARBs,93568-721-36,Medicare Part D Plan B,PLAN_4550,2025,Tier 2,Tier 2,2024-07-29,308,No Change,None,No,No,,856,940,-8.9,Decreased,47.45,45.6,1.85,175.52,222.97,190.86,0.0,0,0.02,0.11,0.792,0.542,3,9,3,1,3.9,25.4,3,Lower,Midwest,MI,Rural,18-35,2025-06,Q2_2025,2024,4.7,0.211,Decreasing
FIA001369,2025-06-08,Losartan,Cozaar,ARBs,10432-571-89,Commercial Plan Alpha,PLAN_7652,2025,Specialty Tier,Tier 3,2024-08-11,301,Worsened,Prior Authorization; Quantity Limit,Yes,No,90.0,129,143,-9.1,Decreased,258.04,78.99,179.05,184.26,442.3,57.06,0.513,1,0.26,0.252,0.402,0.567,14,5,0,3,3.4,14.4,4,Similar,Southwest,IL,Suburban,75+,2025-06,Q2_2025,2024,6.4,0.612,Decreasing
FIA000716,2025-06-15,Losartan,Cozaar,ARBs,95954-301-98,Tricare Standard,PLAN_2448,2025,Non-Formulary,Tier 1,2024-10-16,242,Worsened,Non-Formulary Status,No,No,,257,789,-67.3,Decreased,257.71,17.91,239.8,162.87,420.58,108.09,0.0,0,0.148,0.06,0.216,0.844,15,2,12,1,3.4,10.0,8,Lower,Northeast,PA,Rural,75+,2025-06,Q2_2025,2024,4.8,0.482,Decreasing
FIA000997,2025-06-16,Losartan,Cozaar,ARBs,58009-226-38,Medicare Part D Plan A,PLAN_8014,2025,Specialty Tier,Tier 1,2025-03-21,87,Worsened,Step Therapy,No,Yes,,239,615,-61.1,Decreased,260.35,8.23,252.12,154.37,414.72,99.12,0.0,0,0.171,0.077,0.617,0.484,4,1,12,14,2.9,29.1,3,Similar,Northeast,PA,Suburban,36-50,2025-06,Q2_2025,2024,9.7,0.155,Stable
FIA001489,2025-06-17,Losartan,Cozaar,ARBs,58254-989-88,VA Plan,PLAN_4121,2025,Tier 2,Specialty Tier,2024-11-27,202,Improved,None,No,No,,241,208,15.9,Increased,25.13,187.82,-162.69,165.46,190.59,45.93,0.0,0,0.02,0.161,0.761,0.708,15,5,14,1,3.1,29.4,2,Higher,Southeast,OH,Urban,36-50,2025-06,Q2_2025,2024,7.2,0.02,Stable
FIA001544,2025-06-20,Losartan,Cozaar,ARBs,45307-622-49,Medicare Part D Plan B,PLAN_9626,2025,Tier 1,Tier 2,2025-01-24,147,Improved,Quantity Limit,No,No,90.0,848,916,-7.3,Decreased,9.13,47.68,-38.55,94.8,103.93,88.13,0.0,0,0.023,0.084,0.469,0.488,7,6,6,10,3.6,6.8,4,Lower,Southeast,TX,Rural,51-65,2025-06,Q2_2025,2024,1.7,0.2,Decreasing
FIA000779,2025-07-02,Losartan,Cozaar,ARBs,64723-464-76,Medicare Part D Plan B,PLAN_9757,2025,Tier 1,Tier 3,2025-03-12,112,Improved,None,No,No,,725,602,20.6,Increased,18.95,56.74,-37.79,164.39,183.34,132.92,0.0,0,0.07,0.282,0.896,0.89,0,6,2,15,2.6,29.0,8,Higher,Midwest,OH,Urban,18-35,2025-07,Q3_2025,2024,9.9,0.2,Increasing
FIA002712,2025-07-02,Losartan,Cozaar,ARBs,49419-445-30,Commercial Plan Alpha,PLAN_6232,2025,Specialty Tier,Tier 1,2025-01-11,172,Worsened,Step Therapy,No,Yes,,411,901,-54.3,Decreased,241.77,17.97,223.8,164.9,406.67,167.14,0.0,0,0.162,0.313,0.233,0.7,7,3,20,12,3.4,6.3,6,Lower,Southeast,GA,Urban,51-65,2025-07,Q3_2025,2024,4.1,0.454,Stable
FIA000508,2025-07-07,Losartan,Cozaar,ARBs,40926-656-80,Medicare Part D Plan B,PLAN_5416,2025,Tier 1,Tier 1,2025-04-09,89,No Change,None,No,No,,776,782,-0.7,Stable,5.76,13.83,-8.07,74.66,80.42,62.41,0.0,0,0.062,0.251,0.421,0.767,2,5,5,1,2.8,23.3,2,Higher,Midwest,MI,Suburban,66-75,2025-07,Q3_2025,2024,8.0,0.529,Stable
FIA000237,2025-07-16,Losartan,Cozaar,ARBs,23263-121-96,Commercial Plan Alpha,PLAN_7208,2025,Tier 3,Tier 1,2025-06-01,45,Worsened,Prior Authorization,Yes,No,,115,324,-64.3,Decreased,59.96,9.26,50.7,173.29,233.25,26.82,0.189,2,0.012,0.168,0.347,0.651,11,5,5,13,4.6,7.0,3,Lower,Southeast,NY,Rural,66-75,2025-07,Q3_2025,2024,7.2,0.318,Stable
FIA000295,2025-07-17,Losartan,Cozaar,ARBs,20324-685-58,Medicare Part D Plan A,PLAN_3138,2025,Specialty Tier,Tier 3,2024-09-07,313,Worsened,Step Therapy,No,Yes,,179,195,-8.1,Decreased,131.81,66.12,65.69,122.42,254.23,45.51,0.0,0,0.205,0.394,0.644,0.828,5,3,20,7,2.9,21.1,3,Higher,Southwest,PA,Rural,18-35,2025-07,Q3_2025,2024,3.5,0.935,Decreasing
FIA002800,2025-08-07,Losartan,Cozaar,ARBs,92058-682-68,Medicare Part D Plan A,PLAN_7599,2025,Tier 3,Specialty Tier,2025-05-18,81,Improved,Prior Authorization; Quantity Limit,Yes,No,60.0,346,339,2.2,Stable,65.59,243.7,-178.11,154.11,219.7,76.02,0.49,1,0.034,0.079,0.53,0.667,6,8,6,5,3.7,19.3,5,Higher,Northeast,TX,Urban,18-35,2025-08,Q3_2025,2024,5.7,0.539,Increasing
FIA001619,2025-08-08,Losartan,Cozaar,ARBs,47825-355-92,Tricare Standard,PLAN_7889,2025,Tier 2,Tier 1,2025-01-09,211,Worsened,None,No,No,,907,843,7.6,Increased,39.82,13.38,26.44,55.03,94.85,86.03,0.0,0,0.044,0.383,0.426,0.442,9,6,17,3,3.1,25.6,6,Higher,Southeast,NY,Suburban,51-65,2025-08,Q3_2025,2024,6.6,0.443,Stable
FIA000760,2025-08-10,Losartan,Cozaar,ARBs,75336-754-35,Medicare Part D Plan A,PLAN_3229,2025,Tier 3,Tier 2,2025-04-10,122,Worsened,Prior Authorization,Yes,No,,257,517,-50.2,Decreased,58.1,45.53,12.57,163.02,221.12,56.83,0.184,5,0.013,0.325,0.833,0.758,13,2,8,14,3.1,19.1,8,Higher,Midwest,CA,Rural,51-65,2025-08,Q3_2025,2024,5.5,0.782,Increasing
FIA002171,2025-08-13,Losartan,Cozaar,ARBs,73544-118-69,Medicare Part D Plan A,PLAN_7872,2025,Tier 1,Non-Formulary,2025-04-14,121,Improved,Quantity Limit,No,No,90.0,1173,939,24.9,Increased,7.99,537.76,-529.77,139.01,147.0,172.43,0.0,0,0.059,0.068,0.451,0.739,10,2,15,6,3.7,28.7,8,Higher,Southeast,TX,Rural,18-35,2025-08,Q3_2025,2024,2.4,0.846,Decreasing
FIA002523,2025-08-16,Losartan,Cozaar,ARBs,22486-195-74,Medicare Part D Plan A,PLAN_4193,2025,Tier 2,Non-Formulary,2025-04-24,114,Improved,None,No,No,,847,640,32.5,Increased,38.37,255.18,-216.81,33.67,72.04,61.02,0.0,0,0.025,0.303,0.664,0.584,6,0,12,12,3.2,15.1,4,Similar,Midwest,TX,Rural,51-65,2025-08,Q3_2025,2024,7.4,0.133,Decreasing
FIA002464,2025-08-28,Losartan,Cozaar,ARBs,14195-485-76,Medicaid Plan X,PLAN_1860,2025,Non-Formulary,Tier 2,2025-02-19,190,Worsened,Non-Formulary Status; Quantity Limit,No,No,,330,436,-24.2,Decreased,557.69,29.93,527.76,181.88,739.57,244.06,0.0,0,0.119,0.316,0.203,0.661,9,7,3,2,4.9,9.5,8,Higher,Northeast,TX,Urban,66-75,2025-08,Q3_2025,2024,7.2,0.743,Increasing
FIA002636,2025-08-31,Losartan,Cozaar,ARBs,52765-378-93,Medicaid Plan X,PLAN_1409,2025,Non-Formulary,Tier 3,2024-12-19,255,Worsened,Non-Formulary Status,No,No,,610,624,-2.1,Stable,392.39,67.1,325.29,158.8,551.19,336.23,0.0,0,0.055,0.334,0.871,0.876,0,5,6,5,3.1,27.9,6,Similar,Midwest,NC,Suburban,75+,2025-08,Q3_2025,2024,5.4,0.162,Increasing
FIA002202,2022-01-07,Metformin,Glucophage,Antidiabetics,74030-356-11,Medicare Part D Plan A,PLAN_5728,2022,Specialty Tier,Tier 2,2021-09-17,112,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,291,804,-63.7,Decreased,211.83,29.58,182.25,137.82,349.65,101.75,0.57,1,0.086,0.395,0.371,0.702,9,1,3,11,3.6,26.5,8,Lower,Southwest,CA,Suburban,36-50,2022-01,Q1_2022,2021,3.4,0.371,Increasing
FIA001512,2022-01-17,Metformin,Glucophage,Antidiabetics,21338-441-26,Commercial Plan Beta,PLAN_3753,2022,Non-Formulary,Tier 1,2021-03-27,296,Worsened,Non-Formulary Status,No,No,,615,962,-36.0,Decreased,458.62,11.59,447.03,82.06,540.68,332.52,0.0,0,0.153,0.229,0.835,0.943,12,6,10,2,3.5,19.7,2,Lower,Northeast,MI,Suburban,51-65,2022-01,Q1_2022,2021,6.1,0.116,Stable
FIA002530,2022-01-22,Metformin,Glucophage,Antidiabetics,34696-974-85,VA Plan,PLAN_2081,2022,Tier 2,Tier 3,2021-04-11,286,Improved,Quantity Limit,No,No,,291,216,34.9,Increased,45.36,92.62,-47.26,81.35,126.71,36.87,0.0,0,0.035,0.221,0.582,0.437,4,3,8,6,4.1,24.5,8,Similar,Southeast,OH,Rural,75+,2022-01,Q1_2022,2021,4.3,0.999,Decreasing
FIA001788,2022-01-26,Metformin,Glucophage,Antidiabetics,48293-995-57,VA Plan,PLAN_6149,2022,Non-Formulary,Non-Formulary,2021-05-23,248,No Change,Non-Formulary Status,No,No,,403,412,-2.1,Stable,574.97,721.03,-146.06,47.97,622.94,251.04,0.0,0,0.251,0.245,0.838,0.7,8,3,17,13,3.7,29.8,8,Lower,West,CA,Rural,66-75,2022-01,Q1_2022,2021,8.9,0.274,Stable
FIA000563,2022-01-31,Metformin,Glucophage,Antidiabetics,91304-513-69,Tricare Standard,PLAN_7651,2022,Non-Formulary,Specialty Tier,2021-11-13,79,Worsened,Non-Formulary Status,No,No,,243,253,-3.9,Stable,281.57,232.33,49.24,103.1,384.67,93.47,0.0,0,0.238,0.063,0.868,0.661,2,2,13,15,4.7,11.9,8,Higher,Southeast,FL,Suburban,66-75,2022-01,Q1_2022,2021,7.1,0.028,Stable
FIA000574,2022-02-03,Metformin,Glucophage,Antidiabetics,81626-573-23,Tricare Standard,PLAN_9113,2022,Specialty Tier,Tier 2,2021-10-13,113,Worsened,Step Therapy,No,Yes,,54,153,-64.1,Decreased,232.38,23.97,208.41,74.02,306.4,16.55,0.0,0,0.279,0.162,0.382,0.458,5,4,1,12,3.1,21.2,6,Similar,Southeast,GA,Rural,36-50,2022-02,Q1_2022,2021,4.1,0.872,Increasing
FIA000822,2022-02-09,Metformin,Glucophage,Antidiabetics,81171-542-99,Commercial Plan Alpha,PLAN_9667,2022,Specialty Tier,Tier 3,2021-03-01,345,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,147,140,5.2,Increased,235.56,82.95,152.61,35.69,271.25,39.87,0.495,6,0.117,0.16,0.269,0.897,4,1,11,7,4.0,28.1,6,Similar,Southwest,OH,Rural,36-50,2022-02,Q1_2022,2021,4.2,0.198,Stable
FIA000531,2022-02-15,Metformin,Glucophage,Antidiabetics,20310-666-10,Medicaid Plan Y,PLAN_3280,2022,Tier 2,Specialty Tier,2021-07-17,213,Improved,Quantity Limit,No,No,,893,634,41.0,Increased,33.64,292.68,-259.04,32.5,66.14,59.06,0.0,0,0.023,0.324,0.453,0.681,3,7,15,14,2.9,7.7,7,Lower,Southwest,PA,Suburban,75+,2022-02,Q1_2022,2021,2.7,0.075,Decreasing
FIA002386,2022-02-22,Metformin,Glucophage,Antidiabetics,72423-601-80,Medicare Part D Plan A,PLAN_1184,2022,Tier 2,Tier 2,2021-05-21,277,No Change,None,No,No,,434,446,-2.6,Stable,42.09,31.93,10.16,155.81,197.9,85.89,0.0,0,0.021,0.109,0.279,0.43,6,9,0,7,2.2,14.4,7,Lower,Southwest,GA,Rural,18-35,2022-02,Q1_2022,2021,2.5,0.083,Decreasing
FIA000194,2022-03-01,Metformin,Glucophage,Antidiabetics,85777-881-11,Commercial Plan Beta,PLAN_4138,2022,Tier 2,Tier 3,2021-04-09,326,Improved,None,No,No,,918,612,50.1,Increased,30.44,58.03,-27.59,41.62,72.06,66.15,0.0,0,0.045,0.387,0.32,0.815,0,1,6,15,3.1,22.7,5,Higher,Northeast,FL,Suburban,66-75,2022-03,Q1_2022,2021,4.8,0.514,Stable
FIA001202,2022-03-17,Metformin,Glucophage,Antidiabetics,51667-581-85,VA Plan,PLAN_6859,2022,Tier 1,Tier 2,2021-06-29,261,Improved,None,No,No,,198,192,3.3,Stable,8.2,26.65,-18.45,71.55,79.75,15.79,0.0,0,0.012,0.384,0.495,0.407,2,9,2,10,2.9,8.9,5,Higher,Northeast,GA,Rural,36-50,2022-03,Q1_2022,2021,8.7,0.075,Stable
FIA001235,2022-04-01,Metformin,Glucophage,Antidiabetics,44219-115-10,VA Plan,PLAN_2267,2022,Tier 1,Tier 1,2021-10-05,178,No Change,Quantity Limit,No,No,30.0,189,178,6.5,Increased,13.49,11.21,2.28,153.42,166.91,31.55,0.0,0,0.021,0.233,0.434,0.866,13,6,1,5,4.7,14.4,2,Similar,Southeast,IL,Rural,18-35,2022-04,Q2_2022,2021,8.5,0.829,Increasing
FIA001824,2022-04-02,Metformin,Glucophage,Antidiabetics,42524-706-50,Commercial Plan Beta,PLAN_8981,2022,Tier 3,Tier 1,2021-08-31,214,Worsened,Prior Authorization,Yes,No,,221,335,-34.0,Decreased,65.24,19.94,45.3,178.87,244.11,53.95,0.339,3,0.027,0.393,0.705,0.407,10,3,11,9,3.7,9.6,2,Lower,Southeast,FL,Urban,18-35,2022-04,Q2_2022,2021,2.5,0.112,Decreasing
FIA001892,2022-04-10,Metformin,Glucophage,Antidiabetics,54096-580-70,Medicaid Plan X,PLAN_7861,2022,Tier 3,Non-Formulary,2021-09-29,193,Improved,Prior Authorization,Yes,No,,337,312,8.1,Increased,98.36,291.3,-192.94,136.58,234.94,79.17,0.495,3,0.069,0.388,0.46,0.56,0,1,2,13,3.2,20.3,5,Lower,Southwest,NY,Rural,51-65,2022-04,Q2_2022,2021,1.4,0.78,Decreasing
FIA002754,2022-04-11,Metformin,Glucophage,Antidiabetics,76649-881-28,VA Plan,PLAN_3190,2022,Tier 1,Tier 1,2021-10-14,179,No Change,Quantity Limit,No,No,30.0,731,671,9.0,Increased,15.24,9.6,5.64,108.48,123.72,90.44,0.0,0,0.07,0.101,0.598,0.706,3,8,16,2,3.5,27.0,5,Lower,Midwest,MI,Urban,36-50,2022-04,Q2_2022,2021,8.3,0.438,Stable
FIA000520,2022-04-21,Metformin,Glucophage,Antidiabetics,69234-538-71,Tricare Standard,PLAN_6089,2022,Specialty Tier,Tier 3,2021-05-17,339,Worsened,None,No,No,,138,154,-9.8,Decreased,221.65,61.45,160.2,193.76,415.41,57.33,0.0,0,0.124,0.19,0.735,0.737,12,0,3,2,2.5,26.3,2,Lower,Midwest,NC,Suburban,75+,2022-04,Q2_2022,2021,8.2,0.639,Increasing
FIA001220,2022-05-04,Metformin,Glucophage,Antidiabetics,23994-911-59,Medicaid Plan Y,PLAN_3898,2022,Tier 2,Non-Formulary,2022-03-15,50,Improved,Quantity Limit,No,No,60.0,1014,856,18.6,Increased,40.9,561.46,-520.56,143.49,184.39,186.97,0.0,0,0.018,0.071,0.673,0.602,10,9,0,9,2.7,15.1,2,Similar,Northeast,GA,Suburban,18-35,2022-05,Q2_2022,2021,6.7,0.684,Stable
FIA000421,2022-05-27,Metformin,Glucophage,Antidiabetics,93259-729-85,Medicare Part D Plan A,PLAN_9050,2022,Tier 3,Specialty Tier,2022-02-26,90,Improved,None,No,No,,461,512,-9.8,Decreased,71.1,171.5,-100.4,186.32,257.42,118.67,0.0,0,0.053,0.392,0.55,0.593,8,7,12,3,3.3,22.6,4,Higher,Southwest,CA,Suburban,18-35,2022-05,Q2_2022,2021,9.7,0.759,Increasing
FIA002559,2022-06-11,Metformin,Glucophage,Antidiabetics,91185-995-51,Medicaid Plan X,PLAN_5207,2022,Non-Formulary,Tier 3,2022-03-07,96,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,274,292,-6.0,Decreased,445.42,69.84,375.58,161.09,606.51,166.18,0.0,0,0.266,0.311,0.449,0.633,4,5,8,5,3.4,30.0,8,Lower,West,IL,Rural,51-65,2022-06,Q2_2022,2021,1.7,0.533,Stable
FIA001868,2022-06-14,Metformin,Glucophage,Antidiabetics,60419-478-79,Commercial Plan Beta,PLAN_6373,2022,Tier 2,Tier 3,2022-04-05,70,Improved,None,No,No,,249,206,21.2,Increased,28.81,77.61,-48.8,178.42,207.23,51.6,0.0,0,0.05,0.381,0.322,0.532,6,10,19,13,4.4,21.4,5,Lower,Southwest,MI,Suburban,51-65,2022-06,Q2_2022,2021,7.8,0.511,Stable
FIA000737,2022-06-21,Metformin,Glucophage,Antidiabetics,84003-813-29,Commercial Plan Beta,PLAN_2198,2022,Tier 3,Tier 2,2021-07-16,340,Worsened,Step Therapy,No,Yes,,50,129,-66.9,Decreased,65.58,20.65,44.93,157.9,223.48,11.17,0.0,0,0.027,0.123,0.382,0.59,12,6,19,6,2.4,19.4,6,Higher,Midwest,TX,Suburban,75+,2022-06,Q2_2022,2021,2.8,0.683,Stable
FIA002463,2022-06-24,Metformin,Glucophage,Antidiabetics,54513-714-81,VA Plan,PLAN_5304,2022,Tier 3,Tier 3,2022-05-17,38,No Change,Step Therapy; Quantity Limit,No,Yes,90.0,318,338,-5.7,Decreased,98.82,65.49,33.33,68.33,167.15,53.15,0.0,0,0.011,0.235,0.826,0.687,0,8,11,4,4.8,9.6,3,Similar,West,GA,Suburban,36-50,2022-06,Q2_2022,2021,2.3,0.412,Increasing
FIA002670,2022-06-24,Metformin,Glucophage,Antidiabetics,69282-162-25,Commercial Plan Beta,PLAN_3031,2022,Non-Formulary,Specialty Tier,2022-01-22,153,Worsened,Non-Formulary Status,No,No,,938,890,5.4,Increased,659.78,146.67,513.11,66.13,725.91,680.9,0.0,0,0.181,0.286,0.743,0.616,14,8,1,7,2.7,26.5,3,Lower,Northeast,OH,Suburban,75+,2022-06,Q2_2022,2021,9.4,0.534,Stable
FIA001436,2022-06-26,Metformin,Glucophage,Antidiabetics,19343-878-24,Medicare Part D Plan B,PLAN_9050,2022,Non-Formulary,Non-Formulary,2022-05-11,46,No Change,Non-Formulary Status; Quantity Limit,No,No,60.0,525,502,4.6,Stable,746.85,392.14,354.71,112.49,859.34,451.15,0.0,0,0.218,0.09,0.443,0.791,14,2,18,2,3.2,13.7,3,Lower,Southeast,MI,Urban,51-65,2022-06,Q2_2022,2021,3.2,0.257,Decreasing
FIA000254,2022-07-02,Metformin,Glucophage,Antidiabetics,22697-171-99,VA Plan,PLAN_9600,2022,Non-Formulary,Tier 3,2022-03-21,103,Worsened,Non-Formulary Status,No,No,,848,866,-2.0,Stable,361.41,60.48,300.93,113.59,475.0,402.8,0.0,0,0.092,0.196,0.402,0.637,5,5,5,4,2.6,10.5,2,Similar,West,NY,Urban,36-50,2022-07,Q3_2022,2021,1.5,0.183,Increasing
FIA000501,2022-07-02,Metformin,Glucophage,Antidiabetics,96732-860-77,Tricare Standard,PLAN_5074,2022,Tier 1,Specialty Tier,2021-11-08,236,Improved,None,No,No,,171,142,20.4,Increased,6.57,282.66,-276.09,152.91,159.48,27.27,0.0,0,0.041,0.119,0.636,0.801,1,4,18,6,3.3,15.1,6,Lower,Southeast,GA,Rural,51-65,2022-07,Q3_2022,2021,8.0,0.104,Stable
FIA002661,2022-07-04,Metformin,Glucophage,Antidiabetics,60675-952-54,Medicare Part D Plan A,PLAN_6652,2022,Non-Formulary,Tier 3,2021-08-22,316,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,881,937,-5.9,Decreased,719.17,66.66,652.51,146.87,866.04,762.98,0.0,0,0.142,0.162,0.475,0.517,0,0,1,1,2.7,21.4,2,Lower,Southwest,PA,Urban,36-50,2022-07,Q3_2022,2021,4.9,0.749,Increasing
FIA001845,2022-07-07,Metformin,Glucophage,Antidiabetics,74830-158-34,Commercial Plan Beta,PLAN_5783,2022,Tier 3,Tier 1,2021-10-13,267,Worsened,None,No,No,,673,984,-31.5,Decreased,82.81,16.6,66.21,130.81,213.62,143.77,0.0,0,0.019,0.111,0.28,0.811,8,2,9,15,2.2,25.0,4,Higher,West,FL,Urban,36-50,2022-07,Q3_2022,2021,3.8,0.445,Increasing
FIA000968,2022-07-14,Metformin,Glucophage,Antidiabetics,35864-206-36,VA Plan,PLAN_4169,2022,Specialty Tier,Tier 3,2021-08-22,326,Worsened,None,No,No,,948,939,1.0,Stable,169.92,68.07,101.85,127.55,297.47,282.0,0.0,0,0.112,0.368,0.476,0.717,5,7,12,14,3.3,19.8,5,Similar,West,NY,Suburban,75+,2022-07,Q3_2022,2021,4.8,0.209,Stable
FIA001415,2022-07-24,Metformin,Glucophage,Antidiabetics,62478-609-66,Medicare Part D Plan A,PLAN_6902,2022,Non-Formulary,Tier 2,2021-12-17,219,Worsened,Non-Formulary Status,No,No,,68,101,-31.7,Decreased,319.42,22.94,296.48,147.91,467.33,31.78,0.0,0,0.195,0.104,0.888,0.903,10,10,16,12,3.6,26.5,4,Higher,Southeast,MI,Suburban,36-50,2022-07,Q3_2022,2021,6.3,0.033,Decreasing
FIA000765,2022-07-25,Metformin,Glucophage,Antidiabetics,82267-544-96,VA Plan,PLAN_4001,2022,Tier 2,Tier 2,2021-12-27,210,No Change,None,No,No,,923,989,-6.7,Decreased,37.28,28.24,9.04,74.91,112.19,103.55,0.0,0,0.042,0.332,0.441,0.781,11,7,7,6,3.7,25.3,4,Similar,Midwest,TX,Suburban,66-75,2022-07,Q3_2022,2021,9.8,0.798,Decreasing
FIA000442,2022-07-26,Metformin,Glucophage,Antidiabetics,27495-398-56,Medicaid Plan Y,PLAN_2433,2022,Tier 1,Tier 1,2022-04-11,106,No Change,Quantity Limit,No,No,,210,194,8.7,Increased,13.11,12.39,0.72,60.19,73.3,15.39,0.0,0,0.01,0.108,0.417,0.455,2,0,19,0,4.5,10.8,3,Similar,Southwest,TX,Suburban,75+,2022-07,Q3_2022,2021,3.6,0.837,Increasing
FIA001904,2022-07-30,Metformin,Glucophage,Antidiabetics,49537-790-81,Commercial Plan Alpha,PLAN_1448,2022,Tier 3,Tier 3,2022-03-15,137,No Change,Quantity Limit,No,No,90.0,798,807,-1.1,Stable,86.58,90.69,-4.11,187.23,273.81,218.5,0.0,0,0.01,0.142,0.444,0.924,0,10,0,6,3.9,26.2,3,Similar,Midwest,FL,Rural,75+,2022-07,Q3_2022,2021,9.8,0.61,Increasing
FIA001291,2022-08-03,Metformin,Glucophage,Antidiabetics,19458-601-77,Medicare Part D Plan B,PLAN_8336,2022,Tier 2,Specialty Tier,2022-01-03,212,Improved,None,No,No,,572,496,15.3,Increased,38.57,188.15,-149.58,48.17,86.74,49.62,0.0,0,0.058,0.325,0.212,0.498,7,2,15,10,3.6,21.5,8,Lower,West,IL,Rural,36-50,2022-08,Q3_2022,2021,1.2,0.219,Stable
FIA002680,2022-08-05,Metformin,Glucophage,Antidiabetics,33016-958-45,Medicaid Plan Y,PLAN_7019,2022,Tier 1,Specialty Tier,2022-06-10,56,Improved,None,No,No,,835,643,30.0,Increased,5.04,101.21,-96.17,96.12,101.16,84.47,0.0,0,0.044,0.173,0.606,0.903,7,2,5,4,3.3,34.7,4,Lower,West,NC,Urban,18-35,2022-08,Q3_2022,2021,5.3,0.832,Decreasing
FIA001814,2022-08-11,Metformin,Glucophage,Antidiabetics,49761-495-54,VA Plan,PLAN_7842,2022,Tier 2,Non-Formulary,2022-01-17,206,Improved,None,No,No,,1154,839,37.6,Increased,24.03,492.86,-468.83,79.65,103.68,119.65,0.0,0,0.061,0.278,0.515,0.671,8,3,20,15,2.6,32.8,7,Similar,Northeast,PA,Urban,51-65,2022-08,Q3_2022,2021,9.6,0.86,Stable
FIA001979,2022-08-16,Metformin,Glucophage,Antidiabetics,87977-583-81,Commercial Plan Alpha,PLAN_8086,2022,Tier 3,Tier 1,2022-01-01,227,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,304,784,-61.1,Decreased,64.67,15.53,49.14,162.09,226.76,68.94,0.174,10,0.054,0.057,0.569,0.402,14,0,6,5,2.5,6.2,2,Higher,West,NC,Suburban,36-50,2022-08,Q3_2022,2021,9.2,0.081,Decreasing
FIA001641,2022-08-26,Metformin,Glucophage,Antidiabetics,98003-694-52,Medicare Part D Plan B,PLAN_8796,2022,Non-Formulary,Non-Formulary,2021-09-13,347,No Change,Non-Formulary Status,No,No,,740,711,4.2,Stable,683.53,567.09,116.44,95.69,779.22,576.62,0.0,0,0.231,0.122,0.476,0.614,9,8,3,8,2.7,11.5,5,Similar,Northeast,CA,Rural,18-35,2022-08,Q3_2022,2021,6.1,0.058,Increasing
FIA000357,2022-09-10,Metformin,Glucophage,Antidiabetics,88544-385-50,Medicaid Plan Y,PLAN_2730,2022,Specialty Tier,Tier 2,2022-04-25,138,Worsened,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,60.0,103,282,-63.2,Decreased,298.43,37.12,261.31,67.02,365.45,37.64,0.375,9,0.138,0.237,0.475,0.872,15,7,9,14,2.5,31.2,5,Similar,Northeast,NC,Suburban,66-75,2022-09,Q3_2022,2021,6.9,0.683,Increasing
FIA001719,2022-09-14,Metformin,Glucophage,Antidiabetics,19293-720-83,Tricare Standard,PLAN_9880,2022,Tier 3,Specialty Tier,2022-04-15,152,Improved,None,No,No,,531,525,1.3,Stable,77.15,180.58,-103.43,81.71,158.86,84.35,0.0,0,0.054,0.293,0.425,0.782,7,10,9,9,4.4,26.8,3,Higher,Southeast,MI,Suburban,66-75,2022-09,Q3_2022,2021,5.5,0.492,Stable
FIA001264,2022-09-26,Metformin,Glucophage,Antidiabetics,33584-391-76,Medicare Part D Plan B,PLAN_1028,2022,Tier 2,Non-Formulary,2022-06-24,94,Improved,None,No,No,,977,718,36.1,Increased,32.71,503.55,-470.84,177.33,210.04,205.21,0.0,0,0.078,0.17,0.455,0.71,2,5,16,8,2.7,25.4,4,Similar,Midwest,TX,Rural,36-50,2022-09,Q3_2022,2021,9.9,0.223,Increasing
FIA000453,2022-10-08,Metformin,Glucophage,Antidiabetics,83556-913-41,Medicare Part D Plan B,PLAN_6473,2022,Tier 1,Non-Formulary,2022-09-06,32,Improved,None,No,No,,878,580,51.4,Increased,6.6,486.19,-479.59,57.0,63.6,55.84,0.0,0,0.017,0.109,0.654,0.713,3,10,0,15,2.7,26.2,3,Higher,West,NY,Suburban,18-35,2022-10,Q4_2022,2022,7.1,0.875,Decreasing
FIA000629,2022-10-18,Metformin,Glucophage,Antidiabetics,95036-635-43,Commercial Plan Alpha,PLAN_5621,2022,Tier 3,Tier 1,2022-07-21,89,Worsened,None,No,No,,685,943,-27.3,Decreased,91.94,18.42,73.52,37.89,129.83,88.93,0.0,0,0.024,0.347,0.692,0.782,7,9,4,9,3.6,13.8,2,Lower,Northeast,CA,Suburban,18-35,2022-10,Q4_2022,2022,7.6,0.601,Increasing
FIA001915,2022-10-18,Metformin,Glucophage,Antidiabetics,74039-262-73,Tricare Standard,PLAN_3672,2022,Specialty Tier,Tier 2,2022-02-21,239,Worsened,None,No,No,,321,545,-40.9,Decreased,177.46,48.43,129.03,172.94,350.4,112.48,0.0,0,0.22,0.374,0.666,0.627,14,6,2,8,3.4,18.0,4,Higher,Southwest,TX,Suburban,51-65,2022-10,Q4_2022,2022,1.3,0.156,Stable
FIA002109,2022-11-06,Metformin,Glucophage,Antidiabetics,11465-159-72,Commercial Plan Alpha,PLAN_8075,2022,Non-Formulary,Tier 1,2022-03-28,223,Worsened,Non-Formulary Status,No,No,,157,408,-61.3,Decreased,681.7,17.12,664.58,171.97,853.67,134.03,0.0,0,0.14,0.072,0.858,0.682,11,1,13,9,5.0,31.6,2,Higher,Southwest,PA,Urban,18-35,2022-11,Q4_2022,2022,4.0,0.765,Decreasing
FIA000412,2022-11-07,Metformin,Glucophage,Antidiabetics,81448-163-77,VA Plan,PLAN_7487,2022,Non-Formulary,Tier 2,2022-06-10,150,Worsened,Non-Formulary Status,No,No,,293,465,-36.9,Decreased,255.12,30.81,224.31,113.72,368.84,108.07,0.0,0,0.238,0.293,0.584,0.449,6,7,5,3,4.3,31.1,3,Lower,Northeast,NC,Urban,18-35,2022-11,Q4_2022,2022,6.8,0.697,Stable
FIA000723,2022-11-07,Metformin,Glucophage,Antidiabetics,81810-359-54,Medicaid Plan Y,PLAN_3739,2022,Tier 3,Tier 3,2022-09-14,54,No Change,Quantity Limit,No,No,60.0,417,443,-5.6,Decreased,53.81,61.87,-8.06,41.29,95.1,39.66,0.0,0,0.023,0.111,0.659,0.807,2,0,4,11,2.8,26.6,2,Higher,Southwest,MI,Rural,75+,2022-11,Q4_2022,2022,7.3,0.276,Decreasing
FIA000212,2022-11-12,Metformin,Glucophage,Antidiabetics,83801-714-64,Medicare Part D Plan B,PLAN_7922,2022,Tier 3,Specialty Tier,2022-03-06,251,Improved,Prior Authorization; Step Therapy,Yes,Yes,,817,801,2.1,Stable,86.79,284.34,-197.55,110.99,197.78,161.59,0.345,6,0.072,0.265,0.504,0.634,1,8,10,14,4.0,24.4,7,Lower,Southwest,NC,Rural,75+,2022-11,Q4_2022,2022,1.8,0.468,Increasing
FIA002124,2022-11-19,Metformin,Glucophage,Antidiabetics,49432-378-63,Medicare Part D Plan B,PLAN_8210,2022,Specialty Tier,Specialty Tier,2022-07-19,123,No Change,None,No,No,,252,233,8.6,Increased,226.56,213.22,13.34,48.21,274.77,69.24,0.0,0,0.153,0.116,0.517,0.534,14,6,20,12,3.3,24.6,7,Lower,Northeast,TX,Rural,75+,2022-11,Q4_2022,2022,7.5,0.714,Stable
FIA000375,2022-11-20,Metformin,Glucophage,Antidiabetics,67726-237-87,Medicare Part D Plan A,PLAN_6102,2022,Tier 1,Tier 3,2022-06-29,144,Improved,None,No,No,,340,215,58.6,Increased,6.38,99.41,-93.03,182.68,189.06,64.28,0.0,0,0.039,0.217,0.83,0.541,10,10,17,11,4.9,25.1,2,Similar,Southwest,MI,Urban,36-50,2022-11,Q4_2022,2022,3.0,0.13,Increasing
FIA002017,2022-11-22,Metformin,Glucophage,Antidiabetics,51321-486-94,Medicaid Plan Y,PLAN_4131,2022,Tier 3,Tier 1,2022-09-12,71,Worsened,Prior Authorization,Yes,No,,559,925,-39.5,Decreased,95.48,7.0,88.48,111.47,206.95,115.69,0.168,10,0.06,0.248,0.592,0.517,15,6,20,14,2.7,29.0,5,Similar,Southeast,OH,Rural,66-75,2022-11,Q4_2022,2022,7.9,0.443,Increasing
FIA000144,2022-11-25,Metformin,Glucophage,Antidiabetics,12453-734-56,Commercial Plan Beta,PLAN_6254,2022,Non-Formulary,Tier 2,2022-03-10,260,Worsened,Non-Formulary Status,No,No,,272,475,-42.7,Decreased,377.4,27.9,349.5,154.72,532.12,144.74,0.0,0,0.176,0.302,0.661,0.696,12,3,16,15,4.3,9.6,4,Similar,Southwest,IL,Urban,18-35,2022-11,Q4_2022,2022,5.7,0.067,Increasing
FIA002611,2022-12-03,Metformin,Glucophage,Antidiabetics,61255-844-16,Tricare Standard,PLAN_5118,2022,Specialty Tier,Non-Formulary,2022-02-10,296,Improved,Prior Authorization,Yes,No,,369,404,-8.5,Decreased,269.13,535.17,-266.04,193.39,462.52,170.67,0.469,9,0.085,0.166,0.331,0.68,14,5,10,9,2.4,25.7,3,Higher,Southeast,PA,Suburban,36-50,2022-12,Q4_2022,2022,9.5,0.638,Decreasing
FIA002268,2022-12-08,Metformin,Glucophage,Antidiabetics,42556-451-82,Commercial Plan Beta,PLAN_3490,2022,Tier 2,Non-Formulary,2021-12-14,359,Improved,None,No,No,,171,126,36.3,Increased,45.11,669.93,-624.82,145.75,190.86,32.64,0.0,0,0.028,0.178,0.85,0.908,6,7,1,3,4.4,18.6,8,Similar,Midwest,PA,Urban,66-75,2022-12,Q4_2022,2022,9.2,0.424,Increasing
FIA001779,2022-12-13,Metformin,Glucophage,Antidiabetics,98774-526-50,VA Plan,PLAN_3539,2022,Non-Formulary,Specialty Tier,2022-06-28,168,Worsened,Non-Formulary Status,No,No,,815,850,-4.1,Stable,485.2,109.51,375.69,54.9,540.1,440.18,0.0,0,0.077,0.198,0.81,0.43,12,4,7,0,4.6,5.8,3,Similar,Southwest,OH,Suburban,18-35,2022-12,Q4_2022,2022,9.7,0.357,Decreasing
FIA002683,2022-12-13,Metformin,Glucophage,Antidiabetics,67780-851-80,Medicaid Plan X,PLAN_8247,2022,Tier 3,Specialty Tier,2022-10-26,48,Improved,None,No,No,,1052,966,9.0,Increased,97.31,195.09,-97.78,170.99,268.3,282.25,0.0,0,0.07,0.193,0.444,0.587,15,6,15,8,4.4,24.6,3,Lower,Southeast,NC,Suburban,66-75,2022-12,Q4_2022,2022,5.7,0.199,Increasing
FIA000781,2022-12-18,Metformin,Glucophage,Antidiabetics,15951-417-98,Medicare Part D Plan A,PLAN_4975,2022,Specialty Tier,Tier 2,2022-08-11,129,Worsened,Step Therapy,No,Yes,,649,957,-32.1,Decreased,184.32,23.62,160.7,158.23,342.55,222.31,0.0,0,0.195,0.217,0.314,0.596,9,5,16,10,3.5,15.3,5,Lower,West,MI,Rural,18-35,2022-12,Q4_2022,2022,2.4,0.851,Decreasing
FIA002900,2022-12-26,Metformin,Glucophage,Antidiabetics,94116-637-14,Medicare Part D Plan A,PLAN_5562,2022,Tier 1,Tier 1,2022-05-08,232,No Change,None,No,No,,315,294,7.2,Increased,13.74,11.6,2.14,156.45,170.19,53.61,0.0,0,0.029,0.119,0.476,0.582,13,8,9,2,3.7,27.1,7,Lower,Midwest,NY,Rural,18-35,2022-12,Q4_2022,2022,9.5,0.045,Increasing
FIA000502,2022-12-27,Metformin,Glucophage,Antidiabetics,52813-237-29,Medicaid Plan X,PLAN_7153,2022,Tier 1,Tier 3,2022-11-16,41,Improved,Quantity Limit,No,No,30.0,1025,740,38.6,Increased,16.85,84.15,-67.3,127.99,144.84,148.46,0.0,0,0.07,0.056,0.776,0.507,11,5,12,2,4.4,27.1,2,Lower,West,MI,Suburban,36-50,2022-12,Q4_2022,2022,8.0,0.583,Increasing
FIA000597,2023-01-07,Metformin,Glucophage,Antidiabetics,99857-589-34,Medicaid Plan X,PLAN_5574,2023,Specialty Tier,Tier 3,2022-05-13,239,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,454,435,4.6,Stable,165.34,83.04,82.3,90.56,255.9,116.18,0.356,7,0.266,0.224,0.715,0.643,12,2,18,12,3.8,7.0,4,Lower,Southeast,OH,Urban,75+,2023-01,Q1_2023,2022,6.4,0.257,Stable
FIA001714,2023-01-24,Metformin,Glucophage,Antidiabetics,35308-362-23,Commercial Plan Beta,PLAN_6863,2023,Non-Formulary,Tier 1,2022-09-03,143,Worsened,Non-Formulary Status,No,No,,139,399,-65.1,Decreased,783.47,7.23,776.24,128.63,912.1,126.78,0.0,0,0.283,0.278,0.761,0.913,8,0,14,13,2.8,31.6,2,Higher,West,OH,Rural,36-50,2023-01,Q1_2023,2022,6.7,0.27,Stable
FIA000476,2023-01-25,Metformin,Glucophage,Antidiabetics,71994-258-60,Medicare Part D Plan B,PLAN_8490,2023,Tier 2,Tier 2,2022-07-29,180,No Change,None,No,No,,529,540,-1.9,Stable,43.42,43.29,0.13,198.3,241.72,127.87,0.0,0,0.059,0.317,0.881,0.417,14,2,6,9,3.7,34.8,3,Higher,West,NY,Suburban,75+,2023-01,Q1_2023,2022,9.2,0.65,Decreasing
FIA002755,2023-01-29,Metformin,Glucophage,Antidiabetics,30023-194-43,Medicare Part D Plan B,PLAN_8174,2023,Tier 2,Tier 3,2022-12-14,46,Improved,None,No,No,,222,156,42.9,Increased,23.91,53.65,-29.74,129.92,153.83,34.15,0.0,0,0.03,0.086,0.696,0.731,10,4,1,5,4.7,28.2,8,Higher,Northeast,OH,Suburban,36-50,2023-01,Q1_2023,2022,1.1,0.854,Decreasing
FIA002763,2023-02-03,Metformin,Glucophage,Antidiabetics,77382-983-84,Commercial Plan Alpha,PLAN_1927,2023,Tier 3,Tier 1,2022-08-22,165,Worsened,None,No,No,,147,411,-64.1,Decreased,56.15,8.7,47.45,188.51,244.66,35.97,0.0,0,0.074,0.385,0.212,0.876,5,0,19,7,4.6,18.5,4,Lower,West,TX,Suburban,66-75,2023-02,Q1_2023,2022,8.9,0.663,Stable
FIA002727,2023-02-06,Metformin,Glucophage,Antidiabetics,72173-780-25,Commercial Plan Beta,PLAN_1310,2023,Tier 2,Tier 3,2022-02-11,360,Improved,None,No,No,,1196,879,36.1,Increased,49.99,88.95,-38.96,143.93,193.92,231.93,0.0,0,0.047,0.363,0.589,0.871,1,8,10,8,2.5,6.3,8,Lower,West,FL,Suburban,36-50,2023-02,Q1_2023,2022,1.8,0.293,Increasing
FIA001546,2023-02-08,Metformin,Glucophage,Antidiabetics,29855-688-90,VA Plan,PLAN_2709,2023,Tier 2,Tier 3,2022-05-01,283,Improved,None,No,No,,559,414,35.1,Increased,29.13,76.39,-47.26,133.71,162.84,91.03,0.0,0,0.042,0.311,0.443,0.588,15,9,18,1,3.2,20.2,3,Higher,Midwest,PA,Urban,51-65,2023-02,Q1_2023,2022,2.1,0.506,Decreasing
FIA002692,2023-02-17,Metformin,Glucophage,Antidiabetics,71543-158-81,Tricare Standard,PLAN_3658,2023,Specialty Tier,Specialty Tier,2022-11-17,92,No Change,Quantity Limit,No,No,60.0,768,740,3.9,Stable,267.57,248.4,19.17,115.82,383.39,294.44,0.0,0,0.227,0.065,0.285,0.947,14,6,8,11,4.0,6.0,5,Lower,Southeast,CA,Rural,18-35,2023-02,Q1_2023,2022,5.7,0.206,Decreasing
FIA002955,2023-02-19,Metformin,Glucophage,Antidiabetics,96531-763-89,Medicaid Plan X,PLAN_2125,2023,Tier 1,Non-Formulary,2022-07-15,219,Improved,None,No,No,,664,418,58.9,Increased,14.58,458.73,-444.15,88.89,103.47,68.7,0.0,0,0.045,0.207,0.508,0.696,7,1,13,10,4.8,33.3,4,Similar,Northeast,FL,Suburban,18-35,2023-02,Q1_2023,2022,1.8,0.431,Increasing
FIA000921,2023-02-28,Metformin,Glucophage,Antidiabetics,73472-187-11,Commercial Plan Beta,PLAN_9976,2023,Specialty Tier,Tier 2,2022-10-02,149,Worsened,Quantity Limit,No,No,,445,741,-39.9,Decreased,252.08,46.43,205.65,198.39,450.47,200.46,0.0,0,0.27,0.266,0.821,0.836,15,4,1,10,4.4,5.9,3,Higher,Southeast,FL,Urban,36-50,2023-02,Q1_2023,2022,3.5,0.799,Decreasing
FIA002398,2023-03-05,Metformin,Glucophage,Antidiabetics,11778-826-52,Medicaid Plan Y,PLAN_2655,2023,Tier 2,Tier 2,2022-08-05,212,No Change,None,No,No,,284,277,2.6,Stable,32.47,25.44,7.03,147.02,179.49,50.98,0.0,0,0.071,0.202,0.668,0.471,14,7,4,2,3.2,25.2,8,Similar,West,NY,Suburban,75+,2023-03,Q1_2023,2022,8.5,0.087,Stable
FIA001306,2023-03-23,Metformin,Glucophage,Antidiabetics,26296-166-23,Medicaid Plan X,PLAN_8557,2023,Non-Formulary,Tier 3,2022-11-15,128,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,1014,980,3.5,Stable,372.35,59.42,312.93,54.29,426.64,432.61,0.0,0,0.237,0.374,0.319,0.645,8,7,17,15,4.7,27.5,7,Similar,Midwest,TX,Suburban,51-65,2023-03,Q1_2023,2022,9.4,0.794,Stable
FIA001780,2023-03-23,Metformin,Glucophage,Antidiabetics,74613-583-71,Commercial Plan Alpha,PLAN_5999,2023,Tier 2,Non-Formulary,2022-06-20,276,Improved,None,No,No,,532,390,36.5,Increased,42.7,325.86,-283.16,162.97,205.67,109.42,0.0,0,0.061,0.32,0.323,0.541,15,8,9,2,2.5,21.2,5,Higher,Southwest,TX,Urban,75+,2023-03,Q1_2023,2022,2.3,0.975,Increasing
FIA002060,2023-04-14,Metformin,Glucophage,Antidiabetics,77590-999-65,Tricare Standard,PLAN_6565,2023,Non-Formulary,Tier 1,2022-06-07,311,Worsened,Non-Formulary Status,No,No,,209,317,-33.8,Decreased,412.78,11.72,401.06,189.19,601.97,125.81,0.0,0,0.289,0.29,0.771,0.661,2,5,9,4,4.7,9.0,7,Higher,Southwest,CA,Rural,51-65,2023-04,Q2_2023,2022,4.4,0.455,Decreasing
FIA000202,2023-05-04,Metformin,Glucophage,Antidiabetics,45744-239-13,Medicaid Plan X,PLAN_5551,2023,Tier 2,Tier 2,2023-03-21,44,No Change,None,No,No,,573,575,-0.3,Stable,27.37,44.82,-17.45,64.34,91.71,52.55,0.0,0,0.073,0.281,0.323,0.869,15,0,1,2,2.9,13.9,2,Similar,Midwest,TX,Suburban,36-50,2023-05,Q2_2023,2022,3.1,0.571,Decreasing
FIA002084,2023-05-12,Metformin,Glucophage,Antidiabetics,61108-318-84,Medicaid Plan X,PLAN_9804,2023,Non-Formulary,Tier 3,2022-07-30,286,Worsened,Non-Formulary Status,No,No,,844,820,3.0,Stable,664.34,58.66,605.68,90.88,755.22,637.41,0.0,0,0.105,0.222,0.33,0.54,9,9,1,6,4.4,9.3,8,Higher,Southeast,OH,Urban,51-65,2023-05,Q2_2023,2022,3.3,0.561,Increasing
FIA002277,2023-05-12,Metformin,Glucophage,Antidiabetics,47261-322-52,Medicaid Plan Y,PLAN_7301,2023,Specialty Tier,Tier 2,2023-01-01,131,Worsened,Step Therapy,No,Yes,,193,517,-62.5,Decreased,285.83,23.9,261.93,178.87,464.7,89.69,0.0,0,0.294,0.25,0.799,0.829,15,4,7,9,2.4,35.0,8,Similar,Northeast,FL,Suburban,18-35,2023-05,Q2_2023,2022,8.3,0.831,Stable
FIA002793,2023-05-12,Metformin,Glucophage,Antidiabetics,62683-938-71,Medicare Part D Plan A,PLAN_5385,2023,Non-Formulary,Tier 1,2022-06-15,331,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,193,458,-57.7,Decreased,637.5,19.51,617.99,67.44,704.94,136.05,0.0,0,0.236,0.311,0.504,0.901,14,6,6,9,3.6,30.3,4,Similar,Southwest,FL,Urban,36-50,2023-05,Q2_2023,2022,9.1,0.192,Decreasing
FIA000998,2023-05-19,Metformin,Glucophage,Antidiabetics,39053-306-61,Medicare Part D Plan B,PLAN_7780,2023,Non-Formulary,Tier 2,2022-09-04,257,Worsened,Non-Formulary Status,No,No,,167,283,-40.7,Decreased,369.2,44.0,325.2,37.35,406.55,67.89,0.0,0,0.15,0.389,0.438,0.412,4,4,14,10,3.0,9.5,5,Lower,Northeast,NY,Suburban,66-75,2023-05,Q2_2023,2022,7.7,0.144,Decreasing
FIA001685,2023-05-28,Metformin,Glucophage,Antidiabetics,91918-790-29,Commercial Plan Alpha,PLAN_8778,2023,Non-Formulary,Non-Formulary,2022-08-23,278,No Change,Non-Formulary Status,No,No,,268,287,-6.3,Decreased,607.32,228.6,378.72,63.81,671.13,179.86,0.0,0,0.072,0.39,0.381,0.56,11,4,11,9,4.3,32.4,3,Similar,West,GA,Rural,75+,2023-05,Q2_2023,2022,8.5,0.29,Stable
FIA002085,2023-05-30,Metformin,Glucophage,Antidiabetics,74269-903-31,VA Plan,PLAN_9179,2023,Tier 1,Tier 3,2022-11-24,187,Improved,None,No,No,,914,642,42.5,Increased,10.06,93.29,-83.23,138.27,148.33,135.57,0.0,0,0.052,0.161,0.729,0.622,0,7,6,9,3.0,25.7,5,Lower,Northeast,GA,Urban,66-75,2023-05,Q2_2023,2022,5.6,0.408,Stable
FIA002293,2023-05-31,Metformin,Glucophage,Antidiabetics,37369-800-97,Commercial Plan Beta,PLAN_2593,2023,Tier 3,Non-Formulary,2022-07-01,334,Improved,None,No,No,,800,803,-0.3,Stable,70.21,547.77,-477.56,139.47,209.68,167.74,0.0,0,0.032,0.399,0.821,0.76,0,2,2,10,4.1,12.2,7,Lower,Northeast,NC,Urban,66-75,2023-05,Q2_2023,2022,9.3,0.854,Stable
FIA002814,2023-06-24,Metformin,Glucophage,Antidiabetics,49367-710-17,Medicaid Plan Y,PLAN_8565,2023,Tier 2,Non-Formulary,2022-09-19,278,Improved,None,No,No,,734,515,42.6,Increased,46.32,450.89,-404.57,103.7,150.02,110.11,0.0,0,0.031,0.16,0.202,0.891,9,8,20,13,2.6,24.9,2,Lower,Midwest,NY,Urban,75+,2023-06,Q2_2023,2022,1.8,0.153,Decreasing
FIA001628,2023-06-27,Metformin,Glucophage,Antidiabetics,97641-371-35,Medicaid Plan Y,PLAN_2243,2023,Tier 3,Tier 3,2023-03-13,106,No Change,Prior Authorization; Quantity Limit,Yes,No,60.0,717,660,8.7,Increased,63.7,92.81,-29.11,127.03,190.73,136.75,0.208,1,0.074,0.382,0.465,0.515,4,9,8,12,3.1,28.4,3,Lower,Southwest,TX,Urban,18-35,2023-06,Q2_2023,2022,3.7,0.655,Increasing
FIA001751,2023-06-28,Metformin,Glucophage,Antidiabetics,91137-961-64,VA Plan,PLAN_6908,2023,Tier 3,Specialty Tier,2022-10-09,262,Improved,None,No,No,,164,157,4.9,Stable,83.21,298.91,-215.7,180.08,263.29,43.18,0.0,0,0.075,0.098,0.644,0.787,8,1,18,0,3.5,30.3,3,Similar,Midwest,IL,Rural,66-75,2023-06,Q2_2023,2022,3.5,0.411,Decreasing
FIA002498,2023-07-01,Metformin,Glucophage,Antidiabetics,98486-861-20,Medicare Part D Plan A,PLAN_8289,2023,Tier 3,Non-Formulary,2023-03-22,101,Improved,None,No,No,,96,104,-7.7,Decreased,76.71,368.91,-292.2,61.46,138.17,13.26,0.0,0,0.072,0.249,0.657,0.534,12,6,19,0,5.0,5.1,2,Lower,West,NY,Urban,75+,2023-07,Q3_2023,2022,8.2,0.104,Decreasing
FIA001653,2023-07-04,Metformin,Glucophage,Antidiabetics,26916-336-67,Medicare Part D Plan B,PLAN_7593,2023,Specialty Tier,Tier 3,2022-11-22,224,Worsened,Quantity Limit,No,No,90.0,765,733,4.4,Stable,168.9,93.14,75.76,196.27,365.17,279.36,0.0,0,0.096,0.159,0.892,0.764,6,5,2,14,3.9,9.8,2,Lower,Northeast,IL,Urban,75+,2023-07,Q3_2023,2022,2.5,0.752,Increasing
FIA001068,2023-07-14,Metformin,Glucophage,Antidiabetics,28709-224-12,Commercial Plan Beta,PLAN_6926,2023,Tier 3,Tier 2,2022-11-07,249,Worsened,None,No,No,,276,733,-62.3,Decreased,65.34,21.72,43.62,130.36,195.7,54.01,0.0,0,0.021,0.273,0.304,0.891,6,9,4,5,3.8,16.1,2,Higher,Midwest,MI,Suburban,36-50,2023-07,Q3_2023,2022,6.0,0.026,Stable
FIA000933,2023-07-23,Metformin,Glucophage,Antidiabetics,95149-183-23,Commercial Plan Beta,PLAN_1988,2023,Tier 1,Specialty Tier,2022-09-01,325,Improved,Quantity Limit,No,No,90.0,262,222,18.4,Increased,6.81,297.77,-290.96,94.91,101.72,26.65,0.0,0,0.028,0.177,0.412,0.802,9,7,6,10,4.9,10.5,5,Higher,Southwest,PA,Rural,66-75,2023-07,Q3_2023,2022,5.1,0.057,Decreasing
FIA001128,2023-07-23,Metformin,Glucophage,Antidiabetics,29333-177-65,Medicaid Plan Y,PLAN_1917,2023,Tier 1,Specialty Tier,2022-12-06,229,Improved,None,No,No,,509,394,29.4,Increased,14.4,209.14,-194.74,174.22,188.62,96.01,0.0,0,0.075,0.356,0.838,0.551,6,8,18,6,3.0,27.3,8,Lower,Southwest,TX,Urban,18-35,2023-07,Q3_2023,2022,7.2,0.756,Decreasing
FIA001584,2023-07-24,Metformin,Glucophage,Antidiabetics,96132-118-98,Medicaid Plan Y,PLAN_9625,2023,Specialty Tier,Tier 3,2022-12-04,232,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,439,443,-0.8,Stable,177.95,72.88,105.07,118.79,296.74,130.27,0.569,10,0.054,0.117,0.457,0.633,5,6,5,11,4.2,15.2,4,Similar,Southwest,TX,Suburban,18-35,2023-07,Q3_2023,2022,7.4,0.916,Increasing
FIA002877,2023-07-24,Metformin,Glucophage,Antidiabetics,50566-853-18,Medicaid Plan Y,PLAN_3257,2023,Non-Formulary,Tier 1,2022-10-04,293,Worsened,Non-Formulary Status,No,No,,126,381,-66.9,Decreased,253.27,16.52,236.75,125.29,378.56,47.7,0.0,0,0.219,0.132,0.555,0.485,0,3,2,4,4.2,31.2,3,Higher,Southwest,CA,Urban,66-75,2023-07,Q3_2023,2022,4.6,0.206,Stable
FIA002114,2023-07-31,Metformin,Glucophage,Antidiabetics,27679-573-61,Tricare Standard,PLAN_4120,2023,Tier 2,Specialty Tier,2023-02-22,159,Improved,None,No,No,,557,352,58.4,Increased,44.67,165.12,-120.45,173.25,217.92,121.38,0.0,0,0.052,0.294,0.241,0.832,5,1,16,13,2.8,29.5,7,Lower,Southeast,OH,Urban,66-75,2023-07,Q3_2023,2022,6.6,0.469,Stable
FIA000543,2023-08-09,Metformin,Glucophage,Antidiabetics,14187-685-15,VA Plan,PLAN_1760,2023,Specialty Tier,Non-Formulary,2023-03-02,160,Improved,None,No,No,,300,291,3.2,Stable,136.75,236.69,-99.94,32.59,169.34,50.8,0.0,0,0.074,0.175,0.204,0.82,13,8,8,7,2.0,31.6,2,Lower,Southwest,OH,Suburban,36-50,2023-08,Q3_2023,2022,8.2,0.616,Increasing
FIA000309,2023-08-14,Metformin,Glucophage,Antidiabetics,28051-458-46,Commercial Plan Alpha,PLAN_2409,2023,Tier 3,Tier 1,2022-11-25,262,Worsened,None,No,No,,521,707,-26.2,Decreased,52.05,9.25,42.8,38.48,90.53,47.17,0.0,0,0.068,0.3,0.3,0.803,13,9,2,9,2.7,19.2,4,Lower,Southwest,OH,Suburban,18-35,2023-08,Q3_2023,2022,9.0,0.92,Decreasing
FIA002025,2023-08-14,Metformin,Glucophage,Antidiabetics,15695-962-88,Medicare Part D Plan A,PLAN_3494,2023,Tier 2,Specialty Tier,2022-12-15,242,Improved,None,No,No,,903,772,17.0,Increased,32.09,135.57,-103.48,100.11,132.2,119.38,0.0,0,0.033,0.23,0.432,0.567,2,1,3,4,2.1,15.8,3,Similar,Northeast,IL,Suburban,51-65,2023-08,Q3_2023,2022,7.5,0.464,Decreasing
FIA002742,2023-08-22,Metformin,Glucophage,Antidiabetics,56342-374-31,Medicaid Plan Y,PLAN_1817,2023,Non-Formulary,Tier 1,2023-06-18,65,Worsened,Non-Formulary Status,No,No,,536,671,-20.1,Decreased,267.18,11.02,256.16,85.83,353.01,189.21,0.0,0,0.079,0.145,0.371,0.562,13,10,4,0,2.8,7.7,8,Similar,West,MI,Urban,75+,2023-08,Q3_2023,2022,1.4,0.848,Stable
FIA000619,2023-08-27,Metformin,Glucophage,Antidiabetics,19102-743-32,Medicaid Plan Y,PLAN_6668,2023,Tier 2,Non-Formulary,2023-06-10,78,Improved,None,No,No,,338,242,39.8,Increased,49.77,536.01,-486.24,146.73,196.5,66.42,0.0,0,0.048,0.248,0.401,0.876,12,1,1,1,3.4,10.2,2,Similar,Southwest,OH,Urban,18-35,2023-08,Q3_2023,2022,1.8,0.562,Decreasing
FIA000909,2023-08-31,Metformin,Glucophage,Antidiabetics,78591-821-79,VA Plan,PLAN_8090,2023,Non-Formulary,Tier 1,2023-05-09,114,Worsened,Non-Formulary Status,No,No,,451,634,-28.8,Decreased,577.09,13.26,563.83,185.53,762.62,343.94,0.0,0,0.285,0.254,0.838,0.574,8,6,18,9,2.5,20.0,3,Higher,West,PA,Suburban,18-35,2023-08,Q3_2023,2022,4.0,0.044,Increasing
FIA000441,2023-09-05,Metformin,Glucophage,Antidiabetics,72019-131-52,Medicaid Plan Y,PLAN_2937,2023,Tier 2,Tier 2,2022-09-21,349,No Change,None,No,No,,176,167,5.5,Increased,34.44,47.85,-13.41,56.19,90.63,15.95,0.0,0,0.067,0.158,0.541,0.949,12,9,6,12,3.3,12.1,3,Higher,Southeast,IL,Urban,75+,2023-09,Q3_2023,2022,3.9,0.377,Increasing
FIA000665,2023-09-09,Metformin,Glucophage,Antidiabetics,36233-717-77,Commercial Plan Beta,PLAN_2386,2023,Tier 2,Tier 3,2022-11-15,298,Improved,Quantity Limit,No,No,30.0,1493,987,51.3,Increased,25.18,76.16,-50.98,46.26,71.44,106.66,0.0,0,0.067,0.397,0.482,0.416,2,4,9,1,4.0,24.7,5,Similar,Southeast,MI,Rural,18-35,2023-09,Q3_2023,2022,9.6,0.305,Decreasing
FIA002564,2023-09-29,Metformin,Glucophage,Antidiabetics,11016-245-72,Commercial Plan Beta,PLAN_6494,2023,Specialty Tier,Tier 3,2023-05-16,136,Worsened,Prior Authorization,Yes,No,,1041,993,4.9,Stable,283.45,87.47,195.98,50.26,333.71,347.39,0.576,9,0.085,0.308,0.242,0.843,1,2,9,15,4.6,17.3,8,Higher,Northeast,GA,Rural,66-75,2023-09,Q3_2023,2022,1.3,0.778,Stable
FIA000595,2023-10-03,Metformin,Glucophage,Antidiabetics,88549-194-43,Tricare Standard,PLAN_8440,2023,Specialty Tier,Tier 1,2022-12-20,287,Worsened,Step Therapy,No,Yes,,107,186,-42.4,Decreased,165.54,10.52,155.02,91.76,257.3,27.53,0.0,0,0.209,0.158,0.53,0.821,6,5,4,9,3.3,20.9,7,Higher,Midwest,TX,Suburban,18-35,2023-10,Q4_2023,2023,4.2,0.3,Decreasing
FIA000999,2023-10-06,Metformin,Glucophage,Antidiabetics,19963-891-19,Commercial Plan Alpha,PLAN_2363,2023,Tier 1,Tier 1,2023-03-08,212,No Change,None,No,No,,868,801,8.5,Increased,18.55,17.68,0.87,84.27,102.82,89.25,0.0,0,0.051,0.294,0.264,0.611,6,2,7,11,4.4,10.6,8,Lower,Southeast,CA,Rural,51-65,2023-10,Q4_2023,2023,3.5,0.282,Decreasing
FIA001534,2023-10-16,Metformin,Glucophage,Antidiabetics,54831-993-10,Medicare Part D Plan A,PLAN_1414,2023,Tier 3,Tier 3,2023-05-16,153,No Change,Prior Authorization; Quantity Limit,Yes,No,90.0,733,708,3.5,Stable,93.54,68.87,24.67,36.37,129.91,95.22,0.177,10,0.077,0.351,0.833,0.776,11,5,16,11,4.8,11.6,6,Higher,Southeast,FL,Suburban,51-65,2023-10,Q4_2023,2023,3.9,0.944,Stable
FIA001000,2023-10-17,Metformin,Glucophage,Antidiabetics,64036-867-77,Medicaid Plan Y,PLAN_6421,2023,Specialty Tier,Tier 3,2023-01-18,272,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,666,695,-4.1,Stable,263.54,94.82,168.72,146.18,409.72,272.87,0.174,2,0.094,0.251,0.3,0.419,2,10,2,10,4.1,21.3,2,Similar,Northeast,CA,Rural,36-50,2023-10,Q4_2023,2023,2.7,0.391,Stable
FIA001466,2023-10-21,Metformin,Glucophage,Antidiabetics,26056-181-46,VA Plan,PLAN_4912,2023,Tier 2,Tier 1,2022-12-03,322,Worsened,None,No,No,,190,191,-0.1,Stable,40.79,5.99,34.8,160.24,201.03,38.2,0.0,0,0.042,0.123,0.795,0.71,3,0,10,0,2.8,34.9,4,Higher,Southwest,TX,Rural,66-75,2023-10,Q4_2023,2023,9.1,0.962,Increasing
FIA001557,2023-10-22,Metformin,Glucophage,Antidiabetics,93737-461-87,Medicare Part D Plan B,PLAN_4408,2023,Non-Formulary,Specialty Tier,2023-01-15,280,Worsened,Non-Formulary Status,No,No,,663,663,0.0,Stable,526.14,188.12,338.02,145.43,671.57,445.25,0.0,0,0.29,0.113,0.576,0.502,5,10,12,6,3.0,28.8,5,Higher,Northeast,NY,Urban,66-75,2023-10,Q4_2023,2023,8.4,0.563,Increasing
FIA002816,2023-10-24,Metformin,Glucophage,Antidiabetics,88059-719-96,Medicaid Plan X,PLAN_9562,2023,Specialty Tier,Tier 1,2022-11-24,334,Worsened,None,No,No,,195,600,-67.4,Decreased,262.73,8.92,253.81,72.72,335.45,65.41,0.0,0,0.11,0.055,0.844,0.434,2,8,15,2,4.5,18.8,2,Higher,Southwest,OH,Urban,36-50,2023-10,Q4_2023,2023,6.5,0.723,Increasing
FIA001638,2023-10-31,Metformin,Glucophage,Antidiabetics,85739-387-24,Medicare Part D Plan B,PLAN_8242,2023,Tier 3,Tier 1,2023-06-28,125,Worsened,Prior Authorization,Yes,No,,179,526,-65.8,Decreased,57.01,17.9,39.11,147.24,204.25,36.56,0.412,2,0.042,0.181,0.608,0.434,12,4,16,15,2.7,8.8,4,Higher,Northeast,TX,Urban,51-65,2023-10,Q4_2023,2023,6.4,0.426,Stable
FIA000383,2023-11-05,Metformin,Glucophage,Antidiabetics,93205-369-30,Commercial Plan Beta,PLAN_9966,2023,Tier 3,Specialty Tier,2023-09-22,44,Improved,Step Therapy,No,Yes,,348,359,-2.8,Stable,86.45,269.89,-183.44,85.17,171.62,59.72,0.0,0,0.065,0.277,0.718,0.814,5,7,2,10,3.1,21.1,8,Lower,Midwest,PA,Urban,18-35,2023-11,Q4_2023,2023,6.8,0.313,Stable
FIA002614,2023-11-21,Metformin,Glucophage,Antidiabetics,31148-406-61,VA Plan,PLAN_4423,2023,Tier 3,Non-Formulary,2022-12-07,349,Improved,None,No,No,,434,467,-7.0,Decreased,66.89,765.48,-698.59,148.23,215.12,93.36,0.0,0,0.065,0.218,0.226,0.848,12,4,2,5,2.8,33.3,5,Higher,West,TX,Rural,18-35,2023-11,Q4_2023,2023,2.1,0.779,Decreasing
FIA003000,2023-11-21,Metformin,Glucophage,Antidiabetics,60986-688-53,Commercial Plan Alpha,PLAN_5068,2023,Specialty Tier,Tier 2,2023-01-31,294,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,368,602,-38.7,Decreased,229.06,22.54,206.52,47.6,276.66,101.81,0.59,6,0.106,0.306,0.622,0.791,5,10,5,1,3.7,34.7,3,Similar,Northeast,CA,Suburban,36-50,2023-11,Q4_2023,2023,7.2,0.759,Increasing
FIA001160,2023-11-28,Metformin,Glucophage,Antidiabetics,34037-379-30,Commercial Plan Alpha,PLAN_8926,2023,Tier 3,Non-Formulary,2023-10-08,51,Improved,Prior Authorization,Yes,No,,205,200,2.6,Stable,78.25,438.52,-360.27,148.09,226.34,46.4,0.416,5,0.035,0.357,0.704,0.724,12,6,11,4,3.9,29.5,3,Lower,Midwest,TX,Suburban,18-35,2023-11,Q4_2023,2023,6.3,0.155,Stable
FIA001806,2023-11-30,Metformin,Glucophage,Antidiabetics,90842-114-24,Tricare Standard,PLAN_5451,2023,Non-Formulary,Specialty Tier,2023-06-06,177,Worsened,Non-Formulary Status,No,No,,361,344,5.0,Stable,699.1,274.47,424.63,174.52,873.62,315.38,0.0,0,0.156,0.324,0.871,0.877,9,2,10,5,2.8,17.3,5,Lower,West,NY,Urban,66-75,2023-11,Q4_2023,2023,7.4,0.971,Stable
FIA002360,2023-11-30,Metformin,Glucophage,Antidiabetics,40385-858-17,Medicare Part D Plan B,PLAN_8193,2023,Tier 3,Specialty Tier,2022-12-30,335,Improved,None,No,No,,449,421,6.8,Increased,76.17,108.3,-32.13,38.96,115.13,51.69,0.0,0,0.027,0.343,0.625,0.747,2,0,19,10,3.9,20.0,3,Higher,Southeast,FL,Rural,51-65,2023-11,Q4_2023,2023,6.6,0.7,Decreasing
FIA000831,2023-12-08,Metformin,Glucophage,Antidiabetics,93202-696-71,Medicare Part D Plan A,PLAN_4613,2023,Tier 1,Tier 2,2023-09-28,71,Improved,None,No,No,,810,883,-8.2,Decreased,9.56,47.22,-37.66,92.5,102.06,82.67,0.0,0,0.05,0.169,0.731,0.732,3,7,15,2,4.6,26.0,3,Lower,Midwest,OH,Rural,66-75,2023-12,Q4_2023,2023,9.2,0.893,Stable
FIA002284,2023-12-08,Metformin,Glucophage,Antidiabetics,44070-655-94,Medicare Part D Plan A,PLAN_9662,2023,Tier 3,Tier 1,2023-10-25,44,Worsened,None,No,No,,123,350,-64.7,Decreased,88.85,18.16,70.69,189.97,278.82,34.29,0.0,0,0.067,0.082,0.712,0.824,4,7,8,13,2.0,7.4,2,Lower,Midwest,OH,Suburban,36-50,2023-12,Q4_2023,2023,9.5,0.12,Decreasing
FIA000319,2023-12-10,Metformin,Glucophage,Antidiabetics,39852-121-17,Medicare Part D Plan A,PLAN_4214,2023,Specialty Tier,Non-Formulary,2023-01-01,343,Improved,Prior Authorization,Yes,No,,642,590,8.9,Increased,285.87,732.51,-446.64,111.19,397.06,254.91,0.213,9,0.138,0.263,0.466,0.776,0,8,15,1,3.2,16.3,3,Similar,Southwest,NC,Urban,18-35,2023-12,Q4_2023,2023,4.9,0.897,Stable
FIA001745,2023-12-11,Metformin,Glucophage,Antidiabetics,48922-174-59,Commercial Plan Beta,PLAN_5561,2023,Non-Formulary,Tier 1,2023-08-22,111,Worsened,Non-Formulary Status,No,No,,102,213,-51.8,Decreased,682.75,9.66,673.09,150.55,833.3,85.0,0.0,0,0.268,0.356,0.544,0.757,5,7,20,13,3.8,30.2,7,Lower,West,FL,Urban,51-65,2023-12,Q4_2023,2023,4.3,0.081,Stable
FIA002957,2023-12-13,Metformin,Glucophage,Antidiabetics,43633-782-39,Commercial Plan Beta,PLAN_8983,2023,Tier 2,Specialty Tier,2023-03-10,278,Improved,None,No,No,,977,638,53.2,Increased,26.79,103.17,-76.38,183.31,210.1,205.27,0.0,0,0.069,0.138,0.699,0.6,10,2,17,8,4.1,24.9,2,Lower,Midwest,NY,Urban,51-65,2023-12,Q4_2023,2023,8.8,0.32,Stable
FIA001689,2023-12-19,Metformin,Glucophage,Antidiabetics,88048-853-58,Tricare Standard,PLAN_2632,2023,Tier 2,Specialty Tier,2023-04-21,242,Improved,None,No,No,,1166,921,26.6,Increased,46.6,236.44,-189.84,47.29,93.89,109.48,0.0,0,0.062,0.245,0.769,0.438,4,0,16,8,5.0,27.5,4,Lower,West,IL,Urban,75+,2023-12,Q4_2023,2023,3.4,0.373,Stable
FIA002325,2023-12-25,Metformin,Glucophage,Antidiabetics,14899-532-53,Tricare Standard,PLAN_2673,2023,Non-Formulary,Tier 1,2023-04-25,244,Worsened,Non-Formulary Status,No,No,,298,409,-27.1,Decreased,301.93,16.35,285.58,169.34,471.27,140.44,0.0,0,0.274,0.327,0.592,0.595,6,3,9,0,4.0,28.2,8,Lower,Northeast,NY,Suburban,18-35,2023-12,Q4_2023,2023,8.4,0.309,Decreasing
FIA002312,2024-01-12,Metformin,Glucophage,Antidiabetics,96322-442-73,Commercial Plan Alpha,PLAN_8913,2024,Tier 3,Specialty Tier,2023-08-12,153,Improved,None,No,No,,105,109,-3.5,Stable,78.36,275.62,-197.26,152.1,230.46,24.2,0.0,0,0.05,0.185,0.412,0.859,3,6,4,5,3.2,29.3,3,Similar,Southeast,PA,Urban,51-65,2024-01,Q1_2024,2023,7.0,0.575,Stable
FIA001278,2024-01-17,Metformin,Glucophage,Antidiabetics,50013-388-86,Medicaid Plan X,PLAN_1982,2024,Non-Formulary,Tier 1,2023-08-17,153,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,96,123,-21.3,Decreased,428.72,13.7,415.02,81.66,510.38,49.0,0.0,0,0.199,0.289,0.582,0.581,7,9,8,4,3.5,21.9,2,Higher,Northeast,MI,Rural,36-50,2024-01,Q1_2024,2023,4.9,0.842,Decreasing
FIA001041,2024-01-21,Metformin,Glucophage,Antidiabetics,27204-644-87,Commercial Plan Alpha,PLAN_1620,2024,Tier 1,Tier 2,2023-03-15,312,Improved,None,No,No,,245,225,9.3,Increased,10.67,35.14,-24.47,177.81,188.48,46.18,0.0,0,0.02,0.217,0.655,0.774,10,9,11,5,4.4,33.0,7,Lower,Southwest,OH,Suburban,66-75,2024-01,Q1_2024,2023,8.2,0.183,Decreasing
FIA001634,2024-02-06,Metformin,Glucophage,Antidiabetics,27863-834-79,Medicare Part D Plan B,PLAN_6279,2024,Non-Formulary,Non-Formulary,2023-07-03,218,No Change,Non-Formulary Status,No,No,,683,663,3.0,Stable,391.55,203.1,188.45,74.85,466.4,318.55,0.0,0,0.281,0.284,0.219,0.635,5,5,0,3,4.1,33.2,3,Lower,Midwest,NY,Rural,66-75,2024-02,Q1_2024,2023,5.0,0.125,Decreasing
FIA002302,2024-02-08,Metformin,Glucophage,Antidiabetics,32426-671-24,VA Plan,PLAN_1741,2024,Specialty Tier,Tier 3,2023-03-09,336,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,640,625,2.5,Stable,288.43,94.14,194.29,119.74,408.17,261.23,0.178,3,0.077,0.313,0.838,0.53,9,1,3,0,2.5,6.0,3,Higher,Southeast,TX,Suburban,18-35,2024-02,Q1_2024,2023,6.7,0.574,Increasing
FIA001198,2024-02-16,Metformin,Glucophage,Antidiabetics,42774-147-52,Medicare Part D Plan B,PLAN_6930,2024,Tier 3,Tier 1,2023-04-11,311,Worsened,None,No,No,,82,107,-23.2,Decreased,97.67,7.85,89.82,83.79,181.46,14.88,0.0,0,0.051,0.06,0.252,0.893,0,0,10,13,4.3,28.9,3,Higher,Midwest,FL,Suburban,36-50,2024-02,Q1_2024,2023,4.3,0.369,Stable
FIA000282,2024-02-27,Metformin,Glucophage,Antidiabetics,12248-471-81,Tricare Standard,PLAN_3188,2024,Non-Formulary,Specialty Tier,2023-05-04,299,Worsened,Non-Formulary Status,No,No,,817,866,-5.6,Decreased,546.73,238.7,308.03,198.96,745.69,609.23,0.0,0,0.051,0.372,0.242,0.592,4,4,14,4,4.5,21.5,5,Lower,Southeast,NY,Urban,36-50,2024-02,Q1_2024,2023,2.1,0.696,Increasing
FIA001287,2024-03-02,Metformin,Glucophage,Antidiabetics,36531-719-86,Medicaid Plan X,PLAN_6568,2024,Tier 2,Non-Formulary,2024-01-03,59,Improved,None,No,No,,567,485,17.0,Increased,33.43,535.4,-501.97,165.57,199.0,112.83,0.0,0,0.05,0.076,0.866,0.762,6,8,4,4,2.2,9.4,6,Higher,Southwest,CA,Suburban,36-50,2024-03,Q1_2024,2023,5.4,0.373,Stable
FIA001110,2024-03-03,Metformin,Glucophage,Antidiabetics,48863-294-95,Medicaid Plan X,PLAN_6240,2024,Non-Formulary,Tier 3,2023-09-18,167,Worsened,Non-Formulary Status,No,No,,845,934,-9.5,Decreased,625.06,78.18,546.88,74.8,699.86,591.38,0.0,0,0.19,0.21,0.784,0.943,12,1,7,13,3.0,15.2,8,Higher,Northeast,MI,Urban,51-65,2024-03,Q1_2024,2023,6.3,0.72,Decreasing
FIA002254,2024-03-04,Metformin,Glucophage,Antidiabetics,75765-423-14,Tricare Standard,PLAN_1481,2024,Non-Formulary,Tier 1,2023-07-31,217,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,169,516,-67.1,Decreased,463.45,12.0,451.45,120.19,583.64,98.64,0.0,0,0.1,0.211,0.444,0.508,0,3,6,10,3.9,5.6,3,Lower,Southeast,MI,Urban,18-35,2024-03,Q1_2024,2023,8.1,0.754,Decreasing
FIA001992,2024-03-07,Metformin,Glucophage,Antidiabetics,49930-897-23,Medicaid Plan X,PLAN_6649,2024,Tier 3,Non-Formulary,2024-01-15,52,Improved,Quantity Limit,No,No,,752,724,4.0,Stable,59.34,535.65,-476.31,86.64,145.98,109.78,0.0,0,0.034,0.232,0.867,0.421,12,0,7,13,2.7,5.4,7,Lower,Southwest,TX,Suburban,75+,2024-03,Q1_2024,2023,3.0,0.245,Increasing
FIA000227,2024-03-09,Metformin,Glucophage,Antidiabetics,76115-494-24,Medicaid Plan X,PLAN_1993,2024,Tier 3,Tier 2,2023-07-12,241,Worsened,None,No,No,,331,947,-65.0,Decreased,94.65,27.74,66.91,116.47,211.12,69.88,0.0,0,0.027,0.161,0.587,0.436,0,6,20,7,4.7,5.6,6,Higher,Northeast,NY,Rural,36-50,2024-03,Q1_2024,2023,3.7,0.407,Increasing
FIA001912,2024-03-15,Metformin,Glucophage,Antidiabetics,25177-186-17,VA Plan,PLAN_7697,2024,Specialty Tier,Tier 3,2023-07-16,243,Worsened,None,No,No,,562,574,-2.0,Stable,237.49,87.56,149.93,49.48,286.97,161.28,0.0,0,0.177,0.211,0.473,0.524,5,4,18,13,4.8,11.8,4,Lower,Southwest,MI,Urban,75+,2024-03,Q1_2024,2023,9.2,0.084,Stable
FIA000315,2024-03-17,Metformin,Glucophage,Antidiabetics,62923-169-15,Medicare Part D Plan A,PLAN_3607,2024,Specialty Tier,Specialty Tier,2023-06-20,271,No Change,Quantity Limit,No,No,30.0,895,825,8.5,Increased,221.17,136.07,85.1,134.97,356.14,318.75,0.0,0,0.137,0.084,0.274,0.914,15,5,7,7,2.3,31.4,7,Similar,Southwest,TX,Urban,75+,2024-03,Q1_2024,2023,3.3,0.037,Decreasing
FIA000088,2024-03-18,Metformin,Glucophage,Antidiabetics,52762-425-67,Medicaid Plan X,PLAN_4827,2024,Non-Formulary,Non-Formulary,2024-01-17,61,No Change,Non-Formulary Status; Quantity Limit,No,No,,327,342,-4.2,Stable,460.99,778.53,-317.54,171.42,632.41,206.8,0.0,0,0.148,0.38,0.295,0.824,3,2,3,5,3.3,14.4,2,Higher,Midwest,NY,Suburban,51-65,2024-03,Q1_2024,2023,5.2,0.852,Increasing
FIA002104,2024-03-24,Metformin,Glucophage,Antidiabetics,83913-835-89,Medicaid Plan Y,PLAN_1053,2024,Tier 1,Tier 1,2023-10-09,167,No Change,None,No,No,,127,120,6.5,Increased,14.4,19.09,-4.69,46.52,60.92,7.74,0.0,0,0.076,0.066,0.763,0.707,15,2,12,8,4.6,9.3,2,Similar,Southwest,IL,Urban,18-35,2024-03,Q1_2024,2023,4.3,0.245,Decreasing
FIA001297,2024-04-01,Metformin,Glucophage,Antidiabetics,93421-671-91,Tricare Standard,PLAN_3697,2024,Specialty Tier,Tier 2,2023-12-19,104,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,242,742,-67.3,Decreased,234.73,47.22,187.51,156.39,391.12,94.65,0.273,1,0.184,0.1,0.202,0.865,15,1,0,7,3.2,25.2,3,Similar,Southwest,OH,Suburban,18-35,2024-04,Q2_2024,2023,3.3,0.785,Decreasing
FIA000591,2024-04-05,Metformin,Glucophage,Antidiabetics,67445-654-95,Medicaid Plan X,PLAN_8077,2024,Non-Formulary,Non-Formulary,2023-09-06,212,No Change,Non-Formulary Status,No,No,,455,466,-2.3,Stable,587.03,210.37,376.66,62.57,649.6,295.57,0.0,0,0.242,0.207,0.236,0.819,0,10,3,15,2.5,31.3,8,Lower,Northeast,TX,Rural,36-50,2024-04,Q2_2024,2023,4.8,0.889,Increasing
FIA001616,2024-04-07,Metformin,Glucophage,Antidiabetics,84421-878-83,Commercial Plan Alpha,PLAN_6543,2024,Specialty Tier,Tier 3,2023-04-12,361,Worsened,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,60.0,384,356,8.0,Increased,178.94,71.6,107.34,34.87,213.81,82.1,0.434,9,0.092,0.321,0.238,0.509,11,8,1,14,3.1,23.8,3,Similar,Midwest,MI,Urban,18-35,2024-04,Q2_2024,2023,5.6,0.348,Increasing
FIA000513,2024-05-17,Metformin,Glucophage,Antidiabetics,70324-694-94,VA Plan,PLAN_3977,2024,Tier 3,Specialty Tier,2024-03-26,52,Improved,Prior Authorization; Step Therapy,Yes,Yes,,331,354,-6.5,Decreased,74.72,210.37,-135.65,90.19,164.91,54.59,0.212,5,0.061,0.274,0.819,0.909,9,9,12,12,3.6,26.6,6,Similar,Northeast,PA,Suburban,75+,2024-05,Q2_2024,2023,3.8,0.065,Increasing
FIA000977,2024-05-24,Metformin,Glucophage,Antidiabetics,97645-875-92,Commercial Plan Alpha,PLAN_7715,2024,Tier 3,Tier 3,2024-01-05,140,No Change,None,No,No,,751,771,-2.6,Stable,94.47,72.36,22.11,184.92,279.39,209.82,0.0,0,0.076,0.061,0.732,0.416,12,8,15,10,3.3,19.1,5,Lower,West,TX,Urban,75+,2024-05,Q2_2024,2023,2.6,0.883,Stable
FIA002513,2024-06-01,Metformin,Glucophage,Antidiabetics,99464-242-92,VA Plan,PLAN_5624,2024,Tier 3,Tier 2,2023-12-17,167,Worsened,Prior Authorization,Yes,No,,492,732,-32.8,Decreased,65.42,26.33,39.09,96.91,162.33,79.87,0.208,5,0.049,0.396,0.444,0.823,2,7,6,15,2.4,13.5,7,Lower,West,FL,Urban,75+,2024-06,Q2_2024,2023,6.5,0.334,Stable
FIA001194,2024-07-17,Metformin,Glucophage,Antidiabetics,33210-507-15,Tricare Standard,PLAN_1119,2024,Tier 3,Tier 2,2023-08-26,326,Worsened,Step Therapy,No,Yes,,253,717,-64.7,Decreased,50.89,38.57,12.32,143.04,193.93,49.06,0.0,0,0.065,0.271,0.889,0.915,15,4,16,10,4.7,18.5,6,Higher,West,NC,Rural,36-50,2024-07,Q3_2024,2023,1.6,0.168,Increasing
FIA001841,2024-07-24,Metformin,Glucophage,Antidiabetics,56940-802-86,VA Plan,PLAN_9494,2024,Tier 3,Non-Formulary,2023-09-17,311,Improved,Step Therapy,No,Yes,,459,438,4.9,Stable,82.11,728.77,-646.66,113.99,196.1,90.01,0.0,0,0.019,0.179,0.588,0.727,15,4,16,9,3.2,18.2,6,Lower,Southeast,NY,Urban,75+,2024-07,Q3_2024,2023,4.6,0.995,Increasing
FIA002921,2024-07-31,Metformin,Glucophage,Antidiabetics,56620-303-32,Tricare Standard,PLAN_6766,2024,Tier 1,Tier 2,2024-05-24,68,Improved,None,No,No,,542,544,-0.4,Stable,10.21,41.66,-31.45,43.2,53.41,28.95,0.0,0,0.035,0.257,0.356,0.444,9,0,7,1,3.8,26.5,5,Higher,Southwest,NC,Suburban,18-35,2024-07,Q3_2024,2023,6.9,0.662,Increasing
FIA002913,2024-08-09,Metformin,Glucophage,Antidiabetics,21996-757-45,Tricare Standard,PLAN_4329,2024,Tier 1,Specialty Tier,2023-09-19,325,Improved,None,No,No,,460,385,19.5,Increased,17.95,190.27,-172.32,161.95,179.9,82.75,0.0,0,0.046,0.083,0.661,0.854,13,0,3,1,2.8,15.9,8,Similar,Southeast,TX,Suburban,36-50,2024-08,Q3_2024,2023,9.7,0.66,Increasing
FIA000950,2024-08-11,Metformin,Glucophage,Antidiabetics,25195-294-61,Medicaid Plan Y,PLAN_1592,2024,Non-Formulary,Tier 1,2024-01-03,221,Worsened,Non-Formulary Status,No,No,,304,769,-60.4,Decreased,535.36,10.77,524.59,161.02,696.38,211.7,0.0,0,0.202,0.357,0.435,0.717,7,9,13,14,2.2,18.0,7,Similar,Northeast,GA,Urban,75+,2024-08,Q3_2024,2023,1.1,0.311,Increasing
FIA001298,2024-08-18,Metformin,Glucophage,Antidiabetics,16519-248-90,Medicare Part D Plan A,PLAN_7988,2024,Non-Formulary,Specialty Tier,2024-02-19,181,Worsened,Non-Formulary Status,No,No,,391,403,-2.7,Stable,402.27,112.89,289.38,193.36,595.63,232.89,0.0,0,0.289,0.302,0.445,0.659,10,6,8,4,4.4,25.6,6,Similar,Southeast,OH,Rural,18-35,2024-08,Q3_2024,2023,1.3,0.783,Increasing
FIA000340,2024-08-21,Metformin,Glucophage,Antidiabetics,55934-751-81,Commercial Plan Beta,PLAN_6651,2024,Tier 1,Tier 3,2024-04-17,126,Improved,None,No,No,,739,569,29.9,Increased,7.99,54.69,-46.7,56.6,64.59,47.73,0.0,0,0.043,0.27,0.85,0.551,13,9,9,11,3.9,17.1,4,Higher,West,NY,Urban,75+,2024-08,Q3_2024,2023,2.4,0.731,Stable
FIA002056,2024-08-25,Metformin,Glucophage,Antidiabetics,33770-986-18,Commercial Plan Alpha,PLAN_7308,2024,Tier 2,Tier 1,2024-06-04,82,Worsened,None,No,No,,693,635,9.1,Increased,32.13,18.12,14.01,41.69,73.82,51.16,0.0,0,0.063,0.093,0.613,0.784,0,6,3,1,4.1,9.1,6,Similar,Southwest,PA,Suburban,75+,2024-08,Q3_2024,2023,5.2,0.511,Increasing
FIA000696,2024-08-28,Metformin,Glucophage,Antidiabetics,66152-423-44,Tricare Standard,PLAN_1911,2024,Specialty Tier,Non-Formulary,2023-11-15,287,Improved,Step Therapy,No,Yes,,274,255,7.7,Increased,289.17,216.18,72.99,165.42,454.59,124.56,0.0,0,0.227,0.285,0.587,0.845,14,9,10,8,2.2,28.7,5,Similar,Midwest,IL,Urban,75+,2024-08,Q3_2024,2023,5.7,0.989,Decreasing
FIA002317,2024-09-06,Metformin,Glucophage,Antidiabetics,86789-416-91,Commercial Plan Alpha,PLAN_8470,2024,Tier 1,Tier 3,2023-12-14,267,Improved,None,No,No,,204,162,26.2,Increased,13.06,98.14,-85.08,48.86,61.92,12.63,0.0,0,0.024,0.077,0.243,0.63,12,6,0,13,2.6,21.7,7,Similar,West,NC,Rural,18-35,2024-09,Q3_2024,2023,7.9,0.584,Decreasing
FIA002119,2024-09-09,Metformin,Glucophage,Antidiabetics,72913-568-55,Commercial Plan Beta,PLAN_4457,2024,Tier 1,Non-Formulary,2024-05-07,125,Improved,None,No,No,,792,658,20.4,Increased,7.15,697.76,-690.61,73.67,80.82,64.01,0.0,0,0.025,0.184,0.745,0.527,9,5,8,1,4.0,17.3,7,Higher,Northeast,NY,Rural,36-50,2024-09,Q3_2024,2023,7.8,0.69,Increasing
FIA002391,2024-10-01,Metformin,Glucophage,Antidiabetics,30465-318-85,Commercial Plan Beta,PLAN_2730,2024,Non-Formulary,Tier 2,2024-06-18,105,Worsened,Non-Formulary Status,No,No,,240,302,-20.3,Decreased,667.24,37.65,629.59,89.25,756.49,181.56,0.0,0,0.134,0.168,0.695,0.764,2,0,11,2,3.6,34.4,2,Higher,Southwest,MI,Suburban,36-50,2024-10,Q4_2024,2024,2.5,0.943,Increasing
FIA001150,2024-11-01,Metformin,Glucophage,Antidiabetics,83400-902-43,Medicaid Plan Y,PLAN_2226,2024,Tier 2,Tier 3,2023-12-18,319,Improved,None,No,No,,1093,895,22.1,Increased,35.71,59.51,-23.8,135.72,171.43,187.37,0.0,0,0.067,0.347,0.472,0.874,4,0,7,7,2.2,30.3,7,Similar,Midwest,OH,Rural,51-65,2024-11,Q4_2024,2024,5.5,0.902,Increasing
FIA001582,2024-11-14,Metformin,Glucophage,Antidiabetics,50512-610-69,Commercial Plan Alpha,PLAN_2358,2024,Non-Formulary,Specialty Tier,2023-12-27,323,Worsened,Non-Formulary Status,No,No,,859,899,-4.4,Stable,435.92,127.94,307.98,54.17,490.09,420.99,0.0,0,0.142,0.327,0.746,0.625,6,10,12,4,2.1,34.2,2,Similar,Northeast,PA,Rural,51-65,2024-11,Q4_2024,2024,9.6,0.477,Decreasing
FIA001644,2024-11-22,Metformin,Glucophage,Antidiabetics,52734-719-30,Medicare Part D Plan A,PLAN_9852,2024,Tier 1,Specialty Tier,2024-03-08,259,Improved,None,No,No,,789,552,43.1,Increased,6.65,215.04,-208.39,166.76,173.41,136.82,0.0,0,0.011,0.184,0.351,0.674,8,5,11,6,3.8,7.6,4,Higher,Southwest,OH,Rural,51-65,2024-11,Q4_2024,2024,3.3,0.565,Increasing
FIA002117,2024-11-28,Metformin,Glucophage,Antidiabetics,98839-592-78,Medicaid Plan X,PLAN_4101,2024,Tier 2,Specialty Tier,2024-02-24,278,Improved,None,No,No,,1186,873,35.9,Increased,26.54,251.26,-224.72,177.52,204.06,242.02,0.0,0,0.067,0.217,0.677,0.659,8,2,14,11,3.5,7.4,2,Higher,Southwest,IL,Urban,51-65,2024-11,Q4_2024,2024,5.9,0.828,Decreasing
FIA000754,2024-12-03,Metformin,Glucophage,Antidiabetics,53922-656-86,Commercial Plan Alpha,PLAN_1828,2024,Tier 1,Tier 3,2024-02-05,302,Improved,None,No,No,,1208,759,59.2,Increased,19.51,58.67,-39.16,77.38,96.89,117.04,0.0,0,0.059,0.268,0.361,0.908,7,10,14,13,3.3,12.3,5,Similar,Southeast,NC,Rural,18-35,2024-12,Q4_2024,2024,5.6,0.811,Increasing
FIA000173,2024-12-11,Metformin,Glucophage,Antidiabetics,25963-825-25,Medicare Part D Plan B,PLAN_3128,2024,Specialty Tier,Tier 3,2024-07-22,142,Worsened,Quantity Limit,No,No,90.0,121,134,-9.5,Decreased,245.05,62.59,182.46,131.9,376.95,45.61,0.0,0,0.104,0.28,0.83,0.711,5,1,5,8,2.9,24.8,2,Higher,Southwest,PA,Suburban,51-65,2024-12,Q4_2024,2024,3.3,0.781,Stable
FIA002702,2024-12-12,Metformin,Glucophage,Antidiabetics,12669-109-26,Medicare Part D Plan A,PLAN_8301,2024,Tier 1,Tier 2,2024-04-21,235,Improved,Quantity Limit,No,No,,315,335,-5.8,Decreased,6.94,48.16,-41.22,71.4,78.34,24.68,0.0,0,0.052,0.186,0.405,0.514,10,8,1,0,4.2,27.4,7,Lower,Southwest,PA,Suburban,18-35,2024-12,Q4_2024,2024,7.6,0.466,Stable
FIA001195,2024-12-27,Metformin,Glucophage,Antidiabetics,48891-706-95,Commercial Plan Beta,PLAN_5845,2024,Tier 3,Tier 2,2024-09-10,108,Worsened,Quantity Limit,No,No,90.0,202,277,-26.8,Decreased,79.8,44.79,35.01,36.32,116.12,23.46,0.0,0,0.033,0.32,0.457,0.529,2,8,17,12,4.4,15.8,4,Similar,West,CA,Urban,66-75,2024-12,Q4_2024,2024,8.3,0.831,Decreasing
FIA000165,2024-12-28,Metformin,Glucophage,Antidiabetics,28837-981-88,Medicaid Plan X,PLAN_6954,2024,Specialty Tier,Non-Formulary,2024-09-22,97,Improved,None,No,No,,809,815,-0.6,Stable,118.58,681.41,-562.83,191.07,309.65,250.51,0.0,0,0.168,0.187,0.69,0.766,10,7,15,0,2.2,8.4,5,Similar,Southeast,PA,Suburban,75+,2024-12,Q4_2024,2024,6.2,0.508,Stable
FIA001036,2024-12-29,Metformin,Glucophage,Antidiabetics,17335-810-36,Medicaid Plan Y,PLAN_3808,2024,Tier 3,Non-Formulary,2024-02-06,327,Improved,None,No,No,,123,132,-6.3,Decreased,90.85,594.15,-503.3,89.13,179.98,22.14,0.0,0,0.026,0.228,0.221,0.415,15,5,1,15,4.1,20.3,6,Higher,Southwest,NY,Suburban,51-65,2024-12,Q4_2024,2024,8.1,0.822,Increasing
FIA001311,2025-01-04,Metformin,Glucophage,Antidiabetics,39267-874-17,Commercial Plan Alpha,PLAN_4011,2025,Tier 2,Non-Formulary,2024-03-19,291,Improved,None,No,No,,934,748,25.0,Increased,40.08,466.54,-426.46,137.81,177.89,166.15,0.0,0,0.033,0.326,0.652,0.684,8,6,18,11,2.7,14.5,8,Similar,West,NC,Rural,36-50,2025-01,Q1_2025,2024,3.2,0.966,Increasing
FIA002417,2025-01-07,Metformin,Glucophage,Antidiabetics,64400-969-85,Commercial Plan Beta,PLAN_3912,2025,Non-Formulary,Tier 2,2024-11-11,57,Worsened,Non-Formulary Status,No,No,,72,228,-68.4,Decreased,660.02,47.3,612.72,86.14,746.16,53.72,0.0,0,0.257,0.072,0.816,0.541,8,5,20,13,4.6,33.9,6,Higher,Southwest,NY,Urban,51-65,2025-01,Q1_2025,2024,4.7,0.555,Stable
FIA001711,2025-01-21,Metformin,Glucophage,Antidiabetics,73962-173-74,Tricare Standard,PLAN_3065,2025,Non-Formulary,Non-Formulary,2024-05-31,235,No Change,Non-Formulary Status,No,No,,527,490,7.7,Increased,677.14,563.47,113.67,34.68,711.82,375.13,0.0,0,0.182,0.257,0.833,0.853,5,6,16,6,3.9,15.7,5,Lower,Midwest,FL,Urban,66-75,2025-01,Q1_2025,2024,1.4,0.639,Increasing
FIA002053,2025-01-22,Metformin,Glucophage,Antidiabetics,36941-785-94,Medicare Part D Plan B,PLAN_8822,2025,Tier 2,Non-Formulary,2024-02-26,331,Improved,None,No,No,,600,382,57.2,Increased,27.5,279.24,-251.74,158.87,186.37,111.82,0.0,0,0.056,0.288,0.562,0.909,5,1,8,5,3.4,15.9,5,Similar,Southwest,CA,Suburban,66-75,2025-01,Q1_2025,2024,2.4,0.689,Increasing
FIA000061,2025-03-01,Metformin,Glucophage,Antidiabetics,86434-600-21,Tricare Standard,PLAN_1911,2025,Tier 1,Non-Formulary,2024-05-17,288,Improved,None,No,No,,347,268,29.8,Increased,8.03,522.0,-513.97,64.92,72.95,25.31,0.0,0,0.018,0.209,0.559,0.651,1,8,14,9,4.2,16.9,8,Lower,Southeast,MI,Urban,18-35,2025-03,Q1_2025,2024,4.8,0.7,Decreasing
FIA001228,2025-03-01,Metformin,Glucophage,Antidiabetics,54971-721-32,Medicaid Plan Y,PLAN_1591,2025,Non-Formulary,Tier 1,2024-07-15,229,Worsened,Non-Formulary Status; Quantity Limit,No,No,,440,695,-36.7,Decreased,315.83,15.21,300.62,166.48,482.31,212.22,0.0,0,0.222,0.186,0.252,0.635,15,8,1,15,3.9,9.3,2,Similar,Northeast,CA,Rural,18-35,2025-03,Q1_2025,2024,2.8,0.754,Decreasing
FIA002290,2025-03-05,Metformin,Glucophage,Antidiabetics,81048-254-71,Commercial Plan Beta,PLAN_8516,2025,Tier 3,Tier 2,2024-05-29,280,Worsened,Step Therapy,No,Yes,,238,436,-45.3,Decreased,63.22,47.0,16.22,181.41,244.63,58.22,0.0,0,0.031,0.296,0.216,0.463,6,9,8,5,2.8,20.7,4,Lower,Midwest,NC,Rural,18-35,2025-03,Q1_2025,2024,1.1,0.02,Stable
FIA001656,2025-03-06,Metformin,Glucophage,Antidiabetics,19990-515-14,Medicaid Plan X,PLAN_8626,2025,Tier 3,Specialty Tier,2024-10-07,150,Improved,Prior Authorization,Yes,No,,812,771,5.4,Increased,88.13,133.24,-45.11,177.4,265.53,215.61,0.452,9,0.078,0.288,0.284,0.487,5,3,20,8,4.0,24.0,8,Similar,Midwest,GA,Rural,51-65,2025-03,Q1_2025,2024,5.8,0.525,Decreasing
FIA000207,2025-03-07,Metformin,Glucophage,Antidiabetics,44891-394-73,VA Plan,PLAN_3133,2025,Tier 1,Non-Formulary,2024-06-28,252,Improved,None,No,No,,1376,947,45.3,Increased,16.6,756.97,-740.37,62.39,78.99,108.69,0.0,0,0.06,0.201,0.345,0.519,9,10,6,13,2.5,28.8,2,Similar,Midwest,NY,Rural,66-75,2025-03,Q1_2025,2024,9.2,0.37,Decreasing
FIA001219,2025-03-15,Metformin,Glucophage,Antidiabetics,57026-357-89,Tricare Standard,PLAN_7308,2025,Tier 3,Tier 3,2024-07-07,251,No Change,None,No,No,,115,105,9.5,Increased,67.97,75.96,-7.99,73.33,141.3,16.25,0.0,0,0.06,0.235,0.348,0.802,14,5,5,11,3.2,13.5,6,Higher,West,FL,Suburban,66-75,2025-03,Q1_2025,2024,4.8,0.316,Stable
FIA002209,2025-03-16,Metformin,Glucophage,Antidiabetics,61904-393-77,Medicare Part D Plan A,PLAN_1203,2025,Specialty Tier,Tier 3,2024-11-21,115,Worsened,None,No,No,,591,552,7.1,Increased,188.77,94.73,94.04,31.73,220.5,130.32,0.0,0,0.113,0.36,0.316,0.926,9,0,13,8,4.7,27.3,7,Higher,Southwest,GA,Suburban,51-65,2025-03,Q1_2025,2024,9.5,0.492,Stable
FIA000929,2025-03-20,Metformin,Glucophage,Antidiabetics,83658-378-34,Tricare Standard,PLAN_8592,2025,Specialty Tier,Tier 3,2025-02-02,46,Worsened,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,,552,521,6.1,Increased,208.72,53.48,155.24,136.82,345.54,190.74,0.22,1,0.254,0.292,0.321,0.668,10,10,18,10,4.6,8.7,8,Lower,West,IL,Suburban,51-65,2025-03,Q1_2025,2024,6.5,0.387,Decreasing
FIA002671,2025-03-21,Metformin,Glucophage,Antidiabetics,90462-455-75,Tricare Standard,PLAN_3750,2025,Specialty Tier,Tier 1,2024-09-08,194,Worsened,Quantity Limit,No,No,60.0,87,156,-44.1,Decreased,209.77,5.23,204.54,36.18,245.95,21.4,0.0,0,0.06,0.154,0.739,0.746,7,9,15,7,2.0,31.5,8,Lower,Northeast,CA,Suburban,18-35,2025-03,Q1_2025,2024,8.1,0.385,Decreasing
FIA001862,2025-03-29,Metformin,Glucophage,Antidiabetics,40893-566-13,VA Plan,PLAN_4530,2025,Tier 2,Non-Formulary,2024-06-14,288,Improved,None,No,No,,899,676,33.1,Increased,39.71,728.22,-688.51,144.95,184.66,166.01,0.0,0,0.056,0.101,0.236,0.745,14,1,19,11,4.9,15.7,8,Similar,Southwest,NY,Urban,75+,2025-03,Q1_2025,2024,9.0,0.649,Increasing
FIA002992,2025-04-01,Metformin,Glucophage,Antidiabetics,81273-431-24,Commercial Plan Alpha,PLAN_2424,2025,Tier 2,Tier 3,2024-11-21,131,Improved,None,No,No,,706,528,33.9,Increased,44.24,57.16,-12.92,115.54,159.78,112.8,0.0,0,0.021,0.309,0.483,0.822,1,0,1,0,4.9,21.2,7,Higher,West,OH,Rural,66-75,2025-04,Q2_2025,2024,2.4,0.8,Decreasing
FIA002430,2025-04-11,Metformin,Glucophage,Antidiabetics,41289-361-20,Commercial Plan Beta,PLAN_6381,2025,Tier 2,Tier 1,2024-08-11,243,Worsened,None,No,No,,213,205,4.4,Stable,36.27,19.38,16.89,88.23,124.5,26.52,0.0,0,0.074,0.265,0.55,0.425,12,7,2,11,2.3,9.7,4,Higher,West,OH,Urban,18-35,2025-04,Q2_2025,2024,8.8,0.913,Increasing
FIA001493,2025-04-19,Metformin,Glucophage,Antidiabetics,49965-181-20,VA Plan,PLAN_4758,2025,Tier 1,Specialty Tier,2024-07-26,267,Improved,None,No,No,,899,588,52.9,Increased,11.55,203.63,-192.08,77.87,89.42,80.39,0.0,0,0.079,0.343,0.591,0.809,11,1,18,12,2.8,9.1,6,Similar,West,OH,Urban,66-75,2025-04,Q2_2025,2024,5.0,0.109,Stable
FIA000114,2025-04-20,Metformin,Glucophage,Antidiabetics,33226-808-84,Commercial Plan Alpha,PLAN_3103,2025,Specialty Tier,Specialty Tier,2024-05-24,331,No Change,None,No,No,,549,610,-9.9,Decreased,291.24,126.93,164.31,162.78,454.02,249.26,0.0,0,0.281,0.086,0.66,0.733,10,8,12,13,4.9,32.5,8,Lower,Midwest,OH,Suburban,51-65,2025-04,Q2_2025,2024,5.1,0.133,Stable
FIA002005,2025-04-23,Metformin,Glucophage,Antidiabetics,39592-634-94,Medicaid Plan X,PLAN_6279,2025,Tier 2,Tier 1,2024-11-15,159,Worsened,None,No,No,,656,694,-5.4,Decreased,41.54,17.62,23.92,186.21,227.75,149.4,0.0,0,0.053,0.137,0.708,0.874,3,9,13,12,2.5,10.8,8,Higher,Northeast,CA,Urban,66-75,2025-04,Q2_2025,2024,3.1,0.197,Decreasing
FIA002823,2025-05-19,Metformin,Glucophage,Antidiabetics,60168-818-34,Medicaid Plan Y,PLAN_4558,2025,Tier 3,Non-Formulary,2025-04-14,35,Improved,Step Therapy,No,Yes,,189,204,-7.0,Decreased,62.87,423.15,-360.28,91.63,154.5,29.2,0.0,0,0.064,0.372,0.653,0.563,15,6,5,6,3.2,9.6,6,Lower,West,OH,Rural,18-35,2025-05,Q2_2025,2024,5.2,0.231,Stable
FIA001167,2025-05-29,Metformin,Glucophage,Antidiabetics,97350-473-53,Commercial Plan Alpha,PLAN_3541,2025,Non-Formulary,Tier 3,2025-01-31,118,Worsened,Non-Formulary Status,No,No,,171,164,4.4,Stable,620.23,82.31,537.92,110.4,730.63,124.94,0.0,0,0.238,0.127,0.458,0.886,10,8,15,0,4.6,31.9,3,Lower,Southeast,FL,Rural,36-50,2025-05,Q2_2025,2024,6.5,0.223,Increasing
FIA002153,2025-06-09,Metformin,Glucophage,Antidiabetics,29914-881-98,Medicare Part D Plan B,PLAN_2724,2025,Specialty Tier,Tier 1,2025-01-10,150,Worsened,Step Therapy; Quantity Limit,No,Yes,90.0,196,277,-29.1,Decreased,256.16,6.98,249.18,194.35,450.51,88.3,0.0,0,0.164,0.071,0.456,0.558,12,0,19,0,2.3,27.6,8,Lower,Southwest,FL,Urban,75+,2025-06,Q2_2025,2024,7.0,0.288,Increasing
FIA001422,2025-06-18,Metformin,Glucophage,Antidiabetics,24577-350-23,Medicaid Plan X,PLAN_6945,2025,Specialty Tier,Tier 2,2024-11-04,226,Worsened,None,No,No,,517,763,-32.2,Decreased,162.87,23.19,139.68,117.67,280.54,145.04,0.0,0,0.26,0.386,0.804,0.475,11,3,1,6,2.2,9.2,8,Lower,Southeast,CA,Urban,18-35,2025-06,Q2_2025,2024,2.0,0.066,Stable
FIA001359,2025-06-19,Metformin,Glucophage,Antidiabetics,27644-146-96,Commercial Plan Alpha,PLAN_3570,2025,Tier 1,Tier 1,2024-10-19,243,No Change,None,No,No,,424,414,2.6,Stable,8.75,14.61,-5.86,181.19,189.94,80.53,0.0,0,0.067,0.118,0.421,0.877,15,5,14,7,2.6,28.3,5,Higher,Southeast,NC,Suburban,66-75,2025-06,Q2_2025,2024,4.1,0.449,Decreasing
FIA002646,2025-06-20,Metformin,Glucophage,Antidiabetics,28066-262-31,Commercial Plan Alpha,PLAN_6362,2025,Tier 2,Tier 1,2025-01-27,144,Worsened,Quantity Limit,No,No,60.0,159,161,-1.0,Stable,27.49,10.69,16.8,193.48,220.97,35.13,0.0,0,0.044,0.155,0.832,0.758,7,9,12,6,4.3,25.1,6,Higher,Southeast,OH,Suburban,75+,2025-06,Q2_2025,2024,1.9,0.482,Decreasing
FIA002662,2025-06-20,Metformin,Glucophage,Antidiabetics,43403-491-30,Commercial Plan Alpha,PLAN_7646,2025,Tier 1,Tier 2,2025-04-14,67,Improved,Quantity Limit,No,No,90.0,802,783,2.5,Stable,7.08,21.39,-14.31,157.96,165.04,132.36,0.0,0,0.061,0.15,0.549,0.533,12,3,20,2,3.5,31.0,4,Similar,Midwest,IL,Suburban,66-75,2025-06,Q2_2025,2024,1.1,0.898,Decreasing
FIA001571,2025-06-30,Metformin,Glucophage,Antidiabetics,86436-434-98,Commercial Plan Alpha,PLAN_7526,2025,Non-Formulary,Tier 3,2025-03-31,91,Worsened,Non-Formulary Status,No,No,,579,532,9.0,Increased,384.92,72.98,311.94,122.6,507.52,293.85,0.0,0,0.249,0.06,0.493,0.884,5,8,14,10,4.1,7.1,8,Lower,Northeast,MI,Suburban,66-75,2025-06,Q2_2025,2024,1.6,0.936,Decreasing
FIA002127,2025-07-06,Metformin,Glucophage,Antidiabetics,86855-196-40,Medicaid Plan Y,PLAN_6581,2025,Specialty Tier,Tier 2,2024-10-29,250,Worsened,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,90.0,83,228,-63.5,Decreased,200.46,48.58,151.88,123.01,323.47,26.85,0.564,6,0.159,0.21,0.526,0.702,3,10,16,8,4.0,26.7,8,Similar,Southwest,FL,Rural,36-50,2025-07,Q3_2025,2024,5.6,0.158,Stable
FIA002112,2025-07-19,Metformin,Glucophage,Antidiabetics,11611-543-28,Medicaid Plan X,PLAN_5515,2025,Tier 2,Tier 1,2025-01-05,195,Worsened,Quantity Limit,No,No,60.0,532,533,-0.0,Stable,42.38,11.27,31.11,146.57,188.95,100.52,0.0,0,0.017,0.213,0.865,0.833,4,4,11,10,4.0,16.7,6,Higher,West,GA,Suburban,18-35,2025-07,Q3_2025,2024,1.9,0.285,Decreasing
FIA000389,2025-07-20,Metformin,Glucophage,Antidiabetics,50142-128-82,Medicaid Plan Y,PLAN_2136,2025,Tier 3,Specialty Tier,2025-05-03,78,Improved,Prior Authorization,Yes,No,,656,720,-8.8,Decreased,76.19,104.08,-27.89,85.57,161.76,106.11,0.593,3,0.011,0.116,0.635,0.5,6,5,3,4,3.8,22.2,5,Higher,Southeast,NC,Urban,66-75,2025-07,Q3_2025,2024,1.3,0.039,Decreasing
FIA000001,2025-08-02,Metformin,Glucophage,Antidiabetics,22280-323-39,Medicare Part D Plan A,PLAN_4257,2025,Tier 1,Tier 3,2025-02-28,155,Improved,None,No,No,,1174,792,48.3,Increased,8.35,86.82,-78.47,35.4,43.75,51.36,0.0,0,0.051,0.301,0.691,0.631,14,9,8,0,4.3,9.8,5,Similar,Midwest,FL,Urban,51-65,2025-08,Q3_2025,2024,1.9,0.38,Stable
FIA001981,2025-08-03,Metformin,Glucophage,Antidiabetics,13426-388-96,Commercial Plan Alpha,PLAN_1550,2025,Tier 1,Tier 1,2024-12-31,215,No Change,Quantity Limit,No,No,90.0,573,524,9.5,Increased,16.36,5.09,11.27,111.97,128.33,73.53,0.0,0,0.031,0.286,0.866,0.858,12,6,7,3,4.9,6.5,4,Similar,Southeast,TX,Rural,51-65,2025-08,Q3_2025,2024,2.3,0.915,Stable
FIA001012,2025-08-06,Metformin,Glucophage,Antidiabetics,21685-432-73,Medicare Part D Plan A,PLAN_4090,2025,Tier 2,Tier 2,2024-08-20,351,No Change,None,No,No,,403,428,-5.8,Decreased,37.59,31.09,6.5,43.19,80.78,32.55,0.0,0,0.072,0.155,0.459,0.429,2,6,9,5,3.2,14.1,4,Similar,Midwest,OH,Urban,18-35,2025-08,Q3_2025,2024,9.2,0.962,Increasing
FIA000681,2025-08-08,Metformin,Glucophage,Antidiabetics,89128-815-71,Commercial Plan Beta,PLAN_3183,2025,Non-Formulary,Tier 2,2025-04-17,113,Worsened,Non-Formulary Status,No,No,,407,600,-32.1,Decreased,215.32,30.8,184.52,147.33,362.65,147.6,0.0,0,0.254,0.124,0.899,0.623,8,0,5,4,3.0,27.9,8,Similar,Southwest,OH,Rural,75+,2025-08,Q3_2025,2024,6.9,0.258,Stable
FIA002038,2025-08-08,Metformin,Glucophage,Antidiabetics,99905-748-95,Medicaid Plan Y,PLAN_1560,2025,Tier 2,Tier 2,2025-04-17,113,No Change,None,No,No,,762,697,9.4,Increased,41.38,32.52,8.86,137.83,179.21,136.56,0.0,0,0.022,0.358,0.355,0.718,6,4,15,13,4.0,33.7,6,Similar,Southeast,NY,Urban,51-65,2025-08,Q3_2025,2024,2.8,0.473,Decreasing
FIA002785,2025-08-11,Metformin,Glucophage,Antidiabetics,29587-409-39,Medicare Part D Plan A,PLAN_9552,2025,Non-Formulary,Specialty Tier,2025-03-18,146,Worsened,Non-Formulary Status,No,No,,164,164,0.6,Stable,255.68,128.66,127.02,48.98,304.66,49.96,0.0,0,0.146,0.091,0.624,0.657,6,2,8,6,4.1,23.3,4,Higher,Midwest,FL,Rural,66-75,2025-08,Q3_2025,2024,5.9,0.284,Stable
FIA000065,2025-08-17,Metformin,Glucophage,Antidiabetics,53642-410-11,Commercial Plan Beta,PLAN_4113,2025,Specialty Tier,Tier 3,2025-06-01,77,Worsened,Prior Authorization,Yes,No,,144,152,-4.6,Stable,207.13,91.47,115.66,111.5,318.63,45.88,0.462,2,0.19,0.311,0.728,0.903,6,6,7,10,4.3,16.4,6,Higher,Midwest,PA,Suburban,51-65,2025-08,Q3_2025,2024,5.6,0.497,Increasing
FIA002374,2025-08-19,Metformin,Glucophage,Antidiabetics,60254-787-94,Medicaid Plan Y,PLAN_7585,2025,Specialty Tier,Non-Formulary,2025-04-02,139,Improved,Prior Authorization; Step Therapy,Yes,Yes,,842,787,7.0,Increased,252.95,502.94,-249.99,97.88,350.83,295.4,0.39,7,0.261,0.054,0.665,0.672,4,4,10,2,5.0,12.1,2,Higher,Southwest,TX,Urban,66-75,2025-08,Q3_2025,2024,7.6,0.293,Decreasing
FIA000304,2025-08-20,Metformin,Glucophage,Antidiabetics,44809-221-80,Medicare Part D Plan B,PLAN_6806,2025,Tier 2,Specialty Tier,2025-05-28,84,Improved,None,No,No,,704,571,23.4,Increased,42.35,148.11,-105.76,106.95,149.3,105.11,0.0,0,0.056,0.201,0.305,0.676,10,0,14,8,3.1,6.5,5,Higher,Southwest,NY,Suburban,36-50,2025-08,Q3_2025,2024,4.6,0.594,Decreasing
FIA000230,2025-08-26,Metformin,Glucophage,Antidiabetics,11105-227-69,Medicaid Plan Y,PLAN_4161,2025,Non-Formulary,Tier 1,2024-12-12,257,Worsened,Non-Formulary Status,No,No,,570,932,-38.8,Decreased,603.35,10.29,593.06,172.65,776.0,442.32,0.0,0,0.147,0.206,0.355,0.411,8,10,11,6,2.3,23.4,4,Higher,Southeast,NY,Suburban,51-65,2025-08,Q3_2025,2024,1.3,0.493,Decreasing
FIA002420,2022-01-26,Metoprolol,Lopressor,Beta Blockers,58961-585-91,VA Plan,PLAN_8637,2022,Specialty Tier,Tier 1,2021-08-01,178,Worsened,Step Therapy; Quantity Limit,No,Yes,90.0,440,564,-21.9,Decreased,215.65,19.43,196.22,162.1,377.75,166.21,0.0,0,0.23,0.287,0.283,0.555,6,10,3,5,3.9,28.7,3,Lower,Southeast,MI,Suburban,66-75,2022-01,Q1_2022,2021,8.0,0.534,Increasing
FIA002776,2022-01-31,Metoprolol,Lopressor,Beta Blockers,19376-200-23,Tricare Standard,PLAN_3758,2022,Tier 2,Specialty Tier,2021-02-23,342,Improved,None,No,No,,1047,889,17.8,Increased,40.42,151.93,-111.51,164.8,205.22,214.87,0.0,0,0.047,0.143,0.515,0.794,3,4,13,11,2.7,13.2,5,Lower,West,FL,Suburban,18-35,2022-01,Q1_2022,2021,9.6,0.091,Increasing
FIA001673,2022-02-13,Metoprolol,Lopressor,Beta Blockers,11122-531-91,Tricare Standard,PLAN_3276,2022,Non-Formulary,Tier 2,2021-09-09,157,Worsened,Non-Formulary Status,No,No,,632,799,-20.8,Decreased,610.07,24.4,585.67,110.34,720.41,455.3,0.0,0,0.093,0.269,0.495,0.747,6,0,19,4,2.4,33.6,2,Lower,West,NC,Urban,66-75,2022-02,Q1_2022,2021,6.6,0.205,Stable
FIA002540,2022-02-22,Metoprolol,Lopressor,Beta Blockers,72564-524-21,Medicare Part D Plan A,PLAN_3845,2022,Non-Formulary,Tier 1,2021-12-30,54,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,163,418,-60.9,Decreased,784.76,13.77,770.99,199.59,984.35,160.45,0.0,0,0.094,0.354,0.308,0.665,6,4,2,8,2.4,13.0,4,Higher,Northeast,PA,Rural,18-35,2022-02,Q1_2022,2021,8.9,0.781,Stable
FIA001823,2022-02-23,Metoprolol,Lopressor,Beta Blockers,69360-111-98,VA Plan,PLAN_7317,2022,Tier 1,Specialty Tier,2021-05-14,285,Improved,None,No,No,,1372,903,52.0,Increased,16.74,211.81,-195.07,98.5,115.24,158.11,0.0,0,0.05,0.38,0.557,0.679,6,3,2,13,3.0,22.9,3,Lower,West,TX,Rural,36-50,2022-02,Q1_2022,2021,5.4,0.788,Decreasing
FIA001413,2022-02-25,Metoprolol,Lopressor,Beta Blockers,12365-739-59,Medicaid Plan X,PLAN_4444,2022,Tier 1,Specialty Tier,2021-05-05,296,Improved,Quantity Limit,No,No,60.0,695,448,55.2,Increased,5.2,251.26,-246.06,156.12,161.32,112.12,0.0,0,0.025,0.177,0.791,0.508,8,9,15,6,2.4,5.1,6,Similar,Northeast,TX,Suburban,36-50,2022-02,Q1_2022,2021,4.0,0.804,Increasing
FIA000311,2022-02-26,Metoprolol,Lopressor,Beta Blockers,84130-998-47,Medicare Part D Plan A,PLAN_7433,2022,Non-Formulary,Tier 1,2021-06-26,245,Worsened,Non-Formulary Status,No,No,,166,409,-59.3,Decreased,253.06,7.11,245.95,135.55,388.61,64.51,0.0,0,0.143,0.094,0.669,0.655,14,0,2,1,2.8,34.6,2,Similar,West,TX,Suburban,75+,2022-02,Q1_2022,2021,5.3,0.331,Increasing
FIA000967,2022-03-08,Metoprolol,Lopressor,Beta Blockers,83717-193-24,Medicaid Plan X,PLAN_8094,2022,Tier 3,Non-Formulary,2021-08-10,210,Improved,Quantity Limit,No,No,60.0,291,307,-5.0,Stable,99.43,256.7,-157.27,179.31,278.74,81.11,0.0,0,0.029,0.084,0.877,0.5,0,6,7,14,3.7,7.7,8,Higher,Northeast,PA,Rural,36-50,2022-03,Q1_2022,2021,8.1,0.252,Decreasing
FIA000270,2022-03-14,Metoprolol,Lopressor,Beta Blockers,66466-603-35,Medicare Part D Plan B,PLAN_9668,2022,Specialty Tier,Non-Formulary,2021-06-08,279,Improved,None,No,No,,551,571,-3.4,Stable,111.5,203.53,-92.03,31.51,143.01,78.8,0.0,0,0.151,0.23,0.308,0.468,15,0,4,8,2.7,16.9,4,Similar,Southwest,FL,Rural,51-65,2022-03,Q1_2022,2021,2.0,0.439,Stable
FIA001678,2022-03-15,Metoprolol,Lopressor,Beta Blockers,68538-254-16,Medicare Part D Plan B,PLAN_8797,2022,Non-Formulary,Non-Formulary,2021-08-17,210,No Change,Non-Formulary Status,No,No,,248,236,5.1,Increased,294.96,357.31,-62.35,151.83,446.79,110.8,0.0,0,0.268,0.348,0.685,0.918,2,1,14,10,3.9,15.0,5,Similar,Southwest,PA,Suburban,36-50,2022-03,Q1_2022,2021,4.3,0.043,Stable
FIA002941,2022-03-21,Metoprolol,Lopressor,Beta Blockers,33708-822-83,Medicaid Plan Y,PLAN_7382,2022,Tier 2,Tier 2,2021-11-05,136,No Change,None,No,No,,152,149,2.5,Stable,42.67,23.1,19.57,186.31,228.98,34.8,0.0,0,0.074,0.373,0.682,0.512,15,2,18,6,4.1,29.8,7,Lower,Southwest,NC,Rural,36-50,2022-03,Q1_2022,2021,6.6,0.649,Stable
FIA001620,2022-04-02,Metoprolol,Lopressor,Beta Blockers,76965-907-38,Commercial Plan Beta,PLAN_9555,2022,Non-Formulary,Tier 1,2021-10-05,179,Worsened,Non-Formulary Status,No,No,,595,804,-25.9,Decreased,509.21,16.13,493.08,158.16,667.37,397.09,0.0,0,0.218,0.361,0.79,0.607,13,1,18,15,3.6,29.1,6,Similar,West,TX,Urban,66-75,2022-04,Q2_2022,2021,4.6,0.684,Decreasing
FIA001155,2022-04-13,Metoprolol,Lopressor,Beta Blockers,40207-621-42,Commercial Plan Beta,PLAN_8672,2022,Specialty Tier,Specialty Tier,2021-04-21,357,No Change,Prior Authorization; Step Therapy,Yes,Yes,,578,581,-0.4,Stable,197.27,248.94,-51.67,30.26,227.53,131.51,0.431,9,0.065,0.111,0.212,0.447,14,7,15,11,3.9,10.7,7,Similar,Southeast,FL,Suburban,36-50,2022-04,Q2_2022,2021,6.3,0.941,Increasing
FIA002820,2022-04-18,Metoprolol,Lopressor,Beta Blockers,94439-311-71,Commercial Plan Beta,PLAN_3164,2022,Tier 3,Specialty Tier,2022-01-10,98,Improved,Prior Authorization,Yes,No,,600,661,-9.2,Decreased,67.04,185.69,-118.65,68.9,135.94,81.56,0.538,4,0.073,0.333,0.327,0.734,0,0,8,15,3.3,17.0,6,Higher,Midwest,IL,Rural,36-50,2022-04,Q2_2022,2021,9.0,0.504,Decreasing
FIA001075,2022-04-30,Metoprolol,Lopressor,Beta Blockers,78114-109-79,Commercial Plan Beta,PLAN_5637,2022,Non-Formulary,Specialty Tier,2022-03-26,35,Worsened,Non-Formulary Status,No,No,,313,290,8.1,Increased,280.02,128.13,151.89,141.65,421.67,131.98,0.0,0,0.206,0.269,0.598,0.463,6,2,3,12,4.0,5.4,4,Higher,Southeast,FL,Suburban,18-35,2022-04,Q2_2022,2021,5.9,0.139,Decreasing
FIA002136,2022-05-01,Metoprolol,Lopressor,Beta Blockers,69128-641-84,Medicare Part D Plan A,PLAN_1933,2022,Tier 2,Tier 1,2022-03-06,56,Worsened,None,No,No,,473,435,8.8,Increased,39.81,10.27,29.54,157.44,197.25,93.3,0.0,0,0.072,0.278,0.851,0.724,8,2,7,4,3.1,24.9,8,Lower,Southeast,PA,Rural,36-50,2022-05,Q2_2022,2021,7.2,0.211,Decreasing
FIA000062,2022-05-04,Metoprolol,Lopressor,Beta Blockers,60132-559-58,VA Plan,PLAN_2314,2022,Tier 1,Specialty Tier,2022-03-19,46,Improved,Quantity Limit,No,No,30.0,355,238,49.5,Increased,9.31,136.0,-126.69,101.46,110.77,39.32,0.0,0,0.055,0.279,0.443,0.498,12,8,4,7,4.5,27.7,4,Similar,West,OH,Rural,66-75,2022-05,Q2_2022,2021,8.4,0.248,Stable
FIA001373,2022-05-22,Metoprolol,Lopressor,Beta Blockers,34600-224-52,VA Plan,PLAN_8698,2022,Tier 3,Tier 1,2021-07-14,312,Worsened,Step Therapy,No,Yes,,70,140,-49.9,Decreased,59.46,14.63,44.83,112.48,171.94,12.04,0.0,0,0.014,0.344,0.315,0.438,6,6,5,4,2.9,29.3,7,Higher,West,GA,Rural,66-75,2022-05,Q2_2022,2021,8.8,0.195,Decreasing
FIA001953,2022-05-24,Metoprolol,Lopressor,Beta Blockers,82434-174-22,Medicaid Plan Y,PLAN_6738,2022,Specialty Tier,Non-Formulary,2022-01-16,128,Improved,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,90.0,743,762,-2.5,Stable,171.21,453.03,-281.82,86.2,257.41,191.26,0.435,8,0.182,0.08,0.887,0.643,14,5,15,13,5.0,18.0,3,Similar,Northeast,CA,Rural,66-75,2022-05,Q2_2022,2021,1.9,0.034,Increasing
FIA002581,2022-06-07,Metoprolol,Lopressor,Beta Blockers,29318-719-45,Commercial Plan Alpha,PLAN_3502,2022,Tier 2,Non-Formulary,2022-02-07,120,Improved,None,No,No,,670,511,31.3,Increased,25.9,739.32,-713.42,72.69,98.59,66.06,0.0,0,0.019,0.233,0.743,0.935,13,4,10,6,2.7,14.2,4,Lower,Midwest,GA,Rural,75+,2022-06,Q2_2022,2021,7.9,0.916,Stable
FIA001336,2022-06-15,Metoprolol,Lopressor,Beta Blockers,95060-173-60,Medicaid Plan X,PLAN_3053,2022,Non-Formulary,Non-Formulary,2022-05-16,30,No Change,Non-Formulary Status,No,No,,821,875,-6.1,Decreased,272.48,308.52,-36.04,145.79,418.27,343.4,0.0,0,0.095,0.363,0.258,0.751,12,6,13,8,3.5,34.7,5,Higher,West,NY,Suburban,36-50,2022-06,Q2_2022,2021,5.0,0.42,Increasing
FIA001173,2022-06-16,Metoprolol,Lopressor,Beta Blockers,93787-897-13,Medicare Part D Plan A,PLAN_6303,2022,Non-Formulary,Non-Formulary,2021-08-25,295,No Change,Non-Formulary Status,No,No,,758,706,7.4,Increased,481.44,423.99,57.45,131.09,612.53,464.3,0.0,0,0.097,0.256,0.424,0.593,3,7,7,12,3.0,15.9,2,Similar,West,TX,Rural,36-50,2022-06,Q2_2022,2021,3.5,0.926,Stable
FIA002137,2022-06-21,Metoprolol,Lopressor,Beta Blockers,62415-744-19,Commercial Plan Beta,PLAN_3213,2022,Tier 2,Tier 3,2022-02-10,131,Improved,Quantity Limit,No,No,30.0,906,627,44.6,Increased,43.86,57.05,-13.19,32.82,76.68,69.47,0.0,0,0.027,0.394,0.826,0.804,0,4,20,15,4.8,12.9,5,Higher,Southeast,CA,Rural,75+,2022-06,Q2_2022,2021,1.9,0.839,Decreasing
FIA000920,2022-06-26,Metoprolol,Lopressor,Beta Blockers,88950-151-81,Medicare Part D Plan B,PLAN_7223,2022,Tier 2,Non-Formulary,2022-04-15,72,Improved,None,No,No,,560,396,41.6,Increased,49.82,223.66,-173.84,135.07,184.89,103.54,0.0,0,0.012,0.287,0.411,0.598,6,1,18,3,4.0,31.1,2,Higher,Southeast,TX,Rural,36-50,2022-06,Q2_2022,2021,2.7,0.393,Decreasing
FIA000109,2022-07-02,Metoprolol,Lopressor,Beta Blockers,69867-403-43,Tricare Standard,PLAN_1820,2022,Tier 1,Non-Formulary,2021-09-23,282,Improved,None,No,No,,737,623,18.4,Increased,7.24,254.05,-246.81,139.54,146.78,108.18,0.0,0,0.073,0.085,0.322,0.422,9,5,10,13,4.2,7.8,8,Lower,Northeast,FL,Rural,36-50,2022-07,Q3_2022,2021,4.0,0.895,Decreasing
FIA000662,2022-07-04,Metoprolol,Lopressor,Beta Blockers,42758-724-58,Tricare Standard,PLAN_1012,2022,Tier 2,Tier 2,2021-10-13,264,No Change,None,No,No,,718,664,8.2,Increased,30.93,20.27,10.66,149.72,180.65,129.71,0.0,0,0.067,0.096,0.728,0.533,10,2,9,1,3.1,11.7,8,Similar,Midwest,NC,Urban,75+,2022-07,Q3_2022,2021,8.3,0.79,Stable
FIA002223,2022-07-05,Metoprolol,Lopressor,Beta Blockers,73485-763-78,Commercial Plan Alpha,PLAN_8191,2022,Non-Formulary,Tier 2,2022-03-18,109,Worsened,Non-Formulary Status,No,No,,160,262,-38.8,Decreased,402.37,22.47,379.9,130.99,533.36,85.34,0.0,0,0.233,0.105,0.521,0.502,7,6,19,0,3.7,17.8,3,Lower,West,OH,Urban,18-35,2022-07,Q3_2022,2021,4.7,0.845,Increasing
FIA000430,2022-07-16,Metoprolol,Lopressor,Beta Blockers,44961-665-55,Commercial Plan Beta,PLAN_3485,2022,Specialty Tier,Tier 2,2022-05-27,50,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,81,110,-25.6,Decreased,278.26,37.0,241.26,132.62,410.88,33.28,0.22,1,0.105,0.244,0.422,0.521,12,3,17,0,4.9,7.7,7,Higher,Midwest,GA,Urban,18-35,2022-07,Q3_2022,2021,3.2,0.406,Increasing
FIA002538,2022-07-28,Metoprolol,Lopressor,Beta Blockers,45121-353-13,Commercial Plan Beta,PLAN_6760,2022,Specialty Tier,Tier 3,2022-01-09,200,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,323,349,-7.4,Decreased,140.49,85.74,54.75,43.04,183.53,59.28,0.355,10,0.086,0.071,0.585,0.682,0,2,3,1,3.0,34.9,4,Lower,West,TX,Urban,18-35,2022-07,Q3_2022,2021,8.6,0.286,Decreasing
FIA002966,2022-07-28,Metoprolol,Lopressor,Beta Blockers,58739-588-77,Medicaid Plan Y,PLAN_9458,2022,Tier 3,Non-Formulary,2021-12-28,212,Improved,Step Therapy,No,Yes,,199,203,-1.5,Stable,50.82,479.2,-428.38,127.16,177.98,35.42,0.0,0,0.029,0.371,0.872,0.85,4,9,10,5,2.9,17.4,5,Lower,Southwest,MI,Suburban,18-35,2022-07,Q3_2022,2021,6.4,0.101,Increasing
FIA002894,2022-08-11,Metoprolol,Lopressor,Beta Blockers,81872-162-33,Medicare Part D Plan A,PLAN_7028,2022,Tier 1,Tier 3,2022-05-08,95,Improved,None,No,No,,1155,843,37.1,Increased,8.11,86.32,-78.21,123.91,132.02,152.48,0.0,0,0.077,0.293,0.397,0.407,4,7,19,2,2.8,12.8,2,Higher,West,OH,Rural,75+,2022-08,Q3_2022,2021,1.5,0.404,Increasing
FIA000862,2022-08-14,Metoprolol,Lopressor,Beta Blockers,42576-785-83,VA Plan,PLAN_1104,2022,Non-Formulary,Tier 1,2022-04-28,108,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,276,701,-60.6,Decreased,428.16,10.71,417.45,132.73,560.89,154.81,0.0,0,0.247,0.08,0.385,0.912,2,8,18,3,4.5,29.4,8,Higher,Southeast,IL,Suburban,75+,2022-08,Q3_2022,2021,2.3,0.304,Stable
FIA002811,2022-08-15,Metoprolol,Lopressor,Beta Blockers,99870-401-16,Medicaid Plan X,PLAN_8960,2022,Tier 2,Tier 3,2022-06-30,46,Improved,None,No,No,,354,250,41.9,Increased,31.7,94.87,-63.17,129.73,161.43,57.15,0.0,0,0.045,0.28,0.544,0.9,7,2,1,4,3.6,14.1,6,Higher,West,MI,Suburban,66-75,2022-08,Q3_2022,2021,6.2,0.547,Decreasing
FIA000698,2022-08-23,Metoprolol,Lopressor,Beta Blockers,80781-635-92,VA Plan,PLAN_2610,2022,Non-Formulary,Tier 1,2021-09-04,353,Worsened,Non-Formulary Status,No,No,,238,660,-63.9,Decreased,709.83,16.07,693.76,126.4,836.23,199.02,0.0,0,0.089,0.229,0.294,0.845,15,0,12,12,4.1,30.5,6,Lower,Northeast,CA,Suburban,75+,2022-08,Q3_2022,2021,2.2,0.481,Increasing
FIA000727,2022-08-25,Metoprolol,Lopressor,Beta Blockers,31591-884-92,Commercial Plan Alpha,PLAN_1125,2022,Tier 2,Tier 3,2022-07-11,45,Improved,Quantity Limit,No,No,90.0,520,421,23.7,Increased,44.78,97.28,-52.5,187.7,232.48,120.89,0.0,0,0.076,0.151,0.648,0.915,11,7,17,1,3.8,18.9,3,Lower,Southeast,NC,Urban,18-35,2022-08,Q3_2022,2021,1.2,0.3,Decreasing
FIA002748,2022-08-25,Metoprolol,Lopressor,Beta Blockers,97323-925-39,Commercial Plan Alpha,PLAN_2295,2022,Non-Formulary,Tier 1,2022-07-12,44,Worsened,Non-Formulary Status,No,No,,217,518,-58.0,Decreased,526.17,19.98,506.19,182.35,708.52,153.75,0.0,0,0.084,0.339,0.526,0.718,10,4,18,9,2.3,23.3,7,Similar,West,GA,Rural,66-75,2022-08,Q3_2022,2021,7.0,0.807,Decreasing
FIA000393,2022-08-27,Metoprolol,Lopressor,Beta Blockers,42266-736-95,Medicaid Plan X,PLAN_7927,2022,Tier 3,Tier 1,2022-03-27,153,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,134,438,-69.2,Decreased,82.98,18.73,64.25,54.08,137.06,18.37,0.519,10,0.013,0.299,0.831,0.57,8,6,0,13,4.5,16.3,8,Lower,Southwest,PA,Rural,18-35,2022-08,Q3_2022,2021,6.6,0.395,Decreasing
FIA002531,2022-09-06,Metoprolol,Lopressor,Beta Blockers,16493-368-77,Commercial Plan Alpha,PLAN_8559,2022,Tier 2,Tier 2,2022-07-31,37,No Change,None,No,No,,942,881,7.0,Increased,29.99,29.73,0.26,91.88,121.87,114.8,0.0,0,0.072,0.189,0.401,0.917,6,6,18,6,3.7,30.1,2,Similar,Southwest,FL,Urban,18-35,2022-09,Q3_2022,2021,6.0,0.043,Increasing
FIA000081,2022-09-28,Metoprolol,Lopressor,Beta Blockers,95915-193-22,Medicare Part D Plan A,PLAN_4496,2022,Tier 3,Tier 2,2022-04-11,170,Worsened,Prior Authorization,Yes,No,,112,184,-38.6,Decreased,54.67,30.81,23.86,69.8,124.47,13.94,0.253,8,0.059,0.077,0.616,0.686,14,0,0,10,4.5,34.6,5,Higher,Southeast,GA,Urban,36-50,2022-09,Q3_2022,2021,4.4,0.731,Increasing
FIA002738,2022-10-07,Metoprolol,Lopressor,Beta Blockers,71426-499-12,VA Plan,PLAN_5798,2022,Tier 1,Tier 1,2022-02-03,246,No Change,None,No,No,,495,499,-0.7,Stable,14.94,11.39,3.55,186.13,201.07,99.53,0.0,0,0.038,0.097,0.685,0.484,5,10,11,11,4.9,23.8,6,Similar,Northeast,OH,Rural,51-65,2022-10,Q4_2022,2022,6.1,0.448,Decreasing
FIA000768,2022-10-20,Metoprolol,Lopressor,Beta Blockers,79601-669-77,Medicare Part D Plan A,PLAN_6055,2022,Tier 2,Specialty Tier,2022-02-07,255,Improved,None,No,No,,437,277,57.9,Increased,26.83,260.77,-233.94,170.72,197.55,86.33,0.0,0,0.065,0.226,0.795,0.45,9,10,4,1,2.4,23.2,3,Similar,Midwest,IL,Urban,36-50,2022-10,Q4_2022,2022,6.0,0.785,Increasing
FIA002183,2022-10-25,Metoprolol,Lopressor,Beta Blockers,51531-558-34,Medicaid Plan Y,PLAN_3720,2022,Non-Formulary,Tier 1,2022-01-10,288,Worsened,Non-Formulary Status,No,No,,140,285,-50.8,Decreased,778.06,16.75,761.31,143.48,921.54,129.02,0.0,0,0.176,0.187,0.224,0.646,9,10,18,2,2.6,6.2,5,Higher,Midwest,FL,Suburban,51-65,2022-10,Q4_2022,2022,1.5,0.728,Stable
FIA002303,2022-11-01,Metoprolol,Lopressor,Beta Blockers,29466-678-35,Commercial Plan Beta,PLAN_1853,2022,Non-Formulary,Non-Formulary,2022-06-28,126,No Change,Non-Formulary Status; Quantity Limit,No,No,,743,711,4.6,Stable,475.16,644.88,-169.72,71.6,546.76,406.24,0.0,0,0.283,0.104,0.343,0.699,10,2,3,4,2.8,6.2,8,Lower,Southeast,PA,Urban,66-75,2022-11,Q4_2022,2022,9.6,0.742,Stable
FIA001732,2022-11-13,Metoprolol,Lopressor,Beta Blockers,52185-150-70,Medicaid Plan X,PLAN_2282,2022,Tier 1,Tier 1,2022-06-17,149,No Change,Quantity Limit,No,No,,377,392,-3.6,Stable,8.14,5.22,2.92,142.55,150.69,56.81,0.0,0,0.06,0.394,0.623,0.696,6,6,18,13,4.2,23.7,6,Lower,Southwest,NC,Urban,18-35,2022-11,Q4_2022,2022,3.1,0.014,Increasing
FIA002580,2022-11-13,Metoprolol,Lopressor,Beta Blockers,68673-867-66,Tricare Standard,PLAN_2801,2022,Non-Formulary,Specialty Tier,2021-12-26,322,Worsened,Non-Formulary Status,No,No,,469,428,9.6,Increased,745.6,107.05,638.55,185.41,931.01,436.64,0.0,0,0.236,0.067,0.72,0.459,1,5,14,10,4.9,13.1,2,Lower,Southeast,TX,Suburban,75+,2022-11,Q4_2022,2022,6.5,0.39,Increasing
FIA001277,2022-11-23,Metoprolol,Lopressor,Beta Blockers,41454-560-20,VA Plan,PLAN_6342,2022,Non-Formulary,Tier 2,2022-05-27,180,Worsened,Non-Formulary Status; Quantity Limit,No,No,,346,723,-52.1,Decreased,651.4,32.17,619.23,50.23,701.63,242.76,0.0,0,0.253,0.249,0.669,0.492,6,10,3,11,4.7,17.2,3,Similar,West,TX,Urban,18-35,2022-11,Q4_2022,2022,8.9,0.83,Increasing
FIA002423,2022-12-17,Metoprolol,Lopressor,Beta Blockers,79401-243-48,Medicaid Plan Y,PLAN_9385,2022,Specialty Tier,Tier 2,2022-01-17,334,Worsened,Step Therapy,No,Yes,,52,155,-66.3,Decreased,129.38,33.7,95.68,54.91,184.29,9.58,0.0,0,0.299,0.372,0.298,0.58,12,9,18,11,3.5,10.8,5,Lower,Midwest,TX,Urban,75+,2022-12,Q4_2022,2022,6.4,0.437,Increasing
FIA001123,2022-12-26,Metoprolol,Lopressor,Beta Blockers,22424-613-56,Medicaid Plan X,PLAN_6598,2022,Tier 2,Tier 2,2022-03-10,291,No Change,None,No,No,,969,882,10.0,Increased,42.61,20.03,22.58,128.56,171.17,165.86,0.0,0,0.027,0.179,0.245,0.697,5,5,17,7,2.3,28.0,2,Lower,Midwest,OH,Urban,18-35,2022-12,Q4_2022,2022,2.8,0.915,Decreasing
FIA000733,2022-12-29,Metoprolol,Lopressor,Beta Blockers,39005-229-55,Medicare Part D Plan A,PLAN_4529,2022,Tier 1,Tier 3,2022-07-29,153,Improved,None,No,No,,698,491,42.2,Increased,13.86,94.99,-81.13,30.84,44.7,31.2,0.0,0,0.079,0.092,0.361,0.486,1,4,17,11,2.0,9.5,5,Lower,West,CA,Urban,75+,2022-12,Q4_2022,2022,3.2,0.244,Stable
FIA001821,2022-12-30,Metoprolol,Lopressor,Beta Blockers,13778-375-54,Medicaid Plan X,PLAN_9512,2022,Non-Formulary,Tier 3,2022-11-20,40,Worsened,Non-Formulary Status,No,No,,653,689,-5.1,Decreased,344.17,60.06,284.11,47.45,391.62,255.73,0.0,0,0.089,0.064,0.639,0.919,9,6,0,12,3.1,32.2,7,Higher,Southeast,CA,Rural,66-75,2022-12,Q4_2022,2022,4.7,0.437,Increasing
FIA002166,2023-01-11,Metoprolol,Lopressor,Beta Blockers,62252-107-79,Medicaid Plan Y,PLAN_6815,2023,Tier 3,Non-Formulary,2022-06-29,196,Improved,Step Therapy,No,Yes,,913,946,-3.5,Stable,75.22,534.8,-459.58,138.76,213.98,195.36,0.0,0,0.029,0.066,0.888,0.616,11,9,19,3,2.8,25.3,8,Lower,Midwest,NY,Rural,51-65,2023-01,Q1_2023,2022,9.5,0.803,Stable
FIA001731,2023-01-16,Metoprolol,Lopressor,Beta Blockers,32863-337-35,Medicaid Plan Y,PLAN_8329,2023,Tier 1,Tier 3,2022-01-22,359,Improved,None,No,No,,1234,833,48.2,Increased,13.06,78.14,-65.08,158.62,171.68,211.85,0.0,0,0.013,0.342,0.598,0.912,6,7,20,15,4.1,15.4,2,Lower,Southeast,MI,Urban,75+,2023-01,Q1_2023,2022,8.5,0.621,Decreasing
FIA002547,2023-01-20,Metoprolol,Lopressor,Beta Blockers,74250-949-58,VA Plan,PLAN_6224,2023,Tier 1,Non-Formulary,2022-10-31,81,Improved,Quantity Limit,No,No,60.0,1156,845,36.9,Increased,8.01,597.48,-589.47,79.29,87.3,100.92,0.0,0,0.07,0.101,0.821,0.694,12,6,9,11,4.9,6.8,2,Similar,Southeast,TX,Rural,18-35,2023-01,Q1_2023,2022,3.8,0.721,Increasing
FIA001988,2023-01-31,Metoprolol,Lopressor,Beta Blockers,12325-839-13,Medicare Part D Plan B,PLAN_3132,2023,Tier 1,Tier 1,2022-10-19,104,No Change,None,No,No,,132,139,-4.6,Stable,15.82,5.73,10.09,108.82,124.64,16.45,0.0,0,0.065,0.369,0.788,0.885,5,3,16,9,2.2,22.1,4,Similar,Midwest,CA,Suburban,36-50,2023-01,Q1_2023,2022,5.4,0.557,Increasing
FIA001047,2023-02-01,Metoprolol,Lopressor,Beta Blockers,64980-677-75,Medicaid Plan Y,PLAN_9731,2023,Tier 3,Non-Formulary,2022-09-21,133,Improved,Step Therapy,No,Yes,,205,209,-1.5,Stable,92.92,742.55,-649.63,125.16,218.08,44.71,0.0,0,0.073,0.16,0.39,0.441,2,0,12,13,3.4,9.5,5,Similar,Northeast,NC,Suburban,75+,2023-02,Q1_2023,2022,3.1,0.579,Decreasing
FIA000090,2023-02-09,Metoprolol,Lopressor,Beta Blockers,60165-799-64,Commercial Plan Alpha,PLAN_6799,2023,Specialty Tier,Tier 2,2022-11-24,77,Worsened,Prior Authorization; Quantity Limit,Yes,No,30.0,324,439,-26.1,Decreased,281.02,44.88,236.14,114.34,395.36,128.1,0.317,3,0.231,0.146,0.512,0.482,7,10,9,15,3.2,21.5,2,Lower,Midwest,OH,Urban,66-75,2023-02,Q1_2023,2022,2.8,0.885,Decreasing
FIA000616,2023-02-17,Metoprolol,Lopressor,Beta Blockers,20774-975-80,VA Plan,PLAN_8864,2023,Specialty Tier,Non-Formulary,2022-04-21,302,Improved,None,No,No,,597,570,4.8,Stable,289.01,546.3,-257.29,198.13,487.14,290.82,0.0,0,0.125,0.4,0.472,0.422,0,9,18,8,4.1,12.5,2,Lower,Southeast,GA,Urban,18-35,2023-02,Q1_2023,2022,5.7,0.085,Increasing
FIA000801,2023-02-21,Metoprolol,Lopressor,Beta Blockers,20293-457-36,Medicaid Plan Y,PLAN_3749,2023,Tier 3,Tier 1,2022-05-09,288,Worsened,Step Therapy; Quantity Limit,No,Yes,,251,463,-45.7,Decreased,83.72,5.13,78.59,120.87,204.59,51.35,0.0,0,0.064,0.221,0.622,0.589,1,9,16,9,4.1,25.3,2,Lower,West,OH,Suburban,51-65,2023-02,Q1_2023,2022,8.3,0.84,Increasing
FIA002156,2023-02-24,Metoprolol,Lopressor,Beta Blockers,72217-701-87,Medicare Part D Plan B,PLAN_7629,2023,Non-Formulary,Non-Formulary,2023-01-15,40,No Change,Non-Formulary Status,No,No,,751,721,4.3,Stable,367.47,547.17,-179.7,68.37,435.84,327.32,0.0,0,0.233,0.075,0.559,0.794,5,9,14,12,3.3,28.4,4,Similar,Northeast,MI,Urban,18-35,2023-02,Q1_2023,2022,7.3,0.32,Stable
FIA000219,2023-02-25,Metoprolol,Lopressor,Beta Blockers,67554-525-10,Commercial Plan Beta,PLAN_8760,2023,Tier 3,Tier 2,2022-08-30,179,Worsened,None,No,No,,264,610,-56.6,Decreased,85.41,42.86,42.55,174.26,259.67,68.55,0.0,0,0.02,0.169,0.554,0.447,11,6,11,7,2.5,27.6,5,Lower,Southeast,OH,Suburban,66-75,2023-02,Q1_2023,2022,9.1,0.952,Decreasing
FIA000790,2023-03-11,Metoprolol,Lopressor,Beta Blockers,23958-568-99,Medicare Part D Plan A,PLAN_8098,2023,Tier 3,Tier 3,2022-04-03,342,No Change,None,No,No,,686,628,9.3,Increased,82.25,83.35,-1.1,99.46,181.71,124.65,0.0,0,0.042,0.254,0.26,0.543,14,1,2,0,4.9,11.4,6,Similar,Southwest,TX,Suburban,66-75,2023-03,Q1_2023,2022,5.3,0.358,Stable
FIA000350,2023-03-12,Metoprolol,Lopressor,Beta Blockers,65652-711-60,Medicare Part D Plan B,PLAN_6683,2023,Specialty Tier,Specialty Tier,2022-06-18,267,No Change,Prior Authorization,Yes,No,,193,198,-2.2,Stable,241.24,252.61,-11.37,154.16,395.4,76.31,0.549,8,0.255,0.284,0.879,0.415,5,3,11,11,3.0,29.7,6,Higher,Southwest,TX,Rural,36-50,2023-03,Q1_2023,2022,2.2,0.188,Increasing
FIA002227,2023-03-13,Metoprolol,Lopressor,Beta Blockers,13957-430-75,Commercial Plan Beta,PLAN_1137,2023,Non-Formulary,Tier 3,2022-08-26,199,Worsened,Non-Formulary Status,No,No,,695,695,0.1,Stable,644.18,56.94,587.24,117.86,762.04,529.62,0.0,0,0.264,0.265,0.473,0.416,9,6,6,10,2.1,19.2,7,Lower,West,NC,Suburban,75+,2023-03,Q1_2023,2022,3.1,0.468,Stable
FIA001718,2023-03-26,Metoprolol,Lopressor,Beta Blockers,30992-840-15,Medicare Part D Plan A,PLAN_6003,2023,Specialty Tier,Tier 1,2022-09-04,203,Worsened,Prior Authorization,Yes,No,,356,803,-55.6,Decreased,205.57,12.41,193.16,136.52,342.09,121.78,0.141,1,0.221,0.272,0.35,0.934,4,0,6,7,4.0,21.3,7,Lower,West,PA,Suburban,36-50,2023-03,Q1_2023,2022,4.2,0.033,Increasing
FIA001539,2023-03-29,Metoprolol,Lopressor,Beta Blockers,77020-973-56,Medicaid Plan Y,PLAN_8500,2023,Tier 3,Tier 1,2022-07-29,243,Worsened,Step Therapy,No,Yes,,283,485,-41.6,Decreased,69.74,10.62,59.12,134.99,204.73,57.94,0.0,0,0.079,0.2,0.539,0.89,6,7,18,7,3.8,32.8,4,Similar,Midwest,NY,Suburban,36-50,2023-03,Q1_2023,2022,8.9,0.843,Increasing
FIA001249,2023-03-31,Metoprolol,Lopressor,Beta Blockers,51303-809-86,Medicaid Plan X,PLAN_7108,2023,Specialty Tier,Specialty Tier,2022-05-09,326,No Change,None,No,No,,380,404,-5.8,Decreased,157.43,137.94,19.49,155.67,313.1,118.98,0.0,0,0.127,0.383,0.586,0.465,1,8,18,10,5.0,32.5,5,Higher,Southeast,TX,Rural,66-75,2023-03,Q1_2023,2022,6.6,0.579,Stable
FIA000117,2023-04-07,Metoprolol,Lopressor,Beta Blockers,25643-486-15,VA Plan,PLAN_5572,2023,Tier 3,Non-Formulary,2022-06-02,309,Improved,Step Therapy,No,Yes,,920,842,9.3,Increased,86.92,317.88,-230.96,154.96,241.88,222.53,0.0,0,0.077,0.245,0.291,0.721,8,0,10,14,4.1,9.6,3,Similar,West,CA,Rural,75+,2023-04,Q2_2023,2022,8.6,0.301,Decreasing
FIA002024,2023-04-11,Metoprolol,Lopressor,Beta Blockers,51604-845-99,Medicaid Plan Y,PLAN_8890,2023,Non-Formulary,Tier 1,2022-11-02,160,Worsened,Non-Formulary Status,No,No,,377,517,-27.0,Decreased,222.05,5.78,216.27,151.45,373.5,140.81,0.0,0,0.24,0.085,0.329,0.417,6,1,19,2,4.2,32.9,2,Lower,Midwest,MI,Suburban,36-50,2023-04,Q2_2023,2022,9.5,0.214,Increasing
FIA002108,2023-04-12,Metoprolol,Lopressor,Beta Blockers,70076-936-18,Medicare Part D Plan B,PLAN_8226,2023,Non-Formulary,Tier 3,2022-10-09,185,Worsened,Non-Formulary Status,No,No,,191,193,-0.8,Stable,783.66,69.99,713.67,186.91,970.57,185.38,0.0,0,0.232,0.323,0.406,0.921,9,10,20,2,3.1,10.8,2,Similar,Midwest,TX,Rural,75+,2023-04,Q2_2023,2022,8.9,0.218,Increasing
FIA002361,2023-04-16,Metoprolol,Lopressor,Beta Blockers,32400-268-63,Commercial Plan Alpha,PLAN_4225,2023,Tier 3,Tier 3,2023-01-17,89,No Change,None,No,No,,186,179,3.9,Stable,53.78,92.26,-38.48,188.55,242.33,45.07,0.0,0,0.046,0.183,0.438,0.701,8,9,19,12,4.5,14.9,2,Higher,Midwest,NC,Rural,36-50,2023-04,Q2_2023,2022,9.0,0.145,Decreasing
FIA001696,2023-04-20,Metoprolol,Lopressor,Beta Blockers,16719-186-92,Medicaid Plan Y,PLAN_7272,2023,Tier 2,Specialty Tier,2022-09-16,216,Improved,None,No,No,,253,172,47.7,Increased,29.25,294.82,-265.57,110.37,139.62,35.32,0.0,0,0.035,0.107,0.481,0.816,2,8,1,11,2.4,34.6,6,Lower,Northeast,CA,Rural,51-65,2023-04,Q2_2023,2022,3.3,0.238,Increasing
FIA001396,2023-04-22,Metoprolol,Lopressor,Beta Blockers,12970-635-25,Medicaid Plan X,PLAN_5820,2023,Non-Formulary,Non-Formulary,2022-08-31,234,No Change,Non-Formulary Status; Quantity Limit,No,No,90.0,317,303,4.9,Stable,316.18,730.15,-413.97,132.45,448.63,142.22,0.0,0,0.298,0.399,0.296,0.791,10,3,5,7,4.6,15.3,3,Lower,Southwest,CA,Suburban,75+,2023-04,Q2_2023,2022,8.2,0.104,Increasing
FIA000919,2023-04-30,Metoprolol,Lopressor,Beta Blockers,40569-368-74,Medicaid Plan Y,PLAN_8749,2023,Tier 2,Tier 3,2022-10-28,184,Improved,Quantity Limit,No,No,,841,708,18.9,Increased,32.2,54.32,-22.12,165.99,198.19,166.68,0.0,0,0.018,0.121,0.621,0.777,13,2,14,13,3.6,7.6,5,Lower,Midwest,FL,Urban,18-35,2023-04,Q2_2023,2022,2.4,0.773,Decreasing
FIA001079,2023-05-12,Metoprolol,Lopressor,Beta Blockers,30663-164-34,Medicaid Plan X,PLAN_1453,2023,Tier 2,Non-Formulary,2023-01-07,125,Improved,None,No,No,,1125,806,39.6,Increased,36.94,270.68,-233.74,48.35,85.29,95.95,0.0,0,0.011,0.2,0.337,0.611,0,1,19,1,3.1,10.4,2,Similar,Midwest,TX,Urban,66-75,2023-05,Q2_2023,2022,6.7,0.832,Stable
FIA002096,2023-05-16,Metoprolol,Lopressor,Beta Blockers,10584-733-20,Tricare Standard,PLAN_3748,2023,Non-Formulary,Tier 2,2022-09-02,256,Worsened,Non-Formulary Status,No,No,,242,546,-55.5,Decreased,437.87,44.8,393.07,92.25,530.12,128.29,0.0,0,0.149,0.355,0.88,0.452,1,9,10,13,4.1,28.6,7,Higher,West,NY,Rural,36-50,2023-05,Q2_2023,2022,3.2,0.735,Stable
FIA002526,2023-05-21,Metoprolol,Lopressor,Beta Blockers,41707-888-94,Tricare Standard,PLAN_1434,2023,Tier 3,Tier 3,2023-04-13,38,No Change,Prior Authorization; Step Therapy,Yes,Yes,,585,539,8.6,Increased,94.16,82.52,11.64,130.05,224.21,131.16,0.123,6,0.066,0.214,0.277,0.829,7,2,14,5,4.6,14.6,5,Similar,Southeast,IL,Suburban,75+,2023-05,Q2_2023,2022,2.9,0.738,Decreasing
FIA001637,2023-05-29,Metoprolol,Lopressor,Beta Blockers,94126-132-11,Commercial Plan Beta,PLAN_8883,2023,Tier 2,Tier 2,2022-09-21,250,No Change,None,No,No,,896,960,-6.6,Decreased,43.7,26.96,16.74,109.52,153.22,137.29,0.0,0,0.07,0.32,0.273,0.458,11,0,12,10,2.4,16.4,6,Higher,West,MI,Suburban,75+,2023-05,Q2_2023,2022,2.5,0.675,Decreasing
FIA001552,2023-06-07,Metoprolol,Lopressor,Beta Blockers,90599-975-21,Commercial Plan Beta,PLAN_8114,2023,Tier 1,Tier 3,2023-03-24,75,Improved,None,No,No,,339,217,56.3,Increased,8.88,84.96,-76.08,41.71,50.59,17.15,0.0,0,0.016,0.179,0.417,0.427,5,5,9,5,3.3,6.3,3,Higher,West,FL,Urban,36-50,2023-06,Q2_2023,2022,5.7,0.204,Stable
FIA001645,2023-06-08,Metoprolol,Lopressor,Beta Blockers,92205-787-40,Commercial Plan Alpha,PLAN_1965,2023,Specialty Tier,Non-Formulary,2023-03-16,84,Improved,None,No,No,,521,520,0.3,Stable,258.61,661.38,-402.77,178.44,437.05,227.7,0.0,0,0.235,0.078,0.525,0.745,6,0,15,3,3.4,17.7,3,Higher,Southeast,IL,Suburban,75+,2023-06,Q2_2023,2022,5.9,0.085,Decreasing
FIA000255,2023-06-16,Metoprolol,Lopressor,Beta Blockers,73595-788-22,Medicare Part D Plan A,PLAN_2000,2023,Specialty Tier,Specialty Tier,2022-07-01,350,No Change,None,No,No,,700,751,-6.7,Decreased,282.59,121.84,160.75,69.91,352.5,246.75,0.0,0,0.057,0.143,0.869,0.766,1,1,6,0,3.1,20.6,8,Similar,Southwest,GA,Suburban,75+,2023-06,Q2_2023,2022,4.9,0.371,Stable
FIA001721,2023-06-18,Metoprolol,Lopressor,Beta Blockers,99689-755-93,Medicaid Plan X,PLAN_1287,2023,Tier 1,Specialty Tier,2022-11-10,220,Improved,Quantity Limit,No,No,90.0,662,506,30.9,Increased,14.64,297.49,-282.85,102.09,116.73,77.28,0.0,0,0.075,0.175,0.358,0.456,7,4,11,13,2.5,22.0,3,Similar,West,IL,Suburban,51-65,2023-06,Q2_2023,2022,2.0,0.692,Increasing
FIA001702,2023-06-22,Metoprolol,Lopressor,Beta Blockers,57814-378-82,Tricare Standard,PLAN_1951,2023,Non-Formulary,Non-Formulary,2022-11-26,208,No Change,Non-Formulary Status; Quantity Limit,No,No,60.0,450,444,1.5,Stable,277.51,314.79,-37.28,127.3,404.81,182.16,0.0,0,0.071,0.327,0.636,0.559,8,5,18,3,2.8,9.4,2,Lower,Southeast,CA,Rural,36-50,2023-06,Q2_2023,2022,5.5,0.666,Increasing
FIA000792,2023-06-26,Metoprolol,Lopressor,Beta Blockers,14363-964-26,Medicaid Plan Y,PLAN_1912,2023,Tier 2,Non-Formulary,2022-10-17,252,Improved,Quantity Limit,No,No,30.0,918,649,41.5,Increased,22.16,698.86,-676.7,51.14,73.3,67.29,0.0,0,0.066,0.239,0.81,0.949,13,2,12,9,3.5,28.7,7,Similar,Southeast,NC,Rural,51-65,2023-06,Q2_2023,2022,6.2,0.759,Stable
FIA001340,2023-06-26,Metoprolol,Lopressor,Beta Blockers,71421-457-53,Medicaid Plan X,PLAN_8318,2023,Tier 2,Tier 1,2023-01-12,165,Worsened,None,No,No,,133,126,5.8,Increased,38.36,13.17,25.19,192.0,230.36,30.64,0.0,0,0.021,0.172,0.769,0.827,13,4,2,13,2.6,9.2,2,Lower,Southwest,FL,Rural,36-50,2023-06,Q2_2023,2022,1.5,0.843,Stable
FIA002879,2023-06-27,Metoprolol,Lopressor,Beta Blockers,38289-684-71,VA Plan,PLAN_5306,2023,Non-Formulary,Non-Formulary,2023-01-06,172,No Change,Non-Formulary Status,No,No,,671,663,1.2,Stable,278.93,734.25,-455.32,106.66,385.59,258.73,0.0,0,0.079,0.165,0.285,0.667,11,0,11,3,3.6,31.4,6,Similar,Northeast,TX,Urban,18-35,2023-06,Q2_2023,2022,4.3,0.029,Decreasing
FIA002145,2023-07-01,Metoprolol,Lopressor,Beta Blockers,27750-223-76,Tricare Standard,PLAN_1244,2023,Non-Formulary,Tier 3,2023-04-15,77,Worsened,Non-Formulary Status,No,No,,729,681,7.1,Increased,716.67,68.39,648.28,35.37,752.04,548.24,0.0,0,0.169,0.134,0.457,0.422,8,2,7,11,3.9,5.3,7,Lower,Southwest,MI,Rural,18-35,2023-07,Q3_2023,2022,9.1,0.552,Increasing
FIA000110,2023-07-04,Metoprolol,Lopressor,Beta Blockers,95045-916-31,Medicare Part D Plan B,PLAN_3171,2023,Tier 1,Tier 3,2022-12-11,205,Improved,None,No,No,,721,567,27.2,Increased,7.74,70.04,-62.3,165.98,173.72,125.25,0.0,0,0.07,0.294,0.241,0.918,5,1,13,15,4.4,25.4,3,Higher,Southwest,IL,Rural,18-35,2023-07,Q3_2023,2022,8.8,0.88,Decreasing
FIA000245,2023-07-15,Metoprolol,Lopressor,Beta Blockers,20031-873-23,Medicaid Plan Y,PLAN_7719,2023,Non-Formulary,Tier 3,2023-05-12,64,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,348,322,8.2,Increased,618.83,86.12,532.71,199.2,818.03,284.67,0.0,0,0.188,0.108,0.345,0.425,0,1,20,14,3.1,27.4,8,Lower,Southwest,CA,Urban,51-65,2023-07,Q3_2023,2022,2.0,0.917,Stable
FIA000544,2023-07-31,Metoprolol,Lopressor,Beta Blockers,65508-419-31,VA Plan,PLAN_1760,2023,Tier 3,Specialty Tier,2023-01-11,201,Improved,None,No,No,,707,669,5.8,Increased,87.71,299.2,-211.49,155.28,242.99,171.79,0.0,0,0.022,0.131,0.79,0.63,5,0,4,14,3.1,20.6,2,Similar,Southwest,GA,Urban,75+,2023-07,Q3_2023,2022,2.1,0.907,Increasing
FIA000728,2023-08-13,Metoprolol,Lopressor,Beta Blockers,69524-394-90,Commercial Plan Alpha,PLAN_1596,2023,Tier 3,Tier 2,2023-02-10,184,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,646,877,-26.3,Decreased,53.86,29.99,23.87,124.46,178.32,115.19,0.428,3,0.03,0.08,0.557,0.706,7,0,12,7,4.3,19.9,6,Higher,Northeast,NY,Suburban,75+,2023-08,Q3_2023,2022,6.3,0.115,Increasing
FIA000528,2023-08-16,Metoprolol,Lopressor,Beta Blockers,35557-422-49,VA Plan,PLAN_6183,2023,Tier 3,Tier 2,2022-08-23,358,Worsened,None,No,No,,677,873,-22.4,Decreased,97.17,37.69,59.48,139.06,236.23,159.93,0.0,0,0.07,0.341,0.753,0.419,6,0,14,12,4.7,5.1,8,Similar,Midwest,MI,Suburban,66-75,2023-08,Q3_2023,2022,8.5,0.331,Decreasing
FIA001522,2023-08-22,Metoprolol,Lopressor,Beta Blockers,48578-845-28,Commercial Plan Alpha,PLAN_2614,2023,Specialty Tier,Tier 1,2022-11-03,292,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,570,946,-39.7,Decreased,214.47,12.24,202.23,142.08,356.55,203.23,0.335,1,0.263,0.335,0.547,0.673,8,8,4,2,4.1,31.8,5,Similar,Northeast,GA,Rural,75+,2023-08,Q3_2023,2022,4.8,0.08,Increasing
FIA002719,2023-08-22,Metoprolol,Lopressor,Beta Blockers,25551-401-35,Medicaid Plan Y,PLAN_8126,2023,Non-Formulary,Non-Formulary,2022-11-01,294,No Change,Non-Formulary Status; Quantity Limit,No,No,,802,801,0.2,Stable,240.59,691.35,-450.76,180.8,421.39,337.95,0.0,0,0.117,0.134,0.252,0.896,13,2,11,10,4.3,8.1,8,Higher,Northeast,MI,Suburban,75+,2023-08,Q3_2023,2022,2.8,0.34,Stable
FIA002218,2023-09-09,Metoprolol,Lopressor,Beta Blockers,68863-285-11,Medicaid Plan Y,PLAN_7781,2023,Tier 1,Tier 2,2023-07-10,61,Improved,None,No,No,,318,327,-2.6,Stable,7.92,49.3,-41.38,63.31,71.23,22.65,0.0,0,0.061,0.056,0.645,0.79,9,2,0,5,4.6,30.4,6,Similar,Southeast,MI,Suburban,66-75,2023-09,Q3_2023,2022,8.2,0.446,Increasing
FIA002587,2023-09-28,Metoprolol,Lopressor,Beta Blockers,95733-872-52,Medicare Part D Plan B,PLAN_1207,2023,Tier 2,Tier 1,2022-12-16,286,Worsened,None,No,No,,902,849,6.3,Increased,41.73,17.6,24.13,149.11,190.84,172.14,0.0,0,0.066,0.148,0.511,0.681,15,3,0,11,4.2,23.8,3,Similar,Southeast,NY,Rural,36-50,2023-09,Q3_2023,2022,3.4,0.943,Increasing
FIA000893,2023-10-01,Metoprolol,Lopressor,Beta Blockers,78098-282-98,Commercial Plan Beta,PLAN_7558,2023,Tier 2,Tier 2,2022-10-06,360,No Change,None,No,No,,300,296,1.5,Stable,24.11,32.3,-8.19,36.01,60.12,18.04,0.0,0,0.068,0.248,0.705,0.941,4,6,18,0,2.6,25.6,3,Lower,West,GA,Suburban,51-65,2023-10,Q4_2023,2023,7.1,0.4,Stable
FIA001368,2023-10-17,Metoprolol,Lopressor,Beta Blockers,93172-269-35,Medicaid Plan X,PLAN_1843,2023,Tier 3,Tier 2,2023-08-25,53,Worsened,Prior Authorization,Yes,No,,66,218,-69.7,Decreased,88.19,46.85,41.34,110.46,198.65,13.11,0.365,9,0.052,0.222,0.726,0.63,7,3,10,11,4.9,17.1,6,Similar,West,NC,Urban,75+,2023-10,Q4_2023,2023,7.9,0.557,Increasing
FIA001738,2023-10-18,Metoprolol,Lopressor,Beta Blockers,83912-124-57,Medicare Part D Plan A,PLAN_9290,2023,Tier 2,Non-Formulary,2022-12-29,293,Improved,Quantity Limit,No,No,60.0,1127,723,55.9,Increased,20.78,225.23,-204.45,76.63,97.41,109.78,0.0,0,0.068,0.275,0.611,0.584,2,7,0,8,2.4,6.5,4,Similar,Southeast,CA,Rural,66-75,2023-10,Q4_2023,2023,6.0,0.822,Stable
FIA002240,2023-10-24,Metoprolol,Lopressor,Beta Blockers,24232-823-86,Tricare Standard,PLAN_7423,2023,Tier 3,Specialty Tier,2023-02-27,239,Improved,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,,724,680,6.5,Increased,58.91,185.13,-126.22,145.48,204.39,147.98,0.206,8,0.011,0.339,0.34,0.836,9,1,15,5,4.4,10.6,4,Lower,Midwest,IL,Rural,75+,2023-10,Q4_2023,2023,4.0,0.124,Increasing
FIA002193,2023-10-25,Metoprolol,Lopressor,Beta Blockers,37417-304-41,Medicaid Plan Y,PLAN_8812,2023,Tier 1,Tier 1,2023-04-30,178,No Change,None,No,No,,467,428,9.2,Increased,7.77,16.89,-9.12,130.7,138.47,64.67,0.0,0,0.046,0.082,0.848,0.701,11,3,16,8,3.8,28.8,2,Higher,Midwest,GA,Suburban,36-50,2023-10,Q4_2023,2023,5.2,0.939,Increasing
FIA001015,2023-11-05,Metoprolol,Lopressor,Beta Blockers,87679-282-31,Medicare Part D Plan B,PLAN_2902,2023,Specialty Tier,Tier 3,2022-12-28,312,Worsened,None,No,No,,207,201,3.3,Stable,123.31,82.34,40.97,166.51,289.82,59.99,0.0,0,0.094,0.275,0.272,0.556,8,8,3,9,2.3,5.2,2,Lower,West,IL,Rural,66-75,2023-11,Q4_2023,2023,9.1,0.581,Decreasing
FIA000974,2023-11-13,Metoprolol,Lopressor,Beta Blockers,40090-644-37,Commercial Plan Beta,PLAN_9743,2023,Tier 1,Tier 2,2023-03-03,255,Improved,None,No,No,,715,667,7.3,Increased,17.07,30.48,-13.41,31.24,48.31,34.54,0.0,0,0.044,0.18,0.482,0.504,3,3,13,12,2.9,27.2,2,Higher,Midwest,CA,Suburban,36-50,2023-11,Q4_2023,2023,5.1,0.055,Stable
FIA001767,2023-11-14,Metoprolol,Lopressor,Beta Blockers,72089-929-99,VA Plan,PLAN_2870,2023,Specialty Tier,Tier 1,2023-02-24,263,Worsened,Step Therapy,No,Yes,,185,281,-34.0,Decreased,285.84,17.97,267.87,72.96,358.8,66.38,0.0,0,0.289,0.212,0.234,0.58,6,0,1,10,4.7,20.6,4,Lower,Southwest,FL,Suburban,36-50,2023-11,Q4_2023,2023,3.4,0.391,Stable
FIA001050,2023-11-15,Metoprolol,Lopressor,Beta Blockers,93476-515-53,Commercial Plan Beta,PLAN_3048,2023,Specialty Tier,Non-Formulary,2023-06-30,138,Improved,Step Therapy,No,Yes,,887,814,9.1,Increased,181.45,563.45,-382.0,71.8,253.25,224.63,0.0,0,0.278,0.256,0.426,0.803,8,9,19,14,4.6,29.1,8,Lower,Southwest,CA,Suburban,18-35,2023-11,Q4_2023,2023,1.2,0.272,Stable
FIA000143,2023-11-25,Metoprolol,Lopressor,Beta Blockers,55523-924-66,Commercial Plan Beta,PLAN_1349,2023,Tier 1,Tier 1,2023-04-27,212,No Change,None,No,No,,838,910,-7.9,Decreased,14.67,15.52,-0.85,164.06,178.73,149.78,0.0,0,0.079,0.291,0.451,0.474,1,7,14,9,3.6,19.7,6,Lower,West,IL,Suburban,66-75,2023-11,Q4_2023,2023,3.5,0.831,Decreasing
FIA000217,2023-11-26,Metoprolol,Lopressor,Beta Blockers,91506-312-46,Medicare Part D Plan B,PLAN_8911,2023,Non-Formulary,Specialty Tier,2023-08-21,97,Worsened,Non-Formulary Status,No,No,,544,499,9.2,Increased,729.9,244.6,485.3,173.57,903.47,491.49,0.0,0,0.25,0.095,0.34,0.733,3,6,15,9,2.7,21.7,2,Similar,Midwest,IL,Rural,36-50,2023-11,Q4_2023,2023,2.6,0.859,Decreasing
FIA002733,2023-11-27,Metoprolol,Lopressor,Beta Blockers,51827-313-96,Medicaid Plan Y,PLAN_7201,2023,Tier 3,Specialty Tier,2023-01-20,311,Improved,Quantity Limit,No,No,90.0,98,100,-1.8,Stable,59.15,245.55,-186.4,114.11,173.26,16.98,0.0,0,0.024,0.103,0.675,0.939,12,7,19,11,4.4,28.1,3,Similar,Southwest,MI,Urban,75+,2023-11,Q4_2023,2023,4.0,0.288,Stable
FIA000214,2023-12-01,Metoprolol,Lopressor,Beta Blockers,11743-275-93,Tricare Standard,PLAN_8539,2023,Tier 2,Tier 2,2023-07-30,124,No Change,None,No,No,,392,365,7.4,Increased,22.35,49.47,-27.12,97.14,119.49,46.84,0.0,0,0.011,0.292,0.808,0.931,15,4,19,11,4.1,33.9,7,Similar,Midwest,TX,Urban,36-50,2023-12,Q4_2023,2023,1.1,0.112,Increasing
FIA002075,2023-12-01,Metoprolol,Lopressor,Beta Blockers,27826-113-76,Commercial Plan Alpha,PLAN_8488,2023,Non-Formulary,Tier 2,2022-12-14,352,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,279,818,-65.8,Decreased,415.36,23.42,391.94,159.72,575.08,160.45,0.0,0,0.272,0.266,0.376,0.517,8,8,0,15,2.8,17.1,6,Lower,Northeast,GA,Suburban,18-35,2023-12,Q4_2023,2023,1.9,0.478,Stable
FIA001243,2023-12-22,Metoprolol,Lopressor,Beta Blockers,63198-996-54,VA Plan,PLAN_4159,2023,Non-Formulary,Tier 1,2023-06-13,192,Worsened,Non-Formulary Status,No,No,,206,487,-57.7,Decreased,273.95,11.57,262.38,197.04,470.99,97.02,0.0,0,0.153,0.185,0.891,0.473,11,3,12,15,2.6,9.3,2,Higher,Southeast,FL,Suburban,51-65,2023-12,Q4_2023,2023,4.2,0.805,Increasing
FIA000855,2023-12-25,Metoprolol,Lopressor,Beta Blockers,11576-590-29,Tricare Standard,PLAN_3565,2023,Specialty Tier,Non-Formulary,2023-11-02,53,Improved,Prior Authorization; Step Therapy,Yes,Yes,,790,776,1.8,Stable,298.6,576.63,-278.03,119.08,417.68,329.97,0.18,1,0.17,0.303,0.888,0.462,9,7,4,6,3.4,15.6,4,Lower,Southwest,NC,Urban,18-35,2023-12,Q4_2023,2023,9.6,0.222,Stable
FIA002589,2023-12-27,Metoprolol,Lopressor,Beta Blockers,69179-192-91,Tricare Standard,PLAN_4684,2023,Tier 2,Tier 3,2023-09-15,103,Improved,Quantity Limit,No,No,90.0,1085,802,35.4,Increased,40.41,90.8,-50.39,94.55,134.96,146.43,0.0,0,0.03,0.382,0.644,0.773,11,7,17,14,2.5,25.3,2,Similar,Northeast,NC,Rural,75+,2023-12,Q4_2023,2023,8.0,0.614,Increasing
FIA000615,2024-01-06,Metoprolol,Lopressor,Beta Blockers,41361-707-24,Medicare Part D Plan A,PLAN_1055,2024,Tier 3,Tier 1,2023-08-23,136,Worsened,None,No,No,,95,121,-20.9,Decreased,88.07,5.03,83.04,98.56,186.63,17.73,0.0,0,0.06,0.231,0.6,0.828,2,1,8,3,3.2,5.1,6,Lower,Southwest,MI,Rural,36-50,2024-01,Q1_2024,2023,8.4,0.139,Stable
FIA001914,2024-01-13,Metoprolol,Lopressor,Beta Blockers,10815-635-95,Medicaid Plan Y,PLAN_8402,2024,Tier 3,Non-Formulary,2023-03-13,306,Improved,None,No,No,,768,742,3.6,Stable,81.38,582.51,-501.13,113.98,195.36,150.04,0.0,0,0.065,0.366,0.414,0.84,0,3,12,6,4.0,31.4,3,Higher,Southwest,OH,Urban,36-50,2024-01,Q1_2024,2023,5.5,0.916,Decreasing
FIA002818,2024-01-19,Metoprolol,Lopressor,Beta Blockers,20242-850-70,Medicaid Plan X,PLAN_3241,2024,Tier 1,Tier 2,2023-11-16,64,Improved,None,No,No,,149,149,0.0,Stable,15.98,26.58,-10.6,168.56,184.54,27.5,0.0,0,0.072,0.331,0.381,0.692,3,6,17,7,4.0,20.0,7,Similar,Southeast,OH,Urban,51-65,2024-01,Q1_2024,2023,7.5,0.293,Increasing
FIA001691,2024-01-20,Metoprolol,Lopressor,Beta Blockers,59173-552-95,Tricare Standard,PLAN_9522,2024,Tier 3,Tier 1,2023-08-17,156,Worsened,Step Therapy,No,Yes,,223,424,-47.3,Decreased,84.05,11.79,72.26,70.41,154.46,34.44,0.0,0,0.041,0.117,0.208,0.644,2,6,6,0,3.2,10.4,8,Similar,West,PA,Urban,75+,2024-01,Q1_2024,2023,7.3,0.836,Increasing
FIA000433,2024-01-21,Metoprolol,Lopressor,Beta Blockers,22108-730-99,Medicare Part D Plan A,PLAN_5102,2024,Tier 3,Specialty Tier,2023-10-03,110,Improved,Prior Authorization; Step Therapy,Yes,Yes,,762,760,0.3,Stable,58.43,270.73,-212.3,185.69,244.12,186.02,0.48,2,0.016,0.234,0.379,0.482,4,6,8,5,2.7,14.3,6,Lower,Southeast,TX,Rural,18-35,2024-01,Q1_2024,2023,6.2,0.783,Decreasing
FIA001936,2024-01-22,Metoprolol,Lopressor,Beta Blockers,57850-595-55,Commercial Plan Beta,PLAN_9317,2024,Specialty Tier,Specialty Tier,2023-04-14,283,No Change,Prior Authorization; Quantity Limit,Yes,No,30.0,147,149,-1.2,Stable,110.77,137.93,-27.16,151.7,262.47,38.58,0.575,6,0.144,0.321,0.517,0.54,6,7,2,3,3.4,28.1,8,Higher,West,IL,Rural,66-75,2024-01,Q1_2024,2023,6.6,0.688,Decreasing
FIA000675,2024-02-09,Metoprolol,Lopressor,Beta Blockers,82813-559-10,Commercial Plan Beta,PLAN_7361,2024,Tier 1,Tier 3,2023-09-14,148,Improved,None,No,No,,583,493,18.3,Increased,19.64,56.89,-37.25,93.57,113.21,66.0,0.0,0,0.011,0.231,0.234,0.91,1,6,7,1,3.2,12.2,8,Lower,Midwest,CA,Urban,75+,2024-02,Q1_2024,2023,9.0,0.088,Decreasing
FIA000399,2024-02-27,Metoprolol,Lopressor,Beta Blockers,30428-756-61,Commercial Plan Beta,PLAN_3468,2024,Non-Formulary,Specialty Tier,2023-10-28,122,Worsened,Non-Formulary Status,No,No,,303,311,-2.3,Stable,765.92,104.77,661.15,125.77,891.69,270.18,0.0,0,0.236,0.194,0.528,0.877,4,7,10,1,4.0,28.6,2,Lower,Northeast,CA,Suburban,18-35,2024-02,Q1_2024,2023,3.8,0.902,Increasing
FIA001163,2024-03-03,Metoprolol,Lopressor,Beta Blockers,83431-877-21,Medicare Part D Plan A,PLAN_9179,2024,Non-Formulary,Tier 3,2023-11-21,103,Worsened,Non-Formulary Status,No,No,,581,556,4.6,Stable,730.15,66.3,663.85,31.79,761.94,442.69,0.0,0,0.13,0.112,0.682,0.759,9,7,12,8,4.8,17.5,7,Lower,Southeast,OH,Urban,51-65,2024-03,Q1_2024,2023,6.5,0.639,Decreasing
FIA000016,2024-03-08,Metoprolol,Lopressor,Beta Blockers,80545-865-79,Commercial Plan Beta,PLAN_8999,2024,Non-Formulary,Tier 1,2023-04-19,324,Worsened,Non-Formulary Status,No,No,,299,460,-34.9,Decreased,428.23,5.09,423.14,172.07,600.3,179.49,0.0,0,0.273,0.127,0.505,0.416,10,10,12,5,4.5,32.6,6,Higher,Northeast,OH,Rural,75+,2024-03,Q1_2024,2023,7.0,0.084,Stable
FIA001878,2024-03-12,Metoprolol,Lopressor,Beta Blockers,82803-430-44,Medicare Part D Plan B,PLAN_5771,2024,Specialty Tier,Tier 2,2023-09-22,172,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,286,634,-54.8,Decreased,223.86,46.7,177.16,119.97,343.83,98.34,0.262,7,0.059,0.173,0.506,0.673,5,1,4,14,2.2,23.1,8,Similar,Southeast,OH,Urban,66-75,2024-03,Q1_2024,2023,2.1,0.419,Increasing
FIA000355,2024-03-27,Metoprolol,Lopressor,Beta Blockers,93211-425-22,Commercial Plan Beta,PLAN_4683,2024,Tier 2,Tier 3,2023-10-10,169,Improved,None,No,No,,1202,900,33.6,Increased,20.15,60.36,-40.21,131.84,151.99,182.69,0.0,0,0.029,0.056,0.427,0.435,9,9,14,13,3.9,14.9,5,Similar,West,CA,Suburban,51-65,2024-03,Q1_2024,2023,3.9,0.823,Increasing
FIA001563,2024-04-02,Metoprolol,Lopressor,Beta Blockers,38732-816-83,Commercial Plan Alpha,PLAN_5675,2024,Tier 2,Specialty Tier,2023-10-25,160,Improved,None,No,No,,1232,923,33.5,Increased,22.16,136.53,-114.37,75.38,97.54,120.17,0.0,0,0.032,0.169,0.62,0.798,0,4,4,8,2.1,33.6,5,Similar,Midwest,FL,Suburban,36-50,2024-04,Q2_2024,2023,9.4,0.699,Decreasing
FIA000684,2024-04-28,Metoprolol,Lopressor,Beta Blockers,16862-343-58,Medicare Part D Plan A,PLAN_6489,2024,Non-Formulary,Tier 1,2023-09-08,233,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,462,589,-21.4,Decreased,441.09,9.48,431.61,124.95,566.04,261.51,0.0,0,0.051,0.109,0.552,0.567,9,1,1,15,4.4,13.9,2,Lower,Southwest,PA,Urban,66-75,2024-04,Q2_2024,2023,5.3,0.759,Decreasing
FIA001261,2024-05-11,Metoprolol,Lopressor,Beta Blockers,51927-297-46,Tricare Standard,PLAN_9033,2024,Tier 3,Tier 2,2023-11-05,188,Worsened,Step Therapy,No,Yes,,409,881,-53.6,Decreased,91.6,39.39,52.21,40.35,131.95,53.97,0.0,0,0.074,0.285,0.384,0.445,13,0,5,11,4.1,31.3,3,Higher,West,NC,Rural,66-75,2024-05,Q2_2024,2023,4.1,0.6,Decreasing
FIA001809,2024-06-04,Metoprolol,Lopressor,Beta Blockers,49299-253-53,Commercial Plan Beta,PLAN_3646,2024,Non-Formulary,Specialty Tier,2023-12-04,183,Worsened,Non-Formulary Status,No,No,,925,963,-3.9,Stable,644.71,238.75,405.96,130.57,775.28,717.13,0.0,0,0.289,0.23,0.478,0.528,0,1,3,15,2.5,24.5,6,Higher,Southeast,CA,Urban,18-35,2024-06,Q2_2024,2023,7.3,0.81,Stable
FIA000707,2024-06-08,Metoprolol,Lopressor,Beta Blockers,94259-490-88,Medicaid Plan Y,PLAN_6832,2024,Tier 3,Tier 2,2023-10-30,222,Worsened,Prior Authorization,Yes,No,,333,492,-32.3,Decreased,90.68,23.3,67.38,154.96,245.64,81.8,0.392,10,0.063,0.315,0.648,0.667,14,6,8,2,2.9,6.3,3,Higher,Midwest,CA,Urban,51-65,2024-06,Q2_2024,2023,4.1,0.729,Increasing
FIA000942,2024-06-08,Metoprolol,Lopressor,Beta Blockers,84480-690-96,VA Plan,PLAN_5040,2024,Non-Formulary,Specialty Tier,2023-06-18,356,Worsened,Non-Formulary Status,No,No,,754,761,-0.8,Stable,602.66,107.36,495.3,178.04,780.7,588.65,0.0,0,0.168,0.1,0.609,0.798,2,0,7,10,2.6,9.4,5,Similar,Southeast,FL,Urban,51-65,2024-06,Q2_2024,2023,4.2,0.759,Increasing
FIA001189,2024-06-08,Metoprolol,Lopressor,Beta Blockers,70005-870-47,Commercial Plan Alpha,PLAN_5743,2024,Non-Formulary,Tier 3,2023-08-24,289,Worsened,Non-Formulary Status,No,No,,712,694,2.7,Stable,676.1,93.0,583.1,105.88,781.98,556.77,0.0,0,0.184,0.144,0.627,0.833,6,6,15,11,3.9,19.8,8,Higher,Southwest,OH,Rural,51-65,2024-06,Q2_2024,2023,7.4,0.604,Increasing
FIA000047,2024-06-19,Metoprolol,Lopressor,Beta Blockers,20494-435-94,Medicaid Plan X,PLAN_6021,2024,Specialty Tier,Tier 3,2024-02-15,125,Worsened,Prior Authorization,Yes,No,,919,916,0.4,Stable,199.24,74.88,124.36,84.61,283.85,260.86,0.511,8,0.186,0.261,0.498,0.779,11,7,1,11,3.8,18.0,7,Lower,Northeast,OH,Suburban,75+,2024-06,Q2_2024,2023,8.2,0.679,Increasing
FIA001394,2024-06-22,Metoprolol,Lopressor,Beta Blockers,71321-717-49,Tricare Standard,PLAN_7428,2024,Tier 2,Specialty Tier,2023-06-29,359,Improved,None,No,No,,1136,965,17.8,Increased,39.38,224.1,-184.72,162.25,201.63,229.05,0.0,0,0.034,0.314,0.273,0.793,8,2,18,0,2.0,13.6,6,Lower,Southwest,NC,Suburban,36-50,2024-06,Q2_2024,2023,8.6,0.295,Decreasing
FIA002015,2024-06-28,Metoprolol,Lopressor,Beta Blockers,91400-253-80,Medicaid Plan X,PLAN_3367,2024,Tier 1,Non-Formulary,2023-11-05,236,Improved,None,No,No,,318,211,50.8,Increased,16.32,475.22,-458.9,193.82,210.14,66.82,0.0,0,0.068,0.201,0.564,0.804,14,8,8,0,3.0,21.3,7,Lower,Southeast,CA,Suburban,18-35,2024-06,Q2_2024,2023,2.1,0.378,Stable
FIA002138,2024-06-30,Metoprolol,Lopressor,Beta Blockers,93615-766-34,Commercial Plan Beta,PLAN_6744,2024,Non-Formulary,Tier 1,2023-08-20,315,Worsened,Non-Formulary Status,No,No,,317,592,-46.4,Decreased,492.81,17.37,475.44,63.67,556.48,176.4,0.0,0,0.297,0.287,0.522,0.563,14,0,2,2,3.5,33.5,2,Lower,Southeast,OH,Urban,36-50,2024-06,Q2_2024,2023,4.5,0.481,Stable
FIA000511,2024-07-07,Metoprolol,Lopressor,Beta Blockers,19254-659-61,Medicaid Plan X,PLAN_5982,2024,Tier 2,Tier 1,2024-04-26,72,Worsened,Quantity Limit,No,No,30.0,905,848,6.7,Increased,49.28,19.44,29.84,168.6,217.88,197.18,0.0,0,0.046,0.106,0.284,0.921,11,8,16,7,3.7,18.2,6,Similar,Southwest,CA,Rural,36-50,2024-07,Q3_2024,2023,1.6,0.026,Decreasing
FIA001698,2024-07-07,Metoprolol,Lopressor,Beta Blockers,64805-508-62,Medicare Part D Plan B,PLAN_8643,2024,Tier 1,Tier 1,2023-08-22,320,No Change,None,No,No,,705,649,8.7,Increased,5.32,7.27,-1.95,58.53,63.85,45.01,0.0,0,0.024,0.246,0.556,0.681,12,4,9,2,3.2,34.2,5,Higher,Southwest,OH,Suburban,18-35,2024-07,Q3_2024,2023,2.3,0.732,Stable
FIA001726,2024-07-26,Metoprolol,Lopressor,Beta Blockers,45199-792-26,Medicaid Plan Y,PLAN_8355,2024,Tier 2,Specialty Tier,2024-03-02,146,Improved,None,No,No,,737,624,18.2,Increased,23.01,166.99,-143.98,172.93,195.94,144.41,0.0,0,0.041,0.26,0.881,0.577,1,6,8,4,4.2,20.8,3,Similar,West,NC,Suburban,75+,2024-07,Q3_2024,2023,5.5,0.485,Decreasing
FIA001093,2024-07-28,Metoprolol,Lopressor,Beta Blockers,32352-438-80,Medicaid Plan X,PLAN_7869,2024,Tier 2,Specialty Tier,2024-02-20,159,Improved,Quantity Limit,No,No,90.0,1104,844,30.9,Increased,36.8,249.9,-213.1,42.93,79.73,88.02,0.0,0,0.021,0.328,0.792,0.428,15,5,5,5,4.6,22.7,7,Lower,West,PA,Rural,66-75,2024-07,Q3_2024,2023,3.9,0.162,Decreasing
FIA001686,2024-07-30,Metoprolol,Lopressor,Beta Blockers,10752-797-58,Medicare Part D Plan B,PLAN_4583,2024,Tier 1,Specialty Tier,2024-01-23,189,Improved,None,No,No,,888,671,32.4,Increased,5.36,285.08,-279.72,74.34,79.7,70.77,0.0,0,0.05,0.215,0.626,0.693,5,3,14,12,2.3,21.8,4,Higher,West,NY,Urban,75+,2024-07,Q3_2024,2023,5.4,0.86,Stable
FIA002795,2024-08-08,Metoprolol,Lopressor,Beta Blockers,62194-781-74,Commercial Plan Beta,PLAN_9901,2024,Specialty Tier,Tier 2,2023-10-27,286,Worsened,Step Therapy,No,Yes,,248,397,-37.4,Decreased,288.89,26.79,262.1,153.83,442.72,109.79,0.0,0,0.151,0.343,0.21,0.424,5,6,16,13,3.2,19.6,4,Similar,Midwest,CA,Suburban,18-35,2024-08,Q3_2024,2023,1.1,0.953,Decreasing
FIA002871,2024-08-19,Metoprolol,Lopressor,Beta Blockers,31938-980-93,Commercial Plan Alpha,PLAN_7043,2024,Non-Formulary,Specialty Tier,2023-10-14,310,Worsened,Non-Formulary Status,No,No,,200,216,-7.3,Decreased,431.43,297.35,134.08,53.45,484.88,96.98,0.0,0,0.104,0.185,0.777,0.911,12,7,15,10,2.2,16.8,8,Similar,Southeast,CA,Urban,18-35,2024-08,Q3_2024,2023,5.5,0.15,Increasing
FIA000682,2024-08-27,Metoprolol,Lopressor,Beta Blockers,85396-196-42,Medicare Part D Plan A,PLAN_2069,2024,Tier 2,Non-Formulary,2024-05-08,111,Improved,None,No,No,,643,446,44.3,Increased,26.72,520.95,-494.23,61.0,87.72,56.4,0.0,0,0.027,0.198,0.332,0.819,5,8,8,9,2.4,33.8,5,Higher,Northeast,MI,Rural,75+,2024-08,Q3_2024,2023,2.3,0.608,Decreasing
FIA001740,2024-08-27,Metoprolol,Lopressor,Beta Blockers,54786-959-45,Commercial Plan Beta,PLAN_5987,2024,Tier 1,Non-Formulary,2023-10-31,301,Improved,None,No,No,,769,502,53.4,Increased,8.03,504.51,-496.48,82.97,91.0,69.98,0.0,0,0.037,0.255,0.279,0.814,4,4,11,10,3.4,13.6,5,Higher,Midwest,NY,Urban,36-50,2024-08,Q3_2024,2023,1.5,0.817,Increasing
FIA002565,2024-09-13,Metoprolol,Lopressor,Beta Blockers,79938-375-52,Tricare Standard,PLAN_6312,2024,Tier 3,Tier 3,2024-03-06,191,No Change,None,No,No,,729,764,-4.5,Stable,92.15,95.29,-3.14,68.13,160.28,116.84,0.0,0,0.052,0.149,0.261,0.431,13,7,17,6,5.0,19.6,5,Lower,Southwest,MI,Suburban,75+,2024-09,Q3_2024,2023,9.1,0.736,Stable
FIA001807,2024-09-25,Metoprolol,Lopressor,Beta Blockers,45813-313-52,Medicaid Plan Y,PLAN_2858,2024,Tier 2,Non-Formulary,2024-08-14,42,Improved,None,No,No,,387,297,30.3,Increased,43.11,487.58,-444.47,57.52,100.63,38.94,0.0,0,0.049,0.133,0.358,0.897,13,9,11,8,2.6,12.3,4,Similar,West,NY,Suburban,51-65,2024-09,Q3_2024,2023,2.1,0.617,Decreasing
FIA001262,2024-10-07,Metoprolol,Lopressor,Beta Blockers,39938-150-22,VA Plan,PLAN_5485,2024,Tier 3,Non-Formulary,2024-06-04,125,Improved,Step Therapy,No,Yes,,764,789,-3.1,Stable,52.97,634.18,-581.21,185.88,238.85,182.48,0.0,0,0.065,0.305,0.214,0.762,4,9,15,14,4.1,13.8,8,Similar,Southeast,NY,Rural,36-50,2024-10,Q4_2024,2024,6.3,0.309,Decreasing
FIA002210,2024-10-19,Metoprolol,Lopressor,Beta Blockers,10578-131-19,Medicaid Plan Y,PLAN_1018,2024,Tier 3,Tier 2,2024-07-01,110,Worsened,None,No,No,,148,308,-51.8,Decreased,78.91,49.59,29.32,129.72,208.63,30.88,0.0,0,0.018,0.127,0.592,0.54,0,3,1,5,2.4,25.2,3,Similar,Southeast,OH,Suburban,51-65,2024-10,Q4_2024,2024,4.3,0.425,Increasing
FIA001065,2024-11-04,Metoprolol,Lopressor,Beta Blockers,17863-781-64,Commercial Plan Beta,PLAN_3302,2024,Specialty Tier,Non-Formulary,2024-04-25,193,Improved,None,No,No,,775,716,8.3,Increased,233.73,263.85,-30.12,37.38,271.11,210.11,0.0,0,0.061,0.17,0.712,0.633,15,7,10,9,3.2,21.5,2,Similar,Southeast,NC,Rural,51-65,2024-11,Q4_2024,2024,9.7,0.654,Increasing
FIA002148,2024-11-10,Metoprolol,Lopressor,Beta Blockers,53118-368-19,Medicare Part D Plan B,PLAN_3953,2024,Tier 1,Tier 1,2024-01-08,307,No Change,None,No,No,,192,201,-4.3,Stable,13.03,17.66,-4.63,95.86,108.89,20.91,0.0,0,0.052,0.147,0.702,0.93,13,0,13,2,2.7,21.7,8,Higher,Northeast,GA,Rural,36-50,2024-11,Q4_2024,2024,7.7,0.624,Increasing
FIA000536,2024-11-20,Metoprolol,Lopressor,Beta Blockers,53553-146-29,Medicaid Plan Y,PLAN_7607,2024,Tier 2,Specialty Tier,2024-07-10,133,Improved,None,No,No,,229,184,24.6,Increased,44.14,262.19,-218.05,36.04,80.18,18.36,0.0,0,0.064,0.128,0.328,0.658,9,3,11,14,2.8,27.9,8,Lower,Midwest,FL,Suburban,75+,2024-11,Q4_2024,2024,1.5,0.862,Decreasing
FIA000363,2024-12-09,Metoprolol,Lopressor,Beta Blockers,80481-993-20,Medicare Part D Plan A,PLAN_8317,2024,Tier 2,Tier 2,2024-05-07,216,No Change,None,No,No,,219,201,9.0,Increased,39.93,31.95,7.98,173.92,213.85,46.83,0.0,0,0.077,0.248,0.374,0.541,5,10,7,7,4.1,18.7,2,Higher,Midwest,NC,Suburban,18-35,2024-12,Q4_2024,2024,7.7,0.733,Increasing
FIA000424,2024-12-11,Metoprolol,Lopressor,Beta Blockers,76468-349-27,Medicare Part D Plan B,PLAN_1395,2024,Tier 3,Non-Formulary,2024-09-18,84,Improved,Quantity Limit,No,No,30.0,552,546,1.1,Stable,70.93,220.12,-149.19,110.69,181.62,100.25,0.0,0,0.057,0.08,0.331,0.508,11,8,8,15,2.2,28.7,3,Higher,Southwest,TX,Rural,18-35,2024-12,Q4_2024,2024,3.1,0.147,Increasing
FIA002546,2024-12-18,Metoprolol,Lopressor,Beta Blockers,91900-558-88,Medicare Part D Plan B,PLAN_7655,2024,Specialty Tier,Specialty Tier,2024-05-26,206,No Change,Prior Authorization,Yes,No,,780,845,-7.6,Decreased,152.99,256.44,-103.45,172.36,325.35,253.77,0.321,2,0.115,0.219,0.256,0.84,5,7,13,7,4.7,5.4,8,Lower,Northeast,IL,Suburban,36-50,2024-12,Q4_2024,2024,7.6,0.295,Increasing
FIA000614,2024-12-19,Metoprolol,Lopressor,Beta Blockers,76828-547-44,Tricare Standard,PLAN_1640,2024,Tier 2,Specialty Tier,2024-01-13,341,Improved,None,No,No,,1180,953,23.9,Increased,48.86,225.07,-176.21,121.86,170.72,201.45,0.0,0,0.026,0.226,0.282,0.716,13,5,8,13,2.6,26.4,2,Lower,Northeast,FL,Urban,66-75,2024-12,Q4_2024,2024,7.2,0.743,Increasing
FIA001707,2024-12-19,Metoprolol,Lopressor,Beta Blockers,71284-443-56,VA Plan,PLAN_5804,2024,Specialty Tier,Specialty Tier,2024-03-07,287,No Change,Quantity Limit,No,No,60.0,465,482,-3.5,Stable,158.35,205.35,-47.0,118.84,277.19,128.89,0.0,0,0.16,0.389,0.607,0.672,10,0,2,6,2.4,15.8,7,Similar,Southwest,PA,Rural,51-65,2024-12,Q4_2024,2024,2.2,0.187,Increasing
FIA001246,2025-01-22,Metoprolol,Lopressor,Beta Blockers,75716-433-10,Tricare Standard,PLAN_3683,2025,Tier 3,Specialty Tier,2024-07-08,198,Improved,None,No,No,,656,655,0.2,Stable,64.94,141.95,-77.01,116.79,181.73,119.21,0.0,0,0.037,0.171,0.357,0.407,4,8,11,2,3.0,16.1,2,Lower,Southeast,IL,Urban,51-65,2025-01,Q1_2025,2024,5.2,0.092,Stable
FIA000420,2025-01-28,Metoprolol,Lopressor,Beta Blockers,10078-912-74,Medicare Part D Plan B,PLAN_9113,2025,Specialty Tier,Non-Formulary,2024-06-11,231,Improved,None,No,No,,536,517,3.8,Stable,143.81,410.68,-266.87,158.06,301.87,161.8,0.0,0,0.223,0.101,0.251,0.923,7,6,9,6,3.6,7.9,8,Lower,Northeast,CA,Urban,51-65,2025-01,Q1_2025,2024,2.1,0.186,Decreasing
FIA001834,2025-02-12,Metoprolol,Lopressor,Beta Blockers,65522-428-65,Tricare Standard,PLAN_1804,2025,Specialty Tier,Tier 1,2024-04-21,297,Worsened,None,No,No,,254,441,-42.4,Decreased,191.85,16.12,175.73,112.62,304.47,77.34,0.0,0,0.156,0.286,0.568,0.637,15,8,17,10,2.4,17.8,3,Lower,Southeast,NC,Suburban,36-50,2025-02,Q1_2025,2024,6.9,0.366,Decreasing
FIA000945,2025-02-16,Metoprolol,Lopressor,Beta Blockers,90787-786-12,Commercial Plan Beta,PLAN_9120,2025,Non-Formulary,Tier 2,2024-05-22,270,Worsened,Non-Formulary Status,No,No,,246,745,-67.0,Decreased,508.46,38.42,470.04,165.14,673.6,165.71,0.0,0,0.298,0.084,0.49,0.903,11,10,17,3,2.0,15.5,5,Lower,Midwest,OH,Suburban,75+,2025-02,Q1_2025,2024,8.5,0.255,Stable
FIA000934,2025-02-21,Metoprolol,Lopressor,Beta Blockers,73317-685-84,Medicare Part D Plan A,PLAN_7702,2025,Tier 1,Tier 2,2024-08-01,204,Improved,None,No,No,,183,197,-6.9,Decreased,8.63,30.03,-21.4,58.22,66.85,12.23,0.0,0,0.021,0.283,0.488,0.411,13,5,6,6,4.5,24.4,4,Similar,Northeast,OH,Suburban,66-75,2025-02,Q1_2025,2024,7.8,0.669,Increasing
FIA002176,2025-03-12,Metoprolol,Lopressor,Beta Blockers,42883-430-43,Medicare Part D Plan A,PLAN_8123,2025,Tier 1,Non-Formulary,2024-08-12,212,Improved,None,No,No,,1022,680,50.3,Increased,16.38,413.16,-396.78,154.03,170.41,174.16,0.0,0,0.056,0.163,0.703,0.673,4,9,4,9,2.2,23.4,6,Similar,Southwest,OH,Urban,18-35,2025-03,Q1_2025,2024,8.8,0.868,Stable
FIA000667,2025-03-13,Metoprolol,Lopressor,Beta Blockers,14450-764-57,VA Plan,PLAN_9748,2025,Specialty Tier,Specialty Tier,2024-07-07,249,No Change,Step Therapy; Quantity Limit,No,Yes,30.0,802,737,8.9,Increased,221.73,260.08,-38.35,122.68,344.41,276.22,0.0,0,0.257,0.358,0.26,0.762,7,10,0,14,3.8,17.3,6,Similar,West,IL,Suburban,36-50,2025-03,Q1_2025,2024,7.8,0.652,Decreasing
FIA001357,2025-03-13,Metoprolol,Lopressor,Beta Blockers,93402-531-74,Medicare Part D Plan A,PLAN_9965,2025,Specialty Tier,Tier 3,2024-10-27,137,Worsened,Prior Authorization,Yes,No,,424,429,-1.1,Stable,292.88,82.88,210.0,159.1,451.98,191.64,0.597,5,0.276,0.199,0.62,0.407,3,5,20,3,2.4,11.3,8,Lower,Midwest,FL,Suburban,75+,2025-03,Q1_2025,2024,6.8,0.684,Stable
FIA001248,2025-03-16,Metoprolol,Lopressor,Beta Blockers,16348-484-16,Medicaid Plan Y,PLAN_7762,2025,Non-Formulary,Tier 3,2024-06-30,259,Worsened,Non-Formulary Status,No,No,,682,726,-5.9,Decreased,335.68,73.27,262.41,64.62,400.3,273.0,0.0,0,0.095,0.12,0.768,0.641,4,4,3,6,3.4,23.3,4,Higher,Northeast,FL,Rural,51-65,2025-03,Q1_2025,2024,5.8,0.814,Decreasing
FIA001057,2025-03-17,Metoprolol,Lopressor,Beta Blockers,90953-542-41,Commercial Plan Beta,PLAN_9890,2025,Non-Formulary,Tier 2,2024-03-20,362,Worsened,Non-Formulary Status,No,No,,90,191,-52.8,Decreased,501.0,41.38,459.62,192.39,693.39,62.41,0.0,0,0.292,0.299,0.603,0.791,13,10,8,2,3.4,21.0,3,Similar,Southwest,CA,Rural,18-35,2025-03,Q1_2025,2024,6.4,0.75,Increasing
FIA000182,2025-03-20,Metoprolol,Lopressor,Beta Blockers,22844-563-73,Commercial Plan Beta,PLAN_2361,2025,Tier 1,Specialty Tier,2025-01-27,52,Improved,None,No,No,,1221,887,37.7,Increased,5.6,194.13,-188.53,167.65,173.25,211.54,0.0,0,0.038,0.245,0.209,0.802,6,2,11,9,2.7,35.0,2,Similar,Midwest,FL,Rural,66-75,2025-03,Q1_2025,2024,8.7,0.747,Increasing
FIA001270,2025-03-24,Metoprolol,Lopressor,Beta Blockers,51583-299-21,Medicare Part D Plan B,PLAN_6700,2025,Tier 2,Specialty Tier,2024-09-29,176,Improved,None,No,No,,1102,893,23.4,Increased,40.27,258.69,-218.42,133.87,174.14,191.9,0.0,0,0.046,0.107,0.382,0.836,15,2,0,14,3.0,23.1,7,Lower,Midwest,PA,Suburban,75+,2025-03,Q1_2025,2024,3.4,0.783,Increasing
FIA002080,2025-04-09,Metoprolol,Lopressor,Beta Blockers,29056-219-66,Medicaid Plan Y,PLAN_8721,2025,Specialty Tier,Specialty Tier,2024-04-15,359,No Change,None,No,No,,229,242,-5.2,Decreased,192.4,137.63,54.77,154.3,346.7,79.39,0.0,0,0.281,0.106,0.318,0.796,0,4,7,12,3.8,18.2,7,Similar,Southeast,NY,Rural,18-35,2025-04,Q2_2025,2024,7.8,0.649,Stable
FIA002281,2025-05-05,Metoprolol,Lopressor,Beta Blockers,54071-383-74,Commercial Plan Alpha,PLAN_6224,2025,Tier 3,Specialty Tier,2024-09-12,235,Improved,None,No,No,,803,833,-3.5,Stable,85.28,161.09,-75.81,73.27,158.55,127.32,0.0,0,0.029,0.283,0.863,0.6,2,1,11,9,4.4,32.5,5,Higher,Midwest,CA,Rural,51-65,2025-05,Q2_2025,2024,4.8,0.957,Stable
FIA001086,2025-05-06,Metoprolol,Lopressor,Beta Blockers,57203-345-10,Medicare Part D Plan A,PLAN_8613,2025,Non-Formulary,Specialty Tier,2025-01-08,118,Worsened,Non-Formulary Status,No,No,,405,430,-5.7,Decreased,351.91,245.69,106.22,168.04,519.95,210.58,0.0,0,0.211,0.161,0.283,0.603,2,8,7,8,3.4,22.1,7,Lower,Northeast,IL,Suburban,75+,2025-05,Q2_2025,2024,2.5,0.324,Increasing
FIA002960,2025-05-07,Metoprolol,Lopressor,Beta Blockers,78433-687-39,VA Plan,PLAN_2626,2025,Tier 2,Tier 3,2024-10-07,212,Improved,None,No,No,,980,737,33.1,Increased,21.4,50.21,-28.81,155.11,176.51,172.98,0.0,0,0.072,0.188,0.824,0.469,5,7,20,1,2.1,10.3,2,Similar,Southwest,MI,Suburban,36-50,2025-05,Q2_2025,2024,7.9,0.221,Decreasing
FIA002590,2025-05-08,Metoprolol,Lopressor,Beta Blockers,53650-614-72,Tricare Standard,PLAN_1243,2025,Tier 2,Non-Formulary,2025-01-12,116,Improved,None,No,No,,623,483,29.1,Increased,37.37,324.77,-287.4,162.99,200.36,124.82,0.0,0,0.026,0.366,0.296,0.437,8,4,13,9,2.3,17.7,2,Higher,Southwest,OH,Rural,51-65,2025-05,Q2_2025,2024,4.0,0.312,Increasing
FIA002081,2025-05-19,Metoprolol,Lopressor,Beta Blockers,68912-890-50,Commercial Plan Beta,PLAN_9123,2025,Tier 1,Non-Formulary,2025-03-08,72,Improved,None,No,No,,779,651,19.7,Increased,12.84,544.02,-531.18,149.3,162.14,126.31,0.0,0,0.032,0.351,0.822,0.538,3,0,5,6,2.7,16.6,3,Higher,Southwest,PA,Urban,18-35,2025-05,Q2_2025,2024,4.5,0.604,Stable
FIA001829,2025-05-20,Metoprolol,Lopressor,Beta Blockers,75040-160-47,Tricare Standard,PLAN_4790,2025,Non-Formulary,Specialty Tier,2025-03-28,53,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,275,265,4.1,Stable,333.08,284.22,48.86,157.41,490.49,134.88,0.0,0,0.187,0.157,0.414,0.854,6,10,9,12,2.8,12.7,5,Similar,West,TX,Urban,18-35,2025-05,Q2_2025,2024,1.7,0.07,Stable
FIA001553,2025-06-01,Metoprolol,Lopressor,Beta Blockers,52734-165-92,Tricare Standard,PLAN_5566,2025,Non-Formulary,Tier 2,2024-07-31,305,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,445,686,-35.0,Decreased,587.77,29.58,558.19,58.43,646.2,287.56,0.0,0,0.191,0.163,0.618,0.742,14,5,12,11,2.9,9.9,8,Higher,West,IL,Suburban,36-50,2025-06,Q2_2025,2024,5.8,0.428,Stable
FIA001048,2025-06-05,Metoprolol,Lopressor,Beta Blockers,88333-634-28,Medicaid Plan X,PLAN_5044,2025,Tier 3,Tier 2,2024-09-16,262,Worsened,Step Therapy,No,Yes,,173,263,-33.9,Decreased,73.64,22.17,51.47,144.88,218.52,37.8,0.0,0,0.029,0.395,0.507,0.408,14,0,9,1,3.4,22.7,5,Similar,Northeast,NC,Suburban,51-65,2025-06,Q2_2025,2024,4.5,0.58,Stable
FIA000056,2025-06-06,Metoprolol,Lopressor,Beta Blockers,98587-890-97,Medicaid Plan X,PLAN_8932,2025,Specialty Tier,Tier 1,2025-02-26,100,Worsened,Step Therapy,No,Yes,,436,778,-43.9,Decreased,203.74,13.41,190.33,122.87,326.61,142.4,0.0,0,0.183,0.117,0.373,0.707,7,4,9,6,4.1,19.7,5,Similar,West,PA,Suburban,18-35,2025-06,Q2_2025,2024,6.2,0.543,Stable
FIA000541,2025-06-10,Metoprolol,Lopressor,Beta Blockers,99918-680-53,Commercial Plan Alpha,PLAN_1748,2025,Tier 1,Tier 2,2024-06-11,364,Improved,None,No,No,,303,278,9.2,Increased,10.05,38.46,-28.41,184.58,194.63,58.97,0.0,0,0.063,0.176,0.249,0.433,15,9,18,0,3.9,16.9,5,Higher,Northeast,TX,Rural,66-75,2025-06,Q2_2025,2024,7.5,0.478,Increasing
FIA001654,2025-06-14,Metoprolol,Lopressor,Beta Blockers,25284-845-21,Tricare Standard,PLAN_5023,2025,Non-Formulary,Tier 2,2025-04-17,58,Worsened,Non-Formulary Status,No,No,,500,745,-32.8,Decreased,453.0,34.13,418.87,148.73,601.73,300.87,0.0,0,0.288,0.076,0.254,0.737,3,0,8,12,2.1,29.6,3,Higher,Northeast,PA,Rural,51-65,2025-06,Q2_2025,2024,8.5,0.898,Decreasing
FIA002366,2025-06-25,Metoprolol,Lopressor,Beta Blockers,97346-128-14,Medicare Part D Plan B,PLAN_3820,2025,Specialty Tier,Specialty Tier,2025-04-21,65,No Change,Prior Authorization; Step Therapy,Yes,Yes,,763,823,-7.2,Decreased,148.39,168.57,-20.18,107.69,256.08,195.39,0.317,9,0.215,0.066,0.441,0.799,10,1,14,5,4.0,13.1,6,Higher,West,NC,Urban,36-50,2025-06,Q2_2025,2024,7.3,0.115,Decreasing
FIA000845,2025-06-29,Metoprolol,Lopressor,Beta Blockers,98650-763-15,Commercial Plan Alpha,PLAN_1768,2025,Specialty Tier,Non-Formulary,2024-09-19,283,Improved,None,No,No,,471,485,-2.8,Stable,132.96,784.69,-651.73,182.04,315.0,148.37,0.0,0,0.127,0.317,0.358,0.91,0,10,9,4,2.9,22.4,5,Lower,Northeast,CA,Rural,51-65,2025-06,Q2_2025,2024,1.1,0.066,Decreasing
FIA001735,2025-07-03,Metoprolol,Lopressor,Beta Blockers,49332-194-73,Medicaid Plan Y,PLAN_9993,2025,Tier 3,Tier 3,2025-04-01,93,No Change,None,No,No,,296,308,-3.9,Stable,50.29,97.33,-47.04,131.68,181.97,53.86,0.0,0,0.02,0.142,0.724,0.424,6,9,4,6,2.2,23.1,4,Similar,Northeast,MI,Urban,18-35,2025-07,Q3_2025,2024,3.6,0.24,Decreasing
FIA002520,2025-07-10,Metoprolol,Lopressor,Beta Blockers,46664-579-24,Medicare Part D Plan A,PLAN_8741,2025,Tier 1,Specialty Tier,2025-04-18,83,Improved,Quantity Limit,No,No,30.0,575,454,26.7,Increased,12.88,166.44,-153.56,149.97,162.85,93.64,0.0,0,0.071,0.336,0.819,0.597,10,5,3,1,3.4,14.9,4,Higher,Midwest,GA,Urban,36-50,2025-07,Q3_2025,2024,5.4,0.559,Increasing
FIA000718,2025-07-15,Metoprolol,Lopressor,Beta Blockers,48290-680-68,Medicare Part D Plan B,PLAN_7717,2025,Tier 3,Tier 1,2025-02-25,140,Worsened,None,No,No,,232,617,-62.3,Decreased,69.77,13.59,56.18,184.88,254.65,59.08,0.0,0,0.039,0.208,0.671,0.626,7,3,10,7,3.8,6.0,5,Lower,Southeast,IL,Rural,18-35,2025-07,Q3_2025,2024,2.0,0.776,Increasing
FIA000789,2025-07-21,Metoprolol,Lopressor,Beta Blockers,65305-390-51,Commercial Plan Beta,PLAN_6287,2025,Non-Formulary,Non-Formulary,2024-12-12,221,No Change,Non-Formulary Status,No,No,,631,591,6.9,Increased,565.27,727.48,-162.21,183.73,749.0,472.62,0.0,0,0.157,0.26,0.788,0.659,10,0,8,14,2.4,21.5,3,Lower,Northeast,MI,Rural,51-65,2025-07,Q3_2025,2024,3.5,0.55,Stable
FIA001366,2025-07-22,Metoprolol,Lopressor,Beta Blockers,37214-386-97,VA Plan,PLAN_1033,2025,Tier 1,Tier 2,2024-09-27,298,Improved,None,No,No,,440,489,-9.9,Decreased,16.15,21.33,-5.18,76.55,92.7,40.79,0.0,0,0.068,0.114,0.9,0.888,12,3,7,11,3.2,7.2,5,Higher,Southeast,MI,Rural,66-75,2025-07,Q3_2025,2024,1.3,0.171,Increasing
FIA001658,2025-07-29,Metoprolol,Lopressor,Beta Blockers,67855-753-95,Commercial Plan Beta,PLAN_1987,2025,Tier 2,Tier 3,2024-09-10,322,Improved,Quantity Limit,No,No,90.0,677,552,22.8,Increased,43.35,91.8,-48.45,164.98,208.33,141.04,0.0,0,0.068,0.247,0.369,0.736,6,4,12,12,2.5,26.4,4,Lower,West,TX,Rural,18-35,2025-07,Q3_2025,2024,7.8,0.783,Decreasing
FIA000074,2025-07-30,Metoprolol,Lopressor,Beta Blockers,23886-110-22,Medicaid Plan X,PLAN_4637,2025,Tier 1,Tier 1,2025-02-23,157,No Change,Quantity Limit,No,No,30.0,779,762,2.3,Stable,14.86,10.33,4.53,165.36,180.22,140.39,0.0,0,0.033,0.206,0.474,0.825,4,5,0,15,2.3,17.5,2,Lower,Southeast,IL,Suburban,51-65,2025-07,Q3_2025,2024,5.1,0.207,Stable
FIA002522,2025-08-04,Metoprolol,Lopressor,Beta Blockers,60258-565-29,Tricare Standard,PLAN_2837,2025,Non-Formulary,Non-Formulary,2024-10-11,297,No Change,Non-Formulary Status,No,No,,798,769,3.9,Stable,741.23,536.1,205.13,129.81,871.04,695.09,0.0,0,0.18,0.231,0.862,0.846,2,4,13,7,4.8,27.6,6,Lower,West,CA,Suburban,66-75,2025-08,Q3_2025,2024,6.3,0.435,Increasing
FIA000680,2025-08-09,Metoprolol,Lopressor,Beta Blockers,26129-667-40,Commercial Plan Beta,PLAN_6280,2025,Non-Formulary,Non-Formulary,2024-10-11,302,No Change,Non-Formulary Status,No,No,,435,407,7.0,Increased,438.72,778.65,-339.93,96.02,534.74,232.61,0.0,0,0.157,0.3,0.546,0.745,14,6,17,0,3.1,19.1,8,Lower,Southeast,GA,Suburban,18-35,2025-08,Q3_2025,2024,5.9,0.244,Increasing
FIA001258,2025-08-17,Metoprolol,Lopressor,Beta Blockers,83342-419-35,Tricare Standard,PLAN_2297,2025,Tier 3,Specialty Tier,2024-08-20,362,Improved,Prior Authorization,Yes,No,,664,676,-1.8,Stable,75.05,184.25,-109.2,124.29,199.34,132.36,0.286,5,0.029,0.341,0.606,0.626,15,3,20,11,2.0,17.0,2,Higher,Northeast,FL,Suburban,66-75,2025-08,Q3_2025,2024,8.8,0.855,Decreasing
FIA001883,2022-01-13,Omeprazole,Prilosec,Proton Pump Inhibitors,27712-942-57,Medicaid Plan Y,PLAN_5757,2022,Specialty Tier,Specialty Tier,2021-08-02,164,No Change,Prior Authorization; Quantity Limit,Yes,No,60.0,325,297,9.6,Increased,216.88,238.83,-21.95,56.48,273.36,88.84,0.227,3,0.13,0.109,0.439,0.877,2,4,2,7,4.3,27.1,3,Similar,Midwest,NC,Suburban,18-35,2022-01,Q1_2022,2021,3.1,0.735,Decreasing
FIA001566,2022-01-16,Omeprazole,Prilosec,Proton Pump Inhibitors,40918-171-22,Medicaid Plan Y,PLAN_2498,2022,Tier 2,Tier 3,2021-06-05,225,Improved,None,No,No,,510,378,35.0,Increased,37.26,90.39,-53.13,62.44,99.7,50.85,0.0,0,0.073,0.258,0.552,0.736,9,2,4,13,4.0,10.9,4,Similar,Southeast,CA,Rural,75+,2022-01,Q1_2022,2021,1.3,0.206,Decreasing
FIA002077,2022-01-23,Omeprazole,Prilosec,Proton Pump Inhibitors,63441-117-46,VA Plan,PLAN_3568,2022,Specialty Tier,Tier 2,2021-11-20,64,Worsened,Step Therapy,No,Yes,,82,127,-35.4,Decreased,283.35,37.2,246.15,52.53,335.88,27.54,0.0,0,0.125,0.07,0.747,0.675,9,3,4,5,2.3,27.9,3,Similar,Southeast,MI,Rural,66-75,2022-01,Q1_2022,2021,4.8,0.504,Decreasing
FIA000663,2022-02-03,Omeprazole,Prilosec,Proton Pump Inhibitors,35897-230-39,VA Plan,PLAN_1629,2022,Specialty Tier,Tier 3,2021-04-18,291,Worsened,Prior Authorization,Yes,No,,1038,995,4.3,Stable,209.36,55.94,153.42,55.89,265.25,275.33,0.57,7,0.15,0.191,0.525,0.827,13,4,18,2,2.4,22.4,6,Similar,Southeast,FL,Rural,18-35,2022-02,Q1_2022,2021,9.6,0.186,Decreasing
FIA001025,2022-02-08,Omeprazole,Prilosec,Proton Pump Inhibitors,21435-558-15,Commercial Plan Alpha,PLAN_9483,2022,Specialty Tier,Tier 3,2021-04-04,310,Worsened,None,No,No,,719,793,-9.3,Decreased,290.37,85.76,204.61,34.04,324.41,233.25,0.0,0,0.227,0.142,0.496,0.634,15,8,14,6,2.6,6.9,6,Higher,West,GA,Urban,36-50,2022-02,Q1_2022,2021,7.0,0.963,Stable
FIA001272,2022-03-04,Omeprazole,Prilosec,Proton Pump Inhibitors,64296-539-19,VA Plan,PLAN_7593,2022,Tier 1,Non-Formulary,2021-06-25,252,Improved,None,No,No,,770,588,31.0,Increased,11.79,798.33,-786.54,156.11,167.9,129.28,0.0,0,0.029,0.305,0.68,0.838,2,5,1,8,2.7,34.8,8,Lower,Northeast,FL,Suburban,51-65,2022-03,Q1_2022,2021,4.1,0.378,Stable
FIA000168,2022-03-05,Omeprazole,Prilosec,Proton Pump Inhibitors,30220-395-95,Commercial Plan Alpha,PLAN_3200,2022,Specialty Tier,Non-Formulary,2021-07-17,231,Improved,Prior Authorization,Yes,No,,502,515,-2.4,Stable,225.04,627.06,-402.02,172.79,397.83,199.71,0.292,1,0.281,0.075,0.211,0.797,15,10,13,4,2.3,24.3,5,Similar,West,OH,Rural,36-50,2022-03,Q1_2022,2021,5.1,0.424,Stable
FIA000923,2022-03-05,Omeprazole,Prilosec,Proton Pump Inhibitors,62768-711-60,VA Plan,PLAN_5023,2022,Non-Formulary,Non-Formulary,2021-07-24,224,No Change,Non-Formulary Status,No,No,,523,534,-2.0,Stable,715.83,323.46,392.37,133.28,849.11,444.08,0.0,0,0.136,0.351,0.296,0.821,6,7,1,0,3.5,27.3,4,Higher,Northeast,CA,Rural,66-75,2022-03,Q1_2022,2021,8.8,0.066,Decreasing
FIA001954,2022-03-09,Omeprazole,Prilosec,Proton Pump Inhibitors,91604-949-69,Medicare Part D Plan A,PLAN_1153,2022,Tier 1,Specialty Tier,2021-10-25,135,Improved,None,No,No,,475,339,40.3,Increased,18.82,246.77,-227.95,41.13,59.95,28.48,0.0,0,0.07,0.302,0.852,0.759,12,1,13,0,2.2,20.6,3,Similar,Southwest,IL,Suburban,18-35,2022-03,Q1_2022,2021,7.7,0.298,Decreasing
FIA000569,2022-03-18,Omeprazole,Prilosec,Proton Pump Inhibitors,13589-244-55,Medicare Part D Plan B,PLAN_3234,2022,Tier 1,Tier 1,2021-09-15,184,No Change,None,No,No,,401,411,-2.4,Stable,9.17,11.49,-2.32,126.32,135.49,54.33,0.0,0,0.053,0.323,0.343,0.875,10,6,11,12,2.6,22.5,7,Higher,Southwest,CA,Rural,66-75,2022-03,Q1_2022,2021,9.7,0.079,Decreasing
FIA001008,2022-03-18,Omeprazole,Prilosec,Proton Pump Inhibitors,59009-337-40,Medicaid Plan Y,PLAN_6431,2022,Tier 1,Tier 2,2021-05-08,314,Improved,None,No,No,,440,428,2.8,Stable,12.18,26.5,-14.32,163.1,175.28,77.12,0.0,0,0.062,0.112,0.683,0.429,8,8,15,8,3.4,8.7,3,Higher,Southeast,OH,Rural,75+,2022-03,Q1_2022,2021,2.8,0.746,Increasing
FIA001577,2022-03-19,Omeprazole,Prilosec,Proton Pump Inhibitors,66575-339-50,Tricare Standard,PLAN_9470,2022,Specialty Tier,Specialty Tier,2021-11-28,111,No Change,Prior Authorization; Quantity Limit,Yes,No,,450,442,2.0,Stable,135.04,270.61,-135.57,89.49,224.53,101.04,0.498,2,0.103,0.194,0.751,0.553,13,6,16,8,4.4,8.2,3,Lower,West,CA,Urban,18-35,2022-03,Q1_2022,2021,9.0,0.832,Decreasing
FIA002141,2022-03-19,Omeprazole,Prilosec,Proton Pump Inhibitors,38516-230-21,Commercial Plan Beta,PLAN_4773,2022,Tier 2,Non-Formulary,2021-12-05,104,Improved,None,No,No,,408,277,47.4,Increased,43.54,375.1,-331.56,155.19,198.73,81.08,0.0,0,0.048,0.318,0.819,0.756,9,2,19,10,3.1,10.7,8,Lower,West,NY,Rural,18-35,2022-03,Q1_2022,2021,6.2,0.871,Stable
FIA002616,2022-03-30,Omeprazole,Prilosec,Proton Pump Inhibitors,71751-217-45,Medicare Part D Plan B,PLAN_6976,2022,Tier 2,Non-Formulary,2021-06-21,282,Improved,None,No,No,,1545,969,59.5,Increased,43.39,267.87,-224.48,94.59,137.98,213.18,0.0,0,0.037,0.367,0.693,0.501,3,0,15,7,4.3,25.2,4,Higher,Southeast,TX,Urban,66-75,2022-03,Q1_2022,2021,2.4,0.085,Decreasing
FIA001640,2022-04-07,Omeprazole,Prilosec,Proton Pump Inhibitors,92750-188-57,Medicaid Plan Y,PLAN_9733,2022,Tier 3,Tier 2,2021-11-16,142,Worsened,Step Therapy,No,Yes,,222,457,-51.2,Decreased,70.08,26.68,43.4,192.8,262.88,58.36,0.0,0,0.029,0.387,0.852,0.755,13,6,7,3,5.0,24.5,7,Lower,West,GA,Urban,66-75,2022-04,Q2_2022,2021,2.0,0.343,Increasing
FIA000592,2022-04-08,Omeprazole,Prilosec,Proton Pump Inhibitors,62542-938-57,Commercial Plan Alpha,PLAN_5929,2022,Tier 3,Tier 3,2021-10-05,185,No Change,None,No,No,,728,715,1.9,Stable,97.48,62.6,34.88,183.41,280.89,204.49,0.0,0,0.04,0.379,0.464,0.833,4,1,10,11,3.8,18.1,5,Lower,Midwest,OH,Urban,36-50,2022-04,Q2_2022,2021,9.5,0.181,Decreasing
FIA002242,2022-04-08,Omeprazole,Prilosec,Proton Pump Inhibitors,37199-728-90,Tricare Standard,PLAN_5759,2022,Tier 3,Tier 3,2022-02-09,58,No Change,Prior Authorization,Yes,No,,1014,963,5.3,Increased,83.81,77.26,6.55,78.33,162.14,164.41,0.3,3,0.064,0.102,0.543,0.726,7,0,9,4,2.3,14.6,6,Lower,Southeast,NY,Urban,18-35,2022-04,Q2_2022,2021,2.9,0.884,Increasing
FIA001096,2022-04-09,Omeprazole,Prilosec,Proton Pump Inhibitors,17106-780-33,Medicare Part D Plan A,PLAN_4263,2022,Tier 2,Tier 2,2022-02-07,61,No Change,None,No,No,,355,388,-8.3,Decreased,35.14,31.21,3.93,177.05,212.19,75.33,0.0,0,0.056,0.081,0.53,0.704,1,2,2,1,3.7,32.9,5,Higher,Southwest,GA,Suburban,66-75,2022-04,Q2_2022,2021,5.1,0.853,Stable
FIA002972,2022-04-10,Omeprazole,Prilosec,Proton Pump Inhibitors,27140-493-92,Medicare Part D Plan B,PLAN_2793,2022,Tier 2,Specialty Tier,2021-07-08,276,Improved,Quantity Limit,No,No,30.0,902,621,45.3,Increased,37.39,148.84,-111.45,158.21,195.6,176.43,0.0,0,0.037,0.279,0.602,0.798,4,8,6,5,3.0,34.4,7,Similar,Midwest,PA,Suburban,66-75,2022-04,Q2_2022,2021,6.2,0.371,Increasing
FIA000156,2022-04-11,Omeprazole,Prilosec,Proton Pump Inhibitors,94685-562-21,Medicare Part D Plan B,PLAN_3945,2022,Tier 3,Specialty Tier,2021-08-21,233,Improved,Step Therapy,No,Yes,,388,392,-0.8,Stable,94.22,254.74,-160.52,108.81,203.03,78.78,0.0,0,0.073,0.323,0.856,0.783,4,6,13,10,3.4,10.4,6,Higher,Southeast,GA,Urban,51-65,2022-04,Q2_2022,2021,3.9,0.649,Decreasing
FIA000116,2022-04-26,Omeprazole,Prilosec,Proton Pump Inhibitors,98542-857-81,Commercial Plan Beta,PLAN_7371,2022,Tier 3,Tier 2,2021-11-01,176,Worsened,Step Therapy,No,Yes,,74,163,-54.5,Decreased,84.17,24.39,59.78,47.42,131.59,9.74,0.0,0,0.067,0.133,0.749,0.839,9,10,1,12,3.2,33.7,7,Similar,West,CA,Urban,51-65,2022-04,Q2_2022,2021,2.8,0.869,Stable
FIA001515,2022-04-29,Omeprazole,Prilosec,Proton Pump Inhibitors,64804-734-82,VA Plan,PLAN_4590,2022,Tier 1,Tier 3,2022-02-25,63,Improved,None,No,No,,643,488,31.8,Increased,8.12,88.21,-80.09,84.95,93.07,59.84,0.0,0,0.056,0.241,0.752,0.561,15,1,7,9,2.3,15.2,3,Higher,West,NY,Suburban,18-35,2022-04,Q2_2022,2021,1.2,0.369,Stable
FIA002606,2022-04-30,Omeprazole,Prilosec,Proton Pump Inhibitors,84536-850-98,VA Plan,PLAN_4393,2022,Tier 2,Tier 2,2021-07-05,299,No Change,None,No,No,,464,432,7.4,Increased,28.96,23.45,5.51,148.64,177.6,82.41,0.0,0,0.064,0.287,0.387,0.723,6,2,1,7,3.3,14.7,4,Similar,Southeast,NY,Suburban,66-75,2022-04,Q2_2022,2021,2.5,0.713,Increasing
FIA000721,2022-05-03,Omeprazole,Prilosec,Proton Pump Inhibitors,60090-160-20,Medicaid Plan Y,PLAN_8873,2022,Tier 3,Tier 2,2022-02-24,68,Worsened,Step Therapy; Quantity Limit,No,Yes,,209,679,-69.2,Decreased,71.27,40.86,30.41,186.53,257.8,53.88,0.0,0,0.017,0.349,0.819,0.835,3,3,4,3,3.7,14.3,8,Lower,Southeast,PA,Suburban,18-35,2022-05,Q2_2022,2021,2.5,0.933,Decreasing
FIA002557,2022-05-07,Omeprazole,Prilosec,Proton Pump Inhibitors,31731-454-33,Medicaid Plan X,PLAN_4708,2022,Tier 1,Tier 2,2021-07-20,291,Improved,None,No,No,,192,186,3.7,Stable,11.16,37.9,-26.74,154.68,165.84,31.84,0.0,0,0.075,0.301,0.499,0.865,5,2,5,2,4.9,34.3,7,Similar,Northeast,GA,Suburban,66-75,2022-05,Q2_2022,2021,7.6,0.008,Stable
FIA002441,2022-05-11,Omeprazole,Prilosec,Proton Pump Inhibitors,99636-969-16,Commercial Plan Beta,PLAN_9411,2022,Non-Formulary,Tier 3,2021-08-06,278,Worsened,Non-Formulary Status,No,No,,145,155,-6.4,Decreased,580.68,53.07,527.61,63.48,644.16,93.4,0.0,0,0.272,0.283,0.756,0.739,11,5,7,12,4.0,7.4,7,Similar,Southeast,GA,Urban,36-50,2022-05,Q2_2022,2021,6.0,0.536,Stable
FIA000380,2022-05-25,Omeprazole,Prilosec,Proton Pump Inhibitors,50784-636-23,Tricare Standard,PLAN_4804,2022,Tier 3,Tier 2,2021-10-02,235,Worsened,None,No,No,,570,788,-27.6,Decreased,56.17,42.19,13.98,49.94,106.11,60.48,0.0,0,0.011,0.281,0.409,0.469,14,2,2,10,4.6,33.5,2,Similar,Midwest,TX,Rural,66-75,2022-05,Q2_2022,2021,4.8,0.168,Decreasing
FIA002740,2022-05-25,Omeprazole,Prilosec,Proton Pump Inhibitors,53606-849-54,Tricare Standard,PLAN_4973,2022,Tier 2,Tier 3,2022-03-08,78,Improved,None,No,No,,177,146,21.6,Increased,23.1,89.68,-66.58,155.76,178.86,31.66,0.0,0,0.05,0.104,0.681,0.815,15,1,15,15,2.9,6.7,8,Similar,West,NY,Rural,75+,2022-05,Q2_2022,2021,2.0,0.037,Stable
FIA001211,2022-05-31,Omeprazole,Prilosec,Proton Pump Inhibitors,46558-637-46,Medicare Part D Plan B,PLAN_3793,2022,Tier 2,Tier 1,2022-03-08,84,Worsened,None,No,No,,523,481,8.9,Increased,20.88,9.92,10.96,195.64,216.52,113.24,0.0,0,0.028,0.124,0.776,0.469,7,2,1,15,4.4,20.7,4,Higher,Southwest,CA,Rural,75+,2022-05,Q2_2022,2021,3.7,0.585,Increasing
FIA000146,2022-06-09,Omeprazole,Prilosec,Proton Pump Inhibitors,83193-867-81,VA Plan,PLAN_2728,2022,Non-Formulary,Tier 1,2022-03-20,81,Worsened,Non-Formulary Status,No,No,,206,294,-29.7,Decreased,635.1,12.97,622.13,191.08,826.18,170.19,0.0,0,0.193,0.318,0.604,0.771,13,1,5,5,3.6,20.1,7,Lower,West,MI,Suburban,51-65,2022-06,Q2_2022,2021,9.1,0.55,Stable
FIA001748,2022-06-14,Omeprazole,Prilosec,Proton Pump Inhibitors,50314-489-38,Medicaid Plan Y,PLAN_6623,2022,Specialty Tier,Tier 1,2021-07-22,327,Worsened,Quantity Limit,No,No,60.0,240,648,-62.8,Decreased,276.94,15.26,261.68,112.37,389.31,93.43,0.0,0,0.086,0.1,0.414,0.848,13,3,20,14,2.5,11.3,8,Lower,Southeast,NC,Urban,36-50,2022-06,Q2_2022,2021,7.8,0.481,Stable
FIA001445,2022-06-29,Omeprazole,Prilosec,Proton Pump Inhibitors,35637-877-54,Medicaid Plan X,PLAN_8311,2022,Tier 3,Specialty Tier,2022-02-16,133,Improved,Prior Authorization; Quantity Limit,Yes,No,,301,330,-8.7,Decreased,99.24,241.79,-142.55,94.72,193.96,58.38,0.583,6,0.073,0.355,0.806,0.516,5,5,9,3,3.5,17.3,6,Lower,Southeast,CA,Suburban,75+,2022-06,Q2_2022,2021,2.2,0.947,Decreasing
FIA001181,2022-07-02,Omeprazole,Prilosec,Proton Pump Inhibitors,27055-741-71,Medicare Part D Plan A,PLAN_7654,2022,Tier 3,Tier 1,2022-01-12,171,Worsened,Prior Authorization,Yes,No,,113,146,-22.1,Decreased,72.02,14.82,57.2,129.82,201.84,22.81,0.117,10,0.055,0.268,0.226,0.758,9,9,9,7,3.0,24.5,7,Higher,West,CA,Rural,36-50,2022-07,Q3_2022,2021,8.1,0.394,Decreasing
FIA001282,2022-07-07,Omeprazole,Prilosec,Proton Pump Inhibitors,58582-990-23,Commercial Plan Beta,PLAN_9940,2022,Non-Formulary,Tier 1,2022-04-08,90,Worsened,Non-Formulary Status,No,No,,250,447,-43.9,Decreased,272.43,14.72,257.71,144.27,416.7,104.18,0.0,0,0.245,0.317,0.454,0.603,7,2,6,15,3.1,20.1,3,Higher,Southwest,NY,Urban,66-75,2022-07,Q3_2022,2021,3.9,0.167,Stable
FIA002259,2022-07-11,Omeprazole,Prilosec,Proton Pump Inhibitors,40466-957-63,Medicaid Plan Y,PLAN_1293,2022,Non-Formulary,Non-Formulary,2022-04-13,89,No Change,Non-Formulary Status,No,No,,656,657,-0.0,Stable,212.9,588.22,-375.32,130.21,343.11,225.08,0.0,0,0.288,0.065,0.667,0.95,7,1,19,0,3.6,18.7,8,Higher,Southeast,IL,Rural,51-65,2022-07,Q3_2022,2021,8.8,0.184,Decreasing
FIA000503,2022-07-19,Omeprazole,Prilosec,Proton Pump Inhibitors,43994-176-29,Medicare Part D Plan A,PLAN_3307,2022,Specialty Tier,Tier 1,2022-04-08,102,Worsened,None,No,No,,245,467,-47.5,Decreased,155.09,11.36,143.73,173.88,328.97,80.6,0.0,0,0.083,0.397,0.851,0.632,11,9,5,15,2.7,19.8,2,Lower,West,MI,Urban,66-75,2022-07,Q3_2022,2021,7.5,0.964,Stable
FIA000729,2022-07-19,Omeprazole,Prilosec,Proton Pump Inhibitors,55151-604-57,Medicaid Plan X,PLAN_1341,2022,Non-Formulary,Specialty Tier,2022-02-11,158,Worsened,Non-Formulary Status,No,No,,982,941,4.4,Stable,758.7,280.77,477.93,84.94,843.64,828.45,0.0,0,0.133,0.241,0.395,0.717,0,6,19,13,3.7,6.5,4,Similar,Southeast,NC,Rural,75+,2022-07,Q3_2022,2021,4.9,0.377,Decreasing
FIA002562,2022-07-23,Omeprazole,Prilosec,Proton Pump Inhibitors,94172-969-29,Medicaid Plan X,PLAN_2125,2022,Non-Formulary,Tier 1,2021-09-19,307,Worsened,Non-Formulary Status,No,No,,123,181,-31.6,Decreased,771.74,14.63,757.11,109.33,881.07,108.37,0.0,0,0.193,0.365,0.378,0.917,13,5,8,10,2.3,6.6,2,Lower,Northeast,TX,Urban,36-50,2022-07,Q3_2022,2021,3.4,0.041,Decreasing
FIA000548,2022-07-31,Omeprazole,Prilosec,Proton Pump Inhibitors,17528-452-86,Commercial Plan Beta,PLAN_8208,2022,Tier 3,Tier 2,2022-06-10,51,Worsened,None,No,No,,463,615,-24.7,Decreased,94.93,42.78,52.15,145.97,240.9,111.54,0.0,0,0.024,0.21,0.449,0.897,3,9,17,7,2.4,7.1,2,Higher,Southeast,MI,Urban,66-75,2022-07,Q3_2022,2021,7.1,0.813,Decreasing
FIA002625,2022-08-06,Omeprazole,Prilosec,Proton Pump Inhibitors,40418-771-86,Medicaid Plan X,PLAN_3014,2022,Tier 3,Non-Formulary,2022-04-21,107,Improved,None,No,No,,303,323,-6.0,Decreased,52.75,368.18,-315.43,66.11,118.86,36.01,0.0,0,0.043,0.087,0.365,0.642,2,7,17,9,3.1,19.7,4,Higher,Southwest,FL,Rural,51-65,2022-08,Q3_2022,2021,5.3,0.271,Increasing
FIA000769,2022-08-08,Omeprazole,Prilosec,Proton Pump Inhibitors,43916-298-20,Commercial Plan Beta,PLAN_5901,2022,Tier 3,Tier 2,2021-11-10,271,Worsened,Prior Authorization,Yes,No,,275,487,-43.3,Decreased,68.09,31.13,36.96,78.49,146.58,40.31,0.246,4,0.012,0.203,0.631,0.524,2,0,20,5,4.0,22.6,5,Lower,Northeast,IL,Urban,66-75,2022-08,Q3_2022,2021,2.3,0.585,Decreasing
FIA002846,2022-08-13,Omeprazole,Prilosec,Proton Pump Inhibitors,62388-369-70,Commercial Plan Alpha,PLAN_1401,2022,Tier 1,Tier 2,2022-07-02,42,Improved,None,No,No,,457,492,-7.1,Decreased,15.92,44.37,-28.45,32.3,48.22,22.04,0.0,0,0.073,0.281,0.857,0.606,15,6,0,2,4.1,32.4,7,Higher,Northeast,NY,Rural,36-50,2022-08,Q3_2022,2021,1.5,0.339,Decreasing
FIA001866,2022-08-23,Omeprazole,Prilosec,Proton Pump Inhibitors,26172-460-26,Commercial Plan Alpha,PLAN_4360,2022,Tier 1,Non-Formulary,2021-08-25,363,Improved,None,No,No,,354,295,20.0,Increased,18.41,556.71,-538.3,84.96,103.37,36.59,0.0,0,0.055,0.142,0.754,0.43,13,0,15,2,4.7,30.8,5,Similar,Southwest,GA,Urban,75+,2022-08,Q3_2022,2021,8.9,0.384,Increasing
FIA001145,2022-08-26,Omeprazole,Prilosec,Proton Pump Inhibitors,11459-852-54,Medicaid Plan Y,PLAN_9154,2022,Specialty Tier,Specialty Tier,2021-10-15,315,No Change,None,No,No,,657,673,-2.3,Stable,251.44,282.52,-31.08,35.13,286.57,188.28,0.0,0,0.129,0.053,0.875,0.486,11,0,17,12,3.6,31.7,4,Similar,Northeast,FL,Urban,51-65,2022-08,Q3_2022,2021,9.4,0.587,Decreasing
FIA001497,2022-08-30,Omeprazole,Prilosec,Proton Pump Inhibitors,29139-901-32,Tricare Standard,PLAN_7186,2022,Specialty Tier,Tier 1,2022-02-05,206,Worsened,Step Therapy,No,Yes,,262,614,-57.3,Decreased,139.5,7.51,131.99,160.86,300.36,78.69,0.0,0,0.262,0.199,0.424,0.816,9,2,15,9,4.3,28.1,4,Similar,Midwest,IL,Rural,51-65,2022-08,Q3_2022,2021,6.8,0.189,Decreasing
FIA001505,2022-09-09,Omeprazole,Prilosec,Proton Pump Inhibitors,83808-747-32,Medicare Part D Plan B,PLAN_6519,2022,Tier 1,Tier 1,2022-07-09,62,No Change,None,No,No,,354,343,3.3,Stable,11.67,6.83,4.84,181.57,193.24,68.41,0.0,0,0.039,0.08,0.5,0.57,7,8,15,15,2.2,33.0,3,Similar,West,NY,Suburban,75+,2022-09,Q3_2022,2021,7.1,0.084,Increasing
FIA000851,2022-09-15,Omeprazole,Prilosec,Proton Pump Inhibitors,87038-373-91,Medicare Part D Plan A,PLAN_5479,2022,Tier 2,Tier 3,2022-06-28,79,Improved,None,No,No,,251,191,31.5,Increased,44.57,74.37,-29.8,114.77,159.34,39.99,0.0,0,0.047,0.103,0.827,0.85,9,5,12,9,2.2,22.8,3,Similar,Midwest,TX,Urban,51-65,2022-09,Q3_2022,2021,3.1,0.801,Increasing
FIA000860,2022-09-18,Omeprazole,Prilosec,Proton Pump Inhibitors,34176-468-20,Medicaid Plan Y,PLAN_9497,2022,Tier 1,Tier 2,2022-04-27,144,Improved,None,No,No,,469,481,-2.4,Stable,18.45,28.61,-10.16,192.09,210.54,98.74,0.0,0,0.069,0.247,0.23,0.544,5,8,0,10,2.2,17.1,2,Higher,West,TX,Urban,36-50,2022-09,Q3_2022,2021,6.2,0.488,Decreasing
FIA002121,2022-10-14,Omeprazole,Prilosec,Proton Pump Inhibitors,49216-484-19,Commercial Plan Alpha,PLAN_2191,2022,Specialty Tier,Non-Formulary,2022-07-31,75,Improved,None,No,No,,391,365,7.4,Increased,234.43,632.08,-397.65,189.03,423.46,165.57,0.0,0,0.072,0.14,0.61,0.872,2,2,20,5,3.6,24.6,5,Higher,Southwest,NY,Urban,75+,2022-10,Q4_2022,2022,3.3,0.121,Decreasing
FIA000960,2022-10-29,Omeprazole,Prilosec,Proton Pump Inhibitors,99268-680-59,Commercial Plan Alpha,PLAN_6091,2022,Tier 1,Tier 2,2022-01-21,281,Improved,None,No,No,,860,797,8.0,Increased,14.34,36.98,-22.64,193.22,207.56,178.5,0.0,0,0.056,0.107,0.486,0.946,13,3,10,11,3.5,18.5,4,Similar,Southeast,OH,Urban,51-65,2022-10,Q4_2022,2022,5.5,0.95,Increasing
FIA002959,2022-10-31,Omeprazole,Prilosec,Proton Pump Inhibitors,19400-682-55,Medicaid Plan Y,PLAN_8723,2022,Tier 2,Tier 2,2022-07-08,115,No Change,None,No,No,,105,106,-0.8,Stable,45.45,45.47,-0.02,125.62,171.07,17.96,0.0,0,0.049,0.206,0.809,0.643,13,1,19,1,2.3,23.2,8,Lower,Northeast,MI,Rural,75+,2022-10,Q4_2022,2022,3.2,0.94,Increasing
FIA001204,2022-11-01,Omeprazole,Prilosec,Proton Pump Inhibitors,45433-694-50,Medicare Part D Plan A,PLAN_8047,2022,Tier 3,Specialty Tier,2022-03-16,230,Improved,Quantity Limit,No,No,,870,871,-0.1,Stable,65.93,112.93,-47.0,103.64,169.57,147.53,0.0,0,0.017,0.323,0.652,0.558,3,3,15,3,4.8,24.3,4,Higher,Southwest,NY,Rural,18-35,2022-11,Q4_2022,2022,7.8,0.012,Stable
FIA000400,2022-11-05,Omeprazole,Prilosec,Proton Pump Inhibitors,29925-267-63,Medicare Part D Plan B,PLAN_9721,2022,Tier 3,Tier 1,2022-04-04,215,Worsened,None,No,No,,546,948,-42.3,Decreased,81.16,9.73,71.43,57.17,138.33,75.53,0.0,0,0.066,0.369,0.487,0.709,15,4,7,3,4.0,9.4,5,Lower,Northeast,FL,Suburban,66-75,2022-11,Q4_2022,2022,4.4,0.17,Increasing
FIA001191,2022-11-19,Omeprazole,Prilosec,Proton Pump Inhibitors,35421-173-24,Medicaid Plan Y,PLAN_5522,2022,Specialty Tier,Tier 2,2022-01-18,305,Worsened,Quantity Limit,No,No,30.0,489,711,-31.1,Decreased,111.66,23.58,88.08,92.11,203.77,99.64,0.0,0,0.211,0.247,0.581,0.452,15,3,8,2,4.6,22.4,2,Lower,Southwest,OH,Urban,75+,2022-11,Q4_2022,2022,4.8,0.183,Decreasing
FIA002100,2022-11-20,Omeprazole,Prilosec,Proton Pump Inhibitors,99381-877-38,Tricare Standard,PLAN_1263,2022,Non-Formulary,Tier 3,2022-01-07,317,Worsened,Non-Formulary Status,No,No,,132,121,9.2,Increased,544.96,57.55,487.41,54.09,599.05,79.07,0.0,0,0.069,0.253,0.819,0.458,9,6,9,9,4.7,23.1,7,Lower,Midwest,NY,Urban,75+,2022-11,Q4_2022,2022,9.0,0.561,Increasing
FIA001471,2022-11-24,Omeprazole,Prilosec,Proton Pump Inhibitors,28946-601-74,Tricare Standard,PLAN_7819,2022,Tier 2,Tier 1,2022-06-11,166,Worsened,None,No,No,,804,744,8.1,Increased,27.05,9.13,17.92,159.55,186.6,150.03,0.0,0,0.071,0.134,0.722,0.667,1,8,2,6,4.0,10.2,7,Lower,West,FL,Urban,18-35,2022-11,Q4_2022,2022,3.7,0.519,Decreasing
FIA001315,2022-12-07,Omeprazole,Prilosec,Proton Pump Inhibitors,30369-223-71,Commercial Plan Alpha,PLAN_6453,2022,Non-Formulary,Specialty Tier,2022-10-19,49,Worsened,Non-Formulary Status; Quantity Limit,No,No,,389,432,-9.9,Decreased,369.23,153.73,215.5,138.87,508.1,197.65,0.0,0,0.147,0.37,0.731,0.798,7,7,13,6,4.3,22.7,2,Lower,West,CA,Suburban,36-50,2022-12,Q4_2022,2022,5.4,0.09,Increasing
FIA002674,2022-12-22,Omeprazole,Prilosec,Proton Pump Inhibitors,70713-819-35,Medicaid Plan X,PLAN_7944,2022,Tier 1,Tier 3,2022-11-07,45,Improved,None,No,No,,794,655,21.3,Increased,18.7,95.26,-76.56,156.01,174.71,138.72,0.0,0,0.024,0.285,0.302,0.638,9,9,19,7,4.7,15.2,7,Lower,West,MI,Urban,66-75,2022-12,Q4_2022,2022,5.0,0.247,Stable
FIA000787,2022-12-24,Omeprazole,Prilosec,Proton Pump Inhibitors,18575-740-79,Commercial Plan Beta,PLAN_1266,2022,Specialty Tier,Specialty Tier,2022-05-13,225,No Change,None,No,No,,543,533,2.0,Stable,186.56,232.79,-46.23,72.51,259.07,140.68,0.0,0,0.073,0.343,0.755,0.831,9,2,8,4,2.9,16.4,7,Lower,West,NY,Suburban,66-75,2022-12,Q4_2022,2022,2.7,0.806,Decreasing
FIA002179,2022-12-29,Omeprazole,Prilosec,Proton Pump Inhibitors,52995-324-75,Medicaid Plan X,PLAN_4149,2022,Tier 2,Non-Formulary,2022-10-05,85,Improved,None,No,No,,170,134,26.9,Increased,42.76,280.24,-237.48,152.15,194.91,33.13,0.0,0,0.051,0.055,0.538,0.779,9,6,13,0,3.8,12.3,4,Lower,Midwest,MI,Urban,36-50,2022-12,Q4_2022,2022,3.0,0.233,Increasing
FIA002782,2023-01-01,Omeprazole,Prilosec,Proton Pump Inhibitors,49993-995-42,Medicare Part D Plan B,PLAN_6355,2023,Tier 1,Specialty Tier,2022-05-20,226,Improved,None,No,No,,253,200,26.9,Increased,6.22,276.42,-270.2,117.48,123.7,31.3,0.0,0,0.054,0.33,0.504,0.473,9,3,19,13,3.8,32.9,6,Lower,Midwest,TX,Rural,18-35,2023-01,Q1_2023,2022,4.4,0.245,Stable
FIA000042,2023-01-05,Omeprazole,Prilosec,Proton Pump Inhibitors,91006-234-86,VA Plan,PLAN_3527,2023,Tier 3,Specialty Tier,2022-08-30,128,Improved,None,No,No,,171,179,-4.1,Stable,61.33,127.51,-66.18,142.53,203.86,34.86,0.0,0,0.047,0.107,0.782,0.824,5,7,1,13,3.1,26.6,5,Higher,Midwest,GA,Urban,75+,2023-01,Q1_2023,2022,3.2,0.966,Stable
FIA002773,2023-01-05,Omeprazole,Prilosec,Proton Pump Inhibitors,43765-929-82,Tricare Standard,PLAN_9839,2023,Specialty Tier,Specialty Tier,2022-04-06,274,No Change,Prior Authorization,Yes,No,,184,187,-1.1,Stable,142.62,105.76,36.86,71.36,213.98,39.37,0.589,6,0.237,0.078,0.408,0.438,5,5,11,10,4.1,34.5,3,Lower,Northeast,NC,Urban,18-35,2023-01,Q1_2023,2022,9.0,0.749,Stable
FIA001535,2023-01-10,Omeprazole,Prilosec,Proton Pump Inhibitors,58971-771-20,Tricare Standard,PLAN_7586,2023,Tier 2,Tier 2,2022-10-23,79,No Change,None,No,No,,701,729,-3.8,Stable,29.11,49.18,-20.07,127.21,156.32,109.58,0.0,0,0.066,0.247,0.339,0.916,7,8,2,10,3.3,14.8,2,Similar,Northeast,IL,Rural,66-75,2023-01,Q1_2023,2022,6.4,0.708,Increasing
FIA002043,2023-01-17,Omeprazole,Prilosec,Proton Pump Inhibitors,27732-891-14,Medicare Part D Plan A,PLAN_5657,2023,Tier 2,Tier 1,2022-02-13,338,Worsened,None,No,No,,246,249,-1.0,Stable,38.39,11.07,27.32,31.92,70.31,17.3,0.0,0,0.012,0.066,0.456,0.899,5,2,4,15,2.4,14.4,4,Higher,West,NY,Urban,66-75,2023-01,Q1_2023,2022,5.6,0.334,Stable
FIA002045,2023-01-17,Omeprazole,Prilosec,Proton Pump Inhibitors,58311-792-39,VA Plan,PLAN_6118,2023,Tier 3,Specialty Tier,2022-03-24,299,Improved,Prior Authorization; Step Therapy,Yes,Yes,,772,755,2.3,Stable,57.28,134.87,-77.59,53.93,111.21,85.85,0.124,5,0.021,0.076,0.577,0.661,15,7,20,9,3.0,27.0,4,Lower,West,NC,Urban,66-75,2023-01,Q1_2023,2022,5.6,0.722,Decreasing
FIA001149,2023-01-30,Omeprazole,Prilosec,Proton Pump Inhibitors,77923-837-94,VA Plan,PLAN_1623,2023,Tier 3,Tier 1,2022-07-10,204,Worsened,Prior Authorization,Yes,No,,638,858,-25.6,Decreased,99.7,13.29,86.41,192.72,292.42,186.56,0.574,3,0.025,0.387,0.745,0.95,3,6,13,9,3.3,31.7,7,Lower,Southeast,PA,Suburban,66-75,2023-01,Q1_2023,2022,8.5,0.776,Increasing
FIA000251,2023-02-09,Omeprazole,Prilosec,Proton Pump Inhibitors,59508-271-70,Tricare Standard,PLAN_7925,2023,Specialty Tier,Tier 2,2022-03-06,340,Worsened,Step Therapy,No,Yes,,176,559,-68.4,Decreased,149.79,28.56,121.23,91.13,240.92,42.4,0.0,0,0.288,0.227,0.714,0.818,15,0,12,13,4.6,27.8,4,Higher,West,FL,Rural,36-50,2023-02,Q1_2023,2022,3.3,0.464,Stable
FIA000850,2023-02-10,Omeprazole,Prilosec,Proton Pump Inhibitors,16615-285-39,VA Plan,PLAN_6082,2023,Non-Formulary,Tier 1,2022-09-20,143,Worsened,Non-Formulary Status,No,No,,223,338,-33.9,Decreased,347.76,19.01,328.75,145.47,493.23,109.99,0.0,0,0.275,0.086,0.325,0.561,15,4,0,11,2.6,29.6,3,Lower,Southeast,NY,Suburban,18-35,2023-02,Q1_2023,2022,3.9,0.073,Increasing
FIA001760,2023-02-16,Omeprazole,Prilosec,Proton Pump Inhibitors,61823-713-19,Tricare Standard,PLAN_7639,2023,Non-Formulary,Tier 2,2022-10-08,131,Worsened,Non-Formulary Status,No,No,,423,634,-33.3,Decreased,791.36,40.21,751.15,61.83,853.19,360.9,0.0,0,0.228,0.318,0.603,0.601,14,4,5,14,2.6,14.5,6,Similar,Northeast,GA,Urban,51-65,2023-02,Q1_2023,2022,3.7,0.154,Decreasing
FIA000446,2023-02-18,Omeprazole,Prilosec,Proton Pump Inhibitors,15167-565-85,Medicaid Plan X,PLAN_9827,2023,Tier 2,Tier 3,2022-05-06,288,Improved,None,No,No,,1023,641,59.7,Increased,28.2,69.53,-41.33,103.94,132.14,135.18,0.0,0,0.053,0.399,0.52,0.556,0,6,18,2,3.4,31.3,5,Higher,West,NY,Suburban,75+,2023-02,Q1_2023,2022,3.0,0.265,Decreasing
FIA001733,2023-03-23,Omeprazole,Prilosec,Proton Pump Inhibitors,49213-836-17,Medicaid Plan X,PLAN_9174,2023,Non-Formulary,Tier 2,2022-10-24,150,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,360,865,-58.3,Decreased,750.7,42.49,708.21,98.78,849.48,305.81,0.0,0,0.286,0.077,0.402,0.601,13,1,10,3,3.5,24.4,2,Similar,West,MI,Suburban,36-50,2023-03,Q1_2023,2022,8.2,0.894,Decreasing
FIA002629,2023-03-24,Omeprazole,Prilosec,Proton Pump Inhibitors,73633-935-60,Tricare Standard,PLAN_1707,2023,Tier 2,Tier 3,2022-09-05,200,Improved,None,No,No,,856,591,44.9,Increased,34.87,80.46,-45.59,170.43,205.3,175.74,0.0,0,0.07,0.157,0.325,0.422,9,4,10,1,2.5,11.6,5,Lower,Southeast,PA,Urban,36-50,2023-03,Q1_2023,2022,9.6,0.978,Increasing
FIA001425,2023-04-03,Omeprazole,Prilosec,Proton Pump Inhibitors,97093-582-49,Medicaid Plan X,PLAN_7771,2023,Tier 2,Tier 2,2022-05-26,312,No Change,None,No,No,,292,317,-7.8,Decreased,22.57,29.14,-6.57,176.64,199.21,58.17,0.0,0,0.038,0.254,0.228,0.463,10,1,3,3,3.1,21.4,5,Lower,Southeast,MI,Urban,36-50,2023-04,Q2_2023,2022,5.5,0.322,Stable
FIA001581,2023-04-09,Omeprazole,Prilosec,Proton Pump Inhibitors,19245-588-10,VA Plan,PLAN_2741,2023,Tier 3,Tier 3,2023-03-07,33,No Change,None,No,No,,433,472,-8.2,Decreased,53.06,55.2,-2.14,176.02,229.08,99.19,0.0,0,0.064,0.186,0.706,0.706,8,6,9,4,4.4,34.2,6,Higher,Southwest,FL,Rural,51-65,2023-04,Q2_2023,2022,7.9,0.919,Increasing
FIA001250,2023-04-13,Omeprazole,Prilosec,Proton Pump Inhibitors,23584-777-82,VA Plan,PLAN_1066,2023,Tier 1,Tier 2,2022-12-03,131,Improved,None,No,No,,889,944,-5.8,Decreased,5.12,24.67,-19.55,159.01,164.13,145.91,0.0,0,0.047,0.319,0.427,0.736,4,7,0,8,2.0,28.3,3,Higher,Southwest,OH,Suburban,75+,2023-04,Q2_2023,2022,3.7,0.04,Stable
FIA002658,2023-04-19,Omeprazole,Prilosec,Proton Pump Inhibitors,70106-738-11,Tricare Standard,PLAN_4953,2023,Non-Formulary,Non-Formulary,2022-11-06,164,No Change,Non-Formulary Status,No,No,,545,536,1.7,Stable,499.18,307.99,191.19,150.93,650.11,354.31,0.0,0,0.296,0.122,0.863,0.503,2,6,19,15,4.0,6.8,6,Lower,West,NC,Suburban,51-65,2023-04,Q2_2023,2022,9.2,0.56,Decreasing
FIA000843,2023-05-03,Omeprazole,Prilosec,Proton Pump Inhibitors,31171-707-23,Medicaid Plan Y,PLAN_9774,2023,Tier 2,Non-Formulary,2022-08-16,260,Improved,None,No,No,,993,689,44.1,Increased,45.25,698.8,-653.55,87.88,133.13,132.2,0.0,0,0.043,0.388,0.642,0.605,10,1,2,13,4.5,29.1,7,Similar,Northeast,PA,Rural,36-50,2023-05,Q2_2023,2022,9.8,0.904,Stable
FIA002228,2023-05-07,Omeprazole,Prilosec,Proton Pump Inhibitors,35835-971-51,Medicare Part D Plan A,PLAN_7442,2023,Tier 3,Non-Formulary,2022-11-27,161,Improved,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,60.0,891,926,-3.7,Stable,81.86,542.03,-460.17,155.66,237.52,211.63,0.422,5,0.058,0.135,0.712,0.741,5,5,8,15,4.2,24.9,3,Similar,West,CA,Suburban,66-75,2023-05,Q2_2023,2022,3.3,0.309,Stable
FIA001001,2023-05-23,Omeprazole,Prilosec,Proton Pump Inhibitors,46937-222-61,Medicaid Plan X,PLAN_4822,2023,Specialty Tier,Tier 2,2022-12-23,151,Worsened,Quantity Limit,No,No,90.0,548,890,-38.4,Decreased,101.3,34.46,66.84,169.34,270.64,148.31,0.0,0,0.051,0.375,0.223,0.756,3,7,0,8,3.3,8.3,3,Similar,West,FL,Rural,36-50,2023-05,Q2_2023,2022,8.8,0.92,Decreasing
FIA001614,2023-05-27,Omeprazole,Prilosec,Proton Pump Inhibitors,40533-180-90,Medicare Part D Plan A,PLAN_9749,2023,Specialty Tier,Tier 1,2023-03-24,64,Worsened,Step Therapy,No,Yes,,397,511,-22.2,Decreased,109.44,10.42,99.02,110.41,219.85,87.28,0.0,0,0.071,0.105,0.472,0.756,15,7,10,13,4.5,32.7,6,Higher,West,CA,Suburban,18-35,2023-05,Q2_2023,2022,3.7,0.505,Decreasing
FIA002385,2023-05-28,Omeprazole,Prilosec,Proton Pump Inhibitors,29634-494-96,VA Plan,PLAN_2582,2023,Tier 2,Tier 1,2022-11-10,199,Worsened,None,No,No,,135,130,4.4,Stable,35.86,14.46,21.4,74.34,110.2,14.88,0.0,0,0.011,0.287,0.371,0.757,13,3,9,11,2.4,21.1,7,Lower,West,IL,Rural,18-35,2023-05,Q2_2023,2022,2.9,0.685,Increasing
FIA001302,2023-05-29,Omeprazole,Prilosec,Proton Pump Inhibitors,63661-445-82,Medicare Part D Plan B,PLAN_9793,2023,Non-Formulary,Tier 2,2022-11-15,195,Worsened,Non-Formulary Status; Quantity Limit,No,No,,248,352,-29.3,Decreased,610.09,24.23,585.86,122.06,732.15,181.57,0.0,0,0.267,0.351,0.594,0.87,1,5,5,6,4.4,28.1,2,Similar,Southeast,CA,Suburban,66-75,2023-05,Q2_2023,2022,3.0,0.015,Decreasing
FIA000522,2023-05-30,Omeprazole,Prilosec,Proton Pump Inhibitors,77378-279-49,Commercial Plan Alpha,PLAN_3021,2023,Specialty Tier,Tier 3,2023-01-04,146,Worsened,Quantity Limit,No,No,30.0,827,847,-2.3,Stable,186.02,84.82,101.2,197.18,383.2,316.91,0.0,0,0.092,0.226,0.815,0.599,8,0,1,13,2.8,24.6,4,Higher,Southwest,IL,Rural,36-50,2023-05,Q2_2023,2022,8.8,0.846,Increasing
FIA002933,2023-06-08,Omeprazole,Prilosec,Proton Pump Inhibitors,21141-823-34,Commercial Plan Alpha,PLAN_3848,2023,Tier 1,Tier 3,2022-07-18,325,Improved,None,No,No,,564,420,34.5,Increased,15.51,69.1,-53.59,143.94,159.45,89.93,0.0,0,0.054,0.304,0.24,0.855,15,1,1,8,2.4,16.4,6,Higher,Southeast,NC,Suburban,75+,2023-06,Q2_2023,2022,8.7,0.705,Stable
FIA002998,2023-06-24,Omeprazole,Prilosec,Proton Pump Inhibitors,55062-823-78,VA Plan,PLAN_2252,2023,Non-Formulary,Tier 3,2023-02-10,134,Worsened,Non-Formulary Status,No,No,,587,537,9.3,Increased,794.58,96.04,698.54,98.4,892.98,524.18,0.0,0,0.295,0.168,0.555,0.822,10,8,20,3,2.9,33.3,6,Lower,West,NC,Rural,36-50,2023-06,Q2_2023,2022,3.6,0.92,Decreasing
FIA002263,2023-07-05,Omeprazole,Prilosec,Proton Pump Inhibitors,57583-802-41,Medicare Part D Plan A,PLAN_6359,2023,Tier 1,Non-Formulary,2022-08-05,334,Improved,Quantity Limit,No,No,90.0,285,205,39.4,Increased,19.51,337.29,-317.78,178.27,197.78,56.37,0.0,0,0.027,0.318,0.458,0.699,7,10,16,1,3.3,8.3,2,Similar,Midwest,FL,Suburban,18-35,2023-07,Q3_2023,2022,5.6,0.659,Decreasing
FIA002651,2023-07-14,Omeprazole,Prilosec,Proton Pump Inhibitors,90865-556-94,Commercial Plan Alpha,PLAN_6802,2023,Non-Formulary,Non-Formulary,2022-11-04,252,No Change,Non-Formulary Status,No,No,,230,242,-4.7,Stable,219.55,480.98,-261.43,41.91,261.46,60.14,0.0,0,0.247,0.24,0.582,0.459,4,10,5,15,3.1,34.8,7,Higher,West,CA,Urban,51-65,2023-07,Q3_2023,2022,4.6,0.303,Decreasing
FIA002594,2023-07-25,Omeprazole,Prilosec,Proton Pump Inhibitors,77697-901-38,Medicaid Plan X,PLAN_2008,2023,Non-Formulary,Tier 1,2022-12-31,206,Worsened,Non-Formulary Status,No,No,,310,616,-49.6,Decreased,242.5,9.82,232.68,106.22,348.72,108.1,0.0,0,0.234,0.345,0.798,0.625,13,5,1,9,4.6,29.7,7,Higher,Southeast,NC,Urban,75+,2023-07,Q3_2023,2022,2.6,0.169,Stable
FIA001203,2023-07-28,Omeprazole,Prilosec,Proton Pump Inhibitors,67212-247-45,Commercial Plan Alpha,PLAN_3079,2023,Tier 3,Tier 2,2023-01-24,185,Worsened,Step Therapy,No,Yes,,736,962,-23.5,Decreased,98.02,41.22,56.8,142.01,240.03,176.66,0.0,0,0.071,0.13,0.79,0.754,9,2,2,2,3.3,20.3,5,Lower,Southeast,NC,Rural,51-65,2023-07,Q3_2023,2022,1.9,0.702,Decreasing
FIA002451,2023-08-01,Omeprazole,Prilosec,Proton Pump Inhibitors,82099-266-71,VA Plan,PLAN_9912,2023,Tier 2,Specialty Tier,2023-04-26,97,Improved,None,No,No,,1251,925,35.3,Increased,27.51,121.48,-93.97,189.58,217.09,271.58,0.0,0,0.053,0.085,0.537,0.935,13,4,4,1,4.0,27.3,5,Similar,Southeast,GA,Suburban,18-35,2023-08,Q3_2023,2022,7.0,0.807,Stable
FIA001197,2023-08-03,Omeprazole,Prilosec,Proton Pump Inhibitors,14062-192-89,Commercial Plan Beta,PLAN_4420,2023,Tier 2,Tier 2,2023-05-09,86,No Change,None,No,No,,538,530,1.6,Stable,44.19,31.24,12.95,83.11,127.3,68.49,0.0,0,0.013,0.164,0.205,0.915,5,2,12,1,4.1,11.2,5,Higher,Midwest,FL,Suburban,66-75,2023-08,Q3_2023,2022,8.5,0.227,Increasing
FIA002882,2023-08-03,Omeprazole,Prilosec,Proton Pump Inhibitors,66321-995-56,VA Plan,PLAN_6592,2023,Specialty Tier,Tier 3,2023-02-27,157,Worsened,None,No,No,,585,574,2.0,Stable,234.92,59.92,175.0,159.75,394.67,230.88,0.0,0,0.062,0.249,0.418,0.75,12,7,18,4,4.7,6.9,6,Higher,Midwest,IL,Suburban,18-35,2023-08,Q3_2023,2022,7.2,0.707,Increasing
FIA000280,2023-08-11,Omeprazole,Prilosec,Proton Pump Inhibitors,21115-144-87,Commercial Plan Alpha,PLAN_3917,2023,Specialty Tier,Tier 1,2022-11-03,281,Worsened,None,No,No,,65,204,-67.8,Decreased,133.91,6.65,127.26,187.2,321.11,20.87,0.0,0,0.14,0.2,0.434,0.5,13,2,9,9,3.0,8.1,5,Higher,Midwest,PA,Rural,18-35,2023-08,Q3_2023,2022,8.1,0.862,Increasing
FIA002698,2023-08-14,Omeprazole,Prilosec,Proton Pump Inhibitors,30475-759-37,Medicaid Plan X,PLAN_3924,2023,Tier 1,Tier 3,2023-07-15,30,Improved,None,No,No,,710,593,19.9,Increased,15.11,71.99,-56.88,36.71,51.82,36.79,0.0,0,0.021,0.177,0.628,0.781,2,8,7,0,2.7,20.3,5,Lower,West,MI,Rural,18-35,2023-08,Q3_2023,2022,8.7,0.561,Decreasing
FIA002937,2023-08-26,Omeprazole,Prilosec,Proton Pump Inhibitors,23553-457-27,Tricare Standard,PLAN_5004,2023,Specialty Tier,Specialty Tier,2023-02-15,192,No Change,None,No,No,,721,780,-7.5,Decreased,120.4,282.8,-162.4,97.96,218.36,157.44,0.0,0,0.122,0.313,0.82,0.447,11,5,12,10,4.3,16.1,7,Lower,Southwest,IL,Urban,66-75,2023-08,Q3_2023,2022,1.8,0.272,Increasing
FIA000008,2023-08-31,Omeprazole,Prilosec,Proton Pump Inhibitors,76562-182-33,Medicare Part D Plan B,PLAN_2113,2023,Tier 1,Non-Formulary,2022-10-28,307,Improved,None,No,No,,213,151,41.3,Increased,5.91,388.16,-382.25,56.76,62.67,13.35,0.0,0,0.07,0.286,0.365,0.466,7,9,19,1,3.9,17.6,6,Higher,West,IL,Suburban,36-50,2023-08,Q3_2023,2022,7.0,0.314,Stable
FIA002935,2023-09-01,Omeprazole,Prilosec,Proton Pump Inhibitors,53660-299-33,Medicare Part D Plan B,PLAN_8800,2023,Specialty Tier,Non-Formulary,2023-07-31,32,Improved,Prior Authorization,Yes,No,,157,156,1.0,Stable,116.05,741.28,-625.23,31.52,147.57,23.17,0.119,6,0.118,0.212,0.249,0.851,12,9,11,8,3.1,19.9,7,Higher,West,FL,Urban,18-35,2023-09,Q3_2023,2022,6.7,0.291,Stable
FIA001304,2023-09-26,Omeprazole,Prilosec,Proton Pump Inhibitors,89728-422-86,Tricare Standard,PLAN_3678,2023,Non-Formulary,Specialty Tier,2023-01-17,252,Worsened,Non-Formulary Status,No,No,,391,412,-5.1,Decreased,482.49,210.46,272.03,114.21,596.7,233.31,0.0,0,0.143,0.247,0.326,0.625,5,7,6,5,4.9,33.4,5,Lower,Southeast,MI,Urban,75+,2023-09,Q3_2023,2022,7.0,0.04,Stable
FIA002446,2023-09-28,Omeprazole,Prilosec,Proton Pump Inhibitors,85640-728-95,Medicare Part D Plan B,PLAN_2310,2023,Tier 2,Non-Formulary,2023-01-02,269,Improved,None,No,No,,371,294,26.3,Increased,40.93,292.96,-252.03,130.9,171.83,63.75,0.0,0,0.028,0.25,0.495,0.829,13,2,3,3,4.6,12.1,4,Higher,Southwest,PA,Rural,75+,2023-09,Q3_2023,2022,5.1,0.175,Stable
FIA001391,2023-10-09,Omeprazole,Prilosec,Proton Pump Inhibitors,74563-652-21,Medicare Part D Plan A,PLAN_2895,2023,Tier 3,Specialty Tier,2023-04-17,175,Improved,None,No,No,,547,608,-10.0,Decreased,60.1,286.82,-226.72,34.38,94.48,51.68,0.0,0,0.068,0.051,0.644,0.841,0,8,4,7,2.8,7.9,8,Similar,Northeast,MI,Rural,75+,2023-10,Q4_2023,2023,1.2,0.464,Stable
FIA002664,2023-10-26,Omeprazole,Prilosec,Proton Pump Inhibitors,88728-153-10,Medicare Part D Plan B,PLAN_2522,2023,Tier 2,Tier 2,2023-09-09,47,No Change,None,No,No,,299,289,3.7,Stable,36.62,40.22,-3.6,43.34,79.96,23.91,0.0,0,0.027,0.096,0.388,0.43,3,7,4,7,2.8,26.1,5,Higher,Southwest,GA,Rural,75+,2023-10,Q4_2023,2023,6.8,0.164,Stable
FIA001594,2023-10-28,Omeprazole,Prilosec,Proton Pump Inhibitors,82130-845-14,Tricare Standard,PLAN_8230,2023,Tier 2,Tier 3,2023-07-31,89,Improved,None,No,No,,474,389,22.0,Increased,49.03,64.68,-15.65,116.41,165.44,78.42,0.0,0,0.049,0.176,0.808,0.914,13,5,16,10,4.0,18.2,4,Similar,Midwest,IL,Urban,75+,2023-10,Q4_2023,2023,2.6,0.138,Decreasing
FIA000983,2023-11-02,Omeprazole,Prilosec,Proton Pump Inhibitors,67224-381-26,Medicaid Plan Y,PLAN_2613,2023,Non-Formulary,Tier 1,2023-03-26,221,Worsened,Non-Formulary Status,No,No,,434,597,-27.3,Decreased,714.81,13.04,701.77,177.96,892.77,387.46,0.0,0,0.241,0.227,0.329,0.599,14,10,13,2,3.0,15.2,2,Lower,Northeast,NC,Urban,75+,2023-11,Q4_2023,2023,4.8,0.727,Decreasing
FIA002535,2023-11-06,Omeprazole,Prilosec,Proton Pump Inhibitors,52331-305-45,Medicaid Plan Y,PLAN_9487,2023,Tier 2,Non-Formulary,2022-12-07,334,Improved,None,No,No,,914,785,16.5,Increased,32.34,262.7,-230.36,104.73,137.07,125.28,0.0,0,0.019,0.284,0.449,0.656,9,10,9,6,3.2,11.2,3,Similar,Northeast,NY,Urban,51-65,2023-11,Q4_2023,2023,9.6,0.453,Decreasing
FIA001190,2023-11-08,Omeprazole,Prilosec,Proton Pump Inhibitors,69006-711-11,Medicaid Plan Y,PLAN_4986,2023,Specialty Tier,Specialty Tier,2023-02-27,254,No Change,Step Therapy,No,Yes,,263,291,-9.4,Decreased,229.23,141.85,87.38,48.24,277.47,72.97,0.0,0,0.102,0.156,0.841,0.705,7,3,6,3,4.0,28.9,7,Higher,Northeast,NC,Urban,18-35,2023-11,Q4_2023,2023,4.6,0.28,Increasing
FIA001034,2023-11-09,Omeprazole,Prilosec,Proton Pump Inhibitors,13541-755-27,Medicare Part D Plan A,PLAN_7212,2023,Specialty Tier,Tier 2,2023-05-02,191,Worsened,None,No,No,,179,258,-30.3,Decreased,118.28,39.48,78.8,130.62,248.9,44.55,0.0,0,0.067,0.054,0.272,0.805,6,0,1,11,4.6,10.3,7,Similar,Midwest,FL,Rural,66-75,2023-11,Q4_2023,2023,8.1,0.438,Increasing
FIA000498,2023-11-10,Omeprazole,Prilosec,Proton Pump Inhibitors,78019-348-26,Commercial Plan Alpha,PLAN_1460,2023,Non-Formulary,Specialty Tier,2023-01-15,299,Worsened,Non-Formulary Status,No,No,,318,319,-0.2,Stable,746.4,243.75,502.65,190.79,937.19,298.03,0.0,0,0.288,0.334,0.727,0.454,11,6,1,6,2.5,31.5,4,Higher,Southwest,MI,Rural,66-75,2023-11,Q4_2023,2023,5.7,0.506,Decreasing
FIA001880,2023-11-14,Omeprazole,Prilosec,Proton Pump Inhibitors,10433-387-64,VA Plan,PLAN_2513,2023,Non-Formulary,Tier 2,2023-10-12,33,Worsened,Non-Formulary Status,No,No,,60,182,-66.8,Decreased,406.16,43.64,362.52,186.09,592.25,35.53,0.0,0,0.145,0.06,0.244,0.639,2,9,11,2,4.4,7.7,6,Lower,Southeast,MI,Rural,75+,2023-11,Q4_2023,2023,4.9,0.193,Stable
FIA000992,2023-11-17,Omeprazole,Prilosec,Proton Pump Inhibitors,59657-911-84,Medicare Part D Plan A,PLAN_7144,2023,Tier 1,Tier 3,2023-05-02,199,Improved,None,No,No,,934,769,21.5,Increased,17.12,70.17,-53.05,55.94,73.06,68.24,0.0,0,0.011,0.144,0.869,0.614,13,10,16,2,4.9,8.7,6,Lower,Southeast,MI,Urban,36-50,2023-11,Q4_2023,2023,7.0,0.65,Decreasing
FIA001765,2023-11-20,Omeprazole,Prilosec,Proton Pump Inhibitors,85692-562-92,Medicare Part D Plan A,PLAN_4766,2023,Non-Formulary,Specialty Tier,2023-05-04,200,Worsened,Non-Formulary Status,No,No,,864,811,6.6,Increased,245.51,238.52,6.99,193.34,438.85,379.17,0.0,0,0.24,0.249,0.831,0.803,15,3,7,0,4.6,12.6,2,Similar,Southeast,FL,Rural,66-75,2023-11,Q4_2023,2023,7.6,0.645,Decreasing
FIA002618,2023-11-21,Omeprazole,Prilosec,Proton Pump Inhibitors,42012-584-88,Tricare Standard,PLAN_3632,2023,Non-Formulary,Tier 1,2023-09-26,56,Worsened,Non-Formulary Status,No,No,,214,682,-68.6,Decreased,569.59,9.01,560.58,91.24,660.83,141.42,0.0,0,0.129,0.221,0.786,0.841,2,4,7,0,4.8,9.4,8,Higher,Midwest,IL,Rural,75+,2023-11,Q4_2023,2023,6.1,0.875,Stable
FIA000039,2023-11-27,Omeprazole,Prilosec,Proton Pump Inhibitors,43550-302-32,Commercial Plan Alpha,PLAN_2234,2023,Tier 3,Tier 2,2023-09-19,69,Worsened,Prior Authorization; Quantity Limit,Yes,No,30.0,437,622,-29.7,Decreased,75.52,23.42,52.1,47.48,123.0,53.75,0.423,8,0.02,0.212,0.595,0.719,10,10,10,4,3.3,19.1,7,Similar,Midwest,MI,Urban,51-65,2023-11,Q4_2023,2023,5.6,0.31,Stable
FIA000242,2023-11-27,Omeprazole,Prilosec,Proton Pump Inhibitors,84473-744-87,VA Plan,PLAN_7247,2023,Specialty Tier,Specialty Tier,2023-04-05,236,No Change,None,No,No,,391,406,-3.5,Stable,252.57,238.1,14.47,199.02,451.59,176.57,0.0,0,0.294,0.121,0.473,0.694,6,7,3,10,3.7,18.5,4,Lower,Southeast,TX,Rural,75+,2023-11,Q4_2023,2023,2.6,0.826,Decreasing
FIA000010,2023-12-04,Omeprazole,Prilosec,Proton Pump Inhibitors,67912-664-64,Medicare Part D Plan A,PLAN_2832,2023,Tier 3,Non-Formulary,2023-02-27,280,Improved,Prior Authorization,Yes,No,,139,152,-8.2,Decreased,62.56,744.9,-682.34,57.47,120.03,16.68,0.165,2,0.079,0.381,0.684,0.482,1,5,18,4,3.3,6.3,4,Lower,Midwest,NY,Rural,36-50,2023-12,Q4_2023,2023,7.0,0.354,Decreasing
FIA000377,2023-12-06,Omeprazole,Prilosec,Proton Pump Inhibitors,54217-445-33,Medicaid Plan X,PLAN_6586,2023,Non-Formulary,Specialty Tier,2023-03-20,261,Worsened,Non-Formulary Status,No,No,,372,369,0.9,Stable,795.62,190.64,604.98,117.46,913.08,339.67,0.0,0,0.214,0.332,0.541,0.702,3,10,10,8,2.2,16.0,7,Lower,West,FL,Urban,36-50,2023-12,Q4_2023,2023,9.8,0.83,Increasing
FIA000607,2023-12-16,Omeprazole,Prilosec,Proton Pump Inhibitors,32332-983-39,Medicare Part D Plan B,PLAN_1570,2023,Non-Formulary,Specialty Tier,2023-11-05,41,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,228,236,-3.0,Stable,311.77,125.54,186.23,41.53,353.3,80.55,0.0,0,0.281,0.208,0.294,0.548,8,1,0,1,4.1,19.8,6,Higher,Midwest,TX,Rural,36-50,2023-12,Q4_2023,2023,2.4,0.371,Increasing
FIA002968,2023-12-19,Omeprazole,Prilosec,Proton Pump Inhibitors,71968-902-94,Tricare Standard,PLAN_9748,2023,Tier 1,Non-Formulary,2023-07-21,151,Improved,None,No,No,,1027,766,34.2,Increased,17.09,752.25,-735.16,135.38,152.47,156.59,0.0,0,0.067,0.113,0.874,0.621,2,3,2,8,2.7,8.9,4,Lower,Midwest,MI,Urban,75+,2023-12,Q4_2023,2023,5.1,0.79,Stable
FIA000320,2023-12-22,Omeprazole,Prilosec,Proton Pump Inhibitors,33670-389-15,Medicaid Plan Y,PLAN_6728,2023,Tier 3,Specialty Tier,2023-10-24,59,Improved,Prior Authorization,Yes,No,,103,110,-5.5,Decreased,61.91,118.4,-56.49,51.54,113.45,11.69,0.506,10,0.015,0.279,0.371,0.561,12,7,3,2,2.2,33.2,3,Similar,Midwest,NY,Suburban,51-65,2023-12,Q4_2023,2023,9.5,0.78,Stable
FIA001414,2024-01-05,Omeprazole,Prilosec,Proton Pump Inhibitors,80713-117-48,Tricare Standard,PLAN_1707,2024,Tier 2,Tier 3,2023-04-29,251,Improved,None,No,No,,1264,793,59.5,Increased,42.35,96.35,-54.0,125.48,167.83,212.14,0.0,0,0.062,0.143,0.393,0.886,10,5,11,3,4.0,22.1,3,Lower,Midwest,CA,Suburban,66-75,2024-01,Q1_2024,2023,7.8,0.672,Stable
FIA000987,2024-01-09,Omeprazole,Prilosec,Proton Pump Inhibitors,17324-447-46,Medicaid Plan Y,PLAN_6511,2024,Tier 1,Tier 3,2023-06-05,218,Improved,None,No,No,,389,306,27.4,Increased,19.23,84.67,-65.44,169.25,188.48,73.32,0.0,0,0.075,0.244,0.753,0.594,10,5,13,5,4.9,17.7,6,Higher,Southeast,NY,Suburban,66-75,2024-01,Q1_2024,2023,7.3,0.861,Stable
FIA000327,2024-01-12,Omeprazole,Prilosec,Proton Pump Inhibitors,64899-335-82,Commercial Plan Alpha,PLAN_9808,2024,Specialty Tier,Tier 3,2023-10-15,89,Worsened,None,No,No,,504,519,-2.8,Stable,238.61,72.25,166.36,69.16,307.77,155.12,0.0,0,0.171,0.136,0.836,0.771,4,9,8,9,3.0,8.5,5,Similar,West,FL,Rural,66-75,2024-01,Q1_2024,2023,6.7,0.773,Increasing
FIA000331,2024-01-27,Omeprazole,Prilosec,Proton Pump Inhibitors,27933-385-95,Medicare Part D Plan B,PLAN_6795,2024,Tier 3,Non-Formulary,2023-05-24,248,Improved,Prior Authorization; Step Therapy,Yes,Yes,,941,950,-0.9,Stable,86.6,512.54,-425.94,44.77,131.37,123.62,0.544,2,0.045,0.31,0.356,0.441,5,8,10,8,3.4,27.1,7,Lower,Midwest,CA,Suburban,18-35,2024-01,Q1_2024,2023,9.4,0.794,Stable
FIA001853,2024-01-27,Omeprazole,Prilosec,Proton Pump Inhibitors,55853-495-57,Commercial Plan Alpha,PLAN_6506,2024,Tier 2,Tier 2,2023-05-23,249,No Change,None,No,No,,979,991,-1.1,Stable,47.26,28.26,19.0,106.22,153.48,150.26,0.0,0,0.057,0.386,0.383,0.806,13,8,12,2,2.4,31.8,7,Similar,West,GA,Rural,18-35,2024-01,Q1_2024,2023,9.3,0.005,Increasing
FIA000140,2024-02-14,Omeprazole,Prilosec,Proton Pump Inhibitors,18973-286-27,Medicaid Plan X,PLAN_2808,2024,Tier 3,Tier 1,2023-06-13,246,Worsened,Prior Authorization,Yes,No,,317,919,-65.5,Decreased,81.27,12.75,68.52,100.19,181.46,57.52,0.471,8,0.067,0.266,0.39,0.743,6,5,0,4,2.1,21.0,3,Lower,Midwest,PA,Urban,66-75,2024-02,Q1_2024,2023,7.5,0.233,Increasing
FIA000550,2024-02-24,Omeprazole,Prilosec,Proton Pump Inhibitors,67799-541-60,Commercial Plan Beta,PLAN_6016,2024,Specialty Tier,Tier 2,2023-12-13,73,Worsened,None,No,No,,291,470,-38.1,Decreased,214.07,44.13,169.94,141.52,355.59,103.48,0.0,0,0.114,0.262,0.332,0.524,13,5,0,9,3.9,16.3,5,Lower,Southeast,FL,Suburban,36-50,2024-02,Q1_2024,2023,4.9,0.834,Increasing
FIA001295,2024-02-26,Omeprazole,Prilosec,Proton Pump Inhibitors,23365-501-28,VA Plan,PLAN_8997,2024,Non-Formulary,Tier 3,2023-05-26,276,Worsened,Non-Formulary Status,No,No,,206,203,1.8,Stable,366.77,61.06,305.71,123.95,490.72,101.09,0.0,0,0.057,0.176,0.265,0.571,7,10,3,8,3.2,5.2,8,Lower,Southeast,MI,Suburban,51-65,2024-02,Q1_2024,2023,8.8,0.361,Decreasing
FIA001989,2024-02-26,Omeprazole,Prilosec,Proton Pump Inhibitors,66743-243-91,Medicare Part D Plan A,PLAN_7911,2024,Tier 1,Non-Formulary,2023-04-29,303,Improved,None,No,No,,770,656,17.4,Increased,10.49,365.42,-354.93,94.83,105.32,81.1,0.0,0,0.072,0.163,0.479,0.447,12,5,8,15,4.5,19.5,4,Lower,Northeast,PA,Urban,51-65,2024-02,Q1_2024,2023,2.3,0.555,Stable
FIA001231,2024-02-28,Omeprazole,Prilosec,Proton Pump Inhibitors,99624-911-20,Tricare Standard,PLAN_4348,2024,Specialty Tier,Specialty Tier,2023-09-28,153,No Change,Step Therapy,No,Yes,,864,896,-3.5,Stable,161.3,209.98,-48.68,164.36,325.66,281.37,0.0,0,0.162,0.335,0.481,0.597,10,5,6,5,3.3,23.5,3,Similar,Midwest,NC,Urban,66-75,2024-02,Q1_2024,2023,2.3,0.954,Decreasing
FIA002058,2024-03-02,Omeprazole,Prilosec,Proton Pump Inhibitors,94578-746-30,VA Plan,PLAN_4312,2024,Tier 1,Non-Formulary,2023-03-14,354,Improved,None,No,No,,1010,709,42.6,Increased,6.51,752.22,-745.71,149.57,156.08,157.64,0.0,0,0.053,0.138,0.236,0.482,5,0,9,4,2.8,8.3,4,Lower,Northeast,GA,Urban,75+,2024-03,Q1_2024,2023,2.0,0.067,Decreasing
FIA000795,2024-03-05,Omeprazole,Prilosec,Proton Pump Inhibitors,47598-765-40,Medicaid Plan X,PLAN_9231,2024,Specialty Tier,Specialty Tier,2023-05-05,305,No Change,Prior Authorization,Yes,No,,786,728,8.0,Increased,162.63,108.23,54.4,76.34,238.97,187.83,0.487,6,0.144,0.098,0.448,0.505,14,4,0,7,3.4,19.0,6,Similar,Midwest,CA,Suburban,36-50,2024-03,Q1_2024,2023,1.2,0.867,Stable
FIA001014,2024-03-12,Omeprazole,Prilosec,Proton Pump Inhibitors,18830-492-75,Medicare Part D Plan A,PLAN_6528,2024,Tier 3,Tier 2,2024-01-04,68,Worsened,None,No,No,,80,187,-57.0,Decreased,62.99,42.88,20.11,87.45,150.44,12.04,0.0,0,0.017,0.203,0.665,0.447,10,4,3,6,2.7,10.9,5,Similar,Northeast,FL,Rural,51-65,2024-03,Q1_2024,2023,9.8,0.597,Increasing
FIA002647,2024-03-16,Omeprazole,Prilosec,Proton Pump Inhibitors,87042-363-78,Medicaid Plan X,PLAN_8410,2024,Tier 2,Tier 1,2023-11-14,123,Worsened,Quantity Limit,No,No,,443,421,5.2,Increased,44.16,19.83,24.33,107.92,152.08,67.37,0.0,0,0.051,0.362,0.794,0.673,12,9,9,11,3.9,14.2,6,Lower,Northeast,MI,Rural,75+,2024-03,Q1_2024,2023,6.4,0.054,Increasing
FIA000878,2024-03-25,Omeprazole,Prilosec,Proton Pump Inhibitors,32450-918-24,Medicare Part D Plan A,PLAN_8728,2024,Tier 1,Non-Formulary,2023-12-12,104,Improved,None,No,No,,571,358,59.7,Increased,13.67,299.68,-286.01,67.94,81.61,46.6,0.0,0,0.046,0.289,0.565,0.511,5,10,14,7,4.1,34.4,8,Similar,West,IL,Urban,36-50,2024-03,Q1_2024,2023,1.0,0.134,Increasing
FIA002054,2024-04-16,Omeprazole,Prilosec,Proton Pump Inhibitors,61082-389-51,Medicaid Plan Y,PLAN_9247,2024,Tier 3,Tier 1,2024-01-06,101,Worsened,Step Therapy; Quantity Limit,No,Yes,30.0,75,123,-38.9,Decreased,53.21,7.81,45.4,157.09,210.3,15.77,0.0,0,0.079,0.052,0.678,0.54,2,2,8,8,3.1,16.3,6,Similar,Southwest,IL,Urban,66-75,2024-04,Q2_2024,2023,1.0,0.152,Decreasing
FIA001791,2024-05-08,Omeprazole,Prilosec,Proton Pump Inhibitors,31306-890-68,Commercial Plan Beta,PLAN_4517,2024,Tier 3,Tier 3,2024-03-10,59,No Change,Prior Authorization; Step Therapy,Yes,Yes,,137,135,1.8,Stable,70.62,57.62,13.0,186.99,257.61,35.29,0.308,3,0.077,0.333,0.324,0.907,15,3,2,13,4.4,10.2,3,Similar,West,NC,Urban,36-50,2024-05,Q2_2024,2023,9.0,0.045,Stable
FIA001083,2024-05-17,Omeprazole,Prilosec,Proton Pump Inhibitors,61498-915-96,Medicaid Plan Y,PLAN_3144,2024,Non-Formulary,Non-Formulary,2023-11-12,187,No Change,Non-Formulary Status,No,No,,373,392,-4.7,Stable,659.47,371.71,287.76,84.25,743.72,277.41,0.0,0,0.189,0.299,0.622,0.704,13,10,14,12,2.5,34.1,5,Lower,Midwest,NY,Urban,51-65,2024-05,Q2_2024,2023,9.1,0.939,Decreasing
FIA002620,2024-05-26,Omeprazole,Prilosec,Proton Pump Inhibitors,94769-282-34,Medicaid Plan Y,PLAN_2850,2024,Tier 1,Non-Formulary,2023-08-02,298,Improved,None,No,No,,1003,643,56.0,Increased,12.34,268.77,-256.43,197.85,210.19,210.82,0.0,0,0.047,0.256,0.876,0.411,11,8,12,1,3.0,25.2,4,Similar,West,TX,Suburban,66-75,2024-05,Q2_2024,2023,6.2,0.68,Increasing
FIA001199,2024-06-04,Omeprazole,Prilosec,Proton Pump Inhibitors,22820-155-60,VA Plan,PLAN_6349,2024,Tier 3,Tier 2,2023-12-22,165,Worsened,Step Therapy,No,Yes,,92,128,-27.5,Decreased,55.47,39.56,15.91,111.42,166.89,15.35,0.0,0,0.063,0.31,0.215,0.562,5,3,11,14,3.3,13.6,7,Similar,West,CA,Suburban,66-75,2024-06,Q2_2024,2023,1.8,0.337,Increasing
FIA000695,2024-06-27,Omeprazole,Prilosec,Proton Pump Inhibitors,79419-917-21,Tricare Standard,PLAN_9861,2024,Tier 1,Specialty Tier,2023-11-04,236,Improved,Quantity Limit,No,No,30.0,1223,772,58.5,Increased,7.73,218.07,-210.34,45.69,53.42,65.33,0.0,0,0.016,0.153,0.303,0.61,11,5,18,9,3.2,21.5,8,Lower,Southwest,FL,Urban,36-50,2024-06,Q2_2024,2023,5.1,0.144,Decreasing
FIA002817,2024-06-30,Omeprazole,Prilosec,Proton Pump Inhibitors,42013-287-46,Medicare Part D Plan A,PLAN_9546,2024,Tier 2,Tier 2,2023-12-05,208,No Change,None,No,No,,271,259,4.8,Stable,23.47,28.63,-5.16,80.12,103.59,28.07,0.0,0,0.074,0.291,0.371,0.684,3,6,17,4,4.9,16.5,6,Higher,Southeast,GA,Urban,75+,2024-06,Q2_2024,2023,4.7,0.666,Decreasing
FIA002988,2024-07-02,Omeprazole,Prilosec,Proton Pump Inhibitors,24408-158-24,Medicare Part D Plan B,PLAN_1726,2024,Tier 3,Specialty Tier,2024-03-03,121,Improved,Prior Authorization,Yes,No,,119,132,-9.8,Decreased,60.23,177.65,-117.42,56.8,117.03,13.93,0.253,10,0.031,0.315,0.74,0.881,6,10,14,1,4.4,24.8,6,Higher,Southwest,TX,Suburban,36-50,2024-07,Q3_2024,2023,7.5,0.179,Decreasing
FIA002481,2024-07-09,Omeprazole,Prilosec,Proton Pump Inhibitors,36126-610-33,Commercial Plan Alpha,PLAN_7770,2024,Tier 1,Tier 3,2024-05-13,57,Improved,None,No,No,,973,739,31.7,Increased,18.79,50.38,-31.59,104.19,122.98,119.66,0.0,0,0.068,0.227,0.794,0.612,4,8,17,8,2.8,14.3,4,Lower,Southeast,OH,Urban,36-50,2024-07,Q3_2024,2023,9.2,0.853,Decreasing
FIA001965,2024-07-13,Omeprazole,Prilosec,Proton Pump Inhibitors,19800-429-55,Tricare Standard,PLAN_3231,2024,Specialty Tier,Tier 3,2023-12-11,215,Worsened,Quantity Limit,No,No,,280,263,6.5,Increased,183.0,98.8,84.2,181.59,364.59,102.09,0.0,0,0.158,0.287,0.87,0.937,2,3,18,12,3.6,12.3,6,Higher,Northeast,FL,Rural,36-50,2024-07,Q3_2024,2023,6.2,0.433,Decreasing
FIA001009,2024-07-14,Omeprazole,Prilosec,Proton Pump Inhibitors,42020-681-93,Medicaid Plan X,PLAN_8198,2024,Non-Formulary,Tier 2,2024-04-10,95,Worsened,Non-Formulary Status,No,No,,263,551,-52.2,Decreased,282.47,26.63,255.84,188.56,471.03,123.88,0.0,0,0.134,0.181,0.731,0.757,10,5,15,15,4.2,28.4,6,Lower,Southwest,PA,Urban,18-35,2024-07,Q3_2024,2023,9.2,0.669,Increasing
FIA001818,2024-07-24,Omeprazole,Prilosec,Proton Pump Inhibitors,99487-472-30,Medicaid Plan Y,PLAN_9741,2024,Tier 3,Specialty Tier,2024-05-05,80,Improved,Quantity Limit,No,No,60.0,170,170,0.0,Stable,81.88,178.04,-96.16,65.51,147.39,25.06,0.0,0,0.051,0.354,0.766,0.578,10,1,10,8,2.3,13.7,5,Lower,Midwest,NY,Rural,66-75,2024-07,Q3_2024,2023,2.1,0.287,Increasing
FIA002437,2024-07-26,Omeprazole,Prilosec,Proton Pump Inhibitors,56777-551-70,Tricare Standard,PLAN_8600,2024,Tier 2,Non-Formulary,2024-05-24,63,Improved,None,No,No,,1017,731,39.1,Increased,33.33,409.71,-376.38,192.33,225.66,229.5,0.0,0,0.039,0.244,0.887,0.492,12,7,6,6,4.1,9.5,4,Similar,West,NY,Suburban,36-50,2024-07,Q3_2024,2023,8.8,0.061,Stable
FIA002983,2024-07-27,Omeprazole,Prilosec,Proton Pump Inhibitors,74738-490-98,Medicare Part D Plan B,PLAN_4544,2024,Specialty Tier,Tier 2,2023-08-05,357,Worsened,Step Therapy,No,Yes,,435,683,-36.2,Decreased,266.85,29.39,237.46,165.44,432.29,188.05,0.0,0,0.188,0.192,0.52,0.624,13,5,8,1,3.9,11.0,5,Higher,Southwest,PA,Rural,36-50,2024-07,Q3_2024,2023,6.5,0.077,Decreasing
FIA000596,2024-07-29,Omeprazole,Prilosec,Proton Pump Inhibitors,36350-345-92,Commercial Plan Alpha,PLAN_7997,2024,Tier 3,Tier 3,2023-08-26,338,No Change,None,No,No,,601,600,0.2,Stable,60.16,66.67,-6.51,163.88,224.04,134.65,0.0,0,0.016,0.378,0.559,0.678,5,8,2,11,4.4,19.4,5,Lower,Northeast,PA,Rural,66-75,2024-07,Q3_2024,2023,2.7,0.684,Stable
FIA001692,2024-07-29,Omeprazole,Prilosec,Proton Pump Inhibitors,49807-356-13,Commercial Plan Alpha,PLAN_2308,2024,Specialty Tier,Tier 2,2024-04-04,116,Worsened,None,No,No,,369,611,-39.5,Decreased,223.46,41.72,181.74,160.82,384.28,141.8,0.0,0,0.209,0.37,0.628,0.61,0,10,10,8,3.7,7.1,7,Similar,West,FL,Urban,75+,2024-07,Q3_2024,2023,3.0,0.328,Stable
FIA002517,2024-09-15,Omeprazole,Prilosec,Proton Pump Inhibitors,14038-161-19,Medicare Part D Plan A,PLAN_3252,2024,Non-Formulary,Tier 2,2024-06-28,79,Worsened,Non-Formulary Status,No,No,,383,500,-23.4,Decreased,264.29,23.29,241.0,186.91,451.2,172.81,0.0,0,0.236,0.26,0.527,0.696,4,9,0,9,2.8,27.4,4,Lower,Southwest,IL,Urban,51-65,2024-09,Q3_2024,2023,4.6,0.072,Increasing
FIA002760,2024-09-16,Omeprazole,Prilosec,Proton Pump Inhibitors,90828-786-81,Medicaid Plan X,PLAN_6975,2024,Tier 3,Tier 2,2024-06-17,91,Worsened,Quantity Limit,No,No,30.0,396,692,-42.8,Decreased,97.54,33.04,64.5,176.56,274.1,108.54,0.0,0,0.077,0.34,0.298,0.58,15,9,16,8,4.0,30.3,4,Similar,Southeast,GA,Rural,36-50,2024-09,Q3_2024,2023,1.0,0.517,Stable
FIA000823,2024-09-23,Omeprazole,Prilosec,Proton Pump Inhibitors,55273-939-23,Commercial Plan Beta,PLAN_1119,2024,Tier 3,Tier 3,2023-11-29,299,No Change,None,No,No,,157,159,-0.9,Stable,79.72,52.27,27.45,69.18,148.9,23.38,0.0,0,0.078,0.076,0.333,0.732,9,2,15,9,4.9,11.8,5,Higher,Southeast,IL,Suburban,75+,2024-09,Q3_2024,2023,4.7,0.769,Increasing
FIA000749,2024-09-28,Omeprazole,Prilosec,Proton Pump Inhibitors,65993-223-96,Tricare Standard,PLAN_2774,2024,Tier 1,Tier 3,2023-12-26,277,Improved,None,No,No,,887,557,59.3,Increased,17.73,84.59,-66.86,187.75,205.48,182.26,0.0,0,0.053,0.182,0.697,0.639,12,6,14,13,2.9,23.2,7,Higher,Southwest,NC,Urban,36-50,2024-09,Q3_2024,2023,3.6,0.266,Increasing
FIA000049,2024-10-02,Omeprazole,Prilosec,Proton Pump Inhibitors,48058-407-30,Commercial Plan Alpha,PLAN_6922,2024,Tier 1,Tier 2,2024-07-27,67,Improved,None,No,No,,610,555,9.9,Increased,11.78,46.96,-35.18,123.5,135.28,82.52,0.0,0,0.06,0.228,0.285,0.511,4,3,15,0,3.1,22.2,5,Higher,Southeast,MI,Urban,18-35,2024-10,Q4_2024,2024,3.8,1.0,Decreasing
FIA001209,2024-10-09,Omeprazole,Prilosec,Proton Pump Inhibitors,29799-112-87,Medicaid Plan X,PLAN_4033,2024,Tier 2,Tier 2,2024-04-01,191,No Change,Quantity Limit,No,No,,644,601,7.3,Increased,39.52,26.98,12.54,182.3,221.82,142.85,0.0,0,0.017,0.204,0.367,0.665,3,5,20,14,2.2,26.3,4,Lower,Midwest,CA,Rural,51-65,2024-10,Q4_2024,2024,10.0,0.136,Stable
FIA002372,2024-10-09,Omeprazole,Prilosec,Proton Pump Inhibitors,61540-932-33,Commercial Plan Alpha,PLAN_9191,2024,Tier 2,Tier 2,2024-08-25,45,No Change,None,No,No,,112,109,2.8,Stable,29.03,36.42,-7.39,79.1,108.13,12.11,0.0,0,0.025,0.387,0.833,0.732,4,8,2,15,2.5,10.3,8,Lower,Southeast,PA,Suburban,66-75,2024-10,Q4_2024,2024,2.5,0.021,Decreasing
FIA000286,2024-10-21,Omeprazole,Prilosec,Proton Pump Inhibitors,14903-397-30,Commercial Plan Alpha,PLAN_8587,2024,Tier 3,Specialty Tier,2024-03-23,212,Improved,Step Therapy,No,Yes,,192,199,-3.4,Stable,98.69,240.53,-141.84,111.08,209.77,40.28,0.0,0,0.066,0.078,0.638,0.924,7,3,20,4,4.3,9.8,6,Higher,West,NC,Suburban,66-75,2024-10,Q4_2024,2024,8.1,0.339,Stable
FIA001948,2024-10-23,Omeprazole,Prilosec,Proton Pump Inhibitors,36377-839-75,Medicare Part D Plan A,PLAN_3894,2024,Specialty Tier,Tier 1,2023-11-25,333,Worsened,None,No,No,,310,840,-63.0,Decreased,225.4,15.7,209.7,131.44,356.84,110.62,0.0,0,0.281,0.202,0.73,0.88,4,8,1,7,2.2,8.2,3,Lower,Southwest,IL,Rural,75+,2024-10,Q4_2024,2024,1.8,0.784,Stable
FIA001569,2024-10-27,Omeprazole,Prilosec,Proton Pump Inhibitors,25076-358-23,Medicare Part D Plan A,PLAN_6672,2024,Tier 1,Specialty Tier,2024-04-09,201,Improved,None,No,No,,336,245,37.4,Increased,5.22,179.98,-174.76,75.79,81.01,27.22,0.0,0,0.023,0.094,0.864,0.746,6,6,9,5,3.4,9.6,2,Lower,Southwest,PA,Rural,51-65,2024-10,Q4_2024,2024,9.5,0.203,Stable
FIA002909,2024-11-01,Omeprazole,Prilosec,Proton Pump Inhibitors,97997-408-84,Medicaid Plan X,PLAN_6835,2024,Tier 3,Tier 2,2024-06-14,140,Worsened,None,No,No,,288,689,-58.1,Decreased,84.84,43.09,41.75,116.65,201.49,58.03,0.0,0,0.074,0.368,0.269,0.416,4,9,0,6,3.2,20.1,4,Lower,Southwest,PA,Urban,75+,2024-11,Q4_2024,2024,9.4,0.662,Decreasing
FIA002799,2024-11-11,Omeprazole,Prilosec,Proton Pump Inhibitors,48893-461-48,Medicare Part D Plan A,PLAN_8101,2024,Tier 3,Specialty Tier,2024-07-22,112,Improved,Prior Authorization; Quantity Limit,Yes,No,30.0,532,580,-8.1,Decreased,74.34,241.82,-167.48,98.23,172.57,91.81,0.525,4,0.078,0.278,0.781,0.436,2,3,9,5,3.3,27.0,2,Lower,West,GA,Rural,36-50,2024-11,Q4_2024,2024,8.8,0.508,Increasing
FIA001848,2024-11-18,Omeprazole,Prilosec,Proton Pump Inhibitors,97308-187-78,Commercial Plan Beta,PLAN_8885,2024,Tier 3,Non-Formulary,2024-09-28,51,Improved,None,No,No,,564,614,-8.0,Decreased,91.83,400.61,-308.78,84.86,176.69,99.65,0.0,0,0.051,0.194,0.343,0.652,1,0,10,14,5.0,11.5,4,Lower,Northeast,NC,Urban,66-75,2024-11,Q4_2024,2024,4.2,0.969,Decreasing
FIA000467,2024-11-22,Omeprazole,Prilosec,Proton Pump Inhibitors,84897-760-95,Medicaid Plan X,PLAN_7678,2024,Specialty Tier,Tier 2,2024-01-27,300,Worsened,None,No,No,,251,348,-27.7,Decreased,229.55,31.99,197.56,59.05,288.6,72.44,0.0,0,0.124,0.154,0.214,0.884,4,5,16,13,2.6,14.3,8,Similar,Northeast,GA,Urban,66-75,2024-11,Q4_2024,2024,3.6,0.982,Stable
FIA002989,2024-11-22,Omeprazole,Prilosec,Proton Pump Inhibitors,70473-154-67,Commercial Plan Beta,PLAN_2192,2024,Tier 2,Tier 2,2023-11-24,364,No Change,None,No,No,,609,642,-5.0,Decreased,37.38,49.19,-11.81,58.84,96.22,58.6,0.0,0,0.015,0.374,0.542,0.663,14,6,5,6,3.3,31.0,5,Similar,Southwest,OH,Urban,66-75,2024-11,Q4_2024,2024,4.6,0.735,Stable
FIA000020,2024-11-24,Omeprazole,Prilosec,Proton Pump Inhibitors,63005-808-41,Medicaid Plan X,PLAN_7046,2024,Tier 1,Tier 2,2024-03-31,238,Improved,None,No,No,,803,807,-0.5,Stable,12.33,42.74,-30.41,80.02,92.35,74.16,0.0,0,0.011,0.216,0.572,0.634,10,5,14,8,2.9,11.9,7,Lower,Midwest,TX,Rural,75+,2024-11,Q4_2024,2024,9.6,0.69,Increasing
FIA001403,2024-11-26,Omeprazole,Prilosec,Proton Pump Inhibitors,17954-259-88,Medicaid Plan X,PLAN_9775,2024,Tier 3,Tier 3,2024-07-04,145,No Change,Prior Authorization,Yes,No,,761,734,3.8,Stable,51.23,91.15,-39.92,166.53,217.76,165.72,0.235,1,0.069,0.156,0.497,0.689,1,8,14,12,2.6,31.9,4,Higher,Southeast,GA,Urban,51-65,2024-11,Q4_2024,2024,5.0,0.465,Increasing
FIA000495,2024-11-30,Omeprazole,Prilosec,Proton Pump Inhibitors,55886-591-69,Medicaid Plan Y,PLAN_5265,2024,Specialty Tier,Tier 3,2024-02-24,280,Worsened,Prior Authorization,Yes,No,,556,574,-3.1,Stable,132.03,85.88,46.15,60.71,192.74,107.16,0.433,6,0.094,0.247,0.386,0.475,4,9,1,10,2.4,7.7,8,Higher,Southwest,OH,Rural,75+,2024-11,Q4_2024,2024,3.2,0.102,Increasing
FIA000064,2024-12-03,Omeprazole,Prilosec,Proton Pump Inhibitors,78742-426-99,VA Plan,PLAN_7688,2024,Specialty Tier,Tier 3,2024-06-16,170,Worsened,Prior Authorization,Yes,No,,1047,1000,4.7,Stable,112.19,97.43,14.76,144.13,256.32,268.37,0.586,3,0.285,0.155,0.329,0.696,7,3,9,4,4.4,32.4,6,Similar,Southwest,NC,Rural,36-50,2024-12,Q4_2024,2024,4.5,0.255,Stable
FIA001669,2024-12-07,Omeprazole,Prilosec,Proton Pump Inhibitors,94796-564-49,Tricare Standard,PLAN_5230,2024,Tier 1,Tier 3,2024-01-20,322,Improved,None,No,No,,208,178,17.4,Increased,15.0,53.38,-38.38,167.13,182.13,37.88,0.0,0,0.019,0.295,0.265,0.572,15,9,13,3,5.0,31.1,4,Lower,Southeast,NC,Urban,36-50,2024-12,Q4_2024,2024,7.7,0.173,Stable
FIA002771,2024-12-12,Omeprazole,Prilosec,Proton Pump Inhibitors,91824-828-50,Medicaid Plan X,PLAN_7565,2024,Tier 3,Tier 1,2024-04-14,242,Worsened,None,No,No,,85,126,-31.9,Decreased,73.91,5.08,68.83,103.24,177.15,15.06,0.0,0,0.047,0.218,0.773,0.909,10,2,5,3,3.7,17.7,8,Similar,Midwest,NC,Urban,66-75,2024-12,Q4_2024,2024,1.8,0.757,Increasing
FIA000979,2024-12-16,Omeprazole,Prilosec,Proton Pump Inhibitors,37927-543-52,Medicaid Plan X,PLAN_1118,2024,Non-Formulary,Tier 3,2024-04-05,255,Worsened,Non-Formulary Status,No,No,,318,300,6.1,Increased,518.54,63.45,455.09,89.72,608.26,193.43,0.0,0,0.26,0.354,0.814,0.741,15,2,16,1,3.8,10.7,8,Similar,West,NC,Urban,66-75,2024-12,Q4_2024,2024,8.2,0.256,Decreasing
FIA000552,2024-12-24,Omeprazole,Prilosec,Proton Pump Inhibitors,97616-641-73,VA Plan,PLAN_1458,2024,Tier 2,Tier 2,2024-07-14,163,No Change,None,No,No,,143,135,6.2,Increased,48.48,48.48,0.0,92.19,140.67,20.12,0.0,0,0.059,0.181,0.703,0.603,14,6,18,8,3.5,28.9,5,Higher,Midwest,IL,Urban,51-65,2024-12,Q4_2024,2024,9.7,0.437,Decreasing
FIA000172,2024-12-26,Omeprazole,Prilosec,Proton Pump Inhibitors,79637-752-55,VA Plan,PLAN_5466,2024,Specialty Tier,Specialty Tier,2024-03-29,272,No Change,None,No,No,,491,545,-9.8,Decreased,152.53,206.09,-53.56,46.55,199.08,97.75,0.0,0,0.289,0.167,0.387,0.454,12,7,7,6,3.6,25.3,3,Similar,West,CA,Rural,18-35,2024-12,Q4_2024,2024,8.5,0.012,Increasing
FIA000121,2024-12-28,Omeprazole,Prilosec,Proton Pump Inhibitors,58906-111-80,Commercial Plan Alpha,PLAN_3019,2024,Tier 2,Specialty Tier,2024-02-23,309,Improved,Quantity Limit,No,No,,589,405,45.5,Increased,28.85,226.81,-197.96,153.99,182.84,107.69,0.0,0,0.066,0.052,0.618,0.695,2,4,6,11,2.6,32.2,8,Higher,Southeast,FL,Urban,36-50,2024-12,Q4_2024,2024,6.6,0.253,Increasing
FIA001303,2025-01-13,Omeprazole,Prilosec,Proton Pump Inhibitors,18541-695-92,Medicare Part D Plan B,PLAN_1284,2025,Tier 1,Tier 2,2024-03-02,317,Improved,None,No,No,,216,207,4.8,Stable,18.52,28.69,-10.17,54.19,72.71,15.71,0.0,0,0.038,0.165,0.791,0.885,14,0,19,11,4.9,13.8,8,Similar,Midwest,PA,Urban,66-75,2025-01,Q1_2025,2024,6.3,0.988,Increasing
FIA002850,2025-02-07,Omeprazole,Prilosec,Proton Pump Inhibitors,21089-789-17,Commercial Plan Alpha,PLAN_6626,2025,Tier 1,Tier 2,2024-09-27,133,Improved,None,No,No,,301,277,8.9,Increased,5.47,35.24,-29.77,137.17,142.64,42.93,0.0,0,0.018,0.112,0.229,0.635,3,2,4,12,4.5,25.4,7,Lower,Midwest,FL,Suburban,51-65,2025-02,Q1_2025,2024,6.0,0.272,Stable
FIA001786,2025-02-16,Omeprazole,Prilosec,Proton Pump Inhibitors,16874-338-47,Commercial Plan Alpha,PLAN_8048,2025,Tier 2,Specialty Tier,2024-07-03,228,Improved,None,No,No,,526,412,27.8,Increased,42.86,269.69,-226.83,77.94,120.8,63.54,0.0,0,0.043,0.38,0.526,0.811,8,5,12,13,4.2,31.0,2,Similar,Midwest,OH,Rural,18-35,2025-02,Q1_2025,2024,9.0,0.92,Decreasing
FIA001593,2025-02-23,Omeprazole,Prilosec,Proton Pump Inhibitors,97168-567-33,Medicare Part D Plan A,PLAN_4547,2025,Non-Formulary,Tier 1,2024-08-13,194,Worsened,Non-Formulary Status,No,No,,591,862,-31.3,Decreased,316.33,5.44,310.89,155.96,472.29,279.12,0.0,0,0.148,0.103,0.712,0.686,6,2,7,14,4.7,19.4,4,Similar,Southwest,GA,Rural,51-65,2025-02,Q1_2025,2024,9.4,0.388,Decreasing
FIA002729,2025-03-17,Omeprazole,Prilosec,Proton Pump Inhibitors,51077-756-45,Medicaid Plan X,PLAN_9595,2025,Tier 3,Tier 3,2024-12-14,93,No Change,Step Therapy,No,Yes,,324,328,-1.1,Stable,51.12,94.71,-43.59,75.13,126.25,40.91,0.0,0,0.035,0.064,0.339,0.76,8,4,12,1,2.5,13.7,5,Lower,Southeast,OH,Rural,66-75,2025-03,Q1_2025,2024,9.7,0.954,Decreasing
FIA002860,2025-03-22,Omeprazole,Prilosec,Proton Pump Inhibitors,47334-826-58,Commercial Plan Alpha,PLAN_3682,2025,Tier 1,Tier 3,2024-06-27,268,Improved,None,No,No,,643,499,28.9,Increased,13.95,87.78,-73.83,62.61,76.56,49.23,0.0,0,0.041,0.15,0.482,0.549,14,2,5,7,2.3,26.9,7,Lower,Northeast,PA,Urban,18-35,2025-03,Q1_2025,2024,6.7,0.948,Increasing
FIA002222,2025-04-06,Omeprazole,Prilosec,Proton Pump Inhibitors,66815-305-77,VA Plan,PLAN_9338,2025,Tier 2,Tier 3,2024-08-13,236,Improved,Quantity Limit,No,No,,1020,804,27.0,Increased,41.26,82.61,-41.35,186.35,227.61,232.16,0.0,0,0.076,0.086,0.697,0.607,6,0,1,10,2.9,17.1,8,Lower,Midwest,MI,Suburban,51-65,2025-04,Q2_2025,2024,2.3,0.562,Decreasing
FIA000460,2025-04-08,Omeprazole,Prilosec,Proton Pump Inhibitors,12799-783-45,Commercial Plan Beta,PLAN_3819,2025,Non-Formulary,Tier 3,2025-03-09,30,Worsened,Non-Formulary Status,No,No,,488,465,5.1,Increased,456.26,67.45,388.81,136.63,592.89,289.33,0.0,0,0.074,0.338,0.364,0.425,5,3,6,6,2.4,18.8,7,Similar,Southeast,MI,Urban,18-35,2025-04,Q2_2025,2024,2.1,0.912,Increasing
FIA002243,2025-04-30,Omeprazole,Prilosec,Proton Pump Inhibitors,47714-296-62,Medicare Part D Plan B,PLAN_5633,2025,Non-Formulary,Specialty Tier,2024-05-10,355,Worsened,Non-Formulary Status,No,No,,502,506,-0.7,Stable,508.34,132.51,375.83,40.86,549.2,275.7,0.0,0,0.155,0.222,0.429,0.476,14,8,17,4,2.7,15.2,3,Lower,West,PA,Suburban,51-65,2025-04,Q2_2025,2024,7.4,0.39,Increasing
FIA000778,2025-05-10,Omeprazole,Prilosec,Proton Pump Inhibitors,46800-591-25,Commercial Plan Beta,PLAN_1334,2025,Tier 3,Tier 1,2025-03-19,52,Worsened,None,No,No,,285,860,-66.8,Decreased,95.39,5.75,89.64,117.31,212.7,60.62,0.0,0,0.022,0.081,0.28,0.783,12,10,1,15,3.0,18.4,6,Higher,West,PA,Rural,66-75,2025-05,Q2_2025,2024,9.0,0.582,Stable
FIA000231,2025-05-26,Omeprazole,Prilosec,Proton Pump Inhibitors,99441-717-82,Commercial Plan Alpha,PLAN_2070,2025,Tier 1,Tier 2,2024-06-04,356,Improved,None,No,No,,682,682,0.0,Stable,10.94,46.1,-35.16,126.17,137.11,93.51,0.0,0,0.056,0.256,0.722,0.47,7,8,8,6,4.5,5.7,7,Higher,West,MI,Suburban,75+,2025-05,Q2_2025,2024,8.9,0.002,Stable
FIA000432,2025-05-27,Omeprazole,Prilosec,Proton Pump Inhibitors,40263-488-86,Tricare Standard,PLAN_1397,2025,Tier 3,Tier 2,2025-03-19,69,Worsened,None,No,No,,347,486,-28.4,Decreased,80.05,40.97,39.08,151.54,231.59,80.36,0.0,0,0.029,0.29,0.594,0.755,2,7,0,12,3.7,15.8,2,Similar,Southwest,GA,Suburban,18-35,2025-05,Q2_2025,2024,4.9,0.348,Stable
FIA001320,2025-05-28,Omeprazole,Prilosec,Proton Pump Inhibitors,52407-438-66,Medicare Part D Plan A,PLAN_1670,2025,Tier 1,Non-Formulary,2024-06-01,361,Improved,None,No,No,,249,171,45.9,Increased,15.32,376.58,-361.26,198.92,214.24,53.35,0.0,0,0.024,0.216,0.44,0.613,15,2,7,1,3.1,11.3,5,Similar,Southwest,NC,Urban,66-75,2025-05,Q2_2025,2024,7.3,0.647,Stable
FIA000409,2025-06-02,Omeprazole,Prilosec,Proton Pump Inhibitors,79367-602-69,Medicaid Plan X,PLAN_2096,2025,Tier 2,Specialty Tier,2024-07-19,318,Improved,None,No,No,,963,623,54.6,Increased,34.09,103.88,-69.79,84.68,118.77,114.38,0.0,0,0.02,0.207,0.744,0.835,8,2,11,1,3.4,11.7,2,Similar,Midwest,MI,Suburban,75+,2025-06,Q2_2025,2024,2.3,0.273,Stable
FIA000570,2025-06-02,Omeprazole,Prilosec,Proton Pump Inhibitors,81046-663-57,Medicare Part D Plan A,PLAN_4353,2025,Tier 1,Tier 3,2024-10-31,214,Improved,None,No,No,,1053,812,29.7,Increased,13.29,59.46,-46.17,67.88,81.17,85.47,0.0,0,0.016,0.154,0.328,0.856,5,10,4,1,4.6,10.8,5,Similar,Southeast,PA,Suburban,36-50,2025-06,Q2_2025,2024,6.9,0.019,Increasing
FIA000937,2025-06-06,Omeprazole,Prilosec,Proton Pump Inhibitors,14326-572-43,Medicare Part D Plan A,PLAN_7243,2025,Tier 1,Tier 2,2025-03-04,94,Improved,Quantity Limit,No,No,30.0,349,361,-3.1,Stable,17.68,31.67,-13.99,31.72,49.4,17.24,0.0,0,0.026,0.167,0.503,0.589,4,4,14,12,4.2,16.0,3,Similar,West,NY,Suburban,75+,2025-06,Q2_2025,2024,6.3,0.025,Decreasing
FIA001153,2025-06-09,Omeprazole,Prilosec,Proton Pump Inhibitors,20866-925-32,Tricare Standard,PLAN_6578,2025,Tier 2,Tier 3,2024-07-08,336,Improved,None,No,No,,765,569,34.6,Increased,32.44,57.1,-24.66,121.61,154.05,117.85,0.0,0,0.027,0.131,0.378,0.693,11,5,20,15,4.5,29.6,8,Lower,Southeast,FL,Rural,18-35,2025-06,Q2_2025,2024,1.8,0.454,Increasing
FIA002715,2025-06-09,Omeprazole,Prilosec,Proton Pump Inhibitors,94630-564-44,Commercial Plan Alpha,PLAN_4658,2025,Tier 2,Tier 3,2024-08-31,282,Improved,None,No,No,,561,361,55.4,Increased,29.57,72.42,-42.85,89.87,119.44,67.01,0.0,0,0.048,0.223,0.516,0.417,7,9,6,8,4.9,11.3,3,Higher,Midwest,TX,Rural,51-65,2025-06,Q2_2025,2024,4.5,0.537,Decreasing
FIA000734,2025-06-21,Omeprazole,Prilosec,Proton Pump Inhibitors,98737-387-99,Tricare Standard,PLAN_2048,2025,Specialty Tier,Non-Formulary,2024-09-15,279,Improved,Prior Authorization,Yes,No,,163,159,2.9,Stable,116.95,237.08,-120.13,87.89,204.84,33.39,0.288,9,0.096,0.309,0.448,0.73,0,7,18,4,2.7,13.6,8,Similar,Southeast,FL,Rural,36-50,2025-06,Q2_2025,2024,1.7,0.385,Decreasing
FIA001974,2025-06-22,Omeprazole,Prilosec,Proton Pump Inhibitors,58201-950-20,Medicaid Plan X,PLAN_6726,2025,Non-Formulary,Specialty Tier,2025-01-09,164,Worsened,Non-Formulary Status,No,No,,135,127,6.4,Increased,570.69,107.22,463.47,104.6,675.29,91.16,0.0,0,0.152,0.17,0.739,0.727,9,4,9,4,4.4,23.0,7,Similar,Southeast,GA,Urban,66-75,2025-06,Q2_2025,2024,6.1,0.164,Increasing
FIA002313,2025-07-04,Omeprazole,Prilosec,Proton Pump Inhibitors,60575-342-97,Commercial Plan Alpha,PLAN_2421,2025,Non-Formulary,Tier 3,2024-08-19,319,Worsened,Non-Formulary Status,No,No,,959,998,-3.9,Stable,337.41,79.64,257.77,162.44,499.85,479.36,0.0,0,0.13,0.244,0.511,0.405,12,2,13,13,2.3,6.3,8,Similar,Midwest,GA,Suburban,18-35,2025-07,Q3_2025,2024,6.8,0.969,Decreasing
FIA000873,2025-07-10,Omeprazole,Prilosec,Proton Pump Inhibitors,78979-844-60,Medicaid Plan X,PLAN_2991,2025,Specialty Tier,Tier 3,2024-12-30,192,Worsened,Prior Authorization,Yes,No,,222,241,-7.5,Decreased,244.93,53.51,191.42,157.61,402.54,89.36,0.17,8,0.153,0.185,0.647,0.745,7,0,4,6,3.2,27.9,7,Higher,Southwest,MI,Urban,66-75,2025-07,Q3_2025,2024,5.6,0.317,Decreasing
FIA002253,2025-07-11,Omeprazole,Prilosec,Proton Pump Inhibitors,74054-668-14,Medicare Part D Plan B,PLAN_9524,2025,Tier 3,Specialty Tier,2024-10-10,274,Improved,Prior Authorization,Yes,No,,167,173,-3.1,Stable,94.45,218.48,-124.03,63.22,157.67,26.33,0.238,8,0.032,0.39,0.703,0.449,0,0,12,6,2.9,22.8,8,Lower,Southeast,MI,Rural,36-50,2025-07,Q3_2025,2024,4.4,0.149,Increasing
FIA000238,2025-07-26,Omeprazole,Prilosec,Proton Pump Inhibitors,26575-971-75,Tricare Standard,PLAN_4428,2025,Tier 1,Non-Formulary,2024-08-30,330,Improved,None,No,No,,1104,908,21.7,Increased,7.84,521.28,-513.44,77.61,85.45,94.34,0.0,0,0.054,0.305,0.749,0.835,2,2,16,12,4.3,24.4,6,Similar,Southwest,NC,Suburban,36-50,2025-07,Q3_2025,2024,3.9,0.374,Decreasing
FIA000509,2025-08-01,Omeprazole,Prilosec,Proton Pump Inhibitors,29456-321-72,Medicaid Plan X,PLAN_1804,2025,Tier 1,Tier 2,2024-11-07,267,Improved,None,No,No,,917,933,-1.7,Stable,13.85,40.55,-26.7,192.43,206.28,189.16,0.0,0,0.074,0.22,0.6,0.537,5,5,13,5,2.6,25.7,6,Higher,West,MI,Suburban,75+,2025-08,Q3_2025,2024,6.1,0.114,Decreasing
FIA001528,2025-08-03,Omeprazole,Prilosec,Proton Pump Inhibitors,62239-634-84,Commercial Plan Alpha,PLAN_6660,2025,Non-Formulary,Tier 2,2025-03-01,155,Worsened,Non-Formulary Status,No,No,,368,639,-42.3,Decreased,503.28,41.73,461.55,123.79,627.07,230.76,0.0,0,0.178,0.229,0.872,0.516,13,8,3,12,3.0,27.3,3,Similar,Northeast,GA,Rural,75+,2025-08,Q3_2025,2024,8.5,0.632,Increasing
FIA000321,2025-08-31,Omeprazole,Prilosec,Proton Pump Inhibitors,36680-240-76,Commercial Plan Beta,PLAN_5996,2025,Non-Formulary,Tier 3,2025-02-19,193,Worsened,Non-Formulary Status,No,No,,150,155,-3.1,Stable,618.66,75.17,543.49,77.56,696.22,104.43,0.0,0,0.205,0.31,0.348,0.605,4,0,7,14,3.9,18.6,2,Lower,Southwest,CA,Suburban,51-65,2025-08,Q3_2025,2024,6.3,0.3,Increasing
FIA002602,2022-01-08,Prednisone,Deltasone,Corticosteroids,83412-483-22,VA Plan,PLAN_9362,2022,Non-Formulary,Non-Formulary,2021-02-12,330,No Change,Non-Formulary Status; Quantity Limit,No,No,90.0,488,458,6.7,Increased,775.17,705.77,69.4,49.86,825.03,402.61,0.0,0,0.066,0.111,0.416,0.942,14,8,16,2,4.4,29.0,6,Lower,Midwest,TX,Urban,75+,2022-01,Q1_2022,2021,7.3,0.187,Stable
FIA000759,2022-01-09,Prednisone,Deltasone,Corticosteroids,93814-574-16,Commercial Plan Beta,PLAN_1272,2022,Non-Formulary,Tier 2,2021-07-29,164,Worsened,Non-Formulary Status,No,No,,153,285,-46.1,Decreased,361.86,41.12,320.74,113.52,475.38,72.73,0.0,0,0.259,0.321,0.613,0.41,3,2,10,0,2.2,20.2,8,Higher,Northeast,GA,Suburban,36-50,2022-01,Q1_2022,2021,6.1,0.969,Stable
FIA000884,2022-01-15,Prednisone,Deltasone,Corticosteroids,38860-476-99,Medicaid Plan Y,PLAN_5833,2022,Non-Formulary,Specialty Tier,2021-10-17,90,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,989,918,7.8,Increased,702.06,186.35,515.71,133.56,835.62,826.43,0.0,0,0.083,0.259,0.327,0.579,11,9,13,14,3.0,19.9,6,Lower,Northeast,NY,Suburban,75+,2022-01,Q1_2022,2021,8.2,0.223,Decreasing
FIA001389,2022-01-27,Prednisone,Deltasone,Corticosteroids,24360-859-49,Commercial Plan Beta,PLAN_7767,2022,Tier 2,Non-Formulary,2021-02-06,355,Improved,None,No,No,,192,143,34.8,Increased,42.55,550.62,-508.07,137.16,179.71,34.5,0.0,0,0.018,0.223,0.384,0.408,4,1,14,14,2.8,30.0,7,Lower,Northeast,GA,Suburban,66-75,2022-01,Q1_2022,2021,4.0,0.023,Decreasing
FIA002612,2022-02-12,Prednisone,Deltasone,Corticosteroids,50687-276-53,VA Plan,PLAN_3995,2022,Non-Formulary,Tier 1,2021-05-19,269,Worsened,Non-Formulary Status,No,No,,489,783,-37.5,Decreased,295.06,17.73,277.33,67.87,362.93,177.47,0.0,0,0.177,0.319,0.863,0.561,2,10,3,5,4.9,12.4,4,Lower,Northeast,OH,Suburban,36-50,2022-02,Q1_2022,2021,5.0,0.911,Decreasing
FIA002482,2022-02-17,Prednisone,Deltasone,Corticosteroids,48159-520-40,Medicaid Plan X,PLAN_3854,2022,Non-Formulary,Non-Formulary,2021-05-09,284,No Change,Non-Formulary Status,No,No,,939,940,-0.1,Stable,487.98,782.63,-294.65,174.61,662.59,622.17,0.0,0,0.143,0.226,0.459,0.527,15,4,13,4,4.8,34.0,5,Similar,Southeast,GA,Urban,51-65,2022-02,Q1_2022,2021,7.4,0.649,Stable
FIA001666,2022-02-20,Prednisone,Deltasone,Corticosteroids,77139-980-76,Tricare Standard,PLAN_8994,2022,Tier 3,Tier 3,2021-10-26,117,No Change,Prior Authorization,Yes,No,,865,875,-1.1,Stable,94.1,64.8,29.3,31.08,125.18,108.28,0.35,10,0.017,0.316,0.793,0.443,12,9,18,5,2.4,8.4,7,Lower,Southwest,MI,Urban,18-35,2022-02,Q1_2022,2021,4.6,0.523,Decreasing
FIA001498,2022-03-03,Prednisone,Deltasone,Corticosteroids,82500-276-37,Commercial Plan Alpha,PLAN_5076,2022,Tier 1,Tier 2,2021-03-09,359,Improved,None,No,No,,484,493,-1.7,Stable,6.5,29.01,-22.51,124.2,130.7,63.26,0.0,0,0.074,0.157,0.869,0.798,6,5,12,13,3.5,9.9,3,Higher,West,OH,Suburban,66-75,2022-03,Q1_2022,2021,7.0,0.303,Decreasing
FIA001693,2022-03-11,Prednisone,Deltasone,Corticosteroids,93196-515-34,VA Plan,PLAN_4975,2022,Tier 2,Tier 2,2021-04-12,333,No Change,None,No,No,,151,165,-8.4,Decreased,27.02,30.7,-3.68,198.63,225.65,34.07,0.0,0,0.071,0.374,0.715,0.593,8,6,1,15,2.0,33.4,8,Similar,Southeast,IL,Rural,18-35,2022-03,Q1_2022,2021,5.4,0.606,Increasing
FIA000751,2022-03-18,Prednisone,Deltasone,Corticosteroids,84949-834-36,Medicaid Plan X,PLAN_8679,2022,Tier 1,Tier 1,2022-01-12,65,No Change,None,No,No,,250,255,-1.6,Stable,10.95,17.43,-6.48,89.27,100.22,25.05,0.0,0,0.019,0.368,0.619,0.875,6,3,10,9,3.5,26.4,4,Similar,Northeast,MI,Urban,18-35,2022-03,Q1_2022,2021,3.6,0.403,Decreasing
FIA001486,2022-03-23,Prednisone,Deltasone,Corticosteroids,54986-340-82,Medicaid Plan Y,PLAN_4033,2022,Tier 2,Tier 3,2021-06-05,291,Improved,None,No,No,,386,327,18.1,Increased,38.67,95.63,-56.96,94.61,133.28,51.45,0.0,0,0.019,0.374,0.267,0.808,10,4,5,8,2.0,15.4,7,Higher,Midwest,NY,Rural,66-75,2022-03,Q1_2022,2021,6.5,0.789,Decreasing
FIA002021,2022-03-26,Prednisone,Deltasone,Corticosteroids,12961-748-78,Tricare Standard,PLAN_5476,2022,Tier 1,Specialty Tier,2021-07-09,260,Improved,None,No,No,,842,637,32.3,Increased,19.13,121.19,-102.06,78.77,97.9,82.43,0.0,0,0.057,0.343,0.421,0.869,11,0,14,10,3.5,17.4,4,Higher,Southwest,NY,Rural,36-50,2022-03,Q1_2022,2021,1.9,0.555,Increasing
FIA001854,2022-03-27,Prednisone,Deltasone,Corticosteroids,65847-513-66,Commercial Plan Beta,PLAN_2602,2022,Non-Formulary,Tier 1,2021-06-24,276,Worsened,Non-Formulary Status,No,No,,370,799,-53.6,Decreased,719.44,13.48,705.96,72.22,791.66,292.91,0.0,0,0.295,0.369,0.35,0.731,12,2,16,12,2.7,21.3,5,Similar,Midwest,GA,Urban,18-35,2022-03,Q1_2022,2021,7.0,0.182,Stable
FIA001032,2022-04-07,Prednisone,Deltasone,Corticosteroids,88737-930-96,Medicare Part D Plan A,PLAN_4502,2022,Tier 3,Tier 3,2021-11-14,144,No Change,Prior Authorization; Step Therapy,Yes,Yes,,324,350,-7.3,Decreased,89.29,51.46,37.83,181.66,270.95,87.79,0.407,1,0.044,0.141,0.872,0.682,3,7,14,4,2.8,30.2,3,Similar,Southwest,CA,Suburban,75+,2022-04,Q2_2022,2021,2.1,0.929,Decreasing
FIA001140,2022-04-15,Prednisone,Deltasone,Corticosteroids,50043-257-68,Commercial Plan Beta,PLAN_5380,2022,Specialty Tier,Tier 3,2022-02-24,50,Worsened,None,No,No,,556,597,-6.8,Decreased,188.91,99.59,89.32,182.72,371.63,206.63,0.0,0,0.176,0.141,0.612,0.667,4,5,3,15,4.1,29.4,5,Higher,Midwest,PA,Suburban,51-65,2022-04,Q2_2022,2021,5.6,0.836,Decreasing
FIA000573,2022-05-19,Prednisone,Deltasone,Corticosteroids,51312-355-17,Commercial Plan Alpha,PLAN_5554,2022,Tier 1,Specialty Tier,2021-08-29,263,Improved,None,No,No,,841,548,53.5,Increased,10.48,263.16,-252.68,133.69,144.17,121.25,0.0,0,0.043,0.275,0.347,0.443,5,3,18,8,4.4,10.1,2,Lower,Midwest,FL,Urban,36-50,2022-05,Q2_2022,2021,5.9,0.458,Decreasing
FIA001290,2022-05-29,Prednisone,Deltasone,Corticosteroids,71469-683-72,Medicaid Plan Y,PLAN_7157,2022,Non-Formulary,Tier 1,2021-08-14,288,Worsened,Non-Formulary Status,No,No,,220,624,-64.6,Decreased,232.89,9.57,223.32,130.52,363.41,79.95,0.0,0,0.062,0.229,0.751,0.497,3,8,1,2,4.4,30.4,5,Similar,Southwest,FL,Rural,18-35,2022-05,Q2_2022,2021,7.4,0.693,Increasing
FIA001080,2022-06-09,Prednisone,Deltasone,Corticosteroids,82895-515-34,Medicare Part D Plan B,PLAN_3679,2022,Tier 1,Specialty Tier,2022-04-15,55,Improved,Quantity Limit,No,No,60.0,723,460,57.3,Increased,15.02,154.3,-139.28,185.1,200.12,144.69,0.0,0,0.05,0.34,0.513,0.763,0,4,20,9,3.6,7.4,3,Higher,West,TX,Rural,18-35,2022-06,Q2_2022,2021,9.2,0.1,Stable
FIA001021,2022-06-15,Prednisone,Deltasone,Corticosteroids,10432-607-71,Medicaid Plan Y,PLAN_1100,2022,Specialty Tier,Non-Formulary,2021-07-17,333,Improved,Prior Authorization; Step Therapy,Yes,Yes,,284,295,-3.6,Stable,137.42,248.52,-111.1,199.43,336.85,95.67,0.508,9,0.296,0.243,0.742,0.564,9,10,18,12,2.6,15.4,5,Higher,Southwest,OH,Urban,18-35,2022-06,Q2_2022,2021,3.1,0.934,Stable
FIA000277,2022-06-20,Prednisone,Deltasone,Corticosteroids,33165-362-12,Medicare Part D Plan B,PLAN_7258,2022,Non-Formulary,Tier 3,2022-03-14,98,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,473,432,9.7,Increased,445.01,80.57,364.44,194.09,639.1,302.29,0.0,0,0.105,0.355,0.644,0.703,14,3,10,8,2.6,23.9,8,Similar,Southeast,GA,Urban,66-75,2022-06,Q2_2022,2021,4.3,0.902,Increasing
FIA001573,2022-07-19,Prednisone,Deltasone,Corticosteroids,82541-253-38,Commercial Plan Beta,PLAN_9862,2022,Tier 2,Non-Formulary,2021-08-03,350,Improved,None,No,No,,700,575,21.9,Increased,24.62,771.46,-746.84,71.23,95.85,67.09,0.0,0,0.065,0.266,0.452,0.458,3,3,20,15,4.3,19.1,8,Lower,West,GA,Rural,36-50,2022-07,Q3_2022,2021,5.0,0.991,Stable
FIA001836,2022-07-25,Prednisone,Deltasone,Corticosteroids,97951-491-85,Medicaid Plan Y,PLAN_8567,2022,Specialty Tier,Non-Formulary,2022-01-14,192,Improved,Prior Authorization,Yes,No,,215,196,9.8,Increased,158.08,284.36,-126.28,141.19,299.27,64.34,0.292,2,0.099,0.388,0.769,0.749,11,7,0,1,2.3,21.4,4,Similar,Northeast,FL,Urban,51-65,2022-07,Q3_2022,2021,9.0,0.942,Increasing
FIA002857,2022-07-26,Prednisone,Deltasone,Corticosteroids,69164-991-51,Medicare Part D Plan A,PLAN_3765,2022,Specialty Tier,Tier 1,2021-11-26,242,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,493,671,-26.5,Decreased,125.96,12.49,113.47,77.82,203.78,100.46,0.425,7,0.167,0.093,0.662,0.687,3,8,20,12,2.2,30.2,4,Similar,Northeast,GA,Suburban,18-35,2022-07,Q3_2022,2021,6.9,0.858,Decreasing
FIA002400,2022-08-03,Prednisone,Deltasone,Corticosteroids,97139-609-50,Commercial Plan Beta,PLAN_2713,2022,Specialty Tier,Specialty Tier,2022-02-25,159,No Change,Quantity Limit,No,No,90.0,230,249,-7.6,Decreased,145.16,258.53,-113.37,195.39,340.55,78.33,0.0,0,0.164,0.329,0.406,0.783,2,6,20,8,3.4,26.9,7,Similar,Northeast,MI,Urban,51-65,2022-08,Q3_2022,2021,5.2,0.689,Stable
FIA000095,2022-08-10,Prednisone,Deltasone,Corticosteroids,72847-907-83,Commercial Plan Beta,PLAN_3664,2022,Tier 1,Tier 1,2021-12-26,227,No Change,Quantity Limit,No,No,90.0,290,270,7.7,Increased,11.57,11.29,0.28,93.81,105.38,30.56,0.0,0,0.035,0.076,0.792,0.562,10,4,3,2,3.0,31.6,3,Higher,Northeast,NC,Urban,51-65,2022-08,Q3_2022,2021,6.3,0.614,Stable
FIA002826,2022-08-10,Prednisone,Deltasone,Corticosteroids,60201-874-52,VA Plan,PLAN_4880,2022,Tier 2,Tier 2,2022-06-30,41,No Change,None,No,No,,494,536,-7.8,Decreased,37.47,46.27,-8.8,65.92,103.39,51.07,0.0,0,0.034,0.131,0.793,0.511,12,8,11,6,2.1,34.2,7,Similar,Northeast,NC,Suburban,51-65,2022-08,Q3_2022,2021,5.4,0.997,Stable
FIA001916,2022-08-14,Prednisone,Deltasone,Corticosteroids,87943-189-68,VA Plan,PLAN_5438,2022,Tier 2,Tier 2,2022-03-07,160,No Change,None,No,No,,383,361,6.3,Increased,45.83,37.46,8.37,147.15,192.98,73.91,0.0,0,0.022,0.238,0.836,0.632,9,8,20,2,2.1,22.9,4,Higher,Southwest,NC,Urban,75+,2022-08,Q3_2022,2021,3.2,0.519,Increasing
FIA002906,2022-08-15,Prednisone,Deltasone,Corticosteroids,71206-463-93,Tricare Standard,PLAN_2404,2022,Tier 3,Tier 2,2022-02-12,184,Worsened,Step Therapy,No,Yes,,64,197,-67.1,Decreased,75.09,49.38,25.71,63.08,138.17,8.84,0.0,0,0.047,0.124,0.401,0.815,11,2,4,11,4.4,18.0,7,Higher,Midwest,CA,Urban,66-75,2022-08,Q3_2022,2021,3.5,0.609,Stable
FIA001805,2022-08-31,Prednisone,Deltasone,Corticosteroids,29811-216-87,Tricare Standard,PLAN_5185,2022,Specialty Tier,Specialty Tier,2021-10-31,304,No Change,Prior Authorization; Step Therapy,Yes,Yes,,378,381,-0.6,Stable,144.94,137.98,6.96,164.83,309.77,117.09,0.56,5,0.284,0.197,0.738,0.511,13,8,2,11,4.0,7.2,4,Higher,Northeast,MI,Urban,66-75,2022-08,Q3_2022,2021,1.4,0.271,Stable
FIA000312,2022-09-06,Prednisone,Deltasone,Corticosteroids,30286-408-90,Medicaid Plan X,PLAN_1105,2022,Non-Formulary,Non-Formulary,2022-07-11,57,No Change,Non-Formulary Status,No,No,,707,675,4.8,Stable,620.94,509.76,111.18,138.74,759.68,537.09,0.0,0,0.274,0.332,0.637,0.51,2,0,4,3,3.6,12.4,2,Similar,Northeast,NC,Suburban,66-75,2022-09,Q3_2022,2021,1.5,0.122,Stable
FIA001844,2022-09-10,Prednisone,Deltasone,Corticosteroids,66900-148-49,Medicaid Plan X,PLAN_7378,2022,Specialty Tier,Tier 2,2022-03-23,171,Worsened,None,No,No,,658,900,-26.9,Decreased,258.27,42.78,215.49,113.44,371.71,244.59,0.0,0,0.189,0.1,0.348,0.555,9,5,15,2,3.7,7.3,5,Higher,Southwest,NY,Suburban,36-50,2022-09,Q3_2022,2021,8.7,0.074,Increasing
FIA001200,2022-09-21,Prednisone,Deltasone,Corticosteroids,91847-820-77,Medicare Part D Plan B,PLAN_7570,2022,Specialty Tier,Non-Formulary,2021-10-10,346,Improved,Step Therapy,No,Yes,,943,911,3.6,Stable,269.41,495.92,-226.51,185.16,454.57,428.66,0.0,0,0.166,0.335,0.588,0.537,15,1,10,3,2.3,12.7,7,Similar,Northeast,FL,Suburban,75+,2022-09,Q3_2022,2021,3.8,0.364,Stable
FIA002592,2022-09-22,Prednisone,Deltasone,Corticosteroids,59943-268-25,Tricare Standard,PLAN_6405,2022,Tier 3,Tier 1,2022-02-09,225,Worsened,Prior Authorization,Yes,No,,97,302,-67.6,Decreased,68.56,18.61,49.95,31.4,99.96,9.7,0.106,7,0.041,0.115,0.62,0.481,7,8,7,7,2.2,14.2,5,Higher,Southwest,OH,Suburban,66-75,2022-09,Q3_2022,2021,7.6,0.194,Stable
FIA002735,2022-10-01,Prednisone,Deltasone,Corticosteroids,31992-318-84,Commercial Plan Alpha,PLAN_7889,2022,Non-Formulary,Specialty Tier,2021-12-02,303,Worsened,Non-Formulary Status,No,No,,459,470,-2.2,Stable,355.13,258.4,96.73,48.22,403.35,185.14,0.0,0,0.094,0.174,0.802,0.828,8,4,8,6,3.5,18.3,8,Similar,Midwest,FL,Urban,51-65,2022-10,Q4_2022,2022,6.4,0.816,Increasing
FIA002669,2022-10-08,Prednisone,Deltasone,Corticosteroids,55594-899-24,Tricare Standard,PLAN_8988,2022,Tier 2,Specialty Tier,2022-09-04,34,Improved,Quantity Limit,No,No,60.0,468,397,18.1,Increased,22.38,280.35,-257.97,154.86,177.24,82.95,0.0,0,0.036,0.214,0.799,0.861,2,10,4,7,4.5,29.9,7,Higher,West,GA,Suburban,66-75,2022-10,Q4_2022,2022,2.4,0.613,Decreasing
FIA001513,2022-10-09,Prednisone,Deltasone,Corticosteroids,67316-871-64,Medicaid Plan Y,PLAN_2806,2022,Specialty Tier,Specialty Tier,2022-06-08,123,No Change,None,No,No,,694,731,-5.1,Decreased,256.68,168.93,87.75,51.68,308.36,214.0,0.0,0,0.18,0.184,0.617,0.651,15,1,10,8,3.6,10.8,3,Higher,Northeast,NY,Suburban,18-35,2022-10,Q4_2022,2022,3.1,0.334,Increasing
FIA002048,2022-10-09,Prednisone,Deltasone,Corticosteroids,70912-166-78,Medicare Part D Plan A,PLAN_7386,2022,Non-Formulary,Tier 1,2022-01-28,254,Worsened,Non-Formulary Status,No,No,,180,543,-66.8,Decreased,639.38,9.75,629.63,151.42,790.8,142.34,0.0,0,0.198,0.286,0.649,0.59,7,1,18,3,4.7,13.3,6,Similar,Southwest,NY,Urban,66-75,2022-10,Q4_2022,2022,3.3,0.8,Decreasing
FIA002449,2022-10-12,Prednisone,Deltasone,Corticosteroids,22401-666-94,Commercial Plan Alpha,PLAN_5744,2022,Tier 1,Tier 1,2022-06-07,127,No Change,None,No,No,,142,151,-5.9,Decreased,18.0,7.82,10.18,127.75,145.75,20.7,0.0,0,0.048,0.129,0.459,0.878,12,5,0,9,4.1,13.8,7,Higher,Midwest,IL,Suburban,66-75,2022-10,Q4_2022,2022,6.3,0.714,Increasing
FIA002411,2022-10-20,Prednisone,Deltasone,Corticosteroids,88316-538-10,Tricare Standard,PLAN_6526,2022,Tier 1,Tier 3,2022-08-28,53,Improved,None,No,No,,1258,888,41.7,Increased,5.46,51.95,-46.49,96.22,101.68,127.91,0.0,0,0.057,0.148,0.774,0.59,5,2,6,6,4.6,5.3,8,Higher,West,PA,Urban,51-65,2022-10,Q4_2022,2022,5.0,0.585,Stable
FIA002572,2022-10-25,Prednisone,Deltasone,Corticosteroids,79336-225-64,Medicaid Plan X,PLAN_5873,2022,Specialty Tier,Tier 1,2022-07-14,103,Worsened,None,No,No,,71,108,-34.0,Decreased,216.2,19.42,196.78,47.9,264.1,18.75,0.0,0,0.121,0.132,0.647,0.511,1,0,18,1,3.2,23.6,7,Lower,Southeast,MI,Urban,51-65,2022-10,Q4_2022,2022,1.9,0.645,Stable
FIA001722,2022-11-14,Prednisone,Deltasone,Corticosteroids,97817-881-65,Medicare Part D Plan B,PLAN_3748,2022,Tier 2,Tier 1,2021-12-15,334,Worsened,None,No,No,,462,510,-9.3,Decreased,44.67,9.49,35.18,169.24,213.91,98.83,0.0,0,0.079,0.146,0.841,0.776,7,4,8,3,2.9,19.6,6,Similar,West,NY,Rural,75+,2022-11,Q4_2022,2022,2.3,0.672,Decreasing
FIA001427,2022-11-16,Prednisone,Deltasone,Corticosteroids,62067-904-68,Medicare Part D Plan B,PLAN_2958,2022,Specialty Tier,Tier 3,2022-01-30,290,Worsened,Prior Authorization,Yes,No,,450,414,8.7,Increased,220.48,58.5,161.98,121.58,342.06,153.93,0.578,9,0.122,0.233,0.485,0.689,15,7,20,7,2.9,18.4,4,Higher,Southwest,GA,Rural,51-65,2022-11,Q4_2022,2022,4.4,0.125,Increasing
FIA002703,2022-11-18,Prednisone,Deltasone,Corticosteroids,70450-623-76,Commercial Plan Beta,PLAN_6666,2022,Tier 2,Tier 1,2022-01-15,307,Worsened,None,No,No,,502,512,-1.9,Stable,44.26,13.94,30.32,171.63,215.89,108.38,0.0,0,0.015,0.228,0.738,0.505,2,7,13,10,2.2,17.9,3,Higher,Northeast,MI,Urban,18-35,2022-11,Q4_2022,2022,4.1,0.121,Stable
FIA000388,2022-11-27,Prednisone,Deltasone,Corticosteroids,62894-687-99,VA Plan,PLAN_7677,2022,Tier 2,Tier 2,2021-12-25,337,No Change,None,No,No,,894,955,-6.4,Decreased,43.21,49.69,-6.48,46.01,89.22,79.76,0.0,0,0.033,0.183,0.532,0.866,5,1,9,11,2.5,17.9,4,Similar,Northeast,FL,Suburban,66-75,2022-11,Q4_2022,2022,2.8,0.351,Decreasing
FIA002710,2022-11-30,Prednisone,Deltasone,Corticosteroids,66854-390-36,Medicare Part D Plan A,PLAN_5221,2022,Specialty Tier,Non-Formulary,2022-02-18,285,Improved,Step Therapy,No,Yes,,900,969,-7.1,Decreased,258.95,728.02,-469.07,171.47,430.42,387.38,0.0,0,0.153,0.146,0.631,0.657,13,10,19,15,4.8,18.7,8,Lower,Midwest,GA,Suburban,18-35,2022-11,Q4_2022,2022,4.7,0.79,Increasing
FIA000157,2022-12-02,Prednisone,Deltasone,Corticosteroids,30958-487-80,VA Plan,PLAN_1719,2022,Tier 1,Tier 1,2022-09-05,88,No Change,None,No,No,,187,187,0.5,Stable,15.59,14.51,1.08,134.05,149.64,27.98,0.0,0,0.078,0.319,0.839,0.711,4,2,4,5,4.3,6.5,4,Similar,Southwest,PA,Rural,36-50,2022-12,Q4_2022,2022,2.1,0.132,Increasing
FIA000178,2022-12-11,Prednisone,Deltasone,Corticosteroids,95426-707-46,VA Plan,PLAN_8798,2022,Tier 3,Non-Formulary,2022-08-19,114,Improved,Prior Authorization,Yes,No,,130,141,-7.3,Decreased,71.93,755.41,-683.48,45.15,117.08,15.22,0.103,3,0.023,0.122,0.648,0.688,13,3,5,1,3.8,26.5,6,Lower,Midwest,IL,Suburban,18-35,2022-12,Q4_2022,2022,6.0,0.192,Decreasing
FIA001630,2022-12-12,Prednisone,Deltasone,Corticosteroids,95936-737-31,Medicaid Plan X,PLAN_6964,2022,Tier 3,Non-Formulary,2022-09-18,85,Improved,Step Therapy,No,Yes,,839,891,-5.8,Decreased,57.0,661.58,-604.58,66.01,123.01,103.21,0.0,0,0.018,0.091,0.546,0.449,14,6,3,13,2.0,23.6,2,Lower,Southwest,FL,Rural,36-50,2022-12,Q4_2022,2022,3.1,0.946,Decreasing
FIA002628,2022-12-15,Prednisone,Deltasone,Corticosteroids,55304-185-76,Tricare Standard,PLAN_7979,2022,Tier 1,Non-Formulary,2022-07-12,156,Improved,None,No,No,,602,516,16.7,Increased,19.56,251.62,-232.06,167.53,187.09,112.63,0.0,0,0.031,0.125,0.437,0.694,14,7,4,12,3.4,15.3,2,Lower,Midwest,IL,Rural,75+,2022-12,Q4_2022,2022,6.6,0.042,Stable
FIA001196,2022-12-22,Prednisone,Deltasone,Corticosteroids,54064-657-41,Tricare Standard,PLAN_6912,2022,Tier 3,Specialty Tier,2022-08-04,140,Improved,Prior Authorization,Yes,No,,959,955,0.5,Stable,69.99,297.4,-227.41,171.37,241.36,231.46,0.283,1,0.011,0.055,0.719,0.811,1,9,18,1,4.2,8.5,8,Lower,Northeast,TX,Urban,51-65,2022-12,Q4_2022,2022,9.9,0.707,Increasing
FIA000094,2022-12-30,Prednisone,Deltasone,Corticosteroids,38953-754-82,Medicare Part D Plan B,PLAN_9129,2022,Tier 1,Non-Formulary,2022-05-14,230,Improved,None,No,No,,793,681,16.5,Increased,17.76,662.5,-644.74,194.48,212.24,168.31,0.0,0,0.074,0.099,0.722,0.531,10,2,20,2,4.5,25.1,7,Similar,Southwest,CA,Suburban,36-50,2022-12,Q4_2022,2022,3.2,0.068,Stable
FIA001374,2023-01-09,Prednisone,Deltasone,Corticosteroids,20841-301-74,Medicaid Plan Y,PLAN_3893,2023,Tier 3,Tier 2,2022-03-28,287,Worsened,Step Therapy; Quantity Limit,No,Yes,30.0,135,270,-49.7,Decreased,57.81,28.38,29.43,63.45,121.26,16.37,0.0,0,0.07,0.126,0.621,0.415,4,7,0,9,4.8,29.5,2,Higher,Northeast,PA,Suburban,18-35,2023-01,Q1_2023,2022,2.5,0.338,Increasing
FIA000133,2023-01-10,Prednisone,Deltasone,Corticosteroids,30446-897-23,Medicare Part D Plan B,PLAN_2285,2023,Tier 2,Specialty Tier,2022-08-31,132,Improved,None,No,No,,461,371,24.3,Increased,27.05,148.41,-121.36,135.16,162.21,74.78,0.0,0,0.027,0.287,0.664,0.738,1,7,11,10,3.5,34.6,6,Similar,Southwest,FL,Rural,51-65,2023-01,Q1_2023,2022,4.6,0.75,Increasing
FIA001941,2023-01-10,Prednisone,Deltasone,Corticosteroids,52331-460-34,Commercial Plan Alpha,PLAN_5832,2023,Specialty Tier,Tier 3,2022-07-08,186,Worsened,Prior Authorization,Yes,No,,638,642,-0.6,Stable,118.54,60.17,58.37,80.54,199.08,127.01,0.499,2,0.134,0.372,0.495,0.859,1,7,1,5,4.2,14.0,6,Lower,Midwest,TX,Urban,66-75,2023-01,Q1_2023,2022,8.8,0.472,Decreasing
FIA002673,2023-01-12,Prednisone,Deltasone,Corticosteroids,63744-344-66,Tricare Standard,PLAN_5824,2023,Specialty Tier,Tier 1,2022-05-24,233,Worsened,Step Therapy,No,Yes,,161,375,-56.9,Decreased,182.18,10.53,171.65,30.34,212.52,34.22,0.0,0,0.226,0.072,0.667,0.871,2,9,8,5,4.9,20.2,3,Lower,Northeast,PA,Urban,36-50,2023-01,Q1_2023,2022,7.4,0.637,Stable
FIA002918,2023-01-12,Prednisone,Deltasone,Corticosteroids,57001-360-12,Tricare Standard,PLAN_2811,2023,Non-Formulary,Tier 2,2022-02-22,324,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,217,476,-54.3,Decreased,717.46,34.72,682.74,133.37,850.83,184.63,0.0,0,0.096,0.251,0.611,0.444,3,6,5,2,3.1,9.6,6,Lower,West,FL,Urban,18-35,2023-01,Q1_2023,2022,3.8,0.064,Increasing
FIA001913,2023-01-16,Prednisone,Deltasone,Corticosteroids,42413-524-17,Medicare Part D Plan B,PLAN_1871,2023,Non-Formulary,Tier 2,2022-04-07,284,Worsened,Non-Formulary Status,No,No,,270,558,-51.5,Decreased,559.09,28.53,530.56,67.98,627.07,169.31,0.0,0,0.234,0.384,0.864,0.919,15,6,1,11,2.6,27.4,4,Lower,Southeast,IL,Rural,18-35,2023-01,Q1_2023,2022,4.9,0.74,Decreasing
FIA000961,2023-02-05,Prednisone,Deltasone,Corticosteroids,34453-666-13,Medicaid Plan Y,PLAN_1754,2023,Specialty Tier,Tier 2,2022-07-29,191,Worsened,Quantity Limit,No,No,30.0,110,231,-52.0,Decreased,162.16,42.44,119.72,145.53,307.69,33.85,0.0,0,0.292,0.138,0.456,0.705,5,8,15,5,2.0,12.9,5,Similar,Southwest,OH,Suburban,18-35,2023-02,Q1_2023,2022,5.8,0.54,Stable
FIA001950,2023-02-12,Prednisone,Deltasone,Corticosteroids,87212-690-20,Medicare Part D Plan B,PLAN_8561,2023,Specialty Tier,Tier 3,2022-11-09,95,Worsened,Step Therapy,No,Yes,,162,179,-9.4,Decreased,289.95,54.76,235.19,38.71,328.66,53.24,0.0,0,0.137,0.091,0.553,0.681,11,10,3,2,4.9,6.9,8,Similar,Northeast,PA,Urban,36-50,2023-02,Q1_2023,2022,8.4,0.725,Stable
FIA000946,2023-03-14,Prednisone,Deltasone,Corticosteroids,85051-130-94,Medicaid Plan Y,PLAN_7373,2023,Tier 2,Non-Formulary,2022-07-02,255,Improved,Quantity Limit,No,No,90.0,1290,862,49.7,Increased,43.04,729.31,-686.27,52.23,95.27,122.9,0.0,0,0.06,0.171,0.891,0.704,14,8,9,14,3.3,22.8,8,Higher,West,NY,Suburban,51-65,2023-03,Q1_2023,2022,3.2,0.264,Increasing
FIA000021,2023-03-20,Prednisone,Deltasone,Corticosteroids,15965-155-80,Medicaid Plan X,PLAN_3068,2023,Specialty Tier,Tier 3,2022-04-23,331,Worsened,None,No,No,,426,389,9.6,Increased,295.32,76.23,219.09,51.52,346.84,147.75,0.0,0,0.227,0.273,0.727,0.456,0,9,9,15,3.4,15.2,2,Similar,Southwest,TX,Urban,66-75,2023-03,Q1_2023,2022,5.4,0.577,Decreasing
FIA001613,2023-04-03,Prednisone,Deltasone,Corticosteroids,12166-207-95,Commercial Plan Beta,PLAN_9874,2023,Non-Formulary,Tier 2,2022-11-26,128,Worsened,Non-Formulary Status,No,No,,428,650,-34.0,Decreased,494.72,39.96,454.76,138.49,633.21,271.01,0.0,0,0.184,0.081,0.555,0.793,9,1,17,9,2.5,11.8,5,Higher,Midwest,IL,Suburban,18-35,2023-04,Q2_2023,2022,1.6,0.862,Stable
FIA002761,2023-04-22,Prednisone,Deltasone,Corticosteroids,66576-557-64,Tricare Standard,PLAN_9999,2023,Tier 1,Non-Formulary,2023-02-13,68,Improved,None,No,No,,438,282,55.3,Increased,14.56,683.97,-669.41,107.94,122.5,53.66,0.0,0,0.05,0.333,0.482,0.42,2,2,20,14,3.7,19.8,3,Higher,West,FL,Suburban,66-75,2023-04,Q2_2023,2022,2.8,0.556,Decreasing
FIA002370,2023-05-01,Prednisone,Deltasone,Corticosteroids,73532-845-63,Medicaid Plan Y,PLAN_9008,2023,Tier 2,Specialty Tier,2022-09-21,222,Improved,None,No,No,,362,241,50.6,Increased,22.19,190.91,-168.72,178.66,200.85,72.71,0.0,0,0.061,0.132,0.404,0.415,15,0,11,0,4.7,25.8,2,Higher,Southeast,IL,Urban,51-65,2023-05,Q2_2023,2022,5.6,0.874,Increasing
FIA000177,2023-05-13,Prednisone,Deltasone,Corticosteroids,23937-216-73,Commercial Plan Beta,PLAN_2033,2023,Tier 2,Tier 1,2023-01-15,118,Worsened,None,No,No,,995,940,5.9,Increased,38.98,18.57,20.41,40.87,79.85,79.45,0.0,0,0.068,0.332,0.498,0.846,12,5,3,4,3.0,33.9,3,Lower,West,FL,Suburban,18-35,2023-05,Q2_2023,2022,2.1,0.141,Stable
FIA002380,2023-05-26,Prednisone,Deltasone,Corticosteroids,50169-813-13,Medicaid Plan Y,PLAN_9189,2023,Specialty Tier,Non-Formulary,2022-11-20,187,Improved,None,No,No,,111,122,-8.7,Decreased,208.33,220.43,-12.1,33.99,242.32,26.9,0.0,0,0.129,0.303,0.278,0.429,13,2,1,1,2.5,8.4,2,Lower,Midwest,TX,Urban,51-65,2023-05,Q2_2023,2022,5.6,0.929,Stable
FIA001502,2023-06-11,Prednisone,Deltasone,Corticosteroids,80807-843-86,Medicaid Plan Y,PLAN_6089,2023,Specialty Tier,Tier 1,2022-12-19,174,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,117,306,-61.7,Decreased,288.1,12.59,275.51,52.84,340.94,39.89,0.349,1,0.227,0.175,0.399,0.661,7,8,18,9,3.5,15.1,8,Higher,West,GA,Urban,51-65,2023-06,Q2_2023,2022,4.0,0.607,Decreasing
FIA000352,2023-06-14,Prednisone,Deltasone,Corticosteroids,65583-644-59,Medicare Part D Plan B,PLAN_3463,2023,Tier 1,Non-Formulary,2022-09-27,260,Improved,None,No,No,,1078,829,30.1,Increased,12.53,668.6,-656.07,163.53,176.06,189.79,0.0,0,0.036,0.052,0.864,0.789,8,3,16,14,3.3,18.9,2,Lower,Southwest,GA,Suburban,18-35,2023-06,Q2_2023,2022,9.0,0.686,Stable
FIA002979,2023-06-15,Prednisone,Deltasone,Corticosteroids,87596-103-16,Tricare Standard,PLAN_8222,2023,Tier 3,Tier 3,2022-11-21,206,No Change,Prior Authorization,Yes,No,,418,445,-5.9,Decreased,52.79,63.16,-10.37,52.84,105.63,44.15,0.477,4,0.012,0.218,0.662,0.638,11,5,1,9,4.7,26.9,8,Similar,Southeast,FL,Urban,36-50,2023-06,Q2_2023,2022,4.6,0.601,Decreasing
FIA001684,2023-06-16,Prednisone,Deltasone,Corticosteroids,75208-591-34,VA Plan,PLAN_1318,2023,Non-Formulary,Specialty Tier,2022-07-01,350,Worsened,Non-Formulary Status,No,No,,557,537,3.9,Stable,557.28,197.95,359.33,126.04,683.32,380.61,0.0,0,0.204,0.164,0.729,0.728,2,1,0,0,2.1,30.5,5,Higher,Southeast,TX,Rural,36-50,2023-06,Q2_2023,2022,7.6,0.203,Decreasing
FIA002300,2023-06-16,Prednisone,Deltasone,Corticosteroids,39310-934-66,Tricare Standard,PLAN_2010,2023,Tier 3,Specialty Tier,2022-11-06,222,Improved,None,No,No,,346,323,7.4,Increased,61.78,293.73,-231.95,50.0,111.78,38.68,0.0,0,0.013,0.189,0.63,0.863,1,10,2,14,4.4,7.0,5,Higher,West,MI,Urban,51-65,2023-06,Q2_2023,2022,6.8,0.055,Stable
FIA000704,2023-07-03,Prednisone,Deltasone,Corticosteroids,63017-678-80,Medicare Part D Plan B,PLAN_5696,2023,Non-Formulary,Tier 1,2022-10-29,247,Worsened,Non-Formulary Status; Quantity Limit,No,No,,50,113,-67.4,Decreased,238.19,5.04,233.15,142.95,381.14,19.06,0.0,0,0.069,0.13,0.734,0.861,15,6,1,8,4.5,11.1,5,Similar,Midwest,CA,Rural,36-50,2023-07,Q3_2023,2022,6.3,0.719,Increasing
FIA002297,2023-07-09,Prednisone,Deltasone,Corticosteroids,13378-772-23,Medicaid Plan Y,PLAN_2225,2023,Specialty Tier,Tier 2,2023-01-19,171,Worsened,Quantity Limit,No,No,90.0,92,277,-66.7,Decreased,248.33,24.19,224.14,31.75,280.08,25.77,0.0,0,0.184,0.344,0.664,0.927,13,2,4,0,5.0,21.1,5,Similar,Southeast,OH,Suburban,36-50,2023-07,Q3_2023,2022,6.6,0.596,Increasing
FIA002838,2023-07-21,Prednisone,Deltasone,Corticosteroids,88071-125-52,Commercial Plan Beta,PLAN_7766,2023,Tier 1,Tier 1,2023-02-11,160,No Change,None,No,No,,499,543,-8.0,Decreased,19.9,17.43,2.47,155.23,175.13,87.39,0.0,0,0.074,0.095,0.249,0.92,2,10,7,10,2.6,20.6,6,Higher,Northeast,MI,Suburban,75+,2023-07,Q3_2023,2022,4.2,0.291,Stable
FIA002269,2023-08-10,Prednisone,Deltasone,Corticosteroids,65216-846-22,Tricare Standard,PLAN_6275,2023,Tier 3,Non-Formulary,2022-10-21,293,Improved,None,No,No,,977,940,4.0,Stable,65.29,593.11,-527.82,147.7,212.99,208.09,0.0,0,0.055,0.181,0.89,0.77,12,8,2,8,4.0,33.2,4,Higher,Northeast,TX,Rural,51-65,2023-08,Q3_2023,2022,4.0,0.455,Increasing
FIA000474,2023-08-18,Prednisone,Deltasone,Corticosteroids,97439-663-77,Commercial Plan Alpha,PLAN_7675,2023,Tier 1,Tier 1,2023-03-18,153,No Change,None,No,No,,917,912,0.6,Stable,9.56,13.32,-3.76,70.36,79.92,73.29,0.0,0,0.034,0.066,0.364,0.606,3,0,3,11,3.4,25.8,6,Lower,West,IL,Rural,75+,2023-08,Q3_2023,2022,7.4,0.803,Stable
FIA001397,2023-08-20,Prednisone,Deltasone,Corticosteroids,51776-172-32,Commercial Plan Alpha,PLAN_5120,2023,Non-Formulary,Specialty Tier,2022-10-30,294,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,426,467,-8.8,Decreased,454.9,104.57,350.33,199.36,654.26,278.71,0.0,0,0.11,0.146,0.261,0.515,15,8,16,3,2.9,19.7,7,Similar,Southeast,IL,Urban,66-75,2023-08,Q3_2023,2022,8.2,0.309,Decreasing
FIA001959,2023-08-25,Prednisone,Deltasone,Corticosteroids,82710-627-38,Commercial Plan Alpha,PLAN_8146,2023,Tier 3,Specialty Tier,2023-05-26,91,Improved,Step Therapy,No,Yes,,424,466,-9.0,Decreased,92.75,282.58,-189.83,112.32,205.07,86.95,0.0,0,0.012,0.238,0.779,0.445,1,2,3,10,4.4,17.1,8,Lower,Northeast,GA,Rural,66-75,2023-08,Q3_2023,2022,7.2,0.573,Decreasing
FIA001876,2023-09-06,Prednisone,Deltasone,Corticosteroids,99783-884-93,Medicaid Plan X,PLAN_2581,2023,Non-Formulary,Tier 3,2023-01-06,243,Worsened,Non-Formulary Status,No,No,,109,114,-4.3,Stable,351.06,67.5,283.56,161.82,512.88,55.9,0.0,0,0.056,0.192,0.351,0.634,12,4,3,15,2.2,6.9,3,Similar,West,CA,Suburban,66-75,2023-09,Q3_2023,2022,3.4,0.125,Increasing
FIA002896,2023-09-13,Prednisone,Deltasone,Corticosteroids,17226-439-10,VA Plan,PLAN_9789,2023,Specialty Tier,Non-Formulary,2022-10-21,327,Improved,Quantity Limit,No,No,30.0,345,338,2.3,Stable,288.51,336.83,-48.32,47.87,336.38,116.05,0.0,0,0.151,0.378,0.551,0.662,12,6,6,3,4.7,7.2,6,Higher,Southwest,PA,Rural,18-35,2023-09,Q3_2023,2022,4.4,0.972,Stable
FIA000458,2023-09-20,Prednisone,Deltasone,Corticosteroids,54059-465-70,Commercial Plan Beta,PLAN_9724,2023,Specialty Tier,Tier 3,2023-04-04,169,Worsened,None,No,No,,838,785,6.8,Increased,217.24,81.44,135.8,37.79,255.03,213.72,0.0,0,0.111,0.167,0.359,0.927,0,1,3,4,2.7,31.0,3,Similar,Southwest,NC,Rural,18-35,2023-09,Q3_2023,2022,1.9,0.99,Decreasing
FIA002946,2023-09-23,Prednisone,Deltasone,Corticosteroids,49788-352-77,Medicare Part D Plan B,PLAN_5799,2023,Specialty Tier,Tier 3,2023-04-15,161,Worsened,None,No,No,,669,643,4.2,Stable,156.49,80.03,76.46,57.39,213.88,143.09,0.0,0,0.092,0.081,0.246,0.907,11,5,13,13,2.9,30.1,4,Similar,Southwest,FL,Urban,18-35,2023-09,Q3_2023,2022,6.0,0.022,Stable
FIA001567,2023-09-30,Prednisone,Deltasone,Corticosteroids,21528-312-61,Medicaid Plan X,PLAN_7860,2023,Non-Formulary,Tier 1,2023-04-27,156,Worsened,Non-Formulary Status; Quantity Limit,No,No,30.0,474,755,-37.1,Decreased,245.64,17.31,228.33,103.46,349.1,165.47,0.0,0,0.227,0.165,0.723,0.566,5,2,16,4,2.6,31.4,7,Lower,Midwest,NC,Rural,51-65,2023-09,Q3_2023,2022,7.5,0.824,Decreasing
FIA002902,2023-10-08,Prednisone,Deltasone,Corticosteroids,66716-716-61,VA Plan,PLAN_3920,2023,Tier 1,Tier 1,2023-04-24,167,No Change,None,No,No,,877,877,0.1,Stable,13.2,19.21,-6.01,89.1,102.3,89.72,0.0,0,0.062,0.199,0.835,0.714,15,3,20,0,2.3,11.2,2,Higher,West,MI,Suburban,66-75,2023-10,Q4_2023,2023,4.5,0.398,Stable
FIA000645,2023-10-21,Prednisone,Deltasone,Corticosteroids,93105-491-83,Commercial Plan Beta,PLAN_4423,2023,Non-Formulary,Tier 1,2022-11-23,332,Worsened,Non-Formulary Status,No,No,,69,107,-35.1,Decreased,308.2,18.92,289.28,103.34,411.54,28.4,0.0,0,0.173,0.358,0.73,0.724,13,5,3,11,4.6,33.3,3,Similar,Southwest,NC,Rural,51-65,2023-10,Q4_2023,2023,9.6,0.275,Decreasing
FIA002151,2023-10-22,Prednisone,Deltasone,Corticosteroids,26908-345-96,Medicare Part D Plan B,PLAN_5678,2023,Non-Formulary,Specialty Tier,2023-06-22,122,Worsened,Non-Formulary Status,No,No,,717,756,-5.1,Decreased,644.62,155.73,488.89,154.59,799.21,573.03,0.0,0,0.2,0.281,0.259,0.493,11,8,4,10,4.6,12.7,8,Similar,Northeast,PA,Urban,51-65,2023-10,Q4_2023,2023,3.0,0.934,Stable
FIA000586,2023-10-29,Prednisone,Deltasone,Corticosteroids,10822-750-78,Medicare Part D Plan B,PLAN_5364,2023,Tier 1,Specialty Tier,2023-01-26,276,Improved,None,No,No,,192,144,34.0,Increased,12.4,118.99,-106.59,128.94,141.34,27.14,0.0,0,0.036,0.137,0.253,0.47,14,6,3,14,4.8,25.8,4,Higher,Southwest,MI,Rural,36-50,2023-10,Q4_2023,2023,5.9,0.299,Decreasing
FIA001982,2023-11-01,Prednisone,Deltasone,Corticosteroids,59547-930-29,Commercial Plan Beta,PLAN_4738,2023,Tier 2,Tier 2,2023-02-02,272,No Change,None,No,No,,625,593,5.5,Increased,22.38,46.66,-24.28,111.91,134.29,83.93,0.0,0,0.034,0.337,0.883,0.652,11,0,18,8,4.7,29.5,4,Higher,Southeast,TX,Suburban,51-65,2023-11,Q4_2023,2023,7.7,0.877,Increasing
FIA002608,2023-11-07,Prednisone,Deltasone,Corticosteroids,15337-334-84,Medicare Part D Plan A,PLAN_1021,2023,Specialty Tier,Tier 2,2023-03-29,223,Worsened,None,No,No,,443,896,-50.5,Decreased,109.81,46.89,62.92,51.53,161.34,71.47,0.0,0,0.245,0.104,0.652,0.904,4,3,9,9,3.3,27.6,2,Lower,Midwest,PA,Rural,66-75,2023-11,Q4_2023,2023,5.3,0.497,Increasing
FIA002063,2023-11-13,Prednisone,Deltasone,Corticosteroids,41958-149-95,Medicaid Plan X,PLAN_1334,2023,Specialty Tier,Tier 3,2023-03-01,257,Worsened,Quantity Limit,No,No,90.0,207,225,-7.8,Decreased,181.55,83.23,98.32,88.81,270.36,55.96,0.0,0,0.222,0.329,0.395,0.745,6,8,14,5,4.7,18.5,2,Similar,Midwest,MI,Rural,36-50,2023-11,Q4_2023,2023,3.0,0.619,Increasing
FIA002693,2023-11-14,Prednisone,Deltasone,Corticosteroids,45275-529-52,Medicare Part D Plan A,PLAN_4312,2023,Specialty Tier,Tier 3,2023-01-03,315,Worsened,Step Therapy,No,Yes,,1008,965,4.5,Stable,225.01,82.01,143.0,144.29,369.3,372.25,0.0,0,0.054,0.103,0.697,0.869,6,0,15,0,4.1,6.3,6,Higher,Midwest,PA,Rural,36-50,2023-11,Q4_2023,2023,3.1,0.869,Decreasing
FIA001081,2023-11-18,Prednisone,Deltasone,Corticosteroids,30090-909-22,Tricare Standard,PLAN_7916,2023,Specialty Tier,Specialty Tier,2023-03-28,235,No Change,None,No,No,,174,172,1.7,Stable,192.94,183.22,9.72,36.63,229.57,39.95,0.0,0,0.074,0.157,0.253,0.895,14,0,4,4,4.0,21.7,4,Higher,Midwest,NY,Suburban,66-75,2023-11,Q4_2023,2023,5.5,0.162,Stable
FIA002503,2023-11-20,Prednisone,Deltasone,Corticosteroids,79167-856-75,Commercial Plan Beta,PLAN_4927,2023,Non-Formulary,Specialty Tier,2023-06-08,165,Worsened,Non-Formulary Status,No,No,,231,225,3.1,Stable,472.76,251.76,221.0,74.03,546.79,126.31,0.0,0,0.112,0.34,0.722,0.766,2,1,11,5,3.4,5.3,4,Higher,Midwest,FL,Rural,51-65,2023-11,Q4_2023,2023,6.1,0.175,Stable
FIA002851,2023-11-21,Prednisone,Deltasone,Corticosteroids,36038-335-35,Medicare Part D Plan A,PLAN_8215,2023,Non-Formulary,Tier 2,2023-06-29,145,Worsened,Non-Formulary Status,No,No,,265,650,-59.1,Decreased,237.56,46.25,191.31,170.62,408.18,108.17,0.0,0,0.285,0.206,0.342,0.869,6,4,15,8,3.4,29.0,4,Lower,Southeast,NY,Urban,51-65,2023-11,Q4_2023,2023,8.4,0.355,Stable
FIA001013,2023-12-01,Prednisone,Deltasone,Corticosteroids,40025-382-59,VA Plan,PLAN_2016,2023,Tier 3,Specialty Tier,2022-12-18,348,Improved,Step Therapy,No,Yes,,740,779,-5.0,Decreased,85.46,133.92,-48.46,143.29,228.75,169.28,0.0,0,0.041,0.371,0.761,0.909,8,7,1,1,3.3,28.9,3,Higher,West,TX,Urban,66-75,2023-12,Q4_2023,2023,6.2,0.774,Increasing
FIA002762,2023-12-08,Prednisone,Deltasone,Corticosteroids,11459-218-73,Commercial Plan Alpha,PLAN_3808,2023,Non-Formulary,Tier 2,2023-08-26,104,Worsened,Non-Formulary Status,No,No,,141,439,-67.8,Decreased,242.99,38.66,204.33,96.03,339.02,47.8,0.0,0,0.254,0.198,0.86,0.935,11,1,11,11,3.9,22.6,4,Similar,West,TX,Suburban,75+,2023-12,Q4_2023,2023,2.0,0.467,Increasing
FIA002829,2024-01-02,Prednisone,Deltasone,Corticosteroids,63048-860-14,Commercial Plan Beta,PLAN_6457,2024,Non-Formulary,Tier 2,2023-02-03,333,Worsened,Non-Formulary Status,No,No,,50,138,-64.5,Decreased,361.74,45.8,315.94,150.58,512.32,25.62,0.0,0,0.127,0.363,0.416,0.577,11,10,19,10,3.5,28.8,8,Lower,Southeast,FL,Suburban,51-65,2024-01,Q1_2024,2023,3.7,0.216,Decreasing
FIA001055,2024-01-11,Prednisone,Deltasone,Corticosteroids,46127-135-17,VA Plan,PLAN_8847,2024,Tier 1,Specialty Tier,2023-02-05,340,Improved,None,No,No,,868,578,50.3,Increased,7.55,265.37,-257.82,163.47,171.02,148.45,0.0,0,0.047,0.099,0.49,0.928,6,9,1,7,2.5,31.0,4,Lower,Northeast,NY,Urban,75+,2024-01,Q1_2024,2023,7.3,1.0,Increasing
FIA002225,2024-01-16,Prednisone,Deltasone,Corticosteroids,52380-357-35,Medicare Part D Plan B,PLAN_9264,2024,Non-Formulary,Tier 3,2023-08-12,157,Worsened,Non-Formulary Status,No,No,,849,914,-7.0,Decreased,208.22,84.82,123.4,71.48,279.7,237.47,0.0,0,0.079,0.215,0.848,0.755,11,0,19,5,4.7,7.0,5,Lower,Midwest,MI,Urban,36-50,2024-01,Q1_2024,2023,8.8,0.275,Decreasing
FIA000030,2024-01-18,Prednisone,Deltasone,Corticosteroids,43681-944-71,Medicaid Plan X,PLAN_6549,2024,Tier 2,Tier 1,2023-07-21,181,Worsened,None,No,No,,282,305,-7.4,Decreased,29.8,11.23,18.57,171.18,200.98,56.68,0.0,0,0.074,0.331,0.528,0.441,7,10,12,11,2.3,16.8,4,Higher,Northeast,GA,Suburban,51-65,2024-01,Q1_2024,2023,6.3,0.822,Stable
FIA000466,2024-02-08,Prednisone,Deltasone,Corticosteroids,56540-905-12,Commercial Plan Alpha,PLAN_3060,2024,Tier 1,Non-Formulary,2023-12-20,50,Improved,None,No,No,,392,312,25.8,Increased,14.38,231.82,-217.44,108.2,122.58,48.05,0.0,0,0.053,0.073,0.387,0.426,3,6,8,3,4.7,32.5,7,Lower,Midwest,PA,Rural,36-50,2024-02,Q1_2024,2023,5.9,0.474,Increasing
FIA002867,2024-02-12,Prednisone,Deltasone,Corticosteroids,40118-334-34,Medicaid Plan X,PLAN_4406,2024,Non-Formulary,Specialty Tier,2023-08-28,168,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,840,848,-0.9,Stable,586.69,142.35,444.34,74.59,661.28,555.48,0.0,0,0.167,0.075,0.74,0.678,11,10,3,8,4.8,17.0,7,Similar,Northeast,FL,Urban,75+,2024-02,Q1_2024,2023,3.4,0.502,Increasing
FIA000283,2024-02-13,Prednisone,Deltasone,Corticosteroids,57873-244-20,Commercial Plan Beta,PLAN_2262,2024,Tier 1,Specialty Tier,2023-07-08,220,Improved,Quantity Limit,No,No,,822,695,18.3,Increased,5.81,121.2,-115.39,35.13,40.94,33.65,0.0,0,0.071,0.249,0.77,0.482,5,7,4,9,3.4,26.7,5,Higher,Northeast,PA,Urban,36-50,2024-02,Q1_2024,2023,1.5,0.642,Decreasing
FIA000805,2024-02-19,Prednisone,Deltasone,Corticosteroids,42775-237-25,VA Plan,PLAN_9774,2024,Non-Formulary,Tier 1,2024-01-12,38,Worsened,Non-Formulary Status,No,No,,360,960,-62.5,Decreased,235.32,16.31,219.01,57.21,292.53,105.31,0.0,0,0.209,0.099,0.777,0.909,4,10,2,15,3.1,24.1,3,Higher,Southwest,MI,Rural,66-75,2024-02,Q1_2024,2023,9.6,0.03,Increasing
FIA001799,2024-02-28,Prednisone,Deltasone,Corticosteroids,32342-386-54,VA Plan,PLAN_1993,2024,Tier 3,Non-Formulary,2023-07-16,227,Improved,Prior Authorization,Yes,No,,629,674,-6.6,Decreased,53.29,312.87,-259.58,150.42,203.71,128.13,0.503,6,0.066,0.077,0.322,0.69,1,8,13,3,4.4,18.6,6,Lower,West,GA,Urban,36-50,2024-02,Q1_2024,2023,4.1,0.961,Decreasing
FIA002049,2024-03-07,Prednisone,Deltasone,Corticosteroids,32517-562-68,Medicaid Plan X,PLAN_3005,2024,Tier 2,Non-Formulary,2023-07-28,223,Improved,None,No,No,,251,162,55.4,Increased,28.89,702.71,-673.82,158.77,187.66,47.1,0.0,0,0.048,0.215,0.428,0.877,4,3,19,2,3.2,9.3,2,Similar,West,TX,Suburban,18-35,2024-03,Q1_2024,2023,5.7,0.761,Stable
FIA002892,2024-03-15,Prednisone,Deltasone,Corticosteroids,43689-923-25,Tricare Standard,PLAN_3848,2024,Specialty Tier,Tier 3,2023-05-06,314,Worsened,None,No,No,,960,945,1.7,Stable,153.18,60.94,92.24,46.64,199.82,191.83,0.0,0,0.295,0.101,0.305,0.701,0,4,16,13,4.6,28.2,3,Higher,West,IL,Urban,66-75,2024-03,Q1_2024,2023,6.6,0.883,Decreasing
FIA002789,2024-03-18,Prednisone,Deltasone,Corticosteroids,45816-613-66,Medicaid Plan Y,PLAN_1646,2024,Specialty Tier,Tier 3,2023-07-05,257,Worsened,Prior Authorization,Yes,No,,702,778,-9.7,Decreased,214.28,99.15,115.13,170.65,384.93,270.22,0.322,1,0.221,0.312,0.814,0.895,1,9,13,10,4.7,22.1,4,Lower,Northeast,OH,Rural,51-65,2024-03,Q1_2024,2023,1.7,0.793,Increasing
FIA001442,2024-03-20,Prednisone,Deltasone,Corticosteroids,44483-509-52,Medicaid Plan Y,PLAN_1888,2024,Tier 3,Specialty Tier,2024-01-17,63,Improved,Prior Authorization,Yes,No,,176,187,-5.8,Decreased,98.81,118.7,-19.89,44.84,143.65,25.28,0.387,7,0.051,0.378,0.503,0.782,10,1,12,14,4.6,31.1,7,Similar,Midwest,MI,Rural,75+,2024-03,Q1_2024,2023,1.7,0.958,Stable
FIA002788,2024-03-20,Prednisone,Deltasone,Corticosteroids,71359-150-48,VA Plan,PLAN_9524,2024,Tier 2,Tier 3,2024-02-02,47,Improved,Quantity Limit,No,No,30.0,1273,872,46.0,Increased,30.58,76.58,-46.0,165.86,196.44,250.07,0.0,0,0.053,0.113,0.524,0.774,11,9,9,15,2.3,24.9,7,Similar,Southeast,PA,Rural,18-35,2024-03,Q1_2024,2023,2.0,0.575,Decreasing
FIA002371,2024-03-22,Prednisone,Deltasone,Corticosteroids,56302-771-57,Commercial Plan Alpha,PLAN_7149,2024,Non-Formulary,Tier 2,2023-09-06,198,Worsened,Non-Formulary Status,No,No,,71,149,-51.9,Decreased,662.2,33.76,628.44,169.39,831.59,59.04,0.0,0,0.213,0.359,0.839,0.639,7,4,9,6,2.5,8.9,3,Higher,Southeast,GA,Urban,18-35,2024-03,Q1_2024,2023,9.4,0.008,Decreasing
FIA000257,2024-03-30,Prednisone,Deltasone,Corticosteroids,48517-721-34,Commercial Plan Alpha,PLAN_9520,2024,Non-Formulary,Tier 1,2023-09-04,208,Worsened,Non-Formulary Status; Quantity Limit,No,No,,179,587,-69.3,Decreased,456.75,18.97,437.78,154.83,611.58,109.47,0.0,0,0.276,0.095,0.758,0.566,14,2,14,3,3.4,21.2,3,Lower,Southeast,TX,Urban,66-75,2024-03,Q1_2024,2023,9.9,0.029,Stable
FIA001655,2024-03-31,Prednisone,Deltasone,Corticosteroids,33941-855-86,Medicare Part D Plan A,PLAN_3728,2024,Tier 3,Tier 1,2024-02-20,40,Worsened,Prior Authorization,Yes,No,,323,466,-30.5,Decreased,60.01,17.63,42.38,170.42,230.43,74.43,0.453,6,0.047,0.326,0.327,0.547,0,7,13,13,3.1,19.2,5,Similar,Midwest,NY,Rural,51-65,2024-03,Q1_2024,2023,9.7,0.955,Decreasing
FIA001169,2024-04-05,Prednisone,Deltasone,Corticosteroids,65111-598-86,Tricare Standard,PLAN_5259,2024,Tier 3,Tier 3,2024-02-22,43,No Change,None,No,No,,219,213,3.0,Stable,87.36,66.92,20.44,181.24,268.6,58.82,0.0,0,0.055,0.139,0.505,0.724,14,8,17,13,3.1,29.9,8,Higher,Midwest,OH,Suburban,36-50,2024-04,Q2_2024,2023,9.4,0.234,Stable
FIA001833,2024-04-10,Prednisone,Deltasone,Corticosteroids,77859-853-11,Medicaid Plan X,PLAN_3613,2024,Tier 3,Tier 1,2023-08-28,226,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,710,946,-24.9,Decreased,64.1,9.36,54.74,153.48,217.58,154.48,0.105,1,0.046,0.323,0.813,0.819,12,1,19,1,4.6,23.5,6,Higher,West,OH,Suburban,75+,2024-04,Q2_2024,2023,7.3,0.226,Increasing
FIA002474,2024-04-22,Prednisone,Deltasone,Corticosteroids,20088-320-33,Tricare Standard,PLAN_2851,2024,Non-Formulary,Non-Formulary,2024-02-12,70,No Change,Non-Formulary Status,No,No,,227,235,-3.2,Stable,697.64,552.06,145.58,48.02,745.66,169.26,0.0,0,0.299,0.37,0.757,0.887,3,1,17,10,3.2,33.9,2,Similar,West,CA,Suburban,66-75,2024-04,Q2_2024,2023,6.8,0.195,Increasing
FIA002379,2024-04-27,Prednisone,Deltasone,Corticosteroids,60517-933-79,Commercial Plan Alpha,PLAN_1024,2024,Tier 3,Tier 2,2023-06-05,327,Worsened,None,No,No,,328,647,-49.3,Decreased,96.29,41.07,55.22,38.58,134.87,44.24,0.0,0,0.073,0.366,0.376,0.475,0,2,8,8,2.4,8.6,5,Higher,Southeast,NC,Suburban,75+,2024-04,Q2_2024,2023,4.5,0.733,Stable
FIA001846,2024-05-12,Prednisone,Deltasone,Corticosteroids,57676-539-49,VA Plan,PLAN_7464,2024,Tier 3,Tier 1,2024-03-29,44,Worsened,Prior Authorization,Yes,No,,422,822,-48.6,Decreased,64.01,12.51,51.5,182.39,246.4,103.98,0.419,4,0.065,0.261,0.256,0.675,2,2,1,12,2.6,15.6,5,Similar,West,MI,Rural,66-75,2024-05,Q2_2024,2023,6.6,0.598,Stable
FIA001697,2024-05-15,Prednisone,Deltasone,Corticosteroids,36430-843-38,Commercial Plan Beta,PLAN_2456,2024,Tier 3,Specialty Tier,2024-03-26,50,Improved,Prior Authorization,Yes,No,,720,749,-3.8,Stable,69.99,237.25,-167.26,117.59,187.58,135.06,0.447,5,0.048,0.254,0.656,0.597,9,8,10,5,3.5,33.1,7,Lower,Northeast,OH,Suburban,66-75,2024-05,Q2_2024,2023,3.9,0.259,Decreasing
FIA002090,2024-05-16,Prednisone,Deltasone,Corticosteroids,15990-924-66,Medicaid Plan X,PLAN_8175,2024,Specialty Tier,Specialty Tier,2023-07-24,297,No Change,None,No,No,,732,728,0.6,Stable,175.64,257.56,-81.92,64.69,240.33,175.92,0.0,0,0.164,0.19,0.89,0.447,15,7,14,6,3.9,12.4,6,Similar,Midwest,TX,Suburban,51-65,2024-05,Q2_2024,2023,1.8,0.481,Stable
FIA001224,2024-05-20,Prednisone,Deltasone,Corticosteroids,37603-215-67,VA Plan,PLAN_9130,2024,Specialty Tier,Tier 1,2023-06-13,342,Worsened,Step Therapy,No,Yes,,103,294,-64.7,Decreased,116.32,6.81,109.51,140.27,256.59,26.43,0.0,0,0.194,0.346,0.793,0.692,11,6,14,10,3.7,5.8,4,Higher,Southwest,NY,Rural,75+,2024-05,Q2_2024,2023,6.9,0.824,Stable
FIA001961,2024-05-20,Prednisone,Deltasone,Corticosteroids,70998-954-58,Medicare Part D Plan A,PLAN_7896,2024,Tier 1,Specialty Tier,2023-09-24,239,Improved,None,No,No,,259,187,38.7,Increased,10.41,295.46,-285.05,70.79,81.2,21.03,0.0,0,0.066,0.074,0.692,0.443,11,5,1,14,3.0,13.0,3,Higher,Northeast,GA,Rural,36-50,2024-05,Q2_2024,2023,8.5,0.892,Stable
FIA002508,2024-05-23,Prednisone,Deltasone,Corticosteroids,29708-782-88,Medicaid Plan Y,PLAN_2917,2024,Tier 2,Tier 2,2023-07-17,311,No Change,None,No,No,,418,430,-2.6,Stable,20.75,30.18,-9.43,98.66,119.41,49.91,0.0,0,0.03,0.374,0.662,0.651,14,0,20,4,4.9,19.0,5,Higher,Northeast,MI,Urban,51-65,2024-05,Q2_2024,2023,2.7,0.261,Decreasing
FIA000024,2024-06-03,Prednisone,Deltasone,Corticosteroids,95394-552-45,Commercial Plan Alpha,PLAN_8141,2024,Tier 3,Non-Formulary,2023-12-28,158,Improved,Prior Authorization,Yes,No,,843,790,6.7,Increased,51.29,337.35,-286.06,109.99,161.28,135.96,0.12,8,0.063,0.389,0.529,0.625,10,10,3,5,3.0,25.8,4,Higher,Southwest,NC,Urban,66-75,2024-06,Q2_2024,2023,1.8,0.252,Increasing
FIA002275,2024-06-19,Prednisone,Deltasone,Corticosteroids,52543-200-69,Commercial Plan Alpha,PLAN_9682,2024,Tier 1,Tier 1,2023-06-21,364,No Change,None,No,No,,109,101,8.0,Increased,5.58,16.38,-10.8,142.03,147.61,16.09,0.0,0,0.019,0.187,0.29,0.743,15,8,7,13,4.7,34.6,7,Higher,Northeast,FL,Rural,75+,2024-06,Q2_2024,2023,3.7,0.644,Stable
FIA000459,2024-06-22,Prednisone,Deltasone,Corticosteroids,68961-314-21,Medicaid Plan Y,PLAN_4878,2024,Tier 2,Tier 2,2024-02-04,139,No Change,None,No,No,,326,362,-9.8,Decreased,26.55,22.91,3.64,130.07,156.62,51.06,0.0,0,0.03,0.264,0.265,0.538,7,0,15,8,3.6,24.7,7,Higher,Northeast,GA,Urban,66-75,2024-06,Q2_2024,2023,9.0,0.1,Decreasing
FIA002031,2024-07-01,Prednisone,Deltasone,Corticosteroids,83834-728-65,Tricare Standard,PLAN_3803,2024,Tier 1,Specialty Tier,2024-01-03,180,Improved,None,No,No,,1066,737,44.7,Increased,6.35,201.59,-195.24,56.53,62.88,67.03,0.0,0,0.043,0.112,0.739,0.69,11,1,10,14,2.1,11.1,3,Similar,West,TX,Suburban,18-35,2024-07,Q3_2024,2023,7.0,0.053,Decreasing
FIA000571,2024-07-12,Prednisone,Deltasone,Corticosteroids,95344-421-28,Medicaid Plan X,PLAN_7249,2024,Non-Formulary,Specialty Tier,2023-09-28,288,Worsened,Non-Formulary Status,No,No,,756,773,-2.1,Stable,644.87,234.96,409.91,198.06,842.93,637.26,0.0,0,0.248,0.314,0.871,0.484,2,10,15,14,4.7,6.9,4,Lower,Northeast,PA,Urban,51-65,2024-07,Q3_2024,2023,1.5,0.228,Stable
FIA001679,2024-07-17,Prednisone,Deltasone,Corticosteroids,77534-153-40,Medicare Part D Plan A,PLAN_3714,2024,Tier 3,Tier 3,2024-02-05,163,No Change,Prior Authorization,Yes,No,,910,909,0.2,Stable,84.58,89.48,-4.9,118.29,202.87,184.61,0.299,5,0.054,0.394,0.603,0.475,0,0,17,6,2.7,8.6,6,Similar,Northeast,IL,Rural,51-65,2024-07,Q3_2024,2023,8.1,0.018,Increasing
FIA000904,2024-07-18,Prednisone,Deltasone,Corticosteroids,74925-778-27,Medicare Part D Plan A,PLAN_6487,2024,Tier 2,Tier 3,2023-09-20,302,Improved,Quantity Limit,No,No,60.0,315,259,21.7,Increased,20.25,87.97,-67.72,88.85,109.1,34.37,0.0,0,0.029,0.154,0.778,0.852,15,8,3,4,4.9,30.6,8,Similar,Southwest,PA,Rural,75+,2024-07,Q3_2024,2023,3.5,0.305,Increasing
FIA002716,2024-08-06,Prednisone,Deltasone,Corticosteroids,77748-754-19,Commercial Plan Beta,PLAN_3805,2024,Tier 1,Tier 2,2023-08-27,345,Improved,None,No,No,,854,794,7.6,Increased,10.25,20.86,-10.61,96.85,107.1,91.46,0.0,0,0.024,0.31,0.201,0.614,14,10,5,3,3.3,14.4,5,Higher,Midwest,GA,Rural,75+,2024-08,Q3_2024,2023,3.3,0.299,Stable
FIA001898,2024-08-12,Prednisone,Deltasone,Corticosteroids,10967-129-26,Commercial Plan Alpha,PLAN_4677,2024,Non-Formulary,Non-Formulary,2024-02-17,177,No Change,Non-Formulary Status,No,No,,1019,957,6.5,Increased,500.51,533.47,-32.96,78.76,579.27,590.28,0.0,0,0.116,0.156,0.897,0.764,3,4,5,9,2.6,20.1,6,Lower,Northeast,NY,Rural,66-75,2024-08,Q3_2024,2023,8.8,0.178,Stable
FIA002264,2024-08-12,Prednisone,Deltasone,Corticosteroids,55957-629-58,Medicare Part D Plan B,PLAN_5039,2024,Tier 3,Specialty Tier,2024-01-02,223,Improved,Prior Authorization; Step Therapy,Yes,Yes,,216,203,6.7,Increased,83.41,276.37,-192.96,134.26,217.67,47.02,0.528,10,0.057,0.131,0.849,0.543,11,0,1,9,2.9,6.9,8,Similar,Northeast,CA,Rural,66-75,2024-08,Q3_2024,2023,1.3,0.008,Stable
FIA002346,2024-08-14,Prednisone,Deltasone,Corticosteroids,12979-681-87,Medicaid Plan Y,PLAN_3168,2024,Non-Formulary,Tier 1,2024-03-27,140,Worsened,Non-Formulary Status,No,No,,358,926,-61.3,Decreased,481.96,9.01,472.95,157.54,639.5,228.94,0.0,0,0.07,0.352,0.243,0.546,0,5,19,5,3.2,8.3,7,Similar,Midwest,GA,Rural,66-75,2024-08,Q3_2024,2023,7.0,0.811,Increasing
FIA000871,2024-08-31,Prednisone,Deltasone,Corticosteroids,53157-124-89,Commercial Plan Alpha,PLAN_7380,2024,Tier 1,Non-Formulary,2024-01-12,232,Improved,None,No,No,,333,254,31.3,Increased,10.96,648.42,-637.46,140.24,151.2,50.35,0.0,0,0.068,0.395,0.205,0.767,3,10,1,2,4.5,17.7,5,Lower,West,GA,Urban,75+,2024-08,Q3_2024,2023,3.3,0.252,Decreasing
FIA000191,2024-09-01,Prednisone,Deltasone,Corticosteroids,27759-465-30,Medicare Part D Plan A,PLAN_5467,2024,Tier 1,Tier 3,2023-11-14,292,Improved,None,No,No,,446,365,22.3,Increased,15.99,50.88,-34.89,179.31,195.3,87.1,0.0,0,0.032,0.176,0.645,0.925,1,4,9,2,3.5,28.0,3,Lower,West,FL,Rural,51-65,2024-09,Q3_2024,2023,8.9,0.827,Decreasing
FIA000491,2024-09-01,Prednisone,Deltasone,Corticosteroids,94320-921-23,Medicaid Plan X,PLAN_2427,2024,Non-Formulary,Tier 1,2024-04-03,151,Worsened,Non-Formulary Status; Quantity Limit,No,No,,329,424,-22.3,Decreased,679.28,11.71,667.57,173.92,853.2,280.7,0.0,0,0.116,0.322,0.324,0.611,3,9,16,15,3.7,23.2,8,Lower,Southwest,CA,Suburban,51-65,2024-09,Q3_2024,2023,2.2,0.845,Decreasing
FIA002378,2024-09-09,Prednisone,Deltasone,Corticosteroids,58626-117-94,Medicaid Plan Y,PLAN_8703,2024,Tier 2,Non-Formulary,2023-11-25,289,Improved,Quantity Limit,No,No,60.0,649,471,37.9,Increased,29.18,576.72,-547.54,193.66,222.84,144.62,0.0,0,0.042,0.259,0.83,0.659,6,9,5,2,3.6,28.1,7,Higher,Northeast,MI,Suburban,18-35,2024-09,Q3_2024,2023,4.1,0.501,Stable
FIA000239,2024-09-16,Prednisone,Deltasone,Corticosteroids,65708-486-83,Commercial Plan Alpha,PLAN_7129,2024,Specialty Tier,Specialty Tier,2024-04-02,167,No Change,Step Therapy,No,Yes,,924,909,1.7,Stable,216.24,227.62,-11.38,67.16,283.4,261.86,0.0,0,0.109,0.139,0.259,0.813,9,7,16,11,2.7,6.2,6,Higher,Midwest,OH,Suburban,66-75,2024-09,Q3_2024,2023,4.9,0.368,Stable
FIA002097,2024-10-01,Prednisone,Deltasone,Corticosteroids,19139-191-31,Medicare Part D Plan A,PLAN_3321,2024,Tier 2,Specialty Tier,2024-03-11,204,Improved,None,No,No,,175,148,18.7,Increased,40.6,244.28,-203.68,66.39,106.99,18.72,0.0,0,0.061,0.355,0.318,0.462,7,1,15,9,4.0,23.8,6,Higher,Southeast,NC,Rural,36-50,2024-10,Q4_2024,2024,6.9,0.243,Stable
FIA001947,2024-10-02,Prednisone,Deltasone,Corticosteroids,72044-948-80,VA Plan,PLAN_2542,2024,Tier 3,Specialty Tier,2024-07-15,79,Improved,Prior Authorization,Yes,No,,653,659,-0.8,Stable,79.38,299.74,-220.36,89.0,168.38,109.95,0.32,7,0.059,0.161,0.588,0.455,6,0,1,6,4.8,9.9,5,Similar,Southwest,FL,Urban,66-75,2024-10,Q4_2024,2024,6.9,0.488,Decreasing
FIA002062,2024-10-08,Prednisone,Deltasone,Corticosteroids,75099-228-43,Medicaid Plan X,PLAN_8442,2024,Tier 1,Specialty Tier,2024-06-01,129,Improved,None,No,No,,241,152,58.8,Increased,18.43,180.02,-161.59,180.76,199.19,48.0,0.0,0,0.066,0.376,0.778,0.72,13,7,8,11,2.0,6.9,3,Lower,West,FL,Suburban,36-50,2024-10,Q4_2024,2024,4.9,0.347,Stable
FIA002684,2024-10-10,Prednisone,Deltasone,Corticosteroids,67544-470-71,Commercial Plan Beta,PLAN_3562,2024,Non-Formulary,Tier 3,2024-06-27,105,Worsened,Non-Formulary Status,No,No,,745,777,-4.1,Stable,580.11,91.06,489.05,198.63,778.74,580.16,0.0,0,0.169,0.101,0.335,0.46,3,4,5,0,4.0,6.6,6,Similar,Southeast,PA,Rural,18-35,2024-10,Q4_2024,2024,9.4,0.408,Stable
FIA000216,2024-10-12,Prednisone,Deltasone,Corticosteroids,85550-423-80,Medicare Part D Plan B,PLAN_5388,2024,Non-Formulary,Non-Formulary,2023-12-04,313,No Change,Non-Formulary Status,No,No,,507,509,-0.3,Stable,799.42,222.21,577.21,33.23,832.65,422.15,0.0,0,0.065,0.363,0.492,0.66,15,9,20,11,3.3,18.1,3,Similar,Southeast,GA,Suburban,66-75,2024-10,Q4_2024,2024,3.1,0.22,Decreasing
FIA000602,2024-10-25,Prednisone,Deltasone,Corticosteroids,79590-608-36,VA Plan,PLAN_7587,2024,Tier 1,Tier 1,2024-05-03,175,No Change,None,No,No,,382,406,-5.8,Decreased,9.92,18.19,-8.27,88.35,98.27,37.54,0.0,0,0.015,0.099,0.508,0.519,11,8,19,12,3.7,11.3,3,Higher,Northeast,CA,Rural,51-65,2024-10,Q4_2024,2024,5.9,0.975,Stable
FIA001102,2024-10-26,Prednisone,Deltasone,Corticosteroids,61283-633-75,Medicare Part D Plan B,PLAN_6693,2024,Tier 2,Tier 2,2023-12-14,317,No Change,Quantity Limit,No,No,60.0,594,614,-3.2,Stable,42.63,34.7,7.93,101.89,144.52,85.84,0.0,0,0.058,0.31,0.277,0.579,13,10,13,2,4.6,17.4,6,Similar,Northeast,MI,Urban,66-75,2024-10,Q4_2024,2024,9.4,0.239,Stable
FIA001639,2024-12-03,Prednisone,Deltasone,Corticosteroids,19752-443-49,Commercial Plan Alpha,PLAN_6566,2024,Tier 2,Tier 3,2024-07-09,147,Improved,None,No,No,,1169,801,45.9,Increased,40.96,99.29,-58.33,136.88,177.84,207.89,0.0,0,0.056,0.286,0.846,0.727,10,7,2,9,3.3,31.1,5,Lower,Northeast,GA,Urban,75+,2024-12,Q4_2024,2024,8.3,0.742,Decreasing
FIA000694,2024-12-06,Prednisone,Deltasone,Corticosteroids,77410-925-45,Medicare Part D Plan B,PLAN_7885,2024,Tier 2,Tier 2,2024-11-05,31,No Change,None,No,No,,247,232,6.8,Increased,35.03,42.64,-7.61,97.39,132.42,32.71,0.0,0,0.046,0.106,0.653,0.521,13,0,20,11,4.2,16.3,6,Similar,Southeast,GA,Suburban,66-75,2024-12,Q4_2024,2024,3.6,0.516,Increasing
FIA002150,2024-12-21,Prednisone,Deltasone,Corticosteroids,37747-268-59,Medicare Part D Plan B,PLAN_4839,2024,Specialty Tier,Tier 1,2024-04-14,251,Worsened,None,No,No,,247,650,-61.9,Decreased,139.8,12.17,127.63,105.28,245.08,60.53,0.0,0,0.242,0.196,0.436,0.762,7,6,9,1,3.4,16.8,2,Higher,Southeast,NC,Urban,18-35,2024-12,Q4_2024,2024,5.3,0.629,Decreasing
FIA002570,2024-12-24,Prednisone,Deltasone,Corticosteroids,21970-133-36,Medicare Part D Plan A,PLAN_1183,2024,Specialty Tier,Tier 2,2024-08-15,131,Worsened,None,No,No,,200,499,-59.9,Decreased,245.82,47.69,198.13,83.96,329.78,65.96,0.0,0,0.25,0.19,0.684,0.584,15,3,0,3,3.8,29.8,7,Similar,Northeast,NC,Rural,36-50,2024-12,Q4_2024,2024,3.1,0.533,Increasing
FIA000777,2024-12-25,Prednisone,Deltasone,Corticosteroids,12863-321-58,Commercial Plan Beta,PLAN_1048,2024,Specialty Tier,Tier 2,2024-04-27,242,Worsened,Step Therapy,No,Yes,,215,356,-39.4,Decreased,152.39,20.82,131.57,112.12,264.51,56.87,0.0,0,0.178,0.06,0.579,0.668,7,6,7,2,4.3,22.3,3,Higher,Southeast,MI,Urban,36-50,2024-12,Q4_2024,2024,5.3,0.058,Stable
FIA000275,2024-12-28,Prednisone,Deltasone,Corticosteroids,67163-169-71,VA Plan,PLAN_9581,2024,Tier 2,Tier 1,2024-09-24,95,Worsened,Quantity Limit,No,No,,386,358,7.8,Increased,25.75,13.26,12.49,151.95,177.7,68.59,0.0,0,0.041,0.108,0.392,0.932,9,0,18,1,4.4,25.8,7,Similar,Southwest,NC,Rural,18-35,2024-12,Q4_2024,2024,2.5,0.751,Stable
FIA000530,2024-12-30,Prednisone,Deltasone,Corticosteroids,93267-679-25,Tricare Standard,PLAN_9669,2024,Non-Formulary,Non-Formulary,2024-01-17,348,No Change,Non-Formulary Status,No,No,,602,570,5.7,Increased,443.15,433.05,10.1,118.41,561.56,338.06,0.0,0,0.19,0.398,0.662,0.667,2,5,0,11,4.4,17.9,4,Similar,Northeast,MI,Suburban,66-75,2024-12,Q4_2024,2024,1.2,0.595,Increasing
FIA001052,2025-01-09,Prednisone,Deltasone,Corticosteroids,37163-825-43,Commercial Plan Alpha,PLAN_2346,2025,Specialty Tier,Tier 3,2024-11-06,64,Worsened,Step Therapy,No,Yes,,505,470,7.6,Increased,154.81,74.45,80.36,59.43,214.24,108.19,0.0,0,0.175,0.272,0.295,0.793,5,1,10,0,2.0,26.0,2,Lower,Southeast,CA,Suburban,51-65,2025-01,Q1_2025,2024,9.5,0.259,Stable
FIA001611,2025-01-15,Prednisone,Deltasone,Corticosteroids,53188-145-24,Medicaid Plan Y,PLAN_5521,2025,Tier 2,Tier 2,2024-04-14,276,No Change,Quantity Limit,No,No,,275,268,2.8,Stable,32.82,43.12,-10.3,70.0,102.82,28.28,0.0,0,0.025,0.215,0.483,0.654,13,6,2,1,4.1,6.5,2,Similar,West,TX,Urban,75+,2025-01,Q1_2025,2024,9.1,0.163,Decreasing
FIA002199,2025-01-22,Prednisone,Deltasone,Corticosteroids,77195-483-71,Medicaid Plan Y,PLAN_4737,2025,Tier 2,Tier 3,2024-08-24,151,Improved,None,No,No,,469,346,35.8,Increased,39.1,73.53,-34.43,167.61,206.71,96.95,0.0,0,0.071,0.379,0.245,0.754,3,3,19,8,3.1,28.5,3,Lower,Southeast,GA,Suburban,66-75,2025-01,Q1_2025,2024,9.4,0.088,Increasing
FIA001715,2025-01-27,Prednisone,Deltasone,Corticosteroids,27531-899-12,Tricare Standard,PLAN_9715,2025,Tier 1,Tier 2,2024-11-13,75,Improved,None,No,No,,356,339,5.1,Increased,9.43,29.99,-20.56,109.65,119.08,42.39,0.0,0,0.011,0.348,0.711,0.591,8,5,17,9,2.2,9.0,5,Higher,Southwest,OH,Rural,18-35,2025-01,Q1_2025,2024,2.2,0.554,Increasing
FIA000584,2025-01-31,Prednisone,Deltasone,Corticosteroids,18185-161-67,VA Plan,PLAN_9748,2025,Tier 1,Tier 3,2024-03-24,313,Improved,None,No,No,,1457,962,51.5,Increased,15.34,96.25,-80.91,160.44,175.78,256.11,0.0,0,0.064,0.294,0.315,0.652,13,3,7,5,4.5,34.8,3,Higher,West,OH,Rural,36-50,2025-01,Q1_2025,2024,2.9,0.484,Decreasing
FIA000378,2025-02-01,Prednisone,Deltasone,Corticosteroids,99204-327-12,Commercial Plan Beta,PLAN_6798,2025,Tier 3,Tier 2,2024-07-09,207,Worsened,Prior Authorization; Quantity Limit,Yes,No,30.0,58,184,-68.3,Decreased,65.35,33.08,32.27,54.09,119.44,6.93,0.543,10,0.046,0.351,0.568,0.84,11,8,7,5,3.1,8.0,3,Higher,West,NY,Rural,36-50,2025-02,Q1_2025,2024,5.9,0.955,Stable
FIA000972,2025-02-04,Prednisone,Deltasone,Corticosteroids,72763-982-85,Medicaid Plan X,PLAN_4482,2025,Non-Formulary,Non-Formulary,2024-06-04,245,No Change,Non-Formulary Status,No,No,,878,874,0.5,Stable,652.59,220.96,431.63,94.35,746.94,655.81,0.0,0,0.137,0.382,0.841,0.946,13,4,8,15,2.2,16.5,3,Similar,Southwest,GA,Rural,66-75,2025-02,Q1_2025,2024,9.0,0.765,Stable
FIA001214,2025-02-04,Prednisone,Deltasone,Corticosteroids,27862-846-78,Medicaid Plan X,PLAN_9063,2025,Tier 1,Tier 1,2024-04-19,291,No Change,None,No,No,,286,283,1.3,Stable,5.41,13.33,-7.92,167.02,172.43,49.31,0.0,0,0.033,0.218,0.883,0.82,10,8,15,11,2.7,7.1,4,Similar,Midwest,TX,Suburban,36-50,2025-02,Q1_2025,2024,2.9,0.033,Increasing
FIA002756,2025-02-04,Prednisone,Deltasone,Corticosteroids,45234-679-52,Commercial Plan Beta,PLAN_9790,2025,Specialty Tier,Tier 2,2024-09-21,136,Worsened,None,No,No,,71,163,-55.9,Decreased,233.57,20.6,212.97,108.34,341.91,24.28,0.0,0,0.064,0.28,0.206,0.918,13,1,2,11,4.7,30.9,7,Similar,Midwest,GA,Suburban,66-75,2025-02,Q1_2025,2024,7.7,0.396,Increasing
FIA001792,2025-02-13,Prednisone,Deltasone,Corticosteroids,11948-174-30,Commercial Plan Beta,PLAN_5186,2025,Non-Formulary,Specialty Tier,2024-10-26,110,Worsened,Non-Formulary Status,No,No,,523,479,9.3,Increased,453.26,124.12,329.14,109.68,562.94,294.42,0.0,0,0.231,0.29,0.405,0.883,12,4,12,0,3.5,8.2,2,Lower,Southwest,OH,Suburban,36-50,2025-02,Q1_2025,2024,5.9,0.905,Increasing
FIA002337,2025-02-17,Prednisone,Deltasone,Corticosteroids,13255-124-32,Commercial Plan Beta,PLAN_8719,2025,Non-Formulary,Tier 1,2024-07-20,212,Worsened,Non-Formulary Status,No,No,,272,543,-49.8,Decreased,735.51,6.44,729.07,46.67,782.18,212.75,0.0,0,0.176,0.35,0.784,0.548,2,3,9,11,4.4,25.8,2,Similar,Southeast,NC,Rural,75+,2025-02,Q1_2025,2024,7.8,0.178,Decreasing
FIA000418,2025-02-18,Prednisone,Deltasone,Corticosteroids,29096-428-91,Medicaid Plan Y,PLAN_7668,2025,Specialty Tier,Tier 2,2024-12-26,54,Worsened,None,No,No,,272,476,-42.8,Decreased,157.3,22.65,134.65,123.67,280.97,76.42,0.0,0,0.143,0.111,0.481,0.657,11,4,4,15,4.0,17.2,5,Lower,West,PA,Urban,51-65,2025-02,Q1_2025,2024,9.3,0.645,Stable
FIA001002,2025-03-03,Prednisone,Deltasone,Corticosteroids,74694-857-40,Commercial Plan Beta,PLAN_1500,2025,Specialty Tier,Tier 1,2024-06-17,259,Worsened,None,No,No,,294,483,-39.0,Decreased,228.39,17.7,210.69,132.73,361.12,106.17,0.0,0,0.059,0.317,0.248,0.431,11,5,18,2,4.3,23.2,6,Lower,Southeast,TX,Suburban,75+,2025-03,Q1_2025,2024,2.9,0.889,Stable
FIA001588,2025-03-14,Prednisone,Deltasone,Corticosteroids,28121-364-51,Commercial Plan Alpha,PLAN_8285,2025,Tier 3,Tier 2,2024-07-31,226,Worsened,Prior Authorization,Yes,No,,168,378,-55.4,Decreased,81.14,30.73,50.41,75.01,156.15,26.23,0.464,8,0.057,0.062,0.227,0.693,15,5,10,1,3.0,9.9,4,Higher,Northeast,NC,Rural,75+,2025-03,Q1_2025,2024,5.8,0.821,Stable
FIA001764,2025-03-24,Prednisone,Deltasone,Corticosteroids,22604-772-23,Commercial Plan Beta,PLAN_7917,2025,Non-Formulary,Tier 1,2024-05-16,312,Worsened,Non-Formulary Status,No,No,,542,963,-43.6,Decreased,539.69,8.35,531.34,40.0,579.69,314.19,0.0,0,0.126,0.139,0.578,0.738,12,8,16,14,3.5,21.2,2,Lower,West,TX,Urban,66-75,2025-03,Q1_2025,2024,8.2,0.484,Increasing
FIA001607,2025-03-31,Prednisone,Deltasone,Corticosteroids,41415-453-62,Commercial Plan Alpha,PLAN_4095,2025,Non-Formulary,Tier 1,2024-04-13,352,Worsened,Non-Formulary Status,No,No,,377,778,-51.5,Decreased,270.2,17.33,252.87,199.16,469.36,176.95,0.0,0,0.236,0.253,0.752,0.495,2,1,16,15,2.0,6.3,2,Lower,West,FL,Urban,36-50,2025-03,Q1_2025,2024,9.9,0.359,Increasing
FIA001872,2025-04-01,Prednisone,Deltasone,Corticosteroids,64550-982-19,Medicare Part D Plan A,PLAN_4880,2025,Tier 2,Tier 1,2024-10-11,172,Worsened,None,No,No,,656,649,1.2,Stable,36.91,10.33,26.58,54.33,91.24,59.85,0.0,0,0.044,0.207,0.53,0.536,3,0,5,10,4.1,10.8,5,Higher,Midwest,MI,Urban,36-50,2025-04,Q2_2025,2024,4.0,0.544,Increasing
FIA002412,2025-04-01,Prednisone,Deltasone,Corticosteroids,76651-636-55,Medicaid Plan X,PLAN_9903,2025,Tier 2,Tier 2,2025-01-08,83,No Change,None,No,No,,831,819,1.6,Stable,45.95,23.9,22.05,136.46,182.41,151.58,0.0,0,0.066,0.307,0.279,0.681,13,4,19,0,4.8,22.7,2,Higher,Southeast,IL,Suburban,66-75,2025-04,Q2_2025,2024,2.3,0.425,Increasing
FIA000046,2025-04-06,Prednisone,Deltasone,Corticosteroids,69988-137-47,Commercial Plan Beta,PLAN_1717,2025,Tier 3,Tier 2,2025-02-13,52,Worsened,Prior Authorization,Yes,No,,540,758,-28.8,Decreased,67.61,30.16,37.45,40.73,108.34,58.5,0.416,4,0.067,0.36,0.421,0.571,12,8,15,8,2.1,24.4,4,Similar,Northeast,IL,Suburban,18-35,2025-04,Q2_2025,2024,8.2,0.437,Stable
FIA000401,2025-04-15,Prednisone,Deltasone,Corticosteroids,61592-253-24,Commercial Plan Beta,PLAN_6254,2025,Tier 3,Specialty Tier,2024-05-21,329,Improved,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,60.0,131,120,9.4,Increased,78.6,189.47,-110.87,81.02,159.62,20.91,0.134,2,0.019,0.174,0.888,0.672,13,2,11,8,2.6,13.4,6,Lower,Southwest,IL,Urban,18-35,2025-04,Q2_2025,2024,6.8,0.701,Stable
FIA000450,2025-04-15,Prednisone,Deltasone,Corticosteroids,84834-463-12,Medicaid Plan Y,PLAN_6549,2025,Tier 1,Tier 2,2024-07-06,283,Improved,Quantity Limit,No,No,90.0,441,429,2.9,Stable,13.36,33.74,-20.38,61.97,75.33,33.22,0.0,0,0.013,0.312,0.205,0.573,14,1,4,3,3.8,21.8,2,Higher,Southeast,GA,Suburban,75+,2025-04,Q2_2025,2024,10.0,0.726,Stable
FIA000500,2025-04-16,Prednisone,Deltasone,Corticosteroids,71616-184-36,Tricare Standard,PLAN_2522,2025,Tier 3,Tier 1,2025-01-29,77,Worsened,Quantity Limit,No,No,,281,769,-63.4,Decreased,65.14,12.17,52.97,128.01,193.15,54.28,0.0,0,0.074,0.101,0.234,0.483,4,1,6,5,2.4,25.6,7,Similar,Southwest,GA,Rural,36-50,2025-04,Q2_2025,2024,1.5,0.606,Decreasing
FIA001271,2025-04-30,Prednisone,Deltasone,Corticosteroids,46431-106-83,Commercial Plan Alpha,PLAN_9079,2025,Non-Formulary,Specialty Tier,2024-11-13,168,Worsened,Non-Formulary Status,No,No,,923,877,5.3,Increased,389.34,235.71,153.63,64.43,453.77,418.83,0.0,0,0.116,0.206,0.665,0.864,14,3,20,13,3.6,5.2,5,Lower,Midwest,TX,Rural,36-50,2025-04,Q2_2025,2024,4.1,0.646,Increasing
FIA000669,2025-05-08,Prednisone,Deltasone,Corticosteroids,50699-381-67,Medicaid Plan X,PLAN_1001,2025,Tier 1,Non-Formulary,2024-12-28,131,Improved,None,No,No,,665,570,16.8,Increased,12.73,316.03,-303.3,79.97,92.7,61.65,0.0,0,0.023,0.323,0.545,0.414,13,2,7,10,5.0,32.7,2,Higher,Southwest,OH,Suburban,18-35,2025-05,Q2_2025,2024,8.0,0.608,Stable
FIA000486,2025-05-10,Prednisone,Deltasone,Corticosteroids,14692-811-93,Tricare Standard,PLAN_2501,2025,Tier 3,Non-Formulary,2024-11-12,179,Improved,Prior Authorization,Yes,No,,696,720,-3.2,Stable,82.42,378.88,-296.46,167.74,250.16,174.11,0.373,6,0.042,0.373,0.365,0.699,14,6,15,6,3.6,34.2,3,Lower,West,GA,Suburban,66-75,2025-05,Q2_2025,2024,8.0,0.964,Increasing
FIA001090,2025-05-11,Prednisone,Deltasone,Corticosteroids,40097-129-53,Medicaid Plan Y,PLAN_9174,2025,Non-Formulary,Tier 3,2024-08-21,263,Worsened,Non-Formulary Status,No,No,,803,814,-1.3,Stable,785.17,82.98,702.19,58.97,844.14,677.84,0.0,0,0.202,0.217,0.528,0.851,6,6,14,13,2.0,14.4,7,Lower,Northeast,IL,Rural,36-50,2025-05,Q2_2025,2024,6.4,0.73,Decreasing
FIA002014,2025-05-12,Prednisone,Deltasone,Corticosteroids,18403-543-79,Commercial Plan Alpha,PLAN_7668,2025,Specialty Tier,Specialty Tier,2025-02-15,86,No Change,None,No,No,,572,541,5.7,Increased,215.68,217.97,-2.29,158.81,374.49,214.21,0.0,0,0.172,0.282,0.455,0.671,1,7,6,5,5.0,32.3,8,Lower,Southwest,TX,Rural,36-50,2025-05,Q2_2025,2024,1.8,0.354,Decreasing
FIA000236,2025-05-13,Prednisone,Deltasone,Corticosteroids,39232-809-39,Tricare Standard,PLAN_4492,2025,Tier 3,Non-Formulary,2024-06-28,319,Improved,Step Therapy,No,Yes,,509,528,-3.4,Stable,98.15,569.66,-471.51,30.63,128.78,65.55,0.0,0,0.025,0.134,0.714,0.924,10,6,6,12,2.6,34.7,4,Lower,Northeast,IL,Urban,75+,2025-05,Q2_2025,2024,2.0,0.291,Increasing
FIA000115,2025-05-18,Prednisone,Deltasone,Corticosteroids,98129-235-93,Commercial Plan Alpha,PLAN_9255,2025,Non-Formulary,Tier 3,2024-07-12,310,Worsened,Non-Formulary Status,No,No,,683,666,2.7,Stable,716.42,85.59,630.83,146.72,863.14,589.52,0.0,0,0.229,0.24,0.646,0.791,11,8,15,13,4.0,31.8,6,Similar,Southwest,CA,Rural,18-35,2025-05,Q2_2025,2024,1.2,0.145,Decreasing
FIA002315,2025-05-22,Prednisone,Deltasone,Corticosteroids,19954-560-44,Commercial Plan Beta,PLAN_2042,2025,Tier 3,Tier 2,2025-03-20,63,Worsened,None,No,No,,197,317,-37.8,Decreased,98.93,25.84,73.09,196.09,295.02,58.12,0.0,0,0.056,0.262,0.33,0.907,13,2,2,14,4.3,31.7,2,Similar,Midwest,GA,Urban,66-75,2025-05,Q2_2025,2024,6.9,0.302,Stable
FIA001319,2025-05-30,Prednisone,Deltasone,Corticosteroids,14744-395-23,Medicaid Plan X,PLAN_1321,2025,Non-Formulary,Specialty Tier,2024-07-03,331,Worsened,Non-Formulary Status,No,No,,685,659,4.1,Stable,440.15,245.19,194.96,117.98,558.13,382.32,0.0,0,0.239,0.118,0.887,0.916,14,4,10,3,2.4,27.3,2,Higher,Southeast,GA,Rural,18-35,2025-05,Q2_2025,2024,8.8,0.158,Decreasing
FIA000354,2025-06-01,Prednisone,Deltasone,Corticosteroids,43666-838-93,Medicare Part D Plan B,PLAN_8101,2025,Tier 1,Specialty Tier,2024-08-13,292,Improved,None,No,No,,1118,752,48.7,Increased,19.7,115.75,-96.05,191.56,211.26,236.19,0.0,0,0.012,0.388,0.756,0.714,9,9,16,7,4.1,6.5,6,Similar,Southeast,OH,Suburban,36-50,2025-06,Q2_2025,2024,3.5,0.671,Decreasing
FIA000750,2025-06-13,Prednisone,Deltasone,Corticosteroids,33894-230-21,Medicare Part D Plan B,PLAN_5233,2025,Tier 3,Tier 2,2025-02-21,112,Worsened,Step Therapy,No,Yes,,73,241,-69.3,Decreased,96.81,45.19,51.62,64.05,160.86,11.74,0.0,0,0.042,0.135,0.637,0.407,0,5,9,15,4.0,17.6,8,Lower,Midwest,GA,Rural,75+,2025-06,Q2_2025,2024,2.0,0.908,Stable
FIA000150,2025-06-15,Prednisone,Deltasone,Corticosteroids,57876-456-34,Medicaid Plan Y,PLAN_6644,2025,Non-Formulary,Tier 2,2025-01-12,154,Worsened,Non-Formulary Status,No,No,,197,431,-54.2,Decreased,242.99,43.3,199.69,100.31,343.3,67.63,0.0,0,0.078,0.258,0.217,0.568,11,9,14,4,3.3,32.7,3,Lower,Midwest,FL,Rural,18-35,2025-06,Q2_2025,2024,2.0,0.055,Decreasing
FIA002753,2025-07-04,Prednisone,Deltasone,Corticosteroids,59642-447-28,Medicare Part D Plan A,PLAN_4923,2025,Tier 1,Tier 3,2024-12-27,189,Improved,None,No,No,,760,490,55.2,Increased,12.08,99.65,-87.57,63.33,75.41,57.31,0.0,0,0.05,0.162,0.391,0.448,0,5,20,9,4.5,22.3,2,Lower,Southeast,FL,Suburban,51-65,2025-07,Q3_2025,2024,4.8,0.698,Increasing
FIA001518,2025-07-05,Prednisone,Deltasone,Corticosteroids,90233-155-58,Commercial Plan Alpha,PLAN_4691,2025,Specialty Tier,Non-Formulary,2024-12-05,212,Improved,Step Therapy; Quantity Limit,No,Yes,60.0,172,187,-8.0,Decreased,193.05,548.58,-355.53,140.04,333.09,57.29,0.0,0,0.154,0.084,0.577,0.757,6,2,15,12,3.2,30.7,6,Higher,West,MI,Rural,51-65,2025-07,Q3_2025,2024,2.3,0.021,Increasing
FIA002426,2025-07-06,Prednisone,Deltasone,Corticosteroids,59326-299-71,Medicare Part D Plan A,PLAN_3895,2025,Tier 3,Specialty Tier,2025-06-04,32,Improved,None,No,No,,674,708,-4.7,Stable,74.18,292.82,-218.64,141.07,215.25,145.08,0.0,0,0.072,0.078,0.738,0.795,15,0,18,2,5.0,9.5,7,Similar,Southwest,GA,Urban,66-75,2025-07,Q3_2025,2024,3.0,0.136,Increasing
FIA001609,2025-07-13,Prednisone,Deltasone,Corticosteroids,55663-154-29,Medicaid Plan X,PLAN_6574,2025,Non-Formulary,Tier 3,2024-10-20,266,Worsened,Non-Formulary Status,No,No,,284,287,-0.7,Stable,630.18,88.94,541.24,170.96,801.14,227.52,0.0,0,0.055,0.055,0.776,0.924,4,7,1,11,2.5,32.2,2,Higher,Southwest,MI,Suburban,51-65,2025-07,Q3_2025,2024,4.9,0.3,Decreasing
FIA001112,2025-07-22,Prednisone,Deltasone,Corticosteroids,66178-325-66,Commercial Plan Alpha,PLAN_1285,2025,Tier 2,Non-Formulary,2024-09-14,311,Improved,None,No,No,,165,111,49.1,Increased,23.01,240.01,-217.0,174.91,197.92,32.66,0.0,0,0.04,0.12,0.511,0.562,8,8,7,12,3.1,19.5,5,Higher,Northeast,MI,Rural,18-35,2025-07,Q3_2025,2024,4.1,0.659,Stable
FIA000303,2025-08-18,Prednisone,Deltasone,Corticosteroids,37349-933-85,Medicaid Plan Y,PLAN_6108,2025,Tier 2,Tier 1,2025-06-11,68,Worsened,Quantity Limit,No,No,90.0,116,113,3.4,Stable,49.15,5.9,43.25,47.77,96.92,11.24,0.0,0,0.023,0.279,0.793,0.458,4,3,11,12,4.9,31.0,6,Lower,Southwest,NY,Urban,51-65,2025-08,Q3_2025,2024,4.8,0.686,Decreasing
FIA000416,2022-01-01,Sertraline,Zoloft,Antidepressants,14586-222-48,Commercial Plan Alpha,PLAN_5304,2022,Specialty Tier,Specialty Tier,2021-02-15,320,No Change,Prior Authorization; Step Therapy,Yes,Yes,,448,476,-5.7,Decreased,292.24,119.45,172.79,80.57,372.81,167.02,0.24,8,0.213,0.376,0.821,0.84,6,1,20,0,4.6,33.0,3,Lower,Northeast,TX,Rural,36-50,2022-01,Q1_2022,2021,5.1,0.886,Decreasing
FIA002418,2022-01-13,Sertraline,Zoloft,Antidepressants,24153-795-27,Medicaid Plan X,PLAN_7439,2022,Tier 1,Tier 1,2021-06-11,216,No Change,None,No,No,,674,697,-3.2,Stable,6.81,15.59,-8.78,121.0,127.81,86.14,0.0,0,0.064,0.138,0.566,0.763,1,7,17,1,3.5,28.8,5,Lower,Northeast,MI,Rural,36-50,2022-01,Q1_2022,2021,6.6,0.928,Increasing
FIA000709,2022-01-17,Sertraline,Zoloft,Antidepressants,59017-614-16,Medicare Part D Plan A,PLAN_2636,2022,Tier 1,Non-Formulary,2021-07-07,194,Improved,None,No,No,,1030,766,34.6,Increased,9.28,464.49,-455.21,148.72,158.0,162.74,0.0,0,0.024,0.303,0.575,0.931,2,4,6,2,3.0,33.1,4,Lower,Southwest,GA,Rural,66-75,2022-01,Q1_2022,2021,2.5,0.104,Increasing
FIA001280,2022-01-24,Sertraline,Zoloft,Antidepressants,17696-302-20,Medicaid Plan Y,PLAN_2056,2022,Non-Formulary,Specialty Tier,2021-04-21,278,Worsened,Non-Formulary Status,No,No,,789,819,-3.6,Stable,627.01,217.88,409.13,35.69,662.7,522.87,0.0,0,0.3,0.311,0.564,0.627,14,5,18,13,2.5,9.6,4,Higher,Midwest,GA,Suburban,51-65,2022-01,Q1_2022,2021,6.8,0.101,Stable
FIA002473,2022-01-24,Sertraline,Zoloft,Antidepressants,32300-514-40,Medicaid Plan Y,PLAN_5275,2022,Specialty Tier,Tier 2,2021-03-02,328,Worsened,Step Therapy,No,Yes,,452,718,-37.0,Decreased,110.13,34.45,75.68,139.1,249.23,112.65,0.0,0,0.129,0.069,0.786,0.674,0,1,7,13,2.7,34.7,6,Lower,West,PA,Rural,51-65,2022-01,Q1_2022,2021,5.2,0.372,Stable
FIA001667,2022-01-29,Sertraline,Zoloft,Antidepressants,85555-290-74,Medicaid Plan X,PLAN_3270,2022,Specialty Tier,Specialty Tier,2021-09-01,150,No Change,None,No,No,,885,808,9.6,Increased,145.95,256.14,-110.19,83.46,229.41,203.03,0.0,0,0.076,0.214,0.861,0.609,14,4,3,13,3.0,28.4,4,Similar,Southwest,GA,Rural,51-65,2022-01,Q1_2022,2021,8.4,0.206,Stable
FIA001860,2022-02-18,Sertraline,Zoloft,Antidepressants,27996-107-38,Medicaid Plan Y,PLAN_9427,2022,Specialty Tier,Tier 1,2021-10-28,113,Worsened,None,No,No,,106,226,-52.8,Decreased,138.57,11.8,126.77,154.56,293.13,31.07,0.0,0,0.096,0.092,0.368,0.824,14,9,10,2,3.9,30.7,7,Similar,Southeast,PA,Suburban,36-50,2022-02,Q1_2022,2021,3.4,0.366,Decreasing
FIA000314,2022-02-27,Sertraline,Zoloft,Antidepressants,70076-383-11,Commercial Plan Alpha,PLAN_6861,2022,Specialty Tier,Tier 1,2021-04-15,318,Worsened,Prior Authorization,Yes,No,,63,134,-52.3,Decreased,177.89,13.71,164.18,109.54,287.43,18.11,0.554,9,0.291,0.35,0.552,0.592,12,8,2,5,4.0,15.6,7,Higher,Midwest,GA,Rural,36-50,2022-02,Q1_2022,2021,3.5,0.763,Stable
FIA001793,2022-03-06,Sertraline,Zoloft,Antidepressants,60445-913-54,Tricare Standard,PLAN_8401,2022,Tier 3,Tier 3,2021-06-09,270,No Change,Prior Authorization; Quantity Limit,Yes,No,60.0,512,509,0.7,Stable,84.75,75.46,9.29,33.13,117.88,60.35,0.533,2,0.078,0.154,0.295,0.431,0,3,9,4,2.0,16.4,7,Higher,Southwest,FL,Urban,66-75,2022-03,Q1_2022,2021,1.2,0.835,Stable
FIA000205,2022-03-11,Sertraline,Zoloft,Antidepressants,44205-618-18,Medicaid Plan Y,PLAN_7895,2022,Tier 1,Specialty Tier,2021-06-13,271,Improved,Quantity Limit,No,No,60.0,648,440,47.3,Increased,16.05,285.3,-269.25,170.15,186.2,120.66,0.0,0,0.067,0.209,0.219,0.429,5,10,14,4,2.0,11.0,4,Similar,West,TX,Urban,36-50,2022-03,Q1_2022,2021,3.2,0.714,Decreasing
FIA001435,2022-03-13,Sertraline,Zoloft,Antidepressants,74131-576-14,Commercial Plan Alpha,PLAN_7790,2022,Specialty Tier,Specialty Tier,2022-01-05,67,No Change,None,No,No,,962,977,-1.5,Stable,110.09,293.03,-182.94,75.08,185.17,178.13,0.0,0,0.239,0.21,0.815,0.582,6,5,13,5,2.7,18.5,3,Similar,Southwest,PA,Suburban,66-75,2022-03,Q1_2022,2021,1.1,0.537,Stable
FIA001909,2022-03-13,Sertraline,Zoloft,Antidepressants,37624-174-22,Tricare Standard,PLAN_5667,2022,Tier 3,Tier 3,2021-04-29,318,No Change,Quantity Limit,No,No,60.0,905,873,3.7,Stable,86.6,89.73,-3.13,158.25,244.85,221.59,0.0,0,0.016,0.366,0.836,0.501,7,2,19,10,4.0,31.7,8,Similar,Southeast,GA,Rural,66-75,2022-03,Q1_2022,2021,7.7,0.004,Stable
FIA001294,2022-03-15,Sertraline,Zoloft,Antidepressants,23172-311-38,Commercial Plan Alpha,PLAN_1480,2022,Non-Formulary,Tier 3,2021-08-04,223,Worsened,Non-Formulary Status,No,No,,146,136,7.6,Increased,763.02,74.27,688.75,191.09,954.11,139.3,0.0,0,0.253,0.257,0.51,0.43,4,4,0,15,2.9,24.1,3,Similar,West,OH,Suburban,51-65,2022-03,Q1_2022,2021,3.1,0.563,Increasing
FIA002434,2022-03-22,Sertraline,Zoloft,Antidepressants,37693-542-65,Medicare Part D Plan B,PLAN_7089,2022,Non-Formulary,Non-Formulary,2021-05-19,307,No Change,Non-Formulary Status; Quantity Limit,No,No,30.0,342,377,-9.3,Decreased,231.66,538.68,-307.02,183.41,415.07,141.95,0.0,0,0.085,0.307,0.314,0.549,13,3,16,5,3.1,16.3,5,Lower,Southwest,MI,Rural,18-35,2022-03,Q1_2022,2021,5.1,0.318,Decreasing
FIA001390,2022-03-25,Sertraline,Zoloft,Antidepressants,27337-281-89,Medicaid Plan Y,PLAN_1859,2022,Tier 2,Specialty Tier,2021-09-03,203,Improved,Quantity Limit,No,No,30.0,1191,995,19.7,Increased,39.25,139.82,-100.57,189.74,228.99,272.73,0.0,0,0.035,0.338,0.476,0.899,1,3,13,15,2.9,17.9,8,Similar,Southwest,GA,Suburban,36-50,2022-03,Q1_2022,2021,7.9,0.325,Increasing
FIA001239,2022-03-30,Sertraline,Zoloft,Antidepressants,60089-775-78,Medicare Part D Plan B,PLAN_8194,2022,Tier 2,Tier 3,2022-01-27,62,Improved,None,No,No,,741,617,20.2,Increased,32.33,78.17,-45.84,30.95,63.28,46.89,0.0,0,0.073,0.279,0.231,0.694,8,3,13,11,3.7,9.6,3,Higher,Southwest,OH,Suburban,18-35,2022-03,Q1_2022,2021,7.1,0.313,Increasing
FIA002381,2022-04-01,Sertraline,Zoloft,Antidepressants,54043-267-60,Medicare Part D Plan B,PLAN_9025,2022,Non-Formulary,Specialty Tier,2022-03-02,30,Worsened,Non-Formulary Status,No,No,,148,145,2.4,Stable,281.83,132.31,149.52,115.34,397.17,58.78,0.0,0,0.204,0.099,0.744,0.475,1,2,12,3,2.4,21.9,8,Similar,West,GA,Suburban,18-35,2022-04,Q2_2022,2021,3.3,0.182,Increasing
FIA002327,2022-04-04,Sertraline,Zoloft,Antidepressants,16580-591-10,Medicare Part D Plan A,PLAN_8281,2022,Tier 3,Tier 2,2022-01-20,74,Worsened,Step Therapy,No,Yes,,153,407,-62.3,Decreased,82.13,38.3,43.83,91.27,173.4,26.53,0.0,0,0.069,0.376,0.243,0.884,7,9,15,6,3.0,8.4,2,Higher,Northeast,MI,Urban,36-50,2022-04,Q2_2022,2021,9.9,0.521,Decreasing
FIA000302,2022-04-09,Sertraline,Zoloft,Antidepressants,26552-426-28,VA Plan,PLAN_8320,2022,Tier 1,Tier 3,2021-09-23,198,Improved,None,No,No,,620,488,27.1,Increased,15.32,89.58,-74.26,108.32,123.64,76.66,0.0,0,0.02,0.284,0.565,0.532,15,10,15,8,3.0,26.9,3,Lower,Midwest,PA,Rural,18-35,2022-04,Q2_2022,2021,4.2,0.836,Increasing
FIA002977,2022-04-12,Sertraline,Zoloft,Antidepressants,77461-900-85,Medicaid Plan Y,PLAN_6565,2022,Tier 3,Tier 2,2021-10-21,173,Worsened,Prior Authorization; Quantity Limit,Yes,No,30.0,198,531,-62.6,Decreased,92.16,23.55,68.61,152.19,244.35,48.38,0.344,5,0.052,0.165,0.443,0.691,7,4,16,5,3.9,18.4,8,Higher,West,NY,Suburban,75+,2022-04,Q2_2022,2021,3.3,0.229,Increasing
FIA000322,2022-05-03,Sertraline,Zoloft,Antidepressants,96560-412-14,Medicaid Plan Y,PLAN_1425,2022,Non-Formulary,Specialty Tier,2021-07-24,283,Worsened,Non-Formulary Status,No,No,,503,554,-9.1,Decreased,211.31,176.52,34.79,120.52,331.83,166.91,0.0,0,0.215,0.369,0.728,0.585,8,9,6,0,3.0,29.9,5,Similar,Northeast,TX,Rural,66-75,2022-05,Q2_2022,2021,9.6,0.932,Stable
FIA002563,2022-05-10,Sertraline,Zoloft,Antidepressants,57803-797-40,Medicaid Plan Y,PLAN_6620,2022,Tier 2,Specialty Tier,2021-09-19,233,Improved,Quantity Limit,No,No,90.0,591,421,40.5,Increased,27.42,284.72,-257.3,110.55,137.97,81.54,0.0,0,0.029,0.239,0.513,0.781,13,3,5,7,3.6,18.1,8,Similar,Southeast,MI,Suburban,51-65,2022-05,Q2_2022,2021,6.7,0.945,Stable
FIA001095,2022-05-25,Sertraline,Zoloft,Antidepressants,63427-178-18,Tricare Standard,PLAN_9611,2022,Tier 2,Specialty Tier,2022-01-30,115,Improved,None,No,No,,560,462,21.3,Increased,20.65,111.91,-91.26,74.79,95.44,53.45,0.0,0,0.027,0.224,0.514,0.687,12,5,19,6,4.0,25.7,2,Similar,Northeast,MI,Urban,66-75,2022-05,Q2_2022,2021,1.8,0.884,Stable
FIA000686,2022-06-08,Sertraline,Zoloft,Antidepressants,37202-246-63,VA Plan,PLAN_5859,2022,Non-Formulary,Non-Formulary,2021-10-03,248,No Change,Non-Formulary Status; Quantity Limit,No,No,30.0,448,422,6.3,Increased,220.63,644.06,-423.43,166.07,386.7,173.24,0.0,0,0.199,0.095,0.722,0.936,8,6,3,4,2.3,26.6,6,Higher,West,TX,Rural,18-35,2022-06,Q2_2022,2021,4.0,0.288,Stable
FIA000753,2022-06-26,Sertraline,Zoloft,Antidepressants,17473-760-99,Commercial Plan Beta,PLAN_4841,2022,Specialty Tier,Tier 1,2021-12-15,193,Worsened,Quantity Limit,No,No,60.0,557,884,-36.9,Decreased,117.2,5.36,111.84,140.79,257.99,143.7,0.0,0,0.15,0.365,0.792,0.9,12,9,6,0,2.3,6.7,7,Lower,West,CA,Rural,75+,2022-06,Q2_2022,2021,6.3,0.066,Stable
FIA002018,2022-06-28,Sertraline,Zoloft,Antidepressants,63227-245-72,VA Plan,PLAN_8143,2022,Tier 2,Tier 2,2021-12-06,204,No Change,None,No,No,,753,728,3.5,Stable,39.76,34.57,5.19,107.81,147.57,111.12,0.0,0,0.08,0.141,0.57,0.874,9,8,13,0,3.9,16.5,2,Lower,Northeast,CA,Suburban,66-75,2022-06,Q2_2022,2021,4.5,0.778,Decreasing
FIA000722,2022-06-30,Sertraline,Zoloft,Antidepressants,89635-318-65,Tricare Standard,PLAN_9357,2022,Tier 1,Tier 1,2022-03-25,97,No Change,Quantity Limit,No,No,60.0,716,747,-4.0,Stable,17.61,11.89,5.72,42.76,60.37,43.22,0.0,0,0.075,0.222,0.406,0.636,2,3,17,2,2.1,24.1,4,Higher,Northeast,OH,Urban,75+,2022-06,Q2_2022,2021,10.0,0.169,Decreasing
FIA000515,2022-07-02,Sertraline,Zoloft,Antidepressants,24150-338-37,Tricare Standard,PLAN_7678,2022,Tier 1,Tier 2,2022-04-06,87,Improved,Quantity Limit,No,No,,799,842,-5.0,Decreased,13.8,42.7,-28.9,151.5,165.3,132.07,0.0,0,0.071,0.17,0.887,0.424,8,5,17,3,3.2,28.4,7,Lower,Southeast,IL,Suburban,51-65,2022-07,Q3_2022,2021,5.5,0.262,Decreasing
FIA002133,2022-07-03,Sertraline,Zoloft,Antidepressants,98407-714-58,VA Plan,PLAN_6270,2022,Non-Formulary,Tier 2,2021-07-25,343,Worsened,Non-Formulary Status,No,No,,220,725,-69.6,Decreased,300.75,48.95,251.8,127.36,428.11,94.18,0.0,0,0.142,0.053,0.492,0.466,2,6,11,10,3.6,33.2,4,Lower,Northeast,IL,Urban,36-50,2022-07,Q3_2022,2021,3.9,0.37,Increasing
FIA001893,2022-07-08,Sertraline,Zoloft,Antidepressants,23532-893-34,Medicare Part D Plan B,PLAN_5433,2022,Non-Formulary,Specialty Tier,2021-10-26,255,Worsened,Non-Formulary Status,No,No,,187,176,6.4,Increased,633.77,121.61,512.16,192.26,826.03,154.47,0.0,0,0.212,0.234,0.718,0.708,4,7,13,7,2.8,28.9,4,Similar,Southeast,IL,Suburban,18-35,2022-07,Q3_2022,2021,5.8,0.692,Decreasing
FIA001356,2022-07-16,Sertraline,Zoloft,Antidepressants,86926-363-15,Medicare Part D Plan A,PLAN_3855,2022,Tier 3,Tier 3,2021-09-12,307,No Change,Prior Authorization,Yes,No,,796,730,9.2,Increased,54.04,53.55,0.49,112.22,166.26,132.34,0.358,7,0.048,0.114,0.838,0.684,12,5,17,0,4.9,19.8,3,Lower,Northeast,NC,Rural,18-35,2022-07,Q3_2022,2021,4.2,0.802,Increasing
FIA002908,2022-07-16,Sertraline,Zoloft,Antidepressants,20052-405-60,Medicaid Plan Y,PLAN_9681,2022,Non-Formulary,Non-Formulary,2021-10-24,265,No Change,Non-Formulary Status,No,No,,530,521,1.8,Stable,245.64,206.72,38.92,183.42,429.06,227.4,0.0,0,0.26,0.254,0.33,0.616,12,3,2,14,3.4,25.9,6,Lower,Southeast,CA,Rural,66-75,2022-07,Q3_2022,2021,2.1,0.09,Stable
FIA001289,2022-07-23,Sertraline,Zoloft,Antidepressants,83184-778-74,Medicaid Plan X,PLAN_5277,2022,Non-Formulary,Tier 2,2022-03-11,134,Worsened,Non-Formulary Status,No,No,,281,898,-68.7,Decreased,622.39,20.77,601.62,86.73,709.12,199.26,0.0,0,0.177,0.324,0.39,0.841,15,2,3,6,2.5,30.8,7,Higher,Southwest,GA,Suburban,36-50,2022-07,Q3_2022,2021,8.8,0.781,Increasing
FIA001955,2022-07-23,Sertraline,Zoloft,Antidepressants,86692-813-76,Medicare Part D Plan B,PLAN_4739,2022,Tier 3,Tier 3,2022-02-22,151,No Change,None,No,No,,545,520,4.9,Stable,88.14,63.11,25.03,88.45,176.59,96.24,0.0,0,0.052,0.237,0.846,0.504,9,1,10,10,4.7,22.2,8,Higher,Southeast,GA,Suburban,66-75,2022-07,Q3_2022,2021,9.9,0.454,Increasing
FIA001343,2022-07-26,Sertraline,Zoloft,Antidepressants,70210-554-58,Tricare Standard,PLAN_8903,2022,Specialty Tier,Tier 2,2021-12-29,209,Worsened,None,No,No,,282,537,-47.5,Decreased,274.97,45.2,229.77,59.31,334.28,94.27,0.0,0,0.096,0.334,0.355,0.856,11,1,12,12,2.1,26.8,7,Higher,Southeast,GA,Rural,18-35,2022-07,Q3_2022,2021,1.9,0.676,Increasing
FIA002130,2022-07-30,Sertraline,Zoloft,Antidepressants,18436-342-58,Medicare Part D Plan A,PLAN_6008,2022,Specialty Tier,Specialty Tier,2022-05-04,87,No Change,Prior Authorization,Yes,No,,756,751,0.8,Stable,170.09,116.57,53.52,115.97,286.06,216.26,0.516,4,0.124,0.207,0.441,0.647,12,6,7,9,2.1,7.6,3,Similar,Midwest,NC,Suburban,75+,2022-07,Q3_2022,2021,9.2,0.489,Stable
FIA002835,2022-07-30,Sertraline,Zoloft,Antidepressants,20413-772-95,VA Plan,PLAN_2272,2022,Tier 1,Non-Formulary,2021-12-26,216,Improved,None,No,No,,815,625,30.4,Increased,5.43,497.71,-492.28,105.44,110.87,90.36,0.0,0,0.038,0.061,0.893,0.666,14,9,17,10,2.7,23.8,5,Lower,West,NY,Rural,75+,2022-07,Q3_2022,2021,1.8,0.044,Decreasing
FIA000526,2022-08-03,Sertraline,Zoloft,Antidepressants,36703-951-81,Commercial Plan Beta,PLAN_8365,2022,Specialty Tier,Tier 2,2022-02-25,159,Worsened,Prior Authorization; Quantity Limit,Yes,No,30.0,70,191,-63.1,Decreased,175.37,21.09,154.28,52.47,227.84,15.95,0.455,9,0.094,0.132,0.598,0.457,3,10,17,15,2.1,32.6,3,Higher,Southeast,FL,Rural,75+,2022-08,Q3_2022,2021,9.3,0.712,Decreasing
FIA002288,2022-08-05,Sertraline,Zoloft,Antidepressants,56197-818-70,VA Plan,PLAN_2107,2022,Non-Formulary,Tier 1,2022-06-13,53,Worsened,Non-Formulary Status,No,No,,54,128,-57.5,Decreased,748.09,7.54,740.55,151.63,899.72,48.58,0.0,0,0.268,0.31,0.748,0.598,4,7,5,6,4.0,20.0,4,Similar,Southeast,IL,Suburban,66-75,2022-08,Q3_2022,2021,5.3,0.956,Increasing
FIA000308,2022-08-10,Sertraline,Zoloft,Antidepressants,34978-142-84,Medicaid Plan Y,PLAN_3014,2022,Non-Formulary,Specialty Tier,2021-10-15,299,Worsened,Non-Formulary Status,No,No,,492,457,7.8,Increased,304.97,282.07,22.9,76.96,381.93,187.91,0.0,0,0.286,0.202,0.519,0.932,11,4,3,0,3.5,25.6,5,Higher,Southeast,NC,Suburban,75+,2022-08,Q3_2022,2021,6.0,0.163,Stable
FIA002688,2022-08-19,Sertraline,Zoloft,Antidepressants,23863-607-24,Medicare Part D Plan B,PLAN_6251,2022,Tier 1,Tier 2,2022-03-05,167,Improved,Quantity Limit,No,No,30.0,948,940,0.9,Stable,13.65,39.91,-26.26,146.85,160.5,152.15,0.0,0,0.056,0.103,0.286,0.696,9,1,11,5,3.4,34.7,4,Higher,Midwest,MI,Urban,51-65,2022-08,Q3_2022,2021,3.2,0.155,Stable
FIA001016,2022-09-05,Sertraline,Zoloft,Antidepressants,15630-255-16,Medicaid Plan X,PLAN_6033,2022,Tier 2,Specialty Tier,2022-02-23,194,Improved,None,No,No,,1159,948,22.3,Increased,24.62,281.15,-256.53,81.34,105.96,122.81,0.0,0,0.018,0.203,0.886,0.682,12,6,11,9,3.6,25.7,3,Similar,Southeast,MI,Urban,36-50,2022-09,Q3_2022,2021,7.0,0.457,Decreasing
FIA002518,2022-09-14,Sertraline,Zoloft,Antidepressants,66690-182-49,VA Plan,PLAN_2800,2022,Specialty Tier,Tier 1,2022-03-25,173,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,123,309,-60.2,Decreased,116.21,11.01,105.2,114.85,231.06,28.42,0.253,2,0.061,0.209,0.523,0.905,12,9,6,2,2.3,23.3,8,Higher,West,NC,Urban,75+,2022-09,Q3_2022,2021,8.7,0.87,Increasing
FIA000346,2022-09-29,Sertraline,Zoloft,Antidepressants,48657-365-99,Tricare Standard,PLAN_5334,2022,Tier 1,Specialty Tier,2022-04-06,176,Improved,Quantity Limit,No,No,,565,423,33.6,Increased,7.67,128.09,-120.42,63.87,71.54,40.42,0.0,0,0.029,0.221,0.605,0.592,14,10,5,1,4.8,22.6,3,Higher,West,NY,Rural,66-75,2022-09,Q3_2022,2021,4.1,0.811,Stable
FIA001156,2022-10-02,Sertraline,Zoloft,Antidepressants,23978-774-76,Medicaid Plan Y,PLAN_4058,2022,Tier 2,Tier 3,2021-12-24,282,Improved,None,No,No,,767,566,35.5,Increased,34.31,88.5,-54.19,38.14,72.45,55.57,0.0,0,0.057,0.083,0.855,0.555,9,6,1,7,4.1,10.7,3,Higher,Southwest,NC,Suburban,75+,2022-10,Q4_2022,2022,8.5,0.873,Increasing
FIA000072,2022-10-05,Sertraline,Zoloft,Antidepressants,87908-239-48,Medicaid Plan Y,PLAN_4290,2022,Tier 1,Specialty Tier,2022-03-19,200,Improved,None,No,No,,1274,982,29.8,Increased,17.62,175.98,-158.36,176.12,193.74,246.82,0.0,0,0.067,0.218,0.324,0.619,10,4,20,15,4.9,28.5,4,Similar,Midwest,OH,Suburban,18-35,2022-10,Q4_2022,2022,9.4,0.2,Decreasing
FIA000993,2022-10-07,Sertraline,Zoloft,Antidepressants,18430-308-75,VA Plan,PLAN_9059,2022,Specialty Tier,Non-Formulary,2021-12-30,281,Improved,None,No,No,,328,331,-0.6,Stable,127.47,741.99,-614.52,144.83,272.3,89.31,0.0,0,0.295,0.372,0.695,0.944,10,7,16,7,2.2,13.0,4,Similar,West,OH,Rural,51-65,2022-10,Q4_2022,2022,7.1,0.449,Stable
FIA001784,2022-10-10,Sertraline,Zoloft,Antidepressants,59970-882-62,Medicare Part D Plan A,PLAN_7117,2022,Tier 1,Tier 3,2022-08-21,50,Improved,None,No,No,,1078,907,18.9,Increased,5.86,91.38,-85.52,97.86,103.72,111.81,0.0,0,0.012,0.245,0.231,0.574,5,10,8,6,3.7,33.8,6,Lower,Midwest,NC,Rural,75+,2022-10,Q4_2022,2022,3.2,0.155,Stable
FIA002396,2022-10-19,Sertraline,Zoloft,Antidepressants,79673-680-26,Commercial Plan Beta,PLAN_3374,2022,Tier 2,Specialty Tier,2022-07-15,96,Improved,Quantity Limit,No,No,,254,167,52.2,Increased,47.4,270.17,-222.77,50.45,97.85,24.85,0.0,0,0.011,0.363,0.278,0.553,14,5,6,1,2.3,14.4,5,Lower,Midwest,IL,Suburban,18-35,2022-10,Q4_2022,2022,8.6,0.275,Decreasing
FIA002307,2022-10-30,Sertraline,Zoloft,Antidepressants,42590-223-90,Tricare Standard,PLAN_7287,2022,Tier 2,Tier 1,2022-04-02,211,Worsened,None,No,No,,307,306,0.4,Stable,24.99,15.24,9.75,153.11,178.1,54.68,0.0,0,0.064,0.13,0.754,0.847,10,4,1,0,4.4,32.0,8,Lower,Northeast,FL,Rural,66-75,2022-10,Q4_2022,2022,7.9,0.559,Decreasing
FIA000715,2022-11-12,Sertraline,Zoloft,Antidepressants,64833-301-90,Commercial Plan Beta,PLAN_6308,2022,Tier 2,Specialty Tier,2022-02-03,282,Improved,None,No,No,,267,205,30.2,Increased,47.71,130.15,-82.44,176.78,224.49,59.94,0.0,0,0.055,0.145,0.858,0.558,10,8,13,7,4.0,5.8,8,Lower,Southwest,NC,Urban,51-65,2022-11,Q4_2022,2022,6.1,0.59,Increasing
FIA000063,2022-11-14,Sertraline,Zoloft,Antidepressants,68515-712-96,Medicare Part D Plan A,PLAN_5009,2022,Tier 2,Tier 1,2022-09-29,46,Worsened,None,No,No,,961,884,8.7,Increased,44.28,11.29,32.99,130.97,175.25,168.42,0.0,0,0.015,0.309,0.482,0.529,6,0,4,9,2.7,32.5,6,Similar,West,MI,Rural,51-65,2022-11,Q4_2022,2022,3.1,0.876,Decreasing
FIA001060,2022-11-15,Sertraline,Zoloft,Antidepressants,51073-975-86,Medicaid Plan X,PLAN_2073,2022,Tier 2,Tier 2,2022-04-03,226,No Change,None,No,No,,597,651,-8.2,Decreased,23.85,27.22,-3.37,114.07,137.92,82.34,0.0,0,0.014,0.285,0.826,0.434,9,8,9,6,4.3,15.4,5,Similar,Midwest,CA,Rural,75+,2022-11,Q4_2022,2022,2.9,0.867,Increasing
FIA002571,2022-12-21,Sertraline,Zoloft,Antidepressants,86001-463-88,Tricare Standard,PLAN_2530,2022,Specialty Tier,Tier 1,2022-05-27,208,Worsened,Quantity Limit,No,No,,142,222,-35.9,Decreased,230.86,9.89,220.97,78.29,309.15,43.9,0.0,0,0.267,0.268,0.864,0.625,0,2,3,7,3.6,21.3,8,Lower,Northeast,NC,Urban,75+,2022-12,Q4_2022,2022,3.8,0.624,Stable
FIA000434,2022-12-27,Sertraline,Zoloft,Antidepressants,33426-646-25,Tricare Standard,PLAN_7044,2022,Non-Formulary,Specialty Tier,2022-04-25,246,Worsened,Non-Formulary Status,No,No,,1012,927,9.2,Increased,736.95,147.25,589.7,168.94,905.89,916.76,0.0,0,0.075,0.303,0.307,0.913,7,0,10,5,4.3,20.4,2,Higher,West,CA,Suburban,36-50,2022-12,Q4_2022,2022,2.5,0.469,Increasing
FIA000341,2023-01-01,Sertraline,Zoloft,Antidepressants,90725-784-70,Commercial Plan Beta,PLAN_3754,2023,Non-Formulary,Tier 1,2022-09-29,94,Worsened,Non-Formulary Status,No,No,,537,884,-39.1,Decreased,678.13,13.81,664.32,132.81,810.94,435.47,0.0,0,0.263,0.051,0.362,0.519,4,2,5,15,4.6,14.7,2,Lower,West,GA,Suburban,66-75,2023-01,Q1_2023,2022,3.9,0.5,Increasing
FIA000590,2023-01-02,Sertraline,Zoloft,Antidepressants,49992-782-79,Commercial Plan Beta,PLAN_8761,2023,Non-Formulary,Tier 3,2022-06-03,213,Worsened,Non-Formulary Status; Quantity Limit,No,No,60.0,101,100,1.1,Stable,512.05,88.51,423.54,86.08,598.13,60.41,0.0,0,0.251,0.342,0.72,0.458,11,6,7,0,2.4,33.8,8,Similar,Northeast,CA,Urban,36-50,2023-01,Q1_2023,2022,1.4,0.345,Stable
FIA002224,2023-01-05,Sertraline,Zoloft,Antidepressants,24963-305-73,Tricare Standard,PLAN_8869,2023,Tier 1,Tier 3,2022-12-01,35,Improved,None,No,No,,308,199,54.9,Increased,16.24,60.44,-44.2,134.88,151.12,46.54,0.0,0,0.057,0.345,0.352,0.608,0,4,14,0,2.8,32.8,2,Higher,West,OH,Suburban,51-65,2023-01,Q1_2023,2022,5.4,0.531,Increasing
FIA000274,2023-01-14,Sertraline,Zoloft,Antidepressants,58705-343-93,Medicaid Plan X,PLAN_4441,2023,Specialty Tier,Tier 3,2022-06-27,201,Worsened,Step Therapy,No,Yes,,117,113,3.7,Stable,160.87,54.84,106.03,119.91,280.78,32.85,0.0,0,0.245,0.255,0.261,0.459,3,0,18,6,2.6,18.4,2,Lower,West,MI,Suburban,51-65,2023-01,Q1_2023,2022,7.5,0.99,Increasing
FIA001417,2023-01-22,Sertraline,Zoloft,Antidepressants,60631-176-73,Medicare Part D Plan A,PLAN_1038,2023,Tier 1,Non-Formulary,2022-06-28,208,Improved,None,No,No,,439,380,15.6,Increased,15.37,270.56,-255.19,47.17,62.54,27.46,0.0,0,0.015,0.063,0.393,0.851,9,10,3,4,4.0,25.0,6,Lower,Northeast,MI,Suburban,51-65,2023-01,Q1_2023,2022,2.5,0.327,Increasing
FIA001891,2023-02-04,Sertraline,Zoloft,Antidepressants,35518-935-47,Commercial Plan Beta,PLAN_2461,2023,Tier 1,Non-Formulary,2022-05-17,263,Improved,None,No,No,,1056,908,16.3,Increased,5.81,402.78,-396.97,63.91,69.72,73.62,0.0,0,0.057,0.394,0.529,0.474,15,4,19,13,4.1,7.9,6,Similar,Southeast,PA,Urban,36-50,2023-02,Q1_2023,2022,4.5,0.124,Decreasing
FIA001514,2023-02-18,Sertraline,Zoloft,Antidepressants,51327-411-42,Commercial Plan Alpha,PLAN_2882,2023,Specialty Tier,Tier 1,2022-05-22,272,Worsened,None,No,No,,465,965,-51.7,Decreased,162.23,13.89,148.34,102.74,264.97,123.21,0.0,0,0.236,0.23,0.822,0.947,6,9,17,5,2.3,8.8,4,Similar,West,NC,Suburban,66-75,2023-02,Q1_2023,2022,3.5,0.04,Stable
FIA000379,2023-02-19,Sertraline,Zoloft,Antidepressants,10046-176-42,Medicaid Plan X,PLAN_4420,2023,Tier 1,Specialty Tier,2022-08-22,181,Improved,None,No,No,,824,531,55.2,Increased,10.85,204.35,-193.5,189.48,200.33,165.07,0.0,0,0.02,0.373,0.629,0.928,1,6,4,4,3.4,9.8,8,Lower,Southwest,FL,Rural,66-75,2023-02,Q1_2023,2022,4.5,0.193,Stable
FIA001085,2023-02-21,Sertraline,Zoloft,Antidepressants,20623-746-80,Medicaid Plan X,PLAN_3943,2023,Tier 3,Tier 2,2022-12-10,73,Worsened,Step Therapy,No,Yes,,131,371,-64.5,Decreased,53.87,34.02,19.85,58.34,112.21,14.7,0.0,0,0.055,0.35,0.738,0.608,3,5,2,5,3.9,8.7,5,Similar,Southwest,MI,Urban,51-65,2023-02,Q1_2023,2022,6.9,0.288,Decreasing
FIA000941,2023-02-23,Sertraline,Zoloft,Antidepressants,98727-788-76,Commercial Plan Beta,PLAN_4460,2023,Tier 2,Non-Formulary,2022-04-15,314,Improved,None,No,No,,172,138,24.9,Increased,26.4,681.67,-655.27,109.69,136.09,23.41,0.0,0,0.074,0.078,0.461,0.531,3,9,16,11,4.3,29.7,5,Similar,Midwest,TX,Rural,18-35,2023-02,Q1_2023,2022,2.1,0.012,Stable
FIA001804,2023-02-25,Sertraline,Zoloft,Antidepressants,68159-198-10,Tricare Standard,PLAN_5480,2023,Tier 3,Tier 1,2022-10-29,119,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,199,618,-67.7,Decreased,68.65,13.35,55.3,168.66,237.31,47.22,0.362,9,0.021,0.164,0.256,0.731,13,4,12,0,3.7,18.5,3,Similar,Midwest,GA,Suburban,66-75,2023-02,Q1_2023,2022,4.0,0.946,Decreasing
FIA000076,2023-02-26,Sertraline,Zoloft,Antidepressants,79168-754-50,VA Plan,PLAN_7431,2023,Tier 1,Non-Formulary,2022-12-06,82,Improved,None,No,No,,614,474,29.7,Increased,16.99,522.13,-505.14,176.65,193.64,118.89,0.0,0,0.028,0.255,0.444,0.865,5,10,9,2,4.0,14.4,3,Similar,Northeast,FL,Suburban,36-50,2023-02,Q1_2023,2022,5.6,0.418,Increasing
FIA001473,2023-03-06,Sertraline,Zoloft,Antidepressants,39224-351-54,Medicare Part D Plan B,PLAN_4811,2023,Tier 1,Tier 2,2023-01-05,60,Improved,None,No,No,,592,584,1.5,Stable,17.59,42.17,-24.58,114.66,132.25,78.29,0.0,0,0.055,0.193,0.314,0.489,2,10,10,4,3.8,32.8,5,Higher,Southwest,NC,Suburban,51-65,2023-03,Q1_2023,2022,4.6,0.081,Stable
FIA002491,2023-03-08,Sertraline,Zoloft,Antidepressants,90155-204-37,Tricare Standard,PLAN_7398,2023,Tier 2,Tier 1,2022-03-22,351,Worsened,None,No,No,,162,166,-2.1,Stable,32.28,17.95,14.33,119.13,151.41,24.53,0.0,0,0.026,0.236,0.537,0.739,15,2,8,6,4.5,8.8,7,Higher,Southeast,OH,Rural,66-75,2023-03,Q1_2023,2022,9.2,0.127,Decreasing
FIA002720,2023-03-11,Sertraline,Zoloft,Antidepressants,58258-931-37,Commercial Plan Beta,PLAN_6407,2023,Tier 1,Tier 1,2022-04-12,333,No Change,None,No,No,,576,638,-9.7,Decreased,9.58,11.81,-2.23,107.64,117.22,67.52,0.0,0,0.031,0.286,0.45,0.65,13,0,13,14,4.7,5.8,6,Lower,Northeast,FL,Suburban,66-75,2023-03,Q1_2023,2022,9.4,0.655,Increasing
FIA002282,2023-03-18,Sertraline,Zoloft,Antidepressants,10374-274-82,Tricare Standard,PLAN_5741,2023,Tier 2,Tier 3,2022-09-16,183,Improved,None,No,No,,1207,878,37.5,Increased,39.63,99.15,-59.52,56.02,95.65,115.45,0.0,0,0.026,0.321,0.217,0.577,13,10,17,14,4.0,10.9,3,Similar,Southeast,CA,Urban,75+,2023-03,Q1_2023,2022,6.0,0.454,Increasing
FIA000964,2023-04-09,Sertraline,Zoloft,Antidepressants,17036-827-26,Medicare Part D Plan B,PLAN_7002,2023,Tier 3,Non-Formulary,2022-05-07,337,Improved,Prior Authorization; Step Therapy,Yes,Yes,,681,655,4.0,Stable,74.82,643.34,-568.52,117.0,191.82,130.63,0.146,10,0.075,0.257,0.549,0.54,14,6,7,4,3.5,13.7,8,Lower,Southeast,NY,Urban,36-50,2023-04,Q2_2023,2022,2.5,0.229,Decreasing
FIA000687,2023-04-12,Sertraline,Zoloft,Antidepressants,79606-820-48,Tricare Standard,PLAN_5918,2023,Tier 1,Tier 1,2023-02-04,67,No Change,None,No,No,,893,859,4.0,Stable,7.74,11.76,-4.02,130.57,138.31,123.51,0.0,0,0.024,0.11,0.823,0.75,10,6,14,15,2.2,20.4,6,Higher,Southeast,FL,Urban,66-75,2023-04,Q2_2023,2022,5.7,0.546,Stable
FIA002597,2023-04-13,Sertraline,Zoloft,Antidepressants,10644-198-76,Commercial Plan Beta,PLAN_6890,2023,Specialty Tier,Tier 1,2022-10-25,170,Worsened,None,No,No,,528,774,-31.7,Decreased,231.67,15.83,215.84,169.84,401.51,212.0,0.0,0,0.095,0.327,0.875,0.708,3,7,0,15,2.2,12.8,2,Similar,Midwest,NC,Urban,51-65,2023-04,Q2_2023,2022,4.6,0.565,Stable
FIA000810,2023-04-23,Sertraline,Zoloft,Antidepressants,26527-773-60,Tricare Standard,PLAN_1128,2023,Specialty Tier,Tier 2,2022-06-10,317,Worsened,None,No,No,,62,195,-67.9,Decreased,147.87,30.75,117.12,153.88,301.75,18.71,0.0,0,0.191,0.333,0.379,0.681,12,10,16,13,4.5,15.0,7,Higher,Southeast,MI,Urban,51-65,2023-04,Q2_2023,2022,8.0,0.939,Decreasing
FIA002865,2023-04-26,Sertraline,Zoloft,Antidepressants,55429-128-49,Commercial Plan Beta,PLAN_9107,2023,Tier 1,Tier 2,2022-05-14,347,Improved,None,No,No,,494,495,-0.1,Stable,17.76,31.78,-14.02,169.28,187.04,92.4,0.0,0,0.042,0.356,0.733,0.557,2,9,14,11,2.8,11.7,5,Lower,West,CA,Urban,75+,2023-04,Q2_2023,2022,5.4,0.82,Decreasing
FIA002389,2023-04-29,Sertraline,Zoloft,Antidepressants,85216-322-16,Medicaid Plan X,PLAN_7028,2023,Tier 1,Specialty Tier,2022-12-26,124,Improved,None,No,No,,681,537,27.0,Increased,10.6,122.24,-111.64,106.64,117.24,79.84,0.0,0,0.059,0.3,0.685,0.932,8,1,4,13,2.1,24.8,3,Similar,Southwest,MI,Urban,51-65,2023-04,Q2_2023,2022,3.3,0.319,Increasing
FIA000819,2023-05-09,Sertraline,Zoloft,Antidepressants,94338-358-69,Tricare Standard,PLAN_4747,2023,Tier 1,Tier 3,2022-12-23,137,Improved,None,No,No,,362,227,59.7,Increased,10.4,73.19,-62.79,191.46,201.86,73.07,0.0,0,0.018,0.318,0.63,0.545,2,10,8,15,2.4,15.6,4,Similar,West,IL,Suburban,51-65,2023-05,Q2_2023,2022,1.9,0.343,Decreasing
FIA001595,2023-05-11,Sertraline,Zoloft,Antidepressants,52760-210-21,Tricare Standard,PLAN_8873,2023,Specialty Tier,Non-Formulary,2023-02-05,95,Improved,None,No,No,,732,672,9.1,Increased,269.49,570.15,-300.66,180.43,449.92,329.34,0.0,0,0.173,0.236,0.368,0.947,2,4,9,15,4.0,18.2,5,Similar,Southeast,MI,Suburban,18-35,2023-05,Q2_2023,2022,9.6,0.998,Increasing
FIA002889,2023-05-13,Sertraline,Zoloft,Antidepressants,73268-315-54,Commercial Plan Alpha,PLAN_1245,2023,Tier 1,Tier 3,2022-10-03,222,Improved,Quantity Limit,No,No,,889,770,15.5,Increased,18.17,53.57,-35.4,58.84,77.01,68.46,0.0,0,0.031,0.129,0.405,0.811,12,9,9,12,2.9,22.0,4,Similar,Northeast,CA,Suburban,18-35,2023-05,Q2_2023,2022,2.0,0.452,Decreasing
FIA001452,2023-06-01,Sertraline,Zoloft,Antidepressants,14324-416-12,Medicaid Plan Y,PLAN_3603,2023,Tier 1,Non-Formulary,2022-10-09,235,Improved,None,No,No,,651,418,55.9,Increased,11.94,433.63,-421.69,114.09,126.03,82.05,0.0,0,0.077,0.311,0.684,0.75,14,0,6,11,2.8,18.9,5,Lower,Northeast,GA,Rural,66-75,2023-06,Q2_2023,2022,6.1,0.608,Stable
FIA002040,2023-06-01,Sertraline,Zoloft,Antidepressants,39243-997-16,Commercial Plan Beta,PLAN_3373,2023,Non-Formulary,Non-Formulary,2022-11-05,208,No Change,Non-Formulary Status,No,No,,416,442,-5.8,Decreased,671.37,781.44,-110.07,172.33,843.7,350.98,0.0,0,0.266,0.308,0.844,0.895,3,6,3,14,3.3,15.7,2,Higher,Southwest,NY,Rural,18-35,2023-06,Q2_2023,2022,6.8,0.148,Decreasing
FIA002912,2023-06-05,Sertraline,Zoloft,Antidepressants,62791-474-54,VA Plan,PLAN_3980,2023,Tier 3,Tier 2,2022-08-28,281,Worsened,Step Therapy,No,Yes,,57,162,-64.7,Decreased,69.75,43.57,26.18,31.0,100.75,5.74,0.0,0,0.027,0.082,0.466,0.504,2,6,9,0,2.7,31.6,8,Similar,West,GA,Rural,36-50,2023-06,Q2_2023,2022,4.1,0.026,Increasing
FIA000903,2023-06-08,Sertraline,Zoloft,Antidepressants,22736-219-21,Medicare Part D Plan A,PLAN_9488,2023,Tier 3,Tier 1,2022-07-24,319,Worsened,None,No,No,,222,314,-29.1,Decreased,80.86,13.37,67.49,130.5,211.36,46.92,0.0,0,0.041,0.18,0.685,0.439,8,6,13,10,3.8,29.6,2,Lower,Midwest,MI,Suburban,18-35,2023-06,Q2_2023,2022,5.5,0.21,Decreasing
FIA000525,2023-06-20,Sertraline,Zoloft,Antidepressants,94120-802-93,Medicaid Plan Y,PLAN_4947,2023,Specialty Tier,Tier 1,2022-08-22,302,Worsened,None,No,No,,214,470,-54.4,Decreased,142.05,13.03,129.02,48.22,190.27,40.72,0.0,0,0.246,0.275,0.286,0.695,8,8,12,13,5.0,20.8,8,Lower,West,CA,Suburban,51-65,2023-06,Q2_2023,2022,5.3,0.703,Stable
FIA002373,2023-06-24,Sertraline,Zoloft,Antidepressants,83061-395-81,Commercial Plan Alpha,PLAN_9129,2023,Tier 2,Specialty Tier,2022-11-10,226,Improved,None,No,No,,1009,665,51.8,Increased,47.29,129.15,-81.86,132.7,179.99,181.61,0.0,0,0.036,0.172,0.471,0.603,15,6,20,8,4.9,34.0,2,Lower,West,GA,Urban,18-35,2023-06,Q2_2023,2022,4.8,0.22,Decreasing
FIA000294,2023-06-26,Sertraline,Zoloft,Antidepressants,84997-540-40,VA Plan,PLAN_4156,2023,Specialty Tier,Tier 2,2023-05-25,32,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,90,115,-21.3,Decreased,280.04,32.44,247.6,58.97,339.01,30.51,0.471,10,0.129,0.276,0.78,0.841,13,2,20,12,4.9,10.2,4,Higher,Southeast,OH,Urban,18-35,2023-06,Q2_2023,2022,7.4,0.126,Increasing
FIA001265,2023-06-28,Sertraline,Zoloft,Antidepressants,89999-764-47,Commercial Plan Beta,PLAN_6286,2023,Tier 1,Specialty Tier,2023-05-16,43,Improved,None,No,No,,1404,973,44.4,Increased,12.71,104.02,-91.31,130.46,143.17,201.01,0.0,0,0.061,0.377,0.578,0.831,8,5,19,0,4.2,11.3,7,Higher,Northeast,FL,Rural,36-50,2023-06,Q2_2023,2022,1.7,0.101,Increasing
FIA000414,2023-07-31,Sertraline,Zoloft,Antidepressants,95257-392-67,Medicare Part D Plan A,PLAN_8299,2023,Non-Formulary,Tier 3,2022-10-13,291,Worsened,Non-Formulary Status,No,No,,890,872,2.2,Stable,433.05,91.74,341.31,96.75,529.8,471.52,0.0,0,0.274,0.261,0.656,0.681,12,3,5,3,2.1,29.1,7,Lower,Southeast,MI,Rural,51-65,2023-07,Q3_2023,2022,8.5,0.674,Decreasing
FIA002110,2023-08-13,Sertraline,Zoloft,Antidepressants,24437-964-64,VA Plan,PLAN_5648,2023,Tier 3,Tier 1,2023-05-07,98,Worsened,None,No,No,,242,593,-59.1,Decreased,75.13,7.57,67.56,122.52,197.65,47.83,0.0,0,0.047,0.334,0.618,0.489,8,8,7,4,2.9,23.0,5,Similar,West,IL,Rural,18-35,2023-08,Q3_2023,2022,7.8,0.974,Increasing
FIA001066,2023-08-16,Sertraline,Zoloft,Antidepressants,18527-442-47,VA Plan,PLAN_4288,2023,Specialty Tier,Tier 2,2023-03-27,142,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,303,487,-37.7,Decreased,136.76,28.61,108.15,169.79,306.55,92.88,0.532,6,0.121,0.092,0.419,0.512,2,8,11,3,4.4,30.3,5,Similar,West,OH,Suburban,75+,2023-08,Q3_2023,2022,4.2,0.58,Stable
FIA002280,2023-08-19,Sertraline,Zoloft,Antidepressants,42344-190-32,Medicaid Plan Y,PLAN_2915,2023,Tier 2,Tier 1,2022-11-30,262,Worsened,None,No,No,,365,336,8.8,Increased,21.13,12.34,8.79,152.42,173.55,63.35,0.0,0,0.053,0.081,0.718,0.804,0,5,8,4,2.6,7.3,2,Higher,Southeast,OH,Urban,51-65,2023-08,Q3_2023,2022,8.0,0.271,Decreasing
FIA000896,2023-08-20,Sertraline,Zoloft,Antidepressants,65913-950-43,Tricare Standard,PLAN_3549,2023,Specialty Tier,Specialty Tier,2023-01-15,217,No Change,Step Therapy,No,Yes,,923,858,7.6,Increased,200.65,164.81,35.84,33.31,233.96,215.95,0.0,0,0.223,0.293,0.38,0.849,10,2,11,14,2.7,21.5,7,Similar,Southwest,GA,Rural,75+,2023-08,Q3_2023,2022,3.3,0.442,Decreasing
FIA001987,2023-08-27,Sertraline,Zoloft,Antidepressants,20136-340-72,Commercial Plan Alpha,PLAN_5324,2023,Specialty Tier,Non-Formulary,2023-05-02,117,Improved,Step Therapy,No,Yes,,621,602,3.3,Stable,108.17,265.45,-157.28,144.58,252.75,156.96,0.0,0,0.232,0.111,0.727,0.922,13,5,7,10,2.5,24.7,7,Lower,Midwest,GA,Urban,66-75,2023-08,Q3_2023,2022,8.2,0.455,Decreasing
FIA000192,2023-09-09,Sertraline,Zoloft,Antidepressants,38557-258-74,Commercial Plan Beta,PLAN_4087,2023,Tier 3,Tier 1,2022-11-10,303,Worsened,Step Therapy,No,Yes,,82,113,-26.8,Decreased,79.0,17.35,61.65,57.71,136.71,11.21,0.0,0,0.074,0.328,0.591,0.779,3,6,14,2,2.3,8.9,2,Similar,Midwest,PA,Rural,51-65,2023-09,Q3_2023,2022,2.3,0.442,Decreasing
FIA000301,2023-09-09,Sertraline,Zoloft,Antidepressants,59008-732-23,Medicare Part D Plan A,PLAN_4670,2023,Tier 3,Tier 3,2023-01-18,234,No Change,Step Therapy,No,Yes,,618,605,2.2,Stable,53.99,88.73,-34.74,184.78,238.77,147.56,0.0,0,0.055,0.067,0.207,0.458,10,6,7,5,2.3,26.7,8,Similar,West,CA,Rural,18-35,2023-09,Q3_2023,2022,3.3,0.785,Increasing
FIA000991,2023-09-21,Sertraline,Zoloft,Antidepressants,41407-552-86,Medicaid Plan Y,PLAN_9491,2023,Tier 1,Tier 3,2022-12-28,267,Improved,None,No,No,,1195,800,49.4,Increased,14.72,59.71,-44.99,103.8,118.52,141.63,0.0,0,0.052,0.083,0.685,0.661,9,4,19,5,2.9,20.8,7,Lower,Midwest,PA,Suburban,75+,2023-09,Q3_2023,2022,3.0,0.793,Decreasing
FIA000161,2023-09-23,Sertraline,Zoloft,Antidepressants,98142-590-70,Medicare Part D Plan A,PLAN_3224,2023,Non-Formulary,Non-Formulary,2023-03-12,195,No Change,Non-Formulary Status; Quantity Limit,No,No,90.0,427,441,-3.2,Stable,660.22,268.3,391.92,171.75,831.97,355.25,0.0,0,0.099,0.104,0.522,0.876,10,7,13,1,4.5,14.0,7,Higher,Midwest,NC,Rural,18-35,2023-09,Q3_2023,2022,2.9,0.685,Stable
FIA001218,2023-10-07,Sertraline,Zoloft,Antidepressants,83921-905-32,Medicare Part D Plan A,PLAN_2917,2023,Tier 1,Tier 3,2023-07-26,73,Improved,None,No,No,,1169,807,45.0,Increased,19.61,96.06,-76.45,77.7,97.31,113.76,0.0,0,0.066,0.305,0.652,0.839,7,0,0,2,2.7,12.7,7,Lower,Midwest,CA,Suburban,75+,2023-10,Q4_2023,2023,1.5,0.63,Increasing
FIA001547,2023-10-10,Sertraline,Zoloft,Antidepressants,65826-965-21,Tricare Standard,PLAN_1785,2023,Tier 3,Tier 3,2023-08-02,69,No Change,Prior Authorization,Yes,No,,219,229,-4.2,Stable,79.25,97.46,-18.21,41.33,120.58,26.41,0.256,7,0.028,0.138,0.837,0.567,10,3,7,15,4.1,15.5,3,Lower,Northeast,IL,Suburban,75+,2023-10,Q4_2023,2023,1.9,0.435,Decreasing
FIA000240,2023-10-12,Sertraline,Zoloft,Antidepressants,39850-200-25,Medicare Part D Plan B,PLAN_6902,2023,Specialty Tier,Tier 1,2023-06-13,121,Worsened,Step Therapy,No,Yes,,109,177,-38.0,Decreased,188.34,8.98,179.36,163.6,351.94,38.36,0.0,0,0.211,0.063,0.34,0.508,10,4,9,8,2.6,23.1,3,Higher,West,PA,Urban,51-65,2023-10,Q4_2023,2023,3.5,0.347,Stable
FIA000965,2023-10-21,Sertraline,Zoloft,Antidepressants,78860-323-60,Tricare Standard,PLAN_6073,2023,Non-Formulary,Tier 1,2023-02-09,254,Worsened,Non-Formulary Status,No,No,,594,802,-25.9,Decreased,208.27,11.76,196.51,155.43,363.7,216.04,0.0,0,0.285,0.211,0.706,0.673,0,7,0,7,3.2,17.3,8,Similar,Southwest,CA,Urban,66-75,2023-10,Q4_2023,2023,4.4,0.717,Increasing
FIA002178,2023-10-24,Sertraline,Zoloft,Antidepressants,25405-983-49,Commercial Plan Alpha,PLAN_6228,2023,Specialty Tier,Non-Formulary,2023-01-05,292,Improved,Prior Authorization,Yes,No,,888,912,-2.6,Stable,215.48,678.47,-462.99,182.26,397.74,353.19,0.281,9,0.289,0.057,0.721,0.48,3,2,0,6,5.0,28.4,7,Lower,Southwest,CA,Urban,18-35,2023-10,Q4_2023,2023,3.7,0.187,Increasing
FIA002348,2023-10-27,Sertraline,Zoloft,Antidepressants,30917-475-47,Commercial Plan Beta,PLAN_6782,2023,Tier 1,Non-Formulary,2022-12-13,318,Improved,None,No,No,,1163,801,45.3,Increased,7.54,570.48,-562.94,131.45,138.99,161.65,0.0,0,0.038,0.146,0.46,0.733,10,7,5,13,2.6,20.6,4,Similar,Northeast,CA,Urban,36-50,2023-10,Q4_2023,2023,7.2,0.03,Decreasing
FIA001774,2023-10-30,Sertraline,Zoloft,Antidepressants,10462-606-23,Commercial Plan Beta,PLAN_8897,2023,Tier 3,Tier 3,2022-11-03,361,No Change,Prior Authorization,Yes,No,,106,115,-7.1,Decreased,96.03,87.63,8.4,120.79,216.82,22.98,0.446,8,0.037,0.287,0.792,0.669,0,9,20,10,4.8,26.2,7,Similar,Northeast,GA,Urban,66-75,2023-10,Q4_2023,2023,2.5,0.308,Increasing
FIA000930,2023-11-06,Sertraline,Zoloft,Antidepressants,11570-214-63,Medicare Part D Plan B,PLAN_8320,2023,Tier 2,Tier 1,2023-02-06,273,Worsened,None,No,No,,493,462,6.9,Increased,45.28,15.47,29.81,31.32,76.6,37.76,0.0,0,0.022,0.122,0.414,0.719,9,5,18,5,2.7,25.2,8,Similar,Southeast,NC,Urban,36-50,2023-11,Q4_2023,2023,4.8,0.909,Decreasing
FIA001768,2023-11-07,Sertraline,Zoloft,Antidepressants,82282-756-84,Commercial Plan Alpha,PLAN_3154,2023,Tier 1,Tier 2,2023-07-07,123,Improved,Quantity Limit,No,No,30.0,113,105,8.3,Increased,10.76,41.55,-30.79,187.81,198.57,22.44,0.0,0,0.068,0.066,0.306,0.442,7,3,14,0,2.8,14.7,7,Lower,Southeast,NC,Suburban,18-35,2023-11,Q4_2023,2023,5.5,0.619,Increasing
FIA002856,2023-11-16,Sertraline,Zoloft,Antidepressants,29251-779-36,Commercial Plan Alpha,PLAN_8912,2023,Tier 1,Tier 2,2023-09-13,64,Improved,None,No,No,,826,832,-0.7,Stable,10.83,35.79,-24.96,48.65,59.48,49.13,0.0,0,0.035,0.078,0.359,0.412,1,4,12,12,4.1,31.6,3,Higher,Southwest,NY,Urban,18-35,2023-11,Q4_2023,2023,9.4,0.394,Stable
FIA000136,2023-11-17,Sertraline,Zoloft,Antidepressants,80574-278-46,Medicaid Plan Y,PLAN_6326,2023,Tier 3,Tier 3,2023-01-05,316,No Change,None,No,No,,408,452,-9.6,Decreased,77.87,90.5,-12.63,140.48,218.35,89.09,0.0,0,0.05,0.286,0.541,0.805,2,6,19,9,3.4,33.7,8,Lower,Midwest,OH,Rural,75+,2023-11,Q4_2023,2023,6.1,0.849,Increasing
FIA000838,2023-11-20,Sertraline,Zoloft,Antidepressants,28765-642-10,Medicaid Plan Y,PLAN_5056,2023,Non-Formulary,Specialty Tier,2023-04-30,204,Worsened,Non-Formulary Status,No,No,,710,692,2.6,Stable,347.25,123.29,223.96,193.72,540.97,384.09,0.0,0,0.141,0.391,0.487,0.946,4,5,10,0,3.4,30.8,5,Higher,West,GA,Rural,66-75,2023-11,Q4_2023,2023,1.2,0.18,Increasing
FIA001605,2023-12-05,Sertraline,Zoloft,Antidepressants,37641-219-96,Medicare Part D Plan A,PLAN_3138,2023,Specialty Tier,Tier 3,2022-12-06,364,Worsened,Step Therapy; Quantity Limit,No,Yes,60.0,193,205,-5.4,Decreased,220.5,71.91,148.59,171.75,392.25,75.7,0.0,0,0.25,0.105,0.763,0.575,13,3,18,8,4.9,20.8,4,Higher,Southeast,TX,Urban,75+,2023-12,Q4_2023,2023,1.1,0.857,Decreasing
FIA001717,2023-12-10,Sertraline,Zoloft,Antidepressants,78183-733-75,Commercial Plan Beta,PLAN_3717,2023,Tier 2,Tier 2,2023-03-20,265,No Change,None,No,No,,765,804,-4.8,Stable,49.5,30.13,19.37,118.67,168.17,128.65,0.0,0,0.032,0.106,0.433,0.866,7,5,0,5,4.9,10.5,5,Similar,Southwest,MI,Urban,36-50,2023-12,Q4_2023,2023,3.1,0.255,Increasing
FIA002869,2023-12-23,Sertraline,Zoloft,Antidepressants,67229-220-66,Medicaid Plan Y,PLAN_6193,2023,Tier 1,Specialty Tier,2023-08-10,135,Improved,None,No,No,,930,762,22.1,Increased,7.67,138.77,-131.1,115.79,123.46,114.82,0.0,0,0.079,0.196,0.245,0.512,8,2,12,4,4.2,24.3,7,Similar,Northeast,MI,Suburban,36-50,2023-12,Q4_2023,2023,3.4,0.988,Increasing
FIA001538,2023-12-25,Sertraline,Zoloft,Antidepressants,14840-444-61,VA Plan,PLAN_3509,2023,Specialty Tier,Tier 1,2023-01-11,348,Worsened,Step Therapy,No,Yes,,285,756,-62.2,Decreased,254.15,18.57,235.58,120.01,374.16,106.64,0.0,0,0.164,0.129,0.801,0.91,1,5,12,0,3.8,35.0,4,Higher,Southwest,TX,Suburban,18-35,2023-12,Q4_2023,2023,8.7,0.139,Decreasing
FIA002810,2024-01-17,Sertraline,Zoloft,Antidepressants,51514-164-41,VA Plan,PLAN_7450,2024,Tier 3,Tier 1,2023-03-16,307,Worsened,None,No,No,,666,929,-28.3,Decreased,90.91,8.75,82.16,46.31,137.22,91.39,0.0,0,0.017,0.178,0.748,0.806,0,6,15,2,4.4,11.8,4,Lower,Midwest,OH,Urban,18-35,2024-01,Q1_2024,2023,5.7,0.286,Stable
FIA002365,2024-02-01,Sertraline,Zoloft,Antidepressants,23523-584-29,Medicaid Plan X,PLAN_8750,2024,Specialty Tier,Specialty Tier,2023-03-03,335,No Change,Step Therapy; Quantity Limit,No,Yes,,314,325,-3.1,Stable,117.56,121.82,-4.26,170.23,287.79,90.37,0.0,0,0.295,0.1,0.278,0.927,4,7,5,9,2.3,29.8,7,Similar,West,NY,Urban,36-50,2024-02,Q1_2024,2023,2.9,0.423,Stable
FIA002973,2024-02-05,Sertraline,Zoloft,Antidepressants,65121-220-25,Commercial Plan Beta,PLAN_1032,2024,Tier 1,Tier 1,2023-09-27,131,No Change,Quantity Limit,No,No,,672,666,1.0,Stable,7.48,11.54,-4.06,174.82,182.3,122.51,0.0,0,0.052,0.333,0.399,0.559,1,4,17,13,3.6,32.9,5,Lower,Southwest,OH,Suburban,18-35,2024-02,Q1_2024,2023,7.6,0.265,Decreasing
FIA000003,2024-02-17,Sertraline,Zoloft,Antidepressants,84341-997-50,Commercial Plan Beta,PLAN_9179,2024,Non-Formulary,Tier 2,2023-08-05,196,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,129,334,-61.1,Decreased,705.71,43.28,662.43,41.25,746.96,96.36,0.0,0,0.15,0.36,0.65,0.479,4,3,17,8,4.2,17.9,6,Similar,Midwest,NY,Urban,75+,2024-02,Q1_2024,2023,5.4,0.756,Increasing
FIA001701,2024-02-17,Sertraline,Zoloft,Antidepressants,35254-763-26,Tricare Standard,PLAN_9669,2024,Non-Formulary,Specialty Tier,2023-07-06,226,Worsened,Non-Formulary Status,No,No,,315,291,8.4,Increased,516.95,215.54,301.41,178.31,695.26,219.01,0.0,0,0.163,0.188,0.312,0.689,13,3,11,11,4.8,24.7,2,Lower,Southeast,TX,Rural,75+,2024-02,Q1_2024,2023,7.0,0.567,Increasing
FIA002600,2024-02-17,Sertraline,Zoloft,Antidepressants,47214-837-28,Medicare Part D Plan B,PLAN_5168,2024,Tier 1,Tier 2,2023-03-15,339,Improved,None,No,No,,312,336,-7.1,Decreased,19.5,45.47,-25.97,163.31,182.81,57.04,0.0,0,0.054,0.165,0.508,0.435,12,10,11,11,2.4,21.1,3,Lower,Southwest,OH,Suburban,75+,2024-02,Q1_2024,2023,8.1,0.134,Increasing
FIA002985,2024-02-17,Sertraline,Zoloft,Antidepressants,45051-342-48,Medicaid Plan Y,PLAN_8920,2024,Tier 1,Specialty Tier,2023-04-28,295,Improved,None,No,No,,1115,778,43.4,Increased,16.46,209.33,-192.87,177.89,194.35,216.7,0.0,0,0.059,0.259,0.562,0.492,7,2,9,15,5.0,7.8,4,Similar,Southeast,GA,Suburban,36-50,2024-02,Q1_2024,2023,8.5,0.001,Decreasing
FIA000190,2024-02-21,Sertraline,Zoloft,Antidepressants,49343-755-91,Tricare Standard,PLAN_3034,2024,Non-Formulary,Specialty Tier,2024-01-01,51,Worsened,Non-Formulary Status,No,No,,671,699,-3.9,Stable,693.68,160.4,533.28,56.18,749.86,503.16,0.0,0,0.248,0.279,0.825,0.629,15,10,7,0,2.4,13.3,2,Higher,Midwest,MI,Suburban,75+,2024-02,Q1_2024,2023,4.9,0.258,Decreasing
FIA002287,2024-02-22,Sertraline,Zoloft,Antidepressants,28248-646-96,Medicare Part D Plan A,PLAN_9222,2024,Tier 1,Tier 1,2023-07-08,229,No Change,None,No,No,,422,450,-6.1,Decreased,19.58,9.81,9.77,157.73,177.31,74.82,0.0,0,0.042,0.343,0.729,0.507,4,5,18,11,4.9,17.9,5,Higher,West,MI,Rural,36-50,2024-02,Q1_2024,2023,8.7,0.67,Increasing
FIA001301,2024-02-23,Sertraline,Zoloft,Antidepressants,99194-179-93,Medicaid Plan X,PLAN_5060,2024,Specialty Tier,Tier 3,2023-06-29,239,Worsened,None,No,No,,461,485,-4.8,Stable,267.34,100.0,167.34,90.01,357.35,164.74,0.0,0,0.115,0.328,0.78,0.715,4,5,14,0,4.6,22.4,3,Higher,Southwest,TX,Urban,36-50,2024-02,Q1_2024,2023,5.7,0.629,Increasing
FIA001787,2024-02-24,Sertraline,Zoloft,Antidepressants,81418-261-96,VA Plan,PLAN_2571,2024,Tier 1,Tier 3,2023-06-15,254,Improved,None,No,No,,612,527,16.2,Increased,12.67,92.47,-79.8,110.07,122.74,75.12,0.0,0,0.078,0.353,0.399,0.746,7,0,14,9,4.8,26.6,3,Similar,West,GA,Rural,36-50,2024-02,Q1_2024,2023,9.5,0.903,Increasing
FIA002813,2024-02-26,Sertraline,Zoloft,Antidepressants,91299-482-53,Tricare Standard,PLAN_8353,2024,Specialty Tier,Specialty Tier,2023-03-01,362,No Change,None,No,No,,166,152,9.2,Increased,221.41,164.09,57.32,62.04,283.45,47.05,0.0,0,0.209,0.27,0.385,0.746,13,9,3,14,2.2,23.3,2,Lower,Northeast,PA,Suburban,51-65,2024-02,Q1_2024,2023,3.7,0.405,Stable
FIA000119,2024-03-01,Sertraline,Zoloft,Antidepressants,51984-626-20,Medicare Part D Plan B,PLAN_3742,2024,Non-Formulary,Tier 3,2024-01-19,42,Worsened,Non-Formulary Status,No,No,,484,483,0.3,Stable,746.8,91.11,655.69,140.76,887.56,429.58,0.0,0,0.124,0.39,0.741,0.693,2,3,20,6,4.6,17.7,2,Lower,West,OH,Rural,18-35,2024-03,Q1_2024,2023,7.7,0.154,Stable
FIA000566,2024-03-01,Sertraline,Zoloft,Antidepressants,36986-150-98,Medicaid Plan Y,PLAN_8634,2024,Non-Formulary,Specialty Tier,2023-03-22,345,Worsened,Non-Formulary Status,No,No,,165,180,-7.8,Decreased,311.88,192.88,119.0,67.87,379.75,62.66,0.0,0,0.224,0.302,0.325,0.592,5,8,5,14,3.2,11.2,4,Lower,Northeast,IL,Rural,51-65,2024-03,Q1_2024,2023,9.2,0.621,Decreasing
FIA001754,2024-03-12,Sertraline,Zoloft,Antidepressants,27502-951-62,Tricare Standard,PLAN_2328,2024,Specialty Tier,Non-Formulary,2023-11-03,130,Improved,None,No,No,,996,928,7.3,Increased,172.77,572.54,-399.77,166.47,339.24,337.88,0.0,0,0.087,0.384,0.577,0.855,5,6,15,1,2.3,17.9,6,Lower,Southwest,OH,Suburban,36-50,2024-03,Q1_2024,2023,2.7,0.142,Decreasing
FIA002399,2024-03-21,Sertraline,Zoloft,Antidepressants,75350-446-70,Medicare Part D Plan A,PLAN_5355,2024,Non-Formulary,Specialty Tier,2023-04-06,350,Worsened,Non-Formulary Status,No,No,,156,157,-0.5,Stable,628.37,200.71,427.66,196.17,824.54,128.63,0.0,0,0.263,0.325,0.744,0.611,6,10,14,2,4.7,11.3,2,Lower,Southwest,OH,Urban,18-35,2024-03,Q1_2024,2023,5.4,0.999,Decreasing
FIA000847,2024-03-22,Sertraline,Zoloft,Antidepressants,44851-228-88,Commercial Plan Beta,PLAN_4562,2024,Tier 1,Tier 3,2023-06-15,281,Improved,None,No,No,,1086,685,58.6,Increased,19.4,66.41,-47.01,41.18,60.58,65.79,0.0,0,0.011,0.393,0.628,0.942,8,7,9,5,2.5,21.2,3,Higher,Midwest,MI,Suburban,66-75,2024-03,Q1_2024,2023,9.2,0.481,Stable
FIA002772,2024-04-16,Sertraline,Zoloft,Antidepressants,92578-692-48,Tricare Standard,PLAN_3454,2024,Tier 3,Specialty Tier,2024-02-19,57,Improved,Prior Authorization; Step Therapy,Yes,Yes,,470,506,-6.9,Decreased,51.98,131.07,-79.09,41.66,93.64,44.01,0.539,6,0.035,0.281,0.615,0.559,14,7,12,3,4.7,18.0,6,Similar,Southeast,TX,Suburban,18-35,2024-04,Q2_2024,2023,9.0,0.769,Increasing
FIA002775,2024-05-04,Sertraline,Zoloft,Antidepressants,24563-408-90,Medicare Part D Plan B,PLAN_8334,2024,Specialty Tier,Specialty Tier,2023-11-15,171,No Change,Quantity Limit,No,No,60.0,174,173,0.9,Stable,136.23,212.56,-76.33,194.01,330.24,57.46,0.0,0,0.281,0.225,0.274,0.601,8,9,18,12,4.2,18.8,3,Similar,Southwest,TX,Rural,18-35,2024-05,Q2_2024,2023,5.1,0.072,Stable
FIA001803,2024-05-24,Sertraline,Zoloft,Antidepressants,86936-732-18,Commercial Plan Beta,PLAN_9576,2024,Tier 2,Specialty Tier,2023-09-04,263,Improved,None,No,No,,795,573,38.8,Increased,42.11,221.26,-179.15,173.16,215.27,171.14,0.0,0,0.036,0.163,0.416,0.437,3,7,20,8,2.8,25.2,4,Higher,Northeast,MI,Suburban,51-65,2024-05,Q2_2024,2023,3.5,0.17,Increasing
FIA000676,2024-05-28,Sertraline,Zoloft,Antidepressants,41097-754-13,Commercial Plan Alpha,PLAN_6977,2024,Tier 1,Non-Formulary,2023-07-24,309,Improved,None,No,No,,453,321,41.4,Increased,13.82,206.57,-192.75,39.98,53.8,24.37,0.0,0,0.079,0.097,0.626,0.586,6,7,11,14,4.1,16.0,8,Lower,West,FL,Suburban,18-35,2024-05,Q2_2024,2023,1.4,0.717,Stable
FIA002184,2024-06-03,Sertraline,Zoloft,Antidepressants,86316-234-61,Commercial Plan Beta,PLAN_4196,2024,Tier 3,Tier 3,2024-01-17,138,No Change,None,No,No,,148,157,-5.2,Decreased,53.36,58.89,-5.53,61.54,114.9,17.01,0.0,0,0.028,0.207,0.832,0.927,1,9,11,3,2.2,29.8,6,Lower,Southeast,FL,Urban,66-75,2024-06,Q2_2024,2023,7.5,0.99,Increasing
FIA002238,2024-06-18,Sertraline,Zoloft,Antidepressants,69895-614-26,Medicare Part D Plan A,PLAN_3635,2024,Tier 3,Non-Formulary,2023-11-04,227,Improved,None,No,No,,773,750,3.2,Stable,53.68,513.27,-459.59,121.12,174.8,135.12,0.0,0,0.069,0.313,0.3,0.937,13,5,10,4,2.5,14.4,8,Higher,Midwest,NC,Urban,36-50,2024-06,Q2_2024,2023,1.1,0.954,Increasing
FIA000187,2024-06-21,Sertraline,Zoloft,Antidepressants,13266-514-73,Commercial Plan Alpha,PLAN_8504,2024,Tier 3,Tier 2,2024-02-07,135,Worsened,Quantity Limit,No,No,60.0,131,424,-68.9,Decreased,78.12,21.04,57.08,50.65,128.77,16.87,0.0,0,0.047,0.105,0.879,0.7,10,10,9,15,4.7,34.1,8,Higher,Southeast,MI,Rural,66-75,2024-06,Q2_2024,2023,4.0,0.112,Stable
FIA000943,2024-06-23,Sertraline,Zoloft,Antidepressants,55595-428-46,VA Plan,PLAN_6935,2024,Tier 2,Non-Formulary,2023-10-25,242,Improved,None,No,No,,948,729,30.2,Increased,26.84,562.23,-535.39,124.58,151.42,143.55,0.0,0,0.011,0.202,0.664,0.602,2,7,1,15,2.7,6.6,7,Lower,Northeast,FL,Rural,66-75,2024-06,Q2_2024,2023,9.5,0.38,Stable
FIA001170,2024-06-25,Sertraline,Zoloft,Antidepressants,19734-453-10,Commercial Plan Alpha,PLAN_4581,2024,Non-Formulary,Specialty Tier,2024-01-30,147,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,911,981,-7.0,Decreased,319.18,195.9,123.28,49.46,368.64,335.83,0.0,0,0.093,0.152,0.585,0.751,7,4,10,1,3.0,9.9,6,Similar,Northeast,IL,Rural,18-35,2024-06,Q2_2024,2023,3.3,0.131,Stable
FIA002007,2024-06-27,Sertraline,Zoloft,Antidepressants,91234-200-96,VA Plan,PLAN_6654,2024,Tier 2,Specialty Tier,2023-12-17,193,Improved,None,No,No,,900,635,41.8,Increased,33.33,114.16,-80.83,89.45,122.78,110.5,0.0,0,0.08,0.121,0.626,0.673,8,4,14,8,2.0,25.0,7,Similar,West,OH,Suburban,75+,2024-06,Q2_2024,2023,8.8,0.283,Decreasing
FIA001007,2024-07-09,Sertraline,Zoloft,Antidepressants,26278-281-54,Commercial Plan Alpha,PLAN_1591,2024,Specialty Tier,Specialty Tier,2023-08-04,340,No Change,Prior Authorization,Yes,No,,790,728,8.6,Increased,147.75,272.66,-124.91,130.34,278.09,219.69,0.286,2,0.201,0.264,0.243,0.609,8,6,20,3,2.4,29.3,2,Higher,Northeast,MI,Suburban,75+,2024-07,Q3_2024,2023,6.2,0.211,Increasing
FIA000244,2024-07-28,Sertraline,Zoloft,Antidepressants,85514-140-21,Medicaid Plan X,PLAN_8476,2024,Tier 2,Tier 1,2024-04-16,103,Worsened,Quantity Limit,No,No,60.0,763,719,6.2,Increased,33.37,17.37,16.0,108.23,141.6,108.04,0.0,0,0.072,0.295,0.698,0.564,5,6,7,5,4.7,27.0,5,Similar,Southeast,MI,Urban,66-75,2024-07,Q3_2024,2023,7.3,0.044,Increasing
FIA000103,2024-08-13,Sertraline,Zoloft,Antidepressants,99707-210-71,Medicare Part D Plan B,PLAN_6509,2024,Non-Formulary,Non-Formulary,2023-12-24,233,No Change,Non-Formulary Status,No,No,,850,778,9.3,Increased,550.69,204.41,346.28,78.06,628.75,534.44,0.0,0,0.198,0.396,0.648,0.874,8,10,20,9,2.6,20.5,3,Lower,West,OH,Rural,51-65,2024-08,Q3_2024,2023,7.1,0.721,Decreasing
FIA001421,2024-08-14,Sertraline,Zoloft,Antidepressants,87719-465-57,Commercial Plan Alpha,PLAN_7949,2024,Tier 1,Tier 1,2024-01-07,220,No Change,None,No,No,,480,458,4.8,Stable,13.75,18.75,-5.0,123.81,137.56,66.03,0.0,0,0.034,0.14,0.639,0.477,3,7,6,4,3.7,9.2,8,Higher,Southwest,FL,Rural,75+,2024-08,Q3_2024,2023,1.5,0.162,Increasing
FIA000059,2024-08-16,Sertraline,Zoloft,Antidepressants,35318-279-88,VA Plan,PLAN_8007,2024,Tier 2,Tier 1,2024-01-30,199,Worsened,None,No,No,,378,363,4.4,Stable,24.87,11.88,12.99,126.52,151.39,57.23,0.0,0,0.065,0.23,0.261,0.768,5,2,15,10,4.8,5.2,5,Lower,Southwest,PA,Suburban,51-65,2024-08,Q3_2024,2023,6.2,0.573,Stable
FIA002917,2024-08-26,Sertraline,Zoloft,Antidepressants,15467-809-83,Commercial Plan Beta,PLAN_8737,2024,Non-Formulary,Specialty Tier,2023-12-09,261,Worsened,Non-Formulary Status; Quantity Limit,No,No,,779,819,-4.8,Stable,249.78,213.42,36.36,174.69,424.47,330.66,0.0,0,0.086,0.33,0.623,0.445,13,5,6,15,3.4,14.9,5,Lower,West,PA,Urban,66-75,2024-08,Q3_2024,2023,1.9,0.661,Decreasing
FIA000422,2024-08-30,Sertraline,Zoloft,Antidepressants,71509-135-51,Medicaid Plan X,PLAN_8392,2024,Non-Formulary,Tier 1,2024-06-19,72,Worsened,Non-Formulary Status,No,No,,252,746,-66.1,Decreased,347.23,17.46,329.77,71.03,418.26,105.4,0.0,0,0.237,0.126,0.487,0.406,4,9,0,14,2.2,10.4,4,Higher,West,OH,Rural,18-35,2024-08,Q3_2024,2023,3.3,0.118,Decreasing
FIA000069,2024-08-31,Sertraline,Zoloft,Antidepressants,62205-178-48,Commercial Plan Alpha,PLAN_4939,2024,Tier 1,Tier 1,2024-03-11,173,No Change,None,No,No,,124,133,-6.4,Decreased,18.49,13.45,5.04,54.51,73.0,9.05,0.0,0,0.025,0.248,0.795,0.772,10,6,4,2,3.5,34.2,2,Lower,Southwest,NY,Urban,51-65,2024-08,Q3_2024,2023,6.4,0.614,Decreasing
FIA000213,2024-09-05,Sertraline,Zoloft,Antidepressants,64135-196-69,Medicaid Plan X,PLAN_6823,2024,Tier 2,Tier 2,2024-03-06,183,No Change,Quantity Limit,No,No,60.0,407,402,1.4,Stable,45.25,35.69,9.56,116.81,162.06,65.96,0.0,0,0.046,0.255,0.738,0.409,14,2,5,12,2.1,17.5,7,Similar,Midwest,MI,Rural,66-75,2024-09,Q3_2024,2023,7.8,0.45,Stable
FIA002920,2024-09-06,Sertraline,Zoloft,Antidepressants,67338-261-35,Medicaid Plan Y,PLAN_2743,2024,Non-Formulary,Tier 2,2024-08-07,30,Worsened,Non-Formulary Status,No,No,,230,592,-61.1,Decreased,567.74,36.92,530.82,148.46,716.2,164.73,0.0,0,0.225,0.09,0.835,0.789,5,10,5,5,2.8,21.4,4,Similar,West,TX,Rural,51-65,2024-09,Q3_2024,2023,7.1,0.893,Stable
FIA000337,2024-09-16,Sertraline,Zoloft,Antidepressants,85743-125-60,Commercial Plan Beta,PLAN_8325,2024,Non-Formulary,Non-Formulary,2024-04-14,155,No Change,Non-Formulary Status,No,No,,827,845,-2.1,Stable,429.45,795.89,-366.44,106.89,536.34,443.55,0.0,0,0.229,0.179,0.594,0.754,10,2,20,2,2.3,10.1,8,Similar,West,NY,Urban,36-50,2024-09,Q3_2024,2023,4.6,0.838,Decreasing
FIA002305,2024-09-30,Sertraline,Zoloft,Antidepressants,64580-399-35,Commercial Plan Alpha,PLAN_1154,2024,Tier 3,Tier 2,2024-01-17,257,Worsened,Quantity Limit,No,No,90.0,176,290,-39.2,Decreased,63.33,22.25,41.08,121.17,184.5,32.47,0.0,0,0.07,0.326,0.432,0.743,7,1,4,8,3.6,27.8,6,Lower,Southwest,MI,Urban,66-75,2024-09,Q3_2024,2023,6.7,0.316,Stable
FIA000561,2024-10-04,Sertraline,Zoloft,Antidepressants,11776-775-19,Commercial Plan Beta,PLAN_7313,2024,Tier 1,Tier 2,2024-09-01,33,Improved,None,No,No,,988,977,1.2,Stable,12.28,29.46,-17.18,85.07,97.35,96.18,0.0,0,0.056,0.111,0.663,0.68,9,10,12,7,3.7,26.6,7,Similar,Southwest,TX,Suburban,51-65,2024-10,Q4_2024,2024,8.1,0.045,Stable
FIA000104,2024-10-15,Sertraline,Zoloft,Antidepressants,98063-467-74,Medicaid Plan X,PLAN_3785,2024,Tier 3,Specialty Tier,2024-02-21,237,Improved,Step Therapy,No,Yes,,906,825,9.9,Increased,69.41,107.06,-37.65,110.87,180.28,163.33,0.0,0,0.055,0.344,0.814,0.5,3,7,4,8,4.2,21.8,3,Higher,Midwest,TX,Urban,51-65,2024-10,Q4_2024,2024,3.0,0.871,Stable
FIA001126,2024-10-20,Sertraline,Zoloft,Antidepressants,14531-334-22,Medicare Part D Plan A,PLAN_2604,2024,Non-Formulary,Tier 1,2023-11-02,353,Worsened,Non-Formulary Status,No,No,,232,345,-32.7,Decreased,254.18,17.11,237.07,199.53,453.71,105.26,0.0,0,0.106,0.186,0.364,0.606,5,2,16,8,3.1,14.5,2,Similar,Northeast,NC,Rural,51-65,2024-10,Q4_2024,2024,5.1,0.914,Stable
FIA001688,2024-10-21,Sertraline,Zoloft,Antidepressants,30531-612-93,Medicare Part D Plan B,PLAN_3514,2024,Tier 1,Tier 1,2024-06-28,115,No Change,None,No,No,,144,159,-9.1,Decreased,10.32,15.46,-5.14,41.83,52.15,7.51,0.0,0,0.049,0.152,0.84,0.619,13,6,14,6,2.1,34.1,5,Lower,West,PA,Urban,75+,2024-10,Q4_2024,2024,6.5,0.876,Stable
FIA001859,2024-11-23,Sertraline,Zoloft,Antidepressants,89672-678-57,Medicare Part D Plan B,PLAN_3640,2024,Tier 3,Tier 2,2024-03-12,256,Worsened,Quantity Limit,No,No,,233,619,-62.3,Decreased,98.64,39.17,59.47,187.47,286.11,66.66,0.0,0,0.078,0.273,0.672,0.663,9,10,9,14,4.8,33.7,8,Higher,Southeast,OH,Suburban,18-35,2024-11,Q4_2024,2024,8.7,0.218,Stable
FIA001106,2024-12-02,Sertraline,Zoloft,Antidepressants,50440-885-77,Commercial Plan Alpha,PLAN_8282,2024,Tier 1,Tier 1,2024-06-03,182,No Change,None,No,No,,749,826,-9.3,Decreased,18.2,17.57,0.63,157.91,176.11,131.91,0.0,0,0.011,0.157,0.686,0.61,10,2,7,10,4.5,7.4,6,Higher,Southeast,CA,Urban,75+,2024-12,Q4_2024,2024,1.0,0.843,Decreasing
FIA000163,2024-12-08,Sertraline,Zoloft,Antidepressants,50760-145-97,Medicare Part D Plan B,PLAN_6460,2024,Tier 3,Tier 2,2024-09-19,80,Worsened,None,No,No,,240,792,-69.6,Decreased,91.11,48.14,42.97,49.69,140.8,33.79,0.0,0,0.071,0.213,0.232,0.686,9,0,18,9,3.9,11.3,3,Lower,Midwest,PA,Rural,51-65,2024-12,Q4_2024,2024,8.0,0.671,Stable
FIA001475,2024-12-14,Sertraline,Zoloft,Antidepressants,96338-881-17,Medicaid Plan X,PLAN_9019,2024,Non-Formulary,Non-Formulary,2024-01-16,333,No Change,Non-Formulary Status,No,No,,852,838,1.7,Stable,353.95,362.95,-9.0,173.25,527.2,449.17,0.0,0,0.124,0.138,0.784,0.945,3,7,11,13,2.7,12.7,2,Similar,Southwest,IL,Urban,51-65,2024-12,Q4_2024,2024,3.7,0.305,Decreasing
FIA002969,2024-12-15,Sertraline,Zoloft,Antidepressants,89880-992-58,Commercial Plan Beta,PLAN_2880,2024,Non-Formulary,Tier 3,2024-01-08,342,Worsened,Non-Formulary Status,No,No,,111,114,-2.5,Stable,215.84,93.96,121.88,154.4,370.24,41.1,0.0,0,0.099,0.292,0.867,0.868,9,5,12,13,2.5,10.5,6,Lower,Midwest,TX,Rural,66-75,2024-12,Q4_2024,2024,3.7,0.382,Stable
FIA001690,2025-01-10,Sertraline,Zoloft,Antidepressants,72107-268-27,Medicaid Plan Y,PLAN_8743,2025,Tier 3,Non-Formulary,2024-08-24,139,Improved,None,No,No,,919,1000,-8.0,Decreased,84.7,232.7,-148.0,133.42,218.12,200.45,0.0,0,0.067,0.325,0.661,0.576,4,2,10,7,4.7,29.4,7,Lower,Southeast,GA,Urban,51-65,2025-01,Q1_2025,2024,3.4,0.285,Decreasing
FIA001483,2025-01-24,Sertraline,Zoloft,Antidepressants,72204-237-52,Medicare Part D Plan B,PLAN_2529,2025,Tier 3,Non-Formulary,2024-11-17,68,Improved,Step Therapy,No,Yes,,160,148,8.5,Increased,93.29,336.12,-242.83,62.93,156.22,25.0,0.0,0,0.023,0.099,0.665,0.914,6,1,1,4,3.1,12.0,2,Similar,Northeast,OH,Suburban,51-65,2025-01,Q1_2025,2024,6.0,0.933,Decreasing
FIA002830,2025-01-30,Sertraline,Zoloft,Antidepressants,82350-763-57,Medicaid Plan Y,PLAN_3805,2025,Specialty Tier,Tier 1,2024-02-16,349,Worsened,Prior Authorization,Yes,No,,268,641,-58.0,Decreased,278.71,14.82,263.89,148.06,426.77,114.37,0.546,8,0.074,0.26,0.779,0.731,6,6,12,5,3.0,20.1,7,Higher,Northeast,TX,Rural,18-35,2025-01,Q1_2025,2024,3.0,0.084,Stable
FIA002514,2025-02-06,Sertraline,Zoloft,Antidepressants,90224-386-35,Tricare Standard,PLAN_5022,2025,Specialty Tier,Specialty Tier,2024-09-28,131,No Change,Step Therapy,No,Yes,,647,612,5.8,Increased,196.41,181.42,14.99,83.51,279.92,181.11,0.0,0,0.21,0.311,0.598,0.464,2,5,16,0,4.6,28.1,6,Higher,West,PA,Suburban,66-75,2025-02,Q1_2025,2024,6.7,0.627,Stable
FIA000153,2025-02-10,Sertraline,Zoloft,Antidepressants,50944-719-52,Tricare Standard,PLAN_9883,2025,Tier 2,Tier 2,2024-07-21,204,No Change,None,No,No,,197,189,4.6,Stable,46.92,39.71,7.21,102.5,149.42,29.44,0.0,0,0.05,0.096,0.657,0.72,6,2,9,4,3.3,32.3,8,Lower,West,FL,Suburban,18-35,2025-02,Q1_2025,2024,6.0,0.949,Increasing
FIA000783,2025-02-10,Sertraline,Zoloft,Antidepressants,54259-893-89,Medicare Part D Plan A,PLAN_8022,2025,Tier 3,Tier 2,2024-11-24,78,Worsened,Step Therapy,No,Yes,,76,153,-50.2,Decreased,65.7,26.53,39.17,142.45,208.15,15.82,0.0,0,0.038,0.294,0.414,0.885,14,2,20,8,4.7,6.0,7,Higher,West,FL,Rural,18-35,2025-02,Q1_2025,2024,5.1,0.636,Increasing
FIA000417,2025-02-15,Sertraline,Zoloft,Antidepressants,32940-113-83,Medicare Part D Plan A,PLAN_2032,2025,Tier 3,Tier 1,2024-04-03,318,Worsened,None,No,No,,177,256,-30.8,Decreased,73.99,15.97,58.02,109.17,183.16,32.42,0.0,0,0.04,0.386,0.813,0.79,15,3,8,0,4.0,33.9,3,Lower,Southwest,CA,Rural,18-35,2025-02,Q1_2025,2024,8.9,0.835,Stable
FIA002759,2025-02-25,Sertraline,Zoloft,Antidepressants,58943-283-85,Medicaid Plan X,PLAN_8380,2025,Tier 2,Tier 1,2024-11-10,107,Worsened,Quantity Limit,No,No,30.0,357,378,-5.4,Decreased,43.29,13.48,29.81,189.81,233.1,83.22,0.0,0,0.061,0.273,0.339,0.41,12,7,5,5,5.0,10.1,4,Similar,Southeast,NY,Urban,18-35,2025-02,Q1_2025,2024,6.9,0.208,Stable
FIA000055,2025-02-26,Sertraline,Zoloft,Antidepressants,85821-691-39,Medicare Part D Plan A,PLAN_8871,2025,Specialty Tier,Tier 1,2024-07-23,218,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,267,526,-49.2,Decreased,166.25,6.64,159.61,194.4,360.65,96.29,0.113,3,0.169,0.233,0.705,0.826,12,2,7,1,3.7,26.0,3,Lower,Southwest,IL,Suburban,36-50,2025-02,Q1_2025,2024,4.7,0.204,Decreasing
FIA002495,2025-03-01,Sertraline,Zoloft,Antidepressants,81239-254-66,Commercial Plan Beta,PLAN_6924,2025,Tier 2,Tier 2,2024-04-18,317,No Change,Quantity Limit,No,No,60.0,895,860,4.2,Stable,25.75,41.53,-15.78,82.93,108.68,97.27,0.0,0,0.035,0.242,0.668,0.454,12,1,8,15,4.5,7.9,6,Higher,Southeast,MI,Suburban,75+,2025-03,Q1_2025,2024,9.5,0.148,Increasing
FIA001720,2025-04-05,Sertraline,Zoloft,Antidepressants,41963-933-48,Commercial Plan Alpha,PLAN_9391,2025,Tier 2,Non-Formulary,2024-11-19,137,Improved,None,No,No,,920,637,44.6,Increased,22.66,588.39,-565.73,98.01,120.67,111.02,0.0,0,0.077,0.334,0.622,0.454,8,1,12,5,2.9,28.8,5,Lower,Midwest,PA,Rural,75+,2025-04,Q2_2025,2024,2.0,0.924,Decreasing
FIA000029,2025-04-18,Sertraline,Zoloft,Antidepressants,96275-505-45,Medicare Part D Plan A,PLAN_1803,2025,Specialty Tier,Tier 3,2024-07-29,263,Worsened,None,No,No,,527,493,7.1,Increased,269.06,59.96,209.1,80.19,349.25,184.05,0.0,0,0.298,0.369,0.722,0.858,9,3,19,11,2.7,10.7,4,Higher,Southeast,TX,Rural,18-35,2025-04,Q2_2025,2024,3.8,0.441,Decreasing
FIA002131,2025-04-29,Sertraline,Zoloft,Antidepressants,92676-492-36,Commercial Plan Beta,PLAN_8774,2025,Specialty Tier,Non-Formulary,2024-12-25,125,Improved,None,No,No,,837,920,-9.0,Decreased,269.92,478.57,-208.65,171.94,441.86,369.84,0.0,0,0.129,0.092,0.85,0.779,6,5,3,14,2.1,21.6,2,Similar,Midwest,CA,Rural,18-35,2025-04,Q2_2025,2024,5.2,0.204,Decreasing
FIA001186,2025-05-05,Sertraline,Zoloft,Antidepressants,27699-121-87,Commercial Plan Beta,PLAN_9971,2025,Tier 3,Tier 3,2025-02-20,74,No Change,Prior Authorization; Step Therapy,Yes,Yes,,987,917,7.7,Increased,82.99,91.96,-8.97,170.84,253.83,250.53,0.227,4,0.045,0.205,0.616,0.912,5,4,5,15,4.0,5.1,8,Similar,Midwest,TX,Suburban,66-75,2025-05,Q2_2025,2024,3.4,0.763,Stable
FIA002093,2025-05-11,Sertraline,Zoloft,Antidepressants,73028-525-79,Medicaid Plan Y,PLAN_4217,2025,Tier 3,Specialty Tier,2024-11-18,174,Improved,None,No,No,,467,468,-0.1,Stable,69.45,105.8,-36.35,127.12,196.57,91.8,0.0,0,0.048,0.235,0.362,0.58,4,4,3,11,2.2,32.1,6,Similar,Southeast,TX,Rural,75+,2025-05,Q2_2025,2024,9.3,0.463,Stable
FIA000897,2025-05-26,Sertraline,Zoloft,Antidepressants,81533-413-29,VA Plan,PLAN_9559,2025,Specialty Tier,Tier 3,2024-08-24,275,Worsened,None,No,No,,169,154,9.9,Increased,193.62,88.77,104.85,186.62,380.24,64.26,0.0,0,0.163,0.071,0.619,0.682,4,6,2,12,2.8,18.1,2,Similar,Southeast,GA,Urban,75+,2025-05,Q2_2025,2024,9.5,0.033,Stable
FIA002676,2025-05-26,Sertraline,Zoloft,Antidepressants,58327-431-99,Medicare Part D Plan A,PLAN_4412,2025,Tier 3,Specialty Tier,2025-03-13,74,Improved,Step Therapy,No,Yes,,173,165,4.9,Stable,75.81,233.7,-157.89,178.6,254.41,44.01,0.0,0,0.061,0.362,0.661,0.459,0,9,6,5,3.9,16.3,5,Higher,Southwest,NY,Rural,66-75,2025-05,Q2_2025,2024,7.8,0.485,Decreasing
FIA001749,2025-06-02,Sertraline,Zoloft,Antidepressants,83362-151-31,Commercial Plan Beta,PLAN_5060,2025,Tier 2,Tier 2,2024-09-01,274,No Change,None,No,No,,256,263,-2.4,Stable,49.01,28.78,20.23,74.59,123.6,31.64,0.0,0,0.053,0.092,0.555,0.677,8,8,0,10,4.2,28.6,4,Lower,West,NC,Rural,36-50,2025-06,Q2_2025,2024,5.3,0.488,Stable
FIA000443,2025-06-08,Sertraline,Zoloft,Antidepressants,61562-972-53,Commercial Plan Alpha,PLAN_8744,2025,Tier 2,Tier 1,2024-09-15,266,Worsened,None,No,No,,799,758,5.5,Increased,38.19,8.9,29.29,78.23,116.42,93.02,0.0,0,0.026,0.334,0.451,0.68,9,10,12,13,4.4,12.1,8,Similar,Midwest,NY,Urban,66-75,2025-06,Q2_2025,2024,2.3,0.155,Increasing
FIA002861,2025-06-12,Sertraline,Zoloft,Antidepressants,56135-263-66,Medicare Part D Plan A,PLAN_4501,2025,Non-Formulary,Specialty Tier,2024-07-02,345,Worsened,Non-Formulary Status,No,No,,412,404,2.2,Stable,313.63,258.66,54.97,69.94,383.57,158.03,0.0,0,0.121,0.286,0.318,0.51,2,3,12,4,3.2,22.3,3,Higher,Midwest,FL,Suburban,75+,2025-06,Q2_2025,2024,1.7,0.06,Decreasing
FIA000200,2025-06-13,Sertraline,Zoloft,Antidepressants,22053-834-84,Medicare Part D Plan B,PLAN_6518,2025,Tier 3,Specialty Tier,2025-01-31,133,Improved,Quantity Limit,No,No,60.0,829,906,-8.5,Decreased,74.85,269.47,-194.62,68.4,143.25,118.75,0.0,0,0.038,0.074,0.761,0.661,6,5,2,9,3.5,14.0,7,Higher,Midwest,NY,Suburban,66-75,2025-06,Q2_2025,2024,3.3,0.515,Decreasing
FIA001790,2025-06-22,Sertraline,Zoloft,Antidepressants,63546-402-73,Medicare Part D Plan B,PLAN_9736,2025,Non-Formulary,Specialty Tier,2025-02-07,135,Worsened,Non-Formulary Status,No,No,,549,561,-2.1,Stable,783.2,264.44,518.76,129.17,912.37,500.89,0.0,0,0.146,0.327,0.256,0.914,11,3,8,1,3.7,8.2,7,Higher,West,GA,Rural,51-65,2025-06,Q2_2025,2024,2.0,0.803,Stable
FIA001323,2025-06-30,Sertraline,Zoloft,Antidepressants,55034-843-29,Tricare Standard,PLAN_7749,2025,Non-Formulary,Tier 1,2025-01-07,174,Worsened,Non-Formulary Status,No,No,,272,385,-29.3,Decreased,673.97,8.91,665.06,81.03,755.0,205.36,0.0,0,0.084,0.072,0.621,0.539,5,8,15,8,4.7,18.7,2,Higher,Southeast,MI,Urban,51-65,2025-06,Q2_2025,2024,4.4,0.007,Stable
FIA002191,2025-07-08,Sertraline,Zoloft,Antidepressants,71297-219-31,Medicare Part D Plan B,PLAN_7152,2025,Tier 1,Non-Formulary,2025-01-20,169,Improved,None,No,No,,731,578,26.6,Increased,19.48,636.37,-616.89,163.14,182.62,133.5,0.0,0,0.034,0.379,0.531,0.65,6,3,5,1,2.1,7.9,8,Higher,West,NY,Suburban,75+,2025-07,Q3_2025,2024,6.5,0.934,Decreasing
FIA001253,2025-07-16,Sertraline,Zoloft,Antidepressants,44655-672-10,Medicaid Plan Y,PLAN_5234,2025,Tier 1,Non-Formulary,2024-08-08,342,Improved,None,No,No,,638,553,15.4,Increased,16.79,796.04,-779.25,120.3,137.09,87.46,0.0,0,0.049,0.14,0.571,0.651,1,4,17,7,2.6,17.5,8,Similar,West,OH,Rural,66-75,2025-07,Q3_2025,2024,9.2,0.634,Stable
FIA000806,2025-07-17,Sertraline,Zoloft,Antidepressants,30696-249-13,Medicare Part D Plan A,PLAN_8590,2025,Specialty Tier,Non-Formulary,2025-05-04,74,Improved,Step Therapy,No,Yes,,645,682,-5.4,Decreased,249.15,206.67,42.48,149.59,398.74,257.19,0.0,0,0.164,0.37,0.387,0.587,15,2,8,6,3.7,33.2,3,Higher,Midwest,TX,Suburban,51-65,2025-07,Q3_2025,2024,2.7,0.717,Increasing
FIA002020,2025-07-17,Sertraline,Zoloft,Antidepressants,47124-978-17,VA Plan,PLAN_9465,2025,Tier 2,Tier 2,2025-03-15,124,No Change,Quantity Limit,No,No,30.0,261,262,-0.4,Stable,41.6,20.3,21.3,186.71,228.31,59.59,0.0,0,0.076,0.383,0.77,0.727,8,5,16,15,4.5,6.6,3,Lower,Northeast,GA,Rural,18-35,2025-07,Q3_2025,2024,1.4,0.328,Stable
FIA000821,2025-07-30,Sertraline,Zoloft,Antidepressants,74112-837-98,Commercial Plan Beta,PLAN_5765,2025,Specialty Tier,Tier 1,2025-01-28,183,Worsened,Prior Authorization,Yes,No,,202,510,-60.3,Decreased,103.65,6.53,97.12,143.8,247.45,49.98,0.227,2,0.295,0.245,0.7,0.715,1,8,6,15,4.8,16.2,8,Similar,Northeast,TX,Suburban,18-35,2025-07,Q3_2025,2024,2.7,0.825,Increasing
FIA002739,2025-08-21,Sertraline,Zoloft,Antidepressants,52806-498-96,Medicare Part D Plan B,PLAN_5311,2025,Specialty Tier,Tier 3,2025-07-08,44,Worsened,Prior Authorization,Yes,No,,520,518,0.4,Stable,122.88,53.05,69.83,30.72,153.6,79.87,0.58,10,0.275,0.354,0.638,0.75,8,9,5,6,4.8,8.5,8,Higher,Southwest,GA,Suburban,51-65,2025-08,Q3_2025,2024,5.0,0.81,Increasing
FIA001393,2025-08-23,Sertraline,Zoloft,Antidepressants,85514-322-34,Tricare Standard,PLAN_5496,2025,Specialty Tier,Tier 3,2025-02-05,199,Worsened,None,No,No,,829,824,0.6,Stable,216.95,95.14,121.81,196.25,413.2,342.54,0.0,0,0.113,0.173,0.814,0.93,1,2,7,9,3.7,17.3,8,Higher,Midwest,PA,Suburban,36-50,2025-08,Q3_2025,2024,7.6,0.847,Decreasing
FIA002721,2022-01-07,Warfarin,Coumadin,Anticoagulants,40553-201-43,Tricare Standard,PLAN_6525,2022,Tier 2,Tier 2,2021-02-11,330,No Change,None,No,No,,487,443,9.9,Increased,42.59,46.43,-3.84,185.79,228.38,111.22,0.0,0,0.077,0.178,0.801,0.713,8,1,6,4,4.8,20.8,6,Similar,Midwest,OH,Rural,75+,2022-01,Q1_2022,2021,6.5,0.905,Decreasing
FIA001963,2022-01-20,Warfarin,Coumadin,Anticoagulants,86691-283-77,Tricare Standard,PLAN_3234,2022,Tier 2,Non-Formulary,2021-06-03,231,Improved,None,No,No,,639,555,15.2,Increased,29.87,373.92,-344.05,168.12,197.99,126.52,0.0,0,0.077,0.097,0.6,0.645,2,9,7,9,4.4,19.8,7,Higher,Southwest,CA,Urban,36-50,2022-01,Q1_2022,2021,1.9,0.714,Decreasing
FIA001353,2022-01-21,Warfarin,Coumadin,Anticoagulants,94874-500-31,Medicare Part D Plan B,PLAN_7001,2022,Tier 1,Tier 1,2021-03-20,307,No Change,None,No,No,,716,684,4.8,Stable,5.94,16.45,-10.51,109.45,115.39,82.62,0.0,0,0.06,0.144,0.444,0.938,2,9,17,1,3.3,30.2,7,Lower,Southwest,FL,Rural,36-50,2022-01,Q1_2022,2021,8.5,0.695,Stable
FIA000170,2022-01-23,Warfarin,Coumadin,Anticoagulants,83886-366-17,Tricare Standard,PLAN_3770,2022,Specialty Tier,Non-Formulary,2021-04-28,270,Improved,Quantity Limit,No,No,,503,461,9.2,Increased,214.79,398.91,-184.12,153.59,368.38,185.3,0.0,0,0.237,0.28,0.404,0.806,0,4,15,2,2.4,7.3,8,Similar,Midwest,FL,Rural,51-65,2022-01,Q1_2022,2021,3.5,0.257,Decreasing
FIA000141,2022-01-31,Warfarin,Coumadin,Anticoagulants,29148-157-44,VA Plan,PLAN_2169,2022,Tier 2,Tier 3,2021-05-31,245,Improved,None,No,No,,652,480,35.9,Increased,29.35,89.97,-60.62,173.4,202.75,132.19,0.0,0,0.033,0.24,0.327,0.893,8,6,0,3,4.9,26.4,5,Similar,Southeast,CA,Urban,66-75,2022-01,Q1_2022,2021,7.6,0.094,Decreasing
FIA001730,2022-02-13,Warfarin,Coumadin,Anticoagulants,37493-500-34,Medicare Part D Plan B,PLAN_4421,2022,Tier 3,Specialty Tier,2021-11-16,89,Improved,None,No,No,,939,956,-1.7,Stable,84.51,107.86,-23.35,157.36,241.87,227.12,0.0,0,0.058,0.371,0.3,0.763,4,2,6,1,4.7,34.0,3,Lower,Northeast,NY,Suburban,75+,2022-02,Q1_2022,2021,7.7,0.967,Decreasing
FIA000588,2022-02-16,Warfarin,Coumadin,Anticoagulants,82515-900-86,Tricare Standard,PLAN_6029,2022,Tier 3,Specialty Tier,2021-11-05,103,Improved,None,No,No,,772,704,9.8,Increased,88.24,182.4,-94.16,125.61,213.85,165.09,0.0,0,0.044,0.29,0.549,0.708,9,6,8,2,4.9,10.8,6,Higher,Midwest,TX,Suburban,66-75,2022-02,Q1_2022,2021,3.2,0.839,Decreasing
FIA000438,2022-02-19,Warfarin,Coumadin,Anticoagulants,84232-618-18,Commercial Plan Alpha,PLAN_7191,2022,Specialty Tier,Tier 3,2021-03-13,343,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,380,391,-2.6,Stable,192.06,81.09,110.97,123.16,315.22,119.78,0.357,6,0.217,0.281,0.508,0.797,8,2,4,6,2.3,16.5,5,Lower,Northeast,CA,Suburban,18-35,2022-02,Q1_2022,2021,9.6,0.194,Decreasing
FIA000632,2022-02-25,Warfarin,Coumadin,Anticoagulants,97107-840-17,Commercial Plan Beta,PLAN_2600,2022,Tier 2,Tier 1,2021-05-15,286,Worsened,None,No,No,,880,924,-4.7,Stable,33.92,10.42,23.5,69.08,103.0,90.64,0.0,0,0.055,0.22,0.415,0.526,0,2,14,9,4.5,30.2,6,Similar,Southwest,FL,Suburban,18-35,2022-02,Q1_2022,2021,2.5,0.173,Stable
FIA002591,2022-03-02,Warfarin,Coumadin,Anticoagulants,44798-315-42,Tricare Standard,PLAN_7564,2022,Tier 3,Tier 1,2021-10-13,140,Worsened,None,No,No,,525,806,-34.8,Decreased,79.19,17.53,61.66,129.03,208.22,109.32,0.0,0,0.078,0.371,0.614,0.453,14,1,7,12,2.1,21.6,8,Higher,West,FL,Urban,66-75,2022-03,Q1_2022,2021,4.9,0.154,Decreasing
FIA001991,2022-03-07,Warfarin,Coumadin,Anticoagulants,67068-116-67,Medicare Part D Plan A,PLAN_5400,2022,Tier 2,Specialty Tier,2021-10-07,151,Improved,None,No,No,,759,649,17.0,Increased,47.01,183.85,-136.84,139.26,186.27,141.38,0.0,0,0.068,0.364,0.651,0.412,10,5,18,7,4.2,22.5,4,Higher,Southeast,PA,Suburban,75+,2022-03,Q1_2022,2021,7.4,0.068,Decreasing
FIA000535,2022-03-09,Warfarin,Coumadin,Anticoagulants,76083-687-49,Medicaid Plan Y,PLAN_5801,2022,Tier 1,Specialty Tier,2021-04-10,333,Improved,None,No,No,,752,595,26.5,Increased,9.71,102.94,-93.23,44.73,54.44,40.94,0.0,0,0.079,0.129,0.652,0.839,14,6,18,6,4.6,17.4,3,Higher,Midwest,PA,Suburban,18-35,2022-03,Q1_2022,2021,4.7,0.733,Decreasing
FIA001380,2022-03-17,Warfarin,Coumadin,Anticoagulants,48010-636-11,Medicaid Plan Y,PLAN_7418,2022,Tier 1,Specialty Tier,2021-05-23,298,Improved,None,No,No,,251,170,48.0,Increased,6.19,107.96,-101.77,172.68,178.87,44.9,0.0,0,0.031,0.262,0.408,0.471,3,8,15,9,4.1,24.6,2,Similar,Midwest,MI,Urban,18-35,2022-03,Q1_2022,2021,6.9,0.779,Increasing
FIA002543,2022-03-18,Warfarin,Coumadin,Anticoagulants,53910-466-85,Medicare Part D Plan B,PLAN_7902,2022,Specialty Tier,Tier 1,2021-05-26,296,Worsened,Prior Authorization; Quantity Limit,Yes,No,60.0,222,422,-47.2,Decreased,204.75,10.11,194.64,97.69,302.44,67.14,0.394,5,0.102,0.117,0.629,0.891,14,0,19,15,2.7,23.2,7,Higher,Northeast,TX,Urban,75+,2022-03,Q1_2022,2021,1.8,0.019,Decreasing
FIA000210,2022-03-25,Warfarin,Coumadin,Anticoagulants,45755-676-94,Commercial Plan Beta,PLAN_1067,2022,Tier 3,Non-Formulary,2021-06-20,278,Improved,None,No,No,,898,837,7.3,Increased,72.89,267.49,-194.6,157.49,230.38,206.88,0.0,0,0.068,0.234,0.6,0.629,2,3,15,3,4.7,5.8,7,Higher,Northeast,OH,Suburban,75+,2022-03,Q1_2022,2021,9.4,0.106,Stable
FIA001312,2022-03-29,Warfarin,Coumadin,Anticoagulants,30878-336-16,VA Plan,PLAN_9164,2022,Tier 2,Tier 3,2021-06-11,291,Improved,None,No,No,,243,187,30.3,Increased,32.43,92.99,-60.56,163.98,196.41,47.73,0.0,0,0.057,0.243,0.245,0.717,12,7,1,2,2.8,34.5,8,Lower,West,CA,Suburban,51-65,2022-03,Q1_2022,2021,4.9,0.992,Increasing
FIA002986,2022-04-14,Warfarin,Coumadin,Anticoagulants,33246-667-23,VA Plan,PLAN_5521,2022,Non-Formulary,Tier 3,2021-06-09,309,Worsened,Non-Formulary Status,No,No,,448,478,-6.1,Decreased,678.62,65.97,612.65,97.34,775.96,347.63,0.0,0,0.158,0.093,0.329,0.782,0,9,12,6,4.6,24.0,4,Higher,Southwest,MI,Urban,18-35,2022-04,Q2_2022,2021,2.3,0.329,Increasing
FIA002414,2022-04-15,Warfarin,Coumadin,Anticoagulants,44983-418-13,VA Plan,PLAN_6530,2022,Tier 1,Tier 2,2022-03-07,39,Improved,None,No,No,,266,258,3.2,Stable,16.19,20.88,-4.69,147.97,164.16,43.67,0.0,0,0.021,0.117,0.46,0.791,15,1,14,3,4.6,21.6,3,Lower,Northeast,NY,Urban,66-75,2022-04,Q2_2022,2021,2.3,0.375,Increasing
FIA000679,2022-05-19,Warfarin,Coumadin,Anticoagulants,49612-176-36,Commercial Plan Beta,PLAN_6347,2022,Tier 2,Tier 1,2021-09-15,246,Worsened,None,No,No,,485,533,-8.9,Decreased,34.91,6.41,28.5,60.47,95.38,46.26,0.0,0,0.036,0.158,0.597,0.431,12,4,11,6,2.3,29.3,7,Similar,West,CA,Suburban,66-75,2022-05,Q2_2022,2021,2.1,0.934,Increasing
FIA000518,2022-05-25,Warfarin,Coumadin,Anticoagulants,63843-826-92,Commercial Plan Alpha,PLAN_2638,2022,Tier 1,Specialty Tier,2022-03-25,61,Improved,Quantity Limit,No,No,60.0,1302,870,49.7,Increased,8.41,219.2,-210.79,83.45,91.86,119.6,0.0,0,0.024,0.165,0.62,0.608,0,0,0,9,4.4,14.0,6,Similar,Southeast,CA,Suburban,66-75,2022-05,Q2_2022,2021,10.0,0.682,Stable
FIA001133,2022-05-27,Warfarin,Coumadin,Anticoagulants,46312-642-60,Medicaid Plan Y,PLAN_8975,2022,Tier 1,Specialty Tier,2021-12-20,158,Improved,None,No,No,,448,305,47.0,Increased,17.81,101.98,-84.17,181.24,199.05,89.17,0.0,0,0.047,0.314,0.535,0.829,12,6,12,0,3.3,11.6,5,Higher,Northeast,PA,Suburban,51-65,2022-05,Q2_2022,2021,1.9,0.007,Increasing
FIA002633,2022-05-27,Warfarin,Coumadin,Anticoagulants,69741-609-78,Medicaid Plan X,PLAN_6009,2022,Specialty Tier,Specialty Tier,2021-09-08,261,No Change,Prior Authorization; Step Therapy,Yes,Yes,,200,185,8.4,Increased,264.31,188.04,76.27,50.42,314.73,62.95,0.521,5,0.057,0.179,0.794,0.765,15,0,7,1,2.6,26.8,6,Similar,Southeast,NY,Rural,18-35,2022-05,Q2_2022,2021,2.0,0.555,Stable
FIA000316,2022-05-30,Warfarin,Coumadin,Anticoagulants,67345-795-46,Commercial Plan Beta,PLAN_4296,2022,Tier 3,Non-Formulary,2021-06-11,353,Improved,Step Therapy,No,Yes,,394,428,-7.8,Decreased,92.03,754.13,-662.1,72.92,164.95,64.99,0.0,0,0.024,0.31,0.504,0.691,6,1,18,0,3.9,25.1,3,Lower,Southeast,CA,Suburban,66-75,2022-05,Q2_2022,2021,6.1,0.864,Stable
FIA000549,2022-06-01,Warfarin,Coumadin,Anticoagulants,46163-168-89,VA Plan,PLAN_7420,2022,Tier 3,Specialty Tier,2021-06-25,341,Improved,Step Therapy,No,Yes,,730,696,5.0,Stable,52.04,288.98,-236.94,156.12,208.16,151.96,0.0,0,0.069,0.107,0.597,0.841,6,1,13,15,2.0,6.7,5,Higher,Midwest,OH,Suburban,66-75,2022-06,Q2_2022,2021,9.6,0.877,Increasing
FIA002489,2022-06-09,Warfarin,Coumadin,Anticoagulants,88189-659-66,Medicare Part D Plan B,PLAN_7734,2022,Non-Formulary,Non-Formulary,2022-01-28,132,No Change,Non-Formulary Status,No,No,,359,357,0.7,Stable,516.05,441.71,74.34,75.9,591.95,212.51,0.0,0,0.189,0.237,0.736,0.437,7,1,5,15,3.9,19.1,2,Similar,Southeast,NC,Urban,51-65,2022-06,Q2_2022,2021,6.5,0.001,Increasing
FIA000097,2022-06-17,Warfarin,Coumadin,Anticoagulants,58418-291-67,Medicare Part D Plan A,PLAN_5313,2022,Tier 1,Tier 3,2021-10-27,233,Improved,None,No,No,,441,371,19.1,Increased,12.06,94.74,-82.68,180.53,192.59,84.93,0.0,0,0.023,0.204,0.384,0.86,1,2,3,2,4.0,29.2,5,Higher,Southeast,NC,Urban,66-75,2022-06,Q2_2022,2021,8.4,0.419,Decreasing
FIA002390,2022-06-20,Warfarin,Coumadin,Anticoagulants,74495-843-29,Tricare Standard,PLAN_9330,2022,Tier 1,Tier 2,2021-09-11,282,Improved,None,No,No,,253,276,-8.0,Decreased,11.95,34.55,-22.6,183.16,195.11,49.36,0.0,0,0.049,0.383,0.737,0.587,1,10,6,2,4.2,33.0,4,Similar,West,NY,Suburban,66-75,2022-06,Q2_2022,2021,2.4,0.227,Stable
FIA002797,2022-06-28,Warfarin,Coumadin,Anticoagulants,66891-340-58,Medicare Part D Plan A,PLAN_6845,2022,Specialty Tier,Tier 3,2021-10-22,249,Worsened,None,No,No,,652,650,0.3,Stable,165.73,91.18,74.55,188.26,353.99,230.8,0.0,0,0.147,0.107,0.429,0.82,10,1,14,1,3.1,13.6,4,Lower,Southwest,OH,Urban,66-75,2022-06,Q2_2022,2021,4.1,0.246,Decreasing
FIA000969,2022-07-02,Warfarin,Coumadin,Anticoagulants,35164-305-87,Medicare Part D Plan A,PLAN_9028,2022,Tier 3,Non-Formulary,2022-04-26,67,Improved,Prior Authorization,Yes,No,,1025,933,9.9,Increased,79.24,332.04,-252.8,175.34,254.58,260.94,0.19,7,0.065,0.09,0.806,0.418,2,1,7,3,3.0,20.8,2,Similar,Midwest,FL,Rural,36-50,2022-07,Q3_2022,2021,4.7,0.251,Decreasing
FIA000028,2022-07-25,Warfarin,Coumadin,Anticoagulants,99364-911-33,Commercial Plan Alpha,PLAN_3868,2022,Tier 2,Tier 3,2022-06-11,44,Improved,None,No,No,,524,400,31.1,Increased,21.38,89.81,-68.43,100.05,121.43,63.63,0.0,0,0.027,0.078,0.81,0.741,7,7,18,4,2.7,24.1,5,Similar,Northeast,GA,Suburban,75+,2022-07,Q3_2022,2021,2.4,0.442,Stable
FIA000870,2022-07-27,Warfarin,Coumadin,Anticoagulants,86997-670-88,Commercial Plan Beta,PLAN_7078,2022,Tier 2,Tier 3,2021-11-03,266,Improved,None,No,No,,1004,834,20.5,Increased,38.23,55.92,-17.69,148.57,186.8,187.55,0.0,0,0.012,0.313,0.475,0.62,14,0,3,9,4.0,23.9,4,Similar,Southwest,CA,Urban,75+,2022-07,Q3_2022,2021,7.5,0.251,Increasing
FIA002196,2022-07-27,Warfarin,Coumadin,Anticoagulants,59697-332-87,VA Plan,PLAN_6557,2022,Specialty Tier,Tier 1,2021-12-17,222,Worsened,None,No,No,,582,917,-36.5,Decreased,224.33,5.78,218.55,137.74,362.07,210.72,0.0,0,0.081,0.372,0.825,0.752,6,6,8,13,2.6,16.4,7,Higher,Northeast,IL,Suburban,51-65,2022-07,Q3_2022,2021,2.6,0.589,Decreasing
FIA001958,2022-08-02,Warfarin,Coumadin,Anticoagulants,17348-218-96,Commercial Plan Alpha,PLAN_6401,2022,Specialty Tier,Tier 2,2022-03-28,127,Worsened,Step Therapy,No,Yes,,230,550,-58.1,Decreased,289.04,37.1,251.94,172.9,461.94,106.25,0.0,0,0.106,0.094,0.791,0.94,9,7,0,8,3.6,27.2,4,Lower,Southeast,NY,Urban,36-50,2022-08,Q3_2022,2021,8.0,0.97,Decreasing
FIA001105,2022-08-15,Warfarin,Coumadin,Anticoagulants,97471-454-38,VA Plan,PLAN_1072,2022,Specialty Tier,Tier 2,2022-05-22,85,Worsened,None,No,No,,518,945,-45.1,Decreased,250.63,22.71,227.92,119.11,369.74,191.53,0.0,0,0.054,0.197,0.305,0.506,13,3,11,13,3.4,24.2,4,Similar,Southwest,IL,Suburban,75+,2022-08,Q3_2022,2021,7.6,0.166,Decreasing
FIA000555,2022-09-07,Warfarin,Coumadin,Anticoagulants,30502-314-56,Medicaid Plan X,PLAN_3887,2022,Non-Formulary,Tier 3,2022-05-15,115,Worsened,Non-Formulary Status,No,No,,498,477,4.6,Stable,285.25,56.01,229.24,77.74,362.99,180.77,0.0,0,0.283,0.202,0.834,0.839,8,4,20,15,2.1,19.9,7,Lower,Northeast,NC,Suburban,51-65,2022-09,Q3_2022,2021,8.9,0.82,Increasing
FIA002536,2022-09-12,Warfarin,Coumadin,Anticoagulants,74843-566-69,Medicaid Plan X,PLAN_3480,2022,Tier 2,Tier 2,2022-06-10,94,No Change,None,No,No,,200,183,9.4,Increased,44.39,31.04,13.35,169.88,214.27,42.85,0.0,0,0.044,0.183,0.606,0.731,9,3,12,5,2.1,19.3,8,Lower,Northeast,TX,Suburban,36-50,2022-09,Q3_2022,2021,3.2,0.743,Decreasing
FIA000540,2022-09-22,Warfarin,Coumadin,Anticoagulants,16310-109-60,Medicaid Plan X,PLAN_4542,2022,Non-Formulary,Non-Formulary,2022-07-29,55,No Change,Non-Formulary Status; Quantity Limit,No,No,60.0,728,704,3.5,Stable,758.45,624.98,133.47,170.97,929.42,676.62,0.0,0,0.217,0.321,0.209,0.78,3,0,8,11,2.4,5.9,3,Similar,Northeast,NC,Rural,51-65,2022-09,Q3_2022,2021,1.6,0.543,Decreasing
FIA000111,2022-09-25,Warfarin,Coumadin,Anticoagulants,97797-994-53,Medicare Part D Plan B,PLAN_8091,2022,Specialty Tier,Tier 1,2022-01-28,240,Worsened,Prior Authorization,Yes,No,,495,770,-35.7,Decreased,188.14,5.95,182.19,196.24,384.38,190.27,0.388,4,0.191,0.219,0.665,0.753,4,8,19,1,2.0,33.0,6,Similar,Southwest,FL,Urban,66-75,2022-09,Q3_2022,2021,3.9,0.331,Stable
FIA001342,2022-10-01,Warfarin,Coumadin,Anticoagulants,66218-338-57,Commercial Plan Alpha,PLAN_2396,2022,Tier 1,Specialty Tier,2021-12-11,294,Improved,Quantity Limit,No,No,60.0,312,197,58.4,Increased,6.59,212.93,-206.34,199.87,206.46,64.42,0.0,0,0.071,0.103,0.493,0.511,14,1,2,0,3.4,5.2,5,Higher,Southwest,NC,Rural,66-75,2022-10,Q4_2022,2022,3.5,0.992,Stable
FIA000124,2022-10-02,Warfarin,Coumadin,Anticoagulants,84233-679-94,Commercial Plan Alpha,PLAN_8921,2022,Non-Formulary,Non-Formulary,2022-07-18,76,No Change,Non-Formulary Status,No,No,,737,778,-5.2,Decreased,438.07,501.3,-63.23,57.07,495.14,364.92,0.0,0,0.085,0.379,0.228,0.819,7,1,8,11,2.7,25.1,6,Similar,Southwest,GA,Suburban,18-35,2022-10,Q4_2022,2022,1.4,0.649,Increasing
FIA000620,2022-10-21,Warfarin,Coumadin,Anticoagulants,18997-459-21,Commercial Plan Alpha,PLAN_1481,2022,Tier 1,Tier 1,2022-08-07,75,No Change,None,No,No,,262,279,-6.0,Decreased,15.85,16.18,-0.33,136.61,152.46,39.94,0.0,0,0.079,0.279,0.385,0.693,11,0,15,13,3.3,14.8,8,Higher,Midwest,PA,Suburban,18-35,2022-10,Q4_2022,2022,9.7,0.305,Increasing
FIA000649,2022-10-22,Warfarin,Coumadin,Anticoagulants,78907-830-55,Medicare Part D Plan A,PLAN_1241,2022,Specialty Tier,Tier 1,2022-04-11,194,Worsened,Prior Authorization; Quantity Limit,Yes,No,60.0,341,801,-57.4,Decreased,179.99,11.0,168.99,67.13,247.12,84.27,0.535,4,0.148,0.212,0.34,0.633,14,6,4,7,4.0,11.2,8,Lower,Southwest,TX,Urban,75+,2022-10,Q4_2022,2022,3.3,0.713,Stable
FIA000621,2022-10-23,Warfarin,Coumadin,Anticoagulants,36864-849-49,Tricare Standard,PLAN_3439,2022,Specialty Tier,Tier 2,2021-11-03,354,Worsened,None,No,No,,93,125,-25.4,Decreased,159.97,44.76,115.21,165.75,325.72,30.29,0.0,0,0.23,0.141,0.445,0.929,2,7,13,5,2.5,14.5,2,Higher,Southeast,GA,Rural,36-50,2022-10,Q4_2022,2022,4.5,0.987,Decreasing
FIA002154,2022-11-17,Warfarin,Coumadin,Anticoagulants,74202-225-70,VA Plan,PLAN_3999,2022,Tier 1,Non-Formulary,2022-06-02,168,Improved,None,No,No,,329,274,20.3,Increased,7.94,254.54,-246.6,158.33,166.27,54.7,0.0,0,0.053,0.171,0.657,0.621,2,5,13,7,3.3,21.3,5,Similar,Southwest,IL,Rural,18-35,2022-11,Q4_2022,2022,3.6,0.324,Decreasing
FIA000657,2022-11-24,Warfarin,Coumadin,Anticoagulants,10796-646-64,Medicaid Plan X,PLAN_5299,2022,Tier 1,Non-Formulary,2022-08-08,108,Improved,Quantity Limit,No,No,30.0,1101,887,24.2,Increased,11.28,393.71,-382.43,107.78,119.06,131.09,0.0,0,0.042,0.192,0.404,0.417,7,1,7,10,2.9,34.7,6,Higher,Northeast,TX,Suburban,51-65,2022-11,Q4_2022,2022,8.0,0.61,Stable
FIA002575,2022-12-10,Warfarin,Coumadin,Anticoagulants,92374-686-31,Medicaid Plan Y,PLAN_5368,2022,Specialty Tier,Tier 3,2022-02-14,299,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,496,505,-1.7,Stable,271.77,74.23,197.54,82.07,353.84,175.5,0.304,5,0.13,0.252,0.717,0.438,13,4,5,9,4.3,12.2,5,Lower,West,PA,Rural,75+,2022-12,Q4_2022,2022,8.3,0.419,Increasing
FIA002008,2022-12-18,Warfarin,Coumadin,Anticoagulants,45963-129-27,Commercial Plan Beta,PLAN_1530,2022,Tier 2,Tier 3,2022-07-10,161,Improved,Quantity Limit,No,No,,1377,992,38.8,Increased,29.93,88.84,-58.91,168.42,198.35,273.13,0.0,0,0.061,0.098,0.817,0.81,9,3,19,14,2.3,27.4,4,Lower,Northeast,CA,Urban,36-50,2022-12,Q4_2022,2022,6.1,0.116,Decreasing
FIA001875,2023-01-07,Warfarin,Coumadin,Anticoagulants,48172-397-60,Medicare Part D Plan A,PLAN_7606,2023,Tier 2,Tier 3,2022-09-13,116,Improved,None,No,No,,1163,769,51.4,Increased,35.71,93.46,-57.75,155.51,191.22,222.39,0.0,0,0.048,0.399,0.569,0.582,7,2,2,2,4.0,29.4,3,Lower,Northeast,PA,Suburban,36-50,2023-01,Q1_2023,2022,1.9,0.605,Increasing
FIA001004,2023-01-09,Warfarin,Coumadin,Anticoagulants,25896-674-65,Medicare Part D Plan A,PLAN_2925,2023,Tier 1,Non-Formulary,2022-09-20,111,Improved,None,No,No,,1362,950,43.4,Increased,11.16,656.05,-644.89,193.11,204.27,278.22,0.0,0,0.062,0.059,0.624,0.917,7,6,0,2,3.8,30.3,2,Higher,Northeast,GA,Urban,18-35,2023-01,Q1_2023,2022,8.9,0.995,Stable
FIA000454,2023-01-20,Warfarin,Coumadin,Anticoagulants,87433-521-84,Medicaid Plan X,PLAN_5413,2023,Non-Formulary,Tier 2,2022-11-21,60,Worsened,Non-Formulary Status,No,No,,349,497,-29.6,Decreased,457.83,38.4,419.43,98.77,556.6,194.25,0.0,0,0.136,0.137,0.799,0.469,13,4,20,15,2.0,8.4,6,Lower,Midwest,FL,Rural,36-50,2023-01,Q1_2023,2022,8.3,0.58,Decreasing
FIA001175,2023-01-25,Warfarin,Coumadin,Anticoagulants,96159-683-73,Medicaid Plan Y,PLAN_6488,2023,Specialty Tier,Tier 2,2022-12-02,54,Worsened,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,,165,324,-49.1,Decreased,217.6,34.07,183.53,126.77,344.37,56.82,0.523,1,0.153,0.29,0.405,0.948,1,7,4,12,2.5,23.3,7,Higher,Northeast,TX,Urban,66-75,2023-01,Q1_2023,2022,6.5,0.711,Decreasing
FIA000481,2023-02-20,Warfarin,Coumadin,Anticoagulants,81393-181-69,Medicare Part D Plan A,PLAN_4357,2023,Tier 2,Tier 1,2022-11-15,97,Worsened,None,No,No,,903,832,8.6,Increased,48.63,9.71,38.92,48.48,97.11,87.69,0.0,0,0.077,0.347,0.829,0.49,3,1,19,5,2.0,8.4,8,Similar,Southeast,NC,Rural,51-65,2023-02,Q1_2023,2022,2.2,0.496,Decreasing
FIA000142,2023-03-03,Warfarin,Coumadin,Anticoagulants,38545-215-40,VA Plan,PLAN_6316,2023,Specialty Tier,Tier 3,2022-08-20,195,Worsened,None,No,No,,937,862,8.7,Increased,131.72,86.41,45.31,176.82,308.54,289.1,0.0,0,0.272,0.055,0.756,0.722,12,3,0,1,3.7,25.7,7,Higher,Southeast,IL,Urban,36-50,2023-03,Q1_2023,2022,2.4,0.091,Decreasing
FIA001434,2023-03-07,Warfarin,Coumadin,Anticoagulants,46535-964-24,Commercial Plan Alpha,PLAN_7850,2023,Specialty Tier,Tier 3,2023-01-14,52,Worsened,Prior Authorization,Yes,No,,834,921,-9.4,Decreased,153.95,89.78,64.17,99.66,253.61,211.51,0.405,2,0.187,0.189,0.721,0.579,9,2,14,7,2.6,22.6,5,Lower,Southeast,TX,Suburban,66-75,2023-03,Q1_2023,2022,1.7,0.386,Decreasing
FIA000223,2023-03-16,Warfarin,Coumadin,Anticoagulants,67682-805-72,VA Plan,PLAN_3668,2023,Tier 1,Tier 3,2022-05-21,299,Improved,None,No,No,,1190,897,32.8,Increased,11.04,77.95,-66.91,101.98,113.02,134.49,0.0,0,0.045,0.101,0.289,0.791,4,8,16,3,4.1,18.7,2,Higher,Southeast,NC,Suburban,18-35,2023-03,Q1_2023,2022,6.4,0.409,Increasing
FIA001895,2023-03-26,Warfarin,Coumadin,Anticoagulants,80846-646-62,Medicare Part D Plan B,PLAN_4548,2023,Tier 2,Non-Formulary,2022-04-28,332,Improved,None,No,No,,152,120,27.2,Increased,33.55,598.33,-564.78,87.16,120.71,18.35,0.0,0,0.068,0.188,0.336,0.534,1,6,7,4,4.7,18.7,4,Similar,Midwest,NC,Suburban,18-35,2023-03,Q1_2023,2022,8.6,0.283,Increasing
FIA000627,2023-04-10,Warfarin,Coumadin,Anticoagulants,36581-793-86,VA Plan,PLAN_5117,2023,Tier 1,Specialty Tier,2023-01-16,84,Improved,None,No,No,,748,624,20.0,Increased,11.4,210.5,-199.1,56.29,67.69,50.63,0.0,0,0.078,0.218,0.742,0.695,15,5,7,1,3.3,17.6,8,Lower,Northeast,FL,Suburban,75+,2023-04,Q2_2023,2022,1.1,0.723,Decreasing
FIA002744,2023-04-19,Warfarin,Coumadin,Anticoagulants,46336-810-76,VA Plan,PLAN_5572,2023,Non-Formulary,Non-Formulary,2022-10-13,188,No Change,Non-Formulary Status,No,No,,1013,956,6.0,Increased,701.15,553.06,148.09,194.05,895.2,906.84,0.0,0,0.201,0.282,0.504,0.713,6,5,5,7,3.6,19.5,2,Lower,Northeast,FL,Urban,66-75,2023-04,Q2_2023,2022,8.9,0.118,Increasing
FIA002642,2023-05-04,Warfarin,Coumadin,Anticoagulants,23665-539-16,Commercial Plan Alpha,PLAN_3523,2023,Tier 2,Non-Formulary,2022-12-03,152,Improved,None,No,No,,1017,872,16.7,Increased,21.82,543.9,-522.08,184.49,206.31,209.82,0.0,0,0.049,0.101,0.746,0.766,2,7,17,5,4.1,18.2,2,Lower,Midwest,CA,Rural,18-35,2023-05,Q2_2023,2022,7.3,0.556,Increasing
FIA000542,2023-05-10,Warfarin,Coumadin,Anticoagulants,39494-121-10,VA Plan,PLAN_9040,2023,Non-Formulary,Tier 3,2023-02-05,94,Worsened,Non-Formulary Status,No,No,,730,778,-6.1,Decreased,629.99,97.82,532.17,197.71,827.7,604.22,0.0,0,0.225,0.21,0.731,0.866,10,5,0,6,2.5,15.4,2,Lower,Southwest,NY,Suburban,51-65,2023-05,Q2_2023,2022,3.3,0.899,Increasing
FIA000456,2023-05-13,Warfarin,Coumadin,Anticoagulants,33207-536-11,Tricare Standard,PLAN_9676,2023,Specialty Tier,Tier 3,2022-09-02,253,Worsened,Prior Authorization,Yes,No,,534,574,-6.8,Decreased,109.79,50.15,59.64,78.19,187.98,100.38,0.155,2,0.122,0.255,0.443,0.754,14,3,8,15,4.9,13.1,5,Lower,Southwest,FL,Urban,36-50,2023-05,Q2_2023,2022,6.8,0.385,Decreasing
FIA001212,2023-05-25,Warfarin,Coumadin,Anticoagulants,24628-534-80,Commercial Plan Alpha,PLAN_3302,2023,Tier 1,Non-Formulary,2022-10-27,210,Improved,None,No,No,,783,631,24.2,Increased,13.43,463.76,-450.33,191.48,204.91,160.44,0.0,0,0.019,0.182,0.238,0.404,6,7,2,11,2.3,12.0,5,Higher,Midwest,PA,Rural,75+,2023-05,Q2_2023,2022,5.9,0.787,Increasing
FIA002016,2023-05-25,Warfarin,Coumadin,Anticoagulants,94947-978-87,Commercial Plan Alpha,PLAN_9071,2023,Tier 1,Tier 1,2022-12-08,168,No Change,None,No,No,,956,956,0.0,Stable,8.99,15.16,-6.17,92.39,101.38,96.92,0.0,0,0.059,0.244,0.269,0.801,11,9,16,7,2.6,34.5,7,Higher,Northeast,MI,Suburban,75+,2023-05,Q2_2023,2022,2.9,0.501,Stable
FIA002956,2023-05-31,Warfarin,Coumadin,Anticoagulants,45872-901-20,Medicaid Plan Y,PLAN_5011,2023,Tier 3,Tier 2,2022-10-03,240,Worsened,Prior Authorization,Yes,No,,438,968,-54.7,Decreased,79.13,47.05,32.08,87.28,166.41,72.89,0.424,1,0.038,0.16,0.66,0.637,15,7,5,11,2.7,27.4,7,Lower,West,TX,Rural,51-65,2023-05,Q2_2023,2022,4.9,0.61,Decreasing
FIA000108,2023-06-02,Warfarin,Coumadin,Anticoagulants,23751-623-89,Medicare Part D Plan B,PLAN_5631,2023,Tier 2,Tier 2,2022-06-15,352,No Change,None,No,No,,209,203,3.2,Stable,20.28,32.63,-12.35,101.2,121.48,25.39,0.0,0,0.059,0.09,0.274,0.509,6,4,16,6,3.1,17.3,3,Lower,West,GA,Urban,66-75,2023-06,Q2_2023,2022,4.0,0.003,Decreasing
FIA000714,2023-07-02,Warfarin,Coumadin,Anticoagulants,62995-969-84,Medicaid Plan Y,PLAN_3609,2023,Specialty Tier,Tier 2,2022-11-25,219,Worsened,Prior Authorization,Yes,No,,479,623,-23.0,Decreased,257.51,46.17,211.34,67.26,324.77,155.56,0.336,5,0.298,0.357,0.744,0.922,12,6,10,7,3.0,21.8,7,Higher,Southwest,FL,Rural,75+,2023-07,Q3_2023,2022,6.0,0.339,Increasing
FIA002812,2023-07-03,Warfarin,Coumadin,Anticoagulants,20661-594-37,Medicare Part D Plan B,PLAN_1043,2023,Tier 1,Tier 2,2022-11-09,236,Improved,None,No,No,,958,933,2.8,Stable,14.81,32.64,-17.83,41.43,56.24,53.88,0.0,0,0.02,0.161,0.677,0.814,10,6,5,15,4.8,27.2,2,Lower,Southeast,PA,Urban,75+,2023-07,Q3_2023,2022,7.1,0.637,Increasing
FIA001612,2023-07-04,Warfarin,Coumadin,Anticoagulants,87180-757-96,VA Plan,PLAN_4691,2023,Non-Formulary,Tier 2,2022-07-20,349,Worsened,Non-Formulary Status,No,No,,222,408,-45.4,Decreased,329.15,48.64,280.51,51.83,380.98,84.58,0.0,0,0.121,0.08,0.424,0.785,11,10,16,1,3.9,20.1,4,Similar,Midwest,GA,Suburban,18-35,2023-07,Q3_2023,2022,9.5,0.212,Decreasing
FIA001900,2023-07-06,Warfarin,Coumadin,Anticoagulants,60900-650-49,Medicare Part D Plan A,PLAN_7700,2023,Tier 1,Tier 2,2023-03-12,116,Improved,None,No,No,,176,186,-5.3,Decreased,14.61,49.91,-35.3,32.87,47.48,8.36,0.0,0,0.071,0.147,0.899,0.715,7,8,11,10,3.1,18.2,6,Lower,Southeast,CA,Urban,75+,2023-07,Q3_2023,2022,2.2,0.128,Stable
FIA001339,2023-07-10,Warfarin,Coumadin,Anticoagulants,87210-868-45,Tricare Standard,PLAN_2361,2023,Specialty Tier,Tier 3,2022-09-07,306,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,468,473,-1.0,Stable,225.96,72.73,153.23,84.43,310.39,145.26,0.414,1,0.268,0.336,0.733,0.794,6,7,16,9,3.6,30.6,4,Lower,Southeast,CA,Rural,18-35,2023-07,Q3_2023,2022,3.6,0.839,Increasing
FIA001782,2023-07-20,Warfarin,Coumadin,Anticoagulants,51540-171-33,Medicare Part D Plan A,PLAN_6509,2023,Tier 1,Specialty Tier,2022-12-25,207,Improved,None,No,No,,1141,744,53.5,Increased,18.74,223.13,-204.39,155.66,174.4,198.99,0.0,0,0.065,0.142,0.448,0.471,0,7,16,13,4.6,14.0,8,Similar,Northeast,TX,Suburban,75+,2023-07,Q3_2023,2022,4.4,0.139,Increasing
FIA001346,2023-08-06,Warfarin,Coumadin,Anticoagulants,12698-732-62,Medicaid Plan X,PLAN_9188,2023,Tier 2,Tier 3,2023-02-24,163,Improved,Quantity Limit,No,No,60.0,602,496,21.5,Increased,22.82,71.22,-48.4,79.34,102.16,61.5,0.0,0,0.044,0.096,0.648,0.477,7,4,16,15,2.1,26.6,7,Lower,West,IL,Urban,66-75,2023-08,Q3_2023,2022,7.0,0.56,Decreasing
FIA001377,2023-08-07,Warfarin,Coumadin,Anticoagulants,28271-569-94,Medicare Part D Plan A,PLAN_3829,2023,Tier 3,Tier 2,2022-08-25,347,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,528,857,-38.3,Decreased,54.9,36.43,18.47,53.18,108.08,57.07,0.419,6,0.037,0.337,0.674,0.603,8,10,3,3,4.2,6.9,8,Similar,Midwest,OH,Urban,51-65,2023-08,Q3_2023,2022,9.8,0.143,Decreasing
FIA002326,2023-08-27,Warfarin,Coumadin,Anticoagulants,70059-904-60,Commercial Plan Alpha,PLAN_3777,2023,Tier 3,Tier 2,2023-05-28,91,Worsened,Prior Authorization,Yes,No,,388,856,-54.6,Decreased,63.82,30.09,33.73,80.03,143.85,55.81,0.491,10,0.049,0.199,0.449,0.709,9,7,20,0,3.4,9.7,5,Similar,West,MI,Rural,75+,2023-08,Q3_2023,2022,4.3,0.056,Increasing
FIA001601,2023-09-01,Warfarin,Coumadin,Anticoagulants,79719-679-85,Tricare Standard,PLAN_3907,2023,Non-Formulary,Tier 2,2023-07-06,57,Worsened,Non-Formulary Status,No,No,,566,964,-41.3,Decreased,689.83,24.41,665.42,115.35,805.18,455.73,0.0,0,0.296,0.395,0.388,0.565,7,1,4,8,4.4,25.6,2,Higher,Southeast,GA,Suburban,75+,2023-09,Q3_2023,2022,3.2,0.567,Increasing
FIA002467,2023-09-13,Warfarin,Coumadin,Anticoagulants,30266-839-49,Medicare Part D Plan A,PLAN_4315,2023,Tier 1,Specialty Tier,2023-04-27,139,Improved,None,No,No,,510,426,19.8,Increased,18.28,151.68,-133.4,46.47,64.75,33.02,0.0,0,0.037,0.199,0.874,0.468,5,7,20,5,3.4,22.9,2,Similar,Southwest,CA,Urban,51-65,2023-09,Q3_2023,2022,1.1,0.689,Increasing
FIA001307,2023-09-18,Warfarin,Coumadin,Anticoagulants,12468-114-79,Medicaid Plan X,PLAN_4663,2023,Tier 2,Tier 1,2022-09-20,363,Worsened,None,No,No,,623,646,-3.5,Stable,22.93,10.95,11.98,138.3,161.23,100.45,0.0,0,0.026,0.242,0.232,0.564,11,7,16,3,3.2,32.1,2,Higher,West,CA,Rural,51-65,2023-09,Q3_2023,2022,9.1,0.508,Decreasing
FIA001800,2023-09-21,Warfarin,Coumadin,Anticoagulants,59026-694-33,Medicaid Plan Y,PLAN_8834,2023,Tier 2,Tier 2,2023-04-09,165,No Change,None,No,No,,886,807,9.8,Increased,24.65,21.79,2.86,91.85,116.5,103.22,0.0,0,0.026,0.059,0.709,0.834,15,10,18,5,3.8,26.0,7,Similar,West,MI,Rural,18-35,2023-09,Q3_2023,2022,9.1,0.889,Increasing
FIA000053,2023-09-24,Warfarin,Coumadin,Anticoagulants,95755-788-70,Medicaid Plan X,PLAN_9793,2023,Tier 1,Tier 1,2023-02-05,231,No Change,None,No,No,,325,320,1.7,Stable,12.58,19.5,-6.92,180.0,192.58,62.59,0.0,0,0.045,0.053,0.275,0.474,8,5,12,11,2.1,6.5,6,Lower,Midwest,NC,Suburban,18-35,2023-09,Q3_2023,2022,4.5,0.45,Decreasing
FIA002102,2023-09-30,Warfarin,Coumadin,Anticoagulants,29547-592-53,Commercial Plan Beta,PLAN_9979,2023,Tier 2,Specialty Tier,2022-12-26,278,Improved,None,No,No,,221,139,59.2,Increased,25.4,160.75,-135.35,104.76,130.16,28.77,0.0,0,0.074,0.196,0.585,0.779,1,7,6,9,3.9,8.8,6,Lower,West,MI,Rural,36-50,2023-09,Q3_2023,2022,2.0,0.921,Decreasing
FIA000445,2023-10-25,Warfarin,Coumadin,Anticoagulants,42846-525-21,Tricare Standard,PLAN_6481,2023,Tier 2,Tier 3,2023-02-21,246,Improved,None,No,No,,1220,869,40.5,Increased,39.75,97.9,-58.15,163.15,202.9,247.54,0.0,0,0.011,0.102,0.819,0.532,15,4,6,5,3.3,28.1,7,Similar,Midwest,MI,Suburban,51-65,2023-10,Q4_2023,2023,1.0,0.483,Decreasing
FIA002980,2023-11-17,Warfarin,Coumadin,Anticoagulants,16771-264-19,Commercial Plan Beta,PLAN_3819,2023,Tier 3,Tier 2,2023-01-27,294,Worsened,Prior Authorization,Yes,No,,366,722,-49.2,Decreased,52.2,39.23,12.97,52.15,104.35,38.19,0.454,7,0.054,0.146,0.205,0.799,12,6,4,4,3.3,24.4,3,Higher,Northeast,NC,Urban,51-65,2023-11,Q4_2023,2023,9.5,0.354,Stable
FIA000307,2023-11-19,Warfarin,Coumadin,Anticoagulants,88085-595-24,Medicaid Plan X,PLAN_9508,2023,Specialty Tier,Tier 3,2023-01-14,309,Worsened,None,No,No,,469,473,-0.8,Stable,151.47,74.32,77.15,177.07,328.54,154.09,0.0,0,0.216,0.305,0.215,0.938,7,10,4,11,3.5,12.3,7,Higher,Southwest,IL,Urban,18-35,2023-11,Q4_2023,2023,2.7,0.955,Decreasing
FIA002306,2023-11-22,Warfarin,Coumadin,Anticoagulants,19438-526-33,Medicaid Plan Y,PLAN_3984,2023,Tier 2,Tier 3,2023-01-11,315,Improved,None,No,No,,491,322,52.8,Increased,42.26,63.62,-21.36,189.24,231.5,113.67,0.0,0,0.041,0.128,0.859,0.822,2,9,14,6,4.1,10.8,7,Higher,Midwest,MI,Suburban,51-65,2023-11,Q4_2023,2023,2.3,0.015,Stable
FIA002833,2023-11-26,Warfarin,Coumadin,Anticoagulants,94939-217-31,Commercial Plan Alpha,PLAN_3821,2023,Non-Formulary,Tier 1,2023-02-05,294,Worsened,Non-Formulary Status,No,No,,604,866,-30.2,Decreased,604.43,9.95,594.48,159.14,763.57,461.2,0.0,0,0.241,0.305,0.456,0.74,10,10,13,8,3.2,5.4,4,Similar,Northeast,PA,Urban,18-35,2023-11,Q4_2023,2023,8.3,0.838,Decreasing
FIA002006,2023-12-06,Warfarin,Coumadin,Anticoagulants,80889-331-37,VA Plan,PLAN_9625,2023,Tier 1,Non-Formulary,2023-10-02,65,Improved,None,No,No,,1506,948,58.9,Increased,9.97,616.9,-606.93,107.42,117.39,176.79,0.0,0,0.061,0.115,0.245,0.781,9,6,8,11,4.9,18.4,3,Lower,Northeast,CA,Urban,66-75,2023-12,Q4_2023,2023,8.8,0.955,Decreasing
FIA002239,2023-12-06,Warfarin,Coumadin,Anticoagulants,47846-411-23,Medicaid Plan Y,PLAN_1610,2023,Tier 1,Specialty Tier,2023-10-05,62,Improved,None,No,No,,703,519,35.6,Increased,14.04,242.96,-228.92,141.63,155.67,109.44,0.0,0,0.011,0.205,0.78,0.443,6,10,11,2,2.8,12.4,4,Similar,Southwest,IL,Rural,51-65,2023-12,Q4_2023,2023,5.8,0.725,Decreasing
FIA000075,2023-12-15,Warfarin,Coumadin,Anticoagulants,31542-858-41,Commercial Plan Alpha,PLAN_3623,2023,Tier 1,Specialty Tier,2023-03-29,261,Improved,None,No,No,,1365,929,47.0,Increased,9.78,160.05,-150.27,48.59,58.37,79.68,0.0,0,0.034,0.166,0.498,0.654,12,10,5,5,3.9,18.0,2,Higher,West,NY,Suburban,75+,2023-12,Q4_2023,2023,4.9,0.004,Increasing
FIA002790,2023-12-16,Warfarin,Coumadin,Anticoagulants,97959-329-87,Commercial Plan Alpha,PLAN_2167,2023,Specialty Tier,Tier 2,2023-11-13,33,Worsened,Prior Authorization,Yes,No,,548,734,-25.2,Decreased,204.61,33.89,170.72,96.68,301.29,165.11,0.316,7,0.144,0.08,0.844,0.909,10,8,16,5,2.8,25.9,5,Higher,West,TX,Rural,18-35,2023-12,Q4_2023,2023,5.8,0.055,Increasing
FIA001404,2023-12-20,Warfarin,Coumadin,Anticoagulants,74066-316-58,Tricare Standard,PLAN_2405,2023,Non-Formulary,Specialty Tier,2023-08-13,129,Worsened,Non-Formulary Status,No,No,,181,187,-3.2,Stable,488.26,288.57,199.69,56.67,544.93,98.63,0.0,0,0.271,0.132,0.569,0.672,2,4,0,6,4.7,22.1,8,Lower,Southwest,OH,Suburban,18-35,2023-12,Q4_2023,2023,4.8,0.311,Decreasing
FIA000846,2023-12-27,Warfarin,Coumadin,Anticoagulants,57968-367-86,Commercial Plan Alpha,PLAN_1541,2023,Tier 2,Specialty Tier,2023-04-29,242,Improved,None,No,No,,680,515,32.2,Increased,23.82,275.8,-251.98,53.53,77.35,52.6,0.0,0,0.059,0.127,0.747,0.527,2,4,20,1,4.7,25.4,3,Similar,Southeast,TX,Rural,18-35,2023-12,Q4_2023,2023,7.8,0.184,Increasing
FIA002292,2024-01-08,Warfarin,Coumadin,Anticoagulants,79004-995-45,Commercial Plan Beta,PLAN_7699,2024,Specialty Tier,Tier 2,2023-10-08,92,Worsened,Prior Authorization,Yes,No,,544,912,-40.3,Decreased,290.71,29.86,260.85,49.8,340.51,185.24,0.397,9,0.105,0.108,0.763,0.683,6,3,13,2,3.8,18.2,5,Higher,Southeast,CA,Urban,36-50,2024-01,Q1_2024,2023,1.3,0.368,Stable
FIA001172,2024-01-12,Warfarin,Coumadin,Anticoagulants,18456-545-41,Medicaid Plan Y,PLAN_3966,2024,Tier 1,Tier 2,2023-10-17,87,Improved,Quantity Limit,No,No,60.0,391,359,9.2,Increased,17.0,38.36,-21.36,188.56,205.56,80.37,0.0,0,0.061,0.218,0.534,0.666,7,7,20,5,2.2,11.7,4,Higher,Southwest,GA,Suburban,66-75,2024-01,Q1_2024,2023,9.1,0.073,Decreasing
FIA000204,2024-01-14,Warfarin,Coumadin,Anticoagulants,57560-931-97,Medicare Part D Plan B,PLAN_9763,2024,Tier 3,Tier 3,2023-12-05,40,No Change,Prior Authorization; Step Therapy,Yes,Yes,,144,135,6.8,Increased,82.27,95.26,-12.99,192.94,275.21,39.63,0.376,4,0.032,0.35,0.472,0.9,12,4,9,2,4.8,27.7,4,Lower,Southeast,GA,Rural,51-65,2024-01,Q1_2024,2023,8.9,0.767,Stable
FIA001476,2024-01-14,Warfarin,Coumadin,Anticoagulants,13262-356-40,Medicare Part D Plan B,PLAN_8793,2024,Tier 3,Non-Formulary,2023-11-11,64,Improved,None,No,No,,253,263,-3.7,Stable,89.91,643.55,-553.64,68.99,158.9,40.2,0.0,0,0.049,0.375,0.406,0.442,3,3,13,15,3.0,20.8,6,Lower,Southwest,GA,Suburban,36-50,2024-01,Q1_2024,2023,7.7,0.996,Decreasing
FIA002596,2024-01-18,Warfarin,Coumadin,Anticoagulants,83073-914-19,Commercial Plan Alpha,PLAN_9916,2024,Non-Formulary,Non-Formulary,2023-04-14,279,No Change,Non-Formulary Status,No,No,,768,760,1.1,Stable,444.17,583.91,-139.74,142.52,586.69,450.58,0.0,0,0.266,0.073,0.554,0.874,15,10,12,4,4.7,33.9,5,Similar,West,NC,Suburban,75+,2024-01,Q1_2024,2023,1.2,0.171,Stable
FIA000506,2024-01-21,Warfarin,Coumadin,Anticoagulants,23325-352-16,Tricare Standard,PLAN_4755,2024,Tier 1,Tier 2,2023-02-22,333,Improved,None,No,No,,468,450,4.1,Stable,5.46,41.59,-36.13,99.46,104.92,49.1,0.0,0,0.046,0.166,0.878,0.847,9,5,16,8,3.5,11.0,5,Lower,Northeast,NY,Urban,18-35,2024-01,Q1_2024,2023,6.1,0.182,Decreasing
FIA001317,2024-02-04,Warfarin,Coumadin,Anticoagulants,61680-160-53,Medicaid Plan Y,PLAN_8845,2024,Tier 3,Tier 3,2023-07-26,193,No Change,Prior Authorization,Yes,No,,325,317,2.7,Stable,73.74,76.07,-2.33,163.32,237.06,77.04,0.435,4,0.063,0.233,0.638,0.926,9,1,1,12,2.0,5.9,5,Similar,Northeast,OH,Rural,18-35,2024-02,Q1_2024,2023,6.9,0.194,Increasing
FIA001789,2024-02-05,Warfarin,Coumadin,Anticoagulants,65592-834-67,Tricare Standard,PLAN_3146,2024,Non-Formulary,Tier 3,2023-07-13,207,Worsened,Non-Formulary Status,No,No,,889,839,6.0,Increased,768.39,90.61,677.78,88.2,856.59,761.51,0.0,0,0.266,0.235,0.441,0.633,6,10,0,4,5.0,23.8,8,Lower,Southwest,OH,Urban,75+,2024-02,Q1_2024,2023,9.1,0.394,Decreasing
FIA000802,2024-02-11,Warfarin,Coumadin,Anticoagulants,15380-849-17,Commercial Plan Beta,PLAN_9730,2024,Tier 3,Non-Formulary,2023-10-13,121,Improved,Step Therapy,No,Yes,,895,974,-8.1,Decreased,60.76,323.32,-262.56,151.8,212.56,190.24,0.0,0,0.048,0.073,0.381,0.612,8,2,19,5,2.9,9.7,7,Higher,Midwest,MI,Suburban,36-50,2024-02,Q1_2024,2023,9.8,0.847,Decreasing
FIA002301,2024-02-22,Warfarin,Coumadin,Anticoagulants,77199-402-32,Tricare Standard,PLAN_2941,2024,Tier 2,Tier 3,2023-11-19,95,Improved,None,No,No,,272,234,16.6,Increased,49.14,90.53,-41.39,168.96,218.1,59.32,0.0,0,0.041,0.317,0.852,0.435,14,5,12,9,3.7,17.6,5,Higher,Northeast,PA,Urban,66-75,2024-02,Q1_2024,2023,3.5,0.532,Increasing
FIA001094,2024-03-24,Warfarin,Coumadin,Anticoagulants,84756-831-20,Commercial Plan Alpha,PLAN_5634,2024,Tier 3,Non-Formulary,2023-05-11,318,Improved,None,No,No,,887,939,-5.5,Decreased,80.83,285.33,-204.5,45.24,126.07,111.82,0.0,0,0.028,0.1,0.595,0.576,10,3,17,10,2.2,34.8,7,Higher,Southwest,OH,Rural,36-50,2024-03,Q1_2024,2023,4.0,0.615,Stable
FIA001579,2024-03-28,Warfarin,Coumadin,Anticoagulants,99969-909-68,Medicare Part D Plan B,PLAN_9933,2024,Specialty Tier,Specialty Tier,2024-02-02,55,No Change,None,No,No,,685,674,1.7,Stable,128.57,119.02,9.55,117.14,245.71,168.31,0.0,0,0.268,0.077,0.631,0.864,7,4,15,14,4.2,15.4,2,Lower,Midwest,GA,Urban,18-35,2024-03,Q1_2024,2023,9.9,0.555,Increasing
FIA002644,2024-03-29,Warfarin,Coumadin,Anticoagulants,55419-913-62,Medicare Part D Plan A,PLAN_6595,2024,Tier 1,Specialty Tier,2023-07-25,248,Improved,Quantity Limit,No,No,30.0,728,629,15.8,Increased,7.43,293.74,-286.31,145.87,153.3,111.6,0.0,0,0.077,0.349,0.416,0.749,0,8,20,9,3.5,27.9,8,Higher,Northeast,CA,Urban,36-50,2024-03,Q1_2024,2023,5.0,0.737,Decreasing
FIA001257,2024-04-03,Warfarin,Coumadin,Anticoagulants,15724-543-95,Medicare Part D Plan A,PLAN_2620,2024,Tier 2,Non-Formulary,2023-12-04,121,Improved,Quantity Limit,No,No,60.0,701,574,22.3,Increased,37.18,232.9,-195.72,134.7,171.88,120.49,0.0,0,0.039,0.396,0.382,0.525,5,7,7,13,4.0,20.8,3,Higher,Southeast,NY,Rural,75+,2024-04,Q2_2024,2023,5.7,0.138,Stable
FIA001648,2024-04-03,Warfarin,Coumadin,Anticoagulants,55503-902-81,Medicare Part D Plan B,PLAN_2678,2024,Tier 3,Tier 2,2023-10-25,161,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,654,963,-32.0,Decreased,82.21,25.45,56.76,186.58,268.79,175.79,0.397,3,0.011,0.147,0.73,0.838,14,8,7,13,2.7,6.3,8,Higher,Southwest,NC,Urban,18-35,2024-04,Q2_2024,2023,6.1,0.992,Stable
FIA001408,2024-04-06,Warfarin,Coumadin,Anticoagulants,79842-773-26,Medicaid Plan Y,PLAN_4214,2024,Tier 3,Non-Formulary,2024-02-01,65,Improved,None,No,No,,698,719,-2.8,Stable,64.61,553.26,-488.65,91.26,155.87,108.8,0.0,0,0.044,0.115,0.247,0.546,6,5,9,11,3.2,32.4,3,Similar,Southwest,MI,Rural,75+,2024-04,Q2_2024,2023,7.2,0.983,Increasing
FIA001847,2024-04-08,Warfarin,Coumadin,Anticoagulants,86574-882-45,Medicare Part D Plan A,PLAN_4481,2024,Tier 3,Specialty Tier,2023-10-18,173,Improved,Prior Authorization; Step Therapy,Yes,Yes,,475,486,-2.1,Stable,68.93,184.42,-115.49,47.54,116.47,55.32,0.21,3,0.059,0.156,0.299,0.461,8,5,6,4,4.6,13.5,4,Higher,Southeast,TX,Suburban,66-75,2024-04,Q2_2024,2023,1.9,0.016,Decreasing
FIA002249,2024-04-08,Warfarin,Coumadin,Anticoagulants,64332-177-54,Medicaid Plan X,PLAN_1601,2024,Tier 2,Tier 1,2024-01-15,84,Worsened,None,No,No,,481,493,-2.3,Stable,42.97,6.87,36.1,52.58,95.55,45.96,0.0,0,0.016,0.382,0.559,0.898,11,6,19,2,2.0,22.7,3,Similar,West,TX,Urban,18-35,2024-04,Q2_2024,2023,3.2,0.312,Stable
FIA000362,2024-04-11,Warfarin,Coumadin,Anticoagulants,32167-991-77,Tricare Standard,PLAN_3873,2024,Non-Formulary,Tier 2,2023-09-18,206,Worsened,Non-Formulary Status,No,No,,394,613,-35.7,Decreased,586.31,37.61,548.7,112.49,698.8,275.33,0.0,0,0.266,0.219,0.466,0.768,2,5,7,9,2.6,9.5,6,Higher,Northeast,NY,Suburban,66-75,2024-04,Q2_2024,2023,5.1,0.913,Increasing
FIA001378,2024-04-15,Warfarin,Coumadin,Anticoagulants,32351-961-46,Medicaid Plan Y,PLAN_4253,2024,Specialty Tier,Non-Formulary,2024-03-03,43,Improved,Prior Authorization,Yes,No,,902,947,-4.7,Stable,257.19,760.16,-502.97,169.65,426.84,385.01,0.118,3,0.1,0.058,0.424,0.868,7,2,13,2,2.9,11.6,8,Lower,Southeast,GA,Urban,51-65,2024-04,Q2_2024,2023,2.3,0.842,Stable
FIA001662,2024-04-17,Warfarin,Coumadin,Anticoagulants,97258-949-86,Medicaid Plan Y,PLAN_1298,2024,Tier 3,Tier 1,2024-03-09,39,Worsened,None,No,No,,435,779,-44.0,Decreased,83.31,13.98,69.33,61.5,144.81,62.99,0.0,0,0.056,0.306,0.299,0.52,10,3,1,3,2.5,11.7,7,Lower,Southwest,PA,Suburban,66-75,2024-04,Q2_2024,2023,6.2,0.465,Stable
FIA000913,2024-05-01,Warfarin,Coumadin,Anticoagulants,61245-961-53,VA Plan,PLAN_1166,2024,Non-Formulary,Non-Formulary,2024-02-26,65,No Change,Non-Formulary Status,No,No,,794,752,5.7,Increased,415.81,550.27,-134.46,69.58,485.39,385.4,0.0,0,0.211,0.154,0.876,0.683,8,10,13,15,4.2,11.2,7,Lower,West,TX,Rural,36-50,2024-05,Q2_2024,2023,3.6,0.602,Stable
FIA001201,2024-05-02,Warfarin,Coumadin,Anticoagulants,63722-511-86,Medicaid Plan Y,PLAN_6083,2024,Tier 2,Tier 1,2023-12-20,134,Worsened,None,No,No,,626,581,7.9,Increased,33.31,18.85,14.46,30.09,63.4,39.69,0.0,0,0.072,0.367,0.422,0.429,11,7,0,6,2.8,31.8,7,Lower,Southwest,OH,Urban,66-75,2024-05,Q2_2024,2023,1.3,0.104,Decreasing
FIA001053,2024-05-09,Warfarin,Coumadin,Anticoagulants,87214-957-39,Medicare Part D Plan B,PLAN_2617,2024,Specialty Tier,Tier 1,2023-10-06,216,Worsened,None,No,No,,92,213,-56.7,Decreased,266.01,15.0,251.01,101.01,367.02,33.77,0.0,0,0.124,0.191,0.773,0.571,14,10,12,15,4.8,29.6,5,Similar,Midwest,GA,Rural,66-75,2024-05,Q2_2024,2023,4.5,0.861,Stable
FIA002897,2024-05-13,Warfarin,Coumadin,Anticoagulants,28769-163-61,Medicare Part D Plan A,PLAN_6124,2024,Tier 1,Tier 3,2024-03-02,72,Improved,Quantity Limit,No,No,90.0,297,191,55.7,Increased,9.8,50.5,-40.7,146.72,156.52,46.49,0.0,0,0.067,0.259,0.356,0.85,3,2,2,9,3.5,27.1,4,Lower,Midwest,IL,Suburban,75+,2024-05,Q2_2024,2023,8.9,0.402,Stable
FIA001386,2024-05-22,Warfarin,Coumadin,Anticoagulants,75970-724-38,Medicaid Plan Y,PLAN_2363,2024,Specialty Tier,Specialty Tier,2023-06-11,346,No Change,None,No,No,,561,566,-0.8,Stable,203.33,232.64,-29.31,193.31,396.64,222.52,0.0,0,0.084,0.301,0.803,0.52,3,5,14,5,2.2,10.4,3,Similar,Southwest,TX,Rural,66-75,2024-05,Q2_2024,2023,6.8,0.016,Stable
FIA001448,2024-05-22,Warfarin,Coumadin,Anticoagulants,92943-563-50,VA Plan,PLAN_5224,2024,Tier 2,Tier 1,2023-12-05,169,Worsened,None,No,No,,682,727,-6.1,Decreased,22.67,11.45,11.22,123.83,146.5,99.91,0.0,0,0.072,0.222,0.381,0.889,3,9,4,11,3.0,31.3,5,Similar,Midwest,CA,Suburban,66-75,2024-05,Q2_2024,2023,8.5,0.434,Stable
FIA001382,2024-05-31,Warfarin,Coumadin,Anticoagulants,70008-585-16,Commercial Plan Alpha,PLAN_2065,2024,Tier 3,Tier 1,2023-12-17,166,Worsened,None,No,No,,150,453,-66.9,Decreased,55.8,12.84,42.96,52.37,108.17,16.23,0.0,0,0.029,0.17,0.361,0.614,3,5,3,3,2.2,26.3,3,Higher,Southwest,TX,Suburban,36-50,2024-05,Q2_2024,2023,7.8,0.616,Stable
FIA002445,2024-06-03,Warfarin,Coumadin,Anticoagulants,90879-890-36,Medicare Part D Plan B,PLAN_6679,2024,Tier 3,Non-Formulary,2024-04-14,50,Improved,None,No,No,,557,589,-5.4,Decreased,81.71,308.53,-226.82,188.84,270.55,150.7,0.0,0,0.064,0.361,0.81,0.796,12,5,15,9,3.9,15.1,5,Higher,Midwest,NC,Suburban,36-50,2024-06,Q2_2024,2023,6.9,0.365,Stable
FIA001932,2024-06-23,Warfarin,Coumadin,Anticoagulants,70899-623-60,Medicare Part D Plan B,PLAN_2530,2024,Tier 1,Specialty Tier,2024-02-11,133,Improved,None,No,No,,419,303,38.6,Increased,6.74,163.18,-156.44,140.62,147.36,61.74,0.0,0,0.038,0.231,0.602,0.711,7,10,8,8,2.1,8.9,7,Higher,Northeast,NC,Urban,51-65,2024-06,Q2_2024,2023,7.0,0.898,Decreasing
FIA000556,2024-06-29,Warfarin,Coumadin,Anticoagulants,92483-817-55,Commercial Plan Alpha,PLAN_8197,2024,Specialty Tier,Tier 2,2023-08-09,325,Worsened,Quantity Limit,No,No,,364,516,-29.4,Decreased,185.99,40.46,145.53,37.93,223.92,81.51,0.0,0,0.211,0.059,0.855,0.579,1,0,0,4,3.5,25.5,7,Lower,Northeast,PA,Urban,51-65,2024-06,Q2_2024,2023,5.2,0.847,Increasing
FIA000771,2024-07-13,Warfarin,Coumadin,Anticoagulants,43331-380-50,Medicare Part D Plan A,PLAN_1169,2024,Tier 1,Specialty Tier,2023-07-20,359,Improved,None,No,No,,1225,858,42.8,Increased,9.38,270.09,-260.71,63.4,72.78,89.16,0.0,0,0.036,0.333,0.324,0.472,12,8,7,15,3.7,6.0,3,Higher,Midwest,IL,Urban,36-50,2024-07,Q3_2024,2023,6.4,0.503,Stable
FIA002758,2024-07-13,Warfarin,Coumadin,Anticoagulants,68072-514-77,Medicaid Plan X,PLAN_7614,2024,Tier 2,Specialty Tier,2024-04-28,76,Improved,None,No,No,,533,374,42.6,Increased,29.85,266.78,-236.93,78.24,108.09,57.61,0.0,0,0.018,0.129,0.748,0.699,9,8,13,6,4.1,7.2,6,Similar,Midwest,IL,Rural,18-35,2024-07,Q3_2024,2023,7.2,0.366,Increasing
FIA000183,2024-07-20,Warfarin,Coumadin,Anticoagulants,53634-643-14,Medicaid Plan X,PLAN_7977,2024,Tier 2,Specialty Tier,2024-03-18,124,Improved,None,No,No,,843,575,46.7,Increased,43.7,174.08,-130.38,95.43,139.13,117.29,0.0,0,0.054,0.314,0.689,0.737,6,10,2,10,4.2,6.6,7,Similar,Northeast,TX,Suburban,51-65,2024-07,Q3_2024,2023,5.2,0.041,Stable
FIA000359,2024-08-02,Warfarin,Coumadin,Anticoagulants,30875-350-69,Medicare Part D Plan B,PLAN_1112,2024,Tier 2,Non-Formulary,2023-11-19,257,Improved,None,No,No,,786,572,37.5,Increased,49.69,678.05,-628.36,86.31,136.0,106.9,0.0,0,0.052,0.312,0.677,0.623,15,6,2,13,4.9,31.5,6,Lower,West,NC,Rural,18-35,2024-08,Q3_2024,2023,4.9,0.828,Increasing
FIA000906,2024-08-02,Warfarin,Coumadin,Anticoagulants,86184-808-37,VA Plan,PLAN_1053,2024,Tier 3,Tier 3,2024-02-12,172,No Change,Quantity Limit,No,No,60.0,591,562,5.2,Increased,66.47,62.9,3.57,53.15,119.62,70.7,0.0,0,0.075,0.387,0.504,0.782,10,10,2,6,2.8,31.9,6,Higher,Northeast,TX,Urban,51-65,2024-08,Q3_2024,2023,8.6,0.528,Stable
FIA000246,2024-08-08,Warfarin,Coumadin,Anticoagulants,80078-859-60,Commercial Plan Alpha,PLAN_2271,2024,Specialty Tier,Tier 1,2024-05-28,72,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,399,548,-27.0,Decreased,209.69,8.63,201.06,80.0,289.69,115.59,0.109,1,0.075,0.287,0.307,0.597,6,0,17,6,3.3,6.4,7,Higher,Northeast,OH,Rural,51-65,2024-08,Q3_2024,2023,5.0,0.598,Increasing
FIA002666,2024-08-11,Warfarin,Coumadin,Anticoagulants,28658-188-69,Commercial Plan Beta,PLAN_2888,2024,Tier 1,Specialty Tier,2024-02-11,182,Improved,None,No,No,,1079,744,45.0,Increased,16.23,144.81,-128.58,154.88,171.11,184.63,0.0,0,0.043,0.149,0.456,0.594,9,10,20,5,2.0,13.4,5,Similar,Southeast,NC,Rural,51-65,2024-08,Q3_2024,2023,6.2,0.37,Decreasing
FIA000735,2024-08-17,Warfarin,Coumadin,Anticoagulants,90601-402-55,Commercial Plan Beta,PLAN_2710,2024,Non-Formulary,Tier 1,2024-02-24,175,Worsened,Non-Formulary Status,No,No,,558,851,-34.4,Decreased,398.9,9.34,389.56,155.82,554.72,309.53,0.0,0,0.053,0.372,0.669,0.936,13,6,13,10,2.2,10.3,5,Higher,Southwest,TX,Urban,18-35,2024-08,Q3_2024,2023,8.1,0.16,Increasing
FIA002245,2024-08-23,Warfarin,Coumadin,Anticoagulants,67990-202-74,Commercial Plan Beta,PLAN_5275,2024,Tier 1,Tier 3,2024-05-12,103,Improved,None,No,No,,547,425,28.8,Increased,6.22,99.57,-93.35,44.59,50.81,27.79,0.0,0,0.065,0.362,0.783,0.746,4,2,19,3,2.2,31.7,8,Lower,Southwest,GA,Rural,51-65,2024-08,Q3_2024,2023,9.0,0.507,Stable
FIA001328,2024-09-10,Warfarin,Coumadin,Anticoagulants,82274-374-42,Medicaid Plan Y,PLAN_8335,2024,Non-Formulary,Tier 2,2024-04-10,153,Worsened,Non-Formulary Status,No,No,,180,546,-66.9,Decreased,335.72,44.87,290.85,33.39,369.11,66.44,0.0,0,0.276,0.188,0.465,0.628,5,9,11,1,4.2,13.4,2,Lower,Northeast,NC,Suburban,18-35,2024-09,Q3_2024,2023,6.7,0.938,Stable
FIA002569,2024-09-21,Warfarin,Coumadin,Anticoagulants,36285-462-37,Medicaid Plan Y,PLAN_4856,2024,Tier 2,Non-Formulary,2023-11-23,303,Improved,None,No,No,,443,330,34.4,Increased,49.14,473.73,-424.59,30.31,79.45,35.2,0.0,0,0.064,0.381,0.63,0.738,4,5,16,1,2.2,32.5,8,Higher,Southwest,NY,Urban,75+,2024-09,Q3_2024,2023,1.4,0.751,Decreasing
FIA002714,2024-09-23,Warfarin,Coumadin,Anticoagulants,16680-873-33,Medicare Part D Plan A,PLAN_9076,2024,Tier 1,Tier 3,2024-07-31,54,Improved,None,No,No,,751,641,17.3,Increased,10.84,62.11,-51.27,131.44,142.28,106.85,0.0,0,0.079,0.119,0.579,0.895,1,4,1,9,3.5,14.1,2,Similar,Northeast,FL,Urban,66-75,2024-09,Q3_2024,2023,4.3,0.54,Increasing
FIA001533,2024-09-25,Warfarin,Coumadin,Anticoagulants,21085-874-51,Commercial Plan Beta,PLAN_4882,2024,Non-Formulary,Non-Formulary,2023-10-06,355,No Change,Non-Formulary Status,No,No,,245,264,-7.2,Decreased,466.78,285.45,181.33,154.18,620.96,152.14,0.0,0,0.277,0.382,0.207,0.673,4,7,11,1,4.6,19.3,5,Higher,Southwest,OH,Rural,75+,2024-09,Q3_2024,2023,3.2,0.538,Increasing
FIA001509,2024-09-27,Warfarin,Coumadin,Anticoagulants,32940-475-38,Commercial Plan Beta,PLAN_8103,2024,Tier 3,Tier 1,2023-10-02,361,Worsened,Prior Authorization,Yes,No,,357,941,-62.0,Decreased,94.43,18.48,75.95,64.11,158.54,56.6,0.205,4,0.038,0.064,0.52,0.594,12,6,1,14,5.0,10.6,8,Similar,Northeast,GA,Rural,66-75,2024-09,Q3_2024,2023,4.8,0.045,Stable
FIA000175,2024-10-01,Warfarin,Coumadin,Anticoagulants,17234-747-92,Medicare Part D Plan B,PLAN_6985,2024,Specialty Tier,Specialty Tier,2024-07-28,65,No Change,Quantity Limit,No,No,60.0,856,805,6.4,Increased,208.03,100.66,107.37,81.48,289.51,247.82,0.0,0,0.133,0.078,0.522,0.822,6,2,17,1,4.9,24.8,4,Higher,Southwest,TX,Rural,51-65,2024-10,Q4_2024,2024,5.4,0.885,Stable
FIA001223,2024-10-27,Warfarin,Coumadin,Anticoagulants,43376-974-83,Tricare Standard,PLAN_4371,2024,Non-Formulary,Tier 1,2023-11-03,359,Worsened,Non-Formulary Status,No,No,,354,589,-39.9,Decreased,774.54,16.28,758.26,101.07,875.61,309.97,0.0,0,0.251,0.208,0.232,0.537,4,5,3,3,4.6,18.6,5,Lower,West,MI,Suburban,51-65,2024-10,Q4_2024,2024,5.0,0.807,Stable
FIA002279,2024-11-04,Warfarin,Coumadin,Anticoagulants,30312-321-85,Tricare Standard,PLAN_5589,2024,Tier 1,Tier 1,2024-07-24,103,No Change,None,No,No,,894,868,3.0,Stable,6.02,8.27,-2.25,58.93,64.95,58.07,0.0,0,0.05,0.393,0.674,0.559,3,2,4,14,3.3,25.6,2,Similar,West,OH,Suburban,18-35,2024-11,Q4_2024,2024,9.5,0.929,Stable
FIA002630,2024-11-06,Warfarin,Coumadin,Anticoagulants,25068-360-83,Medicare Part D Plan B,PLAN_8069,2024,Non-Formulary,Non-Formulary,2024-02-03,277,No Change,Non-Formulary Status,No,No,,889,956,-7.0,Decreased,503.03,553.51,-50.48,161.1,664.13,590.41,0.0,0,0.159,0.255,0.59,0.784,0,1,11,10,2.3,34.0,7,Lower,West,PA,Rural,36-50,2024-11,Q4_2024,2024,4.2,0.185,Stable
FIA001465,2024-11-13,Warfarin,Coumadin,Anticoagulants,51044-328-90,Commercial Plan Beta,PLAN_6431,2024,Tier 3,Non-Formulary,2024-02-16,271,Improved,Step Therapy,No,Yes,,184,199,-7.4,Decreased,81.5,389.07,-307.57,197.42,278.92,51.32,0.0,0,0.027,0.225,0.663,0.714,2,6,18,11,2.7,15.4,8,Higher,West,IL,Urban,36-50,2024-11,Q4_2024,2024,6.0,0.473,Decreasing
FIA002083,2024-11-22,Warfarin,Coumadin,Anticoagulants,72154-727-33,Commercial Plan Beta,PLAN_3335,2024,Tier 1,Tier 2,2024-01-13,314,Improved,None,No,No,,198,199,-0.3,Stable,6.29,46.91,-40.62,184.54,190.83,37.78,0.0,0,0.052,0.234,0.342,0.89,7,6,4,6,2.1,14.9,5,Similar,Southeast,CA,Rural,66-75,2024-11,Q4_2024,2024,2.5,0.915,Decreasing
FIA000865,2024-12-11,Warfarin,Coumadin,Anticoagulants,92585-514-48,Medicare Part D Plan B,PLAN_1070,2024,Tier 1,Non-Formulary,2024-07-17,147,Improved,Quantity Limit,No,No,90.0,443,334,32.7,Increased,8.7,263.93,-255.23,45.12,53.82,23.84,0.0,0,0.053,0.056,0.317,0.817,14,5,7,2,4.1,21.7,4,Similar,Southwest,NY,Urban,18-35,2024-12,Q4_2024,2024,1.7,0.996,Decreasing
FIA001255,2024-12-16,Warfarin,Coumadin,Anticoagulants,36251-831-19,Medicaid Plan X,PLAN_3737,2024,Tier 1,Tier 3,2024-10-06,71,Improved,None,No,No,,833,598,39.3,Increased,10.0,97.73,-87.73,154.78,164.78,137.26,0.0,0,0.026,0.391,0.284,0.663,10,6,4,8,3.4,23.1,7,Similar,Southeast,NY,Urban,66-75,2024-12,Q4_2024,2024,9.8,0.159,Increasing
FIA001990,2024-12-18,Warfarin,Coumadin,Anticoagulants,97593-311-75,Medicare Part D Plan B,PLAN_4050,2024,Tier 1,Tier 1,2024-11-15,33,No Change,Quantity Limit,No,No,30.0,413,454,-8.9,Decreased,13.51,10.12,3.39,97.74,111.25,45.95,0.0,0,0.054,0.361,0.782,0.92,6,10,6,13,2.1,16.8,2,Lower,Southwest,OH,Urban,36-50,2024-12,Q4_2024,2024,6.7,0.039,Stable
FIA001737,2024-12-28,Warfarin,Coumadin,Anticoagulants,92364-190-17,Medicare Part D Plan B,PLAN_6056,2024,Tier 2,Non-Formulary,2024-04-29,243,Improved,None,No,No,,500,408,22.7,Increased,23.76,721.26,-697.5,150.6,174.36,87.18,0.0,0,0.036,0.072,0.706,0.69,4,5,18,5,2.6,16.6,2,Lower,Southwest,OH,Rural,36-50,2024-12,Q4_2024,2024,8.6,0.325,Increasing
FIA001117,2024-12-29,Warfarin,Coumadin,Anticoagulants,68683-822-11,Commercial Plan Alpha,PLAN_7305,2024,Tier 3,Tier 3,2023-12-31,364,No Change,Step Therapy,No,Yes,,584,622,-6.1,Decreased,59.72,76.4,-16.68,178.34,238.06,139.03,0.0,0,0.054,0.313,0.37,0.492,0,7,3,11,4.8,21.8,6,Similar,Northeast,NY,Urban,18-35,2024-12,Q4_2024,2024,1.7,0.47,Stable
FIA000914,2024-12-30,Warfarin,Coumadin,Anticoagulants,65279-381-14,Tricare Standard,PLAN_7759,2024,Specialty Tier,Tier 1,2024-11-25,35,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,180,265,-32.0,Decreased,231.85,11.35,220.5,193.01,424.86,76.47,0.396,1,0.26,0.273,0.616,0.513,2,2,1,7,4.6,12.3,6,Lower,Northeast,NY,Rural,75+,2024-12,Q4_2024,2024,5.5,0.867,Stable
FIA000323,2024-12-31,Warfarin,Coumadin,Anticoagulants,42759-889-79,Medicaid Plan X,PLAN_6530,2024,Specialty Tier,Non-Formulary,2024-02-15,320,Improved,None,No,No,,486,490,-0.7,Stable,253.8,356.06,-102.26,44.54,298.34,144.99,0.0,0,0.288,0.25,0.227,0.551,8,10,8,0,2.4,22.1,4,Similar,Southeast,GA,Suburban,18-35,2024-12,Q4_2024,2024,5.0,0.466,Stable
FIA002356,2025-01-10,Warfarin,Coumadin,Anticoagulants,22280-188-55,Commercial Plan Beta,PLAN_5727,2025,Non-Formulary,Tier 1,2024-06-30,194,Worsened,Non-Formulary Status,No,No,,77,225,-65.5,Decreased,740.12,9.51,730.61,94.72,834.84,64.28,0.0,0,0.237,0.057,0.647,0.901,4,4,4,13,4.9,34.4,8,Higher,Southwest,MI,Suburban,75+,2025-01,Q1_2025,2024,9.5,0.446,Decreasing
FIA001500,2025-01-21,Warfarin,Coumadin,Anticoagulants,27970-223-57,Medicare Part D Plan B,PLAN_1630,2025,Specialty Tier,Tier 3,2024-12-03,49,Worsened,Prior Authorization,Yes,No,,330,306,8.0,Increased,215.37,53.21,162.16,158.04,373.41,123.23,0.32,10,0.236,0.245,0.265,0.417,8,4,7,0,2.1,18.8,3,Lower,Northeast,OH,Suburban,66-75,2025-01,Q1_2025,2024,6.1,0.146,Decreasing
FIA001230,2025-02-07,Warfarin,Coumadin,Anticoagulants,40210-676-17,Medicaid Plan Y,PLAN_7304,2025,Non-Formulary,Tier 1,2024-08-27,164,Worsened,Non-Formulary Status,No,No,,343,457,-24.8,Decreased,460.79,10.36,450.43,167.65,628.44,215.55,0.0,0,0.086,0.394,0.676,0.755,8,2,6,9,4.5,21.7,3,Higher,Southwest,IL,Rural,51-65,2025-02,Q1_2025,2024,9.0,0.53,Stable
FIA002952,2025-02-12,Warfarin,Coumadin,Anticoagulants,94145-471-70,Medicare Part D Plan A,PLAN_3199,2025,Specialty Tier,Specialty Tier,2024-11-24,80,No Change,None,No,No,,335,331,1.5,Stable,134.87,138.74,-3.87,33.96,168.83,56.56,0.0,0,0.294,0.362,0.79,0.422,1,2,19,1,3.4,31.7,3,Higher,Northeast,OH,Urban,51-65,2025-02,Q1_2025,2024,8.1,0.583,Increasing
FIA002144,2025-02-22,Warfarin,Coumadin,Anticoagulants,34563-648-46,Medicare Part D Plan A,PLAN_9795,2025,Non-Formulary,Tier 3,2024-11-02,112,Worsened,Non-Formulary Status,No,No,,873,827,5.6,Increased,780.34,68.4,711.94,73.45,853.79,745.36,0.0,0,0.282,0.294,0.573,0.827,11,6,7,0,2.5,21.4,4,Lower,Northeast,FL,Urban,18-35,2025-02,Q1_2025,2024,8.4,0.642,Stable
FIA000132,2025-02-27,Warfarin,Coumadin,Anticoagulants,38885-793-99,Commercial Plan Beta,PLAN_6172,2025,Tier 2,Tier 3,2024-06-08,264,Improved,None,No,No,,1141,982,16.2,Increased,40.45,94.83,-54.38,137.72,178.17,203.29,0.0,0,0.015,0.194,0.447,0.695,8,3,9,2,3.2,27.5,4,Lower,West,FL,Suburban,51-65,2025-02,Q1_2025,2024,4.2,0.894,Stable
FIA001861,2025-03-05,Warfarin,Coumadin,Anticoagulants,88678-259-88,Tricare Standard,PLAN_8906,2025,Tier 2,Tier 2,2024-08-02,215,No Change,None,No,No,,747,681,9.8,Increased,37.86,43.7,-5.84,174.34,212.2,158.51,0.0,0,0.035,0.325,0.327,0.747,9,5,17,10,4.7,30.3,3,Lower,Northeast,IL,Suburban,75+,2025-03,Q1_2025,2024,7.5,0.452,Increasing
FIA001933,2025-03-06,Warfarin,Coumadin,Anticoagulants,57500-743-42,Commercial Plan Alpha,PLAN_9252,2025,Tier 3,Tier 2,2024-07-28,221,Worsened,Step Therapy,No,Yes,,486,891,-45.5,Decreased,82.28,21.82,60.46,80.92,163.2,79.32,0.0,0,0.069,0.223,0.848,0.768,13,7,10,7,4.3,17.3,6,Higher,Northeast,PA,Suburban,36-50,2025-03,Q1_2025,2024,7.8,0.826,Decreasing
FIA000288,2025-03-10,Warfarin,Coumadin,Anticoagulants,58979-185-97,VA Plan,PLAN_9289,2025,Tier 1,Tier 3,2024-09-15,176,Improved,None,No,No,,961,796,20.8,Increased,11.01,92.85,-81.84,191.85,202.86,194.95,0.0,0,0.069,0.208,0.814,0.945,1,9,20,1,4.2,12.3,8,Higher,Northeast,FL,Urban,51-65,2025-03,Q1_2025,2024,4.4,0.57,Increasing
FIA002539,2025-03-13,Warfarin,Coumadin,Anticoagulants,31895-896-18,Medicare Part D Plan A,PLAN_9960,2025,Non-Formulary,Tier 3,2024-03-24,354,Worsened,Non-Formulary Status,No,No,,525,506,3.9,Stable,396.9,62.31,334.59,84.88,481.78,252.93,0.0,0,0.271,0.3,0.42,0.719,9,4,16,13,2.7,21.3,2,Higher,Southeast,FL,Rural,51-65,2025-03,Q1_2025,2024,10.0,0.035,Decreasing
FIA000260,2025-03-21,Warfarin,Coumadin,Anticoagulants,39500-817-16,Commercial Plan Alpha,PLAN_8987,2025,Tier 2,Specialty Tier,2024-09-23,179,Improved,Quantity Limit,No,No,90.0,1207,929,30.0,Increased,41.12,175.34,-134.22,154.55,195.67,236.17,0.0,0,0.025,0.155,0.771,0.902,5,0,17,12,3.0,25.3,4,Similar,Southwest,TX,Rural,51-65,2025-03,Q1_2025,2024,3.5,0.923,Decreasing
FIA001946,2025-03-28,Warfarin,Coumadin,Anticoagulants,41977-806-92,Commercial Plan Alpha,PLAN_9512,2025,Tier 3,Tier 2,2025-01-19,68,Worsened,Step Therapy,No,Yes,,203,471,-56.9,Decreased,89.18,41.58,47.6,66.48,155.66,31.6,0.0,0,0.039,0.237,0.47,0.834,14,0,1,14,2.8,8.2,8,Higher,West,OH,Rural,36-50,2025-03,Q1_2025,2024,7.9,0.687,Decreasing
FIA002466,2025-03-30,Warfarin,Coumadin,Anticoagulants,45674-565-26,Medicaid Plan Y,PLAN_2613,2025,Tier 3,Tier 2,2024-08-27,215,Worsened,Quantity Limit,No,No,30.0,93,162,-42.0,Decreased,93.38,34.53,58.85,173.57,266.95,24.83,0.0,0,0.051,0.294,0.285,0.473,13,10,11,10,2.0,22.1,5,Lower,Northeast,MI,Suburban,36-50,2025-03,Q1_2025,2024,1.0,0.628,Decreasing
FIA001104,2025-04-02,Warfarin,Coumadin,Anticoagulants,39421-159-54,Commercial Plan Alpha,PLAN_9104,2025,Non-Formulary,Tier 3,2024-06-07,299,Worsened,Non-Formulary Status,No,No,,634,619,2.5,Stable,489.04,87.68,401.36,102.23,591.27,374.87,0.0,0,0.071,0.269,0.382,0.513,5,2,11,2,3.3,9.0,2,Lower,Southeast,GA,Suburban,66-75,2025-04,Q2_2025,2024,6.3,0.718,Increasing
FIA000087,2025-04-26,Warfarin,Coumadin,Anticoagulants,53911-101-94,VA Plan,PLAN_6038,2025,Tier 2,Non-Formulary,2024-11-22,155,Improved,None,No,No,,155,124,25.5,Increased,24.52,759.44,-734.92,179.12,203.64,31.56,0.0,0,0.069,0.086,0.571,0.531,15,0,4,8,2.3,32.6,8,Higher,Southwest,IL,Suburban,18-35,2025-04,Q2_2025,2024,6.2,0.505,Decreasing
FIA000023,2025-05-01,Warfarin,Coumadin,Anticoagulants,65723-217-79,Commercial Plan Beta,PLAN_3441,2025,Tier 3,Tier 1,2024-12-04,148,Worsened,Prior Authorization; Step Therapy,Yes,Yes,,561,980,-42.7,Decreased,64.41,9.24,55.17,188.72,253.13,142.01,0.413,5,0.056,0.339,0.25,0.491,9,9,18,9,3.3,19.1,4,Higher,Southwest,PA,Rural,75+,2025-05,Q2_2025,2024,5.4,0.08,Increasing
FIA002123,2025-05-02,Warfarin,Coumadin,Anticoagulants,82437-414-56,VA Plan,PLAN_4182,2025,Tier 2,Tier 1,2024-05-20,347,Worsened,None,No,No,,540,582,-7.1,Decreased,35.62,11.15,24.47,148.6,184.22,99.48,0.0,0,0.017,0.114,0.375,0.59,0,5,7,13,2.0,14.8,6,Lower,Midwest,PA,Rural,18-35,2025-05,Q2_2025,2024,8.5,0.521,Stable
FIA002376,2025-05-08,Warfarin,Coumadin,Anticoagulants,58650-576-45,Medicare Part D Plan A,PLAN_1981,2025,Specialty Tier,Non-Formulary,2025-02-24,73,Improved,None,No,No,,414,460,-9.9,Decreased,114.96,621.55,-506.59,125.92,240.88,99.72,0.0,0,0.156,0.156,0.553,0.937,1,8,0,4,3.1,19.9,6,Lower,Southeast,PA,Rural,18-35,2025-05,Q2_2025,2024,7.6,0.602,Increasing
FIA001724,2025-05-19,Warfarin,Coumadin,Anticoagulants,12746-459-44,Medicare Part D Plan B,PLAN_2058,2025,Tier 1,Non-Formulary,2024-08-23,269,Improved,None,No,No,,564,451,25.3,Increased,15.3,628.1,-612.8,75.58,90.88,51.26,0.0,0,0.057,0.254,0.799,0.722,9,9,17,10,4.0,8.6,2,Similar,Midwest,FL,Suburban,18-35,2025-05,Q2_2025,2024,3.8,0.142,Stable
FIA000856,2025-05-21,Warfarin,Coumadin,Anticoagulants,70483-181-43,VA Plan,PLAN_8877,2025,Non-Formulary,Non-Formulary,2024-06-26,329,No Change,Non-Formulary Status; Quantity Limit,No,No,60.0,210,205,2.8,Stable,577.29,541.82,35.47,64.75,642.04,134.83,0.0,0,0.202,0.248,0.861,0.608,13,7,11,2,4.6,15.1,5,Lower,Northeast,OH,Suburban,51-65,2025-05,Q2_2025,2024,4.9,0.351,Decreasing
FIA001865,2025-05-21,Warfarin,Coumadin,Anticoagulants,32758-796-51,Commercial Plan Beta,PLAN_5716,2025,Tier 1,Specialty Tier,2024-12-06,166,Improved,None,No,No,,228,151,51.1,Increased,19.23,299.4,-280.17,42.2,61.43,14.01,0.0,0,0.056,0.389,0.274,0.579,10,10,10,5,4.5,12.8,2,Lower,Southwest,NC,Rural,36-50,2025-05,Q2_2025,2024,1.5,0.362,Increasing
FIA000931,2025-05-26,Warfarin,Coumadin,Anticoagulants,95998-445-67,VA Plan,PLAN_2227,2025,Tier 1,Tier 1,2025-03-30,57,No Change,None,No,No,,731,669,9.3,Increased,6.36,5.19,1.17,78.26,84.62,61.86,0.0,0,0.06,0.308,0.368,0.871,9,8,9,2,4.1,30.6,3,Higher,Southeast,IL,Rural,51-65,2025-05,Q2_2025,2024,8.0,0.787,Decreasing
FIA001333,2025-05-28,Warfarin,Coumadin,Anticoagulants,99396-459-20,Medicaid Plan Y,PLAN_8289,2025,Tier 3,Specialty Tier,2024-11-03,206,Improved,None,No,No,,762,808,-5.6,Decreased,86.66,188.51,-101.85,35.01,121.67,92.71,0.0,0,0.025,0.241,0.572,0.503,0,10,18,10,3.4,26.8,8,Higher,Southeast,MI,Suburban,75+,2025-05,Q2_2025,2024,2.8,0.682,Increasing
FIA000305,2025-05-29,Warfarin,Coumadin,Anticoagulants,79747-203-45,Commercial Plan Beta,PLAN_7628,2025,Non-Formulary,Specialty Tier,2025-03-05,85,Worsened,Non-Formulary Status; Quantity Limit,No,No,90.0,201,213,-5.6,Decreased,608.7,229.27,379.43,70.59,679.29,136.54,0.0,0,0.194,0.188,0.354,0.853,8,7,6,5,4.4,15.4,4,Higher,West,PA,Rural,18-35,2025-05,Q2_2025,2024,1.8,0.503,Decreasing
FIA002338,2025-06-02,Warfarin,Coumadin,Anticoagulants,83217-192-62,VA Plan,PLAN_1149,2025,Tier 1,Tier 1,2024-10-26,219,No Change,None,No,No,,734,728,0.9,Stable,11.95,8.98,2.97,32.36,44.31,32.52,0.0,0,0.063,0.303,0.582,0.703,3,1,4,3,2.9,19.5,4,Lower,West,PA,Urban,18-35,2025-06,Q2_2025,2024,8.1,0.09,Decreasing
FIA000739,2025-06-10,Warfarin,Coumadin,Anticoagulants,28099-422-10,VA Plan,PLAN_3123,2025,Specialty Tier,Tier 3,2024-08-14,300,Worsened,Prior Authorization,Yes,No,,499,536,-6.8,Decreased,188.26,64.68,123.58,99.16,287.42,143.42,0.515,10,0.055,0.197,0.468,0.911,3,2,1,13,4.3,27.5,5,Higher,Southwest,FL,Rural,36-50,2025-06,Q2_2025,2024,7.7,0.702,Decreasing
FIA002059,2025-06-12,Warfarin,Coumadin,Anticoagulants,86735-730-87,VA Plan,PLAN_8791,2025,Tier 2,Tier 2,2024-06-27,350,No Change,None,No,No,,193,200,-3.2,Stable,25.48,43.67,-18.19,197.97,223.45,43.13,0.0,0,0.076,0.358,0.364,0.433,3,6,18,14,4.3,30.2,2,Higher,West,IL,Rural,75+,2025-06,Q2_2025,2024,3.3,0.457,Stable
FIA000879,2025-06-17,Warfarin,Coumadin,Anticoagulants,66345-880-36,VA Plan,PLAN_6345,2025,Tier 1,Non-Formulary,2024-12-18,181,Improved,None,No,No,,1378,949,45.3,Increased,7.07,481.98,-474.91,113.31,120.38,165.88,0.0,0,0.06,0.073,0.637,0.802,11,5,2,0,2.1,15.9,2,Lower,West,TX,Rural,51-65,2025-06,Q2_2025,2024,7.2,0.769,Decreasing
FIA002682,2025-06-22,Warfarin,Coumadin,Anticoagulants,53533-165-31,Medicare Part D Plan A,PLAN_7118,2025,Tier 3,Tier 3,2025-01-26,147,No Change,Step Therapy,No,Yes,,795,730,9.0,Increased,51.47,72.56,-21.09,136.48,187.95,149.42,0.0,0,0.041,0.142,0.388,0.509,9,5,20,14,3.3,33.1,6,Lower,Midwest,PA,Urban,36-50,2025-06,Q2_2025,2024,8.0,0.923,Decreasing
FIA000235,2025-06-25,Warfarin,Coumadin,Anticoagulants,29321-580-49,Medicaid Plan Y,PLAN_5768,2025,Tier 2,Tier 2,2025-03-17,100,No Change,None,No,No,,426,419,1.7,Stable,43.91,21.81,22.1,161.83,205.74,87.65,0.0,0,0.072,0.179,0.206,0.723,4,0,7,1,3.3,10.9,3,Higher,Southeast,TX,Suburban,36-50,2025-06,Q2_2025,2024,7.0,0.695,Stable
FIA000306,2025-06-28,Warfarin,Coumadin,Anticoagulants,44581-178-31,Medicare Part D Plan A,PLAN_6769,2025,Tier 3,Tier 2,2025-03-03,117,Worsened,Step Therapy,No,Yes,,184,291,-36.6,Decreased,65.76,22.08,43.68,33.54,99.3,18.27,0.0,0,0.04,0.389,0.608,0.669,7,7,3,1,4.5,22.0,4,Lower,West,NC,Urban,36-50,2025-06,Q2_2025,2024,8.0,0.1,Decreasing
FIA002173,2025-07-04,Warfarin,Coumadin,Anticoagulants,80776-124-62,Commercial Plan Alpha,PLAN_1897,2025,Tier 3,Tier 2,2024-08-20,318,Worsened,None,No,No,,740,998,-25.8,Decreased,62.19,38.17,24.02,130.58,192.77,142.65,0.0,0,0.029,0.252,0.421,0.472,15,9,10,12,2.2,9.7,2,Higher,Southeast,NY,Rural,36-50,2025-07,Q3_2025,2024,8.1,0.022,Increasing
FIA001994,2025-07-14,Warfarin,Coumadin,Anticoagulants,22997-242-54,Tricare Standard,PLAN_2016,2025,Non-Formulary,Tier 3,2024-08-26,322,Worsened,Non-Formulary Status,No,No,,794,725,9.6,Increased,257.3,82.69,174.61,198.76,456.06,362.11,0.0,0,0.217,0.188,0.309,0.739,5,2,8,14,2.2,19.3,5,Similar,Midwest,MI,Suburban,51-65,2025-07,Q3_2025,2024,1.3,0.782,Increasing
FIA001703,2025-07-17,Warfarin,Coumadin,Anticoagulants,80953-596-87,Tricare Standard,PLAN_6794,2025,Tier 1,Tier 2,2024-07-27,355,Improved,Quantity Limit,No,No,30.0,213,234,-8.7,Decreased,11.44,45.43,-33.99,78.67,90.11,19.19,0.0,0,0.01,0.078,0.829,0.689,13,5,9,5,3.0,33.2,7,Similar,West,OH,Urban,36-50,2025-07,Q3_2025,2024,2.5,0.055,Decreasing
FIA000820,2025-07-22,Warfarin,Coumadin,Anticoagulants,82441-118-96,Medicaid Plan Y,PLAN_8962,2025,Tier 3,Tier 1,2024-12-03,231,Worsened,Prior Authorization,Yes,No,,273,483,-43.4,Decreased,76.7,18.13,58.57,93.39,170.09,46.43,0.172,10,0.036,0.155,0.541,0.91,3,10,13,12,2.1,28.6,6,Similar,Northeast,NY,Suburban,36-50,2025-07,Q3_2025,2024,3.1,0.742,Decreasing
FIA000748,2025-08-01,Warfarin,Coumadin,Anticoagulants,75701-399-27,Medicaid Plan Y,PLAN_3101,2025,Tier 2,Non-Formulary,2025-04-08,115,Improved,None,No,No,,785,580,35.5,Increased,48.5,676.01,-627.51,50.55,99.05,77.75,0.0,0,0.063,0.293,0.537,0.677,12,3,0,1,2.0,32.2,3,Lower,Northeast,FL,Rural,51-65,2025-08,Q3_2025,2024,2.3,0.295,Stable
FIA002248,2025-08-07,Warfarin,Coumadin,Anticoagulants,61484-619-42,Tricare Standard,PLAN_2004,2025,Tier 3,Specialty Tier,2024-11-28,252,Improved,Prior Authorization,Yes,No,,971,957,1.5,Stable,58.39,212.7,-154.31,32.3,90.69,88.06,0.444,8,0.05,0.073,0.611,0.599,10,1,3,14,2.2,13.9,7,Lower,Southeast,PA,Urban,75+,2025-08,Q3_2025,2024,8.3,0.319,Decreasing
FIA001755,2025-08-09,Warfarin,Coumadin,Anticoagulants,60765-702-68,Medicare Part D Plan B,PLAN_8130,2025,Specialty Tier,Tier 3,2024-09-12,331,Worsened,None,No,No,,370,371,-0.3,Stable,155.39,53.35,102.04,193.04,348.43,128.92,0.0,0,0.106,0.098,0.479,0.836,8,3,18,13,4.0,6.5,5,Lower,Northeast,CA,Suburban,75+,2025-08,Q3_2025,2024,5.8,0.949,Increasing
FIA001003,2025-08-11,Warfarin,Coumadin,Anticoagulants,56523-947-29,Medicaid Plan Y,PLAN_4319,2025,Tier 1,Non-Formulary,2024-09-07,338,Improved,None,No,No,,475,407,16.9,Increased,15.7,354.62,-338.92,137.01,152.71,72.54,0.0,0,0.06,0.376,0.458,0.412,15,6,11,0,3.7,16.8,8,Lower,Southwest,NC,Rural,51-65,2025-08,Q3_2025,2024,4.8,0.653,Decreasing
FIA000208,2025-08-18,Warfarin,Coumadin,Anticoagulants,43584-174-22,Medicare Part D Plan A,PLAN_1853,2025,Tier 1,Tier 1,2024-11-21,270,No Change,None,No,No,,792,809,-2.0,Stable,7.0,9.85,-2.85,155.14,162.14,128.41,0.0,0,0.06,0.167,0.364,0.9,1,0,8,12,2.9,16.8,4,Lower,West,CA,Rural,36-50,2025-08,Q3_2025,2024,3.3,0.504,Stable
FIA000774,2025-08-20,Warfarin,Coumadin,Anticoagulants,57865-992-13,Medicaid Plan Y,PLAN_2707,2025,Specialty Tier,Specialty Tier,2025-04-18,124,No Change,Prior Authorization; Step Therapy; Quantity Limit,Yes,Yes,30.0,212,232,-8.4,Decreased,109.23,104.63,4.6,75.73,184.96,39.21,0.328,4,0.158,0.211,0.57,0.445,3,9,2,8,4.4,14.1,4,Similar,Southwest,MI,Suburban,36-50,2025-08,Q3_2025,2024,6.6,0.344,Stable
FIA001746,2025-08-24,Warfarin,Coumadin,Anticoagulants,24630-470-82,Commercial Plan Alpha,PLAN_7375,2025,Tier 1,Tier 3,2025-01-25,211,Improved,None,No,No,,1074,857,25.4,Increased,18.01,59.44,-41.43,76.32,94.33,101.31,0.0,0,0.028,0.231,0.405,0.521,15,3,3,8,3.9,5.3,6,Lower,Southeast,CA,Urban,75+,2025-08,Q3_2025,2024,2.0,0.687,Increasing
FIA000221,2025-08-28,Warfarin,Coumadin,Anticoagulants,54657-875-91,Commercial Plan Alpha,PLAN_1383,2025,Tier 3,Specialty Tier,2025-04-19,131,Improved,None,No,No,,628,650,-3.3,Stable,94.05,116.86,-22.81,83.08,177.13,111.24,0.0,0,0.046,0.06,0.758,0.726,7,4,13,3,4.2,30.2,4,Higher,West,IL,Urban,18-35,2025-08,Q3_2025,2024,7.8,0.941,Stable
FIA002349,2025-08-28,Warfarin,Coumadin,Anticoagulants,77106-435-89,Medicare Part D Plan A,PLAN_5406,2025,Tier 2,Non-Formulary,2025-01-17,223,Improved,None,No,No,,1217,997,22.1,Increased,40.52,665.19,-624.67,116.21,156.73,190.74,0.0,0,0.016,0.064,0.289,0.713,9,3,9,3,2.0,9.5,3,Higher,Northeast,TX,Rural,36-50,2025-08,Q3_2025,2024,1.5,0.11,Increasing
